sentence	label
These risk differences (drug-placebo difference in the number of cases of suicidality per 1000 patients treated) are provided in Table 1.	0
In some patients additional Factor VIII was given.	0
"In extensive metabolizers (most of the population) and at doses less than or equal to 10 mg, nebivolol is preferentially beta1 selective."	0
It should be noted that clomipramine hydrochloride is not approved for use in treating bipolar depression.	0
The discontinuation rate for rash in clinical trials was 0.5%.	0
Indirect hyperbilirubinemia has occurred frequently during treatment with CRIXIVAN and has infrequently been associated with increases in serum transaminases.	0
"Following a single 20 mg oral zolpidem tartrate dose, mean Cmax and AUC were found to be two times (250 vs. 499 ng/mL) and five times (788 vs. 4,203 ng<U+2219>hr/mL) higher, respectively, in hepatically -compromised patients."	0
"In the same study, patients treated with PRINIVIL and hydrochlorothiazide for up to 24 weeks had a mean decrease in serum potassium of 0.1 mEq/L; approximately 4% of patients had increases greater than 0.5 mEq/L and approximately 12% had a decrease greater than 0.5 mEq/L."	0
Recommended Dosage for PONV (2.2) Adults: 40 mg EMEND capsules within 3 hours prior to induction of anesthesia.	0
Do not co-administer ACCURETIC with aliskiren: in patients with diabetes.	0
"Families and caregivers of patients being treated with antidepressants for major depressive disorder or other indications, both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to health care providers."	0
Isosorbide dinitrate is contraindicated in patients who are allergic to it.	0
Nisoldipine was negative when tested in a battery of genotoxicity assays including the Ames test and the CHO/HGRPT assay for mutagenicity and the in vivo mouse micronucleus test and in vitro CHO cell test for clastogenicity.	0
Thioridazine: Coadministration of single doses of Zaleplon 20 mg and thioridazine 50 mg produced additive effects on decreased alertness and impaired psychomotor performance for 2 to 4 hours after administration.	0
Loxapine is 96.6% bound to human plasma proteins.	0
The conversion of HMG-CoA to mevalonate is an early step in the biosynthetic pathway for cholesterol.	0
"Clinical evaluation and periodic laboratory determinations are necessary to monitor changes in fluid balance, electrolyte concentrations, and acid-base balance during prolonged parenteral therapy or whenever the condition of the patient warrants such evaluation."	0
CRIXIVAN may not be effective due to decreased indinavir concentrations in patients taking these agents concomitantly.	0
Tricyclic Antidepressants (TCAs): Coadministration significantly increased plasma TCA levels.	1
"Antihypertensive therapy may be initiated with the lowest dose of ZIAC, one 2.5/6.25 mg tablet once daily."	0
Patients with certain disorders involving heart failure associated with preserved left ventricular ejection fraction may not benefit from digoxin treatment and may be particularly susceptible to adverse reactions when they are treated with digoxin.	0
"Cases of myopathy, including rhabdomyolysis, have been reported with fluvastatin coadministered with colchicine, and caution should be exercised when prescribing fluvastatin with colchicine."	0
"Examples selective serotonin reuptake inhibitors (SSRI), serotonin norepinephrine reuptake inhibitors (SNRI), triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's Wort CYP2D6 Inhibitors Clinical Impact The concomitant use of VYVANSE and CYP2D6 inhibitors may increase the exposure of dextroamphetamine, the active metabolite of VYVANSE compared to the use of the drug alone and increase the risk of serotonin syndrome."	0
"Absorption Following oral administration of ALTACE, peak plasma concentrations (Cmax) of ramipril are reached within 1 hour."	0
In some patients additional factor VIII was given.	0
"No measurable effects on daytime alertness or performance occurred following temazepam treatment or during the withdrawal period, even though a transient sleep disturbance in some sleep parameters was observed following withdrawal of the higher doses."	0
Initiation of quetiapine in patients taking LEXIVA with ritonavir: Refer to the quetiapine prescribing information for initial dosing and titration of quetiapine.	0
Co-administration of SAMSCA and ketoconazole 200mg daily results in a 5-fold increase in exposure to tolvaptan.	1
MYCOBUTIN Capsules must not be administered for MAC prophylaxis to patients with active tuberculosis.	0
"If patients experience symptomatic bradycardia, reduce the dose of TOPROL-XL."	0
"After at least 10 days following the initiation of ritonavir , resume Tracleer at the recommended initial dose once daily or every other day based upon individual tolerability see Cytochrome P450 Drug Interactions ( 7.1 ) ."	0
Nephrolithiasis: Cases of nephrolithiasis have been reported with fosamprenavir.	0
"In one patient, liver injury, manifested by elevated hepatic enzymes up to 40X ULN and jaundice with bilirubin up to 12X ULN, recurred upon rechallenge, and was followed by recovery upon drug discontinuation, providing evidence that STRATTERA likely caused the liver injury."	0
"If co-administration is necessary, reduce the quetiapine dose to 1/6 of the current dose and monitor for quetiapine-associated adverse reactions."	1
Clinical studies of SURMONTIL (trimipramine maleate) were not adequate to determine whether subjects aged 65 and over respond differently from younger subjects.	0
Monitor for toxicity when coadministering lidocaine with drugs that decrease hepatic blood flow.	1
"Seven-day treatment with ketoconazole (200mg per day), a potent inhibitor of CYP3A4, did not affect the steady-state pharmacokinetics of selegiline in subjects who received EMSAM 6mg per 24 hours for 7 days and no differences in the pharmacokinetics of ketoconazole were observed."	0
This suggests that the use of fluoxetine in patients with liver disease must be approached with caution.	0
Oral doses <U+2265>10 mg of candesartan cilexetil/kg/day administered to pregnant rats during late gestation and continued through lactation were associated with reduced survival and an increased incidence of hydronephrosis in the offspring.	0
"In a study of 21 pediatric cancer patients (4 to 18 years of age) who received three intravenous doses of 0.15 mg/kg of ondansetron at 4-hour intervals, patients older than 15 years of age exhibited ondansetron pharmacokinetic parameters similar to those of adults."	0
"HMG CoA-reductase inhibitors: Lovastatin, simvastatin POTENTIAL for serious reactions such as risk of myopathy including rhabdomyolysis."	0
"Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary)."	0
"Since Ventavis inhibits platelet function , there is a potential for increased risk of bleeding , particularly in patients maintained on anticoagulants or platelet inhibitors ."	0
In patients with hypertension initiate at 25 mg once daily.	0
"Hematologic Effects: Bone marrow depression (leukopenia, anemia, and thrombocytopenia) has occurred in experimental animals receiving large doses of AHA, but has not been seen in man to date."	0
"In these patients, consideration should be given to using a different type of dialysis membrane or a different class of antihypertensive agent."	0
Approximately 70% of circulating inhibitory activity for HMG-CoA reductase is attributed to active metabolites.	0
There are reports that verapamil may result in higher concentrations of the alpha-agonists prazosin and terazosin.	1
"From the dose-ranging studies of candesartan cilexetil, there was a dose related increase in plasma candesartan concentrations."	0
"Stimulants, including Focalin XR, used to treat ADHD are associated with peripheral vasculopathy, including Raynaud's phenomenon."	0
Nucleoside reverse transcriptase inhibitor: Tenofovir disoproxil fumarate <U+2194> Saquinavir No clinically significant effect on saquinavir exposure.	0
"Therefore, monitor renal function and blood pressure periodically in patients receiving irbesartan and NSAID therapy."	0
"In heart failure patients with renal impairment, AUC0-72h was 36% and 65% higher in mild and moderate renal impairment, respectively."	0
"Total doses and frequency of administration must be determined by the patient's response, starting with low doses and increasing gradually."	0
Adverse reactions may occur upon discontinuation of ZOLOFT.	0
Monitor renal function periodically in patients receiving benazepril and NSAID therapy.	0
Do not use in patients with known hypersensitivity to phenothiazines.	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older.	0
There was no evidence of a relationship to dose.	0
Specific Populations Sex No sex-related differences in pharmacokinetics are observed in healthy elderly (age 65-80 years) or in healthy young (age 18-40 years) subjects.	0
There have been reports of spontaneous bleeding in patients with hemophilia A and B treated with protease inhibitors.	0
"In patients taking the HIV protease inhibitors saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, or fosamprenavir plus ritonavir, the dose of LIPITOR should not exceed 20 mg and should be used with caution."	1
A causal relationship to nefazodone has not been established.	0
Any of these conditions can lead to quinidine toxicity if dosage is not appropriately reduced.	0
"Administration of iloperidone with a standard high-fat meal did not significantly affect the Cmax or AUC of iloperidone, P88, or P95, but delayed Tmax by 1 hour for iloperidone, 2 hours for P88 and 6 hours for P95."	1
"If treatment with itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin or telithromycin is unavoidable, therapy with simvastatin must be suspended during the course of treatment."	0
More patients experienced clinically significant INR elevations (<U+2265> 5) usually within 1 week after starting dronedarone versus placebo in patients taking oral anticoagulants in ATHENA.	0
Thiazides have been shown to increase the urinary excretion of magnesium; this may result in hypomagnesemia.	0
Doses of 20 mg or 40 mg of paroxetine were both demonstrated to be significantly superior to placebo on the Hamilton Rating Scale for Anxiety (HAM-A) total score.	0
Vandetanib exposure is increased in patients with impaired renal function.	0
The rate of debrisoquin hydroxylation is felt to depend on the level of CYP2D6 isozyme activity.	0
HORMONAL CONTRACEPTIVES Ethinyl estradiolNorethindrone <U+2193> ethinyl estradiol<U+2193> norethindrone Concentrations of ethinyl estradiol and norethindrone were decreased when coadministered with VIRACEPT.	1
"Drugs Metabolized by Cytochrome CYP2D6: Many drugs, including most drugs effective in the treatment of MDD (paroxetine, other SSRIs, and many tricyclics), are metabolized by the cytochrome P450 isozyme CYP2D6."	0
DIFLUCAN increases the serum concentrations of theophylline.	1
"The AUC0-inf and the Cmax were 36 and 18% higher, respectively, compared with those of healthy volunteers."	0
Marplan should be given to a pregnant woman only if clearly needed.	0
Asymptomatic bradycardia (36 beats/min) with a wandering atrial pacemaker has been observed in a patient receiving concomitant timolol (a beta-adrenergic blocker) eyedrops and oral verapamil.	0
"As with other ACE inhibitors, patients on diuretics, especially those on recently instituted diuretic therapy, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with ACCUPRIL."	0
The risk of myopathy/rhabdomyolysis is increased with concomitant administration of colchicine.	0
Patients on hemodialysis should be given 25 mg or 50 mg after each dialysis; this should be done under hospital supervision as marked falls in blood pressure can occur.	0
"In vitro studies indicate that asenapine is a substrate for UGT1A4, CYP1A2 and to a lesser extent CYP3A4 and CYP2D6."	0
Letairis is only available for females through a restricted program under a REMS.	0
"In such circumstances, nitrates should still only be administered under close medical supervision with appropriate hemodynamic monitoring."	0
The potassium ion (K+) is the principal intracellular cation of most body tissues.	0
Perform a baseline ECG to determine the QT interval and measure and normalize serum potassium and magnesium levels before initiating therapy with starting sotalol injection.	0
"It is not known whether the use of verapamil during labor or delivery has immediate or delayed adverse effects on the fetus, or whether it prolongs the duration of labor or increases the need for forceps delivery or other obstetric intervention."	0
"When DIFLUCAN is used concomitantly with these or other sulfonylurea oral hypoglycemic agents, blood glucose concentrations should be carefully monitored and the dose of the sulfonylurea should be adjusted as necessary."	0
"In addition, administration of alprostadil reopened the closing ductus of new-born rats, rabbits, and lambs."	0
The patient should be cautioned that this drug may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery.	0
Any chloride deficit during thiazide therapy is generally mild and usually does not require any specific treatment except under extraordinary circumstances (as in liver disease or renal disease).	0
Severe renal impairment and end-stage renal disease: Maximum dose 25 mg per day or 50 mg every other day (2.2).	0
Icodextrin functions as a colloid osmotic agent to achieve ultrafiltration during long peritoneal dialysis dwells.	0
WARNING: ABUSE AND DEPENDENCE See full prescribing information for complete boxed warning.	0
TIKOSYN is contraindicated in patients with congenital or acquired long QT syndromes.	0
"In all children, individualization of dosage is required."	0
"However, the LIFE study does not provide evidence that the benefits of losartan potassium tablets on reducing the risk of cardiovascular events in hypertensive patients with left ventricular hypertrophy apply to Black patients."	0
"Alternatively, protease inhibitor-naive children aged 2years and older can be administered LEXIVA (without ritonavir) 30mg per kg twice daily."	0
Race Pharmacokinetic differences related to race were not formally assessed.	0
"Pimozide did not have mutagenic activity in the Ames test with four bacterial test strains, in the mouse dominant lethal test or in the micronucleus test in rats."	0
"A randomized, 3-arm, open-label, cross-over study in healthy volunteers evaluated the bioavailability of PHOSLYRA compared to calcium acetate gelcaps."	0
WARNING: UNRECOGNIZED HYPOGLYCEMIA RESULTING FROM DRUG-DEVICE INTERACTION See full prescribing information for complete boxed warning Use of non-specific glucose monitors has resulted in falsely elevated glucose readings due to maltose interference leading to inappropriate insulin administration or withholding of hypoglycemia treatment.	0
"In animals, amoxapine reduced the uptake of norepinephrine and serotonin and blocked the response of dopamine receptors to dopamine."	0
"Prior to initiation of COREG, it is recommended that fluid retention be minimized."	0
The pharmacodynamic consequences of concomitant use of losartan and inhibitors of P4502C9 have not been examined.	0
"Effects of peripheral vasculopathy, including Raynaud's phenomenon, were observed in postmarketing reports at different times and at therapeutic doses in all age groups throughout the course of treatment."	0
Less than 5% of the drug in the body was cleared during a standard 4-hour hemodialysis procedure.	0
"Verapamil Component With the immediate release formulation, more than 90% of the orally administered dose is absorbed with peak plasma concentrations of verapamil observed 1 to 2 hours after dosing."	0
"By inhibiting the distal tubular exchange mechanism, triamterene maintains or increases the sodium excretion and reduces the excess loss of potassium, hydrogen and chloride ions induced by hydrochlorothiazide."	0
Metabolism and Elimination: Following oral administration perindopril exhibits multicompartment pharmacokinetics including a deep tissue compartment (ACE binding sites).	0
"Although specific studies of its use in treating atrial arrhythmias after infarction have not been conducted, the usual precautions regarding heart failure, avoidance of hypokalemia, bradycardia or prolonged QT interval apply."	0
Thus patients receiving oral anticoagulants and LUVOX CR Capsules should have their prothrombin time monitored and their anticoagulant dose adjusted accordingly.	0
Table 5 provides a listing of established or potentially clinically significant drug interactions.	0
"Patients of all ages who are started on Savella should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior."	0
Elderly patients (aged 65 years or older) may have increased sensitivity to meperidine hydrochloride.	0
"In vitro studies with EXTRANEAL and the following antibiotics have demonstrated no effects with regard to minimum inhibitory concentration (MIC): vancomycin, cefazolin, ampicillin, ampicillin/flucoxacillin, ceftazidime, gentamicin, and amphotericin."	0
Frequent monitoring for adverse events is recommended.	0
"No evidence of carcinogenicity was found in two 2-year bioassays in rats at doses up to 100 mg/kg, which is 24 and 4 times the maximum recommended human daily dose (MRHD) on a mg/kg and mg/m2 basis, respectively, or in a 2-year bioassay in mice at doses up to 80 mg/kg, which is 20 and 1.5 times the MRHD on a mg/kg and mg/m2 basis, respectively."	0
"There are reported instances of prolonged jaundice, extrapyramidal signs, hyperreflexia or hyporeflexia in newborn infants whose mothers received phenothiazines."	0
ANTIDEPRESSANT Trazodone <U+2191> trazodone Concomitant use of trazodone and VIRACEPT may increase plasma concentrations of trazodone.	1
"In controlled clinical trials, treatment with TARKA resulted in mean increases in potassium of 0.1 mEq/L."	0
"In addition, do not start Savella in a patient who is being treated with linezolid or intravenous methylene blue (4.1, 5.2)."	0
Food does not have a clinically relevant effect on teriflunomide pharmacokinetics.	0
There is only limited experience with the concomitant use of Class Ib or Ic antiarrhythmics.	0
"Because ritonavir is a CYP2D6 inhibitor, clinically significant interactions with drugs metabolized by CYP2D6 are possible when coadministered with LEXIVA plus ritonavir."	0
"The resulting elevated levels of thioridazine would be expected to augment the prolongation of the QTc interval associated with thioridazine and may increase the risk of serious, potentially fatal, cardiac arrhythmias, such as Torsades de pointes type arrhythmias."	0
Do not use desvenlafaxine within 14 days of stopping an MAOI intended to treat psychiatric disorders.	0
Food does not affect the bioavailability of irbesartan.	0
"The concomitant use of paroxetine with other SSRIs, SNRIs or tryptophan is not recommended."	0
"The inhibition of PDE-5 in these tissues by sildenafil may be the basis for the enhanced platelet anti-aggregatory activity of nitric oxide observed in vitro, and the mild peripheral arterial-venous dilatation in vivo."	0
"Co-administration of ONIVYDE with other inhibitors of CYP3A4 (e.g.,clarithromycin, indinavir,itraconazole, lopinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telaprevir, voriconazole) orUGT1A1 (e.g., atazanavir, gemfibrozil, indinavir) may increase systemic exposure to irinotecan or SN-38."	1
Chlorthalidone and related drugs may increase the responsiveness to tubocurarine.	0
"Metabolism and Elimination: Iloperidone is metabolized primarily by 3 biotransformation pathways: carbonyl reduction, hydroxylation (mediated by CYP2D6) and O-demethylation (mediated by CYP3A4)."	0
Particular care should be taken in using stimulants to treat ADHD in patients with comorbid bipolar disorder because of concern for possible induction of a mixed/manic episode in such patients.	0
Four placebo-controlled dose response studies were conducted using once daily oral dosing of trandolapril in doses from 0.25 to 16 mg per day in 827 black and non-black patients with mild to moderate hypertension.	0
"Acute Myopia and Secondary Angle-Closure Glaucoma: Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma."	0
The disturbances in parturition were reflected by a slight increase in the number of still born pups and decrease of neonatal survival at these dose levels.	0
"The average time course for effects on aPTT, following approved dosing regimens in patients with various degrees of renal impairment is shown in Figure 2."	0
"Serotonin syndrome may occur with triptans, including MAXALT particularly during co-administration with selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), and MAO inhibitors."	0
Adjustment of oral hypoglycemic drug dosage may be needed.	0
Increasing the dosage beyond 100 mg a day is unlikely to produce any further benefit.	0
"During the initial phase of combination antiretroviral treatment, patients whose immune system responds may develop an inflammatory response to indolent or residual opportunistic infections [such as Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia (PCP), or tuberculosis], which may necessitate further evaluation and treatment."	0
Several guidelines on this subject have been published.25-31 There is no general agreement that all of the procedures recommended in the guidelines are necessary or appropriate.	0
Co-administration of ritonavir in patients on bosentan: Discontinue use of bosentan at least 36 hours prior to initiation of ritonavir.	0
Advise females of reproductive potential to use effective contraception during treatment and for at least 14 days after the last dose.	0
"Statins - Atorvastatin(80mg daily), a drug metabolized by CYP450 3A4, did not alter the pharmacokinetics of prasugrel's active metabolite or its inhibition of platelet aggregation."	0
Administering drugs that act directly on the renin-angiotensin system (RAS) can alter normal renal development.	0
"The clinical effect from risperidone results from the combined concentrations of risperidone and its major metabolite, 9-hydroxyrisperidone."	0
"Although the mechanism of action of chlorthalidone and related drugs is not wholly clear, sodium and water depletion appear to provide a basis for its antihypertensive effect."	0
Hydrochlorothiazide has been shown to have an additive effect.	0
"Pediatric: Pharmacokinetic parameters after multiple doses of losartan (average dose 0.7mg/kg, range 0.36 to 0.97mg/kg) as a tablet to 25hypertensive patients aged 6 to 16years are shown in Table1 below."	0
Set the vent to the close position on a vented intravenous administration set to prevent air embolism.	0
"In the same patients, these reactions were avoided when ACE inhibitors were temporarily withheld, but they reappeared upon inadvertent challenge."	0
"There have been a few reports of serious adverse events associated with the coadministration of dihydroergotamine and potent CYP 3A4 inhibitors, such as protease inhibitors and macrolide antibiotics, resulting in vasospasm that led to cerebral ischemia and/or ischemia of the extremities."	0
Drug interaction studies of quinapril and other agents showed: Multiple dose therapy with propranolol or cimetidine has no effect on the pharmacokinetics of single doses of quinapril.	0
Eligible newly diagnosed patients with Ph+ CML-CP who have received Tasigna for a minimum of 3years and have achieved a sustained molecular response(MR4.5) and patients with Ph+ CML-CP resistant or intolerant to imatinib who have received Tasigna for at least 3 years and have achieved a sustained molecular response (MR4.5) may be considered for treatment discontinuation.	0
"However, aminoglycosides should not be mixed with penicillins due to chemical incompatibility."	0
Monitor hepatic function tests monthly or as clinically indicated [see Warnings and Precautions ( 5.	0
"Sedatives/hypnotics: For contraindicated sedatives/hypnotics,. buspirone, diazepam, estazolam, zoldipem <U+2191> sedatives/hypnotics Titration is recommended when co-administering PREZISTA/ritonavir with sedatives/hypnotics metabolized by CYP3A and a lower dose of the sedatives/hypnotics should be considered with monitoring for adverse events. parenterally administered midazolam Co-administration of parenteral midazolam should be done in a setting which ensures close clinical monitoring and appropriate medical management in case of respiratory depression and/or prolonged sedation."	1
Bipolar Disorder - Screen patients to avoid possible induction of a mixed/manic episode.	0
"When aliskiren was given with cyclosporine or itraconazole , the blood concentrations of aliskiren were significantly increased ."	1
The effects of FLOLAN on mean pulmonary artery pressure (PAPm) were variable and minor.	0
Alkalinization of the urine is a key concept in the management of salicylate overdose.	0
"If it occurs, discontinue ZOLOFT and initiate supportive treatment."	0
"In addition, normal subjects with transient insomnia associated with first night adaptation to the sleep laboratory were evaluated in 24-hour, placebo controlled sleep laboratory studies with temazepam at doses of 7.5 mg, 15 mg and 30 mg, given 30 minutes prior to bedtime."	0
"If such symptoms occur, increase diuretics and restore clinical stability before advancing the dose of TOPROL-XL."	0
Apixaban is not a significant inhibitor of P-gp.	0
"Elimination: In adult cancer patients, the mean ondansetron elimination half-life was 4.0 hours, and there was no difference in the multidose pharmacokinetics over a 4-day period."	0
"Factors such as reduced creatinine clearance, gender (female) and larger doses increase the risk of TdP."	0
This quantity should not induce specific symptoms of intolerance.	0
Irbesartan is not removed by hemodialysis.	0
The ratio of pitavastatin Cmax between patients with mild hepatic impairment (Child-Pugh A disease) and healthy volunteers was 1.3.	0
Patients on PRIFTIN should be monitored for symptoms of liver injury.	0
1.ORAP (pimozide) is contraindicated in the treatment of simple tics or tics other than those associated with Tourette's Disorder.	0
Saturation of this enzyme at clinical doses appears to account for the nonlinearity of paroxetine kinetics with increasing dose and increasing duration of treatment.	0
"For CrCl 15-30 mL/min, start warfarin 1 day before discontinuing PRADAXA."	0
"Additionally, no dosage adjustment is necessary for valproate, lithium, lamotrigine, lorazepam, or sertraline when co-administered with ABILIFY MAINTENA."	0
Ritonavir may decrease plasma levels of phenytoin and phenobarbital.	1
Quetiapine may antagonize the effects of levodopa and dopamine agonists.	0
"Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down."	0
Serum and urine electrolyte determinations are particularly important when the patient is vomiting excessively or receiving parenteral fluids.	0
Other strong selective CYP3A4 inhibitors such as ketoconazole can also be expected to increase the exposure of zaleplon.	1
The relationship between these effects and improvements in 6-minute walk distance is unknown.	0
Safety and effectiveness in pediatric patients have not been established.	0
"At steady state, the concentrations of citalopram's metabolites, DCT and DDCT, in plasma are approximately one-half and one-tenth, respectively, that of the parent drug."	0
"Distribution At the plasma concentrations achieved by therapeutic doses, approximately 98% of the circulating drug is bound to plasma proteins."	0
Consider 5-mg once daily for patients <60kg (2).	0
"No statistically significant difference between lovastatin and placebo was seen for the primary endpoint (mean change per patient in percent diameter stenosis of all lesions), or for most secondary QCA endpoints."	0
Table 1 is a guideline for dosing conversion from mg/hour to mL/hour.	0
Age - Citalopram pharmacokinetics in subjects <U+2265> 60 years of age were compared to younger subjects in two normal volunteer studies.	0
"Co-administration of SAMSCA with 400 mg ketoconazole daily or with other strong CYP 3A inhibitors ( e.g. , clarithromycin , itraconazole , telithromycin , saquinavir , nelfinavir , ritonavir and nefazodone ) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure ."	1
No drug interactions have been reported between PROSTIN VR PEDIATRIC and the therapy standard in neonates with restricted pulmonary or systemic blood flow.	0
"Because the effect of NARDIL on the convulsive threshold may be variable, adequate precautions should be taken when treating epileptic patients."	0
"In such patients, initiate ALTACE therapy under close medical supervision and follow patients closely for the first 2 weeks of treatment and whenever the dose of ALTACE or diuretic is increased."	0
"The patient's ophthalmologist should be prepared for possible modifications to the surgical technique, such as utilization of iris hooks, iris dilator rings, or viscoelastic substances."	0
Both Cmax and AUC increased in approximate proportion to CRESTOR dose.	0
"Patients with chronic insomnia were evaluated in 2-week, placebo controlled sleep laboratory studies with temazepam at doses of 7.5 mg, 15 mg and 30 mg, given 30 minutes prior to bedtime."	0
Terbinafine clearance is unaffected by cyclosporine.	0
"During post-marketing use of sertraline, cases of QTc prolongation and Torsade de Pointes (TdP) have been reported."	0
"Do not administer PRINIVIL within 36 hours of switching to or from sacubitril/valsartan, a product containing a neprilysin inhibitor (4)"	0
Steady-state plasma concentrations of the two components are achieved after about a week of once-daily dosing of TARKA.	0
The effects of food on the bioavailability of paroxetine were studied in subjects administered a single dose with and without food.	0
Lithium generally should not be given with diuretics.	0
"Sertraline hydrochloride was shown to be statistically significantly more effective than placebo as measured by the BSPS total score and fear, avoidance and physiologic factor scores, as well as the FQ-SPS total score, and to have significantly more responders than placebo as defined by the CGI-I."	0
Potential for WELLBUTRIN XL to Affect Other Drugs Animal data indicated that bupropion may be an inducer of drug-metabolizing enzymes in humans.	0
Patients who develop abnormal liver function tests during DIFLUCAN therapy should be monitored for the development of more severe hepatic injury.	0
"Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including telmisartan, may result in deterioration of renal function, including possible acute renal failure."	0
Do not co-administer aliskiren with ACCURETIC in patients with diabetes.	0
Although the overall incidence of FD&C Yellow No.	0
"Indomethacin may also affect plasma renin levels, aldosterone excretion, and renin profile evaluation."	0
"Paliperidone is also active as an antagonist at alpha1 and alpha2 adrenergic receptors and H1 histaminergic receptors, which may explain some of the other effects of the drug."	0
"Pheochromocytoma: If required, first initiate therapy with an alpha blocker."	0
"In a trial in which subjects received ALTACE capsules or the contents of identical capsules dissolved in water, dissolved in apple juice, or suspended in applesauce, serum ramiprilat levels were essentially unrelated to the use or non-use of the concomitant liquid or food."	0
Inappropriate infusion rate - Overly rapid infusion of quinidine may cause peripheral vascular collapse and severe hypotension.	0
The suspension should be refrigerated at 2-8<U+00B0>C (36-46<U+00B0>F) and can be stored for up to 4 weeks.	0
Mutagenicity studies have not been conducted.	0
"Thus, co-administration of APTIVUS/ritonavir with drugs highly dependent on CYP 3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events is contraindicated."	0
The pooled analyses of placebo-controlled trials in adults with MDD or other psychiatric disorders included a total of 295 short-term trials (median duration of 2 months) of 11 antidepressant drugs in over 77000 patients.	0
"Interaction studies of nefazodone with two triazolobenzodiazepines, i.e., triazolam and alprazolam, metabolized by cytochrome P450 3A4, have revealed substantial and clinically important increases in plasma concentrations of these compounds when administered concomitantly with nefazodone."	1
"The antihypertensive effects of losartan potassium tablets were demonstrated principally in 4 placebo-controlled, 6- to 12-week trials of dosages from 10 to 150mg per day in patients with baseline diastolic blood pressures of 95-115."	0
"In hypertensive type ll diabetic patients with nephropathy, nicardipine capsules (20 mg TID) did not change RPF and GFR, but reduced renal vascular resistance."	0
Potential safety risks include substantial increases in progesterone exposure.	1
Food intake does not alter Cmax or exposure (AUC) of fingolimod or fingolimod-phosphate.	0
"Transient abnormalities in liver function tests (e.g., elevation in serum bilirubin, alkaline phosphatase, and serum transaminases) and reduced biliary excretion of contrast media used for visualization of the gallbladder have also been observed."	0
Some assays are more subject to these failings than others.	0
INVIRASE must be used in combination with ritonavir.	0
The physical psychodynamic factors contributing to depressive symptomatology are very complex; spontaneous remissions or exacerbations of depressive symptoms may occur with or without drug therapy.	0
"Pregnancy: Teratogenic Effects: Teratogenicity studies in rats and rabbits at dopamine HCl dosages up to 6 mg/kg/day intravenously during organogenesis produced no detectable teratogenic or embryotoxic effects, although maternal toxicity consisting of mortalities, decreased body weight gain, and pharmacotoxic signs were observed in rats."	0
Patients taking Effient should also take aspirin(75-mg to 325-mg) daily.	0
"Primary Endpoint Events within Demographic Subgroups In the LIFE study, Black patients treated with atenolol were at lower risk of experiencing the primary composite endpoint compared with Black patients treated with losartan potassium tablets."	0
"There are 2 predominant iloperidone metabolites, P95 and P88."	0
"In clinical experience with 4,954 patients, 87 (1.8%) developed congestive heart failure or pulmonary edema."	0
Ritonavir and other Potent CYP3A Inhibitors Concomitant use of REVATIO with ritonavir and other potent CYP3A inhibitors is not recommended.	0
Study 2 was a 12-week flexible-dose study comparing paroxetine (10 to 60 mg daily) and placebo.	0
"Inhibitors of CYP2B6 Ticlopidine, Clopidogrel: In a study in healthy male volunteers, clopidogrel 75 mg once daily or ticlopidine 250 mg twice daily increased exposures (Cmax and AUC) of bupropion by 40% and 60% for clopidogrel, by 38% and 85% for ticlopidine, respectively."	1
Dose adjustment of digoxin may be needed to maintain therapeutic drug concentrations.	0
Tell female patients of childbearing age about the consequences of exposure to ACCUPRIL during pregnancy.	0
Liver abnormalities were noted in 3.2% of patients taking any of several combinations of trandolapril/verapamil doses.	0
NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect (7).	0
"In the case of required volume less than 0.1 mL, a separate device is recommended for adequate measurement."	0
The effect on the Cmax and AUC for d-nebivolol was also small (< 20%).	0
"In a single dose study in four hypercholesterolemic patients, it was estimated that less than 5% of an oral dose of lovastatin reaches the general circulation as active inhibitors."	0
Monitor INR frequently until stable upon initiation or alteration of CRESTOR therapy.	0
"Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down."	0
Rifampin is not recommended for intermittent therapy; the patient should be cautioned against intentional or accidental interruption of the daily dosage regimen since rare renal hypersensitivity reactions have been reported when therapy was resumed in such cases.	0
The combination of nevirapine administered with LEXIVA/ritonavir once-daily regimen has not been studied.	0
In some cases diabetic ketoacidosis has occurred.	0
Appropriate laboratory testing should be performed prior to initiating NORVIR therapy and at periodic intervals or if any clinical signs or symptoms occur during therapy.	0
"Renal Insufficiency Plasma clearance of tirofiban is decreased about 40% in subjects with creatinine clearance <60 mL/min and >50% in patients with creatinine clearance <30 mL/min, including patients requiring hemodialysis."	0
The effect on blood pressure is directly related to the initial degree of elevation above normal.	0
"PRINIVIL can cause symptomatic hypotension, sometimes complicated by oliguria, progressive azotemia, acute renal failure or death."	0
Doses above 120 mg daily are rarely necessary.	0
"In patients with moderate to severe renal dysfunction (creatinine clearance <50 mL/min), accumulation of the intravenous vehicle, SBECD, occurs."	0
"When TRISENOX is used in combination with tretinoin, prednisone prophylaxis is advised."	0
Each extended-release capsule contains 105 mg phendimetrazine tartrate in a Brown/Clear capsule imprinted E 5254.	0
"In patients with more severe renal impairment, loop diuretics are preferred to thiazides, so AVALIDE is not recommended."	0
Clinically significant adverse reactions from greater exposures of LEXIVA/ritonavir.	0
"Pre-existing glaucoma is almost always open-angle glaucoma because angle closure glaucoma, when diagnosed, can be treated definitively with iridectomy."	0
"Other HIV Protease Inhibitors(CYP3A4 Inhibition) In Vivo Studies Showed No Significant Effects on Indinavir Exposure No dosage adjustment for indinavir when coadministered with VFEND In Vitro Studies Demonstrated Potential for Voriconazole to Inhibit Metabolism(Increased Plasma Exposure) Frequent monitoring for adverse events and toxicity related to other HIV protease inhibitors Other NNRTIsNon-Nucleoside Reverse Transcriptase Inhibitors (CYP3A4 Inhibition) A Voriconazole-Efavirenz Drug Interaction Study Demonstrated the Potential for Voriconazole to Inhibit Metabolism of Other NNRTIs(Increased Plasma Exposure) Frequent monitoring for adverse events and toxicity related to NNRTI Benzodiazepines(CYP3A4 Inhibition) In Vitro Studies Demonstrated Potential for Voriconazole to Inhibit Metabolism(Increased Plasma Exposure) Frequent monitoring for adverse events and toxicity (i.e., prolonged sedation) related to benzodiazepines metabolized by CYP3A4 (e.g., midazolam, triazolam, alprazolam)."	1
Sleep latency with Zaleplon 10 mg and 20 mg was on the order of 10-20 minutes (15%-30%) less than with placebo in these studies.	0
ALDACTONE may also be given with diuretics that act more proximally in the renal tubule or with other antihypertensive agents .	0
"NOTE: As with many other drugs, certain advice to patients being treated with quinapril is warranted."	0
Opioids are sought by drug abusers and people with addiction disorders and are subject to criminal diversion.	0
Patients taking concomitant mammalian target of rapamycin (mTOR) inhibitor (e.g. temsirolimus) therapy or a neprilysin inhibitor may be at increased risk for angioedema.	0
The latter decrease may result in a small increase of serum potassium.	0
The effects of propranolol on paroxetine have not been evaluated.	0
"In vitro findings suggest that CYP2B6 is the principal isoenzyme involved in the formation of hydroxybupropion, while cytochrome P450 enzymes are not involved in the formation of threohydrobupropion."	0
Atomoxetine is primarily metabolized by the CYP2D6pathway to 4-hydroxyatomoxetine.	0
Number of Subjects Dosing of Coadministered Drug or Grapefruit Juice Dosing of Lovastatin AUC Ratio (with / without coadministered drug)No Effect = 1.00 Total Lovastatin acidLactone converted to acid by hydrolysis prior to analysis.	0
"If it is almost time for the next dose, skip the missed dose and take the next dose at the regular scheduled time."	0
"If no chemotherapy is given on Days 2 and 3, administer EMEND for oral suspension in the morning."	0
"In patients undergoing major surgery or during anesthesia with agents that produce hypotension , enalapril may block angiotensin II formation secondary to compensatory renin release ."	0
"Two long-term (maximum dosing duration of 18 or 24months) rat studies and one long-term (maximum dosing duration of 18 months) mouse study, each employing dose levels as high as 300 mg/kg/day or 150 times the maximum recommended human antihypertensive dose, did not indicate a carcinogenic potential of atenolol."	0
CYMBALTA should be prescribed with care in patients with a history of a seizure disorder.	0
"The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the caucasian population (about 7% to 10% of Caucasians are so called ""poor metabolizers""); reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African, and other populations are not yet available."	0
"If serotonin syndrome occurs, discontinue VYVANSE and the CYP2D6 inhibitor."	0
"Both free and clot-bound thrombin, and thrombin-induced platelet aggregation are inhibited by the active moieties."	0
Placebo (Mean Percent Change from Baseline After 6Weeks) DOSAGE N TOTAL-C LDL-C HDL-C LDL-C/HDL-C TOTAL-C/ HDL-C TG.	0
Amiodarone is an antiarrhythmic agent with negative chronotropic properties that may be additive to those seen with beta blockers.	0
Aseptic technique should be used throughout the peritoneal dialysis procedure.	0
"Discontinue Tasigna if, following dose-reduction to 400 mg once daily, QTcF returns to greater than 480 msec.5."	0
Higher clozapine plasma concentrations are likely in patients with significant renal or hepatic impairment when given usual doses.	0
Table 4: Dosea in Milliliters Table 4: Dosea in Milliliters Volume to be Given in mLb 2 3 4 5 6 8 10 12 14 16 18 20 30 Table 4: Dosea in Milliliters Weight in kg 2 0.08b 0.12b 0.16b 0.2 0.2 0.3 0.4 0.5 0.6 0.6 0.7 0.8 1.2 3 0.12b 0.18b 0.2 0.3 0.4 0.5 0.6 0.7 0.8 1.0 1.1 1.2 1.8 4 0.16b 0.2 0.3 0.4 0.5 0.6 0.8 1.0 1.1 1.3 1.4 1.6 2.4 5 0.2 0.3 0.4 0.5 0.6 0.8 1.0 1.2 1.4 1.6 1.8 2.0 3.0 6 0.2 0.4 0.5 0.6 0.7 1.0 1.2 1.4 1.7 1.9 2.2 2.4 3.6 7 0.3 0.4 0.6 0.7 0.8 1.1 1.4 1.7 2.0 2.2 2.5 2.8 4.2 8 0.3 0.5 0.6 0.8 1.0 1.3 1.6 1.9 2.2 2.6 2.9 3.2 4.8 9 0.4 0.5 0.7 0.9 1.1 1.4 1.8 2.2 2.5 2.9 3.2 3.6 5.4 10 0.4 0.6 0.8 1.0 1.2 1.6 2.0 2.4 2.8 3.2 3.6 4.0 6.0 11 0.4 0.7 0.9 1.1 1.3 1.8 2.2 2.6 3.1 3.5 4.0 4.4 6.6 12 0.5 0.7 1.0 1.2 1.4 1.9 2.4 2.9 3.4 3.8 4.3 4.8 7.2 13 0.5 0.8 1.0 1.3 1.6 2.1 2.6 3.1 3.6 4.2 4.7 5.2 7.8 14 0.6 0.8 1.1 1.4 1.7 2.2 2.8 3.4 3.9 4.5 5.0 5.6 8.4 15 0.6 0.9 1.2 1.5 1.8 2.4 3.0 3.6 4.2 4.8 5.4 6.0 9.0 20 0.8 1.2 1.6 2.0 2.4 3.2 4.0 4.8 5.6 6.4 7.2 8.0 12.0 30 1.2 1.8 2.4 3.0 3.6 4.8 6.0 7.2 8.4 9.6 10.8 12.0 18.0 40 1.6 2.4 3.2 4.0 4.8 6.4 8.0 9.6 11.2 12.8 14.4 16.0 24.0 50 2.0 3.0 4.0 5.0 6.0 8.0 10.0 12.0 14.0 16.0 18 20.0 30.0 60 2.4 3.6 4.8 6.0 7.2 9.6 12.0 14.4 16.8 19.2 21.6 24.0 36.0 70 2.8 4.2 5.6 7.0 8.4 11.2 14.0 16.8 19.6 22.4 25.2 28.0 42.0 80 3.2 4.8 6.4 8.0 9.6 12.8 16.0 19.2 22.4 25.6 28.8 32.0 48.0 90 3.6 5.4 7.2 9.0 10.8 14.4 18.0 21.6 25.2 28.8 32.4 36.0 54.0 100 4.0 6.0 8.0 10.0 12.0 16.0 20.0 24.0 28.0 32.0 36.0 40.0 60.0 a Recommended dosing regimen for pediatric patients under 10 years of age is twice daily.	0
"During premarketing studies of immediate-release fluvoxamine maleate tablets involving primarily depressed patients, hypomania or mania occurred in approximately 1% of patients treated with fluvoxamine."	0
The infusion duration may be extended up to 4 hours if acute vasomotor reactions are observed.	0
"Diabetes and Hypoglycemia: Beta-blockers may mask tachycardia occurring with hypoglycemia, but other manifestations such as dizziness and sweating may not be significantly affected."	0
The sustained antihypertensive effect of SULAR was demonstrated by 24 hour blood pressure monitoring and examination of peak and trough effects.	0
Pediatric Use: Safety and efficacy of azathioprine in pediatric patients have not been established.	0
"Although there is no evidence to suggest that Anafranil adversely affects growth, development or maturation, the absence of such findings is not adequate to rule out a potential for such effects in chronic use."	0
Consult the full prescribing information prior to and during treatment for potential drug interactions.	0
The recommended adult oral dosage for the treatment of erosive esophagitis that has been diagnosed by endoscopy is 1600 mg daily in divided doses (800 mg twice daily or 400 mg 4 times daily) for 12 weeks.	0
"This interaction, which has not been investigated using higher doses of fluvoxamine, may be more pronounced if a 300 mg daily dose is coadministered, particularly since fluvoxamine exhibits non-linear pharmacokinetics over the dosage range 100-300 mg."	0
"In these same studies, after repetitive dosing, the half-life increased to a range from 4.5 to 12.0 hours (after less than 10 consecutive doses given 6 hours apart)."	0
Cimetidine Cimetidine at a dose of 800 mg QD for 2 days did not affect ziprasidone pharmacokinetics.	0
Reported clinical studies have revealed that the drug usually increases systolic and pulse pressure without any or only a minor elevating effect on diastolic pressure.	0
"Penicillins are rapidly excreted in the urine by glomerular filtration and active tubular secretion, primarily as unchanged drug."	0
"In a fixed-dose controlled trial, 1.3%, 7.1%, 19.3%, and 29.1% of patients lost at least 3.5%of their body weight in the placebo, 0.5, 1.2, and1.8mg/kg/day dose groups."	0
There is no information regarding the efficacy of fluconazole for primary treatment of cryptococcal meningitis in children.	0
"Aldosterone synthesis, which occurs primarily in the adrenal gland, is modulated by multiple factors, including angiotensin II and non-RAAS mediators such as adrenocorticotropic hormone (ACTH) and potassium."	0
Small increases in creatinine levels (about 0.1 mg/dL) following dronedarone treatment initiation have been shown to be a result of inhibition of creatinine's tubular secretion.	0
"If this is not possible, reduce the starting dose of PRINIVIL."	0
These trials measured hemodynamic effects again at 12 to 14weeks.	0
The disposition of mirtazapine was studied in patients with varying degrees of renal function.	0
It did not affect sinus node recovery or SA conduction times.	0
The pharmacokinetics of verapamil and trandolaprilat are significantly different in the elderly (<U+2265>65 years) than in younger subjects.	0
"The following symptoms, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric."	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older.	0
Drug Name Effect Clinical Comment HIV Antiviral Agents Note: <U+2191> = increase; <U+2193> = decrease Delavirdine <U+2191> indinavir concentration Dose reduction of CRIXIVAN to 600 mg every 8 hours should be considered when taking delavirdine 400 mg three times a day.	1
Discontinue use of Tracleer at least 36 hours prior to initiation of ritonavir .	0
Angiograms were evaluated at baseline and at two years by computerized quantitative coronary angiography (QCA).	0
LUNESTA would not be expected to alter the clearance of drugs metabolized by common CYP450 enzymes.	0
"Absorption Because of presystemic first pass metabolism the absolute bioavailability of dronedarone without food is low, about 4%."	0
Absorption: The single-dose pharmacokinetic parameters of loxapine following administration of single doses of ADASUVE 10 mg in healthy adult subjects are presented in Table 3 and Figure 8.	0
"Because animal reproduction studies are not always predictive of human response, PERSANTINE tablets should be used during pregnancy only if clearly needed."	0
"In humans, hepatic esterase appears to be responsible for the hydrolysis of perindopril."	0
"If appropriate care is not taken to reduce the dose of digoxin, such patients are at high risk for toxicity, and toxic effects will last longer in such patients than in patients with normal renal function."	0
REM sleep was found to be increased to 85% of the total sleep time.	0
Clinical studies of Lidocaine Hydrochloride did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
Table 1: Starting Dose for Adult Dialysis Patients Not Taking a Phosphate Binder Serum Phosphorus Renvela >5.5 and <7.5 mg/dL 0.8 g three times daily with meals <U+2265>7.5 mg/dL 1.6 g three times daily with meals Dose Titration for Adult Patients Taking Renvela.	0
Antidiabetic Drugs (oral hypoglycemic agents and insulin) - dosage adjustments of the antidiabetic drug may be required.	0
The potential for adverse cardiac events exists.	0
"Distribution Dipyridamole is highly lipophilic (log P=3.71, pH=7); however, it has been shown that the drug does not cross the blood-brain barrier to any significant extent in animals."	0
Renal Impairment Severe renal impairment had no impact on the pharmacokinetics of teriflunomide.	0
Pediatric: Pharmacokinetic data in the pediatric population are not available.	0
"Because these events have been reported voluntarily during clinical practice, estimates of frequency cannot be made and a causal relationship between protease inhibitor therapy and these events has not been established."	0
"For all females, Letairis is available only through a restricted program called the Letairis REMS, because of the risk of embryo-fetal toxicity."	0
"Interaction with phenytoin, lidocaine and theophylline has also been reported to produce adverse clinical effects."	0
"In most patients (>90%), this CYP2D6 isozyme is saturated early during dosing with paroxetine."	0
Distribution Risperidone is rapidly distributed.	0
"Analyses of seventeen placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients."	0
"For amlodipine, AUC and Cmax were not altered."	0
Hepatic Impairment The pharmacokinetics of eplerenone 400 mg has been investigated in patients with moderate (Child-Pugh Class B) hepatic impairment and compared with normal subjects.	0
"LIPITOR, as well as some of its metabolites, are pharmacologically active in humans."	0
Clarithromycin: Atorvastatin AUC was significantly increased with concomitant administration of atorvastatin 80 mg with clarithromycin (500 mg twice daily) compared to that of atorvastatin alone.	1
"Serotonin-norepinephrine reuptake inhibitors (SNRIs) and SSRIs, including ZOLOFT, can precipitate serotonin syndrome, a potentially life-threatening condition."	0
The use of prazosin and a beta-blocker for the control of severe hypertension in 44 pregnant women revealed no drug-related fetal abnormalities or adverse effects.	0
Use CIALIS<U+00AE> (tadalafil) with caution at reduced doses of 10 mg every 72 hours with increased monitoring for adverse events.	1
"Antineoplastics Irinotecan Atazanavir inhibits UGT1A1 and may interfere with the metabolism of irinotecan, resulting in increased irinotecan toxicities."	1
"The mechanism of action of paliperidone, as with other drugs having efficacy in schizophrenia, is unknown, but it has been proposed that the drug's therapeutic activity in schizophrenia is mediated through a combination of central dopamine Type 2 (D2) and serotonin Type 2 (5HT2A) receptor antagonism."	0
"Before initiating therapy, assess the QTc interval, correct pre-existing electrolyte abnormalities, and consider discontinuing drugs known to prolong QTc interval."	0
The primary verapamil/beta-blocker interaction in this study appeared to be hemodynamic rather than electrophysiologic.	0
The bolus dose may not be appropriate for those with low SBP <110 mm Hg or those recently treated with afterload reducers such as nitroglycerin.	0
"Patients should be advised to inform their physicians if they are taking, or plan to take, any prescription or over-the-counter drugs, since there is a potential for interactions."	0
Do not use nicardipine in patients with advanced aortic stenosis because of the afterload reduction effect of nicardipine.	0
"If concomitant use of CYMBALTA with other serotonergic drugs is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome, particularly during treatment initiation and dose increases (5.4) Abnormal Bleeding: CYMBALTA may increase the risk of bleeding events."	0
Beta-blockers can precipitate or aggravate symptoms of arterial insufficiency in patients with peripheral vascular disease.	0
"In post-marketing experience, spontaneous reports of anemia and acute renal failure were more frequent among patients 65 years of age or older than in those between 12 and 65 years of age."	0
Hepatic Impairment Administration of a single 2 mg dose to patients with cirrhosis (Child-Pugh Class A) showed a 40% increase in exposure to doxazosin.	0
Some patients may experience a large increase in amitriptyline concentration in the presence of topiramate and any adjustments in amitriptyline dose should be made according to the patient's clinical response and not on the basis of plasma levels.	1
There have been reports of anaphylaxis.	0
Twice daily dosing is recommended for pediatric patients under 10 years of age.	0
"Closely monitor patients receiving catecholamine-depleting drugs, such as reserpine or guanethidine, because the added <U+03B2>-blocking action of BYSTOLIC may produce excessive reduction of sympathetic activity."	0
Plasma concentrations of trandolaprilat decline in a triphasic manner.	0
"In addition to the observed /documented interactions mentioned below, there is a risk of increased plasma concentration of other compounds metabolized by CYP2C9, CYP2C19, and CYP3A4 coadministered with fluconazole."	1
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy."	0
Coadministration of immediate-release fluvoxamine maleate tablets 100 mg per day with atenolol 100 mg per day (N=6) did not affect the plasma concentrations of atenolol.	0
The plasma half-life of AHA is approximately 5-10 hours in subjects with normal renal function and is prolonged in patients with reduced renal function.	0
Ketoconazole is a strong inhibitor of CYP 3A and also an inhibitor of P-gp.	0
REYATAZ is not recommended for pregnant women during the second and third trimester taking REYATAZ with both tenofovir DF and an H2RA.	0
"While the mechanism through which ALTACE lowers blood pressure is believed to be primarily suppression of the renin-angiotensin-aldosterone system, ALTACE has an antihypertensive effect even in patients with low-renin hypertension."	0
In vitro studies of irbesartan oxidation by cytochrome P450 isoenzymes indicated irbesartan was oxidized primarily by 2C9; metabolism by 3A4 was negligible.	0
Monitor liver function tests more frequently in patients when it is not feasible to avoid concomitant use.	0
"However, dosage adjustments should be made to maintain the patient on the lowest effective dosage, and patients should be periodically reassessed to determine the need for treatment."	0
PHOSLYRA may decrease the bioavailability of tetracyclines fluoroquinolones or levothyroxine.	1
Warn patients of the symptoms of serotonin syndrome and to seek medical attention right away if symptoms develop.	0
LEXIVA has been studied in patients who have experienced treatment failure with protease inhibitors.	0
"Antagonism of muscarinic, histaminergic, and alpha1-adrenergic receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects of classical tricyclic antidepressant(TCA) drugs."	0
Co-morbidities occurring with ADHD may be associated with an increase in the risk of suicidal ideation and/or behavior.	0
Discontinuation: Symptoms associated with discontinuation have been reported (5.10).	0
"Extensive CYP 2D6 metabolizers convert risperidone rapidly into 9-hydroxyrisperidone, whereas poor CYP 2D6 metabolizers convert it much more slowly."	0
"Rifabutin Tipranavir not changed, <U+2191> Rifabutin <U+2191> Desacetyl-rifabutin Single dose study."	0
"When driving vehicles or operating machines, it should be taken into account that occasionally dizziness or seizures may occur."	0
"In preclinical studies in rats and dogs, sevelamer hydrochloride, which contains the same active moiety as sevelamer carbonate, reduced vitamins D, E, and K (coagulation parameters) and folic acid levels at doses of 6-10 times the recommended human dose."	1
"Closely monitor blood pressure, renal function and electrolytes in patients on ACCUPRIL and other agents that affect the RAS."	0
"The dose may be increased to 1.25 mg twice daily, and up to a maximum dose of 2.5 mg twice daily depending on clinical response and tolerability."	0
"PATIENTS WITH BRONCHOSPASTIC DISEASE SHOULD, IN GENERAL, NOT RECEIVE BETA BLOCKERS."	0
Information on concurrent usage of atenolol and aspirin is limited.	0
"Non-steroidal Anti-inflammatory Drugs Including Selective Cyclooxygenase-2 (COX-2) Inhibitors- In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics."	0
"Sertraline hydrochloride administration did not noticeably change either the plasma protein binding or the apparent volume of distribution of tolbutamide, suggesting that the decreased clearance was due to a change in the metabolism of the drug."	1
"Cleviprex is supplied in sterile, pre-mixed, ready-to-use 50 mL, or 100 mL, or 250 mL vials."	0
A Coombs negative hemolytic anemia has occurred in patients receiving AHA.	0
"Maternal aspirin use during later stages of pregnancy may cause low birth weight, increased incidence for intracranial hemorrhage in premature infants, stillbirths and neonatal death."	0
The in vitro plasma protein binding is approximately 60%<U+00B1>15% and is independent of zaleplon concentration over the range of 10 ng/mL to 1000 ng/mL.	0
"During chronic therapy, most of the blood pressure lowering effect of a given dose is obtained in 1-2 weeks."	0
Dose to be Given Twice Daily < 10 Years of Age Dose to be Given Once Daily > 10 Years of Age and Adults Number of Days Before Steady State Achieve Lean Body Weight Lean Body Weight kg lb 5 11 10 22 20 44 30 66 40 88 50 110 60 132 40 88 50 110 60 132 70 154 80 176 90 198 100 220 10 10 20 40 60 80 100 120 80 100 120 140 160 180 200 19 20 11 23 45 68 90 113 135 90 113 135 158 180 203 225 16 30 13 25 50 75 100 125 150 100 125 150 175 200 225 250 14 40 14 28 55 83 110 138 165 110 138 165 193 220 248 275 13 50 15 30 60 90 120 150 180 120 150 180 210 240 270 300 12 60 16 33 65 98 130 163 195 130 163 195 228 260 293 325 11 70 18 35 70 105 140 175 210 140 175 210 245 280 315 350 10 80 19 38 75 113 150 188 225 150 188 225 263 300 338 375 9 90 20 40 80 120 160 200 240 160 200 240 280 320 360 400 8 100 21 43 85 128 170 213 255 170 213 255 298 340 383 425 7 Determination of the target dose in milliliters of Digoxin Oral Solution based on body weight is shown in Table 4.	0
Mirtazapine is extensively metabolized after oral administration.	0
"In controlled clinical trials, patients with bipolar disorder were generally excluded; however, symptoms of mania or hypomania were reported in 0.4% of patients treated with ZOLOFT."	0
The mechanism of this pharmacodynamic interaction is not known.	0
"The concomitant use of Meperidine Hydrochloride Injection and CYP3A4 or CYP2B6 inducers, such as rifampin, carbamazepine, and phenytoin, can decrease the plasma concentration of meperidine."	1
Thiazide diuretics may accentuate the orthostatic hypotension that may occur with phenothiazines.	0
There are no data that support increased effectiveness at higher doses.	0
REYATAZ oral powder must be mixed with food or beverage for administration and ritonavir must be given immediately afterwards.	0
"Use of EMEND with other drugs that are CYP3A4 substrates, may result in increased plasma concentration of the concomitant drug."	1
"These features are consistent with either a direct toxic effect of SSRIs and SNRIs or, possibly, a drug discontinuation syndrome."	0
"When the CYP2D6 inhibitor is withdrawn from the combination therapy, iloperidone dose could then be increased to the previous level."	1
"The potential for drug-drug interactions must be considered prior to and during therapy (4, 5.1, 7, 12.3) Ritonavir is an inhibitor of cytochrome P450 3A (CYP3A) and may increase plasma concentrations of agents that are primarily metabolized by CYP3A."	1
"Upward titration should be based on therapeutic efficacy, assessed at the end of the dosing interval."	0
"Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) including selective Cyclooxygenase-2 inhibitors (COX-2 inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors with agents that affect the RAAS, including aliskiren, may result in deterioration of renal function, including possible acute renal failure."	0
Potassium depletion induced by the thiazide may be important in this connection.	0
"Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs, warfarin, and other anticoagulants may add to this risk."	0
"Electrophysiology studies in man have demonstrated that bisoprolol fumarate significantly decreases heart rate, increases sinus node recovery time, prolongs AV node refractory periods, and, with rapid atrial stimulation, prolongs AV nodal conduction."	0
Avoid extravasation during injection: local irritation and inflammation due to extravascular infiltration of the infusion have been observed.	0
"Because lithium may enhance the serotonergic effects of citalopram, caution should be exercised when Celexa and lithium are coadministered."	0
Hepatotoxicity: Grade <U+2265>3 elevations in hepatic transaminase elevation have occurred in patients with newly diagnosed low or intermediate risk APL treated with TRISENOX in combination with tretinoin.	0
"However, if discontinuation of PROCARDIA is necessary, sound clinical practice suggests that the dosage should be decreased gradually with close physician supervision."	0
"Fluvoxamine has been shown to be a potent inhibitor of the serotonin reuptake transporter in preclinical studies, both in vitro and in vivo."	0
The dosage may be increased at weekly (or longer) intervals until optimum blood pressure reduction is achieved.	0
"In hypertensive patients, sotalol produces significant reductions in both systolic and diastolic blood pressures."	0
The half-life of rifampin at a dose of 720 mg daily has not been established in patients with renal failure.	0
"Sympathetic stimulation is necessary in supporting circulatory function in congestive heart failure, and beta blockade carries the potential hazard of further depressing myocardial contractility and precipitating more severe failure."	0
Clopidogrel Clinical Impact: Concomitant administration of pantoprazole and clopidogrel in healthy subjects had no clinically important effect on exposure to the active metabolite of clopidogrel or clopidogrel-induced platelet inhibition.	0
"Nicotine may provoke vasoconstriction in some patients, predisposing to a greater ischemic response to ergot therapy."	0
Risk Summary PURIXAN can cause fetal harm when administered to a pregnant woman.	0
Verapamil Component Data on possible interactions between verapamil and disopyramide phosphate are not available.	0
"Special Populations: Geriatrics: The pharmacokinetics of quazepam and 2-oxoquazepam in geriatric subjects are comparable to those seen in young adults; as with desalkyl metabolites of other benzodiazepines, the elimination half-life of N-desalkyl-2-oxoquazepam in geriatric patients is about twice that of young adults."	0
A dose decrease may be needed for these drugs when co-administered with PREZISTA/ritonavir and a lower dose of the beta blocker should be considered.	1
Physicians should completely familiarize themselves with a compatible Hospira infusion device before deciding to administer meperidine hydrochloride injection via the infuser.	0
Withdrawal was operationally defined as the emergence of 3 or more new symptoms after discontinuation.	0
"ACE is identical to kininase, an enzyme that degrades bradykinin."	0
Beta1-blocking effects in the range of 30-80% of the maximal effect (approximately 8-23% reduction in exercise heart rate) correspond to metoprolol plasma concentrations from 30-540 nmol/L.	0
Tobacco smoke is a moderate inducer of CYP1A2.	0
"The renin-aldosterone link is mediated by angiotensin II, so coadministration of an angiotensin II receptor antagonist tends to reverse the potassium loss associated with these diuretics."	0
Co-administration of NORVIR can alter the concentrations of other drugs.	0
"If water is used, food should also be taken at the same time."	0
Use of sildenafil for erectile dysfunction: Sildenafil dose should not exceed a maximum of 25 mg in a 48-hour period in patients receiving concomitant CRIXIVAN therapy.	1
Most patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy.	0
Administer Cleviprex using an infusion device allowing calibrated infusion rates.	0
Pre-existing hypertension should be controlled before initiating treatment with PRISTIQ.	0
Pathogen Susceptible(S) Intermediate(I) Resistant(R) Susceptible(S) Intermediate(I) Resistant(R) Staphylococcus spp.	0
Monitor renal function periodically in patients receiving quinapril and NSAID therapy.	0
"In titrating to the desired increase in systolic blood pressure, the optimum dosage rate for renal response may be exceeded, thus necessitating a reduction in rate after the hemodynamic condition is stabilized."	0
Mild hypercalcemia is usually controlled by reducing the PHOSLYRA dose or temporarily discontinuing therapy.	0
The dose may be increased in increments of 75 mg/day every 3 days.	0
"Renal clearance of penicillin is delayed in premature infants, neonates and in the elderly due to decreased renal function."	0
"Drugs Highly Bound to Plasma Protein Zaleplon is not highly bound to plasma proteins (fraction bound 60%<U+00B1>15%); therefore, the disposition of zaleplon is not expected to be sensitive to alterations in protein binding."	0
CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.	0
"6 ), Use in Specific Populations (8.7)]."	0
"Due to the possible occurrence of uveitis, patients should also be carefully monitored when MYCOBUTIN is given in combination with clarithromycin (or other macrolides) and/or fluconazole and related compounds."	0
Families and caregivers should be advised of the need for close observation and communication with the prescriber.	0
"Excretion is predominantly via the kidney in the unchanged form, and therefore lower doses are necessary in conditions of renal impairment."	0
"However, the pharmacodynamics of coadministration of zaleplon and promethazine have not been evaluated."	0
NORPRAMIN is not approved for use in pediatric patients.	0
A decrease in benzodiazepine dose may be needed.	1
"In healthy male subjects (n=16), mirtazapine (30 mg daily), at steady state, caused a small (0.2) but statistically significant increase in the International Normalized Ratio (INR) in subjects treated with warfarin."	0
5 (tartrazine) which may cause allergic-type reactions (including bronchial asthma) in certain susceptible persons.	0
"See CONTRAINDICATIONS, WARNINGS, and PRECAUTIONS sections for information on drug interactions."	0
"Inform pregnant patient of hazard (5.4, 8.1) Patients with Hereditary Galactose Intolerance Lapp Lactase Deficiency or Glucose-Galactose Malabsorption: Do not use (5.5) Arrhythmias and QT Prolongation: Correct potassium, magnesium and calcium prior to use; caution patients with proarrhythmic conditions (5.6) Infusion Related Reactions (including anaphylaxis): Stop the infusion (5.7) Dermatological Reactions: Discontinue for exfoliative cutaneous reactions or phototoxicity."	0
"The 10-mg dose may provide a greater effect than the 5-mg dose, but may have a greater risk of adverse reactions."	0
Quantitative methods are used to determine antimicrobial minimum inhibitory concentrations (MICs).	0
Intravenous infusions of lidocaine hydrochloride must be administered under constant ECG monitoring to avoid potential overdosage and toxicity.	0
"Families and caregivers of patients should be advised to look for the emergence of such symptoms on a day-to-day basis, since changes may be abrupt."	0
"In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days has no effect on the pharmacodynamics of warfarin (prothrombin time) or pharmacokinetics of digoxin."	0
"Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior."	0
The relative and effective refractory periods of the His-Purkinje system were slightly shortened.	0
Intravenous treatment should be continued for at least 7 days.	0
Avoid use of concomitant drugs known to prolong the QT interval and strong CYP3A4 inhibitors ( 5.8 ).	0
Prescribe Savella with care in patients with a history of seizure disorder (5.5).	0
"Use REVATIO with caution in patients with anatomical deformation of the penis (e.g., angulation, cavernosal fibrosis, or Peyronie's disease) or in patients who have conditions, which may predispose them to priapism (e.g., sickle cell anemia, multiple myeloma, or leukemia)."	0
"Race In healthy black subjects, irbesartan AUC values were approximately 25% greater than whites; there were no differences in Cmax values."	0
"Relative to the adults, both the 6 to 12 year olds and the 13 to 17 year olds showed about 22% lower AUC (0 to 24 hr) and Cmax values when plasma concentration was adjusted for weight."	0
"Eight days after dosing, ACE inhibition is still 40%."	0
Cases with serum sodium lower than 110 mmol/L have been reported.	0
"Withdrawal symptoms, including jitteriness, tremor, and seizures, have been reported in neonates whose mothers had taken Anafranil until delivery."	0
"Recommended adult dosage of colchicine when administered with REYATAZ: Treatment of gout flares: 0.6 mg (1 tablet) for 1 dose, followed by 0.3 mg (half tablet) 1 hour later."	0
"The concomitant use of paroxetine with other SSRIs, SNRIs or tryptophan is not recommended."	0
"When sildenafil 100 mg oral was co-administered with amlodipine, 5 mg or 10 mg oral, to hypertensive patients, the mean additional reduction on supine blood pressure was 8 mmHg systolic and 7 mmHg diastolic."	0
"In vitro metabolism studies have shown that ondansetron is a substrate for multiple human hepatic cytochrome P-450 enzymes, including CYP1A2, CYP2D6, and CYP3A4."	0
Rebound pulmonary hypertension: Do not abruptly discontinue or decrease the dose.	0
Clinical studies have indicated that suppression of nocturnal acid is the most important factor in duodenal ulcer healing.	0
"For the concurrent therapy of either cyclosporine, fibrates, niacin (nicotinic acid), or erythromycin, the risk of myopathy increases."	0
"The average risk of such events in patients receiving antidepressants was 4%, twice the placebo risk of 2%."	0
Diethylpropion hydrochloride may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or driving a motor vehicle; the patient should therefore be cautioned accordingly.	0
Tyramine pressor doses were also studied in 11 subjects after extended treatment with EMSAM 12mg per 24 hours.	0
"Administration of reserpine during therapy with a tricyclic antidepressant has been shown to produce a ""stimulating"" effect in some depressed patients."	0
"Elderly patients, patients taking diuretics, and those who are volume-depleted may be at greater risk of developing hyponatremia with SSRIs and SNRIs."	0
"In patients with chronic stable angina, intravenous administration of 10 mg did not significantly alter A-H and H-V conduction and sinus node recovery time after pacing."	0
Simvastatin Co-administration of simvastatin with amlodipine increases the systemic exposure of simvastatin.	1
Charcoal - The administration of activated charcoal (1g) reduced the Cmax and AUC of oral olanzapine by about 60%.	1
"Pharmacodynamics and Mechanism of Action While Zaleplon is a hypnotic agent with a chemical structure unrelated to benzodiazepines, barbiturates, or other drugs with known hypnotic properties, it interacts with the gamma-aminobutyric acid-benzodiazepine (GABA-BZ) receptor complex."	0
After 7 days: INVIRASE 1000 mg twice daily with ritonavir 100 mg twice daily.	0
Maximum reduction in exercise tachycardia occurs within 5 minutes of an intravenous dose.	0
Increased statin concentrations in plasma have been associated with rhabdomyolysis.	0
See Warnings and Precautions (5.8 and 5.10).	0
"Children 6 to < 17 years of age: For those less than 50 kg, the dose range is 2 to 16 mg per day."	0
"The thiazide component of ACCURETIC may potentiate the action of other antihypertensive drugs, especially ganglionic or peripheral adrenergic-blocking drugs."	0
Every dosing regimen for organic nitrates including dilatrate<U+00AE>-SR must provide a daily nitrate-free interval to avoid the development of tolerance.	0
"The bioavailability of nilotinib is increased with food, thus Tasigna must not be taken with food."	0
LEXIVA/ritonavir: Sildenafil: 25mg every 48hours.	0
Decreases in sperm count have been observed in patients taking endothelin receptor antagonists (5.5).	0
"The development of a potentially life-threatening serotonin syndrome has been reported with SNRIs and SSRIs, including PRISTIQ, alone but particularly with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John's Wort), and with drugs that impair metabolism of serotonin (in particular, MAOIs, both those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue)."	0
"Intravenous Adenocard (adenosine injection) has been effectively administered in the presence of other cardioactive drugs, such as quinidine, beta-adrenergic blocking agents, calcium channel blocking agents, and angiotensin converting enzyme inhibitors, without any change in the adverse reaction profile."	0
"Because of possible effects on blood pressure, Focalin XR should be used cautiously with pressor agents."	0
Initial and subsequent TENORMIN dosages can be adjusted downward depending on clinical observations including pulse and blood pressure.	0
"Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients who are experiencing emergent suicidality or symptoms that might be precursors to emerging suicidality, especially if these symptoms are severe or abrupt in onset, or were not part of the patient's presenting symptoms."	0
"All the relapse subjects with NS5A sequencing data (5 of 6) had pretreatment NS5A resistance-associated polymorphisms (single or combinations at positions 24, 28, 30, 31, and 58)."	0
Candesartan cannot be removed by hemodialysis.	0
"In a pharmacokinetic trial conducted in 8 healthy male subjects, rifampin (600mg daily for 12days) decreased the AUC and Cmax of carvedilol by about 70%."	1
The sofosbuvir-associated resistance substitution S282T in NS5B was not detected in any failure isolate from the Phase 3 trials.	0
"When discontinuing chronically administered DUTOPROL, particularly in patients with ischemic heart disease, gradually reduce the dosage over a period of 1-2 weeks and monitor the patient."	0
Compared to historical controls tipranavir Cmin was decreased approximately 40% with this combination.	0
Lidocaine hydrochloride should not be added to blood transfusion assemblies because of the possibilities of pseudoagglutination or hemolysis.	0
The mean AUC increased by about 1<U+00BD>-fold for hydroxybupropion and about 2<U+00BD>-fold for threo/erythrohydrobupropion.	0
Urinary 4-hydroxy-estazolam and 1-oxo-estazolam account for 11.9% and 4.4% of the dose respectively.	0
Porphyria: Avoid use in patients with porphyria.	0
"Nevertheless, caution is necessary in treating patients with known cardiovascular disease, and gradual dose titration is recommended."	0
It is recommended that FETZIMA extended-release capsules not be taken with alcohol.	0
Treatment of familial Mediterranean fever (FMF): Co-administration of colchicine in patients on APTIVUS/ritonavir: Maximum daily dose of 0.6 mg (may be given as 0.3 mg twice a day).	0
Resuscitation may be required.	0
"Drugs Metabolized by Cytochrome CYP3A4: An in vivo interaction study involving the coadministration under steady-state conditions of paroxetine and terfenadine, a substrate for cytochrome CYP3A4, revealed no effect of paroxetine on terfenadine pharmacokinetics."	0
"Rifampin has been reported to accelerate the metabolism and may reduce the activity of the following drugs; hence, PRIFTIN may also increase the metabolism and decrease the activity of these drugs."	0
"Following multiple oral dosing of ACCUPRIL, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours post-dose."	0
"Mean pitavastatin t<U+00BD> for moderate hepatic impairment, mild hepatic impairment, and healthy were 15, 10, and 8 hours, respectively."	0
Anaphylactic or anaphylactoid reactions may occur.	0
"Because fluoxetine's metabolism, like that of a number of other compounds including TCAs and other selective serotonin reuptake inhibitors(SSRIs), involves the CYP2D6 system, concomitant therapy with drugs also metabolized by this enzyme system (such as the TCAs) may lead to drug interactions."	0
The risk may be increased when TRISENOX is coadministered with medications that can lead to electrolyte abnormalities (such as diuretics or amphotericin B).	0
"The pooled analyses of placebo-controlled trials in children and adolescents with MDD, obsessive compulsive disorder (OCD), or other psychiatric disorders included a total of 24 short-term trials of 9 antidepressant drugs in over 4400 patients."	0
Three patients died in pulmonary edema; all had severe left ventricular outflow obstruction and a past history of left ventricular dysfunction.	0
"Appropriate doses of the combination, with respect to safety and efficacy, have not been established."	0
Serotonin Syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with Savella or within 5 days of stopping treatment with Savella.	0
"Coadministration of terfenadine, astemizole, cisapride, pimozide, or carbamazepine with nefazodone hydrochloride is contraindicated."	0
"Dofetilide is not an inhibitor of CYP3A4 nor of other cytochrome P450 isoenzymes (e.g., CYP2C9, CYP2D6) and is not expected to increase levels of drugs metabolized by CYP3A4."	0
Therapy with Savella may be resumed 24 hours after the last dose of linezolid or intravenous methylene blue.	0
"Monoamine Oxidase Inhibitors (MAOIs): (2.9, 2.10, 4.1, 5.2) Drugs Metabolized by CYP2D6: Fluoxetine is a potent inhibitor of CYP2D6 enzyme pathway (7.7) Tricyclic Antidepressants (TCAs): Monitor TCA levels during coadministration with PROZAC or when PROZAC has been recently discontinued (5.2, 7.7) CNS Acting Drugs: Caution should be used when taken in combination with other centrally acting drugs (7.2) Benzodiazepines: Diazepam <U+2013> increased t<U+00BD>, alprazolam - further psychomotor performance decrement due to increased levels (7.7) Antipsychotics: Potential for elevation of haloperidol and clozapine levels (7.7) Anticonvulsants: Potential for elevated phenytoin and carbamazepine levels and clinical anticonvulsant toxicity (7.7) Serotonergic Drugs: (2.9, 2.10, 4.1, 5.2) Drugs that Interfere with Hemostasis(e.g."	0
It should be noted that PEXEVA<U+00AE> (paroxetine mesylate) is not approved for use in treating bipolar depression.	0
History of angioedema while taking ROZEREM.	0
Monitor appropriately if concomitant treatment is clinically warranted (7.2).	0
Fluconazole increases plasma concentrations of sirolimus presumably by inhibiting the metabolism of sirolimus via CYP3A4 and P-glycoprotein.	1
Photosensitivity reactions can occur during CAPRELSA treatment and up to 4 months after treatment discontinuation.	0
Focalin XR is contraindicated in patients with motor tics or with a family history or diagnosis of Tourette<U+2019>s syndrome.	0
"Cyclosporine ( CYP3A substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine ."	0
A causal relationship has not been established.	0
"The combination of MAO inhibitors and tryptophan has been reported to cause behavioral and neurologic syndromes including disorientation, confusion, amnesia, delirium, agitation, hypomanic signs, ataxia, myoclonus, hyperreflexia, shivering, ocular oscillations, and Babinski signs."	0
ACEON is also contraindicated in patients with hereditary or idiopathic angioedema.	0
"Less potent inhibitors include saquinavir, nefazodone, fluconazole, grapefruit juice, fluoxetine, fluvoxamine, zileuton, and clotrimazole."	0
"In patients with symptomatic heart failure and recent decompensation requiring hospitalization or NYHA Class IV heart failure, MULTAQ doubles the risk of death."	0
This statement is included on the product's bottle label.	0
"Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs."	0
Families and caregivers should be advised of the need for close observation and communication with the prescriber.	0
"Major Surgery/Anesthesia Hypotension may occur during major surgery and anesthesia in patients treated with angiotensin II receptor antagonists, including ATACAND, due to blockade of the renin-angiotensin system."	0
"In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen were observed."	0
Increased urinary output produced by dopamine is usually not associated with decreased urine osmolality.	0
No initial dosage adjustment is necessary in patients with renal insufficiency.	0
"Prescriptions for PEXEVA<U+00AE> (paroxetine mesylate) should be written for the smallest quantity of tablets consistent with good patient management, in order to reduce the risk of overdose."	0
"When the two drugs were coadministered, there were no changes in the steady-state pharmacokinetics of either lithium, nefazodone, or its metabolite HO-NEF; however, there were small decreases in the steady-state plasma concentrations of two nefazodone metabolites, mCPP and triazole-dione, which are considered not to be of clinical significance."	0
"WARNINGS Mortality In the National Heart, Lung and Blood Institute<U+2019>s Cardiac Arrhythmia Suppression Trial (CAST), a long-term, multicentered, randomized, double-blind study in patients with asymptomatic non-life-threatening ventricular arrhythmias who had a myocardial infarction more than six days but less than two years previously, an excessive mortality or non-fatal cardiac arrest rate (7.7%) was seen in patients treated with encainide or flecainide compared with that seen in patients assigned to carefully matched placebo-treated groups (3.0%)."	0
"Antibiotics Compatibility has been demonstrated with vancomycin, cefazolin, ceftazidime, gentamicin, and netilmicin."	0
Removal of the negative feedback of angiotensinII causes a 2- to 3-fold rise in plasma renin activity and consequent rise in angiotensinII plasma concentration in hypertensive patients.	0
"The bioavailability of quetiapine is marginally affected by administration with food, with Cmax and AUC values increased by 25% and 15%, respectively."	1
"When possible, discontinue Effient at least 7days prior to any surgery (5.2)."	0
"Therefore, when AVALIDE (irbesartan-hydrochlorothiazide) tablets and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained."	0
CYMBALTA has an enteric coating that resists dissolution until reaching a segment of the gastrointestinal tract where the pH exceeds 5.5.	0
Oral drugs that have to be separated from Phoslyra Dosing Recommendations Flouroquinolones Take at least 2 hours before or 6 hours after Phoslyra Tetracyclines Take at least 1 hour before Phoslyra Levothyroxine Take at least 4 hours before or 4 hours after Phoslyra Oral medications not listed in the Table There are no empirical data on avoiding drug interactions between Phoslyra and most concomitant oral drugs.	0
Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses.	0
The dose-dependent side effects of verapamil have not been shown to be decreased by the addition of trandolapril nor vice versa.	0
"The plasma concentration of CMI has been reported to be increased by the concomitant administration of haloperidol; plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well."	1
Nefazodone should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.	0
Penicillin G exerts a bactericidal action against penicillin-susceptible microorganisms during the stage of active multiplication.	0
Nortriptyline hydrochloride is not approved for use in pediatric patients.	0
Thiazide may decrease serum protein-bound iodine (PBI) levels without sign of thyroid disturbance.	0
"Cyclosporine ( CYP3A substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine ."	0
"The effect of water administration following 10 mg sublingual SAPHRIS dosing was studied at different time points of 2, 5, 10, and 30 minutes in 15 healthy adult male subjects."	0
The possible combined hypotensive effects of Marplan and spinal anesthesia should be kept in mind.	0
Studies with radiolabeled drug have demonstrated that up to 92% of the orally administered dose is recovered in urine.	0
Use in Patients with Concomitant Illness: Clinical experience with paroxetine in patients with certain concomitant systemic illness is limited.	0
Subgroup analyses did not indicate differences in treatment outcomes as a function of race or gender.	0
"Sedative/hypnotics: Midazolam, triazolam POTENTIAL for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression. a See Clinical Pharmacology (12.3) Tables 10, 11, 12, or 13 for magnitude of interaction."	0
"Drug Interaction Studies Additional reductions in blood pressure may occur when FLOLAN is administered with diuretics, antihypertensive agents, or other vasodilators."	0
"Irbesartan-Hydrochlorothiazide In double-blind clinical trials of various doses of irbesartan and hydrochlorothiazide, the incidence of hypertensive patients who developed hypokalemia (serum potassium <3.5 mEq/L) was 7.5% versus 6.0% for placebo; the incidence of hyperkalemia (serum potassium >5.7 mEq/L) was <1.0% versus 1.7% for placebo."	0
"If the dose is increased to 20 mg, this should occur after a minimum of three weeks."	0
Consider administration of platelet concentrates in cases where thrombocytopenia is present or long-acting antiplatelet drugs have been used.	0
"In a study of 8 healthy male volunteers, following a 14-day administration of bupropion 100 mg three times per day, there was no evidence of induction of its own metabolism."	0
"In clinical trials, 55 hypertensive patients were treated with >500mL of Cleviprex infusion per 24 hour period."	0
Ventavis has the potential to increase the hypotensive effect of vasodilators and antihypertensive agents ( 7.2 ) .	0
Its stereospecific metabolites contribute to the pharmacologic activity.	0
"All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases."	0
REYATAZ Once Daily Dosage Ritonavir Once Daily Dosage Treatment-Naive Adult Patients recommended regimen 300 mg 100 mg unable to tolerate ritonavir 400 mg N/A in combination with efavirenz 400 mg 100 mg Treatment-Experienced Adult Patients recommended regimen 300 mg 100 mg in combination with both H2RA and tenofovir DF 400 mg 100 mg The recommended daily dosage of REYATAZ capsules and ritonavir in pediatric patients (6 years of age to less than 18 years of age) is based on body weight.	0
"The concomitant use of verapamil or the cation transport system inhibitors cimetidine, trimethoprim (alone or in combination with sulfamethoxazole), or ketoconazole with TIKOSYN is contraindicated, as each of these drugs cause a substantial increase in dofetilide plasma concentrations."	1
There has been a report of increased quinidine levels during verapamil therapy.	1
Pregnancy Category D Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.	0
Studies in rats indicate that lisinopril crosses the blood-brain barrier poorly.	0
"Approximately 57% and 30% of the dose was recovered in the urine and feces, respectively."	0
The risk of TdP can be reduced by controlling the plasma concentration through adjustment of the initial dofetilide dose according to creatinine clearance and by monitoring the ECG for excessive increases in the QT interval.	0
Losartan is an orally active agent that undergoes substantial first-pass metabolism by cytochrome P450 enzymes.	0
32 <U+2013>19 <U+2013>28 +8 <U+2013>33 <U+2013>25 <U+2013>7 40 mg q.p.m.	0
Further reductions in dosage to prevent the accumulation of toxic concentrations in the blood may also be desirable.	0
"Gender: Plasma concentrations of LIPITOR in women differ from those in men (approximately 20% higher for Cmax and 10% lower for AUC); however, there is no clinically significant difference in LDL-C reduction with LIPITOR between men and women."	0
"The therapeutic benefits and adverse effects of risperidone in patients receiving quinidine have not been evaluated, but observations in a modest number (n<U+2245>70) of poor metabolizers given risperidone do not suggest important differences between poor and extensive metabolizers."	0
Thioridazine hydrochloride is not approved for the treatment of patients with dementia-related psychosis.	0
Concentrations of doxorubicin may be increased by the administration of verapamil.	1
Starting Dose for Adult Patients Not Taking a Phosphate Binder.	0
"Since atenolol is excreted via the kidneys, TENORETIC should be used with caution in patients with impaired renal function."	0
"In patients with creatinine clearance <U+2264> 30 mL/min, peak benazeprilat levels and the initial (alpha phase) half-life increase, and time to steady-state may be delayed."	0
"If the angina worsens or acute coronary insufficiency develops, it is recommended that TENORMIN be promptly reinstituted, at least temporarily."	0
"Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors ( COX-2 Inhibitors ) : In patients who are elderly , volume-depleted ( including those on diuretic therapy ) , or with compromised renal function , coadministration of NSAIDs , including selective COX-2 inhibitors , with angiotensin II receptor antagonists , including valsartan , may result in deterioration of renal function , including possible acute renal failure ."	0
Dosage adjustment: See respective sections pertaining to dosage adjustment in special situations (2.5).	0
"However, as with any antihypertensive agent, blood pressure lowering should be accomplished over as long a time as is compatible with the patient's clinical status."	0
"When other antiplatelet agents or anticoagulants are used concomitantly, there is a potential for FLOLAN to increase the risk of bleeding."	0
"CARDIZEM is contraindicated in (1) patients with sick sinus syndrome except in the presence of a functioning ventricular pacemaker, (2) patients with second- or third-degree AV block except in the presence of a functioning ventricular pacemaker, (3) patients with hypotension (less than 90 mm Hg systolic), (4) patients who have demonstrated hypersensitivity to the drug, and (5) patients with acute myocardial infarction and pulmonary congestion documented by x-ray on admission."	0
"Warfarin - Administration of 40 mg/day Celexa for 21 days did not affect the pharmacokinetics of warfarin, a CYP3A4 substrate."	0
"Monitor such patients closely, particularly when initiating and titrating Meperidine Hydrochloride Injection and when Meperidine Hydrochloride Injection is given concomitantly with other drugs that depress respiration."	0
"Although not studied in vitro or in vivo, concomitant administration of fluconazole with quinidine may result in inhibition of quinidine metabolism."	1
Administration rates greater than 50 mcg/kg/min have safely been used in adults in advanced circulatory decompensation states.	0
Patients were titrated with mirtazapine from a dose range of 5 mg up to 35 mg/day.	0
"In elderly patients, the clearance of fluvoxamine was reduced by about 50% and, therefore, fluvoxamine maleate tablets should be slowly titrated during initiation of therapy."	0
"No initial dosage adjustment is necessary for elderly patients or for patients with renal impairment, including patients on dialysis."	0
"Do not use EXTRANEAL if it is cloudy or discolored, if it contains particulate matter, or if the container is leaking."	0
Dosage of dopamine should be adjusted according to the patient's response.	0
Avoid concomitant use of St. John's Wort because it can decrease vandetanib exposure unpredictably.	1
"In patients taking the HIV protease inhibitor nelfinavir or the hepatitis C protease inhibitor boceprevir, the dose of LIPITOR should not exceed 40 mg and close clinical monitoring is recommended."	1
"Doses higher than 20 mg usually do not increase efficacy, however a few patients may benefit from further increases up to a daily dose of 40 mg given in divided doses."	0
No dosage adjustment is necessary in the elderly.	0
"Some azoles, including fluconazole, have been associated with prolongation of the QT interval on the electrocardiogram."	0
"Other Agents Antiarrhythmics: For contraindicated antiarrhythmics, , mexiletine, propafenone, quinidine <U+2191> antiarrhythmics Therapeutic concentration monitoring, if available, is recommended for antiarrhythmics when co-administered with PREZISTA/ritonavir. digoxin <U+2191> digoxin The lowest dose of digoxin should initially be prescribed."	0
"Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) including selective Cyclooxygenase-2 inhibitors (COX-2 inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors with agents that affect the RAAS, including aliskiren, may result in deterioration of renal function, including possible acute renal failure."	0
"However, prior to initiating treatment with an antidepressant, patients with depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression."	0
Monitor serum lithium levels during concomitant use.	0
Frequent monitoring of trough blood levels of cyclosporine and tacrolimus is recommended and adjust the dose when appropriate.	0
The drug-drug interaction potential of ledipasvir is primarily limited to the intestinal inhibition of P-gp and BCRP.	0
"Confirmatory tests, such as gas chromatography/mass spectrometry, will distinguish rifampin from opiates."	0
Beta blockers may exacerbate the rebound hypertension which can follow the withdrawal of clonidine.	0
These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24; there was a reduction in risk with antidepressant use in patients aged 65 and older.	0
"Hemodialysis patients have 33 and 36% increases in the mean unbound fraction of pitavastatin as compared to healthy volunteers and patients with moderate renal impairment, respectively."	0
"Clevidipine does not reduce cardiac filling pressure (pre-load), confirming lack of effects on the venous capacitance vessels."	0
Kinetic data indicate that the apparent elimination half-life of quinaprilat increases as creatinine clearance decreases.	0
"In adult placebo-controlled trials in patients with major depressive disorder, activation of mania or hypomania was reported in 0.1% (4/3779) of CYMBALTA-treated patients and 0.04% (1/2536) of placebo-treated patients."	0
"If angina or acute coronary insufficiency develops, appropriate therapy should be instituted promptly."	0
"Alosetron: See CONTRAINDICATIONS (4), WARNINGS AND PRECAUTIONS (5.7), and Lotronex<U+00AE> (alosetron) package insert."	0
"XARELTO affects INR , so INR measurements made during coadministration with warfarin may not be useful for determining the appropriate dose of warfarin ."	0
Renal blood flow and glomerular filtration rate remain essentially unchanged.	0
Altered pharmacokinetics of other drugs: Quinidine slows the elimination of digoxin and simultaneously reduces digoxin's apparent volume of distribution.	1
"The plasma protein binding of lidocaine is dependent on drug concentration, and the fraction bound decreases with increasing concentration."	0
"Serious, sometimes fatal, reactions with signs and symptoms that may include hyperthermia, rigidity, myoclonus, autonomic instability with rapid fluctuations of the vital signs, and mental status changes that include extreme agitation progressing to delirium and coma have been reported with patients receiving a combination of fluoxetine hydrochloride and non-selective MAOIs."	0
"Cyclosporine (CYP3A substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine, despite reduction in dose of cyclosporine."	0
PPI associated SLE is usually milder than non-drug induced SLE.	0
Clinically significant effects have been reported with the tricyclic antidepressants when used concomitantly with cimetidine.	0
"In addition, do not start LUVOX CR Capsules in a patient who is being treated with linezolid or intravenous methylene blue (4.1)."	0
"Pooled analyses of short-term placebo-controlled trials of antidepressant drugs (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18 to 24) with major depressive disorder (MDD) and other psychiatric disorders."	0
Monitor renal function periodically in these patients.	0
"The mirtazapine dose may have to be decreased when concomitant treatment with cimetidine is started, or increased when cimetidine treatment is discontinued."	1
Reduced exposure to asenapine was observed following water administration at 2 minutes (19% decrease) and 5 minutes (10% decrease).	1
To assure safe and effective use of D.H.E.	0
"The actual neurochemical mechanism is unknown, but CMI's capacity to inhibit the reuptake of serotonin (5-HT) is thought to be important."	0
The standard recommended dose of INVIRASE is 1000-mg twice daily (5 <U+00D7> 200-mg capsules or 2 <U+00D7> 500-mg tablets) in combination with ritonavir 100-mg twice daily.	0
Consult the full prescribing information prior to and during treatment for potential drug interactions.	0
Amlodipine Peak plasma concentrations of amlodipine are reached 6 to 12 hours after administration of amlodipine alone.	0
The elimination half-life of dronedarone ranges from 13 to 19 hours.	0
"There is usually a small increase in heart rate, a reflex response to vasodilation."	0
"For convenience, patients who are adequately treated with 20 mg of quinapril and 25 mg of hydrochlorothiazide and experience no significant electrolyte disturbances may instead wish to receive ACCURETIC 20/25."	0
"Such symptoms should be reported to the patient<U+2019>s prescriber or health professional, especially if they are severe, abrupt in onset, or were not part of the patient<U+2019>s presenting symptoms."	0
"HMG-CoA reductase inhibitors lovastatin, simvastatin Potential for serious reactions such as myopathy including rhabdomyolysis.For dosing recommendation regarding atorvastatin, pravastatin and rosuvastatin, see Table 11: Established and Other Potentially Significant Drug Interactions: Alterations in Dose or Regimen May Be Recommended Based on Drug Interaction Studies or Predicted Interaction."	0
It may be necessary to lower the dose of TOPROL-XL or temporarily discontinue it.	0
"In a food effect study, LATUDA mean Cmax and AUC were about 3-times and 2-times, respectively, when administered with food compared to the levels observed under fasting conditions."	1
"Patients should be cautioned about the risk of bleeding associated with the concomitant use of CYMBALTA and NSAIDs, aspirin, or other drugs that affect coagulation (5.5, 7.4) Severe Skin Reactions: Severe skin reactions, including erythema multiforme and Stevens-Johnson Syndrome (SJS), can occur with CYMBALTA."	0
"In addition, 150 adolescent patients have received Anafranil in open-label protocols for periods of several months to several years."	0
WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning.	0
"The rate and extent of absorption of quinapril and hydrochlorothiazide from ACCURETIC tablets are not different, respectively, from the rate and extent of absorption of quinapril and hydrochlorothiazide from immediate-release monotherapy formulations, either administered concurrently or separately."	0
"CARDIZEM CD Capsules: When compared to a regimen of CARDIZEM tablets at steady-state, more than 95% of drug is absorbed from the CARDIZEM CD formulation."	0
"Promptly evaluate any signs or symptoms of blood loss if patients are treated concomitantly with aspirin, other platelet aggregation inhibitors, or NSAIDs [see Warnings and Precautions (5.2)]."	0
"Generalized Anxiety Disorder The effectiveness of paroxetine in the treatment of Generalized Anxiety Disorder (GAD) was demonstrated in two 8-week, multicenter, placebo-controlled studies (Studies 1 and 2) of adult outpatients with Generalized Anxiety Disorder (DSM-IV)."	0
It is recommended that patients being considered for thioridazine treatment have a baseline ECG performed and serum potassium levels measured.	0
In vitro dronedarone and the metabolites SR35021 and SR90154 show no significant potential to inhibit the organic anion transporters OAT1 and OAT3 or the organic cation transporter OCT1.	0
"Grapefruit juice was administered with breakfast for 3 days, and lovastatin was administered in the evening on Day 3. for 4 days 40 mg single dose 1.94 1.57 Cyclosporine 16 Not describedCyclosporine-treated patients with psoriasis or post kidney or heart transplant patients with stable graft function, transplanted at least 9 months prior to study."	0
"In general, avoid combined use of RAS inhibitors."	0
Thioridazine: See CONTRAINDICATIONS and WARNINGS.	0
"Pigmentary retinopathy, which has been observed primarily in patients taking larger than recommended doses, is characterized by diminution of visual acuity, brownish coloring of vision, and impairment of night vision; examination of the fundus discloses deposits of pigment."	0
"When 330 mg aspirin/kg/day was combined with 75 mg dipyridamole/kg/day in the rat, the resorption rate approached 100%, indicating potentiation of aspirin-related fetal toxicity."	0
"To reduce this risk, consider coverage with another anticoagulant if PRADAXA is discontinued for a reason other than pathological bleeding or completion of a course of therapy (2.4, 2.5, 2.6, 5.1)."	0
"Antidepressant:bupropion <U+2193> bupropion <U+2193> active metabolite, hydroxybupropion Patients receiving ritonavir and bupropion concurrently should be monitored for an adequate clinical response to bupropion."	0
"Caution should be used when prescribing with fluvastatin (5.1, 7.3, 7.4) Glyburide: Monitor blood glucose levels when fluvastatin dose is changed (7) Phenytoin: Monitor plasma phenytoin levels when fluvastatin treatment is initiated or when the dosage is changed (7) Warfarin and coumarin derivates: Monitor prothrombin times when fluvastatin coadministration is initiated, discontinued, or the dosage changed (7) Cyclosporine coadministration increases fluvastatin exposure."	0
"Benzodiazepines, including QUAZEPAM, produce additive CNS depressant effects when co-administered with ethanol or other CNS depressants (e.g. psychotropic medications, anticonvulsants, antihistamines)."	0
Mechanisms of Action Hypertension: CARDIZEM CD produces its antihypertensive effect primarily by relaxation of vascular smooth muscle and the resultant decrease in peripheral vascular resistance.	0
"In case of withdrawal of corticosteroids, progressive dose reduction may have to be performed over a longer period."	1
"Under steady-state conditions, diazepam does not appear to affect paroxetine kinetics."	0
"Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality."	0
"There are no well-controlled studies in pregnant women; therefore, use CARDIZEM in pregnant women only if the potential benefit justifies the potential risk to the fetus."	0
<U+2022> Pediatric patients: REYATAZ capsule dosage is based on body weight not to exceed the adult dose and must be taken with food.	0
"In addition to raising urinary pH and citrate, potassium citrate extended-release tablets increase urinary potassium by approximately the amount contained in the medication."	0
"When CARDIZEM CD was coadministered with a high fat content breakfast, the extent of diltiazem absorption was not affected."	0
"Both metabolites have biological activity, especially the 5-mononitrate."	0
"Renal impairment Consistent with the low renal excretion of dronedarone, no pharmacokinetic difference was observed in subjects with mild or moderate renal impairment compared to subjects with normal renal function."	0
"Thalitone<U+00AE> (chlorthalidone USP) has been formulated with PVP (povidone polyvinylpyrrolidone), a bioavailability enhancer that provides 104% to 116% bioavailability relative to an oral solution of chlorthalidone."	0
"In patients with chronic stable angina, intravenous administration of 10 mg did not significantly alter A-H and H-V conduction and sinus node recovery time after pacing."	0
"Furthermore, whenever one of these drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant agent may be required."	0
"Drug interactions Sildenafil: When amlodipine and sildenafil were used in combination, each agent independently exerted its own blood pressure lowering effect."	0
Most patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy.	0
"Changes in mean peak plasma levels were less pronounced, approximately 12% to 26% higher in subjects with impaired renal function."	0
"3.Using a syringe with a 1-inch long, 25- to 19-gauge needle, puncture the medication port and inject additive."	0
"Some patients with paroxysmal and/or chronic atrial fibrillation or atrial flutter and a coexisting accessory AV pathway have developed increased antegrade conduction across the accessory pathway bypassing the AV node, producing a very rapid ventricular response or ventricular fibrillation after receiving intravenous verapamil (or digitalis)."	0
"Established and Other Potentially Significant Drug Interactions Concomitant Drug Class: Drug Name Effect on Concentration of Ritonavir or Concomitant Drug Clinical Comment HIV-Antiviral Agents HIV-1 Protease Inhibitor:atazanavirdarunavirfosamprenavir <U+2191> amprenavir<U+2191> atazanavir<U+2191> darunavir See the complete prescribing information for fosamprenavir, atazanavir, darunavir for details on co-administration with ritonavir."	0
"Agents for Opportunistic Infections Antifungals: FluconazoleItraconazoleKetoconazoleVoriconazole <U+2191> Tipranavir, <U+2194> Fluconazole Fluconazole increases tipranavir concentrations but dose adjustments are not needed."	1
"The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the Caucasian population (about 7% to 10% of Caucasians are so called ""poor metabolizers""); reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are not yet available."	0
Dose should be individualized by titration.	0
Alcohol: May potentiate orthostatic hypotension.	0
"Many additional metabolites have been identified in urine, some representing only minor pathways of elimination."	0
"Tasigna should not be used in patients who have hypokalemia, hypomagnesemia or long QT syndrome."	0
Oral sotalol has been used in a controlled trial following an acute myocardial infarction without evidence of increased mortality.	0
Bolus Volume (mL) = Patient Weight (kg) / 3 Table 1: NATRECOR<U+00AE> Weight-Adjusted Bolus Volume Administered Over 60 Seconds (Final Concentration = 6 mcg/mL) Patient Weight (kg) Volume of Bolus (mL=kg/3) 60 20.0 70 23.3 80 26.7 90 30.0 100 33.3 110 36.7 Step 2.	0
"AHA reversibly inhibits the bacterial enzyme urease, thereby inhibiting the hydrolysis of urea and production of ammonia in urine infected with urea-splitting organisms."	0
"The active isomer (d-nebivolol) has an effective half-life of about 12 hours in CYP2D6 extensive metabolizers (most people), and 19 hours in poor metabolizers and exposure to d-nebivolol is substantially increased in poor metabolizers."	0
"Periodically assess renal function as clinically indicated (i.e., more frequently in clinical situations that may be associated with a decline in renal function) and adjust therapy accordingly."	0
"There is no pharmacokinetic interaction between zaleplon and diphenhydramine following the administration of a single dose (10 mg and 50 mg, respectively) of each drug."	0
Women receiving PURIXAN in the first trimester of pregnancy have an increased incidence of abortion.	0
"Metabolism and Elimination Following a single oral dose of 14C-quetiapine, less than 1% of the administered dose was excreted as unchanged drug, indicating that quetiapine is highly metabolized."	0
The plasma-protein binding is independent of concentration over the therapeutic range.	0
Erythromycin co-administration in healthy volunteers did not significantly change amlodipine systemic exposure.	0
"In most cases, elevated serum potassium levels were isolated values which resolved despite continued therapy."	0
"Focalin XR is contraindicated in patients known to be hypersensitive to methylphenidate, or other components of the product."	0
"However, a One Generation Study in the rat approximated composition of DYAZIDE by using a 1:1 ratio of triamterene to hydrochlorothiazide (30:30mg/kg/day); there was no evidence of teratogenicity at those doses which were, on a body-weight basis, 15 and 30times, respectively, the MRHD, and on the basis of body surface area, 3.1 and 6.2times, respectively, the MRHD."	0
Data with other histamine-2 antagonists are not available.	0
"In most cases, PROCARDIA titration should proceed over a 7<U+2013>14 day period so that the physician can assess the response to each dose level and monitor the blood pressure before proceeding to higher doses."	0
Lithium toxicity has been reported in patients receiving lithium concomitantly with Lotensin.	1
"However, prior to initiating treatment with an antidepressant, patients with depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression."	0
"To avoid potentiation, the physician wishing to terminate treatment with Marplan and begin therapy with another agent should allow for an interval of 10days."	0
"If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus."	0
"In those patients who discontinued protease inhibitor therapy, hyperglycemia persisted in some cases."	0
"Postural hypotension occurred in 1.8% and syncope in 0.1% of hypertensive subjects, primarily following the initial dose or at the time of dose increase and was a cause for discontinuation of therapy in 1% of subjects."	0
"Study outcome was assessed by (a) the Liebowitz Social Anxiety Scale (LSAS), a 24-item clinician administered instrument that measures fear, anxiety and avoidance of social and performance situations, and by (b) the proportion of responders as defined by the Clinical Global Impression of Improvement (CGI-I) criterion of CGI-I <U+2264> 2 (very much or much improved)."	0
Use with ritonavir and other potent CYP3A inhibitors: Not recommended.	0
Metabolism and Elimination: Direct glucuronidation by UGT1A4 and oxidative metabolism by cytochrome P450 isoenzymes (predominantly CYP1A2) are the primary metabolic pathways for asenapine.	0
"Other: trazodone <U+2191> trazodone Antifungals:itraconazole, ketoconazole, posaconazole <U+2191> darunavir<U+2191> itraconazole(not studied)<U+2191> ketoconazole<U+2194> posaconazole (not studied) Monitor for increased PREZISTA/ritonavir adverse events with concomitant use of itraconazole, ketoconazole, or posaconazole."	0
Concomitant use of paroxetine with SAPHRIS increased the paroxetine exposure by 2-fold as compared to use paroxetine alone.	1
"These changes may result in increased adverse events, or delayed or more rapid onset of activity, depending upon the nature of the switch."	0
"Caution is indicated in treating patients whose underlying medical conditions might be compromised by increases in blood pressure or heart rate, e.g., those with preexisting hypertension, heart failure, recent myocardial infarction, or ventricular arrhythmia."	0
Established and Other Potentially Significant Drug Interactions Concomitant Drug Class: Drug Name Effect on Concentration of Amprenavir or Concomitant Drug Clinical Comment HCV/HIV-Antiviral Agents HCV protease inhibitor: Boceprevir LEXIVA: <U+2193>Amprenavir (predicted) <U+2194> or <U+2193>Boceprevir (predicted) LEXIVA/ritonavir: <U+2193>Amprenavir (predicted) <U+2193>Boceprevir (predicted) Coadministration of LEXIVA or LEXIVA/ritonavir and boceprevir is not recommended.	0
"Patients should be cautioned about the risk of bleeding associated with the concomitant use of PRISTIQ and NSAIDs, aspirin, or other drugs that affect coagulation or bleeding."	0
Consider dose-increase and monitor for effectiveness more frequently.	0
"However, the LIFE study provides no evidence that the benefits of losartan potassium tablets on reducing the risk of cardiovascular events in hypertensive patients with left ventricular hypertrophy apply to Black patients."	0
"Subunit modulation of the GABA-BZ receptor chloride channel macromolecular complex is hypothesized to be responsible for some of the pharmacological properties of benzodiazepines, which include sedative, anxiolytic, muscle relaxant, and anticonvulsive effects in animal models."	0
Clinically significant adverse reactions from greater exposures of NORVIR.	0
Dosage adjustment of concomitant medications may be necessary.	0
Caution patients about risk of activation of mania/hypomania (5.6).	0
"A clinically significant fluvoxamine interaction is possible with drugs having a narrow therapeutic ratio such as pimozide, warfarin, theophylline, certain benzodiazepines, omeprazole and phenytoin."	0
Concurrent administration of propranolol (100 mg to 800 mg daily) has been reported to produce increases in plasma levels of thioridazine (approximately 50% to 400%) and its metabolites (approximately 80% to 300%).	1
Initiation of ELIQUIS is not recommended as an alternative to unfractionated heparin for the initial treatment of patients with PE who present with hemodynamic instability or who may receive thrombolysis or pulmonary embolectomy.	0
Digitalis: Administration of CARDIZEM with digoxin in 24 healthy male subjects increased plasma digoxin concentrations approximately 20%.	1
"If a gout flare occurs during ULORIC treatment, ULORIC need not be discontinued."	0
Discontinuation of Treatment with PEXEVA<U+00AE> (paroxetine mesylate): Symptoms associated with discontinuation of paroxetine have been reported.	0
"In the multiple dose studies, the prevalence of patients with sedation peaked following the first week of titration and then remained stable for the duration of the maintenance phase of the study."	0
Clinical studies of mercaptopurine did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
Oral bioavailability is unaffected by food or antacid.	0
Kaplan-Meier estimates of the time to fatal/nonfatal stroke in the groups treated with losartan potassium tablets and atenolol.	0
Acceleration of ventricular rate and/or ventricular fibrillation has been reported in patients with atrial flutter or atrial fibrillation and a coexisting accessory AV pathway following administration of verapamil.	0
Elevations of transaminases with and without concomitant elevations in alkaline phosphatase and bilirubin have been reported.	0
Starting SURMONTIL in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome.	0
Frequent monitoring for adverse events and toxicity related to methadone is recommended during coadministration.	0
"PDE-5 inhibitors, including sildenafil, may potentiate the hypotensive effects of riociguat."	0
Patients should be closely monitored when ROZEREM is coadministered with donepezil.	0
"If the patient develops these signs or symptoms, raise the dose to the previous level and taper more slowly, either by increasing the interval between decreases, decreasing the amount of change in dose, or both."	0
"The blood-to-plasma ratio for eszopiclone is less than one, indicating no selective uptake by red blood cells."	0
In patients with peptic ulcer disease because of its ulcerogenic potential.	0
"In another study in treatment-experienced subjects (SIRIUS), 0/15 (0%) subjects with NS5A polymorphisms at resistance-associated positions relapsed after 12 weeks of treatment with HARVONI + RBV compared to 2/15 (13%) subjects treated with 24 weeks of HARVONI."	0
"Tadalafil <U+2191> tadalafil concentration May result in an increase in PDE5 inhibitor-associated adverse events, including hypotension, visual disturbances, and priapism."	0
"Titrate more rapidly, however, if clinically warranted, provided the patient is assessed frequently."	0
CNS Acting Drugs: Caution should be used when taken in combination with other centrally acting drugs and alcohol.	0
"Therefore, CYP3A inhibitors such as verapamil, diltiazem, indinavir, ciprofloxacin, clarithromycin, and grapefruit juice are not expected to have a significant effect on the pharmacokinetics of the active metabolite of prasugrel."	0
"When administered intravenously, AGGRASTAT inhibits ex vivo platelet aggregation in a dose- and concentration-dependent manner."	0
"If it is almost time for the next dose, skip the missed dose and take the next dose at the regular time."	0
These symptoms can usually be avoided or reduced by gradual reduction of the dosage or by continuing concomitant anti-parkinsonism agents for several weeks after chlorpromazine is withdrawn.	1
"(see WARNINGS) Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
Rare cases of hypertensive reactions associated with ingestion of tyramine-containing foods have been reported in patients taking the recommended daily dose of selegiline.	0
"In controlled clinical trials, bisoprolol fumarate given as a single daily dose has been shown to be an effective antihypertensive agent when used alone or concomitantly with thiazide diuretics."	0
Cimetidine: Increases exposure to doxepin.	1
IMURAN should not be used for treating rheumatoid arthritis in pregnant women.	0
"To minimize relapse, maintenance therapy should be continued for about three months."	0
"When immediate-release fluvoxamine maleate tablets 100 mg twice daily were administered for 3 days prior to single-dose coadministration of ramelteon 16 mg and immediate-release fluvoxamine maleate tablets, the AUC for ramelteon increased approximately 190-fold and the Cmax increased approximately 70-fold compared to ramelteon administered alone."	1
"Although a causal link between the emergence of such symptoms and either the worsening of depression and/or the emergence of suicidal impulses has not been established, there is concern that such symptoms may represent precursors to emerging suicidality."	0
"Despite the large size of the ISIS-1 trial, it is not possible to identify clearly subgroups of patients most likely or least likely to benefit from early treatment with atenolol."	0
Diltiazem-associated prolongation of the AH interval is not more pronounced in patients with first-degree heart block.	0
"Monitor closely for adverse reactions.Reduce rifabutin dosage further, as needed."	0
"Some patients with hypertension or heart failure with no apparent pre-existing renal vascular disease have developed increases in blood urea and serum creatinine , usually minor and transient , especially when VASOTEC has been given concomitantly with a diuretic ."	0
Drug Interactions A summary of the effect of coadministered drugs on dabigatran exposure is shown in Figures 3.1 and 3.2.	0
"In adult placebo-controlled clinical trials, seizures/convulsions occurred in 0.02% (3/12,722) of patients treated with CYMBALTA and 0.01% (1/9513) of patients treated with placebo."	0
Paroxetine does not alter the in vitro protein binding of phenytoin or warfarin.	0
Dabigatran etexilate is a substrate of the efflux transporter P-gp.	0
"Silenor exposure is doubled with concomitant administration of cimetidine, a nonspecific inhibitor of CYP isozymes."	1
"Few adequate, well-controlled studies evaluating the potential for metabolic and/or pharmacologic interactions between botanicals and COUMADIN exist."	0
Recommended Dosage for Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) (2.1) EMEND capsules in adults and pediatric patients 12 years of age and older: is 125 mg on Day 1 and 80 mg on Days 2 and 3.	0
Interactions with general or local anesthetics have not been studied.	0
"Because of the 19-day half-life, adverse reactions including a prolonged QT interval may not resolve quickly."	0
"Because the potential for HIV-1 cross-resistance among protease inhibitors has not been fully explored in APTIVUS/ritonavir treated patients, it is unknown what effect therapy with APTIVUS will have on the activity of subsequently administered protease inhibitors."	0
"Dosage reduction for midazolam should be considered, especially if more than a single dose of midazolam is administered."	1
No teratogenic effects of quinapril were seen in studies of pregnant rats and rabbits.	0
"Non-steroidal Anti-inflammatory Drugs <U+2013> In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium sparing and thiazide diuretics."	0
"Based on a population analysis, the apparent volume of distribution of paliperidone is 487 L. The plasma protein binding of racemic paliperidone is 74%."	0
"The following dose adjustments are recommended for the use of ADCIRCA<U+00AE> (tadalafil) with REYATAZ: Coadministration of ADCIRCA<U+00AE> in patients on REYATAZ (with or without ritonavir): <U+2022>For patients receiving REYATAZ (with or without ritonavir) for at least one week, start ADCIRCA<U+00AE> at 20 mg once daily."	0
"To help monitor potential complications, the following tests are recommended: peripheral blood counts, direct platelet count, hemoglobin, serum albumin, liver function tests, 24-hour urinary protein and routine urinalysis at 3- 6 month intervals during treatment."	0
Table 2: Sotalol Infusion Preparation to Compensate for Dead Space in Infusion Set Target Dose Sotalol Injection Diluent Volume Prepared Volume to Infuse 75 mg 6 mL 114 mL 120 mL 100 mL 112.5 mg 9 mL 111 mL 100 mL 150 mg 12 mL 108 mL 100 mL 75 mg 6 mL 294 mL 300 mL 250 mL 112.5 mg 9 mL 291 mL 250 mL 150 mg 12 mL 288 mL 250 mL The starting dose of intravenous sotalol is 75 mg infused over 5 hours once or twice daily based on the creatinine clearance.	0
"There were no instances of withdrawal delirium, withdrawal associated hallucinations, or any other manifestations of severe sedative/hypnotic withdrawal."	0
"In such patients, dialysis must be stopped immediately, and aggressive therapy for anaphylactoid reactions must be initiated."	0
The absolute bioavailability of olmesartan is approximately 26%.	0
Examination of age and gender subsets of the population did not reveal any differential responsiveness on the basis of these subgroupings.	0
"Age group Cmax (ng/mL) T max * (h) AUC 0-inf (ng/mL*h) CL/F/wt (L/h/Kg) T 1/2 (h) >1 to <U+2264> 24months 277 1 1328 0.26 5.0 n=5 (192,391) (0.6,2) (773,2117) (0.18,0.4) (4,5.8) >2 to <U+2264> 6years 200 2 978 0.36 5.5 n=7 (168,244) (1.4,2.4) (842,1152) (0.31,0.42) (4.7,6.5) >6 to <U+2264> 12years 221 2 1041 0.25 5.5 n=7 (194,258) (1.2,2.2) (855,1313) (0.21,0.31) (4.7,6.5) >12 to <U+2264> 17years 287 2 1794 0.16 5.1 n=8 (217,420) (1.3,2.3) (1478,2340) (0.13,0.21) (4.2,5.7)"	0
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.	0
Pathological changes in the parathyroid gland with hypercalcemia and hypophosphatemia have been observed in a few patients on prolonged thiazide therapy.	0
"For patients with possible depletion of intravascular volume (e.g., patients treated with diuretics, particularly those with impaired renal function), initiateBenicar under close medical supervision and giveconsideration to use of a lower starting dose."	0
A non-controlled study of 151 Chinese outpatients stabilized on warfarin for various indications reported a mean daily warfarin requirement of 3.3 <U+00B1> 1.4 mg to achieve an INR of 2 to 2.5.	0
"Therefore, coadministration with food must be avoided and concomitant use with strong CYP3A4 inhibitors and/or medicinal products with a known potential to prolong QT should be avoided [see Warnings and Precautions (5."	0
"It may also be useful to periodically monitor ECG<U+2019>s and serum potassium during thioridazine treatment, especially during a period of dose adjustment."	0
Women using estrogens may have an increased risk of non-serious rash.	0
Treatment with COREG may be started as an inpatient or outpatient and should be started after the patient is hemodynamically stable and fluid retention has been minimized.	0
"Because of these risks, reserve concomitant prescribing of these drugs for use in patients for whom alternative treatment options are inadequate."	0
"The antihypertensive effect of quinapril continues during long-term therapy, with no evidence of loss of effectiveness."	0
There was a high prevalence of baseline lenticular opacities in the patient population included in the early clinical trials with lovastatin.	0
"Except for some dryness of the eyes, no drug-related abnormal ophthalmological findings were recorded and, according to specialized tests such as electroretinography and macular dazzle, retinal function was unchanged."	0
"The use of CARDURA is contraindicated in patients with a hypersensitivity to doxazosin, other quinazolines (e.g., prazosin, terazosin), or any of its components."	0
Metoprolol - Administration of 40 mg/day Celexa for 22 days resulted in a two-fold increase in the plasma levels of the beta-adrenergic blocker metoprolol.	1
CNS stimulants cause an increase in blood pressure (mean increase about 2-4 mm Hg) and heart rate (mean increase about 3-6 bpm).	0
"Consequently, the recommended dosage regimens are furnished as a guide which may be modified by factors such as the age of the patient, chronicity and severity of the disease, medical condition of the patient, and degree of psychotherapeutic support."	0
"Coadministration of Celexa (40 mg/day for 10 days) with the TCA imipramine (single dose of 100 mg), a substrate for CYP2D6, did not significantly affect the plasma concentrations of imipramine or citalopram."	0
Itraconazole: Atorvastatin AUC was significantly increased with concomitant administration of atorvastatin 40 mg and itraconazole 200 mg.	1
"Use of REYATAZ without ritonavir is not recommended when coadministered with drugs highly dependent on CYP2C8 with narrow therapeutic indices (eg, paclitaxel, repaglinide)."	0
"When the CYP3A4 inducer is discontinued, the dose of quetiapine should be reduced to the original level within 7 to 14 days."	1
"There was considerable variation in risk of suicidality among drugs, but a tendency toward an increase in the younger patients for almost all drugs studied."	0
Gender - Pharmacokinetics of prasugrel's active metabolite are similar in men and women.	0
The primary treatment is to discontinue drug intake as rapidly as possible.	0
"Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8 fold increase in plasma AUC of the TCA)."	1
The effect that symptomatic suppression has upon the long-term course of the syndrome is unknown.	0
"The apparent volume of distribution in neonates is reported as 0.6 to 4 L/kg, leading to an elimination half-life of 5 to 11 minutes."	0
"Cytochrome P450IID6 is an enzyme critical to the metabolism of many drugs, notably including mexiletine, some phenothiazines, and most polycyclic antidepressants."	0
Empty the contents of four RIFADIN 300 mg capsules or eight RIFADIN 150 mg capsules onto a piece of weighing paper.	0
"In patients receiving antidepressants with pharmacological properties similar to nefazodone in combination with a monoamine oxidase inhibitor (MAOI), there have been reports of serious, sometimes fatal, reactions."	0
These effects are similar to those seen in animal studies.	0
The increase in pimozide AUC and Cmax is related to the CYP 2D6 inhibitory properties of paroxetine.	1
"At least one week after starting REYATAZ (with or without ritonavir), resume ADCIRCA<U+00AE> at 20 mg once daily."	0
Discontinue CAPRELSA for severe skin reactions.	0
"Smooth muscle of the ductus arteriosus is especially sensitive to alprostadil, and strips of lamb ductus markedly relax in the presence of the drug."	0
Animal reproduction studies to determine the potential for fetal harm by DYAZIDE have not been conducted.	0
"In another trial, the pharmacokinetics of abiraterone were examined in subjects with baseline severe (N=8) hepatic impairment (Child-Pugh Class C) and in 8 healthy control subjects with normal hepatic function."	0
A dose reduction of diltiazem by 50% should be considered.	1
"In congestive heart failure patients with impaired left ventricular function, nicardipine increased cardiac output both at rest and during exercise."	0
"In TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel), patients with a history of TIA or ischemic stroke (>3 months prior to enrollment) had a higher rate of stroke on Effient (6.5%; of which 4.2% were thrombotic stroke and 2.3% were intracranial hemorrhage [ICH]) than on clopidogrel (1.2%; all thrombotic)."	0
Demethylation and hydroxylation at the phenol ring produce 3 active metabolites with <U+03B2>-receptor blocking activity.	0
Avoid use of aliskiren with AVAPRO in patients with renal impairment (GFR <60 mL/min).	0
The blood pressure effect of SULAR tended to be greater in patients on atenolol than in patients on no other antihypertensive therapy.	0
Pregnancy Category D.	0
"If a higher dose is needed, ECG monitoring should be maintained during the initiation of therapy and at appropriate intervals during stabilization of dose."	0
"Pre-existing glaucoma is almost always open-angle glaucoma because angle-closure glaucoma, when diagnosed, can be treated definitively with iridectomy."	0
Aggressive behavior or hostility should be monitored.	0
MAXALT should not be prescribed to propranolol-treated pediatric patients who weigh less than 40 kg (88 lb).	0
It is likely that this experience underestimates the degree of risk that might occur with higher doses of thioridazine.	0
"As shown in Table 5, the 41 patients with pharmacokinetic data were divided into 2 groups, patients 1 month to 4 months of age and patients 5 to 24 months of age, and are compared to pediatric patients 3 to 12 years of age."	0
"Following an oral administration, the mean apparent total clearance of levomilnacipran is 21-29 L/h."	0
These data indicate that sertraline<U+2019>s extent of inhibition of P450 3A4 activity is not likely to be of clinical significance.	0
"This drug should be administered intravenously only if a narcotic antagonist (i.e., naloxone) and the facilities for assisted or controlled respiration are immediately available."	0
The concomitant use of PRISTIQ with MAOIs intended to treat psychiatric disorders is contraindicated.	0
Cases of interstitial lung disease including pneumonitis and pulmonary fibrosis have been reported in patients treated with MULTAQ in the postmarketing setting.	0
Treatment with nortriptyline hydrochloride oral solution USP and any concomitant serotonergic agents should be discontinued immediately if the above events occur and supportive symptomatic treatment should be initiated.	0
Fever should be managed by means of external cooling.	0
Place the sevelamer carbonate powder in a cup and suspend in the amount of water described in Table 4.	0
"Recommended Dosage (2.3) Infection Loading dose Maintenance Dose IV IV Oral Invasive Aspergillosis 6 mg/kg q12h for the first 24 hours 4 mg/kg q12h 200 mg q12h Candidemia in nonneutropenics and other deep tissue Candida infections 3<U+2013>4 mg/kg q12h 200 mg q12h Scedosporiosis and Fusariosis 4 mg/kg q12h 200 mg q12h Esophageal Candidiasis Not Evaluated not evaluated 200 mg q12h Adult patients weighing less than 40 kg: oral maintenance dose 100 or 150 mg q12 hours See full prescribing information for instructions on reconstitution of lyophilized powder for intravenous use and reconstitution of oral suspension and important administration instructions (2.5, 2.6) VFEND Tablets or Oral Suspension should be taken at least one hour before or after a meal. for Injection requires reconstitution to 10 mg/mL and subsequent dilution to 5 mg/mL or less prior to administration as an infusion, at a maximum rate of 3 mg/kg per hour over 1 to 2 hours."	0
"Closely monitor response in patients with angina (5.3), congestive heart failure (5.4), impaired hepatic function (5.5), portal hypertension (5.5), and renal impairment (5.6) and pheochromocytoma (5.9)."	0
Other risk factors for bleeding are: Age <U+2265>75years.	0
13.Discard the mixing cup along with any remaining suspension.	0
Safety and effectiveness of antiarrhythmic use in pediatric patients have not been established.	0
In vitro studies found ambrisentan to have little to no inhibition of human hepatic transporters.	0
"Administer EMEND 1 hour prior to chemotherapy on Days 1, 2, and 3."	0
"Dose adjustment may be required for hematologic and non-hematologic toxicities, and drug interactions."	0
Population pharmacokinetic analysis of data from patients in clinical trials indicated approximately 3-fold the sildenafil clearance when it was co-administered with mild CYP3A inducers.	1
Thiazides should be discontinued before carrying out tests for parathyroid function.	0
Consult the full prescribing information prior to use for potential drug interactions.	0
Iloperidone accumulation is predictable from single-dose pharmacokinetics.	0
"Digoxin is primarily excreted by the kidneys; therefore, patients with impaired renal function require smaller than usual maintenance doses of digoxin [see Dosage and Administration (2.4)."	0
"This sequence of events may account for two clinical findings reported to occur after several weeks of nightly use of rapidly eliminated benzodiazepine hypnotics, namely, increased wakefulness during the last third of the night, and the appearance of increased signs of daytime anxiety."	0
"There is also an AT2 receptor found in many tissues, but AT2 is not known to be associated with cardiovascular homeostasis."	0
"Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide."	0
Serum potassium should be monitored periodically in patients receiving ACEON.	0
Matulane is contraindicated in patients with known hypersensitivity to the drug or inadequate marrow reserve as demonstrated by bone marrow aspiration.	0
Discontinuation of Savella should be considered in patients with symptomatic hyponatremia.	0
"Atorvastatin: In patients with chronic alcoholic liver disease, plasma concentrations of atorvastatin are markedly increased."	0
This property increases myocardial oxygen delivery in patients with coronary artery spasm and is responsible for the effectiveness of CALAN in vasospastic (Prinzmetal's or variant) as well as unstable angina at rest.	0
"Epileptiform seizures may accompany its administration, as is true of other drugs of its class."	0
Alcohol An additive adverse effect on psychomotor performance between alcohol and oral zolpidem was demonstrated.	0
Discontinue and initiate appropriate treatment if severe skin rash develops.	0
Concurrent administration of maprotiline with electroshock therapy should be avoided because of the lack of experience in this area.	0
"Patients are to be continuously monitored by ECG for a minimum of three days, or for a minimum of 12 hours after electrical or pharmacological conversion to normal sinus rhythm, whichever is greater."	0
Geriatric Patients Evaluation of steady-state plasma tipranavir trough concentrations at 10-14 h after dosing from the controlled clinical trials 1182.12 and 1182.48 demonstrated that there was no change in median trough tipranavir concentrations as age increased for either gender through 65 years of age.	0
"In addition to their role in the catabolism of monoamines in the CNS, MAOs are also important in the catabolism of exogenous amines found in a variety of foods and drugs."	0
See also PRECAUTIONS<U+2014>Pediatric Use for adverse events reported upon discontinuation of treatment with paroxetine in pediatric patients.	0
The use of Adenocard in patients receiving digitalis may be rarely associated with ventricular fibrillation (see Warnings ).	0
Antidepressant:desipramine <U+2191> desipramine Dosage reduction and concentration monitoring of desipramine is recommended.	1
"In older patients, also consider an endoscopy."	0
"Aprepitant is a substrate, a weak-to-moderate (dose-dependent) inhibitor, and an inducer of CYP3A4."	0
Let the concentrate stand for 1hour and then shake for 1minute to disperse the tablet contents.	0
Elderly patients may be at greater risk of developing hyponatremia with SSRIs and SNRIs.	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older.	0
"Calcium channel blockers: Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine <U+2191>Calcium channel blockers Use with caution."	0
Tryptophan: Severe vomiting with coadministration (7.2).	0
Hemodialysis does not appear to have a substantial impact on apixaban exposure.	0
"There is increased potential for sildenafil-associated adverse events (which include visual disturbances, hypotension, prolonged erection, and syncope)."	0
Evidence supporting the conclusion that it is inadvisable to coadminister fluvoxamine and diazepam is derived from a study in which healthy volunteers taking 150 mg/day of immediate-release fluvoxamine maleate tablets were administered a single oral dose of 10 mg of diazepam.	0
WARNING- FETAL TOXICITY S ee ful l pr e s c rib i n g i nformatio n fo r c ompl e t e boxe d warn i ng.	0
Both telmisartan and amlodipine lower blood pressure by reducing peripheral resistance but through complementary mechanisms.	0
"In vivo studies in animals, and in vitro studies in cultured animal and human cells have shown rosuvastatin to have a high uptake into, and selectivity for, action in the liver, the target organ for cholesterol lowering."	0
"The Components of Primary Endpoint (as a first event) counts only the events that define the primary endpoint, while the Secondary Endpoints count all first events of a particular type, whether or not they were preceded by a different type of event."	0
"In hypertensive patients with unilateral or bilateral renal artery stenosis, increases in blood urea nitrogen and serum creatinine may occur; usually reversible upon discontinuation of the ACE inhibitor."	0
Each component complements the action of the other.	0
Plasma concentrations are proportional to the administered dose in the range of 2.5 to 20 mg.	0
C. difficile produces toxins A and B which contribute to the development of CDAD.	0
The active metabolite's exposure(AUC) increases slightly more than proportionally over the dose range of 5 to 60-mg.	0
"Immunosuppressants: cyclosporine, tacrolimus, sirolimus <U+2191> immunosuppressant agents concentration Plasma concentrations may be increased by CRIXIVAN."	1
"Chronic antipsychotic treatment should generally be reserved for patients who suffer from a chronic illness that, 1) is known to respond to antipsychotic drugs, and, 2) for whom alternative, equally effective, but potentially less harmful treatments are not available or appropriate."	0
"There is also an AT2 receptor found in many tissues, but AT2 is not known to be associated with cardiovascular homeostasis."	0
Experience with another ACE inhibitor suggests that these increases would be reversible upon discontinuation of ALTACE and/or diuretic therapy.	0
No initial dosage adjustment is necessary.	0
"Antidepressants:nefazodone, selective serotonin reuptake inhibitors (SSRIs): e.g.fluoxetine,paroxetine,tricyclics: e.g.amitriptyline,nortriptyline <U+2191> antidepressants A dose decrease may be needed for these drugs when co-administered with ritonavir."	1
"Once effective control of symptoms has been achieved, the dosage may be reduced gradually to determine the minimum maintenance dose."	0
CRESTOR significantly increased INR in patients receiving coumarin anticoagulants.	0
Monoamine Oxidase Inhibitors (MAOIs) The use of MAOIs intended to treat psychiatric disorders with Anafranil or within 14 days of stopping treatment with Anafranil is contraindicated because of an increased risk of serotonin syndrome.	0
"Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including atorvastatin."	0
"Since uncorrected hyperkalemia may be fatal, serum potassium levels must be monitored at frequent intervals especially in patients first receiving triamterene and hydrochlorothiazide, when dosages are changed or with any illness that may influence renal function."	0
Dose adjustment of abacavir cannot be recommended at this time.	0
Both CYP1A2 and CYP2D6 are responsible for duloxetine metabolism.	0
There are no clinical studies of the combined use of ECT and escitalopram.	0
"Angiotensin II is a potent peripheral vasoconstrictor, which stimulates aldosterone secretion by the adrenal cortex, and provides negative feedback on renin secretion."	0
No adjustment of dosage on the basis of gender is recommended.	0
"There was modest inhibition of CYP 2C19 at the first dose, but there was marked induction at steady state."	0
"Although refrigerated storage is recommended following reconstitution, use of this diluent is not recommended as a precautionary measure."	0
"Propranolol: In normal volunteers, there was no clinically significant pharmacokinetic or pharmacodynamic interaction with concomitant administration of single doses of lovastatin and propranolol."	0
There are multiple possible causes for this observation and it is unknown to what extent fracture risk is directly attributable to SSRI treatment.	0
"There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on suicide."	0
"Initiation of APTIVUS/ritonavir, a CYP3A inhibitor, in patients receiving medications metabolized by CYP3A or initiation of medications metabolized by CYP3A in patients already receiving APTIVUS/ritonavir, may increase plasma concentrations of medications metabolized by CYP3A."	1
"Prophylactic therapy (i.e., non-steroidal anti-inflammatory drug [NSAID] or colchicine upon initiation of treatment) may be beneficial for up to six months."	0
Nursing mothers Recently decompensated heart failure requiring hospitalization or Class IV heart failure.	0
"Because of its potential for inducing orthostatic hypotension, an additive effect may be observed when INVEGA<U+00AE> is administered with other therapeutic agents that have this potential."	0
Less suitable infusion sites should be used only when larger veins are unavailable and the patient's condition requires immediate attention.	0
Patients should be informed that redistribution or accumulation of body fat may occur in patients receiving antiretroviral therapy and that the cause and long-term health effects of these conditions are not known at this time.	0
Pimozide: See CONTRAINDICATIONS (4) and WARNINGS AND PRECAUTIONS (5.6).	0
"In a number of cases, it appears possible that the cerebrovascular events were primary, the 5-HT1 agonist having been administered in the incorrect belief that the symptoms experienced were a consequence of migraine, when they were not."	0
Sofosbuvir and GS-331007 AUC0<U+2013>24 and Cmax were similar in healthy adult subjects and subjects with HCV infection.	0
There is no apparent rebound effect after abrupt withdrawal of losartan.	0
"<U+2022> Absorption: In clinical pharmacology studies in man, peak plasma concentrations of rosuvastatin were reached 3 to 5hours following oral dosing."	0
"Observational studies suggest that, similar to atypical antipsychotic drugs, treatment with conventional antipsychotic drugs may increase mortality."	0
"Renal disease, genetic factors, age, and other medications affect the metabolism and subsequent elimination of doxepin."	0
Whether any of the symptoms described above represent such a conversion is unknown.	0
The use of chlorthalidone and related drugs in pregnant women requires that the anticipated benefits of the drug be weighed against possible hazards to the fetus.	0
"Adverse reactions occurring in 5-20% of patients include anorexia, nausea, vomiting, diarrhea, malaise and rash."	0
"Following oral administration of 14C-levomilnacipran solution, approximately 58% of the dose is excreted in urine as unchanged levomilnacipran."	0
Individuals with genetic variations resulting in poor CYP 2D6 metabolism (approximately 5 to 10% of the population) exhibit higher pimozide concentrations than extensive CYP 2D6 metabolizers.	0
"However, when adjusted for dose and weight, AUC and Cmax of the parent compound were 41% and 39% lower, respectively, in children and adolescents than in adults."	0
Results of studies in animals indicate that dopamine-induced ventricular arrhythmias during anesthesia can be reversed by propranolol.	0
The use of ACIPHEX delayed-release tablets is not recommended for use in pediatric patients 1 year to less than 12 years of age because the lowest available tablet strength (20 mg) exceeds the recommended dose for these patients.	0
Quinaprilat concentrations are reduced in patients with alcoholic cirrhosis due to impaired deesterification of quinapril.	0
.	0
Refer to the package insert for lithium preparations before use of such preparations with DUTOPROL.	0
"This is rarely, if ever, seen in intact animals or man, probably because of reflex responses to its vasodilating effects."	0
"Nonrenal (i.e., biliary) excretion accounts for approximately 11%-12% of benazeprilat excretion."	0
"No dosage adjustments are recommended when PREZISTA/ritonavir is co-administered with the following medications: atazanavir, dolutegravir, efavirenz, etravirine, nevirapine, nucleoside reverse transcriptase inhibitors (abacavir, emtricitabine, lamivudine, stavudine, tenofovir disoproxil fumarate, zidovudine), pitavastatin, raltegravir, ranitidine, or rilpivirine."	0
Increased tacrolimus levels have been associated with nephrotoxicity.	1
"Protein Binding <U+2014> Over the concentration range from 200to 1000ng/mL, approximately94.5% of fluoxetine is bound invitro to human serum proteins, including albumin and <U+03B1>1-glycoprotein."	0
A nonlinear correlation between the verapamil dose administered and verapamil plasma levels does exist.	0
"Hepatic Insufficiency In patients with hepatic insufficiency, plasma concentrations of telmisartan are increased, and absolute bioavailability approaches 100%."	0
"Elimination of iloperidone is mainly through hepatic metabolism involving 2 P450 isozymes, CYP2D6 and CYP3A4."	0
"Zolpidem, the active moiety of zolpidem tartrate, is a hypnotic agent with a chemical structure unrelated to benzodiazepines, barbiturates, or other drugs with known hypnotic properties."	0
"In general, patients should avoid protein foods in which aging or protein breakdown is used to increase flavor."	0
"Prolonged and painful erections, sometimes requiring surgical intervention, have been reported with methylphenidate products in both pediatric and adult patients."	0
"Mean additional reductions of standing blood pressure of 6/6 mmHg, 11/4 mmHg, and 4/5 mmHg, respectively, were also observed."	0
"In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors."	0
"In patients with impaired renal function who will receive multiple doses of DIFLUCAN, an initial loading dose of 50 to 400 mg should be given."	0
Newly-diagnosed low-risk APL: Induction: 0.15 mg/kg intravenously daily in combination with tretinoin until bone marrow remission.	0
"Distribution Zaleplon is a lipophilic compound with a volume of distribution of approximately 1.4 L/kg following intravenous (IV) administration, indicating substantial distribution into extravascular tissues."	0
"Although in controlled studies paroxetine has not been shown to impair psychomotor performance, patients should be cautioned about operating hazardous machinery, including automobiles, until they are reasonably certain that paroxetine therapy does not affect their ability to engage in such activities."	0
"Although no PK interactions were specifically assessed, there did not appear to be evidence suggesting any clinically significant PK interaction."	0
"In the randomized controlled studies, there was a higher rate of cardiovascular thromboembolic events (cardiovascular deaths, non-fatal myocardial infarctions, and non-fatal strokes) in patients treated with ULORIC (0.74 per 100 P-Y [95% Confidence Interval (CI) 0.36-1.37]) than allopurinol (0.60 per 100 P-Y [95% CI 0.16-1.53])."	0
"If their use is clinically necessary, therapy should be initiated with 2 mg dose and increased in 2<U+2013>4 mg steps daily based on patient response to therapy."	0
"There was a transient increase in electrolyte excretion, including sodium."	0
"This occurs with quinidine, giving essentially all recipients a risperidone pharmacokinetic profile typical of poor metabolizers."	1
Nitrate therapy may aggravate the angina caused by hypertrophic cardiomyopathy.	0
"The side effects of quinapril are generally rare and apparently independent of dose; those of hydrochlorothiazide are a mixture of dose-dependent phenomena (primarily hypokalemia) and dose-independent phenomena (e.g., pancreatitis), the former much more common than the latter."	0
"The risk of hyperkalemia is higher in patients with impaired renal function, proteinuria, diabetes and those concomitantly treated with ACEs, ARBs, NSAIDs and moderate CYP3A inhibitors."	0
Co-administration of multiple 10 mg doses of atorvastatin with 80 mg of ACCUPRIL resulted in no significant change in the steady-state pharmacokinetic parameters of atorvastatin.	0
"For the oral concentrate, Tmax was slightly prolonged from 5.9 hours to 7 hours with food."	1
Category C Rifampin has been shown to be teratogenic in rodents.	0
Absorption of hydrochlorothiazide is reduced in patients with congestive heart failure.	0
"Factors that can increase the risk of developing epidural or spinal hematomas in these patients include: use of indwelling epidural catheters concomitant use of other drugs that affect hemostasis, such as nonsteroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, other anticoagulants a history of traumatic or repeated epidural or spinal punctures a history of spinal deformity or spinal surgery optimal timing between the administration of ELIQUIS and neuraxial procedures is not known Monitor patients frequently for signs and symptoms of neurological impairment."	0
"During concomitant treatment with fluconazole (200 mg daily) and celecoxib (200 mg), the celecoxib Cmax and AUC increased by 68% and 134%, respectively."	1
"DEMSER may have additive sedative effects with alcohol and other CNS depressants , e.g. , hypnotics , sedatives , and tranquilizers ."	0
"If blood pressure is not controlled by losartan potassium tablets alone, a low dose of a diuretic may be added."	0
Another investigator found no increase in digoxin levels in 12 patients with coronary artery disease.	0
"If withdrawal symptoms occur, beta-blocking agent therapy should be reinstituted, at least temporarily."	0
"These studies uncovered no evidence of carcinogenic potential of hydrochlorothiazide in rats or female mice, but there was equivocal evidence of hepatocarcinogenicity in male mice."	0
Extended and frequent monitoring for opiate-associated adverse events may be necessary should be considered when coadministered with VFEND.	0
"Further clinical evaluation (e.g., rheumatology referral) may be appropriate for certain patients."	0
The normalization of prothrombin time for the sertraline hydrochloride group was delayed compared to the placebo group.	0
"The addition of heparin to this regimen does not significantly alter the percentage of subjects with >70% inhibition of platelet aggregation (IPA), but does increase the average bleeding time, as well as the number of patients with bleeding times prolonged to >30 minutes."	0
"Elevated plasma levels of HMG-CoA reductase inhibitory activity increases the risk of myopathy and rhabdomyolysis, particularly with higher doses of simvastatin."	0
Avoid drugs known to prolong the QT interval.	0
"Invitro studies suggest that CYPs1A2 and 2D6, and the flavin-containing monooxygenase system are involved in olanzapine oxidation."	0
Diarrhea is a common problem caused by antibacterials which usually ends when the antibacterial is discontinued.	0
Calcium channel blockers may also have an additive effect when given with TENORMIN.	0
Monitor renal function periodically in patients receiving irbesartan and NSAID therapy.	0
Symptoms usually resolve over days when the combination is discontinued.	0
"In some patients, additional factor VIII was given."	0
"Carbamazepine, Phenobarbital, Phenytoin: While not systematically studied, these drugs may induce the metabolism of bupropion."	1
Acute interstitial nephritis may occur at any point during PPI therapy and is generally attributed to an idiopathic hypersensitivity reaction.	0
Acidosis may be associated with rapid elevations in serum potassium levels.	0
Switching a Patient To or From a Monoamine Oxidase Inhibitor (MAOI) Intended to Treat Psychiatric Disorders: At least 14 days should elapse between discontinuation of an MAOI intended to treat psychiatric disorders and initiation of therapy with PEXEVA<U+00AE>.	0
"In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers."	0
CyclosporineSirolimusTacrolimus <U+2195> Cyclosporine <U+2195> Sirolimus<U+2195> Tacrolimus Inhaled beta agonist: Salmeterol <U+2191> Salmeterol Concurrent administration of APTIVUS/ritonavir is not recommended.	0
(7.2) Remodulin dosage adjustment may be necessary if inhibitors or inducers of CYP2C8 are added or withdrawn.	0
"Appropriate fluid and electrolyte management, protein supplementation, antibacterial treatment of C. difficile, and surgical evaluation should be instituted as clinically indicated."	0
Distribution Levomilnacipran is widely distributed with an apparent volume of distribution of 387-473 L; plasma protein binding is 22% over concentration range of 10 to 1000 ng/mL.	0
Steady-state levels of quazepam and 2-oxoquazepam are attained by the seventh daily dose and that of N-desalkyl-2-oxoquazepam by the thirteenth daily dose.	0
Dosage reduction and/or discontinuation of any diuretic and/or ACCUPRIL may be required.	0
Lotensin should be promptly discontinued and appropriate therapy and monitoring should be provided until complete and sustained resolution of signs and symptoms of angioedema has occurred.	0
Prescribers should consult the full prescribing information and clinical study information of these protease inhibitors if they are co-administered with a reduced dose of ritonavir.	0
"WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning When pregnancy is detected, discontinue ALTACE as soon as possible (5.6)."	0
Hydrochlorothiazide does not affect normal blood pressure.	0
"Closely monitor growth (weight and height) in pediatric patients treated with CNS stimulants, including VYVANSE."	0
Studies in animals also suggest that fluoxetine is a much more potent uptake inhibitor of serotonin than of norepinephrine.	0
"Amiodarone is a substrate for CYP3A and CYP2C8, so inhibitors and inducers affect amiodarone exposure (7) Amiodarone inhibits p-glycoprotein and CYP1A2, CYP2C9, CYP2D6, and CYP3A, increasing exposure to other drugs (7) Drugs prolonging the QT interval: Co-administration of drugs prolonging the QT interval (such as class I and III antiarrhythmics, lithium, certain phenothiazines, tricyclic antidepressants, certain fluoroquinolone and macrolide antibiotics, azole antifungals, halogenated inhalation anesthetic agents) increases the risk of Torsade de Pointes."	0
The extent to which SSRI TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.	0
Brain hemorrhage was seen in a female dog treated with atorvastatin for 3 months at 120 mg/kg/day.	0
"Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death."	0
Patients controlled on diltiazem alone or in combination with other medications may be switched to CARDIZEM CD capsules at the nearest equivalent total daily dose.	0
"Related adverse events including hypertension, syncope, asystole, diaphoresis, seizures, changes in behavioral and mental status, and muscular rigidity have also been reported in some patients receiving selegiline and various tricyclic antidepressants."	0
"The terminal half-life of TIKOSYN is approximately 10 hours; steady state plasma concentrations are attained within 2<U+2013>3 days, with an accumulation index of 1.5 to 2.0."	0
"Anticonvulsants:carbamazepine, phenobarbital, phenytoin <U+2193> indinavir concentration Use with caution."	0
Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have.	0
"Patients taking a <U+03B2>-blocker and a drug that can deplete catecholamines (e.g., reserpine and monoamine oxidase inhibitors) should be observed closely for signs of hypotension and/or severe bradycardia."	0
The therapeutic effects of CARDIZEM CD are believed to be related to its ability to inhibit the cellular influx of calcium ions during membrane depolarization of cardiac and vascular smooth muscle.	0
"Most patients are maintained at less than 0.2 mg/kg/day, or 10 mg/day, whichever is less."	0
"In most cases, muscle symptoms and CK increases resolved when treatment was promptly discontinued."	0
Alcohol Patients should be warned that the concomitant use of alcoholic beverages may be associated with exaggerated effects.	0
"In comparison to conventional metoprolol, the plasma metoprolol levels following administration of TOPROL-XL are characterized by lower peaks, longer time to peak and significantly lower peak to trough variation."	0
"Based on data from other CYP3A4 inhibitors, plasma concentrations of midazolam are expected to be significantly higher when midazolam is given orally."	1
The mean apparent terminal elimination half-lives for R(+)-carvedilol range from 5 to 9hours compared with 7 to 11hours for the S(-)-enantiomer.	0
"If there is evidence of CAD or coronary artery vasospasm, MAXALT should not be administered."	0
"Following administration of candesartan cilexetil, the absolute bioavailability of candesartan was estimated to be 15%."	0
"Ischemic Heart Disease: Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred."	0
"Serotonin syndrome, a potentially life-threatening reaction, may occur when amphetamines are used in combination with other drugs that affect the serotonergic neurotransmitter systems such as monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, and St. John's Wort."	0
Whether this difference has clinical relevance is not yet known.	0
"Increased exposure of other antiretroviral drugs (e.g., saquinavir) when used concomitantly with pantoprazole may increase toxicity of the antiretroviral drugs."	0
The resultant increases in coronary blood flow (epicardial and subendocardial) occur in ischemic and nonischemic models and are accompanied by dose-dependent decreases in systemic blood pressure and decreases in peripheral resistance.	0
Such monitoring should include daily observation by families and caregivers.	0
"In these patients, hepatic laboratory testing should be conducted prior to initiating therapy with REYATAZ and during treatment."	0
"In patients with severe hypocitraturia (urinary citrate < 150 mg/day), therapy should be initiated at a dosage of 60 mEq/day (30 mEq two times/day or 20 mEq three times/day with meals or within 30 minutes after meals or bedtime snack)."	0
Such elevations have sometimes been transient and may disappear even in the face of continued verapamil treatment.	0
"The risk of differences (drug versus placebo), however, were relatively stable within age strata and across indications."	0
Antimycobacterial:bedaquiline <U+2191> bedaquiline Bedaquiline should only be used with ritonavir if the benefit of co-administration outweighs the risk.	0
There may be circumstances when it is necessary to initiate treatment with a MAOI such as linezolid or intravenous methylene blue in a patient taking PRISTIQ.	0
"The sitting diastolic blood pressure (SiDBP) on entry into the study was higher than the 95th percentile level for the patient<U+2019>s age, gender, and height."	0
Pediatric Use-Safety and effectiveness in the pediatric population have not been established.	0
"Gastrointestinal upset characterized by nausea, vomiting, anorexia and generalized malaise have accompanied the most severe forms of hemolytic anemia."	0
Do not use PRIFTIN as a once-weekly continuation phase regimen in HIV-infected patients with active pulmonary tuberculosis because of a higher rate of failure and/or relapse with rifampin-resistant organisms.	0
Permanent neurological damage and death have been reported.	0
Approximately 99% of the drug is bound to plasma proteins.	0
"In primarily depressed patients, worsening of depression, including suicidal thoughts and actions (including completed suicides), has been reported in association with the use of hypnotics."	0
Dosage adjustments of the drugs in Table 4 or of other drugs metabolized by cytochrome P4503A4 or P4502C8/9 may be necessary if they are given concurrently with PRIFTIN.	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP, 5-HT1 agonists (e.g., sumatriptan), ergotamine-containing or ergot-type medications or methysergide should not be used within 24 hours of each other."	0
HIV-1 protease inhibitor: Lopinavir/ritonavir (coformulated tablet) <U+2194> Saquinavir<U+2194> Lopinavir<U+2193> Ritonavir Evidence from several clinical trials indicates that saquinavir concentrations achieved with the saquinavir and lopinavir/ritonavir combination are similar to those achieved following INVIRASE/ritonavir 1000/100 mg.	0
"In a study where paroxetine (30 mg qd) was dosed orally for 4 weeks, steady-state plasma concentrations of paroxetine were increased by approximately 50% during coadministration with oral cimetidine (300 mg tid) for the final week."	1
"In addition, a population pharmacokinetic analysis indicated that the concomitant administration of lithium had no effect on the pharmacokinetics of asenapine."	0
Patients on dialysis may develop orthostatic hypotension; their blood pressure should be closely monitored.	0
Patients should be monitored for the emergence of serotonin syndrome.	0
Mean Plasma Concentrations of Loxapine following Single-Dose Administration ADASUVE 10 mg in Healthy Subjects Distribution: Loxapine is removed rapidly from the plasma and distributed in tissues.	0
"Hepatic Impairment: In patients with hepatic impairment due to liver cirrhosis, fluvastatin AUC and Cmax increased approximately 2.5 fold compared to healthy subjects after administration of a single 40 mg dose."	0
"Such symptoms should be reported to the patient's prescriber or health professional, especially if they are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
Candesartan is highly bound to plasma proteins (>99%) and does not penetrate red blood cells.	0
"In a subset of patients classified as bipolar, the rate of manic episodes was 2.2% for paroxetine and 11.6% for the combined active-control groups."	0
"If such symptoms occur, consideration should be given to a possible causal role of atomoxetine, and discontinuation of treatment should be considered."	0
"ABILIFY MAINTENA activity is presumably primarily due to the parent drug, aripiprazole, and to a lesser extent, to its major metabolite, dehydro-aripiprazole, which has been shown to have affinities for D2 receptors similar to the parent drug and represents about 29% of the parent drug exposure in plasma."	0
CYP3A inhibitors: Co-administration of a 180 mg daily dose of diltiazem with 5 mg amlodipine in elderly hypertensive patients resulted in a 60% increase in amlodipine systemic exposure.	1
"A phenotypic cocktail study was conducted with 16 healthy volunteers to quantify the influence of 10 days of APTIVUS/ritonavir capsule administration on the activity of hepatic CYP 1A2 (caffeine), 2C9 (warfarin), 2C19 (omeprazole), 2D6 (dextromethorphan) and the activity of intestinal and hepatic CYP 3A4/5 (midazolam) and P-glycoprotein (P-gp) (digoxin)."	0
"Use in Concomitant Illness <U+2013> As with closely related tricyclic antidepressants, Anafranil should be used with caution in the following: Hyperthyroid patients or patients receiving thyroid medication, because of the possibility of cardiac toxicity; Patients with increased intraocular pressure, a history of narrow-angle glaucoma, or urinary retention, because of the anticholinergic properties of the drug; Patients with tumors of the adrenal medulla (e.g., pheochromocytoma, neuroblastoma) in whom the drug may provoke hypertensive crises; Patients with significantly impaired renal function."	0
"Once dissolved, mix the cloudy liquid well, and consume it immediately."	0
Antihypertensive Drugs: SAPHRIS may cause hypotension.	0
The steady-state Cmax and Cmin values were about 6 and 14 times what would be predicted from single-dose studies.	0
Starting Anafranil in a patient who is being treated withlinezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome.	0
Plasma concentrations of the metabolite exceed the parent drug on multiple dosing.	0
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.	0
Heterozygous Familial Hypercholesterolemia in Pediatric Patients (10 Years to 17 Years of Age): The recommended starting dose of atorvastatin is 10 mg/day; the usual dose range is 10 to 20 mg orally once daily.	0
Do not have any kind of sex without protection.	0
"Nevertheless, caution is indicated in the co-administration of TCAs with any of the SSRIs and also in switching from one class to the other."	0
"Alpha-Blockers PDE5 inhibitors, including ADCIRCA, and alphaadrenergic blocking agents are both vasodilators with blood-pressure-lowering effects."	0
The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.	0
"At 5 mg and 10 mg, there was no objective and minimal subjective evidence of rebound insomnia on the first night after discontinuation of treatment with Zaleplon."	0
"The action of the benzodiazepines may be potentiated by anticonvulsants, antihistamines, alcohol, barbiturates, monoamine oxidase inhibitors, narcotics, phenothiazines, psychotropic medications, or other drugs that produce CNS depression."	0
"In patients taking the HIV protease inhibitor lopinavir plus ritonavir, caution should be used when prescribing atorvastatin and the lowest dose necessary should be used."	1
"In patients with end stage renal disease (ESRD, GFR < 15 mL/min/1.73 m2), the maximum recommended dose is 30 mg/day."	0
If the dose is more than 1 mL round to the nearest 0.2 mL.	0
Renal Homotransplantation: The dose of IMURAN required to prevent rejection and minimize toxicity will vary with individual patients; this necessitates careful management.	0
"Other identifiable metabolites excreted in the urine are levomilnacipran glucuronide (4%), desethyl levomilnacipran glucuronide (3%), p-hydroxy levomilnacipran glucuronide (1%), and p-hydroxy levomilnacipran (1%)."	0
WARNING: DIFFERENTIATION SYNDROME AND CARDIAC CONDUCTION ABNORMALITIES See full prescribing information for complete boxed warning.	0
2.Prepare medication port site using aseptic technique.	0
Patients Taking 400 mg of ABILIFY MAINTENA Strong CYP2D6 or CYP3A4 inhibitors 300 mg CYP2D6 and CYP3A4 inhibitors 200 mg CYP3A4 inducers Avoid use Patients Taking 300 mg of ABILIFY MAINTENA Strong CYP2D6 or CYP3A4 inhibitors 200 mg CYP2D6 and CYP3A4 inhibitors 160 mg CYP3A4 inducers	0
Increased monitoring for adverse events is recommended when using these drug combinations.	0
"The maximum daily dose should be no more than 1.5 grams, regardless of body weight."	0
"However, biting through the capsule prior to swallowing does result in slightly earlier plasma concentrations (27 ng/mL 10 minutes after 10 mg) than if capsules are swallowed intact."	0
Patients in the TENORMIN group were to receive TENORMIN I.V.	0
"In these situations, consider an alternative non-serotonergic drug or an alternative drug that does not inhibit CYP2D6."	0
Nursing: Patients should be advised to notify their physician if they are breast-feeding an infant.	0
Doses above 1.4mg/kg (or in excess of 100mg) daily have not been studied in pediatric patients.	0
"In a subsequent, similar study, lesions were less severe when glycopyrrolate was omitted."	0
Smokers have an increased clearance of benzodiazepines as compared to nonsmokers; this was seen in studies with estazolam.	0
Use caution and monitor patients closely when using such inhibitors.	0
"Because ritonavir is coadministered with INVIRASE, prescribers should also refer to the prescribing information for ritonavir regarding drug interactions associated with this agent."	0
"In patients at risk of excessive hypotension, ACEON therapy should be started under very close medical supervision."	0
"Concurrent administration of pindolol and thioridazine have resulted in moderate, dose related increases in the serum levels of thioridazine and two of its metabolites, as well as higher than expected serum pindolol levels."	1
Dosage in Newly Diagnosed Ph+ CML-CP The recommended dose of Tasigna is 300 mg orally twicedaily.	0
Clinically or potentially significant drug interactions between DIFLUCAN and the following agents/classes have been observed.	0
"Concomitant use of Meperidine Hydrochloride Injection with CYP3A4 inducers or discontinuation of a CYP3A4 inhibitor could decrease meperidine plasma concentrations, decrease opioid efficacy or, possibly, lead to a withdrawal syndrome in a patient who had developed physical dependence to meperidine."	0
"Generally, histological findings were observed without organ involvement."	0
"As shown, both the probability of a patient's remaining in sinus rhythm at six months and the change in QTc from baseline at steady state of dosing increased in an approximately linear fashion with increasing dose of TIKOSYN."	0
Hemophagocytic Lymphohistiocytosis: Monitor for and treat promptly; discontinue PURIXAN.	0
"Geriatrics In elderly subjects (age 65<U+2013>80 years), irbesartan elimination half-life is not significantly altered, but AUC and Cmax values are about 20% to 50% greater than those of young subjects (age 18<U+2013>40 years)."	0
"Closely observe infants with histories of in utero exposure to ACCUPRIL for hypotension, oliguria, and hyperkalemia."	0
Angiotensin II also stimulates aldosterone secretion by the adrenal cortex.	0
"Plasma levels following oral administration of conventional metoprolol tablets, however, approximate 50% of levels following intravenous administration, indicating about 50% first-pass metabolism."	0
The recommended dose is 75-100 mg four times daily as an adjunct to the usual warfarin therapy.	0
"Because the half-life of prasugrel's active metabolite is short relative to the lifetime of the platelet, it may be possible to restore hemostasis by administering exogenous platelets; however, platelet transfusions within 6hours of the loading dose or 4hours of the maintenance dose may be less effective."	0
"Following absorption, approximately 30 to 50% of systemically available perindopril is hydrolyzed to its active metabolite, perindoprilat, which has a mean bioavailability of about 25%."	0
Resistance selection in cell culture and cross-resistance studies indicate ledipasvir targets NS5A as its mode of action.	0
Transporter Interaction: Iloperidone and P88 are not substrates of P-gp and iloperidone is a weak P-gp inhibitor.	0
"In these study populations, mean additional reductions of supine systolic and diastolic blood pressure of 7/7 mmHg, 9/5 mmHg, and 8/4 mmHg, respectively, were observed."	0
"When pregnancy is detected, discontinue AVALIDE as soon as possible."	0
Discontinuation of stimulant therapy may be indicated.	0
The proportion of normotensive patients with a sitting systolic blood pressure less than 90 mmHg and/or diastolic blood pressure less than 60 mmHg at any time during treatment with CARDURA 1<U+2013>8 mg once daily was 6.7% with doxazosin and not significantly different (statistically) from that with placebo (5%).	0
Caution should be used when prescribing with LIVALO.	0
"Appropriate doses for these combinations, with respect to safety and efficacy, have not been established."	0
"QTc interval prolongation was studied in a double blind, single intravenous dose, placebo- and positive-controlled, crossover study in 58 healthy subjects."	0
Coadministration of VFEND with sirolimus is contraindicated because VFEND significantly increases sirolimus concentrations.	1
"ECG changes Electrocardiograms were obtained from 1,492 desvenlafaxine treated patients with major depressive disorder and 984 placebo-treated patients in clinical studies lasting up to 8 weeks."	0
"Indirectly, the diuretic action of hydrochlorothiazide reduces plasma volume, with consequent increases in plasma renin activity, increases in aldosterone secretion, increases in urinary potassium loss, and decreases in serum potassium."	0
"Therefore, the coadministration of drugs that inhibit P450 2D6 with thioridazine and the use of thioridazine in patients known to have reduced activity of P450 2D6 are contraindicated. for one week) on thioridazine steady-state concentration was evaluated in ten male inpatients with schizophrenia."	0
CYMBALTA should also not be started in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue.	0
"Gout Flare: An increase in gout flares is frequently observed during initiation of anti-hyperuricemic agents, including ULORIC."	0
FANAPT can be administered without regard to meals.	0
The steady-state Cmax and exposure of the main N-debutyl metabolite is similar to that of the parent compound.	0
<U+2022>do not support twice-daily dosing of LEXIVA without ritonavir in pediatric patients younger than 2years.	0
The effect of fluvoxamine (25 mg immediate-release tablets given twice daily for one week) on thioridazine steady-state concentrations was evaluated in 10 male inpatients with schizophrenia.	0
Triptans: There have been rare postmarketing reports of serotonin syndrome with the use of an SSRI and a triptan.	0
"Cmax was 15% and 55% higher in mild and moderate renal impairment, respectively."	0
Tasigna may be given with hydroxyurea or anagrelide if clinically indicated.	0
Do not start Anafranil in a patient who is being treated with linezolid or intravenous methylene blue because there is increased risk of serotonin syndrome.	0
Routinely monitor blood pressure in these patients.	0
Mutagenicity tests of dipyridamole with bacterial and mammalian cell systems were negative.	0
"When administered intravenously, meperidine hydrochloride should be given very slowly."	0
Methamphetamine may decrease the hypotensive effect of guanethidine.	0
LEXIVA/ritonavir: Interaction has not been evaluated.	0
Telaprevir Co-administration of APTIVUS and telaprevir has not been studied.	0
Concomitant administration of Zaleplon (10 mg) and cimetidine (800 mg) produced an 85% increase in the mean Cmax and AUC of zaleplon.	1
"In a study of patients with atrial fibrillation /flutter (AFIB/AFL) receiving three different oral doses of sotalol given q12h (or q24h in patients with a reduced creatinine clearance), mean increases in QT intervals measured from 12-lead ECGs of 25 ms, 40 ms and 54 ms were found in the 80 mg, 120 mg, and 160 mg dose groups, respectively No significant alteration in QRS interval was observed."	0
"Drugs with Hypotensive Effects Because of its potential for inducing hypotension, risperidone may enhance the hypotensive effects of other therapeutic agents with this potential."	0
DOSAGE MUST BE INDIVIDUALIZED AND CLOSELY MONITORED BY A PHYSICIAN DURING UP-TITRATION.	0
A causal relationship has not been established.	0
No differences in pharmacokinetics were observed in a pharmacokinetic study conducted in men and women.	0
It should be noted that NARDIL is not approved for use in treating any indications in the pediatric population.	0
These results were sustained throughout the study.	0
"In clinical trials of quinapril/hydrochlorothiazide using quinapril doses of 2.5 to 40 mg and hydrochlorothiazide doses of 6.25 to 25 mg, the antihypertensive effects were sustained for at least 24 hours, and increased with increasing dose of either component."	0
Signs and symptoms generally improve after reduction in dose or discontinuation of drug.	0
"Zaleplon has been shown to have minimal effects on the kinetics of warfarin (both R- and S-forms), imipramine, ethanol, ibuprofen, diphenhydramine, thioridazine, and digoxin."	0
"In patients in whom withdrawal of the previous antiarrhythmic agent is likely to produce life-threatening arrhythmias, hospitalization of the patient is recommended."	0
The administration of epinephrine should be avoided in the treatment of drug-induced hypotension in view of the fact that phenothiazines may induce a reversed epinephrine effect on occasion.	0
Coadministration of oral midazolam with REYATAZ is CONTRAINDICATED.	0
Declining serum concentrations exhibit a prolonged terminal phase which does not contribute to drug accumulation.	0
"For patients who experience a sustained increase in heart rate while receiving Savella, either reduce the dose or discontinue treatment with Savella if clinically warranted."	0
"The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents."	0
The gender-effect on the pharmacokinetics of estazolam has not been investigated.	0
The pharmacokinetics of fingolimod-phosphate was not evaluated in patients with mild or moderate hepatic impairment.	0
"As an alternate regimen, the total daily dosage may be given once a day."	0
"Adverse events of nausea, dizziness, hypotension and syncope have been observed following coadministration of trazodone and ritonavir."	0
"They do not treat viral infections (e.g., the common cold)."	0
HMG-CoA reductase inhibitors should be discontinued if a marked increase in creatinine kinase is observed or myopathy/rhabdomyolysis is diagnosed or suspected.	0
Treatment of FMF: Maximum daily dose of 1.2mg (may be given as 0.6mg twice a day).	0
"Alternatively, CRIXIVAN may be administered with other liquids such as skim milk, juice, coffee, or tea, or with a light meal, e.g., dry toast with jelly, juice, and coffee with skim milk and sugar; or corn flakes, skim milk and sugar."	0
"A transient hypotensive response is not a contraindication to further treatment, which usually can be continued without difficulty once the blood pressure has stabilized."	0
Plasma levels achieved are highly variable after oral administration.	0
A major depressive episode may be the initial presentation of bipolar disorder.	0
Hydrochlorothiazide can cause hypokalemia and hyponatremia.	0
"All patients with abnormalities should have follow-up, including laboratory testing, if necessary."	0
Nursing Mothers: It is not known whether this drug is excreted in human milk.	0
Coadministration of PRADAXA with a high-fat meal delays the time to Cmax by approximately 2 hours but has no effect on the bioavailability of dabigatran; PRADAXA may be administered with or without food.	1
Losartan potassium tablets are contraindicated in patients who are hypersensitive to any component of this product.	0
Intervention: LATUDA dose should be increased when used concomitantly with moderate inducers of CYP3A4.	1
"Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"Some traditional Chinese and Ayurvedic medicine substances like Chan Su, Siberian Ginseng, Asian Ginseng, Ashwagandha or Dashen, can cause similar interference."	0
"As CYP 1A2 may also contribute to the metabolism of ORAP, prescribers should be aware of the theoretical potential for drug interactions with inhibitors of this enzymatic system."	0
"In patients with severe hepatic impairment (Child-Pugh class C), fingolimod-phosphate Cmax was decreased by 22% and AUC0-96 hours was decreased by 29%."	0
Dabigatran is subject to conjugation forming pharmacologically active acyl glucuronides.	0
<U+2022>Dopaminergic Drugs (levodopa and amantadine): CNS toxicity can occur when used concomitantly with WELLBUTRIN XL.	0
"When dihydroergotamine mesylate nasal spray was administered intranasally to female rats during pregnancy and lactation, decreased body weights and impaired reproductive function (decreased mating indices) were observed in the offspring at doses of 0.16 mg/day or greater."	0
Failure to administer PREZISTA with ritonavir and food may result in a loss of efficacy of darunavir.	0
"Although the prevalence of the syndrome appears to be highest among the elderly, especially elderly women, it is impossible to rely upon prevalence estimates to predict, at the inception of antipsychotic treatment, which patients are likely to develop the syndrome."	0
"If higher doses are required, individual doses rather than dosing frequency should be increased."	0
Figure 1: Effect of Other Drugs on Asenapine Pharmacokinetics The effects of asenapine on the pharmacokinetics of other co-administered drugs are summarized in Figure 2.	0
Initiation or dose adjustments of insulin or oral hypoglycemic agents may be required.	0
"If the two drugs are coadministered, the beta blocker should be withdrawn several days before the gradual withdrawal of clonidine."	0
Concomitant use of telmisartan and ramipril is not recommended.	0
Intervention: A temporary withdrawal of ACIPHEX delayed-release tablets may be considered in some patients receiving high dose methotrexate administration.	0
One study using a crossover design in 13 subjects investigated tyramine pressor doses (TYR30) after administration of EMSAM 6mg per 24 hours and oral selegiline (5mg twice daily) for 9days.	0
The pharmacokinetics of teriflunomide in severe hepatic impairment have not been evaluated.	0
PDE-5 Inhibitors: SildenafilTadalafilVardenafil Only the combination of tadalafil with APTIVUS/ritonavir has been studied (at doses used for treatment of erectile dysfunction).	0
Treatment Discontinuation: Patients must have typical BCR-ABL transcripts.	0
"Clinical drug interaction studies have been performed with substrates of CYP2D6 and show that paroxetine can inhibit the metabolism of drugs metabolized by CYP2D6 including desipramine, risperidone, and atomoxetine."	1
Strong cytochrome P450 (CYP) 3A inhibitors may increase exposure to doxazosin and increased risk of hypotension.	0
"Since safety and effectiveness in pediatric patients below the age of 16 have not been established, diethylpropion hydrochloride is not recommended for use in pediatric patients 16 years of age and under."	0
Most cases occurred when Anafranil was used in combination with other drugs.	0
"In multiple-dose studies in hypertensive patients, there were no notable effects on systemic or renal prostaglandin concentrations, fasting triglycerides, total cholesterol or HDL-cholesterol or fasting glucose concentrations."	0
Lexapro should be used with caution in patients with severe renal impairment.	0
A gradual reduction in dosage rather than abrupt cessation is recommended whenever possible.	0
"Similarly, paroxetine does not cause any clinically important changes in heart rate or blood pressure."	0
Mexiletine: Decreases rate of mexiletine absorption.	1
Treatment with losartan potassium tablets resulted in a 13% reduction (p=0.021) in risk of the primary endpoint compared to the atenolol group ; this difference was primarily the result of an effect on fatal and nonfatal stroke.	0
"Abiraterone accumulation is observed at steady-state, with a 2-fold higher exposure (steady-state AUC) compared to a single 1,000 mg dose of abiraterone acetate."	0
"Consequently, the clinical effect of the drug results from the combined concentrations of risperidone plus 9-hydroxyrisperidone."	0
"Effect of Food In healthy adults, administration of a 3 mg dose of eszopiclone after a high-fat meal resulted in no change in AUC, a reduction in mean Cmax of 21%, and delayed tmax by approximately 1 hour."	1
"Initiate treatment at 25 mg once daily and titrate to the recommended dose of 50 mg once daily, preferably within 4 weeks as tolerated by the patient."	0
A causal relationship to APTIVUS/ritonavir could not be established.	0
"At steady state of ritonavir (about 1 week), the exposure to tadalafil is similar as in the absence of ritonavir [see Dosage and Administration (2.3), Warnings and Precautions (5.2), and Clinical Pharmacology (12.3)]."	0
"If concomitant use of paroxetine with a triptan is clinically warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases."	0
Studies in vitro have shown that sildenafil is selective for PDE-5.	0
Changes in blood pressure in hypertensive patients given SULAR were dose related over the clinical dosage range.	0
"For creatinine clearance <10 mL/min or on hemodialysis, initiate at 2.5 mg (2.4) Initial therapy in adults: The recommended initial dose is 10 mg once a day."	0
Use with ribavirin: The use of ribavirin for hepatitis C in patients receiving azathioprine has been reported to induce severe pancytopenia and may increase the risk of azathioprine-related myelotoxicity.	0
"The increase in AUC for lovastatin and lovastatin acid is presumably due, in part, to inhibition of CYP3A4."	0
Food does not appear to affect the systemic bioavailability of CLOZARIL.	0
The effect of selegiline on fertility has not been adequately assessed.	0
"Therefore, based on these in vitro data, estazolam is very unlikely to inhibit the biotransformation of other drugs metabolized by these CYP isoforms."	0
The difference in concentrations does not warrant a dose adjustment.	0
Administration of stimulants may exacerbate symptoms of behavior disturbance and thought disorder in patients with a preexisting psychotic disorder.	0
"A double-blind, placebo-controlled ABPM study was conducted to evaluate the effects of milnacipran (up to 200 mg/day) on blood pressure in 321 fibromyalgia patients."	0
"Correct hypocalcemia, hypokalemia and/or hypomagnesemia prior to CAPRELSA administration."	0
"Maintenance<U+2014>Following remission, maintenance medication may be required for a longer period of time, at the lowest dose that will maintain remission."	0
"Based on urinary recovery, the mean extent of absorption of lisinopril is approximately 25 percent, with large inter-subject variability (6-60 percent) at all doses tested (5-80 mg)."	0
Steady-state concentrations of risperidone are reached in 1 day in extensive metabolizers and would be expected to reach steady-state in about 5 days in poor metabolizers.	0
Concentrations of hydrochlorothiazide are 1.6-1.8 times higher in whole blood than in plasma.	0
Procarbazine hydrochloride is teratogenic in the rat when given at doses approximately 4 to 13 times the maximum recommended human therapeutic dose of 6 mg/kg/day.	0
Monitor renal function periodically in patients receiving perindopril and NSAID therapy.	0
"Atazanavir is a CYP3A4 substrate; therefore, drugs that induce CYP3A4 may decrease atazanavir plasma concentrations and reduce REYATAZ<U+2019>s therapeutic effect."	1
"Azathioprine or its metabolites are transferred at low levels, both transplacentally and in breast milk."	0
"Losartan potassium tablets may be administered with other antihypertensive agents, and with or without food."	0
Significant elevation in blood pressure has been reported on rare occasions in patients with and without a history of hypertension treated with dihydroergotamine mesylate injection.	0
The increased risk of blood pressure measurements in the hypertensive range in Savella-treated patients is supported by substantial increases in mean SBP and DBP measurements observed in the ABPM study.	0
The absorption of ziprasidone is increased up to two-fold in the presence of food.	1
"In a clinical pharmacology study designed to evaluate the effects of CYMBALTA on various parameters, including blood pressure at supratherapeutic doses with an accelerated dose titration, there was evidence of increases in supine blood pressure at doses up to 200mg twice daily."	0
Atazanavir solubility decreases as pH increases.	0
"There has been a long-standing concern, however, that antidepressants may have a role in inducing worsening of depression and the emergence of suicidality in certain patients during the early phases of treatment."	0
Activation of mania/hypomania has also been reported in a small proportion of patients with major affective disorder who were treated with other marketed antidepressants.	0
In vitro data indicate that fluvastatin metabolism involves multiple Cytochrome P450 (CYP) isozymes.	0
"Patients on diuretics, especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with ALTACE."	0
Anti-gout colchicine Potential for serious and/or life-threatening reactions in patients with renal and/or hepatic impairment.	0
"Paroxetine: Co-administration of paroxetine (20 mg/day for 5-8 days), a potent inhibitor of CYP2D6, with multiple doses of iloperidone (8 or 12 mg twice daily) to patients with schizophrenia ages 18-65 resulted in increased mean steady-state peak concentrations of iloperidone and its metabolite P88, by about 1.6 fold, and decreased mean steady-state peak concentrations of its metabolite P95 by one-half."	1
"Cross Resistance Based on resistance patterns observed in cell culture replicon studies and HCV-infected subjects, cross-resistance between ledipasvir and other NS5A inhibitors is expected."	0
Dosage should be individualized by the prescribing physician experienced in the treatment of end-stage renal disease with PD.	0
"At the first signs of differentiation syndrome, interrupt treatment with TRISENOX and administer dexamethasone 10 mg intravenously twice daily."	0
Discuss treatment options with women planning to become pregnant.	0
None of these patients were discontinued from the trials because of hyperkalemia.	0
"On average, both lorazepam alone and lorazepam with fluvoxamine produced substantial decrements in cognitive functioning; however, the coadministration of fluvoxamine and lorazepam did not produce larger mean decrements compared to lorazepam alone."	0
"The mechanism of action is blockade of the cardiac ion channel carrying the rapid component of the delayed rectifier potassium current, IKr."	0
"In one study Kantola, T, et al., Clin Pharmacol Ther 1998; 63(4):397<U+2013>402."	0
"Patients with Hypertrophic Cardiomyopathy (IHSS) Verapamil Component In 120 patients with hypertrophic cardiomyopathy (most of them refractory or intolerant to propranolol) who received therapy with verapamil at doses up to 720 mg/day, a variety of serious adverse effects were seen."	0
"If symptomatic hypotension develops, a dose reduction or discontinuation of ACCURETIC may be necessary."	0
"If the QT interval prolongs to 500 ms or greater, the dose must be reduced, the duration of the infusion prolonged or the drug discontinued."	0
"Effect of Co-Administered Drugs on Pitavastatin Systemic Exposure * Data presented as x-fold change represent the ratio between co-administration and pitavastatin alone (i.e., 1-fold = no change)."	0
"Therefore, monitoring of plasma drug levels alone should not guide management of the patient."	0
Drugs that raise the gastrointestinal pH may lead to an earlier release of duloxetine.	0
"Results demonstrated that with food, mean AUC and Cmax were decreased by 15% and 25%, respectively, while mean Tmax was prolonged by 60% (from 1.4 to 2.2 hr)."	1
A patient may be initiated on TWYNSTA tablets if it is unlikely that control of blood pressure would be achieved with a single agent.	0
"With once-daily dosing, steady-state plasma concentrations are achieved within approximately 4 to 5 days."	0
"Dipyridamole produces peripheral vasodilation, which can exacerbate pre-existing hypotension."	0
Advise families and caregivers of the need for close observation and communication with the prescriber.	0
Methadone: See WARNINGS AND PRECAUTIONS (5.9).	0
Concomitant use of pimozide and paroxetine or other strong CYP 2D6 inhibitors are contraindicated.	0
Approximately 68% of the prasugrel dose is excreted in the urine and 27% in the feces as inactive metabolites.	0
"Coadministration of eszopiclone 3 mg to subjects receiving ketoconazole, a potent inhibitor of CYP3A4, 400mg daily for 5 days, resulted in a 2.2-fold increase in exposure to eszopiclone."	1
"Digoxin increases the risk of proarrhythmic events (7.1) Calcium blocking drugs may have additive effects on decreasing atrioventricular conduction, ventricular function, and blood pressure (7.2) Concomitant use of catecholamine-depleting drugs may produce hypotension, marked bradycardia, and syncope (7.3) Dosage of insulin or antidiabetic drugs may require adjustment (hyperglycemia)."	0
"Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk."	0
"Population pharmacokinetic analyses indicate that the plasma concentration of dofetilide in patients with supraventricular and ventricular arrhythmias, ischemic heart disease, or congestive heart failure are similar to those of healthy volunteers, after adjusting for renal function."	0
Several recent epidemiologic studies suggest a positive statistical association between SSRI use (including PEXEVA<U+00AE>) in pregnancy and PPHN.	0
"When REYATAZ with ritonavir is coadministered with substrates of CYP2C8, clinically significant interactions are not expected."	0
Carbamazepine Verapamil may increase carbamazepine concentrations during combined therapy.	1
Evaluate patients with repeated severe myelosuppression for thiopurine S-methyltransferase (TPMT) deficiency.	0
Fingolimod and fingolimod-phosphate are not excreted intact in urine but are the major components in the feces with amounts of each representing less than 2.5% of the dose.	0
"NO MORE THAN 200 TO 300 MG OF LIDOCAINE HYDROCHLORIDE INJECTION, USP SHOULD BE ADMINISTERED DURING A ONE HOUR PERIOD."	0
The dosage range of atorvastatin is 10 to 80 mg once daily.	0
Concomitant use of pimozide and Celexa or Lexapro is contraindicated.	0
Potassium-sparing agents should be used with caution in conjunction with angiotensin-converting enzyme (ACE) inhibitors due to an increased risk of hyperkalemia.	0
"Initiation of REYATAZ with ritonavir, a CYP3A inhibitor, in patients receiving medications metabolized by CYP3A or initiation of medications metabolized by CYP3A in patients already receiving REYATAZ with ritonavir, may increase plasma concentrations of medications metabolized by CYP3A."	1
Stevens-Johnson Syndrome was rarely (less than 0.1%) reported during the clinical development program.	0
"If lipase elevations are accompanied by abdominal symptoms, interrupt dosing and consider appropriate diagnostics to exclude pancreatitis."	0
"Quinidine potentiates the actions of depolarizing (succinylcholine, decamethonium) and nondepolarizing (d<U+2013>tubocurarine, pancuronium) neuromuscular blocking agents."	0
Possible risk factors for leukopenia/neutropenia include preexisting low white blood cell count (WBC) and history of drug induced leukopenia/neutropenia.	0
Higher daily doses of carbamazepine may cause an even greater increase in olanzapine clearance.	1
Whether this difference has clinical relevance is not yet known.	0
"This study showed no clear effect of the 10 and 20 mg/day doses, and the 60 mg/day dose was not more effective than the 40 mg/day dose."	0
Dosing recommendations for patients with a CrCl <15 mL/min or on dialysis cannot be provided.	0
It is not known if this effect occurs following single nitroglycerin doses.	0
"Therefore, in patients taking the HIV protease inhibitor tipranavir plus ritonavir, or the hepatitis C protease inhibitor telaprevir, concomitant use of atorvastatin should be avoided."	0
Initiation of quetiapine in patients taking CRIXIVAN: Refer to the quetiapine prescribing information for initial dosing and titration of quetiapine.	0
Monitor patients frequently for signs and symptoms of neurological impairment.	0
"As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals."	0
Caution is recommended during coadministration with triazolam.	0
There is a departure from linearity when dose strengths are increased; the half-life is slightly increased with dose.	0
Patients with one or more variant CYP2C9 alleles have decreased S-warfarin clearance.	0
Screening patients for bipolar disorder A major depressive episode may be the initial presentation of bipolar disorder.	0
After four weeks of oral dosing (120 mg q.i.d.	0
"In healthy subjects, the oral bioavailability of sotalol is 90-100%."	0
NORPRAMIN should be discontinued before initiating treatment with the MAOI.	0
"Children under 15 years of age had significantly lower plasma concentration/dose ratios, compared with adults."	0
"Conversely, adverse effects may result from displacement of protein-bound clomipramine by other highly bound drugs."	0
"The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine; cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide)."	0
"When ready to use, take the cap off the dispenser, place the dispenser in the patient's mouth along the inner cheek on either the right or left side."	0
Food: A crossover study in 26 healthy adult male subjects was performed to evaluate the effect of food on the pharmacokinetics of a single 5 mg dose of asenapine.	0
An effect of this magnitude should not necessitate a change in the fluconazole dose regimen in subjects receiving concomitant diuretics.	0
"Clinical experience suggests that in psychotic children, administration of DESOXYN tablets may exacerbate symptoms of behavior disturbance and thought disorder."	0
There have been rare reports of transient healing of gastric ulcers despite subsequently documented malignancy.	0
"Heart block <U+2014> In patients without implanted pacemakers who are at high risk of complete atrioventricular block (eg, those with digitalis intoxication, second<U+2013>degree atrioventricular block, or severe intraventricular conduction defects), quinidine should be used only with caution."	0
"However, due to the potential for serotonin syndrome, the concurrent administration of paroxetine and lithium should be undertaken with caution."	0
There is some evidence which suggests that more rapid healing can be achieved in this subpopulation with 1600 mg of cimetidine tablets at bedtime.	0
"For patients who are unable to swallow whole tablets, 5 mg and 2.5 mg ELIQUIS tablets may be crushed and suspended in water, 5% dextrose in water (D5W), or apple juice, or mixed with applesauce and promptly administered orally."	0
"Distribution The apparent volume of distribution of vortioxetine is approximately 2600L, indicating extensive extravascular distribution."	0
"During all MDD phase 2 and phase 3 studies, mania was reported for approximately 0.02% of patients treated with PRISTIQ."	0
"Interaction with Combined P-gp and Moderate CYP3A4 Inhibitors in Patients with Renal Impairment XARELTO should not be used in patients with CrCl 15 to <80 mL/min who are receiving concomitant combined P-gp and moderate CYP3A4 inhibitors (e.g., erythromycin) unless the potential benefit justifies the potential risk [see Warnings and Precautions (5.4) and Clinical Pharmacology (12.3)]."	0
"In rats, at 40 mg/kg/day (approximately equivalent to the recommended human daily dose based on body surface area comparisons), rifabutin caused an increase in fetal skeletal variants."	0
"It may also induce CYP2B6, CYP2C8 and CYP2C9."	0
"There is a fall in resting and exercise cardiac output with little observed change in stroke volume, and only a small increase in right atrial pressure, or pulmonary capillary wedge pressure at rest or during exercise."	0
Hypersensitivity to catecholamines has been observed in patients withdrawn from beta-blocker therapy.	0
"Begin treatment at 30mg once daily for 1 week, to allow patients to adjust to the medication before increasing to 60mg once daily."	0
No change in initial dose of either drug is necessary and dose adjustments should be made on the basis of clinical response.	0
Consider additional follow-up and diagnostic testing (5.1).	0
"In a study of 51 pediatric patients (1 month to 24 months of age) who were undergoing surgery requiring general anesthesia, a single intravenous dose of ondansetron, 0.1 or 0.2 mg/kg, was administered prior to surgery."	0
Administration of olanzapine once daily leads to steady-state concentrations in about 1 week that are approximately twice the concentrations after single doses.	0
The rise in urinary pH also increases the ionization of uric acid to the more soluble urate ion.	0
"Nisoldipine accumulation, during multiple dosing, is predictable from a single dose."	0
Very close clinical monitoring is mandatory.	0
"Drugs Metabolized by P450 2D6 <U+2013> The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the Caucasian population (about 7% to 10% of Caucasians are so called <U+201C>poor metabolizers<U+201D>); reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are not yet available."	0
"Because children commonly have gastrointestinal illnesses that lead to vomiting, they may be particularly susceptible to hypertensive episodes resulting from abrupt inability to take medication."	0
"When benzodiazepines and opioids are combined, the potential for benzodiazepines to significantly worsen opioid-related respiratory depression exists."	0
"Eplerenone did not inhibit the metabolism of amiodarone, amlodipine, astemizole, chlorzoxazone, cisapride, dexamethasone, dextromethorphan, diclofenac, 17<U+03B1>-ethinyl estradiol, fluoxetine, losartan, lovastatin, mephobarbital, methylphenidate, methylprednisolone, metoprolol, midazolam, nifedipine, phenacetin, phenytoin, simvastatin, tolbutamide, triazolam, verapamil, or warfarin in vitro."	0
"Patients with creatinine clearance of 30 to 60 mL/min. and patients with hepatic functional impairment had about a 2-fold increase in plasma concentrations (AUC, Cmax)."	0
"Rifampin exhibits in vitro activity against most strains of the following microorganisms; however, the safety and effectiveness of rifampin in treating clinical infections due to these microorganisms have not been established in adequate and well controlled trials."	0
Potent inhibitors of CYP2D6 may increase CYMBALTA concentrations (7.2).	1
"Refer to the Contraindications section of the prescribing information for clarithromycin and amoxicillin, when administered in combination with ACIPHEX (4)."	0
Operant conditioning techniques in rats and pigeons suggest that Pamelor has a combination of stimulant and depressant properties.	0
The primary circulating metabolite is the inactive irbesartan glucuronide conjugate (approximately 6%).	0
Consider alternative corticosteroids.Co-administration with corticosteroids of which exposures are significantly increased by strong CYP3A inhibitors can increase the risk for Cushing<U+2019>s syndrome and adrenal suppression.	0
"Closely monitor blood pressure, renal function and electrolytes in patients on TWYNSTA and other agents that affect the RAS."	0
"In hypertension caused by pheochromocytoma, no therapeutic effect of CATAPRES tablets can be expected."	0
"The responder rate 3 weeks after vaccination, defined as seroconversion or a <U+2265>4-fold increase in antibody directed against at least 1 of the 3 influenza strains, was 54% for GILENYA 0.5 mg and 85% in the placebo group."	0
Intravenous administration of nitroglycerin decreases the thrombolytic effect of tissue-type plasminogen activator ( t-PA ) .	0
"Thalitone<U+00AE> cannot be substituted for other formulations of chlorthalidone and likewise, other formulations of chlorthalidone cannot be substituted for Thalitone<U+00AE>."	0
"Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide."	0
Concomitant use of desvenlafaxine with potent inhibitors of CYP3A4 may result in higher concentrations of desvenlafaxine.	1
"The patient<U+2019>s blood pressure declines within 30 to 60 minutes after an oral dose, the maximum decrease occurring within 2 to 4 hours."	0
"For patients chronically taking potent inducers of CYP3A , such as rifampin , avoid use of ADCIRCA see Drug Interactions ( 7.2 ) and Clinical Pharmacology ( 12.3 ) ."	0
"PDE5 inhibitors such as sildenafil, vardenafil, and tadalafil have been shown to potentiate the hypotensive effects of organic nitrates."	0
"Reproduction studies performed in rabbits at doses up to approximately 3 times the oral maximum recommended daily human dose (MRDHD) of Catapres<U+00AE> (clonidine hydrochloride, USP) tablets produced no evidence of a teratogenic or embryotoxic potential in rabbits."	0
Drugs that are contraindicated specifically due to the observed or expected magnitude of interaction and potential for serious or life-threatening adverse events are listed in Table 1.	0
"The renal clearances of hydrochlorothiazide and the pharmacologically active metabolite of triamterene, the sulfate ester of hydroxytriamterene, have been shown to be reduced and the plasma levels increased following administration of DYAZIDE to elderly patients and patients with impaired renal function."	0
The principal initial pathway of metabolism for sertraline is N-demethylation.	0
"Beta-blockade may mask certain clinical signs (e.g., tachycardia) of hyperthyroidism."	0
"Thus, CLOZARIL may be administered with or without food."	0
"As with other psychotropic medications, patients should be advised to avoid alcohol while taking LUVOX CR Capsules."	0
"Therefore , caution should be observed in patients receiving nitroglycerin during t-PA therapy ."	0
"This property increases myocardial oxygen delivery in patients with coronary artery spasm, and is responsible for the effectiveness of PROCARDIA in vasospastic (Prinzmetal's or variant) angina."	0
"In subacute and chronic dog and rat studies designed to produce toxicity, high doses of diltiazem were associated with hepatic damage."	0
The decision to prescribe selegiline should take into consideration that the MAO system of enzymes is complex and incompletely understood and there is only a limited amount of carefully documented clinical experience with selegiline.	0
"Triamterene and hydrochlorothiazide is a diuretic, antihypertensive drug product, principally due to its hydrochlorothiazide component; the triamterene component reduces the excessive potassium loss which may occur with hydrochlorothiazide use."	0
"The mechanism of action of selegiline (the drug substance of EMSAM) as an antidepressant is not fully understood, but is presumed to be linked to potentiation of monoamine neurotransmitter activity in the central nervous system (CNS) resulting from its irreversible inhibition of the enzyme monoamine oxidase (MAO)."	0
"Until further data are available, verapamil should be administered cautiously to patients with impaired renal function."	0
"Whether increased levels of bradykinin, a potent vasopressor peptide, play a role in the therapeutic effects of ALTACE remains to be elucidated."	0
Pulmonary capillary wedge pressure increased significantly from 6.4 mmHg to 11.8 mmHg in the 11 patients who completed the study.	0
APTIVUS co-administered with ritonavir at the recommended dose is a net inhibitor of CYP 3A and may increase plasma concentrations of agents that are primarily metabolized by CYP 3A.	1
"Withhold Tasigna, and monitor serum lipase or amylase2."	0
The potential for drug-drug interactions must be considered prior to and during drug therapy.	0
Dose titration: The dose may be doubled at short (90 second) intervals initially.	0
Initiate mexiletine therapy with 200 mg every eight hours when rapid control of arrhythmia is not essential.	0
LASIX may lower serum levels of calcium ( rarely cases of tetany have been reported ) and magnesium .	0
"Assays of serum digoxin levels are described elsewhere, as is their use in patient monitoring."	0
"The daily dose can be increased to 6 mg, if clinically indicated."	0
"Conversely, at least 14 days should be allowed after stopping PEXEVA<U+00AE> before starting an MAOI intended to treat psychiatric disorders."	0
"The effects of co-administration of APTIVUS with 200 mg ritonavir on the AUC, Cmax, and Cmin of tipranavir or the co-administered drug, are summarized in Tables 7 and 8, respectively."	0
From pediatric pharmacokinetic data the following is recommended.	0
"Alcohol<U+2014> Although paroxetine does not increase the impairment of mental and motor skills caused by alcohol, patients should be advised to avoid alcohol while taking PEXEVA<U+00AE> (paroxetine mesylate)."	0
These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment.	0
The pharmacokinetics of candesartan in hypertensive patients undergoing hemodialysis are similar to those in hypertensive patients with severe renal impairment.	0
Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A4 inhibitors.	0
"In patients with end-stage renal disease on hemodialysis, the AUC increased by approximately 1.5 fold."	0
Concomitant hypochromic anemia should be treated with intramuscular iron.	0
"In a single dose study, DP2, DP3 and DP4 showed a progressive rise in plasma concentrations with a profile similar to that for total icodextrin, with peak values reached by the end of the dwell and declining thereafter."	0
"Renal Insufficiency: Following oral administration, plasma concentrations and AUCs of losartan and its active metabolite are increased by 50-90% in patients with mild (creatinine clearance of 50 to 74mL/min) or moderate (creatinine clearance 30 to 49mL/min) renal insufficiency."	0
"The main metabolic pathway is through hydroxylation of risperidone to 9-hydroxyrisperidone by the enzyme, CYP 2D6."	0
"After either oral or intravenous administration, sildenafil is excreted as metabolites predominantly in the feces (approximately 80% of the administered oral dose) and to a lesser extent in the urine (approximately 13% of the administered oral dose)."	0
Patients should be cautioned against interruption of CATAPRES tablets therapy without their physician's advice.	0
"40 mg, SD <U+2191> 37% <U+2191> 16% Diltiazem 240 mg QD, 28 days 40 mg, SD <U+2191> 51% No change Erythromycin 500 mg QID, 7 days 10 mg, SD <U+2191> 33% <U+2191> 38% Amlodipine 10 mg, single dose 80 mg, SD <U+2191> 15% <U+2193> 12 % Cimetidine 300 mg QID, 2 weeks 10 mg QD for 2 weeks <U+2193> Less than 1% <U+2193> 11% Colestipol 10 mg BID, 28 weeks 40 mg QD for 28 weeks Not determined <U+2193> 26%Single sample taken 8<U+2013>16 h post dose."	0
"DEMSER may have additive sedative effects with alcohol and other CNS depressants , e.g. , hypnotics , sedatives , and tranquilizers ."	0
Abnormalities in platelet or white blood cell count have not been noted.	0
WARNING: SEVERE NEUTROPENIA AND SEVERE DIARRHEA See full prescribing information for complete boxed warning Fatal neutropenic sepsis occurred in 0.8% of patients receiving ONIVYDE.	0
"If trazodone is used with a CYP3A4 inhibitor such as CRIXIVAN, the combination should be used with caution and a lower dose of trazodone should be considered."	1
A total of 48 healthy subjects were administered ADASUVE 10 mg.	0
"The risk of Torsade de Pointes, however, is related to dose as well as to patient characteristics."	0
Caution should be exercised when these 2 agents are coadministered.	0
"Consequently, the oral clearance of zaleplon was reduced by 70% and 87% in compensated and decompensated cirrhotic patients, respectively, leading to marked increases in mean Cmax and AUC (up to 4-fold and 7-fold in compensated and decompensated patients, respectively), in comparison with healthy subjects."	0
"If consciousness is impaired, the airway should be secured prior to lavage."	0
Studies at clinically relevant doses in humans have demonstrated that paroxetine blocks the uptake of serotonin into human platelets.	0
Subsequently titration may be carried out every 2 weeks up to a maximum of 200/25 mg (two DUTOPROL 100/12.5 mg tablets).	0
Initial dose in patients 6 years of age and older is 0.07 mg/kg (up to 5 mg total) once daily (2.1) Heart Failure: Initiate with 5 mg once daily.	0
Some patients may require a dosage of 200 mg once a day for optimal effect.	0
Anaphylactoid reactions have also been reported in patients undergoing low-density lipoprotein apheresis with dextran sulfate absorption.	0
Absorption The maximal plasma vortioxetine concentration (Cmax) after dosing is reached within 7 to 11 hours postdose (Tmax).	0
Figure 2 Dabigatran etexilate mesylate is absorbed as the dabigatran etexilate ester.	0
"However , Ventavis has the potential to increase the hypotensive effect of vasodilators and antihypertensive agents ."	0
"Hemoglobin and Hematocrit: Greater than 20% decreases in hemoglobin and hematocrit were observed in 0.4% and 0.8%, respectively, of Diovan patients, compared with 0.1% and 0.1% in placebo-treated patients."	0
Cases of myopathy/rhabdomyolysis have been observed with simvastatin coadministered with lipid-modifying doses (<U+2265>1g/day niacin) of niacin-containing products.	0
It should not be used in conditions for which specific pediatric dosages have not been established.	0
Alternative dosing strategies are recommended in patients who are genetically poor CYP 2D6 metabolizers.	0
The concentrations of the reconstituted suspensions are as follows: Fluconazole Content per Bottle Concentration of Reconstituted Suspension 350 mg 10 mg/mL 1400 mg 40 mg/mL Note: Shake oral suspension well before using.	0
"It was not possible to identify significant differences in efficacy and safety between older and younger patients; however, elderly patients with systolic blood pressure < 120 mmHg seemed less likely to benefit."	0
Apixaban is a selective inhibitor of FXa.	0
"ZOLOFT oral solution contains alcohol, and concomitant use of ZOLOFT and disulfiram may result in a disulfiram-alcohol reaction."	0
Mexiletine: See WARNINGS AND PRECAUTIONS (5.9).	0
Administer the adjusted TIKOSYN dose and begin continuous ECG monitoring.	0
Approximately 5% of the administered dose is unaccounted for.	0
"Dabigatran and its acyl glucuronides are competitive, direct thrombin inhibitors."	0
CYMBALTA is a moderate inhibitor of CYP2D6 (7.9).	0
"If hypotension occurs and is considered to be due to this mechanism, it can be corrected by volume expansion."	0
Case reports and epidemiological studies (case-control and cohort design) have demonstrated an association between use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding.	0
A 50% to 60% increase in anti-FXa activity was observed when apixaban was coadministered with enoxaparin or naproxen.	0
Nortriptyline hydrochloride oral solution USP should also not be started in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue.	0
Patients receiving continued paroxetine experienced a significantly lower relapse rate over the subsequent 24 weeks compared to those receiving placebo.	0
"Physicians and patients should be vigilant for the appearance of signs or symptoms of hepatitis, such as fatigue, malaise, anorexia, nausea, jaundice, bilirubinuria, acholic stools, liver tenderness or hepatomegaly."	0
"If these products are needed, they should be given at least 2 hours before cimetidine administration."	0
"Nevertheless, caution is indicated in the co-administration of TCAs with any of the SSRIs and also in switching from one class to the other."	0
"In actual salt depletion, appropriate replacement is the therapy of choice."	0
"Acute bolus administration of nicardipine hydrochloride injection (2.5 mg) in healthy volunteers decreased mean arterial pressure and renal vascular resistance; glomerular filtration rate (GFR), renal plasma flow (RPF), and the filtration fraction were unchanged."	0
Closely monitor potassium in patients receiving concomitant RAAS therapy.	0
The D61G substitution was previously described in subjects infected with HCV genotype 1a in a liver pre-transplant trial.	0
"ACEON<U+00AE> (perindopril erbumine) is a pro-drug for perindoprilat, which inhibits ACE in human subjects and animals."	0
Follow the steps below for preparation of the suspension.	0
Rifampin: Take at same time as CADUET (7.9).	0
"Drugs That Inhibit Both Aldehyde Oxidase and CYP3A4 Cimetidine: Cimetidine inhibits both aldehyde oxidase (in vitro) and CYP3A4 (in vitro and in vivo), the primary and secondary enzymes, respectively, responsible for zaleplon metabolism."	1
Serotonergic Drugs	0
Doses up to 240 mg daily have been administered.	0
Immunologic responses were further decreased with fingolimod 1.25 mg (a dose higher than recommended in MS).	0
The dose range of TENORMIN is narrow and increasing the dose beyond 100 mg once daily is not associated with increased antihypertensive effect.	0
"Concomitant administration of both a CYP2C9 inhibitor ( such as fluconazole or amiodarone ) and a strong CYP3A inhibitor ( e.g. , ketoconazole , itraconazole ) or a moderate CYP3A inhibitor ( e.g. , amprenavir , erythromycin , fluconazole , diltiazem ) with Tracleer will likely lead to large increases in plasma concentrations of bosentan ."	1
Total gastrectomy: May reduce exposure.	0
"The impact on the PR interval of co-administration of saquinavir/ritonavir with other drugs that prolong the PR interval (including calcium channel blockers, beta-adrenergic blockers, digoxin and atazanavir) has not been evaluated."	0
Families and caregivers should be advised of the need for close observation and communication with the prescriber.	0
"ACE inhibitors may cause excessive hypotension, and may be associated with oliguria or azotemia, and rarely with acute renal failure and death."	0
"If patients present with prolonged or inappropriate erections, they should discontinue therapy immediately and consult their physicians."	0
The extent to which SSRI TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.	0
Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have.	0
"Objective: To restore normal urinary citrate (greater than 320 mg/day and as close to the normal mean of 640 mg/day as possible), and to increase urinary pH to a level of 6.0 to 7.0."	0
The usual effective dose range is 10<U+2013>20 mg three times daily.	0
"If acceptable alternatives to linezolid or intravenous methylene blue treatment are not available and the potential benefits of linezolid or intravenous methylene blue treatment are judged to outweigh the risks of serotonin syndrome in a particular patient, Lexapro should be stopped promptly, and linezolid or intravenous methylene blue can be administered."	0
"ALDACTONE is contraindicated for patients with anuria , acute renal insufficiency , significant impairment of renal excretory function , hyperkalemia , Addison 's disease , and with concomitant use of eplerenone ."	0
Studies in normal human subjects have shown that doxazosin competitively antagonized the pressor effects of phenylephrine (an alpha1 agonist) and the systolic pressor effect of norepinephrine.	0
"There were no adverse effects on fertility or reproduction in rats at doses up to 100 mg/kg/day (60 and 10 times the maximum daily human dose when based on mg/kg and mg/m2, respectively)."	0
"Families and caregivers of patients being treated with antidepressants for major depressive disorder or other indications both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to health care providers."	0
"MINIPRESS has been administered without any adverse drug interaction in limited clinical experience to date with the following: (1) cardiac glycosides<U+2013>digitalis and digoxin; (2) hypoglycemics<U+2013>insulin, chlorpropamide, phenformin, tolazamide, and tolbutamide; (3) tranquilizers and sedatives<U+2013>chlordiazepoxide, diazepam, and phenobarbital; (4) antigout<U+2013>allopurinol, colchicine, and probenecid; (5) antiarrhythmics<U+2013>procainamide, propranolol, and quinidine; and (6) analgesics, antipyretics and anti-inflammatories<U+2013>propoxyphene, aspirin, indomethacin, and phenylbutazone."	0
The antihypertensive effects of the drug may be enhanced in the post-sympathectomy patient.	0
"Marplan (isocarboxazid) should not be administered to any patient with a confirmed or suspected cerebrovascular defect or to any patient with cardiovascular disease, hypertension, or history of headache."	0
Clinical studies of quinapril HCl/hydrochlorothiazide did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
Cannot predict effect of TPV/ritonavir on calcium channel blockers that are dual substrates of CYP3A and P-gp due to conflicting effect of TPV/ritonavir on CYP3A and P-gp.	0
Drugs Affecting Hepatic Metabolism: The metabolism and pharmacokinetics of paroxetine may be affected by the induction or inhibition of drug-metabolizing enzymes.	0
"If hypertension cannot be controlled, do not resume CAPRELSA."	0
Monitor patients for respiratory depression and sedation at frequent intervals.	0
Instruct patients to minimize sun exposure due to risk of photosensitivity.	0
The potential for cross-sensitivity between drugs in the sulfonamide class and APTIVUS is unknown.	0
"Co-administration of darunavir and ritonavir and other drugs that inhibit CYP3A, or P-gp may decrease the clearance of darunavir and ritonavir and may result in increased plasma concentrations of darunavir and ritonavir."	1
"Rifampin has enzyme-inducing properties, including induction of delta amino levulinic acid synthetase."	0
"The overall results of the study are compatible with the possibility that patients with borderline blood pressure (less than 120 mm Hg systolic), especially if over 60 years of age, are less likely to benefit."	0
The mechanism of the antihypertensive effect of thiazides is not fully understood.	0
There have been reports of increased INR and prothrombin time in patients receiving a proton pump inhibitor and warfarin concomitantly.	0
"The development of a potentially life-threatening serotonin syndrome has been reported with SNRIs and SSRIs, including nortriptyline hydrochloride, alone but particularly with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, and St. John's Wort) and with drugs that impair metabolism of serotonin (in particular, MAOIs, both those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue)."	0
"In an eccentric dosing study, 40 mg capsules of dilatrate<U+00AE>-SR were administered daily at 0800 and 1400 hours."	0
"Consequently, concomitant use of a drug metabolized by P450 2D6 with sertraline hydrochloride may require lower doses than usually prescribed for the other drug."	1
"Carcinogenicity, mutagenicity, and fertility studies have not been conducted in animals with ACCURETIC."	0
"Growth followed a similar pattern in both extensive and poor metabolizers(EMs, PMs)."	0
The pharmacokinetics of R- and S- warfarin and the INR in healthy subjects given a single 25 mg dose of warfarin were unaffected by continuous subcutaneous infusion of treprostinil at an infusion rate of 10 ng/kg/min.	0
"Care and prudent medical judgment should be exercised when switching, particularly from long-acting agents."	0
"Aldosterone binds to mineralocorticoid receptors in both epithelial (e.g., kidney) and nonepithelial (e.g., heart, blood vessels, and brain) tissues and increases blood pressure through induction of sodium reabsorption and possibly other mechanisms."	0
"If symptoms occur, initiate high-dose steroids immediately and monitor hemodynamics."	0
Use of sotalol in any age group with decreased renal function should be at lower doses or at increased intervals between doses.	0
"Metabolism and Elimination: Iloperidone is metabolized primarily by 3 biotransformation pathways: carbonyl reduction, hydroxylation (mediated by CYP2D6) and O-demethylation (mediated by CYP3A4)."	0
The suspension should be refrigerated at2<U+00BA>to 8<U+00B0>C (36<U+00BA>to 46<U+00B0>F) and can be stored for up to 30 days in the PET bottle with a child-resistantscrew- cap closure.	0
"The following symptoms, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric."	0
"Long-Term Suppression of Growth: Careful follow-up of weight and height in children ages 7 to 10 years who were randomized to either methylphenidate or non-medication treatment groups over 14 months, as well as in naturalistic subgroups of newly methylphenidate-treated and non-medication treated children over 36 months (to the ages of 10 to 13 years), suggests that consistently medicated children (i.e., treatment for 7 days per week throughout the year) have a temporary slowing in growth rate (on average, a total of about 2 cm less growth in height and 2.7 kg less growth in weight over 3 years), without evidence of growth rebound during this period of development."	0
"Monitoring of BCR-ABL Transcript Levels in Patients who have Reinitiated Therapy after Los s of Molecular Response Monitor CBC and BCR-ABL transcripts in patients who re-initiate treatment with Tasigna due to loss of molecular response quantitation every 4 weeks until a major molecular response is re-established, then every 12 weeks."	0
Cyclosporine increased rosuvastatin exposure (AUC) 7<U+2011>fold.	1
Patients included both males (N = 28) and females (N = 33).	0
Additional information from a rising dose study of doses up to 250 mg suggests that DMI may exhibit nonlinear pharmacokinetics over the usual dosing range.	0
"Examples of tricyclic antidepressants include desipramine, Protriptyline."	0
Drug-Drug Interactions Eplerenone is metabolized primarily by CYP3A4.	0
"Co-administration of SAMSCA with 400mg ketoconazole daily or with other strong CYP 3A inhibitors (e.g., clarithromycin, itraconazole, telithromycin, saquinavir, nelfinavir, ritonavir and nefazodone) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure."	1
Pregnancy Category D. Procarbazine hydrochloride can cause fetal harm when administered to a pregnant woman.	0
"Pooled analyses of short-term placebo-controlled trials of antidepressant drugs (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18 to 24) with major depressive disorder (MDD) and other psychiatric disorders."	0
Digoxin is rarely beneficial in patients with this condition.	0
Simultaneous administration of didanosine EC and REYATAZ with food results in a decrease in didanosine exposure.	1
Quetiapine is unlikely to interfere with the metabolism of drugs metabolized by cytochrome P450 enzymes.	0
"Patients should be instructed to notify their health care providers of any change in over-the-counter, prescription, or supplement use."	0
Active pathological bleeding (4.1) Prior transient ischemic attack or stroke (4.2) Hypersensitivity to prasugrel or any component of the product (4.3) Effient is contraindicated in patients with active pathological bleeding such as peptic ulcer or intracranial hemorrhage.	0
Increase dosage gradually until symptoms are controlled.	0
"In a patient who requires more urgent treatment of a psychiatric condition, other interventions, including hospitalization, should be considered."	0
Total daily doses greater than 50 mg are not recommended.	0
"If the QTc is greater than 440 msec (500 msec in patients with ventricular conduction abnormalities), TIKOSYN is contraindicated."	0
Daily dosage may be raised in increments of 5 mg at weekly intervals until an optimum clinical response is achieved.	0
"The maintenance dose of voriconazole should be reduced in patients with mild to moderate hepatic impairment, Child-Pugh Class A and B."	0
Hepatocellular changes should be monitored frequently if this combination is prescribed.	0
"Excretion Elimination of digoxin is predominantly renal, although in adult volunteers about a quarter of serum digoxin is eliminated through the intestine, excreted in bile or secreted directly into the lumen by P-glycoprotein."	0
The administration of guanfacine concomitantly with a known microsomal enzyme inducer ( phenobarbital or phenytoin ) to two patients with renal impairment reportedly resulted in significant reductions in elimination half-life and plasma concentration .	1
Irbesartan does not inhibit ACE or renin or affect other hormone receptors or ion channels known to be involved in the cardiovascular regulation of blood pressure and sodium homeostasis.	0
"There was no evidence of a carcinogenic potential of verapamil administered in the diet of rats for two years at doses of 10, 35, and 120 mg/kg/day or approximately 1, 3.5, and 12 times, respectively, the maximum recommended human daily dose (480 mg/day or 9.6 mg/kg/day)."	0
"After repeated administration of 400 mg twice daily, steady state is reached within 4 to 8 days of treatment and the mean accumulation ratio for dronedarone ranges from 2.6 to 4.5."	0
Do not take two doses of CYMBALTA at the same time.	0
"Atorvastatin Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol."	0
"Cerebral hemorrhage, subarachnoid hemorrhage, stroke, and other cerebrovascular events have been reported in patients treated with D.H.E."	0
"The usefulness of reducing ammonia levels and decreasing urinary pH is suggested by single (not yet replicated) clinical trials in which urease inhibition 1) allowed successful antibiotic treatment of urea-splitting Proteus infections after surgical removal of struvite stones in patients not cured by 3 months of antibacterial treatment alone, and 2) reduced the rate of stone growth in patients who were not candidates for surgical removal of stones."	0
"Such individuals are referred to commonly as <U+201C>poor metabolizers<U+201D> of drugs such as debrisoquin, dextromethorphan, and the tricyclic antidepressants."	0
No dose adjustment is necessary in patients with mild to moderate renal impairment.	0
Dabigatran etexilate is a substrate of the efflux transporter P-gp.	0
"Discontinue treatment with VYVANSE and any concomitant serotonergic agents immediately if symptoms of serotonin syndrome occur, and initiate supportive symptomatic treatment."	0
"DIFLUCAN has been associated with rare cases of serious hepatic toxicity, including fatalities primarily in patients with serious underlying medical conditions."	0
"Co-administration of lovastatin , digoxin , furosemide , and hydrochlorothiazide with SAMSCA has no clinically relevant impact on the exposure to tolvaptan ."	0
There was no indication in this study of any additional benefit for doses higher than 20mg/day.	0
"Discontinuation symptoms have been reported when switching patients from other antidepressants, including venlafaxine, to PRISTIQ."	0
"Prior to excretion, terbinafine is extensively metabolizedby at least 7 CYP isoenzymes with major contributions from CYP2C9, CYP1A2, CYP3A4, CYP2C8, and CYP2C19."	0
"Effects of other drugs on the exposures of aripiprazole and dehydro-aripiprazole are summarized in Figure 19 and Figure 20, respectively."	0
"Hepatotoxicity: Clinical hepatitis and hepatic decompensation, including some fatalities, have been reported."	0
"6 mg/kg q12h for the first 24 hours 4 mg/kg q12h 200 mg q12h Candidemia in nonneutropenic patients and other deep tissue Candida infections 6 mg/kg q12h for the first 24 hours 3<U+2013>4 mg/kg q12hIn clinical trials, patients with candidemia received 3 mg/kg IV q12h as primary therapy, while patients with other deep tissue Candida infections received 4 mg/kg q12h as salvage therapy."	0
"THIOLA<U+00AE> has a rapid onset and offset of action, showing a fall in cystine excretion on the first day of administration and a rise on the first day of drug withdrawal. thiola-formula"	0
The effects on parturition in rats are consistent with the species specific estrogen-lowering property produced by high doses of fluconazole.	0
The combined use of fluconazole at doses of 400 mg or greater with terfenadine is contraindicated.	0
In vitro studies showed minimal inhibitory effect of desvenlafaxine on the CYP2D6 isoenzyme.	0
Fluconazole increases the effect of amitriptyline and nortriptyline.	0
Geriatric Use: Clinical Studies of DESOXYN did not include sufficient numbers of subjects age 65 years and over to determine whether elderly subjects respond differently from younger subjects.	0
"Pooled analyses of short-term placebo-controlled trials of antidepressant drugs (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (aged 18-24) with major depressive disorder (MDD) and other psychiatric disorders."	0
H2-receptor antagonistsThese interactions have been studied in healthy adults.	0
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.	0
"These events were a cause for discontinuation of therapy in 2.5% of subjects receiving COREG, compared with 0.2% of placebo subjects."	0
Hepatitis including cases resulting in hepatic failure and death has been reported in patients treated with CRIXIVAN.	0
Renal excretion accounts for about 27% of total clearance.	0
"Early signs of salicylate overdose (salicylism), including tinnitus (ringing in the ears), occur at plasma concentrations approximating 200 <U+00B5>g/mL."	0
Ambrisentan is highly bound to plasma proteins (99%).	0
Thiazides are excreted in human breast milk.	0
"The total daily dose in children and adolescents should not exceed 1.4mg/kg or 100mg, whichever is less."	0
"The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents."	0
Initiate treatment with a single 60-mg oral loading dose (2).	0
"A meta-analysis of epidemiological data over a 16-year period (1992 to 2008) included a total of 20 distinct studies: 11 studies (including the above noted studies) reported estimates for both cardiovascular defects and overall congenital malformations, 3 studies reported estimates only for cardiovascular defects, and 6 studies reported estimates only for overall congenital malformations."	0
Elimination from the plasma is biphasic with a terminal elimination half-life of about 30<U+2013>50 hours.	0
No active metabolites of eplerenone have been identified in human plasma.	0
Clinical trials establishing the safety and efficacy of INVEGA<U+00AE> were carried out in subjects without regard to the timing of meals.	0
"In such patients, monitor renal function during the first few weeks of therapy."	0
"Increases in AUCs of about 42% in mild renal impairment (24-hr CrCl = 50 to 80 mL/min, Cockcroft-Gault [C-G]), about 56% in moderate renal impairment (24-hr CrCl = 30 to 50 mL/min, C-G), about 108% in severe renal impairment (24-hr CrCl <U+2264>30 mL/min, C-G), and about 116% in ESRD subjects were observed, compared with healthy, age-matched control subjects."	0
"PEXEVA<U+00AE> (paroxetine mesylate) should not be chewed or crushed, and should be swallowed whole."	0
"Instead, start chlorpromazine at low doses and increase as needed."	0
"Once the formulation has been selected and the decision to take with or without food has been made, this regimen should not be altered."	0
Do not use in patients with advanced aortic stenosis (4.1).	0
"Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior."	0
Elimination Dabigatran is eliminated primarily in the urine.	0
Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.	0
"Alcohol, Barbiturates, or Narcotics- potentiation of orthostatic hypotension may occur."	0
Monoamine Oxidase Inhibitors Use of phendimetrazine tartrate is contraindicated during or within 14 days following the administration of monoamine oxidase inhibitors because of the risk of hypertensive crisis.	0
"Prolonged use of Meperidine Hydrochloride Injection during pregnancy can result in neonatal opioid withdrawal syndrome, which may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts."	0
"Depending on the individual patient's urodynamics and BPH symptomatology, the dose may be titrated at 1 to 2 week intervals to 2 mg, and thereafter to 4 mg and 8 mg once daily."	0
Formation of perindoprilat is gradual with peak plasma concentrations occurring between 3 and 7 hours.	0
"Due to the effect of ritonavir on ketoconazole, high doses of ketoconazole and itraconazole (>200 mg/day) should be used cautiously with REYATAZ/ritonavir."	1
"There have been reports of increased bleeding, including spontaneous skin hematomas and hemarthrosis, in patients with hemophilia type A and B treated with protease inhibitors."	0
"ZIAC should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists (particularly of the phenylalkylamine [verapamil] and benzothiazepine [diltiazem] classes), or antiarrhythmic agents, such as disopyramide, are used concurrently."	0
"Amiloride HCl should not be given to patients receiving other potassium-conserving agents, such as spironolactone or triamterene."	0
"Hypercalcemia increases the risk of digoxin toxicity, while digoxin may be therapeutically ineffective in the presence of hypocalcemia."	0
Plasma protein binding is constant over the concentration range achieved with recommended doses.	0
Valproic Acid <U+2193> Valproic Acid Caution should be used when prescribing valproic acid.	0
"Following oral administration of radiolabelled carvedilol to healthy volunteers, carvedilol accounted for only about 7% of the total radioactivity in plasma as measured by area under the curve (AUC)."	0
"Beta-agonists such as albuterol, terbutaline and isoproterenol may have to be administered in increased dosages when used concomitantly with sotalol."	1
"During these periods, patients should avoid situations such as driving or hazardous tasks, where symptoms could result in injury."	0
Patients were followed for a mean duration of 3.4years.	0
"There have been reports of increased bleeding, including spontaneous skin hematomas and hemarthrosis in patients with hemophilia type A and B treated with protease inhibitors."	0
"In vitro, desvenlafaxine does not inhibit or induce the CYP3A4 isozyme."	0
No in vivo data are available and the clinical relevance is unknown.	0
"In general, avoid concomitant use of drugs that prolong the QT interval [see Warnings and Precautions (5.4)]."	0
Potential for serious and/or life-threatening events such as prolonged or increased sedation or respiratory depression.	0
"Discontinuation of Treatment with PEXEVA<U+00AE> (paroxetine mesylate): Recent clinical trials supporting the various approved indications for paroxetine employed a taper-phase regimen, rather than an abrupt discontinuation of treatment."	0
Any dose adjustment should be guided by clinical effect (tolerability and efficacy).	0
"DEMSER may add to the sedative effects of alcohol and other CNS depressants , e.g. , hypnotics , sedatives , and tranquilizers ."	0
"Geriatric Patients: Dosage adjustment on the basis of age is not usually necessary, unless there is also significant renal or hepatic dysfunction."	0
"Withdrawal symptoms have been observed in clinical trials following discontinuation of milnacipran, as with other SNRIs and SSRIs."	0
"At recommended therapeutic doses, dabigatran etexilate prolongs the coagulation markers such as aPTT, ECT, and TT."	0
"In a post-hoc analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) study where atorvastatin 80 mg vs. placebo was administered in 4,731 subjects without CHD who had a stroke or TIA within the preceding 6 months, a higher incidence of hemorrhagic stroke was seen in the atorvastatin 80 mg group compared to placebo (55, 2.3% atorvastatin vs. 33, 1.4% placebo; HR: 1.68, 95% CI: 1.09, 2.59; p=0.0168)."	0
"Although a causal link between the emergence of such symptoms and either the worsening of depression and/or the emergence of suicidal impulses has not been established, there is concern that such symptoms may represent precursors to emerging suicidality."	0
Cleviprex is contraindicated in patients with severe aortic stenosis because afterload reduction can be expected to reduce myocardial oxygen delivery.	0
"During marketing of paroxetine and other SSRIs and SNRIs (serotonin and norepinephrine reuptake inhibitors), there have been spontaneous reports of adverse events occurring upon the discontinuation of these drugs (particularly when abrupt), including the following: dysphoric mood, irritability, agitation, dizziness, sensory disturbances (eg, paresthesias such as electric shock sensations and tinnitus), anxiety, confusion, headache, lethargy, emotional lability, insomnia, and hypomania."	0
"The mean terminal elimination half-life of paliperidone was 24 hours, 40 hours, and 51 hours in subjects with mild, moderate, and severe renal impairment, respectively, compared with 23 hours in subjects with normal renal function (CrCl <U+2265> 80 mL/min)."	0
"Telmisartan has much greater affinity (>3,000 fold) for the AT1 receptor than for the AT2 receptor."	0
These decreases in blood pressure are not accompanied by a significant change in heart rate or plasma catecholamine levels with chronic dosing.	0
In PLATO the use of BRILINTA with maintenance doses of aspirin above 100 mg decreased the effectiveness of BRILINTA .	0
"Its half-life ranges from 21 to 54 hours (5th to 95th percentile; mean of 30hr), and apparent plasma clearance ranges from 12 to 47L/hr (5th to 95th percentile; mean of 25L/hr)."	0
This effect on midazolam appears to be more pronounced following oral administration of fluconazole than with fluconazole administered intravenously.	0
The dosing recommendations should be followed closely and the dose should be lowered if any evidence of bronchospasm is observed during up-titration.	0
The exposure of asenapine following administration of water 10 minutes after sublingual dosing was equivalent to that when water was administered 30 minutes after dosing.	0
"In the setting of normal renal function, the rise in urinary citrate following a single dose begins by the first hour and lasts for 12 hours."	0
<U+2022>Acute exacerbation of coronary artery disease upon cessation of therapy: Do not abruptly discontinue.	0
The concomitant use of ZOLOFT with MAOIs is contraindicated.	0
Monitor for signs and symptoms of myocardial infarction (MI) and stroke.	0
The mean decrease in hemoglobin from baseline to end of treatment for those patients receiving Letairis in the 12-week placebo-controlled studies was 0.8 g/dL.	0
"There have been reports of false-positive urine screening tests for tetrahydrocannabinol (THC) in patients receiving PPIs, including PROTONIX."	0
AdultPatients:Initiatewith10 mgoncedaily (or 5 mg if patients is on diuretic).	0
Treprostinil does not affect the pharmacokinetics or pharmacodynamics of warfarin .	0
"If half-lives are long, drug or metabolites may accumulate during periods of nightly administration and may be associated with impairments of cognitive and/or motor performance during waking hours; the possibility of interaction with other psychoactive drugs or alcohol will be increased."	0
Marked orthostatic hypotension has been reported when calcium channel blockers and organic nitrates were used concomitantly.	0
"Add an additional one tablespoon of food to the small container, mix, and feed the child the residual mixture."	0
"At doses above 4 mg/day, CYP 2D6 genotyping should be performed."	0
Moderate to severe hepatic impairment: Maximum dose 100 mg per day (2.2).	0
Elevated fentanyl concentration may lead to respiratory depression.	1
"During the initial phase of combination antiretroviral treatment, patients whose immune system responds may develop an inflammatory response to indolent or residual opportunistic infections (such as Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia, or tuberculosis), which may necessitate further evaluation and treatment."	0
Saquinavir <U+2191> nelfinavir<U+2191> saquinavir Concentrations of both saquinavir and nelfinavir were increased when the two agents were coadministered.	1
"An open-label, randomized, three-way crossover study in 18 healthy subjects assessed the effect of a single 1200 mg oral dose of azithromycin on the pharmacokinetics of a single 800 mg oral dose of fluconazole as well as the effects of fluconazole on the pharmacokinetics of azithromycin."	0
Exposure to l-nebivolol is higher than to d-nebivolol but l-nebivolol contributes little to the drug's activity as d-nebivolol's beta receptor affinity is > 1000-fold higher than l-nebivolol.	0
"Olanzapine is extensively distributed throughout the body, with a volume of distribution of approximately 1000L. It is 93% bound to plasma proteins over the concentration range of 7 to 1100ng/mL, binding primarily to albumin and <U+03B1>1-acid glycoprotein."	0
"If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus."	0
The concomitant use of PRADAXA and P-gp inhibitors in patients with severe renal impairment (CrCl 15-30 mL/min) should be avoided.	0
The extent to which this interaction is an important clinical problem depends on the extent of the inhibition of P450 2D6 by the antidepressant and the therapeutic index of the co-administered drug.	0
Asenapine is a high clearance drug with a clearance after intravenous administration of 52 L/h.	0
"Inhibition of ACE results in decreased plasma angiotensin II, leading to decreased vasoconstriction, increased plasma renin activity and decreased aldosterone secretion."	0
"Other efficacy assessments included the Hamilton Depression Rating Scale (HAMD-17), and the Clinical Global Impression Severity of Illness (CGI-S) and Improvement (CGI-I) scores."	0
"If asymptomatic elevations in AST or ALT between 5 <U+2013> 10 times the upper limit of normal and increases in total bilirubin greater than 2.5 times the upper limit of normal occur, APTIVUS/ritonavir therapy should be discontinued."	0
Immunosuppressants Amlodipine may increase the systemic exposure of cyclosporine or tacrolimus when co-administered.	1
Specific Populations The elimination half-life of atropine is more than doubled in children under two years and the elderly (>65 years old) compared to other age groups.	0
Antacid The co-administration of 30 mL of Maalox<U+00AE> with ziprasidone did not affect the pharmacokinetics of ziprasidone.	0
Single-dose administration of Tasigna to healthy subjects did not change the pharmacokinetics and pharmacodynamics of warfarin (a CYP2C9 substrate).	0
"If selected for treatment, the recommended starting dose of TOPROL-XL is 1 mg/kg once daily, but the maximum initial dose should not exceed 50 mg once daily."	0
"In some cases, a patient already receiving NORPRAMIN therapy may require urgent treatment with linezolid or intravenous methylene blue."	0
Do not co-administer ACCUPRIL with aliskiren in patients with diabetes.	0
"Circulation problems in fingers and toes [Peripheral vasculopathy, including Raynaud<U+2019>s phenomenon] Instruct patients beginning treatment with DESOXYN about the risk of peripheral vasculopathy, including Raynaud<U+2019>s Phenomenon, and associated signs and symptoms: fingers or toes may feel numb, cool, painful, and/or may change color from pale, to blue, to red."	0
"Anyone considering the use of such drugs in a child, adolescent, or young adult must balance this risk with the clinical need."	0
Withdrawal following chronic therapeutic use may unmask symptoms of the underlying disorder that may require follow-up.	0
Effient can be administered without regard to food.	0
"Elderly patients may be at greater risk of developing hyponatremia with SNRIs, SSRIs, or Savella."	0
"In short-term, placebo-controlled studies in schizophrenia and bipolar depression, no post-baseline QT prolongations exceeding 500 msec were reported in patients treated with LATUDA or placebo."	0
"The mechanism of action of risperidone, in schizophrenia, is unknown."	0
Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products.	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older.	0
"Cytochrome P450: Coadministration of Tracleer with drugs metabolized by CYP2C9 and CYP3A can increase exposure to Tracleer and/or the coadministered drug (4.2, 4.3, 7.1) Hormonal contraceptives: Tracleer use decreases contraceptive exposure and reduces effectiveness (7.2)."	1
"Relapse during the double-blind phase was defined as an increase of <U+2265> 2 points compared to baseline on the CGI-Severity of Illness scale to a score of <U+2265> 4, or withdrawal due to lack of efficacy."	0
"Since there is no indication that hydrochlorothiazide is dialyzable, and limited data suggest that bisoprolol is not dialyzable, drug replacement is not necessary in patients undergoing dialysis."	0
"Risperidone is a selective monoaminergic antagonist with high affinity (Ki of 0.12 to 7.3 nM) for the serotonin Type 2 (5HT2), dopamine Type 2 (D2), <U+03B1>1 and <U+03B1>2 adrenergic, and H1 histaminergic receptors."	0
"Because of the possibility of contact dermatitis, avoid getting solution on hands or clothing."	0
"Also, elimination of bisoprolol fumarate is significantly slower in patients with cirrhosis than in healthy subjects."	0
"Elderly In healthy elderly subjects, renal clearance of both risperidone and 9-hydroxyrisperidone was decreased, and elimination half-lives were prolonged compared to young healthy subjects."	0
"In some cases, reduced levels of circulating 25-hydroxy vitamin D and 1,25-dihydroxy vitamin D have been accompanied by reduced serum calcium and phosphate, and elevated parathyroid hormone."	0
"Concomitant administration of Lotensin and antidiabetic medicines (insulins, oral hypoglycemic agents) may increase the risk of hypoglycemia."	0
"NSAIDs: Increased risk of renal impairment and loss of anti-hypertensive effect (7) If simvastatin is co-administered with amlodipine, do not exceed doses greater than 20 mg daily of simvastatin (7) Do not co-administer aliskiren with TWYNSTA in patients with diabetes (7.2) The pharmacokinetics of amlodipine and telmisartan are not altered when the drugs are co-administered."	0
Pharmacokinetics The kinetics of absorption of isosorbide dinitrate from dilatrate<U+00AE>-SR sustained release capsules have not been well studied.	0
Fluorosis and periostitis have been reported during long-term voriconazole therapy.	0
33 <U+2013>19 <U+2013>27 +6 <U+2013>30 <U+2013>23 +9 10 mg b.i.d.	0
Patients with a QT interval <U+2265> 450 msec should not initiate treatment with INVIRASE/ritonavir.	0
Imipramine pamoate may potentiate the effects of CNS depressant drugs.	0
Do not immerse EXTRANEAL in water for warming.	0
Herbal products St. John's wort (hypericum perforatum) May lead to loss of virologic response and possible resistance to APTIVUS or to the class of protease inhibitors.	0
"If an opioid analgesic is initiated in a patient already taking a benzodiazepine or other CNS depressant, prescribe a lower initial dose of the opioid analgesic, and titrate based on clinical response."	0
Lithium: Increases in serum lithium concentrations and lithium toxicity (7).	1
"In patients with an activated renin-angiotensin system, such as volume or salt-depleted patients (e.g. those being treated with high doses of diuretics), symptomatic hypotension may occur after initialization of treatment with AVAPRO."	0
A major depressive episode may be the initial presentation of bipolar disorder.	0
"The principal pharmacological action of isosorbide dinitrate is relaxation of vascular smooth muscle and consequent dilatation of peripheral arteries and veins, especially the latter."	0
Symptoms such as these may be associated with an increased risk for suicidal thinking and behavior and indicate a need for very close monitoring and possibly changes in the medication.	0
"The elimination half-life of fluoxetine was prolonged in a study of cirrhotic patients, with a mean of 7.6days compared with the range of 2to 3days seen in subjects without liver disease; norfluoxetine elimination was also delayed, with a mean duration of 12days for cirrhotic patients compared with the range of 7to 9days in normal subjects."	0
Ultrasonograms of the carotid walls were used to determine the change per patient from baseline to three years in mean maximum intimal-medial thickness (IMT) of 12 measured segments.	0
The concentration of levomilnacipran at steady state is proportional to dose when administered from 25 to 300 mg once daily.	0
"WARNING: INCREASED RISK OF DEATH, STROKE AND HEART FAILURE IN PATIENTS WITH DECOMPENSATED HEART FAILURE OR PERMANENT ATRIAL FIBRILLATION MULTAQ is contraindicated in patients with symptomatic heart failure with recent decompensation requiring hospitalization or NYHA Class IV heart failure."	0
"Since both drugs exhibit nonlinear pharmacokinetics, the above studies may not address the case where the 2 drugs are both being chronically dosed."	0
Severe exacerbation of angina and the occurrence of myocardial infarction and ventricular arrhythmias have been reported in patients with angina following the abrupt discontinuation of therapy with <U+03B2>-blockers.	0
"<U+03B2>-adrenoreceptor blocking activity has been demonstrated in animal and human studies showing that carvedilol (1) reduces cardiac output in normal subjects, (2) reduces exercise- and/or isoproterenol-induced tachycardia, and (3) reduces reflex orthostatic tachycardia."	0
Instruct patients to call their physician immediately with any signs of unexplained wounds appearing on fingers or toes while taking DESOXYN.	0
"However, systemic exposures after administration of fluvastatin sodium extended-release tablets are lower than after the 40 mg immediate-release capsule."	0
The remainder (10%) of the drug is excreted unchanged in the urine.	0
Angioedema has been reported in patients treated with PRISTIQ.	0
"The coefficient of variation (CV), based on between-subject variability, was 50% to 60% for AUC."	0
The recommended dosage of DIFLUCAN for suppression of relapse of cryptococcal meningitis in patients with AIDS is 200 mg once daily.	0
"Pre-existing glaucoma is almost always open-angle glaucoma because angle-closure glaucoma, when diagnosed, can be treated definitively with iridectomy."	0
"After intramuscular administration of single doses, peak serum concentrations typically occur at approximately 60 minutes post-dose or earlier and the mean half-life (T<U+00BD>) ranges from two to five hours."	0
"Administration of a 12 mg paliperidone extended-release tablet to healthy ambulatory subjects with a standard high-fat/high-caloric meal gave mean Cmax and AUC values of paliperidone that were increased by 60% and 54%, respectively, compared with administration under fasting conditions."	1
"Elimination After either oral or IV administration, zaleplon is rapidly eliminated with a mean t1/2 of approximately 1 hour."	0
"In a longer-term trial, 566 patients meeting DSM-IV criteria for Generalized Anxiety Disorder, who had responded during a single-blind, 8-week acute treatment phase with 20 to 50 mg/day of paroxetine, were randomized to continuation of paroxetine at their same dose, or to placebo, for up to 24 weeks of observation for relapse."	0
"Single daily doses given in the evening were more effective than the same dose given in the morning, perhaps because cholesterol is synthesized mainly at night."	0
4 ) and Use in Specific Populations (8.7)].	0
Laboratory tests are available to identify CYP2D6 PMs.	0
"The elimination half-life of hydroxybupropion is approximately 20 (<U+00B1>5) hours, and its AUC at steady state is about 13 times that of bupropion."	0
Drug Interaction Studies Ledipasvir and sofosbuvir are substrates of drug transporters P-gp and BCRP while GS-331007 is not.	0
Multiple hepatic cytochrome P450 isoenzymes are involved in the oxidative biotransformation of a large number of structurally different drugs and endogenous compounds.	0
Less extensive human studies suggest similar metabolism and excretion in man.	0
"After stabilized, patient can be restarted at low doses such as 3 to 5 mg/hr (2.5)."	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
Safety and effectiveness in pediatric patients have not been established.	0
"Antidepressants: Selective Serotonin Reuptake Inhibitors (SSRIs): paroxetine, sertraline <U+2193> paroxetine<U+2193> sertraline If either sertraline or paroxetine is initiated in patients receiving PREZISTA/ritonavir, dose titrating the SSRI based on a clinical assessment of antidepressant response is recommended."	0
There have been reports of increased blood concentrations of cyclosporine and tacrolimus into toxic ranges when patients received these drugs concomitantly with nefazodone.	1
"Pediatric Patients LATUDA exposure (i.e., steady-state Cmax and AUC) in children and adolescent patients (10 to 17 years of age) was generally similar to that in adults across the dose range from 40 to 160 mg, without adjusting for body weight."	0
VASOTEC attenuates potassium loss caused by thiazide-type diuretics .	0
"Where there is involvement of the tongue, glottis, or larynx likely to cause airway obstruction, emergency therapy including, but not limited to, subcutaneous epinephrine solution 1:1000 (0.3 to 0.5 mL) should be promptly administered."	0
"For serious infections requiring penicillin therapy, laboratories should perform MIC tests and induced <U+03B2>-lactamase testing on all subsequent isolates from the same patient.2 <U+2212> <U+2265>0.25 <U+2265>29 <U+2212> <U+2264>28 Neisseria Gonorrhoeae A positive N. gonorrhoeae <U+03B2>-lactamase test predicts one form of resistance to penicillin."	0
Consider the use of a parenteral anti-platelet agent in acute coronary syndrome patients requiring co-administration of morphine or other opioid agonists.	0
"Consequently, caution is advised when FETZIMA is prescribed in combination with other CNS-active drugs, including those with a similar mechanism of action."	0
"The subsequent decline in plasma concentration shows an apparent mean half-life of 3 to 10 hours for the majority of the elimination, with a prolonged terminal elimination half-life of 30 to 120 hours resulting from slow dissociation of perindoprilat from plasma/tissue ACE binding sites."	0
"Concomitant use can cause severe hypotension, syncope, or myocardial ischemia."	0
"Amiodarone is a substrate for CYP3A and CYP2C8, so inhibitors and inducers affect amiodarone exposure (7) Amiodarone inhibits p-glycoprotein and CYP1A2, CYP2C9, CYP2D6, and CYP3A, increasing exposure to other drugs (7) Drugs prolonging the QT interval: Co-administration of drugs prolonging the QT interval (such as class I and III antiarrhythmics, lithium, certain phenothiazines, tricyclic antidepressants, certain fluoroquinolone and macrolide antibiotics, azole antifungals, halogenated inhalation anesthetic agents) increases the risk of Torsade de Pointes."	0
"Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed."	0
"Drug Interactions In Vitro Studies Studies with human liver tissue indicate that ambrisentan is metabolized by CYP3A, CYP2C19, and uridine 5'-diphosphate glucuronosyltransferases (UGTs) 1A9S, 2B7S, and 1A3S."	0
"A patient Medication Guide about <U+201C>Antidepressant Medicines, Depression and other Serious Mental Illnesses, and Suicidal Thoughts or Actions<U+201D> is available for nefazodone hydrochloride tablets."	0
"Table 7 Drug Interactions: Changes in Pharmacokinetic Parameters for Ledipasvir, Sofosbuvir, and the Predominant Circulating Metabolite GS-331007 in the Presence of the Coadministered DrugAll interaction studies conducted in healthy volunteers."	0
Monitor all patients taking ZOLOFT for the emergence of serotonin syndrome.	0
Digoxin is concentrated in tissues and therefore has a large apparent volume of distribution.	0
"Avoid use of strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin) [see Clinical Pharmacology (12.3) ]."	0
Monitor renal function periodically in patients receiving losartan and NSAID therapy.	0
Such monitoring should include daily observation by families and caregivers.	0
"Therefore, when ZIAC and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained."	0
Moderate (grade 2) nonhematologic reactions Reduce the dose of TRISENOX and/or tretinoin by 1 dose level.	1
"*Ora-Plus<U+00AE> and Ora-Sweet<U+00AE> are registered trademarks of Paddock Laboratories, Inc. OraPlus<U+00AE> contains carrageenan, citric acid, methylparaben, microcrystallinecellulose, carboxymethylcellulose sodium, potassium sorbate, simethicone, sodium phosphatemonobasic, xanthan gum, and water."	0
"Diltiazem has been shown to be a potent dilator of coronary arteries, both epicardial and subendocardial."	0
"Clinically Significant Drug Interactions: Review patient's concomitant medications (5.1, 7) Hepatic Toxicity: Serious hepatic reactions reported."	0
Monitoring of mexiletine plasma levels is recommended during such concurrent use to avoid ineffective therapy.	0
The response rates in Phase 3 trials were similar in HCV-infected subjects who received HARVONI with food or without food.	0
"For oral medication where a reduction in the bioavailability of that medication would have a clinically significant effect on its safety or efficacy (e.g., cyclosporine, tacrolimus, levothyroxine), consider separation of the timing of the administration of the two drugs."	1
"Simultaneous administration of tetracycline with quinapril reduced the absorption of tetracycline by approximately 28% to 37%, possibly due to the high magnesium content in quinapril tablets."	1
Coadministration of Celexa and metoprolol had no clinically significant effects on blood pressure or heart rate.	0
Nursing Mothers Diltiazem is excreted in human milk.	0
Systemic therapies such as corticosteroids may be required.	0
"When possible, discontinue Effient at least 7days prior to any surgery."	0
"Moderate CYP 3A Inhibitors The impact of moderate CYP 3A inhibitors (e.g., erythromycin, fluconazole, aprepitant, diltiazem and verapamil) on the exposure to co-administered tolvaptan has not been assessed."	0
"In vitro enzyme inhibition data did not reveal an inhibitory effect of citalopram on CYP3A4, -2C9, or -2E1, but did suggest that it is a weak inhibitor of CYP1A2, -2D6, and -2C19."	0
"As it is not known whether cross-sensitivity exists among the antipsychotics, pimozide should be used with appropriate caution in patients who have demonstrated hypersensitivity to other antipsychotic drugs."	0
Allowthe suspension to stand for a minimum of 1 hour.	0
"Theophylline: The effect of steady-state immediate-release fluvoxamine maleate tablets (50 mg tablets given twice daily) on the pharmacokinetics of a single dose of theophylline (375 mg as 442 mg aminophylline) was evaluated in 12 healthy non-smoking, male volunteers."	0
Elevations of transaminases with and without concomitant elevations in alkaline phosphatase and bilirubin have been reported.	0
"VYVANSE capsules can be substituted with VYVANSE chewable tablets on a unit per unit/ mg per mg basis (for example, 30 mg capsules for 30 mg chewable tablet)."	0
ALERT: Find out about medicines that should NOT be taken with CRIXIVAN.	0
"In healthy men, orally administered CALAN undergoes extensive metabolism in the liver."	0
Sprinkle granules on one teaspoonful of applesauce.	0
The range of percentages provided in Table 2 (2.4 Estimate of Daily Maintenance Dose) can be used in calculating this dose for patients with normal renal function.	0
"Therefore, patients should be instructed not to exceed the prescribed dose of ORAP and they should realize the need for the initial ECG and for follow-up ECGs during treatment."	0
Read circulars for lithium preparations before use of such concomitant therapy with DYAZIDE.	0
Patients have reported an intensification of dream activity during clozapine therapy.	0
"Approximately 7% - 10% of Caucasians and 3% - 8% of black/African Americans lack the capacity to metabolize CYP2D6 substrates and are classified as poor metabolizers (PM), whereas the rest are intermediate, extensive or ultrarapid metabolizers."	0
Pediatric Patients: Very close clinical monitoring is mandatory.	0
"However, some patients may require treatment despite the presence of the syndrome."	0
A similar exacerbation did not occur in neonates after in utero exposure to indinavir during the third trimester of pregnancy.	0
This adverse effect is self-limiting and in most cases does not recur after the initial period of therapy or during subsequent dose titration.	0
Heart Rate:An increase in heart rate is a normal response to vasodilation and decrease in blood pressure; in some patients these increases in heart rate may be pronounced.	0
Chronic animal studies showed occasional evidence of degeneration of seminiferous tubules at the highest dose of 60 mg/kg/day.	0
"The clinician should, nevertheless, be aware of the possibility of emergent symptoms of serotonin syndrome with such use."	0
VIRACEPT can be used in patients with mild hepatic impairment without any dose adjustment.	0
Metabolism Sixteen percent of digoxin is metabolized.	0
Switching from immediate-release metoprolol to TOPROL-XL: use the same total daily dose of TOPROL-XL.	0
Children < 1 year of age must not receive ATACAND for hypertension.	0
No initial dosage adjustments are considered necessary when these drugs are coadministered; any subsequent adjustments should be guided by clinical effect.	0
TOPROL-XL is not recommended in pediatric patients < 6 years of age.	0
"If an optimal response is not achieved within one week, the dosage should be increased to TENORMIN 100 mg given as one tablet a day."	0
Take sips of water to make sure granules are washed down into the stomach.	0
"To avoid improper insulin administration, educate all patients to alert health care providers of this interaction particularly in hospital settings."	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP and who have or acquire risk factors predictive of CAD, as described above, undergo periodic interval cardiovascular evaluation as they continue to use D.H.E."	0
"As the blood pressure approaches goal, the increase in doses should be less than doubling and the time between dose adjustments should be lengthened to every 5-10 minutes."	0
Hypersensitivity to this product or other sulfonamide derived drugs is also contraindicated.	0
"In clinical trials of ACCURETIC, the average change in serum potassium was near zero in subjects who received HCTZ 6.25 mg in the combination, and the average subject who received 10 to 40/12.5 to 25 mg experienced a milder reduction in serum potassium than that experienced by the average subject receiving the same dose of hydrochlorothiazide monotherapy."	0
Large doses of digoxin are not recommended as the only treatment of these arrhythmias and care must be taken to avoid toxicity if large doses of digoxin are required.	0
Approximately 5% of a radiolabeled oral dose were recovered in urine.	0
Patients with these diagnoses were generally excluded from clinical studies during the product's premarketing testing.	0
"In a pooled analysis of multiple short-term, placebo-controlled studies of CNS stimulants, psychotic or manic symptoms occurred in 0.1% of CNS stimulant-treated patients compared to 0% in placebo-treated patients."	0
A single dose given in the morning with food is recommended; divided doses are unnecessary.	0
"NOTE: As with many other drugs, certain advice to patients being treated with ACCUPRIL is warranted."	0
"Acidifying agents decrease amphetamine blood levels, while alkalinizing agents increase amphetamine blood levels."	1
See Contraindications (4.1) and Warnings and Precautions (5.5).	0
"Consistent with the rapid clearance of zaleplon, memory impairment was no longer present as early as 2 hours post dosing in one study, and in none of the studies after 3-4 hours."	0
Cimetidine There is evidence that cimetidine inhibits the elimination of tricyclic antidepressants.	1
"The appearance of hypotension, orthostatis, or azotemia early in dose titration should not preclude further careful dose titration."	0
The hydrochlorothiazide component of triamterene and hydrochlorothiazide tablets is bioequivalent to single entity hydrochlorothiazide tablet formulations.	0
"Patients with non-fatal events remained in the trial, so that there was also an examination of the first event of each type even if it was not the first event (e.g., a stroke following an initial myocardial infarction would be counted in the analysis of stroke)."	0
"However, at up to 300 and 200 ng/mL concentrations, respectively, sertraline and N-desmethylsertraline did not alter the plasma protein binding of two other highly protein bound drugs, viz., warfarin and propranolol."	0
STRATTERA is approved for ADHD in pediatric and adult patients.	0
Lower starting and maintenance doses of atorvastatin should be considered when taken concomitantly with the aforementioned drugs.	0
"Hepatic impairment In subjects with moderate hepatic impairment, the mean dronedarone exposure increased by 1.3 fold relative to subjects with normal hepatic function and the mean exposure of the N-debutyl metabolite decreased by about 50%."	0
No dose-effect relationship for these transaminase elevations was noted.	0
A further rise in the plasma levels will not enhance the antihypertensive effect.	0
Extent of absorption increases in proportion to atorvastatin dose.	0
"Potential for CYMBALTA to Affect Other Drugs Drugs Metabolized by CYP2D6 <U+2014> Co-administration of CYMBALTA with drugs that are extensively metabolized by CYP2D6 and that have a narrow therapeutic index, including certain antidepressants (tricyclic antidepressants [TCAs], such as nortriptyline, amitriptyline, and imipramine), phenothiazines and Type 1C antiarrhythmics (e.g., propafenone, flecainide), should be approached with caution."	0
"In the clinical trial of patients with relapsed or refractory APL treated with TRISENOX monotherapy, 40% had at least one ECG tracing with a QTc interval greater than 500 msec."	0
Excretion:Approximately 20% of a radiolabeled oral dose is excreted in urine and 70% in the feces.	0
Co-administration of haloperidol with CMI increases plasma concentrations of CMI.	1
"Ritonavir 200 twice daily, 14 days 800 twice daily,14 days 9, 16 See text below for discussion of interaction."	0
"Because telmisartan does not inhibit ACE (kininase II), it does not affect the response to bradykinin."	0
These observations led to the investigation of alprostadil in infants who had congenital defects which restricted the pulmonary or systemic blood flow and who depended on a patent ductus arteriosus for adequate blood oxygenation and lower body perfusion.	0
"Drugs Metabolized by P450 3A4<U+2013>In three separate in vivo interaction studies, sertraline was co-administered with cytochrome P450 3A4 substrates, terfenadine, carbamazepine, or cisapride under steady-state conditions."	0
"An appropriate dose of nelfinavir for this combination, with respect to safety and efficacy, has not been established."	0
The concomitant use of NORPRAMIN with MAOIs intended to treat psychiatric disorders is contraindicated.	0
Concomitant use of lidocaine with a weak CYP1A2 and CYP3A4 inhibitor has been reported to increase lidocaine plasma levels by 24% <U+2013> 75% and may result in toxic accumulation of the drug.	1
"Following a single dose, the plasma concentrations of paliperidone gradually rise to reach peak plasma concentration (Cmax) approximately 24 hours after dosing."	0
"If blood pressure is not controlled with ALTACE alone, a diuretic can be added."	0
"The risk of myopathy during treatment with statins is increased with concurrent administration of cyclosporine, fibric acid derivatives, erythromycin, clarithromycin, the hepatitis C protease inhibitor telaprevir, combinations of HIV protease inhibitors, including saquinavir plus ritonavir, lopinavir plus ritonavir, tipranavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, and fosamprenavir plus ritonavir, niacin, or azole antifungals."	0
"In rats, at maternal doses of 40 and 640 mg/kg/day, fetal plasma drug levels were approximately 10 to 15% and 10 to 20% of maternal plasma drug levels 1 and 2 hours after dosing, respectively."	0
The mechanism of action of lurasidone in the treatment of schizophrenia and bipolar depression is unclear.	0
Such patients may be unresponsive to the usual doses of epinephrine used to treat allergic reactions.	0
Cimetidine<U+2014> Cimetidine inhibits many cytochrome P450 (oxidative) enzymes.	0
Hypokalemia may be avoided or treated by potassium supplementation or increased intake of potassium rich foods.	0
"The volume of distribution of citalopram is about 12 L/kg and the binding of citalopram (CT), demethylcitalopram (DCT) and didemethylcitalopram (DDCT) to human plasma proteins is about 80%."	0
"The gout flare should be managed concurrently, as appropriate for the individual patient."	0
"In studies of hypertensive patients, there is no sex difference in half-life or accumulation, but somewhat higher plasma concentrations of irbesartan are observed in females (11%<U+2013>44%)."	0
This finding was not observed in CYP3A5 non-expressers (N= 6).	0
"In the rat, however, this multiple of the human dose resulted in decreased pregnancies and in the retarded development of fetuses."	0
Anticonvulsants:carbamazepine <U+2194> darunavir<U+2191> carbamazepine The dose of either PREZISTA/ritonavir or carbamazepine does not need to be adjusted when initiating co-administration with PREZISTA/ritonavir and carbamazepine.	0
"ACE inhibitors rarely have been associated with a syndrome of cholestatic jaundice, fulminant hepatic necrosis, and death."	0
Ondansetron has no effect on plasma prolactin concentrations.	0
Drugs That Can Lead to Electrolyte Abnormalities Electrolyte abnormalities increase the risk of serious QT/QTc interval prolongation.	0
N-desmethylsertraline has a plasma terminal elimination half-life of 62 to 104 hours.	0
"Examples: Bosentan, efavirenz, etravirine, modafinil, nafcillin Based on pharmacokinetic studies, no dosage adjustment of LATUDA is required when administered concomitantly with lithium, valproate, or substrates of P-gp or CYP3A4."	0
5.Each pouch of EMEND for oral suspension contains 125 mg of aprepitant which is to be suspended in 4.6 mL of water giving a final concentration of 25 mg/mL.	0
The effects of statins on male fertility have not been studied in adequate numbers of patients.	0
"The long-term effects of increases in concentration of the progestational agent are unknown and could increase the risk of insulin resistance, dyslipidemia, and acne."	0
"After a 150 mg dose, the half-life of CMI ranges from 19 hours to 37 hours (mean, 32 hr) and that of DMI ranges from 54 hours to 77 hours (mean, 69 hr)."	0
There have been reports of anaphylaxis with the use of rifamycins.	0
"Increased plasma concentration of CYMBALTA, and especially of its metabolites, occur in patients with end-stage renal disease (requiring dialysis)."	0
Details on the potential pharmacokinetic interactions between BRINTELLIX and bupropion can be found in Section 7.3.	0
Coronary Artery Disease: The recommended dose range of amlodipine for patients with CAD is 5<U+2013>10 mg once daily.	0
Cross-sensitivity between nortriptyline hydrochloride oral solution USP and other dibenzazepines is a possibility.	0
Theophylline: Clearance decreased; reduce theophylline dose by one-third (5.9).	1
"If the QTc Bazett interval is <U+2265>500 ms, discontinue MULTAQ."	0
"Because bleeding risk is increased when these drugs are used concomitantly with warfarin, closely monitor patients receiving any such drug with warfarin."	0
"Spontaneous reports of congenital malformations have been recorded in humans, but no causal relationship to diethylpropion has been established."	0
Drugs that inhibit the renin-angiotensin system can cause hyperkalemia.	0
Baseline cardiac evaluation should be considered to detect preexisting valvular heart diseases or pulmonary hypertension prior to initiation of diethylpropion hydrochloride treatment.	0
Irbesartan exhibits linear pharmacokinetics over the therapeutic dose range.	0
Eight other patients had pulmonary edema and/or severe hypotension; abnormally high (over 20 mmHg) capillary wedge pressure and a marked left ventricular outflow obstruction were present in most of these patients.	0
The anticoagulant effect of a single dose of warfarin (measured by prothrombin time) was not significantly changed by quinapril coadministration twice-daily.	0
Accurately measure out another 30 mL of water and add this to the bottle.	0
Telmisartan does not bind to or block other hormone receptors or ion channels known to be important in cardiovascular regulation.	0
Diltiazem plasma levels were not significantly affected by lovastatin or pravastatin.	0
Thiazides may add to or potentiate the action of other antihypertensive drugs.	0
"On a mg/m2 basis, some doses were higher and some were lower than the maximum recommended human dose but all were within an order of magnitude of it."	0
A somewhat greater interaction (approximately 40% reduction in the AUC of active metabolite and approximately 30% reduction in the AUC of losartan) has been reported with rifampin.	1
The development of hyperkalemia associated with potassium-sparing diuretics is accentuated in the presence of renal impairment.	0
"The active metabolite P88 accounts for 19.5% and 34.0% of total plasma exposure in EM and PM, respectively."	0
"Dose may be titrated as needed, up to 16 mg once daily."	0
The mechanism of this syndrome is not understood.	0
The usual starting dose of MICARDIS tablets is 40 mg once a day.	0
TARKA is contraindicated in patients who are hypersensitive to any ACE inhibitor or verapamil.	0
Adjust the dosage according to blood pressure response.	0
"Electrolyte imbalances are common in patients with renal impairment, with or without diabetes, and should be addressed."	0
"Because NARDIL is a monoamine oxidase (MAO) inhibitor, NARDIL should not be used concomitantly with a serotoninergic agent."	0
A diet low in tyramine content may be necessary to avoid this interaction.	0
The effect of paroxetine on the pharmacokinetics of atomoxetine has been evaluated when both drugs were at steady state.	0
Angiotensin II also stimulates aldosterone secretion by the adrenal cortex.	0
Hydrochlorothiazide Hydrochlorothiazide is a thiazide diuretic.	0
Clinical data suggest a greater degree of LDL-lowering at any dose of atorvastatin in the elderly population compared to younger adults.	0
"Conversely, adverse effects may result from displacement of protein-bound Anafranil by other highly bound drugs."	0
"There was a significantly greater number of male rats in the high-dose group with reticulum cell sarcomas (1/100, 0/50, 0/50, and 4/50 for control, low-, middle-, and high-dose groups, respectively) and a significantly increased linear trend across groups for the occurrence of lymphoreticular tumors in male rats."	0
"Change in AUC Mean ratio (with/without coadministered drug and no change = 1fold) or % change (with/without coadministered drug and no change = 0%); symbols of <U+2191> and <U+2193> indicate the exposure increase and decrease, respectively."	0
Similar considerations may apply to patients with ischemic heart or cerebrovascular disease in whom an excessive fall in blood pressure could result in myocardial infarction or cerebrovascular accident.	0
"As with standard dilution techniques, diffusion methods require the use of laboratory control microorganisms."	0
"Citalopram: Although citalopram is not primarily metabolized by CYP2D6, in one study bupropion increased the Cmax and AUC of citalopram by 30% and 40%, respectively."	1
"Adults treated for tuberculosis with rifampin should have baseline measurements of hepatic enzymes, bilirubin, serum creatinine, a complete blood count, and a platelet count (or estimate)."	0
Do not use plastic containers in series connections.	0
"During 42 days of chronic sertraline dosing, sertraline was titrated up to 200 mg/day and maintained at that dose for a minimum of 11 days."	0
Most of the antihypertensive effect is apparent within 2 weeks and maximal reduction is generally attained after 4 weeks.	0
"The recommended bolus volume using the 15 mL premixed bolus vial can be calculated using the following equation: The recommended bolus volume using the 100 mL premixed vial or 250 mL premixed bag can be calculated using the following equation: The recommended infusion rate for patients with CrCl (Creatinine Clearance) >60 mL/min using the 100 mL premixed vial or 250 mL premixed bag can be calculated using the following equation: Example calculation of infusion rate for 60 kg patient with CrCl >60 mL/min using the 100 mL premixed vial or 250 mL premixed bag: Drug Compatibilities AGGRASTAT can be administered in the same intravenous line as heparin, atropine sulfate, dobutamine, dopamine, epinephrine hydrochloride (HCl), famotidine injection, furosemide, lidocaine, midazolam HCl, morphine sulfate, nitroglycerin, potassium chloride, and propranolol HCl."	0
"Generally in these studies, there was a slight increase in sleep duration, compared to baseline, for all treatment groups, including placebo, and thus, a significant difference from placebo on sleep duration was not demonstrated."	0
"Patients who receive ALDACTONE should be advised to avoid potassium supplements and foods containing high levels of potassium , including salt substitutes ."	0
Administer diluted solution within 4 hours of preparation when stored at room temperatureor within 24 hours of preparation when stored under refrigerated conditions [2<U+00BA>C to 8<U+00BA>C (36<U+00BA>F to 46<U+00BA>F)].	0
"In a placebo-controlled trial involving patients with congestive heart failure treated with digitalis and diuretics, parenteral quinaprilat, the active metabolite of quinapril, reduced pulmonary capillary wedge pressure and systemic vascular resistance and increased cardiac output/index."	0
Intervention: No dose adjustment of clopidogrel is necessary when administered with an approved dose of PROTONIX.	0
It may be necessary to decrease the dosage of verapamil when it is administered to patients with attenuated neuromuscular transmission.	0
The pharmacokinetics of rifabutin in patients with moderate and severe hepatic impairment is not known.	0
Patients receiving both indomethacin and LASIX should be observed closely to determine if the desired diuretic and/or antihypertensive effect of LASIX is achieved .	0
"Fluconazole increases the AUC of triazolam (single dose) by approximately 50%, Cmax by 20<U+2013>32%, and increases t<U+00BD> by 25<U+2013>50 % due to the inhibition of metabolism of triazolam."	1
"In addition, quinidine has anticholinergic activity, it has negative inotropic activity, and it acts peripherally as an <U+03B1><U+2013>adrenergic antagonist (that is, as a vasodilator)."	0
"To reduce the likelihood of hypotension, the diuretic should, if possible, be discontinued 2 to 3 days prior to beginning therapy with ACCUPRIL."	0
High serum phosphorus can precipitate serum calcium resulting in ectopic calcification.	0
25 mg 3 or 4 times daily; dosage should begin at a low level and be increased as required.	0
Warfarin When coadministered with dronedarone exposure to S-warfarin was slightly higher than when warfarin was administered alone.	1
Anafranil should also not be started in a patient who is being treated withMAOIs such as linezolid or intravenous methylene blue.	0
"In patients with an activated renin-angiotensin aldosterone system, such as volume- and/or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may be anticipated after initiation of treatment with Benicar."	0
"Like other ACE inhibitors, trandolapril has only rarely been associated with symptomatic hypotension in uncomplicated hypertensive patients."	0
"Bronchodilators, including beta2-agonists, should be readily available or administered concomitantly."	0
"An 18-month toxicity study in rats, at a low multiple (6 fold) of the maximum recommended human dose, and not the maximum tolerated dose, did not suggest a tumorigenic potential."	0
"Rosuvastatin is 88% bound to plasma proteins, mostly albumin."	0
"Based on the population pharmacokinetic analysis in HCV-infected subjects, geometric mean steady-state AUC0<U+2013>24 for ledipasvir (N=2113), sofosbuvir (N=1542), and GS-331007 (N=2113) were 7290, 1320, and 12,000 ng<U+2219>hr/mL, respectively."	0
"Adverse reactions occurring in < 5 % of patients include urticaria, hyperuricemia, oral lesions, elevated transaminases, hyperbilirubinemia, hyperpigmentation, and pancreatitis."	0
Distribution In vitro tests show that bupropion is 84% bound to human plasma proteins at concentrations up to 200 mcg/mL.	0
Increase to 40 mg once daily based upon individual tolerability.	0
Patients should be advised to avoid alcohol while taking nefazodone.	0
Clinical monitoring is recommended.	0
"Because escitalopram is metabolized by multiple enzyme systems, inhibition of a single enzyme may not appreciably decrease escitalopram clearance."	0
"Recommended starting doses, based on clinical and pharmacokinetic data from patients with renal impairment, are as follows: Creatinine Clearance Maximum Recommended Initial Dose >60 mL/min 10 mg 30<U+2013>60 mL/min 5 mg 10<U+2013>30 mL/min 2.5 mg <10 mL/min Insufficient data for dosage recommendation Patients should subsequently have their dosage titrated (as described above) to the optimal response."	0
Coadministration of venlafaxine hydrochloride extended-release and weight loss agents is not recommended.	0
"Withhold treatment with TRISENOX and/or tretinoin if elevations in AST), alkaline phosphatase, and/or serum bilirubin occur to greater than 5 times the upper limit of normal."	0
The study was performed with patients with hypercholesterolemia who were at high risk of myocardial infarction.	0
"Avoid use of strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin) [see Clinical Pharmacology (12.3) ]."	0
"Also, patients taking diuretics or who are otherwise volume depleted can be at greater risk."	0
Patients who re-initiate Tasigna therapy should have their BCR-ABL transcript levels monitored monthly until major molecularresponse is re-established and every 12 weeks thereafter.	0
"In clinical trials, the highest dose of 500 mcg BID of TIKOSYN as modified by the dosing algorithm led to greater effectiveness than lower doses of 125 or 250 mcg BID as modified by the dosing algorithm."	0
"Table 5: Comparisons of the Systemic Availability and Equivalent Doses for Preparations of Digoxin Product AbsoluteBioavailability Equivalent Doses (mcg)For example, 125 mcg tablets equivalent to 125 mcg solution equivalent to 100 mcg capsules equivalent to 100 mcg injection/IV."	0
Continue blood pressure monitoring until desired effect is achieved.	0
Angioedema associated with laryngeal edema can be fatal.	0
"10,000ng/mL Dissolve contents of two 0.5<U+2011>mg vials each with 5mL of sterile diluent."	0
It is generally agreed that acute episodes of MDD require several months or longer of sustained pharmacologic therapy.	0
"Coadministration with drugs that are potent inducers of CYP3A (e.g., phenobarbital, phenytoin, carbamazepine) may result in decreased plasma concentrations of saquinavir and reduced therapeutic effect."	1
"Patients may wish to be examined to determine whether they are susceptible to angle closure, and have a prophylactic procedure (e.g., iridectomy), if they are susceptible."	0
Two of the four cases were life-threatening and resolved without treatment or with medication (corticosteroids).	0
"If not administered within 2 hours of preparation, the mixture should be discarded and a new dose prepared."	0
Patients receiving concomitant ACE inhibitor and neprilysin inhibitor therapy may be at increased risk for angioedema.	0
"However, in patients with severe left ventricular dysfunction (eg, pulmonary wedge pressure above 20 mm Hg or ejection fraction less than 30%), or in patients taking beta-adrenergic blocking agents or other cardiodepressant drugs, deterioration of ventricular function may occur."	0
"Pharmacodynamics Blood pressure lowering drugs (e.g., diuretics, antihypertensive agents, or vasodilators): Risk of increased reduction in blood pressure (7.1) Remodulin inhibits platelet aggregation."	0
"Avoid use in patients with known structural cardiac abnormalities, cardiomyopathy, serious heart arrhythmia, or coronary artery disease (5.2) Blood Pressure and Heart Rate Increases: Monitor blood pressure and pulse."	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
"In patients with HIV taking lopinavir plus ritonavir, use the lowest necessary dose of atorvastatin."	1
The risk of administering methylene blue by non-intravenous routes (such as oral tablets or by local injection) or in intravenous doses much lower than 1 mg/kg with nortriptyline hydrochloride is unclear.	0
Resume treatment when the clinical condition improves and reduce the dose of the withheld drug(s) by 50%.	0
Co-administration of Ritonavir in Patients on ADCIRCA .	0
Cleviprex may produce systemic hypotension and reflex tachycardia.	0
Administration Infuse diluted solution intravenously over 90 minutes.	0
The risk of administering methylene blue by non-intravenous routes (such as oral tablets or by local injection) or in intravenous doses much lower than 1 mg/kg with NORPRAMIN is unclear.	0
"Reversible confusional states have been observed on occasion, predominantly, but not exclusively, in severely ill patients."	0
Trazodone <U+2191> trazodone Concomitant use of trazodone and REYATAZ with or without ritonavir may increase plasma concentrations of trazodone.	1
"In an ongoing, double-blind, randomized cardiovascular outcomes trial, an independent safety monitoring committee identified that the incidence of myopathy is higher in Chinese compared with non-Chinese patients taking simvastatin 40 mg coadministered with lipid-modifying doses of a niacin-containing product."	0
"Systemic exposure to abiraterone after a single oral 1,000 mg dose given under fasting conditions increased approximately 1.1-fold and 3.6-fold in subjects with mild and moderate baseline hepatic impairment, respectively."	0
One controlled study in eight normal subjects showed a 72% mean increase (range 35 to 136%) in plasma theophylline levels.	1
Patients with esophageal candidiasis should be treated for a minimum of three weeks and for at least 2 weeks following the resolution of symptoms.	0
"In some cases, a patient already receiving CYMBALTA therapy may require urgent treatment with linezolid or intravenous methylene blue."	0
"Nevertheless, caution is indicated in the coadministration of escitalopram and drugs metabolized by CYP2D6."	0
"Patients may be given the equivalent dose of CADUET or a dose of CADUET with increased amounts of amlodipine, atorvastatin, or both for additional antianginal effects, blood pressure lowering, or lipid-lowering effect."	0
"Weaker inhibitors (e.g., erythromycin, grapefruit juice) have not been studied."	0
<U+2022>Patients in cardiogenic shock or decompensated heart failure requiring the use of IV inotropic therapy.	0
A departure from linearity similar to that seen with CARDIZEM tablets and CARDIZEM SR capsules is observed.	0
"Hypersensitivity to doxepin hydrochloride, inactive ingredients, or other dibenzoxepines."	0
Hepatic Insufficiency Hepatically impaired patients (n=8) had a 30% lower mean oral clearance of quetiapine than normal subjects.	0
"Most patients with heterozygous TPMT deficiency tolerated recommended mercaptopurine doses, but some require dose reduction based on toxicities."	0
"Because conditions of testing (e.g., patient samples, investigators, doses of the treatments administered and compared, outcome measures, etc.) vary among trials, it is virtually impossible to distinguish a difference in drug effect from a difference due to one or more of the confounding factors just enumerated."	0
Spontaneous reporting of adverse events in larger premarketing clinical trials did not suggest a difference between Zaleplon and placebo in the risk of next-day somnolence.	0
"After 5 days, 87% of the administered radioactivity was excreted in human urine."	0
"Although carvedilol has both <U+03B1>- and <U+03B2>-blocking pharmacologic activities, there has been no experience with its use in this condition."	0
"If labetolol is used with nitroglycerin in patients with angina pectoris , additional hypotensive effects may occur ."	0
"Because vortioxetine is highly bound to plasma protein, coadministration of BRINTELLIX with another drug that is highly protein bound may increase free concentrations of the other drug."	1
Patients with a history of hypersensitivity to rabeprazole(4).	0
"Sometimes, after starting treatment with antibacterials, patients can develop watery and bloody stools (with or without stomach cramps and fever) even as late as two or more months after having taken the last dose of the antibacterial."	0
"Following oral administration of 14C-abiraterone acetate, approximately 88% of the radioactive dose is recovered in feces and approximately 5% in urine."	0
No dose adjustment of PRINIVIL is required in patients with creatinine clearance >30 mL/min.	0
Figure1: Impact of Other Drugs on LATUDA Pharmacokinetics	0
No rebound effect has been observed upon discontinuation of PROCARDIA.	0
Figure 2 Dabigatran etexilate mesylate is absorbed as the dabigatran etexilate ester.	0
"Pharmacokinetic considerations<U+2014>Renal or hepatic dysfunction causes the elimination of quinidine to be slowed, while congestive heart failure causes a reduction in quinidine<U+2019>s apparent volume of distribution."	0
"Initiation of medications that inhibit or induce CYP3A may increase or decrease concentrations of CRIXIVAN, respectively."	1
Close supervision and careful adjustment of dosage are required when this drug is given concomitantly with anticholinergic or sympathomimetic drugs.	0
"Signs and symptoms of hyponatremia include headache, difficulty concentrating, memory impairment, confusion, weakness, and unsteadiness, which can lead to falls."	0
Coadministration of REYATAZ can alter the concentration of other drugs and other drugs may alter the concentration of atazanavir.	0
Remodulin dosage adjustment may be necessary if inhibitors or inducers of CYP2C8 are added or withdrawn .	0
"Concomitant administration of ALTACE with potassium supplements, potassium salt substitutes, or potassium-sparing diuretics can lead to increases of serum potassium."	0
Evaluation of the electrocardiograms for patients with depression or OCD who participated in premarketing studies revealed no differences between fluvoxamine and placebo in the emergence of clinically important ECG changes.	0
"If desired blood pressure reduction is not achieved at this dose, increase the infusion rate by 2.5 mg/hr every 15 minutes up to a maximum of15 mg/hr, until desired blood pressure reduction is achieved."	0
Prepare a suspension at time of dispensing as follows: tap bottle until all the powder flows freely.	0
"Increased exposure of other antiretroviral drugs (e.g., saquinavir) when used concomitantly with rabeprazole may increase toxicity."	1
"Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior."	0
Other infusion solutions are not recommended.	0
The extent of the decline in cystine excretion is generally dependent on the THIOLA<U+00AE> dosage.	0
Initiate intravenous infusion through a central venous catheter at 2 ng/kg/min.	0
"Sumatriptan<U+2013>There have been rare post marketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a selective serotonin reuptake inhibitor (SSRI) and sumatriptan."	0
"In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of citalopram and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin."	0
Distribution Ledipasvir is greater than 99.8% bound to human plasma proteins.	0
This change is of unknown clinical significance.	0
"Based on recovery of quinapril and its metabolites in urine, the extent of absorption is at least 60%."	0
"Positive test results were obtained in the in vitro CHO Sister Chromatid Exchange (clastogenicity) test, and in the mouse Lymphoma Cell (mutagenicity) assays, using concentrations of hydrochlorothiazide of 43 to 1,300mcg/mL."	0
Elimination Teriflunomide is eliminated mainly through direct biliary excretion of unchanged drug as well as renal excretion of metabolites.	0
Other nonclinical studies have also shown that zaleplon binds selectively to the brain omega-1 receptor situated on the alpha subunit of the GABAA/chloride ion channel receptor complex and potentiates t-butyl-bicyclophosphorothionate (TBPS) binding.	0
"Coadministration of VIRACEPT and drugs that induce CYP3A or CYP2C19, such as rifampin, may decrease nelfinavir plasma concentrations and reduce its therapeutic effect."	1
"Altered anticoagulant effects, including increased bleeding, have been reported when SSRIs and SNRIs are coadministered with warfarin."	0
EXTRANEAL results in a reduction in the absorbed caloric (carbohydrate) load compared to 4.25% hyperosmolar glucose solutions.	0
"Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma."	0
There was no increase in heart failure in patients with significant left ventricular dysfunction.	0
Patients must be educated at a trained dialysis center before their initial EXTRANEAL treatment.	0
"However, as has been shown for all beta-blocking agents, the antihypertensive effect does not appear to be related to plasma level."	0
Discontinue strong CYP3A4 inhibitors at least 1 week prior to starting ONIVYDE therapy.	0
"If cardiac failure continues despite adequate treatment, TENORMIN should be withdrawn."	0
The pharmacodynamic effects can be explained by a combination of the increase in dofetilide exposure and the reductions in serum potassium.	0
"The risk of myopathy during treatment with statins is increased with concurrent administration of fibric acid derivatives, lipid-modifying doses of niacin, cyclosporine, or strong CYP 3A4 inhibitors (e.g., clarithromycin, HIV protease inhibitors, and itraconazole)."	0
"Dronedarone has antiarrhythmic properties belonging to all four Vaughan-Williams classes, but the contribution of each of these activities to the clinical effect is unknown."	0
The dose of BYSTOLIC may need to be reduced.	0
"Hepatic Impairment In subjects with mild, moderate, or severe hepatic impairment (Child-Pugh class A, B, and C), no change in fingolimod Cmax was observed, but fingolimod AUC0-<U+221E> was increased respectively by 12%, 44%, and 103%."	0
The clinical significance of this finding is unknown.	0
"If coadministration is necessary, reduce the quetiapine dose to 1/6 of the current dose and monitor for quetiapine-associated adverse reactions."	1
Persistent elevations (> 3 times the upper limit of normal [ULN] occurring on 2 or more occasions) in serum transaminases occurred in 0.7% of patients who received atorvastatin in clinical trials.	0
"Based on the pharmacokinetic and metabolic profile, pimozide appears to undergo significant first pass metabolism."	0
ALDACTONE has been shown to increase the half-life of digoxin .	1
Titrate slowly in patients with severe hepatic impairment.	0
"When there are abnormal urinary findings associated with hemoptysis and pulmonary infiltrates suggestive of Goodpasture<U+2019>s syndrome, THIOLA<U+00AE> treatment should be stopped."	0
Information on FDA authorized tests for the detection and quantitation of BCR-ABL transcripts to determine eligibility for treatment discontinuation is available at http://www.fda.gov/CompanionDiagnostics.	0
A 10% reduction in mean FEV1 at 6 hours after dosing was observed in patients receiving fingolimod 1.25 mg (a dose higher than recommended for use in MS) on Day 10 of treatment.	0
"The most important reaction associated with MAO inhibitors is the occurrence of hypertensive crises, which have sometimes been fatal, resulting from the co-administration of MAOIs and certain drugs and foods."	0
Draw up the full amount of the mixture into an oral syringe and administer into either right or left inner cheek of infant.	0
"Weaning: When discontinuing the infusion, it may be necessary to gradually decrease the dose of dopamine HCl while expanding blood volume with intravenous fluids."	0
Thiazides have been shown to decrease arterial responsiveness to norepinephrine (an effect attributed to loss of sodium).	0
"Institute such measures cautiously with frequent determinations of serum potassium levels, especially in patients receiving digitalis or with a history of cardiac arrhythmias."	0
The mechanism of action of olanzapine in the treatment of acute manic or mixed episodes associated with bipolarI disorder is unknown.	0
"Among approximately 1400 patients treated with CMI in the premarketing experience who had ECGs, 1.5% developed abnormalities during treatment, compared with 3.1% of patients receiving active control drugs and 0.7% of patients receiving placebo."	0
Monitor hepatic function tests at least twice weekly during TRISENOX therapy.	0
Please see the dabigatran US prescribing information for specific recommendations. rivaroxaban Co-administration of PREZISTA/ritonavir and rivaroxaban is not recommended. warfarin <U+2193> warfarin<U+2194> darunavir Warfarin concentrations are decreased when co-administered with PREZISTA/ritonavir.	1
"When discontinuing the infusion, it may be necessary to gradually decrease the dose of dopamine HCl while expanding the blood volume with intravenous fluids to prevent the development of marked hypotension."	0
"When necessary, titration may be carried out over a 7- to 14-day period."	0
"Distribution occurs to a central (plasma) and to a peripheral compartment, with a mean elimination half-life of 12 hours."	0
"Imipramine, Chlorpromazine Imipramine in combination with zolpidem produced no pharmacokinetic interaction other than a 20% decrease in peak levels of imipramine, but there was an additive effect of decreased alertness."	0
"Other Cardiovascular Agents: VASOTEC has been used concomitantly with beta adrenergic-blocking agents, methyldopa, nitrates, calcium-blocking agents, hydralazine, prazosin and digoxin without evidence of clinically significant adverse interactions."	0
"VYVANSE may be administered in one of the following ways: Information for VYVANSE capsules: Swallow VYVANSE capsules whole, or Open capsules, empty and mix the entire contents with yogurt, water, or orange juice."	0
"Inhibitors of CYP3A4 (e.g., ketoconazole) or CYP2D6 (e.g., fluoxetine, paroxetine) can inhibit iloperidone elimination and cause increased blood levels."	1
Renal impairment: Anti-FXa activity adjusted for exposure to apixaban was similar across renal function categories.	0
An interdosing interval sufficient to avoid tolerance with dilatrate<U+00AE>-SR has not been demonstrated.	0
"As with adults, after titration, the total daily dose may be given once daily at bedtime to minimize daytime sedation."	0
"In Study 2, involving n = 281 randomized patients, sertraline hydrochloride treatment was initiated at 50 mg/day in the late luteal phase (last 2 weeks) of each menstrual cycle and then discontinued at the onset of menses."	0
Metabolism<U+2013>Sertraline undergoes extensive first pass metabolism.	0
"In the same study, twice-daily coadministration of indinavir (800 mg) and ritonavir (100 or 200 mg) resulted in ritonavir AUC24h increases versus the same doses of ritonavir alone."	1
Dabigatran displays dose-proportional pharmacokinetics in healthy subjects and patients in the range of doses from 10 to 400 mg. Absorption The absolute bioavailability of dabigatran following oral administration of dabigatran etexilate is approximately 3 to 7%.	0
"Consider obtaining periodic hepatic serum enzymes, especially during the first 6 months of treatment, but it is not known whether routine periodic monitoring of serum enzymes will prevent the development of severe liver injury."	0
The discontinuation rate for rash in clinical trials was <1%.	0
"In addition, no treatment-related effects were observed in fecundity or fertility of untreated females mated to treated males."	0
"Three placebo-controlled trials in 752 pediatric patients with MDD have been conducted with paroxetine, and the data were not sufficient to support a claim for use in pediatric patients."	0
Each substrate was examined over a concentration range of 2.5 to 250mcM.	0
The effectiveness and safety of the 5-mg dose have not been prospectively studied.	0
"Conversely, at least 14 days should be allowed after stopping Lexapro before starting an MAOI intended to treat psychiatric disorders."	0
Whether any of the symptoms described above represent such a conversion is unknown.	0
Frequent monitoring of international normalized ratio (INR) values is recommended in patients receiving warfarin.	0
Carvedilol (12.5mg twice daily) did not have an effect on the steady-state prothrombin time ratios and did not alter the pharmacokinetics of R(+)- and S(-)-warfarin following concomitant administration with warfarin in 9healthy volunteers.	0
"Rifabutin was not mutagenic in Schizosaccharomyces pombe P1 and was not genotoxic in V-79 Chinese hamster cells, human lymphocytes in vitro, or mouse bone marrow cells in vivo."	0
"In general, initiate any added antiarrhythmic drug at a lower than usual dose and monitor the patient carefully."	0
"Reduced dosage is indicated in the very young or very old, in patients with impaired renal or hepatic function and in patients receiving other central nervous system depressants, including phenathiazines and other tranquilizers."	0
"Thus, if such treatment is essential, the possibility of increased risk relative to benefits should be considered."	0
"Single daily doses of 37.5 mg triamterene resulted in greater increases in serum potassium than a lower dose (25 mg), while doses greater than 37.5 mg of triamterene, i.e., 75 mg and 100 mg, resulted in no additional elevations in serum potassium levels."	0
"The infusion should be discontinued as soon as sinus rhythm is restored: the QRS complex widens to 130% of its pre<U+2013>treatment duration; the QTc interval widens to 130% of its pre<U+2013>treatment duration, and is then longer than 500 ms; P waves disappear; or the patient develops significant tachycardia, symptomatic bradycardia, or hypotension."	0
Patients receiving continued sertraline hydrochloride treatment experienced a significantly lower rate of discontinuation due to relapse or insufficient clinical response over the subsequent 28 weeks compared to those receiving placebo.	0
Infants exposed to SSRIs in pregnancy may have an increased risk for persistent pulmonary hypertension of the newborn (PPHN).	0
"Such patients should, therefore, be cautioned against interruption or discontinuation of therapy without the physician<U+2019>s advice."	0
"It is eliminated extensively by first pass metabolism, with approximately 40% of the dose metabolized before reaching the systemic circulation."	0
"In some patients treated once daily, the antihypertensive effect may diminish toward the end of the dosing interval."	0
Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.	0
"Age, Gender, and Race The pharmacokinetics of eplerenone at a dose of 100 mg once daily has been investigated in the elderly (<U+2265>65 years), in males and females, and in Blacks."	0
"Drugs Tightly Bound to Plasma Proteins <U+2014> Because fluoxetine is tightly bound to plasma proteins, adverse effects may result from displacement of protein-bound fluoxetine by other tightly-bound drugs."	0
"In patients undergoing major surgery or during anesthesia with agents that produce hypotension, trandolapril will block angiotensin II formation secondary to compensatory renin release."	0
Short-term studies did not show an increase in the risk of suicidality with these drugs compared to placebo in adults beyond age 24; there was a reduction in suicidality risk with antidepressants compared to placebo in adults age 65 and older.	0
"In 4 of the 5 studies, patients received initial doses bioequivalent to 17-25.5 mg SULAR without incident (excessive effects on blood pressure or heart rate)."	0
"PDE5 Inhibitor Sildenafilb when dosed as REVATIO<U+00AE> for the treatment of pulmonary arterial hypertension Potential for sildenafil-associated adverse events (which include visual disturbances, hypotension, priapism, and syncope)."	0
Alprazolam: See WARNINGS AND PRECAUTIONS (5.9).	0
Concomitant potassium-containing salt substitutes should also not be used.	0
Garlic Capsules <U+2193> Saquinavir Coadministration of garlic capsules and saquinavir is not recommended due to the potential for garlic capsules to induce the metabolism of saquinavir which may result in sub-therapeutic saquinavir concentrations.	1
ANA) may be positive and elevated serological test results may take longer to resolve than clinical manifestations.	0
Coadministration of VFEND with rifabutin is contraindicated since VFEND significantly increases rifabutin plasma concentrations and rifabutin also significantly decreases voriconazole plasma concentrations.	1
Similar platelet aggregation recovery rates are observed following discontinuation of a 0.15 mcg/kg/min infusion.	0
"Impairment of Fertility: Some clinical studies have shown that SSRIs (including paroxetine) may affect sperm quality during SSRI treatment, which may affect fertility in some men."	0
"If the decision has been made to discontinue treatment, medication should be tapered, as rapidly as is feasible, but with recognition that abrupt discontinuation can be associated with certain symptoms."	0
"40 mg SD <U+2191> 30% <U+2191> 2.7-fold Rifampin 600 mg QD, 5 days (doses separated) 40 mg SD <U+2193> 80% <U+2193> 40% Gemfibrozil 600 mg BID, 7 days 40mg SD <U+2191> 35% <U+2193> Less than 1% Fenofibrate 160 mg QD, 7 days 40mg SD <U+2191> 3% <U+2191> 2% Boceprevir 800 mg TID, 7 days 40 mg SD <U+2191>2.30 fold <U+2191>2.66 fold Effects of CADUET on Other Drugs Amlodipine: Amlodipine is a weak inhibitor of CYP3A and may increase exposure to CYP3A substrates."	1
Savella is unlikely to be involved in clinically significant pharmacokinetic drug interactions (7).	0
"Monitor digoxin levels when initiating, adjusting, and discontinuing CARDIZEM therapy to avoid possible over- or under-digitalization."	0
"Systemic Bioavailability <U+2014> In man, following a single oral 40 mgdose, peak plasma concentrations of fluoxetine from 15to 55ng/mL are observed after 6to 8hours."	0
Serotonin Syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with CYMBALTA or within 5 days of stopping treatment with CYMBALTA.	0
"Lexapro should generally be administered once daily, morning or evening with or without food (2.1, 2.2)."	0
Discard any doses remaining after 72 hours.	0
There was no evidence of a negative inotropic effect related to TIKOSYN therapy in patients with atrial fibrillation.	0
"The available evidence, however, is considered too limited to be conclusive at this time."	0
Clevidipine is rapidly distributed and metabolized resulting in a very short half life.	0
"Because ondansetron is metabolized by hepatic cytochrome P-450 drug-metabolizing enzymes (CYP3A4, CYP2D6, CYP1A2), inducers or inhibitors of these enzymes may change the clearance and, hence, the half-life of ondansetron."	0
ZOLOFT oral solution must be diluted before use.	0
"Water: In clinical trials establishing the efficacy and safety of SAPHRIS, patients were instructed to avoid drinking for 10 minutes following sublingual dosing."	0
"Hypersensitivity to desvenlafaxine succinate, venlafaxine hydrochloride or any excipients in the PRISTIQ formulation (4.1)."	0
The increase in pimozide AUC and Cmax is due to the CYP2D6 inhibitory properties of paroxetine.	1
"If concomitant treatment of Celexa with a triptan is clinically warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases."	0
"When Marplan is combined with phenothiazine derivatives or other compounds known to cause hypotension, the possibility of additive hypotensive effects should be considered."	0
MICARDIS tablets may be administered with or without food.	0
"Hepatic insufficiency The disposition of desvenlafaxine succinate after administration of 100 mg was studied in subjects with mild (Child-Pugh A, n = 8), moderate (Child-Pugh B, n = 8), and severe (Child-Pugh C, n = 8) hepatic impairment and to healthy subjects (n = 12)."	0
"Patients undergoing dialysis were not included in clinical studies, and appropriate dosing recommendations for these patients are unknown."	0
Concomitant use of rilpivirine with Aptivus/ritonavir may cause an increase in the plasma concentrations of rilpivirine (inhibition of CYP3A enzymes).	1
Monitor renal function periodically in patients receiving enalapril and NSAID therapy .	0
"In case lipase elevations are accompanied by abdominal symptoms, interrupt doses and consider appropriate diagnostics to exclude pancreatitis."	0
Dose changes should occur in 10 mg/day increments and at intervals of at least 1 week.	0
"In a study to assess the effects of terbinafine on desipramine in healthy volunteers characterized as normal metabolizers, the administration of terbinafine resulted in a 2-fold increase in Cmax and a 5-fold increase in area under the curve (AUC)."	1
Discontinuation of ROZEREM should be strongly considered for patients who report any complex sleep behavior.	0
"Withhold or discontinue in any patient with an acute, serious condition suggestive of a myopathy or having a risk factor predisposing to the development of renal failure secondary to rhabdomyolysis (e.g., severe acute infection; hypotension; major surgery; trauma; severe metabolic, endocrine, and electrolyte disorders; and uncontrolled seizures)."	0
The complete text of the Medication Guide is reprinted at the end of this document.	0
Hypertensive animal models respond to diltiazem with reductions in blood pressure and increased urinary output and natriuresis without a change in urinary sodium/potassium ratio.	0
"However, appropriate monitoring of blood glucose should be performed when initiating EXTRANEAL in diabetic patients and insulin dosage should be adjusted if needed."	0
Losartan: Concomitant administration of BYSTOLIC (10 mg single dose) and losartan (50 mg single dose) in 20 healthy adult volunteers did not result in pharmacokinetic interactions.	0
Cross-sensitivity between SURMONTIL and other dibenzazepines is a possibility.	0
"Use of SURMONTIL With Other MAOIs, Such as Linezolid or Methylene Blue: Do not start SURMONTIL in a patient who is being treated with linezolid or intravenous methylene blue because there is increased risk of serotonin syndrome."	0
NORVIR oral solution should not be used in preterm neonates in the immediate postnatal period because of possible toxicities.	0
"Anyone considering the use of LUVOX CR (fluvoxamine maleate) Extended-Release Capsules or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need."	0
The effect of nisoldipine on blood pressure is principally a consequence of a dose-related decrease of peripheral vascular resistance.	0
"At doses above 0.05 mg/kg/day, CYP 2D6 genotyping should be performed."	0
Carvedilol is metabolized primarily by aromatic ring oxidation and glucuronidation.	0
Treatment of hypokalemia: Typical dose range is 40-100 mEq per day.	0
"Similar findings, however, have been observed in normal or well-compensated patients with heart failure with agents possessing significant negative inotropic effects."	0
"The type and duration of hypnotic effects and the profile of unwanted effects during administration of benzodiazepine hypnotics may be influenced by the biologic half-life of the administered drug and for some hypnotics, the half-life of any active metabolites formed."	0
"Voriconazole should be administered with caution to patients with potentially proarrhythmic conditions, such as: Congenital or acquired QT-prolongation Cardiomyopathy, in particular when heart failure is present Sinus bradycardia Existing symptomatic arrhythmias Concomitant medicinal product that is known to prolong QT interval."	0
Thrombotic thrombocytopenic purpura (TTP) has been reported with the use of Effient.	0
The mechanism of action of dronedarone is unknown.	0
Plasma protein binding is constant over the concentration range achieved with recommended doses.	0
"Duloxetine is an inhibitor of the CYP1A2 isoform in in vitro studies, and in two clinical studies the average (90% confidence interval) increase in theophylline AUC was 7% (1%-15%) and 20% (13%-27%) when co-administered with duloxetine (60mg twice daily)."	1
"In the CHARM program (heart failure patients), the incidence of hyperkalemia was 6.3% in patients treated with ATACAND versus 2.1% in patients treated with placebo."	0
"In multiple-dose studies, 10<U+2013>80 mg per day in single or divided doses lowered systolic and diastolic blood pressure throughout the dosing interval, with a trough effect of about 5<U+2013>11/3<U+2013>7 mm Hg."	0
St. John's wort (a CYP3A inducer) caused a small (about 30%) decrease in eplerenone AUC.	1
"DEMSER may have additive sedative effects with alcohol and other CNS depressants , e.g. , hypnotics , sedatives , and tranquilizers ."	0
"If tolerated, dosage may be increased by increments of one tablet (10mg) every 2 to 4days to achieve a dosage of four tablets daily (40mg) by the end of the first week of treatment."	0
The efficacy of aripiprazole could be mediated through a combination of partial agonist activity at dopamine D2 and serotonin 5-HT1A receptors and antagonist activity at 5-HT2A receptors.	0
Patients with Hepatic Impairment: (5.7) Thyrotoxicosis: Abrupt withdrawal in patients with thyrotoxicosis might precipitate a thyroid storm.	0
WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS See full prescribing information for complete boxed warning.	0
Anti-gout: Colchicine <U+2191>Colchicine Patients with renal or hepatic impairment should not be given colchicine with LEXIVA/ritonavir.	0
"The patient should be carefully monitored, since recurrences of NMS have been reported."	0
Patients should be informed of the signs and symptoms of severe allergic reactions and instructed to discontinue Zanaflex and seek immediate medical care should these signs and symptoms occur.	0
TOPROL-XL is an extended-release tablet intended for once daily administration.	0
"ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II."	0
"Conversely, at least 14 days should be allowed after stopping SURMONTIL before starting an MAOI intended to treat psychiatric disorders."	0
"Continuation phase (4 Months): Following the initial phase (2 months), continuation phase (4 months) treatment consists of PRIFTIN 600 mg once-weekly for 4 months in combination with isoniazid or another appropriate anti- tuberculosis agent for susceptible organisms administered as directly observed therapy."	0
"Therefore, NORPRAMIN (desipramine hydrochloride) is not recommended for use in children."	0
"In this study, patients receiving paroxetine experienced a mean reduction of approximately 7 points on the YBOCS total score, which was significantly greater than the mean reduction of approximately 4 points in placebo-treated patients."	0
No reports involved the administration of methylene blue by other routes (such as oral tablets or local tissue injection) or at lower doses.	0
"If concomitant treatment of SNRIs and SSRIs, including sertraline hydrochloride, with a triptan is clinically warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases."	0
The usual dosage range studied in clinical trials was 240 to 360 mg once daily.	0
Dosing should continue for at least 6 weeks.	0
No gender differences were observed in adolescents.	0
It should be discontinued in any patient who develops seizures.	0
Narcotic analgesic: Methadone <U+2193> Methadone Dosage of methadone may need to be increased when coadministered with INVIRASE/ritonavir.	1
"In addition, no dosage adjustment is necessary for substrates of CYP2D6 (e.g., dextromethorphan, fluoxetine, paroxetine, or venlafaxine), CYP2C9 (e.g., warfarin), CYP2C19 (e.g., omeprazole, warfarin), or CYP3A4 (e.g., dextromethorphan) when co-administered with ABILIFY MAINTENA."	0
"Prolonged QT Interval, Torsades de pointes, and sudden death: Monitor electrocardiograms and levels of serum potassium, calcium, magnesium and TSH."	0
"After the standing time, shake the suspension fora minimum of one additional minute."	0
TABLE VI: Lipid-lowering Effects of Lovastatin in Post-Menarchal Girls with Heterozygous Familial Hypercholesterolemia (Mean Percent Change from Baseline at Week24 in Intention-to-Treat Population) DOSAGE N TOTAL-C LDL-C HDL-C TG.data presented as median percent changes Apolipoprotein B Placebo 18 +3.6 +2.5 +4.8 <U+2013>3.0 +6.4 MEVACOR 35 <U+2013>22.4 <U+2013>29.2 +2.4 <U+2013>22.7 <U+2013>24.4 The mean achieved LDL<U+2011>C value was 154.5mg/dL (range: 82-286mg/dL) in the MEVACOR group compared to 203.5mg/dL (range: 135-304mg/dL) in the placebo group.	0
Potassium-conserving therapy should also be avoided in severely ill patients in whom respiratory or metabolic acidosis may occur.	0
"In a study where paroxetine (30 mg once daily) was dosed orally for 4 weeks, steady-state plasma concentrations of paroxetine were increased by approximately 50% during coadministration with oral cimetidine (300 mg three times daily) for the final week."	1
"The combination may result in increased risk of cardiovascular adverse events associated with salmeterol, including QT prolongation, palpitations, and sinus tachycardia."	0
"Therefore, such patients should be cautioned against interruption of therapy without the physician's advice."	0
"Co-administration of APTIVUS/ritonavir with drugs that inhibit CYP 3A may not further increase tipranavir plasma concentrations, because the level of metabolites is low following steady-state administration of APTIVUS/ritonavir 500/200 mg twice daily."	0
"Daily oral dosing of paroxetine (30mg once daily) increased steady-state AUC0-24, Cmax, and Cmin values of procyclidine (5mg oral once daily) by 35%, 37% and 67%, respectively, compared to procyclidine alone at steady state."	1
(with / without coadministered drug)No Effect = 1.00 Lovastatin Lovastatin acid Lovastatin acid refers to the <U+03B2>-hydroxyacid of lovastatin.	0
"ZOLOFT may be administered either continuously (every day throughout the menstrual cycle) or intermittently (only during the luteal phase of the menstrual cycle, i.e., starting the daily dosage 14 days prior to the anticipated onset of menstruation and continuing through the onset of menses)."	0
"Closely observe infants with histories of in utero exposure to ACCURETIC for hypotension, oliguria, and hyperkalemia."	0
"One capsule twice daily (morning and evening) with or without food (2) In case of intolerable headaches during initial treatment, switch to one capsule at bedtime and low-dose aspirin in the morning; resume BID dosing within one week (2) Do not chew capsule (2) Not interchangeable with the individual components of aspirin and dipyridamole tablets (2) Dispense in this unit-of-use container (16) In the event of intolerable headaches during initial treatment, switch to one capsule at bedtime and low-dose aspirin in the morning."	0
The use of Anafranil within 14 days of stopping an MAOI intended to treatpsychiatric disorders is also contraindicated.	0
"Verapamil exerts antihypertensive effects by decreasing systemic vascular resistance, usually without orthostatic decreases in blood pressure or reflex tachycardia."	0
Epidemiological studies of case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding.	0
Steady-state concentrations are expected to be achieved within two days of dosing.	0
"The active ingredient of TRISENOX, arsenic trioxide, is a human carcinogen."	0
"P-gp inducers (e.g., rifampin or St. John<U+2019>s wort) may decrease ledipasvir and sofosbuvir plasma concentrations, leading to reduced therapeutic effect of HARVONI, and the use with P-gp inducers is not recommended with HARVONI."	0
Table1 gives directions for preparing several different concentrations of FLOLAN.	0
"The pooled analyses of placebo-controlled trials in children and adolescents with MDD, obsessive compulsive disorder (OCD), or other psychiatric disorders included a total of 24 short-term trials of 9 antidepressant drugs in over 4400 patients."	0
"In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers."	0
Use vardenafil with caution at reduced doses of no more than 2.5 mg every 72 hours with increased monitoring of adverse events when administered concomitantly with INVIRASE/ritonavir.	1
"Serious hypersensitivity reactions to EXTRANEAL have been reported such as toxic epidermal necrolysis, angioedema, serum sickness, erythema multiforme and vasculitis."	0
Adjustment of adenosine dosage may be necessary.	0
"Drug-Drug Interactions Because zaleplon is primarily metabolized by aldehyde oxidase, and to a lesser extent by CYP3A4, inhibitors of these enzymes might be expected to decrease zaleplon's clearance and inducers of these enzymes might be expected to increase its clearance."	1
Bone marrow depression often occurs 2 to 8 weeks after the start of treatment.	0
Amoxapine is absorbed rapidly and reaches peak blood levels approximately 90 minutes after ingestion.	0
"A totally anuric patient with terminal hepatic cirrhosis had a penicillin half-life of 30.5 hours, while another patient with anuria and liver disease had a serum half-life of 16.4 hours."	0
"Procyclidine<U+2014> Daily oral dosing of paroxetine (30 mg qd) increased steady-state AUC 0-24, Cmax, and C min values of procyclidine (5 mg oral qd) by 35%, 37%, and 67%, respectively, compared to procyclidine alone at steady state."	1
"Generally, the extent of anticoagulation does not need to be assessed."	0
"Similar effects on blood pressure were noted with 25 mg, 50 mg and 100 mg doses of sildenafil, therefore the effects are not related to dose or plasma levels within this dosage range."	0
The usual starting dose of TWYNSTA is 40/5 mg once daily.	0
Transition to an oral antihypertensive agent: Discontinue Cleviprex or titrate downward while appropriate oral therapy is established.	0
"Post-transplant Renal transplant patients are known to have an increased risk of malignancy, predominantly skin cancer and reticulum cell or lymphomatous tumors."	0
"In patients who are elderly , volume-depleted ( including those on diuretic therapy ) , or who have compromised renal function , coadministration of NSAIDs , including selective COX-2 inhibitors , with angiotensin II receptor antagonists , including azilsartan , may result in deterioration of renal function , including possible acute renal failure ."	0
"Tablet and oral suspension: 5 mg or 20 mg three times a day, 4<U+2013>6 hours apart (2.1) Injection: 2.5 mg or 10 mg three times a day administered as an intravenous bolus injection (2.2) The recommended dose of REVATIO is 5 mg or 20 mg three times a day."	0
"In an in vivo drug-drug interaction trial, the Cmax and AUC of dextromethorphan (CYP2D6 substrate) were increased 2.8- and 2.9-fold, respectively when dextromethorphan 30 mg was given with abiraterone acetate 1,000 mg daily (plus prednisone 5 mg twice daily)."	1
Protamine sulfate and vitamin K are not expected to affect the anticoagulant activity of dabigatran.	0
"Co-administration of SAMSCA with 400mg ketoconazole daily or with other strong CYP 3A inhibitors (e.g., clarithromycin, itraconazole, telithromycin, saquinavir, nelfinavir, ritonavir and nefazodone) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure."	1
"Occasionally, therapeutic doses dilate cutaneous blood vessels, particularly in the blush area (atropine flush), and may cause atropine fever due to suppression of sweat gland activity in infants and small children."	0
"If combination therapy is initiated or withdrawn in conjunction with propranolol, an adjustment in the propranolol dose may be warranted."	0
"The available knowledge concerning the relationship of fluvoxamine and the cytochrome P450 isoenzyme system has been obtained mostly from pharmacokinetic interaction studies conducted in healthy volunteers, but some preliminary in vitro data are also available."	0
"Steady-state plasma fluvoxamine concentrations were similar in adults and adolescents at a dose of 300 mg/day, indicating that fluvoxamine exposure was similar in these two populations."	0
Interrupt PURIXAN in patients with onset of clinical or laboratory evidence of hepatotoxicity.	0
"This effect might lead to an increased risk of ventricular arrhythmias, notably torsades de pointes."	0
"Once absorbed into the systemic circulation, doxepin undergoes hepatic metabolism that results in conversion to pharmacologically-active desmethyldoxepin."	0
"Given the primary CNS effects of Savella, caution should be used when it is taken in combination with other centrally acting drugs, including those with a similar mechanism of action."	0
2.Begin infusion of dopamine hydrochloride solution at doses of 2 to 5 mcg/kg/min in adult or pediatric patients who are likely to respond to modest increments of heart force and renal perfusion.	0
Probenecid and cotrimoxazole have been reported to increase the blood level of rifampin.	1
Therapy must be initiated with the specified loading dose regimen of intravenous VFEND on Day 1 followed by the recommended maintenance dose (RMD) regimen.	0
HMG-CoA Reductase Inhibitors (Statins) (CYP3A4 Inhibition) In Vitro Studies Demonstrated Potential for Voriconazole to Inhibit Metabolism(Increased Plasma Exposure) Frequent monitoring for adverse events and toxicity related to statins.	1
Nicardipine reduced afterload without impairing myocardial contractility in preliminary hemodynamic studies of CHF patients.	0
Procedures for proper handling and disposal of this immunosuppressive antimetabolite drug should be considered.	0
"BYSTOLIC can exacerbate the effects of myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists (particularly of the phenylalkylamine [verapamil] and benzothiazepine [diltiazem] classes), or antiarrhythmic agents, such as disopyramide."	0
"If concomitant use of LUVOX CR Capsules with other serotonergic drugs, including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John<U+2019>s Wort, is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome, particularly during treatment initiation and dose increases."	0
Enzyme activities returned to baseline levels 14 days after discontinuing PRIFTIN.	0
Indinavir was administered to Rhesus monkeys during the third trimester of pregnancy (at doses up to 160 mg/kg twice daily) and to neonatal Rhesus monkeys (at doses up to 160 mg/kg twice daily).	0
"To minimize the risk of induced arrhythmia, patients initiated or re-initiated on sotalol should be hospitalized for at least three days or until steady state drug levels are achieved, in a facility that can provide cardiac resuscitation and continuous electrocardiographic monitoring."	0
"The hydrochlorothiazide component blocks the reabsorption of sodium and chloride ions, and thereby increases the quantity of sodium traversing the distal tubule and the volume of water excreted."	0
"Due to age-differences in plasma protein binding, the corresponding increase in the AUC of free (unbound) sildenafil and its active N-desmethyl metabolite were 45% and 57%, respectively."	0
MAO Inhibitors Concomitant use of MAOIs and CNS stimulants can cause hypertensive crisis.	0
"If clonidine and a beta blocker, such as metoprolol are coadministered, withdraw the beta-blocker several days before the gradual withdrawal of clonidine because beta-blockers may exacerbate the rebound hypertension that can follow the withdrawal of clonidine."	0
"Age<U+2013>Sertraline plasma clearance in a group of 16 (8 male, 8 female) elderly patients treated for 14 days at a dose of 100 mg/day was approximately 40% lower than in a similarly studied group of younger (25 to 32 y.o.)"	0
"Rinse the paper and spatula with 20 mL of one of the above-mentioned syrups, and add the rinse to the bottle."	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
Most controlled trials of multiple-dose immediate-release oral ISDN taken every 12 hours (or more frequently) for several weeks have shown statistically significant antianginal efficacy for only 2 hours after dosing.	0
"In these patients, careful monitoring of liver function, especially SGPT/ALT and SGOT/AST should be carried out prior to therapy and then every 2 to 4 weeks during therapy."	0
Epidural or spinal hematomas have occurred in patients treated with XARELTO who are receiving neuraxial anesthesia or undergoing spinal puncture .	0
"There were differences in absolute risk of suicidality across the different indications, with the highest incidence in MDD."	0
"Conversely, the pharmacokinetics of quinidine are not significantly affected by caffeine, ciprofloxacin, digoxin, felodipine, omeprazole, or quinine."	0
"Prior to administration, withdraw from the reconstituted solution a volume equivalent to the amount of rifampin calculated to be administered and add to 500 mL of infusion medium."	0
Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate.	0
No change in the ritonavir dose is required when efavirenz is administered with LEXIVA plus ritonavir twice daily.	0
"If coadministration is necessary, reduce the quetiapine dose to 1/6 of the current dose and monitor for quetiapine-associated adverse reactions."	1
The convulsive potential of meperidine may be further increased if prolonged infusions or repeated doses are administered due to high serum levels of normeperidine.	0
Tamoxifen is a pro-drug requiring metabolic activation by CYP2D6.	0
"Nicardipine has been shown to be rapidly and extensively metabolized by the hepatic cytochrome P450 enzymes, CYP2C8, 2D6, and 3A4."	0
"Following a single 600 mg oral dose of rifampin in healthy adults, the peak serum concentration averages 7 mcg/mL but may vary from 4 to 32 mcg/mL."	0
"The respective mean maximum increases above baseline of the QTc interval, in ms (%), were 23(+6%), 36(+9%) and 55(+14%) ms at the 3 dose levels."	0
"Relapse during the double-blind phase was defined as the following conditions being met (on three consecutive visits for 1 and 2, and for visit 3 for condition 3): (1) YBOCS score increased by <U+2265> 5 points, to a minimum of 20, relative to baseline; (2) CGI-I increased by <U+2265> one point; and (3) worsening of the patient<U+2019>s condition in the investigator<U+2019>s judgment, to justify alternative treatment."	0
"Plasma TCA concentrations may need to be monitored, and the dose of TCA may need to be reduced, if a TCA is coadministered with paroxetine."	1
"Because of potential drug interactions, Zanaflex is contraindicated in patients taking potent CYP1A2 inhibitors, such as fluvoxamine or ciprofloxacin."	0
A clinical study has shown that BRINTELLIX (single dose of 20 or 40 mg) did not increase the impairment of mental and motor skills caused by alcohol (single dose of 0.6 g/kg).	0
"Initiation of CRIXIVAN, a CYP3A inhibitor, in patients receiving medications metabolized by CYP3A or initiation of medications metabolized by CYP3A in patients already receiving CRIXIVAN, may increase plasma concentrations of medications metabolized by CYP3A."	1
Platelet aggregation inhibition is reversible following cessation of the infusion of AGGRASTAT.	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP is excreted in human milk, but there are no data on the concentration of dihydroergotamine in human milk."	0
"If uveitis is suspected, the patient should be referred to an ophthalmologist and, if considered necessary, treatment with MYCOBUTIN should be suspended."	0
"With chronic administration, plasma volume returns toward normal, but peripheral vascular resistance is decreased."	0
"Once a diagnosis is apparent, appropriate measures for the treatment of hemolytic anemia should be instituted, including discontinuation of CRIXIVAN."	0
Plasma levels of d<U+2013>nebivolol increase in proportion to dose in EMs and PMs for doses up to 20mg.	0
Mean changes in serum potassium for patients treated with any dose of bisoprolol in combination with HCTZ 25 mg ranged from -0.1 to -0.3 mEq/L.	0
The protein binding is constant at candesartan plasma concentrations well above the range achieved with recommended doses.	0
These effects were potentiated by atomoxetine (60mg BID for 5days) and were most marked after the initial coadministration of albuterol and atomoxetine.	0
"In patients with Child<U+2011>Pugh B disease, Cmax and AUC were increased 100% and 21%, respectively, compared with patients with normal liver function."	0
A complete blood count should be performed weekly and as clinically indicated to monitor for neutropenia.	0
"VASOTEC is indicated for the treatment of symptomatic heart failure , usually in combination with diuretics and digitalis ."	0
Protease Inhibitors (co-administered with 200 mg of ritonavir): FosamprenavirLopinavirSaquinavir <U+2193> Amprenavir<U+2193> Lopinavir<U+2193> Saquinavir Combining a protease inhibitor with APTIVUS/ritonavir is not recommended.	0
"Hepatic Impairment:In a study comparing the kinetics of pravastatin in patients with biopsy confirmed cirrhosis (N = 7) and normal subjects (N = 7), the mean AUC varied 18 fold in cirrhotic patients and 5 fold in healthy subjects."	0
Immediate release nisoldipine increased plasma quinidine concentrations by about 20%.	1
"In general, dose selection for an elderly patient should be cautious, usually starting at a lower dose."	0
"In the clinical program, patients were included who had baseline liver function tests (ALT, AST) up to 5 times the upper limit of normal."	0
Additive effects on QT and/or PR interval prolongation may occur with INVIRASE/ritonavir.	0
Total peripheral resistance at low and intermediate doses is usually unchanged.	0
.	0
"For patients receiving ELIQUIS doses of 5 mg or 10 mg twice daily, reduce the dose by 50% when ELIQUIS is coadministered with drugs that are combined P-glycoprotein (P-gp) and strong cytochrome P450 3A4 (CYP3A4) inhibitors (e.g., ketoconazole, itraconazole, ritonavir)."	1
"Cyclosporine (CYP3A substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine, despite reduction in dose of cyclosporine."	0
This information is intended to aid in the safe and effective use of this medication.	0
"The coadministration of carbamazepine 200 mg BID with nefazodone 200 mg BID, at steady state for both drugs, resulted in almost 95% reductions in AUCs for nefazodone and hydroxynefazodone, likely resulting in insufficient plasma nefazodone and hydroxynefazodone concentrations for achieving an antidepressant effect for nefazodone."	1
"Like other potassium-conserving agents, amiloride may cause hyperkalemia (serum potassium levels greater than 5.5 mEq per liter) which, if uncorrected, is potentially fatal."	0
"Rifampin, a CYP3A4 inducer, significantly reduced the exposure to and the pharmacodynamic effects of zolpidem."	1
"In contrast, plasma levels of S(-)-carvedilol are increased only about 20% to 25% in poor metabolizers, indicating this enantiomer is metabolized to a lesser extent by cytochrome P450 2D6 than R(+)-carvedilol."	0
"Since the capsules contain lactose, Tasigna is not recommended for patients with rare hereditary problems of galactose intolerance, severe lactase deficiency with a severe degree of intolerance to lactose-containing products, or of glucose-galactose malabsorption."	0
"The rate of quinapril absorption was reduced by 14% when ACCURETIC tablets were administered with a high-fat meal as compared to fasting, while the extent of absorption was not affected."	1
The decision to inform patients and/or their guardians must obviously take into account the clinical circumstances and the competency of the patient to understand the information provided.	0
The recommended starting dose of PURIXAN in multi-agent combination chemotherapy maintenance regimens is 1.5 to 2.5mg/kg (50 to 75 mg/m2) as a single daily dose.	0
"However, there is substantial evidence from placebo-controlled maintenance trials in adults with depression that the use of antidepressants can delay the recurrence of depression."	0
"Coadministration of standard doses of voriconazole with efavirenz doses of 400 mg q24h or higher is contraindicated, because efavirenz significantly decreases plasma voriconazole concentrations in healthy subjects at these doses."	1
Do not use INSPRA with drugs that are strong inhibitors of CYP3A.	0
Perform close perioperative monitoring in patients undergoing general anesthesia who are on amiodarone therapy as they may be more sensitive to the myocardial depressant and conduction defects of halogenated inhalational anesthetics .	0
"Increase of body fat has been observed in patients receiving protease inhibitors, including LEXIVA."	0
Initiate Effient treatment as a single 60-mg oral loading dose and then continue at 10-mg orally once daily.	0
"No significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, cimetidine and phenobarbital."	0
"In addition, there have been postmarketing reports of fluid retention in patients with pulmonary hypertension, occurring within weeks after starting Letairis."	0
"Administration of the IV Bolus After preparation of the infusion bag, withdraw the bolus volume from the NATRECOR<U+00AE> infusion bag, and administer it over approximately 60 seconds through an IV port in the tubing."	0
"In a series of 28 women receiving mercaptopurine after the first trimester of pregnancy, 3 mothers died prior to delivered, 1 delivered a stillborn child, and 1 aborted; there were no cases of macroscopically abnormal fetuses."	0
Subjects with increased average steady-state exposures of diltiazem showed a greater fold increase in simvastatin exposure.	1
"In those patients who discontinued PI therapy, hyperglycemia persisted in some cases."	0
TENORMIN is excreted by the kidneys; consequently dosage should be adjusted in cases of severe impairment of renal function.	0
<U+2022>Serotonin Syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with LUVOX CR Capsules or within 14 days of stopping treatment with LUVOX CR Capsules.	0
The use of anorectic agents for longer than 3 months was associated with a 23-fold increase in the risk of developing pulmonary hypertension.	0
"Due to an observed increased risk of myopathy/rhabdomyolysis, combination therapy with CRESTOR and gemfibrozil should be avoided."	0
"Where there is involvement of the tongue, glottis, or larynx, likely to cause airway obstruction, emergency therapy, including but not limited to subcutaneous epinephrine solution 1:1,000 (0.3 to 0.5 mL) should be promptly administered."	0
Symptoms include acute onset of decreased visual acuity or ocular pain and typically occur within hours to weeks of drug initiation.	0
This may result in increased serum digoxin levels and subsequent digitalis toxicity.	0
The relative oral bioavailability of risperidone from a tablet is 94% (CV=10%) when compared to a solution.	0
"In a pharmacokinetic substudy in patients with congestive heart failure receiving digoxin in whom therapy with FLOLAN was initiated, apparent oral clearance values for digoxin (n=30) were decreased by 15% on the second day of therapy and returned to baseline values by Day 87."	1
"Prolongation of the QTc interval has been associated with the ability to cause Torsades de pointes type arrhythmias, a potentially fatal polymorphic ventricular tachycardia, and sudden death."	0
Reconstitution The powder is reconstituted with 19 mL of Water For Injection to obtain an extractable volume of 20 mL of clear concentrate containing 10 mg/mL of voriconazole.	0
"Sinus bradycardia occurred in 11% of the patients, second-degree AV block in 4%, and sinus arrest in 2%."	0
"The <U+03B2>-blocking effects of BYSTOLIC can be reversed by <U+03B2>-agonists, e.g., dobutamine or isoproterenol."	0
"A fixed-dose trial of Lexapro demonstrated the effectiveness of both 10 mg and 20 mg of Lexapro, but failed to demonstrate a greater benefit of 20 mg over 10 mg."	0
(The reference regimen for indinavir was indinavir/ritonavir 800/100 mg twice daily.) lopinavir/ritonavir <U+2193> darunavir<U+2194> lopinavir Appropriate doses of the combination have not been established.	0
Starting Lexapro in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome.	0
"Do not use CAPRELSA in patients with hypocalcemia, hypokalemia, hypomagnesemia, or long QT syndrome."	0
Observations from drug interaction studies with saquinavir soft gel capsules may not be predictive for INVIRASE/ritonavir.	0
"The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents."	0
"The recovery of radioactivity in urine and feces over a 1<U+2011>week period was 82% and 4% of the administered dose, respectively."	0
The usual recommended starting dose of ATACAND is 16 mg once daily when it is used as monotherapy in patients who are not volume depleted.	0
"Tadalafil is not expected to cause clinically significant inhibition or induction of the clearance of drugs metabolized by cytochrome P450 ( CYP ) isoforms ( e.g. , theophylline , warfarin , midazolam , lovastatin , bosentan ) see Clinical Pharmacology ( 12.3 ) ."	0
CYP3A4 and SULT2A1 are the enzymes involved in the formation of N-oxide abiraterone sulphate and SULT2A1 is involved in the formation of abiraterone sulphate.	0
Co-administration of such combinations of a CYP2C9 inhibitor plus a strong or moderate CYP3A inhibitor with Tracleer is not recommended.	0
Three additional studies examined the antihypertensive effects of losartan and hydrochlorothiazide in combination.	0
"Tacrine: Coadministration increased tacrine Cmax and AUC five- and eight-fold and caused nausea, vomiting, sweating, and diarrhea (7.2)."	0
Atropine may convert partial organic pyloric stenosis into complete obstruction.	0
The interaction between cimetidine and chronically administered verapamil has not been studied.	0
The use of oral sotalol in children with renal impairment has not been investigated.	0
Calculation of the creatinine clearance must precede administration of the first dose of sotalol.	0
Tricyclic Antidepressants May enhance the activity of tricyclic or sympathomimetic agents causing striking and sustained increases in the concentration of d-amphetamine in the brain; cardiovascular effects can be potentiated.	0
This finding may be the result of alteration in the colonic bacteria responsible for the reduction of sulfasalazine to sulfapyridine and mesalamine.	0
Follow special handling and disposal procedures.1 Oral suspension: 2000 mg/100 mL (20 mg/mL).	0
The effects of paroxetine on diazepam were not evaluated.	0
"In i n vitro apixaban studies at concentrations significantly greater than therapeutic exposures, no inhibitory effect on the activity of CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2D6, CYP3A4/5, or CYP2C19, nor induction effect on the activity of CYP1A2, CYP2B6, or CYP3A4/5 were observed."	0
SULAR tablets should be administered orally once daily.	0
"Other than CYP3A4 drug interactions, FETZIMA is predicted, based on in vitro studies, to have a low potential to be involved in clinically significant pharmacokinetic drug interactions."	0
<U+2022>Use of higher-than-approved doses may lead to transaminase elevations.	0
"Continued depression of the myocardium with beta-blocking agents over a period of time can, in some cases, lead to cardiac failure."	0
"Marplan should be administered with caution to patients receiving Antabuse<U+00AE> (disulfiram, Wyeth-Ayerst Laboratories)."	0
Symptoms such as these may be associated with an increased risk for suicidal thinking and behavior and indicate a need for very close monitoring and possibly changes in the medication.	0
"Of the 8 genotype 1b virologic failure subjects, 88% (7/8) had virus with emergent NS5A resistance-associated substitutions L31V/M/I or Y93H at failure."	0
"PR interval prolongation is correlated with verapamil plasma concentrations, especially during the early titration phases of therapy."	0
"For patients who do not achieve a serum uric acid (sUA) less than 6 mg/dL after two weeks with 40 mg, ULORIC 80 mg is recommended."	0
Fluoxetine 20mg/day was administered for up to 62days.	0
Onset of action was in about 24 minutes and effects persisted for about 3 hours.	0
"Avoid use of antidepressants, including ZOLOFT, in patients with untreated anatomically narrow angles."	0
Hallucinations have occurred rarely following high doses of the drug.	0
Fertility of male or female rats was unaffected by clonidine doses as high as 150 <U+00B5>g/kg (approximately 3 times MRDHD).	0
"When multiple doses of zolpidem and fluoxetine were given at steady state and the concentrations evaluated in healthy females, an increase in the zolpidem half-life (17%) was observed."	1
"Sumatriptan: Rare postmarketing reports of weakness, hyperreflexia, and incoordination following use of an SSRI and sumatriptan."	0
"A single-dose interaction study with zolpidem tartrate 10 mg and rifampin 600 mg at steady-state levels in female subjects showed significant reductions of the AUC (-73%), Cmax (-58%), and T1/2 (-36 %) of zolpidem together with significant reductions in the pharmacodynamic effects of zolpidem tartrate."	1
"Refer to Dosage and Administration (2.3), (2.4) and (2.5) for dosing recommendations."	0
The usual starting dose is 50mg once daily.	0
"Once absorbed, the distribution volume of isosorbide dinitrate is 2-4 L/kg and this volume is cleared at the rate of 2-4 L/min, so ISDN's half-life in serum is about an hour."	0
"The mean elimination half-life of desalkyl-flurazepam was longer in elderly male subjects (160 hours) compared with younger male subjects (74 hours), while mean elimination half-life was similar in geriatric female subjects (120 hours) and younger female subjects (90 hours)."	0
The hydrochlorothiazide dose should generally not be increased until 2 to 3 weeks have elapsed.	0
"Similar reductions in the Cmax and AUC of HO-NEF were also observed (85% and 94%), while the reductions in Cmax and AUC of mCPP and triazole-dione were more modest (13% and 44% for the former and 28% and 57% for the latter)."	0
Neither ALDACTONE nor potassium canrenoate produced mutagenic effects in tests using bacteria or yeast .	0
"If the original colchicine regimen was 0.6 mg once a day, the regimen should be adjusted to 0.3 mg once every other day."	0
"These pharmacokinetic effects seen during diltiazem coadministration can result in increased clinical effects (e.g., prolonged sedation) of both midazolam and triazolam."	0
"R-bicalutamide is an inhibitor of CYP 3A4; therefore, caution should be used when bicalutamide is co-administered with CYP 3A4 substrates."	0
Avoid engaging in hazardous activities such as operating a motor vehicle or heavy machinery after taking drug.	0
Coadministration of LEXIVA/ritonavir and paritaprevir/ritonavir/ombitasvir/ dasabuvir is not recommended.	0
ROZEREM should be administered with caution in subjects taking strong CYP3A4 inhibitors such as ketoconazole.	0
"Antipsychotics: For contraindicated antipsychotics,. quetiapine <U+2191> quetiapine Initiation of PREZISTA with ritonavir in patients taking quetiapine: Consider alternative antiretroviral therapy to avoid increases in quetiapine exposures."	1
Do not co-administer aliskiren with TARKA in patients with diabetes.	0
Fusidic acid <U+2191> Saquinavir <U+2191> Fusidic Acid <U+2191> Ritonavir Concomitant use of fusidic acid and INVIRASE/ritonavir is not recommended due to potential for increased mutual toxicities.	0
"Two of the relapsers with genotype 4 HCV infection had an NS5B V321I substitution pretreatment, which was retained post-treatment."	0
"However, in patients with severe left ventricular dysfunction (e.g., pulmonary wedge pressure about 20 mmHg or ejection fraction less than 30%), or in patients taking beta-adrenergic blocking agents or other cardio-depressant drugs, deterioration of ventricular function may occur."	0
"Examples of serotonergic drugs include selective serotonin reuptake inhibitors (SSRI), serotonin norepinephrine reuptake inhibitors (SNRI), triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John<U+2019>s Wort."	0
No specific laboratory tests are deemed essential for the management of patients on selegiline.	0
"For this reason, high and frequent doses are required to maintain the elevated serum levels desirable in treating certain severe infections in individuals with normal kidney function."	0
"Initiation of medications that inhibit or induce CYP3A may increase or decrease concentrations of APTIVUS/ritonavir, respectively."	1
There is no information regarding cross-hypersensitivity between fluconazole and other azole antifungal agents.	0
Therapy with any combination of metoprolol succinate extended release and hydrochlorothiazide will be associated with both sets of dose independent side effects.	0
"Upon coadministration with EMEND, the efficacy of hormonal contraceptives may be reduced during administration of and for 28 days following the last dose of EMEND."	0
Increased monitoring for rifabutin-associated adverse reactions including neutropenia is warranted.	0
Caution is advised if the concomitant administration of PROZAC and such drugs is required.	0
Human pharmacokinetic studies with an oral formulation of treprostinil ( treprostinil diethanolamine ) indicated that co-administration of the cytochrome P450 ( CYP ) 2C8 enzyme inhibitor gemfibrozil increases exposure ( both Cmax and AUC ) to treprostinil .	1
"The pharmacological/toxicological actions of these metabolites are similar to, but less potent than, those of lidocaine."	0
"For the reasons stated above, patients and providers are advised to monitor for melanomas frequently and on a regular basis when using selegiline for any indication."	0
"The sensitivity of cardiac diagnostic procedures to detect cardiovascular disease or predisposition to coronary artery vasospasm is modest, at best."	0
Epidemiological studies of the case-control and cohort design have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding.	0
"Savella is not approved for use in pediatric patients (1, 8.4)."	0
There was no evidence of an additive effect in psychomotor performance.	0
"Therefore, Edarbi may be used concomitantly with these medications."	0
"Ischemic cerebrovascular events, hemorrhage, heart failure, diarrhea, hypertension, and reversible posterior leukoencephalopathy syndrome: Discontinue or interrupt CAPRELSA."	0
Dosage reduction of ALTACE and/or discontinuation of the diuretic may be required.	0
Patients should be monitored for the emergence of serotonin syndrome.	0
"Diethylpropion hydrochloride immediate-release: One immediate-release 25 mg tablet three times daily, one hour before meals, and in midevening if desired to overcome night hunger."	0
"In a study in which normal volunteers (n=12) received perphenazine 4 mg q8h for 5 days, steady-state concentrations of perphenazine were reached within 72 hours."	0
In vitro drug interaction studies demonstrate that duloxetine does not induce CYP1A2 activity.	0
"Such symptoms should be reported to the patient's prescriber or health professional, especially if they are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
Cases of serotonin syndrome have been reported during co-administration of triptans and selective serotonin reuptake inhibitors (SSRIs) or serotonin norepinephrine reuptake inhibitors (SNRIs).	0
A reduction of the resting heart rate due to the beta-blocking effect of sotalol is observed at daily doses <U+2265>90 mg/m2 in children.	0
The starting dose is 200 mg in patients with moderate to severe renal impairment.	0
"Chlorpromazine Hydrochloride Injection, USP is not approved for the treatment of patients with dementia-related psychosis."	0
"The average risk of suicidal ideation in patients receiving STRATTERA was 0.4% (5/1357 patients), compared to none in placebo-treated patients."	0
At least 14 days should elapse between discontinuation of an MAOI intended to treat psychiatric disorders and initiation of therapy with LUVOX CR Capsules.	0
"In in vitro studies, fluvoxamine maleate had no significant affinity for histaminergic, alpha or beta adrenergic, muscarinic, or dopaminergic receptors."	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy."	0
"Antagonism of muscarinic, histaminergic, and adrenergic receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects of other psychotropic drugs."	0
Plasma concentrations of angiotensin I and angiotensin II and plasma renin activity (PRA) increase after single and repeated administration of Benicar to healthy subjects and hypertensive patients.	0
Monitor frequently and adjust or use alternative therapy based on clinical response.	0
"If signs and symptoms of tardive dyskinesia appear in a patient on antipsychotics, drug discontinuation should be considered."	0
"Amiodarone has the potential for interactions with drugs or substances that may be substrates , inhibitors or inducers of CYP450 enzymes ( e.g. , inhibitors such as protease inhibitors , grapefruit juice , certain fluoroquinolone and macrolide antibiotics , azole antifungals and inducers such as St.   John s Wort ) or P-glycoprotein ."	0
Nonlinearity in pharmacokinetics is observed with increasing doses.	0
"If the initial injection of 50 to 100 mg does not produce a desired response, a second dose may be repeated after 5 minutes."	0
"The use of potassium citrate extended-release tablets in patients with chronic renal failure, or any other condition which impairs potassium excretion such as severe myocardial damage or heart failure, should be avoided (5.1) Gastrointestinal lesions: if there is severe vomiting, abdominal pain or gastrointestinal bleeding, potassium citrate extended-release tablets should be discontinued immediately and the possibility of bowel perforation or obstruction investigated (5.2) In patients with impaired mechanisms for excreting potassium, potassium citrate extended-release tablets administration can produce hyperkalemia and cardiac arrest."	0
"Furthermore, among the secondary endpoints, MEVACOR reduced the risk of unstable angina by 32% (1.8 vs. 2.6%; p=0.023), of myocardial infarction by 40% (1.7 vs. 2.9%; p=0.002), and of undergoing coronary revascularization procedures (e.g., coronary artery bypass grafting or percutaneous transluminal coronary angioplasty) by 33% (3.2 vs. 4.8%; p=0.001)."	0
The mixture will be cloudy pink to light pink.	0
Severe hypocitraturia (urinary citrate < 150 mg/day): therapy should be initiated at 60 mEq per day; a dose of 30 mEq two times per day or 20 mEq three times per day with meals or within 30 minutes after meals or bedtime snack (2.2) Mild to moderate hypocitraturia (urinary citrate >150 mg/day): therapy should be initiated at 30 mEq per day; a dose of 15 mEq two times per day or 10 mEq three times per day with meals or within 30 minutes after meals or bedtime snack (2.3) Treatment with extended release potassium citrate should be added to a regimen that limits salt intake (avoidance of foods with high salt content and of added salt at the table) and encourages high fluid intake (urine volume should be at least two liters per day).	0
There is little evidence that behavior improvement in severely disturbed mentally retarded patients is further enhanced by doses beyond 500 mg per day.	0
"If emesis occurs within 30minutes after dosing, re-dosing of LEXIVA oral suspension should occur."	0
"The pharmacokinetics of orally administered telmisartan are nonlinear over the dose range 20 to 160 mg, with greater than proportional increases of plasma concentrations (Cmax and AUC) with increasing doses."	0
"ACE inhibitors also inhibit the degradation of bradykinin, a reaction also catalyzed by ACE."	0
<U+2191> Sildenafil (not studied)<U+2191> Tadalafil with first dose APTIVUS/ritonavir<U+2194> Tadalafil at APTIVUS/ritonavir steady-state<U+2191> Vardenafil (not studied) Use of PDE-5 inhibitors for pulmonary arterial hypertension (PAH): Use of sildenafil (Revatio) is contraindicated when used for the treatment of pulmonary arterial hypertension (PAH).	0
"If creatinine clearance is between 60 and 40 mL/min, administer once daily, if less than 40 mg/mL, sotalol is not recommended (2.1) The dose can be up-titrated to maximal dose of 150 mg twice daily under close ECG and QT interval monitoring (2.5, 2.6) For the safety of the patient, the safety measures required of oral sotalol administration must also be applied for intravenous route."	0
"Patients with low or absent TPMT activity are at an increased risk of developing severe, life-threatening myelotoxicity if receiving conventional doses of IMURAN."	0
The basis for the beneficial effects of COREG in patients with left ventricular dysfunction following an acute myocardial infarction is not established.	0
The pharmacokinetics of iloperidone is more than dose proportional.	0
Discard any unused portion left in the vial or bag.	0
"For surgical patients, dosage should be based on response of the patient, other premedication and concomitant medications, the anesthetic being used and the nature and duration of the operation."	0
NORVIR should be started at 250 mg per m2 twice daily and increased at 2 to 3 day intervals by 50 mg per m2 twice daily.	0
May cause diarrhea with nutritional supplements that contain maltitol.	0
"Although EMSAM has not been shown to increase the impairment of mental and motor skills caused by alcohol (0.75mg per kg) and failed to alter the pharmacokinetic properties of alcohol, patients should be advised that the use of alcohol is not recommended while taking EMSAM."	0
Doses of potassium citrate extended-release tablets greater than 100 mEq/day have not been studied and should be avoided.	0
"5,000ng/mL Dissolve contents of one 0.5<U+2011>mg vial with 5mL of sterile diluent."	0
PURIXAN is a pink to brown viscous oral suspension.	0
Coadministration of INVIRASE/ritonavir with drugs that induce CYP3A may result in decreased plasma concentrations of saquinavir and reduced efficacy.	1
"Loxapine acts as an antagonist at central serotonin and dopamine receptors, with high affinity for serotonin 5-HT2A and dopamine D1, D2, D3, and D4 receptors (Ki values of 2 nM, 18 nM, 10 nM, 21 nM, 9 nM, respectively)."	0
"Alternatively, the amount of rifampin calculated to be administered may be added to 100 mL of infusion medium and infused in 30 minutes."	0
Absorption: Pitavastatin peak plasma concentrations are achieved about 1 hour after oral administration.	0
The time course and dose dependence of this interaction have not been studied.	0
Use the lowest effective dosage for the shortest duration consistent with individual patient treatment goals.	0
Zaleplon AUC and elimination half-life were not significantly affected.	0
The pharmacokinetics of nefazodone and its major metabolites are not altered in these <U+201C>poor metabolizers.<U+201D> Plasma concentrations of one minor metabolite (mCPP) are increased in this population; the adjustment of nefazodone dosage is not required when administered to <U+201C>poor metabolizers.<U+201D> Nefazodone and its metabolites have been shown in vitro to be extremely weak inhibitors of CYP2D6.	0
Savella should be used with caution in patients with moderate renal impairment.	0
Hypersensitivity to MAXALT or MAXALT-MLT (angioedema and anaphylaxis seen).	0
Smokers The effects of cigarette smoking on the pharmacokinetics of bupropion hydrochloride were studied in 34 healthy male and female volunteers; 17 were chronic cigarette smokers and 17 were nonsmokers.	0
"The kinetics of nefazodone, hydroxynefazodone, and triazole-dione were not affected by coadministration of propranolol."	0
The pupillary dilation that occurs following use of many antidepressant drugs including Pexeva may trigger an angle closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy.	0
In in vitro assays asenapine acts as an antagonist at these receptors.	0
"As with other MAO inhibitors, Marplan should be discontinued at least 48hours before myelography and should not be resumed for at least 24hours postprocedure."	0
Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium.	1
"Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8 fold increase in plasma AUC of the TCA)."	0
These patients presented with abdominal pain (with or without nausea or vomiting); in some cases there was no prior history of facial angioedema and C-1 esterase levels were normal.	0
Clostridium difficile -associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents.	0
"BREVIBLOC should therefore be used only after careful individual assessment of the risks and expected benefits in patients receiving drugs that can cause these types of pharmacodynamic interactions , including but not limited to : ."	0
Pediatric Patients: The pharmacokinetics of lisinopril were studied in 29 pediatric hypertensive patients between 6 years and 16 years with glomerular filtration rate >30 mL/min/1.73 m2.	0
Dipyridamole Absorption Peak plasma levels of dipyridamole are achieved 2 hours (range 1<U+2013>6 hours) after administration of a daily dose of 400 mg AGGRENOX (given as 200 mg BID).	0
Rifabutin <U+2193> indinavir concentration<U+2191> rifabutin concentration Dose reduction of rifabutin to half the standard dose and a dose increase of CRIXIVAN to 1000 mg every 8 hours are recommended when rifabutin and CRIXIVAN are coadministered.	1
"Similar favorable hemodynamic effects were seen with oral quinapril in baseline-controlled trials, and such effects appeared to be maintained during chronic oral quinapril therapy."	0
"Angiotensin II is a potent vasoconstrictor formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II)."	0
"Adult Patients In adult patients taking propranolol, only the 5-mg dose of MAXALT is recommended, up to a maximum of 3 doses in any 24-hour period (15 mg)."	0
Pediatric The pharmacokinetics of olmesartan were studied in pediatric hypertensive patients aged 1 to16 years.	0
Bosentan is an inducer of CYP3A and CYP2C9.	0
Grapefruit juice Avoid grapefruit juice Persistent increases (to more than 3X the ULN) in serum transaminases have occurred in approximately 1% of patients who received simvastatin in clinical studies.	0
"(7.1) Coadministration of antiplatelet agents, thrombolytics, heparin, aspirin, and chronic NSAID use increases the risk of bleeding."	0
Figure 1: Mean Weight and Height Percentiles Over Time for Patients With Three Years of STRATTERA Treatment This growth pattern was generally similar regardless of pubertal status at the time of treatment initiation.	0
ROZEREM should not be used in combination with fluvoxamine.	0
"Consequently, a decision to use ORAP should take into consideration the following."	0
Cyclosporine: combination increases exposure.	1
"These interactions may lead to: Clinically significant adverse reactions, potentially leading to severe, life-threatening, or fatal events from greater exposures of concomitant medications."	0
"The antihypertensive effect of ACCUPRIL continues during long-term therapy, with no evidence of loss of effectiveness."	0
Activation of mania/hypomania is a known risk in a small proportion of patients with major affective disorder treated with other marketed antidepressants.	0
"In patients with renal insufficiency (glomerular filtration rate of less than 0.7 ml/kg/min), because of the danger of soft tissue calcification and increased risk for the development of hyperkalemia."	0
"Absorption Following single oral administration of WELLBUTRIN XL tablets to healthy volunteers, the median time to peak plasma concentrations for bupropion was approximately 5 hours."	0
"In the patients with a 2-hour delay in the onset of platelet aggregation (5 of 11), Tmax was delayed and prasugrel active metabolite levels were significantly lower at 30 min (5 vs 120 ng/mL) following co-administration with morphine."	1
The ability of multiple doses of Tasigna to induce metabolism of drugs other than midazolam has not been determined in vivo.	0
The oral bioavailability of dabigatran etexilate increases by 75% when the pellets are taken without the capsule shell compared to the intact capsule formulation.	0
"Many drugs, including most drugs effective in the treatment of major depressive disorder (paroxetine, other SSRIs and many tricyclics), are metabolized by the cytochrome P450 isozyme CYP2D6."	0
Plasma concentrations correlate with effect in both young and elderly patients.	0
"The AUC of active metabolite following oral losartan was not affected by erythromycin, another inhibitor of P4503A4, but the AUC of losartan was increased by 30%."	1
Patients should avoid grapefruit juice beverages while taking amiodarone because exposure to amiodarone is significantly increased [see Clinical Pharmacology (12.3)].	1
Diazepam - The coadministration of LUVOX CR Capsules and diazepam is generally not advisable.	0
Dose adjustment of zidovudine cannot be recommended at this time.	0
No dosage adjustment is necessary for patients with hepatic impairment.	0
This strategy is inappropriate for organic nitrates.	0
The antihypertensive effects of PRINIVIL are maintained during long-term therapy.	0
"In the 12-week acute treatment phase of these studies, CYMBALTA was associated with a small increase in mean fasting blood glucose as compared to placebo."	0
These doses were 6 to 11 times (mouse) and 8 to 16 times (rat) the human AUC (0<U+2013>24) based on the maximum recommended human dose (MRHD) of 80 mg/day.	0
Clinical significance of this interaction is not known.	0
"Other serious reactions (including severe agitation, hallucinations, and death) have been reported in patients receiving this combination."	0
"Patients receiving antihypertensive drugs, beta-adrenergic blockers, and nitrates should be observed for possible additive hypotensive effects."	0
"Because cardiac ischemia can occur in the absence of clinical symptoms, consideration should be given to obtaining on the first occasion of use an electrocardiogram (ECG) during the interval immediately following D.H.E."	0
"Pharmacodynamic drug interaction studies with aspirin, clopidogrel, aspirin and clopidogrel, prasugrel, enoxaparin, and naproxen were conducted."	0
"Following oral administration of Lotensin, peak plasma concentrations of benazepril, and its active metabolite benazeprilat are reached within 0.5 to1.0 hour and 1 to 2 hours, respectively."	0
"In vitro studies suggest that the primary pathway for elimination is via CYP 3A4; however, CYP 2D6 and CYP 2C9 metabolic pathways are also involved to a lesser extent."	0
Periodic monitoring of liver function in patients taking TARKA is therefore prudent.	0
Consider using sevelamer suspension in patients with a history of swallowing disorders.	0
"NATRECOR<U+00AE> is physically and/or chemically incompatible with injectable formulations of heparin, insulin, ethacrynate sodium, bumetanide, enalaprilat, hydralazine, and furosemide."	0
Pharmacokinetics described here refer to the sum of dabigatran and its glucuronides.	0
Beta-blockers can precipitate or aggravate symptoms of arterial insufficiency in patients with peripheral vascular disease.	0
ROZEREM has not been studied in subjects with severe sleep apnea and is not recommended for use in this population.	0
"Selegiline has a greater affinity for MAO-B, compared to MAO-A."	0
An approximately 1-2 mg/hour increase will generally produce an additional 2-4 mmHg decrease in systolic pressure.	0
Pregnancy <U+2014> Pregnancy Category C<U+2014>Animal reproductive studies have not been conducted with quinidine.	0
"Should the physician decide to administer anticoagulation in the context of epidural or spinal anesthesia/analgesia or lumbar puncture, monitor frequently to detect any signs or symptoms of neurological impairment, such as midline back pain, sensory and motor deficits (numbness, tingling, or weakness in lower limbs), bowel and/or bladder dysfunction."	0
Tasigna may be given in combination with hematopoietic growth factors such as erythropoietin or G-CSF if clinically indicated.	0
"Quetiapine and its metabolites are non-inhibitors of major metabolizing CYP<U+2019>s (1A2, 2C9, 2C19, 2D6 and 3A4)."	0
"Thus, this study suggests that drugs that inhibit P450 2D6 or the presence of reduced activity levels of this isozyme will produce elevated plasma levels of thioridazine."	1
"However, prior to initiating treatment with an antidepressant, patients with depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression."	0
A maximum dose of 3 mg is recommended in adults and elderly when cimetidine is co-administered with Silenor.	0
No clinically relevant age-dependent changes in steady-state plasma concentrations of terbinafine have been reported.	0
"During chronic therapy, the maximum reduction in blood pressure with any dose is achieved within one week."	0
Abrupt withdrawal of beta-blockade may be followed by an exacerbation of the symptoms of hyperthyroidism or may precipitate thyroid storm.	0
Whether this difference has clinical relevance is not yet known.	0
Gender: A study in healthy subjects comparing the pharmacokinetics in males and females showed no meaningful difference.	0
"Once-weekly co-administration of 900 mg PRIFTIN with the antiretroviral fixed dose combination of efavirenz 600 mg, emtricitabine 200 mg and tenofovir disoproxyl fumarate 300mg in HIV- infected patients did not result in any substantial change in steady state exposures of efavirenz, emtricitabine, and tenofovir."	0
The pharmacokinetic characteristics of the two enantiomers are similar.	0
It is not known whether Matulane is excreted in human milk.	0
"When BYSTOLIC is co-administered with an inhibitor or an inducer of this enzyme, monitor patients closely and adjust the nebivolol dose according to blood pressure response."	0
"Coadministration of enoxaparin, warfarin, aspirin, clopidogrel and chronic NSAID use may increase the risk of bleeding [see Clinical Pharmacology (12.3)]."	0
"There may be, however, following abrupt withdrawal of high-dose therapy, some symptoms resembling those of physical dependence such as gastritis, nausea and vomiting, dizziness and tremulousness."	0
"In worldwide premarketing paroxetine clinical trials, 17% of paroxetine-treated patients (approximately 700) were 65 years of age or older."	0
"Patients on diuretics and especially those in whom diuretic therapy was recently instituted , may occasionally experience an excessive reduction of blood pressure after initiation of therapy with enalapril ."	0
<U+2194> Saquinavir A pharmacokinetic interaction is unlikely due to different routes of metabolism and excretion.	0
Co-administration of fosamprenavir/ritonavir with paroxetine significantly decreased plasma levels of paroxetine.	1
Pregnancy CategoriesC (first trimester) and D (second and third trimesters).	0
"Anticonvulsants: Carbamazepine, phenobarbital, phenytoin <U+2193> Saquinavir Effect on carbamazepine, phenobarbital, and phenytoin is not well established Saquinavir may be less effective due to decreased saquinavir plasma concentrations in patients taking these agents concomitantly."	1
Hormonal Contraceptives Clinical Impact Decreased hormonal exposure during administration of and for 28 days after administration of the last dose of EMEND.	1
"Therefore, patients receiving inhibitors or inducers of the cytochrome P450 system should be monitored for drug interactions."	0
Ritonavir also inhibits CYP2D6 to a lesser extent.	0
"Like many other drugs, paroxetine is secreted in human milk, and caution should be exercised when PEXEVA<U+00AE> (paroxetine mesylate) is administered to a nursing woman."	0
The patients should be expected to awake at night to urinate; they should drink two more glasses of fluids before returning to bed.	0
"In vitro data from human liver microsomes indicate that cytochrome 2D6 and 1A2 are involved in the formation of the 8-hydroxy metabolite of mirtazapine, whereas cytochrome 3A is considered to be responsible for the formation of the N-desmethyl and N-oxide metabolite."	0
"Both cyclosporine and tacrolimus are substrates of CYP3A4, and nefazodone is known to inhibit this enzyme."	0
"The mean clearances of dofetilide were 16% and 15% lower in patients on thiazide diuretics and inhibitors of tubular organic cation transport, respectively."	1
"Rifampin has been reported to accelerate the metabolism of the following drugs: anticonvulsants (e.g., phenytoin), digitoxin, antiarrhythmics (e.g., disopyramide, mexiletine, quinidine, tocainide), oral anticoagulants, antifungals (e.g., fluconazole, itraconazole, ketoconazole), barbiturates, beta-blockers, calcium channel blockers (e.g., diltiazem, nifedipine, verapamil), chloramphenicol, clarithromycin, corticosteroids, cyclosporine, cardiac glycoside preparations, clofibrate, oral or other systemic hormonal contraceptives, dapsone, diazepam, doxycycline, fluoroquinolones (e.g., ciprofloxacin), haloperidol, oral hypoglycemic agents (sulfonylureas), levothyroxine, methadone, narcotic analgesics, progestins, quinine, tacrolimus, theophylline, tricyclic antidepressants (e.g., amitriptyline, nortriptyline) and zidovudine."	1
"Hyponatremia may occur as a result of treatment with SSRIs and SNRIs, including Lexapro."	0
Premedicate with a corticosteroid and an anti-emetic.	0
"As with other drugs, the potential for interaction by a variety of mechanisms (e.g., pharmacodynamic, pharmacokinetic inhibition or enhancement, etc.) is a possibility."	0
"Potential of Fingolimod and Fingolimod-phosphate to Inhibit the Metabolism of Comedications In vitro inhibition studies using pooled human liver microsomes and specific metabolic probe substrates demonstrate that fingolimod has little or no capacity to inhibit the activity of the following CYP enzymes: CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4/5, or CYP4A9/11 (fingolimod only), and similarly fingolimod-phosphate has little or no capacity to inhibit the activity of CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, or CYP3A4 at concentrations up to 3 orders of magnitude of therapeutic concentrations."	0
"Physicians considering combined therapy with CADUET and fibric acid derivatives, erythromycin, clarithromycin, a combination of saquinavir plus ritonavir, lopinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, or fosamprenavir plus ritonavir, azole antifungals, or lipid-modifying doses of niacin should carefully weigh the potential benefits and risks and should carefully monitor patients for any signs or symptoms of muscle pain, tenderness, or weakness, particularly during the initial months of therapy and during any periods of upward dosage titration of either drug."	0
The reconstituted solution can be diluted with: 9 mg/mL (0.9%) Sodium Chloride USPLactated Ringers USP5% Dextrose and Lactated Ringers USP5% Dextrose and 0.45% Sodium Chloride USP5% Dextrose USP5% Dextrose and 20 mEq Potassium Chloride USP0.45% Sodium Chloride USP5% Dextrose and 0.9% Sodium Chloride USP The compatibility of VFEND I.V. with diluents other than those described above is unknown.	0
"Electrophysiologic Effects:In healthy volunteers, clevidipine or its major carboxylic acid metabolite, at therapeutic and supratherapeutic concentrations (approximately 2.8 times steady-state), did not prolong cardiac repolarization."	0
Patients with inherited little or no thiopurine S-methyltransferase (TPMT) activity are at increased risk for severe mercaptopurine toxicity from conventional doses of mercaptopurine and generally require dose reduction.	0
"Anticonvulsants: carbamazepine phenytoin phenobarbital oxcarbazepine <U+2193> ledipasvir<U+2193> sofosbuvir<U+2193> GS-331007 Coadministration of HARVONI with carbamazepine, phenytoin, phenobarbital, or oxcarbazepine is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI."	1
"Caution should be used in dosing the elderly, especially if there are other factors that might additively influence drug metabolism and/or pharmacodynamic sensitivity."	0
"No drug interaction studies have been conducted with CADUET and other drugs, although studies have been conducted in the individual amlodipine and atorvastatin components, as described below: Increased Risk of Myopathy/Rhabdomyolysis (2, 5.1, 7, 12.3) Cyclosporine, HIV protease inhibitors (tipranavir plus ritonavir), hepatitis C protease inhibitor (telaprevir) Avoid atorvastatin Lopinavir plus ritonavir Use lowest dose necessary Clarithromycin, itraconazole,HIV protease inhibitors (saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir) Do not exceed 20 mg atorvastatin daily HIV protease inhibitor (nelfinavir) Hepatitis C protease inhibitor (boceprevir) Do not exceed 40 mg atorvastatin daily Other Lipid-Lowering Medications: Increased risk of myopathy (7)."	0
Monitor blood pressure after initiation.	0
"Based on observations in rats, LIPITOR is likely to be secreted in human milk."	0
<U+2022> Treatment-naive adults: REYATAZ 300 mg with ritonavir 100 mg once daily with food or REYATAZ 400 mg once daily with food.	0
"Examples of alkalinizing agents include gastrointestinal alkalinizing agents (e.g., sodium bicarbonate) and urinary alkalinizing agents (e.g., acetazolamide, some thiazides)."	0
"With chronic administration, plasma volume returns toward normal, but peripheral vascular resistance is decreased."	0
Approximately 15% of patients receiving AHA have had only laboratory findings of an anemia.	0
Nefazodone should be discontinued if clinical signs or symptoms suggest liver failure.	0
The first pass metabolism of bisoprolol fumarate is about 20%.	0
Caution should be exercised when rosuvastatin is coadministered with protease inhibitors given in combination with ritonavir.	0
Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity.	1
"The patient should be carefully monitored, since recurrences of NMS have been reported."	0
"The pooled analyses of placebo-controlled trials in children and adolescents with MDD, obsessive compulsive disorder (OCD), or other psychiatric disorders included a total of 24 short-term trials of 9 antidepressant drugs in over 4400 patients."	0
"<U+2022>Patients with a history of a serious hypersensitivity reaction (e.g., Stevens-Johnson syndrome, anaphylactic reaction, angioedema) to any component of this medication or other medications containing carvedilol."	0
"There is increased potential for sildenafil-associated adverse events (which include visual disturbances, hypotension, prolonged erection, and syncope)."	0
"Therefore, patients should be monitored closely for signs of toxicity related to a CYP2C8 substrate with a narrow therapeutic index if used concomitantly with ZYTIGA."	0
<U+2022>Coadministration of LEXIVA or LEXIVA and ritonavir may result in clinically significant interactions with drugs metabolized by CYP3A4.	0
"Constitutional deficiency of cytochrome P450IID6 is found in less than 1% of Orientals, in about 2% of American blacks, and in about 8% of American whites."	0
"When a single oral 30 mg dose of paroxetine was administered at phenobarbital steady state (100 mg once daily for 14 days), paroxetine AUC and T<U+00BD> were reduced (by an average of 25% and 38%, respectively) compared to paroxetine administered alone."	1
"If TIKOSYN needs to be discontinued to allow dosing of other potentially interacting drug(s), a washout period of at least two days should be followed before starting the other drug(s)."	0
Resume ONIVYDE whenthe ANC is 1500/mm 3 or above.	0
In clinical trials the effectiveness of paroxetine was demonstrated in patients dosed in a range of 20 to 50 mg/day.	0
"Milnacipran undergoes minimal CYP450 related metabolism, with the majority of the dose excreted unchanged in urine (55%), and has a low binding to plasma proteins (13%)."	0
Coadministration of VFEND with St. John's Wort is contraindicated because this herbal supplement may decrease voriconazole plasma concentration.	1
Ramipril: Concomitant administration of BYSTOLIC (10 mg once daily) and ramipril (5 mg once daily) for 10 days in 15 healthy adult volunteers produced no pharmacokinetic interactions.	0
"Body Weight Daily Dosage of REYATAZ Oral Powder Daily Dosage of Ritonavir Oral Solution 5 kg to less than 15 kg 200 mg (4 packets)c,d 80 mg 15 kg to less than 25 kg 250 mg (5 packets)d 80 mg When transitioning between formulations, a change in dose may be needed."	0
"After toxic side effects have subsided, therapy may then be resumed at the discretion of the physician, based on clinical evaluation and appropriate laboratory studies, at a dosage of 1 to 2 mg/kg/day."	0
"Physicians, in consultation with their patients, may therefore in some cases choose doses lower than determined by the algorithm."	0
"Recent use (i.e., within 24 hours) of another 5-HT1 agonist, ergotamine-containing medication, or ergot-type medication (such as dihydroergotamine or methysergide)."	0
Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.	1
Savella is not approved for use in pediatric patients.	0
Absorption: LIPITOR is rapidly absorbed after oral administration; maximum plasma concentrations occur within 1 to 2 hours.	0
"If the re-sealable rubber plug on the medication port is missing or partly removed, do not use the product."	0
"Geriatric:In a single oral dose study using pravastatin 20 mg, the mean AUC for pravastatin was approximately 27% greater and the mean cumulative urinary excretion (CUE) approximately 19% lower in elderly men (65 to 75 years old) compared with younger men (19 to 31 years old)."	0
": Itraconazole Ketoconazole Posaconazole Voriconazole Erythromycin Clarithromycin Telithromycin HIV protease inhibitors Boceprevir Telaprevir Nefazodone Cobicistat-containing products Gemfibrozil Cyclosporine Danazol Contraindicated with simvastatin Verapamil Diltiazem Dronedarone Do not exceed 10mg simvastatin daily Amiodarone Amlodipine Ranolazine Do not exceed 20mg simvastatin daily Lomitapide For patients with HoFH, do not exceed 20 mg simvastatin dailyFor patients with HoFH who have been taking 80 mg simvastatin chronically (e.g., for 12 months or more) without evidence of muscle toxicity, do not exceed 40 mg simvastatin when taking lomitapide."	0
The pharmacokinetics of vortioxetine (2.5 mg to 60 mg) are linear and dose-proportional when vortioxetine is administered once daily.	0
Such monitoring should include daily observation by families and caregivers.	0
"In a patient who has taken ADCIRCA, where nitrate administration is deemed medically necessary in a lifethreatening situation, at least 48 hours should elapse after the last dose of ADCIRCA before nitrate administration is considered."	0
"Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)."	0
Epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an NSAID or aspirin may potentiate this risk of bleeding.	0
All reports with methylene blue that provided information on the route of administration involved intravenous administration in the dose range of 1 mg/kg to 8 mg/kg.	0
"Following oral administration, losartan is well absorbed (based on absorption of radiolabeled losartan) and undergoes substantial first-pass metabolism; the systemic bioavailability of losartan is approximately 33%."	0
Both alcohol and tadalafil are mild vasodilators .	0
"Avoid concomitant use of XARELTO with drugs that are combined P-gp and strong CYP3A4 inducers ( e.g. , carbamazepine , phenytoin , rifampin , St.   John 's   wort ) see Warnings and Precautions ( 5.6 ) and Clinical Pharmacology ( 12.3 ) ."	0
Food does not affect the bioavailability of irbesartan.	0
"Pediatrics The pharmacokinetics of benazaprilat, evaluated in pediatric patients with hypertension following oral administration of a single dose is presented in table below."	0
"The effects of HARVONI on tenofovir exposures are similar when tenofovir is administered as ATRIPLA, COMPLERA, or TRUVADA + dolutegravir."	0
Discontinue PRADAXA in patients who develop acute renal failure while on PRADAXA and consider alternative anticoagulant therapy.	0
"When the low dose of losartan was randomly withdrawn, the rise in trough diastolic blood pressure was the same in patients receiving placebo and in those continuing losartan, again suggesting that the lowest dose did not have significant antihypertensive efficacy."	0
"Amiodarone inhibits peripheral conversion of thyroxine ( T4 ) to triiodothyronine ( T3 ) and may cause increased T4 levels , decreased T3 levels , and increased levels of inactive reverse T3 ( rT3 ) in clinically euthyroid patients ."	1
Thiazides and triamterene have been shown to cross the placental barrier and appear in cord blood.	0
"Take tablets whole; do not divide, crush, chew, or dissolve (2.1)."	0
Co-administration with CRIXIVAN with or without ritonavir may cause a large increase in the concentration of this benzodiazepine.	1
TENORMIN should not be given to patients with untreated pheochromocytoma.	0
Sildenafil Monitor for hypotension when sildenafil is co-administered with amlodipine.	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
"The concomitant use of proton pump inhibitors, H2 antagonists, and digoxin did not appreciably change the trough concentration of dabigatran."	0
"FEV1 measurements taken when theophylline and nefazodone were coadministered did not differ from baseline dosage (i.e., when theophylline was administered alone)."	0
"Drug-induced hepatitis (e.g., acute hepatitis, cytolytic hepatitis) has been reported with PREZISTA/ritonavir."	0
5.Immediately attach the solution container to patient connector (transfer set) or appropriate peritoneal dialysis set.	0
.	0
"The resulting elevated levels of thioridazine would be expected to augment the prolongation of the QTc interval associated with thioridazine and may increase the risk of serious, potentially fatal, cardiac arrhythmias, such as Torsades de pointes type arrhythmias."	0
Substitute non-enzyme inducing therapies at least 2 weeks prior to initiation of ONIVYDE.	0
"The pharmacokinetic properties of ledipasvir, sofosbuvir, and GS-331007 in pediatric subjects 12 years of age and older are provided in Table 6."	0
Patients should be advised not to breast-feed an infant if they are taking TIKOSYN.	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP associated vasospastic phenomena may also cause muscle pains, numbness, coldness, pallor, and cyanosis of the digits."	0
"ZOCOR therapy should also be temporarily withheld in any patient experiencing an acute or serious condition predisposing to the development of renal failure secondary to rhabdomyolysis, e.g., sepsis; hypotension; major surgery; trauma; severe metabolic, endocrine, or electrolyte disorders; or uncontrolled epilepsy."	0
"Fingolimod is extensively distributed to body tissueswith a volume of distribution of about 1200<U+00B1>260 L. Metabolism The biotransformation of fingolimod in humans occurs by 3 main pathways: by reversible stereoselective phosphorylation to the pharmacologically active (S)-enantiomer of fingolimod-phosphate, by oxidative biotransformation catalyzed mainly by the cytochrome P450 4F2 (CYP4F2) and possibly other CYP4F isoenzymes with subsequent fatty acid-like degradation to inactive metabolites, and by formation of pharmacologically inactive non-polar ceramide analogs of fingolimod."	0
Before you prepare EMEND: Do not open the pouch of EMEND until ready to prepare the medicine.	0
Patients receiving sertraline hydrochloride experienced a mean reduction of approximately 4 points on the YBOCS total score which was significantly greater than the mean reduction of 2 points in placebo-treated patients.	0
Elderly patients may be at greater risk of developing hyponatremia with SSRIs and SNRIs.	0
"Swallow CYMBALTA whole; do not crush or chew, do not open capsule."	0
Urinary excretion is in the form of metabolites.	0
Tricyclic Antidepressants (TCAs): Coadministration significantly increased plasma TCA levels.	1
Dose reduction decreases potassium levels.	0
"The Perpetrator and Dabigatran Etexilate Dose and Dosing Frequency are given as well as the Time of Perpetrator Dosing in Relation to Dabigatran Etexilate Dose (Time Difference) Figure 3.1 Figure 3.2 In RE-LY, dabigatran plasma samples were also collected."	0
The initial dosage of CARDURA is 1 mg given once daily.	0
Discontinue PRADAXA in patients with active pathological bleeding.	0
"As with all antidepressants, several weeks on treatment may be required to obtain a full antidepressant response."	0
Patients should be periodically reassessed to determine the need for maintenance treatment.	0
The antihypertensive effects of thiazides may be enhanced in the postsympathectomy patient.	0
Symptoms such as these may be associated with an increased risk for suicidal thinking and behavior and indicate a need for very close monitoring and possibly changes in the medication.	0
"Avoid use with strong inducers of CYP3A (e.g., rifampin, phenytoin, carbamazepine and phenobarbital) [see Clinical Pharmacology (12.3) ]."	0
Volume and/or salt depletion should be corrected before initiating therapy with ATACAND.	0
"Steady state Cmax and AUC of eplerenone were increased by 3.6% and 42%, respectively."	0
Risk appears to be related to the presence of orthostatic decrease in blood pressure.	0
HIV integrase inhibitor: Raltegravira LEXIVA: <U+2193>Amprenavir <U+2193>Raltegravir LEXIVA/ritonavir: <U+2193>Amprenavir <U+2193>Raltegravir Appropriate doses of the combination with respect to safety and efficacy have not been established.	0
"Similarly, the Cmax and AUC of the pharmacologically active isomer [S-(+)-ibuprofen] were increased by 15% and 82%, respectively, when fluconazole was coadministered with racemic ibuprofen (400 mg) compared to administration of racemic ibuprofen alone."	1
"A slight trend toward declining 24 hour plasma levels was seen after day 4 in the study, however, the 24 hour plasma levels were quite variable."	0
Permanently discontinue ONIVYDE in patients who experience a severe hypersensitivity reaction.	0
This increase was observed at the first test point which was the second day after starting mexiletine.	0
Urinary recovery is reported to be 58<U+2013>85% of the administered dose.	0
The use of PEXEVA<U+00AE> within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated.	0
<U+2264>0.12Penicillin-resistant strains of staphylococci produce <U+03B2>-lactamase.	0
"Hepatomas were increased in female (C3Hf/DP) mice dosed for 60 weeks with rifampicin followed by an observation period of 46 weeks, at 20 to 120 mg/kg (equivalent to 0.1 to 0.5 times the maximum dosage used clinically, based on body surface area comparisons)."	0
"Since treprostinil inhibits platelet aggregation , there may be an increased risk of bleeding , particularly among patients receiving anticoagulants ."	0
In vitro testing for Mycobacterium tuberculosis isolates: Two standardized in vitro susceptibility methods are available for testing rifampin against M tuberculosis organisms.	0
"On the basis of mass balance studies, at least 92% of a single oral dose of venlafaxine is absorbed."	0
"Absorption of lovastatin, estimated relative to an intravenous reference dose, in each of four animal species tested, averaged about 30% of an oral dose."	0
"The changes induced by potassium citrate extended-release tablets produce urine that is less conducive to the crystallization of stone-forming salts (calcium oxalate, calcium phosphate and uric acid)."	0
"The effects, if any, on the pituitary-gonadal axis in premenopausal women are unknown."	0
"However, there is substantial evidence from placebo-controlled maintenance trials in adults with depression that the use of antidepressants can delay the recurrence of depression."	0
Eight other patients had pulmonary edema and/or severe hypotension; abnormally high (greater than 20 mm Hg) pulmonary wedge pressure and a marked left ventricular outflow obstruction were present in most of these patients.	0
"In children, initial dosage may be based on 15 mg/kg/day."	0
"This suggests that fluvoxamine is metabolized, at least in part, by CYP2D6."	0
"If a CYP3A4 or CYP2B6 inducer is discontinued, consider Meperidine Hydrochloride Injection dosage reduction and monitor for signs of respiratory depression."	0
"To learn about the specific REMS requirements and to enroll in the CAPRELSA REMS Program, call 1-800-236-9933 or visit www.caprelsarems.com."	0
A single oral dose of carvedilol 25mg did not alter the pharmacokinetics of a single oral dose of hydrochlorothiazide 25mg in 12subjects with hypertension.	0
No initial dosage adjustments are considered necessary when these drugs are coadministered; any subsequent adjustments should be guided by clinical effect.	0
No reflex tachycardia is associated with the chronic antihypertensive effects.	0
"However, if concomitant use is clinically necessary, initiate Zanaflex with a single 2 mg dose and increase in 2<U+2013>4 mg steps daily based on patient response to therapy."	0
Fingolimod-phosphate is not expected to have clinically significant induction effects on these enzymes at therapeutic dose of fingolimod.	0
Placebo (Percent Change from Baseline <U+2014> Average Values Between Weeks12 and48) DOSAGE NPatients enrolled TOTAL-C(mean) LDL-C(mean) HDL-C(mean) LDL-C/HDL-C (mean) TOTAL-C/HDL-C(mean) TG.	0
"Following oral administration of 10 mg of apixaban as 2 crushed 5 mg tablets mixed with 30 g of applesauce, the Cmax and AUC were 20% and 16% lower, respectively, when compared to administration of 2 intact 5 mg tablets."	0
Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.	0
"In those patients who discontinued protease inhibitor therapy, hyperglycemia persisted in some cases."	0
Do not initiate sotalol therapy if the baseline QTc is longer than 450 ms.	0
It is recommended that the standard loading dose regimens be used but that the maintenance dose be halved in patients with mild to moderate hepatic cirrhosis (Child-Pugh Class A and B).	0
Dose adjustment of warfarin may be necessary.	0
"Some botanicals may cause bleeding events when taken alone (e.g., garlic and Ginkgo biloba) and may have anticoagulant, antiplatelet, and/or fibrinolytic properties."	0
Paroxetine does not alter the in vitro protein binding of phenytoin or warfarin.	0
"The principal drugs given (number of patients in parentheses) were: cardiac glycosides (115), sedatives and hypnotics (103), coronary vasodilators (52), oral hypoglycemics (45), cough and cold preparations (45), NSAIDs (38), antihyperlipidemics (29), antigout drugs (24), oral contraceptives (18), bronchodilators (13), insulin (10), and beta blockers (10)."	0
"On the basis of present evidence, phentolamine is recommended."	0
Screen for the presence of prostate cancer prior to treatment for BPH and at regular intervals afterwards.	0
"These laboratory abnormalities have rarely been associated with clinical symptoms; however, cholestasis with or without jaundice has been reported."	0
Study 3 involved depressed outpatients who had responded by the end of an initial 8-week open treatment phase on sertraline hydrochloride 50 to 200 mg/day.	0
Hypokalemia and hypomagnesemia can provoke ventricular arrhythmias or sensitize or exaggerate the response of the heart to the toxic effects of digitalis.	0
Approximately 50% of the administered dose is excreted in the urine and 30% in the feces.	0
"Begin treatment at 30mg for one week, to allow patients to adjust to the medication before increasing to 60mg once daily."	0
"3.Because ORAP prolongs the QT interval of the electrocardiogram it is contraindicated in patients with congenital long QT syndrome, patients with a history of cardiac arrhythmias, patients taking other drugs which prolong the QT interval of the electrocardiogram or patients with known hypokalemia or hypomagnesemia."	0
"<U+2022>When administered in combination with ritonavir, LEXIVA tablets may be used for pediatric patients weighing at least 39kg; ritonavir capsules may be used for pediatric patients weighing at least 33kg."	0
"To make 100mL of solution with final concentration of: Directions: 3,000ng/mL Dissolve contents of one 0.5<U+2011>mg vial with 5mL of sterile diluent."	0
Initiation of XARELTO is not recommended acutely as an alternative to unfractionated heparin in patients with pulmonary embolism who present with hemodynamic instability or who may receive thrombolysis or pulmonary embolectomy .	0
"Monitor ECG weekly, and more frequently for clinically unstable patients."	0
Atherosclerosis is a chronic process and the discontinuation of lipid-lowering drugs during pregnancy should have little impact on the outcome of long-term therapy of primary hypercholesterolemia.	0
"When renal function is taken into account, quinidine clearance is apparently independent of patient age."	0
The exact mechanism of the antihypertensive effect of hydrochlorothiazide is not known.	0
For adverse reactions The 300 mg daily dose can be reduced to 200 mg (two 100 mg tablets) and then to 100 mg for Common Terminology Criteria for Adverse Events (CTCAE) Grade 3 or greater toxicities.	0
"<U+2022> Chronic kidney disease has been reported during postmarketing surveillance in HIV-infected patients treated with atazanavir, with or without ritonavir."	0
"Corticosteroids, ACTH- intensified electrolyte depletion, particularly hypokalemia."	0
"PROCARDIA, like other calcium channel blockers, decreases platelet aggregation in vitro."	0
The risk of skeletal muscle effects may be enhanced when pravastatin is used in combination with niacin; a reduction in pravastatin sodium dosage should be considered in this setting.	1
Shown are the Geometric Mean Ratios (Ratio) and 90% Confidence Interval (90% CI).	0
"Do not administer TARKA within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor."	0
DO NOT SUBSTITUTEONIVYDE forotherdrugs containing irinotecan HCl.	0
Protracted severe hypotension and difficulty in restoring and maintaining normal cardiac rhythm after anesthesia have been reported in patients receiving beta-blockers.	0
"Initial phase (2 Months): 600 mg twice weekly for two months as directly observed therapy (DOT), with no less than 72 hours between doses, in combination with other anti- tuberculosis drugs."	0
Nardil is not approved for use in pediatric patients.	0
It is generally believed (though not established in controlled trials) that treating such an episode with an antidepressant alone may increase the likelihood of precipitation of a mixed/manic episode in patients at risk for bipolar disorder.	0
"Co-administration of SAMSCA with 400mg ketoconazole daily or with other strong CYP 3A inhibitors (e.g., clarithromycin, itraconazole, telithromycin, saquinavir, nelfinavir, ritonavir and nefazodone) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure."	1
"Telmisartan Following oral administration, peak concentrations (Cmax) of telmisartan are reached in 0.5 to 1 hour after dosing."	0
"Further, if guanfacine is to be discontinued in such patients, careful tapering of the dosage may be necessary in order to avoid rebound phenomena (see Rebound above)."	0
"In vitro studies also suggest that nilotinib may induce CYP2B6, CYP2C8 and CYP2C9, and decrease the concentrations of drugs which are eliminated by these enzymes."	0
"Progressive Multifocal Leukoencephalopathy Cases of JC virus-associated infection resulting in progressive multifocal leukoencephalopathy (PML), sometimes fatal, have been reported in patients treated with immunosuppressants, including Imuran."	0
"This increase is due to reduction in serum uric acid levels, resulting in mobilization of urate from tissue deposits."	0
Diffusion of the smaller icodextrin metabolites from plasma into the peritoneal cavity is also possible after systemic absorption and metabolism of icodextrin.	0
These patients presented with abdominal pain (with or without nausea or vomiting); in some cases there was no prior history of facial angioedema and C-1 esterase levels were normal.	0
"In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers."	0
"The use of THIOLA<U+00AE> during pregnancy is contraindicated, except in those with severe cystinuria where the anticipated benefit of inhibited stone formation clearly outweighs possible hazards of treatment."	0
Quetiapine's antagonism of adrenergic <U+03B1>1 receptors may explain the orthostatic hypotension observed with this drug.	0
The total Silenor dose should not exceed 6 mg per day.	0
"In the newborn period, renal clearance of digoxin is diminished and suitable dosage adjustments must be made as shown in Tables 1 and 2."	0
"Bleeding events related to SSRIs and SNRIs use have ranged from ecchymoses, hematomas, epistaxis, and petechiae to life-threatening hemorrhages."	0
Aliskiren: Do not co-administer aliskiren with MICARDIS in patients with diabetes.	0
"In clinical trials, more patients treated with Savella developed elevated transaminases than did placebo treated patients."	0
"Anyone considering the use of NORPRAMIN or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need."	0
No patients developed persistent liver function abnormalities following the initial 6months of treatment at a given dose.	0
"Toxic neurological effects and malignant hyperpyrexia can occur, sometimes with fatal results."	0
"New onset diabetes mellitus, exacerbation of pre-existing diabetes mellitus and hyperglycemia have been reported during post-marketing surveillance in HIV-1 infected patients receiving protease inhibitor therapy."	0
CARDIZEM CD reduces the renal and peripheral effects of angiotensin II.	0
Figure 5 Write the expiration date of the constituted oral suspension on the bottle label (the expiration date of the constituted oral suspension is 60 days from the date of constitution).	0
Treatment and Reduction in the Risk of Recurrence of Deep Venous Thrombosis and Pulmonary Embolism Avoid use of PRADAXA and concomitant P-gp inhibitors in patients with CrCl <50 mL/min.	0
Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate.	0
Doses above 30 mg/day in pediatrics and 40 mg/day in adults have not been studied and are not recommended.	0
Drug interaction studies of ACCUPRIL with other agents showed: Multiple dose therapy with propranolol or cimetidine has no effect on the pharmacokinetics of single doses of ACCUPRIL.	0
Embryo-Fetal toxicity: Tasigna can cause fetal harm.	0
There are other antiretroviral drugs which do not result in clinically relevant interactions withrabeprazole.	0
"Add an additional 15 mL more of beverage to the drinking cup, mix, and have the child drink the residual mixture."	0
HIV protease inhibitors: Lopinavir/ritonavira <U+2193>Amprenavir <U+2193>Lopinavir An increased rate of adverse events has been observed.	0
"In considering the use of ALTACE, note that in controlled clinical trials ACE inhibitors cause a higher rate of angioedema in Black patients than in non-Black patients."	0
The average volume of distribution is 53 to 93 liters.	0
Do not administer Dobutamine Hydrochloride in 5 %   Dextrose Injection simultaneously with solutions containing sodium bicarbonate or strong alkaline solutions .	0
"Other drugs that are substrates of CYP3A: Fentanyl Alfentanil <U+2191> Fentanyl<U+2191> Alfentanil Coadministration with these drugs may accentuate the side effects reported with use of fentanyl or alfentanil including respiratory depression, apnea and bradycardia."	0
Digoxin toxicity is also more likely in the presence of hypomagnesemia.	0
Hepatic Impairment <U+2014> Avoid use in patients with chronic liver disease or cirrhosis.	0
"The patient should be monitored for symptoms of serotonin syndrome for two weeks or until 24 hours after the last dose of linezolid or intravenous methylene blue, whichever comes first."	0
"However, in a one-year clinical trial, 25-hydroxyvitamin D (normal range 10 to 55 ng/mL) fell from 39 <U+00B1> 22 ng/mL to 34 <U+00B1> 22 ng/mL (p<0.01) with sevelamer hydrochloride treatment."	1
"For both patients with severe renal impairment and healthy volunteers, the mean percentage of protein-unbound pitavastatin was approximately 0.6%."	0
"Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function."	0
"In the L5178Y TK+/- mouse lymphoma assay, dopamine HCl at the highest concentrations used of 750 <U+03BC>g/mL without metabolic activation, and 3000<U+03BC>g/mL with activation, was toxic and associated with increases in mutant frequencies when compared to untreated and solvent controls; at the lower concentrations no increases over controls were noted."	0
"Body Weight The population pharmacokinetic (PK) analyses carried out to determine the effects of demographics and clinical variables on PK parameters showed that clearance of nesiritide is proportional to body weight, supporting the administration of weight-adjusted dosing of nesiritide (i.e., administration on a mcg/kg/min basis)."	0
"APPRAISE-2, a placebo-controlled clinical trial of apixaban in high-risk, post-acute coronary syndrome patients treated with aspirin or the combination of aspirin and clopidogrel, was terminated early due to a higher rate of bleeding with apixaban compared to placebo."	0
"Patients should be advised that taking nortriptyline hydrochloride can cause mild pupillary dilation, which in susceptible individuals, can lead to an episode of angle-closure glaucoma."	0
More than 90% of the recovered radioactivity is excreted within the first 72 hours of collection.	0
Prothrombin times should be closely monitored in patient already receiving coumarin anticoagulants who are started on bicalutamide.	0
Fluconazole has the potential to increase the systemic exposure of the calcium channel antagonists.	1
"In an interaction study in healthy subjects in which a single 3 mg dose of INVEGA<U+00AE> was administered concomitantly with 20 mg per day of paroxetine (a potent CYP2D6 inhibitor), paliperidone exposures were on average 16% (90% CI: 4, 30) higher in CYP2D6 extensive metabolizers."	1
Beta1-selectivity of bisoprolol fumarate has been demonstrated in both animal and human studies.	0
"In man, absorption of an oral dose is rapid and consistent but incomplete."	0
Nelfinavir: Avoid concomitant use with ACIPHEX delayed-release tablets.	0
Less than 2% of a dose of atorvastatin is recovered in urine following oral administration.	0
"Renal function should be monitored periodically in patients receiving ACEON,."	0
"If REYATAZ is administered without ritonavir, the oral contraceptive should contain no more than 30 mcg of ethinyl estradiol."	0
Plasma LIPITOR concentrations are lower (approximately 30% for Cmax and AUC) following evening drug administration compared with morning.	0
"The peak plasma levels following once-daily administration of TOPROL-XL average one-fourth to one-half the peak plasma levels obtained following a corresponding dose of conventional metoprolol, administered once daily or in divided doses."	0
HFrEF Post-MI: Initiate treatment with 25 mg once daily.	0
"In ESPS2, the incidence of gastrointestinal bleeding was 4.1% in the AGGRENOX group, 2.2% in the extended-release dipyridamole group, 3.2% in the aspirin group, and 2.1% in the placebo groups."	0
"Coronary dilatation induced by nicardipine improves perfusion and aerobic metabolism in areas with chronic ischemia, resulting in reduced lactate production and augmented oxygen consumption."	0
"The drug also prevents or abolishes bradycardia or asystole produced by injection of choline esters, anticholinesterase agents or other parasympathomimetic drugs, and cardiac arrest produced by stimulation of the vagus."	0
Monitor blood pressure when co-administering blood pressure lowering drugs with REVATIO.	0
A safe and effective dose has not been established when used with INVIRASE/ritonavir.	0
"Drugs that slow heart rate : Concomitant use of drugs with depressant effects on the sinus and AV node ( e.g. , digoxin , beta blockers , verapamil , diltiazem , ivabradine , clonidine ) can potentiate the electrophysiologic and hemodynamic effects of amiodarone , resulting in bradycardia , sinus arrest , and AV block ."	0
"Promptly evaluate any signs or symptoms of blood loss if patients are treated concomitantly with aspirin, other platelet aggregation inhibitors, or NSAIDs [see Warnings and Precautions (5.2)]."	0
Consider reducing the amount of immunosuppression in patients who develop PML.	0
"Families and caregivers of patients being treated with antidepressants for major depressive disorder or other indications, both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to healthcare providers."	0
"Initiate with lower doses and monitor patients for signs and symptoms of serotonin syndrome, particularly during DESOXYN initiation or dosage increase."	0
"Although similar effects were not seen in rabbits, the compound was not evaluated in rabbits at doses above 25mg/kg/day or 12.5 times the maximum recommended human antihypertensive dose."	0
"It has been reported that verapamil decreases neuromuscular transmission in patients with Duchenne's muscular dystrophy, prolongs recovery from the neuromuscular blocking agent vecuronium, and causes a worsening of myasthenia gravis."	0
"In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers."	0
In most patients no benefit has been associated with using two RAS inhibitors concomitantly.	0
The effective half-life of benazeprilat following once daily repeat oral administration of benazepril hydrochloride is 10 to 11 hours.	0
"At steady state, peak plasma concentration of hydroxybupropion occurred approximately 7 hours after administration of WELLBUTRIN XL, and it was approximately 7 times the peak level of the parent drug."	0
Symptoms of gastrointestinal toxicity most often develop within the first several weeks of therapy with IMURAN and are reversible upon discontinuation of the drug.	0
"Drugs That Interfere With Hemostasis (Non-selective NSAIDs, Aspirin, Warfarin, etc."	0
"As with other drugs that block angiotensinII or its effects, concomitant use of potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride), potassium supplements, or salt substitutes containing potassium may lead to increases in serum potassium."	0
The pharmacokinetics after candesartan cilexetil administration have not been investigated in patients with severe hepatic impairment.	0
Central nervous system adverse reactions become apparent with increasing venous plasma levels above 6.0 <U+03BC>g free base per mL.	0
Resistant or intolerant Ph+ CML-CP and CML-AP: 400 mg orally twicedaily.	0
"In a relative bioavailability study comparing the pharmacokinetics of 100 mg sertraline as the oral solution to a 100 mg sertraline tablet in 16 healthy adults, the solution to tablet ratio of geometric mean AUC and Cmax values were 114.8% and 120.6%, respectively."	0
"If concomitant treatment with sumatriptan and an SSRI (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) is clinically warranted, appropriate observation of the patient is advised."	0
Site-directed mutagenesis of the S282T substitution in replicons of 8 genotypes conferred 2- to 18-fold reduced susceptibility to sofosbuvir.	0
"In some of these cases, Anafranil had been administered with other epileptogenic agents; in others, the patients involved had possibly predisposing medical conditions."	0
Adults The activity of LATUDA is primarily due to the parent drug.	0
"Cases of myopathy, including rhabdomyolysis, have been observed with simvastatin coadministered with lipid-modifying doses (<U+2265>1g/day niacin) of niacin-containing products."	0
"Following intravenous administration, peak plasma levels are reached within 5 minutes."	0
"Race Evaluation of steady-state plasma tipranavir trough concentrations at 10-14 h after dosing from the controlled clinical trials 1182.12 and 1182.48 demonstrated that white males generally had more variability in tipranavir concentrations than black males, but the median concentration and the range making up the majority of the data are comparable between the races."	0
"Delayed or late toxicities include hepatic fibrosis, hyperbilirubinemia, alopecia, pulmonary fibrosis, oligospermia and secondary malignancies."	0
"In most cases, elevated serum potassium levels were isolated values which resolved despite continued therapy."	0
Decreased appetite and weight loss have been observed in association with the use of SSRIs.	0
"At the end of the study, the mean blood pressures were 143/76mmHg for the group treated with losartan potassium tablets and 146/77mmHg for the group treated with placebo."	0
RIFADIN is not to be used for the treatment of meningococcal disease.	0
The effect of losartan is substantially present within one week but in some studies the maximal effect occurred in 3-6weeks.	0
Metabolism and Elimination: Ziprasidone is extensively metabolized after oral administration with only a small amount excreted in the urine (<1%) or feces (<4%) as unchanged drug.	0
Exposure to dabigatran increases with severity of renal function impairment (Table 8).	0
"Inducers of CYP2C9, 1A2, and/or 3A4 have the potential to decrease the effect (decrease INR) of warfarin by decreasing the exposure of warfarin."	0
The recommended initial dosage of ACCUPRIL in patients not on diuretics is 10 or 20 mg once daily.	0
"Perhaps because of competition of the P450IIIA4 metabolic pathway, quinidine levels rise when ketaconazole is coadministered."	1
Previous exposure to a glycoprotein (GP) IIb/IIIa receptor antagonist may increase the risk of developing thrombocytopenia.	0
"Fluconazole was administered orally to pregnant rabbits during organogenesis in two studies at doses of 5, 10, and 20 mg/kg and at 5, 25, and 75 mg/kg, respectively."	0
BYSTOLIC may be administered without regard to meals.	0
"Accumulation and Slow Elimination <U+2014> The relatively slow elimination of fluoxetine (elimination half-life of 1to 3days after acute administration and 4to 6days after chronic administration) and its active metabolite, norfluoxetine (elimination half-life of 4to 16days after acute and chronic administration), leads to significant accumulation of these active species in chronic use and delayed attainment of steady state, even when a fixed dose is used."	0
"The impact on the PR interval of co-administration of ritonavir with other drugs that prolong the PR interval (including calcium channel blockers, beta-adrenergic blockers, digoxin and atazanavir) has not been evaluated."	0
"Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed."	0
This is consistent with a lack of effect of dofetilide on the PR interval and QRS width in patients with pre-existing heart block and/or sick sinus syndrome.	0
"If patients do not convert to normal sinus rhythm within 24 hours of initiation of TIKOSYN therapy, electrical conversion should be considered."	0
"Following administration of INVEGA<U+00AE>, the (+) and (-) enantiomers of paliperidone interconvert, reaching an AUC (+) to (-) ratio of approximately 1.6 at steady state."	0
"In 1 study, daily dosing of paroxetine 20 mg in patients stabilized on risperidone (4 to 8 mg/day) increased mean plasma concentrations of risperidone approximately 4-fold, decreased 9-hydroxyrisperidone concentrations approximately 10%, and increased concentrations of the active moiety (the sum of risperidone plus 9-hydroxyrisperidone) approximately 1.4-fold."	1
Amlodipine is a peripheral arterial vasodilator that acts directly on vascular smooth muscle to cause a reduction in peripheral vascular resistance and reduction in blood pressure.	0
See text below for discussion of interaction.	0
The recommended starting dose of COREG is 6.25mg twice daily.	0
"In more than half of the reported cases, treatment with protease inhibitors was continued or reintroduced if treatment had been discontinued."	0
"Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure , reduce myocardial contractility , or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC s effects on blood pressure , contractility , and impulse propagation ."	0
"There are no adequate, well-controlled studies in pregnant women."	0
There is also an AT2 receptor found in many tissues but it is not known to be associated with cardiovascular homeostasis.	0
"The mechanism of action of asenapine, in schizophrenia and bipolar I disorder, is unknown."	0
"When pregnancy is detected, discontinue TWYNSTA as soon as possible."	0
Metabolism Levomilnacipran undergoes desethylation to form desethyl levomilnacipran and hydroxylation to form p-hydroxy-levomilnacipran.	0
"In patients with permanent atrial fibrillation, MULTAQ doubles the risk of death, stroke and hospitalization for heart failure."	0
"There was considerable variation in risk of suicidality among drugs, but a tendency toward an increase in the younger patients for almost all drugs studied."	0
"The mean half-lives for hydroxybupropion and threo/erythrohydrobupropion were increased 5- and 2-fold, respectively, in patients with severe hepatic cirrhosis compared to healthy volunteers."	0
The degree of ACE inhibition achieved by a given dose appears to diminish over time (the ID50 increases).	0
Drug Interactions A summary of the effect of coadministered drugs on dabigatran exposure is shown in Figures 3.1 and 3.2.	0
Patients should be informed that nefazodone therapy has been associated with liver abnormalities ranging from asymptomatic reversible serum transaminase increases to cases of liver failure resulting in transplant and/or death.	0
"Of the 12 paroxetine-exposed infants with cardiovascular malformations, 9 had VSDs."	0
Dabigatran displays dose-proportional pharmacokinetics in healthy subjects and patients in the range of doses from 10 to 400 mg. Absorption The absolute bioavailability of dabigatran following oral administration of dabigatran etexilate is approximately 3 to 7%.	0
Antipsychotics Lurasidone Pimozide Potential for serious and/or life-threatening reactions.	0
Symptoms have not been relieved by antihistamines in these situations.	0
Terbinafine is an inhibitor of CYP450 2D6 isozyme and has an effect on metabolism of desipramine.	0
"Severe Renal Impairment <U+2014> Avoid use in patients with severe renal impairment, GFR <30 mL/min."	0
"Pressor Amines (e.g., norepinephrine)<U+2014>possible decreased response to pressor amines, but not sufficient to preclude their therapeutic use."	0
"Coadministration of inhibitors of the uptake transporter ( rifampin , cyclosporine ) or efflux transporter ( ritonavir ) may increase the systemic exposure to valsartan ."	1
"In elderly patients (greater than 70 years), ACEON should be given as a 2 mg dose once daily in the first week, followed by 4 mg once daily in the second week and 8 mg once daily for maintenance dose if tolerated."	0
"Duloxetine is an inhibitor of the CYP1A2 isoform in in vitro studies, and in two clinical studies the average (90% confidence interval) increase in theophylline AUC was 7% (1% to 15%) and 20% (13% to 27%) when co-administered with duloxetine (60 mg twice daily)."	1
Midazolam (parenteral administration) <U+2191> midazolam concentration Concomitant use of parenteral midazolam with CRIXIVAN may increase plasma concentrations of midazolam.	1
"Some opacity of the plastic, due to moisture absorption during the sterilization process, may be observed."	0
"IV administration of cardiodepressant calcium-channel antagonists ( e.g. , verapamil ) and BREVIBLOC in close proximity ( i.e. , while cardiac effects from the other are still present ) , fatal cardiac arrests have occurred in patients receiving BREVIBLOC and intravenous verapamil ."	0
"However, the extent of biotransformation of perindopril to the active metabolite, perindoprilat, is reduced approximately 43%, resulting in a reduction in the plasma ACE inhibition curve of approximately 20%, probably clinically insignificant."	0
In some patients additional factor VIII was required.	1
"Great care is required if nortriptyline is given to hyperthyroid patients or to those receiving thyroid medication, since cardiac arrhythmias may develop."	0
"When lidocaine is administered with other antiarrhythmic drugs such as amiodarone, phenytoin, procainamide, propranolol or quinidine, the cardiac effects may be additive or antagonistic and toxic effects may be additive."	0
Patients requiring prophylaxis against both M. tuberculosis and Mycobacterium avium complex may be given isoniazid and MYCOBUTIN concurrently.	0
"The concomitant use of Meperidine Hydrochloride Injection with all cytochrome P450 3A4 inhibitors may result in an increase in meperidine plasma concentrations, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression."	0
The increase in pimozide AUC and Cmax is due to the CYP2D6 inhibitory properties of paroxetine.	1
The average terminal elimination half-life of plasma sertraline is about 26 hours.	0
Activation of Mania/Hypomania: Use cautiously in patients with a history of mania (5.5).	0
Discontinue CAPRELSA in patients who experience a severe ischemic cerebrovascular event.	0
Animal reproductive studies have been inconclusive.	0
A terminal half-life of 200-400 hours may represent the slow elimination of terbinafine from tissues such as skin and adipose.	0
Ziprasidone inhibited synaptic reuptake of serotonin and norepinephrine.	0
Dosage may be increased gradually until optimum therapeutic effect is obtained or the maximum dose of 3 mg/kg/day has been reached.	0
"Measure hemoglobin prior to initiation of Letairis, at one month, and periodically thereafter."	0
"Therefore, apixaban is not expected to alter the metabolic clearance of coadministered drugs that are metabolized by these enzymes."	0
Rifampin: Coadministration of rifampin with diltiazem lowered the diltiazem plasma concentrations to undetectable levels.	1
"In the CHARM-Added program where candesartan or placebo was given in addition to ACE inhibitors, the incidence of hyperkalemia was 9.5% in patients treated with ATACAND versus 3.5% in patients treated with placebo."	0
Clinical experience with the administration of two 37.5 mg/25 mg tablets daily in divided doses (rather than as a single dose) suggests an increased risk of electrolyte imbalance and renal dysfunction.	0
"Following dermal application of radiolabeled selegiline to laboratory animals, selegiline is rapidly distributed to all body tissues."	0
"However, increased early pup mortality was seen in rats at a dose approximately five times the maximum human dose, and decreased pup weights were seen at this and lower doses, when dosing began during pregnancy and continued until weaning."	0
Intervention: Concomitant use of pimozide and ZOLOFT is contraindicated.	0
"These doses represent 10 and 3 times (rabbits), 1250 and 2564 times (rats), and 312 and 108 times (monkeys) the maximum projected human dose of 4 mg based on body-weight and body-surface-area, respectively assuming a 50 kg woman."	0
"In patients undergoing major surgery or during anesthesia with agents that produce hypotension, ACCUPRIL will block angiotensin II formation secondary to compensatory renin release."	0
Peak plasma concentrations of perindoprilat are attained 3 to 7 hours after perindopril administration.	0
"In the event of acute profound thrombocytopenia or a confirmed platelet decrease to 100,000 / mm3 , discontinue INTEGRILIN and heparin ( unfractionated or low-molecular weight ) ."	0
Cases of bowel obstruction and perforation have also been reported with sevelamer use.	0
"This interaction appears to be related both to pressor activity and to the <U+03B2>-adrenergic stimulating properties of these catecholamines, and may produce ventricular arrhythmias and hypertension."	0
"If drainage cannot be established, contact your clinician."	0
"If a patient is hospitalized or is prescribed a new medication for any condition, the patient must inform the health care provider of ongoing TIKOSYN therapy."	0
"As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals."	0
"Lidocaine crosses the blood-brain and placental barriers, presumably by passive diffusion."	0
"If the patient becomes pregnant while taking this drug, ZOCOR should be discontinued immediately and the patient should be apprised of the potential hazard to the fetus."	0
Patients with severe hepatic impairment (Child-Pugh class C) have not been studied.	0
"Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus and the concomitant use of agents such as potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes."	0
"Occasionally, the pharmacologic action of verapamil may produce a decrease in blood pressure below normal levels which may result in dizziness or symptomatic hypotension."	0
Treatment with NORVIR therapy alone or in combination with saquinavir has resulted in substantial increases in the concentration of total cholesterol and triglycerides.	0
In vitro studies using human liver subcellular fractions indicate that S-methyldihydroziprasidone is generated in two steps.	0
Other antihypertensive drugs - additive effect or potentiation.	0
"Literature suggests that concomitant use of PPIs with methotrexate (primarily at high dose; see methotrexate prescribing information) may elevate and prolong serum levels of methotrexate and/or its metabolite, possibly leading to methotrexate toxicities."	1
Withdraw the entire contents of the reconstituted NATRECOR<U+00AE> vial and add to the 250 mL plastic IV bag.	0
Avoid concomitant use of XARELTO with drugs that are known combined P-gp and strong CYP3A4 inducers see Drug Interactions ( 7.3 ) .	0
Patient should be hospitalized in a facility that can provide cardiac resuscitation and continuous electrocardiographic monitoring.	0
"Torsades de pointes, ventricular tachycardia and sudden deaths have occurred in patients treated with CAPRELSA."	0
In the clinical trial no greater efficacy was achieved with the use of higher doses.	0
"Obtain an ECG and serum potassium, calcium, magnesium and TSH at baseline, 2<U+2013>4 weeks and 8<U+2013>12 weeks after starting treatment with CAPRELSA, and every 3 months thereafter."	0
"Hydrochlorothiazide had no adverse effects on the fertility of mice and rats of either sex in studies wherein these species were exposed, via their diet, to doses of up to 100 and 4 mg/kg/day, respectively, prior to mating and throughout gestation."	0
"Healthy subjects, patients with stable atherosclerosis, and patients undergoing PCI show similar pharmacokinetics."	0
"Following oral or intravenous administration of 14C-labeled irbesartan, more than 80% of the circulating plasma radioactivity is attributable to unchanged irbesartan."	0
"In high-dose methotrexate administration, a temporary withdrawal of the PPI may be considered in some patients."	0
These reactions have also been reported in patients who have recently discontinued these drugs and have been started on an MAOI.	0
Insulin and Oral Hypoglycemic Medications Requirements may be altered Adrenergic Neuron Blocking Drugs phendimetrazine tartrate may decrease the hypotensive effect of adrenergic neuron blocking drugs.	0
"These changes appeared soon after initiation of therapy with simvastatin, were often transient, were not accompanied by any symptoms and did not require interruption of treatment."	0
"It is recommended that liver function tests be performed before the initiation of treatment, and thereafter when clinically indicated."	0
"Prior to initiating treatment, screen patients for risk factors for developing a manic episode (e.g., comorbid or history of depressive symptoms or a family history of suicide, bipolar disorder, and depression)."	0
"In the presence of seizures, the drug should be discontinued."	0
"Because patients with a recent history of myocardial infarction or unstable heart disease were excluded from clinical trials, such patients should be treated with caution."	0
Administer NATRECOR<U+00AE> only in settings where blood pressure can be monitored closely and hypotension aggressively treated.	0
Antimycobacterial: Rifabutin <U+2194> Saquinavir<U+2191> Rifabutin<U+2194> Ritonavir No dose adjustment of INVIRASE/ritonavir (1000/100 mg bid) is required if INVIRASE/ritonavir is administered in combination with rifabutin.	0
"In patients with severely damaged hearts, adequate ventricular function may depend on sympathetic drive."	0
"Congenital malformations, primarily spina bifida were increased in the offspring of pregnant rats given rifampin during organogenesis at oral doses of 150 to 250 mg/kg/day (about 1 to 2 times the maximum recommended human dose based on body surface area comparisons)."	0
"Warfarin, Amiodarone, Furosemide, and Hydrochlorothiazide Co-administration of tolvaptan does not appear to alter the pharmacokinetics of warfarin, furosemide, hydrochlorothiazide, or amiodarone (or its active metabolite, desethylamiodarone) to a clinically significant degree."	0
"If cardiac failure continues despite adequate treatment, TENORETIC should be withdrawn."	0
"These metabolites are excreted in urine and feces, following biliary elimination."	0
(mean) MEVACOR 20 mg b.i.d.	0
"During the initial phase of combination antiretroviral treatment, patients whose immune systems respond may develop an inflammatory response to indolent or residual opportunistic infections (such as Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia [PCP], or tuberculosis), which may necessitate further evaluation and treatment."	0
Elimination of quetiapine is mainly via hepatic metabolism with a mean terminal half-life of about 6 hours within the proposed clinical dose range.	0
"At creatinine clearances of 30 to 80 mL/min, AUC is about double that at 100 mL/min."	0
Clinical studies of pimozide with other antidepressants demonstrate an increase in drug interaction or QTprolongation.	0
"When given according to the PRISM-PLUS regimen of 0.4 mcg/kg/min over 30 minutes followed by a 0.1 mcg/kg/min maintenance infusion, >90% inhibition of platelet aggregation is attained by the end of the 30-minute infusion."	0
"Symptomatic hypotension is possible, particularly in patients with severe aortic stenosis."	0
Asenapine enhances the inhibitory effects of paroxetine on its own metabolism by CYP2D6.	1
Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide.	0
Also avoid grapefruit products and other foods that are known to inhibit CYP3A4.	0
"Ketoconazole - Combined administration of Celexa (40 mg) and ketoconazole (200 mg) decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram."	1
Worsening heart failure observed during long-term therapy is more likely to be related to the patients<U+2019> underlying disease than to treatment with carvedilol.	0
"In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including benazepril, may result in deterioration of renal function, including possible acute renal failure."	0
"On the first and/or second night after drug discontinuance (first or second post-drug night), total time asleep, percentage of time spent sleeping, and rapidity of falling asleep frequently were significantly less than on baseline (predrug) nights."	0
"Therefore, the concurrent administration of probenecid prolongs the elimination of penicillin G and, consequently, increases the serum concentrations."	1
"Autoimmune disorders (such as Graves' disease, polymyositis, and Guillain-Barr<U+00E9> syndrome) have also been reported to occur in the setting of immune reconstitution; however, the time to onset is more variable, and can occur many months after initiation of treatment."	0
"The pooled analyses of placebo-controlled trials in children and adolescents with MDD, obsessive compulsive disorder (OCD), or other psychiatric disorders included a total of 24 short-term trials of 9 antidepressant drugs in over 4400 patients."	0
Several studies have demonstrated a moderate (approximately 10%) increase in stroke volume at rest and during exercise.	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy."	0
SURMONTIL should also not be started in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue.	0
The vasodilatory and hemodynamic effects of nitroglycerin may be enhanced by concomitant administration of aspirin.	0
"There were differences in absolute risk of suicidality across the different indications, with the highest incidence in MDD."	0
"Therefore , when DIURIL and non-steroidal anti-inflammatory agents or selective COX-2 inhibitors are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained ."	0
"Since patients may experience a possible sedative effect, dizziness, or accommodation disorder with use of clonidine, caution patients about engaging in activities such as driving a vehicle or operating appliances or machinery."	0
NORPRAMIN should also not be started in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue.	0
"Adults: For adults, it is recommended that 600 mg rifampin be administered twice daily for two days."	0
"After two weeks of this regimen, dilatrate<U+00AE>-SR was statistically indistinguishable from placebo."	0
Effects on male fertility have not been determined.	0
Do not save any unused portions for later administration.	0
Visual Disturbance: Difficulties with accommodation and blurring of vision have been reported with stimulant treatment.	0
Concomitant administration of fluconazole with astemizole may decrease the clearance of astemizole.	1
"In arriving at a diagnosis, it is important to identify cases where the clinical presentation includes both serious medical illness (e.g., pneumonia, systemic infection, etc.) and untreated or inadequately treated extrapyramidal signs and symptoms (EPS)."	0
"Ritonavir initially inhibits and later induces CYP3A , the enzyme involved in the metabolism of tadalafil ."	0
Thiazide-like diuretics have been shown to increase the urinary excretion of magnesium; this may result in hypomagnesemia.	0
Figure 2 Avoid use of PRISTIQ with other desvenlafaxine-containing products or venlafaxine products.	0
Further reductions of levodopa/carbidopa may be possible during continued selegiline therapy.	0
A major depressive episode may be the initial presentation of bipolar disorder.	0
Nicardipine has no negative effect on myocardial relaxation at therapeutic doses.	0
"However, it has been proposed that the drug's therapeutic activity in schizophrenia could be mediated through a combination of dopamine Type 2 (D2) and serotonin Type 2 (5HT2) receptor antagonism."	0
"Rash, including urticarial rash, maculopapular rash, and possible photosensitivity, has been reported in subjects receiving APTIVUS/ritonavir."	0
"In healthy volunteers who were extensive metabolizers of CYP2D6, paroxetine 20 mg daily was given in combination with 20 mg atomoxetine every 12 hours."	0
"By inhibiting NaK<U+2013>ATPase, digoxin causes increased availability of intracellular calcium in the myocardium and conduction system, with consequent increased inotropy, increased automaticity, and reduced conduction velocity; indirectly causes parasympathetic stimulation of the autonomic nervous system, with consequent effects on the sino-atrial (SA) and atrioventricular (AV) nodes; reduces catecholamine reuptake at nerve terminals, rendering blood vessels more sensitive to endogenous or exogenous catecholamines; increases baroreceptor sensitization, with consequent increased carotid sinus nerve activity and enhanced sympathetic withdrawal for any given increment in mean arterial pressure; increases (at higher concentrations) sympathetic outflow from the central nervous system (CNS) to both cardiac and peripheral sympathetic nerves; and allows (at higher concentrations) progressive efflux of intracellular potassium, with consequent increase in serum potassium levels."	0
"These events were a cause for discontinuation of therapy in 1.1% of subjects receiving COREG, compared with 0.8% of placebo subjects."	0
"Prothrombin complex concentrate (PCC), activated prothrombin complex concentrate or recombinant factor VIIa may be considered, but have not been evaluated in clinical studies."	0
"Rarely, fulminant hepatitis has been reported in patients treated with Savella."	0
Fluconazole is primarily cleared by renal excretion as unchanged drug.	0
"Calcium Channel Blockers: Because of significant inotropic and chronotropic effects in patients treated with beta-blockers and calcium channel blockers of the verapamil and diltiazem type, caution should be exercised in patients treated with these agents concomitantly."	0
"Hematologic Changes <U+2013> Although no instances of severe hematologic toxicity were seen in the premarketing experience with Anafranil, there have been postmarketing reports of leukopenia, agranulocytosis, thrombocytopenia, anemia, and pancytopenia in association with Anafraniluse."	0
"Quinidine at 648 mg bid decreased the bioavailability (AUC) of nisoldipine by 26%, but not the peak concentration."	1
The recommended starting dose of COREG is 3.125mg twice daily for 2 weeks.	0
ACE inhibitor-induced cough should be considered in the differential diagnosis of cough.	0
Beta-blockers:	0
Advancing age (50 or more years) and preexisting liver and/or renal disease appear to be contributing factors.	0
The clinical importance and the mechanisms behind these interactions are not always known.	0
"In a U.S. dose-ranging study of 400 mg at bedtime, 800 mg at bedtime and 1600 mg at bedtime, a continuous dose-response relationship for ulcer healing was demonstrated."	0
Use of PDE5 inhibitors for pulmonary arterial hypertension (PAH): <U+2022> Use of sildenafil (REVATIO) is contraindicated when used for the treatment of pulmonary arterial hypertension (PAH).	0
Use of Meperidine Hydrochloride Injection with MAO inhibitors within the last 14 days is contraindicated.	0
"Patients should be advised to be alert for signs and symptoms of liver dysfunction (jaundice, anorexia, gastrointestinal complaints, malaise, etc.) and to report them to their doctor immediately if they occur."	0
"Because PRIFTIN may have similar enzyme induction properties, avoid the use of PRIFTIN in patients with porphyria."	0
Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses.	0
Parameter Mean Standard Deviation Normal Males (n=30) Apparent Oral Clearance (L/hr) 0.320 0.103 Single Dose Peak	0
The mean sertraline hydrochloride dose for completers was 74 mg/day.	0
The unchanged drug was 96% bound to plasma proteins.	0
"1.05(0.83, 1.33) 1.04 (0.67, 1.61) 0.98 (0.56, 1.73) Table 3: Drug Interactions: Pharmacokinetic Parameters for Coadministered Drug in the Presence of Indinavir ; No Effect = 1.00 Cmax AUC Cmin All interaction studies conducted in healthy, HIV-negative adult subjects, unless otherwise indicated."	0
"If acceptable alternatives to linezolid or intravenous methylene blue treatment are not available and the potential benefits of linezolid or intravenous methylene blue treatment are judged to outweigh the risks of serotonin syndrome in a particular patient, LUVOX CR should be stopped promptly, and linezolid or intravenous methylene blue can be administered."	0
"Advise patients treated with MULTAQ to report immediately symptoms suggesting hepatic injury (such as anorexia, nausea, vomiting, fever, malaise, fatigue, right upper quadrant pain, jaundice, dark urine, or itching)."	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
"In severe behavior disorders, higher dosages (50-100 mg daily, and in older children, 200 mg daily or more) may be necessary."	0
"Consider periodic determinations of serum electrolytes to detect possible electrolyte imbalances, particularly in patients at risk."	0
Single doses of 20 mg of quinapril provide over 80% inhibition of plasma ACE for 24 hours.	0
"In intact animals it slows heart rate, decreases AV nodal conduction and increases the refractory periods of atrial and ventricular muscle and conduction tissue."	0
"The major active metabolites present in human plasma are the <U+03B2><U+2011>hydroxyacid of lovastatin, its 6<U+00B4><U+2011>hydroxy derivative, and two additional metabolites."	0
"NORVIR tablets should be swallowed whole, and not chewed, broken or crushed."	0
"Therefore, known CYP3A inducers such as rifampicin, carbamazepine, and other inducers of cytochromesP450 are not expected to have significant effect on the pharmacokinetics of the active metabolite of prasugrel."	0
"The ONTARGET trial enrolled 25,620 patients <U+2265>55 years old with atherosclerotic disease or diabetes with end-organ damage, randomized them to telmisartan only, ramipril only, or the combination, and followed them for a median of 56 months."	0
"<U+2022> Hyperbilirubinemia: Most patients experience asymptomatic increases in indirect bilirubin, which is reversible upon discontinuation."	0
Amlodipine is a peripheral arterial vasodilator that acts directly on vascular smooth muscle to cause a reduction in peripheral vascular resistance and reduction in blood pressure.	0
"The development of a potentially life-threatening serotonin syndrome has been reported with SNRIs and SSRIs, including Lexapro, alone but particularly with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John's Wort) and with drugs that impair metabolism of serotonin (in particular, MAOIs, both those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue)."	0
Dose should be adjusted in patients with severe renal impairment (2.2).	0
"Nisoldipine's low bioavailability is due, in part, to pre-systemic metabolism in the gut wall, and this metabolism decreases from the proximal to the distal parts of the intestine."	0
"When the dose is increased from 240 mg to 360 mg, there is an increase in the area under the curve of 1.6 times."	0
Stop ADCIRCA<U+00AE> at least 24 hours before starting REYATAZ (with or without ritonavir).	0
"Anaphylactic reactions, Stevens-Johnson Syndrome, angioedema, and urticaria have been observed in postmarketing reports."	0
"Levomilnacipran lacks significant affinity for any other receptors, ion channels or transporters tested in vitro, including serotonergic (5HT1-7), <U+03B1>- and <U+03B2>- adrenergic, muscarinic, or histaminergic receptors and Ca2+, Na+, K+ or Cl- channels."	0
"There was a higher incidence of significant blood pressure elevations with the co-administration of EMSAM and PPA than with PPA alone, suggesting a possible pharmacodynamic interaction."	0
"Thus, formation of the major metabolite is the rate limiting step in the biodisposition of temazepam."	0
"Therefore, if combined therapy is used, close surveillance of clinical status should be carried out."	0
"Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with methamphetamine and should counsel them in its appropriate use."	0
Inform patients about the signs and symptoms of GI side effects and what steps to take if they occur.	0
AHA is contraindicated in women who are or may become pregnant.	0
NARDIL should not be used in combination with dextromethorphan or with CNS depressants such as alcohol and certain narcotics.	0
"AUCs are approximately 80% and 35% higher, respectively."	0
Hyperkalemia: Monitor serum potassium periodically.	0
"No major deviation from dose proportionality was observed in the dose range of 250 mg to 1,000 mg."	0
Monitor prothrombin time or international normalized ratio (INR) in patients receiving oral anticoagulant therapy with warfarin.	0
Irbesartan and its metabolites are excreted by both biliary and renal routes.	0
One tablet of 400 mg twice a day with morning and evening meals (2)	0
Patients with these diagnoses were excluded from clinical studies during the product's premarket testing.	0
Antimycobacterial rifampin Rifampin is a potent inducer of CYP450 metabolism.	0
"Diltiazem is well absorbed from the gastrointestinal tract and is subject to an extensive first-pass effect, giving an absolute bioavailability (compared to intravenous administration) of about 40%."	0
<U+2022> Nephrolithiasis and cholelithiasis have been reported.	0
Some compounds known to induce or inhibit CYP3A may affect exposure to zolpidem.	0
Do not open the capsule and sprinkle its contents on food or mix with liquids.	0
"All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases."	0
"Avoid use of strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin) [see Clinical Pharmacology (12.3) ]."	0
Some drugs that inhibit CYP3A may significantly increase the plasma concentration of rifabutin.	1
REYATAZ: Use vardenafil with caution at reduced doses of no more than 2.5 mg every 24 hours with increased monitoring for adverse reactions.	1
1.Fill the mixing cup with room temperature drinking water.	0
"No evidence of drug-related external, visceral, or skeletal fetal abnormalities were observed."	0
"In some cases, diabetic ketoacidosis has occurred."	0
Increase parenteral dosage only if hypotension has not occurred.	0
Concurrent administration of propranolol (100 to 800 mg daily) has been reported to produce increases in plasma levels of thioridazine (approximately 50% to 400%) and its metabolites (approximately 80% to 300%).	1
Fluticasone use is not recommended in situations where CRIXIVAN is coadministered with a potent CYP3A4 inhibitor such as ritonavir unless the potential benefit to the patient outweighs the risk of systemic corticosteroid side effects.	0
The dose should be increased to 100mg once daily based on blood pressure response.	0
"Anticonvulsants Salicylic acid can displace protein-bound phenytoin and valproic acid, leading to a decrease in the total concentration of phenytoin and an increase in serum valproic acid levels."	0
Amlodipine is a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker) that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle.	0
"APPRAISE-2, a placebo-controlled clinical trial of apixaban in high-risk, post-acute coronary syndrome patients treated with aspirin or the combination of aspirin and clopidogrel, was terminated early due to a higher rate of bleeding with apixaban compared to placebo."	0
"Do not use the solution if particulate matter, precipitate, or crystallization is present, or if the container appears damaged."	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction with antidepressants compared to placebo in adults aged 65 and older.	0
"Consequently, estazolam should be avoided in patients receiving ketoconazole and itraconazole, which are very potent inhibitors of CYP3A."	0
O-demethylation and hydroxylation at the 3-oxopiperidinyl moiety are the major sites of biotransformation.	0
"The observed cumulative incidence of seizures among patients exposed to Anafranil at doses up to 300 mg/day was 0.64% at 90 days, 1.12% at 180 days, and 1.45% at 365 days."	0
Tricyclic antidepressants may potentiate the cardiovascular effects of adrenergic agents.	0
Plasma levels of icodextrin and metabolites return to baseline values within approximately two weeks following cessation of icodextrin administration.	0
Frequent monitoring for adverse events and toxicity related to NSAIDs is recommended.	0
Limited accumulation of irbesartan (<20%) is observed in plasma upon repeated once-daily dosing and is not clinically relevant.	0
An ECG should be repeated approximately 7 days after any dose adjustment.	0
"One of these additional studies was conducted in patients similar to those recruited for Studies 1 and 2, while the second additional study was conducted in predominantly male veterans."	0
Transporter Interaction: Iloperidone and P88 are not substrates of P-gp and iloperidone is a weak P-gp inhibitor.	0
Benzodiazepines: parenterally administered midazolamb <U+2191> midazolam Concomitant use of parenteral midazolam with REYATAZ may increase plasma concentrations of midazolam.	1
"In placebo-controlled studies, where 23% of patients receiving TARKA were 65 years and older, and 2.4% were 75 years and older, no overall differences in effectiveness or safety were observed between these patients and younger patients."	0
Clinical studies have shown that desvenlafaxine does not have a clinically relevant effect on CYP2D6 metabolism at the dose of 100 mg daily.	0
Neither quinapril nor quinaprilat were mutagenic in the Ames bacterial assay with or without metabolic activation.	0
"A 3 mg once daily dose may be appropriate for some patients, if clinically indicated."	0
Verapamil hydrochloride and trandolapril have been used individually and in combination for the treatment of hypertension.	0
"The effectiveness of paroxetine in the treatment of Generalized Anxiety Disorder (GAD) was demonstrated in two 8-week, multicenter, placebo-controlled studies (Studies 1 and 2) of adult outpatients with Generalized Anxiety Disorder (DSM-IV)."	0
"For children about 2 years or younger the above pediatric dosage should be reduced by a factor that depends heavily upon age, as shown in the following graph which shows age plotted on a logarithmic scale in months."	0
"When hypotension occurred, however, the duration of symptomatic hypotension was longer with NATRECOR<U+00AE> (mean duration was 2.2 hours) than with nitroglycerin (mean duration was 0.7 hours)."	0
"Integrase Inhibitor: raltegravir <U+2193> raltegravir The effects of ritonavir on raltegravir with ritonavir dosage regimens greater than 100 mg twice daily have not been evaluated, however raltegravir concentrations may be decreased with ritonavir coadministration."	1
It causes less increase in myocardial oxygen consumption than isoproterenol and the effect of dopamine usually is not associated with tachyarrhythmia.	0
The reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
"These include the intravenous administration of calcium chloride solution, sodium bicarbonate solution and/or the oral or parenteral administration of glucose with a rapid-acting insulin preparation."	0
<U+2022>Second-orthird-degree AV block.	0
"AFCAPS/TexCAPS enrolled 6,605 participants (5,608 men, 997 women) based on the following lipid entry criteria: total<U+2011>C range of 180-264mg/dL, LDL<U+2011>C range of 130-190mg/dL, HDL<U+2011>C of <U+2264>45mg/dL for men and <U+2264>47mg/dL for women, and TG of <U+2264>400mg/dL."	0
Monitor blood pressure and for symptoms of hypotension.	0
"The sympatholytic action of clonidine may worsen sinus node dysfunction and atrioventricular (AV) block, especially in patients taking other sympatholytic drugs."	0
"In two similarly sized US postmarketing quinapril trials that, combined, enrolled over 3,000 black patients and over 19,000 non-blacks, angioedema was reported in 0.30% and 0.55% of blacks (in Study 1 and 2, respectively) and 0.39% and 0.17% of non-blacks."	0
"The blister pack should then be peeled open with dry hands and the orally disintegrating tablet placed on the tongue, where it will dissolve and be swallowed with the saliva."	0
Thioridazine hydrochloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.	0
"Nonsteroidal Anti-Inflammatory Drugs ( NSAIDs ) including selective Cyclooxygenase-2 inhibitors ( COX-2 inhibitors ) : In patients who are elderly , volume-depleted ( including those on diuretic therapy ) , or with compromised renal function , coadministration of NSAIDs , including selective COX-2 inhibitors with agents that affect the RAAS , including aliskiren , may result in deterioration of renal function , including possible acute renal failure ."	0
Dosage may be slowly increased to a total daily dose of 20 mg given in divided doses.	0
Coadministration of methylphenidate with STRATTERA did not increase cardiovascular effects beyond those seen with methylphenidate alone.	0
A causal relationship has not been established.	0
The risk of such events may be increased when certain drugs are given together with thioridazine.	0
Patients randomized to paroxetine were significantly less likely to relapse than comparably treated patients who were randomized to placebo.	0
Adults and children 12 years and older: The recommended dose of PRIFTIN should be determined based on weight of the patient up to a maximum of 900 mg once-weekly.	0
Cumulative effects of the thiazides may develop in patients with impaired renal function.	0
Systemic exposure of abiraterone is increased when abiraterone acetate is administered with food.	1
"Metabolism Following oral administration of 14C-abiraterone acetate as capsules, abiraterone acetate is hydrolyzed to abiraterone (active metabolite)."	0
"However, monitor response carefully when combining nicardipine hydrochloride injection with a beta-blocker in the treatment of congestive heart failure patients."	0
"Treatment of gout flares: Co-administration of colchicine in patients on CRIXIVAN: 0.6 mg (1 tablet) x 1 dose, followed by 0.3 mg (half tablet) 1 hour later."	0
INTEGRILIN should be given concomitantly with heparin to achieve a target ACT of 200 to 300 seconds .	0
"In this study, there was a slight potentiation of the propranolol-induced reduction in heart rate and reduction in the exercise diastolic pressure."	0
Avoid concomitant use.	0
"If surgery cannot be delayed, there is an increased risk of bleeding."	0
Patients were randomized to receive once daily losartan potassium tablets 50mg or atenolol 50mg.	0
"Always practice safe sex by using a latex or polyurethane condom to lower the chance of sexual contact with semen, vaginal secretions, or blood."	0
Monitor renal function periodically in patients treated with Lotensin.	0
Removal of angiotensin II negative feedback on renin secretion leads to increased plasma renin activity.	0
The thiazides may decrease arterial responsiveness to norepinephrine.	0
<U+2022>Add the paste to a preparation vessel of suitable size.	0
"Risperidone acts as an antagonist at other receptors, but with lower potency."	0
"XARELTO should not be used in patients with CrCl 15 to 80 mL/min who are receiving concomitant combined P-gp and moderate CYP3A4 inhibitors ( e.g. , erythromycin ) unless the potential benefit justifies the potential risk see Warnings and Precautions ( 5.4 ) and Clinical Pharmacology ( 12.3 ) ."	0
The recommended starting dose for pediatric patients 6 years of age and older is 0.8 g to 1.6 g taken three times per day with meals based on the patient's body surface area (BSA) category; see Table 2.	0
"Published observational studies suggest that PPI therapy like ACIPHEX may be associated with an increased risk of Clostridium difficile-associated diarrhea, especially in hospitalized patients."	0
"Because many drugs are excreted in human milk, caution should be exercised when dopamine HCl is administered to a nursing mother."	0
"Management of respiratory depression may include close observation, supportive measures, and use of opioid antagonists, depending on the patient's clinical status."	0
Opioid withdrawal symptoms were reported following fluvoxamine maleate discontinuation in another patient.	0
"In patients taking clarithromycin, itraconazole, or in patients with HIV taking a combination of saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, or fosamprenavir plus ritonavir, limit therapy with atorvastatin to 20 mg, and make appropriate clinical assessment to ensure that the lowest dose necessary of atorvastatin is employed."	1
"Altered anticoagulant effects, including increased bleeding, have been reported when SSRIs or SNRIs are coadministered with warfarin."	0
Doses above 200 mg/day have not been studied.	0
There were no clinically significant increases in INR.	0
Both 5-mg and 10-mg doses of Zaleplon were superior to placebo in reducing latency to persistent sleep (LPS).	0
Serious hypersensitivity/allergic reactions following administration of NATRECOR<U+00AE> have been reported.	0
"Pancreatitis should be considered if clinical symptoms (nausea, vomiting, abdominal pain) or abnormalities in laboratory values (such as increased serum lipase or amylase values) suggestive of pancreatitis should occur."	0
"Serotonergic Drugs Based on the mechanism of action of BRINTELLIX and the potential for serotonin toxicity, serotonin syndrome may occur when BRINTELLIX is coadministered with other drugs that may affect the serotonergic neurotransmitter systems (e.g., SSRIs, SNRIs, triptans, buspirone, tramadol, and tryptophan products etc."	0
"In the rat, however, this multiple of the human dose was embryocidal and retarded fetal growth and development, probably because of adverse maternal effects reflected in reduced weight gains of the dams."	0
"The following dose adjustments are recommended for use of tadalafil (Adcirca<U+00AE>) with INVIRASE/ritonavir: Coadministration of Adcirca in patients on INVIRASE/ritonavir: In patients receiving INVIRASE/ritonavir for at least one week, start Adcirca at 20 mg once daily."	0
"Total plasma clearance (Cl) is 0.4 L/hrkg, and the apparent volume of distribution (Vd) using a non-compartment model is 8.3 L/kg."	0
Coadministration of Effient and NSAIDs (used chronically) may increase the risk of bleeding.	0
The dose of THIOLA<U+00AE> should not be arbitrary but should be based on that amount required to reduce urinary cystine concentration to below its solubility limit (generally <250 mg/liter).	0
Savella should be tapered and not abruptly discontinued after extended use.	0
Losartan metabolites have been identified in human plasma and urine.	0
"For example, 1 patient-year is equal to 2 patients each treated for 6 months, 3 patients each treated for 4 months, etc."	0
"Interaction with Combined P-gp and Strong CYP3A4 Inhibitors Avoid concomitant administration of XARELTO with known combined P-gp and strong CYP3A4 inhibitors (e.g., ketoconazole and ritonavir) [see Warnings and Precautions (5.6) and Clinical Pharmacology (12.3)]."	0
Fluoxetine can increase the level of pimozide through inhibition of CYP2D6.	1
"DIFLUCAN Powder for Oral Suspension contains sucrose and should not be used in patients with hereditary fructose, glucose/galactose malabsorption, and sucrase-isomaltase deficiency."	0
"Patients who develop complaints consistent with active tuberculosis while on prophylaxis with MYCOBUTIN should be evaluated immediately, so that those with active disease may be given an effective combination regimen of anti-tuberculosis medications."	0
The bioavailability of amlodipine from CADUET was not affected by food.	0
"In these trials, patients were carefully monitored and some interacting medicinal products were excluded."	0
Maintenance dose can be calculated as a percentage of the loading dose.	0
"In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen (BUN) have been reported."	0
"Topic: Antidepressants, Tricyclic Micromedex Inc. Vol."	0
"Tipranavir/ ritonavir 500/200 BID <U+00D7> 15 doses 150 mg single dose Healthy subjects (20) <U+2191> AUC by 190%,<U+2191> Cmax by 70% <U+2194> Reduce rifabutin dose by at least 75% (to a maximum 150 mg every other day or three times per week) when given with tipranavir/ritonavir combination."	1
Dosages over 200 mg/day are not recommended.	0
"Monitor closely plasma concentrations of cyclosporine during nicardipine hydrochloride injection administration, and adjust the dose of cyclosporine accordingly."	0
"Patients whose renal function may depend in part on the activity of the RAAS ( e.g. , patients with renal artery stenosis , severe heart failure , post-myocardial infarction or volume depletion ) or patients receiving ARB , ACEI or nonsteroidal anti-inflammatory drug ( NSAID ) , including selective Cyclooxygenase-2 inhibitors ( COX-2 inhibitors ) , therapy may be at particular risk for developing acute renal failure on Tekturna see Warnings and Precautions ( 5.2 Drug Interactions ( 7 ) , and Use in Specific Populations ( 8.7 ) and Clinical Studies ( 14.3 ) ."	0
"In those patients who discontinued protease inhibitor therapy, hyperglycemia persisted in some cases."	0
No effect of gender on the blood levels of terbinafine was detected in clinical trials.	0
Thalitone<U+00AE> (chlorthalidone USP) should be used with caution in severe renal disease.	0
Published studies have reported a range of lidocaine milk: plasma ratios between 0.4-1.1.	0
"Furthermore, some evidence suggests that pimozide is metabolized partly by the enzyme system cytochrome P450 3A4 (CYP 3A4)."	0
"Prescriptions for PRISTIQ should be written for the smallest quantity of tablets consistent with good patient management, in order to reduce the risk of overdose."	0
"<U+2022>LEXIVA 1,400mg once daily plus ritonavir 100mg once daily. oDosing of LEXIVA 1,400mg once daily plus ritonavir 100mg once daily is supported by pharmacokinetic data."	0
Plasma concentrations achieved are proportional to the oral dose administered.	0
"Renal insufficiency The disposition of desvenlafaxine after administration of 100 mg was studied in subjects with mild (n = 9), moderate (n = 8), severe (n = 7) and end-stage renal disease (ESRD) (n = 9) requiring dialysis and in healthy, age-matched control subjects (n = 8)."	0
"Since sleep disturbances may be the presenting manifestation of a physical and/or psychiatric disorder, symptomatic treatment of insomnia should be initiated only after a careful evaluation of the patient."	0
"Positive test results were obtained in the in vitro CHO sister chromatid exchange (clastogenicity) test and in the mouse lymphoma cell (mutagenicity) assays, using concentrations of hydrochlorothiazide of 43 to 1300 <U+00B5>g/mL."	0
Asymptomatic bradycardia (36 beats/min) with a wandering atrial pacemaker has been observed in a patient receiving concomitant timolol (a beta-adrenergic blocker) eyedrops and oral verapamil.	0
Focalin XR should be given cautiously to patients with a history of drug dependence or alcoholism.	0
"In addition , nephrotoxicity of nephrotoxic drugs such as cisplatin may be enhanced if LASIX is not given in lower doses and with positive fluid balance when used to achieve forced diuresis during cisplatin treatment ."	0
"Vasoconstrictive and positive inotropic agents : Because of the risk of reducing cardiac contractility in presence of high systemic vascular resistance , do not use BREVIBLOC to control tachycardia in patients receiving drugs that are vasoconstrictive and have positive inotropic effects , such as epinephrine , norepinephrine , and dopamine ."	0
Administration of nicardipine to normotensive volunteers at dosages of 0.25 to 3 mg/hr for eight hours produced changes of less than 5 mmHg in systolic blood pressure and less than 3 mmHg in diastolic blood pressure.	0
"<U+2022>Discontinuation: Gradual dose reduction is recommended ( 2.7 , see Warnings and Precautions [5.10])."	0
Trandolapril is an effective antihypertensive in all races studied.	0
The use of REYATAZ in treatment-experienced adult patients without ritonavir is not recommended.	0
There are no adequate and well controlled studies in pregnant women.	0
"Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate."	0
"In most cases, these effects appear to be reversible upon drug discontinuation and with appropriate medical treatment."	0
"Decreases in hemoglobin have been observed within the first few weeks; measure hemoglobin at initiation, at 1 month, and periodically thereafter (5.6)."	0
"ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II."	0
"No treatment-related external, visceral, or skeletal changes were observed in rabbits or dogs."	0
"Impact of other drugs on amlodipine Co-administered cimetidine, magnesium-and aluminum hydroxide antacids, sildenafil, and grapefruit juice have no impact on the exposure to amlodipine."	0
Use an alternative combination where possible in patients with known or suspected integrase inhibitor resistance.	0
"Such reactions may occur several months after therapy is started, but laboratory abnormalities may continue to worsen for several weeks after drug is stopped."	0
"<U+2022> Hyponatremia: May occur with SSRIs and SNRIs, including LUVOX CR Capsules."	0
"No overall differences in effectiveness or safety were observed between these patients and younger patients, but greater sensitivity of some older individuals cannot be ruled out."	0
"Following a single oral dose of TARKA in healthy subjects, peak plasma concentrations are reached within 0.5-2 hours for trandolapril and within 4-15 hours for verapamil."	0
"In addition, in patients with severe hepatic cirrhosis, the bupropion Cmax and AUC were substantially increased (mean difference: by approximately 70% and 3-fold, respectively) and more variable when compared to values in healthy volunteers; the mean bupropion half-life was also longer (29 hours in patients with severe hepatic cirrhosis vs. 19 hours in healthy subjects)."	0
"Efavirenz: In a study of healthy volunteers, efavirenz 600 mg once daily for 2 weeks reduced the AUC and Cmax of bupropion by approximately 55% and 34%, respectively."	1
The median time to onset of rash in clinical studies was 7.3 weeks and the median duration of rash was 1.4 weeks.	0
Distribution: The degree of plasma protein binding for quazepam and its two major metabolites is greater than 95%.	0
Accurate phenotyping (red blood cell TPMT activity) results are not possible in patients who have received recent blood transfusions.	0
"A third (24month) rat study, employing doses of 500 and 1,500mg/kg/day (250 and 750 times the maximum recommended human antihypertensive dose) resulted in increased incidences of benign adrenal medullary tumors in males and females, mammary fibroadenomas in females, and anterior pituitary adenomas and thyroid parafollicular cell carcinomas in males."	0
Caution should be exercised in treating patients whose underlying medical conditions might be compromised by increases in blood pressure or heart rate.	0
Prolonged use of Meperidine Hydrochloride Injection during pregnancy can result in withdrawal in the neonate.	0
"Because GILENYA reduces blood lymphocyte counts via redistribution in secondary lymphoid organs, peripheral blood lymphocyte counts cannot be utilized to evaluate the lymphocyte subset status of a patient treated with GILENYA."	0
"Metabolism and Elimination Although in vitro studies suggested a role for CYP2D6 and CYP3A4 in the metabolism of paliperidone, in vivo results indicate that these isozymes play a limited role in the overall elimination of paliperidone."	0
"Blockade of the renin-angiotensin system with ACE inhibitors, which inhibit the biosynthesis of angiotensin II from angiotensin I, is a mechanism of many drugs used to treat hypertension."	0
"Tell patients that inadequate fluid intake, excessive perspiration, diarrhea, or vomiting can lead to an excessive fall in blood pressure because of reduction in fluid volume, with the same consequences of lightheadedness and possible syncope."	0
"Although there was a reproducible dose-dependent increase in the number of revertant colonies with strains TA100 and TA98, both with and without metabolic activation, the small increase was considered inconclusive evidence of mutagenicity."	0
Hypertension does not significantly alter the pharmacokinetics of nisoldipine.	0
Mean (%CV) Cmax and Cmin values for perphenazine and 7-hydroxyperphenazine at steady-state are listed below: Parameter Perphenazine 7-Hydroxyperphenazine Cmax (pg/mL) 984 (43) 509 (25) Cmin (pg/mL) 442 (76) 350 (56) Peak 7-hydroxyperphenazine concentrations were observed between 2 to 4 hours with a terminal phase half-life ranging between 9.9 to 18.8 hours.	0
"However, in clinical studies the consequences of concomitant irbesartan on the pharmacodynamics of warfarin were negligible."	0
"Participants were treated with standard care, including diet, and either MEVACOR 20-40mg daily (n=3,304) or placebo (n=3,301)."	0
These effects resulted largely from higher plasma concentrations of triazolam in the elderly.	0
A significant increase in time to termination of exercise and a significant decrease in overall angina frequency was observed.	0
Levodopa and Dopamine Agonists Risperidone may antagonize the effects of levodopa and dopamine agonists.	0
Phenotyping and genotyping methods are commercially available.	0
Gemfibrozil Other fibrates Niacin (nicotinic acid) (<U+2265>1 g/day) Cyclosporine: The risk of myopathy/rhabdomyolysis is increased by concomitant administration of cyclosporine.	0
"CYP2C9 and VKORC1 genotype information, when available, can assist in selection of the initial dose of warfarin."	0
Impaired Renal Function: Renal impairment results in increased digoxin exposure and requires dosage adjustments.	0
"In one of the studies, nicardipine capsules improved forced expiratory volume 1 second (FEV1) and forced vital capacity (FVC) in comparison with metoprolol."	0
Dose adjustment in adolescents (up to the adult maximum dose of 300 mg) may be indicated to achieve therapeutic benefit.	0
"Known hypersensitivity to any of the components of NEXTERONE , including iodine ."	0
"The initial rapid decline, which represents distribution of the drug into a large peripheral compartment and subsequent binding to both plasma and tissue ACE, has a half-life of 2<U+2013>4 hours."	0
This may occur within the recommended dosage range.	0
Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.	0
"There was no clear finding, however, of greater average benefits for the higher doses compared to the lower doses."	0
The more prolonged effect of even small multiple doses presumably reflects saturation of ACE binding sites by ramiprilat and relatively slow release from those sites.	0
A history of thrombocytopenia following prior exposure to AGGRASTAT.	0
"Patients receiving immunosuppressants, including IMURAN, are at increased risk of developing lymphoma and other malignancies, particularly of the skin."	0
"ACCUPRIL is contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril)."	0
"In a multi-center, open-label, single-arm trial, 33 patients with metastatic CRPC received ZYTIGA orally at a dose of 1,000 mg once daily at least 1 hour before or 2 hours after a meal in combination with prednisone 5 mg orally twice daily."	0
"Patients receiving azathioprine with ribavirin should have complete blood counts, including platelet counts, monitored weekly for the first month, twice monthly for the second and third months of treatment, then monthly or more frequently if dosage or other therapy changes are necessary."	0
"Antihypertensive agents clonidine, guanfacine, or moxonidine: Beta blockers also increase the risk of clonidine-, guanfacine-, or moxonidine-withdrawal rebound hypertension."	0
The remaining oxidative metabolites do not add appreciably to irbesartan's pharmacologic activity.	0
"Altered anticoagulant effects, including increased bleeding, have been reported when SSRIs and SNRIs are co-administered with warfarin."	0
Half of the celecoxib dose may be necessary when combined with fluconazole.	1
Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.	0
Concomitant use of Savella with drugs that increase blood pressure and heart rate has not been evaluated and such combinations should be used with caution.	0
"The recommended dose of MAXALT is 5 mg in patients weighing less than 40 kg (88 lb), and 10 mg in patients weighing 40 kg (88 lb) or more."	0
"In patients with severe congestive heart failure whose renal function may depend on the activity of the renin-angiotensin-aldosterone system, treatment with ACE inhibitors, including ALTACE, may be associated with oliguria or progressive azotemia and rarely with acute renal failure or death."	0
"Premenstrual Dysphoric Disorder (PMDD) <U+2013> The effectiveness of sertraline hydrochloride for the treatment of PMDD was established in two double-blind, parallel group, placebo-controlled flexible dose trials (Studies 1 and 2) conducted over 3 menstrual cycles."	0
Avoid concomitant use with other glycoprotein (GP) IIb/IIIa inhibitors.	0
No reports involved the administration of methylene blue by other routes (such as oral tablets or local tissue injection) or at lower doses.	0
Maintain the serum calcium-phosphorus (Ca <U+00D7> P) product below 55 mg 2/dL 2.	0
"Mutagenesis: Paroxetine produced no genotoxic effects in a battery of 5 in vitro and 2 in vivo assays that included the following: bacterial mutation assay, mouse lymphoma mutation assay, unscheduled DNA synthesis assay, and tests for cytogenetic aberrations in vivo in mouse bone marrow and in vitro in human lymphocytes and in a dominant lethal test in rats."	0
"Saquinavir/ ritonavir 1000/100 mg BID <U+00D7> 14 or 22 days 150 mg every 3 days <U+00D7> 21<U+2013>22 days Healthy subjects <U+2191> AUC by 53% compared to rifabutin 150 mg QD alone <U+2191> Cmax by 88%(n=11) <U+2193> AUC by 13%,<U+2193> Cmax by 15%,(n=19) Reduce rifabutin dose by at least 75% (to a maximum 150 mg every other day or three times per week) when given with saquinavir/ritonavir combination."	1
Information is not available regarding tipranavir or telaprevir exposure with concomitant use.	0
Dose adjustment of quetiapine will be necessary if it is co-administered with potent CYP3A4 inducers or inhibitors.	0
Nebivolol lacks intrinsic sympathomimetic and membrane stabilizing activity at therapeutically relevant concentrations.	0
"Do not share personal items that can have blood or body fluids on them, like toothbrushes and razor blades."	0
Results of in vitro studies demonstrate that duloxetine does not inhibit activity.	0
"In some cases therapy with SURMONTIL must be discontinued until the episode is relieved, after which therapy may be reinstituted at lower dosages if still required."	0
The possibility of suicide is inherent in any severely depressed patient and persists until a significant remission occurs.	0
"Dietary administration of nisoldipine to male and female rats for up to 24 months (mean doses up to 82 and 111 mg/kg/day, 16 and 19 times the maximum recommended human dose [MRHD] on a mg/m2 basis, respectively and female mice for up to 21 months (mean doses of up to 217 mg/kg/day, 20 times the MRHD on a mg/m2 basis) revealed no evidence of tumorigenic effect of nisoldipine."	0
There is no evidence of carcinogenicity with nefazodone.	0
Effects on electrolytes increase with single doses of amiloride HCl up to approximately 15 mg. Amiloride HCl is not metabolized by the liver but is excreted unchanged by the kidneys.	0
"The CYP2D6 metabolic pathway is not involved, and after administration of 100 mg, the pharmacokinetics of desvenlafaxine was similar in subjects with CYP2D6 poor and extensive metabolizer phenotype."	0
"In a study in normal volunteers, Lexapro 10 mg/day did not produce impairment of intellectual function or psychomotor performance."	0
"When serum creatinine is the only measure of renal function available, the following formula (based on sex, weight, and age of the patient) should be used to estimate the creatinine clearance in adults: Males: Weight (kg) <U+00D7> (140 <U+2013> age) 72 <U+00D7> serum creatinine (mg/100 mL) Females: 0.85 <U+00D7> above value Although the pharmacokinetics of fluconazole has not been studied in children with renal insufficiency, dosage reduction in children with renal insufficiency should parallel that recommended for adults."	0
The precise mechanism of action has not been clearly established.	0
"Thus, co-administration of NORVIR with drugs highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events is contraindicated."	0
Marplan should be discontinued at least 10days before elective surgery.	0
"Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists (including losartan) may result in deterioration of renal function, including possible acute renal failure."	0
"Carcinogenesis, Mutagenesis and Impairment of Fertility No long-term studies in animals have been performed to evaluate the carcinogenic potential of isosorbide dinitrate."	0
LUVOX CR should also not be started in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue.	0
Concomitant use can increase the risk of bradycardia.	0
"If concomitant treatment with sumatriptan and an SSRI (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline, citalopram, escitalopram) is clinically warranted, appropriate observation of the patient is advised."	0
"These conditions should be corrected prior to administration of losartan potassium tablets, or a lower starting dose should be used."	0
Calcium channel blockers may also have an additive effect when given with TENORETIC.	0
"These doses represent 7.5 times and 10 times the MRHD of 300 mg/kg (or 6 mg/kg/day based on a 50 kg patient) for male and female mice, respectively when based on body-weight and 0.7 times and 0.9 times the MRHD when based on body-surface area."	0
"Several cases of hepatocellular injury related to verapamil have been proven by rechallenge; half of these had clinical symptoms (malaise, fever, and/or right upper quadrant pain), in addition to elevation of SGOT, SGPT, and alkaline phosphatase."	0
Interference with adequate oral electrolyte intake will also contribute to hypokalemia.	0
"At recommended doses TENORMIN does not potentiate insulin-induced hypoglycemia and, unlike nonselective beta blockers, does not delay recovery of blood glucose to normal levels."	0
"In hypertensive patients, chronic oral doses of irbesartan (up to 300 mg) had no effect on glomerular filtration rate, renal plasma flow, or filtration fraction."	0
"Although patients have rarely experienced excessive hypotension on PROCARDIA alone, this may be more common in patients on concomitant beta blocker therapy."	0
"CNS-Active Drugs Ethanol: Zaleplon 10 mg potentiated the CNS-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test (DSST), symbol copying test, and the variability component of the divided attention test for 2.5 hours after ethanol administration."	0
The antihypertensive effects of thiazides may be enhanced in the post-sympathectomy patient.	0
The usual dosage is a bolus dose of 1 mg/kg followed by an infusion rate of 20 mcg to 50 mcg/kg/min.	0
"Because animal reproduction studies are not always predictive of human response, pimozide should be given to a pregnant woman only if the potential benefits of treatment clearly outweigh the potential risks."	0
<U+2022> Lopinavir/Ritonavir or atazanavir/ritonavir: Combination increases rosuvastatin exposure.	1
"Patients should be advised to report promptly any unexplained and/or persistent muscle pain, tenderness, or weakness."	0
"In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers."	0
Stimulant:methamphetamine <U+2191> methamphetamine Use with caution.	0
The reduced ammonia levels and decreased pH enhance the effectiveness of antimicrobial agents and allow an increased cure rate of these infections.	0
Doses should be individualized according to the recommended goal of therapy : Highlights of the Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents.	0
Indication Dose Frequency Short-Term Treatment of Erosive Esophagitis Associated With GERD (2.1) Adults 40 mg Once Daily for up to 8 wks Children (5 years and older) <U+2265> 15 kg to < 40 kg 20 mg Once Daily for up to 8 wks <U+2265> 40 kg 40 mg Maintenance of Healing of Erosive Esophagitis (2.1) Adults 40 mg Once DailyControlled studies did not extend beyond 12 months Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome (2.1) Adults 40 mg Twice Daily See full prescribing information for administration instructions PROTONIX is supplied as delayed-release granules in packets for preparation of oral suspensions or as delayed-release tablets.	0
"Nevertheless, prescribers are advised to limit the daily dose to a maximum of 250 mg in adults and 3 mg/kg (or 200 mg) in children and adolescents."	0
Protease Inhibitors (co-administered with 100 mg of ritonavir): Atazanavir <U+2193> Atazanavir<U+2191> Tipranavir Virus Integrase Strand Transfer Inhibitors: Raltegravir <U+2193> Raltegravir APTIVUS/ritonavir reduces plasma concentrations of raltegravir.	1
"At least 14 days should elapse between the discontinuation of an MAO inhibitor and the start of a serotonin re-uptake inhibitor or vice-versa, with the exception of fluoxetine."	0
"Because of the risk of unrecognized hypoglycemia resulting from a drug-device interaction, EXTRANEAL is available only through a restricted program under a REMS."	0
Do not exceed 60 doses for total induction.	0
"To calculate the infusion flow rate to deliver a 0.01 mcg/kg/min dose, use the following formula : Infusion Flow Rate (mL/hr) = Patient Weight (kg) <U+00D7> 0.1 Table 2: NATRECOR<U+00AE> Weight-Adjusted Infusion Flow Rate for a 0.01 mcg/kg/min Dose Following Bolus (Final Concentration = 6 mcg/mL) Patient Weight (kg) Infusion Flow Rate (mL/hr) 60 6 70 7 80 8 90 9 100 10 110 11 The dose-limiting side effect of NATRECOR<U+00AE> is hypotension."	0
"Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs, warfarin, and other anticoagulants may add to the risk."	0
"Nevertheless, a One Generation Study in the rat approximated triamterene and hydrochlorothiazide's composition by using a 1:1 ratio of triamterene to hydrochlorothiazide (30:30 mg/kg/day)."	0
"The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine; cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide)."	0
"WARNING : ( A ) BLEEDING RISK , ( B ) ASPIRIN DOSE AND BRILINTA EFFECTIVENESS ."	0
Use of ACCUPRIL with a thiazide diuretic gives a blood-pressure lowering effect greater than that seen with either agent alone.	0
There are other antiretroviral drugs which do not result in clinically relevant interactions with pantoprazole.	0
This pattern was demonstrated in both male and female patients.	0
"If concomitant use of PRISTIQ with other serotonergic drugs, including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, amphetamines, tryptophan, and St. John's Wort is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome, particularly during treatment initiation and dose increases."	0
"Patients and physicians should be aware, however, that oligohydramnios may not appear until after the fetus has sustained irreversible injury."	0
"When aliskiren was given with cyclosporine or itraconazole , the blood concentrations of aliskiren were significantly increased ."	1
"DIFLUCAN reduces the metabolism of tolbutamide, glyburide, and glipizide and increases the plasma concentration of these agents."	1
Antimycobacterial Agents Rifampin Rifampin should not be administered in patients taking INVIRASE/ritonavir as part of an ART regimen due to the risk of severe hepatocellular toxicity.	0
"MAO Inhibitors (MAOI) Clinical Impact MAOI antidepressants slow amphetamine metabolism, increasing amphetamines effect on the release of norepinephrine and other monoamines from adrenergic nerve endings causing headaches and other signs of hypertensive crisis."	1
"For patients with lesser degrees of impairment, the initial dosage should be 2 mg/day and dosage should not exceed 8 mg/day."	0
"Administer Lidocaine Hydrochloride and 5% Dextrose Injection, USP only with a calibrated infusion device."	0
R-norfluoxetine is significantly less potent than the parent drug in the inhibition of serotonin uptake.	0
"There was considerable variation in risk of suicidality among drugs, but a tendency toward an increase in the younger patients for almost all drugs studied."	0
Atropine Sulfate Injection decreased the rate of mexiletine absorption without altering the relative oral bioavailability; this delay in mexiletine absorption was reversed by the combination of atropine and intravenous metoclopramide during pretreatment for anesthesia.	1
"Alpha-Blockers PDE5 inhibitors, including ADCIRCA, and alphaadrenergic blocking agents are both vasodilators with blood-pressure-lowering effects."	0
The following information was obtained from the literature.	0
"While the principal mechanism of antihypertensive effect is thought to be through the renin-angiotensin-aldosterone system, quinapril exerts antihypertensive actions even in patients with low renin hypertension."	0
"Thus, in patients with cystinuria, sufficient amount of THIOLA<U+00AE> or its active metabolites could appear in urine to react with cystine, lowering cystine excretion."	0
"Proton pump inhibitors: Esomeprazolea, lansoprazole, omeprazole, pantoprazole, rabeprazole LEXIVA: <U+2194>Amprenavir <U+2191>Esomeprazole LEXIVA/ritonavir: <U+2194>Amprenavir <U+2194>Esomeprazole Proton pump inhibitors can be administered at the same time as a dose of LEXIVA with no change in plasma amprenavir concentrations."	0
"It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months."	0
"When pregnancy is detected, discontinue Benicar as soon as possible ( 5.1 )."	0
"Metabolism: Ondansetron is extensively metabolized in humans, with approximately 5% of a radiolabeled dose recovered as the parent compound from the urine."	0
Patients should be advised to notify their physician if they are breast-feeding an infant.	0
"In patients taking potent inhibitors of CYP3A such as ketoconazole and itraconazole , avoid use of ADCIRCA see Drug Interactions ( 7.2 ) and Clinical Pharmacology ( 12.3 ) ."	0
Chromosomal aberrations in spermatocytes and abnormal sperm have been demonstrated in rodents treated with certain antipsychotics.	0
"Avoid use of strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin) [see Clinical Pharmacology (12.3) ]."	0
"Families and caregivers of patients should be advised to observe for the emergence of such symptoms on a day-to-day basis, since changes may be abrupt."	0
"Diluted Remodulin has been shown to be stable at ambient temperature when stored for up to 14 days using high-pH glycine diluent at concentrations as low as 0.004 mg/mL ( 4,000 ng/mL ) ."	0
"Potent inhibition of transporters MDR1 (P-gp), MRP2, and OATP-1B1 does not influence fingolimod disposition."	0
"In healthy adults, the mean biological half-life of rifampin in serum averages 3.35 <U+00B1> 0.66 hours after a 600 mg oral dose, with increases up to 5.08 <U+00B1> 2.45 hours reported after a 900 mg dose."	0
"If signs of toxicity occur at any time during this period, extended monitoring is required."	0
"Renal Insufficiency In hypertensive patients with renal insufficiency, serum concentrations of candesartan were elevated."	0
Known allergy to cornstarch or icodextrin (4.1) Maltose or isomaltose intolerance (4.2) Glycogen storage disease (4.2) Pre-existing severe lactic acidosis (4.3) EXTRANEAL is contraindicated in patients with a known allergy to cornstarch or icodextrin.	0
These are suggested dose adjustments based on pharmacokinetics following administration of multiple doses.	0
Diarrhea of Grade 3 or greater severity occurred in 11% of patients receiving CAPRELSA in the randomized MTC study.	0
Verapamil significantly counteracted the effects of quinidine on AV conduction.	0
This oral dose has also been shown to cause hypotension in rats.	0
A statement to patients and health care providers is included on the product's bottle label.	0
"Penicillin G is distributed to most areas of the body including lung, liver, kidney, muscle, bone and placenta."	0
Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during therapy.	0
This resulted in increases in steady state atomoxetine AUC values that were 6- to 8-fold greater and in atomoxetine Cmax values that were 3- to 4-fold greater than when atomoxetine was given alone.	1
Pimozide: Do not use concomitantly (4.2).	0
"See DOSAGE AND ADMINISTRATION ( 2.6, 2.7 ), CONTRADICTIONS ( 4.1 ), WARNINGS AND PRECAUTIONS ( 5.2 )."	0
Special Populations Renal Impairment The dose of INVEGA<U+00AE> should be reduced in patients with moderate or severe renal impairment.	0
Interstitial lung disease and eosinophilic pneumonia associated with venlafaxine (the parent drug of PRISTIQ) therapy have been rarely reported.	0
Similar effects were observed following IV PERSANTINE<U+00AE> in doses ranging from 0.025 to 2.0 mg/kg.	0
Discontinue ELIQUIS in patients with active pathological hemorrhage.	0
"Nevertheless, over the 24-hour dosing interval, <U+03B2>1-blockade is comparable and dose-related."	0
Worsening heart failure or fluid retention may occur during up-titration of carvedilol.	0
LATUDA is metabolized into two active metabolites (ID-14283 and ID-14326) and two major non-active metabolites (ID-20219 and ID-20220).	0
"(also see CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, Drug Interactions) Indinavir is an inhibitor of the cytochrome P450 isoform CYP3A4."	0
"Beta-Blockers<U+2014> In a study where propranolol (80 mg bid) was dosed orally for 18 days, the established steady-state plasma concentrations of propranolol were unaltered during coadministration with paroxetine (30 mg qd) for the final 10 days."	0
The dosage of CRIXIVAN should be reduced to 600 mg every 8 hours in patients with mild-to-moderate hepatic insufficiency due to cirrhosis.	0
Patients receiving sertraline hydrochloride experienced a mean reduction of approximately 7 points on the YBOCS total score which was significantly greater than the mean reduction of approximately 4 points in placebo-treated patients.	0
"If this drug is used during pregnancy, or if the patient becomes pregnant while taking the drug, the patient should be informed of the potential hazard to the fetus."	0
There are no PK data to allow for dosage adjustment recommendations in patients with severe hepatic impairment (Child-Pugh Class C).	0
Metabolism and Elimination Irbesartan Irbesartan is metabolized via glucuronide conjugation and oxidation.	0
"The spontaneous report data and the cohort study results provide estimates of the upper and lower limits of the risk of liver failure in nefazodone-treated patients, but are not capable of providing a precise risk estimate."	0
"Following treatment with Savella 50mg BID for three weeks in patients who were normotensive at baseline, the mean increase in mean 24-hour heart rate from baseline was 13 beats per minute."	0
"CNS Active Drugs<U+2013>In a study comparing the disposition of intravenously administered diazepam before and after 21 days of dosing with either sertraline (50 to 200 mg/day escalating dose) or placebo, there was a 32% decrease relative to baseline in diazepam clearance for the sertraline group compared to a 19% decrease relative to baseline for the placebo group (p < 0.03)."	1
"In a clinical study, saquinavir 1200 mg coadministered with REYATAZ 400 mg and tenofovir DF 300 mg (all given once daily) plus nucleoside analogue reverse transcriptase inhibitors did not provide adequate efficacy."	0
Orig Submission\Source\eliquis-pkplot-pop-fig3.jpg	0
"Amiodarone has the potential for interactions with drugs or substances that may be substrates , inhibitors or inducers of CYP450 enzymes ( e.g. , inhibitors such as protease inhibitors , grapefruit juice , certain fluoroquinolone and macrolide antibiotics , azole antifungals and inducers such as St.   John s Wort ) or P-glycoprotein ."	0
"Patients receiving high doses of salicylates concomitantly with LASIX , as in rheumatic disease , may experience salicylate toxicity at lower doses because of competitive renal excretory sites ."	1
Mexiletine: Monitor serum mexiletine levels (5.9).	0
"Co-administration of SAMSCA with 400 mg ketoconazole daily or with other strong CYP 3A inhibitors ( e.g. , clarithromycin , itraconazole , telithromycin , saquinavir , nelfinavir , ritonavir and nefazodone ) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure ."	1
Individualize to the needs of the patient and monitor during up-titration.	0
"The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine; cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide)."	0
EMEND for oral suspension in pediatric patients 6 months to less than 12 years of age or pediatric and adult patients unable to swallow capsules: see dosing recommendations in Table 3 in the Full Prescribing Information.	0
"Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed."	0
"Reduction in the Risk of Recurrence of Deep Venous Thrombosis and Pulmonary Embolism For patients with CrCl >30 mL/min, the recommended dose of PRADAXA is 150 mg taken orally, twice daily after previous treatment."	0
"The pooled analyses of placebo-controlled trials in adults with MDD or other psychiatric disorders included 295 short-term trials (median duration of 2months) of 11 antidepressant drugs in over 77,000 patients."	0
Hypotension: Dipyridamole should be used with caution in patients with hypotension since it can produce peripheral vasodilation.	0
"ALTACE is contraindicated in patients who are hypersensitive to this product or any other ACE inhibitor (e.g., a patient who has experienced angioedema during therapy with any other ACE inhibitor)."	0
Dabigatran Exposure to dabigatran is higher when it is administered with dronedarone than when it is administered alone.	1
"Also, mothers with HIV-1 should not breastfeed because HIV-1 can be passed to the baby in the breast milk."	0
"Patients who develop evidence of hepatocellular injury such as increased serum AST or serum ALT levels <U+2265> 3 times the upper limit of NORMAL, while on nefazodone hydrochloride tablets should be withdrawn from the drug."	0
"Mechanism of Action Ledipasvir is an inhibitor of the HCV NS5A protein, which is required for viral replication."	0
There are no data on use of TIKOSYN when the heart rate is <50 beats per minute.)	0
Benicar may be administered with other antihypertensive agents.	0
Pimozide <U+2014> Concomitant use in patients taking pimozide is contraindicated.	0
"The starting dose is one 10 mg capsule, swallowed whole, 3 times/day."	0
Zanaflex should be used with caution in patients with any hepatic impairment.	0
"Dosages above this level, however, do not usually produce a greater response."	0
Consider the diagnosis of PML in any patient presenting with new-onset neurological manifestations and consider consultation with a neurologist as clinically indicated.	0
"In addition, vortioxetine did not induce CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, and CYP3A4/5 in an in vitro study in cultured human hepatocytes."	0
The mean dose for completers was 102 mg/day.	0
Prompt medical or surgical treatments may need to be considered if the intraocular pressure remains uncontrolled.	0
The antihypertensive effects of the thiazide component may also be enhanced in the postsympathectomy patients.	0
"In this trial, patients were carefully monitored and some interacting medicinal products were excluded."	0
Digitalis glycosides: Risk of bradycardia (7) Anticholinesterases: Prolongs neuromuscular blockade (7) Antihypertensive agents: Risk of rebound hypertension (7) Sympathomimetic drugs: Dose adjustment needed (7) Vasoconstrictive and positive inotropic effect substances: Avoid concomitant use (7)	0
No patient on placebo reached a nadir of <200 cells/mcL.	0
ATACAND may be administered with other antihypertensive agents.	0
"Intervention: Temporarily stop PROTONIX treatment at least 14 days before assessing CgA levels and consider repeating the test if initial CgA levels are high. for monitoring), the same commercial laboratory should be used for testing, as reference ranges between tests may vary."	0
Removal of angiotensin II negative feedback on renin secretion leads to increased plasma renin activity (PRA).	0
"SSRIs and SNRIs, including Savella, may increase the risk of bleeding events."	0
Amlodipine is extensively (about 90%) converted to inactive metabolites via hepatic metabolism with 10% of the parent compound and 60% of the metabolites excreted in the urine.	0
"If there is a suspicion that digitalis toxicity exists, elective cardioversion should be delayed."	0
Incompatibilities VFEND for Oral Suspension and the 40 mg/mL reconstituted oral suspension should not be mixed with any other medication or additional flavoring agent.	0
"Dilutional hyponatremia , manifested by dryness of the mouth , thirst , lethargy , and drowsiness , and confirmed by a low serum sodium level , may be caused or aggravated , especially when ALDACTONE is administered in combination with other diuretics , and dilutional hyponatremia may occur in edematous patients in hot weather , appropriate therapy is water restriction rather than administration of sodium , except in rare instances when the hyponatremia is life-threatening ."	0
Fetal plasma drug levels 2 hours after dosing were approximately 3% of maternal plasma drug levels.	0
Studies of the effects of triamterene and hydrochlorothiazide or of triamterene alone on animal reproductive function have not been conducted.	0
"This enzyme is expressed in testicular, adrenal, and prostatic tumor tissues and is required for androgen biosynthesis."	0
"The magnitude of rise in serum digoxin concentration relates to the extent of bacterial inactivation, and may be as much as two-fold in some cases."	0
"Reproduction studies have been performed in mice, rabbits and rats at oral dipyridamole doses of up to 125 mg/kg, 40 mg/kg and 1000 mg/kg, respectively (about 1 <U+00BD>, 2 and 25 times the maximum recommended daily human oral dose, respectively, on a mg/m2 basis) and have revealed no evidence of harm to the fetus due to dipyridamole."	0
"The dosage may be titrated upward until blood pressure, when measured just before the next dose, is controlled or to a maximum of 16 mg per day (2.1) Stable Coronary Artery Disease ACEON should be given at an initial dose of 4 mg once daily for 2 weeks, and then increased, as tolerated, to a maintenance dose of 8 mg once daily (2.2) Use in Uncomplicated Hypertensive Patients: In patients with essential hypertension, the recommended initial dose is 4 mg once a day."	0
"With other drugs that affect brain monoamine concentrations, there have been reports of serious, sometimes fatal reactions (including hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations of vital signs, and mental status changes that include extreme agitation progressing to delirium and coma) when taken in combination with an MAOI."	0
There was a 13-fold interindividual difference in the area under the serum pimozide level-time curve and an equivalent degree of variation in peak serum levels among patients studied.	0
"Quinapril was also negative in the following genetic toxicology studies: in vitro mammalian cell point mutation, sister chromatid exchange in cultured mammalian cells, micronucleus test with mice, in vitro chromosome aberration with V79 cultured lung cells, and in an in vivo cytogenetic study with rat bone marrow."	0
"Therefore CRIXIVAN should not be co-administered with orally administered midazolam , whereas caution should be used with co-administration of CRIXIVAN and parenteral midazolam."	0
It is generally believed (though not established in controlled trials) that treating such an episode with an antidepressant alone may increase the likelihood of precipitation of a mixed/manic episode in patients at risk for bipolar disorder.	0
"Use of LASIX concomitantly with chloral hydrate is , therefore , not recommended ."	0
Renal excretion of parent compound is negligible and urinary excretion of the glucuronide metabolite is low (about 5%).	0
There is no evidence that doses greater than 5 mg/kg daily are useful.	0
The dose of COREG should be reduced if patients experience bradycardia (heart rate less than 55beats per minute).	0
"For continuous infusion protocol, see prescribing information for lidocaine hydrochloride, USP for infusion solution."	0
It is not known whether pimozide is excreted in human milk.	0
"If response to 0.05 micrograms per kilogram of body weight per minute is inadequate, dosage can be increased up to 0.4 micrograms per kilogram of body weight per minute although, in general, higher infusion rates do not produce greater effects."	0
"Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary)."	0
"Elderly patients and patients with hepatic insufficiency have decreased clearance of amlodipine with a resulting increase in AUC of approximately 40<U+2013>60%, and a lower initial dose may be required."	0
"In some cases, diabetic ketoacidosis has occurred."	0
"In addition, patients with amyloid heart disease may be more susceptible to toxicity from digoxin at therapeutic levels because of an increased binding of digoxin to extracellular amyloid fibrils."	0
Doses of 20 mg or 40 mg of paroxetine were both demonstrated to be significantly superior to placebo on the Hamilton Rating Scale for Anxiety (HAM-A) total score.	0
"Digitalis glycosides, such as digoxin, are contraindicated in ventricular fibrillation."	0
"The pharmacokinetics (Cmax and AUC) were not modified by age, sex or body weight."	0
REVATIO injection is for the continued treatment of patients with PAH who are currently prescribed oral REVATIO and who are temporarily unable to take oral medication.	0
Table 3 gives recommended starting doses of Renvela based on a patient's current calcium acetate dose.	0
"Excretion: Following oral administration, fluvastatin is primarily (about 90%) excreted in the feces as metabolites, with less than 2% present as unchanged drug."	0
BID = twice daily; QD = once daily; LA = Long Acting Co-administered drug Dose regimen Change inAUC* Change in Cmax* Atazanavir Pitavastatin 4 mg QD + atazanavir 300 mg daily for 5 days <U+2191> 6% <U+2191> 13% Darunavir Pitavastatin 4mg QD on Days 1-5 and 12-16 + darunavir/ritonavir 800mg/100 mg QD on Days 6-16 <U+2191> 3% <U+2191> 6% Lopinavir Pitavastatin 4 mg QD on Days 1-5 and 20-24 + lopinavir/ritonavir 400 mg/100 mg BID on Days 9 <U+2013> 24 <U+2193> 9% <U+2193> 7% Ritonavir Pitavastatin 4 mg QD on Days 1-5 and 20-24 + lopinavir/ritonavir 400 mg/100 mg BID on Days 9 <U+2013> 24 <U+2193> 11% <U+2193> 11% Ritonavir Pitavastatin 4mg QD on Days 1-5 and 12-16 + darunavir/ritonavir 800mg/100 mg QD on Days 6-16 <U+2191> 8% <U+2191> 2% Enalapril Pitavastatin 4 mg QD + enalapril 20 mgdaily for 5 days Enalapril <U+2191> 12% <U+2191> 12% Enalaprilat <U+2193> 1% <U+2193> 1% Warfarin Individualized maintenance dose of warfarin (2 - 7 mg) for 8 days + pitavastatin 4 mg QD for 9 days R-warfarin <U+2191> 7% <U+2191> 3% S-warfarin <U+2191> 6% <U+2191> 3% Ezetimibe Pitavastatin 2 mg QD + ezetimibe 10 mg for 7 days <U+2191> 9% <U+2191> 2% Digoxin Pitavastatin 4 mg QD + digoxin 0.25 mg for 7 days <U+2193> 3% <U+2193> 4% Diltiazem LA Pitavastatin 4 mg QD on Days 1-5 and 11-15 and diltiazem LA 240 mg on Days 6-15 <U+2193> 2% <U+2193> 7% Rifampin Pitavastatin 4 mg QD + rifampin 600 mg QD for 5 days <U+2193> 15% <U+2193> 18%	0
"TENORMIN is devoid of membrane stabilizing activity, and increasing the dose well beyond that producing beta blockade does not further depress myocardial contractility."	0
"Other than an increased incidence of non-ossified 5th metacarpal, and the occurrence of hydroureter and hydronephroses at doses as low as 1 mg/kg/day in the rat, structural anomalies associated with drug treatment were not observed in either species at doses below 2 mg/kg/day."	0
"If a patient receiving clonidine hydrochloride is also taking tricyclic antidepressants, the hypotensive effect of clonidine may be reduced, necessitating an increase in the clonidine dose."	0
Gemfibrozil 11 600 mg BID for 3 days 40 mg 0.96 2.80 ItraconazoleThe mean total AUC of lovastatin without itraconazole phase could not be determined accurately.	0
Steady-state concentrations of paliperidone are attained within 4<U+2013>5 days of dosing with INVEGA<U+00AE> in most subjects.	0
The next dose should be taken at the usual time.	0
"Following oral administration, peak plasma quinapril concentrations are observed within one hour."	0
"Agents Causing Renin Release: The antihypertensive effect of VASOTEC is augmented by antihypertensive agents that cause renin release (e.g., diuretics)."	0
"It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months."	0
The terminal elimination half-life (reflecting post absorption clearance of nisoldipine) ranges from 13.7 <U+00B1> 4.3 hours.	0
"Also, the use of macrolide antibiotics in patients with prolonged QT intervals has been rarely associated with ventricular arrhythmias."	0
Antidiabetic drugs - (oral agents and insulin) dosage adjustment of the antidiabetic drug may be required.	0
Caution should be exercised when atenolol is administered to a nursing woman.	0
Gemfibrozil: Contraindicated with simvastatin.	0
The degree of anticoagulant activity can also be assessed by the ecarin clotting time (ECT).	0
"Steady-state Cmax for ledipasvir, sofosbuvir, and GS-331007 were 323, 618, and 707 ng/mL, respectively."	0
"Many of the patients who have developed rhabdomyolysis on therapy with simvastatin have had complicated medical histories, including renal insufficiency usually as a consequence of long-standing diabetes mellitus."	0
"Clinical studies have shown that desvenlafaxine (100 mg daily) does not have a clinically relevant effect on tamoxifen and aripiprazole, compounds that are metabolized by a combination of both CYP2D6 and CYP3A4 enzymes (Figure 2)."	0
"Cases of adrenal insufficiency have been reported with opioid use, more often following greater than 1 month of use."	0
Telmisartan is not removed from blood by hemofiltration.	0
"With a median time on therapy of 60 months in the clinical trial,cardiovascular events, including arterial vascular occlusive events, occurred in 9.3% and 15.2% of patients in the Tasigna 300 and 400 mg twice dailyarms, respectively, and in 3.2% in the imatinib arm."	0
"After 1 week of once daily dosing with 8 mg of candesartan cilexetil, the pressor effect was inhibited by approximately 90% at peak with approximately 50% inhibition persisting for 24 hours."	0
Hepatic Insufficiency The pharmacokinetics of candesartan were compared in patients with mild and moderate hepatic impairment to matched healthy volunteers following a single oral dose of 16 mg candesartan cilexetil.	0
Dose reduction of CRIXIVAN to 600 mg every 8 hours should be considered when administering delavirdine 400 mg three times a day.	1
"Intervention: Monitor patients for signs and symptoms of serotonin syndrome, particularly during treatment initiation and dosage increases."	0
"As with all antidepressants, nefazodone should be used cautiously in patients with a history of mania."	0
Alcohol <U+2014> Ethanol (45mg/70kg single dose) did not have an effect on olanzapine pharmacokinetics.	0
Adequate multiple-dose trials of dilatrate<U+00AE>-SR sustained release capsules have not been reported.	0
"Additionally, invitro studies have shown ketoconazole, a potent inhibitor of CYP3A4 activity, to be at least 100times more potent than fluoxetine or norfluoxetine as an inhibitor of the metabolism of several substrates for this enzyme, including astemizole, cisapride, and midazolam."	0
"In a dose proportionality study, systemic exposure to 32 mg of ondansetron was not proportional to dose as measured by comparing dose-normalized AUC values to an 8-mg dose."	0
There is little potential for drug interactions with ziprasidone due to displacement.	0
Pediatric Patients Telmisartan pharmacokinetics have not been investigated in patients <18 years of age.	0
"The 40 mg dose of Letairis increased mean QTc at tmax by 5 ms with an upper 95% confidence limit of 9 ms. For patients receiving Letairis 5<U+2013>10 mg daily and not taking metabolic inhibitors, no significant QT prolongation is expected."	0
"Carcinogenesis: Two-year carcinogenicity studies were conducted in rodents given paroxetine in the diet at 1, 5, and 25 mg/kg/day (mice) and 1, 5, and 20 mg/kg/day (rats)."	0
PRADAXA should be taken with a full glass of water.	0
Anticoagulants : Potentiation of warfarin - type ( CYP2C9 and CYP3A substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .	0
There was no evidence that doses greater than 50 mg per day confer any additional benefit (2.1).	0
Pathological changes in the parathyroid gland with hypercalcemia and hypophosphatemia have been observed in a few patients on thiazide therapy.	0
"Relative to healthy subjects (N=191), ledipasvir AUC0<U+2013>24 and Cmax were 24% lower and 32% lower, respectively, in HCV-infected subjects."	0
"Other risk factors for NAION, such as the presence of crowded optic disc, may have contributed to the occurrence of NAION in these studies."	0
Coadministration of CRIXIVAN and St. John's wort has been shown to substantially decrease indinavir concentrations and may lead to loss of virologic response and possible resistance to CRIXIVAN or to the class of protease inhibitors.	1
"In most cases, this is believed to be due to an excessive postural hypotensive effect, although occasionally the syncopal episode has been preceded by a bout of severe tachycardia with heart rates of 120<U+2013>160 beats per minute."	0
Tirofiban has a half-life of approximately 2 hours.	0
The concomitant use of PRADAXA and P-gp inhibitors in patients with severe renal impairment (CrCl 15-30 mL/min) should be avoided.	0
Patients with a history of angioedema unrelated to ACE inhibitor therapy may be at increased risk of angioedema while receiving an ACE inhibitor.	0
"In four patients with cardiovascular disease, coadministration of propafenone 150 mg t.i.d. with immediate-release metoprolol 50 mg t.i.d. resulted in two- to five-fold increases in the steady-state concentration of metoprolol."	1
"Signs and symptoms are usually intermittent and mild; however, very rare sequelae include digital ulceration and/or soft tissue breakdown."	0
"Following concomitant administration of carvedilol (25mg once daily) and digoxin (0.25mg once daily) for 14days, steady-state AUC and trough concentrations of digoxin were increased by 14% and 16%, respectively, in 12subjects with hypertension."	1
There are no adequate and well<U+2013>controlled studies in pregnant women.	0
"In in vivo and in vitro studies, rosuvastatin produces its lipid-modifying effects in two ways."	0
"To prevent foaming, do not shake the mixing cup."	0
"Given the primary CNS effects of clomipramine, caution is advised in using it concomitantly with other CNS-active drugs."	0
There have been rare postmarketing reports of serotonin syndrome with use of an SSRI and a triptan.	0
"On the other hand, regimens that combine low doses of bisoprolol and hydrochlorothiazide should produce minimal dose-dependent adverse effects, eg, bradycardia, diarrhea, asthenia and fatigue, and minimal dose-dependent adverse metabolic effects, ie, decreases in serum potassium."	0
"Nifedipine administration was associated with a variety of embryotoxic, placentotoxic, and fetotoxic effects, including stunted fetuses (rats, mice, rabbits), rib deformities (mice), cleft palate (mice), small placentas and underdeveloped chorionic villi (monkeys), embryonic and fetal deaths (rats, mice, rabbits), and prolonged pregnancy/decreased neonatal survival (rats; not evaluated in other species)."	0
"Protein binding is also increased in chronic renal failure, but binding abruptly descends toward or below normal when heparin is administered for hemodialysis."	0
Racemic citalopram did not alter the mean AUC or Cmax of pimozide.	0
"If ELIQUIS is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant."	0
Concomitant administration of ALDACTONE with the following drugs or potassium sources may lead to severe hyperkalemia : .	0
Monitor blood pressure regularly during treatment (5.3).	0
Use cautiously in patients with seizure disorder (5.8).	0
These deaths occurred while patients were receiving dosages in the range of 1 mg per kg.	0
"Effect of Food When AGGRENOX capsules were taken with a high fat meal, dipyridamole peak plasma levels (Cmax) and total absorption (AUC) were decreased at steady-state by 20-30% compared to fasting."	1
Use caution; monitor plasma TCA levels; reduce TCA dose if indicated (7.2).	1
"In most patients (>90%), this CYP2D6 isozyme is saturated early during dosing with paroxetine."	0
It increases the pressor effect of norepinephrine but blocks the pressor response of phenethylamine.	0
The complete text of the Medication Guide is reprinted at the end of this document.	0
"While taking MINIPRESS, be careful in the amount of alcohol you drink."	0
Coadministration of nevirapine and LEXIVA without ritonavir is not recommended.	0
"Beyond the immediate newborn period, pediatric patients generally require proportionally larger doses than adults on the basis of body weight or body surface area."	0
Removal of angiotensin II negative feedback on renin secretion leads to increased plasma renin activity (PRA).	0
For details on the preparation and administration of NORVIR oral powder.	0
"If withdrawal of TENORMIN therapy is planned, it should be achieved gradually and patients should be carefully observed and advised to limit physical activity to a minimum."	0
"Atorvastatin Atorvastatin, as well as some of its metabolites, are pharmacologically active in humans."	0
"It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months."	0
"Tell the patient if syncope occurs, discontinue ACCURETIC until the physician has been consulted."	0
Both CYP1A2 and CYP2D6 are responsible for duloxetine metabolism.	0
"Only dry heat should be used (e.g., heating pad, warming plate)."	0
Monitor renal function periodically in patients receiving valsartan and NSAID therapy .	0
"Strong CYP1A2 Inhibitors (e.g., Fluvoxamine) SAPHRIS is metabolized by CYP1A2."	0
"One such standardized procedure uses a standardized dilution method2,4 (broth, agar, or microdilution) or equivalent with rifampin powder."	0
Distribution: Mean volume of distribution of LIPITOR is approximately 381 liters.	0
"However, in vitro data indicate that SR90154 is likely to inhibit the organic anion transporting polypeptides (OATP1B1, OATP1B3) in vivo."	0
Itraconazole <U+2191> indinavir concentration Dose reduction of CRIXIVAN to 600 mg every 8 hours is recommended when administering itraconazole concurrently.	1
The metabolism of paroxetine is accomplished in part by CYP2D6.	0
"Drug Interaction Studies Telmisartan Ramipril and Ramiprilat: Co-administration of telmisartan 80 mg once daily and ramipril 10 mg once daily to healthy subjects increases steady-state Cmax and AUC of ramipril 2.3- and 2.1-fold, respectively, and Cmax and AUC of ramiprilat 2.4- and 1.5-fold, respectively."	1
"In healthy subjects, the pharmacokinetic profile was examined after single doses of up to 7.5 mg and after once-daily administration of 1, 3, and 6 mg for 7 days."	0
"At steady-state, plasma concentrations of verapamil and trandolaprilat are up to two-fold higher than those observed after a single oral TARKA dose."	0
"Mexiletine does not alter serum digoxin levels but magnesium-aluminum hydroxide, when used to treat gastrointestinal symptoms due to mexiletine, has been reported to lower serum digoxin levels."	0
Continued administration of ritonavir 600 mg twice daily following loss of viral suppression may increase the likelihood of cross-resistance to other protease inhibitors.	0
"Evidence of new or worsening liver dysfunction (including clinically significant elevation of liver enzymes and/or symptoms such as fatigue, anorexia, nausea, jaundice, dark urine, liver tenderness, hepatomegaly) in patients on PREZISTA/ritonavir should prompt consideration of interruption or discontinuation of treatment."	0
There is no general agreement about specific pharmacological treatment regimens for uncomplicated NMS.	0
Cleviprex is titrated to the desired reduction in blood pressure.	0
Initial difficulty with titration should not preclude later attempts to introduce TOPROL-XL.	0
"Since diabetes is frequently complicated by renal disease, consider a lower starting dose and gradual increase in dose for patients with renal impairment."	0
"When verapamil and colchicine are administered together, the potential inhibition of P-gp and/or CYP3A by verapamil may lead to increased exposure to colchicine."	1
"In a CYP2D6 drug-drug interaction trial, the Cmax and AUC of dextromethorphan (CYP2D6 substrate) were increased 2.8- and 2.9-fold, respectively, when dextromethorphan was given with abiraterone acetate 1,000 mg daily and prednisone 5 mg twice daily."	1
"Sildenafil is a weak inhibitor of the cytochrome P450 isoforms 1A2, 2C9, 2C19, 2D6, 2E1 and 3A (IC50 greater than150 <U+00B5>M)."	0
"Table 18: The Effect of Quetiapine on the Pharmacokinetics of Other Drugs Coadministered drug Dose schedules Effect on other drugs pharmacokinetics Coadministered drug Quetiapine Lorazepam 2 mg, single dose 250 mg three times daily Oral clearance of lorazepam reduced by 20% Divalproex 500 mg twice daily 150 mg twice daily Cmax and AUC of free valproic acid at steady-state was decreased by 10 to 12% Lithium Up to 2400 mg/day given in twice daily doses 250 mg three times daily No effect on steady-state pharmacokinetics of lithium Antipyrine 1 g, single dose 250 mg three times daily No effect on clearance of antipyrine or urinary recovery of its metabolites"	1
"Inhibition of the metabolism of CYP2C19 substrates is therefore not anticipated, although clinical studies have not been performed."	0
No significant accumulation of TENORMIN occurs until creatinine clearance falls below 35mL/min/1.73m2.	0
"Therefore, in patients taking cyclosporine, the dose of CRESTOR should not exceed 5mg once daily."	1
No formal drug interaction studies of high-dose methotrexate with PPIs have been conducted.	0
The below listed drug interaction information is derived from studies using fluvastatin capsules.	0
SULAR is not known to interfere with the interpretation of laboratory tests.	0
"Of patients receiving ONIVYDE/5-FU/LV in Study 1, 34% received loperamide for late-onset diarrhea and 26% received atropine for early-onset diarrhea."	0
"The basic effects of fluphenazine decanoate appear to be no different from those of fluphenazine hydrochloride, with the exception of duration of action."	0
Changes in plasma selegiline concentrations were nearly 2-fold and variable across the subject population.	0
"Approximately 19% of the administered dose is excreted as the glucuronide metabolite and <5% as the oxidative metabolite (N,O-didesmethylvenlafaxine) in urine."	0
"LEXIVA 1,400 mg once daily may be considered when coadministered with paritaprevir/ritonavir/ombitasvir/ dasabuvir."	0
NARCOTIC ANALGESIC Methadone <U+2193> methadone Concentrations of methadone were decreased when coadministered with VIRACEPT.	1
"The drug also has been reported to produce dilation of the renal vasculature which is accompanied by increases in glomerular filtration rate, renal blood flow and sodium excretion."	0
Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.	1
"While the mechanism through which trandolapril lowers blood pressure is believed to be primarily suppression of the renin-angiotensin-aldosterone system, trandolapril has an antihypertensive effect even in patients with low renin hypertension."	0
"If these symptoms occur, administer supportive measures and discontinue PRIFTIN."	0
Open the INVIRASE capsules and place the contents into an empty container.	0
"Differentiation syndrome, which may be life-threatening or fatal, has been observed in patients with acute promyelocytic leukemia (APL) treated with TRISENOX."	0
"Dual Blockade of the Renin-Angiotensin-Aldosterone System (RAAS): The concomitant use of aliskiren with other agents acting on the RAAS such as ACEIs or ARBs is associated with an increased risk of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
Therefore co-administration of glyburide and Tracleer is contraindicated see Cytochrome P450 Drug Interactions ( 7.1 ) .	0
The manufacturer(s) of the monitor and test strips should be contacted to determine if icodextrin or maltose causes interference or falsely elevated glucose readings.	0
"If a diuretic is also used, the risk of lithium toxicity may be increased."	0
These patients may need follow-up adjustments in blood pressure control.	0
Total amounts of ethanol and propylene glycol from all medicines that are to be given to pediatric patients 1 to 6 months of age should be taken into account in order to avoid toxicity from these excipients.	0
"Patients taking other drugs that are substrates of CYP450 3A4, especially patients with renal and/or hepatic impairment, may require dosage adjustment when starting or stopping concomitantly administered diltiazem in order to maintain optimum therapeutic blood levels."	0
Avoid fetal or neonatal exposure (5.1) Hypotension: Correct any volume or salt depletion before initiating therapy.	0
PPI associated SLE is usually milder than non-drug induced SLE.	0
"As with these other agents, CYMBALTA should be used cautiously in patients with a history of mania."	0
No clinical events have been reported suggestive of a too rapid decrease in blood pressure with nicardipine.	0
The concomitant use of nortriptyline hydrochloride with MAOIs intended to treat psychiatric disorders is contraindicated.	0
"There was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen ."	0
"The development of a potentially life-threatening serotonin syndrome has been reported with SNRIs and SSRIs, including CYMBALTA, alone but particularly with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John's Wort) and with drugs that impair metabolism of serotonin (in particular, MAOIs, both those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue)."	0
Major pathways of biotransformation are demethylation and hydroxylation followed by glucuronide conjugation.	0
"When using a volumetric infusion chamber, the appropriate amount of intravenous infusion solution should be added to the chamber first."	0
"If hypotension does occur, place the patient in the supine position and, if necessary, give an intravenous infusion of normal saline."	0
"In patients taking rifampin, a dose of LIVALO 2 mg once daily should not be exceeded."	1
"EMSAM 6mg per 24 hours for 10 days, co-administered with pseudoephedrine (60mg, 3 times a day) did not affect the pharmacokinetics of pseudoephedrine."	0
"This drug should therefore be used with caution in patients who may be volume depleted or who, for whatever reason, are already hypotensive."	0
Avoid sunlight due to risk of photosensitivity (5.13) Skeletal Events: Fluorosis and periostitis with long-term voriconazole therapy.	0
"There were no relevant effects on hormone level in the 50 mg fluconazole study, while at 200 mg daily, the AUCs of ethinyl estradiol and levonorgestrel were increased 40% and 24%, respectively."	1
"In steady-state dose proportionality studies involving elderly and nonelderly patients, at doses of 20 mg to 40 mg daily for the elderly and 20 mg to 50 mg daily for the nonelderly, some nonlinearity was observed in both populations, again reflecting a saturable metabolic pathway."	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP not be given to patients in whom unrecognized coronary artery disease (CAD) is predicted by the presence of risk factors (e.g., hypertension, hypercholesterolemia, smoker, obesity, diabetes, strong family history of CAD, females who are surgically or physiologically postmenopausal, or males who are over 40 years of age) unless a cardiovascular evaluation provides satisfactory clinical evidence that the patient is reasonably free of coronary artery and ischemic myocardial disease or other significant underlying cardiovascular disease."	0
"Dosage increase of WELLBUTRIN XL may be necessary when coadministered with ritonavir, lopinavir, or efavirenz but should not exceed the maximum recommended dose."	1
Increased risk of pulmonary hypertension with repeated courses of therapy cannot be excluded.	0
Ergot-containing drugs have been reported to cause prolonged vasospastic reactions.	0
Tell patients planning to undergo any surgery and/or anesthesia to inform their physician that they are taking an ACE inhibitor.	0
Hyperkalemia has been reported in diabetic patients with the use of potassium-conserving agents even in the absence of apparent renal impairment.	0
"Adverse events of nausea, dizziness, hypotension and syncope have been observed following coadministration of trazodone and ritonavir."	0
"Formed, visual hallucinations or delusions have been reported in 5 of 170 patients (3%) in two North American controlled clinical studies."	0
"Saquinavir <U+2191> saquinavir concentration The appropriate doses for this combination, with respect to efficacy and safety, have not been established."	0
"Because of the occurrence of serious cardiac dysrhythmias secondary to prolongation of the QTc interval in patients receiving azole antifungals in conjunction with terfenadine, interaction studies have been performed."	0
Titrate the Renvela dose by 0.8 g three times per day with meals at two-week intervals as necessary to achieve target serum phosphorus levels.	0
"Coadministration of asenapine with known inhibitors, inducers or substrates of these metabolic pathways has been studied in a number of drug-drug interaction studies."	0
Dose may be adjusted in 50 or 100 mg increments up or down.	0
"In many of the reported cases, treatment with protease inhibitors was continued or restarted."	0
Hepatic impairment: Changes in anti-FXa activity were similar in patients with mild-to-moderate hepatic impairment and healthy subjects.	0
"Addition of mexiletine to propafenone did not lead to further electrocardiographic parameters changes of QRS, QTc, RR, and PR intervals than propafenone alone."	0
Iloperidone doses should be reduced by one-half when administered with paroxetine.	1
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function and of concomitant disease or other drug therapy."	0
The effects of paroxetine on diazepam were not evaluated.	0
Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.	0
Electroconvulsive Therapy<U+2013>There are no clinical studies establishing the risks or benefits of the combined use of electroconvulsive therapy (ECT) and sertraline.	0
"However, some patients require a smaller dose."	0
"Aspirin and heparin were commonly used in TRITON-TIMI 38 [see Drug Interactions (7.1, 7.2."	0
"May result in an increase in PDE5 inhibitor-associated adverse events, including hypotension, syncope, visual disturbances, and priapism."	0
Ritonavir prolongs the PR interval in some patients.	0
Infectious and aseptic peritonitis has been associated with EXTRANEAL use.	0
"With the exception of neonatal weight gain (which was affected at doses as low as 10mg/kg/day), doses associated with these effects exceeded 25mg/kg/day (approximately three times the maximum recommended human dose of 100mg on a mg/m2 basis)."	0
The volume of distribution for telmisartan is approximately 500 liters indicating additional tissue binding.	0
"After rapid absorption with peak levels occurring on average between 2-3 hours following administration, sotalol was eliminated with a mean half-life of 9.5 hours."	0
"Clarithromycin <U+2191> clarithromycin concentration<U+2191> indinavir concentration The appropriate doses for this combination, with respect to efficacy and safety, have not been established."	0
Activation of mania/hypomania has been reported in a small proportion of patients with major affective disorder who were treated with marketed antidepressants.	0
"In adolescents weighing < 51 kg (< 112 lbs), a 23% higher exposure was observed; this is considered not to be clinically significant."	0
"Nonetheless, at this time, it is recommended that plasma phenytoin concentrations be monitored following initiation of sertraline therapy with appropriate adjustments to the phenytoin dose, particularly in patients with multiple underlying medical conditions and/or those receiving multiple concomitant medications."	0
"In addition to adequate hydration, medical management in patients who experience nephrolithiasis/urolithiasis may include temporary interruption (e.g., 1 to 3 days) or discontinuation of therapy."	0
"As with all drugs, the potential exists for interaction with other drugs by a variety of mechanisms."	0
COREG should not be given to patients with severe hepatic impairment.	0
It also increases levels of atrial natriuretic peptide.	0
"PREZISTA/ritonavir should not be used in combination with rifampin, as this may cause significant decreases in darunavir plasma concentrations."	1
"Aggression: Aggressive behavior or hostility is often observed in children and adolescents with ADHD, and has been reported in clinical trials and the postmarketing experience of some medications indicated for the treatment of ADHD."	0
"Zanaflex is contraindicated in patientstaking potent inhibitors of CYP1A2, such as fluvoxamine or ciprofloxacin."	0
"However, hemodialysis, peritoneal dialysis, exchange transfusions, and forced diuresis generally have been reported as ineffective in tricyclic antidepressant poisoning."	0
"Anyone considering the use of Nardil or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need."	0
The patient's creatinine clearance should be calculated using the one of several formulas.	0
"During long term therapy, cardiac output tends to return to control values, while peripheral resistance remains decreased."	0
Rifampin (strong CYP enzyme inducer): Decreases exposure to and effects of ramelteon.	1
Symptoms include acute onset of decreased visual acuity or ocular pain and typically occur within hours to weeks of drug initiation.	0
The curves represent mean levels without confidence intervals; variations should be expected when measuring aPTT.	0
"Renal Impairment The pharmacokinetics of eszopiclone were studied in 24 patients with mild, moderate, or severe renal impairment."	0
The metabolism of saquinavir is mediated primarily by CYP3A.	0
Stagger the dosage of hydrochlorothiazide and the resin such that AVALIDE is administered at least 4 hours before or 4 to 6 hours after the administration of the resin.	0
Titration of the dose to higher or lower levels may be required to obtain an optimum therapeutic effect and/or to reduce the risk of side effects.	0
"Co-administration of SAMSCA with 400mg ketoconazole daily or with other strong CYP 3A inhibitors (e.g., clarithromycin, itraconazole, telithromycin, saquinavir, nelfinavir, ritonavir and nefazodone) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure."	1
"Pharmacodynamic mechanisms for drug interactions with COUMADIN are synergism (impaired hemostasis, reduced clotting factor synthesis), competitive antagonism (vitamin K), and alteration of the physiologic control loop for vitamin K metabolism (hereditary resistance)."	0
"In these patients, start PRINIVIL under medical supervision and follow such patients for the first two weeks of treatment and whenever the dose of PRINIVIL and/or diuretic is increased."	0
Diuretic activity persists for approximately 6 to 12 hours.	0
"Concurrent administration of fluconazole and amphotericin B in infected normal and immunosuppressed mice showed the following results: a small additive antifungal effect in systemic infection with C. albicans, no interaction in intracranial infection with Cryptococcus neoformans, and antagonism of the two drugs in systemic infection with A. fumigatus."	0
The concomitant use of Savella with MAOIs intended to treat psychiatric disorders is contraindicated.	0
"NARDIL should not be administered together with or in rapid succession to other MAO inhibitors because HYPERTENSIVE CRISES and convulsive seizures, fever, marked sweating, excitation, delirium, tremor, coma, and circulatory collapse may occur."	0
"In addition to age, 63% of the participants had at least one other risk factor (baseline HDL<U+2011>C <35mg/dL, hypertension, family history, smoking and diabetes)."	0
Other antidepressants: Nefazodone <U+2191> SaquinavirNefazodone inhibits CYP3A4; saquinavir concentrations may be increased Monitoring for saquinavir toxicity is recommended.	1
Starting NORPRAMIN in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome.	0
"Losartan potassium tablets were effective in reducing blood pressure regardless of race, although the effect was somewhat less in Black patients (usually a low-renin population)."	0
"Based on in vitro data in human liver microsomes, indinavir does not inhibit CYP1A2, CYP2C9, CYP2E1 and CYP2B6."	0
Do not administer AGGRASTAT through the same IV line as diazepam.	0
"The risk of torsades is increased by any of bradycardia, hypokalemia, hypomagnesemia, and high serum levels of quinidine, but it may appear in the absence of any of these risk factors."	0
Shake the suspension well before each use and return promptly to the refrigerator.	0
Coadministration of Effient and warfarin increases the risk of bleeding.	0
"An ECG should be done at baseline and periodically thereafter, especially during the period of dose adjustment."	0
Concomitant antacid administration may reduce the absorption of rifampin.	1
"In a clinical study, subjects on stable doses of valproate had comparable valproate average plasma concentrations when INVEGA<U+00AE> 3<U+2013>15 mg/day was added to their existing valproate treatment."	0
"Known hypersensitivity to sildenafil or any component of the tablet, injection, or oral suspension."	0
"Therefore, concomitant olanzapine administration does not require dosage adjustment of lithium."	0
"In more severely ill patients, dosage may be further increased to 150 mg/day."	0
The risk of using venlafaxine in combination with other CNS-active drugs has not been systematically evaluated.	0
Recommended dosing regimen for pediatric patients over 10 years of age and adults is once daily. b Use calibrated oral syringe for measurement.	0
Animal experiments have shown that inhalation anesthetics depress cardiovascular activity by decreasing the inward movement of calcium ions.	0
PR-interval prolongation is correlated with verapamil plasma concentrations especially during the early titration phase of therapy.	0
The mean apparent systemic clearance is 7.5 mL/min/kg.	0
"The absolute bioavailability of citalopram was about 80% relative to an intravenous dose, and absorption is not affected by food."	0
Cleviprex is intended for intravenous use.	0
"However, diazepam co-administered with olanzapine increased the orthostatic hypotension observed with either drug given alone."	0
Such patients may be unresponsive to the usual doses of epinephrine used to treat allergic reactions.	0
"Potential Effects of Coadministration of Drugs Highly Bound to Plasma Proteins<U+2013>Because sertraline is tightly bound to plasma protein, the administration of sertraline hydrochloride to a patient taking another drug which is tightly bound to protein (e.g., warfarin, digitoxin) may cause a shift in plasma concentrations potentially resulting in an adverse effect."	0
"Because fluvoxamine reduces the clearance of both diazepam and its active metabolite, N-desmethyldiazepam, there is a strong likelihood of substantial accumulation of both species during chronic coadministration."	1
There is no difference in the pharmacokinetics of candesartan between male and female subjects.	0
"Consequently, regular monitoring of weight and growth should be performed in children and adolescents treated with an SSRI such as PEXEVA<U+00AE>."	0
Reduced susceptibility to ledipasvir was associated with the primary NS5A amino acid substitution Y93H in both genotypes 1a and 1b.	0
"Therefore, serum lithium levels should be monitored carefully if lithium salts are to be co-administered with angiotensin II receptor antagonists."	0
"Similar drug-laboratory interactions should be considered for PRIFTIN; thus, alternative assay methods should be considered."	0
The risk of using FETZIMA in combination with other CNS-active drugs has not been systematically evaluated.	0
"Via this mechanism, platelet aggregation is inhibited in response to various stimuli such as platelet activating factor (PAF), collagen and adenosine diphosphate (ADP)."	0
"After initiation and/or upon titration of atorvastatin, lipid levels should be analyzed within 2 to 4 weeks and dosage adjusted accordingly."	0
"As with other calcium channel blockers, hemodynamic measurements of cardiac function at rest and during exercise (or pacing) in patients with normal ventricular function treated with amlodipine have generally demonstrated a small increase in cardiac index without significant influence on dP/dt or on left ventricular end diastolic pressure or volume."	0
"Patients receiving the combination of telmisartan and ramipril did not obtain any benefit in the composite endpoint of cardiovascular death, MI, stroke and heart failure hospitalization compared to monotherapy, but experienced an increased incidence of clinically important renal dysfunction (death, doubling of serum creatinine, or dialysis) compared with groups receiving telmisartan alone or ramipril alone."	0
The apparent half-life of 9-hydroxyrisperidone was about 21 hours (CV=20%) in extensive metabolizers and 30 hours (CV=25%) in poor metabolizers.	0
"In general, patients with renal failure will require the usual doses of mexiletine hydrochloride."	0
Dosage must be individualized and the smallest effective dosage should be determined for each patient.	0
Daily dosage should be divided into two to four dosages.	0
"Similarly, discontinuation of a CYP3A4 inducer, such as rifampin, carbamazepine, and phenytoin, in Meperidine Hydrochloride Injection-treated patients may increase meperidine plasma concentrations and prolong opioid adverse reactions."	1
Atenolol has been shown to produce a dose-related increase in embryo/fetal resorptions in rats at doses equal to or greater than 50 mg/kg/day or 25 or more times the maximum recommended human antihypertensive dose Based on the maximum dose of 100 mg/day in a 50 kg patient..	0
Onset of SLE typically occurred within days to years after initiating treatment primarily in patients ranging from young adults to the elderly.	0
Trandolaprilat is about 8 times more potent than trandolapril.	0
The recommended dosage of MULTAQ is 400 mg twice daily in adults.	0
Such concomitant therapy can be associated with rapid increases in serum potassium levels.	0
"By binding phosphate in the gastrointestinal tract and decreasing absorption, sevelamer carbonate lowers the phosphate concentration in the serum (serum phosphorus)."	0
Most patients will require 10 mg for adequate effect.	0
Measure heart rate prior to initiating treatment and periodically monitor the heart rate throughout Savella treatment.	0
"Grade 3 or 4 events occurred in 0.7% and 1.4% of patients in the Tasigna 300 mg twice daily and 400 mg twice daily arms, respectively, and in no patients in the imatinib arm."	0
Fingolimod-phosphate has a smaller uptake in blood cells of <17%.	0
Bisoprolol fumarate and HCTZ have been used individually and in combination for the treatment of hypertension.	0
Smokers had a 25% increase in the metabolism of fluvoxamine compared to nonsmokers.	0
"In three additional studies involving 392 patients taking PERSANTINE tablets and coumarin-like anticoagulants, the incidence of thromboembolic events ranged from 2.3 to 6.9%."	0
"The risk of QT prolongation and/or ventricular arrhythmias (e.g., Torsades de Pointes) may be increased with concomitant use of medicines which prolong the QTc interval (e.g., some antipsychotics and antibiotics) and in case of mirtazapine overdose."	0
No criteria for broth microdilution are available.2 26 <U+2212> 34	0
"The risk differences (drug vs placebo), however, were relatively stable within age strata and across indications."	0
Effect on Digoxin - The potential role of prasugrel as a Pgp substrate was not evaluated.	0
Clinical studies of quinidine did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
"By blocking the positive chronotropic and inotropic effects of catecholamines and by decreasing blood pressure, atenolol generally reduces the oxygen requirements of the heart at any given level of effort, making it useful for many patients in the long-term management of angina pectoris."	0
"Hyperpyrexia has been reported when amitriptyline hydrochloride is administered with anticholinergic agents or with neuroleptic drugs, particularly during hot weather."	0
"Patients treated with 10 mg amlodipine who experience any dose-limiting adverse reactions such as edema, may be switched to TWYNSTA 40/5 mg tablets once daily, reducing the dose of amlodipine without reducing the overall expected antihypertensive response."	0
"In one study, pediatric patients 6 to 58 months old were given rifampin suspended in simple syrup or as dry powder mixed with applesauce at a dose of 10 mg/kg body weight."	0
"Because it is known that the risk of myopathy during treatment with HMG-CoA reductase inhibitors is increased with concurrent administration of other fibrates, pravastatin sodium should be administered with caution when used concomitantly with other fibrates."	0
Coadministration with drugs that are highly dependent on CYP3A for clearance and which elevated concentrations are associated with serious and/or life-threatening events (4)	1
Improved left ventricular diastolic function in patients with idiopathic hypertrophic subaortic stenosis (IHSS) and those with coronary heart disease has also been observed with verapamil therapy.	0
Insulin A clinical study in 6 insulin-dependent diabetic patients demonstrated no effect of EXTRANEAL on insulin absorption from the peritoneal cavity or on insulin<U+2019>s ability to control blood glucose when insulin was administered intraperitoneally with EXTRANEAL.	0
"After single and repeated administration, the pharmacokinetics of candesartan are linear for oral doses up to 32 mg of candesartan cilexetil."	0
"Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders."	0
There is a linear correlation between plasma quinaprilat clearance and creatinine clearance.	0
"(7.1, 7.2) Patients receiving more than 40 mg per day of simvastatin or lovastatin may be at increased risk of statin-related adverse effects."	0
Leukocytosis (WBC count greater than 10 Gi/L) Administer hydroxyurea.	0
"During the initial phase of combination antiretroviral treatment, patients whose immune system responds may develop an inflammatory response to indolent or residual opportunistic infections (such as Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia [PCP], or tuberculosis), which may necessitate further evaluation and treatment."	0
"Digoxin is not effectively removed from the body by dialysis, exchange transfusion, or cardiopulmonary bypass because most of the drug is bound to tissue."	0
"Ritonavir: Compared to historical data in patients who received indinavir 800 mg every 8 hours alone, twice-daily coadministration to volunteers of indinavir 800 mg and ritonavir with food for two weeks resulted in a 2.7-fold increase of indinavir AUC24h, a 1.6-fold increase in indinavir Cmax, and an 11-fold increase in indinavir Cmin for a 100-mg ritonavir dose and a 3.6-fold increase of indinavir AUC24h, a 1.8- fold increase in indinavir Cmax, and a 24-fold increase in indinavir Cmin for a 200-mg ritonavir dose."	1
A study of multiple doses of fluvoxamine maleate (50 mg b.i.d.) in healthy male volunteers (N = 12) and a single dose of lorazepam (4 mg single dose) indicated no significant pharmacokinetic interaction.	0
"<U+2022>PPIs, including ACIPHEX, are contraindicated with rilpivirine-containing products."	0
"Subsequent doses should be oral, 25-50 mg tid."	0
"However, prior to initiating treatment with STRATTERA, patients with comorbid depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression."	0
Drain the peritoneal dialysis solution from the peritoneal cavity to treat overinfusion.	0
Ambrisentan is absorbed with peak concentrations occurring approximately 2 hours after oral administration in healthy subjects and PAH patients.	0
"In patients with more severe renal impairment, loop diuretics are preferred to thiazides."	0
"Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including TARKA."	0
"In a patient who requires more urgent treatment of a psychiatric condition, other interventions, including hospitalization, should be considered."	0
"In hemodynamic studies, amlodipine has not been associated with a negative inotropic effect when administered in the therapeutic dose range to intact animals and man, even when co-administered with beta-blockers to man."	0
A reduction of 10 to 30% was achieved with the typical participant in the domestic placebo controlled trials who was assigned to selegiline treatment.	0
"Co-administration of FANAPT with known strong inhibitors of CYP2D6 like fluoxetine results in a 2.3-fold increase in iloperidone plasma exposure, andtherefore one-half of the FANAPT dose should be administered."	1
"In spite of the effect of candesartan cilexetil on aldosterone secretion, very little effect on serum potassium was observed."	0
"When LEXIVA is used in combination with ritonavir, prescribers should consult the full prescribing information for ritonavir."	0
"IMURAN may be continued long-term in patients with clinical response, but patients should be monitored carefully, and gradual dosage reduction should be attempted to reduce risk of toxicities."	0
Monitor patients for changes in blood pressure and heart rate.	0
"Examples of acidifying agents include gastrointestinal acidifying agents (e.g., guanethidine, reserpine, glutamic acid HCl, ascorbic acid) and urinary acidifying agents (e.g., ammonium chloride, sodium acid phosphate, methenamine salts)."	0
"If symptomatic hypotension occurs, the patient should be placed in the supine position and, if necessary, normal saline may be administered intravenously."	0
"Prophylaxis of gout-flares-co-administration of colchicine in patients on INVIRASE/ritonavir: If the original colchicine regimen was 0.6 mg twice a day, the regimen should be adjusted to 0.3 mg once a day."	1
Safety and effectiveness of mirtazapine in the pediatric population have not been established.	0
The optimal duration of thienopyridine therapy is unknown.	0
Distribution The in vitro plasma protein binding of dronedarone and its N-debutyl metabolite is >98% and not saturable.	0
"Angiotensin Converting Enzyme (ACE) Inhibitors Due to the indirect effect of aspirin on the renin-angiotensin conversion pathway, the hyponatremic and hypotensive effects of ACE inhibitors may be diminished by concomitant administration of aspirin."	0
"The approximately 4,000-fold selectivity for PDE-5 versus PDE3 is important because PDE3 is involved in control of cardiac contractility."	0
"Similarly, chlorpromazine in combination with zolpidem produced no pharmacokinetic interaction, but there was an additive effect of decreased alertness and psychomotor performance."	0
"Constant monitoring of the electrocardiogram and blood pressure is essential in the proper administration of Lidocaine Hydrochloride Injection, USP intravenously."	0
Use another rabeprazole formulation for pediatric patients 1 year to less than 12 years of age.	0
It is not recommended that Zanaflex be used with other <U+03B1> 2-adrenergic agonists.	0
Shown are the Geometric Mean Ratios (Ratio) and 90% Confidence Interval (90% CI).	0
Multiple drug ingestion (including alcohol) is common in deliberate tricyclic antidepressant overdose.	0
"Correct volume status, acid-base balance, and electrolyte deficits as appropriate."	0
Pressor responses to exogenous angiotensin I were inhibited by 60% - 90% (up to 4 hours post-dose) at the 10 mg dose.	0
"Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including VASOTEC. mTOR (mammalian target of rapamycin) inhibitors: Patients receiving coadministration of ACE inhibitor and mTOR inhibitor (e.g., temsirolimus, sirolimus, everolimus) therapy may be at increased risk for angioedema (see WARNINGS)."	0
"Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death."	0
"Hepatic Impairment In volunteers with mild to moderate hepatic cirrhosis (Child-Pugh class A and B), sildenafil clearance was reduced, resulting in increases in AUC (84%) and Cmax (47%) compared to age-matched volunteers with no hepatic impairment."	0
"Alternative treatment for clarithromycin should be considered when treating patients receiving rifabutin ANTI-TB (Tuberculosis) Ethambutol 1200 mg 300 mg QD <U+00D7> 7 days Healthy subjects (10) ND <U+2194> Isoniazid 300 mg 300 mg QD <U+00D7> 7 days Healthy subjects (6) ND <U+2194> OTHER Methadone 20 <U+2013> 100 mg QD 300 mg QD <U+00D7> 13 days HIV-infected patients (24) ND <U+2194> Ethinylestradiol (EE)/Norethindrone (NE) 35 mg EE / 1 mg NE <U+00D7> 21 days 300 mg QD <U+00D7> 10 days Healthy female subjects (22) ND EE: <U+2193> AUC by35%, <U+2193> Cmax by 20%NE: <U+2193> AUC by 46% Patients should be advised to use additional or alternative methods of contraception."	0
"4.As with all potent intravenously administered drugs, care should be taken to control the rate of infusion so as to avoid inadvertent administration of a bolus of the drug."	0
"Careful observation for digital changes is necessary during treatment with stimulants (5.6) Serotonin Syndrome: Increased risk when co-administered with serotonergic agents (e.g., SSRIs, SNRIs, triptans), but also during overdosage situations."	0
Experiments in anesthetized rats and dogs show that clevidipine reduces mean arterial blood pressure by decreasing systemic vascular resistance.	0
"Given the primary CNS effects of quetiapine, caution should be used when it is taken in combination with other centrally acting drugs."	0
NS5A resistance-associated substitutions for other NS5A inhibitors have been found to persist for >1 year in some patients.	0
"Based on urinary recovery of total radiolabeled drug, the average oral absorption of pravastatin is 34% and absolute bioavailability is 17%."	0
"Higher tenofovir concentrations could potentiate tenofovir-associated adverse reactions, including renal disorders."	0
"Refer to VIREAD or TRUVADA prescribing information for recommendations on renal monitoring. elvitegravir, cobicistat, emtricitabine, tenofovir DF <U+2191> tenofovir The safety of increased tenofovir concentrations in the setting of HARVONI and the combination of elvitegravir, cobicistat, emtricitabine and tenofovir DF has not been established. tipranavir/ritonavir <U+2193> ledipasvir<U+2193> sofosbuvir<U+2193> GS-331007 Coadministration of HARVONI with tipranavir/ritonavir is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI."	1
Advise patients to use effective alternative or back-up methods of contraception during treatment with EMEND and for 1 month following the last dose of EMEND.	0
"However, in a clinical study with coadministration of BRINTELLIX (10 mg/day) and warfarin (1 mg/day to 10 mg/day), a highly protein-bound drug, no significant change in INR was observed."	0
"In nonclinical studies in rats, vandetanib was embryotoxic, fetotoxic, and teratogenic at exposures equivalent to or lower than those expected at the recommended human dose of 300 mg/day and had adverse effects on female fertility, embryofetal development, and postnatal development of pups."	0
"Ketoconazole: Co-administration of ketoconazole (200 mg twice daily for 4 days), a potent inhibitor of CYP3A4, with a 3 mg single dose of iloperidone to 19 healthy volunteers, ages 18 to 45 years, increased the area under the curve (AUC) of iloperidone and its metabolites P88 and P95 by 57%, 55% and 35%, respectively."	1
An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy.	0
"Genotype 4, 5 or 6 Phylogenetic analysis of HCV sequences from genotype 4-infected subjects in Study 1119 (N=44) and ION-4 (N=8) identified 7 HCV genotype 4 subtypes (4a, 4b, 4d, 4f, 4m, 4o, and 4r)."	0
"Absorption and Binding - Following oral administration, <U+2265>79% of the dose is absorbed."	0
"Based on the nonlinear pharmacokinetic profile of nilotinib, increasing the dose of Tasigna when coadministered with such agents is unlikely to compensate for the loss of exposure."	0
Carbamazepine has been reported to increase the degree of heart block produced by other agents.	0
Most patients improve with discontinuation of the PPI alone in 4 to 12 weeks.	0
The mean change in heart rate in these studies was less than one beat per minute.	0
HIV protease inhibitor: Saquinavira LEXIVA: <U+2193>Amprenavir Effect on saquinavir is not well established.	0
"Therefore , after the initial loading dose of aspirin , use BRILINTA with a maintenance dose of aspirin of 75-100 mg see Dosage and Administration ( 2.1 ) and Clinical Studies ( 14.1 ) ."	0
The latter decrease may result in a small increase of serum potassium.	0
"Serum electrolytes ( particularly potassium ) , CO2 , creatinine and BUN should be determined frequently during the first few months of LASIX therapy and periodically thereafter ."	0
"Reproduction studies with dipyridamole have been performed in mice, rabbits and rats at oral doses of up to 125 mg/kg, 40 mg/kg and 1000 mg/kg, respectively (about 1<U+00BD>, 2 and 25 times the maximum recommended daily human oral dose, respectively, on a mg/m2 basis) and have revealed no evidence of harm to the fetus due to dipyridamole."	0
Resistance to atazanavir may not preclude the subsequent use of other protease inhibitors.	0
"The primary actions of ETA are vasoconstriction and cell proliferation, while the predominant actions of ETB are vasodilation, antiproliferation, and ET-1 clearance."	0
The dosage can be increased to a maximum dose of 300 mg once daily as needed to control blood pressure.	0
Physicians are encouraged to register patients by calling 1-800-258-4263.	0
Figure 3.1<U+2003>Effect of P-gp Inhibitor or Inducer (rifampicin) Drugs on Peak and Total Exposure to Dabigatran (Cmax and AUC).	0
The minor fluctuations in urinary pH associated with normal diet do not affect the excretion of mexiletine.	0
"Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)."	0
"PDE5 inhibitors (phosphodiesterase type 5 inhibitors): Sildenafil, vardenafil, tadalafil <U+2191> Sildenafil<U+2194> Saquinavir <U+2191> Vardenafil<U+2191> Tadalafil Only the combination of sildenafil with saquinavir soft gelatin capsules has been studied at doses used for treatment of erectile dysfunction."	0
Peak plasma levels are obtained in 3 to 4 hours and the plasma half-life varies from 6 to 9 hours.	0
Metabolites were formed with a half-life of 10 hours and excreted with a half-life of approximately 2 hours.	0
"Severe and sometimes fatal skin reactions, including toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome, have occurred in patients treated with CAPRELSA."	0
"Potassium is a normal dietary constituent, and under steady state conditions, the amount of potassium absorbed from the gastrointestinal tract is equal to the amount excreted in the urine."	0
Increasing the dose will not shorten this period but rather increase the incidence of adverse reactions.	0
"The maximum mean (95% upper confidence bound) difference in QTcF from placebo after baseline-correction was 19.5 (21.8) ms and 5.6 (7.4) ms after 15 minute intravenous infusions of 32 mg and 8 mg Ondansetron, respectively."	0
There were no changes in the pharmacokinetic parameters for nefazodone.	0
"When NATRECOR<U+00AE> was initiated at doses higher than 0.01 mcg/kg/min (0.015 and 0.03 mcg/kg/min), there was an increased rate of elevated serum creatinine over baseline compared with standard therapies, although the rate of acute renal failure and need for dialysis was not increased."	0
"Desmethylsertraline exhibits time-related, dose dependent increases in AUC (0 to 24 hour), Cmax and Cmin, with about a 5 to 9 fold increase in these pharmacokinetic parameters between day 1 and day 14."	0
Enalapril and enalaprilat have been detected in human breast milk .	0
"Furthermore, whenever one of these other drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant may be required."	0
"Protease Inhibitors: saquinavir (soft gelatin capsules) <U+2191> saquinavir Appropriate dosing recommendations for this combination, with or without ritonavir, with respect to efficacy and safety have not been established."	0
"Therapeutic benefit may be obtained from concentrations as low as 8 mcg/ml; higher concentrations (i.e., 30 mcg/ml) are expected to provide more complete inhibition of urease."	0
"Patients with Renal Impairment: Renal disease does not affect the plasma concentrations nor LDL-C reduction of atorvastatin; thus, dosage adjustment in patients with renal dysfunction is not necessary."	0
"In the placebo-controlled fibromyalgia trials, increases in the number of patients treated with Savella with mild elevations of ALT or AST (1-3 times the upper limit of normal, ULN) were observed."	0
"Based on this pharmacokinetic parameter, steady-state sertraline plasma levels should be achieved after approximately one week of once-daily dosing."	0
"Whether increased levels of bradykinin, a potent vasodepressor peptide, play a role in the therapeutic effects of Lotensin remains to be elucidated."	0
IMURAN should be administered with caution to patients having one non-functional allele (heterozygous) who are at risk for reduced TPMT activity that may lead to toxicity if conventional doses are given.	0
No pharmacokinetic interaction was observed when single doses of quinapril and hydrochlorothiazide were administered concomitantly.	0
It is not known whether doses lower than 80 mg of telmisartan are effective in reducing the risk of cardiovascular morbidity and mortality.	0
About 50% of the circulating species in plasma have been identified.	0
"The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents."	0
Patients should be advised to notify their physician if they develop visual disturbances.	0
In treatment-naive adult patients: The proton-pump inhibitor (PPI) dose should not exceed a dose comparable to omeprazole 20 mg and must be taken approximately 12 hours prior to the REYATAZ 300 mg with ritonavir 100 mg dose.	1
"Carcinogenesis, Mutagenesis, Impairment of Fertility: Long term animal studies have not been performed to evaluate the carcinogenic potential of dopamine HCl."	0
This interaction should be considered if coprescribing ACCUPRIL and tetracycline or other drugs that interact with magnesium.	0
"Since verapamil is highly metabolized by the liver, it should be administered cautiously to patients with impaired hepatic function."	0
Apixaban is eliminated in both urine and feces.	0
The trough/peak ratios ranged from 70 to 100% for diastolic and systolic blood pressure.	0
"If possible, the dosage of sotalol should be gradually reduced over a period of one to two weeks."	0
"Cyclosporine ( CYP3A substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine ."	0
Steady-state plasma levels of icodextrin metabolites were achieved within one week and stable plasma levels were observed during long-term administration.	0
The effects of COUMADIN may become more pronounced as effects of daily maintenance doses overlap.	0
TPMT genotyping or phenotyping can be used to identify patients with absent or reduced TPMT activity.	0
The pharmacokinetics of R - and S - warfarin and the INR in healthy subjects given a single 25 mg dose of warfarin were unaffected by continuous subcutaneous infusion of treprostinil at an infusion rate of 10 ng/kg/min .	0
Twenty-four hour control with once daily dosing is achieved by giving doses larger than necessary to achieve an immediate maximum effect.	0
"PROCARDIA capsules should not be administered within the first week or two after myocardial infarction, and they should also be avoided in the setting of acute coronary syndrome (when infarction may be imminent)."	0
Fluconazole may increase the serum concentrations of orally administered tacrolimus up to 5 times due to inhibition of tacrolimus metabolism through CYP3A4 in the intestines.	1
"There has been no long-term use of telmisartan in patients with unilateral or bilateral renal artery stenosis, but anticipate an effect similar to that seen with ACE inhibitors."	0
"As with these other agents, Savella should be used cautiously in patients with a history of mania."	0
"The low plasma concentrations of known active and inactive metabolites of doxazosin (2-piperazinyl, 6'- and 7'-hydroxy and 6- and 7-O-desmethyl compounds) compared to parent drug indicate that the contribution of even the most potent compound (6'-hydroxy) to the antihypertensive effect of doxazosin in man is probably small."	0
"In the Phase 3 trials and SOLAR trials, the specific baseline NS5A resistance-associated polymorphisms observed among subjects who relapsed were M28T/V, Q30H/R, L31M, H58D/P, and Y93H/N in genotype 1a, and L28M, L31M, A92T, and Y93H in genotype 1b."	0
Further dosage reduction may be necessary.	0
"If oliguria or hypotension occurs, direct attention toward support of blood pressure and renal perfusion."	0
"In these large, double-blind studies, deaths occurred in 36% (541/1511) of TIKOSYN patients and 37% (560/1517) of placebo patients."	0
"Androgen deprivation therapies, such as treatment with GnRH agonists or orchiectomy, decrease androgen production in the testes but do not affect androgen production by the adrenals or in the tumor."	0
"The pooled analyses of placebo-controlled trials in adults with MDD or other psychiatric disorders included a total of 295 short-term trials (median duration of 2 months) of 11 antidepressant drugs in over 77,000 patients."	0
"Concomitant administration of oral or intravenous nicardipine and cyclosporine results in elevated plasma cyclosporine levels through nicardipine inhibition of hepatic microsomal enzymes, including CYP3A4."	1
"The onset, duration, and severity of neonatal opioid withdrawal syndrome vary based on the specific opioid used, duration of use, timing and amount of last maternal use, and rate of elimination of the drug by the newborn."	0
"The half-life remained unchanged, approximately 6 hours."	0
"Compared with healthy subjects, subjects with heart failure had increased mean AUC and Cmax values for carvedilol and its enantiomers, with up to 50% to 100% higher values observed in 6subjects with NYHA class IV heart failure."	0
"In hypertensive patients, chronic oral doses of irbesartan (up to 300 mg) had no effect on glomerular filtration rate, renal plasma flow or filtration fraction."	0
Didanosine Indinavir and didanosine formulations containing buffer should be administered at least one hour apart on an empty stomach.	0
"New Psychotic or Manic Symptoms CNS stimulants, at recommended doses, may cause psychotic or manic symptoms, e.g. hallucinations, delusional thinking, or mania in children and adolescents without a prior history of psychotic illness or mania."	0
HARVONI is a fixed-dose combination of ledipasvir and sofosbuvir which are direct-acting antiviral agents against the hepatitis C virus.	0
Antihypertensive effects of VASOTEC have been established in hypertensive pediatric patients age 1 month to 16 years .	0
Patients receiving warfarin therapy should be carefully monitored when paroxetine is initiated or discontinued.	0
Potent inhibitors of CYP1A2 should be avoided (7.1).	0
Digoxin The steady-state pharmacokinetics of paroxetine was not altered when administered with digoxin at steady state.	0
"In adult ADHD controlled trials, the rates of urinary retention (1.7%,9/540) and urinary hesitation (5.6%,30/540) were increased among atomoxetine subjects compared with placebo subjects (0%,0/402 ; 0.5%, 2/402, respectively)."	0
Anaphylactoid Reactions During Desensitization Two patients undergoing desensitizingtreatment with hymenoptera venom while receiving ACE inhibitors sustained life-threatening anaphylactoid reactions.	0
"Other Withdrawal-Emergent Phenomena The potential for other withdrawal phenomena was also assessed in 14- to 28-night studies, including both the sleep laboratory studies and the outpatient studies, and in open-label studies of 6- and 12-month durations."	0
"Avoid abrupt withdrawal (including interruptions in drug delivery) or sudden large reductions in dosage of FLOLAN because symptoms associated with rebound pulmonary hypertension (e.g., dyspnea, dizziness, and asthenia) may occur."	0
"In this small study, doses above 400 mg were not more effective and were less well tolerated."	0
Consider reducing the CLOZARIL dosage if necessary.	0
Avoid use of aliskiren with Diovan in patients with renal impairment ( GFR 60 mL/min ) .	0
The usual initial dose of metoprolol succinate extended release is 25 to 100 mg daily in a single dose.	0
"In 19 pruritic eczema patients treated with PRUDOXIN Cream, plasma doxepin concentrations ranged from nondetectable to 47 ng/mL from percutaneous absorption."	0
Refer to the quetiapine prescribing information for recommendations on adverse reaction monitoring.	0
A pH > 7.60 or a pCO2 < 20 mm Hg is undesirable.	0
Triamterene and quinidine have similar fluorescence spectra; thus triamterene and hydrochlorothiazide may interfere with the measurement of quinidine.	0
Uricosuric Agents (probenecid and sulfinpyrazone) Salicylates antagonize the uricosuric action of uricosuric agents.	0
Drugs that prolong the QT interval have been associated with cases of torsades de pointes in patients with bradycardia.	0
Patients over 65 are expected to develop higher plasma concentrations of nisoldipine.	0
Study 3 was a 12-week flexible-dose study comparing paroxetine (10 to 60 mg daily) to placebo in patients concurrently receiving standardized cognitive behavioral therapy.	0
"Diazepam Under steady-state conditions, diazepam does not appear to affect paroxetine kinetics."	0
Caution is indicated in administering REMERON to patients with compromised renal function.	0
Metoprolol succinate extended release doses greater than 400 mg have not been studied.	0
"While the inhibition of cAMP-PDE is weak, therapeutic levels of dipyridamole inhibit cyclic-3',5'-guanosine monophosphate-PDE (cGMP-PDE), thereby augmenting the increase in cGMP produced by EDRF (endothelium-derived relaxing factor, now identified as nitric oxide)."	0
Further dosage reduction may be necessary.	0
Female patients constituted 32% of the patients in the placebo-controlled trials of TIKOSYN.	0
PRISTIQ should be taken at approximately the same time each day.	0
"Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of NORVASC, particularly in patients with severe obstructive coronary artery disease."	0
Concentrations of hydrochlorothiazide are 1.6 to 1.8 times higher in whole blood than in plasma.	0
Benzodiazepines: Parenterally administered midazolam <U+2191> Midazolam Midazolam is extensively metabolized by CYP 3A4.	0
Refer to the idarucizumab prescribing information for additional information.	0
"There was a linear dose-response improvement in total sleep time and sleep latency, with significant drug-placebo differences at 2 weeks occurring only for total sleep time at the two higher doses, and for sleep latency only at the highest dose."	0
"Although some serious heart problems alone carry an increased risk of sudden death, atomoxetine generally should not be used in children or adolescents with known serious structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious cardiac problems that may place them at increased vulnerability to the noradrenergic effects of atomoxetine."	0
The presence of sotalol in the urine may result in falsely elevated levels of urinary metanephrine when measured by fluorimetric or photometric methods.	0
"Class Effect: In clinical trial and/or postmarketing experience, events of leukopenia/neutropenia and agranulocytosis have been reported temporally related to antipsychotic agents."	0
<U+25CF>Newly diagnosed patients who loseMMR must re-initiate treatment within 4 weeksat the dose level prior to discontinuation of therapy.	0
The divided regimen was more effective in controlling trough(pre-dosing) blood pressure than the same dose given as a once-dailyregimen.	0
"Concomitant administration of gemfibrozil, cyclosporine, or danazol."	0
"Greater sensitivity (e.g., confusional states, sedation) of some older individuals cannot be ruled out."	0
"No activation of mania or hypomania was reported in DPNP, GAD, fibromyalgia, or chronic musculoskeletal pain placebo-controlled trials."	0
"Amiodarone is a substrate for CYP3A and CYP2C8, so inhibitors and inducers affect amiodarone exposure (7) Amiodarone inhibits p-glycoprotein and CYP1A2, CYP2C9, CYP2D6, and CYP3A, increasing exposure to other drugs (7) Drugs prolonging the QT interval: Co-administration of drugs prolonging the QT interval (such as class I and III antiarrhythmics, lithium, certain phenothiazines, tricyclic antidepressants, certain fluoroquinolone and macrolide antibiotics, azole antifungals, halogenated inhalation anesthetic agents) increases the risk of Torsade de Pointes."	0
"Metabolism Following oral administration, eszopiclone is extensively metabolized by oxidation and demethylation."	0
"Amiodarone has the potential for interactions with drugs or substances that may be substrates , inhibitors or inducers of CYP450 enzymes ( e.g. , inhibitors such as protease inhibitors , grapefruit juice , certain fluoroquinolone and macrolide antibiotics , azole antifungals and inducers such as St.   John s Wort ) or P-glycoprotein ."	0
Temazepam improved sleep parameters in clinical studies.	0
"Dopamine Hydrochloride in 5% Dextrose Injection, USP contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people."	0
Absorption: Oral administration of ACEON results in peak plasma concentrations that occur at approximately 1 hour.	0
The mechanism of this syndrome is not understood.	0
Inspect the EXTRANEAL container for signs of leakage and check for minute leaks by squeezing the container firmly.	0
Tadalafil (10 mg or 20 mg) did not affect alcohol plasma concentrations and alcohol did not affect tadalafil plasma concentrations.	0
"Four primary metabolic pathways have been identified in vivo, none of which could be shown to account for more than 10% of the dose: dealkylation, hydroxylation, dehydrogenation, and benzisoxazole scission."	0
Dilute to volumes appropriate for the pump delivery system available.	0
Such volume depletion should be corrected prior to administration of antihypertensive therapy.	0
"The adverse effects of bisoprolol are a mixture of dose-dependent phenomena (primarily bradycardia, diarrhea, asthenia, and fatigue) and dose-independent phenomena (eg, occasional rash); those of hydrochlorothiazide are a mixture of dose-dependent phenomena (primarily hypokalemia) and dose-independent phenomena (eg, possibly pancreatitis); the dose-dependent phenomena for each being much more common than the dose-independent phenomena."	0
The usual starting dose is AVALIDE 150/12.5 mg once daily.	0
"Reproduction studies have been performed in rabbits and rats at oral doses up to 1.5 (15 mg/kg/day) and 6 (60 mg/kg/day) times the human oral daily dose, respectively, and have revealed no evidence of teratogenicity."	0
"For patients with severe HI(Child-Pugh ClassC), initial dose and target doses should be reduced to25% of normal."	0
Zanaflex should be used with caution in patients with any hepatic impairment..	0
"Using a suitable size syringe and aseptic technique, withdraw the required volume of VFEND concentrate from the appropriate number of vials and add to the infusion bag or bottle."	0
"Therapeutic doses of meperidine have occasionally precipitated unpredictable, severe, and occasionally fatal reactions in patients who have received such agents within 14 days."	0
Unchanged apixaban is the major drug-related component in human plasma; there are no active circulating metabolites.	0
The QT interval increases linearly with increasing TIKOSYN dose.	0
"After an accelerated elimination procedure with cholestyramine, an additional 23.1% was recovered (mostly in feces)."	0
Consideration should be given to stopping the infusion should these reactions occur.	0
"Tricyclic Antidepressants (TCA): Caution is indicated in the coadministration of tricyclic antidepressants (TCAs) with PEXEVA<U+00AE> (paroxetine mesylate), because paroxetine may inhibit TCA metabolism."	1
The primary treatment is to discontinue hydrochlorothiazide as rapidly as possible.	0
Concomitant use of CLOZARIL with other drugs metabolized by CYP2D6 can increase levels of these CYP2D6 substrates.	1
Elevations of liver transaminases may occur in patients receiving PRIFTIN.	0
Fosamprenavir/Ritonavir<U+2014> Coadministration of fosamprenavir/ ritonavir with paroxetine significantly decreased plasma levels of paroxetine.	1
"As with all drugs effective in the treatment of major depressive disorder, Lexapro should be used cautiously in patients with a history of mania."	0
"Studies in rats have shown that amiloride is excreted in milk in concentrations higher than those found in blood, but it is not known whether amiloride HCl is excreted in human milk."	0
"Tell patients receiving ACCURETIC that lightheadedness can occur, especially during the first days of therapy, and to report it to the prescribing physician."	0
"For patients with risk factors predictive of CAD who are determined to have a satisfactory cardiovascular evaluation, it is strongly recommended that administration of the first dose of D.H.E."	0
Anticoagulants : Potentiation of warfarin - type ( CYP2C9 and CYP3A substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .	0
"(For further information about the description of tardive dyskinesia and its clinical detection, please refer to ADVERSE REACTIONS and PRECAUTIONS - Information for Patients )."	0
"Patients with a preexisting low WBC or a history of drug induced leukopenia/neutropenia should have their complete blood count (CBC) monitored frequently during the first few months of therapy and should discontinue Thioridazine Hydrochloride Tablets, USP at the first sign of a decline in WBC in the absence of other causative factors."	0
Concomitant administration of fluvastatin and glyburide increased glyburide exposures.	1
Penicillin G is no longer considered a drug of choice for infections caused by these organisms.	0
"For patients with a baseline QT interval < 450 msec, an on-treatment ECG is recommended after approximately 10 days of therapy."	0
Adults: 5 or 10 mg single dose; separate repeat doses by at least two hours; maximum dose in a 24-hour period: 30 mg (2.1) Pediatric patients 6 to 17 years: 5 mg single dose in patients less than 40 kg (88 lb); 10 mg single dose in patients 40 kg (88 lb) or more (2.2) Adjust dose if co-administered with propranolol (2.4) The recommended starting dose of MAXALT is either 5 mg or 10 mg for the acute treatment of migraines in adults.	0
Other antihypertensive drugs <U+2013> Additive effect or potentiation.	0
<U+2022> Treatment-experienced adults: REYATAZ 300 mg with ritonavir 100 mg once daily with food.	0
Table 1: Conversion from Oral Sotalol to Intravenous Sotalol Oral dose Once or twice daily Intravenous dose Once or twice daily Administered over 5 hours 80 mg 75 mg (5 mL sotalol injection) 120 mg 112.5 mg (7.5 mL sotalol injection) 160 mg 150 mg (10 mL sotalol injection) Intravenous sotalol must be diluted for infusion.	0
The results of this analysis are included in Table 4 and are compared to the pharmacokinetic results in cancer patients 4 to 18 years of age.	0
"Chronic studies of atenolol performed in animals have revealed the occurrence of vacuolation of epithelial cells of Brunner's glands in the duodenum of both male and female dogs at all tested dose levels (starting at 15 mg/kg/day or 7.5 times the maximum recommended human antihypertensive dose) and increased incidence of atrial degeneration of hearts of male rats at 300 but not 150 mg atenolol/kg/day (150 and 75 times the maximum recommended human antihypertensive dose, respectively)."	0
"Because these events have been reported voluntarily during clinical practice, estimates of frequency cannot be made and a causal relationship between protease inhibitor therapy and these events has not been established."	0
"1996; 53:655<U+2013>8), use of 112 inches of tubing resulted in 30% loss of quinidine, but drug loss was less than 3% when only 12 inches of tubing was used."	0
Pharmacologic studies indicate that there may be additive effects in prolonging AV conduction when using beta-blockers or digitalis concomitantly with CARDIZEM.	0
Caution is indicated in administering REMERON to elderly patients.	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
"Except in life-threatening situations, avoid this combination."	0
No dose adjustment of lamotrigine is required when coadministered with REYATAZ without ritonavir.	0
Failure to correctly co-administer APTIVUS with ritonavir will result in plasma levels of tipranavir that will be insufficient to achieve the desired antiviral effect and will alter some drug interactions.	1
"In early dose titration with verapamil, a relationship exists between plasma concentrations of verapamil and prolongation of the PR interval."	0
Patients should be closely monitored when LUVOX CR Capsules and clozapine are used concurrently.	0
This interaction was not accompanied by ECG changes and its clinical significance is not known.	0
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.	0
Multiple doses of BRINTELLIX did not affect the pharmacokinetics or pharmacodynamics (composite cognitive score) of diazepam.	0
Initiate therapy with 2.5 mg in patients with a low systolic blood pressure (100-120 mmHg) during the first 3 days after the infarct.	0
"Blood products and concentrated electrolytes VFEND I.V. must not be infused concomitantly with any blood product or short-term infusion of concentrated electrolytes, even if the two infusions are running in separate intravenous lines (or cannulas)."	0
"Switching from XARELTO to Anticoagulants other than Warfarin - For patients currently taking XARELTO and transitioning to an anticoagulant with rapid onset , discontinue XARELTO and give the first dose of the other anticoagulant ( oral or parenteral ) at the time that the next XARELTO dose would have been taken see Drug Interactions ( 7.4 ) ."	0
Monitor blood pressure and adjust dosage of antihypertensive drug accordingly.	0
Ask patients to report pregnancies to their physicians as soon as possible.	0
Pregnancy Category B. Reproduction studies have been performed in rats at doses up to 1.6 times the human dose (based on mg/m2) and have revealed no evidence of impaired fertility or harm to the fetus due to diethylpropion hydrochloride.	0
Digitalis therapy may exaggerate metabolic effects of hypokalemia especially with reference to myocardial activity.	0
"It is important to taper beta blockers if possible, rather than stopping them abruptly before beginning PROCARDIA."	0
This dose should also be maintained for 7 to 14days and can then be adjusted upward to 25mg twice daily if tolerated and needed.	0
These tumors were common in control groups as well as treated groups and the difference became apparent only in aged rats.	0
Administration Instructions Withdraw the bolus dose of AGGRASTAT from the 15 mL premixed bolus vial into a syringe.	0
Hypotension may develop in patients given MINIPRESS who are also receiving a beta-blocker such as propranolol.	0
"If laryngeal stridor or angioedema of the face, tongue, or glottis occurs, treatment with ACCUPRIL should be discontinued immediately, the patient treated in accordance with accepted medical care, and carefully observed until the swelling disappears."	0
Dihydroergotamine was not clastogenic in the in vivo mouse and hamster micronucleus tests.	0
"Intravenous Adenocard ( adenosine injection ) has been effectively administered in the presence of other cardioactive drugs , such as quinidine , beta-adrenergic blocking agents , calcium channel blocking agents , and angiotensin converting enzyme inhibitors , without any change in the adverse reaction profile ."	0
"Other Agents Analgesics, Narcotic:tramadol, propoxyphene,methadone,fentanyl <U+2191> analgesics <U+2193> methadone <U+2191> fentanyl A dose decrease may be needed for these drugs when co-administered with ritonavir."	1
"In patients with a history of seizure disorder, because this drug has been shown to lower the seizure threshold."	0
"Hypertension and other Cardiovascular Conditions: Stimulant medications cause a modest increase in average blood pressure (about 2-4 mmHg) and average heart rate (about 3-6 bpm), and individuals may have larger increases."	0
Calcium Channel Blockers Verapamil and diltiazem are moderate CYP 3A inhibitors and increase dronedarone exposure.	1
"If improvement does not occur in 2 to 3 weeks, the dose may be increased to the maximum recommended dose of 250 to 300 mg/day."	0
Patients shown to have CAD and those with Prinzmetal's variant angina should not receive 5-HT1 agonists.	0
"Elimination of aripiprazole is mainly through hepatic metabolism involving two P450 isozymes, CYP2D6 and CYP3A4."	0
"Hypokalemia may develop with LASIX , especially with brisk diuresis , inadequate oral electrolyte intake , when cirrhosis is present , or during concomitant use of corticosteroids , ACTH , licorice in large amounts , or prolonged use of laxatives ."	0
"TWYNSTA may also be given with increased amounts of amlodipine, telmisartan, or both, as needed."	0
Metabolism Risperidone is extensively metabolized in the liver.	0
Findings in clinical hemodynamics studies with bisoprolol fumarate are similar to those observed with other beta-blockers.	0
Concomitant Use of Potent CYP2D6 Inhibitors or Use in patients known to be CYP2D6 PMs <U+2013> Dose adjustment of STRATTERA may be necessary.	0
"MINIPRESS is contraindicated in patients with known sensitivity to quinazolines, prazosin, or any of the inert ingredients."	0
"Exclusive reliance on drug therapy to prevent suicidal attempts is unwarranted, as there may be a delay in the onset of therapeutic effect or an increase in anxiety or agitation."	0
"At 2<U+2013>3 hours after administering the first dose of TIKOSYN, determine the QTc."	0
"Endothelin receptor antagonists: bosentan <U+2191> bosentan Co-administration of bosentan in patients on ritonavir: In patients who have been receiving ritonavir for at least 10 days, start bosentan at 62.5 mg once daily or every other day based upon individual tolerability."	0
"-Bradyasystolic cardiac arrest: 1 mg dose, repeated every 3-5 minutes if asystole persists."	0
Thioridazine: See CONTRAINDICATIONS (4) and WARNINGS AND PRECAUTIONS (5.4).	0
Serum potassium should be normalized before initiating treatment and patients with a QTc interval greater than 450 msec should not receive thioridazine treatment.	0
"Signs and symptoms associated with more severe or acute cases have included hallucination, syncope, seizure, coma, respiratory arrest, and death."	0
"No teratogenic effects were observed in a study of embryo-fetal development in Sprague-Dawley rats at oral doses of 4, 12, and 36 mg/kg or 4, 12 and 35 times the human therapeutic dose on a mg/m2 basis."	0
Most patients will require 10 mg for adequate effect.	0
CRIXIVAN Capsules are sensitive to moisture.	0
"However, the impairment of cognitive and motor skills produced by REMERON were shown to be additive with those produced by alcohol."	0
The rate and extent of perindopril absorption and elimination are not affected by concomitant diuretics.	0
Patients should be monitored for these symptoms when discontinuing treatment with PRISTIQ.	0
Brain hemorrhage and optic nerve vacuolation were seen in another female dog that was sacrificed in moribund condition after 11 weeks of escalating doses up to 280 mg/kg/day.	0
Triazolam 14C was administered orally to pregnant mice.	0
"If it is not prudent to delay cardioversion, the energy level selected should be minimal at first and carefully increased in an attempt to avoid precipitating ventricular arrhythmias."	0
"Confirmatory tests, such as gas chromatography/mass spectrometry, will distinguish desvenlafaxine from PCP and amphetamine."	0
"Although the prevalence of the syndrome appears to be highest among the elderly, especially elderly women, it is impossible to rely upon prevalence estimates to predict, at the inception of antipsychotic treatment, which patients are likely to develop the syndrome."	0
"In such patients, follow closely for the first 2 weeks of treatment and whenever the dose of benazepril or diuretic is increased."	0
Alcohol increases the overall amount of drug in the bloodstream after a dose of Zanaflex.	1
Whether antipsychotic drug products differ in their potential to cause tardive dyskinesia is unknown.	0
The starting dose and maintenance doses of atorvastatin should be individualized according to patient characteristics such as goal of therapy and response.	0
"Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including MYCOBUTIN (rifabutin) Capsules, USP, and may range in severity from mild diarrhea to fatal colitis."	0
"Therefore, caution patients about activities requiring alertness (e.g., operating vehicles or machinery)."	0
Fingolimod and fingolimod-phosphate are >99.7% protein bound.	0
"Verapamil HCl tablets are contraindicated in: Severe left ventricular dysfunction Hypotension (systolic pressure less than 90 mm Hg) or cardiogenic shock Sick sinus syndrome (except in patients with a functioning artificial ventricular pacemaker) Second- or third-degree AV block (except in patients with a functioning artificial ventricular pacemaker) Patients with atrial flutter or atrial fibrillation and an accessory bypass tract (eg, Wolff-Parkinson-White, Lown-Ganong-Levine syndromes) Patients with known hypersensitivity to verapamil hydrochloride"	0
"In patients who have been receiving ritonavir for at least 10 days , start Tracleer at the recommended initial dose once daily or every other day based upon individual tolerability see Cytochrome P450 Drug Interactions ( 7.1 ) ."	0
Clinical studies of amiloride HCl did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
"Available data from clinical trials of ACCUPRIL are insufficient to show that, in patients without prior reactions to other ACE inhibitors, ACCUPRIL does not cause agranulocytosis at similar rates."	0
There are no clinical studies establishing the benefit of the combined use of ECT and fluoxetine.	0
"Positive test results were obtained in the in vitro CHO sister chromatid exchange (clastogenicity) test, and in the mouse lymphoma cell (mutagenicity) assays, using concentrations of hydrochlorothiazide of 43 to 1300 mcg/mL."	0
No dosage adjustment is required in patients with mild or moderate hepatic impairment.	0
Concomitant use can increase the risk of bradycardia.	0
Warn patients not to interrupt therapy without the physician<U+2019>s advice.	0
Digitalis glycosides : Concomitant administration of digoxin and BREVIBLOC leads to an approximate 10 % to 20 % increase of digoxin blood levels at some time points .	1
Coadministration of INVIRASE/ritonavir and ibutilide or sotalol is not recommended.	0
"FLOLAN is a potent pulmonary and systemic vasodilator and can cause hypotension and other reactions such as flushing, nausea, vomiting, dizziness, and headache."	0
"Race and Gender Effects No specific pharmacokinetic study was conducted to investigate race and gender effects, but a population pharmacokinetic analysis did not identify important differences in the disposition of risperidone due to gender (whether corrected for body weight or not) or race."	0
"Rifampin has enzyme induction properties that can enhance the metabolism of endogenous substrates including adrenal hormones, thyroid hormones, and vitamin D. Rifampin and isoniazid have been reported to alter vitamin D metabolism."	1
Extravasation may cause necrosis and sloughing of the surrounding tissue.	0
Monitor renal function periodically in patients treated with ATACAND.	0
"Studies have shown diminished efficacy at serum levels < 0.5 ng/mL, while levels above 2 ng/mL are associated with increased toxicity without increased benefit."	0
Dose reduction of rifabutin to half the standard dose (consult the manufacturer's product circular for rifabutin) and a dose increase of CRIXIVAN to 1000 mg every 8 hours are recommended when rifabutin and CRIXIVAN are coadministered.	1
Less than 2% of the dose was excreted unchanged in the urine.	0
"Monitor blood pressure if sympathomimetic agents (e.g., phenylpropanolamine (PPA) or pseudoephedrine) are used with EMSAM, even though selegiline does not appear to affect the pharmacokinetics of PPA or pseudoephedrine."	0
"The groups were similar in demographic and medical history characteristics and in electrocardiographic evidence of myocardial infarction, bundle branch block, and first degree atrioventricular block at entry."	0
"Coadministration of enoxaparin, warfarin, aspirin, clopidogrel and chronic NSAID use may increase the risk of bleeding [see Clinical Pharmacology (12.3)]."	0
Consider reducing the dose of diuretic prior to starting ACEON.	0
Concomitant use of P-gp inhibitors in patients with renal impairment is expected to produce increased exposure of dabigatran compared to that seen with either factor alone.	1
Any strength of ATACAND tablets can be used in the preparation of the suspension.	0
"Reproduction studies have been performed in rats, rabbits and mice at doses up to 40 times the normal human dose and have revealed no evidence of impaired fertility or harm to the fetus due to cimetidine."	0
"Pressor Amines (e.g., Norepinephrine)- possible decreased response to pressor amines but not sufficient to preclude their use."	0
"As a result, SULAR should be taken on an empty stomach (1 hour before or 2 hours after a meal)."	0
A gradual reduction in the dose rather than abrupt cessation is recommended whenever possible.	0
Routine laboratory monitoring for toxicity in people with normal baseline measurements is generally not necessary.	0
"Therefore, immunosuppressive drug therapy should be maintained at the lowest effective levels."	0
"The effects of coadministration of CRIXIVAN on the AUC, Cmax and Cmin are summarized in Table 2 (effect of other drugs on indinavir) and Table 3 (effect of indinavir on other drugs)."	0
Nisoldipine was neither teratogenic nor fetotoxic at doses that were not maternally toxic.	0
"H2 -Receptor antagonists <U+2193> atazanavir Plasma concentrations of atazanavir were substantially decreased when REYATAZ 400 mg once daily was administered simultaneously with famotidine 40 mg twice daily in adults, which may result in loss of therapeutic effect and development of resistance."	1
"Adverse events of nausea, dizziness, hypotension, and syncope have been observed following co-administration of trazodone and ritonavir."	0
Co-administration with Monoamine Oxidase Inhibitors (MAOIs): Do not administer if patient is taking MAOIs or has used MAOIs within the past two weeks.	0
Drug Interaction Studies: Effects of other drugs on the exposure of asenapine are summarized in Figure 1.	0
"Metabolism In vitro, no detectable metabolism of ledipasvir was observed by human CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and CYP3A4."	0
Discontinue the withheld drug(s) permanently if hepatotoxicity recurs.	0
"Examples: Ketoconazole, clarithromycin, ritonavir, voriconazole, mibefradil Moderate CYP3A4 Inhibitors Clinical Impact: Concomitant use of LATUDA with moderate CYP3A4 inhibitors increased the exposure of lurasidone compared to the use of LATUDA alone."	1
MULTAQ is contraindicated in patients in atrial fibrillation (AF) who will not or cannot be cardioverted into normal sinus rhythm.	0
Monitor serum potassium in such patients.	0
Monitor CBC and adjust the dose of PURIXAN for severe neutropenia and thrombocytopenia.	0
"Manic or hypomanic episodes may occur in some patients, in particular those with cyclic-type disorders."	0
"This suggests that, in general, relief of spasm or dilation of coronary arteries is not an important factor in classical angina."	0
"A patient Medication Guide about ""Antidepressant Medicines, Depression and other Serious Mental Illness, and Suicidal Thoughts or Actions"" is available for Nardil."	0
Concomitant use of HCTZ alone or in combination with triamterene is contraindicated.	0
"Methotrexate Clinical Impact: Concomitant use of rabeprazolewith methotrexate (primarily at high dose) may elevate and prolong serum levels of methotrexate and/or its metabolite hydroxymethotrexate, possibly leading to methotrexate toxicities."	0
"If infused through a multiple-lumen catheter, TPN needs to be administered using a different port from the one used for VFEND I.V."	0
"The risk of myopathy, including rhabdomyolysis, is greater in patients on simvastatin 80mg compared with other statin therapies with similar or greater LDL-C-lowering efficacy and compared with lower doses of simvastatin."	0
"The Cockcroft-Gault formula to determine creatinine clearance is: Creatinine clearance (male) = (140-age) <U+00D7> body weight in kg 72 <U+00D7> serum creatinine (mg/dL) Creatinine clearance (female) = (140-age) <U+00D7> body weight in kg <U+00D7>0.85 72 <U+00D7> serum creatinine (mg/dL) When serum creatinine is given in <U+00B5>mol/L, divide the value by 88.4 (1 mg/dL = 88.4 <U+00B5>mol/L)."	0
Avoid ingestion of grapefruit and grapefruit juice while taking nifedipine.	0
"In those patients who discontinued protease inhibitor therapy, hyperglycemia persisted in some cases."	0
Torsades de pointes and sudden death have occurred in patients receiving CAPRELSA.	0
"The relationship between dose, efficacy, and the increase in QTc from baseline at steady state for the two randomized, placebo-controlled studies (described further below) is shown in Figure 2."	0
"REYATAZ Once Daily Dosage Ritonavir Once Daily Dosage Treatment-Naive and Treatment-Experienced Recommended Regimen 300 mg 100 mg Treatment-Experienced During the Second or Third Trimester When Coadministered with either H2RA or Tenofovir DFb In combination with either H2RA or tenofovir DF 400 mg 100 mg For patients with renal impairment, including those with severe renal impairment who are not managed with hemodialysis, no dose adjustment is required for REYATAZ."	0
"There was no evidence of a carcinogenic potential of verapamil administered in the diet of rats for two years at doses of 10, 35, and 120 mg/kg per day or approximately 1x, 3.5x, and 12x, respectively, the maximum recommended human daily dose (480 mg per day or 9.6 mg/kg/day)."	0
"The atorvastatin component of CADUET is a selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol."	0
Marginal increase of asenapine exposure was observed when SAPHRIS is used with fluvoxamine at 25 mg administered twice daily.	0
"Co-administered amlodipine does not affect the exposure to atorvastatin, digoxin, ethanol and the warfarin prothrombin response time."	0
"Amiodarone has the potential for interactions with drugs or substances that may be substrates , inhibitors or inducers of CYP450 enzymes ( e.g. , inhibitors such as protease inhibitors , grapefruit juice , certain fluoroquinolone and macrolide antibiotics , azole antifungals and inducers such as St.   John s Wort ) or P-glycoprotein ."	0
"Because lidocaine is metabolized mainly in the liver and excreted by the kidneys, patients with renal or hepatic insufficiency may be at increased risk for toxicity."	0
"After administration of a single dose of [14C]-labeled asenapine, about 90% of the dose was recovered; approximately 50% was recovered in urine, and 40% recovered in feces."	0
"In a study including 16 elderly patients between 70<U+2013>78years of age who received MEVACOR 80mg/day, the mean plasma level of HMG<U+2011>CoA reductase inhibitory activity was increased approximately 45% compared with 18 patients between 18<U+2013>30years of age."	0
"Because these effects may be additive, use of ergotamine-containing or ergot-type medications (like dihydroergotamine or methysergide) and MAXALT within 24 hours is contraindicated."	0
"Lesser effects, 4% and 15% reduction in Cmax and AUC respectively, were observed when olmesartan medoxomil was administered 4 hours prior to colesevelam hydrochloride."	1
"When nicardipine was given to mild-to-moderate hypertensive patients with moderate renal impairment, a significantly lower systemic clearance and higher AUC was observed."	0
"Inhibitors of other CYP enzymes Based on in vitro data, drugs that inhibit CYP isozymes 1A1, 1A2, 2A6, 2D6, 2C8, 2C9, 2C19, and 2E1 are not expected to have significant impact on the pharmacokinetic profile of desvenlafaxine. desipramine, dextromethorphan, metoprolol, atomoxetine) In vitro studies showed minimal inhibitory effect of desvenlafaxine on CYP2D6."	0
"The initial dosage should therefore be reduced in patients with severe renal or hepatic impairment, and upward titration, if necessary, should be at increased intervals."	0
The mechanism of action of clozapine is unknown.	0
"Cases of myopathy, including rhabdomyolysis, have been reported with atorvastatin co-administered with colchicine."	0
"Specific Populations Geriatric Amlodipine: Elderly patients have decreased clearance of amlodipine with a resulting increase in AUC of approximately 40<U+2013>60%, and a lower initial dose of amlodipine may be required."	0
"If goal blood pressure (<140/90mmHg) was not reached, hydrochlorothiazide (12.5mg) was added first and, if needed, the dose of losartan potassium tablets or atenolol was then increased to 100mg once daily."	0
No dose adjustment is needed in patients with mild or moderate hepatic impairment (Child-Pugh class A and B).	0
"Age Oral clearance of quetiapine was reduced by 40% in elderly patients (<U+2265> 65 years, n=9) compared to young patients (n=12), and dosing adjustment may be necessary."	0
The administration of guanfacine concomitantly with a known microsomal enzyme inducer ( phenobarbital or phenytoin ) to two patients with renal impairment reportedly resulted in significant reductions in elimination half-life and plasma concentration .	1
No maternal toxicity or adverse effects on fetal development were observed when oral doses up to 1000 mg of candesartan cilexetil/kg/day (approximately 138 times the MRHD on a mg/m2 basis) were administered to pregnant mice.	0
Drugs which inhibit this metabolic pathway may have a profound effect on the clearance of triazolam.	0
Other drugs that inhibit CYP1A2 metabolism include cimetidine and quinolone antimicrobials such as ciprofloxacin and enoxacin.	0
Severe Hepatic Impairment (Child-Pugh Score Ranging from 10 to 15) LEXIVA should be used with caution at a reduced dosage of 350mg twice daily without ritonavir (therapy-naive) or 300mg twice daily plus ritonavir 100mg once daily (therapy-naive or protease inhibitor-experienced).	0
"Nausea, dizziness, hypotension, and syncope have been observed following coadministration of trazodone and ritonavir."	0
"In another study in six normal male volunteers, a 16-mg dose infused over 5 minutes showed no effect of the drug on cardiac output, heart rate, stroke volume, blood pressure, or electrocardiogram (ECG)."	0
Add 100 mL of syrup to the bottle and shake vigorously.	0
Ramelteon: See CONTRAINDICATIONS (4) and WARNINGS AND PRECAUTIONS (5.8).	0
"Dual Blockade of the Renin-Angiotensin System (RAS) Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"For patient comfort, EXTRANEAL can be warmed to 37<U+00B0>C (98.6<U+00B0>F)."	0
Tell patients receiving ACCURETIC not to use potassium supplements or salt substitutes containing potassium without consulting the prescribing physician.	0
<U+2022>Amiodarone may increase carvedilol levels resulting in further slowing of the heart rate or cardiac conduction.	0
STRATTERA should be administered with caution to patients being treated with systemically-administered (oral or intravenous) albuterol (or other beta2agonists) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure.	0
"Before infusion of INTEGRILIN , the following laboratory tests should be performed to identify pre-existing hemostatic abnormalities : hematocrit or hemoglobin , platelet count , serum creatinine , and PT/aPTT ."	0
Increase in QT interval is directly related to dofetilide dose and plasma concentration.	0
"The antihypertensive effect of angiotensin II receptor antagonists , including azilsartan , may be attenuated by NSAIDs , including selective COX-2 inhibitors ."	0
There are several published case reports of Torsades de pointes and sudden death associated with thioridazine treatment.	0
"Initiation of antihypertensive therapy may cause symptomatic hypotension in patients with intravascular volume or sodium-depletion, e.g., in patients treated vigorously with diuretics or in patients on dialysis."	0
"To reconstitute, add 24 mL of distilled water or Purified Water (USP) to fluconazole bottle and shake vigorously to suspend powder."	0
"In clinical trials with angina patients alone, amlodipine therapy did not alter electrocardiographic intervals or produce higher degrees of AV blocks."	0
"The mechanism of the antidepressant effect of vortioxetine is not fully understood, but is thought to be related to its enhancement of serotonergic activity in the CNS through inhibition of the reuptake of serotonin (5-HT)."	0
Further increases of either or both components could depend on clinical response.	0
"Only an infusion pump, preferably a volumetric pump, should be used."	0
"Due to the extended absorption phase of the dipyridamole component, only the terminal phase is apparent from oral treatment with AGGRENOX which, in Trial 9.123 was 13.6 hours."	0
The major inactive metabolites are highly bound to human plasma proteins.	0
Initiation of quetiapine in patients taking REYATAZ with ritonavir: Refer to the quetiapine prescribing information for initial dosing and titration of quetiapine.	0
"If PRADAXA is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant and restart PRADAXA as soon as medically appropriate."	0
"The receptors antagonized by atropine are the peripheral structures that are stimulated or inhibited by muscarine (i.e., exocrine glands and smooth and cardiac muscle)."	0
"Due to an increased risk of myopathy/rhabdomyolysis when HMG-CoA reductase inhibitors are co-administered with gemfibrozil, concomitant administration of LIPITOR with gemfibrozil should be avoided."	0
"Hemodynamic assessments in patients with hypertension indicate that blood pressure reduction produced by quinapril is accompanied by a reduction in total peripheral resistance and renal vascular resistance with little or no change in heart rate, cardiac index, renal blood flow, glomerular filtration rate, or filtration fraction."	0
"In patients with severe heart failure whose renal function may depend on the activity of the renin-angiotensin aldosterone system, treatment with NATRECOR<U+00AE> may be associated with azotemia."	0
The following table provides the outcome classification by treatment group on Global Improvement items of the Clinical Global Impression (CGI) scale for Study 1.	0
"The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine; cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide)."	0
Discontinue ONIVYDE in patients with a confirmed diagnosis ofILD.	0
"COREG may be used with caution, however, in patients who do not respond to, or cannot tolerate, other antihypertensive agents."	0
Mean digoxin AUC at steady state decreased by 15% in the presence of paroxetine.	1
The effect of gender or race on the pharmacokinetics of nisoldipine has not been investigated.	0
Atorvastatin: Plasma concentrations of atorvastatin are higher (approximately 40% for Cmax and 30% for AUC) in healthy elderly subjects (age <U+2265>65 years) than in young adults.	0
"Intervention In patients on chronic warfarin therapy, monitor the prothrombin time (INR) in the 2-week period, particularly at 7 to 10 days, following initiation of the 3-day EMEND regimen with each chemotherapy cycle, or following administration of a single 40-mg dose of EMEND."	0
When pregnancy is detected discontinue ACEON as soon as possible.	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP; and some have resulted in fatalities."	0
"During marketing of other SSRIs and SNRIs (serotonin and norepinephrine reuptake inhibitors), there have been spontaneous reports of adverse events occurring upon discontinuation of these drugs, particularly when abrupt, including the following: dysphoric mood, irritability, agitation, dizziness, sensory disturbances (e.g., paresthesias such as electric shock sensations), anxiety, confusion, headache, lethargy, emotional lability, insomnia, hypomania, tinnitus, and seizures."	0
"The CNS depressant effects of Zanaflex with alcohol and other CNS depressants (e.g., benzodiazepines, opioids, tricyclic antidepressants) may be additive."	0
"In placebo-controlled trials of Lexapro in major depressive disorder, activation of mania/hypomania was reported in one (0.1%) of 715 patients treated with Lexapro and in none of the 592 patients treated with placebo."	0
"No clinically significant drug interactions were observed when REYATAZ was coadministered with methadone, fluconazole, acetaminophen, atenolol, or the nucleoside reverse transcriptase inhibitors lamivudine or zidovudine."	0
"If such symptoms occur, consider discontinuing VYVANSE."	0
Race: The pharmacokinetics of zaleplon have been studied in Japanese subjects as representative of Asian populations.	0
"In a placebo controlled study in patients with permanent AF increased rates of heart failure were observed in patients with normal left ventricular function and no history of symptomatic heart failure, as well as those with a history of heart failure or left ventricular dysfunction."	0
Verapamil clearance values suggest that patients with liver dysfunction may attain therapeutic verapamil plasma concentrations with one third of the oral daily dose required for patients with normal liver function.	0
"Because of the narrow therapeutic index of digoxin, caution should be exercised when nefazodone and digoxin are coadministered; plasma level monitoring for digoxin is recommended."	0
Patients should be advised of the possible need to reduce levodopa dosage after the initiation of selegiline therapy.	1
"Four positional isomers, 1-O, 2-O, 3-O, and 4-O-acylglucuronide exist, and each accounts for less than 10% of total dabigatran in plasma."	0
Drug Resistance Organisms resistant to rifampin are likely to be resistant to other rifamycins.	0
"In rabbits, at 80 mg/kg/day (about 5 times the recommended human daily dose based on body surface area comparisons), rifabutin caused maternotoxicity and increase in fetal skeletal anomalies."	0
"Increases in frequency, duration, or severity of angina have been seen in chronic oral therapy with nicardipine capsules."	0
"Assess Cardiovascular Status: prior to stimulant treatment, assess for cardiac disease with history and exam and, if suggested by findings, conduct further cardiac evaluation."	0
"Subsequently, the physician may continue decreasing the dose but at a more gradual rate."	0
The recommended usual starting dose is 10mg once a day in the evening.	0
"Signs and symptoms of hyponatremia include headache, difficulty concentrating, memory impairment, confusion, weakness, and unsteadiness, which may lead to falls."	0
Specific populations Hepatic Impairment Mild and moderate hepatic impairment had no impact on the pharmacokinetics of teriflunomide.	0
"CYP2D6 Inhibitors: Coadministration of a drug that inhibits CYP2D6 with Celexa is unlikely to have clinically significant effects on citalopram metabolism, based on the study results in CYP2D6 poor metabolizers."	0
Special Populations Renal Impairment Clinical data suggest that dose adjustment is not required in patients with renal impairment.	0
"Amiodarone has the potential for interactions with drugs or substances that may be substrates , inhibitors or inducers of CYP450 enzymes ( e.g. , inhibitors such as protease inhibitors , grapefruit juice , certain fluoroquinolone and macrolide antibiotics , azole antifungals and inducers such as St.   John s Wort ) or P-glycoprotein ."	0
HIV-1 protease inhibitor: Tipranavir/ritonavir <U+2193> Saquinavir Combining saquinavir with tipranavir/ritonavir is not recommended.	0
"For systemic Candida infections including candidemia, disseminated candidiasis, and pneumonia, optimal therapeutic dosage and duration of therapy have not been established."	0
Zidovudine <U+2193> Zidovudine AUC by approximately 35%.	0
"Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular changes (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)."	0
"In the same patients, these reactions were avoided when ACE inhibitors were temporarily withheld, but they reappeared upon inadvertent rechallenge."	0
Activation of Mania/Hypomania: Screen patients for bipolar disorder.	0
Ondansetron is a selective 5-HT3 receptor antagonist.	0
Drugs that increase gastric pH are expected to decrease concentration of ledipasvir.	1
"After oral administration of therapeutic doses of NORVASC, absorption produces peak plasma concentrations between 6 and 12 hours."	0
Iloperidone doses should therefore be reduced by about one-half if administered concomitantly with both a CYP2D6 and CYP3A4 inhibitor.	1
The absolute bioavailability is 24% (range 9% to 50%) after administration of a 10 mg dose.	0
"In a ten-subject randomized, open-label, 4-way crossover study, coadministration of diltiazem (120 mg BID diltiazem SR for 2 weeks) with a single 20 mg dose of lovastatin resulted in 3- to 4-fold increase in mean lovastatin AUC and Cmax versus lovastatin alone."	1
"If the contents of the capsule include any compacted powder, a spoon may be used to break apart the powder."	0
One patient was discontinued because of worsening congestive heart failure.	0
Full therapeutic dose of fluvoxamine is expected to cause a greater increase in asenapine exposure.	1
Assessment of the carcinogenic potential of dihydroergotamine mesylate in mice and rats is ongoing.	0
"Benazepril, like other ACE inhibitors, has had less than additive effects with beta-adrenergic blockers, presumably because both drugs lower blood pressure by inhibiting parts of the renin-angiotensin system."	0
IMURAN should not be given to patients who have shown hypersensitivity to the drug.	0
Urinary excretion of unchanged drug is about 3% to 4% of the dose.	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP, should not exceed the dosing guidelines and should not be used for chronic daily administration."	0
"Prescriptions for SURMONTIL should be written for the smallest quantity of capsules consistent with good patient management, in order to reduce the risk of overdose."	0
"Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, chronic kidney disease, severe heart failure, or volume depletion) may be at particular risk of developing acute renal failure or death on AVAPRO."	0
The relationship to PROCARDIA therapy is uncertain in most cases but probable in some.	0
"Since nicardipine hydrochloride injection may be administered to patients already being treated with other medications, including other antihypertensive agents, careful monitoring of these patients is necessary to detect and to treat promptly any undesired effects from concomitant administration."	0
"Based on pharmacokinetic studies with oral aripiprazole, no dosage adjustment of ABILIFY MAINTENA is required when administered concomitantly with famotidine, valproate, lithium, lorazepam."	0
"Angioedema, including laryngeal edema can occur with treatment with ACE inhibitors, especially following the first dose."	0
Lower doses are recommended for elderly patients.	0
"Treatment should be discontinued if there is hyperkalemia, a significant rise in serum creatinine or a significant fall in blood hemocrit or hemoglobin."	0
"In patients, dofetilide terminates induced re-entrant tachyarrhythmias (e.g., atrial fibrillation/flutter and ventricular tachycardia) and prevents their re-induction."	0
The major metabolic pathways are sulfoxidation to the sulfoxide metabolite and oxidation to the parent acid metabolite; both metabolites are pharmacologically inactive.	0
SURMONTIL is known to be substantially excreted by the kidney.	0
"Whether this effect plays any role in classical angina is not clear, but studies of exercise tolerance have not shown an increase in the maximum exercise rate-pressure product, a widely accepted measure of oxygen utilization."	0
"If possible, manage bleeding without discontinuing Effient."	0
Table 5 Potentially Significant Drug Interactions: Alteration in Dose or Regimen May Be Recommended Based on Drug Interaction Studies or Predicted InteractionThis table is not all inclusive.	0
"Benzodiazepines: Studies showed that diltiazem increased the AUC of midazolam and triazolam by 3- to 4-fold and the Cmax by 2-fold, compared to placebo."	1
"When candesartan is administered orally, about 26% of the dose is excreted unchanged in urine."	0
"Adverse reactions of hyperkalemia were approximately 1-2 % higher when tolvaptan was administered with angiotensin receptor blockers , angiotensin converting enzyme inhibitors and potassium sparing diuretics compared to administration of these medications with placebo ."	0
Leukocyte and differential counts should be performed in any patient who develops fever and sore throat during therapy; the drug should be discontinued if there is evidence of pathologic neutrophil depression.	0
The carboxylic acid metabolite is inactive as an antihypertensive.	0
"Hypersensitivity to doxazosin, other quinazolines, or any other ingredient in CARDURA."	0
"In rats, it has been demonstrated that candesartan crosses the blood-brain barrier poorly, if at all."	0
Letairis may cause fetal harm when administered during pregnancy and is contraindicated for use in females who are pregnant.	0
0.67-2.64 <U+2013> not statistically significant]).	0
Marplan should not be used in combination with dextromethorphan.	0
"If the decision has been made to discontinue treatment due to worsening depressive symptoms or emergent suicidality, medication should be tapered, as rapidly as is feasible, but with recognition that abrupt discontinuation can produce withdrawal symptoms."	0
Once daily dosing is recommended for pediatric patients above 10 years of age and adults.	0
"Co-administration of SAMSCA with 400 mg ketoconazole daily or with other strong CYP 3A inhibitors ( e.g. , clarithromycin , itraconazole , telithromycin , saquinavir , nelfinavir , ritonavir and nefazodone ) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure ."	1
"In the ASCEND-HF trial, the incidence of symptomatic hypotension was 7.1% in NATRECOR<U+00AE>-treated patients compared to 4.0% in placebo-treated patients on a background of standard care."	0
"The risk differences (drug vs placebo), however, were relatively stable within age strata and across indications."	0
"As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals treated with Benicar."	0
"Because nisoldipine, like other vasodilators, decreases peripheral vascular resistance, careful monitoring of blood pressure during the initial administration and titration of SULAR is recommended."	0
"Most of the glucuronide metabolite (about 95%) is excreted via bile into the feces, with some evidence of enterohepatic circulation."	0
"Hepatic Impairment In patients with moderate hepatic impairment, the recommended initial dose is 2.5 mg once daily; titrate up slowly if needed."	0
"However, LDL-C reduction is the same regardless of the time of day of drug administration."	0
"The dose of SAMSCA may have to be reduced when SAMSCA is co-administered with P-gp inhibitors , e.g. , cyclosporine see Dosage and Administration ( 2.3 ) , Drug Interactions ( 7.1 ) ."	0
"(Note interactions with digoxin under PRECAUTIONS ) Occasionally, the pharmacologic action of verapamil may produce a decrease in blood pressure below normal levels, which may result in dizziness or symptomatic hypotension."	0
It is not known whether selegiline hydrochloride is excreted in human milk.	0
Pregnancy Category D: See WARNINGS - Pregnancy and Fetal Injury Atenolol is excreted in human breast milk at a ratio of 1.5 to 6.8 when compared to the concentration in plasma.	0
"With an overall half-life of about 5 hours, the 5-mononitrate is cleared from the serum by denitration to isosorbide; glucuronidation to the 5-mononitrate glucuronide; and denitration/hydration to sorbitol."	0
"Patients should be cautioned about the risk of bleeding associated with the concomitant use of LUVOX CR Capsules and NSAIDs, aspirin, or other drugs that affect coagulation."	0
"Monitor for respiratory depression, especially during initiation of Meperidine Hydrochloride Injection or following a dose increase."	0
A food-effect study in 30 healthy male subjects compared the pharmacokinetics of AMBIEN 10 mg when administered while fasting or 20 minutes after a meal.	0
"CYP 3A Inducers Avoid co-administration of CYP 3A inducers (e.g., rifampin, rifabutin, rifapentin, barbiturates, phenytoin, carbamazepine, St. John's Wort) with SAMSCA, as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment."	1
"Do not administer ACCUPRIL within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor."	0
"A population PK analysis in patients with major depressive disorder showed no substantial change in plasma concentrations of fluoxetine (20 mg/day or 40 mg/day), paroxetine CR (37.5 mg/day or 50 mg/day), or sertraline (100 mg/day or 150 mg/day) dosed to steady-state."	0
"CMI does not induce drug-metabolizing enzymes, as measured by antipyrine half-life."	0
Irbesartan exhibits linear pharmacokinetics over the therapeutic dose range.	0
Atazanavir: See prescribing information for atazanavir for dosing information.	0
"Patients should be carefully monitored for signs and symptoms of myopathy (e.g., muscle weakness, muscle pain, rising creatine kinase)."	0
"Administration Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit."	0
2.Fill the 5 mL oral dosing dispenser with 4.6 mL of water from the mixing cup.	0
"Depending on clinical circumstances, consideration should be given to increasing the dose of DIFLUCAN when it is administered with rifampin."	1
"Following abrupt or tapered discontinuation in adult placebo-controlled clinical trials, the following symptoms occurred at 1% or greater and at a significantly higher rate in CYMBALTA-treated patients compared to those discontinuing from placebo: dizziness, headache, nausea, diarrhea, paresthesia, irritability, vomiting, insomnia, anxiety, hyperhidrosis, and fatigue."	0
It is important to note that some drugs may interact by more than one mechanism.	0
The adverse reaction profile in this age group is similar to that observed in adults.	0
"In patients with severe renal impairment (GFR 15 to < 30 mL/min/1.73 m2), the maximum dose should not exceed 50 mg/day."	0
Zaleplon has not been adequately studied in patients with severe renal impairment.	0
Benign Prostatic Hyperplasia (BPH) Administration of CARDURA to patients with symptomatic BPH resulted in a statistically significant improvement in maximum urinary flow rate.	0
It is desirable to monitor TCA plasma levels whenever an agent of the tricyclic antidepressant class including clomipramine is going to be co-administered with another drug known to be an inhibitor of P450 2D6 (and/or P450 1A2).	0
This edema occurs primarily in the lower extremities and usually responds to diuretic therapy.	0
Chlorthalidone is usually given at a dose of 25 mg daily; the usual initial dose of atenolol is 50 mg daily.	0
"Prior to initiation of therapy, appropriate specimens should be collected for identification of the infecting organism and in vitro susceptibility tests."	0
Clinical studies have shown that atorvastatin does not reduce basal plasma cortisol concentration or impair adrenal reserve.	0
"If the pH response is inadequate, hyperventilation may also be used."	0
The arterial blood concentration of clevidipine declines in a multi-phasic pattern following termination of the infusion.	0
NORPRAMIN use in the elderly has been associated with a proneness to falling as well as confusional states.	0
"There were differences in absolute risk of suicidality across the different indications, with the highest incidence in MDD."	0
BYSTOLIC has not been studied in patients receiving dialysis.	0
The 0.8% solution (8 mg/mL) can be given at a rate of 7.5 to 30 mL/hr (0.12 to 0.5 mL/min).	0
ACCURETIC treatment usually can be continued following restoration of blood pressure and volume.	0
Concomitant use of MAOIs and bupropion is contraindicated because there is an increased risk of hypertensive reactions if bupropion is used concomitantly with MAOIs.	0
Non-clinical studies have shown that desvenlafaxine is a potent and selective serotonin and norepinephrine reuptake inhibitor (SNRI).	0
"When treating a pregnant woman with PEXEVA<U+00AE>, the physician should carefully consider both the potential risks of taking an SSRI, along with the established benefits of treating depression with an antidepressant."	0
Write the date of expiration of the reconstituted suspension on the bottle label (the shelf-life of the reconstituted suspension is 14 days at controlled room temperature 15<U+2013>30<U+00B0>C [59<U+2013>86<U+00B0>F]).	0
Natriuresis causes a secondary loss of potassium.	0
"These drugs and other contraindicated drugs (which may lead to reduced efficacy of nelfinavir) are listed in Table 3 [also see Drug Interactions (7), Table 6 ]."	0
The incidence of hypotension leading to drug discontinuation in ATACAND-treated patients was 4.1% compared with 2.0% in placebo-treated patients.	0
INHALED BETA AGONIST Salmeterol <U+2191> salmeterol Concurrent administration of salmeterol with VIRACEPT is not recommended.	0
"Aspirin - Aspirin 150mg daily did not alter prasugrel-mediated inhibition of platelet aggregation; however, bleeding time was increased compared with either drug alone."	0
Chronic oral administration of CARDIZEM to patients in doses of up to 540 mg/day has resulted in small increases in PR interval and on occasion produces abnormal prolongation.	0
"Cimetidine: Serious anticholinergic symptoms (i.e., severe dry mouth, urinary retention and blurred vision) have been associated with elevations in the serum levels of tricyclic antidepressant when cimetidine therapy is initiated."	0
"When amiloride HCl is administered concomitantly with an angiotensin-converting enzyme inhibitor, an angiotensin II receptor antagonist, cyclosporine or tacrolimus, the risk of hyperkalemia may be increased."	0
The patient should be cautioned about these possible adverse effects and advised what measures to take should they develop.	0
"Conversely, adverse effects could result from displacement of paroxetine by other highly bound drugs."	0
"Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients whose depression is persistently worse, or who are experiencing emergent suicidality or symptoms that might be precursors to worsening depression or suicidality, especially if these symptoms are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
"Therefore, thioridazine is contraindicated with these drugs as well as in patients, comprising about 7% of the normal population, who are known to have a genetic defect leading to reduced levels of activity of P450 2D6."	0
Vardenafil: no more than 2.5mg every 24hours.	0
"However, it is expected that such coadministration would produce additive prolongation of the QTc interval and, thus, such use is contraindicated."	0
"Similarly, they are not expected to inhibit the efflux of comedications and/or biologics transported by the breast cancer resistance protein (BCRP), the bile salt export pump (BSEP), the multidrug resistance-associated protein 2 (MRP2), or P-glycoprotein (P-gp) at therapeutic concentrations."	0
Invitro studies indicate that cytochrome P450 2C9 and 3A4 are involved in the biotransformation of losartan to its metabolites.	0
"These interactions may lead to: Clinically significant adverse reactions, potentially leading to severe, life threatening, or fatal events from greater exposures of concomitant medications."	0
"1.61(1.13, 2.29) 1.72(1.20, 2.48) 1.62(0.93, 2.85) 200 twice daily, 14 days 800 twice daily, 14 days 9, 5 1.19(0.85, 1.66) 1.96(1.39, 2.76) 4.71(2.66, 8.33)n=9, 4 Saquinavir Hard gel formulation 600 single dose 800 three times daily, 2 days 6 4.7(2.7, 8.1) 6.0(4.0, 9.1) 2.9(1.7, 4.7)C6hr Soft gel formulation 800 single dose 800 three times daily, 2 days 6 6.5(4.7, 9.1) 7.2(4.3, 11.9) 5.5(2.2, 14.1) Soft gel formulation 1200 single dose 800 three times daily, 2 days 6 4.0(2.7, 5.9) 4.6(3.2, 6.7) 5.5(3.7, 8.3) Sildenafil 25 single dose 800 three times daily 6 See text below for discussion of interaction."	0
No clinical significance for these findings has been demonstrated.	0
The pupillary dilation that occurs following use of many antidepressant drugs including CYMBALTA may trigger an angle closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy.	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP may increase blood pressure, it should not be given to patients with uncontrolled hypertension."	0
Desmethyldoxepin has a half-life that ranges from 28 to 52 hours and is not affected by multiple dosing.	0
Careful monitoring of therapeutic and adverse effects (including potentially fatal respiratory depression) is recommended when fentanyl is concomitantly administered with NORVIR.	0
"Risks are increased in patients with a personal or family history of substance abuse (including drug or alcohol abuse or addiction) or mental illness (e.g., major depression)."	0
Doses above 150 mg/day are not recommended in these age groups.	0
"Elderly patients: Elderly outpatients with chronic insomnia were evaluated in two 2-week, double-blind, parallel-group outpatient studies that compared the effects of Zaleplon 5 mg and 10 mg with placebo on a subjective measure of time to sleep onset (TSO)."	0
"Quinapril inhibits the elevation in blood pressure caused by intravenously administered angiotensin I, but has no effect on the pressor response to angiotensin II, norepinephrine or epinephrine."	0
Open-angle glaucoma is not a risk factor for angle-closure glaucoma.	0
Studies have not been performed examining drug interactions with PRUDOXIN Cream.	0
Uric Acid Hyperuricemia may occur or frank gout may be precipitated in certain patients receiving chlorthalidone.	0
Indinavir is an inhibitor of the cytochrome P450 isoform CYP3A4.	0
"TARKA and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended."	0
9.Concomitant use of pimozide in patients taking sertraline is contraindicated.	0
Strong inhibitors of CYP3A4 can raise the plasma levels of HMG<U+2011>CoA reductase inhibitory activity and increase the risk of myopathy.	1
", 10 subjects consumed 200mL of double-strength grapefruit juice (one can of frozen concentrate diluted with one rather than 3 cans of water) three times daily for 2 days and an additional 200mL double-strength grapefruit juice together with and 30 and 90minutes following a single dose of 80mg lovastatin on the third day."	0
"Subsequently, the physician may continue decreasing the dose but at a more gradual rate."	0
"Intestinal and hepatic P-gp activity was assessed by administering oral and intravenous digoxin, respectively."	0
Letairis may have an adverse effect on spermatogenesis.	0
"To retain relative selectivity, it is important to use the lowest effective dose."	0
"In chronic animal toxicology studies, verapamil caused lenticular and/or suture line changes at 30 mg/kg/day or greater and frank cataracts at 62.5 mg/kg/day or greater in the beagle dog but not the rat."	0
"When CRESTOR was coadministered with fenofibrate, no clinically significant increase in the AUC of rosuvastatin or fenofibrate was observed."	0
This drug is capable of blocking the antihypertensive effect of guanethidine and similarly acting compounds.	0
"Therefore, in patients taking itraconazole, avoid atorvastatin doses >20 mg."	1
"<U+2022>Non-allergic bronchospasm (e.g., chronic bronchitis and emphysema): Avoid <U+03B2>-blockers."	0
Statins interfere with cholesterol synthesis and theoretically might blunt adrenal and/or gonadal steroid production.	0
Rifampin should be simultaneously co-administered with LIPITOR (7.7).	0
Visual assessment by angiographers who formed a consensus opinion of overall angiographic change (Global Change Score) was also a secondary endpoint.	0
Chlorthalidone and related drugs may decrease arterial responsiveness to norepinephrine.	0
"Although several active metabolites of doxazosin have been identified, the pharmacokinetics of these metabolites have not been characterized."	0
"Drugs That Can Lead to Hepatotoxicity Concomitant use of these drugs and TRISENOX, particularly when given in combination with tretinoin, may increase the risk of serious hepatotoxicity."	0
"Mean peak bisoprolol fumarate plasma concentrations of about 9.0 ng/mL, 19 ng/mL and 36 ng/mL occur approximately 3 hours after the administration of the 2.5 mg/6.25 mg, 5 mg/6.25 mg and 10 mg/6.25 mg combination tablets, respectively."	0
Monitor serum potassium periodically in patients receiving PRINIVIL.	0
"For genotype 6, the EC50 values for ledipasvir varied by subtype."	0
The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear.	0
Enantiomers <U+2014> Fluoxetine is a racemic mixture(50/50) of R-fluoxetine and S-fluoxetine enantiomers.	0
In treatment-experienced adult patients: The use of PPIs in treatment-experienced patients receiving REYATAZ is not recommended.	0
"Analyses of the relationship between treatment outcome and age, gender, and race did not suggest any differential responsiveness on the basis of these patient characteristics."	0
Titrate up to 40 mg daily based on response.	0
"Although the risk of addiction in any individual is unknown, it can occur in patients appropriately prescribed Meperidine Hydrochloride Injection."	0
Geriatric and Sex The pharmacokinetics of candesartan have been studied in the elderly (<U+2265> 65 years) and in both sexes.	0
"If clonidine and a beta blocker, such as metoprolol are coadministered, withdraw the beta-blocker several days before the gradual withdrawal of clonidine because beta-blockers may exacerbate the rebound hypertension that can follow the withdrawal of clonidine."	0
"Serum levels of digitoxin are also raised when quinidine is coadministered, although the effect appears to be smaller."	1
The pharmacokinetics of orally administered VFEND are not significantly affected by renal impairment.	0
"Pediatric (age > 6 years), small adult, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily and this dose may be used when adding amlodipine to other antihypertensive therapy."	0
"In adults, sudden death, stroke, and myocardial infarction have been reported."	0
Calcium channel blockers: diltiazem <U+2191> diltiazem and desacetyl-diltiazem Caution is warranted.	0
"In pediatric patients, if a loading dose is needed, it can be administered with roughly half the total given as the first dose."	0
"Interaction with Combined P-gp and Moderate CYP3A4 Inhibitors in Patients with Renal Impairment XARELTO should not be used in patients with CrCl 15 to <80 mL/min who are receiving concomitant combined P-gp and moderate CYP3A4 inhibitors (e.g., erythromycin) unless the potential benefit justifies the potential risk [see Warnings and Precautions (5.4) and Clinical Pharmacology (12.3)]."	0
"The ester is then hydrolyzed, forming dabigatran, the active moiety."	0
"In patients taking the HIV protease inhibitor nelfinavir or the hepatitis C protease inhibitor boceprevir, limit therapy with atorvastatin to 40 mg, and make appropriate clinical assessment to ensure that the lowest dose necessary of atorvastatin is employed."	1
"In the pediatric clinical trial, the frequency of rash (all grades, all causality) through 48 weeks of treatment was 21%."	0
Concomitant use of Strong CYP3A4 Inducers is not recommended.	0
About 70% of an administered dose of verapamil is excreted as metabolites in the urine.	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
"Accordingly, triamterene and hydrochlorothiazide should be avoided in diabetic patients."	0
"Both sertraline and N-desmethylsertraline undergo oxidative deamination and subsequent reduction, hydroxylation, and glucuronide conjugation."	0
"In clinical studies, establishing the safety and efficacy of LATUDA, patients were instructed to take their daily dose with food."	0
Follow the instructions for the feeding tube to administer the medicine.	0
"The importance of these observations to the routine, clinical use of controlled-release oral isosorbide dinitrate is not known."	0
Uncontrolled hypertension.	0
"This metabolism is catalyzed mainly by the cytochrome P450 3A4 (CYP 3A4) enzymatic system and to a lesser extent, by cytochrome P450 1A2 (CYP 1A2) and cytochrome P450 2D6 (CYP 2D6)."	0
Symptoms such as these may be associated with an increased risk for suicidal thinking and behavior and indicate a need for very close monitoring and possibly changes in the medication.	0
"The antihypertensive effect of angiotensin II receptor antagonists , including valsartan , may be attenuated by NSAIDs including selective COX-2 inhibitors ."	0
Interpretation involves correlation of the diameter obtained in the disk test with the MIC for penicillin.	0
"These crises are characterized by some or all of the following symptoms: occipital headache which may radiate frontally, palpitation, neck stiffness or soreness, nausea, vomiting, sweating (sometimes with fever and sometimes with cold, clammy skin), dilated pupils, and photophobia."	0
It is desirable to monitor TCA plasma levels whenever a TCA is going to be co-administered with another drug known to be an inhibitor of P450 2D6.	0
"The recommended dosage for treatment of acute cryptococcal meningitis is 400 mg on the first day, followed by 200 mg once daily."	0
"Based on monitoring of adverse events, vital signs, electrocardiograms, and results of laboratory tests, no overall differences in safety between elderly and younger patients were observed in clinical studies."	0
"Drugs Prolonging the QT Interval (Inducing Torsade de Pointes) Coadministration of drugs prolonging the QT interval (such as certain phenothiazines, tricyclic antidepressants, certain macrolide antibiotics, and Class I and III antiarrhythmics) is contraindicated because of the potential risk of torsade de pointes<U+2013>type ventricular tachycardia."	0
Antiemetic:dronabinol <U+2191> dronabinol A dose decrease of dronabinol may be needed when co-administered with ritonavir.	1
"The clinician should, nevertheless, be aware of the possibility of emergent symptoms of serotonin syndrome with such use."	0
"The patient should be monitored for symptoms of serotonin syndrome for 2 weeks or until 24 hours after the last dose of linezolid or intravenous methylene blue, whichever comes first."	0
Hepatic insufficiency The pharmacokinetics of irbesartan following repeated oral administration are not significantly affected in patients with mild to moderate cirrhosis of the liver.	0
"However, due to Eli Lilly and Company, Inc.'s marketing exclusivity rights, this drug product is not labeled with that pediatric information."	0
The aPTT test provides an approximation of PRADAXA<U+2019>s anticoagulant effect.	0
"An increased plasma concentration of pimozide causes QT prolongation and has been associated with torsades de pointes-type ventricular tachycardia, sometimes fatal."	0
Patients should be advised that initiation of treatment and (to a lesser extent) dosage increases may be associated with transient symptoms of dizziness or lightheadedness (and rarely syncope) within the first hour after dosing.	0
HCTZ 50 mg QD or HCTZ/triamterene 50/100 mg QD was co-administered with TIKOSYN (500 mcg BID) for 5 days (following 2 days of diuretic use at half dose).	0
The long-term efficacy of lovastatin therapy in childhood to reduce morbidity and mortality in adulthood has not been established.	0
"Anyone considering the use of SURMONTIL or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need."	0
"Also, they should not be given cocaine or local anesthesia containing sympathomimetic vasoconstrictors."	0
"In the overall clinical program, TIKOSYN did not affect blood pressure."	0
"P-gp inducers (e.g., rifampin, St. John<U+2019>s wort): May alter concentrations of ledipasvir and sofosbuvir."	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
There is no general agreement about specific pharmacological treatment regimens for uncomplicated NMS.	0
<U+2022>Loss of therapeutic effect of LEXIVA/ritonavir and possible development of resistance.	0
"These include itraconazole, ketoconazole, posaconazole, voriconazole, the macrolide antibiotics erythromycin and clarithromycin, and the ketolide antibiotic telithromycin, HIV protease inhibitors, boceprevir, telaprevir, the antidepressant nefazodone, cobicistat-containing products, or grapefruit juice."	0
"Use of alcohol while taking EMSAM is not recommended, even though EMSAM has not been shown to increase the impairment of mental and motor skills caused by alcohol (0.75mg per kg)."	0
"In general, a loading dose of twice the daily dose is recommended on the first day of therapy to result in plasma concentrations close to steady-state by the second day of therapy."	0
PRISTIQ has not been systematically evaluated in patients with a seizure disorder.	0
Initiation of LEXIVA with ritonavir in patients taking quetiapine: Consider alternative antiretroviral therapy to avoid increases in quetiapine drug exposures.	1
WARNING: SUICIDAL IDEATION IN CHILDREN AND ADOLESCENTS See full prescribing information for complete boxed warning.	0
"Chronic constrictive pericarditis is not generally associated with any inotropic defect, so heart failure of this etiology is unlikely to respond to treatment with digoxin."	0
"In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers."	0
"In vitro radioligand binding studies indicate that paroxetine has little affinity for muscarinic, alpha1-, alpha2-, beta-adrenergic-, dopamine (D2)-, 5-HT1-, 5-HT2-, and histamine (H1)-receptors; antagonism of muscarinic, histaminergic, and alpha1-adrenergic receptors has been associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs."	0
These patients should be carefully monitored for abnormal prolongation of the PR interval or other signs of overdosage.	0
No carcinogenic potential was demonstrated in an 18 month study in rats with MINIPRESS at dose levels more than 225 times the usual maximum recommended human dose of 20 mg per day.	0
Hemodialysis reduces the level of circulating cimetidine.	0
The volume of distribution (Vss) is approximately 21 liters.	0
"Such individuals have been referred to as ""poor metabolizers"" (PM) of drugs such as debrisoquin, dextromethorphan, and tricyclic antidepressants."	0
In vitro studies in hepatocytes indicated that CYP3A4 may contribute to fingolimod metabolism in the case of strong induction of CYP3A4.	0
Treatment with losartan potassium tablets reduced the risk of stroke by 25% relative to atenolol (p=0.001).	0
"Because of its relative beta1 cardio-selectivity, however, TOPROL-XL may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment."	0
"If adverse reactions such as hypotension, bradycardia, or excessive drowsiness occur, reduce or discontinue Zanaflex therapy."	0
"Other HIV Protease Inhibitors(CYP3A4 Inhibition) In Vivo Studies Showed No Significant Effects of Indinavir on Voriconazole Exposure No dosage adjustment in the voriconazole dosage needed when coadministered with indinavir In Vitro Studies Demonstrated Potential for Inhibition of Voriconazole Metabolism(Increased Plasma Exposure) Frequent monitoring for adverse events and toxicity related to voriconazole when coadministered with other HIV protease inhibitors Other NNRTIsNon-Nucleoside Reverse Transcriptase Inhibitors (CYP3A4 Inhibition or CYP450 Induction) In Vitro Studies Demonstrated Potential for Inhibition of Voriconazole Metabolism by Delavirdine and Other NNRTIs (Increased Plasma Exposure) Frequent monitoring for adverse events and toxicity related to voriconazole A Voriconazole-Efavirenz Drug Interaction Study Demonstrated the Potential for the Metabolism of Voriconazole to be Induced by Efavirenz and Other NNRTIs(Decreased Plasma Exposure) Careful assessment of voriconazole effectiveness Table 8: Effect of Voriconazole on Pharmacokinetics of Other Drugs AUC<U+03C4> Significantly Increased; No Significant Effect on Cmax When initiating therapy with VFEND in patients already receiving cyclosporine, reduce the cyclosporine dose to one-half of the starting dose and follow with frequent monitoring of cyclosporine blood levels."	1
"Peripheral edema is a known class effect of endothelin receptor antagonists, and is also a clinical consequence of PAH and worsening PAH."	0
"Because there is a linear relationship between dofetilide plasma concentration and QTc, concomitant drugs that interfere with the metabolism or renal elimination of dofetilide may increase the risk of arrhythmia (Torsade de Pointes)."	0
Most patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy [see Clinical Studies (14.3)].	0
For continuous infusion the usual adult dose is 15 to 35 mg per hour administered intravenously as required.	0
"When quinidine and digoxin are coadministered, digoxin doses usually need to be reduced."	1
<U+2022> Cyclosporine: Combination increases rosuvastatin exposure.	1
"The relationship between dose and CMI/DMI concentrations at higher daily doses has not been systematically assessed, but if there is significant dose dependency at doses above 150 mg/day, there is the potential for dramatically higher Css and AUC even for patients dosed within the recommended range."	0
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.	0
Amlodipine: Elderly patients have decreased clearance of amlodipine with a resulting increase in AUC of approximately 40% to 60%.	0
"In matched samples, older assays might unpredictably have given results that were as much as two or three times higher."	0
"Given the likelihood that some patients exposed chronically to antipsychotics will develop tardive dyskinesia, it is advised that all patients in whom chronic use is contemplated be given, if possible, full information about this risk."	0
Bipolar Disorder: Use with particular care in ADHD patients with comorbid Bipolar Disorder.	0
"Concomitant use of prostaglandin synthase inhibiting drugs, eg, indomethacin, may decrease the hypotensive effects of beta blockers."	0
"HMG CoA reductase inhibitors Lovastatin, simvastatin Potential for myopathy including rhabdomyolysis."	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
Reversal of Anticoagulant Effect: A specific reversal agent (idarucizumab) for dabigatran is available when reversal of the anticoagulant effect of dabigatran is needed: For emergency surgery/urgent procedures In life-threatening or uncontrolled bleeding Hemodialysis can remove dabigatran; however the clinical experience supporting the use of hemodialysis as a treatment for bleeding is limited.	0
Reduction of Risk of Stroke and Systemic Embolism in Non-valvular Atrial Fibrillation Reduce the dose of PRADAXA to 75 mg twice daily when dronedarone or systemic ketoconazole is coadministered with PRADAXA in patients with moderate renal impairment (CrCl 30-50 mL/min).	1
Cleviprex should not be administered in the same line as other medications.	0
Grapefruit juice Avoid grapefruit juice Other Lipid-lowering Medications: Use with other fibrate products or lipid-modifying doses (<U+2265>1 g/day) of niacin increases the risk of adverse skeletal muscle effects.	0
"Administration of PRIFTIN with a meal increases oral bioavailability and may reduce the incidence of gastrointestinal upset, nausea, and/or vomiting."	0
"After administering TWYNSTA 80/10 mg tablet with a high-fat meal, the total area under the plasma concentration-time curve (AUC) and Cmax for telmisartan decreased by about 24% and 60%, respectively."	1
"TOPROL-XL tablets are scored and can be divided; however, do not crush or chew the whole or half tablet."	0
The intersubject variation for oral clearance was 22%.	0
Each patient must be individually titrated to the desired hemodynamic or renal response to dopamine.	0
"Monitor heart rate in patients receiving clonidine concomitantly with agents known to affect sinus node function or AV nodal conduction, e.g., digitalis, calcium channel blockers and beta-blockers."	0
"During marketing of Lexapro and other SSRIs and SNRIs (serotonin and norepinephrine reuptake inhibitors), there have been spontaneous reports of adverse events occurring upon discontinuation of these drugs, particularly when abrupt, including the following: dysphoric mood, irritability, agitation, dizziness, sensory disturbances (e.g., paresthesias such as electric shock sensations), anxiety, confusion, headache, lethargy, emotional lability, insomnia, and hypomania."	0
Thiazides do not affect normal blood pressure.	0
"Effient is contraindicated in patients with hypersensitivity (e.g., anaphylaxis) to prasugrel or any component of the product."	0
Immunosuppressants: Amlodipine may increase the systemic exposure of cyclosporine or tacrolimus when co-administered.	1
The mechanism of action of sertraline is presumed to be linked to its inhibition of CNS neuronal uptake of serotonin (5HT).	0
"Anuria, acute or chronic renal insufficiency, and evidence of diabetic nephropathy are contraindications to the use of amiloride HCl."	0
"In clinical trials, immediate-release oral isosorbide dinitrate has been administered in a variety of regimens, with total daily doses ranging from 30 to 480 mg. Do not exceed 160 mg (4 capsules) per day."	0
Butyrophenones (such as haloperidol) and phenothiazines can suppress the dopaminergic renal and mesenteric vasodilation induced with low-dose dopamine infusion.	0
"Long term animal studies have not been performed to evaluate carcinogenic potential, mutagenic potential or the effect on fertility of lidocaine hydrochloride."	0
Ziprasidone should not be used with any drug that prolongs the QT interval.	0
"Some hypertensive patients with no apparent pre-existing renal vascular disease have developed increases in blood urea nitrogen and serum creatinine, usually minor and transient, especially when ALTACE has been given concomitantly with a diuretic."	0
"If there is any foam, wait for the foam to disappear before going on to Step 9."	0
"Dosage reduction for midazolam should be considered, especially if more than a single dose of midazolam is administered."	1
"In studies up to 72 hours of continuous infusion, in patients that were not transitioned to other antihypertensive therapies, there was some evidence of rebound hypertension following Cleviprex discontinuation."	0
"The steady-state plasma concentrations of fluoxetine and norfluoxetine increased by about 18% and 36%, respectively, and concentrations of paroxetine decreased by about 27%."	1
Distribution Teriflunomide is extensively bound to plasma protein (>99%) and is mainly distributed in plasma.	0
"Serotonergic Drugs: Based on the mechanism of action of paroxetine and the potential for serotonin syndrome, caution is advised when paroxetine is coadministered with other drugs or agents that may affect the serotonergic neurotransmitter systems, such as triptans, linezolid (an antibiotic which is a reversible non-selective MAOI), lithium, fentanyl, tramadol, amphetamines, or St. John's Wort."	0
This pharmacologic action is thought to be responsible for the drug's antidepressant and anxiolytic effects.	0
"REYATAZ/ritonavir <U+2191> fluticasone Concomitant use of fluticasone propionate and REYATAZ/ritonavir may increase plasma concentrations of fluticasone propionate, resulting in significantly reduced serum cortisol concentrations."	1
Nonselective <U+03B2>-blockers may potentiate insulin-induced hypoglycemia and delay recovery of serum glucose levels.	0
There is no experience with the use of more than one 75 mg/50 mg (75 mg triamterene and 50 mg hydrochlorothiazide) tablet daily or more than two 37.5 mg/25 mg (37.5 mg triamterene and 25 mg hydrochlorothiazide) tablets daily.	0
"With repeated administration, the half-life decreases and reaches average values of approximately 2 to 3 hours."	0
"The clinician should, nevertheless, be aware of the possibility of emergent symptoms of serotonin syndrome with such use."	0
"Neonates exposed to antipsychotic drugs, during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery."	0
"This suggests that an interaction of iloperidone with inhibitors or inducers of these enzymes, or other factors, like smoking, is unlikely."	0
"After about 12months, gain in height stabilizes, and at 3years, patients treated with STRATTERA have gained 19.4cm on average, 0.4cm less than predicted by their baseline data."	0
Advise patients to swallow the capsules whole with water.	0
"AMBIEN demonstrated linear kinetics in the dose range of 5 to 20 mg. Total protein binding was found to be 92.5 <U+00B1> 0.1% and remained constant, independent of concentration between 40 and 790 ng/mL."	0
Each capsule contains lactose (anhydrous) 63.3 mg.	0
Figure 3: Effect of Intrinsic Factors on Asenapine Pharmacokinetics Figure 3	0
The blood levels in PMs are similar to those attained by taking strong inhibitors of CYP2D6.	0
It is not recommended to administer SAMSCA with a V2-agonist.	0
Consider monitoring rifabutin concentrations to ensure adequate exposure.	0
"Examples Urinary acidifying agents (e.g., ammonium chloride, sodium acid phosphate, methenamine salts)."	0
The increased CgA level may cause false positive results in diagnostic investigations for neuroendocrine tumors.	0
"Thus, the prescriber should be aware that there is some risk of postural hypotension in association with nefazodone use."	0
"When the solution is taken after meals, the peak serum concentrations increase by 20% and the total amount of digoxin absorbed increases by 43%, but the rate of digoxin absorption is unchanged."	0
"Patients who develop evidence of hepatocellular injury such as increased serum AST or serum ALT levels <U+2265> 3 times the upper limit of NORMAL, while on nefazodone should be withdrawn from the drug."	0
This had no effect on the efficacy or safety of LIVALO in elderly subjects in clinical studies.	0
Atorvastatin: Table 5 shows the effects of atorvastatin on the pharmacokinetics of other drugs.	0
Lovastatin SAMSCA is a weak inhibitor of CYP 3A.	0
It is not a disclosure of all possible adverse or intended effects.	0
"Because animal reproduction studies are not always predictive of human response, this drug should be used in pregnancy only if clearly needed."	0
"Monitor for and promptly treat infections such as EBV and cytomegalovirus (CMV), as these are known triggers for MAS."	0
"Since metabolic interactions are unlikely between nefazodone and HMG-CoA reductase inhibitors that undergo little or no metabolism by the CYP3A4 isozyme, such as pravastatin or fluvastatin, dosage adjustments should not be necessary."	0
"An antihypertensive effect is usually present within 2 weeks, with full effect generally obtained within 4 weeks of treatment with ATACAND."	0
Interstitial lung disease (ILD): Fatal ILD has occurred in patients receiving irinotecan HCl.	0
SAPHRIS activity is primarily due to the parent drug.	0
Pharmacokinetic interaction between lithium and INVEGA<U+00AE> is unlikely.	0
Maintenance therapy may be on an intermittent basis.	0
"This effect is often called ""rebound"" insomnia."	0
Patients receiving ACE inhibitors who develop jaundice or marked elevations of hepatic enzymes should discontinue the ACE inhibitor and receive appropriate medical follow-up.	0
"In patients taking potent inhibitors of CYP3A such as ketoconazole and itraconazole , avoid use of ADCIRCA see Drug Interactions ( 7.2 ) and Clinical Pharmacology ( 12.3 ) ."	0
"Symptomatic hypotension sometimes associated with oliguria and/or progressive azotemia, and rarely acute renal failure and/or death, include patients with the following conditions or characteristics: heart failure, hyponatremia, high dose diuretic therapy, recent intensive diuresis or increase in diuretic dose, renal dialysis or severe volume and/or salt depletion of any etiology."	0
"In hypothyroidism, the digoxin requirements are reduced."	0
"Children 1 to < 6 years of age, given 0.2 mg/kg had exposure similar to adults given 8 mg. Children > 6 years of age had exposure similar to adults given the same dose."	0
Plasma TCA concentrations may need to be monitored and the dose of the TCA may need to be reduced if a TCA is co-administered with CYMBALTA.	1
"Clomipramine: In a drug-drug interaction study, an increase in euphoria and postural hypotension was observed in patients who switched from clomipramine to Savella."	0
"CONSEQUENTLY, BEFORE INITIATING TREATMENT WITH THIORIDAZINE, IT IS STRONGLY RECOMMENDED THAT A PATIENT BE GIVEN AT LEAST TWO TRIALS, EACH WITH A DIFFERENT ANTIPSYCHOTIC DRUG PRODUCT, AT AN ADEQUATE DOSE, AND FOR AN ADEQUATE DURATION."	0
The N-debutyl metabolite exhibits pharmacodynamic activity but is 1/10 to 1/3 as potent as dronedarone.	0
No formal pharmacokinetic studies have been carried out in hypertensive patients with impaired liver function.	0
<U+2022>LEXIVA 700mg twice daily plus ritonavir 100mg twice daily. oDosing of LEXIVA 700mg twice daily plus 100mg ritonavir twice daily is supported by pharmacokinetic and safety data.	0
Intervention: Monitor INR and prothrombin time.	0
Most of the patients were aware that the events were unreal.	0
A study in six healthy volunteers has shown a significant increase in peak nifedipine plasma levels (80%) and area-under-the-curve (74%) after a one week course of cimetidine at 1000 mg per day and nifedipine at 40 mg per day.	1
"Two large case-control studies using separate databases, each with >9,000 birth defect cases and >4,000 controls, found that maternal use of paroxetine during the first trimester of pregnancy was associated with a 2- to 3-fold increased risk of right ventricular outflow tract obstructions."	0
The most common substitution detected at failure was Y93H.	0
"In the absence of metabolic activation , neither ALDACTONE nor potassium canrenoate has been shown to be mutagenic in mammalian tests in vitro ."	0
The relevance of these findings to tumor development in humans is unknown.	0
"As with other acute migraine therapies, before treating headaches in patients not previously diagnosed as migraineurs, and in migraineurs who present with atypical symptoms, care should be taken to exclude other potentially serious neurological conditions."	0
"Because there are multiple metabolic pathways, the risk of metabolic interactions caused by an effect on an individual isoform is minimal."	0
Erythromycin co-administration in healthy volunteers did not significantly change amlodipine systemic exposure.	0
"If serum potassium concentration is less than 2.5 mEq/L, use intravenous potassium instead of oral supplementation."	0
"Carbamazepine is an enzyme inducer and typically causes decreases in drug exposure; however, approximately 2-fold increased systemic exposure of selegiline and its metabolites, L-amphetamine and L-methamphetamine were seen after single application of EMSAM 6 mg per 24 hours in subjects who had received carbamazepine (400mg per day) for 14 days."	1
"After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours, and lasts about 6 to 12 hours."	0
"Feeding tubes that are compatible with ethanol and propylene glycol, such as silicone and polyvinyl chloride (PVC) feeding tubes, can be used for administration of NORVIR oral solution."	0
"In post-MI HFrEF patients taking a moderate CYP3A inhibitor, do not exceed 25 mg once daily."	1
There are no adequate and well-controlled studies in pregnant women.	0
"Discontinue treatment with DESOXYN and any concomitant serotonergic agents immediately if the above symptoms occur, and initiate supportive symptomatic treatment."	0
BRILINTA increases serum concentrations of simvastatin and lovastatin because these drugs are metabolized by CYP3A4 .	1
"Beneficial effects on the severity of heart failure as measured by New York Heart Association (NYHA) classification and Quality of Life and on symptoms of dyspnea, fatigue, and edema were evident after 6 months in a double-blind, placebo-controlled study."	0
"In patients with stable coronary artery disease, ACEON should be given at an initial dose of 4 mg once daily for 2 weeks, and then increased as tolerated, to a maintenance dose of 8 mg once daily."	0
"Patients receiving sertraline in this study were initiated at doses of either 25 mg/day (children, ages 6 to 12) or 50 mg/day (adolescents, ages 13 to 17), and then titrated over the next four weeks to a maximum dose of 200 mg/day, as tolerated."	0
"Food decreases the rate and extent of absorption of atorvastatin from CADUET by approximately 32% and 11%, respectively, as it does with atorvastatin when given alone."	1
"In the VALsartan In Acute myocardial iNfarcTion trial ( VALIANT ) , hypotension in post-myocardial infarction patients led to permanent discontinuation of therapy in 1.4 % of valsartan-treated patients and 0.8 % of captopril-treated patients ."	0
"Levels of excretion of isocarboxazid and/or its metabolites in human milk have not been determined, and effects on the nursing infant are unknown."	0
Do NOT administer if solution is darker than slightly yellow or discolored in any other way.	0
"If tolerated, patients may have their dose increased to 6.25, 12.5, and 25mg twice daily over successive intervals of at least 2 weeks."	0
"The risk of hyperkalemia may be increased when potassium-conserving agents, including amiloride HCl, are administered concomitantly with an angiotensin-converting enzyme inhibitor, an angiotensin II receptor antagonist, cyclosporine or tacrolimus."	0
Patients should be monitored for these symptoms when discontinuing treatment.	0
"At doses <U+2265>25 mg, apixaban displays dissolution-limited absorption with decreased bioavailability."	0
"Combined P-gp and strong CYP3A4 inhibitors and inducers: Avoid concomitant use (7.2, 7.3) Anticoagulants: Avoid concomitant use (7.4) Rivaroxaban is a substrate of CYP3A4/5, CYP2J2, and the P-gp and ATP-binding cassette G2 (ABCG2) transporters."	0
"Caution should be exercised when coadministering mirtazapine with potent CYP3A4 inhibitors, HIV protease inhibitors, azole antifungals, erythromycin, or nefazodone."	0
"Lower dosages are also recommended for outpatients compared to hospitalized patients, who are closely supervised."	0
More frequent INR monitoring should be performed when starting or stopping botanicals.	0
The clinical significance of this apparent gender interaction is unknown at this time.	0
"If replacing clonidine by beta-blocker therapy, delay the introduction of beta-blockers for several days after clonidine administration has stopped."	0
"Prasugrel is not anticipated to have significant effect on the pharmacokinetics of drugs that are primarily metabolized by CYP2B6, such as halothane, cyclophosphamide, propofol, and nevirapine."	0
"With repetitive dosing, irbesartan accumulates to no clinically relevant extent."	0
Invert the IV bag several times to ensure complete mixing of the solution.	0
The half-life of elimination averages 51 hours.	0
"In patients undergoing surgery or during anesthesia with agents that produce hypotension, ACEON may block angiotensin II formation that would otherwise occur secondary to compensatory renin release."	0
No clinically significant pharmacokinetic interaction has been found between trandolapril (or its metabolites) and cimetidine.	0
Serious Cardiovascular Events Sudden Death and Pre-existing Structural Cardiac Abnormalities or Other Serious Heart Problems: Children and Adolescents: Sudden death has been reported in association with CNS stimulant treatment at usual doses in children and adolescents with structural cardiac abnormalities or other serious heart problems.	0
"The use of drugs that act directly on the renin-angiotensin system during the second and third trimesters of pregnancy has been associated with fetal and neonatal injury, including hypotension, neonatal skull hypoplasia, anuria, reversible or irreversible renal failure, and death."	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older.	0
Protein binding was similar (92%-94%) between healthy controls and ESRD subjects during the on-dialysis and off-dialysis periods.	0
"MICARDIS is contraindicated in patients with known hypersensitivity (e.g., anaphylaxis or angioedema) to telmisartan or any other component of this product."	0
"Coadministration of EMEND with warfarin, a CYP2C9 substrate, may result in a clinically significant decrease in International Normalized Ratio (INR) of prothrombin time."	0
The 5-mg dose was less consistently effective than were the 10-mg and 20-mg doses.	0
"Thus, an interaction between iloperidone and other CYP2D6 substrates is unlikely."	0
"In a single-dose pharmacokinetic study using EXTRANEAL, a median of 40% (60 g) of the instilled icodextrin was absorbed from the peritoneal solution during a 12-hour dwell."	0
Antipsychotic drugs elevate prolactin levels; the elevation persists during chronic administration.	0
PRIFTIN should not be used in the treatment of active pulmonary tuberculosis caused by rifampin-resistant strains.	0
"Because many drugs are excreted in human milk, consideration should be given to discontinuing the use of all but absolutely essential drug treatments in nursing women."	0
"Because the relative potencies of paroxetine<U+2019>s major metabolites are at most 1/50 of the parent compound, they are essentially inactive."	0
"Systematic evaluation of continuing Lexapro 10 or 20 mg/day in adults patients with major depressive disorder who responded while taking Lexapro during an 8-week, acute-treatment phase demonstrated a benefit of such maintenance treatment."	0
"Coadministration of terfenadine, astemizole, cisapride, pimozide or quinidine with VFEND is contraindicated because increased plasma concentrations of these drugs can lead to QT prolongation and rare occurrences of torsade de pointes."	0
Black patients receiving ACE inhibitors have a higher incidence of angioedema compared to nonblacks.	0
"Chronically administered beta-blocking therapy should not be routinely withdrawn prior to major surgery, however, the impaired ability of the heart to respond to reflex adrenergic stimuli may augment the risks of general anesthesia and surgical procedures."	0
"When pregnancy is detected, discontinue TWYNSTA as soon as possible (5.1, 8.1) Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus (5.1, 8.1)"	0
Invitro drug-displacement studies were conducted with atomoxetine and other highly-bound drugs at therapeutic concentrations.	0
"Neutropenia/Agranulocytosis Trandolapril Component Another ACE inhibitor, captopril, has been shown to cause agranulocytosis and bone marrow depression rarely in patients with uncomplicated hypertension, but more frequently in patients with renal impairment, especially if they also have a collagen-vascular disease such as systemic lupus erythematosus or scleroderma."	0
Clearance is affected primarily by denitration to the 2-mononitrate (15 to 25%) and the 5-mononitrate (75 to 85%).	0
Consider these risks when scheduling patients for spinal procedures.	0
It should be noted that LUVOX CR Capsules are not approved for use in treating bipolar depression.	0
Titrate by 0.8 g per meal in two week intervals for adult patients as needed to obtain serum phosphorus target.	0
Gender No dosage adjustment is recommended based on gender.	0
Antifungal Voriconazole Voriconazole is contraindicated with ritonavir doses of 400 mg every 12 hours or greater due to the potential for loss of antifungal response.	0
CYP2D6 Inhibitors are likely to increase metoprolol concentration.	1
"Patients who develop symptoms such as exertional chest pain, unexplained syncope, or other symptoms suggestive of cardiac disease during stimulant treatment should undergo a prompt cardiac evaluation."	0
"These doses are 313 and 32 times (mice), and 100 and 23 times (rats) the maximum recommended human daily dose (MRHDD) of 4 mg based on body-weight and body-surface-area, respectively assuming a 50 kg individual."	0
Intestinal Angioedema Intestinal angioedema has been reported in patients treated with ACE inhibitors.	0
Intervention 3-day EMEND regimen Monitor for benzodiazepine-related adverse reactions.	0
"Triamterene and hydrochlorothiazide should not be given to patients receiving other potassium-conserving agents such as spironolactone, amiloride hydrochloride or other formulations containing triamterene."	0
Coadministration of fluconazole and quinidine is contraindicated.	0
Few well-controlled clinical trials of organic nitrates have been designed to detect rebound or withdrawal effects.	0
It is generally believed (though not established in controlled trials) that treating such an episode with an antidepressant alone may increase the likelihood of precipitation of a mixed/manic episode in patients at risk for bipolar disorder.	0
"For Patients Treated for Hypertension INSPRA is contraindicated for the treatment of hypertension in patients with: type 2 diabetes with microalbuminuria, serum creatinine >2.0 mg/dL in males or >1.8 mg/dL in females, creatinine clearance <50 mL/min, or concomitant administration of potassium supplements or potassium-sparing diuretics (e.g., amiloride, spironolactone, or triamterene)."	0
Elimination of quinaprilat is reduced in elderly patients (<U+2265>65 years) and in those with heart failure; this reduction is attributable to decrease in renal function.	0
"Patients should resist the temptation to avoid headaches by altering the schedule of their treatment with isosorbide dinitrate, since loss of headache may be associated with simultaneous loss of antianginal efficacy."	0
USE IN PREGNANCY: Pregnancy category C. D-penicillamine has been shown to cause skeletal defects and cleft palates in the fetus when given to pregnant rats at 10 times the dose recommended for human use.	0
"Patients receiving catecholamine-depleting drugs, such as reserpine or guanethidine, should be closely monitored because the added beta-adrenergic blocking action of bisoprolol fumarate may produce excessive reduction of sympathetic activity."	0
"In a 7-day study, in which subjects were given a 30 mg capsule of a marketed bioequivalent temazepam product one hour before retiring, steady-state (as measured by the attainment of maximal trough concentrations) was achieved by the third dose."	0
"Cytochrome P450 Substrates Tadalafil is not expected to cause clinically significant inhibition or induction of the clearance of drugs metabolized by cytochrome P450 (CYP) isoforms (e.g., theophylline, warfarin, midazolam, lovastatin, bosentan) [see Clinical Pharmacology (12.3)]."	0
"Metabolism and Elimination Following either intravenous or oral administration of 14C-labeled telmisartan, most of the administered dose (>97%) was eliminated unchanged in feces via biliary excretion; only minute amounts were found in the urine (0.91% and 0.49% of total radioactivity, respectively)."	0
It is generally believed (though not established in controlled trials) that treating such an episode with an antidepressant alone may increase the likelihood of precipitation of a mixed/manic episode in patients at risk for bipolar disorder.	0
Metabolism and Excretion Eplerenone metabolism is primarily mediated via CYP3A4.	0
Literature reports indicate that coadministration of indomethacin may reduce the natriuretic and antihypertensive effects of LASIX ( furosemide ) in some patients by inhibiting prostaglandin synthesis .	0
"Citalopram is a racemic mixture (50/50), and the inhibition of 5-HT reuptake by citalopram is primarily due to the (S)-enantiomer."	0
"Alcohol: Although paroxetine has not been shown to increase the impairment of mental and motor skills caused by alcohol, patients should be advised to avoid alcohol while taking PEXEVA<U+00AE> (paroxetine mesylate)."	0
Bipolar Illness: Particular care should be taken in using stimulants to treat ADHD in patients with comorbid bipolar disorder because of concern for possible induction of a mixed/manic episode in such patients.	0
Sotalol shows very little intersubject variability in plasma levels.	0
"In vitro studies using human liver microsomes revealed that the cytochrome P450 3A4 isoenzyme is involved in the metabolism of quetiapine to its major, but inactive, sulfoxide metabolite and in the metabolism of its active metabolite N-desalkyl quetiapine."	0
"Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including VASOTEC. mTOR (mammalian target of rapamycin) inhibitors: Patients receiving coadministration of ACE inhibitor and mTOR inhibitor (e.g., temsirolimus, sirolimus, everolimus) therapy may be at increased risk for angioedema (see WARNINGS)."	0
"If symptoms re-appear, decrease TRISENOX and/or tretinoin to the previous dose."	0
"For patients on hemodialysis or creatinine clearance <10 mL/min, the recommended initial dose is 2.5 mg once daily."	0
"Because the kinetics of absorption may vary with the patient's peripheral perfusion, intramuscular injection of quinidine gluconate is not recommended."	0
"Studies Pertinent to Safety Concerns for Sedative/Hypnotic Drugs Memory Impairment Studies involving the exposure of normal subjects to single fixed doses of Zaleplon (10 mg or 20 mg) with structured assessments of short-term memory at fixed times after dosing (eg, 1, 2, 3, 4, 5, 8, and 10 hours) generally revealed the expected impairment of short-term memory at 1 hour, the time of peak exposure to zaleplon, for both doses, with a tendency for the effect to be greater after 20 mg."	0
"Withhold ONIVYDE in patients with new or progressive dyspnea, cough, and fever, pending diagnostic evaluation."	0
"Although zaleplon is well absorbed, its absolute bioavailability is approximately 30% because it undergoes significant presystemic metabolism."	0
"Pediatric Patients 6 Years of Age and Older with Hypertension For pediatric patients with glomerular filtration rate >30 mL/min/1.73 m2, the recommended starting dose is 0.07 mg/kg once daily (up to 5 mg total)."	0
Store in moisture barrier overwrap and in carton until ready to use.	0
The risk of administering methylene blue by non-intravenous routes (such as oral tablets or by local injection) or in intravenous doses much lower than 1 mg/kg with PEXEVA<U+00AE> is unclear.	0
"A reduced pregnancy rate was found in reproduction studies in rats at a dose of paroxetine of 15 mg/kg/day, which is 2.9 times the MRHD for MDD and GAD or 2.4 times the MRHD for OCD on a mg/m2 basis."	0
This time to peak levels is identical to the time measured when quinidine salts are administered orally.	0
<U+2022>Drug laboratory test interactions: WELLBUTRIN XL can cause false-positive urine test results for amphetamines.	0
The recommended regimen for the administration of Selegiline Hydrochloride Tablets USP is 10 mg per day administered as divided doses of 5 mg each taken at breakfast and lunch.	0
Male patients are not enrolled in the REMS.	0
"Based on the prolonged half-life seen in premature newborns (gestational age 26 to 29 weeks), these children, in the first two weeks of life, should receive the same dosage (mg/kg) as in older children, but administered every 72 hours."	0
Safety and effectiveness in the pediatric population have not been established.	0
"Based on in vitro data, ZYTIGA is a substrate of CYP3A4."	0
Increase as tolerated to a maximum of 40 mg once daily.	0
The pharmacokinetics of benazepril are approximately dose-proportional within the dosage range of 10 to 80 mg.	0
"There are, however, no adequate and well controlled studies in pregnant women."	0
Plasma concentrations of trandolaprilat but not trandolapril increase in proportion with dose.	0
"With concomitant use, changes in exposure were observed both for boceprevir and certain protease inhibitors used for the treatment of HIV-1 infection or either medication."	0
"Administration of the Continuous Infusion Immediately following the administration of the bolus, infuse NATRECOR<U+00AE> at a flow rate of 0.1 mL/kg/hr."	0
"Zaleplon 10 mg and 20 mg were consistently superior to placebo for TSO, generally for the full duration of all three studies."	0
An evaluation of the effect of food on LamisilTablets was conducted.	0
"It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months."	0
"The pooled analyses of placebo-controlled trials in children and adolescents with MDD, obsessive compulsive disorder (OCD), or other psychiatric disorders included a total of 24 short-term trials of 9 antidepressant drugs in over 4400 patients."	0
Patients should be started on 20 mg/day and the dose can be increased in 10 mg/day increments.	0
"Procyclidine Daily oral dosing of paroxetine (30 mg once daily) increased steady-state AUC0-24, Cmax, and Cmin values of procyclidine (5 mg oral once daily) by 35%, 37%, and 67%, respectively, compared to procyclidine alone at steady state."	1
"In comparison to Cmin values after 20 mg daily, values after 40 mg daily were only about 2 to 3 times greater than doubled."	0
Specific Populations Renal impairment The pharmacokinetics of systemic exposure to benazepril and benazeprilat in patients with mild-to-moderate renal insufficiency (creatinine clearance >30 mL/min) is similar to that in patients with normal renal function.	0
Syncope has been reported in the post marketing setting.	0
"Cimetidine - In subjects who had received 21 days of 40 mg/day Celexa, combined administration of 400 mg twice a day cimetidine for 8 days resulted in an increase in citalopram AUC and Cmax of 43% and 39%, respectively."	1
The overall systemic clearance of dofetilide is decreased and plasma concentration increased with decreasing creatinine clearance.	0
There was a moderate dose related effect on the QTc-interval with an increase of +10 ms at 400 mg twice daily and up to +25 ms with 1600 mg twice daily.	0
"In combination with APTIVUS/ritonavir, the following dosage adjustments are recommended in patients with normal renal and hepatic function: Treatment of gout flares: Co-administration of colchicine in patients on APTIVUS/ritonavir: 0.6 mg (1 tablet) x 1 dose, followed by 0.3 mg (half tablet) 1 hour later."	0
"Closely monitor blood pressure, renal function and electrolytes in patients on Lotensin and other agents that affect the RAS."	0
TIKOSYN (dofetilide) shows Vaughan Williams Class III antiarrhythmic activity.	0
"Dosage for Elderly or Debilitated, and Patients with Severe Renal or Hepatic Impairment : The recommended initial dose is 10 mg/day for elderly patients, debilitated patients, and/or patients with severe renal or hepatic impairment."	0
The effect of immediate-release fluvoxamine maleate tablets (100 mg daily for four days) on the pharmacokinetics and pharmacodynamics of a single dose of tizanidine has been studied in 10 healthy male subjects.	0
"Therefore, the concomitant use of NARDIL with serotoninergic agents is contraindicated."	0
"Because of the hydrochlorothiazide component, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs."	0
"Drugs that slow heart rate : Concomitant use of drugs with depressant effects on the sinus and AV node ( e.g. , digoxin , beta blockers , verapamil , diltiazem , ivabradine , clonidine ) can potentiate the electrophysiologic and hemodynamic effects of amiodarone , resulting in bradycardia , sinus arrest , and AV block ."	0
Concomitant use with meperidine is contraindicated.	0
"Although a causal link between the emergence of such symptoms and either the worsening of depression and/or the emergence of suicidal impulses has not been established, there is concern that such symptoms may represent precursors to emerging suicidality."	0
Withdraw entire vial contents and add sufficient sterile diluent to make a total of 100mL.	0
A similar increase in AUC was observed in patients with moderate to severe heart failure.	0
Dosage adjustment of atomoxetine may be necessary and it is recommended that atomoxetine be initiated at a reduced dose when it is given with paroxetine.	1
"In clinical trial and postmarketing experience, events of leukopenia/neutropenia and agranulocytosis have been reported temporally related to antipsychotic agents."	0
"Subjects 65 to 75 years of age (n = 15) had no change in Cmax, but an approximately 32% increase in AUC, compared to subjects 18 to 45 years of age."	0
Vortioxetine pharmacological activity is due to the parent drug.	0
"Therefore, caution should be taken in the administration of carvedilol to patients suspected of having pheochromocytoma."	0
"The effect of verapamil on AV conduction and the SA node may lead to asymptomatic first-degree AV block and transient bradycardia, sometimes accompanied by nodal escape rhythms."	0
"Prothrombin time was increased by 5%, the clinical significance of which is unknown."	0
"Sumatriptan has been reported to cause coronary artery vasospasm, and its effect could be additive with D.H.E."	0
Serum calcium concentration is not affected by amlodipine.	0
"Increased risk of suicidal thinking and behavior in children, adolescents and young adults taking antidepressants for major depressive disorder (MDD) and other psychiatric disorders."	0
Once daily doses of 2 to 4 mg lowered blood pressures 4-6/3-4 mmHg below placebo responses in black patients.	0
Care should be taken to administer the drug slowly in order to avoid producing an excessive hypotensive effect.	0
"Number of patients evaluated for QTc change: 478 TIKOSYN, 167 placebo. figure 1 figure 2"	0
"ET-1 and ET-1 mRNA concentrations are increased as much as 9-fold in the lung tissue of patients with PAH, primarily in the endothelium of pulmonary arteries."	0
Monitor serum potassium in such patients.	0
COREG is contraindicated in the following conditions: <U+2022>Bronchial asthma or related bronchospastic conditions.	0
"Reported clinical findings have included respiratory distress, cyanosis, apnea, seizures, temperature instability, feeding difficulty, vomiting, hypoglycemia, hypotonia, hypertonia, hyperreflexia, tremor, jitteriness, irritability, and constant crying."	0
"As with all antidepressants, PRISTIQ should be used cautiously in patients with a history or family history of mania or hypomania."	0
In most patients no benefit has been associated with using two RAS inhibitors concomitantly.	0
"Once the stopper is punctured, use within 12 hours and discard any unused portion."	0
Use with caution in patients with preexisting conduction system abnormalities and certain heart diseases.	0
Solutions containing carbohydrate in the form of dextrose restore blood glucose levels and provide calories.	0
"Therefore, amiloride HCl should be avoided, if possible, in diabetic patients and, if it is used, serum electrolytes and renal function must be monitored frequently."	0
"If paradoxical aggravation of symptoms or other adverse events occur, the dosage should be reduced, or, if necessary, the drug should be discontinued."	0
No relevant clinical effects or significant changes in pharmacokinetics have been observed in healthy male subjects on concurrent treatment with subtherapeutic levels of lithium (600 mg/day for 10 days) at steady state and a single 30-mg dose of mirtazapine.	0
"Tardive dyskinesia, a syndrome consisting of potentially irreversible, involuntary, dyskinetic movements may develop in patients treated with antipsychotic drugs."	0
The risk of myopathy/rhabdomyolysis is increased with concomitant administration of clarithromycin.	0
Metabolism Teriflunomide is the major circulating moiety detected in plasma.	0
MAO inhibitors can suppress anginal pain that would otherwise serve as a warning of myocardial ischemia.	0
"In patients taking AUBAGIO, exposure of drugs metabolized by CYP2C8 (e.g., paclitaxel, pioglitazone, repaglinide, rosiglitazone) may be increased."	1
The half-life observed after intramuscular administration is similar to that observed after oral dosing.	0
"Following a single oral dose, peak flurazepam plasma concentrations ranging from 0.5 to 4.0 ng/mL occur at 30 to 60 minutes post-dosing."	0
"If hypotension occurs and is considered to be due to this mechanism, it can be corrected by volume expansion."	0
Peak plasma concentrations are reached between 1 and 2 hours after oral administration.	0
"However, infrequently, symptomatic postural hypotension has also been reported later than a few hours after dosing."	0
The less concentrated 800 mcg/mL solution may be preferred when fluid expansion is not a problem.	0
Co-administration of SAMSCA with digoxin increased digoxin AUC by 20 % and Cmax by 30 % .	1
Monitor for signs and symptoms of MI and stroke.	0
Amplification of the vasodilatory effects of dilatrate<U+00AE> -SR by sildenafil can result in severe hypotension.	0
The safe use of DYAZIDE in pregnancy has not been established since there are no adequate and well-controlled studies with DYAZIDE in pregnant women.	0
N-desethyl levomilnacipran is the major metabolite excreted in the urine and accounted for approximately 18% of the dose.	0
Intestinal Angioedema: Intestinal angioedema has been reported in patients treated with ACE inhibitors.	0
"In some patients treated once daily, the antihypertensive effect may diminish toward the end of the dosing interval."	0
"In a clinical study, ketoconazole (200 mg BID) increased the area under the concentration vs. time curve (AUC) of desvenlafaxine (400 mg single dose) by about 43% and Cmax by about 8%."	1
Patients with severe neutropenia (absolute neutrophil count <1000/mm3) should discontinue ORAP and have their WBC followed until recovery.	0
"Irbesartan In healthy subjects, single oral irbesartan doses of up to 300 mg produced dose-dependent inhibition of the pressor effect of angiotensin II infusions."	0
"CYP3A4 Inhibitors Ketoconazole Ketoconazole, a potent CYP3A4 inhibitor, increased the exposure to and pharmacodynamic effects of zolpidem."	0
Excretion Amlodipine: Elimination from the plasma is biphasic with a terminal elimination half-life of about 30<U+2013>50 hours.	0
"Overall, the data suggest that rebound insomnia may be dose dependent."	0
A lower starting dose should be used in such patients.	0
Protease inhibitor:atazanavir Both CRIXIVAN and atazanavir are associated with indirect (unconjugated) hyperbilirubinemia.	0
Intervention: Monitor for adverse reactions and reduce dosage of ZOLOFT or other protein-bound drugs as warranted.	1
Celexa 20 mg/day is the maximum recommended dose in CYP2C19 poor metabolizers due to the risk of QT prolongation.	0
Elderly patients exhibited increased area under the plasma concentration time curve and peak levels for quinaprilat compared to values observed in younger patients; this appeared to relate to decreased renal function rather than to age itself.	0
"If the QTc has increased by greater than 15% compared to the baseline established in Step 1 OR if the QTc is greater than 500 msec (550 msec in patients with ventricular conduction abnormalities), subsequent dosing should be adjusted as follows: If the Starting Dose Based onCreatinine Clearance is: Then the Adjusted Dose(for QTc Prolongation) is: 500 mcg twice daily 250 mcg twice daily 250 mcg twice daily 125 mcg twice daily 125 mcg twice daily 125 mcg once a day Step 6."	0
Apixaban has no effect on the QTc interval in humans at doses up to 50 mg. Apixaban demonstrates linear pharmacokinetics with dose-proportional increases in exposure for oral doses up to 10 mg.	0
"CYP2D6 is the primary enzyme catalyzing the metabolism of vortioxetine to its major, pharmacologically inactive, carboxylic acid metabolite, and poor metabolizers of CYP2D6 have approximately twice the vortioxetine plasma concentration of extensive metabolizers."	0
"The Veterans Affairs Nephropathy in Diabetes (VA NEPHRON-D) trial enrolled 1448 patients with type 2 diabetes, elevated urinary-albumin-to-creatinine ratio, and decreased estimated glomerular filtration rate (GFR 30 to 89.9 ml/min), randomized them to lisinopril or placebo on a background of losartan therapy and followed them for a median of 2.2 years."	0
"Studies, primarily in patients with good ventricular function, have not revealed evidence of a negative inotropic effect; cardiac output, ejection fraction, and left ventricular end diastolic pressure have not been affected."	0
"Consistent with its negative chronotropic effect due to beta blockade of the SA node, TENORMIN increases sinus cycle length and sinus node recovery time."	0
"Physicians should also discuss the increased risk of NAION with patients who have already experienced NAION in one eye, including whether such individuals could be adversely affected by use of vasodilators, such as PDE-5 inhibitors."	0
"Concomitant administration of LIPITOR with inducers of cytochrome P450 3A4 (e.g., efavirenz, rifampin) can lead to variable reductions in plasma concentrations of atorvastatin."	1
"The effectiveness of paroxetine in the treatment of social anxiety disorder was demonstrated in three 12-week, multicenter, placebo-controlled studies (Studies 1, 2, and 3) of adult outpatients with social anxiety disorder (DSM-IV)."	0
"Since beta1-selectivity is not absolute, the lowest possible dose of TENORETIC should be used and a beta2-stimulating agent (bronchodilator) should be made available."	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
"If a CYP3A4 or CYP2B6 inhibitor is discontinued, consider increasing the Meperidine Hydrochloride Injection dosage until stable drug effects are achieved."	0
Changes in serum prostate specific antigen (PSA) levels may be observed but have not been shown to correlate with clinical benefit in individual patients.	0
Diethylpropion hydrochloride should not be administered to patients with severe hypertension.	0
Higher plasma levels in the 6 to 12 year old group were largely attributable to patients with lower body weights.	0
"Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides , including endogenous bradykinin , patients receiving ACE inhibitors ( including VASOTEC ) may be subject to a variety of adverse reactions , some of them serious ."	0
"There is an increased potential for sildenafil-associated adverse events (which include visual disturbances, hypotension, prolonged erection, and syncope)."	0
LASIX should not be used concomitantly with ethacrynic acid because of the possibility of ototoxicity .	0
"In one study of 45 elderly patients suffering from dementia treated with perphenazine, the 5 patients who were prospectively identified as poor P450 2D6 metabolizers had reported significantly greater side effects during the first 10 days of treatment than the 40 extensive metabolizers, following which the groups tended to converge."	0
"Tricyclic Antidepressants (TCAs): amitriptyline, desipramine, imipramine, nortriptyline <U+2191> amitriptyline<U+2191> desipramine<U+2191> imipramine<U+2191> nortriptyline Use a lower dose of the tricyclic antidepressants and trazodone due to potential increased adverse events such as nausea, dizziness, hypotension and syncope."	0
"At a dose of Clomipramine Hydrochloride Capsules, 200 mg, subjects who had a single blood sample taken approximately 9 to 22 hours, (median 16 hours), after the dose had plasma concentrations of up to 605 ng/mL for CMI, 781 ng/mL for DMI, and 1386 ng/mL for both."	0
"If the decision is made to prescribe a benzodiazepine or other CNS depressant concomitantly with an opioid analgesic, prescribe the lowest effective dosages and minimum durations of concomitant use."	0
"Metabolism and Elimination Telmisartan Following either intravenous or oral administration of 14C-labeled telmisartan, most of the administered dose (>97%) was eliminated unchanged in feces via biliary excretion; only minute amounts were found in the urine (0.91% and 0.49% of total radioactivity, respectively)."	0
"Transient Insomnia Normal adults experiencing transient insomnia during the first night in a sleep laboratory were evaluated in a double-blind, parallel-group trial comparing the effects of two doses of Zaleplon (5 mg and 10 mg) with placebo."	0
The mean elimination half-life is approximately 21 hours (CV 32%) after oral dosing of 30 mg tablets of paroxetine daily for 30 days.	0
Pitavastatin was absorbed in the small intestine but very little in the colon.	0
"Theophylline 5 mg/kg 300 mg <U+00D7> 14 days Healthy subjects (11) ND <U+2194> The structurally similar drug, rifampin, is known to reduce the plasma concentrations of a number of other drugs."	0
"Metoprolol is a racemic mixture of R- and S- enantiomers, and is primarily metabolized by CYP2D6."	0
The recommended dose of ELIQUIS is 10 mg taken orally twice daily for the first 7 days of therapy.	0
"Withhold Tasigna, and monitor bilirubin2."	0
(QT interval should be used if the heart rate is <60 beats per minute.	0
"In patients with an activated renin-angiotensin system , such as volume - and/or salt-depleted patients ( e.g. , those being treated with high doses of diuretics ) , symptomatic hypotension may occur after initiation of treatment with Edarbi ."	0
Drug interaction studies of ULORIC with cytotoxic chemotherapy have not been conducted.	0
The mechanism of action of citalopram HBr as an antidepressant is presumed to be linked to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).	0
Elderly patients may be at greater risk of developing hyponatremia with SSRIs and SNRIs.	0
"The following symptoms, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric."	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
Advise patients not to drive or operate heavy machinery until the effects of concomitant use of the benzodiazepine or other CNS depressant have been determined.	0
Intervention: Inform patients of the increased risk of bleeding associated with the concomitant use of ZOLOFT and antiplatelet agents and anticoagulants.	0
"Drug-Drug Interactions In vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites with the known cytochrome CYP2C9 substrates/inhibitors sulphenazole, tolbutamide and nifedipine."	0
"Some quinapril-treated hypertensive patients with no apparent preexisting renal vascular diseases have developed increases in blood urea nitrogen and serum creatinine, usually minor and transient, especially when quinapril has been given concomitantly with a diuretic."	0
Baseline laboratory data should be obtained prior to initiation of therapy.	0
REMERON (mirtazapine) Tablets are rapidly and completely absorbed following oral administration and have a half-life of about 20 to 40 hours.	0
"Although a risk of this occurring with oral verapamil has not been established, such patients receiving oral verapamil may be at risk and its use in these patients is contraindicated."	0
"Mechanisms of Action <U+2014> In patients with malaria, quinidine acts primarily as an intraerythrocytic schizonticide, with little effect upon sporozoites or upon pre<U+2013>erythrocytic parasites."	0
No dosage adjustment is necessary in patients with mild to severe renal impairment unless a patient with renal impairment is also volume depleted.	0
"In patients receiving anticoagulants and rifampin concurrently, it is recommended that the prothrombin time be performed daily or as frequently as necessary to establish and maintain the required dose of anticoagulant."	0
"Renal Impairment In volunteers with mild (CLcr = 50<U+2013>80 mL/min) and moderate (CLcr = 30<U+2013>49 mL/min) renal impairment, the pharmacokinetics of a single oral dose of sildenafil (50 mg) was not altered."	0
"Adjust VYVANSE dosage accordingly (2.6, 7.1) Table 5 Drugs having clinically important interactions with amphetamines."	0
"The reported rate in the United States is about 1 case of liver failure resulting in death or transplant per 250,000 to 300,000 patient-years of nefazodone treatment."	0
"As clonidine hydrochloride is excreted in human milk, caution should be exercised when CATAPRES tablets are administered to a nursing woman."	0
"Accordingly, diazepam and fluvoxamine should not ordinarily be coadministered."	0
METHAMPHETAMINE HAS A HIGH POTENTIAL FOR ABUSE.	0
"Effect on Normotensive Patients with Benign Prostatic Hyperplasia (BPH) Although blockade of alpha1 adrenoceptors also lowers blood pressure in hypertensive patients with increased peripheral vascular resistance, CARDURA treatment of normotensive men with BPH did not result in a clinically significant blood pressure lowering effect (Table 4)."	0
The unbound fraction in human plasma is 35%.	0
"Because there are no outcome data with this regimen and headaches become less of a problem as treatment continues, patients should return to the usual regimen as soon as possible, usually within one week."	0
"Caution is indicated in treating patients whose underlying medical conditions might be compromised by increases in blood pressure or heart rate, e.g., those with pre-existing hypertension, heart failure, recent myocardial infarction, or ventricular arrhythmia."	0
"In addition to effects on serum phosphorus levels, sevelamer hydrochloride has been shown to bind bile acids in vitro and in vivo in experimental animal models."	0
Physicians should inform patients of the risk of malignancy with IMURAN.	0
"In animals, the vasodilatory effects reduce right- and left-ventricular afterload and increase cardiac output and stroke volume."	0
DUTOPROL may be substituted for treatment with individual components.	0
Theophylline: See WARNINGS AND PRECAUTIONS (5.9).	0
The maximum dose is 70 mg/day.	0
Initiation of PROCARDIA treatment will not prevent this occurrence and might be expected to exacerbate it by provoking reflex catecholamine release.	0
These patients often have reduced nefazodone clearance and/or increased sensitivity to the side effects of CNS-active drugs.	0
Verapamil regularly reduces the total systemic resistance (afterload) by dilating peripheral arterioles.	0
Severe vomiting has been reported with the coadministration of immediate-release fluvoxamine maleate tablets and tryptophan.	0
"Cyclosporine 5.2 mg/kg/day, stable dose 10 mg QD for 28 days <U+2191> 8.7 fold <U+2191>10.7 fold"	0
"If a patient develops a skin lesion consistent with premalignant skin lesions, squamous cell carcinoma or melanoma, VFEND should be discontinued."	0
The absolute bioavailability of a 20 mg dose under fed conditions is approximately 60%.	0
"<U+2022>Patients receiving REYATAZ may develop new onset or exacerbations of diabetes mellitus/hyperglycemia (5.9), immune reconstitution syndrome (5.10), and redistribution/accumulation of body fat (5.11)."	0
"In vitro studies in human liver microsomes showed that paliperidone does not substantially inhibit the metabolism of drugs metabolized by cytochrome P450 isozymes, including CYP1A2, CYP2A6, CYP2C8/9/10, CYP2D6, CYP2E1, CYP3A4, and CYP3A5."	0
"Digoxin: In patients with hypercholesterolemia, concomitant administration of lovastatin and digoxin resulted in no effect on digoxin plasma concentrations."	0
Thiazides should be discontinued before carrying out tests for parathyroid function.	0
"If such symptoms occur, discontinue PRISTIQ and initiate supportive treatment."	0
"IMPORTANT <U+2500> Antidote for Peripheral Ischemia: To prevent sloughing and necrosis in ischemic areas, the area should be infiltrated as soon as possible with 10 to 15 mL of 0.9% Sodium Chloride Injection, USP, containing from 5 to 10 mg of Regitine<U+00AE> (brand of phentolamine) an adrenergic blocking agent."	0
"There was 1 suicide attempt among these approximately 2200 patients, occurring in a patient treated with STRATTERA."	0
Hypotension: Correct volume depletion prior to administration.	0
Mean peak plasma nebivolol concentrations occur approximately 1.5 to 4 hours post-dosing in EMs and PMs.	0
"Methotrexate Salicylate can inhibit renal clearance of methotrexate, leading to bone marrow toxicity, especially in the elderly or renal impaired."	0
"These complications have varied in severity; while in some cases symptoms have been self-limited, in other cases neonates have required intensive care unit support and prolonged hospitalization."	0
"Drug interactions <U+2014> Altered pharmacokinetics of quinidine: Drugs that alkalinize the urine (carbonic<U+2013>anhydrase inhibitors, sodium bicarbonate, thiazide diuretics) reduce renal elimination of quinidine."	1
Epidemiological studies of case-control and cohort design have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding.	0
"There have been post-marketing reports of prolonged visual adverse events, including optic neuritis and papilledema."	0
"The effectiveness of sertraline hydrochloride for the treatment of OCD was also demonstrated in a 12-week, multicenter, placebo-controlled, parallel group study in a pediatric outpatient population (children and adolescents, ages 6 to 17)."	0
"Systemic exposure to abiraterone after a single oral 1,000 mg dose did not increase in subjects with end-stage renal disease on dialysis, compared to subjects with normal renal function."	0
"If hypokalemia should develop, corrective measures should be taken such as potassium supplementation or increased dietary intake of potassium-rich foods."	0
Citalopram would be expected to have little inhibitory effect on in vivo metabolism mediated by these enzymes.	0
"The following have no clinically relevant effects on the pharmacokinetics of amlodipine: cimetidine, grapefruit juice, magnesium and aluminum hydroxide antacid, sildenafil."	0
"To minimize the risk of induced arrhythmia, patients initiated or re-initiated on TIKOSYN should be placed for a minimum of 3 days in a facility that can provide calculations of creatinine clearance, continuous electrocardiographic monitoring, and cardiac resuscitation."	0
See Full Prescribing Information for recommended dosages of concomitant dexamethasone and 5-HT3 antagonist for HEC and MEC.	0
"If a disproportionate rise in diastolic pressure (i.e., a marked decrease in pulse pressure) is observed in patients receiving dopamine, the infusion rate should be decreased and the patient observed carefully for further evidence of predominant vasoconstrictor activity, unless such an effect is desired."	0
"HIV-1 Protease Inhibitor:indinavir <U+2191> indinavir Appropriate doses for this combination, with respect to efficacy and safety, have not been established."	0
"Any indication of prolongation of QTc interval beyond an absolute limit of 0.47 seconds (children) or 0.52 seconds (adults), or more than 25% above the patient<U+2019>s original baseline should be considered a basis for stopping further dose increase and considering a lower dose."	0
"Rash was mostly mild-to-moderate, often occurring within the first four weeks of treatment and resolving with continued dosing."	0
The basis for the beneficial effects of COREG in heart failure is not established.	0
Patients with renal failure may therefore receive the usual initial dose.	0
"Grade 3 or 4 neutropenic fever/neutropenic sepsis occurred in 3% of patients receiving ONIVYDE/5-FU/LV, and did not occur in patients receiving 5-FU/LV."	0
Terminal half-life and total clearance appear to be independent of dose.	0
Significant prolongation of the QT interval may occur when Tasigna is inappropriately taken with food and/or strong CYP3A4 inhibitors and/or medicinal products with a known potential to prolong QT.	0
Acute Interstitial Nephritis: Observed in patients taking PPIs.	0
"Patients receiving doses of 40 and 60 mg paroxetine experienced a mean reduction of approximately 6 and 7 points, respectively, on the YBOCS total score which was significantly greater than the approximate 4-point reduction at 20 mg and a 3-point reduction in the placebo-treated patients."	0
"Thus, fluoxetine may be administered with or without food."	0
Two patients undergoing desensitizing treatment with Hymenoptera venom while receiving ACE inhibitors sustained life-threatening anaphylactoid reactions.	0
"Newly diagnosed patients must reinitiate Tasigna therapy within 4 weeks of a loss of Major Molecular Response (MMR, corresponding to MR3.0 or= BCR-ABL/ABL <U+2264>0.1%IS)."	0
The 5 mcg rifampin disk should provide the following zone diameters in these quality control strains: Microorganism Zone Diameter (mm) S. aureus ATCC 25923 26 - 34 E. coli ATCC 25922 8 - 10 H. influenzae ATCC 49247 22 - 30	0
Moderate renal impairment: Maximum dose 50 mg per day (2.2).	0
Paroxetine 20mg was demonstrated to be significantly superior to placebo on both the LSAS Total Score and the CGI Improvement responder criterion; there were trends for superiority over placebo for the 40mg and 60mg/day dose groups.	0
"If the response is insufficient after a suitable trial, the dosage may be increased to 30 mg and then to a single daily dose of 45-50 mg."	0
Savella should be discontinued before initiating treatment with the MAOI.	0
"Substrates primarily metabolized by CYP2D6 (e.g., desipramine , atomoxetine, dextromethorphan, metoprolol, nebivolol, perphenazine, tolterodine) should be dosed at the original level when co-administered with PRISTIQ 100 mg or lower or when PRISTIQ is discontinued."	1
"Concomitant use of rifapentine with other drugs metabolized by these enzymes, such as protease inhibitors, certain reverse transcriptase inhibitors, and hormonal contraception may cause a significant decrease in plasma concentrations and loss of therapeutic effect."	1
"Conversely , LASIX may decrease renal elimination of other drugs that undergo tubular secretion ."	0
"In patients who get these headaches, the headaches are a marker of the activity of the drug."	0
"These complications have varied in severity; while in some cases symptoms have been self-limited, in other cases neonates have required intensive care unit support and prolonged hospitalization."	0
"Pediatrics In children 1 to 17 years of age, plasma levels are greater than 10<U+2013>fold higher at peak (approximately 4 hours) than 24 hours after a single dose."	0
"Three of the relapse subjects (1 each for genotype 4, 5, and 6) had virus with emergent sofosbuvir resistance-associated substitution S282T at relapse; the genotype 5 relapse subject also had emergent nucleotide inhibitor substitution M289I."	0
"Drug interaction studies of ULORIC with other drugs that are metabolized by XO (e.g., mercaptopurine and azathioprine) have not been conducted."	0
The systemic exposure to apixaban administered 2 hours prior to a 4-hour hemodialysis session with a dialysate flow rate of 500 mL/min and a blood flow rate in the range of 350 to 500 mL/min is 17% higher compared to those with normal renal function.	0
"Patients, both adult and pediatric, with depression or other psychiatric disorders may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking these medications, and this risk may persist until significant remission occurs."	0
Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.	0
"Phenytoin When a single oral 30 mg dose of paroxetine was administered at phenytoin steady state (300 mg once daily for 14 days), paroxetine AUC and T<U+00BD> were reduced (by an average of 50% and 35%, respectively) compared to paroxetine administered alone."	1
Therapy with ACCURETIC should be interrupted for a few days before carrying out tests of parathyroid function.	0
"Additionally, patients should not be discharged within 12 hours of electrical or pharmacological conversion to normal sinus rhythm."	0
"For children unable to swallow tablets, VIRACEPT 250 mg tablet(s) may be dissolved in a small amount of water or, VIRACEPT Oral Powder may be administered."	0
"In addition, perhaps because wax-matrix preparations are not enteric-coated and release some of their potassium content in the stomach, there have been reports of upper gastrointestinal bleeding associated with these products."	0
Dosing regimens for most chronically used drugs are designed to provide plasma concentrations that are continuously greater than a minimally effective concentration.	0
Follow applicable special handling and disposal procedures.	0
"In general, dosage adjustments may proceed at approximately weekly intervals."	0
"In clinical studies in which lipid profiles were followed, there were generally no adverse changes noted between pre- and post-treatment lipid levels."	0
The major biotransformation pathway appears to be the hydroxylation of the isobutyl ester.	0
<U+2022>MAOIs: Increased risk of hypertensive reactions can occur when used concomitantly with WELLBUTRIN XL.	0
"Plasma concentrations increase at a much slower rate after the first few hours, and approach steady state at 24to 48 hours."	0
"Therefore, it is recommended that paroxetine not be used in combination with thioridazine."	0
Patients with these diagnoses were systematically excluded from many clinical studies during premarketing testing of these products.	0
Steady-state levels after multiple dosing are typically reached within 7 to 14 days for CMI.	0
"Nine metabolites were identified following a 5 mg radiolabelled dose of fluvoxamine maleate, constituting approximately 85% of the urinary excretion products of fluvoxamine."	0
<U+2022> REYATAZ oral powder: Must be taken with ritonavir and food and should not be used in pediatric patients who weigh less than 5 kg.	0
The risk of myopathy is increased by high levels of HMG<U+2011>CoA reductase inhibitory activity in plasma.	0
Paroxetine is equally bioavailable from the oral suspension and tablet.	0
Dose to be repeated no earlier than 3 days.	0
"Effects of REVATIO on Vision At single oral doses of 100 mg and 200 mg, transient dose-related impairment of color discrimination (blue/green) was detected using the Farnsworth-Munsell 100-hue test, with peak effects near the time of peak plasma levels."	0
Only after nitrates have been absent from the body for several hours has their antianginal efficacy been restored.	0
"In this double-blind, controlled clinical trial, 919 patients were randomized in a 2x2 factorial design to placebo, lovastatin 10-40mg daily and/or warfarin."	0
"<U+2022>LEXIVA 1,400mg once daily plus ritonavir 200mg once daily."	0
"If severe vomiting, abdominal pain, distention, or gastrointestinal bleeding occurs, discontinue K-TAB and consider possibility of ulceration, obstruction or perforation."	0
MINIPRESS has been shown to be excreted in small amounts in human milk.	0
Careful monitoring of patients for benzodiazepine effects is warranted; a decrease in benzodiazepine dose may be needed.	1
"In a multicenter clinical trial (ISIS-1) conducted in 16,027 patients with suspected myocardial infarction, patients presenting within 12 hours (mean = 5 hours) after the onset of pain were randomized to either conventional therapy plus TENORMIN (n = 8,037), or conventional therapy alone (n = 7,990)."	0
"In healthy subjects abiraterone Cmax and AUC0<U+2013><U+221E> were approximately 7- and 5-fold higher, respectively, when a single dose of abiraterone acetate was administered with a low-fat meal (7% fat, 300 calories) and approximately 17- and 10-fold higher, respectively, when a single dose of abiraterone acetate was administered with a high-fat (57% fat, 825 calories) meal compared to overnight fasting."	1
Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses.	0
Patients should be monitored for these symptoms when discontinuing treatment with paroxetine.	0
"Maintenance digoxin doses should be reduced when verapamil is administered, and the patient should be carefully monitored to avoid over- or under-digitalization."	1
"In patients taking potent inhibitors of CYP3A such as ketoconazole , and itraconazole , avoid use of ADCIRCA see Warnings and Precautions ( 5.2 ) and Clinical Pharmacology ( 12.3 ) ."	0
"Examples: selegiline, tranylcypromine, isocarboxazid, phenelzine, linezolid, methylene blue Pimozide Clinical Impact: Increased plasma concentrations of pimozide, a drug with a narrow therapeutic index, may increase the risk of QTc prolongation and ventricular arrhythmias."	1
Food does not affect the bioavailability of apixaban.	0
Taper doses of FLOLAN after initiation of cardiopulmonary bypass in patients receiving lung transplants.	0
The block on the chart at which the two rows (weight and target dose) intersect is the milliliter amount that should be given to the patient.	0
"The adverse events include the following: dysphoric mood, irritability, agitation, dizziness, sensory disturbances (e.g., paresthesias such as electric shock sensations), anxiety, confusion, headache, lethargy, emotional lability, insomnia, hypomania, tinnitus, and seizures."	0
Do not use Savella within 14 days of stopping an MAOI intended to treat psychiatric disorders.	0
The excess accumulation is a consequence of the fact that 1 of the enzymes that metabolizes paroxetine is readily saturable.	0
Food with a high fat content does not affect the bioavailability of candesartan after candesartan cilexetil administration.	0
It is recommended that a conservative treatment program should be attempted first.	0
"When MICROZIDE is administered with food, its bioavailability is reduced by 10%, the maximum plasma concentration is reduced by 20%, and the time to maximum concentration increases from 1.6 to 2.9 hours."	1
"As a result of this inhibition, large amounts of tyramine may enter the systemic circulation and precipitate a sudden, large rise in blood pressure or hypertensive crisis."	0
"Similarly, in a pooled analysis (all the parallel-group, placebo-controlled studies) of spontaneously reported daytime anxiety, no difference was observed between Zaleplon and placebo."	0
"Although a causal link between the emergence of such symptoms and either the worsening of depression and/or the emergence of suicidal impulses has not been established, there is concern that such symptoms may represent precursors to emerging suicidality."	0
"While a 120mg once daily dose was shown to be effective, there is no evidence that doses greater than 60mg/day confer additional benefit."	0
There have been reports that verapamil may elevate the concentrations of the oral anti-diabetic glyburide.	1
"Accordingly, patients should be advised to avoid alcohol while taking REMERON."	0
"Hydrochlorothiazide also decreases the excretion of calcium and uric acid, may increase the excretion of iodide and may reduce glomerular filtration rate."	0
These decreases in blood pressure are not accompanied by a significant change in heart rate or plasma catecholamine levels with chronic dosing.	0
Do not co-administer aliskiren with MICARDIS in patients with diabetes.	0
Follow applicable special handling and disposal procedures.1	0
"However, it has been proposed that the efficacy of quetiapine in schizophrenia and its mood stabilizing properties in bipolar depression and mania are mediated through a combination of dopamine type 2 (D2) and serotonin type 2 (5HT2) antagonism."	0
"Protein Binding: No meaningful changes in the extent of in vitro binding of nebivolol to human plasma proteins were noted in the presence of high concentrations of diazepam, digoxin, diphenylhydantoin, enalapril, hydrochlorothiazide, imipramine, indomethacin, propranolol, sulfamethazine, tolbutamide, or warfarin."	0
"Consequently, concomitant use of paroxetine with tryptophan is not recommended."	0
Rifapentine is an inducer of CYP450 enzymes.	0
"PARTICULAR ATTENTION SHOULD BE PAID TO THE POSSIBILITY OF SUBJECTS OBTAINING METHAMPHETAMINE FOR NON-THERAPEUTIC USE OR DISTRIBUTION TO OTHERS, AND THE DRUG SHOULD BE PRESCRIBED OR DISPENSED SPARINGLY."	0
Counsel women of childbearing potential regarding appropriate contraceptive choices.	0
"In spite of the effect of losartan on aldosterone secretion, very little effect on serum potassium was observed."	0
"The dosage of penicillin G should be reduced in patients with severe renal impairment, with additional modifications when hepatic disease accompanies the renal impairment."	0
"Priapism was not reported with drug initiation but developed after some time on the drug, often subsequent to an increase in dose."	0
Most reports were confounded by other risk factors.	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP is contraindicated in patients with uncontrolled hypertension."	0
"No additional dose adjustment is required for concomitant use of substrates of CYP3A4, 1A2, 2A6, 2C8, 2C9, and 2C19 isozymes, and P-glycoprotein transporter."	0
"Patient Selection Eligibility for Discontinuation of Treatment Ph+ CML-CP patients with typical BCR-ABL transcripts who have been taking Tasigna for a minimum of 3 years and have achieved a sustained molecular response (MR4.5,corresponding to = BCR-ABL/ABL <U+2264> 0.0032% IS) may be eligible for treatment discontinuation."	0
Baseline mean blood pressure was 174/98mmHg in both treatment groups.	0
Inspect parenteral drug products for particulate matter and discoloration prior to administration whenever solution and container permit.	0
The increase in pimozide AUC and Cmax is related to the CYP 2D6 inhibitory properties of paroxetine.	1
"Warfarin is thought to interfere with clotting factor synthesis by inhibition of the C1 subunit of vitamin K epoxide reductase (VKORC1) enzyme complex, thereby reducing the regeneration of vitamin K1 epoxide."	0
Seek advice from the prescribing physician regarding the possibility to switch to drugs that do not slow the heart rate or atrioventricular conduction before initiating GILENYA.	0
"Isolates yielding results suggestive of ""Non-susceptible"" should be submitted to a reference laboratory for further testing."	0
Serotonergic Drugs The concomitant use of DESOXYN and serotonergic drugs increases the risk of serotonin syndrome.	0
Both the plasma and urine levels of this metabolite greatly exceed triamterene levels.	0
"Due to its potential for significant, possibly life threatening, proarrhythmic effects, thioridazine should be reserved for use in the treatment of schizophrenic patients who fail to show an acceptable response to adequate courses of treatment with other antipsychotic drugs, either because of insufficient effectiveness or the inability to achieve an effective dose due to intolerable adverse effects from those drugs."	0
ULORIC can be taken without regard to food or antacid use.	0
"The active metabolite is 10 to 40times more potent by weight than losartan and appears to be a reversible, non-competitive inhibitor of the AT1 receptor."	0
"Prior to the initial use of the product by a patient, the prescriber should take steps to ensure that the patient understands how to use the product as provided."	0
Geriatric Use Clinical studies of diltiazem did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
GI Motility Agent Cisapride Potential for serious and/or life threatening reactions such as cardiac arrhythmias.	0
Patients receiving ACE inhibitors who develop jaundice or marked elevations of hepatic enzymes should discontinue the ACE inhibitor and receive appropriate medical follow-up.	0
Continue monitoring and reduce digoxin dose as necessary.	0
The healthcare provider should assess appropriate formulation and dosage for each patient.	0
Sildenafil exposure at a dose of 80 mg three times a day without concomitant medication is shown to be 5-fold the exposure at a dose of 20 mg three times a day.	0
Blood pressure should be observed frequently to detect evidence of any pressor response in all patients receiving NARDIL.	0
FluoxetineParoxetineSertraline <U+2191> Fluoxetine<U+2191> Paroxetine<U+2191> Sertraline Anti-HCV agents: Boceprevir Co-administration of APTIVUS and boceprevir has not been studied.	0
"As PTSD is a more common disorder in women than men, the majority (76%) of patients in these trials were women (152 and 139 women on sertraline and placebo versus 39 and 55 men on sertraline and placebo; Studies 1 and 2 combined)."	0
"In children experiencing photoaging injuries such as lentigines or ephelides, sun avoidance and dermatologic follow-up are recommended even after treatment discontinuation."	0
"It should be noted that patients with migraine may be at increased risk of certain cerebrovascular events (e.g., stroke, hemorrhage, transient ischemic attack)."	0
"ORAP is intended only for use in patients with Tourette<U+2019>s Disorder whose symptoms are severe and who cannot tolerate, or who do not respond to HALDOL<U+00AE> (haloperidol)."	0
"The risk differences (drug vs placebo), however, were relatively stable within age strata and across indications."	0
"PDE5 inhibitors , including ADCIRCA , and alpha adrenergic blocking agents are both vasodilators with blood-pressure-lowering effects ."	0
The infusion line should be left open until suppression of the arrhythmia appears to be satisfactorily maintained.	0
"Signs and symptoms of these reactions may include hypotension, urticaria, angioedema, acute bronchospasm, conjunctivitis, thrombocytopenia, neutropenia or flu-like syndrome (weakness, fatigue, muscle pain, nausea, vomiting, headache, fever, chills, aches, rash, itching, sweats, dizziness, shortness of breath, chest pain, cough, syncope, palpitations)."	0
The recommended infusion rate for patients with CrCl <U+2264>60 mL/min using the 100 mL premixed vial or 250 mL premixed bag can be calculated using the following equation: equation-5	0
Safety and effectiveness in the pediatric population have not been established.	0
Table 1: Recommended Dosage Use Dose (adults) Repeat Antisialagogue or other antivagal 0.5 to 1 mg 1-2 hours Organophosphorus or muscarinic mushroom poisoning 2 to 3 mg 20-30 minutes Bradyasystolic cardiac arrest 1 mg 3-5 minutes; 3 mg maximum total dose Dosing in pediatric populations has not been well studied.	0
"With other statins, clinically evident bleeding and/or increased prothrombin time has been reported in a few patients taking coumarin anticoagulants concomitantly."	0
Antihypertensives: CARDIZEM CD has an additive antihypertensive effect when used with other antihypertensive agents.	0
Avoid use of aliskiren with MICARDIS in patients with renal impairment (GFR <60 mL/min).	0
"If concomitant treatment with sumatriptan and an SSRI (e.g., citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline) is clinically warranted, appropriate observation of the patient is advised."	0
"In usual therapeutic doses, lidocaine hydrochloride produces no change in myocardial contractility, systemic arterial pressure or in absolute refractory period."	0
"Angina: Dosages for the treatment of angina should be adjusted to each patient<U+2019>s needs, starting with a dose of 120 or 180 mg once daily."	0
"However, the exposure was not significantly increased when the dose was doubled from 1,000 to 2,000 mg (8% increase in the mean AUC)."	0
"PDE5 inhibitors: Concomitant use contraindicated (4.1, 7.1) Antihypertensives: Possible additive hypotensive effects (7.2) Aspirin: increased nitroglycerin levels (7.3) Tissue-type plasminogen activator (t-PA): decreased thrombolytic effect (7.4) Heparin: anticoagulant effect of heparin may be reduced."	0
"Angiotensin converting enzyme is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II."	0
"Apixaban is metabolized mainly via CYP3A4 with minor contributions from CYP1A2, 2C8, 2C9, 2C19, and 2J2."	0
Alternative dosing strategies are recommended in patients who are genetically poor CYP 2D6 metabolizers.	0
Fluconazole should be administered with caution to patients with renal dysfunction.	0
"Vasospastic Angina: Amlodipine has been demonstrated to block constriction and restore blood flow in coronary arteries and arterioles in response to calcium, potassium epinephrine, serotonin, and thromboxane A2 analog in experimental animal models and in human coronary vessels in vitro."	0
Candesartan inhibits the pressor effects of angiotensin II infusion in a dose-dependent manner.	0
"Females of reproductive potential: Exclude pregnancy before the start of treatment, monthly during treatment, and 1 month after stopping treatment."	0
Eszopiclone and lorazepam decreased each other's Cmax by 22%.	1
"The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents."	0
ULORIC should be used with caution in these patients.	0
"In hypertensive patients with normal renal function, therapeutic doses of COREG decreased renal vascular resistance with no change in glomerular filtration rate or renal plasma flow."	0
"In healthy subjects, single oral irbesartan doses of up to 300 mg produced dose-dependent inhibition of the pressor effect of angiotensin II infusions."	0
Desipramine Combination with APTIVUS/ritonavir not studied<U+2191> Desipramine Dosage reduction and concentration monitoring of desipramine is recommended.	1
"Overall, 63.2% of the patients were men, and 66.4% were under the age of 65 years."	0
"Electroconvulsive Therapy <U+2013> As with closely related tricyclic antidepressants, concurrent administration of Anafranil with electroconvulsive therapy may increase the risks; such treatment should be limited to those patients for whom it is essential, since there is limited clinical experience."	0
Many of these patients had other medical conditions or were receiving concomitant medications that may have caused or contributed to these events.	0
"Nilotinib is a substrate of the efflux transporter P-glycoprotein (P-gp, ABCB1)."	0
<U+2022> Activation of Mania/Hypomania has occurred (5.12).	0
"The potential drug-drug concentrations must be considered prior to and during therapy (4, 7, 12.3) VIRACEPT should be given with food one hour after or more than 2 hours before didanosine (7) Nelfinavir is an inhibitor of CYP3A."	0
Dosage should be adjusted according to blood pressure response up to a maximum of 0.61 mg/kg (up to 40 mg) once daily.	0
"Given the difficulty in interpreting subset differences in large trials, it cannot be known whether the observed difference is the result of chance."	0
Such monitoring should include daily observation by families and caregivers.	0
"Following long-term treatment, potassium citrate extended-release tablets at a dosage of 60 mEq/day raises urinary citrate by approximately 400 mg/day and increases urinary pH by approximately 0.7 units."	0
"Distribution:Iloperidone has an apparent clearance (clearance/bioavailability) of 47 to 102 L/h, with an apparent volume of distribution of 1340 to 2800 L. At therapeutic concentrations, the unbound fraction of iloperidone in plasma is ~3% and of each metabolite (P88 and P95) it is ~8%."	0
Monitoring of blood pressure is recommended during dose escalation and periodically thereafter.	0
"Plasma concentrations of rizatriptan may be increased by drugs that are selective MAO-A inhibitors (e.g., moclobemide) or nonselective MAO inhibitors [type A and B] (e.g., isocarboxazid, phenelzine, tranylcypromine, and pargyline)."	1
Alkalinizing Agents Increase blood levels and potentiate the action of amphetamine.	1
"There has been no long-term use of MICARDIS in patients with unilateral or bilateral renal artery stenosis, but anticipate an effect similar to that seen with ACE inhibitors."	0
"Absorption of tipranavir in humans is limited, although no absolute quantification of absorption is available."	0
"In these patients, during titration, the individual doses should be reduced."	0
PEXEVA<U+00AE> should be discontinued before initiating treatment with the MAOI.	0
It is generally believed (though not established in controlled trials) that treating such an episode with an antidepressant alone may increase the likelihood of precipitation of a mixed/manic episode in patients at risk for bipolar disorder.	0
The resulting ventricular rate may be very high (greater than 200 beats per minute) and poorly tolerated.	0
"Cimetidine: Following oral administration of bupropion 300 mg with and without cimetidine 800 mg in 24 healthy young male volunteers, the pharmacokinetics of bupropion and hydroxybupropion were unaffected."	0
"Due to wide interindividual variability in the dose adjustment required, it is recommended that cyclosporine concentrations be monitored closely after initiation of carvedilol therapy and that the dose of cyclosporine be adjusted as appropriate."	0
"In clinical trials, however, no significant increases in blood pressure response or in the incidence of orthostatic hypotension were found in women."	0
"The data suggest the risk may be elevated in patients with rheumatoid arthritis, though lower than for renal transplant patients."	0
AUC and Cmax were 10-15% higher in women than in men.	0
"Bisoprolol is an effective treatment of hypertension in once-daily doses of 2.5 to 40 mg, while hydrochlorothiazide is effective in doses of 12.5 to 50 mg."	0
"Inhibition of the pressor response to angiotensin I is shorter-lived, with a 20-mg dose giving 75% inhibition for about 4 hours, 50% inhibition for about 8 hours, and 20% inhibition at 24 hours."	0
The dose of Zaleplon should therefore be reduced in patients with mild to moderate hepatic impairment.	0
The presence of food in the stomach has a minimal effect on both the rate and extent of absorption and does not require a dosage adjustment.	0
"However, indinavir may be a weak inhibitor of CYP2D6."	0
"Serotonin syndrome signs and symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)."	0
"Like other ACE inhibitors, quinapril has been only rarely associated with hypotension in uncomplicated hypertensive patients."	0
"It is not known whether losartan is excreted in human milk, but significant levels of losartan and its active metabolite were shown to be present in rat milk."	0
Patients should be advised of the following issues and asked to alert their prescriber if these occur while taking Marplan.	0
Dosage modifications based on gender should not be needed.	0
Verapamil has been shown to be an inhibitor of CYP3A4 enzymes and P-glycoprotein (P-gp).	0
"Since resistance can emerge rapidly, appropriate susceptibility tests should be performed in the event of persistent positive cultures."	0
"However, this effect is not consistent and may be offset by an increased rate of cervical dilation, which tends to shorten labor."	0
"Drug-Drug Interactions: Data from drug-drug interactions studies involving coadministration of gemfibrozil, niacin, itraconazole, erythromycin, tolbutamide or clopidogrel indicate that the PK disposition of fluvastatin is not significantly altered when fluvastatin is coadministered with any of these drugs."	0
"Symptoms may include fever, dyspnea, acute respiratory distress, pulmonary infiltrates, pleural or pericardial effusions, weight gain or peripheral edema, hypotension, and renal, hepatic, or multi-organ dysfunction, in the presence or absence of leukocytosis."	0
"Concomitant use of catecholamine-depleting drugs, such as reserpine and guanethidine, with a beta-blocker may produce an excessive reduction of resting sympathetic nervous tone."	0
Withhold ONIVYDE for absolute neutrophil count below 1500/mm3 or neutropenic fever.	0
Drug-related material appeared uniformly distributed in the fetus with 14C concentrations approximately the same as in the brain of the mother.	0
Essentially all nebivolol was excreted as multiple oxidative metabolites or their corresponding glucuronide conjugates.	0
Binding to serum proteins has been reported to be approximately 40% to 68%.	0
The no observed adverse effect dose in both species was 0.5 mg/kg/day.	0
BYSTOLIC was not studied in patients with angina pectoris or who had a recent MI.	0
Patients with deep seated fungal infections who develop rashes during treatment with DIFLUCAN should be monitored closely and the drug discontinued if lesions progress.	0
Absolute bioavailability has been estimated to be between 64 and 90%.	0
"Predisposing factors for myopathy include advanced age (<U+2265>65 years), female gender, uncontrolled hypothyroidism, and renal impairment."	0
Further adjustment may be needed depending upon clinical condition.	0
"The static component is related to an increase in prostate size caused, in part, by a proliferation of smooth muscle cells in the prostatic stroma."	0
Patients were dosed in a range of 20 to 60 mg/day in the clinical trials demonstrating the effectiveness of paroxetine in the treatment of OCD.	0
"Wh en p re gnanc y is d e t ec t e d, d i s c ont i nu e Lot e ns in a s soo n a s poss i bl e. ( 5.1 ) D r ug s tha t a ct di r e c tl y o n th e re n i n-ang i ot e ns in syst em c a n c aus e i nju ry an d d e at h t o th e d e ve l op i n g f e tus."	0
"Colchicine Colchicine is a substrate for both CYP3A and the efflux transporter, P-gp."	0
Toxic levels of digoxin are only slightly higher than therapeutic levels.	0
"Symptoms associated with discontinuation of PRISTIQ, other SNRIs and SSRIs have been reported."	0
"However, the concentration of the imipramine metabolite desipramine was increased by approximately 50%."	0
The relative early occurrence of some of these deaths relative to the initiation of nilotinib suggests the possibility that ventricular repolarization abnormalities may have contributed to their occurrence.	0
There was insufficient information to determine the effect of race or age on outcome.	0
"The elimination T1/2 of bisoprolol ranges from 7 to 15 hours, and that of hydrochlorothiazide ranges from 4 to 10 hours."	0
The elimination half<U+2013>life is about 6<U+2013>8 hours in adults and 3<U+2013>4 hours in pediatric patients.	0
"Zaleplon at both doses was superior to placebo on TSO, generally for the full duration of both studies, with an effect size generally similar to that seen in younger persons."	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
The magnitude of CYP3A-mediated drug interactions on coadministered drug may change when REYATAZ is coadministered with ritonavir.	0
"Changes in the electrocardiogram, particularly in QRS axis or width, are clinically significant indicators of tricyclic antidepressant toxicity."	0
Please refer to the ritonavir full prescribing information for additional precautionary measures.	0
"Monitor blood pressure, renal function and electrolytes in patients on PRINIVIL and other agents that affect the RAS."	0
"Coadministration of enoxaparin, warfarin, aspirin, clopidogrel and chronic NSAID use may increase the risk of bleeding [see Clinical Pharmacology (12.3)]."	0
These risk differences (drug-placebo difference in the number of cases of suicidality per 1000 patients treated) are provided in Table 1.	0
"Combination of NSAIDs, e.g., indomethacin, with potassium-sparing diuretics has been associated with severe hyperkalemia."	0
The mean initial elimination phase was estimated to be approximately 2 minutes.	0
The decision to add medication should be made by the physician after careful evaluation of the patient.	0
"Because of the risk of unrecognized hypoglycemia that could result from drug-device interaction, EXTRANEAL is available only through a restricted program."	0
"Avoid concomitant administration of XARELTO with known combined P-gp and strong CYP3A4 inhibitors ( e.g. , ketoconazole and ritonavir ) see Warnings and Precautions ( 5.6 ) and Clinical Pharmacology ( 12.3 ) ."	0
Dronedarone increases exposure to digoxin.	1
Hepatic Dysfunction : No study has been conducted with AGGRENOX in patients with hepatic dysfunction.	0
"It may be advisable to eliminate the diuretic (except in patients with heart failure), reduce the diuretic dose or cautiously increase salt intake (except in patients with heart failure) before initiating therapy with ACCUPRIL in patients at risk for excessive hypotension who are able to tolerate such adjustments."	1
"Drug Interactions: Cyclopropane or halogenated hydrocarbon anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines, such as dopamine."	0
"If a child is unable to reliably swallow an APTIVUS capsule, the APTIVUS oral solution formulation should be prescribed."	0
"Carbamazepine - Combined administration of Celexa (40 mg/day for 14 days) and carbamazepine (titrated to 400 mg/day for 35 days) did not significantly affect the pharmacokinetics of carbamazepine, a CYP3A4 substrate."	0
Lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity.	1
"Drugs Metabolized by P450 2D6<U+2013>Many drugs effective in the treatment of major depressive disorder, e.g., the SSRIs, including sertraline, and most tricyclic antidepressant drugs effective in the treatment of major depressive disorder inhibit the biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase), and, thus, may increase the plasma concentrations of co-administered drugs that are metabolized by P450 2D6."	1
"Although acute hemodynamic studies of nisoldipine in patients with NYHA Class II-IV heart failure have not demonstrated negative inotropic effects, safety of SULAR in patients with heart failure has not been established."	0
"EMSAM did not alter the clinical pharmacodynamic effects of warfarin as measured by INR, Factor VII or Factor X levels."	0
Avoid food for at least 2 hours before the dose is taken and avoid food for at least 1 hour after the dose is taken.	0
"Based on studies conducted in mice, it is known that pimozide can produce a dose-related increase in pituitary tumors."	0
"Pediatric:After 2 weeks of once-daily 20 mg oral pravastatin administration, the geometric means of AUC were 80.7 (CV 44%) and 44.8 (CV 89%) ng*hr/mL for children (8 to 11 years, N = 14) and adolescents (12 to 16 years, N = 10), respectively."	0
About 50% of the absorbed dose is metabolized in the liver.	0
No increased incidence of overall tumors or tumors at any site was observed in either sex.	0
The clinical significance of results obtained in these studies is unknown.	0
"Administration of eplerenone with moderate CYP3A inhibitors (e.g., erythromycin 500 mg BID, verapamil 240 mg once daily, saquinavir 1200 mg three times a day, fluconazole 200 mg once daily) resulted in increases in Cmax of eplerenone ranging from 40% to 60% and AUC from 100% to 190%."	1
The toxicity of these metabolites has not been fully characterized.	0
"The mean dofetilide AUCs(0<U+2013>24hr) at this dose in the rat and mouse are estimated to be about equal to the maximum likely human AUC and about half the likely human AUC, respectively."	0
The increased risk appears to be related to the degree and duration of immunosuppression.	0
"Treatment emergent psychotic or manic symptoms, e.g., hallucinations, delusional thinking, or mania in children and adolescents without a prior history of psychotic illness or mania can be caused by stimulants at usual doses."	0
PROCARDIA should be used during pregnancy only if the potential benefit justifies the potential risk.	0
"Because initiation of GILENYA treatment may result in an additional decrease in heart rate, concomitant use of these drugs during GILENYA initiation may be associated with severe bradycardia or heart block."	0
Beta-adrenergic blockers (e.g. propranolol): Concomitant use of lidocaine with beta-adrenergic blockers may increase lidocaine plasma levels by decreasing hepatic blood flow and thereby decrease lidocaine clearance.	0
The recommended dose of ONIVYDE is 70 mg/m 2administered by intravenous infusionover 90 minutes every 2 weeks.	0
"Alcohol, barbiturates, or narcotics - potentiation of orthostatic hypotension may occur."	0
"Amphetamines and amphetamine derivatives are known to be metabolized, to some degree, by cytochrome P450 2D6 (CYP2D6) and display minor inhibition of CYP2D6 metabolism."	0
"<U+2022> The following dose adjustments are recommended for use of tadalafil (ADCIRCA<U+00AE>) with LEXIVA: Coadministration of ADCIRCA in patients on LEXIVA: In patients receiving LEXIVA for at least one week, start ADCIRCA at 20mg once daily."	0
"There are no adequate and well-controlled studies of use with ZOCOR during pregnancy; however, in rare reports congenital anomalies were observed following intrauterine exposure to statins."	0
"Digoxin <U+2013> When nefazodone (200 mg BID) and digoxin (0.2 mg QD) were coadministered for 9 days to healthy male volunteers (n = 18) who were phenotyped as CYP2D6 extensive metabolizers, Cmax, Cmin, and AUC of digoxin were increased by 29%, 27%, and 15%, respectively."	1
Safety and effectiveness in pediatric patients have not been established.	0
"In normal female volunteers, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone) did not increase dofetilide exposure."	0
Hepatitis C direct acting antiviral: simeprevir <U+2191>simeprevir It is not recommended to co-administer ritonavir with simeprevir.	0
"When administered orally, it exhibits stereoselective metabolism that is dependent on oxidation phenotype."	0
"Although a causal link between the emergence of such symptoms and either the worsening of depression and/or the emergence of suicidal impulses has not been established, there is concern that such symptoms may represent precursors to emerging suicidality."	0
"The following symptoms, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric."	0
"Concomitant use with potent inhibitors of CYP1A2, such as fluvoxamine or ciprofloxacin( 4, 5.5, 7.1, 7.2)"	0
Children and Adolescents Sudden death has been reported in association with CNS stimulant treatment at usual doses in children and adolescents with structural cardiac abnormalities or other serious heart problems.	0
"Traces are found in various secretions, including milk."	0
"Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders."	0
"Further clinical evaluation (e.g., rheumatology referral) may be appropriate for certain patients."	0
Drug-drug interaction studies were conducted with a 100 mg dose of eplerenone.	0
See DOSAGE AND ADMINISTRATION: Pediatric Patients.	0
Cyclosporine increases ambrisentan exposure; limit ambrisentan dose to 5 mg once daily (7).	1
A significant difference from placebo was observed only for the 40 mg/day group.	0
"The main metabolic pathways include: 1) hydroxylation to form 8-OH-loxapine by CYP1A2 and 7-OH-loxapine by CYP3A4 and CYP2D6, 2) N-oxidation to form loxapine N-oxide by flavanoid monoamine oxidases (FMOs), and 3) de-methylation to form amoxapine."	0
"As the dose of CARDIZEM CD capsules is increased from a daily dose of 120 mg to 240 mg, there is an increase in the area under the curve of 2.7 times."	0
Digitalis glycosides: Risk of bradycardia (7) Anticholinesterases: Prolongs neuromuscular blockade (7) Antihypertensive agents: Risk of rebound hypertension (7) Sympathomimetic drugs: Dose adjustment needed (7) Vasoconstrictive and positive inotropic effect substances: Avoid concomitant use (7)	0
Neither losartan nor its metabolite accumulate in plasma upon repeated once-daily dosing.	0
Fatal outcomes have been reported in patients with serious underlying diseases.	0
"Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure and death."	0
Adverse embryo-fetal findings were reported in women receiving mercaptopurine after the first trimester of pregnancy and included abortion and stillbirth.	0
Carvedilol is subject to the effects of genetic polymorphism with poor metabolizers of debrisoquin (a marker for cytochrome P450 2D6) exhibiting 2- to 3-fold higher plasma concentrations of R(+)-carvedilol compared with extensive metabolizers.	0
Distribution The volume of distribution of candesartan is 0.13 L/kg.	0
"Patients with Renal or Hepatic Impairment: As noted in the WARNINGS section, caution must be used in dosing/titrating patients with hepatic impairment or renal dysfunction."	0
"Do not co-administer ALTACE with aliskiren: in patients with diabetes Angioedema related to previous treatment with an ACE inhibitor, or a history of hereditary or idiopathic angioedema (4)."	0
Withdraw entire vial contents and add sufficient sterile diluent to make a total of 100mL. a Higher concentrations may be prepared for patients who receive FLOLAN long-term.	0
Cardiovert patients who are in atrial fibrillation (if clinically indicated) or discontinue MULTAQ.	0
"In a patient who requires more urgent treatment of a psychiatric condition, other interventions, including hospitalization, should be considered."	0
"Peptic Ulcer Disease Avoid using aspirin in patients with a history of active peptic ulcer disease, which can cause gastric mucosal irritation and bleeding."	0
"Then, if blood pressure is not controlled with ACCUPRIL alone, diuretic therapy should be resumed."	0
"Ritonavir 500 mg BID <U+00D7> 10 days 150 mg QD <U+00D7> 16 days Healthy subjects (5) <U+2191> AUC by 300%,<U+2191> Cmax by 150% ND Reduce rifabutin dose by at least 75% (to a maximum 150 mg every other day or three times per week) when given with lopinavir/ritonavir combination."	1
"When urinary pH increases above 7.0 with alkali therapy, the complication of calcium phosphate nephrolithiasis may ensue because of the enhanced urinary supersaturation of hydroxyapatite in an alkaline environment."	0
"Although a risk of this occurring with oral verapamil has not been established, such patients receiving oral verapamil may be at risk and its use in these patients is contraindicated."	0
"However, based on a cross study comparison, following single dose administration (400 mg), Asian males (Japanese) have about a 2-fold higher exposure than Caucasian males."	0
"Prasugrel: In healthy subjects, prasugrel increased bupropion Cmax and AUC values by 14% and 18%, respectively, and decreased Cmax and AUC values of hydroxybupropion by 32% and 24%, respectively."	1
"Drugs that slow heart rate : Concomitant use of drugs with depressant effects on the sinus and AV node ( e.g. , digoxin , beta blockers , verapamil , diltiazem , ivabradine , clonidine ) can potentiate the electrophysiologic and hemodynamic effects of amiodarone , resulting in bradycardia , sinus arrest , and AV block ."	0
Intervention: A temporary withdrawal of PROTONIX may be considered in some patients receiving high-dose methotrexate.	0
"Also, diabetes mellitus may become manifest during thiazide administration."	0
"In clinical pharmacology studies, after adjusting for body weight, the AUC of the active metabolite was approximately 19%higher in Chinese, Japanese, and Korean subjects than in Caucasian subjects."	0
Close supervision and careful adjustment of the dosage are required when nortriptyline hydrochloride oral solution USP is used with other anticholinergic drugs and sympathomimetic drugs.	0
Coadministration of fluconazole and pimozide is contraindicated.	0
Recommended starting dose for patients at high risk of CHD is 40mg/day.	0
"Therapy with a combination of bisoprolol and hydrochlorothiazide will be associated with both sets of dose-independent adverse effects, and to minimize these, it may be appropriate to begin combination therapy only after a patient has failed to achieve the desired effect with monotherapy."	0
The apparent terminal elimination half-life of levomilnacipran is approximately 12 hours.	0
"In normal adult volunteers, the following mean pharmacokinetic data have been determined following a single 0.15-mg/kg intravenous dose."	0
It is not known whether nefazodone or its metabolites are excreted in human milk.	0
"Avoid abrupt withdrawal of beta-blockade which might be followed by an exacerbation of symptoms of hyperthyroidism, including thyroid storm."	0
Renal clearance is further reduced in the premature infant.	0
"Whenever overdigitalization is suspected, the daily dose of digoxin should be reduced or temporarily discontinued."	1
"At the dose of 1,000 mg daily in patients with metastatic CRPC, steady-state values (mean <U+00B1> SD) of Cmax were 226 <U+00B1> 178 ng/mL and of AUC were 993 <U+00B1> 639 ng.hr/mL."	0
Plasma concentrations of CMI were significantly lower in smokers than in nonsmokers.	0
"A population pharmacokinetic analysis showed that women have approximately 12<U+2013>18% lower dofetilide oral clearances than men (14<U+2013>22% greater plasma dofetilide levels), after correction for weight and creatinine clearance."	0
The rate and extent of absorption (bioavailability) of amlodipine and atorvastatin from CADUET are not significantly different from the bioavailability of amlodipine and atorvastatin administered separately.	0
Cimetidine at doses of 100 mg BID (OTC dose) resulted in a 13% increase in dofetilide plasma levels (500 mcg single dose).	1
Other inhibitors of CYP3A4 would be expected to have similar effects.	0
"In some cases rash was accompanied by joint pain or stiffness, throat tightness, or generalized pruritus."	0
"For pediatric patients with schizophrenia who are unresponsive to other agents, the recommended initial dose is 0.5 mg/kg/day given in divided doses."	0
"In vitro, desvenlafaxine is not a substrate or an inhibitor for the P-glycoprotein transporter."	0
"After initiation of ULORIC, an increase in gout flares is frequently observed."	0
"Following multiple intramuscular doses, the plasma concentrations of aripiprazole gradually rise to maximum plasma concentrations at a median Tmax of 5 - 7 days for the gluteal muscle and 4 days for the deltoid muscle."	0
"Treatment with losartan potassium tablets also reduced the occurrence of sustained doubling of serum creatinine by 25% and ESRD by 29% as separate endpoints, but had no effect on overall mortality."	0
"Iloperidone is not a substrate for CYP1A1, CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, or CYP2E1 enzymes."	0
More than 90% of the orally administered dose of CALAN is absorbed.	0
Dose and plasma level related flattening or inversion of T-waves have been observed in a few small studies.	0
"The most important of quinidine's metabolites is 3<U+2013>hydroxy<U+2013>quinidine (3HQ), serum levels of which can approach those of quinidine in patients receiving conventional doses of quinidine gluconate."	0
"In multiple dose studies with hypertensive patients, there were no clinically significant changes in electrolytes (serum potassium or sodium), or in metabolic function (including serum levels of cholesterol, triglycerides, HDL, LDL, glucose, or uric acid)."	0
"Because of the potential for adverse reactions in nursing infants from verapamil, nursing should be discontinued while verapamil is administered."	0
Adequate hydration is recommended in all patients treated with CRIXIVAN.	0
Such concomitant administration should not be undertaken.	0
Symptoms such as these may be associated with an increased risk for suicidal thinking and behavior and indicate a need for very close monitoring and possibly changes in the medication.	0
"Peak plasma concentrations of the active desmethyl metabolite of verapamil, norverapamil, are reached within 5-15 hours."	0
No suicides occurred in any of the pediatric studies.	0
Elimination of digoxin follows first order kinetics.	0
The mechanism of its antidepressant action in man is not known.	0
"As elderly patients tend to have a higher underlying risk for falls due to a higher prevalence of risk factors such as use of multiple medications, medical comorbidities and gait disturbances, the impact of increasing age by itself is unclear."	0
"<U+03B2>-blockers may mask clinical signs of hyperthyroidism, such as tachycardia."	0
Both adults and pediatric patients with abnormal renal function need to have the dose of digoxin proportionally reduced.	0
"Drugs Dependent on Gastric pH for Absorption (e.g., iron salts, erlotinib, dasatinib, nilotinib, mycophenolate mofetil, ketoconazole/itraconazole) Clinical Impact: Pantoprazole can reduce the absorption of other drugs due to its effect on reducing intragastric acidity."	1
Increases in serum lithium concentrations and lithium toxicity have been reported with concomitant use of irbesartan or thiazide diuretics.	1
"In these studies patients with uncontrolled heart failure were excluded (i.e., NYHA Functional Classes III or IV)."	0
"PROCARDIA and other immediate-release nifedipine capsules have also been used for the long-term control of essential hypertension, although PROCARDIA capsules have not been approved for this purpose and no properly controlled studies have been conducted to define an appropriate dose or dose interval for such treatment."	0
"Following a 60-mg loading dose of Effient, approximately 90% of patients had at least 50% inhibition of platelet aggregation by 1hour."	0
The potential for selegiline or N-desmethylselegiline to inhibit individual CYP450-dependent enzyme pathways was also examined in vitro with human liver microsomes.	0
"If patient is unable to tolerate 4 mg/kg IV q12h, reduce the intravenous maintenance dose to 3 mg/kg q12h."	0
Amoxapine may enhance the response to alcohol and the effects of barbiturates and other CNS depressants.	0
The rise in citrate excretion is directly dependent on the potassium citrate extended-release tablets dosage.	0
"However, no significant differences in the degree of bisoprolol accumulation is found between young and elderly populations."	0
"Superiority of mirtazapine over placebo was also found for certain factors of the HDRS, including anxiety/somatization factor and sleep disturbance factor."	0
These events can occur in hypnotic-naive as well as in hypnotic-experienced persons.	0
The metabolism of R-fluoxetine in these poor metabolizers appears normal.	0
General: DESOXYN tablets should be used with caution in patients with even mild hypertension.	0
Human BNP (hBNP) is secreted by the ventricular myocardium in response to stretch and exists in several isoforms in the human body.	0
TENORETIC is contraindicated in patients with: sinus bradycardia; heart block greater than first degree; cardiogenic shock; overt cardiac failure ; anuria; hypersensitivity to this product or to sulfonamide-derived drugs.	0
"Because of rapid biotransformation of verapamil during its first pass through the portal circulation, bioavailability ranges from 20% to 35%."	0
"If coadministration is necessary, monitor for tenofovir-associated adverse reactions."	0
"Phendimetrazine tartrate should not be used in combination with other anorectic agents, including prescribed drugs, over-the-counter preparations and herbal products."	0
Monitor renal function periodically in patients receiving lisinopril and NSAID therapy.	0
"The typical value of lisinopril oral clearance (systemic clearance/absolute bioavailability) in a child weighing 30 kg is 10 L/h, which increases in proportion to renal function."	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP take place in the setting of a physician's office or similar medically staffed and equipped facility unless the patient has previously received dihydroergotamine mesylate."	0
Effects on Urine Outflow <U+2013> Urinary hesitancy and retention may occur.	0
Administer intravenously 25 mcg/kg within 5 minutes and then 0.15 mcg/kg/min for up to 18 hours.	0
"Patients at risk of excessive hypotension include those with the following conditions or characteristics: heart failure with systolic blood pressure below 100 mm Hg, ischemic heart disease, cerebrovascular disease, hyponatremia, high dose diuretic therapy, renal dialysis, or severe volume and/or salt depletion of any etiology."	0
"If, however, a patient who is currently tolerating the 80-mg dose of ZOCOR needs to be initiated on an interacting drug that is contraindicated or is associated with a dose cap for simvastatin, that patient should be switched to an alternative statin with less potential for the drug-drug interaction."	0
"There is little or no effect on normal myocardium, suggesting the improvement is mainly by indirect mechanisms such as afterload reduction and reduced ischemia."	0
Quinidine's actions fall into class Ia in the Vaughan<U+2013>Williams classification.	0
"The administration of toxic dosage levels in females (300/200mg/kg/day) was associated with a significant (p<0.05) decrease in the number of corpora lutea/female, implants/female, and live fetuses/female at C-section."	0
"Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death."	0
See Contraindications (4.1) and Warnings and Precautions (5.4).	0
"Although no evidence of liver injury was detected in clinical trials of about 6000 patients, there have been rare cases of clinically significant liver injury that were considered probably or possibly related to STRATTERA use in postmarketing experience."	0
Nortriptyline hydrochloride oral solution USP is administered orally in the form of an oral solution.	0
"May administer INTEGRILIN in the same intravenous line as alteplase , atropine , dobutamine , heparin , lidocaine , meperidine , metoprolol , midazolam , morphine , nitroglycerin , or verapamil ."	0
PROCARDIA is highly bound by serum proteins.	0
"Suspect bleeding in any patient who is hypotensive and has recently undergone coronary angiography, percutaneous coronary intervention (PCI), CABG, or other surgical procedures in the setting of Effient."	0
"Fetal testing may be appropriate, based on the week of pregnancy."	0
"Studies suggest that Pamelor interferes with the transport, release, and storage of catecholamines."	0
These agents may subsequently be reinstated at low doses and increased as needed.	0
"In contrast, 16 mg infused intravenously over 15 min using the same model had a mean predicted (95% upper prediction interval) <U+0394><U+0394>QTcF of 9.1 (11.2) ms."	0
Seizures: Use with caution in patients with seizure disorders.	0
"<U+2022>Drugs metabolized by CYP2D6: Bupropion inhibits CYP2D6 and can increase concentrations of: antidepressants (e.g., venlafaxine, nortriptyline, imipramine, desipramine, paroxetine, fluoxetine, sertraline), antipsychotics (e.g., haloperidol, risperidone, thioridazine), beta-blockers (e.g., metoprolol), and Type 1C antiarrhythmics (e.g., propafenone, flecainide)."	1
"Although it has not been definitively demonstrated that fluvoxamine is a potent CYP3A4 inhibitor, it is likely to be, given the substantial interaction of fluvoxamine with alprazolam."	0
Higher doses of paroxetine have not been studied.	0
"In addition, patients moving from a supine to fixed upright position may be at increased risk for hypotension and orthostatic effects."	0
Advise pregnant women using opioids for a prolonged period of the risk of neonatal opioid withdrawal syndrome and ensure that appropriate treatment will be available.	0
"Syncopal episodes have usually occurred within 30 to 90 minutes of the initial dose of the drug; occasionally, they have been reported in association with rapid dosage increases or the introduction of another antihypertensive drug into the regimen of a patient taking high doses of MINIPRESS."	0
"Usually, prepare in a volume of 100-250 mL."	0
The mechanism for this increase is not known.	0
Anticoagulant: rivaroxaban <U+2191> rivaroxaban Avoid concomitant use of rivaroxaban and ritonavir.	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
"In patients who had shown severe toxicity to d-penicillamine, THIOLA<U+00AE> might be begun at a lower dosage."	0
Single doses of ramipril of 2.5 mg<U+2013>20 mg produce approximately 60%<U+2013>80% inhibition of ACE activity 4 hours after dosing with approximately 40%<U+2013>60% inhibition after 24 hours.	0
"All patients being treated with drugs inhibiting the reuptake of norepinephrine and/or serotonin for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases."	0
"Drugs Metabolized by CYP3A4 <U+2014> In an invivo interaction study involving coadministration of fluoxetine with single doses of terfenadine (a CYP3A4 substrate), no increase in plasma terfenadine concentrations occurred with concomitant fluoxetine."	0
"Co-administration of a CYP2C8 enzyme inducer ( e.g. , rifampin ) decreases exposure to treprostinil see Drug Interactions ( 7.5 ) and Clinical Pharmacology ( 12.3 ) ."	1
Amiloride HCl is contraindicated in patients who are hypersensitive to this product.	0
"Verapamil may reduce total body clearance and extrarenal clearance of digitoxin by 27% and 29%, respectively."	1
"No apparent difference in the plasma protein binding between healthy subjects and subjects with hepatic (mild, moderate) or renal (mild, moderate, severe, ESRD) impairment is observed."	0
Concurrent drug therapy or dietary regimens which may markedly alter urinary pH should be avoided during mexiletine hydrochloride therapy.	0
"General Considerations ALTACE can cause symptomatic hypotension, after either the initial dose or a later dose when the dosage has been increased."	0
"In a 24-month toxicity study conducted in rats, at dose levels of 150, 378 and 950 mg/kg/day (approximately 8 to 48 times the recommended human dose), there was a small increase in the incidence of benign Leydig cell tumors in each dose group; when the combined drug-treated groups and control groups were compared, this increase reached statistical significance."	0
Maximum dose: Most patients have received maximum doses of 16 mg/hour or less.	0
"Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (eg, increased ventricular irritability)."	0
"In 2clinical trials of LEXIVA plus low-dose ritonavir, rash occurred in 8 of 50subjects (16%) with a history of sulfonamide allergy compared with 50 of 412subjects (12%) with no history of sulfonamide allergy."	0
Additive medications should not be delivered via this solution.	0
DYAZIDE may raise the level of blood uric acid; dosage adjustments of antigout medication may be necessary to control hyperuricemia and gout.	0
These modest cardiodepressant effects persisted for greater than 6 but less than 30 hours after abrupt withdrawal of beta-blockers and were closely related to plasma levels of propranolol.	0
MULTAQ should only be initiated in patients in sinus rhythm who are receiving appropriate antithrombotic therapy.	0
"Serum creatinine levels should be closely monitored in these patients, and, if increases occur, consideration should be given to changing to oral voriconazole therapy."	0
PREZISTA/ritonavir is not recommended in pediatric patients below 3 years of age in view of toxicity and mortality observed in juvenile rats dosed with darunavir up to days 23 to 26 of age.	0
"It is suggested that patients on IMURAN have complete blood counts, including platelet counts, weekly during the first month, twice monthly for the second and third months of treatment, then monthly or more frequently if dosage alterations or other therapy changes are necessary."	0
See CONTRAINDICATIONS about concurrent usage of tricyclic antidepressants and monoamine oxidase inhibitors.	0
Lithium <U+2014> There have been reports of both increased and decreased lithium levels when lithium was used concomitantly with fluoxetine.	1
Switching a Patient To or From a Monoamine Oxidase Inhibitor (MAOI) Intended to Treat Psychiatric Disorders: At least 14 days should elapse between discontinuation of an MAOI intended to treat psychiatric disorders and initiation of therapy with SURMONTIL.	0
Hypokalemia may be avoided or treated by use of potassium supplements or foods with a high potassium content.	0
"Losartan potassium tablets may be administered with insulin and other commonly used hypoglycemic agents (e.g., sulfonylureas, glitazones and glucosidase inhibitors)."	0
"In in vitro receptor binding assays, selegiline has demonstrated affinity for the human recombinant adrenergic <U+03B1>2B receptor (Ki = 0.3mcM)."	0
Previous toleration of higher doses does not eliminate the need for rehospitalization.	0
Caution is recommended when the drug is administered to patients with a history of convulsive disorders.	0
Discontinue PRIFTIN if evidence of liver injury occurs.	0
Monoamine Oxidase Inhibitors: See CONTRAINDICATIONS and WARNINGS.	0
The pharmacokinetics of sofosbuvir were studied following 7-day dosing of 400 mg sofosbuvir in HCV-infected subjects with moderate and severe hepatic impairment (Child-Pugh Class B and C).	0
Patients should be monitored for adequate clinical effect when amlodipine is co-administered with CYP3A4 inducers.	0
"In patients with chronic mild liver impairment (N = 10, 8 patients with Child-Pugh scores of 5 to 6 and 2 patients with Child-Pugh scores of 7 to 8) who received 50 mg sertraline per day maintained for 21 days, sertraline clearance was reduced, resulting in approximately 3-fold greater exposure compared to age-matched volunteers with no hepatic impairment (N = 10)."	0
"The possibility of these adverse events should be considered in patients treated with PRISTIQ who present with progressive dyspnea, cough, or chest discomfort."	0
"There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on suicide."	0
"Closely monitor plasma concentrations of tacrolimus during nicardipine administration, and adjust the dose of tacrolimus accordingly."	0
Angle-Closure Glaucoma The pupillary dilation that occurs following use of many antidepressant drugs including Anafranil may trigger an angle closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy.	0
"In vitro, abiraterone and its major metabolites were shown to inhibit the hepatic uptake transporter OATP1B1."	0
Infusion rate should be reduced by approximately one-half to compensate for decreased rate of clearance after prolonged infusion (24 hours).	0
"Consequently, the full spectrum of possible responses to selegiline may not have been observed in pre-marketing evaluation of the drug."	0
No food should be consumed for at least 2 hours before the dose is taken and for at least 1 hour after the dose is taken.	0
"Multiple-dose administration of the potent CYP3A4 inducer rifampin (600 mg every 24 hours, q24h, for 14 days), however, reduced zaleplon Cmax and AUC by approximately 80%."	1
"Amprenavir, the active metabolite of fosamprenavir, is an inhibitor of CYP3A4 metabolism and therefore should not be administered concurrently with medications with narrow therapeutic windows that are substrates of CYP3A4."	0
The pupillary dilation that occurs following use of many antidepressant drugs including nefazodone hydrochloride tablets may trigger an angle closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy.	0
"In general, doses of 40<U+2013>80 mg and divided doses give a somewhat greater effect at the end of the dosing interval."	0
"Post-baseline NS5A and NS5B deep nucleotide sequence analysis data (assay sensitivity of 1%) were available for 37/37 and 36/37 subjects' viruses, respectively."	0
Warn patients against interruption or discontinuation of therapy without the physician<U+2019>s advice.	0
"In addition, administration of Zaleplon to a patient taking another drug that is highly protein bound should not cause transient increase in free concentrations of the other drug."	0
CYP2D6 metabolism <U+2014> Poor metabolizers(PMs) of CYP2D6 have a 10-fold higher AUC and a 5-fold higher peak concentration to a given dose of STRATTERA compared with extensive metabolizers(EMs).	0
"For adult patients switching from sevelamer hydrochloride tablets to sevelamer carbonate tablets or powder, use the same dose in grams."	0
This pattern was demonstrated in male and female subjects.	0
"All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases."	0
"Presumably because of the inhibition of the degradation of endogenous bradykinin, persistent nonproductive cough has been reported with all ACE inhibitors, generally resolving after discontinuation of therapy."	0
Elderly <U+2014> Initiate CYMBALTA at a dose of 30mg once daily for 2 weeks before considering an increase to the target dose of 60mg.	0
"Prior to initiating treatment with ZOLOFT, screen patients for any personal or family history of bipolar disorder, mania, or hypomania."	0
Serotonin release by platelets plays an important role in hemostasis.	0
"In this circumstance, hepatic clearance is influenced primarily by changes in liver blood flow rather than by changes in the intrinsic clearance, i.e., the metabolizing enzymatic activity."	0
PEXEVA<U+00AE> should also not be started in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue.	0
Taper BYSTOLIC over 1 to 2 weeks when possible.	0
Give a low dose of calcium channel blockers initially and increase only after ECG verification of good tolerability.	0
"Ranitidine produced smaller, non-significant increases."	0
"Agents Causing Renin Release: The antihypertensive effect of VASOTEC is augmented by antihypertensive agents that cause renin release (e.g., diuretics)."	0
Diltiazem is both a substrate and an inhibitor of the cytochrome P450 3A4 enzyme system.	0
"Perhaps by competing for pathways of renal clearance, coadministration of quinidine causes an increase in serum levels of procainamide."	1
They should be advised not to consume excessive amounts of caffeine in any form.	0
"Because Matulane exhibits some monoamine oxidase inhibitory activity, sympathomimetic drugs, tricyclic antidepressant drugs (eg, amitriptyline HCI, imipramine HCI) and other drugs and foods with known high tyramine content, such as wine, yogurt, ripe cheese and bananas, should be avoided."	0
An increased rate of stroke was observed during the transition from XARELTO to warfarin in clinical trials in atrial fibrillation patients .	0
Minimum therapeutic plasma diltiazem concentrations appear to be in the range of 50 to 200 ng/mL.	0
"For women, this result should be multiplied by 0.85."	0
"However, LDL-C reduction is the same regardless of the time of day of drug administration."	0
Inducers of CYP3A4 and P-gp decrease exposure to apixaban and increase the risk of stroke and other thromboembolic events.	1
These adverse outcomes are usually associated with use of these drugs in the second and third trimester of pregnancy.	0
Inhibitors of CYP2D6 Fluoxetine: Fluoxetine (60mg single dose or 60mg daily dose for 8 days) causes a small (mean 16%) increase in the maximum concentration of olanzapine and a small (mean 16%) decrease in olanzapine clearance.	1
"However, it does not act primarily by stimulation of the central nervous system."	0
Patients in all studies had moderate to severe OCD (DSM-IIIR) with mean baseline ratings on the Yale Brown Obsessive Compulsive Scale (YBOCS) total score ranging from 23 to 26.	0
The need for continued treatment should be reassessed periodically.	0
See full prescribing information for administration instructions (2) Adults and adolescents 13 years and older (tablets): 1250 mg twice daily or 750 mg three times daily with a meal (2.1) Children 2 to less than 13 years (oral powder or 250 mg tablets): 45 to 55 mg/kg twice daily or 25 to 35 mg/kg three times daily with a meal.	0
"In about 30% of subjects, the dose of cyclosporine had to be reduced in order to maintain cyclosporine concentrations within the therapeutic range, while in the remainder no adjustment was needed."	1
"Drugs Metabolized by CYP2D6 <U+2014> Fluoxetine inhibits the activity of CYP2D6, and may make individuals with normal CYP2D6 metabolic activity resemble a poor metabolizer."	0
"Possible allergic reactions, including anaphylactic reactions, angioneurotic edema, urticaria, and rash."	0
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus (5.1).	0
Dosage of orally administered tacrolimus should be decreased depending on tacrolimus concentration.	1
The primary metabolites are the carboxylic acid metabolite and formaldehyde formed by hydrolysis of the ester group.	0
"Table2: Incidence of Primary Endpoint Events Losartan Atenolol Risk ReductionAdjusted for baseline Framingham risk score and level of electrocardiographic left ventricular hypertrophy 95% CI p-Value N (%) RateRate per 1000 patient-years of follow-up N (%) Rate Primary Composite Endpoint 508 (11) 23.8 588 (13) 27.9 13% 2% to 23% 0.021 Components of Primary Composite Endpoint (as a first event) Stroke (nonfatalFirst report of an event, in some cases the patient died subsequently to the event reported) 209 (5) 286 (6) Myocardial infarction (nonfatal) 174 (4) 168 (4) Cardiovascular mortality 125 (3) 134 (3) Secondary Endpoints (any time in study) Stroke (fatal/nonfatal) 232 (5) 10.8 309 (7) 14.5 25% 11% to 37% 0.001 Myocardial infarction (fatal/nonfatal) 198 (4) 9.2 188 (4) 8.7 -7% -13% to 12% 0.491 Cardiovascular mortality 204 (4) 9.2 234 (5) 10.6 11% -7% to 27% 0.206 Due to CHD 125 (3) 5.6 124 (3) 5.6 -3% -32% to 20% 0.839 Due to Stroke 40 (1) 1.8 62 (1) 2.8 35% 4% to 67% 0.032 OtherDeath due to heart failure, non-coronary vascular disease, pulmonary embolism, or a cardiovascular cause other than stroke or coronary heart disease 39 (1) 1.8 48 (1) 2.2 16% -28% to 45% 0.411 Although the LIFE study favored losartan potassium tablets over atenolol with respect to the primary endpoint (p=0.021), this result is from a single study and, therefore, is less compelling than the difference between losartan potassium tablets and placebo."	0
Coadministration with drugs that inhibit P-gp and/or BCRP may increase ledipasvir and sofosbuvir plasma concentrations without increasing GS-331007 plasma concentration; HARVONI may be coadministered with P-gp and/or BCRP inhibitors.	1
"Dual Blockade of the Renin-Angiotensin System (RAS) Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"Aspirin and/or acetaminophen, on the other hand, often successfully relieve isosorbide dinitrate-induced headaches with no deleterious effect on isosorbide dinitrate's antianginal efficacy."	0
"In the randomized, double-blind, controlled clinical trial, patients were treated with conventional measures (usually diet and 325mg of aspirin every other day) and either lovastatin 20-80mg daily or placebo."	0
"Because pediatric obesity is a chronic condition requiring long-term treatment, the use of phendimetrazine tartrate ER approved for short-term therapy, is not recommended in patients less that 17 years of age."	0
Herbal products: St. John<U+2019>s wort (Hypericum perforatum) May lead to loss of virologic response and possible resistance to LEXIVA or to the class of protease inhibitors.	0
"This difference is not expected to be clinically significant; therefore, PRISTIQ can be taken without regard to meals."	0
Administration with food or antacid is recommended.	0
"Inhibitors of CYP2C9, 1A2, and/or 3A4 have the potential to increase the effect (increase INR) of warfarin by increasing the exposure of warfarin."	0
"Clinical manifestations of NMS are hyperpyrexia, muscle rigidity, altered mental status (including catatonic signs) and evidence of autonomic instability (irregular pulse or blood pressure, tachycardia, diaphoresis, and cardiac dysrhythmias)."	0
"Alternatively, the bolus dose of AGGRASTAT may be administered from the 100 mL premixed vial or from the 250 mL premixed bag."	0
0.39-4.88 <U+2013> not statistically significant]).	0
"Resume treatment at 400 mg oncedaily if hepatic transaminases returns to less than or equal to Grade 1 Other Non- H ematologic Toxicities If other clinically significant moderate or severe non-hematologic toxicity develops, withhold dosing, and resume at 400 mg oncedaily when the toxicity has resolved."	0
"In a separate study, when a single oral 300 mg dose of phenytoin was administered at paroxetine steady state (30 mg once daily for 14 days), phenytoin AUC was slightly reduced (12% on average) compared to phenytoin administered alone."	1
A delayed rate but similar extent of absorption is observed for the sustained release formulation when compared to the immediate release formulation.	0
Dosage should be increased more gradually in debilitated or emaciated patients.	0
"Cases of anaphylaxis, toxic epidermal necrolysis (TEN), and Stevens-Johnson syndrome have also been reported."	0
Periodic attempts should be made to reduce the dosage of ORAP to see whether or not tics persist at the level and extent first identified.	0
"Therapeutic response occurs after several weeks of treatment, usually 6 to 8; an adequate trial should be a minimum of 12weeks."	0
Doses above 150 mg per day are not recommended.	0
No gender-associated difference in fluoxetine pharmacokinetics was observed.	0
"In animals, voriconazole administration was associated with teratogenicity, embryotoxicity, increased gestational length, dystocia and embryomortality."	0
Dosage should be initiated at a lower level and increased according to tolerance and clinical response to a usual maximum of 100 mg daily.	0
"In another healthy volunteer study, lopinavir 400 mg/ritonavir 100 mg twice daily decreased bupropion AUC and Cmax by 57%."	1
"Metabolism and Excretion Clozapine is almost completely metabolized prior to excretion, and only trace amounts of unchanged drug are detected in the urine and feces."	0
"Provided is the volume required per dose, NOT per day."	0
"Similar tumors were not seen in rats given pimozide, nor at lower doses in mice, which is reassuring."	0
Blood flow to peripheral vascular beds may decrease while mesenteric blood flow is increased.	0
CYMBALTA should be discontinued in patients who develop jaundice or other evidence of clinically significant liver dysfunction and should not be resumed unless another cause can be established.	0
"If mexiletine and theophylline are to be used concurrently, theophylline blood levels should be monitored, particularly when the mexiletine dose is changed."	0
"Coadministration of enoxaparin, warfarin, aspirin, clopidogrel and chronic NSAID use may increase the risk of bleeding [see Clinical Pharmacology (12.3)]."	0
"Cyclosporine (CYP3A substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine, despite reduction in dose of cyclosporine."	0
"The combination may result in increased risk of cardiovascular adverse events associated with salmeterol, including QT prolongation, palpitations and sinus tachycardia."	0
"Hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, and urticaria."	0
A portion of the additional sodium presented to the distal tubule is exchanged there for potassium and hydrogen ions.	0
The patient should be observed for a sufficient duration at a given dose to ensure that a maximal benefit has been achieved before a dose increase is considered.	0
"Telmisartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in many tissues, such as vascular smooth muscle and the adrenal gland."	0
"Because animal reproduction studies are not always predictive of human response, physicians should carefully consider the potential risks and benefits for each specific patient before prescribing lidocaine hydrochloride."	0
Carbamazepine: Elevated carbamazepine levels and symptoms of toxicity with coadministration (7.2).	0
Dosing of children and adolescents over 70kg body weight and adults<U+2014> STRATTERA should be initiated at a total daily dose of 40mg and increased after a minimum of 3days to a target total daily dose of approximately 80mg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening.	0
Nelfinavir: Avoid concomitant use with PROTONIX.	0
"For a child aged 1 month, the starting dose should be multiplied by 0.68; the initial starting dose would be (30 <U+00D7> 0.68) = 20 mg/m2, administered orally three times daily."	0
"It is important that this drug be dispensed in the least possible quantities to depressed outpatients, since suicide has been accomplished with this class of drug."	0
Avoid concomitant use of XARELTO with known combined P-gp and strong CYP3A4 inhibitors see Drug Interactions ( 7.2 ) .	0
"In postmarketing experience, there have been rare reports of adverse neuropsychiatric events or reduced alcohol tolerance in patients who were drinking alcohol during treatment with WELLBUTRIN XL."	0
Patients whose blood pressures are not adequately controlled with quinapril monotherapy may instead be given ACCURETIC 10/12.5 or 20/12.5.	0
Do not administer DESOXYN concomitantly or within 14 days after discontinuing MAOI.	0
The risk may also be increased by traumatic or repeated epidural or spinal puncture.	0
"Amiodarone and its metabolite desethyl amiodarone, inhibitors of CYP2C9, and P-glycoprotein increased concentrations of the S(-)-enantiomer of carvedilol by at least 2 fold."	1
Race Effect of race on the pharmacokinetics of teriflunomide cannot be adequately assessed due to a low number of non-white patients in the clinical trials.	0
"If signs and symptoms of tardive dyskinesia appear in a patient on antipsychotics, drug discontinuation should be considered."	0
Albuterol (600mcgiv over 2hours) induced increases in heart rate and blood pressure.	0
"(A) PREMATURE DISCONTINUATION OF PRADAXA INCREASES THE RISK OF THROMBOTIC EVENTSPremature discontinuation of any oral anticoagulant, including PRADAXA, increases the risk of thrombotic events."	0
Binding is also dependent on the plasma concentration of alpha-1-acid glycoprotein.	0
TWYNSTA Tablets TWYNSTA tablets have been shown to be effective in lowering blood pressure.	0
"Lidocaine Hydrochloride Injection, USP readily crosses the placental barrier."	0
"For patients requiring further reduction in blood pressure after 2 weeks of therapy, the dose of Benicar may be increased to a maximum of 20mg once daily for patients who weigh <35kg or 40 mgonce daily for patients who weigh <U+2265>35kg."	0
Interference with adequate oral electrolyte intake will also contribute to hypokalemia.	0
"Life-threatening disturbances of cardiac rhythm, including ventricular tachycardia and ventricular fibrillation leading to death, have been reported within a few hours following the administration of 5-HT1 agonists."	0
The potential for a pharmacokinetic interaction exists with the co-administration of CYP2D6 inhibitors which may increase the risk with increased exposure to the active metabolite of VYVANSE (dextroamphetamine).	1
"Buspirone: In nine healthy subjects, diltiazem significantly increased the mean buspirone AUC 5.5-fold and Cmax 4.1-fold compared to placebo."	1
Discontinue ACIPHEXif acute interstitial nephritis develops.	0
"Geriatric Use: This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function."	0
"Akathisia: The use of paroxetine or other SSRIs has been associated with the development of akathisia, which is characterized by an inner sense of restlessness and psychomotor agitation such as an inability to sit or stand still usually associated with subjective distress."	0
The recommended oral maintenance dose of 200 mg achieves a voriconazole exposure similar to 3 mg/kg IV; a 300 mg oral dose achieves an exposure similar to 4 mg/kg IV.	0
Ziprasidone may antagonize the effects of levodopa and dopamine agonists.	0
"Although not studied, fluconazole may increase the plasma levels of the vinca alkaloids (e.g., vincristine and vinblastine) and lead to neurotoxicity, which is possibly due to an inhibitory effect on CYP3A4."	1
"Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"Age, gender, race, and ideal body weight had no significant effects on metoprolol pharmacokinetics."	0
"Following oral administration, peak hydrochlorothiazide plasma levels are attained in approximately 2 hours."	0
Ischemic bowel disease.	0
"If a patient develops an exfoliative cutaneous reaction, VFEND should be discontinued."	0
The cardiovascular activity of norverapamil appears to be approximately 20% that of verapamil.	0
Both findings suggest a lower clearance and/or a higher oral bioavailability of sildenafil in patients with PAH compared to healthy volunteers.	0
Increased risk of pulmonary hypertension with repeated courses of therapy cannot be excluded.	0
"Because thrombin (serine protease) enables the conversion of fibrinogen into fibrin during the coagulation cascade, its inhibition prevents the development of a thrombus."	0
"Following infusion, nicardipine plasma concentrations decline triexponentially, with a rapid early distribution phase (<U+03B1>-half-life of 3 minutes), an intermediate phase (<U+00DF>-half-life of 45 minutes), and a slow terminal phase (<U+01B4>-half-life of 14 hours) that can only be detected after long-term infusions."	0
"Methotrexate and other drugs that , like LASIX , undergo significant renal tubular secretion may reduce the effect of LASIX ."	0
"As a consequence of extensive hepatic extraction of lovastatin, the availability of drug to the general circulation is low and variable."	0
"Propranolol <U+2013> The coadministration of nefazodone (200 mg BID) and propranolol (40 mg BID) for 5.5 days to healthy male volunteers (n = 18), including 3 poor and 15 extensive CYP2D6 metabolizers, resulted in 30% and 14% reductions in Cmax and AUC of propranolol, respectively, and a 14% reduction in Cmax for the metabolite, 4-hydroxypropranolol."	1
Systemic ketoconazole: Monitor during concomitant use.	0
"FANAPT functions as an antagonist at the dopamine D2, D3, serotonin 5-HT1A and norepinephrine <U+03B1>1/<U+03B1>2C receptors."	0
"From a pharmacokinetic perspective, it may be better to separate the first90 mgweekly dose and the last 20 mgonce-daily dose by 1week."	0
CAPRELSA can prolong the QT interval in a concentration-dependent manner.	0
"Concomitant Drug Class: Drug Name Effect on Concentration<U+2193> = decrease, <U+2191> = increase Clinical Comment Acid Reducing Agents: <U+2193> ledipasvir Ledipasvir solubility decreases as pH increases."	0
"These hazards include fetal or neonatal jaundice, thrombocytopenia, and possibly other adverse reactions that have occurred in the adult."	0
"Triamterene and hydrochlorothiazide may produce an elevated blood urea nitrogen level (BUN), creatinine level or both."	0
"Liver transaminase elevations resulted in the discontinuation of 0.3% (92/34,756) of CYMBALTA-treated patients."	0
"If concomitant use of NORPRAMIN with other serotonergic drugs including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, tryptophan, and St. John's Wort is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome particularly during treatment initiation and dose increases."	0
<U+2022>Rinse the mortar and pestle clean using the vehicle and add this to the vessel.	0
A significant exposure-response relationship was identified between ondansetron concentration and <U+0394><U+0394>QTcF.	0
"In clinical trials, there have been uncommon cases of serious hepatic reactions during treatment with VFEND (including clinical hepatitis, cholestasis and fulminant hepatic failure, including fatalities)."	0
The pupillary dilation that occurs following use of many antidepressant drugs including Norpramin may trigger an angle closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy.	0
"Higher average steady-state fluoxetine and norfluoxetine concentrations were observed in children relative to adults; however, these concentrations were within the range of concentrations observed in the adult population."	0
The extent to which SSRI TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.	0
"40 twice daily, 7 days 800 three times daily, 7 days 13 0.86(0.73, 1.03) 1.21(1.09, 1.33) Not Done Theophylline 250 single dose (on Days 1 and 7) 800 three times daily, 6 days (Days 2 to 7) 12, 4 0.88(0.76, 1.03) 1.14(1.04, 1.24) 1.13(0.86, 1.49)n=7, 3 Trimethoprim/Sulfamethoxazole Trimethoprim 800 Trimethoprim/ 160 Sulfamethoxazole q12h, 7 days 400 q6h, 7 days 12 1.18(1.05, 1.32) 1.18(1.05, 1.33) 1.18(1.00, 1.39) Trimethoprim/Sulfamethoxazole Sulfamethoxazole 800 Trimethoprim/160 Sulfamethoxazole q12h, 7 days 400 q6h, 7 days 12 1.01(0.95, 1.08) 1.05(1.01, 1.09) 1.05(0.97, 1.14) Vardenafil 10 single dose 800 three times daily 18 See text below for discussion of interaction."	0
"In a placebo-controlled trial of subjects with severe heart failure, worsening heart failure during the first 3months was reported to a similar degree with carvedilol and with placebo."	0
Titrate Cleviprex to achieve the desired blood pressure reduction.	0
Use of Rifampin in combination with zolpidem may decrease the efficacy of zolpidem and is not recommended.	0
"Serum potassium levels should be carefully monitored when digoxin is given to patients at high risk of hypokalemia (e.g., those receiving diuretics, corticosteroids, or other drugs that commonly lead to potassium loss; those with gastrointestinal losses through diarrhea, vomiting, or nasogastric suction; or those with potassium-losing endocrinopathies or nephropathies)."	0
"The apparent steady-state volume of distribution (mean <U+00B1> SD) is 19,669 <U+00B1> 13,358 L. In vitro studies show that at clinically relevant concentrations, abiraterone acetate and abiraterone are not substrates of P-glycoprotein (P-gp) and that abiraterone acetate is an inhibitor of P-gp."	0
Anyone considering the use of paroxetine mesylate in a child or adolescent must balance the potential risks with the clinical need.	0
The risk of myopathy and rhabdomyolysis with statins metabolized by CYP3A4 may be increased with concomitant use of diltiazem.	0
Patients with a history of ischemic stroke within 3 months of screening and patients with a history of hemorrhagic stroke at any time were excluded from TRITON-TIMI 38.	0
This decision can only be made on a case by case basis.	0
"Pooled analyses of short-term placebo-controlled trials of antidepressant drugs (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18-24) with major depressive disorder (MDD) and other psychiatric disorders."	0
Such an increased risk may result also from the additive effect of coadministering thioridazine with other agents that prolong the QTc interval.	0
"However, no excess risk of bleeding was observed in the dronedarone group."	0
The recommended dose of ELIQUIS for most patients is 5 mg taken orally twice daily.	0
"Subjects who do not metabolize losartan to active metabolite have been shown to have a specific, rare defect in cytochrome P4502C9."	0
"Hemodialysis: While studies have not been conducted in patients with end-stage renal disease, hemodialysis is not expected to significantly enhance clearance of LIPITOR since the drug is extensively bound to plasma proteins."	0
Low lymphocyte counts are maintained with chronic daily dosing of GILENYA 0.5 mg daily.	0
Hypersensitivity to any component of this product.	0
"Sedative/Hypnotics Triazolam, oral midazolam Potential for serious and/or life threatening reactions such as prolonged or increased sedation or respiratory depression."	0
Patients should avoid engaging in hazardous activities that require concentration (such as operating a motor vehicle or heavy machinery) after taking ROZEREM.	0
"In formal electrophysiologic studies, predominantly in patients with normal conduction systems, PROCARDIA has had no tendency to prolong atrioventricular conduction, prolong sinus node recovery time, or slow sinus rate."	0
Discontinue MAXALT if a cerebrovascular event occurs.	0
"The effectiveness of paroxetine in the treatment of panic disorder was demonstrated in three 10- to 12-week multicenter, placebo-controlled studies of adult outpatients (Studies 1 to 3)."	0
The elimination half-life of eplerenone is approximately 3 to 6 hours.	0
"Haloperidol <U+2013> When a single oral 5 mg dose of haloperidol was coadministered with nefazodone (200 mg BID) at steady state, haloperidol apparent clearance decreased by 35% with no significant increase in peak haloperidol plasma concentrations or time of peak."	1
"Although a causal link between the emergence of such symptoms and either the worsening of depression and/or the emergence of suicidal impulses has not been established, there is concern that such symptoms may represent precursors to emerging suicidality."	0
There are no adequate and well-controlled studies in pregnant women.	0
Evidence that the C ss and AUC for CMI and DMI may increase disproportionately with increasing oral doses suggests that the metabolism of CMI and DMI may be capacity limited.	0
"Serious Cardiovascular Events <U+2013> Sudden death, stroke and myocardial infarction have been reported in association with atomoxetine treatment."	0
Sotalol elimination is predominantly via the kidney in the unchanged form.	0
Heart block greater than first degree.	0
Most patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy.	0
Both losartan and its principal active metabolite do not exhibit any partial agonist activity at the AT1 receptor and have much greater affinity (about 1000-fold) for the AT1 receptor than for the AT2 receptor.	0
"If patients do not tolerate 400 mg per m2 twice daily due to adverse events, the highest tolerated dose may be used for maintenance therapy in combination with other antiretroviral agents, however, alternative therapy should be considered."	0
Avoid aspirin in patients with severe renal failure (glomerular filtration rate less than 10 mL/minute).	0
"Patients at risk of excessive hypotension include those with the following conditions or characteristics: heart failure with systolic blood pressure below 100 mmHg, ischemic heart disease, cerebrovascular disease, hyponatremia, high dose diuretic therapy, renal dialysis, or severe volume and/or salt depletion of any etiology."	0
The usual dosage range is 5 to 40mg/day.	0
"Pulmonary Function: Verapamil does not induce bronchoconstriction and hence, does not impair ventilatory function."	0
The interdosing interval sufficient to avoid tolerance to ISDN has not been well defined.	0
"There is not adequate experience to define the dose adjustment that would be needed to allow safe use of tolvaptan with strong CYP 3A inhibitors such as clarithromycin , ketoconazole , itraconazole , ritonavir , indinavir , nelfinavir , saquinavir , nefazodone , and telithromycin ."	0
The mean mirtazapine dose for patients who completed these 4 studies ranged from 21 to 32 mg/day.	0
"IV ROUTE IS ONLY FOR SEVERE HICCUPS, SURGERY AND TETANUS."	0
"In patients who tolerate the full intravenous dose (10 mg), TENORMIN Tablets 50 mg should be initiated 10 minutes after the last intravenous dose followed by another 50 mg oral dose 12 hours later."	0
"However, caution should be exercised when ZOCOR is administered to patients with severe renal impairment; such patients should be started at 5mg/day and be closely monitored."	0
Intestinal angioedema should be included in the differential diagnosis of patients on ACE inhibitors presenting with abdominal pain.	0
Safety and effectiveness in pediatric patients have not been established in adequate and well-controlled trials.	0
"The plasma concentration of candesartan was higher in the elderly (Cmax was approximately 50% higher, and AUC was approximately 80% higher) compared to younger subjects administered the same dose."	0
Marked elevation in triglyceride levels is a risk factor for development of pancreatitis.	0
It will take much longer to reach steady-state with any dose and/or frequency of administration in these children.	0
"Effusions (including pleural effusion, pericardial effusion, ascites) or pulmonary edema, were observed in 2.2% and 1.1% of patients receiving Tasigna 300 mg twice daily and 400 mg twice daily, respectively, and in 2.1% of patients receiving imatinib."	0
"Following a single 5 mg dose of SAPHRIS, the mean Cmax was approximately 4 ng/mL and was observed at a mean tmax of 1 hour."	0
"NS5B substitutions S282T, L320V/I, and V321I in combination with NS5A substitutions L31M, Y93H, and Q30L were detected in one subject at failure following 8 weeks of treatment with HARVONI in a Phase 2 trial."	0
None of the dose was recovered as unchanged nicardipine.	0
"Table 12: Clinically Important Drug Interactions with SAPHRIS Concomitant Drug Name or Drug Class Clinical Rationale Clinical Recommendation Antihypertensive Drugs Because of its <U+03B1>1-adrenergic antagonism with potential for inducing hypotension, SAPHRIS may enhance the effects of certain antihypertensive agents."	0
"Increase dose as tolerated toward a target dose of 5 mg twice daily, with dosage increases about 3 weeks apart (2.3)."	0
"In controlled studies, syncope was observed in 0.4% of patients (N=3203); this incidence was similar to that observed for captopril (1%) and enalapril (0.8%)."	0
"Nevertheless, even sertraline has the potential for clinically important 2D6 inhibition."	0
Monitor lithium levels in patients receiving irbesartan and lithium.	0
"Eplerenone binds to the mineralocorticoid receptor and blocks the binding of aldosterone, a component of the renin-angiotensin-aldosterone-system (RAAS)."	0
"Nevertheless, lower doses may be advisable for pediatric patients given their lower body weights, especially in very young patients, in order to avoid excessive plasma levels."	0
"Drug recovered in the feces may represent both biliary excretion of metabolites and/or unabsorbed drug, however the proportion of a dose eliminated by the bile has not been determined."	0
Other Agents IbutilideSotalol Additive effects on QT and/or PR interval prolongation may occur with INVIRASE/ritonavir.	0
Correct volume- and salt-depletion before initiating therapy with ALTACE.	0
"Because of possible effects on blood pressure, STRATTERA should be used cautiously with antihypertensive drugs and pressor agents (e.g., dopamine, dobutamine) or other drugs that increase blood pressure."	0
"Analysis of age, gender, and race subgroups of patients showed that men and women, and patients over and under 65, had generally similar responses."	0
"Measure serum potassium before initiating INSPRA therapy, within the first week, and at one month after the start of treatment or dose adjustment."	0
"Antidiabetic drug requirements (i.e., insulin) may be altered."	0
Flurazepam is rapidly metabolized and is excreted primarily in the urine.	0
"Metabolism and Elimination Aspirin is rapidly hydrolyzed in plasma to salicylic acid, with a half-life of 20 minutes."	0
Increases in liver function tests (LFT) in other patients were not associated with jaundice or other clinical signs or symptoms.	0
"If an alternate etiology is not found, do not restart CADUET."	0
Care should be taken to administer this drug slowly in order to avoid producing an excessive hypotensive effect.	0
Close monitoring of the patient<U+2019>s clinical condition and hematologic status is recommended.	0
"Intervention: ZOLOFT is contraindicated in patients taking MAOIs, including MAOIs such as linezolid or intravenous methylene blue."	0
"On the basis of limited available data, no dosage adjustment is recommended for patients on these drugs."	0
Effect on reproductive axis in developing humans is unknown.	0
Physicians may consider alternative therapies for patients who have low or absent TPMT activity (homozygous for non-functional alleles).	0
Mean steady-state inhibition of platelet aggregation was about 70% following 3to 5days of dosing at 10-mg daily after a 60-mg loading dose of Effient.	0
"Pharmacokinetics in Pediatric Surgery Patients 1 Month to 12 Years of Age Subjects and Age Group N CL(L/h/kg) Vdss (L/kg) T<U+00BD> (h) Geometric Mean Mean Pediatric Surgery Patients3 to 12 years of age N = 21 0.439 1.65 2.9 Pediatric Surgery Patients5 to 24 months of age N = 22 0.581 2.3 2.9 Pediatric Surgery Patients1 month to 4 months of age N = 19 0.401 3.5 6.7 In general, surgical and cancer pediatric patients younger than 18 years tend to have a higher ondansetron clearance compared to adults leading to a shorter half-life in most pediatric patients."	0
"Cholinesterase Inhibitors Dipyridamole may counteract the anticholinesterase effect of cholinesterase inhibitors, thereby potentially aggravating myasthenia gravis."	0
"The use of potent CYP 3A4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, troleandomycin, ketoconazole, itraconazole) with dihydroergotamine is, therefore contraindicated."	0
Treatment with antibacterial agents can alter the normal flora of the colon and may permit overgrowth of C. difficile.	0
"Coadministration of fluoxetine with other drugs that are metabolized by CYP2D6, including certain antidepressants (e.g., TCAs), antipsychotics (e.g., phenothiazines and most atypicals), and antiarrhythmics (e.g., propafenone, flecainide, and others) should be approached with caution."	0
The incidence of thromboembolic events in patients receiving the combination of PERSANTINE tablets and warfarin ranged from 1.2 to 1.8%.	0
"SSRIs and SNRIs, including PEXEVA<U+00AE> (paroxetine mesylate), have been associated with cases of clinically significant hyponatremia in elderly patients, who may be at greater risk for this adverse event."	0
"Interaction with Combined P-gp and Moderate CYP3A4 Inhibitors in Patients with Renal Impairment XARELTO should not be used in patients with CrCl 15 to <80 mL/min who are receiving concomitant combined P-gp and moderate CYP3A4 inhibitors (e.g., erythromycin) unless the potential benefit justifies the potential risk [see Warnings and Precautions (5.4) and Clinical Pharmacology (12.3)]."	0
"Both losartan and its active metabolite are highly bound to plasma proteins, primarily albumin, with plasma free fractions of 1.3% and 0.2%, respectively."	0
Both inhibit angiotensin-converting enzyme (ACE) in human subjects and in animals.	0
"Depending on the clinical situation (e.g., elderly patients) and degree of monitoring available, reduce the dose of intravenous midazolam Single 40 mg dose of EMEND No dosage adjustment of the benzodiazepine needed Dexamethasone Clinical Impact Increased dexamethasone exposure."	1
"Families and caregivers of patients should be advised to look for the emergence of such symptoms on a day-to-day basis, since changes may be abrupt."	0
No dosage adjustment is necessary for patients with renal impairment unless they are volume-depleted.	0
The effects of nicardipine are more selective to vascular smooth muscle than cardiac muscle.	0
"In the presence of impaired renal function, the <U+03B2>-phase serum half-life of penicillin G is prolonged."	0
"In a study in which normal male subjects (n = 15) received 30 mg tablets daily for 30 days, steady-state paroxetine concentrations were achieved by approximately 10 days for most subjects, although it may take substantially longer in an occasional patient."	0
Serotonin Syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with Lexapro or within 14 days of stopping treatment with Lexapro.	0
Emergence of New Psychotic or Manic Symptoms: Treatment-emergent psychotic or manic symptoms without a prior history can be caused by stimulants at usual doses.	0
"Ziprasidone exhibited high in vitro binding affinity for the dopamine D2 and D3, the serotonin 5HT2A, 5HT2C, 5HT1A, 5HT1D, and <U+03B1>1-adrenergic receptors (Ki s of 4.8, 7.2, 0.4, 1.3, 3.4, 2, and 10 nM, respectively), and moderate affinity for the histamine H1 receptor (Ki=47 nM)."	0
"During premarketing testing, hypomania or mania occurred in 0.3% of nefazodone-treated unipolar patients, compared to 0.3% of tricyclic- and 0.4% of placebo-treated patients."	0
"To obtain similar clinical benefit without toxicity, doses given to poor metabolizers may need to be greatly reduced."	0
"Rifampicin, a strong CYP3A4 inducer, decreased vandetanib plasma concentrations."	1
This suggests that zaleplon disposition should not be sensitive to alterations in protein binding.	0
"SULAR has been used safely with diuretics, ACE inhibitors, and beta-blocking agents."	0
"However, there is substantial evidence from placebo-controlled maintenance trials in adults with depression that the use of antidepressants can delay the recurrence of depression."	0
"After oral administration of radiolabeled dabigatran, 7% of radioactivity is recovered in urine and 86% in feces."	0
The risk of administering methylene blue by non-intravenous routes (such as oral tablets or by local injection) or in intravenous doses much lower than 1 mg/kg with LUVOX CR is unclear.	0
"Meperidine hydrochloride is incompatible with soluble barbiturates, aminophylline, heparin, morphine sulfate, methicillin, phenytoin, sodium bicarbonate, iodide, sulfadiazine and sulfisoxazole."	0
"In a study involving labeled and unlabeled enantiomers administered as a racemate, these individuals metabolized S-fluoxetine at a slower rate and thus achieved higher concentrations of S-fluoxetine."	0
"HMG-CoA Reductase Inhibitors Lovastatin, Simvastatin Potential for myopathy including rhabdomyolysis."	0
The reporting rate is generally accepted to be an underestimate due to underreporting.	0
"CYP3A4 Inducers Rifampin Rifampin, a CYP3A4 inducer, significantly reduced the exposure to and the pharmacodynamic effects of zolpidem."	1
"In two large, randomized, open-label, controlled clinical trials with an active comparator (1182.12 and 1182.48) of treatment-experienced patients, Grade 3 and 4 increases in hepatic transaminases were observed in 10.3% (10.9/100 PEY) receiving APTIVUS/ritonavir through week 48."	0
Maximum IM Dosage: Pediatric patients 6 months to 5 years (or 50 lbs.	0
Aerobic Gram-Positive Microorganisms: Staphylococcus aureus (including Methicillin-Resistant S. aureus/MRSA) Staphylococcus epidermis Aerobic Gram-Negative Microorganisms: Haemophilus influenzae <U+201C>Other<U+201D> Microorganisms: Mycobacterium leprae <U+00DF>-lactamase production should have no effect on rifampin activity.	0
"Patients who were pubertal (girls>8to <U+2264>13years old, boys >9to <U+2264>14years old) or late pubertal (girls>13years old, boys>14years old) had average weight and height gains that were close to or exceeded those predicted after threeyears of treatment."	0
Both elevation and lowering of blood sugar have been reported with tricyclic antidepressants.	0
Monitor serum creatinine until values have stabilized.	0
"For antiretroviral agents used in combination with INVIRASE, physicians should refer to the complete product information for these drugs for dose adjustment recommendations and for information regarding drug-associated adverse reactions."	0
"An additional 17% is recovered in feces within 6 days, most as 5-oxo-zaleplon."	0
"In humans, the known metabolites are labile or have no known pharmacologic activity."	0
The usual dietary intake of potassium is 50 to 100 mEq per day.	0
Sertraline does not inhibit monoamine oxidase.	0
"In children and adolescents over 70kg body weight and adults administered strong CYP2D6 inhibitors, e.g.,paroxetine, fluoxetine, and quinidine, STRATTERA should be initiated at 40mg/day and only increased to the usual target dose of 80mg/day if symptoms fail to improve after 4weeks and the initial dose is well tolerated."	0
Co-administration of rifampin and SAMSCA reduces exposure to tolvaptan by 85 % .	1
It is recommended that a further dose reduction or alternative therapies be considered for patients with low or absent TPMT activity receiving IMURAN and allopurinol because both TPMT and XO inactivation pathways are affected.	1
The patient<U+2019>s dose should be carefully adjusted to a point where the suppression of tics and the relief afforded is balanced against the untoward side effects of the drug.	0
"Telmisartan has much greater affinity (>3,000 fold) for the AT1 receptor than for the AT2 receptor."	0
"With this regimen in those studies, the following adverse events were reported at an incidence of 2% or greater for paroxetine at an incidence at least twice that reported for placebo: abnormal dreams, paresthesia, and dizziness."	0
Several published epidemiologic studies do not suggest an increased risk of congenital anomalies associated with low dose exposure to fluconazole in pregnancy (most subjects received a single oral dose of 150 mg).	0
One approach is to discontinue XARELTO and begin both a parenteral anticoagulant and warfarin at the time the next dose of XARELTO would have been taken .	0
No dosage adjustment is required for LUVOX CR Capsules.	0
"DEMSER may add to the sedative effects of alcohol and other CNS depressants , e.g. , hypnotics , sedatives , and tranquilizers ."	0
"Symptomatic hypotension is possible, particularly in patients with severe aortic stenosis (5.2) Titrate slowly in patients with hepatic (5.4) or severe renal impairment (5.5) Heart failure: Monitor for worsening (5.8) Avoid concomitant use with an ACE inhibitor (5.6) Myocardial infarction: Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of TWYNSTA, particularly in patients with severe obstructive coronary artery disease (5.7) Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death."	0
"Patients treated with TRISENOX may develop differentiation syndrome, which can be fatal."	0
"Reduction in the dose of SAMSCA may be required in patients concomitantly treated with P-gp inhibitors , such as e.g. , cyclosporine , based on clinical response see Dose and Administration ( 2.3 ) and Warnings and Precautions ( 5.5 ) ."	0
Letairis 10 mg daily had no significant effect on the QTc interval.	0
Consider withholding or discontinuing therapy in patients who develop a clinically significant decrease in renal function on ATACAND.	0
"Antipsychotics should be administered with caution to patients receiving anticonvulsant medication, with a history of seizures, or with EEG abnormalities, because they may lower the convulsive threshold."	0
"Base changes in the chronic infusion rate on persistence, recurrence, or worsening of the patient's symptoms of pulmonary hypertension and the occurrence of adverse vasodilatory reactions."	0
"In particular, daily headaches sometimes accompany treatment with isosorbide dinitrate."	0
"Bleeding: PRADAXA can cause serious and fatal bleeding (5.2) Bioprosthetic heart valves: PRADAXA use not recommended (5.4) Premature discontinuation of any oral anticoagulant, including PRADAXA, in the absence of adequate alternative anticoagulation increases the risk of thrombotic events."	0
Intervention Increase dose based on clinical response.	0
No increase in the signs of daytime anxiety was observed in clinical trials with Zaleplon.	0
"Lexapro should be administered once daily, in the morning or evening, with or without food."	0
These results are consistent with those seen after oral administration of nicardipine.	0
Table 1: Susceptibility Test Interpretive Criteria for Penicillin MIC (mcg/mL) Disk Diffusion (zone diameter in mm)Organisms for which no values for disk susceptibility appear cannot be reliably tested with this method.	0
"When possible, discontinue the drug for several days prior to elective surgery."	0
Negative inotropic effects can be detected in vitro but such effects have not been seen in intact animals at therapeutic doses.	0
Monitor for signs of angioedema.	0
The metabolism of atropine is inhibited by organophosphate pesticides.	1
"There is no effect on clearance of tirofiban by sex, race, age, or hepatic impairment."	0
"The magnitude of the impact of this factor is small in comparison to the overall variability between individuals, and therefore dose modification is not routinely recommended."	0
Cases with serum sodium lower than 110mmol/L have been reported and appeared to be reversible when CYMBALTA was discontinued.	0
"The initial metabolic pathway includes N-debutylation to form the active N-debutyl metabolite, oxidative deamination to form the inactive propanoic acid metabolite, and direct oxidation."	0
"When administered in combination with aspirin , tadalafil 20 mg did not prolong bleeding time , relative to aspirin alone ."	0
Atropine may lead to complete urinary retention in patients with prostatic hypertrophy.	0
The MIC values should be interpreted according to the criteria in Table 1.	0
No significant changes in eplerenone pharmacokinetics were observed when eplerenone was administered with aluminum- and magnesium-containing antacids.	0
In vitro data indicate that darunavir may be a P-gp substrate.	0
"In general, wait 7 to 14 days between titration steps."	0
ANTIPSYCHOTICS Quetiapine <U+2191> quetiapine Initiation of VIRACEPT in patients taking quetiapine: Consider alternative antiretroviral therapy to avoid increases in quetiapine drug exposures.	1
"In the first study, the immunogenicity of keyhole limpet hemocyanin (KLH) and pneumococcal polysaccharide vaccine (PPV-23) immunization were assessed by IgM and IgG titers in a steady-state, randomized, placebo-controlled study in healthy volunteers."	0
"Such data have no predictive value with respect to effects in patients with poor ventricular function, and increased heart failure has been reported in patients with preexisting impairment of ventricular function."	0
Reproduction studies have been performed in rats at doses up to five times the maximum human dose and have revealed no significant findings.	0
"To minimize the risk of peripheral venous irritation, change the site of infusion of nicardipine every 12 hours (5.7)."	0
The mean serum concentration eight minutes after completion of the bolus was 45 mcg/mL and eight minutes after completion of the infusion was 14.4 mcg/mL.	0
The steady-state plasma concentrations of sertraline and desmethylsertraline were not substantially changed when these antidepressant therapies were coadministered with aripiprazole.	0
"Conversely, at least 5 days should be allowed after stopping CYMBALTA before starting an MAOI intended to treat psychiatric disorders."	0
The mean half-life of abiraterone is prolonged to approximately 18 hours in subjects with mild hepatic impairment and to approximately 19 hours in subjects with moderate hepatic impairment.	0
"The precise mechanism of action of eszopiclone as a hypnotic is unknown, but its effect is believed to result from its interaction with GABA-receptor complexes at binding domains located close to or allosterically coupled to benzodiazepine receptors."	0
"At steady state, mean values of Cmax, Tmax, Cmin, and T<U+00BD> were 61.7 ng/mL (CV 45%), 5.2 hr."	0
Carbamazepine: Increased clearance of olanzapine.	1
"Following coadministration of stable doses of warfarin (1 to 10 mg/day) with multiple daily doses of BRINTELLIX, no significant effects were observed in INR, prothrombin values or total warfarin (protein bound plus free drug) pharmacokinetics for both R- and S-warfarin."	0
Eighteen of 30 patients with persistent LFT elevations continued treatment with a reduced dose of atorvastatin.	0
Phendimetrazine may decrease the hypotensive effect of guanethidine.	0
Adjustment of benzodiazepine dosage may be needed.	0
"Activation of Mania/Hypomania: During premarketing testing, hypomania or mania occurred in approximately 1.0% of paroxetine-treated unipolar patients compared to 1.1% of active-control and 0.3% of placebo-treated unipolar patients."	0
Telmisartan shows bi-exponential decay kinetics with a terminal elimination half life of approximately 24 hours.	0
Safety and effectiveness of ACCURETIC in children have not been established.	0
Maximal plasma concentrations of nisoldipine are reached at 9.2 <U+00B1> 5.1 hours.	0
Data from in vitro studies of triazolam suggest a possible drug interaction with triazolam for the following: sertraline and paroxetine.	0
Anti-diabetic Agents The concomitant use of ACE inhibitors such as trandolapril with antidiabetic medications (insulin or oral hypoglycemic agents) may result in increased blood glucose lowering effects.	0
"Propranolol: In a study of concurrent administration of propranolol 240 mg/day and a single dose of rizatriptan 10 mg in healthy adult subjects (n=11), mean plasma AUC for rizatriptan was increased by 70% during propranolol administration, and a four-fold increase was observed in one subject."	1
The dosage can be increased after 1 to 2 weeks of therapy to a maximum of 300/25 mg once daily as needed to control blood pressure.	0
"Hydrochlorothiazide was not genotoxic in in vitro assays using strains TA 98, TA 100, TA 1535, TA 1537 and TA 1538 of Salmonella typhimurium (the Ames test), in the Chinese hamster ovary (CHO) test for chromosomal aberrations, or in in vivo assays using mouse germinal cell chromosomes, Chinese hamster bone marrow chromosomes, and the Drosophila sex-linked recessive lethal trait gene."	0
"However, co-administration of duloxetine (60 or 120 mg) with warfarin (2 to 9 mg), a highly protein-bound drug, did not result in significant changes in INR and in the pharmacokinetics of either total S-or total R-warfarin (protein bound plus free drug)."	0
"The elevation has a rapid onset, reaches a plateau after 7 days and is reversible after discontinuation."	0
Use central hemodynamic monitoring and do not exceed 0.03 mcg/kg/min.	0
"Co-administration of tolvaptan does not appear to alter the pharmacokinetics of warfarin , furosemide , hydrochlorothiazide , or amiodarone ( or its active metabolite , desethylamiodarone ) to a clinically significant degree ."	0
"Families and caregivers of patients being treated with antidepressants for major depressive disorder or other indications, both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to healthcare providers."	0
"FANAPT has moderate affinity for dopamine D4, and serotonin 5-HT6 and 5-HT7 receptors (Ki values of 25, 43, and 22, nM respectively), and low affinity for the serotonin 5-HT1A, dopamine D1, and histamine H1 receptors (Ki values of 168, 216 and 437 nM, respectively)."	0
"There is some clinical evidence that stimulants may lower the convulsive threshold in patients with prior history of seizures, in patients with prior EEG abnormalities in absence of seizures, and, very rarely, in patients without a history of seizures and no prior EEG evidence of seizures."	0
The administration of PROSTIN VR PEDIATRIC to neonates may result in gastric outlet obstruction secondary to antral hyperplasia.	0
"Steady-state concentrations of ramiprilat are somewhat higher than those seen after the first dose of ALTACE, especially at low doses (2.5 mg), but the difference is clinically insignificant."	0
"Use in Elderly Patients: The recommended initial daily dosage of ACEON for the elderly is 4 mg daily, given in one or two divided doses."	0
Precise dosage regimen is determined by patient characteristics and response.	0
Triamterene and hydrochlorothiazide should not be used in patients who are hypersensitive to triamterene or hydrochlorothiazide or other sulfonamide-derived drugs.	0
Periodic monitoring of liver function in patients receiving verapamil is therefore prudent.	0
"Do not add other drugs or remove solution directly from the bag with a syringe. equation-1 equation-2 equation-3 equation-4 The recommended dosage in patients with CrCl <U+2264>60 mL/min is 25 mcg/kg intravenously within 5 minutes and then 0.075 mcg/kg/min, for up to 18 hours."	0
Rare case reports have suggested possible additive effects of pimozide and fluoxetine leading to bradycardia.	0
HIV-1 Protease Inhibitor:saquinavir <U+2191> saquinavir See the complete prescribing information for saquinavir for details on co-administration of saquinavir and ritonavir.Saquinavir/ritonavir in combination with rifampin is not recommended due to the risk of severe hepatotoxicity (presenting as increased hepatic transaminases) if the three drugs are given together.	0
"NSAIDs and selective COX-2 inhibitors: Can reduce diuretic, natriuretic of diuretic, may lead to increased risk of renal impairment and reduced antihypertensive effect."	0
Whether antipsychotic drug products differ in their potential to cause tardive dyskinesia is unknown.	0
"Postmarketing reports of serious skin and hypersensitivity reactions, including Stevens-Johnson Syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) and toxic epidermal necrolysis (TEN) have been reported in patients taking ULORIC."	0
Hydroxyurea may be discontinued when the WBC declines below 10 Gi/L.	0
"Since the drug may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks, such as operating an automobile or machinery, the patient should be cautioned accordingly."	0
The initial dose of TENORMIN is 50 mg given as one tablet a day either alone or added to diuretic therapy.	0
Persistent hyperkalemia may require dialysis.	0
"The patient should be monitored for symptoms of serotonin syndrome for two weeks or until 24 hours after the last dose of linezolid or intravenous methylene blue, whichever comes first."	0
"Sofosbuvir and GS-331007 are not inhibitors of drug transporters P-gp, BCRP, MRP2, BSEP, OATP1B1, OATP1B3, and OCT1, and GS-331007 is not an inhibitor of OAT1, OCT2, and MATE1."	0
"In orthopedic hip surgery patients, maximum aPTT response (Emax) to dabigatran and baseline aPTT were higher shortly after surgery than at later time points (e.g."	0
The usual starting dose of NARDIL is one tablet (15 mg) three times a day.	0
A meal slows absorption of losartan and decreases its Cmax but has only minor effects on losartan AUC or on the AUC of the metabolite (about 10% decreased).	1
"The observed mean elimination half-lives for iloperidone, P88 and P95 in CYP2D6 extensive metabolizers (EM)are 18, 26, and 23 hours, respectively, and in poor metabolizers (PM) are 33, 37, and 31 hours, respectively."	0
"The mean elimination half-life of clozapine after a single 75 mg dose was 8 hours (range: 4 to12 hours), compared to a mean elimination half-life of 12 hours (range: 4 to 66 hours), after achieving steady state with 100 mg twice daily dosing."	0
Infants exposed to Meperidine Hydrochloride Injection through breast milk should be monitored for excess sedation and respiratory depression.	0
"There may be an increased risk for transaminase elevations in patients with underlying hepatitis B or C. Therefore, caution should be exercised when administering NORVIR to patients with pre-existing liver diseases, liver enzyme abnormalities, or hepatitis."	0
"This selective binding of zolpidem on the BZ1 receptor is not absolute, but it may explain the relative absence of myorelaxant and anticonvulsant effects in animal studies as well as the preservation of deep sleep (stages 3 and 4) in human studies of zolpidem tartrate at hypnotic doses."	0
Pretreatment with pindolol did not affect the serum concentration of lidocaine.	0
For these combinations the dose of CRESTOR should not exceed 10mg once daily.	0
"In a clinical pharmacology study , indomethacin or sulindac was administered to hypertensive patients receiving VASOTEC ."	0
There was no evidence of impairment of fertility in rats given intranasal doses of Migranal<U+00AE> Nasal Spray up to 1.6 mg/day (associated with mean plasma dihydroergotamine mesylate exposures [AUC] approximately 9 to 11 times those in humans receiving the MRDD of 4 mg).	0
"Rifabutin was not carcinogenic in the rat at doses up to 60 mg/kg/day, about 12 times the recommended human dose."	0
"GS-331007 is not a substrate for renal transporters, including organic anion transporter OAT1 or OAT3, or organic cation transporter OCT2."	0
"Peak (6hour) effects were uniformly, but moderately, larger than trough effects, with the trough-to-peak ratio for systolic and diastolic responses 50-95% and 60-90%, respectively."	0
Renal clearance of dabigatran is 80% of total clearance after intravenous administration.	0
The antihypertensive effects of these agents are additive; HCTZ 6.25 mg significantly increases the antihypertensive effect of bisoprolol fumarate.	0
"Drug interactions might be expected because of these factors; however, a clinically relevant interaction has been demonstrated only with cyclosporine."	0
HMG-CoA Reductase Inhibitors : Limit the dose of simvastatin in patients on amiodarone to 20 mg daily .	0
This dose may be administered at the rate of approximately 25 to 50 mg/min.	0
"Cyclosporine (CYP3A substrate) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine, despite reduction in dose of cyclosporine."	0
"The incidence of fatal hemorrhagic stroke was similar across treatment groups (17 vs. 18 for the atorvastatin and placebo groups, respectively)."	0
Dosages above 300 mg/day are not recommended.	0
Frequent monitoring of serum lithium concentration is recommended.	0
Use of PDE5 inhibitors for pulmonary arterial hypertension (PAH): Sildenafil (Revatio<U+00AE>) is contraindicated.	0
Undue toxicity may occur if Matulane is used in patients with impairment of renal and/or hepatic function.	0
Such patients may be unresponsive to the usual doses of epinephrine used to treat the allergic reaction.	0
Body surface area (BSA) can be calculated as follows1: Pediatric Dosage Guidelines for Oral Powder NORVIR oral powder should be used only for dosing increments of 100 mg. NORVIR powder should not be used for doses less than 100 mg or for incremental doses between 100 mg intervals.	0
All of the powder mixed with soft food or liquid should be administered within 2 hours of preparation.	0
The dose of TRISENOX can be increased to 0.15 mg/kg in the absence of QTc prolongation during that 14-day dose-escalation period.	0
Long term studies with triamterene and hydrochlorothiazide have not been conducted.	0
"In patients receiving HCTZ in combination with triamterene, dofetilide AUC increased by 30% and Cmax by 16%."	1
"However, the syndrome can develop, although much less commonly, after relatively brief treatment periods at low doses."	0
Do not use PRISTIQ within 14 days of stopping an MAOI intended to treat psychiatric disorders.	0
"Although disturbances such as galactorrhea, amenorrhea, gynecomastia, and impotence have been reported with antipsychotic drugs, the clinical significance of elevated serum prolactin levels is unknown for most patients."	0
Withhold ONIVYDE if the absolute neutrophil count (ANC) is below 1500/mm 3 or if neutropenic fever occurs.	0
"Patients with known hypersensitivity to any component of the formulation or to substituted benzimidazoles (4) Patients receiving rilpivirine-containing products (4,7)"	0
Serotonin release by platelets plays an important role in hemostasis.	0
"In a crossover study in 24 normotensive subjects, the pharmacokinetics and safety of doxazosin were shown to be similar with morning and evening dosing regimens."	0
"Sotalol should not be used in patients with hypokalemia or hypomagnesemia prior to correction of imbalance, as these conditions increase the potential for Torsade de Pointes."	0
"Bisoprolol fumarate, alone or in combination with HCTZ, has been associated with increases in uric acid."	0
"Pediatric Pharmacokinetics (children and adolescents) <U+2014> Fluoxetine pharmacokinetics were evaluated in 21pediatric patients (10children ages6 to <13, 11adolescents ages13 to <18) diagnosed with Major Depressive Disorder or Obsessive Compulsive Disorder(OCD)."	0
"In the unusual case that there is no appropriate alternative to therapy with drugs affecting the renin-angiotensin system for a particular patient, apprise the mother of the potential risk to the fetus."	0
Dosage adjustment of carbamazepine may be necessary depending on concentration measurements/effect.	0
"Moreover, the use of digoxin may result in potentially detrimental increases in coronary vascular resistance mediated through alpha adrenergic receptor stimulation."	0
"As a consequence of the very rapid absorption of loxapine after oral inhalation, there is substantial variability in the early plasma concentrations of loxapine."	0
Sharp wave activity and spike and wave complexes may also develop.	0
It is unknown whether the concomitant administration of proton pump inhibitors affects duloxetine absorption.	0
In some patients additional factor VIII was given.	0
"Inhibition of ACE results in decreased plasma angiotensin II, which leads to decreased vasopressor activity and to decreased aldosterone secretion."	0
"When used as an obstetrical analgesic, meperidine crosses the placental barrier and can produce depression of respiration and psychophysiologic functions in the newborn."	0
Similar results were obtained in patients receiving amlodipine and concomitant beta-blockers.	0
Closely monitor INR when starting or stopping any antibiotic or antifungal in patients taking warfarin.	0
Amlodipine: Patients with hepatic insufficiency have decreased clearance of amlodipine with a resulting increase in AUC of approximately 40% to 60%.	0
"Such drugs include phenothiazines, cisapride, bepridil, tricyclic antidepressants, certain oral macrolides, and certain fluoroquinolones."	0
"Caution patients about the risk of bleeding associated with the concomitant use of Savella and NSAIDs, aspirin, or other drugs that affect coagulation (5.9)."	0
Do not coadminister aliskiren with VASOTEC in patients with diabetes .	0
"Lithium renal clearance is reduced by chlorthalidone, increasing the risk of lithium toxicity."	1
"However, the antiplatelet activity as measured by arachidonic acid induced platelet aggregation was similar between the treatment arms at steady-state."	0
"It is rapidly hydrolyzed in the intestine to a thiolactone, which is then converted to the active metabolite by a single step, primarily by CYP3A4 and CYP2B6 and to a lesser extent by CYP2C9 and CYP2C19."	0
"During repeated oral once daily dosing with perindopril, perindoprilat accumulates about 1.5 to 2 fold and attains steady state plasma levels in 3 to 6 days."	0
"This enzyme, the <U+201C>sodium pump,<U+201D> is responsible for maintaining the intracellular milieu throughout the body by moving sodium ions out of and potassium ions into cells."	0
Serum potassium levels do not necessarily indicate true body potassium concentration.	0
(B) SPINAL/EPIDURAL HEMATOMA: Epidural or spinal hematomas may occur in patients treated with ELIQUIS who are receiving neuraxial anesthesia or undergoing spinal puncture.	0
Cobicistat is also not recommended in combination with regimens containing ritonavir due to similar effects of cobicistat and ritonavir on CYP3A.	0
The two primary metabolites accounted for 79.9% of urinary excretion.	0
Thirty-six to sixty-five percent (36-65%) of the oral dosage is excreted unchanged in the urine.	0
"As with all drugs effective in the treatment of MDD, paroxetine should be used cautiously in patients with a history of mania."	0
"Therefore , the expected clinical effects of SAMSCA in the presence of rifampin and other inducers ( e.g. , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine and St.   John 's   Wort ) may not be observed at the usual dose levels of SAMSCA ."	0
Cases with serum sodium lower than 110 mmol/L have been reported.	0
"Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders."	0
These cases have had a very aggressive disease course and have been fatal.	0
These patients should be presumed to be at increased risk for liver injury if nefazodone is reintroduced.	0
"In general, no detrimental effects on the cardiac conduction system have been seen with nicardipine."	0
Periodic determination of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals.	0
"Given the likelihood that some patients exposed chronically to antipsychotics will develop tardive dyskinesia, it is advised that all patients in whom chronic use is contemplated be given, if possible, full information about this risk."	0
"Fluconazole, an inhibitor of P450 2C9, decreased active metabolite concentration and increased losartan concentration."	1
"In patients who are managed with PCI and stent placement, premature discontinuation of any antiplatelet medication, including thienopyridines, conveys an increased risk of stent thrombosis, myocardial infarction, and death."	0
The use of Meperidine Hydrochloride Injection in patients with acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment is contraindicated.	0
"The antihypertensive effect of angiotensin II receptor antagonists , including azilsartan , may be attenuated by NSAIDs , including selective COX-2 inhibitors ."	0
"There were differences in absolute risk of suicidality across the different indications, with the highest incidence in MDD."	0
"Terfenadine, astemizole, cisapride, and pimozide are all metabolized by the cytochrome P450 3A4 (CYP3A4) isozyme, and it has been demonstrated that ketoconazole, erythromycin, and other inhibitors of CYP3A4 can block the metabolism of these drugs, which can result in increased plasma concentrations of parent drug."	0
"If signs or symptoms of nephrolithiasis and/or cholelithiasis occur, temporary interruption or discontinuation of therapy may be considered."	0
"Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation."	0
"Quetiapine potentiated the cognitive and motor effects of alcohol in a clinical trial in subjects with selected psychotic disorders, and alcoholic beverages should be limited while taking quetiapine."	0
"If anticholinergic effects are seen, the dose of procyclidine should be reduced."	0
"The active metabolite P88 accounts for 19.5% and 34.0% of total plasma exposure in EM and PM, respectively."	0
"Patients whose renal function may depend in part on the activity of the RAAS ( e.g. , patients with renal artery stenosis , severe heart failure , post-myocardial infarction or volume depletion ) or patients receiving ARB , ACEI or nonsteroidal anti-inflammatory drug ( NSAID ) , including selective Cyclooxygenase-2 inhibitors ( COX-2 inhibitors ) , therapy may be at particular risk for developing acute renal failure on Tekturna see Warnings and Precautions ( 5.2 Drug Interactions ( 7 ) , and Use in Specific Populations ( 8.7 ) and Clinical Studies ( 14.3 ) ."	0
"For the treatment of post-myocardial infarction patients who have shown signs of congestive heart failure, the recommended starting dose of ALTACE is 2.5 mg twice daily (5 mg per day)."	0
"Mirtazapine is a moderate antagonist at muscarinic receptors, a property that may explain the relatively low incidence of anticholinergic side effects associated with its use."	0
"A lower starting dose may be used (3.125mg twice daily) and/or the rate of up-titration may be slowed if clinically indicated (e.g., due to low blood pressure or heart rate, or fluid retention)."	0
The median time to peak concentration (Tmax) of levomilnacipran is 6-8 hours after oral administration.	0
Concomitant use of desvenlafaxine with a drug metabolized by CYP3A4 can result in lower exposures to that drug.	1
"As with ""sleep-driving"", patients usually do not remember these events."	0
"Alcohol Warning Because AGGRENOX contains aspirin, counsel patients who consume three or more alcoholic drinks every day about the bleeding risks involved with chronic, heavy alcohol use while taking aspirin."	0
All reports with methylene blue that provided information on the route of administration involved intravenous administration in the dose range of 1 mg/kg to 8 mg/kg.	0
<U+2022> Coumarin anticoagulants: Combination prolongs INR.	0
Potent inhibitors of CYP2D6 may increase duloxetine concentrations (7.2).	1
VFEND has not been studied in patients with severe cirrhosis (Child-Pugh Class C).	0
"In healthy male patients (n=12), when cimetidine, a weak inhibitor of CYP1A2, CYP2D6, and CYP3A4, given at 800 mg b.i.d. at steady state was coadministered with mirtazapine (30 mg daily) at steady state, the Area Under the Curve (AUC) of mirtazapine increased more than 50%."	1
"In general, avoid combined use of RAS inhibitors."	0
A minimum of two to three days between dose adjustments is recommended.	0
Serotonergic Drugs	0
Patients with Renal Impairment The pharmacokinetics of abiraterone were examined in patients with end-stage renal disease (ESRD) on a stable hemodialysis schedule (N=8) and in matched control subjects with normal renal function (N=8).	0
"With continued use of hydrochlorothiazide and depletion of sodium, compensatory mechanisms tend to increase this exchange and may produce excessive loss of potassium, hydrogen, and chloride ions."	0
"However, acute myelogenous leukemia as well as solid tumors have been reported in patients with rheumatoid arthritis who have received IMURAN."	0
"Cimetidine: In healthy volunteers, the administration of a single 1 mg dose of doxazosin on day 1 of a four-day regimen of oral cimetidine (400 mg twice daily) resulted in a 10% increase in mean AUC of doxazosin, and a slight but not significant increase in mean Cmax and mean half-life of doxazosin."	1
"Nonetheless, when patients become pregnant, physicians should have the patient discontinue the use of losartan potassium tablets as soon as possible."	0
"Therefore, in patients taking the HIV protease inhibitor tipranavir plus ritonavir, or the hepatitis C protease inhibitor telaprevir, concomitant use of LIPITOR should be avoided."	0
"Hyperuricemia may occur, or acute gout may be precipitated in certain patients receiving thiazide therapy."	0
"Thus, it is not likely that nefazodone will decrease the metabolic clearance of drugs metabolized by this isozyme."	0
"The dose of risperidone should be adjusted when used in combination with CYP2D6 enzyme inhibitors (e.g., fluoxetine, and paroxetine) and enzyme inducers (e.g., carbamazepine)."	0
Significant <U+03B2>-adrenoreceptor blocking effect is usually seen within 1hour of drug administration.	0
"Diphenhydramine: Diphenhydramine is reported to be a weak inhibitor of aldehyde oxidase in rat liver, but its inhibitory effects in human liver are not known."	0
"If patients develop acute pulmonary edema during initiation of therapy with vasodilating agents such as Letairis, the possibility of PVOD should be considered, and if confirmed Letairis should be discontinued."	0
CALAN does not alter total serum calcium levels.	0
WARNING: HEPATOTOXICITY and INTRACRANIAL HEMORRHAGE See full prescribing information for complete boxed warning.	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction with antidepressants compared to placebo in adults aged 65 and older.	0
"With continued use of hydrochlorothiazide and depletion of sodium, compensatory mechanisms tend to increase this exchange and may produce excessive loss of potassium, hydrogen and chloride ions."	0
Patients should be advised of the potential risks of the use of IMURAN during pregnancy and during the nursing period.	0
"Meperidine Hydrochloride Injection - treated patients with significant chronic obstructive pulmonary disease or cor pulmonale, and those with a substantially decreased respiratory reserve, hypoxia, hypercapnia, or pre-existing respiratory depression are at increased risk of decreased respiratory drive including apnea, even at recommended dosages of Meperidine Hydrochloride Injection."	0
Avoid use of aliskiren with AVALIDE in patients with renal impairment (GFR <60 mL/min).	0
"The first trial demonstrated that the half-life of hydroxybupropion was significantly longer in 8 subjects with alcoholic liver disease than in 8 healthy volunteers (32<U+00B1>14 hours versus 21<U+00B1>5 hours, respectively)."	0
"During the first few minutes of the infusion, the patient should be monitored especially closely for possible hypersensitive or idiosyncratic reactions."	0
"Initiation of medications that inhibit or induce CYP3A may increase or decrease concentrations of NORVIR, respectively."	1
"Quinapril inhibits the elevation in blood pressure caused by intravenously administered angiotensin I, but has no effect on the pressor response to angiotensin II, norepinephrine, or epinephrine."	0
Differences in clearance between patients on these medications (at any occasion in the study) and those off medications varied between -16% and +3%.	0
Verapamil may increase blood alcohol concentrations and prolong its effects.	0
Limit pravastatin to 20 mg once daily for concomitant use with cyclosporine.	1
"Amnesia, anxiety and other neuro-psychiatric symptoms may occur unpredictably."	0
Some cases presented with features resembling neuroleptic malignant syndrome.	0
"Computer-based simulations showed that at a daily dose of 480 mg of diltiazem, an 8- to 9-fold mean increase in simvastatin AUC can be expected."	1
"As much as 80% of the circulating alprostadil may be metabolized in one pass through the lungs, primarily by <U+03B2>- and <U+03C9>- oxidation."	0
A lower dose of trazodone should be considered.	1
Letairis was consistently shown to have teratogenic effects when administered to animals.	0
Elderly patients may be at greater risk of developing hyponatremia with SSRIs and SNRIs.	0
Other opioids may be tried as some cases reported use of a different opioid without recurrence of adrenal insufficiency.	0
Remove child-resistant cap and push bottle adaptor into the neck of the bottle.	0
"The multiple dose elimination half-life of fluvoxamine was 17.4 and 25.9 hours in the elderly compared to 13.6 and 15.6 hours in the young subjects at steady state for 50 and 100 mg doses, respectively."	0
Downward dose adjustment of flurazepam and/or concomitant CNS depressants may be necessary because of additive effects.	0
Herbal product St. John's wort (Hypericum perforatum) Patients taking PREZISTA/ritonavir should not use products containing St. John's wort because co-administration may result in reduced plasma concentrations of darunavir.	1
"During the treatment period (days 0-7), the vascular mortality rates were 3.89% in the TENORMIN group (313deaths) and 4.57% in the control group (365 deaths)."	0
Twelve metabolites have been identified in plasma; all except norverapamil are present in trace amounts only.	0
"Therefore, the slight decrease of sildenafil exposure in the presence of epoprostenol is not considered clinically relevant."	1
"Based on in vitro data, no dose adjustment is required for PRISTIQ when used concomitantly with inhibitors of CYP3A4 and CYP1A1, 1A2, 2A6, 2D6, 2C8, 2C9, 2C19, 2E1, and the P-glycoprotein transporter."	0
"There have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a selective serotonin reuptake inhibitor (SSRI) and sumatriptan."	0
Patients receiving warfarin therapy should be carefully monitored when PRISTIQ is initiated or discontinued.	0
Both the risk of developing the syndrome and the likelihood that it will become irreversible are believed to increase as the duration of treatment and the total cumulative dose of antipsychotic drugs administered to the patient increase.	0
PURIXAN can cause fetal harm when administered to a pregnant woman.	0
Absorption and Distribution: LATUDA is absorbed and reaches peak serum concentrations in approximately 1-3 hours.	0
Patients in Study 2 met DSM-IV criteria for PMDD.	0
"Renal Function CrCl (mL/min) Increase in AUC Increase in Cmax t1/2 (h) Normal <U+2265> 80 1x 1x 13 Mild 50-80 1.5x 1.1x 15 Moderate 30-50 3.2x 1.7x 18 Severe+ 15-30 6.3x 2.1x 27 Hepatic Impairment Administration of PRADAXA in patients with moderate hepatic impairment (Child-Pugh B) showed a large inter-subject variability, but no evidence of a consistent change in exposure or pharmacodynamics."	0
The effect that symptomatic suppression has upon the long-term course of the syndrome is unknown.	0
"Like all antiarrhythmic agents , NEXTERONE may cause a worsening of existing arrhythmias or precipitate a new arrhythmia , sometimes leading to fatal outcomes see Adverse Reactions ( 6.2 ) ."	0
Clinical studies have demonstrated no clinically significant pharmacokinetic interaction between PRISTIQ and CYP3A4 substrates (Figure 2).	0
"At least 2weeks should be allowed after stopping sertraline (Zoloft<U+00AE>, Pfizer) or paroxetine (Paxil<U+00AE>, SmithKline Beecham Pharmaceuticals) before starting Marplan."	0
"If excessive hypotension occurs, the patient should be placed in a supine position and, if necessary, treated with intravenous infusion of normal saline."	0
"Prasugrel produces inhibition of platelet aggregation to 20<U+03BC>M or 5<U+03BC>M ADP, as measured by light transmission aggregometry."	0
Studies have shown that oral nicardipine usually does not alter digoxin plasma concentrations.	0
The suspension should be refrigerated at 2-8<U+00B0>C (36-46<U+00B0>F) and can be stored for up to 4weeks.	0
"Following acute treatment by bolus in patients in whom arrhythmias tend to recur and who are incapable of receiving oral antiarrhythmic agents, intravenous infusion of Lidocaine Hydrochloride and 5% Dextrose Injection, USP is administered continuously at the rate of 1 to 4 mg/min (0.020 to 0.050 mg/kg/min in the average 70 kg adult)."	0
"Corticosteroids, ACTH<U+2013>intensified electrolyte depletion, particularly hypokalemia."	0
"Nifedipine has been shown to produce teratogenic findings in rats and rabbits, including digital anomalies similar to those reported for phenytoin."	0
Fifty (50) mg per square meter of body surface per day is recommended for the first week.	0
"Losartan, administered for 12 days, did not affect the pharmacokinetics or pharmacodynamics of a single dose of warfarin."	0
Acidifying Agents Clinical Impact Urinary acidifying agents can lower blood levels and efficacy of amphetamines.	1
Alprostadil (prostaglandin E1) is one of a family of naturally occurring acidic lipids with various pharmacologic effects.	0
"In patients taking potent inhibitors of CYP3A such as ketoconazole and itraconazole , avoid use of ADCIRCA see Drug Interactions ( 7.2 ) and Clinical Pharmacology ( 12.3 ) ."	0
"Those factors are: Lean body weight Renal function Patient age Concurrent disease Concomitant medication Because the pharmacokinetics of digoxin are complex, and because toxic levels of digoxin are only slightly higher than therapeutic levels, digoxin dosing can be difficult."	0
"In a study on five patients given from 12 to 24 mg of prazosin per day for 10 to 14 days, there was an average increase of 42% in the urinary metabolite of norepinephrine and an average increase in urinary VMA of 17%."	0
"Significant caution is indicated if nefazodone is to be used in combination with XANAX<U+00AE>1 (alprazolam), concomitant use with HALCION<U+00AE>1 (triazolam) should be avoided for most patients including the elderly, and concomitant use with SELDANE<U+00AE>2 (terfenadine), HISMANAL<U+00AE>3 (astemizole), PROPULSID<U+00AE>3 (cisapride), ORAP<U+00AE>4 (pimozide), or TEGRETOL<U+00AE>5 (carbamazepine) is contraindicated."	0
It may be necessary to decrease the dose of verapamil and/or the dose of the neuromuscular blocking agent when the drugs are used concomitantly.	0
"In normal volunteers, single intravenous doses of 0.15 mg/kg of ondansetron had no effect on esophageal motility, gastric motility, lower esophageal sphincter pressure, or small intestinal transit time."	0
"Dofetilide had no genotoxic effects, with or without metabolic activation, based on the bacterial mutation assay and tests of cytogenetic aberrations in vivo in mouse bone marrow and in vitro in human lymphocytes."	0
"The principal urinary excretion product is an unidentified metabolite, presumed to be a metabolic product of 4-hydroxy-estazolam, accounting for at least 27% of the administered dose."	0
The mechanism and long-term consequences of these events are currently unknown.	0
"In some patients, additional factor VIII was required."	1
Aprepitant is also an inducer of CYP2C9.	0
"SSRIs and SNRIs, including CYMBALTA, may increase the risk of bleeding events."	0
Patients with heart rates <50 beats per minute have not been studied.	0
"If the dose of lovastatin is changed, the same procedure should be repeated."	0
Monoamine Oxidase Inhibitors <U+2013> See WARNINGS.	0
Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide.	0
"After 7 days, the recommended dose is 5mg taken orally twice daily."	0
There was no evidence of mutagenic or clastogenic potential in these in vitro and in vivo assays.	0
Hepatitis C Direct- Acting Antivirals Elbasvir/grazoprevir May increase the risk of ALT elevations due to a significant increase in grazoprevir plasma concentrations.	1
No teratogenic effects of ACCUPRIL were seen in studies of pregnant rats and rabbits.	0
The incidence of such structural alterations has not been defined.	0
"However, such patients may be subject to protracted severe hypotension."	0
"The applicability of the CAST results to other populations (e.g., those without recent myocardial infarction) is uncertain."	0
Bupropion is primarily metabolized to hydroxybupropion by CYP2B6.	0
"Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients whose depression is persistently worse, or who are experiencing emergent suicidality or symptoms that might be precursors to worsening depression or suicidality, especially if these symptoms are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
"Stimulant products generally should not be used in patients with known structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, coronary artery disease, or other serious heart problems."	0
"In healthy subjects, orally administered verapamil undergoes extensive metabolism in the liver."	0
"Administration of 40 mg/day racemic citalopram for 21 days did not affect the pharmacokinetics of warfarin, a CYP3A4 substrate."	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP, the information and instructions provided in the patient information sheet should be discussed with patients."	0
The safety of resumption of CAPRELSA therapy after resolution of an ischemic cerebrovascular event has not been studied.	0
The systemic exposure to apixaban administered 2 hours prior to a 4-hour hemodialysis session with a dialysate flow rate of 500 mL/min and a blood flow rate in the range of 350 to 500 mL/min is 17% higher compared to those with normal renal function.	0
"Following a single 400 mg oral dose of [14C]-sofosbuvir, mean total recovery of the dose was greater than 92%, consisting of approximately 80%, 14%, and 2.5% recovered in urine, feces, and expired air, respectively."	0
"As ramipril is primarily metabolized by hepatic esterases to its active moiety, ramiprilat, patients with impaired liver function could develop markedly elevated plasma levels of ramipril."	0
Procarbazine hydrochloride has been shown to be mutagenic in a variety of bacterial and mammalian test systems.	0
Patients receiving both drugs should be observed closely to determine if the desired diuretic and/or antihypertensive effect of LASIX is achieved .	0
"While taking beta-blockers, patients with a history of anaphylactic reaction to a variety of allergens may have a more severe reaction on repeated challenge, either accidental, diagnostic, or therapeutic."	0
"In a detailed case report, 13 documented lymphopenia, diminished IgG and IgM levels, CMV infection, and a decreased thymic shadow were noted in an infant born to a mother receiving 150mg azathioprine and 30mg prednisone daily throughout pregnancy."	0
Anaphylactoid reactions have also been reported in patients undergoing low-density lipoprotein apheresis with dextran sulfate absorption.	0
"LEXIVA is contraindicated: <U+2022>in patients with previously demonstrated clinically significant hypersensitivity (e.g., Stevens-Johnson syndrome) to any of the components of this product or to amprenavir."	0
Rifabutin was not mutagenic in the bacterial mutation assay (Ames Test) using both rifabutin-susceptible and resistant strains.	0
"The pooled analyses of placebo-controlled trials in adults with MDD or other psychiatric disorders included a total of 295 short-term trials (median duration of 2 months) of 11 antidepressant drugs in over 77,000 patients."	0
"<U+2022>Combined inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7)."	0
"Monitor patients for signs of severe fluid retention (e.g., unexpected rapid weight gain or swelling) and for symptoms of respiratory or cardiac compromise (e.g., shortness of breath) during Tasigna treatment; evaluate etiology and treat patients accordingly."	0
"Ordinarily, patients with active liver disease should not be treated with nefazodone."	0
"The concomitant use of proton pump inhibitors, H2 antagonists, and digoxin did not appreciably change the trough concentration of dabigatran."	0
The intravenous infusion rate required to produce an average plasma concentration equivalent to a given oral dose at steady state is shown in the following table: Oral Nicardipine Dose Equivalent Intravenous Infusion Rate 20 mg q8h 0.5 mg/hr 30 mg q8h 1.2 mg/hr 40 mg q8h 2.2 mg/hr The time course of blood pressure decrease is dependent on the initial rate of infusion and the frequency of dosage adjustment.	0
"Concomitant administration of Remodulin with diuretics , antihypertensive agents or other vasodilators may increase the risk of symptomatic hypotension ."	0
Dose reduction or interruption for hypertension may be necessary.	0
"COREG significantly reduced systemic blood pressure, pulmonary artery pressure, right atrial pressure, systemic vascular resistance, and heart rate, while stroke volume index was increased."	0
"Other clinical endpoints of the LIFE study were: total mortality, hospitalization for heart failure or angina pectoris, coronary or peripheral revascularization procedures, and resuscitated cardiac arrest."	0
"Do not administer unless solution is clear, the seal is intact, and the container is undamaged."	0
"Wolff-Parkinson-White, Lown-Ganong-Levine syndromes)."	0
"If anticoagulation with ELIQUIS is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant."	0
"Amlodipine has been compared to placebo in four 8 to 12 week studies of patients with NYHA class II/III heart failure, involving a total of 697 patients."	0
Verapamil is a calcium channel blocker that exerts its pharmacologic effects by modulating the influx of ionic calcium across the cell membrane of the arterial smooth muscle as well as in conductile and contractile myocardial cells.	0
"The recommended dose of AGGRENOX is one capsule given orally twice daily, one in the morning and one in the evening."	0
"1649 <U+2013>29 <U+2013>40 +9.5 <U+2013>44 <U+2013>34 <U+2013>19 The Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS), a double-blind, randomized, placebo-controlled, primary prevention study, demonstrated that treatment with MEVACOR decreased the rate of acute major coronary events (composite endpoint of myocardial infarction, unstable angina, and sudden cardiac death) compared with placebo during a median of 5.1years of follow-up."	0
Females of reproductive potential must use acceptable methods of contraception during treatment with Letairis and for one month after treatment.	0
"In patients with bipolar disorder, treating a depressive episode with ZOLOFT or another antidepressant may precipitate a mixed/manic episode."	0
Population pharmacokinetic analyses were conducted on plasma concentration data from 1445 patients in clinical trials to examine the effects of concomitant medications on clearance or volume of distribution of dofetilide.	0
PROTON PUMP INHIBITORS Omeprazole <U+2193> nelfinavir Omeprazole decreases the plasma concentrations of nelfinavir.	1
"These doses are, respectively, about 5 and 16 times the MRHD when compared on a mg/m2 basis."	0
"The recommended dose for PRISTIQ is 50 mg once daily, with or without food."	0
This unloading of the heart reduces myocardial energy consumption and oxygen requirements and probably accounts for the effectiveness of PROCARDIA in chronic stable angina.	0
"Treatment with Class I or III antiarrhythmics (e.g., amiodarone, flecainide, propafenone, quinidine, disopyramide, dofetilide, sotalol) or drugs that are strong inhibitors of CYP3A (e.g., ketoconazole) must be stopped before starting MULTAQ."	0
This is due to lack of specificity of the screening tests.	0
"The possibility of a pathological fracture, that is, a fracture produced by minimal trauma in a patient with decreased bone mineral density, should be considered in patients treated with paroxetine who present with unexplained bone pain, point tenderness, swelling, or bruising."	0
Pediatric dosage of Regitine<U+00AE> should be 0.1<U+2500>0.2mg/kg up to a maximum of 10mg per dose.	0
"However, the metabolic clearance of mexiletine in the extensive metabolizer phenotype decreased by about 70% making the poor and extensive metabolizer groups indistinguishable."	0
"Maintenance of Effect: In studies up to 72 hours of continuous infusion, there was no evidence of tolerance or hysteresis."	0
Nicardipine hydrochloride injection is administered by slow continuous infusion at a concentration of 0.1 mg/mL.	0
"Beta-blockers: Controlled and uncontrolled domestic studies suggest that concomitant use of CARDIZEM and beta-blockers is usually well tolerated, but available data are not sufficient to predict the effects of concomitant treatment in patients with left ventricular dysfunction or cardiac conduction abnormalities."	0
WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning.	0
Avoid concomitant use of aliskiren with ALTACE in patients with renal impairment (GFR <60 mL/min/1.73 m2).	0
Eplerenone metabolism is predominantly mediated via CYP3A.	0
"Five subjects experienced nausea, vomiting, sweating, and diarrhea following coadministration, consistent with the cholinergic effects of tacrine."	0
The patient should also be cautioned to avoid situations where injury could result should syncope occur during the initiation of MINIPRESS therapy.	0
"In a patient who requires more urgent treatment of a psychiatric condition, other interventions, including hospitalization, should be considered."	0
"When creatinine clearance drops below 30 mL/min, AUC increases more markedly."	0
Figure 1 Figure 2 Figure 3 Figure 4 Figure 5 Incompatibilities Do not mix with any other medication or additional flavoring agent.	0
There are no clinically relevant pharmacokinetic interactions of quetiapine on other drugs based on the CYP pathway.	0
Flare prophylaxis with a non-steroidal anti-inflammatory drug (NSAID) or colchicine is recommended upon initiation of ULORIC.	0
"Quinapril is deesterified to the principal metabolite, quinaprilat, which is an inhibitor of ACE activity in human subjects and animals."	0
"If concomitant use of LUVOX CR Capsules with other serotonergic drugs is clinically warranted, patients should be made aware of a potential increased risk for serotonim syndrome, particularly during treatment initiation and dose increases (5.2)."	0
Therapeutic levels of the penicillins are easily achieved under normal circumstances in extracellular fluid and most other body tissues.	0
"Symptoms of hypoglycemia may be masked (7.4) Dose of beta-2 receptor agonists may have to be increased (7.5) Sotalol may potentiate the rebound hypertension after discontinuation of clonidine (7.6) Proarrhythmic events were more common in sotalol treated patients also receiving digoxin; it is not clear whether this represents an interaction or is related to the presence of heart failure, a known risk factor for proarrhythmia, in the patients receiving digoxin."	0
ALDACTONE should not be administered concurrently with other potassium-sparing diuretics .	0
No absorption studies have been performed in patients with renal disease.	0
Paroxetine (CYP2D6 substrate and inhibitor): Reduce paroxetine by half when used in combination with SAPHRIS.	1
"(See WARNINGS and PRECAUTIONS, Information for Patients .)"	0
"No effect on absorption or mean oral clearance Thioridazine 200 mg twice daily 300 mg twice daily 65% increase in oral clearance Cimetidine 400 mg three times daily for 4 days 150 mg three times daily 20% decrease in mean oral clearance Ketoconazole (potent CYP 3A4 inhibitor) 200 mg once daily for 4 days 25 mg single dose 84% decrease in oral clearance resulting in a 6.2 fold increase in AUC of quetiapine Fluoxetine 60 mg once daily 300 mg twice daily No change in steady state PK Imipramine 75 mg twice daily 300 mg twice daily No change in steady state PK Haloperidol 7.5 mg twice daily 300 mg twice daily No change in steady state PK Risperidone 3 mg twice daily 300 mg twice daily No change in steady state PK In vitro enzyme inhibition data suggest that quetiapine and 9 of its metabolites would have little inhibitory effect on in vivo metabolism mediated by cytochromes CYP 1A2, 2C9, 2C19, 2D6 and 3A4."	1
"An electrocardiogram should be performed before ORAP treatment is initiated and periodically thereafter, especially during the period of dose adjustment."	0
Administer the full amount prepared for each dose.	0
"In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including ramipril, may result in deterioration of renal function, including possible acute renal failure."	0
"By decreasing the influx of calcium, verapamil prolongs the effective refractory period within the AV node and slows AV conduction in a rate-related manner."	0
It is recommended that careful observations of patients undergoing NARDIL treatment be maintained until control of depression is achieved.	0
"Alcohol, Barbiturates, or Narcotics<U+2014>potentiation of orthostatic hypotension may occur."	0
"<U+2022>Patients receiving LEXIVA may develop new onset or exacerbations of diabetes mellitus, hyperglycemia (5.5), immune reconstitution syndrome (5.6), increase of body fat (5.7), and elevated triglyceride and cholesterol concentrations (5.8)."	0
Potassium-sparing therapy should also be avoided in severely ill patients in whom respiratory or metabolic acidosis may occur.	0
Increase the dose of the withheld drug(s) to the recommended dosage after 7 days in the absence of recurrence of symptoms of differentiation syndrome.	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction with antidepressants compared to placebo in adults aged 65 and older.	0
TWYNSTA may be taken with or without food.	0
"Dosage, therefore, should be individualized."	0
"Doses should be adjusted to individual patient needs, but should not usually exceed 2400 mg per day and should continue as long as clinically indicated."	0
Clonidine: Sinus bradycardia resulting in hospitalization and pacemaker insertion has been reported in association with the use of clonidine concurrently with diltiazem.	0
"Mammalian Target of Rapamycin (mTOR) Inhibitors Patients taking concomitant mTOR inhibitor (e.g., temsirolimus, sirolimus, everolimus) therapy may be at increased risk for angioedema."	0
"MEVACOR significantly decreased plasma total<U+2011>C, LDL<U+2011>C, total<U+2011>C/HDL<U+2011>C ratio and LDL<U+2011>C/HDL<U+2011>C ratio."	0
At least 14 days should elapse between discontinuation of an MAOI intended to treat depression and initiation of treatment with WELLBUTRIN XL.	0
The use of chlorpromazine and other potential hepatotoxins should be avoided in children and adolescents whose signs and symptoms suggest Reye<U+2019>s syndrome.	0
"Adverse reactions after discontinuation of serotonergic antidepressants, particularly after abrupt discontinuation, include: nausea, sweating, dysphoric mood, irritability, agitation, dizziness, sensory disturbances (e.g., paresthesia, such as electric shock sensations), tremor, anxiety, confusion, headache, lethargy, emotional lability, insomnia, hypomania, tinnitus, and seizures."	0
Pediatric patients over 10 years of age require adult dosages in proportion to their body weight.	0
Amitriptyline hydrochloride is an antidepressant with sedative effects.	0
The effects of carvedilol on ejection fraction were related to dose.	0
"Although the demonstration of efficacy of TENORMIN is based entirely on data from the first seven postinfarction days, data from other beta blocker trials suggest that treatment with beta blockers that are effective in the postinfarction setting may be continued for one to three years if there are no contraindications."	0
Do not use dilatrate<U+00AE>-SR in patients who are taking the soluble guanylate cyclase stimulator riociguat.	0
"Lithium Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists, including BENICAR."	1
Administration of venlafaxine hydrochloride extended-release (150 mg once daily) generally resulted in lower Cmax and later Tmax values than for venlafaxine hydrochloride immediate-release administered twice daily (Table 16).	0
"Timing of Loading Dose In the clinical trial that established the efficacy and safety of Effient, the loading dose of Effient was not administered until coronary anatomy was established in UA/NSTEMI patients and in STEMI patients presenting more than 12 hours after symptom onset."	0
"Other ventricular arrhythmias that have been reported with quinidine include frequent extrasystoles, ventricular tachycardia, ventricular flutter, and ventricular fibrillation."	0
"Reduce dosage of these other drugs and monitor for adverse reactions (4, 7) Phenytoin or Efavirenz: with co-administration, increase maintenance oral and intravenous dosage of VFEND (2.3, 7)"	1
Patients receiving sertraline hydrochloride doses of 50 and 200 mg/day experienced mean reductions of approximately 6 points on the YBOCS total score which were significantly greater than the approximately 3 point reduction in placebo-treated patients.	0
Adjustments should be made at intervals of 4 weeks or more.	0
Beneficial effect may not be seen in some patients for 3 to 6weeks.	0
Lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity.	1
7.Concomitant use in patients taking Celexa or Lexapro is contraindicated.	0
It also stimulates aldosterone secretion by the adrenal cortex.	0
Pharmacokinetics described here refer to the sum of dabigatran and its glucuronides.	0
"Viracept Oral Powder Mix VIRACEPT Oral Powder with a small amount of water, milk, formula, soy formula, soy milk, or dietary supplements Once mixed, the entire contents must be consumed in order to obtain the full dose."	0
Anaphylactoid reactions have been reported in patients dialyzed with high-flux membranes and treated concomitantly with an ACE inhibitor.	0
"TWYNSTA is a combination of two drugs with antihypertensive properties: a dihydropyridine calcium antagonist (calcium ion antagonist or slow-channel blocker), amlodipine besylate, and an angiotensin II receptor blocker, telmisartan."	0
"Based on reports involving thiazides, ZIAC (bisoprolol fumarate and hydrochlorothiazide) may decrease serum levels of protein-bound iodine without signs of thyroid disturbance."	0
"This may lead to increased ventricular automaticity and polymorphic ventricular tachycardias, including torsades de pointes."	0
"Short- and long-term treatment with digoxin slows heart rate, increases cardiac output and lowers pulmonary artery pressure, pulmonary capillary wedge pressure, and systemic vascular resistance."	0
"In a pharmacokinetic trial conducted in 10healthy male subjects, cimetidine (1,000mg per day) increased the steady-state AUC of carvedilol by 30% with no change in Cmax."	1
"Consistent with the terminal elimination half-life, there is an approximately two-fold accumulation, compared to a single dose, of sertraline with repeated dosing over a 50 to 200 mg dose range."	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older.	0
"In treatment-naive adult patients: If REYATAZ is combined with efavirenz, REYATAZ 400 mg (two 200-mg capsules) should be administered with ritonavir 100 mg simultaneously once daily with food, and efavirenz 600 mg should be administered once daily on an empty stomach, preferably at bedtime."	0
Monitor platelet counts beginning about 6 hours after treatment initiation and daily thereafter.	0
"This regimen of grapefruit juice resulted in a mean increase in the serum concentration of lovastatin and its <U+03B2><U+2011>hydroxyacid metabolite (as measured by the area under the concentration-time curve) of 15<U+2011>fold and 5<U+2011>fold, respectively [as measured using a chemical assay <U+2014> high performance liquid chromatography]."	1
The interaction would be expected to be greater with irreversible MAO inhibitors.	0
"Antimycobacterial:rifabutin <U+2191> rifabutin and rifabutin metabolite Dosage reduction of rifabutin by at least three-quarters of the usual dose of 300 mg per day is recommended (e.g., 150mg every other day or three times a week)."	1
"When dosing continuously, patients not responding to a 50 mg dosage may benefit from dosage increases at 50 mg increments per menstrual cycle up to 150 mg per day."	0
Drugs that raise the gastrointestinal pH may lead to an earlier release of duloxetine.	1
"Antidepressant:trazodone <U+2191> trazodone Adverse events of nausea, dizziness, hypotension and syncope have been observed following co-administration of trazodone and NORVIR."	0
Thirty-eight percent of each group were treated within 4 hours of onset of pain.	0
Elevations of hepatic enzymes and hepatic failure have been reported in association with dipyridamole administration.	0
"Hemodynamic assessments in patients with hypertension indicate that blood pressure reduction produced by quinapril is accompanied by a reduction in total peripheral resistance and renal vascular resistance with little or no change in heart rate, cardiac index, renal blood flow, glomerular filtration rate, or filtration fraction."	0
It may also be appropriate to modify the rate of subsequent dose titration.	0
"The steady-state percent increases in the RR interval were 3, 9 and 12%."	0
"However, since plasma levels of doxepin following topical application of PRUDOXIN Cream can reach levels obtained with oral doxepin HCl therapy, the following drug interactions are possible following topical PRUDOXIN Cream application: Drugs Metabolized by P450 2D6: The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the Caucasian population (about 7-10% of Caucasians are so-called ""poor metabolizers""); reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are not yet available."	0
"The usual initial dosage is 100 mg daily, given in a single dose."	0
"The average norfluoxetine steady-state concentrations in these children were 1.5-fold higher than in adolescents (195and 113ng/mL, respectively)."	0
"Using the established exposure-response relationship, 24 mg infused intravenously over 15 min had a mean predicted (95% upper prediction interval) <U+0394><U+0394>QTcF of 14.0 (16.3) ms."	0
More than 180 mg per day is not recommended.	0
Verapamil Component Increased sensitivity to the effects of lithium (neurotoxicity) has been reported during concomitant verapamil-lithium therapy with either no change or an increase in serum lithium levels.	0
For Helicobacter pylorieradication take ACIPHEX delayed-release tablets with food.	0
These MICs provide estimates of the susceptibility of bacteria to antimicrobial compounds.	0
"Periodic CBC, differential, and platelet counts are advised during prolonged therapy."	0
"In many cases, this hyponatremia appears to be the result of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)."	0
Increase to 40mg once daily based upon individual tolerability.	0
"Nevertheless, spontaneous reporting of adverse events in larger premarketing clinical trials revealed a difference between Zaleplon and placebo in the risk of next-day amnesia (3% vs 1%), and an apparent dose-dependency for this event."	0
Serious side effects and even death have been reported following the concomitant use of certain drugs with MAO inhibitors.	0
"In this clinical context, if the patient is found to have abnormal liver tests (ALT greater than three times the upper limit of the reference range), ULORIC treatment should be interrupted and investigation done to establish the probable cause."	0
Some substrates of CYP3A4 are contraindicated with EMEND.	0
Treatment of familial Mediterranean fever (FMF): Maximum daily dose of 0.6 mg (may be given as 0.3 mg twice a day).	0
"At clinically relevant doses, BYSTOLIC does not demonstrate <U+03B1>1-adrenergic receptor blockade activity."	0
Prepare the dose using the required number of packets.	0
"CYP2D6 is thought to be the major enzyme in the 4<U+2019>- and 5<U+2019>-hydroxylation of carvedilol, with a potential contribution from 3A4."	0
ATACAND is contraindicated in patients who are hypersensitive to candesartan.	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function and of concomitant disease or other drug therapy."	0
Amiloride HCl is not an aldosterone antagonist and its effects are seen even in the absence of aldosterone.	0
"Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down."	0
Rifampin (strong CYP enzyme inducer): Administration of multiple doses of rifampin resulted in a mean decrease of approximately 80% in total exposure to ramelteon and metabolite M-II.	1
After IV administration the plasma clearance of dronedarone ranges from 130 to 150 L/h.	0
"The most common substitutions detected at failure were Q30R, Y93H or N, and L31M."	0
"Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
Clomipramine (CMI) is presumed to influence obsessive and compulsive behaviors through its effects on serotonergic neuronal transmission.	0
"However, one report suggested that calcium levels above the normal range may alter the therapeutic effect of CALAN."	0
"Insufficient clinical response indicated a worsening of the patient<U+2019>s condition that resulted in study discontinuation, as assessed by the investigator."	0
Monitor INR after initiating dronedarone in patients taking warfarin.	0
"Promptly evaluate any signs or symptoms of blood loss (e.g., a drop in hemoglobin and/or hematocrit or hypotension)."	0
Epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an NSAID or aspirin may potentiate this risk of bleeding.	0
"When a patient with a serious suicidal potential is not hospitalized, the prescription should be for the smallest amount feasible."	0
Do not use after the expiry date stated on the bottle.	0
Cumulative drug effects may be observed in patients with impaired renal function.	0
"In patients with more severe hypertension, TENORETIC may be administered with other antihypertensives such as vasodilators."	0
"HMG-CoA Reductase Inhibitors Lovastatin, Simvastatin Potential for serious reactions such as myopathy including rhabdomyolysis."	0
Figure 2 Avoid use of PRISTIQ with other desvenlafaxine-containing products or venlafaxine products.	0
"TTP is characterized by thrombocytopenia, microangiopathic hemolytic anemia (schistocytes [fragment red blood cells] seen on peripheral smear), neurological findings, renal dysfunction, and fever."	0
STRATTERA is not approved for major depressive disorder.	0
There have been rare reports of prolonged seizures in patients on fluoxetine receiving ECT treatment.	0
"Concomitant administration of PRINIVIL and antidiabetic medicines (insulins, oral hypoglycemic agents) may cause an increased blood-glucose-lowering effect with risk of hypoglycemia."	0
The potential of clevidipine to interact with other drugs is low.	0
"Distribution Cleavage of the ester group (primarily in the liver) converts ramipril to its active diacid metabolite, ramiprilat."	0
ANTICOAGULANT Warfarin Warfarin Coadministration of warfarin and VIRACEPT may affect concentrations of warfarin.	0
"In patients who are elderly , volume-depleted ( including those on diuretic therapy ) , or who have compromised renal function , coadministration of NSAIDs , including selective COX-2 inhibitors , with angiotensin II receptor antagonists , including azilsartan , may result in deterioration of renal function , including possible acute renal failure ."	0
Dermatologic: Exfoliative skin disorders during treatment with DIFLUCAN have been reported.	0
Atorvastatin is <U+2265>98% bound to plasma proteins.	0
No pharmacokinetic interactions were observed with hydrochlorothiazide or warfarin.	0
"Conjugates with glucuronic acid and sulfate predominate, and major metabolites have been isolated and identified."	0
"Antimycobacterials: Clarithromycin <U+2191> Tipranavir, <U+2191> Clarithromycin, <U+2193> 14-hydroxy-clarithromycin metabolite No dose adjustment of APTIVUS or clarithromycin for patients with normal renal function is necessary."	0
"Except for mild shortening of sinus cycle, SA conduction time and AH intervals, single oral doses up to 20 mg of immediate release nisoldipine did not significantly change other conduction parameters."	0
"At low doses, there is vagally-mediated bradycardia, but at higher doses, epoprostenol causes reflex tachycardia in response to direct vasodilation and hypotension."	0
"If dosage is escalated substantially above recommended levels because of tolerance development, convulsions may occur in individuals without a history of convulsive disorders."	0
"Changes in excretion of sodium, potassium, uric acid, and phosphorus in hypertensive patients with normal renal function were similar after COREG and placebo."	0
Consider these increases when selecting an oral contraceptive for a woman taking CADUET.	0
"Verapamil may reduce total body clearance and extrarenal clearance of digitoxin by 27% and 29%, respectively."	1
Warfarin: The steady-state pharmacodynamics (international normalized ratio [INR] and prothrombin time [PT]) and pharmacokinetics of warfarin in healthy volunteers were unaffected by the co-administration of LIVALO 4 mg daily.	0
"Patients receiving coadministration of an ACE inhibitor with an mTOR (mammalian target of rapamycin) inhibitor (e.g., temsirolimus, sirolimus, everolimus) or a neprilysin inhibitor (e.g., sacubitril) may be at increased risk for angioedema."	0
Symptoms related to orthostatic hypotension were reported in another 0.8% of patients.	0
"If acceptable alternatives to linezolid or intravenous methylene blue treatment are not available and the potential benefits of linezolid or intravenous methylene blue treatment are judged to outweigh the risks of serotonin syndrome in a particular patient, PRISTIQ should be stopped promptly, and linezolid or intravenous methylene blue can be administered."	0
"Pimozide and Celexa: In a controlled study, a single dose of pimozide 2 mg coadministered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone."	0
Observe for signs and symptoms of hypotension in volume- or salt-depleted patients with treatment initiation (5.3).	0
Adjust dosage according to blood pressure response.	0
<U+2191> Itraconazole (not studied) <U+2191> Ketoconazole (not studied) Based on theoretical considerations itraconazole and ketoconazole should be used with caution.	0
Homozygous deficient patients may require up to a 90% dosage reduction (10% of the standard PURIXAN dose).	0
"Like other drugs effective in the treatment of major depressive disorder, Lexapro should be introduced with care in patients with a history of seizure disorder."	0
Interconversion between levomilnacipran and its stereoisomer does not occur in humans.	0
"Following administration of apixaban dosed to steady state, endogenous thrombin potential (ETP) returned to pre-apixaban levels 4 hours after the initiation of a 30-minute PCC infusion, compared to 45 hours with placebo."	0
"Starting at the low end of the PURIXAN dosing range, or increasing the dosing interval to 36-48 hours can be considered in patients with baseline renal impairment."	0
Renal impairment: Anti-FXa activity adjusted for exposure to apixaban was similar across renal function categories.	0
"For patients requiring further reduction in blood pressure after 2 weeks of therapy, the dose of Benicar may be increased to 40 mg. Doses above 40 mg do not appear to have greater effect."	0
PRISTIQ should be prescribed with caution in patients with a seizure disorder.	0
The effect of sertraline hydrochloride on valproate levels has not been evaluated in clinical trials.	0
"In the compassionate use program, convulsions were reported in about 2 of 1000 patients."	0
"If laryngeal stridor or angioedema of the face, tongue or glottis occurs, treatment with TARKA should be discontinued immediately, the patient treated in accordance with accepted medical care and carefully observed until the swelling disappears."	0
"Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed."	0
"Very rarely, hypotension may be severe such that it may warrant the use of intravenous fluids and/or vasopressors."	0
"However, at antidepressant doses, selegiline inhibits both isoenzymes."	0
The mechanism of bisoprolol fumarate<U+2019>s antihypertensive effect has not been completely established.	0
"Hypotension: Not recommended for patients for whom vasodilating agents are not appropriate, or other conditions in which cardiac output is dependent upon venous return, or for patients suspected to have low cardiac filling pressures."	0
Monitor these patients and adjust the dose of the concomitant drug(s) metabolized by CYP2C8 as required.	0
"To make sure that the entire dose is taken, rinse the container once or twice with apple juice to remove any remaining granules."	0
"Approximately 10% and 2% of a radiolabeled dose applied dermally, as a DMSO solution, was recovered in urine and feces respectively, with at least 63% of the dose remaining unabsorbed."	0
Intervention: An alternative confirmatory method should be considered to verify positive results.	0
"As a V2-receptor antagonist , tolvaptan may interfere with the V2-agonist activity of desmopressin ( dDAVP ) ."	0
"The patient should be monitored for symptoms of serotonin syndrome for 2 weeks or until 24 hours after the last dose of linezolid or intravenous methylene blue, whichever comes first."	0
The initial dose of TENORMIN is 50 mg given as one tablet a day.	0
"In the second study, the immunogenicity of Northern hemisphere seasonal influenza and tetanus toxoid vaccination was assessed in a 12-week steady-state, randomized, placebo-controlled study of GILENYA 0.5 mg in multiple sclerosis patients (n=136)."	0
"Sumatriptan: Rare postmarketing reports of weakness, hyperreflexia, and incoordination following use of an SSRI and sumatriptan."	0
"Patients whose renal function may depend in part on the activity of the RAAS ( e.g. , patients with renal artery stenosis , severe heart failure , post-myocardial infarction or volume depletion ) or patients receiving ARB , ACEI or nonsteroidal anti-inflammatory drug ( NSAID ) , including selective Cyclooxygenase-2 inhibitors ( COX-2 inhibitors ) , therapy may be at particular risk for developing acute renal failure on Tekturna see Warnings and Precautions ( 5.2 Drug Interactions ( 7 ) , and Use in Specific Populations ( 8.7 ) and Clinical Studies ( 14.3 ) ."	0
"Effect of Atorvastatin on the Pharmacokinetics of Co-administered Drugs Atorvastatin Co-administered drug and dosing regimen Drug/Dose (mg) Change in AUC Change in Cmax 80 mg QD for 15 days Antipyrine, 600 mg SD <U+2191> 3% <U+2193> 11% 80 mg QD for 14 days See Section 7 for clinical significance."	0
"Thus, potassium citrate extended-release tablets therapy appears to increase urinary citrate principally by modifying the renal handling of citrate, rather than by increasing the filtered load of citrate."	0
"In some patients, the administration of an NSAID can reduce the diuretic, natriuretic, and antihypertensive effect of loop, potassium-sparing, and thiazide diuretics."	0
Hypersensitivity to sulfonamide-derived drugs.	0
It is likely that this experience significantly underestimates the degree of accumulation that might occur with repeated diazepam administration.	0
This may pose a potential risk to some patients.	0
"In severe renal failure, accumulation may occur and the lowest frequency of dosing compatible with an adequate patient response should be used."	0
The study medications were administered three times per day with meals from Day 0 through Day 2 and one morning dose on Day 3 of each period.	0
Pharmacokinetics in Normal Adult Volunteers Age-group(years) n Peak Plasma Concentration (ng/mL) Mean EliminationHalf-life (h) Plasma Clearance(L/h/kg) 19-40 11 102 3.5 0.381 61-74 12 106 4.7 0.319 <U+2265> 75 11 170 5.5 0.262 Absorption: A study was performed in normal volunteers (n = 56) to evaluate the pharmacokinetics of a single 4-mg dose administered as a 5-minute infusion compared to a single intramuscular injection.	0
"Since they appear to be more susceptible to hypotension and neuromuscular reactions, such patients should be observed closely."	0
"Measure liver tests promptly in patients who report symptoms that may indicate liver injury, including fatigue, anorexia, right upper abdominal discomfort, dark urine or jaundice."	0
"Teriflunomide did not affect the pharmacokinetics of bupropion (a CYP2B6 substrate), midazolam (a CYP3A4 substrate), S-warfarin (a CYP2C9 substrate), omeprazole (a CYP2C19 substrate), and metoprolol (a CYP2D6 substrate)."	0
The multiple-dose pharmacokinetics of fluvoxamine were determined in male and female children (ages 6-11) and adolescents (ages 12-17).	0
Need to Evaluate for Co-morbid Diagnoses: Reevaluate if insomnia persists after 7 to 10 days of use.	0
The half-life of elimination of N1-desalkyl-flurazepam ranged from 47 to 100 hours.	0
O:\E-Submissions\PBO\PRODUCTS\Eliquis 202155\08.	0
Effient can be administered with drugs that are inducers or inhibitors of cytochromeP450 enzymes.	0
"In the fixed-dose study, the decreased rate of depression relapse was similar in patients receiving 20 or 40 mg/day of Celexa."	0
"If liver function tests become markedly elevated compared to baseline, VFEND should be discontinued unless the medical judgment of the benefit-risk of the treatment for the patient justifies continued use."	0
"Sympathetic stimulation is necessary in supporting circulatory function in heart failure, and beta-blockade carries the potential hazard of further depressing myocardial contractility and precipitating more severe failure."	0
Thiazides do not affect normal blood pressure.	0
"Dosage can be gradually increased by 2 mg to 4 mg at each dose, with 1 to 4 days between dosage increases, until a satisfactory reduction of muscle tone is achieved."	0
Oral Contraceptives The coadministration of fingolimod 0.5 mg daily with oral contraceptives (ethinylestradiol and levonorgestrel) did not elicit any clinically significant change in oral contraceptives exposure.	0
"In patients who have developed localized contact sensitization to Catapres-TTS<U+00AE> (clonidine), continuation of Catapres-TTS or substitution of oral clonidine hydrochloride therapy may be associated with the development of a generalized skin rash."	0
"Type 1A and 1C antiarrhythmics are generally contraindicated (e.g., quinidine, disopyramide, and procainamide)."	0
"However, rash that was considered drug related occurred at similar rates for all three groups."	0
"Adults Sudden death, stroke, and myocardial infarction have been reported in adults taking stimulant drugs at usual doses for ADHD."	0
"The patient described above recovered from his liver injury, and did not require a liver transplant."	0
"AUC and Cmax of ledipasvir were 77% and 58% higher, respectively, in females than males; however, the relationship between gender and ledipasvir exposures was not considered clinically relevant, as high response rates (SVR >90%) were achieved in male and female subjects across the Phase 3 studies and the safety profiles are similar in females and males."	0
"Mean pressor doses (TYR30) of tyramine capsules administered without food were 338mg and 385mg in subjects treated with EMSAM and oral selegiline, respectively."	0
CYP2D6 Inhibitors The concomitant use of DESOXYN and CYP2D6 inhibitors may increase the exposure of DESOXYN compared to the use of the drug alone and increase the risk of serotonin syndrome.	0
Do not use unless the solution is clear and the seal is intact.	0
"Effect of Co-administered Drugs on the Pharmacokinetics of Atorvastatin Co-administered drug and dosing regimen Atorvastatin Dose (mg) Change in AUC Data given as x-fold change represent a simple ratio between co-administration and atorvastatin alone (i.e., 1-fold = no change)."	0
"However, in rats, there was an increase in pup deaths during the first 4 days of lactation when dosing occurred during the last trimester of gestation and continued throughout lactation."	0
"When renal function is impaired, elimination of TENORMIN is closely related to the glomerular filtration rate; significant accumulation occurs when the creatinine clearance falls below 35mL/min/1.73m2."	0
Patients taking Matulane should also be warned against the use of prescription drugs without the knowledge and consent of their physician.	0
"Coadministration of AVALIDE with other drugs that raise serum potassium levels may result in hyperkalemia, sometimes severe."	0
Avoid concomitant use of aliskiren with MICARDIS in patients with renal impairment (GFR <60 mL/min/1.73 m2).	0
Coadministration of bosentan and REYATAZ without ritonavir is not recommended.	0
Apixaban is eliminated in both urine and feces.	0
Silenor is not an inhibitor of any CYP isozymes at therapeutically relevant concentrations.	0
However those clinical trials excluded patients with current major depressive episode.	0
"Following toxic doses (10<U+2013>20 g), the plasma half-life may be increased to over 20 hours."	0
Patients who receive prolonged Cleviprex infusions and are not transitioned to other antihypertensive therapies should be monitored for the possibility of rebound hypertension for at least 8 hours after the infusion is stopped.	0
Coronary artery disease: The recommended dose range for patients with coronary artery disease is 5<U+2013>10 mg once daily.	0
"In patients with altered renal function, the presence of hepatic insufficiency further alters the elimination of penicillin G. In one study, the serum half-lives in two anuric patients (excreting <400 mL urine/day) were 7.2 and 10.1 hours."	0
Drugs with a Narrow Therapeutic Index Digoxin: A single dose of eszopiclone 3 mg did not affect the pharmacokinetics of digoxin measured at steady state following dosing of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days.	0
THIOLA<U+00AE> may also be substituted for d-penicillamine in patients who have developed toxicity to the latter drug.	0
"Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapy, including CRIXIVAN."	0
"Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma."	0
"Distribution: Approximately 60% of circulating perindopril is bound to plasma proteins, and only 10 to 20% of perindoprilat is bound."	0
"Pregnancy Reproduction studies have been conducted in mice, rats, and rabbits."	0
Sprue-like enteropathy has been reported.	0
"Drug interaction studies have been carried out with treprostinil ( oral or subcutaneous ) co-administered with acetaminophen ( 4 g/day ) , warfarin ( 25 mg/day ) , and fluconazole ( 200 mg/day ) , respectively in healthy volunteers ."	0
Steady-state levels after prolonged dosing are similar to levels seen at 4to 5weeks.	0
"Based on in vitro data, no interaction would be expected with drugs whose metabolism is dependent upon cytochrome P450 isoenzymes 1A1, 1A2, 2A6, 2B6, 2D6, 2E1, or 3A4."	0
"Metabolism: Quazepam, the active parent compound, is extensively metabolized in the liver; two of the plasma metabolites are 2-oxoquazepam and N-desalkyl-2-oxoquazepam."	0
"In many of the reported cases, treatment with protease inhibitors was continued or restarted."	0
"In patients with severe heart failure whose renal function may depend on the activity of the renin-angiotensin-aldosterone system , treatment with angiotensin converting enzyme inhibitors , including VASOTEC , may be associated with oliguria and/or progressive azotemia and rarely with acute renal failure and/or death ( see PRECAUTIONS , Drug Interactions ) ."	0
Changes in renal function including acute renal failure can be caused by drugs that inhibit the renin-angiotensin system.	0
"Concomitant treatment with drugs which are inducers of CYP1A2 and/or CYP3A4 (e.g., phenytoin) has the potential to decrease lidocaine plasma levels and higher doses may be required."	1
ACE inhibitors have been associated with a higher rate of angioedema in Black than in non-Black patients.	0
"Similar administration to pregnant rats throughout gestation or for 5 days starting on gestation day 10 or 15 resulted in decreased body weight gains, increased mortalities and slight increases in cataract formation among the offspring."	0
Clinical studies of Anafranil did not include sufficient numbers of subjects age 65 and over to determine whether they respond differently from younger subjects; 152 patients at least 60 years of age participating in various U.S. clinical trials received Anafranil for periods of several months to several years.	0
"Male and female mice exposed to the highest tested concentration received triamterene at about 45 and 60 mg/kg/day, respectively."	0
Pregnancy Category D.	0
Acute interstitial nephritis has been observed in patients taking PPIs including PROTONIX.	0
"Lurasidone exhibits little or no affinity for histamine H1 and muscarinic M1 receptors (IC50 > 1,000 nM)."	0
"20 mg/day is the maximum recommended dose for patients who are greater than 60 years of age , due to the risk of QT prolongation."	0
The primary route of elimination appears to be hepatic metabolism to inactive metabolites excreted by the kidney.	0
"However, prior to initiating treatment with an antidepressant, patients with depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression."	0
"Calcium channel antagonists : In patients with depressed myocardial function , use of BREVIBLOC with cardiodepressant calcium channel antagonists ( e.g. , verapamil ) can lead to fatal cardiac arrests ."	0
"Potassium-sparing agents should be used very cautiously, if at all, in conjunction with angiotensin-converting enzyme (ACE) inhibitors due to a greatly increased risk of hyperkalemia."	0
Longer acting drugs should be used only when recurrent convulsions are evidenced.	0
The interaction between duloxetine and other highly protein bound drugs has not been fully evaluated.	0
Onset of therapeutic effect is usually observed within 30 minutes to two hours.	0
Refer to the package insert for lithium preparations before use of such preparations with DIURIL.	0
"Ketoconazole Ketoconazole, a potent inhibitor of CYP3A4, at a dose of 400 mg QD for 5 days, increased the AUC and Cmax of ziprasidone by about 35<U+2013>40%."	1
"Since thioridazine hydrochloride tablets are associated with a dose related prolongation of the QTc interval, which is a potentially life threatening event, its use should be reserved for schizophrenic patients who fail to respond adequately to treatment with other antipsychotic drugs."	0
"Ongoing clinical assessment of patients should govern physician interventions, including diagnostic evaluations and treatment."	0
"Consequently , no potassium supplement should ordinarily be given with ALDACTONE ."	0
No studies have been conducted at intermediate doses of cimetidine.	0
The 25 mg per day dose is intended for a gradual reduction in dose when discontinuing treatment.	0
Dofetilide did not influence cardiac conduction velocity and sinus node function in a variety of studies in patients with or without structural heart disease.	0
Increases in INR and prothrombin time may lead to abnormal bleeding and even death.	0
"Due to the narrow therapeutic index of pimozide and its known ability to prolong the QT interval, concomitant use of pimozide and paroxetine is contraindicated."	0
"In such patients, doses of 20<U+2013>30 mg three or four times daily may be effective."	0
"Coadministration of antiplatelet agents, fibrinolytics, heparin, aspirin, and chronic NSAID use increases the risk of bleeding."	0
NSAIDs: Increased risk of renal impairment and loss of anti-hypertensive effect (7) Do not co-administer aliskiren with MICARDIS in patients with diabetes (7)	0
"CNS effects: Potential impairment of activities requiring complete mental alertness such as operating machinery or driving a motor vehicle, after ingesting the drug."	0
The clinical significance of this decrease in tolbutamide clearance is unknown.	1
"There was no effect on serum uric acid during chronic oral administration, and no uricosuric effect."	0
"Tacrine: Coadministration increased tacrine Cmax and AUC five- and eight-fold and caused nausea, vomiting, sweating, and diarrhea (7.2)."	0
"Some botanicals and foods can interact with COUMADIN through CYP450 interactions (e.g., echinacea, grapefruit juice, ginkgo, goldenseal, St. John<U+2019>s wort)."	0
This effect appears to be related to duration of therapy and cumulative dose of the drug.	0
Avoid concomitant use of CAPRELSA with agents that may prolong the QT interval.	0
"A reduction in urinary cystine of 250-350 mg/day at a THIOLA<U+00AE> dosage of 1 g/day, and a decline of approximately 500 mg/day at a dosage of 2 g/day, might be expected."	0
Dose adjustment is recommended when FETZIMA is co-administered with strong inhibitors of CYP3A4 (e.g. ketoconazole).	0
"Patients at risk appear to be those with low blood pressure (systolic blood pressure less than 100mm Hg), ischemic heart disease and diffuse vascular disease, and/or underlying renal insufficiency."	0
Intervention: Monitor digoxin concentrations.	0
Effect on QT Interval In clinical trials quetiapine was not associated with a persistent increase in QT intervals.	0
Use in Patients with Concomitant Illness: Use caution in patients with diseases or conditions that produce altered metabolism or hemodynamic responses (5.10).	0
The drug should be used with caution in patients who consume substantial quantities of alcohol and/or have a past history of liver disease.	0
The effects of higher doses of lithium on the pharmacokinetics of mirtazapine are unknown.	0
"Closely monitor blood pressure, renal function and electrolytes in patients on ATACAND and other agents that affect the RAS."	0
This mechanism accounts in large part for the potassium sparing action of amiloride.	0
"For patients who experience a sustained increase in blood pressure while receiving PRISTIQ, either dose reduction or discontinuation should be considered."	0
"Pressor amines (e.g., norepinephrine) - possible decreased response to pressor amines but not sufficient to preclude their use."	0
"In a placebo-controlled trial in normal volunteers, the administration of two doses of sertraline hydrochloride did not significantly alter steady-state lithium levels or the renal clearance of lithium."	0
"Peak concentrations of 9-hydroxyrisperidone occurred at about 3 hours in extensive metabolizers, and 17 hours in poor metabolizers."	0
Concurrent use with general anesthetics may result in arrhythmias.	0
"The following dose adjustments are recommended for use of tadalafil with PREZISTA/ritonavir: Co-administration of tadalafil in patients on PREZISTA/ritonavir: In patients receiving PREZISTA/ritonavir for at least one week, start tadalafil at 20 mg once daily."	0
The magnitude of interaction with multiple doses of erythromycin is unknown.	0
"HMG-CoA Reductase Inhibitors: atorvastatin,rosuvastatin <U+2191> atorvastatin concentration <U+2191> rosuvastatin concentration The atorvastatin and rosuvastatin doses should be carefully titrated; use the lowest dose necessary with careful monitoring during treatment with CRIXIVAN."	1
"For patients receiving ELIQUIS at a dose of 2.5 mg twice daily, avoid coadministration with combined P-gp and strong CYP3A4 inhibitors."	0
Reserve the combination of amiodarone with other antiarrhythmic therapies that prolong the QTc to patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent .	0
"The extent of absorption is at least 50%<U+2013>60%, and is not significantly influenced by the presence of food in the gastrointestinal tract, although the rate of absorption is reduced."	0
PRISTIQ should be discontinued before initiating treatment with the MAOI.	0
Limited safety data are available from treatment use in 22 HIV-positive children with MAC who received MYCOBUTIN in combination with at least two other antimycobacterials for periods from 1 to 183 weeks.	0
Long-term carcinogenicity studies were conducted with rifabutin in mice and in rats.	0
"Excretion/Elimination In a mass balance study with orally administered dronedarone (14C-labeled) approximately 6% of the labeled dose was excreted in urine, mainly as metabolites (no unchanged compound excreted in urine), and 84% was excreted in feces, mainly as metabolites."	0
Patients received hemodialysis immediately before pitavastatin dosing and did not undergo hemodialysis during the pharmacokinetic study.	0
Treatment-experienced adult patients with at least one darunavir resistance associated substitution: 600 mg (one 600 mg tablet) taken with ritonavir 100 mg twice daily and with food.	0
Safety and effectiveness in the pediatric population have not been established.	0
The development of hyperkalemia associated with potassium-sparing diuretics is accentuated in the presence of renal impairment.	0
This decrease in MPA is not greater than that typically produced by a 10-mg maintenance dose of prasugrel alone.	0
"Despite this decrease in systemic bioavailability, the efficacy of pravastatin administered once daily in the evening, although not statistically significant, was marginally more effective than that after a morning dose."	0
"Monitoring of aminotransferase levels is recommended for baseline and 1 month after maximum dose is achieved, or if hepatic injury is suspected."	0
"At least 14 days should elapse between the discontinuation of NARDIL and the institution of another antidepressant or buspirone HCl, or the discontinuation of another MAO inhibitor and the institution of NARDIL."	0
Most edema was mild to moderate in severity.	0
"Inhibitors of CYP3A4 (e.g., ketoconazole) or CYP2D6 (e.g., fluoxetine, paroxetine) can inhibit iloperidone elimination and cause increased blood levels."	1
"In standard animal or human pharmacological tests, beta-adrenoreceptor blocking activity of TENORMIN has been demonstrated by: (1) reduction in resting and exercise heart rate and cardiac output, (2) reduction of systolic and diastolic blood pressure at rest and on exercise, (3) inhibition of isoproterenol induced tachycardia, and (4) reduction in reflex orthostatic tachycardia."	0
"The concomitant use of opioids with other drugs that affect the serotonergic neurotransmitter system, such as selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that effect the serotonin neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), and monoamine oxidase (MAO) inhibitors (those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue), has resulted in serotonin syndrome."	0
"If these symptoms occur, administer supportive measures and discontinue MYCOBUTIN."	0
None of these patients were discontinued from the trials because of hyperkalemia.	0
"Drug dosage, rather than systemic drug concentration, correlates better with LDL-C reduction."	0
"Immunosuppressive Agents Verapamil therapy may increase serum levels of cyclosporin, sirolimus and tacrolimus."	1
Rats and mice treated with dofetilide in the diet for two years showed no evidence of an increased incidence of tumors compared to controls.	0
Elimination Dabigatran is eliminated primarily in the urine.	0
Unused portions of each vial should be discarded properly.	0
Activity in vitro and in vivo Rifampin has bactericidal activity in vitro against slow and intermittently growing M tuberculosis organisms.	0
"Although it is not known whether CRIXIVAN is excreted in human milk, there exists the potential for adverse effects from indinavir in nursing infants."	0
"In general, dose selection for an elderly patient should be cautious, reflecting the greater frequency of decreased hepatic, renal or cardiac function and of concomitant disease or other drug therapy."	0
"Pediatric Patients Among pediatric patients in clinical trial 1182.14, steady-state plasma tipranavir trough concentrations were obtained 10 to 14 hours following study drug administration."	0
"In pediatric short-term controlled clinical trials, 21/1308 (1.6%) of atomoxetine patients versus 9/806 (1.1%) of placebo-treated patients spontaneously reported treatment emergent hostility-related adverse events (overall risk ratio of 1.33 [95% C.I."	0
The higher risk for bleeding events in patients treated with Effient persisted up to 7days from the most recent dose of study drug.	0
Symptoms appeared immediately upon initiating the infusion.	0
"In a study of healthy subjects given a single 15-mg dose, the AUC of the active metabolite was unaffected by a high fat, high calorie meal, but Cmax was decreased by 49% and Tmax was increased from 0.5 to 1.5hours."	1
"Adverse experiences, consisting primarily of headache, nausea, sweating, and dizziness, have been reported when tryptophan was administered to patients taking paroxetine."	0
"If such symptoms occur, discontinue CYMBALTA and initiate supportive treatment."	0
Concomitant therapy with flecainide and verapamil may result in additive negative inotropic effect and prolongation of atrioventricular conduction.	0
"Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors ( COX-2 Inhibitors ) : In patients who are elderly , volume-depleted ( including those on diuretic therapy ) , or with compromised renal function , coadministration of NSAIDs , including selective COX-2 inhibitors , with angiotensin II receptor antagonists , including valsartan , may result in deterioration of renal function , including possible acute renal failure ."	0
"The efficacy of REMERON (mirtazapine) Tablets as a treatment for major depressive disorder was established in 4 placebo-controlled, 6-week trials in adult outpatients meeting DSM-III criteria for major depressive disorder."	0
"Bone Fracture: Epidemiological studies on bone fracture risk following exposure to some antidepressants, including SSRIs, have reported an association between antidepressant treatment and fractures."	0
"Subsequent titration (14 day intervals) may be carried out with ZIAC tablets up to the maximum recommended dose 20/12.5 mg (two 10/6.25 mg tablets) once daily, as appropriate."	0
"Adverse experiences, consisting primarily of headache, nausea, sweating, and dizziness, have been reported when tryptophan was administered to patients taking paroxetine."	0
"Hydrochlorothiazide blocks the reabsorption of sodium and chloride ions, and it thereby increases the quantity of sodium traversing the distal tubule and the volume of water excreted."	0
The systemic exposure (AUC) of abiraterone increased by approximately 7-fold in subjects with severe baseline hepatic impairment compared to subjects with normal hepatic function.	0
A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on tolazamide (1 g/day) 11 days after the addition of oral doxepin (75 mg/day).	0
Use of HARVONI with P-gp inducers is not recommended.	0
"Clinical Worsening and Suicide Risk <U+2013> Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down."	0
Minimize the risk of hyperkalemia with proper patient selection and monitoring.	0
Obtain monthly pregnancy tests during treatment.	0
"Coadministration of propranolol usually does not affect quinidine pharmacokinetics, but in some studies, the <U+00DF><U+2013>blocker appeared to cause increases in the peak serum levels of quinidine, decreases in quinidine's volume of distribution and decreases in total quinidine clearance."	1
"Thiazides may alter fluid and electrolyte balance, which may precipitate hepatic coma."	0
"Hepatic Impairment The effect of hepatic impairment on the pharmacokinetics of bupropion was characterized in 2 single-dose trials, one in subjects with alcoholic liver disease and one in subjects with mild to severe cirrhosis."	0
Steady-state studies in hypertensive patients given doxazosin doses of 2 to 16 mg once daily showed linear kinetics and dose proportionality.	0
"Study 1 utilized daily dosing throughout the study, while Study 2 utilized luteal phase dosing for the 2 weeks prior to the onset of menses."	0
Dosage adjustment of haloperidol may be necessary when coadministered with nefazodone.	0
"The effect on exercise tachycardia of a single 10 mg intravenous dose is largely dissipated by 12 hours, whereas beta-blocking activity of single oral doses of 50 mg and 100 mg is still evident beyond 24 hours following administration."	0
"Chronic studies employing oral atenolol performed in animals have revealed the occurrence of vacuolation of epithelial cells of Brunner's glands in the duodenum of both male and female dogs at all tested dose levels of atenolol (starting at 15 mg/kg/day or 7.5 times the maximum recommended human antihypertensive dose) and increased incidence of atrial degeneration of hearts of male rats at 300 but not 150 mg atenolol/kg/day (150 and 75times the maximum recommended human antihypertensive dose, respectively)."	0
"After maximum clinical response is achieved, an attempt should be made to reduce the dosage slowly over a period of several weeks without jeopardizing the therapeutic response."	0
It should be noted that SURMONTIL is not approved for use in treating bipolar depression.	0
Most patients require 15 to 20 mL with each meal.	0
"The following list includes some other MAO inhibitors, dibenzazepine-related entities, and tricyclic antidepressants."	0
"Initiate dosing at 2.5 mg once daily for 1 week, 5 mg once daily for the next 3 weeks, and then increase as tolerated, to a maintenance dose of 10 mg once daily."	0
Both Cmax and AUC0-inf increased in an approximately dose-proportional manner for single LIVALO doses from 1 to 24 mg once daily.	0
"Tablets should not be chewed, divided or crushed."	0
"Amlodipine Following administration of therapeutic doses to patients with hypertension, amlodipine produces vasodilation resulting in a reduction of supine and standing blood pressures."	0
"Although PRINIVIL was antihypertensive in all races studied, Black hypertensive patients (usually a low-renin hypertensive population) had a smaller average response to monotherapy than non-Black patients."	0
Coadministration of fluticasone propionate and INVIRASE/ritonavir is not recommended unless the potential benefit to the patient outweighs the risk of systemic corticosteroid side effects.	0
Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.	0
"In patients taking AUBAGIO, exposure of drugs metabolized by CYP1A2 (e.g., alosetron, duloxetine, theophylline, tizanidine) may be reduced."	1
"Following an oral dose of PERSANTINE tablets, the average time to peak concentration is about 75 minutes."	0
The antihypertensive effect diminished somewhat at the end of the dosing interval.	0
INVIRASE is not recommended for use in combination with cobicistat.	0
"If unnecessary fluid expansion is of concern, adjustment of drug concentration may be preferred over increasing the flow rate of a less concentrated dilution."	0
Alternative or additional contraceptive measures should be used when oral contraceptives containing ethinyl estradiol or norethindrone and VIRACEPT are coadministered.	0
"In the case of molecular remission, resume TRISENOX and tretinoin at 1 dose level lower."	0
Dosage should then be maintained at 100 mg per square meter of body surface per day until maximum response is obtained or until leukopenia or thrombocytopenia occurs.	0
"In rats, olmesartan crossed the blood-brain barrier poorly, if at all."	0
Tasigna can cause increases in serum lipase.	0
"The mechanism of the LDL-lowering effect of MEVACOR may involve both reduction of VLDL<U+2011>C concentration, and induction of the LDL receptor, leading to reduced production and/or increased catabolism of LDL<U+2011>C."	0
The pharmacokinetics of carvedilol do not appear to be different in poor metabolizers of S-mephenytoin (patients deficient in cytochrome P450 2C19).	0
Verapamil is known to inhibit CYP3A and P-gp.	0
The effectiveness of methenamine may be decreased when used concurrently with hydrochlorothiazide because of alkalinization of the urine.	0
The reduction in atenolol clearance follows the general trend that the elimination of renally excreted drugs is decreased with increasing age.	0
"Thus, steady-state concentrations of benazeprilat should be reached after 2 or 3 doses of benazepril hydrochloride given once daily."	0
"Whether increased levels of bradykinin, a potent vasodepressor peptide, play a role in the therapeutic effects of ACEON remains to be elucidated."	0
AVALIDE is contraindicated in patients who are hypersensitive to any component of this product.	0
Avoid simvastatin and lovastatin doses greater than 40 mg [see Clinical Pharmacology (12.3) ].	0
"The drug is detectable in serum 10 minutes after oral administration, and peak blood levels occur in approximately 30 minutes."	0
"While the possibility exists that renally excreted metabolites of fluoxetine may accumulate to higher levels in patients with severe renal dysfunction, use of a lower or less frequent dose is not routinely necessary in renally impaired patients."	0
Consideration should be given to reducing the dose of concomitant diuretics.	1
"In addition, the following commonly coprescribed substances had no clinically relevant effect (<20%) on fingolimod or fingolimod-phosphate predose concentrations: baclofen, gabapentin, oxybutynin, amantadine, modafinil, amitriptyline, pregabalin, and corticosteroids."	0
"Pre-existing glaucoma is almost always open-angle glaucoma because angle closure glaucoma, when diagnosed, can be treated definitively with iridectomy."	0
"Therefore , the expected clinical effects of SAMSCA in the presence of rifampin and other inducers ( e.g. , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine and St.   John 's   Wort ) may not be observed at the usual dose levels of SAMSCA ."	0
"If possible, discontinue drugs that are known to prolong the QTc interval."	0
"Sudden death, stroke, and myocardial infarction have been reported in adults taking stimulant drugs at usual doses for ADHD."	0
"Catapres<U+00AE> (clonidine hydrochloride, USP) tablets should not be used in patients with known hypersensitivity to clonidine."	0
Figure 3: Impact of Other Patient Factors on Latuda Pharmacokinetics	0
Photosensitivity reactions and possible exacerbation or activation of systemic lupus erythematosus have been reported in patients receiving thiazides.	0
"Two placebo<U+2011>controlled trials compared the acute hemodynamic effects of COREG with baseline measurements in 59 and 49subjects with NYHA class II<U+2011>IV heart failure receiving diuretics, ACE inhibitors, and digitalis."	0
"Hypertensive crises, severe convulsive seizures, coma, or circulatory collapse may occur in patients receiving such combinations."	0
"In situations where there is a normal serum potassium level or hypokalemia, the addition of potassium chloride (up to a concentration of 4 mEq/L) may be indicated to prevent severe hypokalemia."	0
"In 30 hypertensive patients with normal renal function treated for 8 weeks with telmisartan 80 mg or telmisartan 80 mg in combination with hydrochlorothiazide 12.5 mg, there were no clinically significant changes from baseline in renal blood flow, glomerular filtration rate, filtration fraction, renovascular resistance, or creatinine clearance."	0
"When multiple doses of atorvastatin and digoxin were co-administered, steady-state plasma digoxin concentrations increased by approximately 20%."	1
Choose the dispenser based on dose: Use 1 mL dispenser if dose is 1 mL or less.	0
"Profound sedation, respiratory depression, coma, and death may result from the concomitant use of Meperidine Hydrochloride Injection with benzodiazepines or other CNS depressants (e.g., non-benzodiazepine sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, other opioids, alcohol)."	0
The duration of action of a single dose of racemic warfarin is 2 to 5 days.	0
"However, strong inhibitors of CYP3A (e.g., itraconazole, clarithromycin) may increase the plasma concentrations of amlodipine to a greater extent."	1
The initial dose should be taken 12 to 24 hours after surgery.	0
Concomitant administration of warfarin (2-9mg once daily) under steady state conditions with duloxetine 60 or 120mg once daily for up to 14 days in healthy subjects (n=15) did not significantly change INR from baseline (mean INR changes ranged from 0.05 to +0.07).	0
"Hypokalemia or hypomagnesemia may occur with administration of potassium-depleting diuretics, increasing the potential for Torsade de Pointes."	0
"Pooled analyses of short-term placebo-controlled trials of antidepressant drugs (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18<U+2013>24) with major depressive disorder (MDD) and other psychiatric disorders."	0
Trials designed to examine the effects of carvedilol on glycemic control in patients with diabetes and heart failure have not been conducted.	0
The average duration of treatment with encainide or flecainide in this study was ten months.	0
"TENORMIN is also compatible with methyldopa, hydralazine, and prazosin, each combination resulting in a larger fall in blood pressure than with the single agents."	0
"Most arrhythmias that will respond to intravenous quinidine will respond to a total dose of less than 5 mg/kg, but some patients may require as much as 10 mg/kg."	0
Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide.	0
Dronedarone induces a moderate (average of about 10 ms but much greater effects have been observed) QTc (Bazett) prolongation.	0
Epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an NSAID or aspirin may potentiate this risk of bleeding.	0
"Effect of Pitavastatin Co-Administration on Systemic Exposure to Other Drugs *Data presented as % change represent % difference relative to the investigated drug alone (i.e., 0% = no change)."	0
"Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs, warfarin, and other anticoagulants may add to this risk."	0
.	0
Fatal neutropenic sepsis occurred in 0.8% of patients receiving ONIVYDE.	0
"Coumarin Anticoagulants: In a small clinical trial in which lovastatin was administered to warfarin treated patients, no effect on prothrombin time was detected."	0
These results should not be extrapolated to other P-gp inhibitors.	0
"Elimination of iloperidone is mainly through hepatic metabolism involving 2 P450 isozymes, CYP2D6 and CYP3A4."	0
"(7.1) Coadministration of antiplatelet agents, thrombolytics, heparin, aspirin, and chronic NSAID use increases the risk of bleeding."	0
"Sofosbuvir is an inhibitor of the HCV NS5B RNA-dependent RNA polymerase, which is required for viral replication."	0
"Cytogenetic studies in vivo (murine bone marrow cells, following oral administration of fluconazole) and in vitro (human lymphocytes exposed to fluconazole at 1000 <U+00B5>g/mL) showed no evidence of chromosomal mutations."	0
"Therefore, concomitant olanzapine administration does not require dosage adjustment of valproate."	0
ASPIRIN DOSE AND BRILINTA EFFECTIVENESS .	0
"When adjusted for dose and weight, the pharmacokinetics of the metabolite, norquetiapine, was similar between children and adolescents and adults."	0
"Sevelamer hydrochloride, which contains the same active moiety as sevelamer carbonate, has been studied in human drug-drug interaction studies (2.4<U+2013>2.8 grams single dose or three times daily with meals or two times daily without meals) with ciprofloxacin, digoxin, enalapril, iron, metoprolol, mycophenolate mofetil, and warfarin."	0
"Rarely, ACE inhibitors, including ALTACE, have been associated with a syndrome that starts with cholestatic jaundice and progresses to fulminant hepatic necrosis and sometimes death."	0
"Instances of a second nonlymphoid malignancy, including lung cancer and acute myelocytic leukemia, have been reported in patients with Hodgkin's disease treated with procarbazine in combination with other chemotherapy and/or radiation."	0
Patients receiving both rifampin and isoniazid should be monitored close for hepatotoxicity.	0
"With intravenous (i.v.) treatment of dipyridamole, a triphasic profile is obtained: a rapid alpha phase, with a half-life of about 3.4 minutes, a beta phase, with a half-life of about 39 minutes, (which, together with the alpha phase accounts for about 70% of the total area under the curve, AUC) and a prolonged elimination phase <U+03BB>z with a half-life of about 15.5 hours."	0
"It is not active against the penicillinase-producing bacteria, which include many strains of staphylococci or against organisms resistant to beta-lactams because of alterations in the penicillin-binding proteins, such as methicillin-resistant staphylococci."	0
"The active ingredient dissolves completely once dispersed; however, a film containing the inactive ingredients may remain in the glass or container once the mixture is consumed."	0
Overall 3% of pediatric patients interrupted APTIVUS treatment due to rash and the discontinuation rate for rash in pediatric patients was 0.9%.	0
"However, there is substantial evidence from placebo-controlled maintenance trials in adults with depression that the use of antidepressants can delay the recurrence of depression."	0
"After correction for renal function, clearance of dofetilide is not related to age."	0
"IV: 2 mg per fractional injection, at 2-minute intervals."	0
Cases of symptomatic hypoglycemia have been reported in children with ALL receiving mercaptopurine.	0
Tumor lysis syndrome cases have been reported in Tasigna treated patients with resistant or intolerant CML.	0
"Although doxepin HCl does have H1 and H2 histamine receptor blocking actions, the exact mechanism by which doxepin exerts its antipruritic effect is unknown."	0
The pharmacokinetics of estazolam have not been studied in pediatric patients.	0
"Stimulant medications cause a modest increase in average blood pressure (about 2-4 mmHg) and average heart rate (about 3-6 bpm), and individuals may have larger increases."	0
"Avoid use in patients with known structural cardiac abnormalities, cardiomyopathy, serious heart arrhythmia, coronary artery disease, and other serious heart problems."	0
The Cmax and AUC of pitavastatin did not differ following evening or morning drug administration.	0
"If actual syncope occurs, tell patients to temporarily discontinue the drug until they have consulted with their physician."	0
Drug Interactions Potential for Other Drugs to Affect WELLBUTRIN XL In vitro studies indicate that bupropion is primarily metabolized to hydroxybupropion by CYP2B6.	0
A blood/plasma ratio of approximately 0.25 indicates poor drug penetration into red blood cells.	0
The steps described above are summarized in the following diagram: flow chart Renal function and QTc should be re-evaluated every three months or as medically warranted.	0
"If serious adverse effects occur, dosage should be reduced or treatment should be altered."	0
"Strong CYP3A4 Inhibitors: Avoid the use of strong CYP3A4 or UGT1A1 inhibitors, if possible; discontinue strong CYP3A4 inhibitors at least 1 week prior to starting therapy."	0
"CYP 3A Inducers Avoid co-administration of CYP 3A inducers (e.g., rifampin, rifabutin, rifapentin, barbiturates, phenytoin, carbamazepine, St. John's Wort) with SAMSCA, as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment."	1
Effect of Coadministered Drugs on Rosuvastatin Systemic Exposure Coadministered drug and dosing regimen Rosuvastatin Dose (mg) Single dose unless otherwise noted.	0
The principal pharmacokinetic parameters in adults and children are shown in the table below.	0
"Furthermore, whenever one of these other drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant may be required."	0
FANAPT should not be used with any other drugs that prolong the QT interval.	0
"However, a crossover study in healthy subjects receiving either 300 mg 4 times daily or 800 mg at bedtime of cimetidine concomitantly with a 300 mg twice daily dose of theophylline extended-release tablets demonstrated less alteration in steady-state theophylline peak serum levels with the 800 mg at bedtime regimen, particularly in subjects aged 54 years and older."	0
The remaining 25% of the dose was unaccounted for.	0
"Much of the drug is destroyed by enzymatic hydrolysis, particularly in the liver; from 13 to 50% is excreted unchanged in the urine."	0
"While the dose-response relationship is relatively flat, doses of 40<U+2013>80 mg were somewhat more effective at trough than 10<U+2013>20 mg, and twice daily dosing tended to give a somewhat lower trough blood pressure than once daily dosing with the same total dose."	0
The coadministration of ondansetron had no effect on the pharmacokinetics and pharmacodynamics of temazepam.	0
Safety and effectiveness in pediatric patients have not been established.	0
Inhaled beta agonist: Salmeterol <U+2191> Salmeterol Concurrent administration of salmeterol with INVIRASE/ritonavir is not recommended.	0
"Because of reports of upper gastrointestinal mucosal lesions following administration of potassium chloride (wax-matrix), an endoscopic examination of the upper gastrointestinal mucosa was performed in 30 normal volunteers after they had taken glycopyrrolate 2 mg p.o. t.i.d., potassium citrate extended-release tablets 95 mEq/day, wax-matrix potassium chloride 96 mEq/day or wax-matrix placebo, in thrice daily schedule in the fasting state for one week."	0
"PD is a chronic condition, and it is reasonable to consider continuation for a responding patient."	0
"Concomitant use of hyperventilation and sodium bicarbonate should be done with extreme caution, with frequent pH monitoring."	0
Other less strong CYP1A2 inhibitors have not been adequately studied.	0
Signs and symptoms generally improve after reduction in dose or discontinuation of drug.	0
Female rats given the highest dose level had an increased incidence of mesenteric lymph node hemangiomas and skin/subcutaneous lipomas.	0
"Alternatively, approximately 94% of all patients will also heal in 8 weeks with 800 mg of cimetidine tablets at bedtime Other regimens of cimetidine tablets in the United States which have been shown to be effective are: 300 mg 4 times daily, with meals and at bedtime, the original regimen with which U.S. physicians have the most experience, and 400 mg twice daily, in the morning and at bedtime."	0
"Prior to initiating treatment with a stimulant, patients with comorbid depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression."	0
"Antipsychotics: perphenazine, risperidone, thioridazine <U+2191> antipsychotics For contraindicated antipsychotics,.A dose decrease may be needed for these drugs when co-administered with ritonavir."	1
"Hydrochlorothiazide was orally administered to pregnant mice and rats during respective periods of major organogenesis at doses up to 3,000 and 1,000mg/kg/day, respectively."	0
This category implies possible clinical applicability in body sites where the drug is physiologically concentrated or in situations where the maximum acceptable dose of drug can be used.	0
Bleeding is the most common complication encountered during therapy with AGGRASTAT.	0
"Recent animal studies, however, have suggested that the vasodilator effect of prazosin is also related to blockade of postsynaptic alpha-adrenoceptors."	0
Drugs with a Narrow Therapeutic Index Digoxin: Zaleplon (10 mg) did not affect the pharmacokinetic or pharmacodynamic profile of digoxin (0.375 mg q24h for 8 days).	0
"Like other alpha1-adrenergic blocking agents, doxazosin has a greater effect on blood pressure and heart rate in the standing position."	0
"Table 4: Effect of Fluvastatin Coadministration on Systemic Exposure of Other Drugs Fluvastatin dosage regimen Coadministered drug Name and Dose (mg) Single dose unless otherwise noted Change in AUC Mean ratio (with/without coadministered drug and no change = 1 fold) or % change (with/without coadministered drug and no change = 0%); symbols of <U+2191> and <U+2193> indicate the exposure increase and decrease, respectively."	0
"Experience with GILENYA in patients receiving concurrent therapy with drugs that slow the heart rate or atrioventricular conduction (e.g., beta blockers, digoxin, or heart rate-slowing calcium channel blockers such as diltiazem or verapamil) is limited."	0
Promptly evaluate signs and symptoms of blood loss.	0
"Since Ventavis inhibits platelet function , there is a potential for increased risk of bleeding , particularly in patients maintained on anticoagulants or platelet inhibitors ."	0
Untreated acute angle-closure glaucoma can lead to permanent vision loss.	0
"A transient hypotensive response is not a contraindication to further doses of ACCUPRIL, which usually can be given without difficulty once the blood pressure has stabilized."	0
Anti-gout:colchicine <U+2191> colchicine The coadministration of PREZISTA/ritonavir with colchicine in patients with renal or hepatic impairment is contraindicated.	0
No specific laboratory tests are recommended.	0
It is generally believed (though not established in controlled trials) that treating such an episode with an antidepressant alone may increase the likelihood of precipitation of a mixed/manic episode in patients at risk for bipolar disorder.	0
"Patients with dysphagia, swallowing disorders, severe gastrointestinal (GI) motility disorders, including severe constipation, or major GI tract surgery were not included in the Renvela clinical studies."	0
"Dobutamine Hydrochloride in 5 %   Dextrose Injection contains sodium bisulfite , a sulfite that may cause allergic-type reactions , including anaphylactic symptoms and life-threatening or less severe asthmatic episodes , in certain susceptible people ."	0
Prolonged use of opioid analgesics during pregnancy for medical or nonmedical purposes can result in physical dependence in the neonate and neonatal opioid withdrawal syndrome shortly after birth.	0
"Discontinue treatment with ZOLOFT and any concomitant serotonergic agents immediately if the above symptoms occur, and initiate supportive symptomatic treatment."	0
"Thus, this study suggests that drugs that inhibit P450 2D6 or the presence of reduced activity levels of this isozyme will produce elevated plasma levels of thioridazine."	1
Prophylactic Nitrate Therapy: CARDIZEM CD may be safely coadministered with short- and long-acting nitrates.	0
"Patients at risk of excessive hypotension, sometimes associated with oliguria and/or progressive azotemia, and rarely with acute renal failure and/or death, include patients with the following conditions or characteristics: heart failure, hyponatremia, high dose diuretic therapy, recent intensive diuresis or increase in diuretic dose, renal dialysis, or severe volume and/or salt depletion of any etiology."	0
"Most of these reports involved seriously ill patients with multiple confounding risk factors, such as structural heart disease, electrolyte abnormalities, and concomitant medications that may have been contributory."	0
LATUDA exposure was not affected as meal size was increased from 350 to 1000 calories and was independent of meal fat content.	0
"In in vitro experiments, tipranavir was observed to inhibit human platelet aggregation at levels consistent with exposures observed in patients receiving APTIVUS/ritonavir."	0
The reconstituted solution contains 60 mg rifampin per mL and is stable at room temperature for up to 30 hours.	0
Trough plasma concentrations of telmisartan with once daily dosing are about 10% to 25% of peak plasma concentrations.	0
Potential for serious and/or life<U+2011>threatening reactions such as cardiac arrhythmias.	0
"All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases."	0
Most subjects were infected with subtype 4a (N=32; 62%) or 4d (N=11; 21%); 1 to 3 subjects were infected with each of the other genotype 4 subtypes.	0
"Although some serious heart problems alone carry an increased risk of sudden death, stimulant products generally should not be used in children or adolescents with known serious structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious cardiac problems that may place them at increased vulnerability to the sympathomimetic effects of a stimulant drug."	0
"In the event of severe acute reactions such as DRESS, discontinue clomipramine therapy immediately and institute appropriate treatment."	0
"Therefore, if concomitant use of these agents is indicated because of demonstrated hypokalemia, they should be used with caution and with frequent monitoring of serum potassium."	0
"Avoid co-administration of CYP 3A inducers ( e.g. , rifampin , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine , St.   John 's   Wort ) with SAMSCA , as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment ."	1
"Increased AST/ALT monitoring should be considered in these patients, especially during the first three months of NORVIR treatment."	0
"If the decision has been made to discontinue treatment, medication should be tapered, as rapidly as is feasible, but with recognition that discontinuation can be associated with certain symptoms."	0
"As with other psychotropic medications, patients should be advised to avoid alcohol while taking fluvoxamine maleate tablets."	0
"Indeed, the trial protocol reflected that judgment by excluding patients with blood pressure consistently below 100 mm Hg systolic."	0
"Hypokalemia may develop with thiazide therapy, especially with brisk diuresis, when severe cirrhosis is present, or during concomitant use of corticosteroids, ACTH, amphotericin B or after prolonged thiazide therapy."	0
This sequence of events is believed to be responsible for two clinical findings reported to occur after several weeks of nightly use of other rapidly eliminated hypnotics: increased wakefulness during the last quarter of the night and the appearance of increased signs of daytime anxiety.	0
Usual maintenance dosage is 17 to 34 mg once daily.	0
"Do not use ADCIRCA in patients who are using a GC stimulator , such as riociguat ."	0
"The cumulative frequency of nephrolithiasis events increases with increasing exposure to CRIXIVAN; however, the risk over time remains relatively constant."	0
The apparent elimination half-life after single or multiple dosing is 5 to 8 hours.	0
"Nevertheless, there may be the potential for clinically important alterations of blood levels of coadministered drugs."	0
No granules should remain in the syringe.	0
Potentiation occurs with ganglionic or peripheral adrenergic blocking drugs.	0
It may be necessary to decrease the dosage of verapamil when it is administered to patients with attenuated neuromuscular transmission.	0
Plasma concentrations of hydrochlorothiazide are increased and the elimination half-life is prolonged in patients with renal disease.	0
Lithium generally should not be given with diuretics because they reduce lithium's renal clearance and add a high risk of lithium toxicity.	1
Drugs may interact with COUMADIN through pharmacodynamic or pharmacokinetic mechanisms.	0
"Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)."	0
"Although not statistically significant, the AUCs for bupropion and hydroxybupropion were more variable and tended to be greater (by 53% to 57%) in patients with alcoholic liver disease."	0
No definitive in vitro chromosomal aberration or in vitro mammalian gene mutation assays have been performed.	0
HIV-1 protease inhibitor: Nelfinavir <U+2191> Saquinavir Combining saquinavir/ritonavir with nelfinavir is not recommended.	0
"In patients receiving ONIVYDE/5-FU/LV, theincidence of Grade 3 or 4 neutropenia was higher among Asian patients [18 of 33 (55%)]compared toWhite patients [13 of 73 (18%)]."	0
"Over the dose range of Isoptin-SR 120 to 240 mg once-a-day and trandolapril 0.5 to 8 mg once-a-day, the effects of the combination increase with increasing doses of either component."	0
"In addition, in vitro studies have shown ketoconazole, a potent inhibitor of CYP3A4 activity, to be at least 100 times more potent than paroxetine as an inhibitor of the metabolism of several substrates for this enzyme, including terfenadine, astemizole, cisapride, triazolam, and cyclosporine."	0
"For patients presenting with unexplained amenorrhea, galactorrhea, decreased libido, or problems with fertility, assessment of prolactin levels and testosterone levels should be considered as appropriate."	0
The peak plasma concentration at steady-state is 319 ng/mL (175<U+2013>463 ng/mL).	0
"In vitro, desvenlafaxine does not inhibit CYP1A2, 2A6, 2C8, 2C9, and 2C19, isozymes, and P-glycoprotein transporter and would not be expected to affect the pharmacokinetics of drugs that are substrates of these CYP isozymes and transporter."	0
No long-term animal studies have been done to evaluate diethylpropion hydrochloride for carcinogenicity.	0
This procedure uses paper disks impregnated with 10 units of penicillin to test the susceptibility of microorganisms to penicillin.	0
Results of in vitro studies demonstrate that duloxetine does not inhibit activity.	0
Enhanced effects and increased toxicity of buspirone may be possible during concomitant administration with diltiazem.	0
"However, there is substantial evidence from placebo-controlled maintenance trials in adults with depression that the use of antidepressants can delay the recurrence of depression."	0
"The concomitant use of vasopressors, vasoconstricting agents (such as ergonovine) and some oxytocic drugs may result in severe hypertension."	0
Patients with homozygous-TPMT deficiency require substantial dose reductions of PURIXAN.	0
The antihypertensive effect of CARDURA results from a decrease in systemic vascular resistance.	0
"For adults with a GFR <30 mL/min/1.73 m2 (serum creatinine >3 mg/dL), therecommendedinitial dose is 5 mg Lotensin once daily."	0
"Catecholamine-depleting drugs (eg, reserpine) may have an additive effect when given with beta-blocking agents."	0
Increases in heart rate <U+2265> 20 beats per minute occurred more frequently in Savella-treated patients when compared to placebo (8% in the Savella 50 mg BID and 100 mg BID treatment arms versus 0.3% in the placebo arm).	0
Patients receiving 25 mg hydrochlorothiazide who become hypokalemic may be transferred to this 37.5 mg/25 mg product directly.	0
"The concurrent use of ADASUVE with other CNS depressants (e.g., alcohol, opioid analgesics, benzodiazepines, tricyclic antidepressants, general anesthetics, phenothiazines, sedative/hypnotics, muscle relaxants, and/or illicit CNS depressants) can increase the risk of respiratory depression, hypotension, profound sedation, and syncope."	0
"The 3<U+03B1>-hydroxyisomeric metabolite (SQ 31,906) has 1/10 to 1/40 the HMG-CoA reductase inhibitory activity of the parent compound."	0
Dabigatran is metabolized to four different acyl glucuronides and both the glucuronides and dabigatran have similar pharmacological activity.	0
"Amiodarone is a substrate for CYP3A and CYP2C8, so inhibitors and inducers affect amiodarone exposure (7) Amiodarone inhibits p-glycoprotein and CYP1A2, CYP2C9, CYP2D6, and CYP3A, increasing exposure to other drugs (7) Drugs prolonging the QT interval: Co-administration of drugs prolonging the QT interval (such as class I and III antiarrhythmics, lithium, certain phenothiazines, tricyclic antidepressants, certain fluoroquinolone and macrolide antibiotics, azole antifungals, halogenated inhalation anesthetic agents) increases the risk of Torsade de Pointes."	0
"(7.5) Strong CYP3A inhibitors substantially increase ticagrelor exposure and so increase the risk of dyspnea, bleeding, and other adverse events."	0
"Approximately 90% of lidocaine administered is excreted in the form of various metabolites, and less than 10% is excreted unchanged."	0
Advise families and caregivers of the need for close observation and communication with the prescriber.	0
"Hypotension and bradyarrhythmias have been observed in patients receiving concurrent telithromycin, an antibiotic in the ketolide class."	0
"Concomitant administration of VASOTEC with potassium supplements , potassium salt substitutes , or potassium-sparing diuretics may lead to increases of serum potassium ( see PRECAUTIONS ) ."	0
QT interval prolongation and torsades de pointes have been reported rarely with INVIRASE/ritonavir use.	0
"Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death."	0
"However, strong inhibitors of CYP3A4 (e.g., ketoconazole, itraconazole, ritonavir) may increase the plasma concentrations of amlodipine to a greater extent."	1
"Warning signs or symptoms of fluid and electrolyte imbalance include dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia, and gastrointestinal disturbances such as nausea and vomiting."	0
These have generally occurred in patients taking multiple concomitant medications and/or with advanced AIDS.	0
"After 30days of dosing at 40mg/day, plasma concentrations of fluoxetine in the range of 91to 302ng/mL and norfluoxetine in the range of 72to 258ng/mL have been observed."	0
"It is not known whether chlorothiazide can cause fetal harm when administered to a pregnant woman , however , thiazides cross the placental barrier and appear in cord blood ."	0
"This finding can likely be attributed to differences in body weight, or alternatively, may represent differences in enzyme activities resulting from differences in diet, environment, or other factors."	0
Decreased sperm counts have been observed in human and animal studies with another endothelin receptor antagonist and in animal fertility studies with ambrisentan.	0
Iloperidone doses should therefore be reduced by about one-half if administered concomitantly with both a CYP2D6 and CYP3A4 inhibitor.	1
Potentiation of orthostatic hypotension may occur.	0
"An alternative non-CYP3A4 substrate hypnotic agent may be considered in patients taking CYP3A4 inducers such as rifampin, phenytoin, carbamazepine, and phenobarbital."	0
Do not exceed a final dose of 8 mg per day of respiridone.	0
"Additional signs may include elevated creatine phosphokinase, myoglobinuria (rhabdomyolysis) and acute renal failure."	0
Chlorpromazine Hydrochloride should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.	0
"However, there is substantial evidence from placebo-controlled maintenance trials in adults with MDD that antidepressants delay the recurrence of depression."	0
Avoid use of concomitant P-gp inhibitors in patients with CrCl <50 mL/min.	0
Do not take a missed dose within 12 hours of the next dose.	0
Changes in renal function including acute renal failure can be caused by drugs that inhibit the renin-angiotensin system.	0
"If QTcF is between 450 msec and 480 msec after 2 weeks, reduce the dose to 400 mg oncedaily.4."	0
"If a patient becomes pregnant while taking paroxetine, she should be advised of the potential harm to the fetus."	0
Coadministration of alprazolam and fluoxetine has resulted in increased alprazolam plasma concentrations and in further psychomotor performance decrement due to increased alprazolam levels.	0
VFEND has been associated with photosensitivity skin reaction.	0
"The major circulating metabolite results from N-desmethylation of sildenafil, and is, itself, further metabolized."	0
"Neonates exposed to antipsychotic drugs, during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery."	0
Dosing was once a day in the morning or evening.	0
"There was no evidence of mutagenicity in both prokaryotic (Salmonella typhi, Escherichia coli) and eukaryotic (Saccharomyces cerevisiae) bacteria, Drosophila melanogaster, or ICR/Ha Swiss mice."	0
Pediatric Management The principles of management of child and adult overdosages are similar.	0
"Because calcium excretion is decreased by thiazides, TENORETIC should be discontinued before carrying out tests for parathyroid function."	0
The potentiation of sympathomimetic substances and related compounds by MAO inhibitors may result in hypertensive crises.	0
Fluoxetine can also prolong the QT interval.	0
"(CYP2C9 Inhibition) Tacrolimus (CYP3A4 Inhibition) Significantly Increased When initiating therapy with VFEND in patients already receiving tacrolimus, reduce the tacrolimus dose to one-third of the starting dose and follow with frequent monitoring of tacrolimus blood levels."	1
"It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months."	0
4.Add the 4.6 mL of water from the dispenser back into the mixing cup.	0
"Irrespective of the CYP3A5 genotype status, the possibility of an interaction cannot be excluded with these drugs."	0
"Two placebo-controlled trials in 286 pediatric patients with MDD have been conducted with nefazodone, and the data were not sufficient to support a claim for use in pediatric patients."	0
"A transient hypotensive response is not a contraindication to further treatment, which usually can be continued without difficulty once the blood pressure has stabilized."	0
Bisoprolol is not metabolized by cytochrome P450 II D6 (debrisoquin hydroxylase).	0
"No drug interactions were detected except for an increase in symptomatic hypotension in patients receiving afterload reducers or affecting the renin-angiotensin system (i.e., ARBs and/or ACE inhibitors)."	0
Coadministration of venetoclax and NORVIR may increase the risk of tumor lysis syndrome.	0
Ethyl alcohol should not be used since there may be an Antabuse (disulfiram)-like reaction.	0
There are no data indicating that either should be preferred to the other.	0
"In a thorough QTc study with prospectively determined criteria, desvenlafaxine did not cause QT prolongation."	0
Studies in lactating rats have demonstrated that indinavir is excreted in milk.	0
In the majority of reported cases treatment with protease inhibitors was continued or restarted.	0
The effect of VFEND on visual function is not known if treatment continues beyond 28 days.	0
"Bupropion (a CYP2B6 substrate): Co-administration of a single dose of 150 mg Bupropion Hydrochloride XL with steady state quazepam did not significantly affect the AUC and Cmax of bupropion or its primary metabolite, hydroxybupropion."	0
"Dosing Recommendations for Treatment-Na<U+00EF>ve Pediatric Patients or Antiretroviral Treatment-Experienced Pediatric Patients with No Darunavir Resistance Associated Substitutions Pediatric patients weighing at least 10 kg but less than 15 kg The weight-based dose in antiretroviral treatment-na<U+00EF>ve pediatric patients or antiretroviral treatment-experienced pediatric patients with no darunavir resistance associated substitutions is PREZISTA 35 mg/kg once daily with ritonavir 7 mg/kg once daily using the following table: Table 2: Recommended Dose for Pediatric Patients Weighing 10 kg to Less Than 15 kg Who are Treatment-Na<U+00EF>ve or Treatment-Experienced with No Darunavir Resistance Associated Substitutionsdarunavir resistance associated substitutions: V11I, V32I, L33F, I47V, I50V, I54M, I54L, T74P, L76V, I84V and L89V Body weight (kg) Formulation: PREZISTA oral suspension (100 mg/mL) and ritonavir oral solution (80 mg/mL) Dose: once daily with food Greater than or equal to 10 kg to less than 11 kg PREZISTA 3.6 mLThe 350 mg, 385 mg, 455 mg and 490 mg darunavir dose for the specified weight groups were rounded up for suspension dosing convenience to 3.6 mL, 4 mL, 4.6 mL and 5 mL, respectively."	0
An 8 mL PREZISTA dose should be taken as two 4 mL administrations with the included oral dosing syringe.	0
"Macrolide antibiotics: clarithromycin <U+2191> clarithromycin<U+2193> 14-OH clarithromycin<U+2191> atazanavir Increased concentrations of clarithromycin may cause QTc prolongations; therefore, a dose reduction of clarithromycin by 50% should be considered when it is coadministered with REYATAZ."	1
There is conflicting evidence as to whether or not MAO inhibitors affect glucose metabolism or potentiate hypoglycemic agents.	0
Asian patients may require lower initiation and maintenance doses of warfarin.	0
"If the drug has a short elimination half-life, it is possible that a relative deficiency of the drug or its active metabolites (ie, in relationship to the receptor site) may occur at some point in the interval between each night's use."	0
"VFEND has been associated with elevations in liver function tests and clinical signs of liver damage, such as jaundice, and should only be used in patients with severe hepatic impairment if the benefit outweighs the potential risk."	0
"3.For ULTRABAG system for manual exchange, uncoil tubing and drain bag."	0
This will yield a solution with a concentration of NATRECOR<U+00AE> of approximately 6 mcg/mL.	0
"To reduce the potential risk of bleeding associated with the concurrent use of dabigatran and epidural or spinal anesthesia/analgesia or spinal puncture, consider the pharmacokinetic profile of dabigatran."	0
"Gender: In a study evaluating the effect of age and gender on fluvastatin pharmacokinetics, there were no significant differences in fluvastatin exposures between males and females, except between younger females and younger males (both ages 21 to 49 years), where there was an approximate 30% increase in AUC in females."	0
It may be necessary to increase the CLOZARIL dose if used concomitantly with inducers of these enzymes.	0
Angioedema associated with laryngeal edema can be fatal.	0
Serum and urine electrolyte determinations are especially important and should be frequently performed when the patient is vomiting or receiving parenteral fluids.	0
"Manifestations of hypersensitivity, such as fever, lymphadenopathy or laboratory abnormalities (including eosinophilia, liver abnormalities) may be present even though rash is not evident."	0
Elevated levels of BNP have been associated with advanced heart failure and are considered to be a compensatory mechanism in this disease.	0
"One approach is to discontinue ELIQUIS and begin both a parenteral anticoagulant and warfarin at the time the next dose of ELIQUIS would have been taken, discontinuing the parenteral anticoagulant when INR reaches an acceptable range."	0
"PDE5 inhibitors: Sildenafil, tadalafil, vardenafil <U+2191>Sildenafil <U+2191>Tadalafil <U+2191>Vardenafil For contraindicated PDE5 inhibitors [sildenafil (REVATIO)],."	0
The contractile processes of cardiac muscle and vascular smooth muscle are dependent upon the movement of extracellular calcium ions into these cells through specific ion channels.	0
"Transdermal dosing results in significantly higher exposure to selegiline with significantly lower exposure for all metabolites when compared to oral dosing, due to extensive first-pass metabolism."	0
"After initiating PURIXAN, continuation of appropriate dosing requires periodic monitoring of absolute neutrophil count (ANC) and platelet count to assure sufficient drug exposure (that is to maintain ANC at a desirable level) and to adjust for excessive hematological toxicity."	0
These individuals may develop higher than expected plasma concentrations of clozapine when given usual doses.	0
"Typically, a concentration of 1 mg/mL will be suitable for the prescribed dose."	0
Consider use of parenteral anti-platelet agent (7.3).	0
Figure1: Non-CABG-Related TIMI Major or Minor Bleeding Events.	0
"In clinical trials of ACCURETIC, the average change in serum potassium was near zero when 2.5 to 40 mg of quinapril was combined with hydrochlorothiazide 6.25 mg, and the average subject who received 10 to 20/12.5 to 25 mg experienced a milder reduction in serum potassium than that experienced by the average subject receiving the same dose of hydrochlorothiazide monotherapy."	0
Increase to 40 mg once daily based upon individual tolerability.	0
"After at least one week following the initiation of ritonavir, resume ADCIRCA at 20 mg once daily."	0
"RIFADIN is contraindicated in patients with a history of hypersensitivity to rifampin or any of the components, or to any of the rifamycins."	0
Venlafaxine and ODV exhibited linear kinetics over the dose range of 75 to 450 mg per day.	0
"However, the severity of BPH symptoms and the degree of urethral obstruction do not correlate well with the size of the prostate."	0
"GeneralHypokalemia and other electrolyte abnormalities, including hyponatremia and hypochloremic alkalosis, are common in patients receiving chlorthalidone."	0
"Nilotinib undergoes metabolism by CYP3A4, and concomitant administration of strong inhibitors or inducers of CYP3A4 can increase or decrease nilotinib concentrations significantly."	1
<U+2022>Hypertension: Start at 6.25mg twice daily and increase if needed for blood pressure control to 12.5mg then 25mg twice daily over intervals of 1to2 weeks.	0
Chlorpromazine diminishes the effect of oral anticoagulants.	0
"Closely monitor blood pressure, renal function, and electrolytes in patients on MICARDIS and other agents that affect the RAS."	0
"Assess each patient's risk for opioid addiction, abuse, or misuse prior to prescribing Meperidine Hydrochloride Injection, and monitor all patients receiving Meperidine Hydrochloride Injection for the development of these behaviors or conditions."	0
"Acute antihypertensive effects of thiazides are thought to result from a reduction in blood volume and cardiac output, secondary to a natriuretic effect, although a direct vasodilatory mechanism has also been proposed."	0
"Like other agents that are metabolized by CYP2D6, paroxetine may significantly inhibit the activity of this isozyme."	0
"In humans, carmustine, etoposide, and cisplatin do not affect the pharmacokinetics of ondansetron."	0
"At endpoint, 51% of paroxetine patients were free of panic attacks compared to 32% of placebo-treated patients."	0
"Non-steroidal Anti-inflammatory Drugs Including Selective Cyclooxygenase-2 (COX-2) Inhibitors- In some patients, the administration of a non-steroidal anti-inflammatory agent including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics."	0
"CYP2C9 isoenzyme is primarily involved in the metabolism of fluvastatin (approximately 75%), while CYP2C8 and CYP3A4 isoenzymes are involved to a much less extent, i.e., approximately 5% and approximately 20%, respectively."	0
Accurately measure out 60 mL of water and pour the water into the bottle.	0
"Patients with congenital or documented acquired QT prolongation, patients with refractory hypokalemia or hypomagnesemia, or those on concomitant therapy with other drugs that prolong the QT interval."	0
"Approximately 80% of fluvoxamine is bound to plasma protein, mostly albumin, over a concentration range of 20 to 2000 ng/mL."	0
"Similarly, IgG titers were decreased by 45% and 50%, in response to KLH and PPV-23, respectively, in subjects on GILENYA 0.5 mg daily compared to placebo."	0
"Sumatriptan: - There have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a selective serotonin reuptake inhibitor (SSRI) and sumatriptan."	0
"Elimination is mainly by biotransformation in the liver, and the plasma half-life ranges from approximately 3 to 7 hours."	0
"Given the normal variation in the content and composition of meals, taking ZYTIGA with meals has the potential to result in increased and highly variable exposures."	1
"Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily."	0
Over the oral dosage range 160-640 mg/day sotalol displays dose proportionality with respect to plasma concentrations.	0
ROZEREM is not recommended in patients with severe hepatic impairment.	0
Clinical studies of NORPRAMIN did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
The recommended starting dose in adult patients with hypertension taking diuretics is 5 mg once per day.	0
"In clinical studies, abiraterone acetate plasma concentrations were below detectable levels (<0.2 ng/mL) in >99% of the analyzed samples."	0
Biliary and direct intestinal excretion contributes to elimination of apixaban in the feces.	0
At least 14 days should elapse between discontinuation of a MAOI intended to treat psychiatric disorders and initiation of therapy with Savella.	0
The doses associated with placentotoxic effects in monkeys were equivalent to or lower than the maximum recommended human dose on a mg/m2 basis.	0
Testing for TPMT gene polymorphism should be considered in patients who experience severe bone marrow toxicities.	0
"Miscellaneous Concentrated yeast extract (e.g., Marmite), sauerkraut, most soybean products (including soy sauce and tofu), OTC supplements containing tyramine Brewer<U+2019>s yeast, baker<U+2019>s yeast, soy milk, commercial chain restaurant pizzas prepared with cheeses low in tyramine The use of EMSAM with sympathomimetic amines or buspirone may produce substantial elevations in blood pressure."	0
The results of a study in patients with primary hypercholesterolemia are presented in TableII.	0
"Following oral and intravenous administration of 14C-labeled losartan potassium, circulating plasma radioactivity is primarily attributed to losartan and its active metabolite."	0
"Silenor is contraindicated in individuals who have shown hypersensitivity to doxepin HCl, any of its inactive ingredients, or other dibenzoxepines."	0
"MEVACOR was compared to placebo in 8,245 patients with hypercholesterolemia (total-C 240-300mg/dL [6.2mmol/L - 7.6mmol/L], LDL<U+2011>C >160mg/dL [4.1mmol/L]) in the randomized, double-blind, parallel, 48<U+2011>week EXCEL study."	0
"Co-administration of voriconazole and ritonavir 100 mg should be avoided, unless an assessment of the benefit/risk to the patient justifies the use of voriconazole."	0
Subgroup analyses did not indicate that there were any differences in treatment outcomes as a function of age or gender.	0
Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.	0
CYMBALTA increased the risk of elevation of serum transaminase levels in development program clinical trials.	0
Paroxetine demonstrated statistically significant superiority over placebo on the Hamilton Rating Scale for Anxiety (HAM-A) total score.	0
"If PRADAXA is not started on the day of surgery, after hemostasis has been achieved initiate treatment with 220 mg once daily."	0
The contractile processes of cardiac muscle and vascular smooth muscle are dependent upon the movement of extracellular calcium ions into these cells through specific ion channels.	0
"The precise mechanisms by which amlodipine relieves angina have not been fully delineated, but are thought to include the following: Exertional Angina: In patients with exertional angina, NORVASC reduces the total peripheral resistance (afterload) against which the heart works and reduces the rate pressure product, and thus myocardial oxygen demand, at any given level of exercise."	0
A statistically significantly lower relapse rate was observed for patients taking sertraline hydrochloride compared to those on placebo.	0
The mean elimination half-life in single-dose studies ranged from 2.8 to 7.4 hours.	0
Grapefruit products should be avoided before and after dosing.	0
"Hormonal contraceptives , including oral , injectable , transdermal , and implantable forms , may not be reliable when Tracleer is co-administered ."	0
Consider a diagnosis of ILD in patients presenting with non-specific respiratory signs and symptoms.	0
Participants with <U+2265>2 risk factors had risk reductions (RR) in both acute major coronary events (RR43%) and coronary revascularization procedures (RR37%).	0
"There was considerable variation in risk of suicidality among drugs, but a tendency toward an increase in the younger patients for almost all drugs studied."	0
"In an in vivo interaction study in healthy, CYP2D6 extensive metabolizer patients (n=24), mirtazapine (30 mg/day), at steady state, did not cause relevant changes in the pharmacokinetics of steady state paroxetine (40 mg/day), a CYP2D6 inhibitor."	0
There is no evidence that additional benefit will be obtained from the administration of higher doses.	0
"Such conditions include: chronic renal failure, uncontrolled diabetes mellitus, acute dehydration, strenuous physical exercise in unconditioned individuals, adrenal insufficiency, extensive tissue breakdown or the administration of a potassium-sparing agent (such as triamterene, spironolactone or amiloride)."	0
"In a single-dose study, citalopram AUC and half-life were increased in the subjects <U+2265> 60 years old by 30% and 50%, respectively, whereas in a multiple-dose study they were increased by 23% and 30%, respectively."	0
"While subject to limitations, this meta-analysis suggested an increased occurrence of cardiovascular malformations (prevalence odds ratio [POR] 1.5; 95% confidence interval 1.2 to 1.9) and overall malformations (POR 1.2; 95% confidence interval 1.1 to 1.4) with paroxetine use during the first trimester."	0
"Results could be representative of strong CYP3A4 inhibitors such as ketoconazole, posaconazole, clarithromycin, telithromycin, HIV protease inhibitors, and nefazodone."	0
"A case of significant hypoglycemia has been reported in a type II diabetic patient maintained on chlorpropamide (250 mg/day), after the addition of nortriptyline (125 mg/day)."	0
"In three additional placebo-controlled depression trials, the difference in response to treatment between patients receiving Celexa and patients receiving placebo was not statistically significant, possibly due to high spontaneous response rate, smaller sample size, or, in the case of one study, too low a dose."	0
Dosage should be adjusted according to blood pressure response measured at peak (2<U+2013>6 hours after dosing) and trough (predosing).	0
"The exact mechanism of the antidepressant action of levomilnacipran is unknown, but is thought to be related to the potentiation of serotonin and norepinephrine in the central nervous system, through inhibition of reuptake at serotonin and norepinephrine transporters."	0
It is unknown whether CRIXIVAN administered to the mother in the perinatal period will exacerbate physiologic hyperbilirubinemia in neonates.	0
"Myopathy should be considered in any patient with diffuse myalgias, muscle tenderness or weakness, or marked elevation of CPK."	0
"The combination may result in increased risk of cardiovascular adverse events associated with salmeterol, including QT prolongation, palpitations and sinus tachycardia."	0
10 mg/day is the recommended dose for most elderly patients and patients with hepatic impairment (2.3).	0
"Due to potential for tumor lysis syndrome, maintain adequate hydration and correct uric acid levels prior to initiating therapy with Tasigna."	0
"No appreciable affinity was exhibited for other receptor/binding sites tested, including the cholinergic muscarinic receptor (IC50 >1 <U+00B5>M)."	0
"Anyone considering the use of clomipramine hydrochloride or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need."	0
The increased CgA level may cause false positive results in diagnostic investigations for neuroendocrine tumors.	0
Onset of dyspnea or non-productive cough may be related to pulmonary toxicity and patients should be carefully evaluated clinically.	0
"Normal sinus rhythm is usually not affected, but in patients with sick sinus syndrome, verapamil may interfere with sinus node impulse generation and may induce sinus arrest or sinoatrial block."	0
"The usual initial dose for adult administration via a compatible Hospira infusion device is 10 mg, with a range of 1 to 5 mg per incremental dose."	0
"Since mexiletine is metabolized in the liver, and hepatic impairment has been reported to prolong the elimination half-life of mexiletine, patients with liver disease should be followed carefully while receiving mexiletine."	0
Starting LUVOX CR in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome.	0
"It did not induce chromosomal aberrations in Chinese hamster ovary (CHO) cells in vitro with or without metabolic activation, but it did induce sister chromatid exchanges in CHO cells in vitro with and without metabolic activation."	0
"Thus, alternate assay methods should be considered."	0
"The major fraction, 63-74% is excreted in the urine, 7-22% in the feces."	0
"Hypersensitivity reactions , including anaphylaxis , to esmolol or any of the inactive ingredients of the product ( cross-sensitivity between beta blockers is possible ) ."	0
"In the SOLAR-1 and SOLAR-2 trials (liver transplant recipients or subjects with decompensated liver disease), there were 24 virologic failures with genotype 1 infection (20 relapsers and 4 subjects who discontinued treatment prior to achieving HCV RNA < LLOQ)."	0
"Patients on INVIRASE therapy may develop new onset or exacerbations of diabetes mellitus (5.4), hyperglycemia (5.4), elevated cholesterol and/or triglyceride concentrations (5.7), redistribution/accumulation of body fat (5.9), and immune reconstitution syndrome (5.10)."	0
"CRIXIVAN is not a cure for HIV-1 infection and patients may continue to experience illnesses associated with HIV-1 infection, including opportunistic infections."	0
"Therefore, patients under the care of another physician or dentist should inform him/her that they are taking NARDIL."	0
"Paroxetine: In a study of the interaction between the selective serotonin reuptake inhibitor (SSRI) paroxetine 20 mg/day for two weeks and a single dose of MAXALT 10 mg in healthy subjects (n=12), neither the plasma concentrations of rizatriptan nor its safety profile were affected by paroxetine."	0
Discontinue use of EXTRANEAL if serious reaction is suspected.	0
Hypoglycemics: Combination with APTIVUS/ritonavir not studied Careful glucose monitoring is warranted.	0
The clinical relevance of this increase in ETP is unknown.	0
"Physicians are advised to discuss the following issues with patients for whom they prescribe Anafranil: The risk of seizure ; Patients should be cautioned about using alcohol, barbiturates, or other CNS depressants concurrently, since Anafranil may exaggerate their response to these drugs; Patients should notify their physician if they become pregnant or intend to become pregnant during therapy; Patients should notify their physician if they are breast-feeding."	0
"In clinical studies, the majority of patients required 10 mg."	0
"No evidence of mutagenicity or genotoxicity was observed in in vitro microbial mutagenesis (Ames) tests, in vitro alkaline elution assays for DNA breakage, in vitro and in vivo chromosomal aberration studies, and in vitro mammalian cell mutagenesis assays."	0
"In such patients, renal function should be monitored during the first few weeks of therapy."	0
Studies 1 and 2 were flexible-dose studies comparing paroxetine (20 to 50mg daily) and placebo.	0
"Drugs that Elevate Gastric pH - Daily coadministration of ranitidine(an H2 blocker) or lansoprazole(a proton pump inhibitor) decreased the Cmax of the prasugrel active metabolite by 14% and 29%, respectively, but did not change the active metabolite's AUC and Tmax."	1
"Eplerenone selectively binds to human mineralocorticoid receptors relative to its binding to recombinant human glucocorticoid, progesterone, and androgen receptors."	0
"The half-life of R-warfarin ranges from 37 to 89 hours, while that of S-warfarin ranges from 21 to 43 hours."	0
"Ribavirin is known to inhibit IMDH, thereby leading to accumulation of an azathioprine metabolite, 6-methylthioionosine monophosphate (6-MTITP), which is associated with myelotoxicity (neutropenia, thrombocytopenia, and anemia)."	0
"Due to a lack of manufacturing standardization with botanical medicinal preparations, the amount of active ingredients may vary."	0
Encapsulating peritoneal sclerosis (5.3) Peritonitis: Initiate appropriate antimicrobial therapy.	0
"There was no effect on mating or fertility when dofetilide was administered to male and female rats at doses as high as 1.0 mg/kg/day, a dose that would be expected to provide a mean dofetilide AUC(0<U+2013>24hr) about 3 times the maximum likely human AUC."	0
"Exercise and isoproterenol induced tachycardia are antagonized by sotalol, and total peripheral resistance increases by a small amount."	0
Reconstitute one 1.5 mg vial of NATRECOR<U+00AE> by adding 5 mL of diluent removed from a pre-filled 250 mL plastic IV bag containing the diluent of choice.	0
"Warning signs or symptoms of hyperkalemia include paresthesias, muscular weakness, fatigue, flaccid paralysis of the extremities, bradycardia, shock, and ECG abnormalities."	0
"Periodic BUN or serum creatinine determinations should be made, especially in elderly patients and in patients with suspected or confirmed renal insufficiency."	0
Untreated narrow angle glaucoma or severe urinary retention.	0
Potassium is omitted from EXTRANEAL solutions because dialysis may be performed to correct hyperkalemia.	0
"PRADAXA capsules should therefore not be broken, chewed, or opened before administration."	0
There are case reports of patients succumbing to fatal dysrhythmias late after overdose; these patients had clinical evidence of significant poisoning prior to death and most received inadequate gastrointestinal decontamination.	0
Avoid concomitant use of aliskiren with ACCUPRIL in patients with renal impairment (GFR<60 mL/min/1.73 m2).	0
Fever should be managed by means of external cooling.	0
"The pressor effects of diethylpropion and those of other drugs may be additive when the drugs are used concomitantly; conversely, diethylpropion may interfere with antihypertensive drugs (i.e., guanethidine, <U+03B1>-methyldopa)."	0
"In view of the long and variable half-life of amiodarone, potential for drug interactions exists not only with concomitant medication but also with drugs administered after discontinuation of amiodarone [see Clinical Pharmacology (12.3)]."	0
"HMG-CoA Reductase Inhibitors Lovastatin, simvastatin Potential for serious reactions such as myopathy, including rhabdomyolysis."	0
"Dronedarone has no significant potential to inhibit CYP1A2, CYP2C9, CYP2C19, CYP2C8 and CYP2B6."	0
"In patients with Child<U+2011>Pugh A disease, Cmax and AUC were increased by 60% and 5%, respectively, as compared with patients with normal liver function."	0
"In TRITON-TIMI 38, Effient was administered without regard to coadministration of a proton pump inhibitor or H2 blocker."	0
"AUC0-2h, AUCinf, and Cmax increased in a dose-dependent manner."	0
The risk of administering methylene blue by non-intravenous routes (such as oral tablets or by local injection) or in intravenous doses much lower than 1 mg/kg with Anafranil is unclear.	0
ACCUPRIL is indicated as adjunctive therapy when added to conventional therapy including diuretics and/or digitalis.	0
Avoid systemic hypotension when administering the drug to patients who have sustained an acute cerebral infarction or hemorrhage.	0
"If LEXIVA is used in combination with ritonavir, see full prescribing information for ritonavir for additional information on drug interactions."	0
Intravenous diltiazem in doses of 20 mg prolongs AH conduction time and AV node functional and effective refractory periods by approximately 20%.	0
Ondansetron does not appear to induce or inhibit the cytochrome P-450 drug-metabolizing enzyme system of the liver.	0
Residual medication effects (<U+201C>hangover<U+201D>) were essentially absent.	0
"However, a statistically significant increase in benign Leydig cell tumor incidence was seen in the rats that received 378 and 950 mg/kg/day."	0
"Hypomagnesemia, symptomatic and asymptomatic, has been reported rarely in patients treated with PPIs for at least three months, and in most cases after a year of therapy."	0
"A prolonged QTc was observed between 1 and 5 weeks after start of TRISENOX infusion, and it usually resolved by 8 weeks after TRISENOX infusion."	0
"If use of CARDIZEM is deemed essential, an alternative method of infant feeding should be instituted."	0
Reports of malignancy include post-transplant lymphoma and hepatosplenic T-cell lymphoma (HSTCL) in patients with inflammatory bowel disease.	0
"If continuous fluid flow from connector is observed, discard solution container."	0
Sick sinus syndrome without a pacemaker.	0
"In an analysis of 506 DIAMOND patients with atrial fibrillation/flutter at baseline, one year mortality on TIKOSYN was 31% vs. 32% on placebo."	0
Effect of AUBAGIO on BCRP and organic anion transporting polypeptide B1 and B3 (OATP1B1/1B3) substrates Teriflunomide inhibits the activity of BCRP and OATP1B1/1B3 in vivo.	0
"In plasma, the AUC of 4-hydroxymethyl ambrisentan accounts for approximately 4% relative to parent ambrisentan AUC."	0
<U+2021> Dashed vertical lines illustrate pharmacokinetic changes that were used to inform dosing recommendations.	0
Itraconazole Atorvastatin AUC was significantly increased with concomitant administration of LIPITOR 40 mg and itraconazole 200 mg.	1
TWYNSTA tablets may be used to provide additional blood pressure lowering for patients not adequately controlled with amlodipine (or another dihydropyridine calcium channel blocker) alone or with telmisartan (or another angiotensin receptor blocker) alone.	0
"Steady State Selegiline Trough Concentrations Associated with Administration of EMSAM 15 mg/15 cm2 Daily for 7 Days Trough Concentration, pg/mL 6 to 11 year old age group 12 to 14 year old age group (N = 6) (N = 4) Mean (SD) 2,562 (974) 1,821 (146) The pharmacokinetics and pharmacodynamics of alcohol (0.75mg per kg) alone or in combination with EMSAM 6mg per 24 hours for 7 days of treatment was examined in 16 healthy volunteers."	0
"Voriconazole 400 mg BID <U+00D7> 7 days (maintenance dose) 300 mg QD <U+00D7> 7 days Healthy male subjects (12) <U+2191> AUC by 331%,<U+2191> Cmax by 195% <U+2191> AUC by ~100%,<U+2191> Cmax by ~100%compared to voriconazole 200 mg BID alone CONTRAINDICATED ANTI-PCP (Pneumocystis carinii pneumonia) Dapsone 50 mg QD 300 mg QD HIV-infected patients (16) ND <U+2193> AUC by 27 <U+2013>40% Sulfamethoxazole- Trimethoprim 800/160 mg 300 mg QD HIV-infected patients (12) <U+2194> <U+2193> AUC by 15<U+2013>20% ANTI-MAC (Mycobacterium avium intracellulare complex) Azithromycin 500 mg QD <U+00D7> 1 day, then 250 mg QD <U+00D7> 9 days 300 mg QD Healthy subjects (6) <U+2194> <U+2194> Clarithromycin 500 mg BID 300 mg QD HIV-infected patients (12) <U+2191> AUC by 75% <U+2193> AUC by 50% Monitor for rifabutin associated adverse events."	0
"During the interdosing intervals in some of these trials, anginal attacks have been more easily provoked than before treatment and patients have demonstrated hemodynamic rebound and decreased exercise tolerance."	0
The recommended dose of paroxetine in the treatment of OCD is 40 mg daily.	0
Thus a causal association between Anafranil treatment and these fatalities has not been established.	0
The mechanism and long-term consequences of these events are currently unknown.	0
These patients presented with abdominal pain (with or without nausea or vomiting); in some cases there was no prior history of facial angioedema and C-1 esterase levels were normal.	0
"In the controlled fibromyalgia trials, dysuria occurred more frequently in patients treated with Savella (1%) than in placebo-treated patients (0.5%)."	0
Do not coadminister aliskiren with Edarbi in patients with diabetes see Drug Interactions ( 7 ) .	0
Such monitoring should include daily observation by families and caregivers.	0
The concentrations observed in poor CYP 2D6 metabolizers are similar to those seen with strong CYP 2D6 inhibitors such as paroxetine.	0
"Antimycobacterials: rifabutin <U+2191> rifabutin A rifabutin dose reduction of up to 75% (eg, 150 mg every other day or 3 times per week) is recommended."	1
Studies at clinically relevant doses in man have demonstrated that sertraline blocks the uptake of serotonin into human platelets.	0
"Certain single nucleotide polymorphisms in the VKORC1 gene (e.g., <U+2013>1639G>A) have been associated with variable warfarin dose requirements."	0
Atorvastatin: Mean volume of distribution of atorvastatin is approximately 381 liters.	0
Children in the lowest dose group were given losartan in a suspension formulation.	0
"If such symptoms occur, consideration should be given to a possible causal role of the stimulant, and discontinuation of treatment may be appropriate."	0
Newly-Diagnosed Low-Risk Acute Promyelocytic Leukemia (APL) A treatment course for patients with newly-diagnosed low-risk APL consists of 1 induction cycle and 4 consolidation cycles.	0
"The patient should be monitored for symptoms of serotonin syndrome for 2 weeks or until 24 hours after the last dose of linezolid or intravenous methylene blue, whichever comes first."	0
Fluvoxamine acid and fluvoxethanol were tested in an in vitro assay of serotonin and norepinephrine reuptake inhibition in rats; they were inactive except for a weak effect of the former metabolite on inhibition of serotonin uptake (1 to 2 orders of magnitude less potent than the parent compound).	0
Freshly prepared reconstituted solutions or reconstituted solutions that have been stored at 2<U+00B0>C to 8<U+00B0>C (36<U+00B0>F to 46<U+00B0>F) for no longer than 8 days can be administered up to: 72 hours at up to 25<U+00B0>C (77<U+00B0>F).	0
"Diuretics: Excessive drop in blood pressure (7.1) Potassium-sparing diuretics/potassium supplements: Hyperkalemia (7.2) Lithium: Increase serum lithium levels, symptoms of lithium toxicity (7.3) Injectable gold: Nitritoid reactions (facial flushing, nausea, vomiting, and hypotension) (7.4) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7.7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7.8)."	0
<U+2022>REYATAZ oral powder must be taken with ritonavir and is not recommended for use in children who weigh less than 5 kg.	0
"Hemodynamic studies following intravenous dosing in patients with coronary artery disease and normal or moderately abnormal left ventricular function have shown significant increases in ejection fraction and cardiac output with no significant change, or a small decrease, in left ventricular end-diastolic pressure (LVEDP)."	0
Combined P-gp and strong CYP3A4 inhibitors increase exposure to rivaroxaban and may increase the risk of bleeding .	0
Accumulation ratio based on AUC of benazeprilat was 1.19 following once daily administration.	0
"However, due to the nonlinear pharmacokinetics of phenytoin, the failure to observe a significant effect on the single-dose pharmacokinetics of phenytoin does not preclude the possibility of a clinically significant interaction with nefazodone when phenytoin is dosed chronically."	0
Avoid concomitant use of known strong CYP3A4 inducers during CAPRELSA therapy.	0
"The Cmax and AUC of flurbiprofen were increased by 23% and 81%, respectively, when coadministered with fluconazole compared to administration of flurbiprofen alone."	1
"Chlorpromazine may impair mental and/or physical abilities, especially during the first few days of therapy."	0
"Tipranavir is a P-gp substrate, a weak P-gp inhibitor, and appears to be a potent P-gp inducer as well."	0
This is probably not the result of renal toxicity but is secondary to a reversible reduction of the glomerular filtration rate or a depletion of the intravascular fluid volume.	0
"In patients with severe congestive heart failure, whose renal function may depend on the activity of the renin-angiotensin-aldosterone system, treatment with angiotensin-converting enzyme inhibitors (including quinapril) may be associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death."	0
"On the other hand, atenolol can increase oxygen requirements by increasing left ventricular fiber length and end diastolic pressure, particularly in patients with heart failure."	0
"Once opened, PURIXAN should be used within 8 weeks."	0
"Should this occur, the solution and the volumetric infusion chamber should be replaced."	0
Whether this difference has clinical relevance is not yet known.	0
"VASOTEC is contraindicated in combination with a neprilysin inhibitor ( e.g. , sacubitril ) ."	0
Appropriate management of maternal hypertension during pregnancy is important to optimize outcomes for both mother and fetus.	0
Pregnancy Category D Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.	0
"Hyperkalemia may occur in patients on ARBs, particularly in patients with advanced renal impairment, heart failure, on renal replacement therapy, or on potassium supplements, potassium-sparing diuretics, potassium-containing salt substitutes or other drugs that increase potassium levels."	0
There has been no clinical experience with carvedilol in these patients although the <U+03B1>-blocking activity may prevent such symptoms.	0
"In long-term rodent studies, pantoprazole was carcinogenic and caused rare types of gastrointestinal tumors."	0
"The effect of ledipasvir 120 mg twice daily (2.67 times the maximum recommended dosage) for 10 days on QTc interval was evaluated in a randomized, multiple-dose, placebo-, and active-controlled (moxifloxacin 400 mg) three period crossover thorough QT trial in 59 healthy subjects."	0
Do not start CYMBALTA in a patient who is being treated with linezolid or intravenous methylene blue because there is an increased risk of serotonin syndrome.	0
The decision to prescribe DESOXYN tablets should depend on the physician<U+2019>s assessment of the chronicity and severity of the child<U+2019>s symptoms and their appropriateness for his/her age.	0
"At endpoint, 51% of paroxetine patients were free of panic attacks compared to 32% of placebo-treated patients."	0
Caution should therefore be observed in using rifampin in elderly patients.	0
INHALED/NASAL STEROID Fluticasone <U+2191> fluticasone Concomitant use of fluticasone propionate and VIRACEPT may increase plasma concentrations of fluticasone propionate.	1
"Because their vasospastic effects may be additive, co-administration of MAXALT and other 5-HT1 agonists within 24 hours of each other is contraindicated."	0
Various degrees of cross-resistance have been observed.	0
"ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor, angiotensin II."	0
"There is no known treatment for established cases of tardive dyskinesia, although the syndrome may remit, partially or completely, if antipsychotic treatment is withdrawn."	0
"Altered pharmacodynamics of other drugs: Quinidine's anticholinergic, vasodilating, and negative inotropic actions may be additive to those of other drugs with these effects, and antagonistic to those of drugs with cholinergic, vasoconstricting, and positive inotropic effects."	0
"When converting from PRADAXA to warfarin, adjust the starting time of warfarin based on creatinine clearance as follows: For CrCl <U+2265>50 mL/min, start warfarin 3 days before discontinuing PRADAXA."	0
There have also been reports of confusional states following tricyclic antidepressant administration in the elderly.	0
Prescribers should select the appropriate dose of PREZISTA/ritonavir for each individual child based on body weight (kg) and should not exceed the recommended dose for adults.	0
may be stored for up to 40 hours refrigerated at 2<U+00B0>C to 8<U+00B0>C (36<U+00B0>F to 46<U+00B0>F) before use.	0
Irbesartan Irbesartan is an orally active agent that does not require biotransformation into an active form.	0
The absorption of sotalol was reduced by approximately 20% compared to fasting when it was administered with a standard meal.	0
"Alcohol, in particular, has been found to exhibit additive effects of this variety."	0
"Diuretics: No pharmacokinetic interactions were observed in healthy adults between nebivolol (10 mg daily for 10 days) and furosemide (40 mg single dose), hydrochlorothiazide (25 mg once daily for 10 days), or spironolactone (25 mg once daily for 10 days)."	0
"Suicidal Ideation <U+2013> Monitor for suicidality, clinical worsening, and unusual changes in behavior."	0
Table 3: Usual Maintenance DoseThe doses are rounded to whole numbers.	0
Clinically significant adverse reactions from greater exposures of APTIVUS/ritonavir.	0
A few published case reports describe a distinctive and rare pattern of birth defects among infants whose mothers received high-dose (400<U+2013>800 mg/day) fluconazole during most or all of the first trimester of pregnancy.	0
Catecholamines/Anticholinergics It has been reported that tricyclic antidepressants can potentiate the effects of catecholamines.	0
Grapefruit juice contains one or more components that inhibit CYP3A4 and can increase the plasma concentrations of drugs metabolized by CYP3A4.	1
Titrate atorvastatin dose carefully and use the lowest necessary dose; do not exceed atorvastatin 20mg/day.	1
The recommended dose in patients with hepatic impairment is 50 mg per day.	0
No dosage adjustment required when nevirapine is administered with LEXIVA/ritonavir twice daily.	0
"These are tiny, almost transparent, asymptomatic peripheral and central corneal deposits which do not impair vision."	0
"As phendimetrazine tartrate is excreted in urine, exposure increases can be expected in patients with renal impairment."	0
The pharmacokinetics of irbesartan are not affected by coadministration of nifedipine or hydrochlorothiazide.	0
Some placental passage occurred when quinapril was administered to pregnant rats.	0
"Laboratory testing to determine liver enzyme levels should be done upon the first symptom or sign of liver dysfunction (e.g., pruritus, dark urine, jaundice, right upper quadrant tenderness, or unexplained <U+201C>flu like<U+201D> symptoms)."	0
Seizures: Cases have been reported with Savella therapy.	0
"In patients who have a family history of sudden death, cardiac dysrhythmias, or cardiac conduction disturbances."	0
"Cytochrome P450: Coadministration of Tracleer with drugs metabolized by CYP2C9 and CYP3A can increase exposure to Tracleer and/or the coadministered drug (4.2, 4.3, 7.1) Hormonal contraceptives: Tracleer use decreases contraceptive exposure and reduces effectiveness (7.2)."	1
Dosing of children and adolescents up to 70kg body weight<U+2014> STRATTERA should be initiated at a total daily dose of approximately 0.5mg/kg and increased after a minimum of 3days to a target total daily dose of approximately 1.2mg/kg administered either as a single daily dose in the morning or as evenly divided doses in the morning and late afternoon/early evening.	0
"If hepatic injury is suspected, promptly discontinue MULTAQ and test serum enzymes, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phosphatase, as well as serum bilirubin, to establish whether there is liver injury."	0
ACEON<U+00AE> (perindopril erbumine) is contraindicated in patients known to be hypersensitive (including angioedema) to this product or to any other ACE inhibitor.	0
The pharmacokinetics of irbesartan were not affected by coadministration of nifedipine or hydrochlorothiazide.	0
The recommended starting dose in these patients with hyponatremia (serum sodium <130 mEq/L) is 2.5 mg once daily.	0
Monitor electrolytes and ECGs more frequently in patients who experience diarrhea.	0
There were no active metabolites formed and the only significant metabolite present in blood was the O-conjugate.	0
"Titrate atorvastatin, pravastatin or rosuvastatin dose carefully and use the lowest necessary dose while monitoring for adverse events. cyclosporine, tacrolimus, sirolimus <U+2191> immunosuppressants Therapeutic concentration monitoring of the immunosuppressive agent is recommended when co-administered with PREZISTA/ritonavir."	1
Please refer to the ritonavir prescribing information for additional information on precautionary measures.	0
"These cases usually involved seriously ill patients with multiple confounding risk factors, such as history of cardiotoxic chemotherapy, cardiomyopathy, hypokalemia and concomitant medications that may have been contributory."	0
Pheochromocytoma or history of pheochromocytoma.	0
Captopril 58% 39% Clarithromycin NA 70% Dronedarone NA 150% Gentamicin 129 to 212% NA Erythromycin 100% NA Itraconazole 80% NA Lapatinib NA 180% Propafenone NA 60 to 270% Quinidine 100% NA Ranolazine 50% NA Ritonavir NA 86% Telaprevir 50% 85% Tetracycline 100% NA Verapamil 50 to 75% NA Digoxin Concentrations Increased Less than 50% Atorvastatin 22% 15% Measure serum digoxin concentrations before initiating concomitant drugs.	1
"After 2to4additional weeks, the dose may be increased to a maximum of 100mg in patients who have not achieved an optimal response."	0
"Because alprostadil inhibits platelet aggregation, use PROSTIN VR PEDIATRIC cautiously in neonates with bleeding tendencies."	0
Coadministration of losartan and cimetidine led to an increase of about 18% in AUC of losartan but did not affect the pharmacokinetics of its active metabolite.	1
"Hypotension, bradyarrhythmias, and lactic acidosis have been observed in patients receiving concurrent clarithromycin."	0
"Patients receiving immunosuppressants, including Imuran, are at increased risk for bacterial, viral, fungal, protozoal, and opportunistic infections, including reactivation of latent infections."	0
<U+2022>Coadministration of LEXIVA and ritonavir may result in clinically significant interactions with drugs metabolized by CYP2D6.	0
"Metabolism After oral administration, zaleplon is extensively metabolized, with less than 1% of the dose excreted unchanged in urine."	0
SULAR is contraindicated in patients with known hypersensitivity to dihydropyridine calcium channel blockers.	0
"In patients with CML, multiple doses of Tasigna increased the systemic exposure of oral midazolam (a substrate of CYP3A4) 2.6-fold."	1
Amlodipine Closely monitor patients with heart failure.	0
Hepatic Impairment: Discontinue for signs and symptoms of clinical hepatitis or asymptomatic increases in ALT/AST >10 times ULN or asymptomatic increases in ALT/AST 5-10 times ULN with concomitant increases in total bilirubin.	0
"Patients whose renal function may depend, in part, on the activity of the renin-angiotensin system (e.g., patient with renal artery stenosis, chronic kidney disease, severe heart failure, or volume depletion) may be at particular risk of developing oliguria, progressive azotemia or acute renal failure when treated with ATACAND."	0
"Sofosbuvir is a nucleotide prodrug that undergoes intracellular metabolism to form the pharmacologically active uridine analog triphosphate (GS-461203), which can be incorporated into HCV RNA by the NS5B polymerase and acts as a chain terminator."	0
Penicillin G penetrates poorly into human polymorphonuclear leukocytes.	0
Liver dysfunction has usually been reversible on discontinuation of therapy.	0
Studies of the mutagenic potential of DYAZIDE (the triamterene/hydrochlorothiazide combination) or of triamterene alone have not been performed.	0
There is no recommended dose of ONIVYDE for patients with serum bilirubin above the upper limit of normal.	0
"Prescriptions for clomipramine hydrochloride should be written for the smallest quantity of capsules consistent with good patient management, in order to reduce the risk of overdose."	0
"If an optimal response is not achieved, the dosage should be increased to TENORMIN 100 mg given as one tablet a day."	0
Caution should be exercised when it is used in such patients or in patients with preexisting sinus node dysfunction or intraventricular conduction abnormalities.	0
"Thus, patients being treated with STRATTERA should be observed for the emergence of such symptoms."	0
ONIVYDE can cause severe and life-threatening diarrhea.	0
The maximum daily dose should not exceed 30 mg in any 24-hour period.	0
The mean baseline LDL<U+2011>C value was 218.3mg/dL (range: 136.3-363.7mg/dL) in the MEVACOR group compared to 198.8mg/dL (range: 151.1-283.1mg/dL) in the placebo group.	0
"Titrate to maximum of 50 mg once daily within 4 weeks, as tolerated."	0
The effect of renal impairment on metabolite elimination has not been studied.	0
"CNS Acting Drugs <U+2014> Given the primary CNS effects of CYMBALTA, it should be used with caution when it is taken in combination with or substituted for other centrally acting drugs, including those with a similar mechanism of action."	0
Induction of enzyme activities by PRIFTIN occurred within 4 days after the first dose.	0
The enzyme inhibiting effect of fluconazole persists 4<U+2013>5 days after discontinuation of fluconazole treatment due to the long half-life of fluconazole.	0
"The usual recommended dose of TIKOSYN is 500 mcg BID, as modified by the dosing algorithm described below."	0
"To report SUSPECTED ADVERSE REACTIONS, contact Rare Disease Therapeutics, Inc., at 888-470-0578 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch."	0
"Diminution of established urine flow rate, increasing tachycardia or development of new dysrhythmias are reasons to consider decreasing or temporarily suspending the dosage."	0
"When pregnancy is detected, discontinue ALTACE as soon as possible."	0
In man the same qualitative hemodynamic effects have been observed.	0
"Since comparable efficacy was observed for this combination in phase 3 studies, dose adjustment is not recommended."	0
Monitor renal function periodically.	0
Twenty-four hour ACE inhibition is about 60% after these doses.	0
CAPRELSA may be taken with or without food.	0
Doses up to 80 mg have been used but do not appear to give a greater effect.	0
Distribution Amlodipine: Ex vivo studies have shown that approximately 93% of the circulating amlodipine drug is bound to plasma proteins in hypertensive patients.	0
Treatment of life<U+2013>threatening ventricular arrhythmias<U+2014>Dosing regimens for the use of intravenous quinidine gluconate in controlling life<U+2013>threatening ventricular arrhythmias have not been adequately studied.	0
The use of nortriptyline hydrochloride oral solution USP within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated.	0
"However, acute intravenous administration of PERSANTINE may worsen regional myocardial perfusion distal to partial occlusion of coronary arteries."	0
Verapamil may shorten the antegrade effective refractory period of accessory bypass tracts.	0
"Given the 24-hour elimination half-life of ZOLOFT, the recommended interval between dose changes is one week."	0
"The bioavailability of perindoprilat was reduced by diuretics, however, and this was associated with a decrease in plasma ACE inhibition."	0
Savella should ordinarily not be prescribed to patients with substantial alcohol use or evidence of chronic liver disease.	0
Toxicity in preterm neonates: NORVIR oral solution should not be used in preterm neonates in the immediate postnatal period because of possible toxicities.	0
"Based on pharmacokinetic data which demonstrate significantly increased plasma concentrations of losartan in cirrhotic patients, a lower dose should be considered for patients with impaired liver function."	0
"Complex behaviors such as ""sleep-driving"" (i.e., driving while not fully awake after ingestion of a hypnotic, with amnesia for the event) have been reported with hypnotics."	0
"Therefore, use the lowest dose necessary.Saquinavir 400 mg BID/ritonavir 400mg BID, 15 days 40 mg QD for 4 days <U+2191> 390% <U+2191> 430% Clarithromycin 500 mg BID, 9 days 80 mg QD for 8 days <U+2191> 440% <U+2191> 540% Darunavir 300 mg BID/ritonavir 100 mg BID, 9 days 10 mg QD for 4 days <U+2191> 340% <U+2191> 230% Itraconazole 200 mg QD, 4 days 40 mg SD <U+2191> 330% <U+2191> 20% Fosamprenavir 700 mg BID/ritonavir 100 mg BID, 14 days 10 mg QD for 4 days <U+2191> 250% <U+2191> 280% Fosamprenavir 1400 mg BID, 14 days 10 mg QD for 4 days <U+2191> 230% <U+2191> 400% Nelfinavir 1250 mg BID, 14 days 10 mg QD for 28 days <U+2191> 74% <U+2191> 220% Grapefruit Juice, 240 mL QDGreater increases in AUC (up to 2.5-fold) and/or Cmax (up to 71%) have been reported with excessive grapefruit consumption (<U+2265> 750 mL <U+2013> 1.2 liters per day)."	1
"For this group, Cmax and AUC were increased 37% and 64%, respectively."	0
Standard rifampin powder should give the following MIC values: Microorganism MIC (mcg/mL) Staphylococcus aureus ATCC 29213 0.008 - 0.06 Enterococcus faecalis ATCC 29212 1 - 4 Escherichia coli ATCC 25922 8 - 32 Pseudomonas aeruginosa ATCC 27853 32 - 64 Haemophilus influenzae ATCC 49247 0.25 - 1 Diffusion Techniques: Quantitative methods that require measurement of zone diameters provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds.	0
"The administration of Tasigna with agents that may prolong the QT interval such as anti-arrhythmic medicines should be avoided [see Boxed Warning, Dosage and Administration (2."	0
"Blockade of the angiotensin II receptor inhibits the negative regulatory feedback of angiotensin II on renin secretion, but the resulting increased plasma renin activity and angiotensin II circulating levels do not overcome the effect of telmisartan on blood pressure."	0
"In addition, since MYCOBUTIN may rarely be associated with myositis and uveitis, patients should be advised to notify their physicians if they develop signs or symptoms suggesting either of these disorders."	0
TARKA has not been evaluated in patients with impaired renal function.	0
"Elimination The in vitro half<U+2011>life of epoprostenol in human blood at 37<U+00B0>C and pH 7.4 is approximately 6minutes; therefore, the in vivo half<U+2011>life of epoprostenol in humans is expected to be no greater than 6minutes."	0
Hepatic toxicity: Monitor for jaundice or signs of liver failure.	0
Hepatic testing should be performed in patients with underlying liver disease prior to initiation of REYATAZ and continued during treatment with REYATAZ.	0
"A patient Medication Guide about ""Antidepressant Medicines, Depression and other Serious Mental Illness, and Suicidal Thoughts or Actions"" is available for nortriptyline hydrochloride."	0
Tizanidine: See CONTRAINDICATIONS (4) and WARNINGS AND PRECAUTIONS ( 5.5 ).	0
"Because coronary artery disease is common and may be unrecognized, avoid abruptly discontinuing DUTOPROL in patients treated only for hypertension."	0
"Thus, his/her dosing requirements resemble those of poor metabolizers."	0
"Due to the immunosuppression associated with maintenance chemotherapy for ALL, response to all vaccines may be diminished and there is a risk of infection with live virus vaccines."	0
4.Remove pull ring from connector of solution container.	0
Several cases of toxic psychosis have been reported following the excessive use of the drug and some have been reported in which the recommended dose appears not to have been exceeded.	0
Dihydropyridine Calcium Channel Blockers(CYP3A4 Inhibition) In Vitro Studies Demonstrated Potential for Voriconazole to Inhibit Metabolism(Increased Plasma Exposure) Frequent monitoring for adverse events and toxicity related to calcium channel blockers.	1
It is not necessary to monitor the effect of ZYTIGA on serum testosterone levels.	0
"Sedative/hypnotics Oral midazolamc, triazolam Prolonged or increased sedation or respiratory depression. a see Drug Interactions (7), Table 5 for colchicine doses in patients with normal hepatic and renal function. b see Drug Interactions (7), Table 5 for co-administration of sildenafil in patients with erectile dysfunction. c see Drug Interactions (7), Table 5 for parenterally administered midazolam."	0
Recommended Dosage for Treatment of HIV-1: The recommended dosage of NORVIR is 600 mg twice daily by mouth to be taken with meals.	0
This extemporaneously prepared suspension must be shaken well prior to administration.	0
"Dose increases should occur in increments of 100 mg/day to 200 mg/day, again on a BID schedule, at intervals of no less than 1 week."	0
Deaths from status asthmaticus have been reported following single doses of COREG.	0
Antimycobacterial: rifampin May lead to loss of virologic response and possible resistance to CRIXIVAN or to the class of protease inhibitors or other coadministered antiretroviral agents.	0
Cimetidine Cimetidine inhibits many cytochrome P450 (oxidative) enzymes.	0
"All females, regardless of reproductive potential, must enroll in the Letairis REMS program prior to initiating Letairis."	0
Chronic fingolimod dosing leads to a mild decrease in the neutrophil count to approximately 80% of baseline.	0
Small reductions in blood pressure occurred following coadministration of tadalafil with these agents compared with placebo [see Warnings and Precautions (5.1) and Clinical Pharmacology (12.2)].	0
"Patients should be cautioned about the risk of bleeding associated with the concomitant use of Savella and NSAIDs, aspirin, or other drugs that affect coagulation."	0
"Elimination Following oral administration of 200 mg of 14C-bupropion in humans, 87% and 10% of the radioactive dose were recovered in the urine and feces, respectively."	0
"In a study of 21 pediatric patients (3 to 12 years of age) who were undergoing surgery requiring anesthesia for a duration of 45 minutes to 2 hours, a single intravenous dose of ondansetron, 2 mg (3 to 7 years) or 4 mg (8 to 12 years), was administered immediately prior to anesthesia induction."	0
The single dose bioavailability of sertraline tablets is approximately equal to an equivalent dose of solution.	0
"Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
CYP3A4 inducers including bosentan Concomitant administration of potent CYP3A inducers is expected to cause substantial decreases in plasma levels of sildenafil.	1
"Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine)- possible increased responsiveness to the muscle relaxant."	0
"Other Statins Because of multiple mechanisms of interaction with statins (CYPs and transporters), follow statin label recommendations for use with CYP 3A and P-gp inhibitors such as dronedarone."	0
"Although a causal link between the emergence of such symptoms and either the worsening of depression and/or the emergence of suicidal impulses has not been established, there is concern that such symptoms may represent precursors to emerging suicidality."	0
"In addition, in vitro studies suggest that paroxetine, sertraline, norfluoxetine, fluvoxamine, and nelfinavir inhibit the hydroxylation of bupropion."	0
"Skeletal muscle relaxants, nondepolarizing (e.g., tubocurarine) - possible increased responsiveness to the muscle relaxant."	0
Diazepam: See WARNINGS AND PRECAUTIONS (5.9).	0
"In orthopedic hip surgery patients, maximum aPTT response (Emax) to dabigatran and baseline aPTT were higher shortly after surgery than at later time points (e.g."	0
<U+2022>Left ventricular dysfunction following myocardial infarction: Start at 6.25mg twice daily and increase to 12.5 mg then 25 mg twice daily after intervals of 3 to 10days.	0
"Antifungals: Ketoconazolea, itraconazole <U+2191>Ketoconazole <U+2191>Itraconazole Increase monitoring for adverse events."	0
"Various metabolites, including glucuronides, contribute to <U+03B2>-blocking activity."	0
"Doses up to 12 mg/kg/day may be used, based on medical judgment of the patient's response to therapy."	0
Serum potassium levels should be monitored during concomitant drug therapy.	0
An increase in chromatid breaks was noted when whole blood cell cultures were treated with rifampin.	0
"Dosage should be tailored to the individual, response carefully monitored, and dosage adjusted accordingly."	0
"Concurrent administration of tricyclic antidepressants and indirect-acting sympathomimetic amines such as the amphetamines, should be closely supervised and dosage carefully adjusted."	0
"Some patients have had additional symptoms such as dyspnea, throat closing, or nausea and vomiting that suggest anaphylaxis."	0
FLOLAN is contraindicated in patients with a hypersensitivity to the drug or any of its ingredients.	0
Antipsychotics lurasidone Potential for serious and/or life-threatening reactions. pimozide Potential for serious and/or life-threatening reactions such as cardiac arrhythmias.	0
The excess accumulation is a consequence of the fact that 1 of the enzymes that metabolizes paroxetine is readily saturable.	0
VFEND has not been studied in patients with severe hepatic cirrhosis (Child-Pugh Class C) or in patients with chronic hepatitis B or chronic hepatitis C disease.	0
Dopamine-induced renal and mesenteric vasodilation is not antagonized by either <U+03B1>- or <U+03B2>-adrenergic blocking agents.	0
The use of REYATAZ without ritonavir in pregnant women is not recommended.	0
The long-term effect of PHOSLYRA on the progression of vascular or soft-tissue calcification has not been determined.	0
"ORAP (pimozide) may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks, such as driving a car or operating machinery, especially during the first few days of therapy."	0
<U+03B2>-blockers can precipitate or aggravate symptoms of arterial insufficiency in patients with peripheral vascular disease.	0
"A report of <U+201C>intermediate<U+201D> indicates that the result should be considered equivocal, and if the microorganism is not fully susceptible to alternative, clinically feasible drugs, the test should be repeated."	0
Bisoprolol fumarate is a beta1-selective (cardioselective) adrenoceptor blocking agent without significant membrane stabilizing or intrinsic sympathomimetic activities in its therapeutic dose range.	0
Use of PDE-5 inhibitors for erectile dysfunction: Concomitant use of PDE-5 inhibitors with APTIVUS/ritonavir should be used with caution and in no case should the starting dose of: sildenafil exceed 25 mg within 48 hours tadalafil exceed 10 mg every 72 hours vardenafil exceed 2.5 mg every 72 hours Use with increased monitoring for adverse events.	0
"In a study comparing 14-day dosing with WELLBUTRIN XL, 300 mg once-daily to the immediate-release formulation of bupropion at 100 mg 3 times daily, equivalence was demonstrated for peak plasma concentration and area under the curve for bupropion and the three metabolites (hydroxybupropion, threohydrobupropion, and erythrohydrobupropion)."	0
Lexapro should be discontinued before initiating treatment with the MAOI.	0
Open transfer set to drain the solution from abdomen.	0
"Lithium: Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium, including ACE inhibitors."	1
Examples: warfarin Drugs Metabolized by CYP2D6 Clinical Impact: ZOLOFT is a CYP2D6 inhibitor.	0
Deaths were first observed after about 1 year and causes of death were typical of patients with PAH.	0
"The appearance of hypotension after the initial dose of ALTACE does not preclude subsequent careful dose titration with the drug, following effective management of the hypotension."	0
"Intracranial bleeding, sometimes fatal, has been reported in association with the increase in blood pressure."	0
Comparisons of the systemic availability and equivalent doses for preparations of digoxin are shown in Table 5.	0
WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning.	0
"Patients on concomitant ondansetron self administered tramadol more frequently in these studies, leading to an increased cumulative dose in patient controlled administration (PCA) of tramadol."	1
"Healthcare professionals should pay special attention to accurate dose selection of PREZISTA, transcription of the medication order, dispensing information and dosing instruction to minimize risk for medication errors, overdose, and underdose."	0
"In some studies, slight, asymptomatic increases in airway resistance (AWR) and decreases in forced expiratory volume (FEV1) were observed with doses of bisoprolol fumarate 20 mg and higher, similar to the small increases in AWR noted with other cardioselective beta-blocking agents."	0
Water is an essential constituent of all body tissues and accounts for approximately 70% of total body weight.	0
"Titrate according to heart rate, PR interval, blood pressure and symptoms."	0
"Allow at least five weeks between discontinuation of fluoxetine and initiation of NARDIL and at least 14 days between discontinuation of NARDIL and initiation of fluoxetine, or other serotoninergic agents."	0
Mirtazapine has no significant affinity for the 5-HT1A and 5-HT1B receptors.	0
"Lorazepam (IM) <U+2014> Administration of intramuscular lorazepam (2mg) 1 hour after intramuscular olanzapine for injection (5mg) did not significantly affect the pharmacokinetics of olanzapine, unconjugated lorazepam, or total lorazepam."	0
The 75 mg dose can be titrated upward to 112.5 or 150 mg after at least 3 days.	0
"Thus, in neonates the time to steady-state may be as long as a week or longer."	0
"The main human metabolite was fluvoxamine acid which, together with its N-acetylated analog, accounted for about 60% of the urinary excretion products."	0
"CABG-related bleeding may be treated with transfusion of blood products, including packed red blood cells and platelets; however, platelet transfusions within 6hours of the loading dose or 4hours of the maintenance dose may be less effective."	0
Mexiletine should be used with caution in patients with hypotension and severe congestive heart failure because of the potential for aggravating these conditions.	0
"In patients with such arrhythmias subjected to programmed electrical stimulation or to exercise provocation, 10 to 15% of patients had exacerbation of the arrhythmia, a rate not greater than that of other agents."	0
"In subjects who had received EMSAM 6mg per 24 hours for 10 days, co-administration with olanzapine, a substrate for CYP1A2, CYP2D6, and possibly CYP2A6, did not affect the pharmacokinetics of selegiline or olanzapine."	0
"Conversely, adverse effects could result from displacement of paroxetine by other highly bound drugs."	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP is also contraindicated in patients with known peripheral arterial disease, sepsis, following vascular surgery and severely impaired hepatic or renal function."	0
Drug-Drug Interaction Studies.	0
"Limit fluvastatin dose to 20 mg (2.4, 7.1) Fluconazole: Combination increases fluvastatin exposure."	1
Dosage adjustment of atomoxetine may be necessary and it is recommended that atomoxetine be initiated at a reduced dose when it is given with paroxetine.	1
NORVIR must be used in combination with other antiretroviral agents.	0
Discontinue treatment if severe reaction develops.	0
"Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies with Major Depressive Disorder (MDD) and other psychiatric disorders."	0
Patients with renal insufficiency: Patients with renal insufficiency have not been studied.	0
"FANAPT has moderate affinity for dopamine D4, and serotonin 5-HT6 and 5-HT7 receptors (Ki values of 25, 43, and 22, nM respectively), and low affinity for the serotonin 5-HT1A, dopamine D1, and histamine H1 receptors (Ki values of 168, 216 and 437 nM, respectively)."	0
"In general, avoid combined use of RAS inhibitors."	0
"The mean washout half-life of desalkyl-flurazepam was longer in elderly male and female subjects (126 and 158 hours, respectively) compared with younger male and female subjects (111 and 113 hours, respectively).1 1 Greenblatt DJ, Divoll M, Hammatz JS, MacLauglin DS, Shader RI: Kinetics and clinical effects of flurazepam in young and elderly noninsomniacs."	0
"Adults: 500 mg APTIVUS, co-administered with 200 mg ritonavir, twice daily (2.1) Pediatric patients (age 2 to 18 years): Dosing is based on body weight or body surface area not to exceed adult dose (2.2) APTIVUS taken with ritonavir capsules or solution can be taken with or without meals (2) APTIVUS taken with ritonavir tablets must be taken with meals (2) Store unopened bottles of APTIVUS capsules in the refrigerator (16) Do not freeze or refrigerate APTIVUS oral solution (16) The recommended adult dose of APTIVUS is 500 mg (two 250 mg capsules or 5 mL oral solution) co-administered with 200 mg of ritonavir, twice daily."	0
Focalin XR is intended for oral administration once daily in the morning.	0
Increase to 40 mg once daily based upon individual tolerability.	0
The dosing algorithm shown above should be used to determine the individualized dose of TIKOSYN.	0
Avoid administration of PPIs for longer than medically indicated.	0
"However, it is recommended that didanosine be administered on an empty stomach; therefore, didanosine should be given one hour before or two hours after VIRACEPT (given with food)."	0
"This is followed by a much more gradual decline in the serum concentration of the drug, which is dependent on the elimination of digoxin from the body."	0
Mean pressor doses (TYR30) of tyramine capsules administered without food were 270mg in subjects treated with EMSAM 6mg per 24 hours and 10mg in subjects treated with tranylcypromine.	0
Verapamil component The use of HMG-CoA reductase inhibitors that are CYP3A4 substrates in combination with verapamil has been associated with reports of myopathy/rhabdomyolysis.	0
"Based on observations in rats, atorvastatin calcium is likely to be secreted in human milk."	0
"Antacids (e.g., aluminum and magnesium hydroxide) It is recommended to separate antacid and HARVONI administration by 4 hours."	0
"Such drugs include many antiarrhythmics, some phenothiazines, tricyclic antidepressants, and certain oral macrolides."	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy."	0
"ZOLOFT is contraindicated in patients: Taking, or within 14 days of stopping, MAOIs, (including the MAOIs linezolid and intravenous methylene blue) because of an increased risk of serotonin syndrome."	0
Single oral doses of sildenafil up to 100 mg in healthy volunteers produced no clinically relevant effects on ECG.	0
The effect of cyclosporine on diltiazem plasma concentrations has not been evaluated.	0
"Patients whose renal function may depend in part on the activity of the RAAS ( e.g. , patients with renal artery stenosis , severe heart failure , post-myocardial infarction or volume depletion ) or patients receiving ARB , ACEI or nonsteroidal anti-inflammatory drug ( NSAID ) , including selective Cyclooxygenase-2 inhibitors ( COX-2 inhibitors ) , therapy may be at particular risk for developing acute renal failure on Tekturna see Warnings and Precautions ( 5.2 Drug Interactions ( 7 ) , and Use in Specific Populations ( 8.7 ) and Clinical Studies ( 14.3 ) ."	0
Apixaban has no effect on the QTc interval in humans at doses up to 50 mg. Apixaban demonstrates linear pharmacokinetics with dose-proportional increases in exposure for oral doses up to 10 mg.	0
The safety of doses above 120mg once daily has not been adequately evaluated.	0
"During randomized controlled studies, transaminase elevations greater than three times the upper limit of normal (ULN) were observed (AST: 2%, 2%, and ALT: 3%, 2% in ULORIC and allopurinol-treated patients, respectively)."	0
Erythromycin co-administration in healthy volunteers did not significantly change amlodipine systemic exposure.	0
Fluvoxamine decreases the plasma clearance of lidocaine by 41%-60% and prolonged the mean half-life by one hour.	1
The lowest pressor dose was 50mg in one subject in the 33-day group.	0
"If concomitant use of PEXEVA<U+00AE> with other serotonergic drugs including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, tryptophan, amphetamines, and St. John's Wort is clinically warranted, be aware of a potential increased risk for serotonin syndrome, particularly during treatment initiation and dose increases."	0
"In patients receiving thiazides, sensitivity reactions may occur with or without a history of allergy or bronchial asthma."	0
These reactions may be severe and DRESS may be fatal.	0
"Rebound insomnia following discontinuation of Zaleplon relative to baseline was examined at both nights 1 and 2 following discontinuation in three sleep laboratory studies (14, 28, and 35 nights) and five outpatient studies utilizing patient diaries (14 and 28 nights)."	0
Meperidine Hydrochloride Injection may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery.	0
"Well controlled studies have demonstrated that doses of hydrochlorothiazide as low as 25 mg given once daily are effective in treating hypertension, but the dose-response has not been clearly established."	0
Epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an NSAID or aspirin may potentiate this risk of bleeding.	0
"Meperidine Hydrochloride Injection exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death."	0
Lithium generally should not be given with diuretics because they reduce its renal clearance and increase the risk of lithium toxicity.	1
Patients with insufficient blood pressure effects with metoprolol succinate extended release or hydrochlorothiazide alone may be switched to DUTOPROL.	0
"If, during concomitant use of a beta blocker, antihypertensive therapy needs to be interrupted or discontinued, discontinue the beta blocker first, and the discontinuation should be gradual."	0
"Drug I nteractions Lotensin has been used concomitantly with beta-adrenergic-blocking agents, calcium- channel-blocking agents, diuretics, digoxin, and hydralazine, without evidence of clinically important adverse interactions."	0
"Completing Course of Therapy: While patients may notice improvement with paroxetine therapy in 1 to 4 weeks, they should be advised to continue therapy as directed."	0
Caution should be observed when initiating therapy in patients with heart failure.	0
There is little experience beyond 72 hours at any dose.	0
Coadministration of aspirin 150 mg/day with multiple daily doses of BRINTELLIX had no significant inhibitory effect on platelet aggregation or pharmacokinetics of aspirin and salicylic acid.	0
"Hydrochlorothiazide also decreases the excretion of calcium and uric acid, may increase the excretion of iodide, and may reduce glomerular filtration rate."	0
Patients receiving ACE inhibitors who develop jaundice or marked elevations of hepatic enzymes should discontinue the ACE inhibitor and receive appropriate medical follow-up.	0
The mechanism and long-term consequences of these events are currently unknown.	0
The risk of skeletal muscle effects may be enhanced when fluvastatin sodium is used in combination with lipid-modifying doses (<U+2265> 1 g/day) of niacin; a reduction in fluvastatin sodium dosage should be considered in this setting.	0
"While taking beta blockers, patients with a history of anaphylactic reaction to a variety of allergens may have a more severe reaction on repeated challenge, either accidental, diagnostic or therapeutic."	0
The concentrations observed in poor CYP 2D6 metabolizers are similar to those seen with strong CYP 2D6 inhibitors such as paroxetine.	0
The possible exacerbation or activation of systemic lupus erythematosus has been reported.	0
"As the primary effect of adenosine is to decrease conduction through the A-V node , higher degrees of heart block may be produced in the presence of carbamazepine ."	0
"Dosage reduction for midazolam should be considered, especially if more than a single dose of midazolam is administered."	1
Administration Take K-TAB with meals and with a glass of water or other liquid.	0
There is evidence that chlorpromazine is excreted in the breast milk of nursing mothers.	0
"Antifungals:ketoconazoleitraconazolevoriconazole <U+2191> ketoconazole<U+2191> itraconazole<U+2193> voriconazole For contraindicated antifungals,."	0
"Like other agents that are metabolized by CYP2D6, paroxetine may significantly inhibit the activity of this isozyme."	0
"Therefore, LUVOX CR Capsules should not be coadministered with thioridazine."	0
An active ion transport system maintains this gradient across the plasma membrane.	0
Nicardipine may occasionally produce symptomatic hypotension or tachycardia.	0
"Switching from Anticoagulants other than Warfarin to XARELTO - For patients currently receiving an anticoagulant other than warfarin , start XARELTO 0 to 2 hours prior to the next scheduled evening administration of the drug ( e.g. , low molecular weight heparin or non-warfarin oral anticoagulant ) and omit administration of the other anticoagulant ."	0
"In one study involving 15 patients treated with high doses of propranolol (median dose: 480 mg/day; range: 160 to 1,280 mg/day) for severe angina, with preserved left ventricular function (ejection fraction greater than 35%), the hemodynamic effects of additional therapy with verapamil HCl were assessed using invasive methods."	0
Triazolam/Alprazolam <U+2013> See CONTRAINDICATIONS and WARNINGS.	0
"Therefore, it is not recommended that the drug be given to pregnant patients except when, in the judgment of the physician, it is essential."	0
"If alprazolam is coadministered with LUVOX CR Capsules, the initial alprazolam dosage should be at least halved and titration to the lowest effective dose is recommended."	1
Clinical studies have demonstrated no clinically significant pharmacokinetic interaction between PRISTIQ and CYP3A4 substrates (Figure 2).	0
"CYP3A Substrate (e.g., Midazolam) <U+2014> Coadministration of STRATTERA (60mg BID for 12days) with midazolam, a model compound for CYP3A4 metabolized drugs (single dose of 5mg), resulted in 15% increase in AUC of midazolam."	1
"Chronic oral administration of 120 mg of verapamil HCl every 6 hours resulted in plasma levels of verapamil ranging from 125 to 400 ng/ml, with higher values reported occasionally."	0
"When tamoxifen is used for the treatment or prevention of breast cancer, prescribers should consider using an alternative antidepressant with little or no CYP2D6 inhibition."	0
"Race: In pharmacokinetic studies pitavastatin Cmax and AUC were 21 and 5% lower, respectively in Black or African American healthy volunteers compared with those of Caucasian healthy volunteers."	0
Atorvastatin and atorvastatin-metabolites are substrates of the OATP1B1 transporter.	0
Not recommended for use in children.	0
There have been rare postmarketing reports of serotonin syndrome with the use of an SSRI and a triptan.	0
It is recommended that International Normalized Ratio (INR) be monitored.	0
The increase in QT interval observed on the surface ECG is a result of prolongation of both effective and functional refractory periods in the His-Purkinje system and the ventricles.	0
Less than 2% of the dose is excreted in the feces.	0
"Candesartan has much greater affinity (>10,000-fold) for the AT1 receptor than for the AT2 receptor."	0
"The mechanism of action of olanzapine, as with other drugs having efficacy in schizophrenia, is unknown."	0
Carcinoma of the prostate should therefore be ruled out prior to commencing therapy with CARDURA for the treatment of BPH.	0
Nortriptyline hydrochloride oral solution USP is contraindicated during the acute recovery period after myocardial infarction.	0
"Nevertheless, the physician who elects to use Lexapro for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient."	0
"In an in vivo animal model used to test for antidepressant activity (Forced Swim Test), selegiline administered by transdermal system exhibited antidepressant properties only at doses that inhibited both MAO-A and MAO-B activity in the brain."	0
Elimination was significantly correlated with creatinine clearance.	0
Non-clinical studies have shown that levomilnacipran is a potent and selective serotonin and norepinephrine reuptake inhibitor (SNRI).	0
Ramipril and ramiprilat inhibit ACE in human subjects and animals.	0
Digoxin crosses both the blood-brain barrier and the placenta.	0
The concomitant use of aliskiren with an ARB or an ACEI in diabetic patients is contraindicated [see Contraindications (4)].	0
"RIFADIN should be used with caution in patients with a history of diabetes mellitus, as diabetes management may be more difficult."	0
"When pregnancy is detected, discontinue MICARDIS as soon as possible (5.1, 8.1) Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus (5.1, 8.1)"	0
"The treatment regimens described below are based on those used in controlled clinical trials of Anafranil in 520 adults, and 91 children and adolescents with OCD."	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP should only be used where a clear diagnosis of migraine headache has been established."	0
Marplan should not be administered to any patient with a confirmed or suspected cerebrovascular defect or to any patient with cardiovascular disease or hypertension.	0
A rapid dose-related increase in nicardipine plasma concentrations is seen during the first two hours after the start of an infusion of nicardipine.	0
"In a study comparing prothrombin time AUC (0 to 120 hr) following dosing with warfarin (0.75 mg/kg) before and after 21 days of dosing with either sertraline (50 to 200 mg/day) or placebo, there was a mean increase in prothrombin time of 8% relative to baseline for sertraline compared to a 1% decrease for placebo (p < 0.02)."	0
Patients taking concomitant neprilysin inhibitors may be at increased risk for angioedema.	0
"In both young and elderly populations, plasma accumulation is low; the accumulation factor ranges from 1.1 to 1.3, and is what would be expected from the half-life and once-daily dosing."	0
"Because any psychoactive drug may impair judgment, thinking, or motor skills, however, patients should be cautioned about operating hazardous machinery, including automobiles, until they are reasonably certain that Lexapro therapy does not affect their ability to engage in such activities."	0
"The pooled analyses of placebo-controlled trials in adults with MDD or other psychiatric disorders included a total of 295 short-term trials (median duration of 2 months) of 11 antidepressant drugs in over 77,000 patients."	0
"The clearance of benzodiazepines metabolized by glucuronidation (e.g., lorazepam, oxazepam, temazepam) is unlikely to be affected by fluvoxamine."	0
"Supplements Calcium If administered rapidly by intravenous route, can produce serious arrhythmias in digitalized patients."	0
Avoid simvastatin and lovastatin doses greater than 40 mg [see Clinical Pharmacology (12.3) ].	0
Caution should be exercised in such individuals.	0
"ACE inhibitors also inhibit the degradation of bradykinin, a reaction also catalyzed by ACE."	0
Prosthetic heart valves: ELIQUIS use not recommended.	0
Sudden Death and Pre-existing Structural Cardiac Abnormalities or Other Serious Heart Problems Children and Adolescents <U+2014> Sudden death has been reported in association with atomoxetine treatment at usual doses in children and adolescents with structural cardiac abnormalities or other serious heart problems.	0
"Ergot derivatives: Dihydroergotamine, ergonovine, ergotamine, methylergonovine POTENTIAL for serious and/or life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues."	0
(high dose) 10 200 mL of double-strength TIDDouble-strength: one can of frozen concentrate diluted with one can of water.	0
The mechanism by which <U+03B2>-blockade produces an antihypertensive effect has not been established.	0
Figure 2 False-positive urine immunoassay screening tests for phencyclidine (PCP) and amphetamine have been reported in patients taking venlafaxine.	0
"The following symptoms, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric."	0
"Although significant beta-blockade occurs at oral doses as low as 25 mg, significant Class III effects are seen only at daily doses of 160 mg and above."	0
"Consequently, concomitant use of paroxetine with tryptophan is not recommended."	0
"If signs or symptoms consistent with CLE or SLE are noted in patients receiving ACIPHEX, discontinue the drug and refer the patient to the appropriate specialist for evaluation."	0
"When pregnancy is detected, discontinue ACEON as soon as possible."	0
Information for Patients: Patients being started on IMURAN should be informed of the necessity of periodic blood counts while they are receiving the drug and should be encouraged to report any unusual bleeding or bruising to their physician.	0
"This inhibition results in an increase in local concentrations of adenosine which acts on the platelet A2-receptor thereby stimulating platelet adenylate cyclase and increasing platelet cyclic-3',5'-adenosine monophosphate (cAMP) levels."	0
"In normal volunteers, bisoprolol fumarate therapy resulted in a reduction of exercise- and isoproterenol-induced tachycardia."	0
"Effects of peripheral vasculopathy, including Raynaud's phenomenon, were observed in post-marketing reports at different times and at therapeutic doses in all age groups throughout the course of treatment."	0
"Because it is known that the risk of myopathy during treatment with HMG-CoA reductase inhibitors is increased with concomitant use of fenofibrates, caution should be used when prescribing fenofibrates with CRESTOR."	0
MULTAQ doubles the risk of cardiovascular death (largely arrhythmic) and heart failure events in patients with permanent AF.	0
Subjects on fingolimod treatment had a normal bronchodilator response to inhaled beta-agonists.	0
The cardiovascular status of patients should be evaluated and cardiovascular risk factors should be monitored and actively managed during Tasigna therapy according to standard guidelines [see Dosage and Administration (2.	0
Consumption of ethanol with STRATTERA did not change the intoxicating effects of ethanol.	0
Digoxin: Patients should be monitored appropriately (7.8).	0
Lisinopril does not undergo metabolism and is excreted unchanged entirely in the urine.	0
"There has been a long-standing concern, however, that antidepressants may have a role in inducing worsening of depression and the emergence of suicidality in certain patients during the early phases of treatment."	0
PROCARDIA capsules should not be used for the acute reduction of blood pressure.	0
Dosages above 400 mg per day have not been studied.	0
"Maintenance doses of aspirin above 100 mg reduce the effectiveness of BRILINTA and should be avoided ( 2.1 , 5.2 , 14.1 ) ."	0
"As with all vasodilators , enalapril should be given with caution to patients with obstruction in the outflow tract of the left ventricle ."	0
"Proton pump inhibitors (PPIs), including PROTONIX, are contraindicated with rilpivirine-containing products."	0
The final VFEND solution must be infused over 1<U+2013>2 hours at a maximum rate of 3 mg/kg per hour.	0
"There are case reports of patients who developed increased BUN , serum creatinine and serum potassium levels , and weight gain when furosemide was used in conjunction with NSAIDs ."	0
Do not coadminister aliskiren with PRINIVIL in patients with diabetes.	0
Other strong inhibitors of CYP2D6 would be expected to have similar effects and would need appropriate dose reductions.	1
There are no data on the effect of TRISENOX on the QTc interval during the infusion of the drug.	0
There are few data on the interaction of diltiazem and beta-blockers in patients with poor ventricular function.	0
"When treating acute hypertensive episodes in patients with chronic hypertension, discontinuation of infusion is followed by a 50% offset of action in 30 minutes<U+00B1> 7 minutes but plasma levels of drug and gradually decreasing antihypertensive effects exist for many hours."	0
"The risk is increased with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John's Wort) and with drugs that impair metabolism of serotonin, i.e., MAOIs."	0
"Co-administration of SAMSCA with inhibitors of P-gp ( e.g. , cyclosporine ) may necessitate a decrease in SAMSCA dose see Warnings and Precautions ( 5.5 ) , Drug Interactions ( 7.1 ) ."	0
"Serotonin Syndrome Serotonin syndrome, a potentially life-threatening reaction, may occur when amphetamines are used in combination with other drugs that affect the serotonergic neurotransmitter systems such as monoamine oxidase inhibitors (MAOIs), selective serotonin reuptake inhibitors (SSRIs), serotonin norepinephrine reuptake inhibitors (SNRIs), triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, and St. John<U+2019>s Wort."	0
Use with increased monitoring for adverse events.	0
"Dosage modifications for race are, therefore, not recommended."	0
Serum electrolytes should be determined before initiating therapy and at periodic intervals during therapy.	0
"In treating patients with congestive heart failure after an initial diuresis has been achieved, potassium loss may also decrease and the need for amiloride HCl should be re-evaluated."	0
Table1:Recommended Dose Modifications for ONIVYDE Toxicity NCI CTCAE v4.0 <U+2020> Occurrence ONIVYDE adjustment in patients receiving 7 0 mg/m 2 Patients homozygous for UGT1A1 *28 without previous increase to 7 0 mg/m 2 Grade 3 or 4 adverse reactions Withhold ONIVYDE.	0
"Macrophage activation syndrome (MAS) (hemophagocytic lymphohistiocytosis) is a known, life-threatening disorder that may develop in patients with autoimmune conditions, in particular with inflammatory bowel disease (IBD), and there could potentially be an increased susceptibility for developing the condition with the use of mercaptopurine (an unapproved use)."	0
"Hydrochlorothiazide Administration of a non-steroidal anti-inflammatory agent, including a selective COX-2 inhibitor can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing, and thiazide diuretics."	0
"The mechanism of action of FANAPT, as with other drugs having efficacy in schizophrenia, is unknown."	0
Possible risk factors for leukopenia/neutropenia include preexisting low white blood cell count (WBC) and history of drug induced leukopenia/neutropenia.	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
"Presumably due to the inhibition of the degradation of endogenous bradykinin, persistent non-productive cough has been reported with all ACE inhibitors, always resolving after discontinuation of therapy."	0
"No pattern of abnormal coagulation parameters has been observed in patients in general, or preceding the development of ICH."	0
"Marplan should not be used in combination with some central nervous system depressants, such as narcotics, barbiturates, or alcohol."	0
"Co-administration of a CYP2C8 enzyme inducer ( e.g. , rifampin ) decreases exposure to treprostinil see Drug Interactions ( 7.5 ) and Clinical Pharmacology ( 12.3 ) ."	1
"Concomitant use of duloxetine (40 mg once daily) with paroxetine (20 mg once daily) increased the concentration of duloxetine AUC by about 60%, and greater degrees of inhibition are expected with higher doses of paroxetine."	1
Hydrochlorothiazide is well absorbed (65% to 75%) following oral administration.	0
"Monitor patients with conditions known to increase the risk of lactic acidosis [e.g., severe hypotension or sepsis that can be associated with acute renal failure, inborn errors of metabolism, treatment with drugs such as nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs)] for lactic acidosis before the start of treatment and during treatment with EXTRANEAL."	0
Approximately 70% of an administered dose is excreted as metabolites in the urine and 16% or more in the feces within 5 days.	0
"The initial phase half-life is approximately 1 minute, and accounts for 85-90% of clevidipine elimination."	0
"Increased citrate in the urine, by complexing with calcium, decreases calcium ion activity and thus the saturation of calcium oxalate."	0
"Preterm neonates may be at an increased risk of propylene glycol-associated adverse events due to diminished ability to metabolize propylene glycol, thereby leading to accumulation and potential adverse events."	0
"Sotalol and calcium blocking drugs can be expected to have additive effects on atrioventricular conduction, ventricular function, and blood pressure."	0
The effect of paroxetine on cimetidine's pharmacokinetics was not studied.	0
"In infants with restricted systemic blood flow, alprostadil often increased pH in those having acidosis, increased systemic blood pressure, and decreased the ratio of pulmonary artery pressure to aortic pressure."	0
ATACAND can be administered once or twice daily with total daily doses ranging from 8 mg to 32 mg.	0
"Fluconazole, an inhibitor of cytochrome P450 2C9, decreased the AUC of the active metabolite by approximately 40%, but increased the AUC of losartan by approximately 70% following multiple doses."	1
Antipsychotics: quetiapine and lurasidone <U+2191> quetiapine Initiation of REYATAZ with ritonavir in patients taking quetiapine: Consider alternative antiretroviral therapy to avoid increases in quetiapine exposures.	1
Active liver disease or unexplained persistent transaminase elevations are contraindications to the use of CADUET.	0
"Patients receiving the combination of losartan and lisinopril did not obtain any additional benefit compared to monotherapy for the combined endpoint of decline in GFR, end stage renal disease, or death, but experienced an increased incidence of hyperkalemia and acute kidney injury compared with the monotherapy group."	0
The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.	0
"In clinical trials of primarily mild<U+2011>to<U+2011>moderate heart failure, hypotension and postural hypotension occurred in 9.7% and syncope in 3.4% of subjects receiving COREG compared with 3.6% and 2.5% of placebo subjects, respectively."	0
An increased rate of stroke was observed during the transition from ELIQUIS to warfarin in clinical trials in atrial fibrillation patients.	0
"The magnitude of reduction in blood pressure with amlodipine is also correlated with the height of pretreatment elevation; thus, individuals with moderate hypertension (diastolic pressure 105 to 114 mmHg) had about a 50% greater response than patients with mild hypertension (diastolic pressure 90 to 104 mmHg)."	0
The oral dispensing syringe is intended for multiple use: wash the oral dispensing syringe with warm <U+2018>soapy<U+2019> water and rinse well; hold the oral dispensing syringe under water and move the plunger up and down several times to make sure the inside of the oral dispensing syringe is clean; ensure the oral dispensing syringe is completely dry before use of the oral dispensing syringe again for dosing; and store the oral dispensing syringe in a hygienic place with the medicine.	0
"DEMSER may add to the sedative effects of alcohol and other CNS depressants , e.g. , hypnotics , sedatives , and tranquilizers ."	0
There was a 23% increase in Tmax for desmethyldiazepam in the sertraline hydrochloride group compared to a 20% decrease in the placebo group (p < 0.03).	1
"If the two drugs are to be used in combination, a low dose of buspirone (e.g., 2.5 mg QD) is recommended."	1
The metabolism of estazolam to the major circulating metabolite 4-hydroxy-estazolam and the metabolism of other triazolobenzodiazepines is catalyzed by CYP3A.	0
Protease Inhibitor-Experienced Adults <U+2022>LEXIVA 700mg twice daily plus ritonavir 100mg twice daily.	0
"Savella is a selective serotonin and norepinephrine re-uptake inhibitor (SNRI), similar to some drugs used for the treatment of depression and other psychiatric disorders."	0
ZOCOR therapy should be discontinued if markedly elevated CPK levels occur or myopathy is diagnosed or suspected.	0
"Because squamous cell carcinoma has been reported in patients who experience photosensitivity reactions, stringent measures for photoprotection are warranted in children."	0
A possible mechanism of action is fluconazole's inhibition of CYP3A4.	0
"For patients who received their last dose of thienopyridine within 4 to 7days prior to CABG, the frequencies decreased to 11.3% (9 of 80patients) in the prasugrel group and 3.4% (3 of 89patients) in the clopidogrel group."	0
"However, as with all CNS-active drugs, patients should be advised to avoid alcohol consumption while taking PRISTIQ."	0
"Because it is possible that milnacipran may aggravate pre-existing liver disease, Savella should not be prescribed to patients with substantial alcohol use or evidence of chronic liver disease."	0
It is unknown whether the concomitant administration of proton pump inhibitors affects duloxetine absorption.	0
Antimycobacterials: Rifampina May lead to loss of virologic response and possible resistance to LEXIVA or to the class of protease inhibitors.	0
ZOCOR should be administered to women of childbearing age only when such patients are highly unlikely to conceive.	0
"Because of the gradual onset of action, acute hypotension is unlikely."	0
Pediatrics: The effective antihypertensive oral dose of amlodipine in pediatric patients ages 6<U+2013>17 years is 2.5 mg to 5 mg once daily.	0
Children 2<U+2013>11 years: The recommended dose of PRIFTIN should be determined based on weight of the patient up to a maximum of 900 mg once- weekly.	0
"Because hypotensive effects may be cumulative, it is not recommended that Zanaflex be used with other <U+03B1> 2-adrenergic agonists."	0
Symptomatic postural hypotension is usually not observed although it can occur and should be anticipated in volume and/or salt-depleted patients.	0
Inhibitors of CYP3A4 and P-gp increase exposure to apixaban and increase the risk of bleeding.	0
The clearance of olmesartan in pediatric patients was similar to that in adult patients when adjusted by the body weight.	0
Patients should be monitored for the emergence of serotonin syndrome.	0
"Figure 3 Distribution In patients with heart failure (HF), NATRECOR<U+00AE> administered intravenously by infusion or bolus exhibits biphasic disposition from the plasma."	0
"Although there is no systematic evidence that stimulants cause aggressive behavior or hostility, patients beginning treatment for ADHD should be monitored for the appearance of or worsening of aggressive behavior or hostility."	0
"Concurrent use of rifampin increases the metabolic clearance of bisoprolol fumarate, shortening its elimination half-life."	1
Administration of fluvastatin 40 mg single dose to healthy volunteers pre-treated with fluconazole for 4 days results in an increase of fluvastatin exposure.	1
"However, co-administration of CYMBALTA with aluminum- and magnesium-containing antacids (51mEq) or CYMBALTA with famotidine, had no significant effect on the rate or extent of duloxetine absorption after administration of a 40mg oral dose."	0
A 4-hour hemodialysis session does not remove a sufficient amount of voriconazole to warrant dose adjustment.	0
"Clinically significant interactions have been reported with inhibitors of CYP3A4 (e.g., erythromycin, ritonavir) causing elevation of plasma levels of verapamil while inducers of CYP3A4 (e.g., rifampin) have caused a lowering of plasma levels of verapamil."	1
"If fluoxetine is administered to patients with liver disease, a lower or less frequent dose should be used."	0
Pharmacodynamic interactions of Savella with other drugs can occur (7).	0
"Elimination After oral administration, eszopiclone is eliminated with a mean t1/2 of approximately 6 hours."	0
"Following intravenous administration to healthy volunteers, 50% to 70% of a digoxin dose is excreted unchanged in the urine."	0
"In contrast, the metabolite P95 only shows affinity for 5-HT2A (Ki value of 3.91) and the NE<U+03B1>1A, NE<U+03B1>1B, NE<U+03B1>1D, and NE<U+03B1>2 C receptors (Ki values of 4.7, 2.7, 8.8, and 4.7 nM respectively)."	0
Clinical studies have demonstrated that amoxapine has a more rapid onset of action than either amitriptyline or imipramine.	0
"Anti-gout: Colchicine <U+2191> Colchicine Treatment of gout flares-coadministration of colchicine in patients on INVIRASE/ritonavir: 0.6 mg (1 tablet) <U+00D7> 1 dose, followed by 0.3 mg (half tablet) 1 hour later."	0
"Patients with a history of seizures should be followed closely when nortriptyline is administered, inasmuch as this drug is known to lower the convulsive threshold."	0
"When bicalutamide is combined with LHRH analog therapy, the suppression of serum testosterone induced by the LHRH analog is not affected."	0
"The serum protein binding of ramipril is about 73% and that of ramiprilat about 56%; in vitro, these percentages are independent of concentration over the range of 0.01 <U+00B5>g/mL<U+2013>10 <U+00B5>g/mL."	0
About 14% of an orally-administered dose of losartan is converted to the active metabolite.	0
"In healthy volunteers who were extensive metabolizers of CYP2D6, paroxetine 20 mg daily was given in combination with 20 mg atomoxetine every 12 hours."	0
Use of PDE5 inhibitors for erectile dysfunction: Use sildenafil with caution at reduced doses of 25 mg every 48 hours with increased monitoring of adverse events when administered concomitantly with INVIRASE/ritonavir.	1
"Agents Causing Renin Release: The antihypertensive effect of VASOTEC is augmented by antihypertensive agents that cause renin release (e.g., diuretics)."	0
Severe hypersensitivity reaction to ONIVYDE or irinotecan HCl.	0
The curves represent mean levels without confidence intervals; variations should be expected when measuring aPTT.	0
"Avoid concomitant administration of XARELTO with known combined P-gp and strong CYP3A4 inhibitors ( e.g. , ketoconazole and ritonavir ) see Warnings and Precautions ( 5.6 ) and Clinical Pharmacology ( 12.3 ) ."	0
"To reduce the possibility of venous thrombosis, phlebitis, and vascular impairment, do not use small veins, such as those on the dorsum of the hand or wrist."	0
Induction of a Manic Episode in Patients with Bipolar Disorder CNS stimulants may induce a mixed/manic episode in patients with bipolar disorder.	0
"Usual starting dose(mg daily) Maximum dose(mg daily) Amlodipine 5Start small adults or children, fragile, or elderly patients, or patients with hepatic insufficiency on 2.5 mg once daily (2) 10 Atorvastatin 10<U+2013>20Start patients requiring large LDL-C reduction (> 45%) at 40 mg once daily (2) 80 CADUET Dosage of CADUET must be individualized on the basis of both effectiveness and tolerance for each individual component in the treatment of hypertension/angina and hyperlipidemia."	0
Patients with atrial flutter or atrial fibrillation and an accessory bypass tract (e.g.	0
"The 13 to 17 year old group exhibited a mean sertraline AUC (0 to 24 hr) of 2296 ng-hr/mL, mean Cmax of 123 ng/mL, and mean half-life of 27.8 hr."	0
"There is no experience with antifibrinolytic agents (tranexamic acid, aminocaproic acid) in individuals receiving apixaban."	0
Atenolol is a beta1-selective (cardioselective) beta-adrenergic receptor blocking agent without membrane stabilizing or intrinsic sympathomimetic (partial agonist) activities.	0
"Use caution when BYSTOLIC is co-administered with CYP2D6 inhibitors (quinidine, propafenone, fluoxetine, paroxetine, etc.)"	0
Adenocard ( adenosine injection ) is a respiratory stimulant ( probably through activation of carotid body chemoreceptors ) and intravenous administration in man has been shown to increase minute ventilation ( Ve ) and reduce arterial PCO2 causing respiratory alkalosis .	0
"Ranolazine: The risk of myopathy, including rhabdomyolysis, may be increased by concomitant administration of ranolazine."	0
"Clinical circumstances, some of which may be more common in the elderly, such as hepatic or renal impairment, should be considered."	0
"Savella is a selective serotonin and norepinephrine reuptake inhibitor (SNRI), similar to some drugs used for the treatment of depression and other psychiatric disorders."	0
"In a published study, dopamine HCl administered at 10 mg/kg subcutaneously for 30 days, markedly prolonged metestrus and increased mean pituitary and ovary weights in female rats."	0
There may be circumstances when it is necessary to initiate treatment with an MAOI such as linezolid or intravenous methylene blue in a patient taking Lexapro.	0
"Alternative corticosteroids including beclomethasone and prednisolone (whose PK and/or PD are less affected by strong CYP3A inhibitors relative to other studied steroids) should be considered, particularly for long-term use."	0
"12.When ready to use, the mixture can be kept at room temperature [between 68<U+00B0>F-77<U+00B0>F (20<U+00B0>C-25<U+00B0>C)] for up to 3 hours."	0
"Antiarrhythmics: Flecainide, propafenone POTENTIAL for serious and/or life-threatening reactions such as cardiac arrhythmias secondary to increases in plasma concentrations of antiarrhythmics if LEXIVA is co-prescribed with ritonavir."	0
"If thrombocytopenia is confirmed, discontinue AGGRASTAT and heparin."	0
"These interactions may lead to: Clinically significant adverse reactions, potentially leading to severe, life-threatening, or fatal events from greater exposures of concomitant medications."	0
"Signs and symptoms of hyponatremia include headache, difficulty concentrating, memory impairment, confusion, weakness, and unsteadiness, which may lead to falls."	0
Clinical trials show that the usual dose is 80 mg to 120 mg three times a day.	0
"The ester is then hydrolyzed, forming dabigatran, the active moiety."	0
Adjust dose according to blood pressure response.	0
"Select a concentration for the solution of FLOLAN that is compatible with the infusion pump being used with respect to minimum and maximum flow rates, reservoir capacity, and the infusion pump criteria listed above."	0
"Administer atropine, if not contraindicated, for early diarrhea of any severity ( 2.2 ), ( 5.2 )."	0
"However, the combination should be used with caution as increased lumefantrine exposure may increase the risk of QT prolongation."	0
"Since any psychoactive drug may impair judgment, thinking, or motor skills, patients should be cautioned about operating hazardous machinery, including automobiles, until they are reasonably certain that nefazodone therapy does not adversely affect their ability to engage in such activities."	0
Geriatric Use Clinical studies of dilatrate<U+00AE>-SR did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
Coadministration of rosuvastatin with certain protease inhibitors given in combination with ritonavir has differing effects on rosuvastatin exposure.	0
"When a 200 mg dose of nefazodone was administered to subjects who had been receiving fluoxetine for 1 week, there was an increased incidence of transient adverse events such as headache, lightheadedness, nausea, or paresthesia, possibly due to the elevated mCPP levels."	0
"CYP2D6 Inhibitors <U+2014> Because CYP2D6 is involved in CYMBALTA metabolism, concomitant use of CYMBALTA with potent inhibitors of CYP2D6 would be expected to, and does, result in higher concentrations (on average of 60%) of CYMBALTA."	1
No conclusion can be made based on these findings due to the small number of samples and large variability.	0
"As measured by antiarrhythmic effects in animals, by QTc prolongation in human volunteers, or by various in vitro techniques, 3HQ has at least half the antiarrhythmic activity of the parent compound, so it may be responsible for a substantial fraction of the effect of quinidine gluconate in chronic use."	0
The chance of significant hypotension may possibly be minimized by titration of the dose and by focusing attention on signs and symptoms of hypotension prior to dose advancement.	0
The rate of debrisoquin hydroxylation is felt to depend on the level of cytochrome P450 2D6 isozyme activity.	0
Concomitant antacids should be given as needed for relief of pain.	0
"The interference most often causes results to be falsely positive or falsely elevated, but sometimes it causes results to be falsely reduced."	0
Fluoxetine: A single 3 mg dose of iloperidone had no effect on the pharmacokinetics of fluoxetine (20 mg twice daily).	0
"With concomitant use of ABILIFY MAINTENA with a strong CYP3A4 inhibitor or CYP2D6 inhibitor for more than 14 days, reduce the ABILIFY MAINTENA dosage."	1
Both oxidative metabolites undergo further conjugation with glucuronide to form conjugates.	0
"In TRITON-TIMI 38, the mean exposure(AUC) of the active metabolite was 19%higher in patients <U+2265>75years of age than in patients <75years of age."	0
Repeat in 1/2 hour if necessary and if no hypotension occurs.	0
"Atomoxetine did not cause clinically important inhibition or induction of cytochromeP450 enzymes, including CYP1A2, CYP3A, CYP2D6, and CYP2C9."	0
"Stimulants, including VYVANSE, are associated with peripheral vasculopathy, including Raynaud's phenomenon."	0
Aqueous penicillin G is rapidly absorbed following both intramuscular and subcutaneous injection.	0
"The metabolism of fluvoxamine has not been fully characterized and the effects of potent cytochrome P450 isoenzyme inhibition, such as the ketoconazole inhibition of CYP3A4, on fluvoxamine metabolism have not been studied."	0
"Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs."	0
Sotalol augments bradycardia and QTc prolongation following cardioversion.	0
Risk of Intraoperative Floppy Iris Syndrome during cataract surgery.	0
"Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes."	0
"Increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists, including ATACAND."	1
Biliary and direct intestinal excretion contributes to elimination of apixaban in the feces.	0
"During treatment with TRISENOX, monitor liver chemistries at least 2-3 times per week through recovery from toxicities."	0
"When used concomitantly with WELLBUTRIN XL, it may be necessary to decrease the dose of these CYP2D6 substrates, particularly for drugs with a narrow therapeutic index."	1
"Rarely, patients, particularly those who have severe obstructive coronary artery disease, have developed well documented increased frequency, duration, and/or severity of angina or acute myocardial infarction on starting PROCARDIA or at the time of dosage increase."	0
"In reproduction studies, no effects on fertility were found in rats given up to 24 mg/kg, which is 6 times, and approximately equal to, the MRHD on a mg/kg and mg/m2 basis, respectively."	0
"Consider longer times for patients undergoing major surgery, spinal puncture, or placement of a spinal or epidural catheter or port, in whom complete hemostasis may be required."	0
Caution should be exercised when administering APTIVUS/ritonavir to patients with mild hepatic impairment (Child-Pugh Class A) because tipranavir concentrations may be increased.	0
This apparently is secondary to a reversible reduction of glomerular filtration rate or a depletion of intravascular fluid volume (prerenal azotemia) rather than renal toxicity; levels usually return to normal when DYAZIDE is discontinued.	0
"Metabolism and Elimination Dipyridamole is metabolized in the liver, primarily by conjugation with glucuronic acid, of which monoglucuronide which has low pharmacodynamic activity is the primary metabolite."	0
Injection should be initiated as soon as possible after the patient's arrival in the hospital and after eligibility is established.	0
"However, reports suggest that NSAIDs may diminish the antihypertensive effect of ACE inhibitors."	0
"The studies allowed comparisons of two doses (50-100mg/day) as once-daily or twice-daily regimens, comparisons of peak and trough effects, and comparisons of response by gender, age, and race."	0
No pharmacokinetic interactions were observed.	0
"Altered anticoagulant effects, including increased bleeding, have been reported when SSRIs or SNRIs are coadministered with warfarin."	0
Creatinine Clearance (mL/min/1.73m2) Atenolol Elimination Half-Life (hrs) Maximum Dosage 15-35 16-27 50 mg daily <15 >27 50 mg every other day	0
"Hydrochlorothiazide had no adverse effects on the fertility of mice and rats of either sex in studies wherein these species were exposed, via their diet, to doses of up to 100 and 4 mg/kg, respectively, prior to conception and throughout gestation."	0
"Symptoms of postural hypotension are seen most commonly, but not exclusively, in patients with preexistent hypertension; blood pressure usually returns rapidly to pretreatment levels upon discontinuation of the drug."	0
"Systemic clearance (CL/F) was decreased by approximately 20% and 36% in patients with moderate and severe hepatic impairment, respectively, as compared to healthy subjects."	0
"In humans, the mean 5-HT transporter occupancy, based on the results from 2 clinical PET studies using 5-HTT ligands ([11C]-MADAM or [11C]-DASB), was approximately 50% at 5 mg/day, 65% at 10 mg/day and approximately 80% at 20 mg/day in the regions of interest."	0
<U+2022>REYATAZ 400 mg with ritonavir 100 mg once daily (all as a single dose with food) if taken with either tenofovir DF or an H2RA for pregnant women during the second and third trimester.	0
"Consequently, caution is advised if the concomitant administration of sertraline hydrochloride and such drugs is required."	0
"Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed."	0
Instances of hepatic reactions were noted to occur primarily in patients with serious underlying medical conditions (predominantly hematological malignancy).	0
"Similar effects would be expected with other potent CYP2D6 inhibitors (e.g., fluoxetine, quinidine)."	0
Increases in serum lithium concentrations and lithium toxicity have been reported with concomitant use of irbesartan and lithium.	1
This should include large volume gastric lavage followed by activated charcoal.	0
Most of the antihypertensive effect is apparent within 2 weeks and maximal reduction is generally attained after 4 weeks.	0
"The following symptoms, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric."	0
Intervention: Monitor INR and prothrombin time.	0
"Figure 2: Relationship Between TIKOSYN Dose, QTc Increase and Maintenance of NSR Number of patients evaluated for maintenance of NSR: 503 TIKOSYN, 174 placebo."	0
The effects of coadministered drugs on the pharmacokinetics of apixaban are summarized in Figure 2.	0
Consolidation: 0.15 mg/kg intravenously daily 5 days per week during weeks 1-4 of an 8-week cycle for a total of 4 cycles in combination with tretinoin.	0
Increased mortality with increasing doses in pediatric patients.	0
Peak plasma levels are achieved within one hour after dosing.	0
"However, more variability was observed in some of the pharmacokinetic parameters for bupropion (AUC, Cmax, and Tmax) and its active metabolites (t<U+00BD>) in subjects with mild to moderate hepatic cirrhosis."	0
Plasma concentrations of the active metabolites are about one-tenth of those observed for carvedilol and have pharmacokinetics similar to the parent.	0
"Following oral administration, human plasma concentrations reach a peak at about three hours with a plasma half-life of two to three hours."	0
Such patients should first be weaned from intravenous therapy before initiating COREG.	0
"When substituting for oral nicardipine therapy, use the intravenous infusion rate as follows (2.3): Oral Nicardipine Dose Equivalent IV Infusion Rate 20 mg q8h 0.5 mg/hr 30 mg q8h 1.2 mg/hr 40 mg q8h 2.2 mg/hr In a drug-free patient, initiate therapy at 5 mg/hr."	0
Rare reports of cyanocobalamin deficiency occurring with acid-suppressing therapy have been reported in the literature.	0
"Effect of Olanzapine on Drug Metabolizing Enzymes <U+2014> Invitro studies utilizing human liver microsomes suggest that olanzapine has little potential to inhibit CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A."	0
Patients must continue to be monitored for possible loss of molecular remission after treatment discontinuation.	0
"NSAIDs, Aspirin, Warfarin): May potentiate the risk of bleeding (7.4) Drugs Tightly Bound to Plasma Proteins: May cause a shift in plasma concentrations (7.6, 7.7) Olanzapine: When used in combination with PROZAC, also refer to the Drug Interactions section of the package insert for Symbyax (7.7) Drugs that Prolong the QT Interval: Do not use Prozac with thioridazine or pimozide."	0
Metabolism and Elimination: LATUDA is metabolized mainly via CYP3A4.	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
"In PROCARDIA treated patients where surgery using high dose fentanyl anesthesia is contemplated, the physician should be aware of these potential problems and, if the patient's condition permits, sufficient time (at least 36 hours) should be allowed for PROCARDIA to be washed out of the body prior to surgery."	0
"Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue TENORMIN therapy abruptly even in patients treated only for hypertension."	0
Caution should be exercised when imipramine pamoate is used with agents that lower blood pressure.	0
Desacetyl diltiazem is also present in the plasma at levels of 10% to 20% of the parent drug and is 25% to 50% as potent as a coronary vasodilator as diltiazem.	0
"The antihypertensive effect of VASOTEC is augmented by antihypertensive agents that cause renin release ( e.g. , diuretics ) ."	0
Adjustment of the statin dosage may be needed.	0
"In general, wait 7 to 14 days between titration steps."	0
Lithium : Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists including MICARDIS.	1
Marked leukopenia or agranulocytosis did not occur in any patient receiving mexiletine alone; five of the six cases of agranulocytosis were associated with procainamide (sustained release preparations in four) and one with vinblastine.	0
"Concurrent administration or recent discontinuation (i.e., within 2 weeks) of a MAO-A inhibitor."	0
The role of CYP2D6 in ondansetron in vivo metabolism is relatively minor.	0
Transporters: The results from an in vitro study with human liver tissue indicate that valsartan is a substrate of the hepatic uptake transporter OATP1B1 and the hepatic efflux transporter MRP2.	0
Therapy with PEXEVA<U+00AE> may be resumed 24 hours after the last dose of linezolid or intravenous methylene blue.	0
Apixaban is not a significant inhibitor of P-gp.	0
CL/F values were comparable in mild hepatic impairment and healthy subjects (< 5% difference).	0
"PRUDOXIN Cream can produce drowsiness which may reduce awareness, including awareness of pruritic symptoms."	0
Patients with severe hepatic impairment were not studied.	0
Coadministration should be done in a setting which ensures close clinical monitoring and appropriate medical management in case of respiratory depression and/or prolonged sedation.	0
They can precipitate hepatic coma in patients with severe liver disease.	0
LIPITOR had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment.	0
CABG-related bleeding: Risk increases in patients receiving Effient who undergo CABG (5.2).	0
Phenytoin <U+2013> Pretreatment for 7 days with 200 mg BID of nefazodone had no effect on the pharmacokinetics of a single 300 mg oral dose of phenytoin.	0
It should rarely be necessary to continue intravenous infusions beyond 24 hours.	0
Alcohol <U+2014> Multiple doses of olanzapine did not influence the kinetics of ethanol.	0
"When administered with food, the rate of absorption is slowed, as evidenced by a delay in the time to reach peak plasma levels, with no significant difference in extent of bioavailability."	1
"There are 2 predominant iloperidone metabolites, P95 and P88."	0
Activation of mania and hypomania have been reported in patients with mood disorders who were treated with other similar drugs for major depressive disorder.	0
"Known hypersensitivity (e.g., anaphylaxis or angioedema) to telmisartan, amlodipine or any other component of this product (4) Do not co-administer aliskiren with TWYNSTA in patients with diabetes (4)"	0
"Insulin requirements in diabetic patients may be increased, decreased or unchanged."	0
"Patients who cannot switch, should have overnight continuous ECG monitoring after the first dose."	0
"Screen patients for risk of substance use disorders, including opioid abuse and misuse, and warn them of the risk for overdose and death associated with the use of additional CNS depressants including alcohol and illicit drugs."	0
Hypomania and agitation have also been reported at higher than recommended doses or following long-term therapy.	0
"Because of its potential for inducing hypotension, ziprasidone may enhance the effects of certain antihypertensive agents."	0
"In addition, at least 7 days should be allowed after stopping nefazodone before starting an MAOI."	0
No reports involved the administration of methylene blue by other routes (such as oral tablets or local tissue injection) or at lower doses.	0
"The inhibition of cholesterol biosynthesis reduces the cholesterol in hepatic cells, which stimulates the synthesis of LDL receptors and thereby increases the uptake of LDL particles."	0
"On the average for the group, the dose of cyclosporine was reduced about 20% in these subjects."	1
Figure 1 Clinical studies have shown that desvenlafaxine does not have a clinically relevant effect on CYP2D6 metabolism at the dose of 100 mg daily (Figure 2).	0
"CYP2C19 poor metabolizers -<U+2013> In CYP2C19 poor metabolizers, citalopram steady state Cmax and AUC was increased by 68% and 107%, respectively."	0
Area under the curve achieved after an intramuscular dose is similar to that achieved after oral administration of the same dose.	0
Combined P-gp and strong CYP3A4 inhibitors increase exposure to rivaroxaban and may increase the risk of bleeding .	0
It must be appreciated that this group of patients had a serious disease with a high mortality rate.	0
Refer to the package insert for lithium preparations before use of such preparations with MICROZIDE.	0
"In those patients who discontinued protease inhibitor therapy, hyperglycemia persisted in some cases."	0
"Although specific interaction studies were not performed , in clinical studies tolvaptan was used concomitantly with beta-blockers , angiotensin receptor blockers , angiotensin converting enzyme inhibitors and potassium sparing diuretics ."	0
Tadalafil ( 10 mg or 20 mg ) did not affect alcohol plasma concentrations and alcohol did not affect tadalafil plasma concentrations .	0
"In the intact animal, prolongation of the AH interval can be seen at higher doses."	0
Hypotension that occurs as a result of this mechanism can be corrected by volume expansion.	0
AHA taken in association with alcoholic beverages has resulted in a rash.	0
"When doses above 100 mg daily are administered, plasma levels of nortriptyline should be monitored and maintained in the optimum range of 50 to 150 ng/mL."	0
during the first few months of treatment in those receiving antidepressants.	0
Exacerbation of Pre-existing Psychosis CNS stimulants may exacerbate symptoms of behavior disturbance and thought disorder in patients with a pre-existing psychotic disorder.	0
Reports from the laboratory providing results of the standard single-disk susceptibility test with a 10 unit penicillin disk should be interpreted according to the following criteria in Table 1.	0
For the treatment of BPH: Initiate therapy at 1 mg once daily.	0
"Following oral administration, when postural hypotension has occurred, it has been transient and is uncommon when COREG is administered with food at the recommended starting dose and titration increments are closely followed."	0
"Abiraterone AUC0<U+2013><U+221E> was approximately 7-fold or 1.6-fold higher, respectively, when a single dose of abiraterone acetate was administered 2 hours after or 1 hour before a medium fat meal (25% fat, 491 calories) compared to overnight fasting."	1
"Pediatric Acute Placebo-Controlled Adult Acute Placebo-Controlled Maximumb Endpoint Maximumb Endpoint Atomoxetine Placebo Atomoxetine Placebo Atomoxetine Placebo Atomoxetine Placebo % % % % % % % % DBP (<U+2265>15 mm Hg) 21.5 14.1 9.3 4.8 12.6 8.7 4.8 3.5 SBP (<U+2265>20 mm Hg) 12.5 8.7 4.9 3.3 12.4 7.8 4.2 3.2 HR (<U+2265>20 bpm) 23.4 11.5 12.2 3.8 22.4 8.3 10.2 2.0 In placebo-controlled registration studies involving pediatric patients, tachycardia was identified as an adverse event for 0.3% (5/1597) of these STRATTERA patients compared with 0% (0/934) of placebo patients."	0
No rebound increase to levels above baseline state was observed.	0
"From a pharmacokinetic perspective, no dose adjustment for drugs that are substrates of CYP1A2 (e.g. theophylline, duloxetine, melatonin), CYP2D6 (e.g. atomoxetine, desipramine, venlafaxine), CYP2C19 (e.g. omeprazole, lansoprazole, clobazam), and CYP3A4 (e.g. midazolam, pimozide, simvastatin) is necessary when VYVANSE is co-administered."	0
"In some of the trials, patients who received immediate-release nifedipine had significantly worse outcomes than patients who received placebo."	0
NATRECOR<U+00AE> may be subsequently restarted at a dose that is reduced by 30% (with no bolus administration) once the patient has stabilized.	0
"Oral Hypoglycemic Agents: In pharmacokinetic studies of MEVACOR in hypercholesterolemic non-insulin dependent diabetic patients, there was no drug interaction with glipizide or with chlorpropamide."	0
DYAZIDE should be used with caution in patients with a history of renal stones.	0
Lithium toxicity was usually reversible upon discontinuation of lithium and the ACE inhibitor.	0
"However, if a cardiac origin is suspected, patients should be evaluated."	0
"Autoimmune disorders (such as Graves' disease, polymyositis, and Guillain-Barr<U+00E9> syndrome) have also been reported to occur in the setting of immune reconstitution; however, the time to onset is more variable, and can occur many months after initiation of treatment."	0
"Doses of 50, 100 and 150mg once daily gave statistically significant systolic/diastolic mean decreases in blood pressure, compared to placebo in the range of 5.5-10.5/3.5-7.5mmHg, with the 150-mg dose giving no greater effect than 50-100mg. Twice-daily dosing at 50-100mg/day gave consistently larger trough responses than once-daily dosing at the same total dose."	0
"In patients taking potent inhibitors of CYP3A such as ketoconazole , and itraconazole , avoid use of ADCIRCA see Warnings and Precautions ( 5.2 ) and Clinical Pharmacology ( 12.3 ) ."	0
Patients who have been treated with MAO inhibitors within two to three weeks prior to the administration of dopamine should receive initial doses of dopamine hydrochloride no greater than one-tenth (1/10) of the usual dose.	1
"Following single dose oral administration of14C-pravastatin, the radioactive elimination t<U+00BD>for pravastatin is 1.8 hours in humans."	0
"Renal Impairment: In patients with severe renal impairment (eGFR less than 30 mL/min/1.73 m2), administer lidocaine at lower maintenance infusion rate with close monitoring of toxicity."	0
The safety and effectiveness of TARKA in children below the age of 18have not been established.	0
"The onset of symptoms generally occurs within several hours to a few days of concomitant use, but may occur later than that."	0
Coadministration of LEXIVA in patients on ADCIRCA: Avoid use of ADCIRCA during the initiation of LEXIVA.	0
"Use with Aminosalicylates: There is in vitro evidence that aminosalicylate derivatives (e.g., sulphasalazine, mesalazine, or olsalazine) inhibit the TPMT enzyme."	0
"The mechanism of action of ziprasidone, as with other drugs having efficacy in schizophrenia, is unknown."	0
"Following absorption, quinapril is deesterified to its major active metabolite, quinaprilat (about 38% of oral dose), and to other minor inactive metabolites."	0
Falls with serious consequences including bone fractures and hospitalizations have been reported.	0
Other strong inhibitors of CYP2D6 would be expected to have similar effects and would need appropriate dose reductions.	1
The use of LUVOX CR within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated.	0
Tolazamide: A case of severe hypoglycemia has been reported in a type II diabetic patient maintained on tolazamide (1 gm/day) 11 days after the addition of oral doxepin (75 mg/day).	0
"These events , which may be accompanied by tinnitus and dizziness , have been reported in temporal association to the intake of PDE5 inhibitors , including ADCIRCA ."	0
"Poor metabolizers and extensive metabolizers who concomitantly use CYP2D6 inhibiting drugs will have increased (several-fold) metoprolol blood levels, decreasing metoprolol's cardioselectivity."	1
Symptoms include acute onset of decreased visual acuity or ocular pain and typically occur within hours to weeks of drug initiation.	0
There are no adequate and well-controlled studies in pregnant patients.	0
"Hypersensitivity to any product ingredients (4.1) Patients with known allergy to NSAIDs (4.2) Patients with the syndrome of asthma, rhinitis, and nasal polyps (4.2) AGGRENOX is contraindicated in patients with known hypersensitivity to any of the product components."	0
"For more rapid blood pressure reduction, titrate every 5 minutes."	0
"Transfer the rifampin powder blend to a 4-ounce amber glass or plastic (high density polyethylene [HDPE], polypropylene, or polycarbonate) prescription bottle."	0
Extra vigilance is warranted in patients with chronic hepatitis B or hepatitis C co-infection.	0
Allopurinol: Avoid use (7.1) Warfarin: PURIXAN may inhibit the anticoagulant effect.	0
No significant differences in liver blood flow were observed in these patients.	0
"Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.3, 2.4, 4, 5.1, 7.1, 7.2, 7.3, 12.3) Interacting Agents Prescribing Recommendations Strong CYP3A4 inhibitors (e.g., itraconazole, ketoconazole, posaconazole, voriconazole, erythromycin, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone, cobicistat-containing products), gemfibrozil, cyclosporine, danazol Contraindicated with simvastatin Verapamil, diltiazem, dronedarone Do not exceed 10mg simvastatin daily Amiodarone, amlodipine, ranolazine Do not exceed 20mg simvastatin daily Lomitapide For patients with HoFH, do not exceed 20 mg simvastatin dailyFor patients with HoFH who have been taking 80 mg simvastatin chronically (e.g., for 12 months or more) without evidence of muscle toxicity, do not exceed 40 mg simvastatin when taking lomitapide."	0
Meperidine should not be used concomitantly with MAO inhibitors or within 2 or 3weeks following MAO therapy.	0
"If the strong inhibitor is discontinued, a washout period should be allowed before the Tasigna dose is adjusted upward to the indicated dose."	0
The pupillary dilation that occurs following use of SNRI drugs including Savella may trigger an angle closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy.	0
<U+2022>Administer ritonavir immediately following REYATAZ powder administration.	0
Phenytoin (CYP2C9 Inhibition) Significantly Increased Frequent monitoring of phenytoin plasma concentrations and frequent monitoring of adverse effects related to phenytoin.	1
"Crushed ELIQUIS tablets are stable in water, D5W, apple juice, and applesauce for up to 4 hours."	0
Triamterene has been found in renal stones in association with the other usual calculus components.	0
"The serum concentration of digoxin should always be interpreted in the overall clinical context, and an isolated measurement should not be used alone as the basis for increasing or decreasing the dose of the drug."	0
Steady state is attained in most subjects after 7-10 days of dosing.	0
"However, the estimated lean body mass (dry weight) is used if the patient is obese or if there has been a spurious weight gain due to edema, ascites or other forms of abnormal fluid retention."	0
"Inflammatory Bowel Disease Postmarketing cases of hepatosplenic T-cell lymphoma (HSTCL), a rare type of T-cell lymphoma, have been reported in patients treated with IMURAN."	0
"Interactions of carvedilol with potent inhibitors of CYP2D6 isoenzyme (such as quinidine, fluoxetine, paroxetine, and propafenone) have not been studied, but these drugs would be expected to increase blood levels of the R(+) enantiomer of carvedilol."	1
Administer Nicardipine Hydrochloride by slow continuous infusion by a central line or through a large peripheral vein.	0
"8.Check the EMEND mixture for any clumps or foaming: If any clumps are present, repeat Step 7 until there are no clumps."	0
No change in LEXIVA/ritonavir dose is recommended.	0
"In healthy volunteers, both bisoprolol fumarate and hydrochlorothiazide are well absorbed following oral administration of ZIAC."	0
"Consult the full prescribing information prior to and during treatment for potential drug interactions (5.1, 7.3) Hepatic impairment: should not be used in patients with either moderate or severe hepatic impairment (2.4, 5.2) Phenylketonuria: the oral powder contains 11.2 mg phenylalanine per gram of powder (5.3) Diabetes mellitus/hyperglycemia: new onset or exacerbation of pre-existing diabetes mellitus and hyperglycemia reported with protease inhibitors."	0
FANAPT has no appreciable affinity (Ki >1000 nM) for cholinergic muscarinic receptors.	0
There are other agents that may result in serious and/or life-threatening drug interactions. provides a listing of established or potentially clinically significant drug interactions.	0
"Although paroxetine does not increase the impairment of mental and motor skills caused by alcohol, patients should be advised to avoid alcohol while taking paroxetine."	0
Clinical experience in the concurrent administration of ECT and antidepressant drugs is limited.	0
"Venlafaxine and ODV are minimally bound at therapeutic concentrations to plasma proteins (27% and 30%, respectively)."	0
There is no information to guide use of Cleviprex in treating hypertension associated with pheochromocytoma.	0
"WELLBUTRIN XL should be used with caution in patients with renal impairment, and a reduced frequency and/or dose should be considered."	0
"In addition to chest X-ray and sputum culture, the following studies may be useful in the diagnosis of tuberculosis in the HIV-positive patient: blood culture, urine culture, or biopsy of a suspicious lymph node."	0
The diagnostic evaluation of patients with this syndrome is complicated.	0
"In addition, 27 males on MINIPRESS for up to 51 months did not have changes in sperm morphology suggestive of drug effect."	0
All reports with methylene blue that provided information on the route of administration involved intravenous administration in the dose range of 1 mg/kg to 8 mg/kg.	0
"Weakness, hyperreflexia, and incoordination have been reported rarely when 5-HT1 agonists have been co-administered with SSRI's (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline)."	0
"Because not all commercially available dosage forms of triazolam permit a sufficient dosage reduction, the coadministration of triazolam and nefazodone should be avoided for most patients, including the elderly."	1
Coadministration of REYATAZ (with or without ritonavir) in patients on ADCIRCA<U+00AE>: <U+2022>Avoid the use of ADCIRCA<U+00AE> when starting REYATAZ (with or without ritonavir).	0
Monitor for signs and symptoms of bleeding and medically manage as needed.	0
The usual recommended starting dose is 0.7mg/kg once daily (up to 50mg total) administered as a tablet or a suspension.	0
Do not administer as an IV bolus injection.	0
"If blood counts remain low for greater than 2 weeks, reduce the dose to 400 mg oncedaily *ANC=absolute neutrophil count See Table 3 for dose adjustments for elevations of lipase, amylase, bilirubin, and/or hepatic transaminases."	0
"Stratification of exposure data following treatment with EMSAM indicated that pre-dose (trough) selegiline plasma concentrations at steady state appeared higher (p = 0.12) in children aged < 12 years old, compared to adolescents aged <U+2265> 12 years as shown in Table 6."	0
IMURAN should not be given during pregnancy without careful weighing of risk versus benefit.	0
"Digitalis glycosides, clonidine, diltiazem and verapamil slow atrioventricular conduction and decrease heart rate."	0
"PPHN occurs in 1 <U+2013> 2 per 1,000 live births in the general population and is associated with substantial neonatal morbidity and mortality."	0
Lower dosages are recommended for elderly patients and adolescents.	0
"Onset of diuresis with DYAZIDE takes place within 1hour, peaks at 2 to 3hours, and tapers off during the subsequent 7 to 9hours."	0
"Cleavage of the ester group converts trandolapril to its active diacid metabolite, trandolaprilat, which reaches peak plasma concentrations within 2-12hours."	0
"In controlled clinical trials, rash (all grades, regardless of causality) occurred in approximately 20% of patients treated with REYATAZ."	0
"At delivery, the serum digoxin concentration in the newborn is similar to the serum concentration in the mother."	0
The coadministration of REYATAZ with ritonavir in patients with any degree of hepatic impairment is not recommended.	0
"Glycemic Control in Patients with Diabetes <U+2014> As observed in DPNP trials, CYMBALTA treatment worsens glycemic control in some patients with diabetes."	0
Venlafaxine: Coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine ER (extended release) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine.	0
"A dose of 80 mg gives an increased response, but experiencewith this dose is limited."	0
"Closely monitor blood pressure , renal function and electrolytes in patients on Diovan and other agents that affect the RAS ."	0
CYP3A inhibitors: Co-administration of a 180 mg daily dose of diltiazem with 5 mg amlodipine in elderly hypertensive patients resulted in a 60% increase in amlodipine systemic exposure.	1
Rifampin is indicated in the treatment of all forms of tuberculosis.	0
"Caution patients about risk of bleeding associated with concomitant use of PRISTIQ and NSAIDs, aspirin, or other drugs that affect coagulation (5.4)."	0
Mean Plasma Concentrations of Loxapine following Single-Dose Administration ADASUVE 10 mg in Healthy Subjects The mechanism of action of loxapine in the treatment of agitation associated with schizophrenia is unknown.	0
"In the CHARM-Added program, where candesartan or placebo was given in addition to ACE inhibitors, hypotension was reported in 22.6% of patients treated with ATACAND versus 13.8% treated with placebo."	0
11 Limited immunologic and other abnormalities have occurred in a few infants born of renal allograft recipients on IMURAN.	0
These findings suggest that ET-1 may play a critical role in the pathogenesis and progression of PAH.	0
"Hypermetabolic States: In patients with atrial arrhythmias associated with hypermetabolic states, control of resting ventricular rate is particularly resistant to digoxin treatment."	0
"Study 1 was a 10-week dose-range finding study; patients were treated with fixed paroxetine doses of 10, 20, or 40 mg/day or placebo."	0
False-positive urine immunoassay screening tests for phencyclidine (PCP) and amphetamine have been reported in patients taking desvenlafaxine.	0
Controlled clinical studies were limited to 6 weeks of treatment.	0
"A patient Medication Guide about ""Antidepressant Medicines, Depression and other Serious Mental Illnesses, and Suicidal Thoughts or Actions"" is available for NORPRAMIN."	0
"The precise dose at which selegiline becomes a non-selective inhibitor of all MAO is unknown, but may be in the range of 30 to 40 mg a day."	0
"Skeletal muscle effects (e.g., myopathy and rhabdomyolysis): Risks increase with higher doses and concomitant use of certain medicines."	0
"Nesiritide has been shown to relax isolated human arterial and venous tissue preparations that were precontracted with either endothelin-1 or the alpha-adrenergic agonist, phenylephrine."	0
These risk differences (drug-placebo difference in the number of cases of suicidality per 1000 patients treated) are provided in Table 1.	0
"After intravenous administration of radiolabeled pravastatin to normal volunteers, approximately 47% of total body clearance was via renal excretion and 53% by non-renal routes (i.e., biliary excretion and biotransformation)."	0
"In this trial, patients with PD assigned to paroxetine demonstrated a lower relapse rate compared to patients on placebo."	0
"On a mg/kg basis, all of the doses associated with the teratogenic embryotoxic or fetotoxic effects in animals were higher (5 to 50 times) than the maximum recommended human dose of 120 mg/day."	0
"At higher doses, the elimination of salicylic acid follows zero-order kinetics (i.e., the rate of elimination is constant in relation to plasma concentration), with an apparent half-life of 6 hours or higher."	0
Direct glucuronidation and cytochromeP450(CYP) mediated oxidation are the primary metabolic pathways for olanzapine.	0
"Confirmatory tests, such as gas chromatography/mass spectrometry, will distinguish bupropion from amphetamines."	0
The recommended initial dose of PHOSLYRA for the adult dialysis patient is 10 mL with each meal.	0
"CALAN does not alter the normal atrial action potential or intraventricular conduction time, but in depressed atrial fibers it decreases amplitude, velocity of depolarization, and conduction velocity."	0
Study 1 was an 8-week study comparing fixed paroxetine doses of 20 mg or 40 mg/day with placebo.	0
There was no evidence of a tumorigenic effect when amiloride HCl was administered for 92 weeks to mice at doses up to 10 mg/kg/day (25 times the maximum daily human dose).	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
Intravenous doses of 1 to 10 micrograms of alprostadil per kilogram of body weight lower the blood pressure in mammals by decreasing peripheral resistance.	0
TABLE I: The Effect of Other Drugs on Lovastatin Exposure When Both Were Co-administered Number of Subjects Dosing of Coadministered Drug or Grapefruit Juice Dosing of Lovastatin AUC RatioResults based on a chemical assay.	0
"Concomitant administration of both a CYP2C9 inhibitor ( such as fluconazole or amiodarone ) and a strong CYP3A inhibitor ( e.g. , ketoconazole , itraconazole ) or a moderate CYP3A inhibitor ( e.g. , amprenavir , erythromycin , fluconazole , diltiazem ) with Tracleer will likely lead to large increases in plasma concentrations of bosentan ."	1
"If serious liver injury with clinical symptoms and/or hyperbilirubinemia or jaundice occurs during treatment with CADUET, promptly interrupt therapy."	0
"The sofosbuvir resistance-associated substitution S282T was not detected in the baseline NS5B sequence of any subject with genotype 4, 5, or 6 HCV in clinical trials by population or deep nucleotide sequence analysis."	0
"The demethylated, hydroxylated, and N-oxide derivatives are components in both urine and feces."	0
Protease inhibitors act as substrates or inhibitors of CYP3A4 mediated metabolism.	0
And the effects of Latuda on the exposures of other drugs are summarized in Figure2.	0
"For the treatment of acute cryptococcal meningitis, the recommended dosage is 12 mg/kg on the first day, followed by 6 mg/kg once daily."	0
Digoxin and verapamil use may be rarely associated with ventricular fibrillation when combined with Adenocard (see Warnings ).	0
Savella has not been systematically evaluated in patients with a seizure disorder.	0
"There has been a long-standing concern, however, that antidepressants may have a role in inducing worsening of depression and the emergence of suicidality in certain patients during the early phases of treatment."	0
"As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function have been reported in susceptible individuals treated with losartan potassium tablets; in some patients, these changes in renal function were reversible upon discontinuation of therapy."	0
"In a pharmacokinetic trial conducted in 106 Japanese subjects with heart failure, coadministration of small loading and maintenance doses of amiodarone with carvedilol resulted in at least a 2-fold increase in the steady-state trough concentrations of S(-)-carvedilol."	1
These electrophysiologic effects reflect an expected effect of the drug and are not indicative of toxicity.	0
Second- or third-degree AV block (except in patients with a functioning artificial ventricular pacemaker).	0
Administer as a single daily exchange for the long dwell in continuous ambulatory peritoneal dialysis or automated peritoneal dialysis.	0
"There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on suicide."	0
Some patients required either initiation or dose adjustments of insulin or oral hypoglycemic agents for treatment of these events.	0
"Adverse reactions, some of which were serious, have been reported in patients who have recently been discontinued from an MAOI and started on antidepressants with pharmacological properties similar to venlafaxine hydrochloride extended-release (SNRIs or SSRIs), or who have recently had SNRI or SSRI therapy discontinued prior to initiation of an MAOI."	0
"After adjustment for creatinine clearance, no additional dose adjustment is required for patients with mild or moderate hepatic impairment."	0
Its action is therefore independent of the pathways for angiotensin II synthesis.	0
"At 2<U+2013>3 hours after each subsequent dose of TIKOSYN, determine the QTc (for in-hospital doses 2<U+2013>5)."	0
"The mean sertraline hydrochloride doses for completers to 10 weeks were 131 mg/day and 144 mg/day, respectively, for Studies 1 and 2."	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP should not be used with peripheral vasoconstrictors because the combination may cause synergistic elevation of blood pressure."	0
These risk differences (drug-placebo difference in the number of cases of suicidality per 1000 patients treated) are provided in Table 1.	0
"A large cohort study of antidepressant users found no cases of liver failure leading to death or transplant among nefazodone users in about 30,000 patient-years of exposure."	0
Extravasation may cause necrosis and sloughing of surrounding tissue.	0
Irbesartan is not removed by hemodialysis.	0
MEVACOR has been shown to reduce elevated LDL<U+2011>C concentrations.	0
"No drug-related external, visceral, or skeletal abnormalities were observed in fetuses of pregnant rabbits and pregnant monkeys at doses more than 225 times and 12 times the usual maximum recommended human dose, respectively."	0
"However, during chronic administration, this relationship may disappear."	0
SULAR is an extended release tablet and should be swallowed whole.	0
"In the ESRD cohort of the trial, a single 1,000 mg ZYTIGA dose was given under fasting conditions 1 hour after dialysis, and samples for pharmacokinetic analysis were collected up to 96 hours post dose."	0
"The pooled analyses of placebo-controlled trials in children and adolescents with MDD, obsessive compulsive disorder (OCD), or other psychiatric disorders included a total of 24 short-term trials of 9 antidepressant drugs in over 4400 patients."	0
"Urinalysis, transaminase, alkaline phosphatase and blood urea nitrogen tests should be repeated at least weekly."	0
It blocks the renal tubular absorption of sodium and chloride ions.	0
"Amiodarone has the potential for interactions with drugs or substances that may be substrates , inhibitors or inducers of CYP450 enzymes ( e.g. , inhibitors such as protease inhibitors , grapefruit juice , certain fluoroquinolone and macrolide antibiotics , azole antifungals and inducers such as St.   John s Wort ) or P-glycoprotein ."	0
<U+2022> Bipolar Disorder: Screen for bipolar disorder (5.1).	0
Careful observation for digital changes is necessary during treatment with stimulants.	0
Draw up residual mixture into the syringe and administer into either right or left inner cheek of infant.	0
"The protein binding of CMI is approximately 97%, principally to albumin, and is independent of CMI concentration."	0
"Among 839subjects with NYHA class II<U+2011>III heart failure treated for 26 to 52weeks in 4U.S. placebo<U+2011>controlled trials, average left ventricular ejection fraction (EF) measured by radionuclide ventriculography increased by 9EF units (%) in subjects receiving COREG and by 2EF units in placebo subjects at a target dose of 25 to 50mg twice daily."	0
ROZEREM should be used with caution in patients taking other CYP1A2 inhibiting drugs.	0
"Digoxin as an inotropic agent is of limited value in patients with restrictive cardiomyopathies, although it has been used for ventricular rate control in the subgroup of patients with atrial fibrillation."	0
THIOLA<U+00AE> causes a sustained reduction in cystine excretion without apparent loss of effectiveness.	0
"Requirements (mcg) of Digoxin Based upon Age, Lean Body Weight and Renal Function Corrected Ccr (mL/min per 70 kg) Ccr is creatinine clearance, corrected to 70 kg body weight or 1.73 m 2 body surface area."	0
The capsules may be carefully opened and the beads sprinkled over a spoonful of applesauce.	0
"Therefore, concurrent administration of these agents with INVIRASE/ritonavir is contraindicated."	0
"A patient Medication Guide about <U+201C>Antidepressant Medicines, Depression and other Serious Mental Illness, and Suicidal Thoughts or Actions<U+201D> is available for SURMONTIL."	0
"After the QTc normalizes, resume treatment with TRISENOX at a 50% reduced dose (0.075 mg/kg once daily) for 7 days."	0
"Avoid use of strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin) [see Clinical Pharmacology (12.3) ]."	0
Avoid concomitant strong CYP3A4 inducers during ZYTIGA treatment.	0
SULAR should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.	0
"Upon discontinuation of any verapamil-containing regime including TARKA (trandolapril/verapamil hydrochloride ER), the patient should be reassessed to avoid underdigitalization."	0
"The pooled analyses of placebo-controlled trials in adults with MDD or other psychiatric disorders included a total of 295 short-term trials (median duration of 2 months) of 11 antidepressant drugs in over 77,000 patients."	0
No pharmacokinetic interaction was observed when single doses of ACCUPRIL and hydrochlorothiazide were administered concomitantly.	0
Treatment with NORPRAMIN and any concomitant serotonergic agents should be discontinued immediately if the above events occur and supportive symptomatic treatment should be initiated.	0
Avoid concomitant use of XARELTO with known combined P-gp and strong CYP3A4 inhibitors see Drug Interactions ( 7.2 ) .	0
"Caution should be used if nefazodone is administered in combination with HMG-CoA reductase inhibitors that are metabolized by CYP3A4, such as simvastatin, atorvastatin, and lovastatin, and dosage adjustments of these HMG-CoA reductase inhibitors are recommended."	0
"When the adverse reaction resolves to no more than mild (grade 1), resume TRISENOX and tretinoin reduced by 2 dose levels."	0
"Known hypersensitivity to any component , Do not coadminister aliskiren with Diovan in patients with diabetes ( 4 ) ."	0
Such measures include the intravenous administration of sodium bicarbonate solution or oral or parenteral glucose with a rapid-acting insulin preparation.	0
"Absorption: Following oral administration of the capsule, fluvastatin reaches peak concentrations in less than 1 hour."	0
One case of bradycardia and hypotension and a second case of orthostatic hypotension have been reported with the coadministration of immediate-release fluvoxamine maleate tablets and metoprolol.	0
"In clinical trials, 78 patients with abnormal hepatic function (one or more of the following: elevated serum bilirubin, AST/SGOT, ALT/SGPT) and 121 patients with moderate to severe renal impairment were treated with Cleviprex."	0
"Serious adverse events include tetany, arrhythmias, and seizures."	0
The concomitant use of ZOLOFT with a CYP2D6 substrate may increase the exposure of the CYP2D6 substrate.	1
"Examples of inhibitors and inducers of CYP2C9, 1A2, and 3A4 are below in Table 2; however, this list should not be considered all-inclusive."	0
"Iloperidone doses should be reduced by about one-half when administered with ketoconazole or other strong inhibitors of CYP3A4 (e.g., itraconazole)."	1
"Like other phenothiazines, chlorpromazine is not known to cause psychic dependence and does not produce tolerance or addiction."	0
"There was considerable variation in risk of suicidality among drugs, but a tendency toward an increase in the younger patients for almost all drugs studied."	0
Quetiapine is extensively metabolized by the liver.	0
"Patients should be cautioned about the risk of bleeding associated with the concomitant use of Lexapro and NSAIDs, aspirin, or other drugs that affect coagulation."	0
"<U+2022>when coadministered with drugs that are highly dependent on CYP3A or UGT1A1 for clearance, and for which elevated plasma concentrations of the interacting drugs are associated with serious and/or life-threatening events."	0
"Therefore, use with caution when coadministering ULORIC with theophylline."	0
Tolerance to the inhibition of 5-HT uptake is not induced by long-term (14-day) treatment of rats with citalopram.	0
"Following oral administration of midazolam, fluconazole resulted in substantial increases in midazolam concentrations and psychomotor effects."	0
Drug Interactions Neprilysin Inhibitors: Patients taking concomitant neprilysin inhibitors may be at increased risk for angioedema.	0
No change is observed in the bioavailability of either agent when given together in a single tablet.	0
Drug Interactions Dronedarone is metabolized primarily by CYP3A and is a moderate inhibitor of CYP3A and CYP2D6.	0
"Intervention: Mycophenolate mofetil (MMF): Co-administration of PPIs in healthy subjects and in transplant patients receiving MMF has been reported to reduce the exposure to the active metabolite, mycophenolic acid (MPA), possibly due to a decrease in MMF solubility at an increased gastric pH."	1
"Because of the limited number of animals surviving this study, the meaning of these results is unclear."	0
"<U+2022> Mixing with food: Using a spoon, mix the recommended number of REYATAZ oral powder packets with a minimum of one tablespoon of food (such as applesauce or yogurt)."	0
"Dual Blockade of the Renin-Angiotensin System (RAS) Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"During the initial phase of combination antiretroviral treatment, patients whose immune system responds may develop an inflammatory response to indolent or residual opportunistic infections (such as Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia, or tuberculosis), which may necessitate further evaluation and treatment."	0
See Table 2 for storage and administration time limits for the reconstituted FLOLAN.	0
Distribution Bicalutamide is highly protein-bound (96%).	0
200 mg q12h Esophageal Candidiasis Not evaluated in patients with esophageal candidiasis.	0
These patients should be asked to report pregnancies to their physicians as soon as possible.	0
CYP3A4 Isozyme <U+2013> Nefazodone has been shown in vitro to be an inhibitor of CYP3A4.	0
The recommended dose of isoniazid is 25 mg/kg (rounded to the nearest 50 mg or 100mg) up to a maximum of 900 mg once-weekly for 12 weeks.	0
The most common form of CLE reported in patients treated with PPIs was subacute CLE (SCLE) and occurred within weeks to years after continuous drug therapy in patients ranging from infants to the elderly.	0
The recommended starting dosage and the established effective dosage is 20 mg/day.	0
Acetazolamide Concurrent use of aspirin and acetazolamide can lead to high serum concentrations of acetazolamide (and toxicity) due to competition at the renal tubule for secretion.	0
Use 5 mL dispenser if dose is more than 1 mL.	0
The dose of Silenor should be individualized.	0
There are no clinical studies establishing the benefits or risks of combined use of ECT and fluvoxamine maleate.	0
"Observe patients treated with DUTOPROL plus a catecholamine depletor for evidence of hypotension or marked bradycardia, which may produce vertigo, syncope, or postural hypotension."	0
"Initiation of PREZISTA/ritonavir, a CYP3A inhibitor, in patients receiving medications metabolized by CYP3A or initiation of medications metabolized by CYP3A in patients already receiving PREZISTA/ritonavir, may increase plasma concentrations of medications metabolized by CYP3A."	1
Combined P-gp and strong CYP3A4 inhibitors increase blood levels of apixaban.	1
Monitor serum potassium in such patients.	0
"Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants."	0
"In most patients, including those with organic cardiac disease, the negative inotropic action of verapamil is countered by a reduction of afterload and cardiac index is usually not reduced."	0
Oral Contraceptives containing ethinyl estradiol and norethindrone (CYP3A4 Inhibition) Increased Monitoring for adverse events related to oral contraceptives is recommended during coadministration.	0
"This decrease is caused, to a substantial degree, by a 35% increase in renal clearance of paliperidone."	0
"Angioedema of the face , extremities , lips , tongue , glottis and/or larynx has been reported in patients treated with angiotensin converting enzyme inhibitors , including VASOTEC ."	0
"STRATTERA should be used with caution in patients whose underlying medical conditions could be worsened by increases in blood pressure or heart rate such as certain patients with hypertension, tachycardia, or cardiovascular or cerebrovascular disease."	0
"Increased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants (5.1) Monitor for worsening and emergence of suicidal thoughts and behaviors (5.1)"	0
A dose reduction of buprenorphine may be considered.	1
"In drug interaction studies, risperidone did not significantly affect the pharmacokinetics of donepezil and galantamine, which are metabolized by CYP 2D6."	0
"Alcohol Although paroxetine does not increase the impairment of mental and motor skills caused by alcohol, patients should be advised to avoid alcohol while taking paroxetine."	0
"Although the data are limited, baseline HCV NS5A resistance-associated polymorphisms are not expected to impact the likelihood of achieving SVR when HARVONI is used as recommended to treat HCV genotype 4, 5, or 6-infected patients, based on the low virologic failure rate observed in Study 1119 and ELECTRON-2."	0
Food does not influence the absorption of triamterene or hydrochlorothiazide from Triamterene and Hydrochlorothiazide Tablets.	0
Clinically significant drug interactions with HARVONI mediated by CYP or UGT1A1 enzymes are not expected.	0
Hypertension: Adjust dosage to individual patient needs.	0
Co-administration with other CYP 3A substrates may require a dose adjustment or additional monitoring.	0
Seizures have been reported with the coadministration of fluvoxamine maleate and lithium.	0
Do not exceed doses greater than 20 mg daily of simvastatin.	0
Avoid concomitant use of ivabradine and diltiazem.	0
Relapse was defined as <U+2265> 2 point increase in the Clinical Global Impression <U+2013> Severity of Illness (CGI-S) score compared to baseline or study discontinuation due to lack of efficacy.	0
"In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers."	0
A 10 mg dose of REVATIO Injection is predicted to provide a pharmacological effect of sildenafil and its N-desmethyl metabolite equivalent to that of a 20 mg oral dose.	0
"If the original colchicine regimen was 0.6 mg once a day, the regimen should be adjusted to 0.3 mg once every other day."	0
"The average minimum concentration at steady state was 122 ng/mL (range: 41 to 343 ng/mL), after 100 mg twice daily dosing."	0
Irbesartan would be expected to behave similarly.	0
"Elderly Patients: In a multiple-dose study in the elderly at daily paroxetine doses of 20, 30, and 40 mg, Cmin concentrations were about 70% to 80% greater than the respective Cmin concentrations in nonelderly subjects."	0
The mechanism of this pharmacodynamic interaction is not known.	0
"In the long-term safety studies, Tenex was given concomitantly with many drugs without evidence of any interactions."	0
"In patients with severe congestive heart failure, where renal function may depend on the activity of the renin-angiotensin-aldosterone system, treatment with ACE inhibitors, including ACEON, may be associated with oliguria, progressive azotemia, and, rarely, acute renal failure and death."	0
"Families and caregivers of patients being treated with antidepressants for major depressive disorder or other indications, both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to health care providers."	0
Savella is given orally with or without food.	0
"Sedative/hypnotics:Oral midazolam, triazolam, alprazolam CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression."	0
"Combined administration of racemic citalopram (40 mg) and ketoconazole (200 mg), a potent CYP3A4 inhibitor, decreased the Cmax and AUC of ketoconazole by 21% and 10%, respectively, and did not significantly affect the pharmacokinetics of citalopram."	1
"However, given the long half-life and nonlinear disposition of the drug, a single-dose study is not adequate to rule out the possibility of altered pharmacokinetics in the elderly, particularly if they have systemic illness or are receiving multiple drugs for concomitant diseases."	0
This inhibition of coronary spasm is responsible for the effectiveness of NORVASC in vasospastic (Prinzmetal's or variant) angina.	0
Dextromethorphan: A study in healthy volunteers showed that changes in the pharmacokinetics of dextromethorphan (80 mg dose) when a 3 mg dose of iloperidone was co-administered resulted in a 17% increase in total exposure and a 26% increase in the maximum plasma concentrations (Cmax)of dextromethorphan.	1
Concomitant treatment with other inhibitors of platelet receptor GP IIb/IIIa should be avoided.	0
"Because sevelamer binds bile acids, it may interfere with normal fat absorption and thus may reduce absorption of fat soluble vitamins such as A, D and K. In clinical trials of sevelamer hydrochloride, both the mean total and LDL cholesterol declined by 15%<U+2013>31%; the clinical significance of this finding, which was observed after 2 weeks, is unclear."	1
"After at least 10 days following the initiation of ritonavir, resume bosentan at 62.5 mg once daily or every other day based upon individual tolerability."	0
Plasma levels of 8-OH-loxapine are similar to those of the parent compound.	0
"Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide."	0
PRIFTIN has not been evaluated as part of the initial phase treatment regimen in HIV-infected patients with active pulmonary TB.	0
The diagnostic evaluation of patients with this syndrome is complicated.	0
Use of phendimetrazine tartrate within 14 days following the administration of monoamine oxidase inhibitors may result in a hypertensive crisis.	0
"Quetiapine at doses of 750 mg/day did not affect the single dose pharmacokinetics of antipyrine, lithium or lorazepam (Table 18)."	0
"LASIX combined with angiotensin converting enzyme inhibitors or angiotensin II receptor blockers may lead to severe hypotension and deterioration in renal function , including renal failure ."	0
"With the dosing regimens used in TRITON-TIMI 38, TIMI (Thrombolysis in Myocardial Infarction) Major (clinically overt bleeding associated with a fall in hemoglobin <U+2265>5g/dL, or intracranial hemorrhage) and TIMI Minor (overt bleeding associated with a fall in hemoglobin of <U+2265>3g/dL but <5g/dL) bleeding events were more common on Effient than on clopidogrel."	0
Vaccination may be less effective during and for up to 2 months after discontinuation of treatment with GILENYA.	0
Alcohol: Studies involving single 40 g doses of ethanol (oral administration in one study and intravenous in the other) and multiple dosing with immediate-release fluvoxamine maleate tablets (50 mg given twice daily) revealed no effect of either drug on the pharmacokinetics or pharmacodynamics of the other.	0
"In general, avoid combined use of RAS inhibitors."	0
"In patients with hypertrophic cardiomyopathy (formerly called idiopathic hypertrophic subaortic stenosis), the positive inotropic effect of digoxin leads to an increased subvalvular outflow gradient and therefore, may compromise cardiac output."	0
"Postural hypotension with or without symptoms (e.g., dizziness) may develop within a few hours following administration of CARDURA."	0
"Irinotecan HCl can cause severe hypersensitivity reactions, including anaphylactic reactions."	0
"Limit the daily dose of lovastatin to 40 mg. Lower starting and maintenance doses of other CYP3A4 substrates (e.g., atorvastatin) may be required as amiodarone may increase the plasma concentration of these drugs."	1
"Irbesartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively binding to the AT1 angiotensin II receptor found in many tissues (e.g., vascular smooth muscle, adrenal gland)."	0
AVAPRO is contraindicated in patients who are hypersensitive to any component of this product.	0
There have been reports of second-degree AV block and other conduction abnormalities.	0
"Hypokalemia may develop with LASIX , especially with brisk diuresis , inadequate oral electrolyte intake , when cirrhosis is present , or during concomitant use of corticosteroids , ACTH , licorice in large amounts , or prolonged use of laxatives ."	0
PEXEVA<U+00AE> (paroxetine mesylate) is not approved for use in pediatric patients.	0
"<U+2191> darunavir<U+2191> rifabutin<U+2191> 25-O-desacetylrifabutin Dose reduction of rifabutin by at least 75% of the usual dose (300 mg once daily) is recommended (i.e., a maximum dose of 150 mg every other day)."	1
"Quinaprilat is eliminated primarily by renal excretion, up to 96% of an IV dose, and has an elimination half-life in plasma of approximately 2 hours and a prolonged terminal phase with a half-life of 25 hours."	0
"Patients should be advised to report to the physician immediately any of the following: numbness or tingling in the fingers and toes, muscle pain in the arms and legs, weakness in the legs, pain in the chest, temporary speeding or slowing of the heart rate, swelling, or itching."	0
This interaction should be considered if coprescribing quinapril and tetracycline or other drugs that interact with magnesium.	0
"However, if the benefit of using NORVIR oral solution to treat HIV infection in infants immediately after birth outweighs the potential risks, infants should be monitored closely for increases in serum osmolality and serum creatinine, and for toxicity related to NORVIR oral solution including: hyperosmolality, with or without lactic acidosis, renal toxicity, CNS depression (including stupor, coma, and apnea), seizures, hypotonia, cardiac arrhythmias and ECG changes, and hemolysis."	0
CDAD must be considered in all patients who present with diarrhea following antibacterial use.	0
"ECG Changes The effects of LATUDA on the QTc interval were evaluated in a randomized, double-blind, multiple-dose, parallel-dedicated thorough QT study in 43 patients with schizophrenia or schizoaffective disorder, who were treated with LATUDA doses of 120 mg daily, 600 mg daily and completed the study."	0
"For a gradual reduction in blood pressure, initiate therapy at a rate of 5 mg/hr."	0
The mechanism of action of fluvoxamine maleate in obsessive compulsive disorder is presumed to be linked to its specific serotonin reuptake inhibition in brain neurons.	0
Antagonism at receptors other than dopamine and 5HT2 may explain some of the other therapeutic and side effects of olanzapine.	0
"Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies."	0
This is more likely to occur in patients with preexisting renal impairment.	0
Insufficient data exists to accurately characterize the optimum dose and/or dose interval in patients with moderate degrees of renal insufficiency.	0
"Extreme caution should be used when this drug is given in the following situations: In patients with cardiovascular disease, because of the possibility of conduction defects, arrhythmias, tachycardias, strokes, and acute myocardial infarction."	0
"Cutaneous lupus erythematosus (CLE) and systemic lupus erythematosus (SLE) have been reported in patients taking PPIs, including rabeprazole."	0
Pooled analyses of short-term (6 to 18 weeks) placebo-controlled trials of STRATTERA in children and adolescents have revealed a greater risk of suicidal ideation early during treatment in those receiving STRATTERA.	0
Nicardipine may increase cyclosporine and tacrolimus plasma levels.	1
"The patient should be monitored for symptoms of serotonin syndrome for 2 weeks or until 24 hours after the last dose of linezolid or intravenous methylene blue, whichever comes first."	0
"Elimination Fingolimod blood clearance is 6.3<U+00B1>2.3 L/h, and the average apparent terminal half-life (t1/2) is 6 to 9 days."	0
"Studies in rats indicate that losartan crosses the blood-brain barrier poorly, if at all."	0
Figure 2: Effect of Asenapine on Other Drug Pharmacokinetics Figure 1 Figure 2 Studies in Special Populations: Exposures of asenapine in special populations are summarized in Figure 3.	0
"Approximately 80% of a single dose of dofetilide is excreted in urine, of which approximately 80% is excreted as unchanged dofetilide with the remaining 20% consisting of inactive or minimally active metabolites."	0
"Children, adolescents, or adults who are being considered for treatment with stimulant medications should have a careful history (including assessment for a family history of sudden death or ventricular arrhythmia) and physical exam to assess for the presence of cardiac disease, and should receive further cardiac evaluation if findings suggest such disease (e.g., electrocardiogram and echocardiogram)."	0
Hypotension attributable to this mechanism can be corrected by volume expansion.	0
Apnea is most often seen in neonates weighing less than 2 kg at birth and usually appears during the first hour of drug infusion.	0
"Medications that increase the risk of bleeding (e.g., oral anticoagulants, chronic use of non-steroidal anti-inflammatory drugs [NSAIDs], and fibrinolytic agents)."	0
"Alternatively, PROSTIN VR PEDIATRIC may be administered through an umbilical artery catheter placed at the ductal opening."	0
"These risk differences (drug-placebo difference in the number of cases of suicidality per 1,000 patients treated) are provided in Table 1."	0
Severe or life-threatening neutropenic fever or sepsis occurred in 3% and severe or life-threatening neutropenia occurred in 20% of patients receiving ONIVYDE in combination with fluorouracil and leucovorin.	0
Sudden deaths have been reported in patients receiving nilotinib ( 5.3 ).	0
Patients receiving warfarin therapy should be carefully monitored when PRISTIQ is initiated or discontinued.	0
"If patient is unable to tolerate 300 mg orally every 12 hours, reduce the oral maintenance dose by 50 mg steps to a minimum of 200 mg every 12 hours (or to 100 mg every 12 hours for adult patients weighing less than 40 kg)."	0
"If such circumstances are suspected to be present, initiate dosing at 1.25 mg once daily."	0
Drugs that act directly on the renin-angiotensin system can cause fetal and neonatal morbidity and death when administered to pregnant women.	0
A causal relationship between protease inhibitor therapy and these episodes has not been established.	0
"During chronic therapy, most of the blood pressure lowering effect of a given dose is obtained in 1 to 2 weeks."	0
Patients should be monitored for these symptoms when discontinuing treatment with CYMBALTA.	0
"Lovastatin, Digoxin, Furosemide, and Hydrochlorothiazide Co-administration of lovastatin, digoxin, furosemide, and hydrochlorothiazide with SAMSCA has no clinically relevant impact on the exposure to tolvaptan."	0
"Pediatric Patients For pediatric patients weighing 40 kg (88 lb) or more, taking propranolol, only a single 5-mg dose of MAXALT is recommended (maximum dose of 5 mg in a 24-hour period)."	0
Herbal products St. John's wort (Hypericum perforatum) Plasma concentrations of nelfinavir can be reduced by concomitant use of the herbal preparation St. John's wort.	1
The benefit of maintaining patients with OCD on immediate-release fluvoxamine maleate tablets after achieving a response for an average duration of about 4 weeks in a 10-week single-blind phase during which patients were titrated to effect was demonstrated in a controlled trial.	0
Agents that alter urinary pH can impact urinary excretion and alter blood levels of amphetamine.	0
"Systemic Bioavailability<U+2013>In man, following oral once-daily dosing over the range of 50 to 200 mg for 14 days, mean peak plasma concentrations (Cmax) of sertraline occurred between 4.5 to 8.4 hours post-dosing."	0
The decreased clearance and longer half-life of lidocaine should be taken into consideration with prolonged (24 hour) infusions.	0
"Increase the Remodulin dose gradually as the Flolan dose is decreased , based on constant observation of response ."	0
Avoid use of aliskiren with VASOTEC in patients with renal impairment ( GFR 60 mL/min ) .	0
"At recommended doses, teriflunomide and leflunomide result in a similar range of plasma concentrations of teriflunomide."	0
"Amiodarone is a substrate for CYP3A and CYP2C8, so inhibitors and inducers affect amiodarone exposure (7) Amiodarone inhibits p-glycoprotein and CYP1A2, CYP2C9, CYP2D6, and CYP3A, increasing exposure to other drugs (7) Drugs prolonging the QT interval: Co-administration of drugs prolonging the QT interval (such as class I and III antiarrhythmics, lithium, certain phenothiazines, tricyclic antidepressants, certain fluoroquinolone and macrolide antibiotics, azole antifungals, halogenated inhalation anesthetic agents) increases the risk of Torsade de Pointes."	0
"In a drug interaction study, co-administration of INVEGA<U+00AE> (12 mg once daily for 5 days) with divalproex sodium extended-release tablets (500 mg to 2000 mg once daily) did not affect the steady-state pharmacokinetics (AUC24h and Cmax,ss) of valproate in 13 patients stabilized on valproate."	0
"DIFLUCAN is a potent inhibitor of cytochrome P450 (CYP) isoenzyme 2C9 and 2C19, and a moderate inhibitor of CYP3A4."	0
"Because of the hydrochlorothiazide components, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs."	0
The lowest pressor dose without food was 25mg in three subjects at day 30 while on EMSAM 12mg per 24 hours.	0
Monitor phenytoin levels in patients taking both drugs.	0
The effects of sertraline in patients with moderate and severe hepatic impairment have not been studied.	0
"Chronic abusive use can lead to marked tolerance and psychological dependence, with varying degrees of abnormal behavior."	0
Blood pressure response is dose related over the range of 2 to 32 mg.	0
NOTE: Intracranial bleeding has been reported in association with the increase in blood pressure.	0
"Patients should be advised of the increased risk of myopathy, including rhabdomyolysis, and to report promptly any unexplained muscle pain, tenderness or weakness."	0
Peak plasma levels were significantly increased in subjects with creatinine clearances below 30mL/min.	0
"Families and caregivers of patients should be advised to look for the emergence of such symptoms on a day-to-day basis, since changes may be abrupt."	0
Quinapril reduced renal hepatic vascular resistance and increased renal and hepatic blood flow with glomerular filtration rate remaining unchanged.	0
"Concurrent use of rifampin and enalapril has resulted in decreased concentrations of enalaprilat, the active metabolite of enalapril."	1
Arsenic trioxide was embryolethal and teratogenic in rats when administered on gestation day 9 at a dose approximately 10 times the recommended human daily dose on a mg/m<U+00B2> basis.	0
"In Rhesus monkeys, fetal plasma drug levels were approximately 1 to 2% of maternal plasma drug levels approximately 1 hour after maternal dosing at 40, 80, or 160 mg/kg twice daily."	0
Both benazepril and benazeprilat undergo glucuronidation.	0
Chronic use of opioids may cause reduced fertility in females and males of reproductive potential.	0
"Ritonavir Ritonavir initially inhibits and later induces CYP3A, the enzyme involved in the metabolism of tadalafil."	0
"Elimination After a single oral administration of 14C-nebivolol, 38% of the dose was recovered in urine and 44% in feces for EMs and 67% in urine and 13% in feces for PMs."	0
"Also, the use of macrolide antibiotics in patients with prolonged QT intervals has been rarely associated with ventricular arrhythmias."	0
The use of MAOIs intended to treat psychiatric disorders with SURMONTIL or within 14 days of stopping treatment with SURMONTIL is contraindicated because of an increased risk of serotonin syndrome.	0
Co-administration of APTIVUS/ritonavir and drugs that induce CYP 3A and/or P-gp may decrease tipranavir plasma concentrations.	1
Absorption is not affected by food.The absolute bioavailability of eplerenone is 69% following administration of a 100 mg oral tablet.	0
Profound thrombocytopenia has been reported with AGGRASTAT.	0
"Atorvastatin: After oral administration alone, atorvastatin is rapidly absorbed; maximum plasma concentrations occur within 1 to 2 hours."	0
Mothers maintained on THIOLA<U+00AE> treatment should not nurse their infants.	0
"Autoimmune disorders (such as Graves<U+2019> disease, polymyositis, and Guillain-Barr<U+00E9> syndrome) have also been reported to occur in the setting of immune reconstitution; however, the time to onset is more variable, and can occur many months after initiation of treatment."	0
Close observation is especially recommended for patients already taking medications that are known to lower blood pressure.	0
"Figure 2: Effect of Coadministered Drugs on the Pharmacokinetics of Apixaban In dedicated studies conducted in healthy subjects, famotidine, atenolol, prasugrel, and enoxaparin did not meaningfully alter the pharmacokinetics of apixaban."	0
This pharmacokinetic profile may be responsible for the clinical observation that flurazepam is increasingly effective on the second or third night of consecutive use and that for 1 or 2 nights after the drug is discontinued both sleep latency and total wake time may still be decreased.	0
EXTRANEAL is contraindicated in patients with maltose or isomaltose intolerance and in patients with glycogen storage disease.	0
Patients should be monitored for the emergence of serotonin syndrome.	0
"Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides , including endogenous bradykinin , patients receiving ACE inhibitors ( including VASOTEC ) may be subject to a variety of adverse reactions , some of them serious ."	0
"Thus, patients should be cautioned about the use of such drugs concurrently with fluvoxamine."	0
"Telmisartan is not expected to interact with drugs that inhibit cytochrome P450 enzymes; it is also not expected to interact with drugs metabolized by cytochrome P450 enzymes, except for possible inhibition of the metabolism of drugs metabolized by CYP2C19."	1
The T1/2 and Tmax of buspirone were not significantly affected by diltiazem.	0
Remove protector from outlet port at bottom of container.	0
"Pharmacokinetic mechanisms for drug interactions with COUMADIN are mainly enzyme induction, enzyme inhibition, and reduced plasma protein binding."	0
Avoid intraarterial administration or extravasation (5.7).	0
LEXIVA/ritonavir: Use of lurasidone is contraindicated.	0
"Marplan should not be used in the presence of pheochromocytoma, as such tumors secrete pressor substances whose metabolism may be inhibited by Marplan."	0
Leukopenia of the granulocytic series may develop without eosinophilia.	0
"Electrical activity through the AV node depends, to a significant degree, upon calcium influx through the slow channel."	0
Empty the contents of the packet into the barrel of the syringe.	0
The bioavailability of olmesartan was not significantly altered by the co-administration of antacids [Al(OH)3/Mg(OH)2].	0
The use of Lexapro within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated.	0
The mechanism of this pharmacodynamic interaction is not known.	0
Titrate drug to achieve the desired blood pressure reduction.	0
"Chronic antipsychotic treatment should generally be reserved for patients who suffer from a chronic illness that, 1) is known to respond to antipsychotic drugs, and, 2) for whom alternative, equally effective, but potentially less harmful treatments are not available or appropriate."	0
"Similar findings were observed in the RE-LY, RE-COVER and RE-NOVATE II trials."	0
"Sedatives/hypnotics Oral midazolam, triazolam Prolonged or increased sedation or respiratory depression."	0
"The risk differences (drug vs placebo), however, were relatively stable within age strata and across indications."	0
Concomitant use of desvenlafaxine with a drug metabolized by CYP2D6 can result in higher concentrations of that drug.	1
"The benefits of the combined use of simvastatin with the following drugs should be carefully weighed against the potential risks of combinations: other lipid-lowering drugs (other fibrates, <U+2265>1g/day of niacin, or, for patients with HoFH, lomitapide), amiodarone, dronedarone, verapamil, diltiazem, amlodipine, or ranolazine."	0
"Of the approximately 7000 patients in clinical studies who received nefazodone for the treatment of depression, 18% were 65 years and older, while 5% were 75 years and older."	0
"By blocking the renin-angiotensin-aldosterone axis, administration of quinapril tends to reduce the potassium loss associated with the diuretic."	0
"Fluoxetine: Fluoxetine, a CYP2D6 inhibitor, administered at 20 mg per day for 21 days prior to a single 10 mg dose of nebivolol to 10 healthy adults, led to an 8-fold increase in the AUC and 3-fold increase in Cmax for d-nebivolol."	1
"Cytochrome P450: Coadministration of Tracleer with drugs metabolized by CYP2C9 and CYP3A can increase exposure to Tracleer and/or the coadministered drug (4.2, 4.3, 7.1) Hormonal contraceptives: Tracleer use decreases contraceptive exposure and reduces effectiveness (7.2)."	1
"If the assay being used is sensitive to these substances, it may be prudent to obtain a baseline measurement before digoxin therapy is started, and correct later values by the reported baseline level."	0
"As the majority of telmisartan is eliminated by biliary excretion, patients with biliary obstructive disorders or hepatic insufficiency can be expected to have reduced clearance."	0
Growth should be monitored during treatment with STRATTERA.	0
"In many cases, this hyponatremia appears to be the result of the syndrome of inappropriate antidiuretic hormone secretion (SIADH), and was reversible when Lexapro was discontinued."	0
This medicinal product is for single use only and any unused solution should be discarded.	0
"However, there is substantial evidence from placebo-controlled maintenance studies in adults with depression that the use of antidepressants can delay the recurrence of depression."	0
"Concomitant administration of both a CYP2C9 inhibitor ( such as fluconazole or amiodarone ) and a strong CYP3A inhibitor ( e.g. , ketoconazole , itraconazole ) or a moderate CYP3A inhibitor ( e.g. , amprenavir , erythromycin , fluconazole , diltiazem ) with Tracleer will likely lead to large increases in plasma concentrations of bosentan ."	1
"Therefore, drugs that induce/inhibit P-glycoprotein have the potential to alter digoxin pharmacokinetics."	0
Avoid use of PRADAXA and P-gp inhibitors in patients with CrCl <50 mL/min.	0
HIV-1 Protease Inhibitor:tipranavir <U+2191> tipranavir See the complete prescribing information for tipranavir for details on co-administration of tipranavir and ritonavir.	0
Coadministration of valsartan and warfarin did not change the pharmacokinetics of valsartan or the time-course of the anticoagulant properties of warfarin .	0
"Avoid use of strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin) [see Clinical Pharmacology (12.3) ]."	0
The administration of guanfacine concomitantly with a known microsomal enzyme inducer ( phenobarbital or phenytoin ) to two patients with renal impairment reportedly resulted in significant reductions in elimination half-life and plasma concentration .	1
"In patients with severe heart failure whose renal function may depend on the activity of the renin-angiotensin-aldosterone system, treatment with ACE inhibitors, including trandolapril, may be associated with oliguria and/or progressive azotemia and rarely with acute renal failure and/or death."	0
"If use of the combination drug product is deemed essential, the patient should stop nursing."	0
"Fluconazole showed no evidence of carcinogenic potential in mice and rats treated orally for 24 months at doses of 2.5, 5, or 10 mg/kg/day (approximately 2<U+2013>7<U+00D7> the recommended human dose)."	0
Pharmacokinetic behavior of paroxetine has not been evaluated in subjects who are deficient in CYP2D6 (poor metabolizers).	0
"Trends in risk reduction associated with treatment with MEVACOR were consistent across men and women, smokers and non-smokers, hypertensives and non-hypertensives, and older and younger participants."	0
"If a patient develops these symptoms during treatment with olmesartan, exclude other etiologies."	0
"The basic pharmacological activity of thioridazine is similar to that of other phenothiazines, but is associated with minimal extrapyramidal stimulation."	0
"For patients with severe renal impairment (creatinine clearance less than 30 mL/min), consider reducing the dose of MYCOBUTIN by 50%, if toxicity is suspected."	0
Do not use if pull ring is not attached to the connector.	0
"A close monitoring of serum potassium and renal function is recommended, especially in patients at risk for impaired renal function, e.g., the elderly."	0
"The adverse reactions of telmisartan are uncommon and independent of dose; those of amlodipine are a mixture of dose-dependent phenomena (primarily peripheral edema) and dose-independent phenomena, the former much more common than the latter."	0
"When substituting for individual components, increase the dose of TWYNSTA if blood pressure control has not been satisfactory."	0
Atenolol excretion would be expected to decrease with advancing age.	0
"Do not administer VASOTEC within 36 hours of switching to or from sacubitril/valsartan , a neprilysin inhibitor ( see WARNINGS ) ."	0
Most patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy.	0
At least 14 days should elapse between discontinuation of an MAOI intended to treat psychiatric disorders and initiation of therapy with nortriptyline hydrochloride oral solution USP.	0
Patients with a QT interval prolongation over pre-treatment by > 20 msec should discontinue INVIRASE/ritonavir.	0
"Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium."	0
Symptomatic hypotension is also possible in patients with severe aortic stenosis or hypertrophic cardiomyopathy.	0
"In more than half of the reported cases, treatment with protease inhibitors was continued or reintroduced."	0
"The metabolism of fluvoxamine has not been fully characterized and the effects of potent cytochrome P450 isoenzyme inhibition, such as the ketoconazole inhibition of CYP3A4, on fluvoxamine metabolism have not been studied."	0
"Omeprazole (CYP2C19/3A4 Inhibition) Significantly Increased When initiating therapy with VFEND in patients already receiving omeprazole doses of 40 mg or greater, reduce the omeprazole dose by one-half."	1
"See CLINICAL PHARMACOLOGY, WARNINGS, PRECAUTIONS:Laboratory Tests and ADVERSE REACTIONS sections."	0
"10 ), Use in Specific Populations (8.7)]."	0
"After toxic side effects have subsided, therapy may then be resumed."	0
These increases were almost always reversible upon discontinuation of the ACE inhibitor and/or diuretic therapy.	0
Nebivolol exposure increases with inhibition of CYP2D6.	1
Neonates born to mothers who are receiving atenolol at parturition or breast-feeding may be at risk for hypoglycemia and bradycardia.	0
"In 120 patients with hypertrophic cardiomyopathy (most of them refractory or intolerant to propranolol) who received therapy with verapamil at doses up to 720 mg/day, a variety of serious adverse effects were seen."	0
"(Boxed Warning, 4) Second or third-degree atrioventricular (AV) block or sick sinus syndrome (except when used in conjunction with a functioning pacemaker) (4) Bradycardia <50 bpm (4) Concomitant use of a strong CYP3A inhibitor (4) Concomitant use of drugs or herbal products that prolong the QT interval and may induce Torsade de Pointes (4) Liver or lung toxicity related to the previous use of amiodarone (4) Severe hepatic impairment (4) QTc Bazett interval <U+2265>500 ms (4) Pregnancy (4, 8.1) and Nursing mothers (4, 8.3) Hypersensitivity to the active substance or to any of the excipients (4)"	0
"In patients who do require chronic treatment, the smallest dose and the shortest duration of treatment producing a satisfactory clinical response should be sought."	0
"CYP2D6 Substrate (e.g., Desipramine) <U+2014> Coadministration of STRATTERA (40or 60mg BID for 13days) with desipramine, a model compound for CYP2D6 metabolized drugs (single dose of 50mg), did not alter the pharmacokinetics of desipramine."	0
"Following oral administration of solution or tablet, mean peak plasma concentrations of risperidone occurred at about 1 hour."	0
Fluvoxamine: May increase olanzapine levels.	1
Dextrose solutions without electrolytes should not be administered simultaneously with blood through the same infusion set because of the possibility that pseudoagglutination of red cells may occur.	0
The following is a general guide to its administration.	0
"This may produce carbamazepine side effects such as diplopia, headache, ataxia, or dizziness."	0
"Hypersensitivity including angioedema has been reported in patients receiving Effient, including patients with a history of hypersensitivity reaction to other thienopyridines."	0
Levodopa and Dopamine Agonists: May antagonize levodopa/dopamine agonists.	0
"Due to its - alpha1-adrenergic receptor antagonism, FANAPT has the potential to enhance the effect of certain antihypertensive agents."	0
Propranolol or Metoprolol: Reduce dose if coadministered with fluvoxamine and titrate more cautiously (7.3).	1
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
"Beta-adrenergic blockade may mask certain clinical signs (eg, tachycardia) of hyperthyroidism."	0
"Also, inform patients that this sedative effect may be increased by concomitant use of alcohol, barbiturates, or other sedating drugs."	0
"In hemodynamically stable patients within 24 hours of the onset of symptoms of acute myocardial infarction, give PRINIVIL 5 mg orally, followed by 5 mg after 24 hours, 10 mg after 48 hours and then 10 mg once daily."	0
"At the end of study or at the last visit before a primary endpoint, 77% of the group treated with losartan potassium tablets and 73% of the group treated with atenolol were still taking study medication."	0
Hypersensitivity reactions including anaphylactic reactions have been reported.	0
"Metabolism:The major biotransformation pathways for pravastatin are: (a) isomerization to 6-epi pravastatin and the 3<U+03B1>-hydroxyisomer of pravastatin (SQ 31,906) and (b) enzymatic ring hydroxylation to SQ 31,945."	0
"Autoimmune disorders (such as Graves<U+2019> disease, polymyositis, and Guillain-Barr<U+00E9> syndrome) have also been reported to occur in the setting of immune reconstitution; however, the time to onset is more variable, and can occur many months after initiation of treatment."	0
"At doses <U+2265>25 mg, apixaban displays dissolution-limited absorption with decreased bioavailability."	0
<U+2022>CYP P450 2D6 enzyme inhibitors may increase and rifampin may decrease carvedilol levels.	1
"Although the acute intravenous administration of amlodipine decreases arterial blood pressure and increases heart rate in hemodynamic studies of patients with chronic stable angina, chronic oral administration of amlodipine in clinical trials did not lead to clinically significant changes in heart rate or blood pressures in normotensive patients with angina."	0
Hydrochlorothiazide Thiazide diuretics have been reported to cause exacerbation or activation of systemic lupus erythematosus.	0
Chlorpromazine should generally not be used in pediatric patients under 6 months of age except where potentially lifesaving.	0
"In some patients, additional factor VIII was given."	0
The pharmacokinetics of eszopiclone have been investigated in healthy subjects (adult and elderly) and in patients with hepatic disease or renal disease.	0
"600/200/300 once daily 90 once daily 400 once daily 14 ledipasvir 0.66 (0.59, 0.75) 0.66(0.59, 0.75) 0.66(0.57, 0.76) sofosbuvir 1.03 (0.87, 1.23) 0.94 (0.81, 1.10) NA GS-331007 0.86 (0.76, 0.96) 0.90 (0.83, 0.97) 1.07 (1.02, 1.13) Elvitegravir/ cobicistat 150/150 once daily 90 once daily 400 once daily 29 ledipasvir 1.63 (1.51, 1.75) 1.78 (1.64, 1.94) 1.91 (1.76, 2.08) sofosbuvir 1.33 (1.14, 1.56) 1.36 (1.21, 1.52) NA GS-331007 1.33 (1.22, 1.44) 1.44 (1.41, 1.48) 1.53 (1.47, 1.59) Famotidine 40 single dose simultaneously with HARVONI 90 single dose 400 single dose 12 ledipasvir 0.80 (0.69, 0.93) 0.89 (0.76, 1.06) NA sofosbuvir 1.15 (0.88, 1.50) 1.11 (1.00, 1.24) NA GS-331007 1.06 (0.97, 1.14) 1.06 (1.02, 1.11) NA 40 single dose 12 hours prior to HARVONI 12 ledipasvir 0.83 (0.69, 1.00) 0.98 (0.80, 1.20) NA sofosbuvir 1.00 (0.76, 1.32) 0.95 (0.82, 1.10) NA GS-331007 1.13 (1.07, 1.20) 1.06 (1.01, 1.12) NA Methadone 30 to 130 daily ND 400 once daily 14 sofosbuvir 0.95(0.68, 1.33) 1.30 (1.00, 1.69) NA GS-331007 0.73(0.65, 0.83) 1.04 (0.89, 1.22) NA Omeprazole 20 once daily simultaneously with HARVONI 90 single dose 400 single dose 16 ledipasvir 0.89 (0.61, 1.30) 0.96 (0.66, 1.39) NA sofosbuvir 1.12 (0.88, 1.42) 1.00 (0.80, 1.25) NA GS-331007 1.14 (1.01, 1.29) 1.03 (0.96, 1.12) NA 20 once daily 2 hours prior to ledipasvir 30 single dose ND 17 ledipasvir 0.52(0.41, 0.66) 0.58(0.48, 0.71) NA RifampinThis study was conducted in the presence of two other investigational HCV direct-acting agents."	0
No clinically significant pharmacokinetic interaction has been found between trandolapril (or its metabolites) and nifedipine.	0
Other Clinically Important Drug Interactions Alcohol <U+2014> Use of CYMBALTA concomitantly with heavy alcohol intake may be associated with severe liver injury.	0
"The involvement of low-density lipoprotein cholesterol (LDL<U+2011>C) in atherogenesis has been well-documented in clinical and pathological studies, as well as in many animal experiments."	0
Renal Impairment: Initiate with 5 mg once daily in patients with GFR<30 mL/min/1.73 m2 (serum creatinine >3 mg/dL)(2.2) ADULTS The recommended initial dose for patients not receiving a diuretic is 10 mg once a day.	0
"Tell patients to promptly report any indication of infection (eg, sore throat, fever) which could be a sign of neutropenia."	0
There are no adequate and well-controlled studies of Diflucan in pregnant women.	0
"Unless the benefits of paroxetine to the mother justify continuing treatment, consideration should be given to either discontinuing paroxetine therapy or switching to another antidepressant."	0
Biliary excretion contributes to the elimination of candesartan.	0
"In primarily depressed patients, worsening of depression (including suicidal ideation and completed suicides) has been reported in association with the use of hypnotics."	0
"In females of reproductive potential, exclude pregnancy prior to initiation of therapy, ensure use of acceptable contraceptive methods, and obtain monthly pregnancy tests."	0
QTc Prolongation: ZOLOFT should be used with caution in patients with risk factors for QTc prolongation.	0
"Periodic creatine phosphokinase (CPK) determinations may be considered in such situations, but there is no assurance that such monitoring will prevent the occurrence of severe myopathy."	0
Perform serial ultrasound examinations to assess the intra-amniotic environment.	0
A study of the immediate release formulation showed no effect of nisoldipine on the renin-angiotensin-aldosterone system or on plasma norepinephrine concentration in normals.	0
Marplan is not approved for use in pediatric patients.	0
"Cyclosporine The pharmacokinetics of single-dose fingolimod was not altered during coadministration with cyclosporine at steady-state, nor was cyclosporine steady-state pharmacokinetics altered by fingolimod."	0
"In some cases, diabetic ketoacidosis has occurred."	0
One case of hypertensive crisis has been reported in a patient taking the recommended doses of selegiline and a sympathomimetic medication (ephedrine).	0
"Blockade of the renin-angiotensin system with ACE inhibitors, which inhibit the biosynthesis of angiotensin II from angiotensin I, is widely used in the treatment of hypertension."	0
Studies in healthy volunteers have shown that TIKOSYN does not affect the pharmacokinetics of digoxin.	0
Distribution Fingolimod highly (86%) distributes in red blood cells.	0
"Adverse reactions of hyperkalemia were approximately 1-2 % higher when tolvaptan was administered with angiotensin receptor blockers , angiotensin converting enzyme inhibitors and potassium sparing diuretics compared to administration of these medications with placebo ."	0
"Effect of Rosuvastatin Coadministration on Systemic Exposure To Other Drugs Rosuvastatin Dosage Regimen Coadministered Drug Name and Dose Change in AUC Change in Cmax 40mg QD for 10 days WarfarinClinically significant pharmacodynamic effects QD for 21 Days EE <U+2191> 26% NG <U+2191> 34% EE <U+2191> 25% NG <U+2191> 23% EE = ethinyl estradiol, NG = norgestrel"	0
"Clinical symptoms of intolerance, especially drowsiness, dizziness, and postural hypotension, should also alert the physician to the need for reduction in dosage."	0
Caution is advised in administering nonsteroidal anti-inflammatory agents with DYAZIDE.	0
"Patients with milder ventricular dysfunction should, if possible, be controlled with optimum doses of digitalis and/or diuretics before verapamil treatment (Note interactions with digoxin under: PRECAUTIONS )."	0
Both elevation and lowering of blood sugar levels have been reported.	0
"Confirmatory tests, such as gas chromatography/mass spectrometry, will distinguish venlafaxine from PCP and amphetamine."	0
Multiday administration of ondansetron has been shown to slow colonic transit in normal volunteers.	0
Cases of elevated blood pressure requiring immediate treatment have been reported.	0
"During the first year of life, the value of k is 0.33 for pre-term babies and 0.45 for term infants."	0
"Of the 196 adolescents studied, 50 were 13 years of age or less and 146 were 14 to 17 years of age."	0
Use ACIPHEX delayed-release tablets with caution in transplant patients receiving MMF.See the prescribing information for other drugs dependent on gastric pH for absorption.	0
"Renal Impairment In patients with severe renal impairment, fingolimod Cmax and AUC are increased by 32% and 43%, respectively, and fingolimod-phosphate Cmax and AUC are increased by 25% and 14%, respectively, with no change in apparent elimination half-life."	0
"Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide."	0
"For example, in patients who developed symptomatic hypotension in the VMAC (Vasodilation in the Management of Acute Congestive Heart Failure) trial, half of the recovery of SBP toward the baseline value after discontinuation or reduction of the dose of NATRECOR<U+00AE> was observed in about 60 minutes."	0
Patients with hepatic impairment must be carefully monitored for drug toxicity.	0
"Warfarin Clinical Impact: Increased INR and prothrombin time in patients receiving PPIs, including rabeprazole,and warfarin concomitantly."	0
"Therapy-Naive Adults <U+2022>LEXIVA 1,400mg twice daily (without ritonavir)."	0
Patients treated concomitantly with WELLBUTRIN XL and such drugs may require increased doses of the drug.	0
Voriconazole can cause fetal harm when administered to a pregnant woman.	0
"The results confirm that the therapeutic effect is a fall in blood pressure unaccompanied by a clinically significant change in cardiac output, heart rate, renal blood flow and glomerular filtration rate."	0
"In hemodynamic studies, amlodipine has not been associated with a negative inotropic effect when administered in the therapeutic dose range to intact animals and man, even when co-administered with beta-blockers to man."	0
"For patients who are unable to swallow capsules, the contents of each capsule may be dispersed in 1 teaspoon of applesauce (pur<U+00E9>ed apple)."	0
"For the primary endpoint and stroke, the effects of losartan potassium tablets in patient subgroups defined by age, gender, race and presence or absence of isolated systolic hypertension (ISH), diabetes, and history of cardiovascular disease (CVD) are shown in Figure3 below."	0
"After further treatment with Savella 100 mg BID for two weeks, the mean increase from baseline in SBP and DBP was 6 mmHg."	0
"In a clinical study to determine the effects of abiraterone acetate 1,000 mg daily (plus prednisone 5 mg twice daily) on a single 100 mg dose of the CYP1A2 substrate theophylline, no increase in systemic exposure of theophylline was observed."	0
Patients who develop hyperkalemia (5.5<U+2013>5.9 mEq/L) may continue INSPRA therapy with proper dose adjustment.	0
"A case of significant hypoglycemia has been reported in a type II diabetic patient maintained on chlorpropamide (250 mg/day), after the addition of nortriptyline (125 mg/day)."	0
Refer to the venetoclax prescribing information for dosing instructions.	0
"Similarly, PMs of CYP2D6 have higher exposure to iloperidone compared with EMsand PMs should have their dose reduced by one-half."	0
"A second study, comparing normal subjects and subjects with moderate-to-severe renal impairment (GFR 30.9 <U+00B1> 10.8 mL/min) showed that after a single 150 mg dose of sustained-release bupropion, exposure to bupropion was approximately 2-fold higher in subjects with impaired renal function, while levels of the hydroxybupropion and threo/erythrohydrobupropion (combined) metabolites were similar in the 2 groups."	0
Zolpidem pharmacokinetics were not significantly different in renally impaired patients.	0
"Use with Diuretics: In patients who are currently being treated with a diuretic, symptomatic hypotension can occur following the initial dose of ACEON."	0
Immunosuppressants: Combination with APTIVUS/ritonavir not studied.	0
Renal elimination of venlafaxine and its metabolites is thus the primary route of excretion.	0
NORVIR oral solution is not recommended for use with polyurethane feeding tubes due to potential incompatibility.	0
Evaluation of hypertensive patients should always include assessment of renal function.	0
"In a male subject with mild Von Willebrand (vW) disease, intravenous infusion of dDAVP 2 hours after administration of oral tolvaptan did not produce the expected increases in vW Factor Antigen or Factor VIII activity."	0
Monitor renal function and serum potassium.	0
See Contraindications (4.1) and Warnings and Precautions (5.6).	0
Nitrates Verapamil has been given concomitantly with short- and long-acting nitrates without any undesirable drug interactions.	0
"Non-nucleoside reverse transcriptase inhibitor: Efavirenza LEXIVA: <U+2193>Amprenavir LEXIVA/ritonavir: <U+2193>Amprenavir For contraindicated NNRTIs (delavirdine),."	0
Most patients improve with discontinuation of the PPI alone in 4 to 12 weeks.	0
"Based on in vitro studies utilizing human liver enzymes, paliperidone is not a substrate for CYP1A2; smoking should, therefore, not have an effect on the pharmacokinetics of paliperidone."	0
Patients using oral or other systemic hormonal contraceptives should be advised to change to nonhormonal methods of birth control during rifampin therapy.	0
"Thereafter, TENORMIN can be given orally either 100 mg once daily or 50 mg twice a day for a further 6-9 days or until discharge from the hospital."	0
"Titrate the Renvela dose as needed to achieve target levels at two-week intervals based on BSA category, as shown in Table 2."	0
Renal clearance of dabigatran is 80% of total clearance after intravenous administration.	0
"Furthermore, narcotics produce adverse reactions which may obscure the clinical course of patients with head injuries."	0
"Ritonavir <U+2191> atazanavir If REYATAZ is coadministered with ritonavir, it is recommended that REYATAZ 300 mg once daily be given with ritonavir 100 mg once daily with food in adults."	0
"Dual blockade of the RAS with angiotensin-receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"Average AUC was increased by approximately 31% and 35% in patients with moderate and severe hepatic impairment, respectively, as compared to healthy subjects."	0
"See also Contraindications (4), Warnings and Precautions (5.1), and Clinical Pharmacology (12.3) When co-administering NORVIR with other protease inhibitors (atazanavir, darunavir, fosamprenavir, saquinavir, and tipranavir), see the full prescribing information for that protease inhibitor including important information for drug interactions."	0
"In patients with coronary artery disease, nicardipine improves left ventricular diastolic distensibility during the early filling phase, probably due to a faster rate of myocardial relaxation in previously underperfused areas."	0
Relapse during the double-blind phase was determined by the individual investigators.	0
SURMONTIL is not approved for use in pediatric patients.	0
"In these studies, 28% of patients receiving Anafranil had a weight gain of at least 7% of their initial body weight, compared with 4% of patients receiving placebo."	0
A lower starting dose is recommended for patients with a history of hepatic impairment.	0
"HIV protease inhibitors: Indinavira, nelfinavira LEXIVA: <U+2191>Amprenavir Effect on indinavir and nelfinavir is not well established."	0
"The degree of tone in this area is mediated by the alpha1 adrenoceptor, which is present in high density in the prostatic stroma, prostatic capsule and bladder neck."	0
These increases in plasma concentration would decrease the cardioselectivity of metoprolol.	0
Class I or Class III antiarrhythmic agents should be withheld for at least three half-lives prior to dosing with sotalol.	0
Consideration should be given to not treating adults with clinically significant cardiac abnormalities.	0
The use of REYATAZ in patients with severe hepatic impairment (Child-Pugh Class C) is not recommended.	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction with antidepressants compared to placebo in adults aged 65 and older.	0
1642 <U+2013>17 <U+2013>24 +6.6 <U+2013>27 <U+2013>21 <U+2013>10 40 mg q.p.m.	0
Antihypertensive activity commences within 1 hour with peak effects usually achieved by 2 to 4 hours after dosing.	0
"Consequently, no reduction in metoprolol succinate dosage is usually needed in patients with chronic renal failure."	0
"Renal Disease The apparent clearance of nebivolol was unchanged following a single 5 mg dose of BYSTOLIC in patients with mild renal impairment (ClCr 50 to 80 mL/min, n=7), and it was reduced negligibly in patients with moderate (ClCr 30 to 50 mL/min, n=9), but clearance was reduced by 53% in patients with severe renal impairment (ClCr <30 mL/min, n=5)."	0
"After the initial dose of ALTACE, observe the patient under medical supervision for at least two hours and until blood pressure has stabilized for at least an additional hour."	0
"As with most psychoactive medications, patients should be advised to avoid alcohol while taking ABILIFY MAINTENA."	0
"Misidentification of their etiology might lead the clinician to continue or increase digoxin dosing, when dosing should actually be suspended."	0
Patients should be advised to discontinue tobacco use.	0
Instructions for use Shake the closed bottle of reconstituted suspension for approximately 10 seconds before each use.	0
"Drug Interactions with PRIFTIN: Dosage Adjustment may be Necessary Drug Class Examples of Drugs Within Class Antiarrhythmics Disopyramide, mexiletine, quinidine, tocainide Antibiotics Chloramphenicol, clarithromycin, dapsone, doxycycline; Fluoroquinolones (such as ciprofloxacin) Oral Anticoagulants Warfarin Anticonvulsants Phenytoin Antimalarials Quinine Azole Antifungals Fluconazole, itraconazole, ketoconazole Antipsychotics Haloperidol Barbiturates Phenobarbital Benzodiazepines Diazepam Beta-Blockers Propanolol Calcium Channel Blockers Diltiazem, nifedipine, verapamil Cardiac Glycoside Preparations Digoxin Corticosteroids Prednisone Fibrates Clofibrate Oral Hypoglycemics Sulfonylureas (e.g., glyburide, glipizide) Hormonal Contraceptives/ Progestins Ethinyl estradiol, levonorgestrel Immunosuppressants Cyclosporine, tacrolimus Methylxanthines Theophylline Narcotic analgesics Methadone Phophodiesterase-5 (PDE-5) Inhibitors Sildenafil Thyroid preparations Levothyroxine Tricyclic antidepressants Amitriptyline, nortriptyline The conversion of PRIFTIN to 25-desacetyl rifapentine is mediated by an esterase enzyme."	0
Available human data do not suggest an increased risk of congenital anomalies following a single maternal dose of 150 mg. A few published case reports describe a rare pattern of distinct congenital anomalies in infants exposed in utero to high dose maternal fluconazole (400<U+2013>800 mg/day) during most or all of the first trimester.	0
"In clinical studies in which amlodipine was administered in combination with beta-blockers to patients with either hypertension or angina, no adverse effects on electrocardiographic parameters were observed."	0
The absolute bioavailability of atorvastatin (parent drug) is approximately 14% and the systemic availability of HMG-CoA reductase inhibitory activity is approximately 30%.	0
Both metabolites lack pharmacological activity at the concentrations observed.	0
"The angioedema was diagnosed by procedures including abdominal CT scan or ultrasound, or at surgery, and symptoms resolved after stopping the ACE inhibitor."	0
<U+2022>Protease Inhibitor-Experienced Adults: LEXIVA 700mg twice daily plus ritonavir 100mg twice daily.	0
Renal Impairment - Pharmacokinetics of prasugrel's active metabolite and its inhibition of platelet aggregation are similar in patients with moderate renal impairment(CrCL=30 to 50mL/min) and healthy subjects.	0
Open-angle glaucoma is not a risk factor for angle closure glaucoma.	0
"If fluoxetine is added to the treatment regimen of a patient already receiving a drug metabolized by CYP2D6, the need for decreased dose of the original medication should be considered."	1
Monitoring No standard monitoring is required.	0
Inhaled beta agonist:salmeterol <U+2191> salmeterol Co-administration of salmeterol and PREZISTA/ritonavir is not recommended.	0
"Concomitant use of FETZIMA with alprazolam or carbamazepine, substrates of CYP3A4, had no significant effect on alprazolam or carbamazepine plasma concentrations."	0
Treatment of familial Mediterranean fever (FMF)-co-administration of colchicine in patients on ritonavir: Maximum daily dose of 0.6 mg (may be given as 0.3 mg twice a day).	0
Increased pimozide plasma concentrations can lead to QT prolongation and rare occurrences of torsade de pointes.	1
One additional case of hypomania has been reported in association with Lexapro treatment.	0
Efficacy of DIFLUCAN has not been established in infants less than 6 months of age.	0
Orally administered calcium acetate from pharmaceutical dosage forms is systemically absorbed up to approximately 40% under fasting conditions and up to approximately 30% under non-fasting conditions.	0
"However, there are limited in vivo data suggesting a modest CYP2D6 inhibitory effect for escitalopram, i.e., coadministration of escitalopram (20 mg/day for 21 days) with the tricyclic antidepressant desipramine (single dose of 50 mg), a substrate for CYP2D6, resulted in a 40% increase in Cmax and a 100% increase in AUC of desipramine."	1
Oral Suspension: 2000 mg/100 mL (20 mg/mL) - pink to brown in color.	0
Patients receiving warfarin therapy should be carefully monitored when Celexa is initiated or discontinued.	0
Hydrochlorothiazide Hydrochlorothiazide can cause hypokalemia and hyponatremia.	0
"Blockade of the angiotensin II receptor inhibits the negative regulatory feedback of angiotensin II on renin secretion, but the resulting increased plasma renin activity and angiotensin II circulating levels do not overcome the effect of candesartan on blood pressure."	0
Patients with severe sleep apnea: Silenor is ordinarily not recommended for use in this population.	0
"Serotonergic Drugs Based on the mechanism of action of SNRIs and SSRIs, including paroxetine hydrochloride, and the potential for serotonin syndrome, caution is advised when paroxetine is coadministered with other drugs that may affect the serotonergic neurotransmitter systems, such as triptans, lithium, fentanyl, tramadol, or St. John<U+2019>s Wort."	0
Syncope was not reported during short-term child and adolescent placebo-controlled ADHD registration studies.	0
"Because pimozide prolongs the QT interval of the electrocardiogram, an additive effect on QT interval would be anticipated if administered with other drugs, such as phenothiazines, tricyclic antidepressants or antiarrhythmic agents, which prolong the QT interval."	0
Monitor serum potassium in such patients.	0
Screening Patients for Bipolar Disorder A major depressive episode may be the initial presentation of bipolar disorder.	0
Ritonavir <U+2191> nelfinavir<U+2194> ritonavir Concentrations of nelfinavir were increased when coadministered with ritonavir.	1
Response during the open phase was defined as a CGI-I score of 1(very much improved) or 2 (much improved).	0
"Cimetidine, apparently through an effect on certain microsomal enzyme systems, has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants, phenytoin, propranolol, nifedipine, chlordiazepoxide, diazepam, certain tricyclic antidepressants, lidocaine, theophylline and metronidazole, thereby delaying elimination and increasing blood levels of these drugs."	1
"Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), warfarin, and other anti-coagulants may add to this risk."	0
Negative inotropic effects can be detected in vitro but such effects have not been seen in intact animals at therapeutic doses.	0
Sinus bradycardia resulting in hospitalization and pacemaker insertion has been reported in association with the use of clonidine concurrently with verapamil.	0
"Nevertheless, caution is indicated in the coadministration of TCAs with any of the SSRIs and also in switching from one class to the other."	0
"Unlike propranolol and metoprolol which undergo hepatic metabolism, atenolol is eliminated primarily by renal excretion."	0
"Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapy, including VIRACEPT."	0
"Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders."	0
The recommended starting dose is 30 mg/day to be titrated in increments of 20 mg at approximately weekly intervals to achieve the recommended target dose of 50 to 70 mg/day.	0
Approximately 25% of an orally administered apixaban dose is recovered in urine and feces as metabolites.	0
"These crises are characterized by some or all of the following symptoms: occipital headache which may radiate frontally, palpitation, neck stiffness or soreness, nausea or vomiting, sweating (sometimes with fever and sometimes with cold, clammy skin), and photophobia."	0
Correct volume or salt depletion prior to administration of AVAPRO or use a lower starting dose.	0
"Serotonin Syndrome: Serotonin syndrome has been reported with SSRIs and SNRIs, including with PRISTIQ, both when taken alone, but especially when co-administered with other serotonergic agents (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John's Wort)."	0
Elimination of quinaprilat may be reduced in elderly patients (<U+2265>65 years) and in those with heart failure; this reduction is attributable to decrease in renal function.	0
Aldosterone plasma concentrations fall following losartan administration.	0
"At endpoint, 76% of patients receiving paroxetine 40 mg/day were free of panic attacks, compared to 44% of placebo-treated patients."	0
"Fingolimod-phosphate is a sphingosine 1-phosphate receptor modulator, and binds with high affinity to sphingosine 1-phosphate receptors 1, 3, 4, and 5."	0
The terminal half-life of losartan is about 2hours and of the metabolite is about 6-9hours.	0
The mechanism whereby its therapeutic action is exerted is unknown.	0
A safe and effective dose has not been established when used with nelfinavir.	0
"Elevated transaminases resulted in the discontinuation of 8 patients from therapy in the simvastatin group (n=2,221) and 5 in the placebo group (n=2,223)."	0
Such monitoring should include daily observation by families and caregivers.	0
"Therefore, routine measurement of coagulation parameters is not currently indicated in the management of patients on APTIVUS."	0
"Treatment of DVT and PE: The recommended dose is 10 mg taken orally twice daily for 7 days, followed by 5 mg taken orally twice daily."	0
Coadministration of VFEND with high-dose ritonavir (400 mg q12h) is contraindicated because ritonavir (400 mg q12h) significantly decreases plasma voriconazole concentrations.	1
"Caution all patients that inadequate fluid intake or excessive perspiration, diarrhea, or vomiting can lead to an excessive fall in blood pressure because of reduction in fluid volume, with the same consequences of lightheadedness and possible syncope."	0
"Declines from peak levels are rapid (5- to 10-fold) during the first 7 hours; thereafter, plasma levels decay with a half-life similar to that of orally administered drug."	0
Do not co-administer aliskiren with ATACAND in patients with diabetes.	0
Dipyridamole inhibits phosphodiesterase (PDE) in various tissues.	0
Verapamil therapy may increase carbamazepine concentrations during combined therapy.	1
"If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus."	0
The efficacy of ledipasvir/sofosbuvir has not been established in patients who have previously failed treatment with other regimens that include an NS5A inhibitor.	0
When administered to male and female rats at doses of up to 30 mg/kg/day (about 5 times the MRHD on a mg/m2 basis) nisoldipine had no effect on fertility.	0
"Since diethylpropion hydrochloride and/or its metabolites have been shown to be excreted in human milk, caution should be exercised when diethylpropion hydrochloride is administered to a nursing woman."	0
"Marplan may aggravate coexisting symptoms in depression, such as anxiety and agitation."	0
"Rare cases of angioedema involving the tongue, glottis or larynx have been reported in patients after taking the first or subsequent doses of ROZEREM."	0
Postural hypotension is infrequently noted upon suddenly assuming an upright position.	0
"If hypotension persists, dopamine HCl should be discontinued and a more potent vasoconstrictor agent such as norepinephrine should be administered."	0
"Consequently, the degree of drug absorption may be 1/3 higher than the average amounts of 6mg to 12mg per 24 hours."	0
This lower selectivity is thought to be the basis for abnormalities related to color vision observed with higher doses or plasma levels.	0
ATACAND may be administered once daily or divided into two equal doses.	0
"When Anafranil and a neuroleptic were used concomitantly, the cases were sometimes considered to be examples of a neuroleptic malignant syndrome."	0
"Disopyramide has been associated with severe bradycardia, asystole and heart failure when administered with beta blockers."	0
The primary treatment is to discontinue hydrochlorothiazide as rapidly as possible.	0
Reserve concomitant prescribing of meperidine hydrochloride and benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate.	0
"When discontinuing therapy with CATAPRES tablets, the physician should reduce the dose gradually over 2 to 4 days to avoid withdrawal symptomatology."	0
Where possible consider monitoring clinical responses and/or blood levels of concomitant drugs that have a narrow therapeutic range.	0
Angioedema: Discontinue PRINIVIL (5.2) Renal impairment: Monitor renal function periodically (5.3) Hypotension: Monitor blood pressure after initiation (5.4) Hyperkalemia: Monitor serum potassium periodically (5.5) Cholestatic jaundice and hepatic failure: Discontinue PRINIVIL (5.6) Pregnancy Category D Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.	0
"Although no study specifically investigated this risk, in post-hoc analyses, no increased mortality was observed in females on TIKOSYN compared to females on placebo."	0
Physicians should consider dose reduction or stopping the medication if a patient develops such urges while taking selegiline.	0
<U+2022>Severe bradycardia (unless a permanent pacemaker is in place).	0
Ventricular Arrhythmias: If an increased number of ectopic beats are observed the dose should be reduced if possible.	0
"Because irbesartan does not inhibit ACE, it does not affect the response to bradykinin; whether this has clinical relevance is not known."	0
"Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary)."	0
"If a patient develops minor side effects, the dosage should be reduced."	0
"Combination of Protease Inhibitors: Atorvastatin AUC was significantly increased with concomitant administration of LIPITOR with several combinations of HIV protease inhibitors, as well as with the hepatitis C protease inhibitor telaprevir, compared to that of LIPITOR alone."	1
The mechanism and long-term consequences of these events are currently unknown.	0
Selegiline rapidly penetrates the blood-brain barrier.	0
"However, it has been proposed that this drug's efficacy in schizophrenia is mediated through a combination of dopamine and serotonin type2(5HT2) antagonism."	0
"Absorption: Ziprasidone is well absorbed after oral administration, reaching peak plasma concentrations in 6 to 8 hours."	0
Therefore the initial dosage in the elderly should be reduced.	0
Cases of seizure have been reported in pre-marketing clinical studies with PRISTIQ.	0
"Co-administration of SAMSCA with 400 mg ketoconazole daily or with other strong CYP 3A inhibitors ( e.g. , clarithromycin , itraconazole , telithromycin , saquinavir , nelfinavir , ritonavir and nefazodone ) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure ."	1
Peak plasma levels are reached within 2 hours following oral administration.	0
"Irbesartan In patients who are elderly, volume depleted (including those on diuretic therapy), or with compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including irbesartan, may result in deterioration of renal function, including possible acute renal failure."	0
"Vasospastic Angina: NORVASC has been demonstrated to block constriction and restore blood flow in coronary arteries and arterioles in response to calcium, potassium epinephrine, serotonin, and thromboxane A2 analog in experimental animal models and in human coronary vessels in vitro."	0
No unusual age-associated pattern of adverse reactions was observed in those elderly patients.	0
The effects of hepatic and renal impairment on the disposition of clomipramine hydrochloride have not been determined.	0
"Based on a life-table analysis, the one-year incidence of new or worsened heart failure was 3% in patients without a prior history and 10% in patients with a prior history of heart failure."	0
Corresponding multiples of the MRHD are 100 (mice) and 4 (rats) on the basis of body-weight and 9.4 (mice) and 0.8 (rats) on the basis of body-surface area.	0
"The recommended starting dose is 2 mg. Because the effect of Zanaflex peaks at approximately 1 to 2 hours post-dose and dissipates between 3 to 6 hours post-dose, treatment can be repeated at 6 to 8 hour intervals, as needed, to a maximum of three doses in 24 hours."	0
"For the small fraction of patients that required urgent CABG after treatment with Effient, the risk of significant bleeding was substantial."	0
TRISENOX can cause fetal harm when administered to a pregnant woman.	0
"Altered anticoagulant effects, including increased bleeding, have been reported when SSRIs and SNRIs are coadministered with warfarin."	0
The administration of guanfacine concomitantly with a known microsomal enzyme inducer ( phenobarbital or phenytoin ) to two patients with renal impairment reportedly resulted in significant reductions in elimination half-life and plasma concentration .	1
Therapy with CRIXIVAN should be initiated and maintained at the recommended dosage.	0
"There were differences in absolute risk of suicidality across the different indications, with the highest incidence in MDD."	0
Advise of potential risk to a fetus and use of effective contraception.	0
The mechanism of this effect is not established.	0
"Children who weighed <50kg received 2.5, 25 or 50mg of losartan daily and patients who weighed <U+2265>50kg received 5, 50 or 100mg of losartan daily."	0
No dosage adjustment is necessary in patients with mild renal impairment.	0
"Drug Interactions There are only limited data on the effects of drugs known to influence the hepatic metabolism of doxazosin (e.g., cimetidine)."	0
"The magnitude of reduction in blood pressure with NORVASC is also correlated with the height of pretreatment elevation; thus, individuals with moderate hypertension (diastolic pressure 105<U+2013>114 mmHg) had about a 50% greater response than patients with mild hypertension (diastolic pressure 90<U+2013>104 mmHg)."	0
Studies in animals indicate that radiolabeled irbesartan weakly crosses the blood-brain barrier and placenta.	0
"Because of its anticholinergic activity, nortriptyline should be used with great caution in patients who have a history of urinary retention."	0
"May result in an increase in PDE5 inhibitor-associated adverse events, including hypotension, syncope, visual disturbances, and priapism."	0
"Bleeding events related to drugs that interfere with serotonin reuptake have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages."	0
Animal reproduction studies have revealed no evidence of impairment of fertility.	0
Increases in AST were more frequently observed in the patients treated with Savella 100 mg/day (3%) and Savella 200 mg/day (5%) compared to the patients treated with placebo (2%).	0
DIFLUCAN should be discontinued if clinical signs and symptoms consistent with liver disease develop that may be attributable to DIFLUCAN.	0
Increases in blood pO2 (torr) have been the same in neonates who received the drug by either route of administration.	0
"When a single oral 30 mg dose of paroxetine was administered at phenobarbital steady state (100 mg once daily for 14 days), paroxetine AUC and T<U+00BD> were reduced (by an average of 25% and 38%, respectively) compared to paroxetine administered alone."	1
"There was a linear dose-response improvement in total sleep time, sleep latency and number of awakenings, with significant drug-placebo differences occurring for sleep latency at all doses, for total sleep time at the two higher doses and for number of awakenings only at the 30 mg dose."	0
Monitor toxicity when coadministering lidocaine with cimetidine.	1
The usual adolescent and geriatric dose is 25 to 100 mg daily.	0
"There is no evidence that doses greater than 60mg/day confer additional benefit, even in patients who do not respond to a 60mg dose, and higher doses are associated with a higher rate of adverse reactions."	0
There is limited experience with administering NATRECOR<U+00AE> for longer than 96 hours.	0
Coadministration of fluvoxamine maleate 100 mg per day and propranolol 160 mg per day in normal volunteers resulted in a mean five-fold increase (range 2 to 17) in minimum propranolol plasma concentrations.	1
"In animal studies, after oral dosing, lovastatin had high selectivity for the liver, where it achieved substantially higher concentrations than in non-target tissues."	0
"Studies of immediate-release formulations of ISDN have found highly variable bioavailability (10 to 90%), with extensive first-pass metabolism in the liver."	0
"Response during the open phase was defined as a CGI-I of 1 (very much improved) or 2 (much improved), and a decrease in the CAPS-2 score of > 30% compared to baseline."	0
The degree of anticoagulant activity can also be assessed by the ecarin clotting time (ECT).	0
"Conversely, on discontinuation of the strong inducer, it may be necessary to decrease the dose of INVEGA<U+00AE>."	0
"Special Populations: Pharmacokinetics in Smokers: Loxapine exposures in nonsmokers and smokers are similar, with geometric mean ratios of 92%, 85%, and 99% for AUC0-2h, AUCinf, and Cmax respectively."	0
Paliperidone is the major active metabolite of risperidone.	0
Severe vomiting has been reported with the coadministration of fluvoxamine maleate and tryptophan.	0
The major metabolite in human plasma is the lactone which is formed via an ester-type pitavastatin glucuronide conjugate by uridine 5'-diphosphate (UDP) glucuronosyltransferase (UGT1A3 and UGT2B7).	0
"Approximately 95% and 93% of paroxetine is bound to plasma protein at 100 ng/mL and 400 ng/mL, respectively."	0
"There is no known treatment for established cases of tardive dyskinesia, although the syndrome may remit, partially or completely, if antipsychotic treatment is withdrawn."	0
A maximum dose of 50mg twice daily has been administered to patients with mild-to-moderate heart failure weighing over 85kg (187lbs).	0
Absorption: Quazepam is rapidly (absorption half-life of about 30 minutes) and well absorbed from the gastrointestinal tract.	0
Study 2 was a flexible-dose study comparing paroxetine (20 mg to 50 mg daily) and placebo.	0
Specific Populations Geriatric The pharmacokinetics of CARDURA in young (<65 years) and elderly (<U+2265>65 years) subjects were similar for plasma half-life values and oral clearance.	0
(7.6) Administration of NitroMist is contraindicated in patients who are using a selective inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type5 (PDE5).	0
"Because of the voluntary nature of the reports and the natural increase in the incidence of anemia and renal failure in the elderly, it is however not possible to establish a casual relationship to drug exposure."	0
A single study in nine patients with severely impaired renal function showed no difference in the pharmacokinetic profile of diltiazem compared to patients with normal renal function.	0
"There have been reports of agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress and feeding disorder in these neonates."	0
"Due to an increased risk of myopathy/rhabdomyolysis when HMG-CoA reductase inhibitors are coadministered with gemfibrozil, concomitant administration of LIVALO with gemfibrozil should be avoided."	0
"OAT3 Substrates There was an increase in mean cefaclor Cmax and AUC (1.43- and 1.54-fold, respectively), following repeated doses of teriflunomide, suggesting that teriflunomide is an inhibitor of organic anion transporter 3 (OAT3) in vivo."	1
"Elimination of duloxetine is mainly through hepatic metabolism involving two P450 isozymes, CYP1A2 and CYP2D6."	0
"Ritonavir <U+2191> indinavir concentration<U+2191> ritonavir concentration The appropriate doses for this combination, with respect to efficacy and safety, have not been established."	0
ULORIC can be administered without regard to food or antacid use.	0
Other CNS Active Agents No clinically relevant effect was observed on steady state lithium exposure following coadministration with multiple daily doses of BRINTELLIX.	0
"Emergence of New Psychotic or Manic Symptoms: Treatment emergent psychotic or manic symptoms, e.g., hallucinations, delusional thinking, or mania in children and adolescents without a prior history of psychotic illness or mania can be caused by stimulants at usual doses."	0
Nitrates Concomitant use of REVATIO with nitrates in any form is contraindicated.	0
Both CYP1A2 and CYP2D6 are responsible for CYMBALTA metabolism.	0
"Because statins have the potential for serious adverse reactions in nursing infants, women who require treatment with ZOCOR should not breastfeed their infants."	0
"Potential to Prolong the QT Interval In a thorough QT interval study of doses of 1.25 or 2.5 mg fingolimod at steady-state, when a negative chronotropic effect of fingolimod was still present, fingolimod treatment resulted in a prolongation of QTc, with the upper boundary of the 90% confidence interval (CI) of 14.0 msec."	0
In the lovastatin group there was a significant reduction in the number of patients with major cardiovascular events relative to the placebo group (5 vs. 14) and a significant reduction in all-cause mortality (1 vs. 8).	0
"Co-administration of NORVIR with several classes of drugs including sedative hypnotics, antiarrhythmics, or ergot alkaloid preparations may result in potentially serious and/or life-threatening adverse events due to possible effects of NORVIR on the hepatic metabolism of certain drugs."	0
A study of outpatients with major depressive disorder who had responded to paroxetine (HDRS total score <8) during an initial 8-week open-treatment phase and were then randomized to continuation on paroxetine or placebo for 1 year demonstrated a significantly lower relapse rate for patients taking paroxetine (15%) compared to those on placebo (39%).	0
General: Solutions containing dextrose should be used with caution in patients with known subclinical or overt diabetes mellitus.	0
Rare hypertensive reactions with selegiline at recommended doses associated with dietary influences have been reported.	0
Invert vial gently several times before use to ensure uniformity of the emulsion prior to administration.	0
"Other CYP2D6 substrates, including other beta-blockers, tricyclic antidepressants, and selective serotonin reuptake inhibitors (SSRIs) may have increased exposure upon coadministration with dronedarone."	1
"In Study 2, CGI Improvement responders were 77% and 42% for the paroxetine- and placebo-treated patients, respectively."	0
Sildenafil 25 single dose 800 three times daily 6 See text below for discussion of interaction.	0
The taper-phase regimen used in GAD and PTSD clinical trials involved an incremental decrease in the daily dose by 10 mg/day at weekly intervals.	0
Telmisartan shows bi-exponential decay kinetics with a terminal elimination half-life of approximately 24 hours.	0
Patients on concomitant therapy of glyburide and fluvastatin should continue to be monitored appropriately.	0
"When fill complete, close transfer set and clamp solution line."	0
"In clinical trials of Lexapro, cases of convulsion have been reported in association with Lexapro treatment."	0
Figure 3.1<U+2003><U+2022>Effect of P-gp Inhibitor or Inducer (rifampicin) Drugs on Peak and Total Exposure to Dabigatran (Cmax and AUC).	0
"If necessary, additional measures (ECT, hospitalization, etc) should be instituted."	0
Pulmonary Function Single fingolimod doses <U+2265>5 mg (10-fold the recommended dose) are associated with a dose-dependent increase in airway resistance.	0
L-type calcium channels mediate the influx of calcium during depolarization in arterial smooth muscle.	0
"Sudden, unexpected deaths have occurred in experimental studies of conditions other than Tourette<U+2019>s Disorder."	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction with antidepressants compared to placebo in adults aged 65 and older.	0
"Because clomipramine is highly bound to serum protein, the administration of clomipramine to patients taking other drugs that are highly bound to protein (e.g., warfarin, digoxin) may cause an increase in plasma concentrations of these drugs, potentially resulting in adverse effects."	1
"Additionally, fluvoxamine (a strong inhibitor of CYP1A2 and a weak inhibitor of CYP3A4 and CYP2C9) and ciprofloxacin (a strong inhibitor of CYP1A2 and a moderate inhibitor of CYP3A4) are also likely to inhibit zolpidem's metabolic pathways, potentially leading to an increase in zolpidem exposure."	1
The following is a guide to its administration: 1 mg two or three times a day	0
Less than 4% of the dose was excreted unchanged.	0
"Hypotension: At lower infusion rates, if hypotension occurs, the infusion rate should be rapidly increased until adequate blood pressure is obtained."	0
"Because coronary artery disease is common and may be unrecognized, avoid abruptly discontinuing TOPROL-XL in patients treated only for hypertension."	0
Monitor heart rate in patients taking or recently discontinuing amiodarone when starting antiviral treatment .	0
"If CDAD is suspected or confirmed, ongoing antibacterial use not directed against C. difficile may need to be discontinued."	0
Thiazides may increase the responsiveness to tubocurarine.	0
These recommendations are based on either drug interaction studies or predicted interactions due to the expected magnitude of interaction and potential for serious events or loss of efficacy.	0
Patients with hepatic impairment (liver cirrhosis) have a longer disposition half-life and higher bioavailability of nifedipine than healthy volunteers.	0
The full effect of this dose will usually be seen within one to two weeks.	0
The use of thiazides and triamterene in pregnant women requires that the anticipated benefit be weighed against possible hazards to the fetus.	0
"Closely monitor blood pressure, renal function and electrolytes in patients on Benicar and other agents that affect the RAS."	0
Infusion rates may be calculated using the following formula: Flolan infusion rate formula	0
"Reduction of Risk of Stroke and Systemic Embolism in Non-valvular Atrial Fibrillation In patients with moderate renal impairment (CrCl 30-50 mL/min), concomitant use of the P-gp inhibitor dronedarone or systemic ketoconazole can be expected to produce dabigatran exposure similar to that observed in severe renal impairment."	1
"Sevelamer carbonate or sevelamer hydrochloride did not alter the pharmacokinetics of enalapril, digoxin, iron, metoprolol, and warfarin when coadministered."	0
"There were no pharmacodynamic effects of zolpidem detected on subjective drowsiness, postural sway, or psychomotor performance."	0
"The carcinogenicity of procarbazine hydrochloride in mice, rats and monkeys has been reported in a considerable number of studies."	0
"Table 2: Estimate of the Daily Maintenance Dose Age Daily Oral Maintenance Dose, mcg/kg/day Dose Regimen, mcg/kg/dose Premature 4.7 to 7.8 2.3 to 3.9 Twice Daily Full-Term 7.5 to 11.3 3.8 to 5.6 Twice Daily 1 to 24 months 11.3 to 18.8 5.6 to 9.4 Twice Daily 2 to 5 years 9.4 to 13.1 4.7 to 6.6 Twice Daily 5 to 10 years 5.6 to 11.3 2.8 to 5.6 Twice Daily Over 10 years 3.0 to 4.5 3.0 to 4.5 Once Daily Dosage guidelines provided are based upon average patient response and substantial individual variation can be expected."	0
Use of PDE5 inhibitors for pulmonary arterial hypertension (PAH): <U+2022>Use of sildenafil (REVATIO) is contraindicated when used for the treatment of PAH.	0
Dilute to at least 1 mg per mL and administer at a rate of 1 mg per minute.	0
The studies examined the effectiveness of TIKOSYN in conversion to sinus rhythm and maintenance of normal sinus rhythm after conversion in patients with atrial fibrillation/flutter of >1 week duration.	0
These patients presented with abdominal pain (with or without nausea or vomiting); in some cases there was no prior history of facial angioedema and C-1 esterase levels were normal.	0
"In a study of patients with severe renal insufficiency (creatinine clearance 10<U+2013>30mL/min), the plasma concentrations of total inhibitors after a single dose of lovastatin were approximately two-fold higher than those in healthy volunteers."	0
Non-Nucleoside Reverse Transcriptase Inhibitors: Etravirine <U+2193> Etravirine APTIVUS/ritonavir when coadministered with etravirine may cause a significant decrease in the plasma concentrations of etravirine and loss of therapeutic effect of etravirine.	1
"Consistent with competitive inhibition, both selegiline and N-desmethylselegiline caused a concentration dependent inhibition of CYP2D6 at 10 to 250mcM and CYP3A4 and CYP3A5 at 25 to 250mcM."	0
Drugs that Affect Drug Metabolism via Cytochrome P450 Some compounds known to inhibit CYP3A may increase exposure to zolpidem.	1
Tasigna should be taken twicedaily at approximately 12-hour intervals and must be taken on an empty stomach.	0
"Accordingly, pimozide should not be given with dofetilide, sotalol, quinidine, other Class Ia and III anti-arrhythmics, mesoridazine, thioridazine, chlorpromazine, droperidol, sparfloxacin, gatifloxacin, moxifloxacin, halofantrine, mefloquine, pentamidine, arsenic trioxide, levomethadyl acetate, dolasetron mesylate, probucol, tacrolimus, ziprasidone, or other drugs that have demonstrated QT prolongation as one of their pharmacodynamic effects."	0
Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma concentrations of the tricyclic antidepressant.	1
"In a patient who requires more urgent treatment of a psychiatric condition, other interventions, including hospitalization, should be considered."	0
The normal adult plasma concentration is 3.5 to 5 mEq per liter.	0
"Although disturbances such as galactorrhea, amenorrhea, gynecomastia, and impotence have been reported, the clinical significance of elevated serum prolactin levels is unknown for most patients."	0
"Drug-Drug Interactions No significant drug-drug pharmacokinetic (or pharmacodynamic) interactions have been found in interaction studies with hydrochlorothiazide, digoxin, warfarin, and nifedipine."	0
Avoid fetal or neonatal exposure (5.1) Hypotension: Correct any volume or salt depletion before initiating therapy.	0
The steady state volume of distribution of tirofiban ranges from 22 to 42 liters.	0
Hypokalemia or hypomagnesemia must be corrected prior to initiating Tasigna and these electrolytes should be monitored periodically during therapy.	0
"Hypokalemia may develop with LASIX , especially with brisk diuresis , inadequate oral electrolyte intake , when cirrhosis is present , or during concomitant use of corticosteroids , ACTH , licorice in large amounts , or prolonged use of laxatives ."	0
Do not use MAOIs intended to treat psychiatric disorders with desvenlafaxine or within 7 days of stopping treatment with desvenlafaxine.	0
"No clear evidence of clastogenic potential was reported in the in vivo mouse or male rat bone marrow micronucleus test when the animals were treated intravenously with up to 224 mg/kg and 30 mg/kg of dopamine HCl, respectively."	0
Nortriptyline hydrochloride oral solution USP is not recommended for children.	0
Antipsychotics <U+2014> Some clinical data suggests a possible pharmacodynamic and/or pharmacokinetic interaction between SSRIs and antipsychotics.	0
"In a healthy volunteer crossover study (N=10), coadministration of a single 20 mg dose of simvastatin at the end of a 14-day regimen with 120 mg BID diltiazem SR resulted in a 5-fold increase in mean simvastatin AUC versus simvastatin alone."	1
"Co-administration of SAMSCA with 400mg ketoconazole daily or with other strong CYP 3A inhibitors (e.g., clarithromycin, itraconazole, telithromycin, saquinavir, nelfinavir, ritonavir and nefazodone) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure."	1
"Upon repeat dosing, steady state levels are reached within 2 days."	0
"The dosage of lovastatin (once daily in the evening) was 10mg for the first 8weeks, 20mg for the second 8weeks, and 40mg thereafter."	0
Severe or life-threatening neutropenia occurred in 20% of patients receiving ONIVYDE/5-FU/LV compared to 2% of patients receiving fluorouracil/leucovorin alone (5-FU/LV).	0
In vitro and in vivo studies showed that Savella is unlikely to be involved in clinically significant pharmacokinetic drug interactions.	0
Drug Interaction Studies No specific drug interaction studies have been performed with ABILIFY MAINTENA.	0
Avoid concomitant use of aliskiren with TWYNSTA in patients with renal impairment (GFR <60 mL/min /1.73 m2).	0
Note: Chlorpromazine does not intensify the anticonvulsant action of barbiturates.	0
"Frank psychotic episodes can occur, especially with parenteral abuse."	0
Figure 1: Effect of interacting drugs on the pharmacokinetics of venlafaxine and active metabolite O-desmethylvenlafaxine (ODV).	0
"Where there is involvement of the tongue, glottis, or larynx likely to cause airway obstruction, emergency therapy including, but not limited to, subcutaneous epinephrine solution 1:1000 (0.3 to 0.5 mL) should be promptly administered."	0
Avoid driving or performing hazardous tasks for the first 24 hours after taking this medicine or when the dose is increased.	0
"In patients already receiving an opioid analgesic, prescribe a lower initial dose of the benzodiazepine or other CNS depressant than indicated in the absence of an opioid, and titrate based on clinical response."	0
Digoxin<U+2014> The steady-state pharmacokinetics of paroxetine was not altered when administered with digoxin at steady state.	0
"Administer DYAZIDE cautiously and be alert for such early signs of impending coma as confusion, drowsiness, and tremor; if mental confusion increases, discontinue DYAZIDE for a few days."	0
The mean elimination half-life is approximately 21hours (CV32%) after oral dosing of 30mg tablets daily for 30days of Paroxetinehydrochloride.	0
Patients should be advised to avoid doing things that can spread HIV-1 infection to others.	0
"Under steady-state conditions for duloxetine (60mg Q 12 hours) and lorazepam (2mg Q 12 hours), the pharmacokinetics of duloxetine were not affected by co-administration."	0
Hypovolemia should be corrected with suitable volume expanders before treatment with dobutamine is instituted .	0
"In such patients, renal function should be monitored during the first few weeks of therapy."	0
"Therefore, caution should be exercised in the management of patients subjected to regional or general anesthesia while they are being treated with ALDACTONE."	0
Renal Disease<U+2013>Sertraline is extensively metabolized and excretion of unchanged drug in urine is a minor route of elimination.	0
Do not administer INTEGRILIN through the same intravenous line as furosemide .	0
Consider these risks when scheduling patients for spinal procedures.	0
Symptomatic response to cimetidine tablets does not preclude the presence of a gastric malignancy.	0
(Figure 3) Figure 3 Replace the cap and shake the bottle vigorously for a minimum of 30 seconds.	0
This is due to lack of specificity of some screening tests.	0
Whether any of the symptoms described above represent such a conversion is unknown.	0
The mechanism of this syndrome is not understood.	0
"Please refer to the dasatinib and nilotinib prescribing information for dosing instructions. vinblastine, vincristine For vincristine and vinblastine, consideration should be given to temporarily withholding the ritonavir-containing antiretroviral regimen in patients who develop significant hematologic or gastrointestinal side effects when PREZISTA/ritonavir is administered concurrently with vincristine or vinblastine."	0
Antipsychotic drugs elevate prolactin levels; the elevation persists during chronic administration.	0
Most bleeding associated with AGGRASTAT occurs at the arterial access site for cardiac catheterization.	0
"While the dose-response relationship is relatively flat, doses of 40 to 80 mg were somewhat more effective at trough than 10 to 20 mg, and twice-daily dosing tended to give a somewhat lower trough blood pressure than once-daily dosing with the same total dose."	0
"Coadministration of thioridazine, tizanidine, pimozide, alosetron, or ramelteon with LUVOX CR Capsules is contraindicated."	0
"Pimozide In a controlled study of healthy volunteers, after paroxetine was titrated to 60 mg daily, coadministration of a single dose of 2 mg pimozide was associated with mean increases in pimozide AUC of 151% and Cmax of 62%, compared to pimozide administered alone."	1
Drug Interactions	0
History of known serious hypersensitivity reaction to ADCIRCA or CIALIS ( 4.3 ) .	0
Some clinical trials in angina patients have provided nitroglycerin for about 12 continuous hours of every 24-hour day.	0
Asenapine does not cause induction of CYP1A2 or CYP3A4 activities in cultured human hepatocytes.	0
"Pressor amines (e.g., norepinephrine) - possible decreased response to pressor amines but not sufficient to preclude their use."	0
Acidifying and Alkalinizing Agents: Agents that alter urinary pH can alter blood levels of amphetamine.	0
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.	0
Duloxetine is a moderate inhibitor of CYP2D6.	0
There does not appear to be a benefit of stopping alpha1 blocker therapy prior to cataract surgery.	0
"Daily dosage should then be maintained at 4 to 6 mg/kg/day until maximum response is obtained or until the white blood count falls below 4000/cmm or the platelets fall below 100,000/cmm."	0
The usual maintenance dosage range is 2.5 mg to 20 mg per day administered as a single dose or in two equally divided doses.	0
"For consideration of a lower dose, see Special Considerations below."	0
The exact mechanism of action is unknown.	0
Evaluation of patients with hypertension or myocardial infarction should always include assessment of renal function.	0
"If peritonitis occurs, treat with appropriate therapy."	0
HbA1c increased by 0.5% in the CYMBALTA and by 0.2% in the routine care groups.	0
"If transient worsening of heart failure occurs, consider treating with increased doses of diuretics, lowering the dose of TOPROL-XL or temporarily discontinuing it."	0
"Long-term studies to evaluate carcinogenic potential have not been conducted with this drug, and there is no information concerning mutagenesis or impairment of fertility."	0
"Cholinesterase Inhibitors: Dipyridamole may counteract the anticholinesterase effect of cholinesterase inhibitors, thereby potentially aggravating myasthenia gravis."	0
"Verapamil does not alter the normal atrial action potential or intraventricular conduction time, but depresses amplitude, velocity of depolarization and conduction in depressed atrial fibers."	0
"A transient hypotensive response is not a contraindication to further treatment, which usually can be continued without difficulty once the blood pressure has stabilized."	0
"With 4 mg, 8 mg and 16 mg doses of ACEON, Cmax and AUC of perindopril and perindoprilat increase in a dose-proportional manner following both single oral dosing and at steady state during a once-a-day multiple dosing regimen."	0
"Therefore, the dosage of CARDIZEM CD or the concomitant antihypertensives may need to be adjusted when adding one to the other."	0
"Because of the additive effect of ALDACTONE when administered concurrently with such diuretics , an enhanced diuresis usually begins on the first day of combined treatment , combined therapy is indicated when more rapid diuresis is desired ."	0
It is important to follow gastric ulcer patients to assure rapid progress to complete healing.	0
"For convenience, patients receiving trandolapril (up to 8 mg) and verapamil (up to 240mg) in separate tablets, administered once-a-day, may instead wish to receive tablets of TARKA containing the same component doses."	0
Potential for serious and/or life threatening reactions such as cardiac arrhythmias.	0
Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.	0
Rashes were generally mild-to-moderate maculopapular skin eruptions.	0
"Avoid administration of Tasigna with agents that may increase nilotinib exposure (e.g., strong CYP3A4 inhibitors) or anti-arrhythmic drugs (including, but not limited to amiodarone, disopyramide, procainamide, quinidine and sotalol) and other drugs that may prolong QT interval (including, but not limited to chloroquine, clarithromycin, haloperidol, methadone, moxifloxacin and pimozide)."	0
"ORAP may be capable of potentiating CNS depressants, including analgesics, sedatives, anxiolytics, and alcohol."	0
Effects of REVATIO on Blood Pressure Single oral doses of sildenafil 100 mg administered to healthy volunteers produced decreases in supine blood pressure (mean maximum decrease in systolic/diastolic blood pressure of 8/5 mmHg).	0
The mean length of follow-up was 4.8years.	0
TPMT Testing: It is recommended that consideration be given to either genotype or phenotype patients for TPMT.	0
No initial dosage adjustment is necessary in patients with mild hepatic impairment.	0
"**If symptoms do not resolve completely after 4 weeks, an additional course of treatment may be considered."	0
Severe bradycardia (4) Heart block greater than first degree (4) Patients with cardiogenic shock (4) Decompensated cardiac failure (4) Sick sinus syndrome (unless a permanent pacemaker is in place) (4) Patients with severe hepatic impairment (Child-Pugh >B) (4) Hypersensitive to any component of this product (4)	0
No dosage adjustment is recommended in the elderly.	0
"Atorvastatin, like other statins, occasionally causes myopathy, defined as muscle aches or muscle weakness in conjunction with increases in creatine phosphokinase (CPK) values > 10 times upper limit of normal [ULN]."	0
"Because the contractile process of vascular smooth muscle is dependent upon the movement of extracellular calcium into the muscle through specific ion channels, inhibition of the calcium channel results in dilation of the arterioles."	0
CRIXIVAN is contraindicated in patients with clinically significant hypersensitivity to any of its components.	0
"These hazards include fetal or neonatal jaundice, pancreatitis, thrombocytopenia, and possible other adverse reactions which have occurred in the adult."	0
"Patients should also avoid cheeses (especially aged varieties), pickled herring, beer, wine, liver, yeast extract (including brewer's yeast in large quantities), dry sausage (including Genoa salami, hard salami, pepperoni, and Lebanon bologna), pods of broad beans (fava beans), and yogurt."	0
Reduction of risk of stroke and systemic embolism in nonvalvular atrial fibrillation: The recommended dose is 5 mg orally twice daily.	0
Methylphenidate may decrease the effectiveness of drugs used to treat hypertension.	0
The complete text of the Medication Guide is available at www.recordatirarediseases.com.	0
"Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including VASOTEC. mTOR (mammalian target of rapamycin) inhibitors: Patients receiving coadministration of ACE inhibitor and mTOR inhibitor (e.g., temsirolimus, sirolimus, everolimus) therapy may be at increased risk for angioedema (see WARNINGS)."	0
"See full prescribing information for general rules and safety measures (2.1), dose selection (2.2) and preparation of infusion (2.3) Maintenance of sotalol therapy <U+2013> Replacement of Oral Dosing The intravenous dose is approximately equal to the oral dose and administered at the same dosing frequency."	0
The clearance of mexiletine was reduced by 38% following coadministration with fluvoxamine compared to mexiletine alone.	1
"Doxepin: The AUC0-inf and Cmax of ramelteon increased by approximately 66% and 69%, respectively, upon coadministration of doxepin with ROZEREM."	1
"The appearance of hypotension after the initial dose of PRINIVIL does not preclude subsequent careful dose titration with the drug, following effective management of the hypotension."	0
No testicular changes were seen in rats or dogs at 10 mg/kg/day (30 times the usual maximum recommended human dose).	0
"On a mg/kg basis, the doses used were up to 180 times (in rats) and one time (in rabbits) the maximum recommended human dose."	0
Resulting increased plasma concentrations of astemizole can lead to QT prolongation and rare occurrences of torsade de pointes.	0
"In this clinical trial, there was limited (2.3%) use of dual antiplatelet therapy with ELIQUIS."	0
Therapy with CYMBALTA may be resumed 24 hours after the last dose of linezolid or intravenous methylene blue.	0
"Initiation of medications that inhibit or induce CYP3A may increase or decrease concentrations of PREZISTA/ritonavir, respectively."	1
"After multiple daily doses of ALTACE 5 mg<U+2013>10 mg, the half-life of ramiprilat concentrations within the therapeutic range was 13<U+2013>17 hours."	0
Adenosine effects are potentiated by dipyridamole .	0
"<U+03B2>-blockers may mask some of the manifestations of hypoglycemia, particularly tachycardia."	0
"Special Populations Elderly: In the elderly, the dose for AMBIEN should be 5 mg."	0
Monitor electrolytes during concomitant use.	0
There is a risk of developing carbamazepine toxicity.	0
"Potential for increased risk of bleeding, particularly among patients on anticoagulants."	0
The risk of administering methylene blue by non-intravenous routes (such as oral tablets or by local injection) or in intravenous doses much lower than 1 mg/kg with Savella is unclear.	0
Increases in resorption were observed at much higher dose levels (40 times the oral MRDHD on a mg/kg basis; 4 to 8 times the MRDHD on a mg/m2 basis) in mice and rats treated on gestation days 1 to 14 (lowest dose employed in the study was 500 <U+00B5>g/kg).	0
"In clinical trials, TIKOSYN was administered to patients previously treated with oral amiodarone only if serum amiodarone levels were below 0.3 mg/L or amiodarone had been withdrawn for at least three months."	0
"In patients with renal tubular acidosis in whom urinary pH may be high, potassium citrate extended-release tablets produce a relatively small rise in urinary pH."	0
Study 2 was not readily interpretable regarding a dose response relationship for effectiveness.	0
Information on heart rate was also collected.	0
Distribution: Ziprasidone has a mean apparent volume of distribution of 1.5 L/kg.	0
"Since the physician is the primary source of information about the use of a drug in any disease, it is recommended that the following information be discussed with patients and/or their families."	0
The dose should not be doubled to make up for a missed dose.	0
"Subgroup analyses did not indicate that there were any differences in treatment outcomes as a function of age, race, or gender."	0
"Amiodarone has the potential for interactions with drugs or substances that may be substrates , inhibitors or inducers of CYP450 enzymes ( e.g. , inhibitors such as protease inhibitors , grapefruit juice , certain fluoroquinolone and macrolide antibiotics , azole antifungals and inducers such as St.   John s Wort ) or P-glycoprotein ."	0
Antidepressant:Trazodone <U+2191> trazodone concentration Concomitant use of trazodone and CRIXIVAN may increase plasma concentrations of trazodone.	1
Switching from XARELTO to Warfarin - No clinical trial data are available to guide converting patients from XARELTO to warfarin .	0
"Quinaprilat is eliminated primarily by renal excretion, up to 96% of an IV dose, and has an elimination half-life in plasma of approximately 2 hours and a prolonged terminal phase with a half-life of 25 hours."	0
"Nevertheless, caution is indicated in the co-administration of TCAs with any of the SSRIs and also in switching from one class to the other."	0
"Since cumulative effects may develop in the presence of impaired renal function, if progressive renal impairment becomes evident, TENORETIC should be discontinued."	0
"With chronic once daily administration, antihypertensive effectiveness is maintained for at least 24 hours."	0
"Table 3: Effect of Coadministered Drugs on Fluvastatin Systemic Exposure Coadministered drug and dosing regimen Fluvastatin Dose (mg) Single dose unless otherwise noted Change in AUC Mean ratio (with/without coadministered drug and no change = 1 fold) or % change (with/without coadministered drug and no change = 0%); symbols of <U+2191> and <U+2193> indicate the exposure increase and decrease, respectively."	0
Fluconazole inhibits the metabolism of losartan to its active metabolite (E-31 74) which is responsible for most of the angiotensin Il-receptor antagonism which occurs during treatment with losartan.	0
These doses are approximately 8 (rat) and 2 (rabbit) times the MRHD on an mg/m2 basis.	0
"After a single dose, the glucuronide represents approximately 11% of the measured radioactivity in plasma."	0
"If necessary, gently crush the capsule contents with a spatula to produce a fine powder."	0
"Do not heat Renvela Powder (e.g., microwave) or add to heated foods or liquids."	0
Voriconazole is hemodialyzed with clearance of 121 mL/min.	0
Consider discontinuation of treatment in patients with Ph+ CML-CP that are resistant or intolerant to treatment with imatinib who have achieved a sustained molecular response(MR4.5) on Tasignawho have: <U+25CF> been treated with Tasigna for a minimum of 3 years <U+25CF> been treated with imatinib only prior to treatment with Tasigna <U+25CF> achieved a molecular response of MR.4.5(corresponding to=BCR-ABL/ABL <U+2264>0.0032% IS) <U+25CF> sustained an MR4.5 for a minimum of one year immediately prior to discontinuation of therapy <U+25CF> been confirmed to express the typical BCR-ABL transcripts (e13a2/b2a2 or e14a2/b3a2) <U+25CF> no history of accelerated phase or blast crisis <U+25CF> no history of prior attempts of treatment-free remission discontinuation that resulted in relapse.	0
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.	0
Anticholinesterases : BREVIBLOC prolonged the duration of succinylcholine-induced neuromuscular blockade and moderately prolonged clinical duration and recovery index of mivacurium .	0
The recommended duration of treatment for initial therapy of cryptococcal meningitis is 10<U+2013>12 weeks after the cerebrospinal fluid becomes culture negative.	0
It should not be used in those who have shown prior hypersensitivity to the drug.	0
"ECGs should be performed at baseline, 7 days after initiation of Tasigna, and periodically as clinically indicated and following dose adjustments [see Warnings and Precautions (5."	0
R(-)-methamphetamine and R(-)-amphetamine are mainly excreted unchanged in urine.	0
"Because of the potential for serious adverse reactions in nursing infants from hydrochlorothiazide and the unknown effects of quinapril in infants, a decision should be made whether to discontinue nursing or to discontinue ACCURETIC, taking into account the importance of the drug to the mother."	0
"If concomitant use is necessary, consider dosage reduction of Meperidine Hydrochloride Injection until stable drug effects are achieved."	0
Lorazepam: A study of multiple doses of immediate-release fluvoxamine maleate tablets (50 mg given twice daily) in healthy male volunteers (N=12) and a single dose of lorazepam (4 mg single dose) indicated no significant pharmacokinetic interaction.	0
"Distribution Following drug administration, a 6- to 8-hour tissue distribution phase is observed."	0
Reduced aldosterone secretion by quinapril may result in a small increase in serum potassium.	0
LEXIVA/ritonavir: High doses of ketoconazole or itraconazole (greater than 200mg/day) are not recommended.	0
"Because of the potential for tumorigenicity shown for rifampin in animal studies, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother."	0
"The following agents given together with triamterene may promote serum potassium accumulation and possibly result in hyperkalemia because of the potassium-sparing nature of triamterene, especially in patients with renal insufficiency: blood from blood bank (may contain potassium up to 30mEq/L of plasma or up to 65mEq/L of whole blood when stored for more than 10days); low-salt milk (may contain potassium up to 60mEq/L); potassium-containing medications (such as parenteral penicillin G potassium); salt substitutes (most contain substantial amounts of potassium)."	0
"Methotrexate and other drugs that , like LASIX , undergo significant renal tubular secretion may reduce the effect of LASIX ."	0
"Other Concomitant Medications: Utilizing population pharmacokinetic analyses, derived from hypertensive patients, the following drugs were observed not to have an effect on the pharmacokinetics of nebivolol: acetaminophen, acetylsalicylic acid, atorvastatin, esomeprazole, ibuprofen, levothyroxine sodium, metformin, sildenafil, simvastatin, or tocopherol."	0
PROTONIX is contraindicated in patients with known hypersensitivity to any component of the formulation or any substituted benzimidazole.	0
Administration of LIVALO with a high fat meal (50% fat content) decreases pitavastatin Cmax by 43% but does not significantly reduce pitavastatin AUC.	1
"WARNING: DRUG-DRUG INTERACTIONS LEADING TO POTENTIALLY SERIOUS AND/OR LIFE THREATENING REACTIONS See full prescribing information for complete boxed warning Co-administration of NORVIR with several classes of drugs including sedative hypnotics, antiarrhythmics, or ergot alkaloid preparations may result in potentially serious and/or life-threatening adverse events due to possible effects of NORVIR on the hepatic metabolism of certain drugs."	0
"CYP 3A Inducers Avoid co-administration of CYP 3A inducers (e.g., rifampin, rifabutin, rifapentin, barbiturates, phenytoin, carbamazepine, St. John's Wort) with SAMSCA, as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment."	1
Agents Increasing Serum Potassium: VASOTEC attenuates potassium loss caused by thiazide-type diuretics.	0
"Studies were also carried out to examine the time course of effects on memory and psychomotor function, and to examine withdrawal phenomena."	0
The protein binding is constant at plasma olmesartan concentrations well above the range achieved with recommended doses.	0
"Potential for Prasugrel to Affect Other Drugs In vitro metabolism studies demonstrate that prasugrel's main circulating metabolites are not likely to cause clinically significant inhibition of CYP1A2, CYP2C9, CYP2C19, CYP2D6, or CYP3A, or induction of CYP1A2 or CYP3A."	0
"Race: The results across pharmacokinetic studies in normal subjects showed no differences in apixaban pharmacokinetics among White/Caucasian, Asian, and Black/African American subjects."	0
No long-term safety data are available for patients experiencing persistent elevations in total bilirubin >5 times the upper limit of normal (ULN).	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction with antidepressants compared to placebo in adults aged 65 and older.	0
"During dose initiation, asymptomatic increases in pulmonary artery pressure coincident with increases in cardiac output may occur."	0
"Because of the gradual onset of action, acute hypotension is unlikely."	0
"With oral doses of 160 to 640 mg/day, the surface ECG shows dose-related mean increases of 40-100 ms in QT and 10-40 ms in QTc."	0
Figure 1 Routine laboratory tests are not required.	0
"If the original regimen was 0.6mg once a day, the regimen should be adjusted to 0.3mg once a day."	0
It undergoes minor hepatic metabolism by O-deethylation to an inactive metabolite.	0
Unchanged ledipasvir excreted in feces accounted for a mean of 70% of the administered dose and the oxidative metabolite M19 accounted for 2.2% of the dose.	0
"Following 6 weeks of monotherapy in placebo-controlled trials in patients with mild to moderate hypertension, once daily doses of 2 to 4 mg lowered supine or standing systolic/diastolic blood pressure 24 hours after dosing by an average 7-10/4-5 mmHg below placebo responses in non-black patients."	0
"If persistent hypokalemia is documented with 10 mg, the dose can be increased to 15 mg, then 20 mg, with careful monitoring of electrolytes."	0
"Also, since the metabolism of quinapril to quinaprilat is normally dependent upon hepatic esterases, patients with impaired liver function could develop markedly elevated plasma levels of quinapril."	0
An H2RA dose comparable to famotidine 20 mg once daily up to a dose comparable to famotidine 40 mg twice daily can be used with REYATAZ 300 mg with ritonavir 100 mg in treatment-naive patients.	0
Pravastatin should be used cautiously with macrolide antibiotics due to a potential increased risk of myopathies.	0
"For a list of toll free numbers for glucose monitor and test strip manufacturers, please contact the Baxter Renal Clinical Help Line 1-888-RENAL-HELP or visit www.glucosesafety.com."	0
Patients with severe sleep apnea: Rozerem is not recommended for use in this population.	0
Serum calcium concentration is not affected by amlodipine.	0
Women receiving PURIXAN have an increased incidence of abortion and stillbirth.	0
Carcinogenesis: Arsenic trioxide is a human carcinogen.	0
"Following absorption, quinapril is deesterified to its major active metabolite, quinaprilat (about 38% of oral dose), and to other minor inactive metabolites."	0
"Consequently, it may be useful to inform patients (or their families) about the signs and symptoms associated with MAOI induced hypertensive reactions."	0
"Study 1 was a 10-week dose-range finding study; patients were treated with fixed paroxetine doses of 10, 20, or 40 mg/day or placebo."	0
"Pitavastatin competitively inhibits HMG-CoA reductase, which is a rate-determining enzyme involved with biosynthesis of cholesterol, in a manner of competition with the substrate so that it inhibits cholesterol synthesis in the liver."	0
"Weaker inhibitors (e.g., erythromycin, grapefruit juice) have not been studied."	0
"Consider the potential for drug interactions prior to and during NORVIR therapy; review concomitant medications during NORVIR therapy, and monitor for the adverse reactions associated with the concomitant medications."	0
Drugs that inhibit the renin-angiotensin system can cause hyperkalemia.	0
"After at least 10 days following the initiation of APTIVUS/ritonavir, resume bosentan at 62.5 mg once daily or every other day based upon individual tolerability."	0
"Mania/Hypomania <U+2013> During premarketing testing of Anafranil in patients with affective disorder, hypomania or mania was precipitated in several patients."	0
Consider lowering the maintenance dose to 5-mg in patients <60kg.	0
"If a child is unable to reliably swallow a tablet, the use of PREZISTA oral suspension should be considered."	0
"In a limited study involving 12subjects, coadministration of DYAZIDE with a high-fat meal resulted in: (1) an increase in the mean bioavailability of triamterene by about 67% (90% confidence interval=0.99, 1.90), p-hydroxytriamterene sulfate by about 50% (90% confidence interval=1.06, 1.77), hydrochlorothiazide by about 17% (90% confidence interval=0.90, 1.34); (2) increases in the peak concentrations of triamterene and p-hydroxytriamterene; and (3) a delay of up to 2hours in the absorption of the active constituents."	1
"Once prepared, it may be administered either by a healthcare provider, patient, or caregiver."	0
Food does not affect the rate or extent of olanzapine absorption.	0
Known hypersensitivity to product components (4).	0
"Therefore, if necessary, an antacid may be administered approximately 2 hours before or approximately 2 hours after the dose of Tasigna."	0
"In the SOLAR-1 and SOLAR-2 trials (liver transplant recipients or subjects with decompensated liver disease), after 12 weeks of treatment with HARVONI and RBV, relapse rates were 7% (5/71) and 5% (10/217) in genotype 1 subjects with and without baseline NS5A polymorphisms at resistance-associated positions, respectively."	0
The metabolites are observed in the urine.	0
"Serotonin syndrome with agitation, hyperthermia, diarrhea, tachycardia, sweating, tremors and impaired consciousness may also occur."	0
Patients who have been treated with monoamine oxidase (MAO) inhibitors prior to administration of dopamine should receive substantially reduced dosage of the latter.	1
"This regimen was continued for 7 days, except that in patients able to swallow, the maintenance infusions were discontinued, and approximately the same daily doses of quinidine were supplied orally, using 300<U+2013>mg tablets of quinidine sulfate."	0
The exposure to desmethylsertraline was approximately 2-fold greater compared to age-matched volunteers with no hepatic impairment.	0
"Other important considerations in the differential diagnosis include central anticholinergic toxicity, heat stroke, drug fever, and primary central nervous system (CNS) pathology."	0
"Reversible posterior leukoencephalopathy syndrome (RPLS), a syndrome of subcortical vasogenic edema diagnosed by an MRI of the brain, has occurred in patients treated with CAPRELSA."	0
"In vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites with the known cytochrome CYP2C9 substrates/inhibitors sulphenazole, tolbutamide, and nifedipine."	1
Laboratory tests are available to identify CYP2D6 PMs.	0
"Almost all of the patients (96.6%) had a history of hypertension, and the patients entered the trial with a mean serum creatinine of 1.9mg/dl and mean proteinuria (urinary albumin/creatinine) of 1808mg/g at baseline."	0
Co-administration of DESOXYN and gastrointestinal alkalinizing agents should be avoided.	0
"Use with Cyclosporine, Clarithromycin, Itraconazole, or Certain Protease Inhibitors: In patients taking cyclosporine or the HIV protease inhibitors (tipranavir plus ritonavir) or the hepatitis C protease inhibitor (telaprevir), avoid therapy with atorvastatin."	0
LIPITOR is <U+2265>98% bound to plasma proteins.	0
"When pregnancy is detected, discontinue ATACAND as soon as possible."	0
"In a study conducted with an intravenous formulation of dipyridamole, patients with mild to severe hepatic insufficiency showed no change in plasma concentrations of dipyridamole but showed an increase in the pharmacologically inactive monoglucuronide metabolite."	0
Intervention: See Contraindications and Warnings and Precautions in prescribing information for clarithromycin.See Drug Interactions in prescribing information for amoxicillin.	0
"If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, inform the patient of the potential hazard to the fetus."	0
Accessory AV Pathway: Increased risk of rapid ventricular response leading to ventricular fibrillation.	0
No reduction in dose or dosing frequency in these patients is warranted.	0
Distribution Aspirin is poorly bound to plasma proteins and its apparent volume of distribution is low (10 L).	0
The effect of severe hepatic impairment on the pharmacokinetics of dronedarone was not assessed.	0
"In a 35-night study, Zaleplon 10 mg was significantly more effective than placebo in reducing LPS at the primary efficacy endpoint on nights 29 and 30."	0
"Also, there has been a report of an interaction between NARDIL and dextromethorphan (ingested as a lozenge) causing drowsiness and bizarre behavior."	0
Dose adjustment of warfarin may be needed to maintain target INR range.	0
Cases of elevated blood pressure requiring immediate treatment have been reported with PRISTIQ.	0
Reflex increases in cardiac output and rate accompany the reduction in blood pressure.	0
"In very limited experience, doses of 20 to 40 mg/kg/day have been used."	0
"The combined use of simvastatin with gemfibrozil, cyclosporine, or danazol is contraindicated."	0
This had no effect on the efficacy or safety of LIVALO in women in clinical studies.	0
"Dilatation of the veins promotes peripheral pooling of blood and decreases venous return to the heart, thereby reducing left ventricular end-diastolic pressure and pulmonary capillary wedge pressure (preload)."	0
"Steady-state mean Cmax values were 9, 18, and 33 ng/mL following doses of 5, 10, and 20 mg/day."	0
One report suggests that concentrations in breast milk may approximate serum levels.	0
There may be circumstances when it is necessary to initiate treatment with an MAOI such as linezolid or intravenous methylene blue in a patient taking Anafranil.	0
Rifampin can be administered by the oral route or by IV infusion.	0
"Therefore, patients using oral, transdermal patch, or other systemic hormonal contraceptives should be advised to change to non-hormonal methods of birth control."	0
"Aspirin can displace warfarin from protein binding sites, leading to prolongation of both the prothrombin time and the bleeding time."	0
Effects of concomitant medication and genetic variations on pimozide metabolism are described in the CONTRAINDICATIONS and PRECAUTIONS sections.	0
"Although clinical studies have not been conducted with Ventavis (inhaled iloprost), in vitro studies of iloprost indicate that no relevant inhibition of cytochrome P450 drug metabolism would be expected."	0
"As dipyridamole is excreted in human milk, caution should be exercised when PERSANTINE tablets are administered to a nursing woman."	0
"Because of its antiandrogenic activity and the requirement of testosterone for male morphogenesis , ALDACTONE may have the potential for adversely affecting sex differentiation of the male during embryogenesis ."	0
Concomitant Lipid-Lowering Therapy: Atorvastatin may be used with bile acid resins.	0
Combinations of these drugs have not been studied and coadministration of CRIXIVAN and atazanavir is not recommended.	0
"Prematurity, intrauterine growth retardation, and patent ductus arteriosus have also been reported, although it is not clear whether these occurrences were due to exposure to the drug."	0
Two patients undergoing desensitizing treatment with hymenoptera venom while receiving ACE inhibitors sustained life-threatening anaphylactoid reactions.	0
"During premarketing studies with immediate-release fluvoxamine maleate tablets, seizures were reported in 0.2% of fluvoxamine-treated patients."	0
A specific MAO-A inhibitor increased the systemic exposure of rizatriptan and its metabolite.	1
"Autoimmune disorders (such as Graves<U+2019> disease, polymyositis, and Guillain-Barr<U+00E9> syndrome) have also been reported to occur in the setting of immune reconstitution, however, the time to onset is more variable, and can occur many months after initiation of treatment."	0
"Because of the above and because of the known effects of nonsteroidal anti-inflammatory drugs (NSAIDs) on the fetal cardiovascular system (closure of the ductus arteriosus), avoid AGGRENOX in the third trimester of pregnancy."	0
There are no significant interactions between aspirin and dipyridamole.	0
"Consequently, caution is advised when venlafaxine hydrochloride extended-release is taken in combination with other CNS-active drugs."	0
"The patient should be monitored for symptoms of serotonin syndrome for 5 days or until 24 hours after the last dose of linezolid or intravenous methylene blue, whichever comes first."	0
Individualization of drug dosage should be based on therapeutic response.	0
"Avoid concomitant use of XARELTO with drugs that are combined P-gp and strong CYP3A4 inducers ( e.g. , carbamazepine , phenytoin , rifampin , St.   John 's   wort ) see Warnings and Precautions ( 5.6 ) and Clinical Pharmacology ( 12.3 ) ."	0
Absorption of rifampin is reduced by about 30% when the drug is ingested with food.	1
Untreated acute angle-closure glaucoma can lead to permanent vision loss.	0
"Food slightly reduces the bioavailability of telmisartan, with a reduction in the area under the plasma concentration-time curve (AUC) of about 6% with the 40 mg tablet and about 20% after a 160 mg dose."	1
Coadministration of lamotrigine and REYATAZ without ritonavir is not expected to decrease lamotrigine plasma concentrations.	0
"Antimycobacterials: rifabutin rifampin rifapentine <U+2193> ledipasvir<U+2193> sofosbuvir<U+2193> GS-331007 Coadministration of HARVONI with rifabutin or rifapentine is expected to decrease the concentration of ledipasvir and sofosbuvir, leading to reduced therapeutic effect of HARVONI."	1
The electrophysiologic effects of quinidine and verapamil on AV conduction were studied in 8 patients.	0
The clinical impact of this decrease is unknown.	0
"PRADAXA increases the risk of bleeding and can cause significant and, sometimes, fatal bleeding."	0
Intermittent dosing would be repeated with each new cycle.	0
Diltiazem: Bradycardia has been reported with the coadministration of immediate-release fluvoxamine maleate tablets and diltiazem.	0
Sildenafil is not expected to affect the pharmacokinetics of compounds which are substrates of these CYP enzymes at clinically relevant concentrations.	0
Sotalol has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties.	0
"The foods and beverages listed in Table 5 should be avoided beginning on the first day of EMSAM 9mg per 24 hours or 12mg per 24 hours treatment, and should continue to be avoided for 2 weeks after a dose reduction to EMSAM 6mg per 24 hours or following the discontinuation of EMSAM 9mg per 24 hours or 12mg per 24 hours."	0
Data indicate that the metabolites have no more than 1/50 the potency of the parent compound at inhibiting serotonin uptake.	0
"Interaction with Secretin Stimulation Test Clinical Impact: Hyper-response in gastrin secretion in response to secretin stimulation test, falsely suggesting gastrinoma."	0
"REYATAZ <U+2191> lurasidone REYATAZ without ritonavir If coadministration is necessary, reduce the lurasidone dose."	1
Hypersensitivity to FLOLAN or any of its ingredients.	0
No dosing regimen for dilatrate<U+00AE>-SR sustained release capsules has actually been shown to achieve this duration of effect.	0
THIOLA<U+00AE> should be used during pregnancy only if the potential benefit justifies potential risk to the fetus.	0
MAINTENANCE: Maintenance doses may often be lower than initial doses and should be adjusted according to the individual patient.	0
"Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including ZOCOR."	0
The plasma protein binding of eplerenone is about 50% and it is primarily bound to alpha 1-acid glycoproteins.	0
<U+2022>Hepatically impaired: Decreased clearance may require modified dose and titration (2.3).	0
"30 to 50 mg/day, in divided doses, or the total daily dosage may be given once a day."	0
"However, in view of the desirability of keeping the administration of all drugs to a minimum during pregnancy, thioridazine should be given only when the benefits derived from treatment exceed the possible risks to mother and fetus."	0
"Accordingly, atropine is an unreliable respiratory stimulant and large or repeated doses may depress respiration."	0
Absolute doses exceeding 600 mg/day are not recommended. mg/kg 400 mg Experience with DIFLUCAN in neonates is limited to pharmacokinetic studies in premature newborns.	0
"As noted under Clinical Pharmacology, only one trial has ever studied the use of extended-release isosorbide dinitrate for more than one dose."	0
Less than 2% of the administered dose is recovered in urine as unchanged ramipril.	0
The digoxin results indicate P-gp was inhibited after the first dose of APTIVUS/ritonavir followed by induction of P-gp over time.	0
"Following either oral or intravenous administration of 14C-labeled irbesartan, about 20% of radioactivity is recovered in the urine and the remainder in the feces, as irbesartan or irbesartan glucuronide."	0
Quetiapine's antagonism of histamine H1 receptors may explain the somnolence observed with this drug.	0
"Diuretics: Excessive drop in blood pressure(7.1) Antidiabetics: Increased risk of hypoglycemia (7.2) NSAIDS: Increased risk of renal impairment and loss of antihypertensive efficacy(7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension and hyperkalemia(7.4) Lithium: Symptoms of lithium toxicity(7.6) Neprilysin Inhibitor: Increased risk of angioedema (7.7) Gold: Nitritoid reactions (7.8) Hypotension Patients on diuretics, especially those in whom diuretic therapy was recently instituted,may occasionally experience an excessive reduction of blood pressure after initiation of therapy with Lotensin."	0
Subgroup analyses can be difficult to interpret and it is not known whether these represent true differences or chance effects.	0
Carcinogenicity studies were conducted in mice and rats.	0
"In animal models, diltiazem interferes with the slow inward (depolarizing) current in excitable tissue."	0
"As steady-state plasma levels do not change with age, the final target dose based on a careful assessment of the patient<U+2019>s clinical response may be similar in healthy younger and older patients."	0
"The pooled analyses of placebo-controlled studies in adults with MDD or other psychiatric disorders included a total of 295 short-term studies (median duration of 2 months) of 11 antidepressant drugs in over 77,000 patients."	0
Triazolam is a hypnotic with a short mean plasma half-life reported to be in the range of 1.5 to 5.5 hours.	0
DO NOT USE OTHER FOODS OR CRUSH OR CHEW THE GRANULES.	0
"Nevertheless, caution is indicated in the co-administration of TCAs with any of the SSRIs and also in switching from one class to the other."	0
Taking pimozide.	0
"After maximum benefit from NARDIL is achieved, dosage should be reduced slowly over several weeks."	0
"However, plasma concentrations of rosuvastatin increased to a clinically significant extent (about 3<U+2011>fold) in patients with severe renal impairment (CLcr<30 mL/min/1.73 m2) not receiving hemodialysis compared with healthy subjects (CLcr> 80mL/min/1.73m2)."	0
"Similar effects would be expected with other potent CYP2D6 inhibitors (e.g., fluoxetine, quinidine)."	0
"One week following administration of a single oral dose of 1 mg immediate-release 14C-paliperidone to 5 healthy volunteers, 59% (range 51% <U+2013> 67%) of the dose was excreted unchanged into urine, 32% (26% <U+2013> 41%) of the dose was recovered as metabolites, and 6% <U+2013> 12% of the dose was not recovered."	0
Pharmacokinetics of the active enantiomer of bicalutamide in normal males and patients with prostate cancer are presented in Table 3.	0
Psychosis abated after the drug was discontinued.	0
"Overinfusion of peritoneal dialysis solution volume into the peritoneal cavity may be characterized by abdominal distention, feeling of fullness and/or shortness of breath."	0
"While advice cannot be provided on the level of recovery of aPTT needed in any particular clinical setting, the curves can be used to estimate the time to get to a particular level of recovery, even when the time since the last dose of PRADAXA is not precisely known."	0
Omit tretinoin during weeks 5-6 of the fourth cycle of consolidation.	0
"When REVATIO is taken with a high-fat meal, the rate of absorption is reduced, with a mean delay in Tmax of 60 minutes and a mean reduction in Cmax of 29%."	1
There were infrequent reports of patients who experienced symptomatic postural hypotension.	0
"There is no evidence that pre-existing liver disease increases the likelihood of developing liver failure, however, baseline abnormalities can complicate patient monitoring."	0
"If concomitant treatment of LUVOX CR Capsules with a triptan is clinically warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases."	0
"In addition, some blood glucose monitoring systems using glucose dehydrogenase flavin-adenine dinucleotide (GDH-FAD)-based methods must not be used."	0
May increase metabolism and decrease the activity of drugs metabolized by cytochrome P450 3A4 and 2C8/9.	1
"Whenever possible, THIOLA<U+00AE> should be given in divided doses 3 times/day at least one hour before or 2 hours after meals."	0
Antagonism at receptors other than D2 and 5HT2 may explain some of the other effects of risperidone.	0
The median EC50 value of ledipasvir was 0.03 nM against genotype 5a isolates (range 0.008-0.081 nM; N=35).	0
"If such symptoms occur, discontinue LUVOX CR Capsules and initiate supportive treatment."	0
"Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular changes (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)."	0
"The efficacy of paroxetine in the treatment of major depressive disorder, social anxiety disorder, obsessive compulsive disorder (OCD), panic disorder (PD), generalized anxiety disorder (GAD) is presumed to be linked to potentiation of serotonergic activity in the central nervous system resulting from inhibition of neuronal reuptake of serotonin (5-hydroxy-tryptamine, 5-HT)."	0
"Therefore, when these drugs are administered concurrently, dosage adjustment of paroxetine after the 20 mg starting dose should be guided by clinical effect."	0
Troublesome patient hostility may be aroused by the use of nortriptyline hydrochloride.	0
AGGRENOX Drug Interaction A dedicated drug interaction study was conducted in 60 healthy volunteers to evaluate the effects of omeprazole 80 mg administered once daily on the pharmacokinetics (PK) of dipyridamole and the pharmacodynamics (PD) of acetylsalicylic acid when co-administered with AGGRENOX twice daily.	0
"Treatment with Savella and any concomitant serotonergic agents should be discontinued immediately if the above events occur, and supportive symptomatic treatment should be initiated."	0
Initial Treatment Adults The recommended starting dose of Lexapro is 10 mg once daily.	0
WARNING: SUICIDALTHOUGHTS AND BEHAVIORS See full prescribing information for complete boxed warning.	0
Some patients required either initiation or dose adjustments of insulin or oral hypoglycemic agents for treatment of these events.	0
"Although the exact mechanism of PROZAC is unknown, it is presumed to be linked to its inhibition of CNS neuronal uptake of serotonin."	0
The safety and effectiveness of ACCUPRIL in pediatric patients have not been established.	0
"In post marketing experience, cases of urinary retention have been observed."	0
Patients should be monitored for the development of abnormal renal function.	0
"Bleeding events related to SSRIs and SNRIs use have ranged from ecchymoses, hematomas, epistaxis, and petechiae to life-threatening hemorrhages."	0
"In more than half of the reported cases, treatment with protease inhibitors was continued or reintroduced."	0
"If such drugs are given to patients already receiving CAPRELSA and no alternative therapy exists, perform ECG monitoring of the QT interval more frequently."	0
"Ordinary prudence requires that children not have access to this drug or to potent drugs of any kind; if possible, this drug should be dispensed in containers with child-resistant safety closures."	0
"TENORMIN has been studied in combination with thiazide-type diuretics, and the blood pressure effects of the combination are approximately additive."	0
ROZEREM should be administered with caution to patients taking less strong CYP1A2 inhibitors.	0
"In general , avoid combined use of aliskiren with ACE inhibitors or ARBs , particularly in patients with CrCl less than 60 mL/min ."	0
"Similarly, nebivolol has no significant effects on the anticoagulant activity of warfarin, as assessed by Prothrombin time and INR profiles from 0 to 144 hours after a single 10 mg warfarin dose in 12 healthy adult volunteers."	0
Do not start Effient in patients likely to undergo urgent CABG.	0
"The antiemetic action of chlorpromazine may mask the signs and symptoms of overdosage of other drugs and may obscure the diagnosis and treatment of other conditions such as intestinal obstruction, brain tumor and Reye<U+2019>s syndrome."	0
HMG-CoA Reductase Inhibitors : Limit the dose of simvastatin in patients on amiodarone to 20 mg daily .	0
"CYP450 isozymes involved in the metabolism of warfarin include CYP2C9, 2C19, 2C8, 2C18, 1A2, and 3A4."	0
"If the 50% reduced dose is tolerated for 7 days (in the absence of QTc prolongation), increase the dose of TRISENOX to 0.11 mg/kg once daily for 7 days."	0
Theophylline Reports of elevated theophylline levels associated with treatment with paroxetine have been reported.	1
LEXIVA should be used with caution in patients with a known sulfonamide allergy.	0
"In addition, do not start desvenlafaxine in a patient who is being treated with linezolid or intravenous methylene blue."	0
"Warfarin: Eszopiclone 3 mg administered daily for 5 days did not affect the pharmacokinetics of (R)- or (S)-warfarin, nor were there any changes in the pharmacodynamic profile (prothrombin time) following a single 25 mg oral dose of warfarin."	0
Assess glucose levels before initiating treatment with Tasigna and monitor during treatment as clinically indicated.	0
"Interaction with Combined P-gp and Strong CYP3A4 Inhibitors Avoid concomitant administration of XARELTO with known combined P-gp and strong CYP3A4 inhibitors (e.g., ketoconazole and ritonavir) [see Warnings and Precautions (5.6) and Clinical Pharmacology (12.3)]."	0
"In a noncomparative study of children with serious systemic fungal infections, most of which were candidemia, the effectiveness of DIFLUCAN was similar to that reported for the treatment of candidemia in adults."	0
"Single daily doses of 75 mg triamterene resulted in greater increases in serum potassium than lower doses (25 mg and 50 mg), while doses greater than 75 mg of triamterene resulted in no additional elevations in serum potassium levels."	0
"Letairis is very likely to produce serious birth defects if used by pregnant females, as this effect has been seen consistently when it is administered to animals."	0
"Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death."	0
All reactions occurred during the first month of treatment.	0
"Use of potassium-sparing diuretics (spironolactone, amiloride, triamterene and others), potassium supplements or other drugs capable of increasing serum potassium (indomethacin, heparin, cyclosporine and others) can increase the risk of hyperkalemia."	0
"Ora-Sweet<U+00AE> contains citric acid, berry citrus flavorant,glycerin, methylparaben, potassium sorbate, sodium phosphate monobasic, sorbitol, sucrose, andwater."	0
Drug interaction studies have been completed with both INVIRASE and saquinavir soft gel capsules.	0
This difference was not observed in five other pharmacokinetic studies (total N=114).	0
"Although trough citalopram plasma levels were unaffected, given the enzyme-inducing properties of carbamazepine, the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered."	1
"In post-marketing experience, as with other azole antifungals, bleeding events (bruising, epistaxis, gastrointestinal bleeding, hematuria, and melena) have been reported in association with increases in prothrombin time in patients receiving fluconazole concurrently with warfarin."	0
Their blood pressure should be monitored closely during any dosage adjustment.	0
"Consequently, caution is indicated in the combined use of nefazodone with any drugs known to be metabolized by CYP3A4."	0
"Administer EMEND for oral suspension 1 hour prior to chemotherapy treatment on Days 1, 2, and 3."	0
Patients receiving LASIX should be advised that they may experience symptoms from excessive fluid and/or electrolyte losses .	0
The peak plasma concentration of quazepam is approximately 20 ng/mL after a 15 mg dose and occurs at about 2 hours.	0
Only a small fraction of the drug (about 12%) is bound to human serum albumin.	0
"In animal studies, benazepril had no inhibitory effect on the vasopressor response to angiotensin II and did not interfere with the hemodynamic effects of the autonomic neurotransmitters acetylcholine, epinephrine, and norepinephrine."	0
"Because of the potential for adverse reactions, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother."	0
There have been rare reports of increased prothrombin time in patients taking coumarin anticoagulants to whom PROCARDIA was administered.	0
"Data given as % change represent % difference relative to atorvastatin alone (i.e., 0% = no change)."	0
Oxycodone (CYP3A4 Inhibition) Significantly Increased Reduction in the dose of oxycodone and other long-acting opiates metabolized by CYP3A4 should be considered when coadministered with VFEND.	1
Concomitant use of trimethoprim alone or in combination with sulfamethoxazole is contraindicated.	0
"Following administration of lovastatin tablets the coefficient of variation, based on between-subject variability, was approximately 40% for the area under the curve (AUC) of total inhibitory activity in the general circulation."	0
"Although the efficacy of Anafranil after 10 weeks has not been documented in controlled trials, patients have been continued in therapy under double-blind conditions for up to 1 year without loss of benefit."	0
"Larger doses do not appear to have a greater effect, and there is relatively little experience with such doses."	0
"In multiple dose studies with hypertensive patients, there were no clinically significant changes in electrolytes (serum potassium or sodium), or in metabolic function (including serum levels of cholesterol, triglycerides, HDL, LDL, glucose, or uric acid)."	0
Strict adherence to the manufacturer<U+2019>s instructions for sample processing and data interpretation is required for this assay.	0
Ledipasvir is an inhibitor of the drug transporters P-gp and breast cancer resistance protein (BCRP) and may increase intestinal absorption of coadministered substrates for these transporters.	0
"Such patients should undergo a prompt medical evaluation, and discontinuation of PRISTIQ should be considered."	0
"Based on the mechanism of action of desvenlafaxine and the potential for serotonin syndrome, caution is advised when desvenlafaxine is co-administered with other drugs that may affect the serotonergic neurotransmitter systems."	0
No significant QT prolongation effect of venlafaxine 450 mg was detected.	0
Aging may affect the pharmacokinetics of verapamil.	0
"At steady state, the extent of accumulation of citalopram in plasma, based on the half-life, is expected to be 2.5 times the plasma concentrations observed after a single dose."	0
Co-administration of atorvastatin and an oral contraceptive increased AUC values for norethindrone and ethinyl estradiol.	1
Concurrent use of PURIXAN and warfarin may result in decreased anticoagulant effectiveness.	0
"Examples of CYP2D6 Inhibitors include paroxetine and fluoxetine (also serotonergic drugs), quinidine, ritonavir."	0
Appropriate laboratory testing such as serum liver biochemistries should be conducted prior to initiating therapy with PREZISTA/ritonavir.	0
"During premarketing testing, a recurrence of a petit mal seizure was observed in a patient receiving nefazodone who had a history of such seizures."	0
"The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the Caucasian population (about 7% to 10% of Caucasians are so called ""poor metabolizers""); reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are not yet available."	0
Whether the dose of antidepressant needed to induce remission is identical to the dose needed to maintain euthymia is unknown.	0
"In patients with coronary artery disease, nicardipine, administered after beta-blockade, significantly improved systolic and diastolic left ventricular function."	0
Treat with dexamethasone 10 mg intravenously every 12 hours until the resolution of signs and symptoms for a minimum of 3 days.	0
Each vial is intended for SINGLE DOSE ONLY.	0
Caution should be observed in administering DEMSER to patients receiving phenothiazines or haloperidol because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .	0
Maprotiline should be used with caution in patients receiving guanethidine or similar agents since it may block the pharmacologic effects of these drugs.	0
The mechanism of this syndrome is not understood.	0
Haloperidol A study involving haloperidol and zolpidem revealed no effect of haloperidol on the pharmacokinetics or pharmacodynamics of zolpidem.	0
"NORVIR is contraindicated in patients with known hypersensitivity to ritonavir (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome) or any of its ingredients (4) Co-administration with drugs highly dependent on CYP3A for clearance and for which elevated plasma concentrations may be associated with serious and/or life-threatening events (4) Co-administration with drugs that significantly reduce ritonavir (4)"	1
"New onset diabetes mellitus, exacerbation of preexisting diabetes mellitus and hyperglycemia have been reported during postmarketing surveillance in HIV-1-infected patients receiving protease-inhibitor therapy."	0
The risk of using sertraline hydrochloride in combination with other CNS active drugs has not been systematically evaluated.	0
CARDIZEM (diltiazem hydrochloride) is extensively metabolized by the liver and excreted by the kidneys and in bile.	0
"At the end of three weeks, losartan reduced systolic and diastolic blood pressure, measured at trough, in a dose-dependent manner."	0
Plasma levels of aspirin are essentially undetectable 2<U+2013>2.5 hours after dosing and peak salicylic acid concentrations occur 1 hour (range: 0.5<U+2013>2 hours) after administration of aspirin.	0
Antianginal activity is present about 1 hour after dosing.	0
"There are post-marketing reports of patients with conduction abnormalities and/or taking other sympatholytic drugs who developed severe bradycardia requiring IV atropine, IV isoproterenol and temporary cardiac pacing while taking clonidine."	0
"If patients must be coadministered a strong CYP3A4 inhibitor, based on pharmacokinetic studies, consider a dose reduction to 300 mg oncedaily in patients with resistant or intolerant Ph+ CML or to 200 mg oncedaily in patients with newly diagnosed Ph+ CML-CP."	1
"Prior to initiation of TIKOSYN therapy, the patient should be advised to read the Medication Guide and reread it each time therapy is renewed in case the patient's status has changed."	0
A portion of the additional sodium presented to the distal tubule is exchanged there for potassium and hydrogen ions.	0
"Sublingual nitroglycerin may be taken as required for the control of acute manifestations of angina, particularly during PROCARDIA titration."	0
Mexiletine hydrochloride capsules are contraindicated in the presence of cardiogenic shock or preexisting second- or third-degree AV block (if no pacemaker is present).	0
Correct electrolyte abnormalities prior to initiating Tasigna and during therapy.	0
The recommended dose of Lexapro in hepatically impaired patients is 10 mg/day.	0
"Small children have received this regimen without dose adjustment and with apparent good results, notwithstanding the known differences in quinidine pharmacokinetics between pediatric patients and adults."	0
Nursing mothers<U+2013> Quinidine is present in human milk at levels slightly lower than those in maternal serum; a human infant ingesting such milk should (scaling directly by weight) be expected to develop serum quinidine levels at least an order of magnitude lower than those of the mother.	0
"The recommended starting dose is 12 mg/kg/day, administered at 6-8 hour intervals at a time when the stomach is empty."	0
The clinical relevance of reduced MPA exposure on organ rejection has not been established in transplant patients receiving ACIPHEX delayed-release tablets and MMF.	0
"Digoxin: Thiazide-induced electrolyte disturbances, i.e. hypokalemia, hypomagnesemia, increase the risk of digoxin toxicity, which may lead to fatal arrhythmic events."	0
"Based on in vitro data, no dose adjustment is required for PRISTIQ when used concomitantly with inhibitors of CYP3A4 and CYP1A1, 1A2, 2A6, 2D6, 2C8, 2C9, 2C19, 2E1, and the P-glycoprotein transporter."	0
This is supported by recent clinical trials.	0
The type and duration of hypnotic effects and the profile of unwanted effects during administration of benzodiazepine drugs may be influenced by the biologic half-life of administered drug and any active metabolites formed.	0
"The clinician should, nevertheless, be aware of the possibility of emergent symptoms of serotonin syndrome with such use."	0
"In cardiac muscle and in Purkinje fibers, quinidine depresses the rapid inward depolarizing sodium current, thereby slowing phase<U+2013>0 depolarization and reducing the amplitude of the action potential without affecting the resting potential."	0
"The use of Tasigna can cause hypophosphatemia, hypokalemia, hyperkalemia, hypocalcemia, and hyponatremia."	0
"A complete blood count, including a reticulocyte count, is recommended after two weeks of treatment."	0
"Since paroxetine exhibits nonlinear pharmacokinetics, the results of this study may not address the case where the 2 drugs are both being chronically dosed."	0
Lidocaine must not be infused simultaneously through the same tubing with other medicinal products without first verifying their compatibility.	0
Consequently plasma concentrations of drugs metabolized by these two isozymes will be decreased when Tracleer is co-administered.	0
"After reconstitution of the vial, each mL contains 0.32 mg of nesiritide."	0
ADASUVE is a central nervous system (CNS) depressant.	0
"Patients who are started on therapy should be monitored closely for suicidality (suicidal thinking and behavior), clinical worsening, or unusual changes in behavior."	0
"In 1 study, daily dosing of paroxetine (20 mg once daily) under steady-state conditions increased single dose desipramine (100 mg) Cmax, AUC, and T<U+00BD> by an average of approximately 2-, 5-, and 3-fold, respectively."	1
"PRINIVIL is contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril)."	0
This terminal phase probably represents saturable binding to ACE and is not proportional to dose.	0
"Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure , reduce myocardial contractility , or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC s effects on blood pressure , contractility , and impulse propagation ."	0
Propranolol attenuated the heart rate increase following administration of immediate release nisoldipine.	0
"Amphetamines and amphetamine derivatives are known to be metabolized, to some degree, by cytochrome P450 2D6 (CYP2D6) and display minor inhibition of CYP2D6 metabolism."	0
"Closely monitor blood pressure, renal function and electrolytes in patients on ACEON and other agents that affect the RAS."	0
The risk of administering methylene blue by non-intravenous routes (such as oral tablets or by local injection) or in intravenous doses much lower than 1 mg/kg with Lexapro is unclear.	0
"Pharmacokinetics and Metabolism <U+2014> After intramuscular injection of quinidine gluconate, peak serum levels of quinidine are achieved in a little less than two hours."	0
Valvular heart disease associated with the use of some anorectic agents such as fenfluramine and dexfenfluramine has been reported.	0
"The following table provides short-term, placebo-controlled clinical trial data for the proportions of patients having an increase in: diastolic blood pressure <U+2265>15 mm Hg; systolic blood pressure <U+2265>20 mm Hg; heart rate greater than or equal to 20 bpm, in both the pediatric and adult populations."	0
"For pediatric and adult patients in whom capsule swallowing is difficult or where lower doses are needed, a liquid suspension may be prepared as follows: RIFADIN 1% w/v suspension (10 mg/mL) can be compounded using one of four syrups<U+2013>Simple Syrup (Syrup NF), Simple Syrup (Humco Laboratories), SyrPalta<U+00AE> Syrup (Emerson Laboratories), or Raspberry Syrup (Humco Laboratories)."	0
"Prior to Tasigna administration and periodically, monitor for hypokalemia or hypomagnesemia and correct deficiencies ( 5.2 )."	0
Patients with sick sinus syndrome or with 2nd or 3rd degree heart block were not included in the Phase 3 clinical trials unless a functioning pacemaker was present.	0
"Due to the need for co-administration of APTIVUS with ritonavir, please refer to the ritonavir prescribing information for a description of ritonavir contraindications."	0
"Therefore, thioridazine is contraindicated with these drugs as well as in patients, comprising about 7% of the normal population, who are known to have a genetic defect leading to reduced levels of activity of P450 2D6."	0
Fatal and non-fatal intracranial hemorrhage (5.2)	0
The usual maintenance dosage range is 20 mg to 40 mg per day administered as a single dose orin two equally divided doses.	0
Families and caregivers should be advised of the need for close observation and communication with the prescriber.	0
"If unacceptable opioid-related adverse reactions are observed, consider reducing the dosage."	0
The recommended usual dosage range of trandolapril for hypertension is 1 to 4 mg per day administered in a single dose or two divided doses.	0
Steady-stateblood concentrations are reached within 1 to 2months following once-daily administration and steady-state levels are approximately 10-fold greater than with the initial dose.	0
"Intensified electrolyte depletion, particularly hypokalemia, may occur."	0
The median Tmax was observed 19 hours later for hydroxybupropion and 31 hours later for threo/erythrohydrobupropion.	0
"Latent tuberculosis infection: PRIFTIN should be administered in combination with isoniazid once-weekly for 12 weeks as directly observed therapy.Adults and children <U+2265> 12 years: PRIFTIN (based on weight, see table below) and isoniazid 15 mg/kg (900 mg maximum)Children 2<U+2013>11 years: PRIFTIN (based on weight, see table below) and isoniazid 25 mg/kg (900 mg maximum) Weight range PRIFTIN dose Number of PRIFTIN tablets 10<U+2013>14 kg 300 mg 2 14.1<U+2013>25 kg 450 mg 3 25.1<U+2013> 32 kg 600 mg 4 32.1<U+2013>50 kg 750 mg 5 > 50 kg 900 mg 6 For Latent Tuberculosis Infection, the maximum recommended dose of PRIFTIN is 900 mg once-weekly for 12 weeks."	0
Absorption and Distribution Orally administered duloxetine hydrochloride is well absorbed.	0
Therapy with Lexapro may be resumed 24 hours after the last dose of linezolid or intravenous methylene blue.	0
Avoid using CAPRELSA with drugs known to prolong the QT interval.	0
AMBIEN did not accumulate in elderly subjects following nightly oral dosing of 10 mg for 1 week.	0
"When compared with normal metabolizers, the total sum at steady state of the plasma concentrations of the 4active enantiomers was not significantly greater among poor metabolizers."	0
"5-HT1 agonists, including MAXALT may cause coronary artery vasospasm (Prinzmetal's Angina), even in patients without a history of CAD."	0
Dihydroergotamine mesylate should not be used with peripheral and central vasoconstrictors because the combination may result in additive or synergistic elevation of blood pressure.	0
"For CrCl 30-50 mL/min, start warfarin 2 days before discontinuing PRADAXA."	0
MAO plays a vital physiological role in terminating the biological activity of both endogenous and exogenous amines.	0
Coadministration of LEXIVA and drugs that inhibit CYP3A4 may increase amprenavir concentrations and increase the incidence of adverse effects.	1
Drugs that are Contraindicated with NORVIR Drug Class Drugs Within Class That Are Contraindicated With NORVIR** Clinical Comments Alpha1-adrenoreceptor antagonist Alfuzosin HCL Potential for hypotension.	0
"Quinidine also raises the fibrillation thresholds of the atria and ventricles, and it raises the ventricular defibrillation threshold as well."	0
Nefazodone plasma concentrations were unaffected by alprazolam.	0
"If intolerable symptoms occur following a decrease in the dose or upon discontinuation of treatment, then resuming the previously prescribed dose may be considered."	0
The risk of blood pressure decreases may be greater in patients taking concomitant medications that induce orthostatic hypotension (such as antihypertensives) or are potent CYP1A2 inhibitors and in patients taking CYMBALTA at doses above 60mg daily.	0
"Following oral administration of a single 150 mg dose of bupropion, there was no statistically significant difference in Cmax, half-life, Tmax, AUC, or clearance of bupropion or its active metabolites between smokers and nonsmokers."	0
Patients with a history of angioedema unrelated to ACE inhibitor therapy may be at increased risk of angioedema while receiving an ACE inhibitor.	0
The volume of distribution of digoxin is proportional to lean body weight and doses listed in Table 3 assume average body composition.	0
"Patients should be advised of the signs and symptoms of both MAC and tuberculosis, and should be instructed to consult their physicians if they develop new complaints consistent with either of these diseases."	0
Patients with renal or hepatic impairment should not be given colchicine with INVIRASE/ritonavir.	0
"No significant change 2.18 (1.16, 4.12) Delavirdine 400 three times daily 600 three times daily, 7 days 28 No significant change 1.53 (1.07, 2.20) 3.98 (2.04, 7.78) EfavirenzStudy conducted in HIV-positive subjects."	0
Depression: Worsening of depression or suicidal thinking may occur.	0
"As a result, co-administration of saquinavir/ritonavir with these drugs should be undertaken with caution, particularly with those drugs metabolized by CYP3A, and clinical monitoring is recommended."	0
"In heart failure patients, greater than 20% increases in serum potassium were observed in 10.0% of Diovan-treated patients compared to 5.1% of placebo-treated patients."	0
Hypotension (systolic pressure less than 90 mmHg) or cardiogenic shock.	0
Coadministration of REYATAZ/ritonavir and boceprevir is not recommended.	0
"If concomitant use of Savella with other serotonergic drugs including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, tryptophan, amphetamines, and St. John's Wort is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome, particularly during treatment initiation and dose increases."	0
In vivo studies showed no clinically meaningful change in levomilnacipran exposure when co-administered with the CYP3A4 inducer carbamazepine or the CYP3A4 substrate alprazolam.	0
"Bone Fracture: Long-term and multiple daily dose PPI therapy may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist, or spine (5.5)."	0
"After taking ROZEREM, patients should confine their activities to those necessary to prepare for bed."	0
"The potential effects of several concomitant medications on quetiapine pharmacokinetics were studied Because of its potential for inducing hypotension, quetiapine may enhance the effects of certain antihypertensive agents."	0
"While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition."	0
Hydrochlorothiazide is effective in doses of 12.5 mg to 50 mg once daily.	0
Patients should be informed that thioridazine has been associated with potentially fatal heart rhythm disturbances.	0
One possible mechanism for such deaths is prolongation of the QT interval predisposing patients to ventricular arrhythmia.	0
"Evaluate TPMT status in patients with clinical or laboratory evidence of severe bone marrow toxicity, or repeated episodes of myelosuppression."	0
"If hyperkalemia occurs in patients taking amiloride HCl, the drug should be discontinued immediately."	0
Approximately 35% to 50% of the absorbed dose is recovered in urine while the remainder is eliminated in feces via the bile.	0
Theophylline <U+2014> Multiple doses of olanzapine did not affect the pharmacokinetics of theophylline or its metabolites.	0
"Weight Changes <U+2013> In controlled studies of OCD, weight gain was reported in 18% of patients receiving Anafranil, compared with 1% of patients receiving placebo."	0
Consult labeling of all concurrently used drugs for complete information about interactions with COUMADIN or increased risks for bleeding.	0
"Co-administration of SAMSCA with inhibitors of P-gp ( e.g. , cyclosporine ) may necessitate a decrease in SAMSCA dose see Warnings and Precautions ( 5.5 ) , Drug Interactions ( 7.1 ) ."	0
Consider administering olmesartan at least 4 hours before the colesevelam hydrochloride dose.	0
"Information for Patients Patients should be told that the antianginal efficacy of isosorbide dinitrate is strongly related to its dosing regimen, so the prescribed schedule of dosing should be followed carefully."	0
Patients with severe hepatic impairment were not studied.	0
<U+2022> Angle Closure Glaucoma: Angle closure glaucoma has occurred in patients with untreated anatomically narrow angles treated with antidepressants ( 5.3 ).	0
"Fluvastatin administered as fluvastatin sodium extended-release 80 mg tablets reaches peak concentration in approximately 3 hours under fasting conditions, after a low fat meal, or 2.5 hours after a low fat meal."	0
At least 61% of the oral dose is eliminated unchanged within 24 hours.	0
"Generally, dosage adjustments should be made at intervals of at least 2 weeks."	0
"PDE5 inhibitors , including ADCIRCA , and alpha adrenergic blocking agents are vasodilators with blood pressure lowering effects ."	0
A minimum urine output of 2 liters/day on a consistent basis should be sought.	0
"Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary)."	0
"Therefore, in patients taking itraconazole, caution should be used when the LIPITOR dose exceeds 20 mg."	1
"If QTc exceeds 500 milliseconds (550 msec in patients with ventricular conduction abnormalities), TIKOSYN therapy should be discontinued and patients should be carefully monitored until QTc returns to baseline levels."	0
"THIOLA<U+00AE> should not be begun again in patients with a prior history of developing agranulocytosis, aplastic anemia or thrombocytopenia on this medication."	0
"In rare instances, treatment with ACE inhibitors may be associated with mild reductions in red blood cell count and hemoglobin content, blood cell or platelet counts."	0
"Hypotension, bradyarrhythmias, and lactic acidosis have been observed in patients receiving concurrent erythromycin ethylsuccinate."	0
"Amlodipine The usual initial antihypertensive oral dose of amlodipine is 5 mg once daily, and the maximum dose is 10 mg once daily."	0
Beta2-adrenergic blockade results in passive bronchial constriction by interfering with endogenous adrenergic bronchodilator activity in patients subject to bronchospasm and may also interfere with exogenous bronchodilators in such patients.	0
IMURAN has been reported to cause temporary depression in spermatogenesis and reduction in sperm viability and sperm count in mice at doses 10times the human therapeutic dose;10 a reduced percentage of fertile matings occurred when animals received 5mg/kg.	0
"Left Ventricular Dysfunction During a chronic dosing study with bupropion in 14 depressed patients with left ventricular dysfunction (history of CHF or an enlarged heart on x-ray), there was no apparent effect on the pharmacokinetics of bupropion or its metabolites, compared to healthy volunteers."	0
Similar elevations occurred in Savella-treated patients who were hypertensive at baseline.	0
"In clinical studies, three of four patients who developed RPLS while taking CAPRELSA also had hypertension."	0
"While taking beta blockers, patients with a history of anaphylactic reaction to a variety of allergens may have a more severe reaction on repeated challenge, either accidental, diagnostic or therapeutic."	0
"Abbreviations: ODV, O-desmethylvenlafaxine; AUC, area under the curve; Cmax, peak plasma concentrations; EM's, extensive metabolizers; PM's, poor metabolizers * No dose adjustment on co-administration with CYP2D6 inhibitors (Fig 3 and Metabolism Section 12.3) Figure 1 Figure 2: Effect of venlafaxine on the pharmacokinetics interacting drugs and their active metabolites."	0
"The onset or aggravation of exertional dyspnea, or unexplained symptoms of angina pectoris, syncope, or lower extremity edema suggest the possibility of occurrence of pulmonary hypertension."	0
Variable results on clearance have been obtained in acute studies of healthy volunteers; clearance of verapamil was either reduced or unchanged.	0
HCV protease inhibitor: Simeprevir LEXIVA: <U+2194>Amprenavir (predicted) <U+2191> or <U+2193>Simeprevir (predicted) LEXIVA/ritonavir: <U+2194>Amprenavir (predicted) <U+2191>Simeprevir (predicted) Coadministration of LEXIVA or LEXIVA/ritonavir and simeprevir is not recommended.	0
Early drug discontinuation may be considered in patients with abnormal CBC results that do not respond to dose reduction.	0
Neutropenia: Neutropenia was observed in 1.9% of patients treated with Diovan and 0.8% of patients treated with placebo.	0
"Hemodialysis While studies have not been conducted in patients with end-stage renal disease, hemodialysis is not expected to clear atorvastatin or amlodipine since both drugs are extensively bound to plasma proteins."	0
"If trazodone is used with a CYP3A4 inhibitor such as VIRACEPT, the combination should be used with caution and a lower dose of trazodone should be considered."	1
"Systemic/Inhaled/Nasal/OphthalmicCorticosteroids:e.g., betamethasonebudesonideciclesonidedexamethasonefluticasonemethylprednisolonemometasoneprednisonetriamcinolone <U+2191> glucocorticoids Coadministration with corticosteroids whose exposures are significantly increased by strong CYP3A inhibitors can increase the risk for Cushing<U+2019>s syndrome and adrenal suppression."	0
Digitalis derivatives: Monitor toxicity when lidocaine is used in patients with digitalis toxicity accompanied by supraventricular arrhythmia and/or atrioventricular block.	0
"Other CYP2C9 alleles associated with reduced enzymatic activity occur at lower frequencies, including *5, *6, and *11 alleles in populations of African ancestry and *5, *9, and *11 alleles in Caucasians."	0
Grapefruit Juice Co-administration of grapefruit juice and SAMSCA results in a 1.8-fold increase in exposure to tolvaptan [see Dose and Administration (2.3) and Warnings and Precautions (5.5)].	0
"Renal elimination involves both glomerular filtration and active tubular secretion (via the cation transport system, a process that can be inhibited by cimetidine, trimethoprim, prochlorperazine, megestrol, ketoconazole and dolutegravir)."	1
Dihydropyridine calcium channel blockers can produce negative inotropic effects and exacerbate heart failure.	0
Serotonin syndrome and MAOIs: Do not use MAOIs intended to treat psychiatric disorders with PRISTIQ or within 7 days of stopping treatment with PRISTIQ.	0
Individualize dosage based upon the severity of hypertension and response of the patient during dosing (2.1).	0
"Prescriptions for NORPRAMIN should be written for the smallest quantity of tablets consistent with good patient management, in order to reduce the risk of overdose."	0
It reversibly competes with other dihydropyridines for binding to the calcium channel.	0
Avoid administration of PPIs for longer than medically indicated.	0
Patients already on a beta blocker must be evaluated carefully before TENORMIN is administered.	0
"Human pharmacologic studies have shown that racemic methylphenidate may inhibit the metabolism of coumarin anticoagulants, anticonvulsants (e.g., phenobarbital, phenytoin, primidone), and tricyclic drugs (e.g., imipramine, clomipramine, desipramine)."	1
"Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8-fold increase in plasma AUC of the TCA)."	0
"In patients with moderate or severe renal impairment (creatinine clearance <50 mL/min), accumulation of the intravenous vehicle, SBECD, occurs."	0
"All patients should be followed closely with clinical and laboratory monitoring, especially those with chronic hepatitis B or C co-infection, as these patients have an increased risk of hepatotoxicity."	0
The possibility of hypotensive effects can be minimized by either decreasing the dose of or discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with perindopril.	0
"If necessary, other antihypertensive treatments (e.g., increase in dose of hydrochlorothiazide therapy to 25mg or addition of other diuretic therapy, calcium-channel blockers, alpha-blockers, or centrally acting agents, but not ACE inhibitors, angiotensin II antagonists, or beta-blockers) were added to the treatment regimen to reach the goal blood pressure."	0
Dose adjustment for lithium is not recommended.	0
"(see WARNINGS) Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"Due to an increased risk of myopathy/rhabdomyolysis when HMG-CoA reductase inhibitors are coadministered with gemfibrozil, concomitant administration of fluvastatin sodium with gemfibrozil should be avoided."	0
"Generally, 3,000ng/mL and 10,000ng/mL are satisfactory concentrations to deliver between 2 to 16ng/kg/min in adults."	0
"Following administration of 40 mg of LATUDA, the mean (%CV) apparent volume of distribution was 6173 (17.2) L. LATUDA is highly bound (~99%) to serum proteins."	0
Telmisartan does not bind to or block other hormone receptors or ion channels known to be important in cardiovascular regulation.	0
Improved left ventricular diastolic function in patients with Idiopathic Hypertrophic Subaortic Stenosis (IHSS) and those with coronary heart disease has also been observed with CALAN therapy.	0
"Hepatic Impairment If possible, consider alternative therapies."	0
The dose must be used within 72 hours of preparation.	0
"If no chemotherapy is given on Days 2 and 3, administer EMEND in morning."	0
"Onset of Effect: In the perioperative patient population, Cleviprex produces a 4-5% reduction in systolic blood pressure within 2-4 minutes after starting a 0.4 mcg/kg/min infusion (approximately 1-2 mg/hr)."	0
"There is minimal potential for PRIFTIN metabolism to be inhibited or induced by another drug, based upon the characteristics of the esterase enzymes."	0
MAXALT is contraindicated in patients with uncontrolled hypertension.	0
"In adults, symptomatic response to therapy with PROTONIX does not preclude the presence of gastric malignancy."	0
"The median EC50 value of sofosbuvir against chimeric replicons encoding NS5B sequences from clinical isolates was 62 nM for genotype 1a (range 29<U+2013>128 nM; N=67), 102 nM for genotype 1b (range 45<U+2013>170 nM; N=29), 29 nM for genotype 2 (range 14<U+2013>81 nM; N=15), and 81 nM for genotype 3a (range 24<U+2013>181 nM; N=106)."	0
It has not been possible to define the precise risk of malignancy due to IMURAN.	0
"Based on a comparison to historical data, there was little or no change in indinavir AUC."	0
"As the blood pressure falls under the potentiating effect of LASIX , a further reduction in dosage or even discontinuation of other antihypertensive drugs may be necessary ."	0
Normotensive subjects experienced no clinically significant change in blood pressures (+1/<U+2013>2 mmHg).	0
"Angiotensin II is the primary vasoactive hormone of the renin-angiotensin system, and an important component in the pathophysiology of hypertension."	0
Initiate treatment with Letairis in females of reproductive potential only after a negative pregnancy test.	0
"In hypertensive patients with normal renal function, therapeutic doses of amlodipine resulted in a decrease in renal vascular resistance and an increase in glomerular filtration rate and effective renal plasma flow without change in filtration fraction or proteinuria."	0
"Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium."	0
"Effects of peripheral vasculopathy, including Raynaud<U+2019>s phenomenon, were observed in post-marketing reports at different times and at therapeutic doses in all age groups throughout the course of treatment."	0
All patients changed from less bioavailable formulations to this product should be monitored clinically and for serum potassium after the transfer.	0
Switching from Sevelamer Hydrochloride Tablets.	0
Constant monitoring with an electrocardiograph is essential to the administration of lidocaine hydrochloride intravenously.	0
Plasma concentrations are dose proportional.	0
"In patients with liver cirrhosis, the rate of elimination of bisoprolol is more variable and significantly slower than that in healthy subjects, with a plasma half-life ranging from 8 to 22 hours."	0
Stir for 5 seconds (granules will not dissolve) and swallow immediately.	0
Intervention Co-administration of VYVANSE and urinary alkalinizing agents should be avoided.	0
"When it is essential, the drug may be administered with electroconvulsive therapy, although the hazards may be increased."	0
Carvedilol is contraindicated in patients with severe liver impairment.	0
"When duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide, duloxetine did not increase the impairment of mental and motor skills caused by alcohol."	0
Less than 1% of the dose is excreted in the urine as N1-desalkyl-flurazepam.	0
"While priapism did not occur during premarketing experience with nefazodone, rare reports of priapism have been received since market introduction."	0
Concomitant administration with propranolol results in increased plasma levels of both drugs.	1
"Use with caution with patients with preexisting conduction system disease, ischemic heart disease, cardiomyopathy, underlying structural heart disease or when administering with other drugs that may prolong the PR interval (5.6, 12.3) Total cholesterol and triglycerides elevations: Monitor prior to therapy and periodically thereafter (5.7) Patients may develop new onset or exacerbations of diabetes mellitus, hyperglycemia (5.8) Patients may develop immune reconstitution syndrome (5.9) Patients may develop redistribution/accumulation of body fat (5.10) Hemophilia: Spontaneous bleeding may occur, and additional factor VIII may be required (5.11) Initiation of NORVIR, a CYP3A inhibitor, in patients receiving medications metabolized by CYP3A or initiation of medications metabolized by CYP3A in patients already receiving NORVIR, may increase plasma concentrations of medications metabolized by CYP3A."	0
"Concomitant use of TARKA with other antihypertensive agents including diuretics, vasodilators, beta-adrenergic blockers, and alpha-antagonists may result in additive hypotensive effects."	0
Distribution Irbesartan is 90% bound to serum proteins (primarily albumin and <U+03B1>1-acid glycoprotein) with negligible binding to cellular components of blood.	0
Drugs that inhibit the renin-angiotensin system can cause hyperkalemia.	0
"In some instances of urinary retention associated with CYMBALTA use, hospitalization and/or catheterization has been needed."	0
"While the principal mechanism of antihypertensive effect is thought to be through the renin-angiotensin-aldosterone system, quinapril exerts antihypertensive actions even in patients with low renin hypertension."	0
The half-life increases up to 41 hours in patients with severe impairment of renal function.	0
"In terms of overall ondansetron turnover, CYP3A4 plays a predominant role while formation of the major in vivo metabolites is apparently mediated by CYP1A2."	0
Risk factors for PML include treatment with immunosuppressant therapies and impairment of immune function.	0
"Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down."	0
"Titration may proceed more rapidly, however, if clinically warranted, provided the patient is assessed frequently."	0
Antagonism at receptors other than dopamine and 5HT2 with similar receptor affinities may explain some of the other effects of quetiapine.	0
"In infants with restricted systemic blood flow, measure efficacy by monitoring improvement of systemic blood pressure and blood pH."	0
"Paradoxical increase in ventricular rate in atrial flutter/fibrillation<U+2014> When quinidine is administered to patients with atrial flutter/fibrillation, the desired pharmacologic reversion to sinus rhythm may (rarely) be preceded by a slowing of the atrial rate with a consequent increase in the rate of beats conducted to the ventricles."	0
Use with Angiotensin-Converting Enzyme Inhibitors: The use of angiotensin-converting enzyme inhibitors to control hypertension in patients on azathioprine has been reported to induce anemia and severe leukopenia.	0
Prescribing and dispensing of methamphetamine should be limited to the smallest amount that is feasible at one time in order to minimize the possibility of overdosage.	0
"Meperidine Hydrochloride Injection contains meperidine, a Schedule II controlled substance."	0
"In clinical studies, doses of 10 mg to 400 mg per day were studied."	0
"Antineoplastic, Immunosuppressive, or Immune-Modulating Therapies Antineoplastic, immune-modulating, or immunosuppressive therapies, (including corticosteroids) are expected to increase the risk of immunosuppression, and the risk of additive immune system effects must be considered if these therapies are coadministered with GILENYA."	0
"Patients 75 Years of Age and Older In most patients, initiate amlodipine therapy at 2.5 mg. Titrate slowly in patients 75 years of age and older."	0
"Pooled analyses of short-term placebo-controlled trials of antidepressant drugs (selective serotonin reuptake inhibitors [SSRIs] and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18<U+2013>24) with major depressive disorder (MDD) and other psychiatric disorders."	0
"Prescribers should calculate the appropriate dose of APTIVUS for each individual child based on body weight (kg) or body surface area (BSA, m2) and should not exceed the recommended adult dose."	0
"Because AGGRENOX contains aspirin, AGGRENOX can cause fetal harm when administered to a pregnant woman."	0
"This property increases myocardial oxygen delivery in patients with coronary artery spasm, and is responsible for the effectiveness of verapamil in vasospastic (Prinzmetal's or variant) as well as unstable angina at rest."	0
Post marketing cases of second or third degree atrioventricular block have been reported in patients.	0
Monitorlipid profilesand glucose periodically during the first year of Tasigna therapyand at least yearly during chronic therapy.	0
"If symptomatic hypotension develops , a dose reduction or discontinuation of VASOTEC or concomitant diuretic may be necessary ."	0
"Do not administer ACCURETIC within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor."	0
"Similarly, the peak pravastatin values varied 47 fold for cirrhotic patients compared to 6 fold for healthy subjects."	0
Telmisartan has an accumulation index in plasma of 1.5 to 2.0 upon repeated once daily dosing.	0
Note: *: Administration of venlafaxine in a stable regimen did not exaggerate the psychomotor and psychometric effects induced by ethanol in these same subjects when they were not receiving venlafaxine.	0
MULTAQ is contraindicated in patients with: Permanent atrial fibrillation (patients in whom normal sinus rhythm will not or cannot be restored) : MULTAQ may cause fetal harm when administered to a pregnant woman.	0
Patients with a history of seizures were excluded from pre-marketing clinical studies.	0
Antidepressants: Trazodone <U+2191> Trazodone Concomitant use of trazodone and APTIVUS/ritonavir may increase plasma concentrations of trazodone.	1
"Since paroxetine exhibits nonlinear pharmacokinetics, the results of this study may not address the case where the 2 drugs are both being chronically dosed."	0
"Embryotoxicity and teratogenicity were observed following treatment with irinotecan HCl, at doses resulting in irinotecan exposures lower than those achieved with ONIVYDE 70 mg/m 2 in humans, administered to pregnant rats and rabbits during organogenesis."	0
"Isoproterenol, Atropine, Atenolol, and Diltiazem Single-dose fingolimod and fingolimod-phosphate exposure was not altered by coadministered isoproterenol or atropine."	0
"HCV replicons with reduced susceptibility to sofosbuvir have been selected in cell culture for multiple genotypes including 1b, 4a, 5a, and 6a."	0
"Independent of concentration, estazolam in plasma is 93% protein bound."	0
Initiation of Letairis therapy is not recommended for patients with clinically significant anemia.	0
"In patients with heart failure and diabetes, carvedilol therapy may lead to worsening hyperglycemia, which responds to intensification of hypoglycemic therapy."	0
Psychiatric Adverse Events Pre-existing Psychosis: Administration of stimulants may exacerbate symptoms of behavior disturbance and thought disorder in patients with a pre-existing psychotic disorder.	0
"If the condition persists for more than 24 hours, a urologist should be consulted to determine appropriate management."	0
Reduce the starting dose to 200 mg in patients with moderate to severe renal impairment and monitor the QT interval closely.	0
"Initiation of medications that inhibit or induce CYP3A may increase or decrease concentrations of LEXIVA/ritonavir, respectively."	1
"For those patients with propensity to nausea, vomiting, or other gastrointestinal upset, administration of MYCOBUTIN at doses of 150 mg twice daily taken with food may be useful."	0
"There was considerable variation in risk of suicidality among drugs, but a tendency toward an increase in the younger patients for almost all drugs studied."	0
"The drug interactions described are based on studies conducted with either HARVONI, the components of HARVONI (ledipasvir and sofosbuvir) as individual agents, or are predicted drug interactions that may occur with HARVONI."	0
"In hypertensive patients with unilateral or bilateral renal artery stenosis, increases in blood urea nitrogen and serum creatinine have been observed in some patients following ACE inhibitor therapy."	0
Anticoagulant: Warfarin <U+2191> Warfarin Concentrations of warfarin may be affected.	0
"Patients with advanced renal insufficiency (i.e., serum creatinine more than 2.5 mg/dl) should not be treated with AHA."	0
"<U+2022> Excretion: Following oral administration, rosuvastatin and its metabolites are primarily excreted in the feces (90%)."	0
"However, the major metabolite, 8-hydroxyamoxapine, has a biologic half-life of 30 hours."	0
"Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides , including endogenous bradykinin , patients receiving ACE inhibitors ( including VASOTEC ) may be subject to a variety of adverse reactions , some of them serious ."	0
Pharmacodynamic Interactions Tolvaptan produces a greater 24hour urine volume/excretion rate than does furosemide or hydrochlorothiazide.	0
"The dose can be repeated, as needed, at 1 hour intervals to a total dose of 3 mL for intramuscular or subcutaneous delivery or 2 mL for intravenous delivery in a 24 hour period."	0
This is thought to be a function of inhibition of calcium transport across the platelet membrane.	0
A nonlinear correlation exists between verapamil dose and plasma concentrations.	0
"The study population was diverse with regard to race (Asian 16.7%, Black 15.2%, Hispanic 18.3%, White 48.6%)."	0
"While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition."	0
Frequent monitoring of INR values is recommended during treatment and post-treatment follow-up.	0
Manage by treatment interruption or dose-reduction.	0
VIRACEPT may not be effective due to decreased nelfinavir plasma concentrations in patients taking these agents concomitantly.Phenytoin plasma/serum concentrations should be monitored; phenytoin dose may require adjustment to compensate for altered phenytoin concentration.	0
"In the supraventricular arrhythmia population (patients with AF and other supraventricular arrhythmias), the overall incidence of Torsade de Pointes was 0.8%."	0
"Inhibition of HMG<U+2011>CoA reductase is the basis for an assay in pharmacokinetic studies of the <U+03B2><U+2011>hydroxyacid metabolites (active inhibitors) and, following base hydrolysis, active plus latent inhibitors (total inhibitors) in plasma following administration of lovastatin."	0
Orthostatic hypotension and syncope have been reported in patients taking STRATTERA.	0
Protamine sulfate and vitamin K are not expected to affect the anticoagulant activity of rivaroxaban .	0
Immunosuppressants Amlodipine may increase the systemic exposure of cyclosporine or tacrolimus when co-administered.	1
"When possible, dose should be administered using a calibrated dosing syringe."	0
Pharmacokinetic data indicate that quinapril elimination is dependent on level of renal function.	0
Telmisartan is metabolized by conjugation to form a pharmacologically inactive acyl glucuronide; the glucuronide of the parent compound is the only metabolite that has been identified in human plasma and urine.	0
Clinical monitoring is recommended if PREZISTA/ritonavir and buprenorphine or buprenorphine/naloxone are coadministered. methadone <U+2193> methadone No adjustment of methadone dosage is required when initiating co-administration of PREZISTA/ritonavir.	0
"Total plasma clearance of losartan and the active metabolite is about 600mL/min and 50mL/min, respectively, with renal clearance of about 75mL/min and 25mL/min, respectively."	0
"Digoxin is a substrate for P-glycoprotein, at the level of intestinal absorption, renal tubular section and biliary-intestinal secretion."	0
"Calcium channel blockers : Diltiazem, felodipine, nifedipine, nicardipine, nimodipine, verapamil, amlodipine, nisoldipine, isradipine <U+2191> Calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended."	0
For use as a single-dose unit to provide analgesia via the intravenous route using a compatible Hospira infusion device.	0
No dose adjustment of FETZIMA is needed when co-administered with a CYP3A4 inducer or substrate.	0
The increase in pimozide AUC and Cmax is due to the CYP2D6 inhibitory properties of paroxetine.	1
"The incidence of myopathy, including rhabdomyolysis, was highest during the first year and then notably decreased during the subsequent years of treatment."	0
Nefazodone hydrochloride tablets should be discontinued if clinical signs or symptoms suggest liver failure.	0
"Therefore, an increase or decrease in the metabolism of CYP3A substrates (e.g., oral contraceptives and other steroidal agents) resulting from induction or inhibition is not anticipated, although clinical studies have not been performed."	0
"Myocardial infarction, arrhythmia, and strokes have occurred."	0
Clinically significant adverse reactions from greater exposures of PREZISTA/ritonavir.	0
"Either tachycardia or bradycardia may be present, and associated constricting chest pain and dilated pupils may occur."	0
Digoxin: Concomitant administration of BYSTOLIC (10 mg once daily) and digoxin (0.25 mg once daily) for 10 days in 14 healthy adult individuals resulted in no significant changes in the pharmacokinetics of digoxin or nebivolol.	0
Such a hormone change has not been observed in women treated with fluconazole.	0
"If BYSTOLIC is to be continued perioperatively, monitor patients closely when anesthetic agents which depress myocardial function, such as ether, cyclopropane, and trichloroethylene, are used."	0
"In a study in subjects with stable atherosclerosis, the AUC of the active metabolite on average was 38% lower in subjects <60kg taking 5-mg (N=34) than in subjects <U+2265>60kg taking 10-mg (N=38)."	0
"Discontinue treatment if severe reactions develop (5.5, 6.2) PR interval prolongation may occur in some patients."	0
"During TRISENOX therapy, maintain potassium concentrations above 4 mEq/L and magnesium concentrations above 1.8 mg/dL."	0
Change infusion site every 12 hours if administered via peripheral vein.	0
Twenty-four hour urinary citrate and/or urinary pH measurements should be used to determine the adequacy of the initial dosage and to evaluate the effectiveness of any dosage change.	0
ZOLOFT has not been systematically evaluated in patients with seizure disorders.	0
"Celexa 20 mg/day is the maximum recommended dose in patients taking concomitant cimetidine or another CYP2C19 inhibitor, because of the risk of QT prolongation."	1
The amount of triamterene added to the 25 mg of hydrochlorothiazide in triamterene and hydrochlorothiazide 37.5 mg/25 mg tablets was also determined from steady-state dose-response evaluations in which various doses of liquid preparations of triamterene were administered to hypertensive persons who developed hypokalemia with hydrochlorothiazide (25 mg given once daily).	0
No relationship has been established between the plasma concentration of verapamil and a reduction in blood pressure.	0
It is not known whether CRIXIVAN will exacerbate the physiologic hyperbilirubinemia seen in neonates.	0
"Drug treatment is not indicated in all cases of the behavioral syndrome characterized by moderate to severe distractibility, short attention span, hyperactivity, emotional lability and impulsivity."	0
"If potassium supplementation is used, careful monitoring of the serum potassium level is necessary."	0
"Nevertheless, caution is indicated in the co-administration of TCAs with any of the SSRIs and also in switching from one class to the other."	0
"The effect may be mediated by cimetidine<U+2019>s known inhibition of hepatic cytochrome P450, the enzyme system responsible for the first-pass metabolism of diltiazem."	1
"After repeated dosing, the AUC was approximately tripled in patients with severe renal impairment (creatinine clearance <20 mL/min)."	0
TENORETIC should be used with caution in these patients.	0
"An in vivo interaction study involving the coadministration under steady-state conditions of paroxetine and terfenadine, a substrate for cytochrome CYP3A4, revealed no effect of paroxetine on terfenadine pharmacokinetics."	0
"Because of the potential for serious adverse reactions in nursing infants from chlorpromazine, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother."	0
Similar results were obtained in patients with hepatic disease when nicardipine hydrochloride was administered for 24 hours at 0.6 mg/hr.	0
"Patients treated with TRISENOX can develop QTc prolongation, torsade de pointes, and complete heart block."	0
"As fluoxetine and its major metabolite have very long elimination half-lives, at least 5 weeks should be allowed after stopping fluoxetine before starting Marplan."	0
Protein Binding<U+2013> In vitro protein binding studies performed with radiolabeled 3H-sertraline showed that sertraline is highly bound to serum proteins (98%) in the range of 20 to 500 ng/mL.	0
"Consideration should be given to beginning titration at 40 mg three times per day in patients who might respond to lower doses, such as the elderly or people of small stature."	0
"The Perpetrator and Dabigatran Etexilate Dose and Dosing Frequency are given as well as the Time of Perpetrator Dosing in Relation to Dabigatran Etexilate Dose (Time Difference) Figure 3.2<U+2003>Effect of Non-P-gp Inhibitor or Inducer, Other Drugs, on Peak and Total Exposure to Dabigatran (Cmax and AUC)."	0
"Blockade of the renin-angiotensin system with ACE inhibitors, which inhibit the biosynthesis of angiotensin II from angiotensin I, is widely used in the treatment of hypertension."	0
"However, its efficacy could be mediated through a combination of antagonism of central dopamine D2 and serotonin 5-HT2A receptors."	0
"Mean plasma elimination half-life of atorvastatin in humans is approximately 14 hours, but the half-life of inhibitory activity for HMG-CoA reductase is 20 to 30 hours because of the contribution of active metabolites."	0
"For administration via an endotracheal tube, dilute 1-2 mg in no more than 10mL of sterile water or normal saline."	0
"Monitor patients for signs and symptoms such as unexpected rapid weight gain, swelling, and shortness of breath."	0
"Overall, greater than 90% of active plasma HMG<U+2011>CoA reductase inhibitory activity is accounted for by the parent compound."	0
"Patients recently withdrawn from beta blockers may develop a withdrawal syndrome with increased angina, probably related to increased sensitivity to catecholamines."	0
"Use of GDH-PQQ, GDO, and GDH-FAD-based glucose monitors and test strips has resulted in falsely elevated glucose readings (due to the presence of maltose)."	0
"Reserve azole antifungals, including voriconazole, for patients receiving a vinca alkaloid who have no alternative antifungal treatment options."	0
88 <U+2013>17 <U+2013>23 +8 <U+2013>27 <U+2013>21 +2 +11 MEVACOR was studied in controlled trials in hypercholesterolemic patients with well-controlled non-insulin dependent diabetes mellitus with normal renal function.	0
"Sedative/hypnotics:buspirone, clorazepate, diazepam, estazolam, flurazepam, zolpidem <U+2191> sedative/hypnotics A dose decrease may be needed for these drugs when co-administered with ritonavir."	1
"In clinical trials evaluating Savella in patients with fibromyalgia, seizures/convulsions have not been reported."	0
Patients subject to spontaneous hypoglycemia or diabetic patients receiving insulin or oral hypoglycemic agents should be cautioned about these possibilities.	0
"It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months."	0
Thiazide diuretics may cause an exacerbation or activation of systemic lupus erythematosus.	0
"In patients whose renal function may depend on the activity of the renin-angiotensin-aldosterone system (e.g., patients with severe congestive heart failure or renal dysfunction), treatment with angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death."	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
"Elderly Of the total number of subjects in clinical studies of dronedarone, 73% were 65 years of age and over and 34% were 75 and over."	0
Treatment (baseline-subtracted) related changes (AUC and Cmax) in serum calcium and phosphorus assessed over the 6 hours following dosing were similar for PHOSLYRA and calcium acetate gelcaps.	0
Dosage reduction for SAPHRIS based on clinical response may be necessary.	0
"Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II)."	0
"Hepatic elimination of quinidine may be accelerated by coadministration of drugs (phenobarbital, phenytoin, rifampin) that induce production of cytochrome P450IIIA4."	1
Concomitant use of VYVANSE with other serotonergic drugs or CYP2D6 inhibitors should be used only if the potential benefit justifies the potential risk.	0
Digital anomalies have been reported to occur with other members of the dihydropyridine class and are possibly a result of compromised uterine blood flow.	0
Serotonin syndrome can also occur when these drugs are used alone.	0
Women of childbearing potential should be advised to avoid becoming pregnant while receiving PURIXAN.	0
"There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on suicide."	0
"Of 17 subjects with culture-confirmed candidemia, 11 of 14 (79%) with baseline symptoms (3 were asymptomatic) had a clinical cure; 13/15 (87%) of evaluable patients had a mycologic cure at the end of treatment but two of these patients relapsed at 10 and 18 days, respectively, following cessation of therapy."	0
"As a result, assays of free digoxin levels in protein-free ultrafiltrate (which tend to be about 25% less than total levels, consistent with the usual extent of protein binding) are less affected by spironolactone or DLIS."	0
"Focalin XR capsules and/or their contents should not be crushed, chewed, or divided."	0
"Chronic dietary administration of clonidine was not carcinogenic to rats (132 weeks) or mice (78 weeks) dosed, respectively, at up to 46 or 70 times the maximum recommended daily human dose as mg/kg (9 or 6 times the MRDHD on a mg/m2 basis)."	0
"On discontinuation of CALAN use, the patient should be reassessed to avoid under-digitalization."	0
Use with increased monitoring for adverse events.	0
"Although sotalol is usually well-tolerated hemodynamically, in patients with marginal cardiac compensation, deterioration in cardiac performance may occur."	0
At least 14days should elapse between discontinuation of an MAO inhibitor and initiation of treatment with buproprion hydrochloride.	0
Icodextrin acts in the peritoneal cavity by exerting osmotic pressure across small intercellular pores resulting in transcapillary ultrafiltration throughout the dwell.	0
These responses have usually occurred during initial titration or at the time of subsequent upward dosage adjustment.	0
Temazepam was completely metabolized through conjugation prior to excretion; 80% to 90% of the dose appeared in the urine.	0
"While there are no systematic studies that answer the question of how long to continue Anafranil, OCD is a chronic condition and it is reasonable to consider continuation for a responding patient."	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP is contraindicated in patients who have previously shown hypersensitivity to ergot alkaloids."	0
Carbamazepine The coadministration of carbamazepine (a potent CYP450 enzyme inducer) 600 mg twice-daily at steady-state and a single dose of fingolimod 2 mg decreased blood concentrations (AUC) of fingolimod and fingolimod-phosphate by approximately 40%.	1
"Drug Interaction Studies In a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide in whom therapy with FLOLAN was initiated, apparent oral clearance values for furosemide (n=23) were decreased by 13% on the second day of therapy and returned to baseline values by Day 87."	1
"Parathyroid Disease: Calcium excretion is decreased by thiazides, and pathologic changes in the parathyroid glands, with hypercalcemia and hypophosphatemia, have been observed in a few patients on prolonged thiazide therapy."	0
"If progressive renal impairment becomes apparent, ZIAC should be discontinued."	0
HMG-CoA Reductase Inhibitors: AtorvastatinRosuvastatin <U+2191> Atorvastatin<U+2193> Hydroxy-atorvastatin metabolites<U+2191> Rosuvastatin Avoid co-administration with atorvastatin.	0
"Coadministration of bosentan in adult patients on REYATAZ/ritonavir: For patients who have been receiving REYATAZ/ritonavir for at least 10days, start bosentan at 62.5 mg once daily or every other day based on individual tolerability."	0
"Quinapril was an effective antihypertensive in all races studied, although it was somewhat less effective in blacks (usually a predominantly low renin group) than in non-blacks."	0
Simvastatin is metabolized by CYP3A4 but has no CYP3A4 inhibitory activity; therefore it is not expected to affect the plasma concentrations of other drugs metabolized by CYP3A4.	0
The clearance of theophylline was decreased approximately 3-fold.	1
"Administration of Catapres<U+00AE> (clonidine hydrochloride, USP) tablets should be continued to within 4 hours of surgery and resumed as soon as possible thereafter."	0
"If concomitant use of Lexapro with other serotonergic drugs is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome, particularly during treatment initiation and dose increases (5.2)."	0
"In a double-blind, parallel, dose-response study utilizing doses ranging from 90 to 540 mg once daily, CARDIZEM CD lowered supine diastolic blood pressure in an apparent linear manner over the entire dose range studied."	0
"Therefore, the 80-mg dose of ZOCOR should be used only in patients who have been taking simvastatin 80mg chronically (e.g., for 12 months or more) without evidence of muscle toxicity."	0
"The results suggest an approximate 2-fold increase in the risk of NAION, with a risk estimate of 2.15 (95% CI 1.06, 4.34)."	0
"Altered anticoagulant effects, including increased bleeding, have been reported when SSRIs and SNRIs are coadministered with warfarin."	0
In vitro tests show that amoxapine binding to human serum is approximately 90%.	0
"When pregnancy is detected, discontinue Benicar as soon as possible."	0
"There are, however, no adequate and well-controlled studies in pregnant women."	0
Cases of nephrolithiasis and/or cholelithiasis have been reported during postmarketing surveillance in HIV-infected patients receiving REYATAZ therapy.	0
"Candesartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in many tissues, such as vascular smooth muscle and the adrenal gland."	0
Table 3: Starting Dose for Dialysis Patients Switching from Calcium Acetate to Renvela Calcium Acetate 667 mg (Tablets per meal) Renvela 1 tablet 0.8 g 2 tablets 1.6 g 3 tablets 2.4 g Sevelamer carbonate powder is available in 0.8 or 2.4 g packets.	0
Patients with severe renal impairment (creatinine clearance <20 mL/min) were not included in clinical or pharmacokinetic studies.	0
These changes were characterized as hyperplasia at doses approximating the human dose and adenoma at doses about fifteen times the maximum recommended human dose on a mg per kg basis.	0
"However, it has been demonstrated in an antidepressant screening test in mice that hydroxybupropion is one half as potent as bupropion, while threohydrobupropion and erythrohydrobupropion are 5-fold less potent than bupropion."	0
The potential risk of possible serious adverse effects such as valvular heart disease and pulmonary hypertension should be assessed carefully against the potential benefit of weight loss.	0
Untreated acute angle-closure glaucoma can lead to permanent vision loss.	0
Shake the suspension prior to each use and return promptly to the refrigerator.	0
Careful monitoring for abnormal prolongation of the PR interval or other signs of excessive pharmacologic effects should be carried out.	0
CMI distributes into cerebrospinal fluid (CSF) and brain and into breast milk.	0
"Caution should be employed in the repeated use of Lidocaine Hydrochloride Injection, USP in patients with severe liver or renal disease because accumulation may occur and lead to toxic phenomena since Lidocaine Hydrochloride Injection, USP is metabolized mainly in the liver and excreted by the kidneys."	0
"If replacing clonidine by beta-blocker therapy, the introduction of beta blockers should be delayed for several days after clonidine administration has stopped."	0
Concomitant use can increase the risk of bradycardia.	0
Absorption The Tmaxof fingolimod is 12-16 hours.	0
"Age: The effects of age on the pharmacokinetics of bupropion and its metabolites have not been fully characterized, but an exploration of steady-state bupropion concentrations from several depression efficacy studies involving patients dosed in a range of 300 to 750 mg/day, on a 3-times-a-day schedule, revealed no relationship between age (18 to 83 years) and plasma concentration of bupropion."	0
"In animal reproduction studies, administration of nilotinib to pregnant rats and rabbits during organogenesis caused adverse developmental outcomes including embryo-fetal lethality/fetal effects (small renal papilla, fetal edema, and skeletal variations) in rats and increased resorptions of fetuses and fetal skeletal variations in rabbits at maternal AUCs approximately 2 and 0.5 times, respectively, the AUC in patients receiving the recommended dose."	0
"However, in patients with moderate hepatic impairment, there is no clear understanding of the impact of this degree of hepatic function impairment on the coagulation cascade and its relationship to efficacy and bleeding."	0
Gender <U+2014> Clearance of olanzapine is approximately 30% lower in women than in men.	0
"Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of other drugs that raise serum potassium levels."	0
"Therefore, monitor digoxin levels when initiating, adjusting, and discontinuing telmisartan for the purpose of keeping the digoxin level within the therapeutic range."	0
These risk differences (drug-placebo difference in the number of cases of suicidality per 1000 patients treated) are provided in Table 1.	0
Microsomal Enzyme Induction<U+2013>Preclinical studies have shown sertraline to induce hepatic microsomal enzymes.	0
"ELIQUIS is contraindicated in patients with the following conditions: Active pathological bleeding Severe hypersensitivity reaction to ELIQUIS (e.g., anaphylactic reactions) Active pathological bleeding (4) Severe hypersensitivity to ELIQUIS (4)"	0
Add 10 mL (2 teaspoonfuls) of apple juice and gently tap and/or shake the barrel of the syringe to help rinse the syringe and tube.	0
Renal Impairment Establish baseline renal function in patients initiating ALTACE.	0
"For the treatment of Candida urinary tract infections and peritonitis, daily doses of 50<U+2013>200 mg have been used in open, noncomparative studies of small numbers of patients."	0
Large controlled studies with other nitrates suggest that no dosing regimen with dilatrate<U+00AE>-SR should be expected to provide more than about 12 hours of continuous antianginal efficacy per day.	0
The aPTT test provides an approximation of PRADAXA<U+2019>s anticoagulant effect.	0
"Hepatic impairment In patients with hepatic insufficiency (due to cirrhosis), the pharmacokinetics of benazeprilat are essentially unaltered."	0
"If coadministration is necessary, reduce the quetiapine dose to 1/6 of the current dose and monitor for quetiapine-associated adverse reactions."	1
Treatment with doses higher than 20 mg three times a day is not recommended.	0
"Everolimus(CYP3A4 Inhibition) Not Studied In Vivo or In Vitro, but Drug Plasma Exposure Likely to be Increased Concomitant administration of voriconazole and everolimus is not recommended."	1
"Telmisartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in many tissues, such as vascular smooth muscle and the adrenal gland."	0
Cyclosporine significantly increased pitavastatin exposure.	1
"Some patients require higher dosages (e.g., 800 mg daily is not uncommon in discharged mental patients)."	0
"Although its exact mode of action has not been established, the ability of pimozide to suppress motor and phonic tics in Tourette<U+2019>s Disorder is thought to be a function of its dopaminergic blocking activity."	0
Concomitant administration of antacids does not affect the absorption of PROTONIX Delayed-Release Tablets.	0
PROCARDIA is extensively converted to inactive metabolites and approximately 80 percent of PROCARDIA and metabolites are eliminated via the kidneys.	0
"As a result, co-administration of ritonavir with these drugs should be undertaken with caution, particularly with those drugs metabolized by CYP3A."	0
Avoid the use of strong CYP3A4 or UGT1A1 inhibitors if possible.	0
Patients on long-term treatment with fluconazole and prednisone should be carefully monitored for adrenal cortex insufficiency when fluconazole is discontinued.	0
"Post hoc exploratory analyses revealed a significant difference between sertraline and placebo on the CAPS, IES and CGI in women, regardless of baseline diagnosis of comorbid major depressive disorder, but essentially no effect in the relatively smaller number of men in these studies."	0
Herbal products:St. John's wort (Hypericum perforatum) May lead to loss of virologic response and possible resistance to CRIXIVAN or to the class of protease inhibitors.	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy."	0
"These hazards include fetal or neonatal jaundice, pancreatitis, thrombocytopenia, and possibly other adverse reactions that have occurred in the adult."	0
"If a serious or severe toxicity occurs during treatment with INVIRASE, INVIRASE should be interrupted until the etiology of the event is identified or the toxicity resolves."	0
Simvastatin Dronedarone increased simvastatin/simvastatin acid exposure.	1
"The patient should be monitored for symptoms of serotonin syndrome for two weeks or until 24 hours after the last dose of linezolid or intravenous methylene blue, whichever comes first."	0
The mechanism of action of imipramine is not definitely known.	0
"In animals, nesiritide had no effects on cardiac contractility or on measures of cardiac electrophysiology such as atrial and ventricular effective refractory times or atrioventricular node conduction."	0
The mechanism and long-term consequences of these events are currently unknown.	0
"For patients who cannot avoid use of strong CYP3A4 inhibitors, monitor closely for prolongation of the QT interval [see Boxed Warning, Warnings and Precautions (5.2, 5."	0
Monitor ECGs more frequently in patients when it is not feasible to avoid concomitant use.	0
"Heart Failure The pharmacokinetics of candesartan were linear in patients with heart failure (NYHA class II and III) after candesartan cilexetil doses of 4, 8, and 16 mg. After repeated dosing, the AUC was approximately doubled in these patients compared with healthy, younger patients."	0
The metabolism and pharmacokinetics of paroxetine may be affected by the induction or inhibition of drug-metabolizing enzymes.	0
Angioedema or history of hereditary or idiopathic angioedema(4) Hypersensitivity(4) Coadministration with aliskiren in patients with diabetes(4)	0
Co-administration of Savella and intravenous digoxin should be avoided.	0
"At steady state, plasma BNP levels increase from baseline endogenous levels by approximately 3-fold to 6-fold with NATRECOR<U+00AE> infusion doses ranging from 0.01 to 0.03 mcg/kg/min."	0
"IMURAN can be discontinued abruptly, but delayed effects are possible."	0
Antianginal ranolazine Potential for serious and/or life-threatening reactions.	0
Do not use SAMSCA with strong inhibitors of CYP 3A [see Contraindications (4.4)] and avoid concomitant use with moderate CYP 3A inhibitors.	0
"Verapamil should be avoided in patients with severe left ventricular dysfunction (e.g., ejection fraction less than 30%, pulmonary wedge pressure above 20mmHg, or severe symptoms of cardiac failure) and in patients with any degree of ventricular dysfunction if they are receiving a beta adrenergic blocker."	0
"Participants were middle-aged and elderly men (ages 45-73) and women (ages 55-73) without symptomatic cardiovascular disease with average to moderately elevated total<U+2011>C and LDL<U+2011>C, below average HDL<U+2011>C, and who were at high risk based on elevated total<U+2011>C/HDL<U+2011>C."	0
Drugs That Inhibit CYP3A4 (Ketoconazole) CYP3A4 is a major metabolic pathway for elimination of eszopiclone.	0
Digoxin does not significantly decrease heart rate during exercise.	0
"The particular isoenzyme system responsible for its metabolism has not been identified, but other dihydropyridines are metabolized by cytochrome P450 IIIA4."	0
The cases of gynecomastia seen in patients treated for one month or longer may be related to this effect.	0
For further details see complete prescribing information for Selzentry<U+00AE> (maraviroc).	0
"Examples birth control pills, skin patches, implants, and certain IUDs CYP2C9 Substrates Warfarin Clinical Impact Decreased warfarin exposure and prolongation of prothrombin time (INR)."	1
"When using Meperidine Hydrochloride Injection with CYP3A4 inducers or discontinuing CYP3A4 inhibitors, monitor patients closely at frequent intervals and consider increasing the opioid dosage if needed to maintain adequate analgesia or if symptoms of opioid withdrawal occur [PRECAUTIONS; Drug Interactions, DOSAGE AND ADMINISTRATION]."	0
"In subjects with creatinine clearance less than 40 mL/min, the plasma half-life is increased approximately threefold compared to healthy subjects."	0
Stop CAPRELSA in patients who develop a QTcF greater than 500 ms until the QTcF returns to less than 450 ms. Dosing of CAPRELSA can then be resumed at a reduced dose.	0
"AHA should be administered orally, one tablet 3-4 times a day in a total daily dose of 10-15 mg/kg/day."	0
"After an intravenous infusion of penicillin G, peak serum concentrations are attained immediately after completion of the infusion."	0
"When dialysis was started 2 hours after ingestion of 10 mg of benazepril, approximately 6% of benazeprilat was removed in 4 hours of dialysis."	0
"If serotonin syndrome occurs, discontinue VYVANSE and the concomitant serotonergic drug(s)."	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP should not be used by patients with documented ischemic or vasospastic coronary artery disease."	0
"Onset of action occurs within 2 hours of dosing, peak effect is observed at about 4 hours, and activity persists for up to 24 hours."	0
The concomitant use of SURMONTIL with MAOIs intended to treat psychiatric disorders is contraindicated.	0
"Beta-adrenergic blockade may mask certain clinical signs of hyperthyroidism, such as tachycardia."	0
Three patients died in pulmonary edema; all had severe left ventricular outflow obstruction and a past history of left ventricular dysfunction.	0
Dose reduction of LUNESTA is needed for patient co-administered LUNESTA with potent CYP3A4 inhibitors.	1
For patients with an inadequate blood pressure response to 50 mg once daily increase the dosage of INSPRA to 50 mg twice daily.	0
Frequent monitoring of trough blood levels of cyclosporine and tacrolimus and dose adjustment when appropriate is recommended.	0
"Clonidine acutely stimulates growth hormone release in both children and adults, but does not produce a chronic elevation of growth hormone with long-term use."	0
Thiazides should be discontinued before carrying out tests for parathyroid function.	0
COREG is a racemic mixture in which nonselective <U+03B2>-adrenoreceptor blocking activity is present in the S(-) enantiomer and <U+03B1>1-adrenergic blocking activity is present in both R(+) and S(-) enantiomers at equal potency.	0
"Patients with bronchospastic disease (e.g., chronic bronchitis, emphysema) should, in general, not receive <U+03B2>-blockers."	0
"In some cases, the dosage of MYCOBUTIN may need to be reduced when it is coadministered with CYP3A inhibitors."	1
ROZEREM should be used with caution in patients with moderate hepatic impairment.	0
"If TOPROL-XL is used in the setting of pheochromocytoma, it should be given in combination with an alpha blocker, and only after the alpha blocker has been initiated."	0
LEXIVA/ritonavir: <U+2193>Atazanavir <U+2194>Amprenavir Appropriate doses of the combinations with respect to safety and efficacy have not been established.	0
The recommended dose of MICARDIS tablets is 80 mg once a day and can be administered with or without food.	0
Include intestinal angioedema in the differential diagnosis of patients on ACE inhibitors presenting with abdominal pain.	0
"(A) PREMATURE DISCONTINUATION OF ELIQUIS INCREASES THE RISK OF THROMBOTIC EVENTS Premature discontinuation of any oral anticoagulant, including ELIQUIS, increases the risk of thrombotic events."	0
Decreases in hemoglobin concentration and hematocrit have followed administration of other endothelin receptor antagonists and were observed in clinical studies with Letairis.	0
"Patients who were pre-pubertal at the start of treatment (girls<U+2264>8years old, boys<U+2264>9years old) gained an average of 2.1kg and 1.2cm less than predicted after threeyears."	0
"Drug interaction studies were performed with APTIVUS capsules co-administered with ritonavir, and other drugs likely to be co-administered and some drugs commonly used as probes for pharmacokinetic interactions."	0
Concurrent use of DEMSER with alcohol or other CNS depressants can increase their sedative effects .	0
"In clinical trials, perindopril was generally administered in a non-fasting state."	0
"Epoprostenol The mean reduction of sildenafil (80 mg three times a day) bioavailability when co-administered with epoprostenol was 28%, resulting in about 22% lower mean average steady state concentrations."	1
"SSRIs and SNRIs, including LUVOX CR Capsules, may increase the risk of bleeding events."	0
"After daily dosing of FETZIMA 120 mg, the mean Cmax value is 341 ng/mL, and the mean steady-state AUC value is 5196 ng<U+00B7>h/mL."	0
There have been reports of spontaneous bleeding in patients with hemophilia A and B treated with protease inhibitors.	0
"Following therapeutic doses, about 10% is excreted as salicylic acid and 75% as salicyluric acid, as the phenolic and acyl glucuronides, in urine."	0
"However, hypokalemia of this type is usually prevented by the triamterene component of triamterene and hydrochlorothiazide."	0
"When given according to the recommended regimen of 25 mcg/kg followed by a 0.15 mcg/kg/min maintenance infusion, >90% inhibition of platelet aggregation is attained within 10 minutes."	0
"Lithium: As with other drugs which affect the excretion of sodium, lithium excretion may be reduced."	1
4.Reposition container with container ports up and evacuate medication port by squeezing and tapping it.	0
"By inhibiting FXa, apixaban decreases thrombin generation and thrombus development."	0
Figure 2 Effects of Other Drugs on Ambrisentan Pharmacokinetics * Omeprazole: based on population pharmacokinetic analysis in PAH patients** Rifampin: AUC and Cmax were measured at steady-state.	0
"Once a stable prothrombin time has been documented, prothrombin times can be monitored at the intervals usually recommended for patients on coumarin anticoagulants."	0
"However, there is substantial evidence from placebo-controlled maintenance trials in adults with depression that the use of antidepressants can delay the recurrence of depression."	0
"If a dose of ELIQUIS is not taken at the scheduled time, the dose should be taken as soon as possible on the same day and twice-daily administration should be resumed."	0
Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.	1
The exact length of time may vary depending on the particular MAOI dosage and duration of treatment.	0
Septal defects range in severity from those that resolve spontaneously to those which require surgery.	0
"Effect of Food When AGGRENOX capsules were taken with a high fat meal, there was no difference for aspirin in AUC at steady-state, and the approximately 50% decrease in Cmax was not considered clinically relevant based on a similar degree of cyclooxygenase inhibition comparing the fed and fasted state."	1
"In phenotypic analyses, post-baseline isolates from subjects who harbored NS5A resistance-associated substitutions at failure showed 20- to >243-fold reduced susceptibility to ledipasvir."	0
Reduce the dose of PRADAXA to 75 mg twice daily.	0
"Key to successful outcome of fulminant hypermetabolism is early recognition of premonitory signs, i.e., unexplained or unexpected tachycardia and increased metabolic rate as evidenced by respiratory and/or metabolic acidosis."	0
These results suggest that the effects of Zaleplon on sleep onset may be reduced if it is taken with or immediately after a high-fat/heavy meal.	0
"Hepatic Impairment: In patients with mild-to-moderate hepatic impairment, clearance is reduced 2-fold and mean half-life is increased to 11.6 hours compared to 5.7 hours in those without hepatic impairment."	0
Paroxetine demonstrated statistically significant superiority over placebo on the Hamilton Rating Scale for Anxiety (HAM-A) total score.	0
Increase to 40 mg once daily based on individual tolerability.	0
"Aspirin has been shown to be teratogenic in rats (spina bifida, exencephaly, microphthalmia and coelosomia) and rabbits (congested fetuses, agenesis of skull and upper jaw, generalized edema with malformation of the head, and diaphanous skin) at oral doses of 330 mg/kg/day and 110 mg/kg/day, respectively."	0
"Hypertension, including hypertensive crisis, has occurred in patients treated with CAPRELSA."	0
"Focalin XR should not be used in patients being treated (currently or within the preceding two weeks) with MAO Inhibitors (4.5) Focalin XR should be used cautiously with pressor agents (7) Antacids or acid suppressants could alter the release of Focalin XR (7) Racemic methylphenidate may inhibit the metabolism of coumarin anticoagulants, anticonvulsants, and tricyclic drugs (7)"	1
"In placebo-controlled registration studies involving adult patients, tachycardia was identified as an adverse event for 1.5% (8/540) of STRATTERA patients compared with 0.5% (2/402) of placebo patients."	0
It is not known whether mercaptopurine is excreted in human milk.	0
"Five subjects experienced nausea, vomiting, sweating, and diarrhea following coadministration, consistent with the cholinergic effects of tacrine."	0
"Hospitalized Patients<U+2014>Initially, 100 mg/day in divided doses."	0
"In four patients with cardiovascular disease, coadministration of propafenone 150 mg t.i.d. with immediate<U+2014>release metoprolol 50 mg t.i.d. resulted in two<U+2014> to five-fold increases in the steady-state concentration of metoprolol."	1
Dosing modification may be necessary in patients who exhibit a combination of factors that may result in slower metabolism of olanzapine.	0
"In patients of all ages who are started on antidepressant therapy, monitor closely for worsening, and for emergence of suicidal thoughts and behaviors."	0
Drug interaction studies were performed with CRIXIVAN and other drugs likely to be coadministered and some drugs commonly used as probes for pharmacokinetic interactions.	0
The predictive value of changes in IMT for stroke has not yet been established.	0
"These have generally occurred in patients with advanced HIV-1 disease taking multiple concomitant medications, having co-morbidities including hepatitis B or C co-infection, and/or developing immune reconstitution syndrome."	0
"(2.4)(2.5) Patients should be monitored for toxicity and therapeutic effect and doses should be adjusted, accordingly."	0
"Coadministration of antiplatelet agents, thrombolytics, heparin, aspirin, and chronic NSAID use increases the risk of bleeding."	0
"CYMBALTA has not been systematically evaluated in patients with a seizure disorder, and such patients were excluded from clinical studies."	0
"There is variability among the drugs effective in the treatment of major depressive disorder in the extent of clinically important 2D6 inhibition, and in fact sertraline at lower doses has a less prominent inhibitory effect on 2D6 than some others in the class."	0
"After a therapeutic response is achieved (increased pO2 in infants with restricted pulmonary blood flow or increased systemic blood pressure and blood pH in infants with restricted systemic blood flow), reduce the infusion rate to provide the lowest possible dosage that maintains the response."	0
"Presentation of adrenal insufficiency may include non-specific symptoms and signs including nausea, vomiting, anorexia, fatigue, weakness, dizziness, and low blood pressure."	0
"These effects are consistent with the inhibition of estrogen synthesis in rats and may be a result of known effects of lowered estrogen on pregnancy, organogenesis, and parturition Fluconazole is secreted in human milk at concentrations similar to maternal plasma concentrations."	0
"Before initiating Tasigna and periodically, test electrolyte, calcium and magnesium blood levels."	0
"If withdrawal of ZIAC therapy is planned, it should be achieved gradually over a period of about 2 weeks."	0
"Antimycobacterial: Rifabutina <U+2191>Rifabutin and rifabutin metabolite For contraindicated antimycobacterials (rifampin),."	0
"The appropriate doses for this combination, with respect to efficacy and safety, have not been established."	0
"Due to additive pharmacologic effect, the concomitant use of benzodiazepines or other CNS depressants such as alcohol, other sedatives/hypnotics, anxiolytics, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, and other opioids, can increase the risk of respiratory depression, profound sedation, coma, and death."	0
The effect of inhibitors of other P450 enzymes on the pharmacokinetics of zolpidem is unknown.	0
"The elimination half-life of oral TENORMIN is approximately 6 to 7 hours, and there is no alteration of the kinetic profile of the drug by chronic administration."	0
"Therefore, if concomitant use of such agents is indicated, monitor the patient's serum potassium frequently."	0
Immediately shake for at least 2minutes.	0
Instruct patients to swallow the capsules whole.	0
"In pregnant rabbits, decreased fetal and placental weights were observed at a dose of 30 mg/kg/day, about 10 times the MRHD when compared on a mg/m2 basis."	0
Co-administration of PREZISTA/ritonavir is contraindicated with drugs that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events (narrow therapeutic index).	0
"When pregnancy is detected, discontinue ACCUPRIL as soon as possible."	0
"Therefore, therapy with cimetidine cannot be recommended for children under 16, unless, in the judgement of the physician, anticipated benefits outweigh the potential risks."	0
Discontinue CAPRELSA in patients with severe hemorrhage.	0
"Mean peak concentrations of losartan and its active metabolite are reached in 1hour and in 3-4hours, respectively."	0
"These metabolites are all levorotatory (l-)enantiomers and no racemic biotransformation to the dextrorotatory form (i.e., S(+)-amphetamine or S(+)-methamphetamine) occurs."	0
"Inhibition of the pressor response to angiotensin I is shorter-lived, with a 20 mg dose giving 75% inhibition for about 4 hours, 50% inhibition for about 8 hours, and 20% inhibition at 24 hours."	0
"ALDACTONE , when used with ACE inhibitors or indomethacin , even in the presence of a diuretic , has been associated with severe hyperkalemia ."	0
"If it is almost time for the next dose, skip the missed dose and go back to the normal schedule."	0
Effectiveness was similar for male and female patients.	0
Concomitant use of agents in the tricyclic antidepressant class (which includes Anafranil) with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant agent or the other drug.	1
Consider the benefits and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated.	0
"Transporters Based on in vitro data, fingolimod as well as fingolimod-phosphate are not expected to inhibit the uptake of comedications and/or biologics transported by the organic anion transporting polypeptides OATP1B1, OATP1B3, or the sodium taurocholate co-transporting polypeptide (NTCP)."	0
"Drug Interactions Potential for Other Drugs to Affect Prasugrel Inhibitors of CYP3A - Ketoconazole(400mg daily), a selective and potent inhibitor of CYP3A4 and CYP3A5, did not affect prasugrel-mediated inhibition of platelet aggregation or the active metabolite's AUC and Tmax, but decreased the Cmax by 34% to 46%."	1
"Therefore, when discontinuing chronically administered sotalol, particularly in patients with ischemic heart disease, carefully monitor the patient and consider the temporary use of an alternative beta-blocker if appropriate."	0
Monitor serum potassium levels and adjust dose as needed.	0
"Conversely, an increase in dosage of a CYP2D6 substrate may be needed if ZOLOFT is discontinued."	1
"When available, the clinical microbiology laboratory should provide the results of in vitro susceptibility test results for antimicrobial drugs used in local hospitals and practice areas to the physician as periodic reports that describe the susceptibility profile of nosocomial and community-acquired pathogens."	0
"In vitro studies show that citalopram is at least 8 times more potent than its metabolites in the inhibition of serotonin reuptake, suggesting that the metabolites evaluated do not likely contribute significantly to the antidepressant actions of citalopram."	0
Rare instances of allergic hepatitis have been reported.	0
Protease Inhibitors Indinavir Both REYATAZ and indinavir are associated with indirect (unconjugated) hyperbilirubinemia.	0
"Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents (e.g., SSRI, SNRI, triptans), but also when taken alone."	0
"In rat and rabbit animal reproduction studies, simvastatin revealed no evidence of teratogenicity."	0
<U+2020> Considered clinically significant BID = twice daily; QD = once daily; LA = Long Acting Co-administered drug Dose regimen Change inAUC* Change in Cmax* Cyclosporine Pitavastatin 2 mg QD for 6 days + cyclosporine 2 mg/kg on Day 6 <U+2191> 4.6 fold<U+2020> <U+2191> 6.6 fold <U+2020> Erythromycin Pitavastatin 4 mg single dose on Day 4 + erythromycin 500 mg 4 times daily for 6 days <U+2191> 2.8 fold <U+2020> <U+2191> 3.6 fold <U+2020> Rifampin Pitavastatin 4 mg QD + rifampin 600 mg QD for 5 days <U+2191> 29% <U+2191> 2.0 fold Atazanavir Pitavastatin 4 mg QD + atazanavir 300 mg daily for 5 days <U+2191> 31% <U+2191> 60% Darunavir/Ritonavir Pitavastatin 4mg QD on Days 1-5 and 12-16 + darunavir/ritonavir 800mg/100 mg QD on Days 6-16 <U+2193> 26% <U+2193> 4% Lopinavir/Ritonavir Pitavastatin 4 mg QD on Days 1-5 and 20-24 + lopinavir/ritonavir 400 mg/100 mg BID on Days 9 <U+2013> 24 <U+2193> 20% <U+2193>4 % Gemfibrozil Pitavastatin 4 mg QD + gemfibrozil 600 mg BID for 7 days <U+2191> 45% <U+2191> 31% Fenofibrate Pitavastatin 4 mg QD + fenofibrate 160 mg QD for 7 days <U+2191>18% <U+2191> 11% Ezetimibe Pitavastatin 2 mg QD + ezetimibe 10 mg for 7 days <U+2193> 2% <U+2193>0.2% Enalapril Pitavastatin 4 mg QD + enalapril 20 mg daily for 5 days <U+2191> 6% <U+2193> 7% Digoxin Pitavastatin 4 mg QD + digoxin 0.25 mg for 7 days <U+2191> 4% <U+2193> 9% Diltiazem LA Pitavastatin 4 mg QD on Days 1-5 and 11-15 and diltiazem LA 240 mg on Days 6-15 <U+2191>10% <U+2191>15% Grapefruit Juice Pitavastatin 2 mg single dose on Day 3 + grapefruit juice for 4 days <U+2191> 15% <U+2193> 12% Itraconazole Pitavastatin 4 mg single dose on Day 4 + itraconazole 200 mg daily for 5 days <U+2193> 23% <U+2193> 22% Table 3.	0
"PDE5 Inhibitors:avanafil sildenafil, tadalafil,vardenafil <U+2191> avanafil<U+2191> sildenafil<U+2191> tadalafil<U+2191> vardenafil For contraindicated PDE5 inhibitors,.Do not use ritonavir with avanafil because a safe and effective avanafil dosage regimen has not been established."	0
"Such episodes do not preclude subsequent successful titration of, or a favorable response to, carvedilol."	0
"By slowing conduction and prolonging the effective refractory period, quinidine can interrupt or prevent reentrant arrhythmias and arrhythmias due to increased automaticity, including atrial flutter, atrial fibrillation, and paroxysmal supraventricular tachycardia."	0
The AUC of rosuvastatin does not differ following evening or morning drug administration.	0
"Sotalol Proarrhythmic events were more common in patients receiving sotalol and digoxin than on either alone; it is not clear whether this represents an interaction or is related to the presence of CHF, a known risk factor for proarrhythmia, in patients receiving digoxin."	0
Administer intravenous or subcutaneous atropine 0.25 to 1 mg (unless clinically contraindicated) for early onset diarrhea of any severity.	0
The recommended dosage of DIFLUCAN for vaginal candidiasis is 150 mg as a single oral dose.	0
"The incidence of side effects increases as the dose increases with first-degree AV block, dizziness, and sinus bradycardia bearing the strongest relationship to dose."	0
"Benzodiazepine : Intravenously administered Midazolam <U+2191> Midazolam If INVIRASE/ritonavir is coadministered with parenteral midazolam, close clinical monitoring for respiratory depression and/or prolonged sedation should be exercised and dosage adjustment should be considered."	0
The extent to which the findings of increased mortality in observational studies may be attributed to the antipsychotic drug as opposed to some characteristic(s) of the patients is not clear.	0
Angina or myocardial infarction may occur with initiation or dose increase (5.3).	0
Diovan may be administered with other antihypertensive agents .	0
Discard any solution more than 24 hours old.	0
Efficacy may be reduced when ROZEREM is used in combination with strong CYP enzyme inducers such as rifampin.	0
<U+2022>Use a clean pair of scissors to cut each packet along the dotted line.	0
No data are available regarding the safety of ULORIC during cytotoxic chemotherapy.	0
"Six metabolites resulting from hydrolysis, glucuronidation and cyclization via dehydration have been identified."	0
"<U+03B1>1-adrenoreceptor blocking activity has been demonstrated in human and animal studies, showing that carvedilol (1)attenuates the pressor effects of phenylephrine, (2)causes vasodilation, and (3)reduces peripheral vascular resistance."	0
The ratio of pitavastatin AUCinf between patients with mild hepatic impairment and healthy volunteers was 1.6.	0
"In a crossover study in 76 pediatric patients, intravenous ondansetron did not increase blood levels of high-dose methotrexate."	0
"Pressor amines (eg, norepinephrine) <U+2013> Possible decreased response to pressor amines but not sufficient to preclude their use."	0
"Following administration of a crushed 5 mg ELIQUIS tablet that was suspended in 60 mL D5W and delivered through a nasogastric tube, exposure was similar to that seen in other clinical trials involving healthy volunteers receiving a single oral 5 mg tablet dose."	0
Concomitant use of Monoamine Oxidase Inhibitors (MAOIs) and serotonergic drugs may potentially cause life threatening adverse events.	0
"In addition, in pediatric patients (10 to 17 years of age) administered with oral aripiprazole (20 mg to 30 mg), the body weight corrected aripiprazole clearance was similar to the adults."	0
It does not contribute to the accumulation of the drug.	0
Leukopenia (white blood count under 4000).	0
"In placebo-controlled trials, the mean increases in heart rate were 7<U+00B1> 1 bpm in postoperative patients and 8<U+00B1> 1 bpm in patients with severe hypertension at the end of the maintenance period."	0
"Anaphylaxis: In rare cases, anaphylaxis has been reported."	0
There have been rare reports of an interaction between quinidine and nifedipine (with a decreased plasma level of quinidine).	1
"Amlodipine inhibits calcium ion influx across cell membranes selectively, with a greater effect on vascular smooth muscle cells than on cardiac muscle cells."	0
Potent inhibitors of CYP1A2 should be avoided (7.1).	0
Monitor liver function more frequently in patients who are receiving mercaptopurine with other hepatotoxic drugs or with known pre-existing liver disease.	0
Bridging anticoagulation during the 24 to 48 hours after stopping ELIQUIS and prior to the intervention is not generally required.	0
The latter decrease may result in a small increase of serum potassium.	0
"The cardiologic consequences of these direct and indirect effects are an increase in the force and velocity of myocardial systolic contraction (positive inotropic action), a slowing of the heart rate (negative chronotropic effect), and decreased conduction velocity through the AV node, and a decrease in the degree of activation of the sympathetic nervous system and renin-angiotensin system (neurohormonal deactivating effect)."	0
Calcium phosphate stones are more stable in alkaline urine.	0
Peripheral edema/fluid retention is more common with Letairis plus tadalafil than with Letairis or tadalafil alone.	0
Failure to adjust the rate of infusion in keeping with this altered ability to eliminate lidocaine may result in toxic accumulation of the drug in the patient<U+2019>s serum.	0
"In a study involving single oral doses of 300 mg of CARDIZEM in six normal volunteers, the average maximum PR prolongation was 14% with no instances of greater than first-degree AV block."	0
"Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium."	0
"Treatment with Lexapro and any concomitant serotonergic agents, should be discontinued immediately if the above events occur and supportive symptomatic treatment should be initiated."	0
Thiazides may add to or potentiate the action of other antihypertensive drugs.	0
"In addition, levomilnacipran is not a substrate of BCRP, OATP1B1, OATP1B3, OAT1, OAT3, or OCT2 and is a weak substrate of P-gp."	0
The effects of nicardipine on blood pressure significantly correlate with plasma concentrations.	0
"Switching from ELIQUIS to warfarin: ELIQUIS affects INR, so that initial INR measurements during the transition to warfarin may not be useful for determining the appropriate dose of warfarin."	0
"In patients receiving SAMSCA who develop medically significant signs or symptoms of hypovolemia , interrupt or discontinue SAMSCA therapy and provide supportive care with careful management of vital signs , fluid balance and electrolytes ."	0
Pindolol and thioridazine should not be coadministered.	0
The 10-mg dose tended to have a greater effect in reducing TSO.	0
These reports should aid the physician in selecting the most effective antimicrobial.	0
Double the dose every two weeks to the highest dosage level tolerated by the patient or up to 200 mg of TOPROL-XL.	0
Patients with two non-functional alleles (homozygous) have low or absent TPMT activity and those with one non-functional allele (heterozygous) have intermediate activity.	0
Adults The recommended dose of Lexapro is 10 mg once daily.	0
"No dose adjustment is recommended for nonvalvular atrial fibrillation patients unless at least 2 of the following patient characteristics are present: age > 79 years, body weight < 61 kg, or serum creatinine > 1.4 mg/dL."	0
"Before prescribing APTIVUS 250 mg capsules, children should be assessed for the ability to swallow capsules."	0
Consider temporary interruption or discontinuation.	0
A report of <U+201C>resistant<U+201D> indicates that usually achievable concentrations of the antimicrobial compound in the blood are unlikely to be inhibitory and that other therapy should be selected.	0
"Because these events have been reported voluntarily during clinical practice, estimates of frequency cannot be made and a causal relationship between protease inhibitor therapy and these events has not been established."	0
Bioequivalence was established between the 20 mg tablet and the 10 mg/mL oral suspension when administered as a 20 mg single oral dose of sildenafil (as citrate).	0
"Warfarin (a CYP2C9 substrate): Risk of decreased INR of prothrombin time; monitor INR in 2-week period, particularly at 7 to 10 days, following initiation of EMEND."	0
Anafranil should not be used with MAO inhibitors.	0
"Clostridium difficile-associated diarrhea (CDAD) has been reported with the use of nearly all systemic antibacterial agents, including PRIFTIN, with severity ranging from mild diarrhea to fatal colitis."	0
"In a clinical study, desvenlafaxine 400 mg daily (8 times the recommended 50 mg dose) was co-administered with a single 4 mg dose of midazolam (a CYP3A4 substrate)."	0
"Mean plasma elimination half-life of LIPITOR in humans is approximately 14 hours, but the half-life of inhibitory activity for HMG-CoA reductase is 20 to 30 hours due to the contribution of active metabolites."	0
The dose may be increased thereafter every other day.	0
Pregnancy Category D Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.	0
Most of the patients described as having been treated with this regimen also underwent exchange transfusion.	0
A similar reaction has been reported for a patient on amitriptyline and selegiline.	0
Edarbi may be administered with other antihypertensive agents .	0
PROSTIN VR PEDIATRIC should not be used in neonates with respiratory distress syndrome.	0
"Study 1 was a 12-week, multicenter, flexible dose study comparing sertraline hydrochloride (50 to 200 mg/day) to placebo, in which sertraline hydrochloride was initiated at 25 mg/day for the first week."	0
Warfarin is a substrate for CYP2C9 and CYP3A4 metabolism pathways.	0
Unchanged ziprasidone represents about 44% of total drug-related material in serum.	0
Renal impairment: Not recommended for patients with severe renal impairment (creatinine clearance <30 mL/min).	0
"In hypertensive patients with moderate hepatic impairment, consideration should be given to initiation of ATACAND at a lower dose."	0
"In actual salt depletion, appropriate replacement is the therapy of choice."	0
"If it is necessary to use amiloride HCl alone, the starting dosage should be one 5 mg tablet daily."	0
"Since beta1-selectivity is not absolute, the lowest possible dose of ZIAC should be used."	0
Smoking Smoking has no effect on the oral clearance of quetiapine.	0
"If used together, the dose of CRESTOR should not exceed 10mg once daily."	0
Data also suggest that amprenavir induces CYP3A4.	0
"Indication Starting Dose Target Dose Maximum Dose MDD (2.1) 40 mg/day to 60 mg/day Acute Treatment: 40 mg/day (20 mg twice daily) to 60 mg/day (once daily or as 30 mg twice daily); Maintenance Treatment: 60 mg/day 120 mg/day GAD (2.2) Adults 60 mg/day 60 mg/day (once daily) 120 mg/day Elderly 30 mg/day 60 mg/day (once daily) 120 mg/day Children and Adolescents (7 to 17 years of age) 30 mg/day 30 to 60 mg/day (once daily) 120 mg/day DPNP (2.3) 60 mg/day 60 mg/day (once daily) 60 mg/day FM (2.4) 30 mg/day 60 mg/day (once daily) 60 mg/day Chronic Musculoskeletal Pain (2.5) 30 mg/day 60 mg/day (once daily) 60 mg/day Some patients may benefit from starting at 30 mg once daily (2) There is no evidence that doses greater than 60 mg/day confers additional benefit, while some adverse reactions were observed to be dose-dependent (2) Discontinuing CYMBALTA: Gradually reduce dosage to avoid discontinuation symptoms (2.7, 5.7) Hepatic Impairment: Avoid use in patients with chronic liver disease or cirrhosis (5.14) Renal Impairment: Avoid use in patients with severe renal impairment, GFR <30 mL/min (5.14) Administer CYMBALTA at a total dose of 40mg/day (given as 20mg twice daily) to 60mg/day (given either once daily or as 30mg twice daily)."	0
"Administration of CMI has been reported to increase the plasma levels of phenobarbital, if given concomitantly."	1
The fifth study started patients on lower doses of SULAR.	0
"During infusions in animals, steady<U+2011>state plasma concentrations of tritium<U+2011>labeled epoprostenol were reached within 15minutes and were proportional to infusion rates."	0
Patients with neutropenia should be carefully monitored for fever or other symptoms or signs of infection and treated promptly if such symptomsoccur.	0
Other Serotonergic Drugs Clinical Impact: The concomitant use of serotonergic drugs with ZOLOFT increases the risk of serotonin syndrome.	0
The antihypertensive action of guanethidine and similar agents may be blocked.	0
Biperiden <U+2014> Multiple doses of olanzapine did not influence the kinetics of biperiden.	0
"LASIX ( furosemide ) produced no impairment of fertility in male or female rats , at 100 mg/kg/day ( the maximum effective diuretic dose in the rat and 8 times the maximal human dose of 600 mg/day ) ."	0
The concomitant use of aliskiren with an ARB or an ACEI in diabetic patients is contraindicated [see Contraindications (4)].	0
Volume and/or salt depletion should be corrected before initiating therapy with ACCURETIC.	0
Six month oral administration studies were conducted in rats and dogs using TENORETIC doses up to 12.5 mg/kg/day (atenolol/chlorthalidone 10/2.5 mg/kg/day -- approximately five times the maximum recommended human antihypertensive dose1).	0
Levodopa and Dopamine Agonists <U+2014> Olanzapine may antagonize the effects of levodopa and dopamine agonists.	0
Longer infusions may exaggerate the discrepancy from onset and offset effects.	0
Activation of mania/hypomania has also been reported in a small proportion of patients with major affective disorders treated with racemic citalopram and other marketed drugs effective in the treatment of major depressive disorder.	0
"Therefore, if a dose is missed, patients should take the next dose at the regularly scheduled time and should not double this dose."	0
Consider dose increase or alternative therapy in patients with total gastrectomy.	0
Rilpivirine The use of rilpivirine co-administered with APTIVUS/ritonavir has not been studied.	0
Quinidine's pharmacokinetics are also unaffected by cigarette smoking.	0
Discontinue treatment if severe reactions develop.	0
"Onset of action occurs within 2 hours of dosing, peak effect is observed at about 4 hours, and activity persists for up to 24 hours."	0
TABLE V: Lipid-lowering Effects of Lovastatin in Adolescent Boys with Heterozygous Familial Hypercholesterolemia (Mean Percent Change from Baseline at Week48 in Intention-to-Treat Population) DOSAGE N TOTAL-C LDL-C HDL-C TG.data presented as median percent changes Apolipoprotein B Placebo 61 <U+2013>1.1 <U+2013>1.4 <U+2013>2.2 <U+2013>1.4 <U+2013>4.4 MEVACOR 64 <U+2013>19.3 <U+2013>24.2 +1.1 <U+2013>1.9 <U+2013>21 The mean achieved LDL<U+2011>C value was 190.9mg/dL (range: 108-336mg/dL) in the MEVACOR group compared to 244.8mg/dL (range: 135-404mg/dL) in the placebo group.	0
The effects of selegiline hydrochloride in children have not been evaluated.	0
Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide.	0
"Although some nonconjugated metabolites have pharmacologic activity, these are not found in plasma at concentrations likely to significantly contribute to the biological activity of ondansetron."	0
"Before using IM, see Important Notes On Injection."	0
"Atorvastatin: Apparent oral clearance of atorvastatin in pediatric subjects appeared similar to that of adults when scaled allometrically by body weight as the body weight was the only significant covariate in atorvastatin population pharmacokinetics model with data including pediatric HeFH patients (ages 10 years to 17 years of age, n=29) in an open-label, 8-week study."	0
"When eszopiclone was coadministered with olanzapine, no pharmacokinetic interaction was detected in levels of eszopiclone or olanzapine, but a pharmacodynamic interaction was seen on a measure of psychomotor function."	0
"Narcotic analgesics/treatment of opioid dependence:buprenorphine, buprenorphine/naloxone <U+2194> buprenorphine, naloxone<U+2191> norbuprenorphine (metabolite) No dose adjustment for buprenorphine or buprenorphine/naloxone is required with concurrent administration of PREZISTA/ritonavir."	0
"Patients with milder ventricular dysfunction should, if possible, be controlled with optimum doses of digitalis and/or diuretics before verapamil treatment."	0
Phenobarbital therapy may increase verapamil clearance.	1
"Plasma concentrations of risperidone, its major metabolite, 9-hydroxyrisperidone, and risperidone plus 9-hydroxyrisperidone are dose proportional over the dosing range of 1 to 16 mg daily (0.5 to 8 mg twice daily)."	0
Do not coadminister aliskiren with Diovan in patients with diabetes see Drug Interactions ( 7 ) .	0
"If serotonin syndrome occurs, discontinue DESOXYN and the concomitant serotonergic drug(s)."	0
"Lidocaine Hydrochloride Injection, USP is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type."	0
Avoid the concurrent use of allopurinol and PURIXAN.	0
Monitor renal laboratory tests prior to therapy and during treatment.	0
The active metabolite has an elimination half-life of about 7hours (range 2-15hours).	0
THIORIDAZINE HAS NOT BEEN SYSTEMATICALLY EVALUATED IN CONTROLLED TRIALS IN THE TREATMENT OF REFRACTORY SCHIZOPHRENIC PATIENTS AND ITS EFFICACY IN SUCH PATIENTS IS UNKNOWN.	0
"Fluvastatin sodium is a competitive inhibitor of HMG-CoA reductase, the rate limiting enzyme that converts 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) to mevalonate, a precursor of sterols, including cholesterol."	0
"Aspirin can increase the anticoagulant activity of heparin, increasing bleeding risk."	0
"In the orthopedic hip surgery patients, limited clinical data with P-gp inhibitors is available."	0
"Chronic antipsychotic treatment should generally be reserved for patients who suffer from a chronic illness that, 1) is known to respond to antipsychotic drugs, and, 2) for whom alternative, equally effective, but potentially less harmful treatments are not available or appropriate."	0
The 10- and 25-mg doses produced some effect at peak (6hours after dosing) but small and inconsistent trough (24hour) responses.	0
<U+2022>Prepare the final volume by adding the remaining vehicle.	0
Serum chromogranin A (CgA) levels increase secondary to drug-induced decreases in gastric acidity.	0
"Dose reduction of NORVIR is necessary when used with other protease inhibitors: atazanavir, darunavir, fosamprenavir, saquinavir, and tipranavir."	1
Zanaflex may cause hepatocellular liver injury.	0
Binding to serum proteins is approximately 30%.	0
The dose of PRADAXA should not be doubled to make up for a missed dose.	0
"See also Contraindications (4.2), Warnings and Precautions (5.3), and Clinical Pharmacology (12.3)."	0
Avoid use of concomitant drugs known to prolong the QT interval and strong CYP3A4 inhibitors (5.8).	0
After three weeks of incubation MIC99 values are calculated by comparing the quantity of organisms growing in the medium containing drug to the control cultures.	0
Nicardipine is not a beta-blocker and therefore gives no protection against the dangers of abrupt beta-blocker withdrawal.	0
"If oliguria occurs, attention should be directed toward support of blood pressure and renal perfusion."	0
"Antihypertensives PDE5inhibitors, including ADCIRCA, are mild systemic vasodilators."	0
"CYP3A inhibitors such as fluconazole, itraconazole, clarithromycin, erythromycin, nefazodone, fluoxetine, saquinavir, indinavir, and nelfinavir may result in increased exposure to nifedipine when co-administered."	1
Dilutions in normal saline are stable at room temperature for up to 6 hours and should be prepared and used within this time.	0
Telmisartan has indications other than hypertension which can be found in the Micardis<U+00AE> (telmisartan) tablets package insert.	0
Sick sinus syndrome (except in patients with a functioning artificial ventricular pacemaker).	0
A minor metabolic pathway is through N-dealkylation.	0
"Further clinical evaluation (e.g., rheumatology referral) may be appropriate for certain patients."	0
Whether any of the symptoms described above represent such a conversion is unknown.	0
"Rarely (probably less often than once in every thousand pregnancies), no alternative to an angiotensinII receptor antagonist will be found."	0
"Total clearance of paliperidone was reduced in subjects with impaired renal function by 32% on average in mild (CrCl = 50 mL/min to < 80 mL/min), 64% in moderate (CrCl = 30 mL/min to < 50 mL/min), and 71% in severe (CrCl = 10 mL/min to < 30 mL/min) renal impairment, corresponding to an average increase in exposure (AUCinf) of 1.5 fold, 2.6 fold, and 4.8 fold, respectively, compared to healthy subjects."	0
"In the study the upper bound of the one-sided 95% confidence interval for the QTc was below 10 ms, the threshold for regulatory concern."	0
"Pharmacokinetics in man are generally similar to rodents including the dose-related increase in half-life, but they are not as well characterized as in the rodent."	0
"Therefore, if concomitant use of these agents is indicated because of demonstrated hypokalemia, they should be used with caution and with frequent monitoring of serum potassium."	0
"Quinidine is not metabolized by cytochrome P450IID6, but therapeutic serum levels of quinidine inhibit the action of cytochrome P450IID6, effectively converting extensive metabolizers into poor metabolizers."	0
Disopyramide is a Type I antiarrhythmic drug with potent negative inotropic and chronotropic effects.	0
Clonidine crosses the placental barrier.	0
Please refer patient to the Medication Guide.	0
Potentially fatal hyperkalemia can develop rapidly and be asymptomatic.	0
This effect may be greater when higher doses of carbamazepine are administered.	0
"At 30, 60, and 90 days, the mean pressor doses (TYR30) of tyramine administered without food were 95mg, 72mg, and 88mg, respectively."	0
Co-administration of triazolam or orally administered midazolam with PREZISTA/ritonavir may cause large increases in the concentrations of these benzodiazepines.	1
"Cardiac effects of dopamine are antagonized by <U+03B2>-adrenergic blocking agents, such as propranolol and metoprolol."	0
Compatibility with other concentrations is unknown.	0
Use caution when administering phendimetrazine tartrate to patients with renal impairment.	0
Anticonvulsants <U+2014> Patients on stable doses of phenytoin and carbamazepine have developed elevated plasma anticonvulsant concentrations and clinical anticonvulsant toxicity following initiation of concomitant fluoxetine treatment.	0
Epidemiological and clinical studies have established that high LDL<U+2011>C and low high-density lipoprotein cholesterol (HDL<U+2011>C) are both associated with coronary heart disease.	0
"After a single 400 mg oral dose of [14C]-sofosbuvir, GS-331007 accounted for approximately greater than 90% of total systemic exposure."	0
Most adverse effects responded well to dose reduction and only rarely did verapamil have to be discontinued.	0
"An AT2 receptor is found also in many tissues, but this receptor is not known to be associated with cardiovascular homeostasis."	0
"The plasma protein binding of nicardipine was not altered when therapeutic concentrations of furosemide, propranolol, dipyridamole, warfarin, quinidine, or naproxen were added to human plasma in vitro."	0
Distribution The volume of distribution of olmesartan is approximately 17 L. Olmesartan is highly bound to plasma proteins (99%) and does not penetrate red blood cells.	0
Serotonin release by platelets plays an important role in hemostasis.	0
"Ergot Derivatives Dihydroergotamine, ergonovine, ergotamine, methylergonovine Potential for serious and life threatening reactions such as ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues."	0
All interactions studies have been conducted with oral ziprasidone.	0
"As with other serotonin reuptake inhibitors, an interaction between paroxetine and tryptophan may occur when they are coadministered."	0
"Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including VASOTEC. mTOR (mammalian target of rapamycin) inhibitors: Patients receiving coadministration of ACE inhibitor and mTOR inhibitor (e.g., temsirolimus, sirolimus, everolimus) therapy may be at increased risk for angioedema (see WARNINGS)."	0
"Such individuals have been referred to as <U+201C>poor metabolizers<U+201D> (PM) of drugs such as debrisoquin, dextromethorphan, and tricyclic antidepressants."	0
"In such cases, consider dose reduction, but such an increase does not imply that chronic treatment is contraindicated."	0
"In subsequent cycles, patients were dosed in the range of 50 to 100 mg/day in the luteal phase of each cycle, on the basis of clinical response and toleration."	0
"It is recommended that the INR (international normalized ratio) be monitored carefully during treatment with VIRACEPT, especially when commencing therapy."	0
STRATTERA (atomoxetine) increased the risk of suicidal ideation in short-term studies in children or adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD).	0
"In the presence of seizure, discontinue treatment."	0
"Two major metabolites have been identified, 1-(4-piperidyl)-2-benzimidazolinone and 4,4-bis(4-fluorophenyl) butyric acid."	0
"Systemic hypersensitivity reactions, including Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) syndrome, may occur in patients receiving RIFADIN."	0
ALERT: Find out about medicines that should not be taken with VIRACEPT.	0
Follow instructions for use of the feeding tube to administer the medicine.	0
"Until further data are obtained, combined therapy of verapamil and quinidine in patients with hypertrophic cardiomyopathy should probably be avoided."	0
"As at a higher dose of mirtazapine, a more pronounced effect can not be excluded, it is advisable to monitor the INR in case of concomitant treatment of warfarin with mirtazapine."	0
"If concomitant use of DESOXYN with other serotonergic drugs or CYP2D6 inhibitors is clinically warranted, initiate DESOXYN with lower doses, monitor patients for the emergence of serotonin syndrome during drug initiation or titration, and inform patients of the increased risk for serotonin syndrome."	0
"In a clinical study, the pharmacokinetics of S-warfarin, a CYP2C9 substrate, were not significantly affected by duloxetine."	0
Both values correspond well with data from the literature at lower doses which state a resultant half-life of approximately 2<U+2013>3 hours.	0
Carvedilol undergoes stereoselective first-pass metabolism with plasma levels of R(+)-carvedilol approximately 2 to 3times higher than S(-)-carvedilol following oral administration in healthy subjects.	0
"Minimize the use of traumatic or potentially traumatic procedures such as arterial and venous punctures, intramuscular injections, nasotracheal intubation, etc."	0
The exact mechanism by which teriflunomide exerts its therapeutic effect in multiple sclerosis is unknown but may involve a reduction in the number of activated lymphocytes in CNS.	0
"Hypersensitivity, including anaphylactic reaction, anaphylactic shock and anaphylactoid reaction, has been reported in association with the use of sildenafil."	0
The mean apparent terminal elimination half<U+2011>life for carvedilol was similar to that observed in healthy subjects.	0
"Diuretics: Excessive drop in blood pressure (7.1) NSAIDs: Increased risk of renal impairment and loss of antihypertensive efficacy (7.3) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, syncope, and hyperkalemia (7.4) Lithium: Symptoms of lithium toxicity (7.5) Gold: Nitritoid reactions (7.6) Initiation of PRINIVIL in patients on diuretics may result in excessive reduction of blood pressure."	0
Metabolism: Pitavastatin is marginally metabolized by CYP2C9 and to a lesser extent by CYP2C8.	0
"The pooled analyses of placebo-controlled trials in children and adolescents with MDD, obsessive compulsive disorder (OCD), or other psychiatric disorders included a total of 24 short-term trials of 9 drugs used to treat depression in over 4400 patients."	0
Adjusting for body weight decreases the magnitude of the differences seen.	0
The absolute bioavailability of telmisartan is dose dependent.	0
"Venlafaxine <U+2193> indinavir concentration In a study of 9 healthy volunteers, venlafaxine administered under steady-state conditions at 150 mg/day resulted in a 28% decrease in the AUC of a single 800 mg oral dose of indinavir and a 36% decrease in indinavir Cmax."	1
Use caution when coadministering CLOZARIL with other drugs that are metabolized by CYP2D6.	0
Absorption is not affected whether ZIAC is taken with or without food.	0
Summary results are presented in TableIII.	0
"In one neonate whose mother had received quinidine throughout her pregnancy, the serum level of quinidine was equal to that of the mother, with no apparent ill effect."	0
"Except for vasoconstrictive effects caused by inadvertent infusion of dopamine into the umbilical artery, adverse effects unique to the pediatric population have not been identified, nor have adverse effects identified in adults been found to be more common in pediatric patients."	0
Patients should be monitored for these symptoms when discontinuing treatment.	0
"The S-enantiomer exhibits 2 to 5 times more anticoagulant activity than the R-enantiomer in humans, but generally has a more rapid clearance."	0
Verapamil does not alter total serum calcium levels.	0
"Prophylaxis of Deep Vein Thrombosis and Pulmonary Embolism Following Hip Replacement Surgery For patients with CrCl >30 mL/min, the recommended dose of PRADAXA is 110 mg taken orally 1-4 hours after surgery and after hemostasis has been achieved, then 220 mg taken once daily for 28-35 days."	0
"CYP1A2 and CYP3A4 Inducers Concomitant treatment with drugs that induce CYP1A2 or CYP3A4 can decrease the plasma concentration of clozapine, resulting in decreased effectiveness of CLOZARIL."	1
"Ambrisentan demonstrated weak dose-dependent inhibition of OATP1B1, OATP1B3, and NTCP (IC50 of 47 <U+00B5>M, 45 <U+00B5>M, and approximately 100 <U+00B5>M, respectively) and no transporter-specific inhibition of BSEP, BRCP, P-gp, or MRP2."	0
"If leaks are found, discard solution as sterility may be impaired."	0
HMG-CoA REDUCTASE INHIBITORS AtorvastatinRosuvastatin <U+2191> atorvastatin<U+2191> rosuvastatin Titrate atorvastatin dose carefully and use the lowest necessary dose; do not exceed atorvastatin 40 mg/day.	1
Peak plasma clonidine levels are attained in approximately 1 to 3 hours.	0
False Positive Urine Tests for THC Clinical Impact: There have been reports of false positive urine screening tests for tetrahydrocannabinol (THC) in patients receiving PPIs.	0
Reduce the dose of these substrates by up to one-half if co-administered with 400 mg of PRISTIQ.	0
"Via this mechanism, it may reduce uric acid excretion although it has no tubular effect on uric acid reabsorption or secretion."	0
"Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with clomipramine hydrochloride and should counsel them in its appropriate use."	0
"All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases."	0
False-positive urine immunoassay screening tests for amphetamines have been reported in patients taking bupropion.	0
The recommended initial IV dose of sotalol is 75 mg (once or twice daily) and is initiated as shown in the dosing algorithm described below.	0
"Panic Disorder<U+2013>The effectiveness of sertraline in the treatment of panic disorder was demonstrated in three double-blind, placebo-controlled studies (Studies 1 to 3) of adult outpatients who had a primary diagnosis of panic disorder (DSM-III-R), with or without agoraphobia."	0
"Following administration of non-liposomal irinotecan (i.e., irinotecan HCl), exposure to irinotecan or its active metabolite, SN-38, is substantially reduced in adult and pediatric patients concomitantly receiving the CYP3A4 enzyme-inducing anticonvulsants phenytoin and strong CYP3A4 inducers."	1
Cimetidine at 400 mg BID (the usual prescription dose) co-administered with TIKOSYN (500 mcg BID) for 7 days has been shown to increase dofetilide plasma levels by 58%.	1
Use of quinapril with a thiazide diuretic gives blood pressure lowering effect greater than that seen with either agent alone.	0
"If liver injury is found, institute appropriate treatment and investigate the probable cause."	0
Coadministration of REYATAZ and drugs primarily metabolized by CYP3A or UGT1A1 may result in increased plasma concentrations of the other drug that could increase or prolong its therapeutic and adverse effects.	1
"Occasional acceleration of ventricular rate may occur when Lidocaine Hydrochloride Injection, USP is administered to patients with atrial fibrillation."	0
"This variant of small pupil syndrome is characterized by the combination of a flaccid iris that billows in response to intraoperative irrigation currents, progressive intraoperative miosis despite preoperative dilation with standard mydriatic drugs, and potential prolapse of the iris toward the phacoemulsification incisions."	0
The active metabolite is metabolized to two inactive compounds by S-methylation or conjugation with cysteine.	0
LEXIVA/ritonavir: Dosage reduction of rifabutin by at least 75% of the usual dose of 300mg/day is recommended (a maximum dose of 150mg every other day or 3times per week).	1
"When fluoxetine is withdrawn from the combination therapy, the iloperidone dose should be returned to the previous level."	0
Increased steady-state levels of phenytoin during concomitant therapy with amiodarone have been reported.	1
The normal adult range of serum potassium is 3.5 to 5.0mEq/L with 4.5mEq often being used for a reference point.	0
"Distribution: Plasma protein binding of ondansetron as measured in vitro was 70% to 76%, over the pharmacologic concentration range of 10 to 500 ng/mL."	0
"About 36% was excreted in the feces (probably via the bile), mostly as metabolites and less than 1% as the parent compound over the 10-day post-dosing period."	0
"Patients treated with TENORETIC plus a catecholamine depletor (eg, reserpine) should be closely observed for evidence of hypotension and/or marked bradycardia which may produce vertigo, syncope or postural hypotension."	0
Patients with renal impairment may benefit from a lower initial dose.	0
"In a study of 19 healthy male subjects, which included 6 slow and 13 rapid hydroxylators of debrisoquin, a single 25 mg oral dose of thioridazine produced a 2.4-fold higher Cmax and a 4.5-fold higher AUC for thioridazine in the slow hydroxylators compared to rapid hydroxylators."	0
"Renal Impairment: In patients with moderate renal impairment (glomerular filtration rate of 30 <U+2013> 59 mL/min/1.73 m2) and end stage renal disease receiving hemodialysis, pitavastatin AUC0-inf is 102 and 86% higher than those of healthy volunteers, respectively, while pitavastatin Cmax is 60 and 40% higher than those of healthy volunteers, respectively."	0
"Dilution VFEND must be infused over 1<U+2013>2 hours, at a concentration of 5 mg/mL or less."	0
Appropriate dose should be based on the severity and nature of the infection.	0
"There are no controlled clinical data on the safety or efficacy of REVATIO in patients with retinitis pigmentosa, a minority whom have genetic disorders of retinal phosphodiesterases."	0
CADUET may be used to initiate treatment in patients with hyperlipidemia and either hypertension or angina.	0
Effects generally persisted for 24 hours at doses of 5 mg or greater.	0
"When half-lives are long, drug (and for some drugs their active metabolites) may accumulate during periods of nightly administration and be associated with impairments of cognitive and/or motor performance during waking hours; the possibility of interaction with other psychoactive drugs or alcohol will be enhanced."	0
A variety of cognitive and behavior changes have been reported to occur in association with the use of hypnotics.	0
"The following preservative-free diluents are recommended for reconstitution: 5% Dextrose Injection (D5W), USP; 0.9% Sodium Chloride Injection, USP; 5% Dextrose and 0.45% Sodium Chloride Injection, USP, or 5% Dextrose and 0.2% Sodium Chloride Injection, USP."	0
"Therefore, consider reducing the dose of CNS depressants if used concomitantly with ADASUVE."	1
Treatment with Anafranil and any concomitant serotonergic agents should be discontinued immediately if the above events occur and supportive symptomatic treatment should be initiated.	0
Acute interstitial nephritis may occur at any point during PPI therapy and is generally attributed to an idiopathic hypersensitivity reaction.	0
Discontinue VYVANSE if binge eating does not improve.	0
"Systemic exposure as measured by mean AUC were equivalent, with values of 156 [95% CI 136, 180] and 161 [95% CI 137, 190] ng<U+2022>h/mL for intravenous and intramuscular groups, respectively."	0
Drug Interaction Studies In vitro studies Sildenafil metabolism is principally mediated by the CYP3A (major route) and CYP2C9 (minor route) cytochrome P450 isoforms.	0
Carbamazepine Carbamazepine is an inducer of CYP3A4; administration of 200 mg twice daily for 21 days resulted in a decrease of approximately 35% in the AUC of ziprasidone.	1
"An overdose of PHOSLYRA may lead to progressive hypercalcemia, which may require emergency measures."	0
"Indinavir 800 mg TID <U+00D7> 10 days 300 mg QD <U+00D7> 10 days Healthy subjects (10) <U+2191> AUC by 173%,<U+2191> Cmax by 134% <U+2193> AUC by 34%,<U+2193> Cmax by 25%,<U+2193> Cmin by 39% Reduce rifabutin dose by 50%, and increase indinavir dose from 800 mg to 1000 mg TID."	1
Dosage adjustment of atomoxetine may be necessary and it is recommended that atomoxetine be initiated at a reduced dose when it is given with paroxetine.	1
Liver enzyme abnormalities: Persistent elevations in hepatic transaminases can occur.	0
"Upon administration of a single oral dose to fasted normal male volunteers, the following mean pharmacokinetic parameters were determined: AUC(0-48) ng*h/mL (<U+00B1> SD) Cmax ng/mL (<U+00B1> SD) Median Tmax h Ae Mg (<U+00B1> SD) Triamterene 148.7 (87.9) 46.4 (29.4) 1.1 2.7 (1.4) hydroxytriamterene sulfate 1,865 (471) 720 (364) 1.3 19.7 (6.1) hydrochlorothiazide 834 (177) 135.1 (35.7) 2.0 14.3 (3.8) where AUC(0-48), Cmax, Tmax, and Ae represent area under the plasma concentration versus time plot, maximum plasma concentration, time to reach Cmax, and amount excreted in urine over 48hours."	0
Use with diuretics in adults The recommended starting dose of Lotensin in a patient on a diuretic is 5 mg once daily.	0
Tolerance to the anorectic effect usually develops within a few weeks.	0
"Therefore, in patients receiving Tasigna, select alternative therapeutic agents with less potential for CYP3A4 induction for concomitant use."	0
"Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), other antiplatelet drugs, warfarin, and other anticoagulants may add to this risk."	0
PRADAXA<U+2019>s anticoagulant activity and half-life are increased in patients with renal impairment.	0
"After completion of quinidine/quinine therapy, adults able to swallow received a single 1500<U+2013>mg/75<U+2013>mg dose of sulfadoxine/pyrimethamine (FANSIDAR<U+00AE>, Roche Laboratories) or a seven<U+2013>day course of tetracycline (250 mg four times daily), while those unable to swallow received seven<U+2013>day courses of intravenous doxycycline hyclate (VIBRAMYCIN<U+00AE>, Roerig), 100 mg twice daily."	0
"All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases."	0
Telmisartan has an accumulation index in plasma of 1.5 to 2.0 upon repeated once daily dosing.	0
"Although a causal link between the emergence of such symptoms and either the worsening of depression and/or the emergence of suicidal impulses has not been established, there is concern that such symptoms may represent precursors to emerging suicidality."	0
"Abnormal Bleeding: SSRIs and SNRIs, including PEXEVA<U+00AE> (paroxetine mesylate), may increase the risk of bleeding events."	0
Careful medical history is necessary because CDAD has been reported to occur over two months after the administration of antibacterial agents.	0
"Therefore, patients should inform the prescriber that they are receiving thioridazine treatment before taking any new medication."	0
Quinidine prolongs the QT interval in a dose<U+2013>related fashion.	0
Whether any of the symptoms described above represent such a conversion is unknown.	0
Dosage should be initiated at a lower level and increased according to tolerance and clinical response.	0
Anaphylactoid Reactions Anaphylactoid Reactions During Desensitization Two patients undergoing desensitizing treatment with hymenoptera venom while receiving ACE inhibitors sustained life-threatening anaphylactoid reactions.	0
Hydrochlorothiazide decreases urinary calcium excretion and may cause elevations of serum calcium.	0
"Metabolism After oral administration, dabigatran etexilate is converted to dabigatran."	0
Not recommended for use in pediatric patients.	0
"Although the efficacy of LUVOX CR Capsules beyond 12 weeks of dosing has not been documented in controlled trials, OCD is a chronic condition, and it is reasonable to consider continuation for a responding patient."	0
"In the CNS, MAO-A and MAO-B play important roles in the catabolism of neurotransmitter amines such as norepinephrine, dopamine, and serotonin, as well as neuromodulators such as phenylethylamine."	0
It is not known what effect chronic or even chronic intermittent use of ROZEREM may have on the reproductive axis in developing humans.	0
"Pediatric use<U+2013> In antimalarial trials, quinidine was as safe and effective in pediatric patients as in adults."	0
"Heart Failure In heart failure patients, candesartan <U+2265> 8 mg resulted in decreases in systemic vascular resistance and pulmonary capillary wedge pressure."	0
"Because nefazodone is highly bound to plasma protein , administration of nefazodone to a patient taking another drug that is highly protein bound may cause increased free concentrations of the other drug, potentially resulting in adverse events."	1
Refer to Tables 1 and 2 of the full prescribing information for specific dosing guidelines based on age and body weight (2.2) The recommended dose is 1250 mg (five 250 mg tablets or two 625 mg tablets) twice daily or 750 mg (three 250 mg tablets) three times daily.	0
The clinician should nevertheless be aware of the possibility of emergent symptoms of serotonin syndrome with such use.	0
"Dosing intervals that have succeeded in avoiding tolerance during trials of moderate doses (e.g., 30 mg) of immediate release ISDN have generally been somewhat longer (at least 14 hours), but this is consistent with the longer half-lives of ISDN and its active metabolites."	0
"The lowest dose of TWYNSTA is 40/5 mg; therefore, initial therapy with TWYNSTA tablets is not recommended in hepatically impaired patients."	0
"Avoid concomitant use of XARELTO with drugs that are combined P-gp and strong CYP3A4 inducers ( e.g. , carbamazepine , phenytoin , rifampin , St.   John 's   wort ) see Warnings and Precautions ( 5.6 ) and Clinical Pharmacology ( 12.3 ) ."	0
Approximate dose-proportional increases in aripiprazole and dehydro-aripiprazole exposure were observed after every four week ABILIFY MAINTENA injections of 300 mg and 400 mg.	0
"Absorption Amlodipine: After oral administration of therapeutic doses of amlodipine alone, absorption produces peak plasma concentrations between 6 and 12 hours."	0
The safety and efficacy of taking ADCIRCA together with CIALIS or other PDE5 inhibitors have not been studied .	0
"If symptoms so warrant, titration may proceed more rapidly provided that the patient is assessed frequently."	0
Do not coadminister aliskiren with Diovan in patients with diabetes .	0
Blood pressure response is dose-related over the range of 20 to 80 mg.	0
"At steady state, when the CYP2D6 pathway is essentially saturated, paroxetine clearance is governed by alternative P450 isozymes, which, unlike CYP2D6, show no evidence of saturation."	0
PRISTIQ is not approved for use in pediatric patients.	0
CALAN is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) that exerts its pharmacologic effects by modulating the influx of ionic calcium across the cell membrane of the arterial smooth muscle as well as in conductile and contractile myocardial cells.	0
The relative beta1-selectivity of metoprolol diminishes and blockade of beta2-adrenoceptors increases at plasma concentration above 300 nmol/L.	0
This product is for DIRECT INJECTION ONLY.	0
NORVIR oral solution is the preferred formulation for patients requiring doses less than 100 mg or incremental doses between 100 mg intervals. norvir equation For details on the preparation and administration of NORVIR oral powder.	0
Switching from warfarin to ELIQUIS: Warfarin should be discontinued and ELIQUIS started when the international normalized ratio (INR) is below 2.0.	0
"CYP1A2 and CYP3A4 mediated N-dealkylation, a major pathway of biotransformation, yields the metabolites monoethyl glycine xylidide (MEGX) and glycine xylidide (GX)."	0
"In a long<U+2011>term, placebo<U+2011>controlled trial in severe heart failure (COPERNICUS), hypotension and postural hypotension occurred in 15.1% and syncope in 2.9% of heart failure subjects receiving COREG compared with 8.7% and 2.3% of placebo subjects, respectively."	0
The electrophysiological effects of quinidine and verapamil on AV conduction were studied in 8 patients.	0
"Geriatric Patients: Population pharmacokinetic analysis in HCV-infected subjects showed that within the age range (18 to 80 years) analyzed, age did not have a clinically relevant effect on the exposure to ledipasvir, sofosbuvir, and GS-331007."	0
"Fluoxetine: Co-administration of fluoxetine (20 mg twice daily for 21 days), a potent inhibitor of CYP2D6, with a single 3 mg dose of iloperidone to 23 healthy volunteers, ages 29 to 44 years, who were classified as CYP2D6 extensive metabolizers, increased the AUC of iloperidone and its metabolite P88, by about 2- to 3-fold, and decreased the AUC of its metabolite P95 by one-half."	1
"Hydrochlorothiazide had no adverse effects on the fertility of mice and rats of either sex in studies wherein these species were exposed, via their diet, to doses of up to 100 and 4mg/kg/day, respectively, prior to mating and throughout gestation."	0
Dose reduction to maintenance levels of 1 to 3mg/kg daily is usually possible.	0
Less than 1% of the dose is excreted in the urine as unchanged drug.	0
Plasma levels of EXTRANEAL (icodextrin) and its metabolites return to baseline within approximately 14 days following cessation of EXTRANEAL (icodextrin) administration.	0
"Patients over age 65, or patients with impaired liver function are expected to develop higher plasma concentrations of nisoldipine."	0
It competitively inhibits the action of androgens by binding to cytosol androgen receptors in the target tissue.	0
Discontinuation of PEXEVA<U+00AE> (paroxetine mesylate) should be considered in patients with symptomatic hyponatremia and appropriate medical intervention should be instituted.	0
"Bosentan had no relevant inhibitory effect on any CYP isozyme in vitro (CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A)."	0
Atorvastatin: Table 4 shows effects of other drugs on the pharmacokinetics of atorvastatin.	0
"If acceptable alternatives to linezolid or intravenous methylene blue treatment are not available and the potential benefits of linezolid or intravenous methylene blue treatment are judged to outweigh the risks of serotonin syndrome in a particular patient, CYMBALTA should be stopped promptly, and linezolid or intravenous methylene blue can be administered."	0
In vitro studies did not reveal an inhibitory effect of escitalopram on CYP2D6.	0
Lithium toxicity was usually reversible upon discontinuation of lithium or Lotensin.	1
The peripheral vasoconstriction caused by high doses of dopamine HCl is antagonized by <U+03B1>-adrenergic blocking agents.	0
"In addition, other known inhibitors of the renal cation transport system such as prochlorperazine, dolutegravir and megestrol should not be used in patients on TIKOSYN."	0
"In the CHARM program (heart failure patients), the incidence of abnormal renal function (e.g., creatinine increase) was 12.5% in patients treated with ATACAND versus 6.3% in patients treated with placebo."	0
"The safety of treating, on average, more than four headaches in a 30-day period has not been established."	0
Flexible Containers Dilution is not required for Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection.	0
"The majority of patients presented with rash; however, arthralgia and cytopenia were also reported."	0
"If an optimal response is not achieved, the dosage should be increased to one TENORETIC 100 tablet given once a day."	0
"No initial dosage adjustment is recommended for elderly patients, for patients with moderate to marked renal impairment (creatinine clearance <40mL/min) or with moderate to marked hepatic dysfunction."	0
Ziprasidone dosed adjunctively to lithium in a maintenance trial of bipolar patients did not affect mean therapeutic lithium levels.	0
"Salicylic acid is widely distributed to all tissues and fluids in the body, including the central nervous system, breast milk, and fetal tissues."	0
CNS Depressants and Sedating Antihistamines: Sedative effects may be increased with doxepin.	0
"These elevations were often asymptomatic and transient, usually not associated with elevated bilirubin levels and usually did not require discontinuation of therapy."	0
"Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients whose depression is persistently worse, or who are experiencing emergent suicidality or symptoms that might be precursors to worsening depression or suicidality, especially if these symptoms are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
"Increased sensitivity to the effects of lithium (neurotoxicity) has been reported during concomitant verapamil-lithium therapy; lithium levels have been observed sometimes to increase, sometimes to decrease, and sometimes to be unchanged."	0
"Bradycardia itself increases the risk of Torsade de Pointes, so carefully monitor patients receiving concomitant digoxin."	0
"If sotalol is to be administered, use the smallest effective dose, to minimize inhibition of bronchodilation produced by endogenous or exogenous catecholamine stimulation of beta2 receptors."	0
Use a lower starting dose for patients with mild to severe hepatic impairment (at baseline) and monitor the QT interval frequently [see Dosage and Administration (2.	0
"When this occurs, the recommended dose should not be exceeded in an attempt to increase the effect; rather, the drug should be discontinued."	0
Patients are likely to have a nonreactive purified protein derivative (PPD) despite active disease.	0
"At therapeutic concentrations, the protein binding of fluvastatin is not affected by warfarin, salicylic acid and glyburide."	0
"The no effect doses for these findings in chronic administration studies in these 3 species (3, 0.1, and 6 mg/kg/day) were associated with mean dofetilide AUCs that were about 4, 1.3, and 3 times the maximum likely human AUC, respectively."	0
"Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan."	1
"Angioedema, increased risk in patients with a prior history (5.1) Hypotension and hyperkalemia (5.5, 5.8) Renal impairment: monitor renal function during therapy (5.3) Avoid concomitant use of an ACE inhibitor and angiotensin blocker (5.7) Rare cholestatic jaundice and hepatic failure (5.2) Rare neutropenia and agranulocytosis (5.4) Presumably because drugs that act directly on the renin-angiotensin-aldosterone system (e.g., ACE inhibitors) affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving these drugs (including ALTACE) may be subject to a variety of adverse reactions, some of them serious."	0
"Coadministration of VFEND with rifampin, carbamazepine and long-acting barbiturates is contraindicated because these drugs are likely to decrease plasma voriconazole concentrations significantly."	1
See Full Prescribing Information for a list of clinically significant drug interactions.	0
"Tissue culture experiments indicate that approximately one-third of human breast cancers are prolactin-dependent in vitro, a factor of potential importance if the prescription of these drugs is contemplated in a patient with a previously detected breast cancer."	0
The dosage should subsequently be titrated (as described above) to the optimal response.	0
"Because many drugs are excreted in human milk, caution should be exercised when isosorbide dinitrate is administered to a nursing woman."	0
Fluoxetine: A single 3 mg dose of iloperidone had no effect on the pharmacokinetics of fluoxetine (20 mg twice daily).	0
"If heart rate is less than 60 beats per minute, QT interval should be used."	0
"In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or BUN have been reported."	0
Elevated carbamazepine levels and symptoms of toxicity have been reported with the coadministration of fluvoxamine maleate and carbamazepine.	0
"Either correct this condition prior to administration of MICARDIS, or start treatment under close medical supervision with a reduced dose."	0
"Paroxetine metabolism is mediated in part by CYP2D6, and the metabolites are primarily excreted in the urine and to some extent in the feces."	0
"In other studies, treatment with TOPROL-XL produced an improvement in left ventricular ejection fraction."	0
"Pharmacological testing has shown the desmethyl metabolite (norclozapine) to have only limited activity, while the hydroxylated and N-oxide derivatives were inactive."	0
Both lovastatin and its <U+03B2><U+2011>hydroxyacid metabolite are highly bound (>95%) to human plasma proteins.	0
The dose of digoxin must be reduced in patients whose lean weight is an abnormally small fraction of their total body mass because of obesity or edema.	0
"Closely monitor blood pressure, renal function and electrolytes in patients on TARKA and other agents that affect the RAS."	0
Consider reducing the CLOZARIL dosage when discontinuing coadministered enzyme inducers; because discontinuation of inducers can result in increased clozapine plasma levels and an increased risk of adverse reactions.	0
Amiloride HCl has little effect on glomerular filtration rate or renal blood flow.	0
"If the patient develops pulmonary edema during initiation with FLOLAN, discontinue therapy and do not readminister."	0
"However, analyses of stored plasma from adult patients treated with APTIVUS capsules and pediatric patients treated with APTIVUS oral solution (which contains a vitamin E derivative) showed no effect of APTIVUS/ritonavir on vitamin K-dependent coagulation factors (Factor II and Factor VII), Factor V, or on prothrombin or activated partial thromboplastin times."	0
Phenothiazines are reported in the literature to antagonize the CNS stimulant action of the amphetamines.	0
Mix any remaining residue with 4 additional ounces of water and swallow.	0
Drug Interaction Studies Teriflunomide is not metabolized by Cytochrome P450 or flavin monoamine oxidase enzymes.	0
"Patients receiving a phosphodiesterase type 5 (PDE5) inhibitor (sildenafil, tadalafil, or vardenafil) should be advised that they may be at an increased risk of PDE5 inhibitor-associated adverse events including hypotension, visual changes, and priapism, and should promptly report any symptoms to their doctors."	0
Hepatic Impairment Amlodipine: Elderly patients and patients with hepatic insufficiency have decreased clearance of amlodipine with a resulting increase in AUC of approximately 40<U+2013>60%.	0
Antagonism at receptors other than dopamine and 5HT 2 with similar receptor affinities may explain some of the other therapeutic and side effects of ziprasidone.	0
"CYP1A2 Substrates Repeated doses of teriflunomide decreased mean Cmax and AUC of caffeine by 18% and 55%, respectively, suggesting that teriflunomide may be a weak inducer of CYP1A2 in vivo."	1
The use of MAOIs intended to treat psychiatric disorders with PEXEVA<U+00AE> or within 14 days of stopping treatment with PEXEVA<U+00AE> is contraindicated because of an increased risk of serotonin syndrome.	0
"If concomitant use of Lexapro with other serotonergic drugs including, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, tryptophan, amphetamine and St. John's Wort is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome, particularly during treatment initiation and dose increases."	0
"Hyponatremia may occur as a result of treatment with SSRIs and SNRIs, including PRISTIQ."	0
Dosage adjustments of triazolam may be necessary.	0
"Withdrawal Symptoms <U+2013> A variety of withdrawal symptoms have been reported in association with abrupt discontinuation of Anafranil, including dizziness, nausea, vomiting, headache, malaise, sleep disturbance, hyperthermia, and irritability."	0
"When pregnancy is detected, discontinue ALTACE as soon as possible (5.6)."	0
Dosage may be adjusted in 5 mg increments for pediatric patients and in 10 mg increments for adult patients.	0
Concomitant use of agents in tricyclic antidepressant class (which includes clomipramine) with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant agent or the other drug.	1
Initial Treatment Adolescents The recommended dose of Lexapro is 10 mg once daily.	0
"ACE is identical to kininase II, an enzyme that degrades bradykinin, a potent peptide vasodilator; whether increased levels of bradykinin play a role in the therapeutic effect of quinapril remains to be elucidated."	0
The possibility of permanent neurological damage cannot be excluded.	0
"Coadministration of IV cardiodepressant calcium-channel antagonists ( e.g. verapamil ) in close proximity to BREVIBLOC injection ( 4 , 7 ) ."	0
"In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including quinapril, may result in deterioration of renal function, including possible acute renal failure."	0
Carbon dioxide (CO2) retention from opioid-induced respiratory depression can exacerbate the sedating effects of opioids.	0
<U+2022>Coadministration with drugs that inhibit CYP3A4 may increase amprenavir concentrations.	1
"While ondansetron's mechanism of action has not been fully characterized, it is not a dopamine-receptor antagonist."	0
TENORMIN is a beta1-selective (cardioselective) beta-adrenergic receptor blocking agent without membrane stabilizing or intrinsic sympathomimetic (partial agonist) activities.	0
"On a mg/kg basis, the doses used were up to 180 times (in rats) and one time (in rabbits) the maximum recommended human dose."	0
"No clinically significant pharmacokinetic interactions were observed when Diovan ( valsartan ) was coadministered with amlodipine , atenolol , cimetidine , digoxin , furosemide , glyburide , hydrochlorothiazide , or indomethacin ."	0
"Meperidine <U+2193> Meperidine, <U+2191> Normeperidine Methadone <U+2193> Methadone <U+2193> S-Methadone, <U+2193> R-Methadone Dosage of methadone may need to be increased when co-administered with APTIVUS and 200 mg of ritonavir."	1
The selectivity is further diminished with increasing daily doses.	0
"Angiotensin II also stimulates the secretion of aldosterone from the adrenal cortex, thereby facilitating renal sodium and fluid reabsorption."	0
"If intolerable symptoms occur following a decrease in the dose or upon discontinuation of treatment, then resuming the previously prescribed dose may be considered."	0
"In a case-control epidemiological study, the use of anorectic agents, including diethylpropion, was associated with an increased risk of developing pulmonary hypertension, a rare, but often fatal disorder."	0
The monitoring described in Section 2.2 may suggest increases or decreases in digoxin doses.	0
"These interactions may lead to: Clinically significant adverse reactions potentially leading to severe, life threatening, or fatal events from greater exposures of concomitant medications."	0
"Venlafaxine is not highly bound to plasma proteins; therefore, administration of venlafaxine hydrochloride extended-release to a patient taking another drug that is highly protein-bound should not cause increased free concentrations of the other drug."	0
"Electrophysiology: Sotalol prolongs the plateau phase of the cardiac action potential in the isolated myocyte, as well as in isolated tissue preparations of ventricular or atrial muscle (Class III activity)."	0
"Pretreatment with propranolol, metoprolol and nadolol increased the serum concentration of lidocaine."	1
Angle-Closure Glaucoma: The pupillary dilation that occurs following use of many antidepressant drugs including Pristiq may trigger an angle closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy.	0
Paroxetine is extensively metabolized and the metabolites are considered to be inactive.	0
Coadministration of fluticasone and LEXIVA/ritonavir is not recommended unless the potential benefit to the patient outweighs the risk of systemic corticosteroid side effects.	0
The mechanism of this syndrome is not understood.	0
"Combination Therapy with Clarithromycin and Amoxicillin Clinical Impact: Concomitant administration of clarithromycin with other drugs can lead to serious adverse reactions, including potentially fatal arrhythmias, and arecontraindicated.Amoxicillin also has drug interactions."	0
The antihypertensive effects of CALAN are evident within the first week of therapy.	0
Treatment with ORAP exposes the patient to serious risks.	0
<U+2022>LEXIVA suspension: Adults should take without food; pediatric patients should take with food.	0
These studies have also shown that concurrent use of an NSAID or aspirin may potentiate this risk of bleeding.	0
"Conversely, at least 14 days should be allowed after stopping Anafranil before starting an MAOIintended to treat psychiatric disorders."	0
"It is known that ergotamine is excreted in breast milk and may cause vomiting, diarrhea, weak pulse, and unstable blood pressure in nursing infants."	0
Co-administration of bicalutamide with food has no clinically significant effect on rate or extent of absorption.	0
Symptomatic postural hypotension is infrequent although it can occur in patients who are salt-and/or volume-depleted.	0
Trough plasma concentrations of telmisartan with once daily dosing are about 10% to 25% of peak plasma concentrations.	0
The dose of TIKOSYN must be adjusted based on creatinine clearance.	0
Anyone considering the use of nortriptyline hydrochloride in a child or adolescent must balance the potential risks with the clinical need.	0
Testing with debrisoquine is sometimes used to distinguish the P450IID6<U+2013>deficient poor metabolizers from the majority<U+2013>phenotype extensive metabolizers.	0
"Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (2.6, 5.1, 7, 12.3) Interacting Agents Prescribing Recommendations Cyclosporine, HIV protease inhibitors (tipranavir plus ritonavir), hepatitis C protease inhibitor (telaprevir) Avoid atorvastatin HIV protease inhibitor (lopinavir plus ritonavir) Use with caution and lowest dose necessary Clarithromycin, itraconazole, HIV protease inhibitors (saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir) Do not exceed 20 mg atorvastatin daily HIV protease inhibitor (nelfinavir)Hepatitis C protease inhibitor (boceprevir) Do not exceed 40 mg atorvastatin daily Other Lipid-Lowering Medications: Use with fibrate products or lipid-modifying doses (<U+2265>1 g/day) of niacin increases the risk of adverse skeletal muscle effects."	0
Only use glucose-specific monitoring systems in patients using EXTRANEAL.	0
Laboratory tests are available to identify CYP2D6PMs.	0
Indinavir did not affect the pharmacokinetics of venlafaxine and ODV.	0
"In these patients, consideration should be given to using a different type of dialysis membrane or a different class of antihypertensive agent."	0
Olmesartan appears to be eliminated in a biphasic manner with a terminal elimination half-life of approximately 13 hours.	0
No pharmacokinetic interaction is anticipated in patients receiving selective MAO-B inhibitors.	0
These studies did not show a clinically significant effect on the pharmacokinetics of treprostinil.	0
"Obtain CBC every 2 weeks for the first 2 months, then monthly."	0
Such monitoring should include daily observation by families and caregivers.	0
Avoid use of aliskiren with Edarbi in patients with renal impairment ( GFR 60 mL/min ) .	0
"In healthy, CYP2D6 extensive metabolizer patients (n=32), amitriptyline (75 mg daily), at steady state, did not cause relevant changes in the pharmacokinetics of steady state mirtazapine (30 mg daily); mirtazapine also did not cause relevant changes to the pharmacokinetics of amitriptyline."	0
The smallest children (BSA <0.33 m2) exhibited a greater drug exposure (+59%) than the larger children who showed a uniform drug concentration profile.	0
"There is no experience with systemic hemostatics (desmopressin and aprotinin) in individuals receiving apixaban, and they are not expected to be effective as a reversal agent."	0
These patients (N = 295) were randomized to continuation for 44 weeks on double-blind sertraline hydrochloride 50 to 200 mg/day or placebo.	0
Plasma concentrations correlate with effect in both young and elderly patients.	0
Dosage increases should be made more gradually in patients showing a tendency toward hypotension at the beginning of therapy.	0
"Beta blockers , including BREVIBLOC , have been associated with increases in serum potassium levels and hyperkalemia ."	0
"The effects of coadministered drugs on the exposure of ledipasvir, sofosbuvir, and GS-331007 are shown in Table 7."	0
"The risks, if any, that may be associated with Anafranil's extended use in children and adolescents with OCD have not been systematically assessed."	0
"Of the 437patients who underwent CABG during TRITON-TIMI 38, the rates of CABG-related TIMI Major or Minor bleeding were 14.1% in the Effient group and 4.5% in the clopidogrel group."	0
The usual maintenance dose following titration is 2.5 mg to 20 mg daily as a single dose or equally divided doses (2.1).	0
"When used as monotherapy, reasonable starting doses are 180 to 240 mg once daily, although some patients may respond to lower doses."	0
"There was no evidence of teratogenicity at those doses that were, on a body-weight basis, 15 and 30 times, respectively, the MRHD, and, on the basis of body-surface area, 3.1 and 6.2 times, respectively, the MRHD."	0
"The reduction in peripheral blood white count to less than 3500/cubic mm or in platelet count to below 100,000 cubic mm mandates cessation of therapy."	0
"Changes in blood pressure must be carefully monitored when LASIX is used with other antihypertensive drugs , especially during initial therapy ."	0
The S-fluoxetine enantiomer is eliminated more slowly and is the predominant enantiomer present in plasma at steady state.	0
"While the mechanism of this interaction is unknown, due to the narrow therapeutic index of pimozide and due to the interaction noted at a low dose of pimozide, concomitant administration of sertraline hydrochloride and pimozide should be contraindicated."	0
"If clinically appropriate, escalation of the dose back to 300 mg (newly diagnosed Ph+ CML-CP) or 400 mg (resistant or intolerant Ph+ CML-CP and CML-AP) twicedaily should be considered."	0
Laboratory parameters of renal and hepatic function should be monitored at regular intervals.	0
"In a large compassionate use program mexiletine has been used concurrently with commonly employed antianginal, antihypertensive, and anticoagulant drugs without observed interactions."	0
Antipsychotics:Quetiapine <U+2191> quetiapine Initiation of CRIXIVAN in patients taking quetiapine: Consider alternative antiretroviral therapy to avoid increases in quetiapine drug exposures.	1
There are no clinical studies of the combined use of ECT and paroxetine.	0
Monitor patients for the development of second primary malignancies.	0
The liver is the primary site of action and the principal site of cholesterol synthesis and LDL clearance.	0
"Ritonavir Ritonavir initially inhibits and later induces CYP3A, the enzyme involved in the metabolism of tadalafil."	0
Renal Dysfunction : Avoid aspirin in patients with severe renal failure (glomerular filtration rate less than 10 mL/min).	0
Metabolites are excreted in the urine in conjugated form as glucuronides.	0
"Consider alternatives to fluticasone, particularly for long-term use."	0
"Changes in standing blood pressure were similar: MEAN SUPINE TROUGH SYSTOLIC AND DIASTOLIC BLOOD PRESSURE CHANGES (mm Hg) SULAR Doses bioequivalent to: (mg/day) 8.5 mg 17 mg 25.5 mg 34 mg 8.5-34 mg titrated Systolic 8 11 11 14 15 Diastolic 3 5 7 7 8 In patients receiving atenolol, supine blood pressure reductions with SULAR doses bioequivalent to 17 and 34 mg once daily were 12/6 and 19/8 mm Hg, respectively."	0
Gradually increase the dosage at weekly intervals until optimum clinical response has been obtained or there is a pronounced slowing of the heart rate.	0
"NEXTERONE Premixed Injection is available in GALAXY containers as a single-use , ready-to-use , iso-osmotic solution in dextrose for intravenous administration ."	0
CYP3A4 is the cytochrome P450 isozyme mediating the oxidative metabolism (N-demethylation) of desvenlafaxine.	0
Monitor heart failure patients carefully.	0
Administer lidocaine at lower maintenance infusion rate with close monitoring of toxicity in patients with hepatic impairment.	0
About 40 to 45% of the administered radioactivity was recovered in urine in 9 days.	0
Dose reduction is recommended for patients with severe hepatic impairment.	0
"All pediatric patients being treated with STRATTERA should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases."	0
"Intracranial Hemorrhage/Platelet Aggregation and Coagulation: Use with caution in patients at risk for increased bleeding or who are receiving medications that increase the risk of bleeding (5.2, 5.4) The concomitant use of APTIVUS/ritonavir and certain other drugs may result in known or potentially significant drug interactions."	0
Slight nonspecific embryo/fetotoxic effects were seen in the offspring of treated rats given 50 and 100 mg/kg and of treated mice given 100 mg/kg.	0
"After administration of perindopril, ACE is inhibited in a dose and blood concentration-related fashion, with the maximal inhibition of 80 to 90% attained by 8 mg persisting for 10 to 12 hours."	0
Concomitant use can increase the risk of bradycardia.	0
The drug should be discontinued promptly if adverse effects of a serious nature or allergic manifestations occur.	0
These interactions should be considered in patients taking NSAIDs including selective COX-2 inhibitors concomitantly with diuretics and angiotensin II antagonists or ACE inhibitors.	0
Lopinavir/ ritonavir 400/100 mg BID <U+00D7> 20 days 150 mg QD <U+00D7> 10 days Healthy subjects (14) <U+2191> AUC by 203% also taking zidovudine 500 mg QD <U+2193> Cmax by 112% <U+2194> Reduce rifabutin dose by at least 75% (to a maximum 150 mg every other day or three times per week) when given with lopinavir/ritonavir combination.	1
Do not use aliskiren with ARBs or ACEIs in patients with diabetes see Warnings and Precautions ( 5.2 ) and Clinical Studies ( 14.3 ) .	0
"Oral Hypoglycemics Moderate doses of aspirin may increase the effectiveness of oral hypoglycemic drugs, leading to hypoglycemia."	0
"Approximately 7% to 10% of Caucasians and 3% to 8% of black/African Americans lack the capacity to metabolize CYP2D6 substrates and are classified as poor metabolizers (PM), whereas the rest are intermediate, extensive or ultrarapid metabolizers."	0
"Cases of myopathy, including rhabdomyolysis, have been reported with atorvastatin co-administered with colchicine, and caution should be exercised when prescribing atorvastatin with colchicine."	0
"In some individuals, however, it may induce hyperkalemia."	0
Concentration monitoring of these drugs is recommended if they are used concomitantly with REYATAZ.	0
"Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"There were no functional or morphological abnormalities resulting from dosing either compound alone or together other than minor changes in heart rate, blood pressure and urine chemistry which were attributed to the known pharmacologic properties of atenolol and/or chlorthalidone."	0
"An inter-trial comparison between normal subjects and patients with end-stage renal failure demonstrated that the parent drug Cmax and AUC values were comparable in the 2 groups, whereas the hydroxybupropion and threohydrobupropion metabolites had a 2.3- and 2.8-fold increase, respectively, in AUC for subjects with end-stage renal failure."	0
"Overall, most of the pediatric patients had mild rash and 5 (5%) had moderate rash."	0
Concomitant use of ketoconazole is contraindicated.	0
"However, other studies have failed to demonstrate such a risk."	0
"In a clinical trial of LEXIVA used as the sole protease inhibitor, rash occurred in 2 of 10subjects (20%) with a history of sulfonamide allergy compared with 42 of 126 subjects (33%) with no history of sulfonamide allergy."	0
The patient canthen proceed to the original monitoring schedule.	0
Children <1 year of age must not receive Benicar for hypertension.	0
"In general, avoid combined use of RAS inhibitors."	0
"In general, avoid combined use of RAS inhibitors."	0
"The onset or aggravation of exertional dyspnea, or unexplained symptoms of angina pectoris, syncope, or lower extremity edema suggest the possibility of occurrence of pulmonary hypertension."	0
Effects on Blood Pressure and Heart Rate <U+2013> Increase in blood pressure and heart rate; orthostasis and syncope may occur.	0
The exact mechanism of the hypotensive action of prazosin is unknown.	0
<U+2022>Acute hemolytic anemia has been reported with amprenavir.	0
Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.	0
An in vitro induction study in human hepatocytes showed an increase in UGT1A1 by tipranavir similar to that evoked by rifampin.	0
Gout flares may occur after initiation of ULORIC due to changing serum uric acid levels resulting in mobilization of urate from tissue deposits.	0
Studies at clinically relevant doses in man have demonstrated that fluoxetine blocks the uptake of serotonin into human platelets.	0
"In treatment-naive adult patients: REYATAZ 300 mg with ritonavir 100 mg once daily with food should be administered simultaneously with, and/or at least 10 hours after, a dose of the H2-receptor antagonist (H2RA)."	0
"Atorvastatin should be used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) in these patients or if such treatments are unavailable."	0
Dizziness or drowsiness may occur after the first dose of this medicine.	0
Severe exacerbation of angina and the occurrence of myocardial infarction and ventricular arrhythmias have been reported in angina patients following the abrupt discontinuation of therapy with beta blockers.	0
"Indinavir had no effect on delavirdine pharmacokinetics , based on a comparison to historical delavirdine pharmacokinetic data."	0
"The following maximum oral dosages are recommended for elderly, renally-impaired patients and for patients with renal impairment due to other causes: Creatinine Clearance (mL/min/1.73m2) Atenolol Elimination Half-Life (h) Maximum Dosage 15-35 16-27 50 mg daily <15 >27 25 mg daily Some renally-impaired or elderly patients being treated for hypertension may require a lower starting dose of TENORMIN: 25 mg given as one tablet a day."	0
"Animal studies indicate that prazosin hydrochloride is extensively metabolized, primarily by demethylation and conjugation, and excreted mainly via bile and feces."	0
The median terminal half-life of ledipasvir following administration of HARVONI was 47 hours.	0
"Concomitant administration of both a CYP2C9 inhibitor ( such as fluconazole or amiodarone ) and a strong CYP3A inhibitor ( e.g. , ketoconazole , itraconazole ) or a moderate CYP3A inhibitor ( e.g. , amprenavir , erythromycin , fluconazole , diltiazem ) with Tracleer will likely lead to large increases in plasma concentrations of bosentan ."	1
This finding was not observed in CYP3A5 non-expressers (N= 6).	0
Coadministered single dose of 2.8 grams of sevelamer hydrochloride in fasted state decreased the bioavailability of ciprofloxacin by approximately 50% in healthy subjects.	1
"In a small study (n=25) of patients with implanted defibrillators treated concurrently with sotalol, the average defibrillatory threshold was 6 joules (range 2-15 joules) compared to a mean of 16 joules for a non-randomized comparative group primarily receiving amiodarone."	0
"The pharmacokinetics of desvenlafaxine are unlikely to be affected by drugs that inhibit the P-glycoprotein transporter, and desvenlafaxine is not likely to affect the pharmacokinetics of drugs that are substrates of the P-glycoprotein transporter."	0
"Sevelamer has demonstrated interaction with ciprofloxacin, mycophenolate mofetil, and therefore, these drugs should be dosed separately from Renvela."	0
The most common form of CLE reported in patients treated with PPIs was subacute CLE (SCLE) and occurred within weeks to years after continuous drug therapy in patients ranging from infants to the elderly.	0
Add 50 mL of Bicitra Registered trademark of Alza Corporation to a polyethylene terephthalate ( PET ) bottle containing ten 20 mg tablets of VASOTEC and shake for at least 2 minutes .	0
Lower doses of olanzapine should be considered in patients receiving concomitant treatment with fluvoxamine.	1
"An interruption or reduction in the dosage of LASIX , angiotensin converting enzyme inhibitors , or angiotensin receptor blockers may be necessary ."	0
Dosage adjustments may be necessary if given concomitantly.	0
Female patients appear to have a greater tendency to orthostatic hypotension than male patients.	0
"With multiple doses the rise in citrate excretion reaches its peak by the third day and averts the normally wide circadian fluctuation in urinary citrate, thus maintaining urinary citrate at a higher, more constant level throughout the day."	0
Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.	1
"St. John<U+2019>s wort Use of St. John<U+2019>s wort, a CYP3A4 inducer, in combination with zolpidem may decrease blood levels of zolpidem and is not recommended."	1
Avoid use of aliskiren with ATACAND in patients with renal impairment (GFR <60 ml/min).	0
General Considerations Maximum effects within 2 to 4 weeks after dose change.	0
"For children who cannot swallow tablets, the same dose can be given using an extemporaneous suspension as described below."	0
"Redistribution/accumulation of body fat including central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, and ""cushingoid appearance"" have been observed in patients receiving antiretroviral therapy."	0
No initial paroxetine dosage adjustment is considered necessary when coadministered with phenobarbital; any subsequent adjustment should be guided by clinical effect.	0
Severe Cardiovascular Disorders that might deteriorate with clinically important increases in HR and BP.	0
Amiloride HCl has potassium-conserving activity in patients receiving kaliuretic-diuretic agents.	0
"In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including candesartan, may result in deterioration of renal function, including possible acute renal failure."	0
"In comparison to Cmin values after 20 mg daily, values after 40 mg daily were only about 2 to 3 times greater than doubled."	0
The absolute bioavailability of venlafaxine is approximately 45%.	0
"However, in patients with worse impairment, 25% of the usual dose of ramipril is expected to produce full therapeutic levels of ramiprilat."	0
"With chronic dosing, however, there is substantial inhibition of angiotensin II levels at 24 hours by doses of 20<U+2013>80 mg. Administration of 10 to 80 mg of ACCUPRIL to patients with mild to severe hypertension results in a reduction of sitting and standing blood pressure to about the same extent with minimal effect on heart rate."	0
Intervention: Rilpivirine -containing products: Concomitant use with ACIPHEX delayed-release tablets is contraindicated.	0
"Reduced cytochrome P450 2D6 isozyme activity, drugs which inhibit this isozyme (e.g., fluoxetine and paroxetine), and certain other drugs (e.g., fluvoxamine, propranolol, and pindolol) appear to appreciably inhibit the metabolism of thioridazine."	1
The use of digoxin may result in potentially detrimental increases in coronary vascular resistance.	0
"Dilute ONIVYDE in 500mL 5% Dextrose Injection, USP or 0.9% Sodium Chloride Injection, USP and mix diluted solution by gentle inversion."	0
GILENYA has not been studied in patients treated with drugs that prolong the QT interval.	0
"Compared with the controls, steady state AUC and Cmax in patients with stable heart failure were 38% and 30% higher, respectively."	0
"The safety profile of DIFLUCAN in children has been studied in 577 children ages 1 day to 17 years who received doses ranging from 1 to 15 mg/kg/day for 1 to 1,616 days."	0
The increases of bilirubin observed in the fibromyalgia clinical trials were not clinically significant.	0
These data suggest that pediatric patients metabolize sertraline with slightly greater efficiency than adults.	0
Subsequent titration to a maximum of 60 mg/m2 (approximately equivalent to the 360 mg total daily dose for adults) can then occur.	0
This is especially important in patients who may use alcohol excessively.	0
"There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on suicide."	0
Repeat 1-minute shaking and 1-minute standing for four additional times.	0
Consider discontinuation of Benicar in cases where no other etiology is identified.	0
The clinical situation dictates the procedures to be employed.	0
The recommended starting dose is 8 to 16 mg. Doses above 0.4 mg/kg (1 to < 6 year olds) or 32 mg (6 to < 17 year olds) have not been studied in pediatric patients.	0
Recommended dose: 50 mg once daily with or without food (2.1).	0
Patients must be frequently monitored by the FDA authorized test to detect possible loss of remission.	0
Avoid the concomitant use of drugs known to prolong the QTc interval.	0
Falsely elevated glucose readings have led patients or health care providers to withhold treatment of hypoglycemia or to administer insulin inappropriately.	0
"Discontinue the drug for several days, if possible, prior to elective surgery."	0
"Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide."	0
"In clinical trials, hyperkalemia (serum potassium >6.00mEq/L) occurred in approximately 0.4 percent of hypertensive patients receiving trandolapril and in 0.8% of patients receiving a dose of trandolapril (0.5-8 mg) in combination with a dose of verapamil SR (120-240 mg)."	0
A patient who misses a dose should NOT double the next dose.	0
"The antihypertensive effect of ACE inhibitors, including ramipril, may be attenuated by NSAIDs."	0
The risks of using ziprasidone in combination with other drugs have been evaluated as described below.	0
"Conversely, adverse effects may result from displacement of protein bound sertraline hydrochloride by other tightly bound drugs."	0
This is consistent with a small decrease in systemic clearance with increasing plasma concentrations.	0
Titrate based on BSA category for pediatric patients in two week intervals for 6 weeks and then every 4 weeks as needed to obtain serum phosphorus target.	0
Reduce ELIQUIS dose or avoid coadministration.	0
"Insulin requirements in diabetic patients may be increased, decreased or unchanged; latent diabetes mellitus may become manifest during chlorthalidone administration."	0
"If hypotension does occur, the patient should be placed in the supine position and, if necessary, given an intravenous infusion of normal saline."	0
"CNS Acting Drugs <U+2014> Given the primary CNS effects of olanzapine, caution should be used when olanzapine is taken in combination with other centrally acting drugs and alcohol."	0
Renal excretion of digoxin is proportional to glomerular filtration rate.	0
Effect of AUBAGIO on warfarin Coadministration of AUBAGIO with warfarin requires close monitoring of the international normalized ratio (INR) because AUBAGIO may decrease peak INR by approximately 25%.	0
A fertility study in rats showed a slight decrease in fertility at 200 mg/kg/day (approximately three times the maximum human daily dose on a mg/m2 basis) but not at 100 mg/kg/day (approximately 1.5 times the maximum human daily dose on a mg/m2 basis).	0
Immunosuppressant Tacrolimus Potential for serious and/or life-threatening cardiac arrhythmia.	0
Secondary acute angle-closure glaucoma and/or acute myopia.	0
"By slowing the resting heart rate, digoxin may actually decrease cardiac output in these patients."	0
The once-daily administration of up to 80 mg telmisartan to healthy subjects did not influence plasma aldosterone concentrations.	0
Subsequent PURIXAN doses should be adjusted based on efficacy and toxicity.	0
Adjunctive Use in Prophylaxis of Thromboembolism after Cardiac Valve Replacement.	0
"Data presented as % change represent % difference relative to pitavastatin alone (i.e., 0% = no change)."	0
"This has less importance than usual, however, because the metabolites, including the hydroxyl metabolite and glucuronides (the predominant circulating metabolites), contribute to <U+03B2>-blocking activity."	0
At least 10days should elapse between the discontinuation of Marplan and the institution of buspirone HCL.	0
Such patients may be unresponsive to the usual doses of epinephrine used to treat the allergic reaction.	0
"The genotoxic potential of trandolapril was evaluated in the microbial mutagenicity (Ames) test, the point mutation and chromosome aberration assays in Chinese hamster V79 cells, and the micronucleus test in mice."	0
"All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases."	0
"Prophylaxis of gout flares: Co-administration of colchicine in patients on APTIVUS/ritonavir : If the original colchicine regimen was 0.6 mg twice a day, the regimen should be adjusted to 0.3 mg once a day."	0
Known hypersensitivity to any component of AGGRASTAT.	0
A no effect level was seen at 1.2 mg/day (maternal exposures approximately 2.5 times human exposures at the MRDD).	0
"When PCCs are used, monitoring for the anticoagulation effect of apixaban using a clotting test (PT, INR, or aPTT) or anti-factor Xa (FXa) activity is not useful and is not recommended."	0
"Reproduction studies in rats did not show any impairment of fertility at doses up to 100mg/kg/day (710 mg/m2/day) of trandolapril, or 1250 and 260 times the MRHDD on the basis of body-weight and body-surface-area, respectively."	0
Saquinavir: See the prescribing information for saquinavir and monitor for potential saquinavir toxicities.	0
"The median terminal half-lives of sofosbuvir and GS-331007 following administration of HARVONI were 0.5 and 27 hours, respectively."	0
Consider withholding or discontinuing therapy in patients who develop a clinically significant decrease in renal function on AVAPRO.	0
"In cases of DIFLUCAN-associated hepatotoxicity, no obvious relationship to total daily dose, duration of therapy, sex, or age of the patient has been observed."	0
"In a clinical study with nicardipine capsules in patients with severe liver disease, plasma concentrations were elevated and the half-life was prolonged."	0
The mean maximum increase in QTc interval following the 50 mg dose was about 23 msec; greater prolongation may be observed in the clinical treatment of unscreened patients.	0
"Reduction in concentrations of cyclosporine and tacrolimus leading to dose increases has also been reported in transplant patients when coadministered with sevelamer hydrochloride without any clinical consequences (for example, graft rejection)."	1
Urinary excretion appeared to be biphasic in its time course.	0
Long-term liver abnormalities can occur in APL patients treated with TRISENOX in combination with tretinoin.	0
Treatment with LEXIVA plus ritonavir has resulted in increases in the concentration of triglycerides and cholesterol.	0
"Patients taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive crisis."	0
"The dose of SAMSCA may have to be reduced when SAMSCA is co-administered with P-gp inhibitors , e.g. , cyclosporine see Dosage and Administration ( 2.3 ) , Drug Interactions ( 7.1 ) ."	0
"These results suggest that, for faster sleep onset, AMBIEN should not be administered with or immediately after a meal."	0
"In administrating nicardipine, close monitoring of blood pressure and heart rate is required."	0
May administer INTEGRILIN in the same IV line with 0.9 % NaCl or 0.9 % NaCl/5 % dextrose .	0
"Concomitant use of Strong CYP1A2 Inhibitors: Reduce CLOZARIL dose to one-third when coadministered with strong CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin, enoxacin)."	1
The mean plasma concentrations in patients with creatinine clearance below 30 mL/min. were approximately 4 times greater than seen in normal volunteers.	0
"Potassium ions participate in a number of essential physiological processes including the maintenance of intracellular tonicity; the transmission of nerve impulse; the contraction of cardiac, skeletal and smooth muscle; and the maintenance of normal renal function."	0
"It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months."	0
"Chronic kidney disease in HIV-infected patients treated with atazanavir, with or without ritonavir, has been reported during postmarketing surveillance."	0
"Antimycobacterials: For contraindicated antimycobacterials,"	0
"The relationship of these findings to drug-treatment is uncertain since there was no effect at these dosage levels on implants/pregnant female, percent post-implantation loss, or live animals/litter at parturition."	0
This resulted in increases in steady state atomoxetine AUC values that were 6- to 8-fold greater and in atomoxetine Cmax values that were 3- to 4-fold greater than when atomoxetine was given alone.	1
Patients at risk for osteoporosis-related fractures should be managed according to established treatment guidelines.	0
Colesevelam hydrochloride: Consider administering olmesartan at least 4 hours before colesevelam hydrochloride dose (7).	0
"Tacrolimus Clinical Impact: Potentially increased exposure of tacrolimus, especially in transplant patients who are intermediate or poor metabolizers of CYP2C19."	1
CYP2D6 can be inhibited by a number of drugs.	0
"Amlodipine Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of TWYNSTA, particularly in patients with severe obstructive coronary artery disease."	0
Counsel family members or caregivers of patients to monitor for changes in behavior and to alert the healthcare provider.	0
No differences in pharmacokinetics were observed in a pharmacokinetic study conducted in Japanese and Caucasians.	0
LEXIVA may be less effective due to decreased amprenavir plasma concentrations.	0
"Signs and symptoms of hyponatremia include headache, difficulty concentrating, memory impairment, confusion, weakness, and unsteadiness, which may lead to falls."	0
"If either particulate matter or discoloration is noted, do not use."	0
"Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed."	0
"Chronically administered <U+03B2>-blocking therapy should not be routinely withdrawn prior to major surgery; however, the impaired ability of the heart to respond to reflex adrenergic stimuli may augment the risks of general anesthesia and surgical procedures."	0
"While all the SSRIs, e.g., fluoxetine, sertraline, paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition."	0
Neither losartan nor its active metabolite can be removed by hemodialysis.	0
Drugs Affecting Hepatic Metabolism The metabolism and pharmacokinetics of paroxetine may be affected by the induction or inhibition of drug-metabolizing enzymes.	0
"In some cases after treatment discontinuation, hyperglycemia persisted (5.4) Hemophilia: increased bleeding, including spontaneous skin hematomas and hemarthrosis reported with protease inhibitors."	0
"For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), healthcare professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically."	0
"Also, there was a transient increase in the average steady-state concentrations of fluoxetine observed following transition the next day to the once-weekly regimen."	0
Oral bioavailability is not significantly affected by food.	0
The risk of skeletal muscle effects may be enhanced when LIPITOR is used in combination with niacin; a reduction in LIPITOR dosage should be considered in this setting.	0
"Therefore, MAO inhibitors should be discontinued at least two weeks prior to the cautious initiation of therapy with PRUDOXIN Cream."	0
"The relationship to PROCARDIA therapy is uncertain in most cases, but probable in some."	0
Angioedema Head and Neck Angioedema Patients with a history of angioedema unrelated to ACE inhibitor therapy may be at increased risk of angioedema while receiving an ACE inhibitor.	0
The complete text of the Medication Guide is reprinted at the end of this document.	0
"Rash (all grades, regardless of causality) occurred in 10.3% of subjects treated with PREZISTA/ritonavir [also see Adverse Reactions (6)]."	0
0.1 mg tablet twice daily (morning and bedtime).	0
"In vitro, terbinafine exhibits satisfactory MIC<U+2019>s against most strains of the following microorganisms; however, the safety and efficacy of terbinafine in treating clinical infections due to these microorganisms have not been established in adequate and well-controlled clinical trials: Candida albicans Epidermophyton floccosum Scopulariopsis brevicaulis"	0
"The presence of hepatic (mild or moderate) or renal impairment (mild, moderate, severe and ESRD) did not affect the apparent clearance of vortioxetine."	0
"Gender - In three pharmacokinetic studies (total N=32), citalopram AUC in women was one and a half to two times that in men."	0
Prolonged use of diethylpropion hydrochloride may induce dependence with withdrawal syndrome on cessation of therapy.	0
Patients were randomized to receive losartan potassium tablets 50mg once daily or placebo on a background of conventional antihypertensive therapy excluding ACE inhibitors and angiotensinII antagonists.	0
Studies of nitroglycerin (an organic nitrate with a very short half-life) have shown that dosing intervals of 10-12 hours are usually sufficient to prevent or attenuate tolerance.	0
"Genotype 4, 5 or 6 Resistance analysis was performed for 6 relapse subjects infected with HCV genotype 4 (Study 1119 and ION-4, N=3), genotype 5 (Study 1119, N=2) or genotype 6 (ELECTRON-2, N=1) and treated with HARVONI for 12 weeks."	0
"Reproduction studies have been performed in rats at doses as high as 20 times the Maximum Recommended Human Dose (MRHD) on the basis of body-weight, and 6 times the MRHD on the basis of body-surface area without evidence of harm to the fetus due to triamterene."	0
"Endogenous substances of unknown composition (digoxin-like immunoreactive substances, DLIS) can interfere with standard radioimmunoassays for digoxin."	0
"Patients with bronchospastic diseases should, in general, not receive beta-blockers."	0
"The following are examples of drugs known to inhibit the metabolism of other related benzodiazepines, presumably through inhibition of CYP3A: nefazodone, fluvoxamine, cimetidine, diltiazem, isoniazide, and some macrolide antibiotics."	1
"These include: specific antipsychotics (e.g., ziprasidone, iloperidone, chlorpromazine, mesoridazine, droperidol); specific antibiotics (e.g., erythromycin, gatifloxacin, moxifloxacin, sparfloxacin); Class 1A antiarrhythmic medications (e.g., quinidine, procainamide); Class III antiarrhythmics (e.g., amiodarone, sotalol); and others (e.g., pentamidine, levomethadyl acetate, methadone, halofantrine, mefloquine, dolasetron mesylate, probucol or tacrolimus)."	0
"Sertraline hydrochloride was initiated at 25 mg/day for the first week, and then patients were dosed in a range of 50 to 200 mg/day on the basis of clinical response and toleration."	0
"Caution is indicated in the coadministration of tricyclic antidepressants (TCAs) with paroxetine, because paroxetine may inhibit TCA metabolism."	1
<U+2022>Dispense into suitably sized amber PET bottles.	0
"<U+2022>Hypotensive agents (e.g., reserpine, MAO inhibitors, clonidine) may increase the risk of hypotension and/or severe bradycardia."	0
CYP2D6 Isozyme <U+2013> A subset (3% to 10%) of the population has reduced activity of the drug-metabolizing enzyme CYP2D6.	0
"The specific baseline polymorphisms observed in subjects with virologic failure were L28M/V, L30R, and P58T for genotype 4; L31M for genotype 5; and Q24K, F28V, R30A, and T58P for genotype 6."	0
"When additional blood pressure reduction beyond that achieved with 80 mg MICARDIS is required, a diuretic may be added."	0
SURMONTIL should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.	0
CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias.	0
This diminution is not sufficient to preclude the therapeutic effectiveness of norepinephrine.	0
INR is relatively insensitive to the exposure to dabigatran and cannot be interpreted the same way as used for warfarin monitoring.	0
A drug interaction study of eplerenone with lithium has not been conducted.	0
In such patients consideration should be given to the insertion of a pacemaker before treatment with digoxin.	0
The exposures of hydroxybupropion were decreased.	0
"Severe CNS toxicity associated with hyperpyrexia and death have been reported with the combination of tricyclic antidepressants and non-selective MAOIs (Phenelzine, Tranylcypromine)."	0
"Dabigatran is not a substrate, inhibitor, or inducer of CYP450 enzymes."	0
"If hypotension or tachycardia ensues, discontinue the infusion."	0
"In man, PROCARDIA causes decreased peripheral vascular resistance and a fall in systolic and diastolic pressure, usually modest (5<U+2013>10 mm Hg systolic), but sometimes larger."	0
Flurazepam hydrochloride is rapidly absorbed from the gastro-intestinal tract.	0
Sympathetic blockade with phentolamine causes immediate and conspicuous local hyperemic changes if the area is infiltrated within 12 hours.	0
SVR was achieved in all 24 subjects (N=20 with L159F+C316N; N=1 with L159F; and N=3 with N142T) who had baseline polymorphisms associated with resistance to sofosbuvir and/or other NS5B nucleoside inhibitors.	0
"Coadministration of single, oral doses of zaleplon with erythromycin (10 mg and 800 mg, respectively), a strong, selective CYP3A4 inhibitor, produced a 34% increase in zaleplon's maximal plasma concentrations and a 20% increase in the area under the plasma concentration-time curve."	1
The interaction between INVIRASE/ritonavir and fusidic acid has not been formally evaluated.	0
Safety and effectiveness in pediatric patients have not been established.	0
"Indication Recommended Dosage ( 2 ) Healing of Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD) 20 mg once daily for 4 to 8 weeks Maintenance of Healing of Erosive or Ulcerative GERD*studied for 12 months 20 mg once daily* Symptomatic GERD in Adults 20 mg once daily for 4 weeks Healing of Duodenal Ulcers 20 mg once daily after morning meal for up to 4 weeks Helicobacter pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence Three Drug Regimen:ACIPHEX20 mgAmoxicillin 1000 mgClarithromycin 500 mg All three medications should be taken twice daily with morning and evening meals for 7 days Pathological Hypersecretory Conditions, Including Zollinger-Ellison Syndrome Starting dose 60 mg once daily then adjust to patient needs Symptomatic GERD in Adolescents 12 Years of Age and Older 20 mg once daily for up to 8 weeks Administration Instructions ( 2 ): Swallow ACIPHEX delayed-releasetablets whole."	0
<U+2022>Insulin and oral hypoglycemics action may be enhanced.	0
Clinical studies have shown that patients taking less bioavailable formulations of triamterene and hydrochlorothiazide in daily doses of 25 mg to 50 mg hydrochlorothiazide and 50 mg to 100 mg triamterene may be safely changed to one triamterene and hydrochlorothiazide 37.5 mg/25 mg tablet daily.	0
These abnormalities are dose-related but may occur even at the lowest marketed doses of chlorthalidone.	0
Advise women of potential risk to a fetus.	0
"Families and caregivers of patients being treated with antidepressants for major depressive disorder or other indications, both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to health care providers.Such monitoring should include daily observation by families and caregivers."	0
An ECG should be done at baseline and periodically thereafter throughout the period of dose adjustment.	0
"Conversely, at least 14 days should be allowed after stopping LUVOX CR Capsules before starting an MAOI intended to treat psychiatric disorders."	0
Such use could result in air embolism due to residual air being drawn from the primary container before the administration of the fluid from the secondary container is complete.	0
"Ledipasvir, sofosbuvir, and GS-331007 are not inhibitors or inducers of CYP or UGT1A1 enzymes."	0
"Drugs That Interfere With Hemostasis (NSAIDs, Aspirin, Warfarin, etc.)"	0
Preclinical studies have shown that duloxetine is a potent inhibitor of neuronal serotonin and norepinephrine reuptake and a less potent inhibitor of dopamine reuptake.	0
"In multicenter, double-blind studies in patients with familial or non-familial hypercholesterolemia, MEVACOR, administered in doses ranging from 10mg q.p.m. to 40mg b.i.d., was compared to placebo."	0
"While these events are generally self-limiting, there have been reports of serious discontinuation symptoms."	0
Hypercalcemia (>11 mg/dL) was reported in 16% of patients in a 3-month study of a solid dose formulation of calcium acetate; all cases resolved upon lowering the dose or discontinuing treatment.	0
Major Depressive Disorder The efficacy of paroxetine as a treatment for major depressive disorder has been established in 6 placebo-controlled studies of patients with major depressive disorder (aged 18 to 73).	0
Thiazides and triamterene in combination have not been studied in nursing mothers.	0
"When nicardipine was given to mild-to-moderate hypertensive patients with moderate degrees of renal impairment, significant reduction in glomerular filtration rate (GFR) and effective renal plasma flow (RPF) were observed."	0
"Study 2 was a 12-week fixed-dose study, including sertraline hydrochloride doses of 50, 100, and 200 mg/day."	0
Limit the dose of simvastatin in patients on verapamil to 10 mg daily.	1
Systemic corticosteroid effects including Cushing<U+2019>s syndrome and adrenal suppression have been reported during postmarketing use in patients receiving ritonavir and inhaled or intranasally administered fluticasone.	0
Nifedipine was administered orally to rats for two years and was not shown to be carcinogenic.	0
"In one study, daily dosing of paroxetine (20 mg qd) under steady-state conditions increased single dose desipramine (100 mg) Cmax, AUC, and T 1/2 by an average of approximately 2-, 5-, and 3-fold, respectively."	1
"Following abrupt cessation of therapy with certain beta-blocking agents, exacerbations of angina pectoris and, in some cases, myocardial infarction have occurred."	0
"If intolerable symptoms occur following a decrease in the dose or upon discontinuation of treatment, then resuming the previously prescribed dose may be considered."	0
Titration may be needed in some patients.	0
Radiographic evaluation of suspected anatomical regions may be helpful in early detection of soft-tissue calcification.	0
Advise patient how to avoid symptoms resulting from postural hypotension and what measures to take should they develop.	0
"If treatment continues beyond 28 days, visual function including visual acuity, visual field and color perception should be monitored."	0
Monitor diuretic effects when furosemide is coadministered with aliskiren .	0
May be increased to 200 mg/day based on individual patient response (2.1).	0
"In this study, there was no apparent dose (exposure)-response relationship."	0
"Nevertheless, caution is indicated in the coadministration of TCAs with Celexa."	0
"Because renal clearance of lithium is reduced by thiazides, the risk of lithium toxicity is presumably raised further when, as in therapy with ACCURETIC, a thiazide diuretic is coadministered with the ACE inhibitor."	1
"The renal clearance, which is extremely rapid, is the result of glomerular filtration and active tubular transport, with the latter route predominating."	0
"The initial dosage should therefore be reduced in patients with severe renal or hepatic impairment, and upward titration, if necessary, should be at increased intervals."	0
A history of renal impairment may be a risk factor for the development of rhabdomyolysis.	0
"In a published series, mild liver dysfunction and hepatic steatosis were seen in 15% and 43%, respectively, of patients at a median of 7 years (range 0-14 years) after treatment with arsenic trioxide in combination with tretinoin."	0
"For dose increments of 0.4 g, use one half of a 0.8 g packet."	0
"Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapy, including INVIRASE."	0
"Strong CYP3A4 Inducers (e.g., carbamazepine) The concomitant use of oral aripiprazole and carbamazepine decreased the exposure of aripiprazole."	1
"In healthy volunteers titrated with Coumadin<U+00AE># (warfarin sodium) to clinical levels of anticoagulation (INR of 1.5 to 2), co-administration with EMSAM 6mg per 24 hours for 7 days did not affect the pharmacokinetics of the individual warfarin enantiomers."	0
Initiate treatment under close medical supervision.	0
Reduce digoxin dose by approximately 15% to 30% or by modifying the dosing frequency and continue monitoring.	0
Triamterene and hydrochlorothiazide should be used with caution in patients with histories of renal lithiasis.	0
"The end metabolites include 3-<U+03B2>-digoxigenin, 3-keto-digoxigenin, and their glucuronide and sulfate conjugates."	0
"Heart rate progressively increases after the first day, returning to baseline values within 1 month of the start of chronic treatment."	0
CYMBALTA is in a class of drugs known to affect urethral resistance.	0
Digitalis glycosides: Risk of bradycardia (7) Anticholinesterases: Prolongs neuromuscular blockade (7) Antihypertensive agents: Risk of rebound hypertension (7) Sympathomimetic drugs: Dose adjustment needed (7) Vasoconstrictive and positive inotropic effect substances: Avoid concomitant use (7)	0
Monitor blood pressure and for symptoms of hypotension when CARDURA is used concomitantly with strong CYP3A inhibitors.	0
"A syndrome consisting of potentially irreversible, involuntary, dyskinetic movements may develop in patients treated with antipsychotic drugs."	0
"Adult dosage -Antisialagogue or for antivagal effects: Initial single dose of 0.5 mg to 1mg. (2.2) -Antidote for organophosphorus or muscarinic mushroom poisoning: Initial single dose of 2 mg to 3 mg, repeated every 20-30 minutes."	0
The following table provides the outcome classification by treatment group on Global Improvement items of the Clinical Global Impression (CGI) scale for Study 1.	0
The bitter aftertaste of NORVIR oral powder may be lessened if administered with food.	0
"Absorption Following oral administration, peak serum concentrations of digoxin occur at 30 to 90 minutes."	0
"PRADAXA capsules should therefore not be broken, chewed, or opened before administration."	0
"Additional fractions of this planned total dose may be given at 4- to 8-hour intervals, with careful assessment of clinical response before each additional dose."	0
"Based on multicenter cooperative group ALL trials, the most common adverse reaction occurring in > 20% of patients is mylelosuppression including anemia, neutropenia, lymphopenia and thrombocytopenia."	0
"WARNING : ( A ) BLEEDING RISK , and ( B ) ASPIRIN DOSE AND BRILINTA EFFECTIVENESS ."	0
"If the drug has a short elimination half-life, it is possible that a relative deficiency of the drug, or, if appropriate, its active metabolites (i.e., in relationship to the receptor site) may occur at some point in the interval between each night<U+2019>s use."	0
Animal Findings: Reproduction studies were performed at doses up to 50 mg/kg/day in rats and 6 mg/kg/day in rabbits administered during organogenesis.	0
"The antihypertensive effect of angiotensin II receptor antagonists, including telmisartan may be attenuated by NSAIDs including selective COX-2 inhibitors."	0
"Concomitant administration of both a CYP2C9 inhibitor ( such as fluconazole or amiodarone ) and a strong CYP3A inhibitor ( e.g. , ketoconazole , itraconazole ) or a moderate CYP3A inhibitor ( e.g. , amprenavir , erythromycin , fluconazole , diltiazem ) with Tracleer will likely lead to large increases in plasma concentrations of bosentan ."	1
Dronedarone caused fetal harm in animal studies at doses equivalent to recommended human doses.	0
"While the mean changes alone would not be expected to have short-term consequences, all patients should be monitored for larger changes in heart rate and blood pressure."	0
"ACCURETIC should be used with caution in patients with impaired hepatic function or progressive liver disease, since minor alterations of fluid and electrolyte balance may precipitate hepatic coma."	0
This test is not recommended for assessing the anticoagulant effect of apixaban.	0
33 <U+2013>22 <U+2013>31 +5 <U+2013>33 <U+2013>25 <U+2013>8 20 mg b.i.d.	0
"CNS stimulants (amphetamines and methylphenidate-containing products), including VYVANSE, have a high potential for abuse and dependence (5.1, 9.2, 9.3) Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy (5.1, 9.2)"	0
"For pregnant women taking REYATAZ with ritonavir and tenofovir DF, see Dosage and Administration (2.6)."	0
"The risk differences (drug vs. placebo), however, were relatively stable within age strata and across indications."	0
"SSRIs and SNRIs, including PRISTIQ, may increase the risk of bleeding events."	0
"Concomitant Medication: Patients should be advised to inform their physician if they are taking, or plan to take, any prescription or over-the-counter drugs, since there is a potential for interactions."	0
Carbamazepine: Elevated carbamazepine levels and symptoms of toxicity with coadministration (7.2).	1
Pediatric starting dose: 2.5 mg to 5 mg once daily.	0
"Should signs of pulmonary edema occur when REVATIO is administered, consider the possibility of associated PVOD."	0
Cannot predict effect of TPV/ritonavir on immunosuppressants due to conflicting effect of TPV/ritonavir on CYP 3A and P-gp.	0
Non-Nucleoside Reverse Transcriptase Inhibitor:delavirdine <U+2191> ritonavir Appropriate doses of this combination with respect to safety and efficacy have not been established.	0
"However, measurement of serum digoxin concentrations can be helpful to the clinician in determining the adequacy of digoxin therapy and in assigning certain probabilities to the likelihood of digoxin intoxication."	0
On average only 4.8% of the dose was excreted as unchanged drug in the feces and only a trace of the total radioactivity in the urine was attributed to unchanged drug.	0
"Rifabutin was not carcinogenic in mice at doses up to 180 mg/kg/day, or approximately 36 times the recommended human daily dose."	0
"Verapamil Component Concomitant therapy with beta-adrenergic blockers and verapamil may result in additive negative effects on heart rate, atrioventricular conduction, and/or cardiac contractility."	0
"Similarly, atropine-like effects may be more pronounced in patients receiving anticholinergic therapy."	0
"Antiparasitic:atovaquone <U+2193> atovaquone Clinical significance is unknown; however, increase in atovaquone dose may be needed."	1
"Congestive Heart Failure In patients with congestive heart failure, with or without associated renal insufficiency, ACE inhibitor therapy may cause excessive hypotension, which may be associated with oliguria or azotemia and rarely, with acute renal failure and death."	0
"The clinician should, nevertheless, be aware of the possibility of emergent symptoms of serotonin syndrome with such use."	0
Co-administration of APTIVUS/ritonavir with drugs that are highly dependent on CYP 3A for clearance or are potent CYP 3A inducers are contraindicated.	0
The recommended dose of Silenor for adults is 6 mg once daily.	0
There are no clinical data available to confirm transporter based interaction.	0
"Usually, clinically detectable jaundice appears early in the course of treatment (1 to 2 months)."	0
Any dose adjustment should be guided by clinical effect (tolerability and efficacy).	0
"After chronic dosing of 80 mg three times a day to patients with PAH, no clinically relevant effects on ECG were reported."	0
Consider increasing the omeprazole dose in patients whose symptoms are not well controlled; avoid use of more than 40 mg per day of omeprazole.	1
Lower dosages are recommended for elderly patients and adolescents.	0
Treatment-Experienced Adult Patients The recommended oral dosage for treatment-experienced adult patients is summarized in Table 1.	0
5.ORAP is contraindicated in patients with hypersensitivity to it.	0
"OR For patients unable to tolerate ritonavir, REYATAZ 400 mg once daily with food should be administered at least 2 hours before and at least 10 hours after a dose of the H2RA."	0
"The relative beta1-selectivity of metoprolol has been confirmed by the following: (1) In normal subjects, metoprolol is unable to reverse the beta2-mediated vasodilating effects of epinephrine."	0
Total plasma clearance of telmisartan is >800 mL/min.	0
"For patients demonstrating a subsequent increase in QT interval by > 20 msec after commencing concomitant therapy, the physician should use best clinical judgment to discontinue either INVIRASE/ritonavir or the concomitant therapy or both."	0
"Co-administration of a cytochrome P450 ( CYP ) 2C8 enzyme inhibitor ( e.g. , gemfibrozil ) increases exposure ( both Cmax and AUC ) to treprostinil ."	1
"The recommended DIFLUCAN daily dosage for the prevention of candidiasis in patients undergoing bone marrow transplantation is 400 mg, once daily."	0
"Additionally, saquinavir is a substrate for P-glycoprotein (P-gp)."	0
"After multiple daily doses of 150 mg of clomipramine hydrochloride, steady-state maximum plasma concentrations range from 94 ng/mL to 339 ng/mL (mean, 218 ng/mL) for CMI and from 134 ng/mL to 532 ng/mL (mean, 274 ng/mL) for DMI."	0
Myelosuppression: Monitor complete blood count (CBC) and adjust the dose of PURIXAN for severe neutropenia and thrombocytopenia.	0
No effect of food on the pharmacokinetics was observed.	0
Both in vitro biochemical and in vivo pharmacological testing have shown N-desmethylsertraline to be substantially less active than sertraline.	0
In vitro and in vivo studies in animals suggest that citalopram is a highly selective serotonin reuptake inhibitor (SSRI) with minimal effects on norepinephrine (NE) and dopamine (DA) neuronal reuptake.	0
These rashes were mild to moderate in severity and did not limit therapy; there were no discontinuations due to rash.	0
"Severe exacerbation of angina, myocardial infarction and ventricular arrhythmias have been reported in patients with coronary artery disease following the abrupt discontinuation of therapy with <U+03B2>-blockers."	0
"Altered anticoagulant effects, including increased bleeding, have been reported when SSRIs or SNRIs are co-administered with warfarin."	0
"Preliminary studies indicate that the concomitant use of dobutamine and nitroprusside results in a higher cardiac output and , usually , a lower pulmonary wedge pressure than when either drug is used alone ."	0
"However, there was a 20% increase in valproate peak plasma concentration (Cmax) after concomitant administration of risperidone."	1
Subgroup analyses did not suggest differences in treatment outcome on the basis of gender.	0
There is no information on the effect that alterations in gastric motility may have on the stability of CYMBALTA's enteric coating.	0
Studies in animals indicate that radiolabeled irbesartan weakly crosses the blood-brain barrier and placenta.	0
Renal excretion of unchanged drug depends upon urinary pH.	0
"At the highest 200mg twice daily dose, the increase in mean pulse rate was 5.0 to 6.8 beats and increases in mean blood pressure were 4.7 to 6.8mm Hg (systolic) and 4.5 to 7mm Hg (diastolic) up to 12 hours after dosing."	0
"In vivo data suggest that tipranavir/ritonavir, at the dose of 500/200 mg, is a P-gp inhibitor after the first dose and induction of P-gp occurs over time."	0
<U+2022> Renal Impairment: Mild to moderate renal impairment (CLcr<U+2265>30mL/min/1.73 m2) had no influence on plasma concentrations of rosuvastatin.	0
Add 75 mL of Ora-Sweet<U+00AE>* oral syrup vehicle to thebottle and shake the suspension to disperse the ingredients.	0
Initiation of quetiapine in patients taking NORVIR: Refer to the quetiapine prescribing information for initial dosing and titration of quetiapine.	0
"After a 25 mg radiolabeled dose of CMI in two subjects, 60% and 51%, respectively, of the dose were recovered in the urine and 32% and 24%, respectively, in feces."	0
"However, the impairment of motor skills produced by REMERON has been shown to be additive with those caused by diazepam."	0
"Adverse reactions of hyperkalemia were approximately 1-2 % higher when tolvaptan was administered with angiotensin receptor blockers , angiotensin converting enzyme inhibitors and potassium sparing diuretics compared to administration of these medications with placebo ."	0
"The principal metabolite of quinapril, quinaprilat, is an inhibitor of ACE activity in human subjects and animals."	0
"Although minor upper GI symptoms, such as dyspepsia, are common and can occur anytime during therapy, physicians should remain alert for signs of ulceration and bleeding, even in the absence of previous GI symptoms."	0
Examples Urinary alkalinizing agents (e.g.	0
"Therefore, patients receiving warfarin-type anticoagulants should have their prothrombin times closely monitored when fluvastatin sodium is initiated or the dosage of fluvastatin sodium is changed."	0
"Rebound insomnia, defined as a dose-dependent temporary worsening in sleep parameters (latency, total sleep time, and number of awakenings) compared to baseline following discontinuation of treatment, is observed with short- and intermediate-acting hypnotics."	0
"In patients with hypokalemia or hypomagnesemia, toxicity may occur at concentrations within therapeutic range because potassium or magnesium depletion sensitizes the myocardium to digoxin."	0
"Patients should be advised that taking Anafranil can cause mild pupillary dilation, which in susceptible individuals, can lead to an episode of angle-closure glaucoma."	0
"In a placebo-controlled study in patients with permanent atrial fibrillation, dronedarone was associated with an increased risk of stroke, particularly in the first two weeks of therapy."	0
"In a 14-day placebo-controlled study of patients with moderate asthma, no effect was seen for GILENYA 0.5 mg (recommended dose in MS)."	0
Warfarin <U+2014> Single doses of olanzapine did not affect the pharmacokinetics of warfarin.	0
"In addition, do not initiate ZOLOFT in a patient being treated with MAOIs such as linezolid or intravenous methylene blue."	0
"The AUC and Cmax of hydroxybupropion metabolite were decreased by 50% and 31%, respectively."	0
Meperidine Hydrochloride Injection is contraindicated in patients with: Significant respiratory depression Hypersensitivity to meperidine.	0
Aripiprazole has no appreciable affinity for cholinergic muscarinic receptors (IC50>1000nM).	0
Opioids: Decreased exposure to prasugrel.	1
The results from long-term studies have not shown any diminution of the antihypertensive efficacy of TENORMIN with prolonged use.	0
Olmesartan shows linear pharmacokinetics following single oral doses of up to 320 mg and multiple oral doses of up to 80 mg. Steady-state levels of olmesartan are achieved within 3 to 5 days and no accumulation in plasma occurs with once-daily dosing.	0
It should also be noted that hypertensive or hypotensive heart disease of extreme degree is a contraindication of phenothiazine administration.	0
"For patients with severe renal impairment (indicated by an estimated creatinine clearance of 5-29 mL/min), the maintenance dose should be reduced by 50% to 50 mg/day (25 mg twice daily)."	0
"Sudden deaths have been reported in 0.3% of patients with CML treated with nilotinib in clinical studies of 5,661 patients."	0
"A minimum of six hours of observation with cardiac monitoring and observation for signs of CNS or respiratory depression, hypotension, cardiac dysrhythmias and/or conduction blocks, and seizures is necessary."	0
Prothrombin time may be increased in patients receiving concomitant DIFLUCAN and coumarin-type anticoagulants.	0
Addiction can occur at recommended dosages and if the drug is misused or abused.	0
The level of quinidine in amniotic fluid was about three times higher than that found in serum.	0
"Drugs that slow heart rate : Concomitant use of drugs with depressant effects on the sinus and AV node ( e.g. , digoxin , beta blockers , verapamil , diltiazem , ivabradine , clonidine ) can potentiate the electrophysiologic and hemodynamic effects of amiodarone , resulting in bradycardia , sinus arrest , and AV block ."	0
The anticoagulant effect of a single dose of warfarin (measured by prothrombin time) was not significantly changed by quinapril coadministration twice daily.	0
"The impact of moderate CYP 3A inhibitors ( e.g. , erythromycin , fluconazole , aprepitant , diltiazem and verapamil ) on the exposure to co-administered tolvaptan has not been assessed ."	0
Hydrochlorothiazide is eliminated primarily by renal pathways.	0
"Co-administration of SAMSCA with 400 mg ketoconazole daily or with other strong CYP 3A inhibitors ( e.g. , clarithromycin , itraconazole , telithromycin , saquinavir , nelfinavir , ritonavir and nefazodone ) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure ."	1
"40 mg, SD <U+2191> 37% <U+2191> 16% Diltiazem 240 mg QD, 28 days 40 mg, SD <U+2191> 51% No change Erythromycin 500 mg QID, 7 days 10 mg, SD <U+2191> 33% <U+2191> 38% Amlodipine 10 mg, single dose 80 mg, SD <U+2191> 15% <U+2193> 12 % Cimetidine 300 mg QID, 2 weeks 10 mg QD for 2 weeks <U+2193> Less than 1% <U+2193> 11% Colestipol 10 mg BID, 28 weeks 40 mg QD for 28 weeks Not determined <U+2193> 26%Single sample taken 8<U+2013>16 h post dose."	0
"Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide."	0
"In general, treatment with ORAP should be initiated with a dose of 1 to 2 mg a day in divided doses."	0
"Only prescribers and pharmacies certified with the restricted distribution program are able to prescribe and dispense CAPRELSA (5.1, 5.15)."	0
False-positive test results may result even following discontinuation of bupropion therapy.	0
Thioridazine should be discontinued in patients who are found to have a QTc interval over 500 msec.	0
"On the basis of body surface area, these doses are 56times (in mice) and 21times (in rats) the MRHD."	0
It is not known whether nebivolol has these effects.	0
"The incidence of Grade 3 or 4 early onset diarrhea was 3% in patients receiving ONIVYDE/5-FU/LV,compared to no Grade 3 or 4 early onset diarrhea in patients receiving 5-FU/LV."	0
Thiazides cross the placental barrier and appear in cord blood.	0
There was a small uricosuric effect leading to a minimal decrease in serum uric acid (mean decrease <0.4mg/dL) during chronic oral administration.	0
Hypertension: Initiate adults at 10 mg (monotherapy) or 5 mg (on a diuretic) once daily.	0
"<U+2022>Prepare the vehicle by adding equal volumes of Ora-Plus<U+00AE> (80 mL) and Ora-Sweet SF<U+00AE> (80 mL) or, alternatively, use Ora-Blend SF<U+00AE> (160 mL)."	0
Feed the mixture to the infant or young child.	0
Pharmacokinetic data indicate reduced elimination of lidocaine after prolonged (24 hours) infusion with resultant prolongation of the half-life to approximately three times that seen following a single administration.	0
The recommended dose of CAPRELSA is 300 mg taken orally once daily until disease progression or unacceptable toxicity occurs.	0
"When initiating MICARDIS therapy for cardiovascular risk reduction, monitoring of blood pressure is recommended, and if appropriate, adjustment of medications that lower blood pressure may be necessary."	0
"Chlorpromazine Hydrochloride Injection contains sodium metabisulfite and sodium sulfite, sulfites that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people."	0
Discuss treatment options with women planning to become pregnant.	0
Patients currently receiving diltiazem therapy should be carefully monitored for a change in pharmacological effect when initiating and discontinuing therapy with cimetidine.	0
"In clinical trials, amlodipine has been safely administered with thiazide diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, long-acting nitrates, sublingual nitroglycerin, digoxin, warfarin, non-steroidal anti-inflammatory drugs, antibiotics, and oral hypoglycemic drugs."	0
"Inhibition was complete (100%) 4 hours following oral doses of 150 mg or 300 mg and partial inhibition was sustained for 24 hours (60% and 40% at 300 mg and 150 mg, respectively)."	0
"Drugs Contraindicated with LEXIVA (Information in the table applies to LEXIVA with or without ritonavir, unless otherwise indicated.)"	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP, in those patients with risk factors."	0
"In addition, do not start CYMBALTA in a patient who is being treated with linezolid or intravenous methylene blue (4)"	0
"Patients to be discharged on TIKOSYN therapy from an inpatient setting as described above must have an adequate supply of TIKOSYN, at the patient's individualized dose, to allow uninterrupted dosing until the patient can fill a TIKOSYN prescription."	0
"Other important considerations in the differential diagnosis include central anticholinergic toxicity, heat stroke, drug fever and primary central nervous system (CNS) pathology."	0
"Ideally, the dosage schedule should be adjusted so that the timing of a scheduled dose coincides with the end of hemodialysis."	0
5- nortriptyline and/or S-amitriptyline may be measured at initiation of the combination therapy and after one week.	0
Concomitant use should be avoided unless the necessity for Zanaflex therapy is clinically evident.	0
"The pharmacokinetics of intravenous ondansetron did not differ between subjects who were poor metabolisers of CYP2D6 and those who were extensive metabolisers of CYP2D6, further supporting the limited role of CYP2D6 in ondansetron disposition in vivo."	0
"Consistent with the rapid clearance of zaleplon, impairment of psychomotor function was no longer present as early as 2 hours post dosing in one study, and in none of the studies after 3-4 hours."	0
Subgroup analyses did not indicate differences in treatment outcomes as a function of race or gender.	0
"The ambulatory infusion pump used to administer FLOLAN should: (1)be small and lightweight, (2)be able to adjust infusion rates in 2<U+2011>ng/kg/min increments, (3)have occlusion, end-of-infusion, and low-battery alarms, (4)be accurate to <U+00B1>6% of the programmed rate, and (5)be positive-pressure<U+2011>driven (continuous or pulsatile) with intervals between pulses not exceeding 3minutes at infusion rates used to deliver FLOLAN."	0
"The use of verapamil in combination with a beta-adrenergic blocker should be used only with caution, and close monitoring."	0
Tamoxifen is a pro-drug requiring metabolic activation by CYP2D6.	0
"As with all drugs, the potential for interaction by a variety of mechanisms (e.g., pharmacodynamic, pharmacokinetic drug inhibition or enhancement, etc.)"	0
No gender associated differences were observed.	0
"In patients with PAH, the average steady-state concentrations were 20<U+2013>50% higher when compared to those of healthy volunteers."	0
Continuation phase (4 Months): 600 mg once-weekly for 4 months as directly observed therapy with isoniazid or another appropriate anti- tuberculosis agent.	0
The mechanism and long-term consequences of these events are currently unknown.	0
(Figure 1) Figure 1 Replace the cap and shake the bottle vigorously for a minimum of 30 seconds.	0
ACE activity was not altered in healthy subjects after repeated candesartan cilexetil administration.	0
Maximum improvement may not be seen for weeks or even months.	0
"Four metabolites were identified as 1-oxo-estazolam, 4<U+2019>-hydroxy-estazolam, 4-hydroxy-estazolam, and benzophenone, as free metabolites and glucuronides."	0
"In clinical trials of subjects with heart failure, subjects with bronchospastic disease were enrolled if they did not require oral or inhaled medication to treat their bronchospastic disease."	0
Exchange transfusion or dialysis may be required as means of reversing hypotension and/or substituting for disordered renal function.	0
Cimetidine and Antacids <U+2014> Single doses of cimetidine (800mg) or aluminum- and magnesium-containing antacids did not affect the oral bioavailability of olanzapine.	0
CMI from clomipramine hydrochloride capsules is as bioavailable as CMI from a solution.	0
"Undue toxicity, evidenced by tremors, coma and convulsions, has occurred in a few cases."	0
"Use of sildenafil for pulmonary arterial hypertension (PAH): Use of RevatioRegistered trademark of Pfizer, Inc. (sildenafil) is contraindicated when used for the treatment of pulmonary arterial hypertension (PAH)."	0
"As with other serotonergic drugs, lithium may enhance the serotonergic effects of fluvoxamine and, therefore, the combination should be used with caution."	0
"Inducers of CytochromesP450 - Rifampicin(600mg daily), a potent inducer of CYP3A and CYP2B6 and an inducer of CYP2C9, CYP2C19, and CYP2C8, did not significantly change the pharmacokinetics of prasugrel's active metabolite or its inhibition of platelet aggregation."	0
Fluconazole causes QT prolongation via the inhibition of Rectifier Potassium Channel current (Ikr).	0
It has been suggested that the efficacy of asenapine in schizophrenia could be mediated through a combination of antagonist activity at D2 and 5-HT2A receptors.	0
Systemic lupus erythematosus (SLE) is less commonly reported than CLE in patients receiving PPIs.	0
Patients with renal failure may therefore receive the usual initial amlodipine dose.	0
"Upon improvement, resume CAPRELSA at a reduced dose."	0
"Alpha1 antagonists, including doxazosin, have been associated with priapism (painful penile erection, sustained for hours and unrelieved by sexual intercourse or masturbation)."	0
Fluconazole is an inhibitor of CYP2C9 and CYP3A enzymes.	0
Administration of CARDIZEM (diltiazem hydrochloride) concomitantly with propranolol in five normal volunteers resulted in increased propranolol levels in all subjects and bioavailability of propranolol was increased approximately 50%.	1
"Endothelin receptor antagonists Bosentan <U+2191> Bosentan Co-administration of bosentan in patients on APTIVUS/ritonavir: In patients who have been receiving APTIVUS/ritonavir for at least 10 days, start bosentan at 62.5 mg once daily or every other day based upon individual tolerability."	0
The dispersion can also be administered through nasogastric or gastrostomy tubes.	0
"Similarly, patients who experience other symptoms or signs suggestive of decreased arterial flow, such as ischemic bowel syndrome or Raynaud's syndrome following the use of any 5-HT agonist are candidates for further evaluation. see WARNINGS: Fibrotic Complications The text of a patient information sheet is printed at the end of this insert."	0
Use of the products in combination may have an additive effect.	0
Ziprasidone dosed adjunctively to valproate in a maintenance trial of bipolar patients did not affect mean therapeutic valproate levels.	0
"Although ambrisentan has a 15-hour terminal half-life, the mean trough concentration of ambrisentan at steady-state is about 15% of the mean peak concentration and the accumulation factor is about 1.2 after long-term daily dosing, indicating that the effective half-life of ambrisentan is about 9 hours."	0
There is a linear correlation between plasma quinaprilat clearance and creatinine clearance.	0
Approximately 25% of digoxin in the plasma is bound to protein.	0
Tacrolimus: A prospective study in healthy Chinese volunteers (N=9) with CYP3A5 expressers showed a 2.5- to 4-fold increase in tacrolimus exposure when concomitantly administered with amlodipine compared to tacrolimus alone.	1
Inform patients of the increased risk of bleeding associated with the concomitant use of ZOLOFT and antiplatelet agents or anticoagulants.	0
"All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases."	0
"Avoid concomitant use of ELIQUIS with strong dual inducers of CYP3A4 and P-gp (e.g., rifampin, carbamazepine, phenytoin, St. John<U+2019>s wort) because such drugs will decrease exposure to apixaban."	1
Hypokalemia may be avoided or treated by potassium supplementation or increased intake of potassium-rich foods.	0
Clinically significant adverse reactions from greater exposures of CRIXIVAN.	0
On the basis of this experience the recommended dosage is 300 mg every 12 hours orally.	0
The exact relationship of these pharmacologic actions to the antihypertensive effect of clonidine has not been fully elucidated.	0
"In subjects who had received EMSAM 6mg per 24 hours for 11 days, combined administration with the CYP2C9 substrate ibuprofen (800mg single dose) did not affect the pharmacokinetics of either selegiline or ibuprofen."	0
Metabolism Tritium<U+2011>labeled epoprostenol has been administered to humans in order to identify the metabolic products of epoprostenol.	0
Renal clearance accounts for 39 to 69% of plasma clearance.	0
"Possible contributing factors include use for extended periods of time, higher than recommended dose, and/or use in combination with other anorectic drugs."	0
Gastrointestinal Decontamination All patients suspected of tricyclic antidepressant overdose should receive gastrointestinal decontamination.	0
Plasma concentrations of losartan and its active metabolite are similar in elderly and young hypertensives.	0
"Anticonvulsants:carbamazepine, clonazepam, ethosuximide <U+2191> anticonvulsants A dose decrease may be needed for these drugs when co-administered with ritonavir and therapeutic concentration monitoring is recommended for these anticonvulsants, if available."	1
Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.	1
"Drugs metabolized by CYP1A2, 2A6, 2C8, 2C9 and 2C19 In vitro, desvenlafaxine does not inhibit CYP1A2, 2A6, 2C8, 2C9, and 2C19 isozymes and would not be expected to affect the pharmacokinetics of drugs that are metabolized by these CYP isozymes."	0
"The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine; cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide)."	0
Concomitant use in patients taking thioridazine is contraindicated.	0
Effect of Baseline HCV Polymorphisms on Treatment Response Adults Genotype 1 Analyses were conducted to explore the association between pre-existing baseline NS5A polymorphisms at resistance-associated positions and relapse rates.	0
Any chloride deficit during thiazide therapy is generally mild and usually does not require specific treatment except under extraordinary circumstances (as in liver disease or renal disease).	0
"Dabigatran is not a substrate, inhibitor, or inducer of CYP450 enzymes."	0
", as clearance is reduced by more than 50%."	0
It increases to approximately 15% when dronedarone is administered with a high fat meal.	0
"A dose-related ( above 20 mg/kg/day ) incidence of myelocytic leukemia was observed in rats fed daily doses of potassium canrenoate ( a compound chemically similar to ALDACTONE and whose primary metabolite , canrenone , is also a major product of ALDACTONE in man ) for a period of one year ."	0
Risk from the lower dose of doxepin in Silenor can not be excluded.	0
"Fluconazole, with or without metabolic activation, was negative in tests for mutagenicity in 4 strains of S. typhimurium, and in the mouse lymphoma L5178Y system."	0
"With once daily dosing, steady state plasma concentrations are achieved within approximately one week."	0
Erythromycin: Combination increases pitavastatin exposure.	1
"Starting Dose Target Dose Adult Hypertension (2.1) 16 mg tablet once daily 8 <U+2013> 32 mg tablet total daily dose Pediatric Hypertension (1 to < 6 years) (2.2) 0.20 mg/kg oral suspension once daily 0.05 <U+2013> 0.4 mg/kg oral suspension once daily or consider divided dose Pediatric Hypertension (6 to < 17 years) (2.2) < 50 kg 4 <U+2013> 8 mg tablet once daily >50 kg 8 <U+2013> 16 mg tablet once daily < 50 kg 4 <U+2013> 16 mg tablet once daily or consider divided dose > 50 kg 4 <U+2013> 32 mg tablet once daily or consider divided dose Adult Heart Failure (2.3) 4 mg tablet once daily 32 mg tablet once dailyThe target dose is 32 mg once daily, which is achieved by doubling the dose at approximately 2-week intervals, as tolerated by patient Dosage must be individualized."	0
"There has been a long-standing concern, however, that antidepressants may have a role in inducing worsening of depression and the emergence of suicidality in certain patients during the early phases of treatment."	0
LEXIVA tablets may be taken with or without food.	0
Such episodes do not preclude subsequent successful titration of TOPROL-XL.	0
"If phototoxic reactions occur, the patient should be referred to a dermatologist and VFEND discontinuation should be considered."	0
"As with other beta blockers, when discontinuation of TENORMIN is planned, the patients should be carefully observed and advised to limit physical activity to a minimum."	0
"If triazolam is coadministered with nefazodone, a 75% reduction in the initial triazolam dosage is recommended."	1
"<U+2022>Bradycardia, hypotension, worsening heart failure/fluid retention may occur."	0
P-glycoprotein Substrates Digoxin Dronedarone increased digoxin exposure by inhibiting the P-gp transporter.	1
Drug Interactions Ketoconazole The coadministration of ketoconazole (a potent inhibitor of CYP3A and CYP4F) 200 mg twice-daily at steady-state and a single dose of fingolimod 5 mg led to a 70% increase in AUC of fingolimod and fingolimod-phosphate.	1
No dose adjustment is recommended for drugs metabolized by CYP3A.	0
Paroxetine demonstrated statistically significant superiority over placebo on both the CGI Improvement responder criterion and the Liebowitz Social Anxiety Scale (LSAS).	0
Non-renal routes of elimination have yet to be clarified.	0
A gradual reduction in the dose rather than abrupt cessation is recommended whenever possible.	0
The Rotachrom<U+00AE> Heparin chromogenic assay was used to measure the effect of apixaban on FXa activity in humans during the apixaban development program.	0
"Administration of TARKA 4/240 (4 mg trandolapril and 240 mg verapamil hydrochloride ER) with a high-fat meal does not alter the bioavailability of trandolapril whereas verapamil peak concentrations and area under the curve (AUC) decrease 37% and 28%, respectively."	1
"These studies have shown that mirtazapine acts as an antagonist at central presynaptic <U+03B1>2<U+2013>adrenergic inhibitory autoreceptors and heteroreceptors, an action that is postulated to result in an increase in central noradrenergic and serotonergic activity."	0
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus (5.6).	0
"Patients should inform their physician if they experience new or increased gambling urges, increased sexual urges or other intense urges while taking selegiline."	0
Patients with these diagnoses were generally excluded from clinical studies during the product's premarketing testing.	0
Dosage should be adjusted according to blood pressure response.	0
Coadministration of INVIRASE/ritonavir with rifampin due to the risk of severe hepatotoxicity.	0
"Because of the unpredictable pharmacokinetics of amiodarone, TIKOSYN should not be initiated following amiodarone therapy until amiodarone plasma levels are below 0.3 mcg/mL or until amiodarone has been withdrawn for at least three months."	0
"In healthy male patients (n=24), carbamazepine (400 mg b.i.d.) clearance about 2-fold, resulting in a decrease in average plasma mirtazapine concentrations of 60%."	1
Administer loperamide for late diarrhea of any severity.	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
"At least 10 days after starting REYATAZ/ritonavir, resume bosentan at 62.5 mg once daily or every other day based on individual tolerability."	0
"After one month, investigators were instructed to titrate study drug to 100mg once daily if the trough blood pressure goal (140/90mmHg) was not achieved."	0
"In some cases, a patient already receiving therapy with SURMONTIL may require urgent treatment with linezolid or intravenous methylene blue."	0
"In manic-depressive patients, nortriptyline hydrochloride may cause symptoms of the manic phase to emerge."	0
This test is a more specific measure of the effect of dabigatran than activated partial thromboplastin time (aPTT).	0
"For genotype 5 and 6, SVR12 was achieved in subjects who had baseline NS5B polymorphisms at positions associated with resistance to sofosbuvir and other nucleoside inhibitors (N=1 with N142T in genotype 5; N=1 with M289I in genotype 5; N=15 with M289L/I in genotype 6)."	0
"Antihypertensive Drugs Due to its alpha adrenergic antagonism, aripiprazole has the potential to enhance the effect of certain antihypertensive agents."	0
No gender-related dosage adjustment is necessary.	0
The pharmacokinetics of dronedarone and its N-debutyl metabolite both deviate moderately from dose proportionality: a 2-fold increase in dose results in an approximate 2.5 to 3.0-fold increase with respect to Cmax and AUC.	0
"Patients with involvement of the tongue, glottis or larynx are likely to experience airway obstruction, especially those with a history of airway surgery."	0
"Heart Failure: Perindoprilat clearance is reduced in congestive heart failure patients, resulting in a 40% higher dose interval AUC."	0
Other antiretrovirals: See prescribing information.	0
"In the RE-LY trial, the median (10th to 90th percentile) trough aPTT in patients receiving the 150 mg dose was 52 (40 to 76) seconds."	0
"The in vitro plasma protein binding of ziprasidone was not altered by warfarin or propranolol, two highly protein-bound drugs, nor did ziprasidone alter the binding of these drugs in human plasma."	0
"Monitor liver function before and during therapy, especially in patients with underlying hepatic disease, including hepatitis B and hepatitis C, or marked transaminase elevations (5.3, 8.6) Pancreatitis: Fatalities have occurred; suspend therapy as clinically appropriate (5.4) Allergic Reactions/Hypersensitivity: Allergic reactions have been reported and include anaphylaxis, toxic epidermal necrolysis, Stevens-Johnson syndrome, bronchospasm and angioedema."	0
"Presumably because angiotensin converting inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including quinapril) may be subject to a variety of adverse reactions, some of them serious."	0
"Angiotensin II is the principal pressor agent of the RAS and also stimulates aldosterone synthesis and secretion by adrenal cortex, cardiac contraction, renal resorption of sodium, activity of the sympathetic nervous system, and smooth muscle cell growth."	0
"<U+2022>Strong inhibitors of CYP2D6: Reduce BRINTELLIX dose by half when a strong CYP2D6 inhibitor (e.g., bupropion, fluoxetine, paroxetine, or quinidine) is coadministered (2.6 and 7.3)."	1
The recommended dose of XARELTO for the reduction in the risk of recurrence of DVT and/or PE after at least 6 months of standard anticoagulant treatment in patients at continued risk of DVT and/or PE is 10 mg taken orally once daily with or without food see Clinical Studies ( 14.3 ) .	0
"In these clinical trials, AHA reduced the pathologically elevated urinary ammonia and pH levels that result from the hydrolysis of urea by the enzyme, urease."	0
High doses (>200 mg/day) are not recommended.	0
DESOXYN tablets should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus.	0
"If a patient is taking TIKOSYN and requires anti-ulcer therapy, omeprazole, ranitidine, or antacids (aluminum and magnesium hydroxides) should be used as alternatives to cimetidine, as these agents have no effect on the pharmacokinetics of TIKOSYN."	0
Use BRILINTA with a daily maintenance dose of aspirin of 75-100 mg see Warnings and Precautions ( 5.2 ) and Clinical Studies ( 14.1 ) .	0
"Mercaptopurine is mutagenic in animals and humans, carcinogenic in animals, and may increase the risk of secondary malignancies."	0
"In such patients, obtain serum transaminase levels prior to therapy and every 2<U+2013>4 weeks while on therapy."	0
The pharmacodynamic (PD) half-life of the onset and offset of the hemodynamic effect of NATRECOR<U+00AE> is longer than what the PK half-life of 18 minutes would predict.	0
Concomitant administration may lead to severe hyperkalemia.	0
Procarbazine hydrochloride has not been adequately studied in animals for its effects on peri- and postnatal development.	0
"Quinidine: Diltiazem significantly increases the AUC(0-<U+221E>) of quinidine by 51%, T1/2 by 36%, and decreases its CLoral by 33%."	1
"Initiation of LEXIVA/ritonavir, a CYP3A inhibitor, in patients receiving medications metabolized by CYP3A or initiation of medications metabolized by CYP3A in patients already receiving LEXIVA/ritonavir, may increase plasma concentrations of medications metabolized by CYP3A."	1
"Patients with Hepatic Impairment The pharmacokinetics of abiraterone was examined in subjects with baseline mild (N=8) or moderate (N=8) hepatic impairment (Child-Pugh Class A and B, respectively) and in 8 healthy control subjects with normal hepatic function."	0
Renal Impairment In patients with severe renal impairment (ClCr less than 30 mL/min) the recommended initial dose is 2.5 mg once daily; titrate up slowly if needed.	0
"However, there was no consistent difference between the older and younger patients with respect to individual side effects."	0
"Several well-documented reports describe cases of profound hypotension, myocardial infarction, and death when immediate-release nifedipine was used in this way."	0
The time to achieve steady state pimozide concentrations is expected to be longer (approximately 2 weeks) in poor CYP 2D6 metabolizers because of the prolonged half-life.	0
The steady-state pharmacokinetics of nicardipine are similar in elderly hypertensive patients (greater than 65 years) and young healthy adults.	0
"For patients who cannot swallow tablets, the tablets may be crushed and added to a small amount of semi-solid food, all of which should be consumed immediately."	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
Monitoring of BCR-ABL Transcript Levels in Patients Who Discontinued Tasigna Monitor BCR-ABL transcript levels in patients eligible for treatment discontinuation using an FDA authorized test validated to measure molecular response levels with a sensitivity of at least MR4.5 (BCR-ABL/ABL <U+2264> 0.0032% IS).	0
"Teratogenicity studies with amiloride HCl in rabbits and mice given 20 and 25 times the maximum human dose, respectively, revealed no evidence of harm to the fetus, although studies showed that the drug crossed the placenta in modest amounts."	0
"DLIS are present in up to half of all neonates and in varying percentages of pregnant women, patients with hypertrophic cardiomyopathy, patients with renal or hepatic dysfunction, and other patients who are volume-expanded for any reason."	0
The primary metabolic pathway is hydroxylation on the indole ring followed by subsequent glucuronide or sulfate conjugation.	0
"No initial dosage adjustment is necessary for elderly patients or patients with renal impairment, including those on hemodialysis."	0
Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses.	0
Coadministration of SULAR with phenytoin should be avoided and alternative antihypertensive therapy should be considered.	0
Seizures have been reported with the coadministration of immediate-release fluvoxamine maleate tablets and lithium.	0
"REVATIO has vasodilatory properties, resulting in mild and transient decreases in blood pressure."	0
Peak plasma concentrations are attained within approximately 1 hour after oral administration.	0
Patients who wear contact lenses should be cautioned that treatment with CATAPRES tablets may cause dryness of eyes.	0
"In some cases, diabetic ketoacidosis has occurred."	0
APTIVUS oral solution co-administered with ritonavir capsules demonstrated similar effects as APTIVUS capsules co-administrated with ritonavir.	0
Combined P-gp and strong CYP3A4 inducers decrease exposure to rivaroxaban and may increase the risk of thromboembolic events .	0
Triamterene has been reported in renal stones in association with other calculus components.	0
The pharmacokinetics of dronedarone in other races has not been assessed.	0
"For patients who do not achieve a sUA less than 6 mg/dL after two weeks with 40 mg, ULORIC 80 mg is recommended."	0
It is desirable to monitor TCA plasma levels whenever a TCA is going to be coadministered with another drug known to be an inhibitor of P450 2D6.	0
"At steady state, administration of fluvastatin with the evening meal results in a 50% decrease in Cmax, an 11% decrease in AUC, and a more than two-fold increase in tmax as compared to administration 4 hours after the evening meal."	0
"Terbinafine has been shown to be active against most strains of the following microorganisms both in vitro and in clinical infections: Trichophyton mentagrophytes Trichophyton rubrum The following in vitro data are available, but their clinical significance is unknown."	0
For patients with renal impairment Reduce the starting dose to 200 mg in patients with moderate (creatinine clearance <U+2265>30 to <50 mL/min) and severe (creatinine clearance <30 mL/min) renal impairment.	0
Nisoldipine is highly metabolized; 5 major urinary metabolites have been identified.	0
"Sedative/hypnotics Orally administered midazolam, triazolam Triazolam and orally administered midazolam are extensively metabolized by CYP3A."	0
"Administration of atenolol, starting in the second trimester of pregnancy, has been associated with the birth of infants that are small for gestational age."	0
Lopinavir/ritonavir in combination with INVIRASE should be used with caution.	0
"No clinically meaningful change in selegiline exposure was seen when EMSAM was co-administered with alcohol, alprazolam, ibuprofen, olanzapine, risperidone, levothyroxine, and ketoconazole."	0
Intestinal biopsies of patients often demonstrated villous atrophy.	0
Angioedema associated with laryngeal edema can be fatal.	0
"At present, there is no way to predict who is likely to develop liver failure."	0
"The potential for these risks should not, however, prevent the proper management of pain in any given patient."	0
"In addition to the contraindications for all ZOLOFT formulations listed above, ZOLOFT oral solution is contraindicated in patients: Taking disulfiram."	0
QTc prolongation is directly related to the concentration of sotalol.	0
PROTONIX For Delayed-Release Oral Suspension - Oral Administration in Applesauce Open packet.	0
"Other Agents Antacids and buffered medications <U+2193> atazanavir Reduced plasma concentrations of atazanavir are expected if antacids, including buffered medications, are administered with REYATAZ."	1
"The CYP450 isozymes involved in the metabolism of warfarin include CYP2C9, 2C19, 2C8, 2C18, 1A2, and 3A4."	0
"Some signs and symptoms (anorexia, nausea, vomiting, and certain arrhythmias) can equally result from digoxin toxicity as from congestive heart failure."	0
CYMBALTA should be discontinued before initiating treatment with the MAOI.	0
"In vitro studies suggest the importance of atorvastatin metabolism by cytochrome P4503A4, consistent with increased plasma concentrations of atorvastatin in humans following co-administration with erythromycin, a known inhibitor of this isozyme."	1
<U+2022>REYATAZ 400 mg with ritonavir 100 mg once daily (all as a single dose with food) if taken with both tenofovir DF and an H2RA.	0
Special Populations Age: The pharmacokinetics of Zaleplon have been investigated in three studies with elderly men and women ranging in age from 65 to 85 years.	0
"Figure 2<U+2003><U+2022>Average Time Course for Effects of Dabigatran on aPTT, Following Approved PRADAXA Dosing Regimens in Patients with Various Degrees of Renal Impairment* *Simulations based on PK data from a study in subjects with renal impairment and PK/aPTT relationships derived from the RE-LY study; aPTT prolongation in RE-LY was measured centrally in citrate plasma using PTT Reagent Roche Diagnostics GmbH, Mannheim, Germany."	0
The recommended dosing regimen need not be altered in patients who received treatment with an IV or oral <U+03B2>-blocker during the acute phase of the myocardial infarction.	0
Acute hemolytic anemia has been reported in a patient treated with amprenavir.	0
"Like other antihypertensive agents , Tenex ( guanfacine hydrochloride ) should be used with caution in patients with severe coronary insufficiency , recent myocardial infarction , cerebrovascular disease , or chronic renal or hepatic failure ."	0
"However, during nightly use for an extended period, pharmacodynamic tolerance or adaptation to some effects of benzodiazepine hypnotics may develop."	0
"Coadministration of oral contraceptives increased maximum plasma concentration by 6%, decreased clearance by 32%, and increased half-life by 16%."	1
Phendimetrazine tartrate is not recommended in patients with known heart murmur or valvular heart disease.	0
Voriconazole REYATAZ/ritonavir in subjects with a functional CYP2C19 allele: <U+2193> voriconazole<U+2193> atazanavir REYATAZ/ritonavir in subjects without a functional CYP2C19 allele: <U+2191> voriconazole<U+2193> atazanavir The use of voriconazole in patients receiving REYATAZ/ritonavir is not recommended unless an assessment of the benefit/risk to the patient justifies the use of voriconazole.	0
"The AUC after morning dosing was, however, 11% less than that after evening dosing and the time to peak concentration after evening dosing occurred significantly later than that after morning dosing (5.6 vs. 3.5 hours)."	0
"Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan."	1
"In a clinical study, the pharmacokinetics of S-warfarin, a CYP2C9 substrate, were not significantly affected by duloxetine."	0
Irbesartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively binding to the AT1 angiotensin II receptor.	0
"During maintenance, the total daily dose may be given once daily at bedtime."	0
"Antidepressant: Paroxetine, trazodone <U+2193>Paroxetine <U+2191>Trazodone Any paroxetine dose adjustment should be guided by clinical effect (tolerability and efficacy)."	0
"The observed mean elimination half-lives for iloperidone, P88 and P95 in CYP2D6 extensive metabolizers (EM)are 18, 26, and 23 hours, respectively, and in poor metabolizers (PM) are 33, 37, and 31 hours, respectively."	0
"Dopamine in 5% Dextrose Injection should not be infused through ordinary intravenous apparatus, regulated only by gravity and mechanical clamps."	0
"<U+2022>CYP2B6 inducers: Dose increase may be necessary if coadministered with CYP2B6 inducers (e.g., ritonavir, lopinavir, efavirenz, carbamazepine, phenobarbital, and phenytoin) based on clinical exposure, but should not exceed the maximum recommended dose."	1
"Myelosuppression: Associated with neutropenia, thrombocytopenia and anemia."	0
Radionuclide angiography has confirmed that wall motion remained improved during increased oxygen demand.	0
INVIRASE must be used in combination with ritonavir because ritonavir significantly inhibits saquinavir's metabolism to provide increased plasma saquinavir levels.	1
AUC and Cmax in children were 1.5- to 2.7-fold higher than that in adolescents.	0
Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity.	1
Amlodipine Amlodipine binds to both dihydropyridine and nondihydropyridine binding sites.	0
"Perform complete blood counts every 2 weeks for the first 2 months and then monthly thereafter, or as clinically indicated."	0
"For patients receiving ELIQUIS 5 mg or 10 mg twice daily, the dose of ELIQUIS should be decreased by 50% when coadministered with drugs that are combined P-gp and strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir)."	1
The dialysis clearance of apixaban is approximately 18 mL/min.	0
Solid dosage forms of potassium chlorides have produced stenotic and/or ulcerative lesions of the small bowel and deaths.	0
Check liver enzyme tests before initiating therapy and as clinically indicated thereafter.	0
Severe hypercalcemia can be treated by acute hemodialysis and discontinuing PHOSLYRA therapy.	0
The potency and toxicity of the metabolites relative to bupropion have not been fully characterized.	0
The metabolic activation pathway involves sequential hydrolysis of the carboxyl ester moiety catalyzed by human cathepsin A (CatA) or carboxylesterase 1 (CES1) and phosphoramidate cleavage by histidine triad nucleotide-binding protein 1 (HINT1) followed by phosphorylation by the pyrimidine nucleotide biosynthesis pathway.	0
"In isolated cases, agranulocytosis, pancytopenia, and bone marrow depression may occur."	0
Parathyroid Hormone Analog Teriparatide Sporadic case reports have suggested that hypercalcemia may predispose patients to digitalis toxicity.	0
It reaches about 50% of its ultimate decrease in about 45 minutes.	0
"In clinical trials with cancer patients, safety and efficacy were similar in patients over 65 years of age and those under 65 years of age; there was an insufficient number of patients over 75 years of age to permit conclusions in that age-group."	0
Close supervision and careful adjustment of dosage is required when imipramine pamoate is administered concomitantly with anticholinergic drugs.	0
Hypothyroidism may reduce the requirements for digoxin.	0
"Advise patients to consult a physician if they develop signs or symptoms of heart failure, such as weight gain, dependent edema, or increasing shortness of breath."	0
Reports of transient and permanent blindness and significant partial vision loss have been reported with the use of 5-HT1 agonists.	0
"Use extreme caution when coadministering WELLBUTRIN XL with other drugs that lower the seizure threshold (e.g., other bupropion products, antipsychotics, antidepressants, theophylline, or systemic corticosteroids)."	0
The mildly alkaline nature of this diluent caused slight degradation of VFEND after 24 hours storage at room temperature.	0
"CYP 3A Inducers Avoid co-administration of CYP 3A inducers (e.g., rifampin, rifabutin, rifapentin, barbiturates, phenytoin, carbamazepine, St. John's Wort) with SAMSCA, as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment."	1
"Based on retrospective analysis, adverse events may be higher in the upper therapeutic range."	0
TPMT testing may also be considered in patients with abnormal CBC results that do not respond to dose reduction.	0
"For treatment-na<U+00EF>ve patients initiating treatment with INVIRASE/ritonavir, the recommended starting dose of INVIRASE is 500-mg twice daily with ritonavir 100-mg twice daily for the first 7 days of treatment."	0
"Because it is known that the risk of myopathy during treatment with HMG-CoA reductase inhibitors is increased with concurrent administration of other fibrates, LIPITOR should be administered with caution when used concomitantly with other fibrates."	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
Use with caution due to potential cardiac arrhythmias.	0
Coadministration of aspirin and nitroglycerin has been reported to result in increased nitroglycerin maximum concentrations by as much as 67 % and AUC by 73 % when administered as a single dose .	1
"In vitro radioligand binding studies indicate that paroxetine has little affinity for muscarinic, alpha1-, alpha2-, beta-adrenergic-, dopamine (D2)-, 5-HT1-, 5-HT2-, and histamine (H1)-receptors; antagonism of muscarinic, histaminergic, and alpha1-adrenergic receptors has been associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs."	0
Switching between Sevelamer Carbonate Tablets and Powder.	0
"The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the caucasian population (about 7% to 10% of Caucasians are so called <U+201C>poor metabolizers<U+201D>); reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African, and other populations are not yet available."	0
"Multiple dose coadministration of ambrisentan and cyclosporine resulted in an approximately 2-fold increase in ambrisentan exposure in healthy volunteers; therefore, limit the dose of ambrisentan to 5 mg once daily when coadministered with cyclosporine."	1
"Physicians should also note the results of a prospective longitudinal study of 201 pregnant women with a history of major depression, who were either on antidepressants or had received antidepressants less than 12 weeks prior to their last menstrual period, and were in remission."	0
"When transferring from lidocaine to mexiletine, the lidocaine infusion should be stopped when the first oral dose of mexiletine hydrochloride is administered."	0
"Increase the dose gradually to lower serum phosphorus levels to the target range, as long as hypercalcemia does not develop."	0
"In vitro, no detectable metabolism of ledipasvir by CYP enzymes has been observed."	0
"Serious, life-threatening, or fatal respiratory depression has been reported with the use of opioids, even when used as recommended."	0
Patients receiving continued paroxetine experienced a significantly lower relapse rate over the subsequent 24 weeks compared to those receiving placebo.	0
The steady-state pharmacokinetics of paroxetine was not altered when administered with digoxin at steady state.	0
"Drugs that elevate gastricpH (magnesium hydroxide/aluminum hydroxide, omeprazole) had no effect on STRATTERA bioavailability."	0
The need for continued treatment should be reassessed periodically.	0
"Monoamine Oxidase Inhibitors (MAOIs) - See CONTRAINDICATIONS , WARNINGS and DOSAGE AND ADMINISTRATION."	0
A capsule of DYAZIDE is bioequivalent to a single entity 25-mg hydrochlorothiazide tablet and 37.5-mg triamterene capsule used in the double-blind clinical trial below.	0
Worsening cardiac failure may occur during up-titration of TOPROL-XL.	0
"In addition to those conditions mentioned above, D.H.E."	0
Co-administration of cyclosporine A and bosentan resulted in markedly increased plasma concentrations of bosentan .	1
"Table 4: Sevelamer Carbonate Powder Preparation Instructions Amount of Renvela Powder Minimum Amount of Water for Dose Preparation (either ounces, mL, or tablespoon) Ounces mL Tablespoons 0.4 g 1 30 2 0.8 g 1 30 2 2.4 g 2 60 4 Instruct patients to stir the mixture vigorously (it does not dissolve), resuspend, if necessary, right before administration, and drink the entire preparation within 30 minutes."	0
"Assessments up to Cycle 2 Day 2 showed no large changes in the QTc interval (i.e., >20 ms) from baseline."	0
The infusion rate for which half the maximal effect is observed is approximately 10 mg/hour.	0
"While the withdrawal effects of Anafranil have not been systematically evaluated in controlled trials, they are well known with closely related tricyclic antidepressants, and it is recommended that the dosage be tapered gradually and the patient monitored carefully during discontinuation."	0
"During marketing of SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors), and SSRIs (Selective Serotonin Reuptake Inhibitors), there have been spontaneous reports of adverse events occurring upon discontinuation of these drugs, particularly when abrupt, including the following: dysphoric mood, irritability, agitation, dizziness, sensory disturbances (e.g., paresthesia, such as electric shock sensations), anxiety, confusion, headache, lethargy, emotional lability, insomnia, hypomania, tinnitus, and seizures."	0
"In an in vitro dissolution study, the release rate of diltiazem from CARDIZEM CD increased significantly as the alcohol percentage in the dissolution medium increased."	0
Do not share needles or other injection equipment.	0
"Cardiovascular events, including arterial vascular occlusive events, were reported in a randomized, clinical trial in newly diagnosed CML patients and observed in the postmarketing reports of patients receiving nilotinib therapy."	0
MULTAQ should be taken as one tablet with the morning meal and one tablet with the evening meal.	0
The systemic exposure of apixaban is 14% lower on dialysis when compared to not on dialysis.	0
"When using Meperidine Hydrochloride Injection with CYP3A4 inhibitors or discontinuing CYP3A4 inducers in Meperidine Hydrochloride Injection treated patients, monitor patients closely at frequent intervals and consider dosage reduction of Meperidine Hydrochloride Injection until stable drug effects are achieved [PRECAUTIONS; Drug Interactions, DOSAGE AND ADMINISTRATION]."	0
Therapy should be discontinued immediately upon the occurrence of palpitation or frequent headaches during therapy.	0
"Animal studies following oral administration suggest an initial preferential distribution in the lungs, brain, spleen, heart, and kidney."	0
"In healthy volunteers, amlodipine, phenytoin, glyburide, ranitidine, omeprazole, hormone replacement therapy (a combination of conjugated estrogens and medroxyprogesterone), antacid (aluminum and magnesium hydroxides), and theophylline did not affect the pharmacokinetics of TIKOSYN."	0
"Bradycardia generally occurred within hours to days, but in some cases up to 2 weeks after initiating antiviral treatment."	0
The systematic approach described above is currently recommended as a method to identify patients in whom D.H.E.	0
Consider discontinuation of Benicar in cases where no other etiology is found (5.5).	0
"Nortriptyline may impair the mental and/or physical abilities required for the performance of hazardous tasks, such as operating machinery or driving a car; therefore, the patient should be warned accordingly."	0
AVALIDE may be administered with or without food.	0
"Thus, multiple dose use of fluconazole at these doses is unlikely to have an effect on the efficacy of the combined oral contraceptive."	0
Clozapine: Elevated serum levels of clozapine have been reported in patients taking immediate-release fluvoxamine maleate tablets and clozapine.	1
Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.	0
"Concomitant use of PRIFTIN with other drugs metabolized by these enzymes, such as protease inhibitors and certain reverse transcriptase inhibitors, may cause a significant decrease in plasma concentrations and loss of therapeutic effect of the protease inhibitor or reverse transcriptase inhibitor."	1
"As tolerance to isosorbide dinitrate develops, the effect of sublingual nitroglycerin on exercise tolerance, although still observable, is somewhat blunted."	0
The interaction between cimetidine and chronically administered verapamil has not been studied.	0
"In clinical trials establishing the efficacy and safety of SAPHRIS, patients were instructed to avoid eating for 10 minutes following sublingual dosing."	0
Intestinal angioedema should be included in the differential diagnosis of patients on ACE inhibitors presenting with abdominal pain.	0
Obsessive-Compulsive Disorder (OCD)<U+2013>The effectiveness of sertraline in the treatment of OCD was demonstrated in three multicenter placebo-controlled studies of adult outpatients (Studies 1 to 3).	0
"Tryptophan: Tryptophan may enhance the serotonergic effects of fluvoxamine, and the combination should, therefore, be used with caution."	0
Adult dose: 8 mg taken within 30 minutes of going to bed.	0
Treatment should be initiated at a dose of 0.05 mg/kg preferably taken once at bedtime.	0
Many of these patients were seriously ill and receiving concomitant medications with known hematologic adverse effects.	0
An appropriate dose of nelfinavir with respect to safety and efficacy has not been established.	0
"Its apparent volume of distribution is 3.6 to 7.8 L/kg, consistent with measured plasma protein binding of 67.9%."	0
"Once improvement is noted, it is important for patients to continue drug treatment as directed by their physician."	0
Amlodipine: The pharmacokinetics of amlodipine are not significantly influenced by renal impairment.	0
"An observational case-crossover study evaluated the risk of NAION when PDE-5 inhibitor use, as a class, occurred immediately before NAION onset (within 5 half-lives), compared to PDE-5 inhibitor use in a prior time period."	0
"No clinically significant drug interactions have been observed in studies of azilsartan medoxomil or azilsartan given with amlodipine , antacids , chlorthalidone , digoxin , fluconazole , glyburide , ketoconazole , metformin , pioglitazone , and warfarin ."	0
"In patients receiving HCTZ alone, dofetilide AUC increased by 27% and Cmax by 21%."	1
"Beta blockers may mask tachycardia occurring with hypoglycemia, but other manifestations such as dizziness and sweating may not be significantly affected."	0
Other concomitant potent CYP3A inhibitors : Avoid use with ADCIRCA .	0
"Potent Inducers of CYP3A : Avoid use of ADCIRCA in patients chronically taking potent inducers of CYP3A ( e.g. , rifampin ) ."	0
Teratogenic Effects Pregnancy Category C SURMONTIL has shown evidence of embryotoxicity and/or increased incidence of major anomalies in rats or rabbits at doses 20 times the human dose.	0
"ACE is identical to kininase II, an enzyme that degrades bradykinin, a potent peptide vasodilator; whether increased levels of bradykinin play a role in the therapeutic effect of quinapril remains to be elucidated."	0
"Monoamine oxidase inhibitors: Rizatriptan is principally metabolized via monoamine oxidase, 'A' subtype (MAO-A)."	0
There is evidence that nicardipine increases blood flow.	0
"Duloxetine has no significant affinity for dopaminergic, adrenergic, cholinergic, histaminergic, opioid, glutamate, and GABA receptors in vitro."	0
"As with all antidepressants, LUVOX CR Capsules should be used cautiously in patients with a history of mania."	0
<U+2195> Diltiazem<U+2191> Felodipine (CYP3A substrate but not P-gp substrate)<U+2195> Nicardipine<U+2195> Nisoldipine (CYP3A substrate but not clear whether it is a P-gp substrate)<U+2195> Verapamil Caution is warranted and clinical monitoring of patients is recommended.	0
"Dosage adjustment of some CYP3A4 and CYP2C9 substrates may be warranted, as shown in Table 10."	0
"In animals, the ortho-hydroxy metabolite undergoes further glucuronidation."	0
"In several studies in which pregnant rats received fluconazole orally during organogenesis, maternal weight gain was impaired and placental weights were increased at 25 mg/kg."	0
"Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function."	0
"At that time, resumption of treatment with full-dose INVIRASE may be considered."	0
Take each Tasigna dose approximately 12 hours apart.	0
"Do not administer VASOTEC within 36 hours of switching to or from sacubitril/valsartan , a neprilysin inhibitor ( see WARNINGS ) ."	0
"Subsequently, the physician may continue decreasing the dose but at a more gradual rate."	0
Renal clearance of nebivolol is decreased in patients with severe renal impairment.	0
"In 2 controlled clinical studies in 1,105 patients, the 12-month incidence of persistent hepatic transaminase elevation without regard to drug relationship was 0.9% and 2.1% at the 40- and 80-mg dose, respectively."	0
In vitro studies show that clevidipine and its metabolite at the concentrations achieved in clinical practice will not inhibit or induce any CYP enzyme.	0
"Cleviprex should not be diluted, but it can be administered with the following: Water for Injection, USP Sodium Chloride (0.9%) Injection, USP Dextrose (5%) Injection, USP Dextrose (5%) in Sodium Chloride (0.9%) Injection, USP Dextrose (5%) in Ringers Lactate Injection, USP Lactated Ringers Injection, USP 10% amino acid"	0
"MethadoneResults based on in vivo clinical study following repeat oral dosing with 400 mg q12h for 1 day, then 200 mg q12h for 4 days voriconazole to subjects receiving a methadone maintenance dose (30<U+2013>100 mg q24h) (CYP3A4 Inhibition) Increased Increased plasma concentrations of methadone have been associated with toxicity including QT prolongation."	1
"Several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine, clonidine, or similar agents, and such an effect may be anticipated with CMI because of its structural similarity to other tricyclic antidepressants."	0
The recommended starting dose is 5 mg twice daily.	0
"Reproductive studies in rodents have demonstrated potential for embryotoxicity, increased neonatal mortality and nursing transfer of the drug."	0
"For example, when quinidine and verapamil are coadministered in doses that are each well tolerated as monotherapy, hypotension attributable to additive peripheral <U+03B1><U+2013>blockade is sometimes reported."	0
"Silenor is primarily metabolized by hepatic cytochrome P450 isozymes CYP2C19 and CYP2D6, and to a lesser extent, by CYP1A2 and CYP2C9."	0
The apparent volume of distribution at steady state ranged from 42 to 90 L. Eplerenone does not preferentially bind to red blood cells.	0
Acute interstitial nephritis has been observed in patients taking PPIs including ACIPHEX.	0
"Further, the sustained inhibition of cholesterol synthesis in the liver decreases levels of very low density lipoproteins."	0
No dosage adjustment is necessary in the elderly.	0
"Thus, an interaction between iloperidone and other CYP3A4 substrates is unlikely."	0
"The following symptoms, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric."	0
Mirtazapine is approximately 85% bound to plasma proteins over a concentration range of 0.01 to 10 mcg/mL.	0
"The renal clearances of hydrochlorothiazide and the pharmacologically active metabolite of triamterene, the sulfate ester of hydroxytriamterene, have been shown to be reduced and the plasma levels increased following triamterene and hydrochlorothiazide administration to elderly patients and patients with impaired renal function."	0
"Bleeding events related to SSRIs and SNRIs use have ranged from ecchymoses, hematomas, epistaxis, and petechiae to life-threatening hemorrhages."	0
"See CLINICAL PHARMACOLOGY, WARNINGS, ADVERSE REACTIONS and DOSAGE AND ADMINISTRATION sections."	0
"Consequently, caution is advised if concomitant administration of nefazodone and such drugs is required."	0
"Hence, it is not recommended to co-administer lopinavir/ritonavir and PREZISTA, with or without ritonavir. saquinavir <U+2193> darunavir<U+2194> saquinavir Appropriate doses of the combination have not been established."	0
Lower doses should be considered in patients with hepatic insufficiency.	0
"If an alternative treatment cannot be used, exercise caution and consider a dose reduction of the concomitant CYP2D6 substrate."	1
"Thrombocytopenia (platelets under 100,000)."	0
"Caution therefore should be exercised when using SULAR in patients with heart failure or compromised ventricular function, particularly in combination with a beta-blocker."	0
Increasing the dose from 5 mg to 10 mg twice daily (a two-fold increase) results in less than linear (1.7 times) increases in both the extent of exposure and maximum concentration.	0
Similar trends were observed in the clinical trials where Savella treatment was associated with mean increases in heart rate of approximately 7 to 8 beats per minute.	0
Restart PRADAXA as soon as medically appropriate.	0
"Apixaban has no direct effect on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin."	0
Results of in vitro studies demonstrate that duloxetine does not inhibit or induce CYP3A activity.	0
"There is no information available from adequate drug-drug interaction studies with the following classes of drugs: oral contraceptives, hormone replacement therapies, hypoglycemics, phenytoins, thiazide diuretics, and calcium channel blockers."	0
"It has been shown that patients who both have an endoscopically demonstrated ulcer larger than 1 cm and are also heavy smokers (i.e., smoke one pack of cigarettes or more per day) are more difficult to heal."	0
Follow patients closely for signs and symptoms of respiratory depression and sedation.	0
"Presumably due to the inhibition of the degradation of endogenous bradykinin, persistent nonproductive cough has been reported with all ACE inhibitors, always resolving after discontinuation of therapy."	0
Treatment should be administered for at least 2 weeks to decrease the likelihood of relapse.	0
Squamous cell carcinoma of the skin and melanoma have been reported during long-term VFEND therapy in patients with photosensitivity skin reactions.	0
"Ledipasvir is not an inhibitor of transporters MRP2, MRP4, OCT2, OAT1, OAT3, MATE1, and OCT1."	0
Lower dosages are also recommended for outpatients than for hospitalized patients who will be under close supervision.	0
"This effect may increase the risk of serious, potentially fatal, ventricular arrhythmias, such as Torsades de pointes type arrhythmias."	0
Titrateasneeded to 0.6 mg/kg once per day.	0
"Lipid disorders should be managed as clinically appropriate, taking into account any potential drug-drug interactions with NORVIR and HMG CoA reductase inhibitors."	0
"In a trial designed to examine the effects of carvedilol on glycemic control in a population with mild-to-moderate hypertension and well-controlled type 2 diabetes mellitus, carvedilol had no adverse effect on glycemic control, based on HbA1c measurements."	0
"An ECG should be performed prior to initiation of the concomitant therapy, and patients with a QT interval > 450 msec should not initiate the concomitant therapy."	0
"As the severity of CNS side effects increases with total daily dose, the dose should not exceed 1200 mg/day."	0
The development and health benefits of breastfeeding should be considered along with the mother<U+2019>s clinical need for lidocaine and any potential adverse effects on the breastfed infant from lidocaine or from the underlying maternal condition.	0
The clinical significance of the desipramine change is unknown.	0
CYP3A4 Inhibitors: Co-administration of a 180 mg daily dose of diltiazem with 5 mg amlodipine in elderly hypertensive patients resulted in a 60% increase in amlodipine systemic exposure.	1
"Although the acute intravenous administration of amlodipine decreases arterial blood pressure and increases heart rate in hemodynamic studies of patients with chronic stable angina, chronic oral administration of amlodipine in clinical trials did not lead to clinically significant changes in heart rate or blood pressures in normotensive patients with angina."	0
Dosage should be increased to at least 60 mg per day at a fairly rapid pace consistent with patient tolerance.	0
Concomitant use of verapamil is contraindicated.	0
"There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on suicide."	0
"Injection should be administered under carefully controlled conditions including monitoring of blood pressure, heart rate, and electrocardiogram."	0
Terminal half-life and total clearance appear to be independent of dose.	0
"Patients may develop an inflammatory response to indolent or residual opportunistic infections (5.7) Initiation of VIRACEPT, a CYP3A inhibitor, in patients receiving medications metabolized by CYP3A or initiation of medications metabolized by CYP3A in patients already receiving VIRACEPT, may increase plasma concentrations of medications metabolized by CYP3A."	1
At least 14 days should elapse between discontinuation of selegiline and initiation of treatment with a tricyclic antidepressant or selective serotonin reuptake inhibitors.	0
"Population Pharmacokinetics Age, gender, race, and renal and hepatic function were included as factors assessed in the population pharmacokinetic model to evaluate sildenafil pharmacokinetics in patients with PAH."	0
"Beta blockers , like BREVIBLOC injection , can cause depression of myocardial contractility and may precipitate heart failure and cardiogenic shock ."	0
The failure of insomnia to remit after 7 to 10 days of treatment may indicate the presence of a primary psychiatric and/or medical illness that should be evaluated.	0
"Risk factors for the development of hyperkalemia include renal insufficiency , diabetes mellitus , and the concomitant use of potassium-sparing diuretics , potassium supplements and/or potassium-containing salt substitutes , which should be used cautiously , if at all , with VASOTEC ( see Drug Interactions ) ."	0
Concomitant use of P-gp inhibitors in patients with renal impairment is expected to produce increased exposure of dabigatran compared to that seen with either factor alone.	1
Rifampin is readily absorbed from the gastrointestinal tract.	0
An initial Cleviprex infusion rate of 1-2 mg/hour is appropriate in these patients.	0
The cause of the increased risk of myopathy is not known.	0
Each syringe is intended for single dose only.	0
"Where possible, drug administration should be interrupted occasionally to determine if there is a recurrence of behavioral symptoms sufficient to require continued therapy."	0
Monitor serum potassium periodically during maintenance therapy to ensure potassium remains in desired range.	0
"For patients with lesser elevations of serum ALT or bilirubin and with an alternate probable cause, treatment with ULORIC can be used with caution."	0
"Hyponatremia may occur as a result of treatment with SSRIs and SNRIs, including CYMBALTA."	0
"There have been rare reports of serious cardiac adverse reactions, including acute myocardial infarction, occurring within a few hours following administration of MAXALT."	0
Patients should be counseled that antibacterial drugs including rifampin should only be used to treat bacterial infections.	0
"It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months."	0
NORVIR is contraindicated with drugs that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening reactions.	1
There was no significant difference in the incidence of the composite endpoint of cardiovascular morbidity and mortality.	0
"Healthcare professionals should pay special attention to accurate calculation of the dose of APTIVUS, transcription of the medication order, dispensing information and dosing instruction to minimize risk for medication errors, overdose, and underdose."	0
Treatment-naive patients with end-stage renal disease managed with hemodialysis should receive REYATAZ 300 mg with ritonavir 100 mg. REYATAZ is not recommended in HIV-treatment-experienced patients with end-stage renal disease managed with hemodialysis.	0
Monitoring Monitor serum potassium and adjust the dose based on serum potassium level.	0
"Cases of sudden decrease or loss of hearing, which may be accompanied by tinnitus and dizziness, have been reported in temporal association with the use of PDE-5 inhibitors, including REVATIO."	0
"Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from amiloride HCl, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother."	0
Adjustments of the warfarin dose may be necessary in order to maintain the desired level of anticoagulation.	0
"In vitro studies have demonstrated that at therapeutically relevant concentrations, d- and l-nebivolol do not inhibit any cytochrome P450 pathways."	0
"In general, sotalol is not recommended in patients with sick sinus syndrome associated with symptomatic arrhythmias, because it may cause sinus bradycardia, sinus pauses, or sinus arrest."	0
Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.	1
This compounding procedure results in a 1% w/v suspension containing 10 mg rifampin/mL.	0
"Because paroxetine is highly bound to plasma protein, administration of paroxetine to a patient taking another drug that is highly protein bound may cause increased free concentrations of the other drug, potentially resulting in adverse events."	1
Increased exposure may be associated with life-threatening reactions such as cardiac arrhythmias.	0
"If angioedema involves the tongue, glottis or larynx, airway obstruction may occur and be fatal."	0
Amiloride HCl usually begins to act within 2 hours after an oral dose.	0
"If anticholinergic effects are seen, the dose of procyclidine should be reduced."	0
"Table 4: Mean Hemodynamic Change from Baseline in the VMAC study Effects at 3 Hours Placebo(n=62) Nitroglycerin(n=60) NATRECOR<U+00AE> (n=124) Pulmonary capillary wedge pressure (mm Hg) -2.0 -3.8 -5.8 Right atrial pressure (mm Hg) 0.0 -2.6 -3.1 Cardiac index (L/min/M2) 0.0 0.2 0.1 Mean pulmonary artery pressure (mm Hg) -1.1 -2.5 -5.4 Systemic vascular resistance (dynes<U+2219>sec<U+2219>cm-5) -44 -105 -144 Systolic blood pressureBased on all treated patients: placebo n=142, nitroglycerin n=143, NATRECOR<U+00AE> n=204 (mm Hg) -2.5 -5.7 -5.6p <0.05 compared to placebo Figure 3: PCWP through 3 Hours in VMAC With this dosing regimen, 60% of the 3-hour effect on PCWP reduction is achieved within 15 minutes after the bolus, reaching 95% of the 3-hour effect within 1 hour."	0
"Skeletal muscle relaxants, nondepolarizing (eg, tubocurarine) <U+2013> Possible increased responsiveness to the muscle relaxant."	0
Careful monitoring of phenytoin concentrations in patients receiving DIFLUCAN and phenytoin is recommended.	0
"Since clozapine-related seizures and orthostatic hypotension appear to be dose related, the risk of these adverse reactions may be higher when fluvoxamine and clozapine are coadministered."	0
"In patients with moderate hepatic impairment, consideration should be given to initiation of DUTOPROL with lower doses of hydrochlorothiazide."	0
Patients currently using Focalin (dexmethylphenidate) may be switched to the same daily dose of Focalin XR.	0
"No data are available regarding the use of PREZISTA/ritonavir when co-administered to subjects with severe hepatic impairment; therefore, PREZISTA/ritonavir is not recommended for use in patients with severe hepatic impairment."	0
"With patients whose angina is complicated by congestive heart failure, care should be taken to differentiate this peripheral edema from the effects of increasing left ventricular dysfunction."	0
"There was no overall adverse effect on survival or cardiac morbidity (as defined by life-threatening arrhythmia, acute myocardial infarction, or hospitalization for worsened heart failure)."	0
"Carcinogenesis, Mutagenesis, Impairment of Fertility A 24-month study in rats at oral dosage levels of up to 100 mg/kg/day and a 21-month study in mice at oral dosage levels of up to 30 mg/kg/day showed no evidence of carcinogenicity."	0
"CALAN does not induce bronchoconstriction and, hence, does not impair ventilatory function."	0
<U+2022>Drugs that lower seizure threshold: Dose WELLBUTRIN XL with caution.	0
"The physician may adjust the dosage either upward or downward; or, increase or decrease the Lockout Interval, depending on patient response."	0
"In vitro studies indicate that LATUDA is not expected to inhibit transporters OATP1B1, OATP1B3, OCT1, OCT2, OAT1, OAT3, MATE1, MATE2-K and BSEP at clinically relevant concentrations."	0
Marplan should not be used in patients with known hypersensitivity to isocarboxazid.	0
Monitor renal function periodically in patients receiving telmisartan and NSAID therapy.	0
Alcohol Concomitant use of alcohol with phendimetrazine tartrate may result in an adverse drug reaction.	0
Co-administration of ritonavir in patients on ADCIRCA: Avoid use of ADCIRCA during the initiation of ritonavir.	0
"Nisoldipine should not be administered with grapefruit juice, as this has been shown, in a study of 12 subjects, to interfere with nisoldipine metabolism, resulting in a mean increase in Cmax of about 3-fold (ranging up to about 7-fold) and AUC of almost 2-fold (ranging up to about 5-fold)."	1
A decrease in metoprolol and propranolol clearance has been observed when either drug is administered concomitantly with verapamil.	1
The mean elimination half-life of quazepam and 2-oxoquazepam is 39 hours and that of N-desalkyl-2-oxoquazepam is 73 hours.	0
Soft contact lenses may be permanently stained.	0
No sex-related dosage adjustment is necessary.	0
"While these events are generally self-limiting, there have been reports of serious discontinuation symptoms."	0
The use of cimetidine tablets beyond 12 weeks has not been established.	0
"Because duloxetine is highly bound to plasma protein, administration of duloxetine to a patient taking another drug that is highly protein bound may cause increased free concentrations of the other drug, potentially resulting in adverse reactions."	1
Anti-gout:Colchicine <U+2191> colchicine concentration Patients with renal or hepatic impairment should not be given colchicine with CRIXIVAN.	0
"Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients whose depression is persistently worse, or who are experiencing emergent suicidality or symptoms that might be precursors to worsening depression or suicidality, especially if these symptoms are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
"This preferential effect is not absolute, however, and at higher plasma concentrations, metoprolol also inhibits beta2-adrenoreceptors, chiefly located in the bronchial and vascular musculature."	0
"Hepatic Impairment In most patients, initiate amlodipine therapy at 2.5 mg. Titrate slowly in patients with hepatic impairment."	0
For Direct Injection <U+2013>The usual dose is 50 to 100 mg administered intravenously under ECG monitoring.	0
"Following remission, maintenance medication may be required for a period of time and should be at the lowest dose that will maintain remission."	0
"Since nicardipine is metabolized in the liver, consider lower dosages and closely monitor response."	0
Patients should be warned not to drink alcoholic beverages while on Matulane therapy since there may be an Antabuse (disulfiram)-like reaction.	0
(B) SPINAL/EPIDURAL HEMATOMAEpidural or spinal hematomas may occur in patients treated with PRADAXA who are receiving neuraxial anesthesia or undergoing spinal puncture.	0
Mechanical prosthetic heart valve.	0
Phenobarbital induces many cytochrome P450 (oxidative) enzymes.	0
The absorption of iron and AHA from the intestinal lumen may be reduced when both drugs are taken concomitantly.	1
"Amiodarone is a substrate for CYP3A and CYP2C8, so inhibitors and inducers affect amiodarone exposure (7) Amiodarone inhibits p-glycoprotein and CYP1A2, CYP2C9, CYP2D6, and CYP3A, increasing exposure to other drugs (7) Drugs prolonging the QT interval: Co-administration of drugs prolonging the QT interval (such as class I and III antiarrhythmics, lithium, certain phenothiazines, tricyclic antidepressants, certain fluoroquinolone and macrolide antibiotics, azole antifungals, halogenated inhalation anesthetic agents) increases the risk of Torsade de Pointes."	0
"Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)."	0
"Effects of Other Drugs on CADUET Amlodipine: Co-administered cimetidine, magnesium-and aluminum hydroxide antacids, sildenafil, and grapefruit juice have no impact on the exposure to amlodipine."	0
"Ingestion of CRIXIVAN with a meal high in calories, fat, and protein reduces the absorption of indinavir."	1
The interaction between clozapine and other highly protein-bound drugs has not been fully evaluated but may be important.	0
"Reduction of digoxin dosage may be desirable prior to electrical cardioversion to avoid induction of ventricular arrhythmias, but the physician must consider the consequences of a rapid increase in ventricular response to atrial fibrillation if digoxin is withheld 1 to 2 days prior to cardioversion."	0
"In the cases of severe liver injury, there were significant underlying clinical conditions and/or the use of multiple concomitant medications."	0
"Anticancer Agents: dasatinib, nilotinib,venetoclax,vincristine,vinblastine <U+2191> anticancer agents For vincristine and vinblastine, consideration should be given to temporarily withholding the ritonavir containing antiretroviral regimen in patients who develop significant hematologic or gastrointestinal side effects when ritonavir is administered concurrently with vincristine or vinblastine.Clinicians should be aware that if the ritonavir containing regimen is withheld for a prolonged period, consideration should be given to altering the regimen to not include a CYP3A or P-gp inhibitor in order to control HIV-1 viral load.A decrease in the dosage or an adjustment of the dosing interval of nilotinib and dasatinib may be necessary for patients requiring co-administration with strong CYP3A inhibitors such as NORVIR."	0
"Drugs that induce CYP3A activity would be expected to increase the clearance of darunavir and ritonavir, resulting in lowered plasma concentrations of darunavir and ritonavir."	1
See INDICATIONS AND USAGE for concomitant use with other antihypertensive drugs.	0
Patients with a history of angioedema unrelated to ACE inhibitor therapy may be at increased risk of angioedema while receiving an ACE inhibitor.	0
Advise patients of signs and symptoms of blood loss and to report them immediately or go to an emergency room.	0
Institute such measures cautiously with frequent determinations of serum potassium levels.	0
"At doses ranging from 80 to 320 mg/kg (approximately 2 to 8 times the 400 mg clinical dose based on BSA), embryolethality in rats was increased and fetal abnormalities included wavy ribs, cleft palate, and abnormal cranio-facial ossification."	0
Administer ONIVYDE prior to leucovorin and fluorouracil.	0
Other P-gp substrates are expected to have increased exposure when coadministered with dronedarone.	1
The possibility of hypotensive effects with ALTACE can be minimized by either decreasing or discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with ALTACE.	0
"No teratogenic effects were observed in a study of embryo-fetal development in New Zealand White rabbits at oral doses of 5, 25, and 50 mg/kg or 10, 48, and 95 times the human therapeutic dose on a mg/m2 basis; however, in this study, the number of litters produced at the two higher doses was less than recommended for assessing teratogenic potential."	0
"The effect on vital signs (e.g., pulse and blood pressure) was approximately the sum of the effects of sildenafil and nebivolol."	0
Most patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy.	0
"If replacing clonidine by beta-blocker therapy, delay the introduction of beta-blockers for several days after clonidine administration has stopped."	0
"Postmarketing life-threatening cases of cardiac toxicity (including complete AV block, bradycardia, and cardiomyopathy), lactic acidosis, acute renal failure, CNS depression and respiratory complications leading to death have been reported, predominantly in preterm neonates receiving lopinavir/ritonavir oral solution which also contains the excipients ethanol and propylene glycol."	0
Serotonin release by platelets plays an important role in hemostasis.	0
"However, pharmacokinetic studies, including one conducted in the US, have demonstrated an approximate 2<U+2011>fold elevation in median exposure (AUC and Cmax) in Asian subjects when compared with a Caucasian control group."	0
Circulating drug also distributes into erythrocytes.	0
Co-administration of PREZISTA/ritonavir and avanafil is not recommended.	0
The protease inhibitor combinations lopinavir/ritonavir and atazanavir/ritonavir increase rosuvastatin exposure (AUC) up to threefold.	1
The antipsychotic activity of these metabolites is undetermined.	0
"Tachycardia (5.1)Glaucoma (5.2)Pyloric obstruction (5.3)Worsening urinary retention (5.4)Viscid bronchial plugs (5.5) When the recurrent use of atropine is essential in patients with coronary artery disease, the total dose should be restricted to 2 to 3 mg (maximum 0.03 to 0.04 mg/kg) to avoid the detrimental effects of atropine-induced tachycardia on myocardial oxygen demand."	0
Metabolism Bupropion is extensively metabolized in humans.	0
No dosage adjustment is recommended based on smoking status.	0
"Geriatric In elderly subjects (age 65 to 80 years), irbesartan elimination half-life was not significantly altered, but AUC and Cmax values were about 20% to 50% greater than those of young subjects (age 18 to 40 years)."	0
Advise women of childbearing potential that they must use effective contraception during CAPRELSA treatment and for at least four months following the last dose of CAPRELSA.	0
Determine cardiac rhythm at least once every 3 months.	0
"The risk differences (drug vs. placebo), however, were relatively stable within age strata and across indications."	0
"In mice, pimozide causes a dose-related increase in pituitary and mammary tumors."	0
Concomitant use of Marplan and other psychotropic agents is generally not recommended because of possible potentiating effects.	0
Alcohol by itself impairs performance and can cause sleepiness.	0
"Alpha-Blockers PDE5 inhibitors, including ADCIRCA, and alphaadrenergic blocking agents are both vasodilators with blood-pressure-lowering effects."	0
"Therefore, ACCURETIC is not recommended for use in these patients."	0
Special attention should be given to electrolyte and acid-base balance in patients experiencing severe or prolonged diarrhea or patients receiving concomitant diuretic drugs.	0
Hematologic toxicities are dose-related and may be more severe in renal transplant patients whose homograft is undergoing rejection.	0
"Co-administered Drug Dose of Co-administered Drug (mg) Ledipasvir Dose(mg) Sofosbuvir Dose(mg) N Mean Ratio (90% CI) of Coadministered Drug PK With/Without Ledipasvir, Sofosbuvir, or HARVONINo Effect=1.00 Cmax AUC Cmin NA = not available/not applicable, ND = not dosed."	0
ANTICONVULSANTS Carbamazepine PhenobarbitalPhenytoin <U+2193> nelfinavir <U+2193> phenytoin Concentrations of nelfinavir may be decreased.	1
It contains multiple amines separated by one carbon from the polymer backbone.	0
"*PA = conduction time from high to low right atrium; AH = conduction time from low right atrium to His bundle deflection, or AV nodal conduction time; HV = conduction time through the His bundle and the bundle branch-Purkinje system."	0
A concentration-dependent increase in anti-FXa activity was observed in the dose range tested and was similar in healthy subjects and patients with AF.	0
"Excretion In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean <U+00B1> SD) is 12 <U+00B1> 5 hours."	0
Patients should be advised of the following issues and asked to alert their prescriber if these occur while taking clomipramine hydrochloride.	0
"The capacity to mount a skin delayed-type hypersensitivity reaction to Candida and tetanus toxoid was decreased by approximately 30% in subjects on GILENYA 0.5 mg daily, compared to placebo."	0
These effects contribute to the reduction of blood pressure and usually are seen within 30minutes of drug administration.	0
It is not known whether this action is important at the doses used in man.	0
An appropriate adjustment in theophylline dose should be considered.	0
"The pharmacodynamic effect of ELIQUIS can be expected to persist for at least 24 hours after the last dose, i.e., for about two drug half-lives."	0
It is not possible to prescribe a single dosage schedule of SURMONTIL that will be therapeutically effective in all patients.	0
The father was on long-term azathioprine therapy.	0
The effects of ledipasvir or sofosbuvir on the exposure of coadministered drugs are shown in Table 8.	0
Whether any of the symptoms described above represent such a conversion is unknown.	0
"Redistribution/accumulation of body fat including central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, and ""cushingoid appearance"" have been observed in patients receiving antiretroviral therapy."	0
Periodically reassess to determine the need for maintenance treatment and the appropriate dose for such treatment.	0
Coadministration of bosentan in patients on VIRACEPT or coadministration of VIRACEPT in patients on bosentan:Start at or adjust bosentan to 62.5 mg once daily or every other day based upon individual tolerability.	0
"Avoid use of strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin) [see Clinical Pharmacology (12.3) ]."	0
"Administration of IV Remodulin with a high pH glycine diluent has been associated with a lower incidence of BSIs when compared to neutral diluents ( sterile water , 0.9 %   sodium chloride ) when used along with catheter care guidelines ."	0
"When blood pressure and heart rate stabilize, restart infusion at low doses such as 30 mL/hr to 50 mL/hr (3 mg/hr to 5 mg/hr) and titrate to maintain desired blood pressure."	0
"Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs."	0
The usual precautions should be observed in elderly patients who have concomitant medical illnesses or who are receiving concomitant drugs.	0
Patients receiving these combinations should be appropriately monitored.	0
The clinical importance and the mechanisms behind these interactions are not always known.	0
"Normal postural reflexes are intact; therefore, orthostatic symptoms are mild and infrequent."	0
The absolute difference translates into a proportional reduction of 15% (3.89-4.57/4.57 = -0.15).	0
The failure of insomnia to remit after 7 to 10 days of treatment may indicate the presence of a primary psychiatric and/or medical illness that should be evaluated.	0
"For children who cannot swallow tablets, an oral suspension may be substituted as described below: Preparation of Oral Suspension: ATACAND oral suspension can be prepared in concentrations within the range of 0.1 to 2.0 mg/mL."	0
The tablets can be dispersed in 2 ounces of water by stirring for approximately 10 minutes (will not completely dissolve).	0
"Sertraline hydrochloride administered in the late luteal phase of the menstrual cycle was significantly more effective than placebo on change from baseline to endpoint on the DRSP total score and the CGI-S score, as well as the CGI-I score at endpoint."	0
The concomitant use of paroxetine with MAOIs (including linezolid and intravenous methylene blue) is contraindicated.	0
"Patients with severe neutropenia (absolute neutrophil count < 1000 mm3) should discontinue Thioridazine Hydrochloride Tablets, USP and have their WBC followed until recovery."	0
"When duloxetine was administered (at a dose of 60mg twice daily) in conjunction with a single 50mg dose of desipramine, a CYP2D6 substrate, the AUC of desipramine increased 3-fold."	1
"Patients with typical BCR-ABL transcripts (i.e., 13a2/b2a2 or e14a2/b3a2) who achieve the sustained MR4.5criteria are eligible for discontinuation of Tasigna treatment."	0
HARVONI can be administered without regard to food.	0
In this study there was no evidence of a blunting of the antihypertensive action of VASOTEC .	0
These risk differences (drug-placebo difference in the number of cases of suicidality per 1000 patients treated) are provided in Table 1.	0
"The responder rate for GILENYA 0.5 mg as measured by the number of subjects with a >4-fold increase in KLH IgG was comparable to placebo and 25% lower for PPV-23 IgG, while the number of subjects with a >4 fold increase in KLH and PPV-23 IgM was 75% and 40% lower, respectively, compared to placebo."	0
"Effect of other drugs on amiodarone Amiodarone is metabolized to the active metabolite desethylamiodarone (DEA) by the cytochrome P450 (CYP450) enzyme group, specifically CYP3A and CYP2C8."	0
It interacts with a GABA-BZ receptor complex and shares some of the pharmacological properties of the benzodiazepines.	0
"Titration should be guided by clinical response, heart rate and QTc, with increased dosing being carried out in-hospital."	0
Dosage may be titrated upward until blood pressureis controlled or to a maximum total daily dose of 40 mg. Lotensin can also worsen renalfunction.	0
Consider a multi<U+2011>lumen catheter if other intravenous therapies are routinely administered.	0
Lidocaine hydrochloride exerts an antiarrhythmic effect by increasing the electrical stimulation threshold of the ventricle during diastole.	0
VIRACEPT Oral Powder should not be reconstituted with water in its original container.	0
"Doses of rifampin greater than 600 mg given once or twice weekly have resulted in a higher incidence of adverse reactions, including the ""flu syndrome"" (fever, chills and malaise), hematopoietic reactions (leukopenia, thrombocytopenia, or acute hemolytic anemia), cutaneous, gastrointestinal, and hepatic reactions, shortness of breath, shock, anaphylaxis, and renal failure."	0
Unchanged apixaban is the major drug-related component in human plasma; there are no active circulating metabolites.	0
The magnitude of CYP3A4-mediated drug interactions (effect on amprenavir or effect on coadministered drug) may change when LEXIVA is coadministered with ritonavir.	0
"Quinidine clearance is unaffected by hepatic cirrhosis, so the increased volume of distribution seen in cirrhosis leads to a proportionate increase in the elimination half<U+2013>life."	0
"Titrate based on heart rate, PR interval, blood pressure and symptoms."	0
In some patients these confusional states have been mild and have not required discontinuation of cimetidine.	0
Monitor for worsening and emergence of suicidal thoughts and behaviors (5.1).	0
Monitor neonates exposed to opioid analgesics during labor for signs of excess sedation and respiratory depression.	0
The time to liver injury for the reported liver failure cases resulting in death or transplant generally ranged from 2 weeks to 6 months on nefazodone therapy.	0
This finding is due to lack of specificity of the screening tests.	0
TENORETIC may potentiate the action of other antihypertensive agents used concomitantly.	0
A 30 to 45% increase in AUC and Cmax of nisoldipine was observed with concomitant administration of cimetidine 400 mg twice daily.	1
Discontinue CAPRELSA if ILD is confirmed.	0
Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents.	0
"Special Populations Geriatric Patients : In ESPS2, plasma concentrations (determined as AUC) of dipyridamole in healthy elderly subjects (>65 years) were about 40% higher than in subjects younger than 55 years receiving treatment with AGGRENOX."	0
The site of the action appears to be the distal convoluted tubule of the nephron.	0
"Concurrent administration of pindolol and thioridazine have resulted in moderate, dose related increases in the serum levels of thioridazine and two of its metabolites, as well as higher than expected serum pindolol levels."	1
Close supervision and careful adjustment of dosage are required when administering maprotiline concomitantly with anticholinergic or sympathomimetic drugs because of the possibility of additive atropine like effects.	0
"Ergot Derivatives Dihydroergotamine, ergotamine, methylergonovine Potential for acute ergot toxicity characterized by vasospasm and ischemia of the extremities and other tissues including the central nervous system."	0
"See WARNINGS, Fetal/Neonatal Morbidity andMortality."	0
ROZEREM should be administered with caution in subjects taking strong CYP2C9 inhibitors such as fluconazole.	0
"In a study of two subjects administered radiolabelled doxazosin 2 mg orally and 1 mg intravenously on two separate occasions, approximately 63% of the dose was eliminated in the feces and 9% of the dose was found in the urine."	0
Adults Quetiapine fumarate activity is primarily due to the parent drug.	0
Use caution in patients with portal hypertension.	0
"Compared to placebo, antigen-specific IgM titers were decreased by 91% and 25% in response to KLH and PPV-23, respectively, in subjects on GILENYA 0.5 mg."	0
No malformations were observed in the offspring as a result of nefazodone treatment.	0
Patients receiving this combination should be monitored for the development of zidovudine-related adverse reactions.	0
These recommendations are based on either drug interaction studies or they are predicted interactions due to the expected magnitude of interaction and potential for serious events or loss of efficacy.	0
Meperidine may aggravate pre-existing convulsions in patients with convulsive disorders.	0
The mean plasma elimination half-life is approximately 12 hours.	0
The pupillary dilation that occurs following use of many antidepressant drugs including ZOLOFT may trigger an angle closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy.	0
"Co-administration of SAMSCA with potent CYP 3A inducers ( e.g. , rifampin ) reduces tolvaptan plasma concentrations by 85 % ."	1
"Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors) In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including olmesartan medoxomil, may result in deterioration of renal function, including possible acute renal failure."	0
"Danazol, Diltiazem, Dronedarone or Verapamil: The risk of myopathy/rhabdomyolysis is increased by concomitant administration of danazol, diltiazem, dronedarone or verapamil particularly with higher doses of lovastatin."	0
Undiluted PROSTIN VR PEDIATRIC Sterile Solution may interact with the plastic sidewalls of volumetric infusion chambers causing a change in the appearance of the chamber and creating a hazy solution.	0
The dataset available for the population pharmacokinetic evaluation contained a wide range of demographic data and laboratory parameters associated with hepatic and renal function.	0
"Pharmacodynamics Blood pressure lowering drugs (e.g., diuretics, antihypertensive agents, or vasodilators): Risk of increased reduction in blood pressure (7.1) Remodulin inhibits platelet aggregation."	0
"Amiloride HCl is a potassium-conserving (antikaliuretic) drug that possesses weak (compared with thiazide diuretics) natriuretic, diuretic, and antihypertensive activity."	0
The metabolism and pharmacokinetics of REMERON (mirtazapine) Tablets may be affected by the induction or inhibition of drug-metabolizing enzymes.	0
"Urine, feces, saliva, sputum, perspiration, tears, and skin may be colored brown-orange with rifabutin and some of its metabolites."	0
Both pharmacodynamic and pharmacokinetic interactions have been reported with benzodiazepines.	0
Do not initiate NATRECOR<U+00AE> at a dose that is above the recommended dose.	0
LDL-C reduction is similar whether atorvastatin is given with or without food.	0
"Renal Insufficiency In patients with renal insufficiency, serum concentrations of olmesartan were elevated compared to subjects with normal renal function."	0
Bosentan is metabolized by CYP2C9 and CYP3A.	0
Cmax for fluoxetine following the 90 mg dose was approximately 1.7-fold higher than the Cmax value for the established 20 mg once-daily regimen following transition the next day to the once-weekly regimen.	0
Relapse during the double-blind phase was defined as the following conditions being met on two consecutive visits: (1) CGI-I <U+2265> 3; (2) CAPS-2 score increased by <U+2265> 30% and by <U+2265> 15 points relative to baseline; and (3) worsening of the patient's condition in the investigator's judgment.	0
Calcium excretion is decreased by thiazides.	0
There have been occasional reports of increased angina in a setting of beta blocker withdrawal and PROCARDIA initiation.	0
Unchanged ledipasvir is the major species present in feces.	0
"In the rat study, there was a decrease in fetal body weight at the highest dose tested."	0
"For this reason, the prescriber should be thoroughly familiar with the changes in kinetics associated with these different conditions."	0
"While taking <U+03B2>-blockers, patients with a history of severe anaphylactic reaction to a variety of allergens may be more reactive to repeated challenge, either accidental, diagnostic, or therapeutic."	0
This study determined the first-dose and steady-state effects of 500 mg of APTIVUS co-administered with 200 mg of ritonavir twice daily in capsule form.	0
Safety and effectiveness in pediatric patients have not been established.	0
"Disopyramide has been associated with severe bradycardia, asystole and heart failure when administered with beta blockers."	0
"Drugs Highly Bound to Plasma Protein Eszopiclone is not highly bound to plasma proteins (52-59% bound); therefore, the disposition of eszopiclone is not expected to be sensitive to alterations in protein binding."	0
Both procedures require the use of M tuberculosis H37Rv ATCC 27294 as a control organism.	0
"When MYCOBUTIN is used concomitantly with clarithromycin for MAC treatment, a decreased dose of MYCOBUTIN is recommended due to the increase in plasma concentrations of MYCOBUTIN."	1
"In patients who continue to form cystine stones on the above conservative program, THIOLA<U+00AE> may be added to the treatment program."	0
Concomitant administration of quinidine preceded the severe hypotension in 3 of the 8 patients (2 of whom developed pulmonary edema).	0
"More important, dofetilide is eliminated by cationic renal secretion, and three inhibitors of this process have been shown to increase systemic dofetilide exposure."	1
"Hyponatremia may occur as a result of treatment with SNRIs and SSRIs, including ZOLOFT."	0
"In addition, NS5B substitutions at highly conserved positions D61G (n=3), A112T (n=2), E237G (n=2), and S473T (n=1) were detected at low frequency by next generation sequencing in treatment failure subjects infected with HCV GT1a."	0
"The chronic administration of sertraline was found in animals to down regulate brain norepinephrine receptors, as has been observed with other drugs effective in the treatment of major depressive disorder."	0
"After chronic dosing of 80 mg three times a day sildenafil to patients with systemic hypertension, the mean change from baseline in systolic and diastolic blood pressures was a decrease of 9.4 mmHg and 9.1 mmHg, respectively."	0
"Although these events are generally self-limiting, some have been reported to be severe."	0
"Dosing adjustment for hepatically impaired patients <U+2014> For those ADHD patients who have hepatic insufficiency (HI), dosage adjustment is recommended as follows:For patients with moderate HI(Child-Pugh ClassB), initial and target doses should be reduced to 50%of the normal dose (for patients without HI)."	0
"LIPITOR is a selective, competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3-hydroxy-3-methylglutaryl-coenzyme A to mevalonate, a precursor of sterols, including cholesterol."	0
"Apixaban inhibits free and clot-bound FXa, and prothrombinase activity."	0
Patients should be carefully monitored for voriconazole-associated adverse reactions and loss of either voriconazole or atazanavir efficacy during the coadministration of voriconazole and REYATAZ/ritonavir.	0
The renin-angiotensin system (RAS) plays a critical role in kidney development.	0
"The diuretic should , if possible , be discontinued for two to three days before beginning therapy with VASOTEC to reduce the likelihood of hypotension ( see WARNINGS ) ."	0
"Substrates primarily metabolized by CYP2D6 (e.g., desipramine , atomoxetine, dextromethorphan, metoprolol, nebivolol, perphenazine, tolterodine) should be dosed at the original level when co-administered with PRISTIQ 100 mg or lower or when PRISTIQ is discontinued."	0
The benefit of maintaining pediatric patients (ages 6-15 years) with ADHD on STRATTERA after achieving a response in a dose range of 1.2 to 1.8 mg/kg/day was demonstrated in a controlled trial.	0
"In a meta-analysis of paroxetine from 4 studies done in healthy volunteers following multiple dosing of 20 mg/day to 40 mg/day, males did not exhibit a significantly lower Cmax or AUC than females."	0
Dosage reduction of ACCURETIC may be required.	0
Concomitant alpha-blockers or amlodipine: Note additive blood pressure lowering effects.	0
Several cases of Cushing's disease associated with this interaction have been reported in the literature.	0
"INVIRASE is contraindicated in patients with complete atrioventricular (AV) block without implanted pacemakers, or patients who are at high risk of complete AV block."	0
No formal drug interaction studies of methotrexate with PPIs have been conducted.	0
"In general, avoid combined use of RAS inhibitors."	0
"This suggests that, in general, relief of spasm or dilation of coronary arteries is not an important factor in classical angina."	0
"Families and caregivers of patients being treated with antidepressants for major depressive disorder or other indications, both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to healthcare providers."	0
"Additionally, treprostinil does not induce cytochrome P450 isoenzymes CYP1A2, CYP2B6, CYP2C9, CYP2C19, and CYP3A."	0
"However, a 3-fold increase in plasma exposure to tacrolimus in a renal transplant patient (CYP3A5 non-expresser) upon initiation of amlodipine for the treatment of post-transplant hypertension resulting in reduction of tacrolimus dose has been reported."	1
"Concomitant use of duloxetine (40mg once daily) with paroxetine (20mg once daily) increased the concentration of duloxetine AUC by about 60%, and greater degrees of inhibition are expected with higher doses of paroxetine."	1
"Altered anticoagulant effects, including increased bleeding, have been reported when SSRIs and SNRIs are coadministered with warfarin."	0
"Dilutional hyponatremia may occur in edematous patients in hot weather; appropriate therapy is water restriction, rather than administration of salt, except in rare instances when the hyponatremia is life threatening."	0
EXTRANEAL is intended for intraperitoneal administration only.	0
Symptoms include acute onset of decreased visual acuity or ocular pain and typically occur within hours to weeks of drug initiation.	0
Daily doses of rifampin should be given at least 1 hour before the ingestion of antacids.	0
"Therefore, APTIVUS should not be given with orally administered midazolam."	0
Tipranavir is principally metabolized by the liver.	0
It should not be used in patients with severe cardiac or vascular disorders whose condition would be expected to deteriorate if they experienced clinically important increases in blood pressure or heart rate.	0
Consult the dosing table for the specific formulation.	0
Reports included biopsy-proven cases of granulomatous interstitial nephritis associated with the deposition of atazanavir drug crystals in the renal parenchyma.	0
"Rarely, ACE inhibitors have been associated with a syndrome that starts with cholestatic jaundice and progresses to fulminant hepatic necrosis and sometimes death."	0
Doses higher than the adult maximum dose of 2500 mg per day have not been studied in children.	0
"If test results warrant therapy, physician should follow their local standards of practice and treatment guidelines."	0
"However, caution should be taken in the administration of carvedilol to patients suspected of having Prinzmetal<U+2019>s variant angina."	0
Avoid use of aliskiren with Lotensin in patients with renal impairment (GFR <60mL/min).	0
"Dyspnea was usually mild to moderate in intensity and often resolved during continued treatment , but led to study drug discontinuation in 0.9 % of BRILINTA and 0.1 % of clopidogrel patients in PLATO and 4.3 % of BRILINTA 60 mg and 0.7 % on aspirin alone patients in PEGASUS ."	0
Normotensive subjects experienced no clinically significant change in blood pressures (+1/<U+2013>2 mmHg).	0
"In subjects who had received EMSAM 6 mg per 24 hours for 7 days, co-administration with alprazolam (15 mg per day), a CYP3A4 and CYP3A5 substrate, did not affect the pharmacokinetics of alprazolam or selegiline."	0
Pediatric Dosage Guidelines for Oral Solution* Body Surface Area (m2) Twice Daily Dose 250 mg per m2 Twice Daily Dose 300 mg per m2 Twice Daily Dose 350 mg per m2 Twice Daily Dose 400 mg per m2 0.20 0.6 mL (50 mg) 0.75 mL (60 mg) 0.9 mL (70 mg) 1.0 mL (80 mg) 0.25 0.8 mL (62.5 mg) 0.9 mL (75 mg) 1.1 mL (87.5 mg) 1.25 mL (100 mg) 0.50 1.6 mL (125 mg) 1.9 mL (150 mg) 2.2 mL (175 mg) 2.5 mL (200 mg) 0.75 2.3 mL (187.5 mg) 2.8 mL (225 mg) 3.3 mL (262.5 mg) 3.75 mL (300 mg) 1.00 3.1 mL (250 mg) 3.75 mL (300 mg) 4.4 mL (350 mg) 5 mL (400 mg) 1.25 3.9 mL (312.5 mg) 4.7 mL (375 mg) 5.5 mL (437.5 mg) 6.25 mL (500 mg) 1.50 4.7 mL (375 mg) 5.6 mL (450 mg) 6.6 mL (525 mg) 7.5 mL (600 mg) *The concentration of the oral solution is 80 mg per mL.	0
"The effect of ADASUVE on QTc prolongation was evaluated in a randomized, double-blinded, positive- (moxifloxacin 400 mg) and placebo-controlled parallel study in healthy subjects."	0
Inhaled beta-agonist: Salmeterol <U+2191>Salmeterol Concurrent administration of salmeterol with LEXIVA is not recommended.	0
"The bioavailability of verapamil and norverapamil are increased by 87% and 77%, respectively, and that of trandolapril by approximately 35% in the elderly."	0
Bioavailability is proportional to dose from 10 to 30 mg; half-life does not change significantly with dose.	0
Urinary excretion of unchanged selegiline accounted for 0.1% of the applied dose with the remainder of the dose recovered in urine being metabolites.	0
This is not a clinically relevant change.	0
Hematologic Monitoring: periodic monitoring of CBC with differential is advised during prolonged therapy.	0
PROTONIX For Delayed-Release Oral Suspension Administer PROTONIX For Delayed-Release Oral Suspension approximately 30 minutes prior to a meal via oral administration in apple juice or applesauce or nasogastric tube in apple juice only.	0
Hepatic Impairment: The disposition of pitavastatin was compared in healthy volunteers and patients with various degrees of hepatic impairment.	0
"When a single oral 0.25 mg dose of triazolam was coadministered with nefazodone (200 mg BID) at steady state, triazolam half-life and AUC increased 4 fold and peak concentrations increased 1.7 fold."	1
Careful medical history is necessary since CDAD has been reported to occur over two months after the administration of antibacterial agents.	0
"After at least 10 days following the initiation of INVIRASE/ritonavir, resume bosentan at 62.5 mg once daily or every other day based upon individual tolerability."	0
The pharmacokinetics of nicardipine is linear over the dosage range of 0.5 mg/hr to 40 mg/hr.	0
"Older patients, on average, have (approximately doubled) higher blood levels and area under the plasma concentration time curve (AUC) than younger patients."	0
"Therefore, in patients taking clarithromycin, caution should be used when the LIPITOR dose exceeds 20 mg."	1
"Anyone considering the use of Lexapro or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need."	0
"In premature neonates , however , dobutamine is less effective than dopamine in raising systemic blood pressure without causing undue tachycardia , and dobutamine has not been shown to provide any added benefit when given to such infants already receiving optimal infusions of dopamine ."	0
Changes from Baseline in Hemodynamic Parameters at Week 12 [mean (95% CI)] for the REVATIO 20 mg Three Times a Day and Placebo Group Placebo(n = 65)The number of patients per treatment group varied slightly for each parameter due to missing assessments.	0
A patient whose blood pressure is not adequately controlled with 2.5-20 mg bisoprolol daily may instead be given ZIAC.	0
Delayed skeletal ossification was also noted in rabbit fetuses following intranasal administration of 3.6 mg/day (maternal exposures approximately 7 times human exposures at the MRDD) during organogenesis.	0
11 Pregnancy: Pregnancy Category D. IMURAN can cause fetal harm when administered to a pregnant woman.	0
Increases in INR and prothrombin time may lead to abnormal bleeding and even death.	0
Concomitant use of cimetidine is contraindicated.	0
CYP2C19 and CYP2B6 were also inhibited at concentrations of 100mcM or greater.	0
"Improper clamping or priming sequence may result in infusion of air into the peritoneal cavity, which may result in abdominal pain and/or peritonitis."	0
"A combination of multiple immunosuppressants, given concomitantly increases the risk of Epstein-Barr virus (EBV)-associated lymphoproliferative disorders."	0
Less than 5% of an oral dose of metoprolol is recovered unchanged in the urine; the rest is excreted by the kidneys as metabolites that appear to have no beta-blocking activity.	0
Terbinafine is distributed to the sebum and skin.	0
"Its effect is more potent on PDE-5 than on other known phosphodiesterases (10-fold for PDE6, greater than 80-fold for PDE1, greater than 700-fold for PDE2, PDE3, PDE4, PDE7, PDE8, PDE9, PDE10, and PDE11)."	0
"Patients should be treated for at least 14 days following resolution of symptoms or following last positive culture, whichever is longer."	0
"For patients unable to swallow a 40 mg tablet, two 20 mg tablets may be taken."	0
"Avoid use with strong inducers of CYP3A (e.g., rifampin, phenytoin, carbamazepine and phenobarbital) [see Clinical Pharmacology (12.3) ]."	0
"Examples desipramine, protriptyline From a pharmacokinetic perspective, no dose adjustment of VYVANSE is necessary when VYVANSE is co-administered with guanfacine, venlafaxine, or omeprazole."	0
"Most, but not all, of these patients had underlying anatomic or vascular risk factors for developing NAION, including but not necessarily limited to: low cup to disc ratio (crowded disc), age over 50, diabetes, hypertension, coronary artery disease, hyperlipidemia and smoking."	0
Reproduction studies have been carried out in rats and rabbits given rifabutin using dose levels up to 200 mg/kg (about 6 to 13 times the recommended human daily dose based on body surface area comparisons).	0
"If adequate suppression is achieved on a mexiletine hydrochloride dose of 300 mg or less every eight hours, the same total daily dose may be given in divided doses every 12 hours while carefully monitoring the degree of suppression of ventricular ectopy."	0
"However, systemic lupus erythematosus has not been reported following chlorthalidone administration."	0
"Sertraline hydrochloride administered daily throughout the menstrual cycle was significantly more effective than placebo on change from baseline to endpoint on the DRSP total score, the HAMD-17 total score, and the CGI-S score, as well as the CGI-I score at endpoint."	0
"They should also be cautioned to avoid foods with known high tyramine content such as wine, yogurt, ripe cheese and bananas."	0
Sotalol is eliminated principally via the kidneys through glomerular filtration and to a small degree by tubular secretion.	0
"Cleviprex is not a beta-blocker, does not reduce heart rate, and gives no protection against the effects of abrupt beta-blocker withdrawal."	0
Nebivolol is a <U+03B2>-adrenergic receptor blocking agent.	0
No dosage adjustment is necessary for patients with mild or moderate renal impairment.	0
"Closely monitor blood pressure , renal function and electrolytes in patients on Edarbi and other agents that affect the RAS ."	0
Candesartan is mainly excreted unchanged in urine and feces (via bile).	0
ZIAC should not be combined with other beta-blocking agents.	0
The risks of using olanzapine in combination with other drugs have not been extensively evaluated in systematic studies.	0
"The incidence of hypotension observed in 4,954 patients enrolled in clinical trials was 2.5%."	0
Concomitant use of cyclosporine and LASIX is associated with increased risk of gouty arthritis secondary to LASIX-induced hyperurecemia and cyclosporine impairment of renal urate excretion .	0
"When rapid control of ventricular arrhythmia is essential, an initial loading dose of 400 mg of mexiletine hydrochloride may be administered, followed by a 200 mg dose in eight hours."	0
"Concomitant use of prostaglandin synthase inhibiting drugs, eg, indomethacin, may decrease the hypotensive effects of beta blockers."	0
A few cases of lithium toxicity have been reported in patients receiving concomitant VASOTEC and lithium and were reversible upon discontinuation of both drugs .	1
Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.	0
"After dilution, TRISENOX is chemically and physically stable when stored for 24 hours at room temperature and 48 hours when refrigerated."	0
"The total warfarin (protein bound plus free drug) pharmacokinetics (AUC<U+03C4>,ss, Cmax,ss or tmax,ss) for both R- and S-warfarin were not altered by duloxetine."	0
Patients receiving warfarin therapy should be carefully monitored when Lexapro is initiated or discontinued.	0
Use of a diuretic may further increase the risk of lithium toxicity.	0
"Given the primary CNS effects of ziprasidone, caution should be used when it is taken in combination with other centrally acting drugs."	0
"Ritonavir initially inhibits and later induces CYP3A , the enzyme involved in the metabolism of tadalafil ."	0
"Should hypercalcemia develop, reduce the PHOSLYRA dosage or discontinue the treatment, depending on the severity of hypercalcemia."	0
There have been reports of pleural and retroperitoneal fibrosis in patients following prolonged daily use of injectable dihydroergotamine mesylate.	0
"At steady state the average bioavailability of metoprolol following administration of TOPROL-XL, across the dosage range of 50 to 400 mg once daily, was 77% relative to the corresponding single or divided doses of conventional metoprolol."	0
"The dose may be titrated, as needed to a maximum of 16 mg per day."	0
Drugs that slow gastrointestinal transit time: These agents (such as anticholinergics) can be expected to increase the gastrointestinal irritation produced by potassium salts.	0
"Inhibition of the metabolism of CYP2C19 substrates is therefore not anticipated, although clinical studies have not been performed."	0
"Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen."	0
"Therefore, the coadministration of drugs that inhibit P450 2D6 with thioridazine and the use of thioridazine in patients known to have reduced activity of P450 2D6 are contraindicated. for one week) on thioridazine steady-state concentration was evaluated in ten male inpatients with schizophrenia."	0
No clinically significant pharmacokinetic interaction has been found between trandolapril (or its metabolites) and digoxin.	0
Usual initial dose is 0.01 to 0.03 mg/kg.	0
No additional benefit has been demonstrated for doses higher than 1.2mg/kg/day.	0
"ALDACTONE in a dosage ranging from 25 mg to 100 mg daily is useful in treating a diuretic-induced hypokalemia , when oral potassium supplements or other potassium-sparing regimens are considered inappropriate ."	0
"Anti-infective:clarithromycin <U+2191> clarithromycin For patients with renal impairment, adjust clarithromycin dose as follows: For patients with CLCR 30 to 60 mL per min the dose of clarithromycin should be reduced by 50%."	1
"Co-administration of SAMSCA with potent CYP 3A inducers ( e.g. , rifampin ) reduces tolvaptan plasma concentrations by 85 % ."	1
"The elimination of ambrisentan is predominantly by non-renal pathways, but the relative contributions of metabolism and biliary elimination have not been well characterized."	0
"In a longer-term study, patients meeting (DSM-IV) criteria for major depressive disorder who had responded during an initial 8 to 12 weeks of acute treatment on REMERON were randomized to continuation of REMERON or placebo for up to 40 weeks of observation for relapse."	0
Monitor liver function tests prior to therapy and frequently thereafter.	0
"When vasodilators are used in combination, an additive effect on blood pressure may be anticipated."	0
"Based on a drug interaction study in healthy patients, febuxostat altered the metabolism of theophylline (a substrate of XO) in humans."	0
Administer TRISENOX intravenously over 2 hours.	0
Bradycardia generally resolved after discontinuation of antiviral treatment.	0
"There have been reports of agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress and feeding disorder in these neonates."	0
"Pharmacokinetics In a human pharmacokinetic study conducted with bosentan (250 mg/day) and an oral formulation of treprostinil (treprostinil diethanolamine), no pharmacokinetic interactions between treprostinil and bosentan were observed."	0
The recommended initial dose of AVAPRO is 150 mg once daily.	0
"Morphine - Co-administration of 5 mg intravenous morphine with 60 mg loading dose of prasugrel in healthy adults decreased the Cmax of prasugrel's active metabolite by 31% with no change in AUC, Tmax, or inhibition of ADP-induced platelet aggregation."	1
"Due to the similar degree of inhibition of adenosine uptake at these plasma concentrations, this food effect is not considered clinically relevant."	0
Whether any of the symptoms described above represent such a conversion is unknown.	0
A similar teratogenicity might be expected for THIOLA<U+00AE> although no such findings could be related to the drug in studies in mice and rats at doses up to 10 times the highest recommended human dose.There are no adequate and well-controlled studies in pregnant women.	0
Monitor closely when titrating nicardipine hydrochloride injection in patients with congestive heart failure or impaired hepatic or renal function.	0
"CYMBALTA should not be prescribed to patients with substantial alcohol use or evidence of chronic liver disease (5.2) Orthostatic Hypotension, Falls and Syncope: Cases have been reported with CYMBALTA therapy (5.3) Serotonin Syndrome: Serotonin syndrome has been reported with SSRIs and SNRIs, including with CYMBALTA, both when taken alone, but especially when co-administered with other serotonergic agents (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John's Wort)."	0
"CARDIZEM CD, 180 mg once daily, or placebo was administered in a double-blind study to patients receiving concomitant treatment with long-acting nitrates and/or beta-blockers."	0
"Initial phase (2 Months): PRIFTIN should be administered at a dose of 600 mg twice weekly for two months as directly observed therapy (DOT), with an interval of no less than 3 consecutive days (72 hours) between doses, in combination with other anti- tuberculosis drugs as part of an appropriate regimen which includes daily companion drugs such as isoniazid (INH), ethambutol (EMB) and pyrazinamide (PZA)."	0
"The elimination of the major metabolites of bupropion may be affected by reduced renal or hepatic function, because they are moderately polar compounds and are likely to undergo further metabolism or conjugation in the liver prior to urinary excretion."	0
"Atropine inhibits the muscarinic actions of acetylcholine on structures innervated by postganglionic cholinergic nerves, and on smooth muscles which respond to endogenous acetylcholine but are not so innervated."	0
"Thioridazine administration produces a dose-related prolongation of the QT interval, which is associated with serious ventricular arrhythmias, such as TorsadesdePointes-type arrhythmias, and sudden death."	0
Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents.	0
"Because dosages of this drug are titrated to response, no additives should be made to Lidocaine Hydrochloride and 5% Dextrose Injection, USP."	0
"If blood pressure still is not controlled, another antihypertensive agent may be added."	0
PRISTIQ is not approved for use in pediatric patients (8.4).	0
"In clinical studies in hypertensive patients with unilateral renal artery stenosis, treatment with ACE inhibitors was associated with increases in blood urea nitrogen and serum creatinine; these increases were reversible upon discontinuation of ACE inhibitor, concomitant diuretic, or both."	0
"The full significance of this finding is not known, but should be taken into consideration in the physician<U+2019>s and patient<U+2019>s decisions to use this drug product."	0
"Tricyclic antidepressants: Amitriptyline, imipramine <U+2191>Tricyclics Therapeutic concentration monitoring is recommended for tricyclic antidepressants. a See Clinical Pharmacology (12.3) Tables 10, 11, 12, or 13 for magnitude of interaction."	0
"In studies of hypertensive patients, there was no gender difference in half-life or accumulation, but somewhat higher plasma concentrations of irbesartan were observed in females (11% to 44%)."	0
"<U+2022> Pregnancy: REYATAZ 300 mg with ritonavir 100 mg once daily with food, with dosing modifications for some concomitant medications."	0
"Antiarrhythmics : The metabolism of quinidine , procainamide , flecainide can be inhibited by amiodarone ."	1
Epidemiological studies have shown that patients with Parkinson's disease have a higher risk (2-to approximately 6-fold higher) of developing melanoma than the general population.	0
Based on a finding of substantial interactions of fluvoxamine with certain of these drugs.	0
The dosage in digitalized patients with chronic atrial fibrillation ranges from 240 to 320 mg/day in divided (t.i.d.	0
"Concomitant administration of both a CYP2C9 inhibitor ( such as fluconazole or amiodarone ) and a strong CYP3A inhibitor ( e.g. , ketoconazole , itraconazole ) or a moderate CYP3A inhibitor ( e.g. , amprenavir , erythromycin , fluconazole , diltiazem ) with Tracleer will likely lead to large increases in plasma concentrations of bosentan ."	1
"Approximately 60 percent of the total dose of 300,000 units is excreted in the urine within this 5-hour period."	0
"Beta Blockers The hypotensive effects of beta blockers may be diminished by the concomitant administration of aspirin due to inhibition of renal prostaglandins, leading to decreased renal blood flow and salt and fluid retention."	0
In vitro drug interaction studies demonstrate that duloxetine does not induce CYP1A2 activity.	0
"The exact mechanism of the antidepressant action of venlafaxine in humans is unknown, but is thought to be related to the potentiation of serotonin and norepinephrine in the central nervous system, through inhibition of their reuptake."	0
An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy.	0
It takes approximately 3 months respectively to reach steady-state concentrations.	0
Stop the infusion immediately and drain the solution from the peritoneal cavity if any signs or symptoms of a suspected hypersensitivity reaction develop.	0
Discuss with patients the appropriate action to take in the event that they experience anginal chest pain requiring nitroglycerin following intake of ADCIRCA .	0
Patients with pre-existing conduction abnormalities or left ventricular dysfunction are particularly susceptible.	0
"In addition, drugs that are actively secreted via this route (e.g., triamterene, metformin, and amiloride) should be co-administered with care as they might increase dofetilide levels."	1
"Because PRADAXA can increase INR, the INR will better reflect warfarin<U+2019>s effect only after PRADAXA has been stopped for at least 2 days."	0
Dronedarone is extensively metabolized and has low systemic bioavailability; its bioavailability is increased by meals.	0
Correct electrolyte abnormalities prior to initiating Tasigna and monitor periodically during therapy.	0
"Hypokalemia may develop with LASIX , especially with brisk diuresis , inadequate oral electrolyte intake , when cirrhosis is present , or during concomitant use of corticosteroids , ACTH , licorice in large amounts , or prolonged use of laxatives ."	0
Discontinue PROTONIX if acute interstitial nephritis develops.	0
Doses above 2 mg/kg (or in excess of 200 mg) once daily have not been studied in pediatric patients.	0
TPMT genotyping or phenotyping can help identify patients who are at an increased risk for developing IMURAN toxicity.2-9.	0
"When duloxetine 60mg was co-administered with fluvoxamine 100mg, a potent CYP1A2 inhibitor, to male subjects (n=14) duloxetine AUC was increased approximately 6-fold, the Cmax was increased about 2.5-fold, and duloxetine t1/2 was increased approximately 3-fold."	1
Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have.	0
"Premature discontinuation of any oral anticoagulant, including ELIQUIS, in the absence of adequate alternative anticoagulation increases the risk of thrombotic events."	0
Triamterene is a weak folic acid antagonist and may contribute to the appearance of megaloblastosis in instances where folic acid stores are decreased.	0
Monitor heart rate in patients receiving concomitant diltiazem and clonidine.	0
Patients taking concomitant mTOR inhibitor (e.g. temsirolimus) therapy or a neprilysin inhibitor may be at increased risk for angioedema.	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
Remove clamp from solution line and flush new solution to flow into the drainage container for 5 seconds to prime the line.	0
Close supervision and careful adjustment of dosage are required when Anafranil is administered with anticholinergic or sympathomimetic drugs.	0
"Clozapine is a substrate for many cytochrome P450 isozymes, in particular CYP1A2, CYP3A4, and CYP2D6."	0
"Relapse occurred in 2 of 3 genotype 4 subjects who had baseline NS5B V321I, a polymorphism at a position associated with treatment failure to sofosbuvir and other nucleoside inhibitors; these two subjects also had baseline NS5A resistance-associated polymorphisms."	0
The red blood cell to plasma partitioning of dabigatran measured as total radioactivity is less than 0.3.	0
These interactions should be considered in patients taking NSAIDs including selective COX-2 inhibitors concomitantly with diuretics and angiotensin II antagonists or ACE inhibitors.	0
Amlodipine has indications other than hypertension which can be found in the Norvasc<U+00AE> package insert.	0
The clinical significance of these substitutions is currently unknown.	0
"Depending on the concentration of the drug and the fungal species test in vitro, terbinafine hydrochloride may be fungicidal."	0
"Therefore, the potential exists for drug interactions between WELLBUTRIN XL and drugs that are inhibitors or inducers of CYP2B6."	0
Its elimination half life is 13<U+2013>19 hours.	0
The heart rate effects could be clinically important in some PM patients.	0
"The mean AMBIEN elimination half-life was 2.6 (range: 1.4 to 4.5) and 2.5 (range: 1.4 to 3.8) hours, for the 5 and 10 mg tablets, respectively."	0
The tablet formulation is 100% bioavailable relative to solution.	0
The safety and efficacy of IMURAN for the treatment of Crohn's disease and ulcerative colitis have not been established.	0
"When the CYP2D6 inhibitor is withdrawn from the combination therapy, iloperidone dose could then be increased to previous levels."	1
"There were also no changes in the pharmacokinetics of nefazodone or its triazole-dione metabolite, but the AUC and Cmax of mCPP increased by 44% and 48%, respectively, while the AUC of HO-NEF decreased by 19%."	0
Oral contraceptives: Ethinyl estradiol <U+2193> Ethinyl estradiol Alternative or additional contraceptive measures should be used when estrogen-based oral contraceptives and INVIRASE/ritonavir are coadministered.	0
AUC and Cmax were similar in the patients compared with demographically matched healthy control subjects.	0
It is recommended that patients who are intermittent long-term users of D.H.E.	0
The frequency of TdP by dose is shown in Table 4.	0
"Trandolapril Component Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"Autonomic responses of the heart, including diurnal variation of heart rate and response to exercise, are not affected by fingolimod treatment."	0
"The precise mechanisms by which amlodipine relieves angina have not been fully delineated, but are thought to include the following: Exertional Angina: In patients with exertional angina, amlodipine reduces the total peripheral resistance (afterload) against which the heart works and reduces the rate pressure product, and thus myocardial oxygen demand, at any given level of exercise."	0
"In clinical trials with ALTACE, hyperkalemia (serum potassium >5.7 mEq/L) occurred in approximately 1% of hypertensive patients receiving ALTACE."	0
Cyclosporine: A prospective study in renal transplant patients (N=11) showed on an average of 40% increase in trough cyclosporine levels when concomitantly treated with amlodipine.	1
Such monitoring should include daily observation by families and caregivers.	0
"CYP2D6 and CYP3A4 Inhibitors Concomitant treatment with CLOZARIL and CYP2D6 or CYP3A4 inhibitors (e.g., cimetidine, escitalopram, erythromycin, paroxetine, bupropion, fluoxetine, quinidine, duloxetine, terbinafine, or sertraline) can increase clozapine levels and lead to adverse reactions."	1
"Since there is little clinical experience, the concomitant administration of paroxetine and warfarin should be undertaken with caution."	0
"Four positional isomers, 1-O, 2-O, 3-O, and 4-O-acylglucuronide exist, and each accounts for less than 10% of total dabigatran in plasma."	0
Healthy subjects who received rifampin 600 mg once daily concomitantly with saquinavir 1000 mg/ritonavir 100 mg twice daily (ritonavir-boosted saquinavir) developed severe hepatocellular toxicity.	0
"Tell patients receiving ACCURETIC to immediately report any signs or symptoms suggesting angioedema (swelling of face, eyes, lips, or tongue, or difficulty in breathing) and to temporarily discontinue Accuretic until after consulting with the prescribing physician."	0
Coadministration of Lexapro and metoprolol had no clinically significant effects on blood pressure or heart rate.	0
"In healthy subjects, the plasma clearance of tirofiban ranges from 213 to 314 mL/min."	0
INR is relatively insensitive to the exposure to dabigatran and cannot be interpreted the same way as used for warfarin monitoring.	0
"Families and caregivers of patients should be advised to look for the emergence of such symptoms on a day-to-day basis, since changes may be abrupt."	0
Nefazodone plasma concentrations were unaffected by triazolam.	0
"Thienopyridines inhibit platelet aggregation for the lifetime of the platelet (7-10days), so withholding a dose will not be useful in managing a bleeding event or the risk of bleeding associated with an invasive procedure."	0
Effects on development occurred at doses below those that produced evidence of significant maternal toxicity in these studies.	0
Mean digoxin AUC at steady state decreased by 15% in the presence of paroxetine.	1
Abnormal Bleeding: PRISTIQ may increase risk of bleeding events.	0
"Benzodiazepines: Benzodiazepines metabolized by hepatic oxidation (e.g., alprazolam, midazolam, triazolam, etc.) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine."	1
Cardioversion has been used safely and effectively after oral verapamil.	0
LUVOX CR Capsules or immediate-release fluvoxamine maleate tablets have not been evaluated or used to any appreciable extent in patients with a recent history of myocardial infarction or unstable heart disease.	0
Patient race and gender did not influence the blood pressure lowering effect of SULAR.	0
"Treatment of Pregnant Women During the Third Trimester: Neonates exposed to paroxetine and other SSRIs or SNRIs late in the third trimester have developed complications requiring prolonged hospitalization, respiratory support, and tube feeding."	0
Consider reducing the dose of concomitant diuretic to decrease the incidence of hypotension.	0
"Ergot Derivatives Dihydroergotamine, ergotamine, ergonovine, methylergonovine Potential for serious and/or life-threatening events such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues."	0
"Interstitial Lung Disease (ILD) or pneumonitis, including fatalities, has occurred in patients treated with CAPRELSA."	0
Concurrent use with chlorpropamide may increase the risk of severe hyponatremia.	0
Fill the dispenser with the prescribed dose from the cup.	0
"Avoid concomitant use of ELIQUIS with combined P-gp and strong CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin, St. John<U+2019>s wort) because such drugs will decrease exposure to apixaban."	1
"Although behaviors such as ""sleep-driving"" may occur with hypnotics alone at therapeutic doses, the use of alcohol and other CNS depressants with hypnotics appears to increase the risk of such behaviors, as does the use of hypnotics at doses exceeding the maximum recommended dose."	0
"Abrupt discontinuation or dose reduction has been associated with the appearance of new symptoms that include dizziness, nausea, headache, irritability, insomnia, diarrhea, anxiety, fatigue, abnormal dreams, and hyperhidrosis."	0
"A third metabolite, fluvoxethanol, formed by oxidative deamination, accounted for about 10%."	0
Onset of hydrochlorothiazide's diuretic effect occurs within 2 hours and the peak action takes place in 4 hours.	0
All the information is obtained from studies with oral aripiprazole.	0
"Nonteratogenic Effects: Neonates exposed to PEXEVA<U+00AE> and other SSRIs or serotonin and norepinephrine reuptake inhibitors (SNRIs), late in the third trimester have developed complications requiring prolonged hospitalization, respiratory support, and tube feeding."	0
"In the elderly (<U+2265>65 years), verapamil clearance is reduced resulting in increases in elimination half-life."	0
"Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior."	0
Dose Adjustment in Heart Failure Post-MI Serum Potassium (mEq/L) Dose Adjustment <5.0 25 mg every other day to 25 mg once daily25 mg once daily to 50 mg once daily 5.0<U+2013>5.4 No adjustment 5.5<U+2013>5.9 50 mg once daily to 25 mg once daily25 mg once daily to 25 mg every other day25 mg every other day to withhold <U+2265>6.0 Withhold and restart at 25 mg every other day when potassium levels fall to <5.5 mEq/L The recommended starting dose of INSPRA is 50 mg administered once daily.	0
"It should be noted that, in some cases, the clinical picture is consistent with serotonin syndrome."	0
"Warfarin acts by inhibiting the synthesis of vitamin K-dependent clotting factors, which include Factors II, VII, IX, and X, and the anticoagulant proteins C and S. Vitamin K is an essential cofactor for the post ribosomal synthesis of the vitamin K-dependent clotting factors."	0
The clearance is decreased resulting in a higher AUC in the elderly.	0
"However, initial dose modification is generally not necessary."	0
"There were suicides in the adult studies, but the number was not sufficient to reach any conclusion about drug effect on suicide."	0
"As with other calcium channel blockers, hemodynamic measurements of cardiac function at rest and during exercise (or pacing) in patients with normal ventricular function treated with NORVASC have generally demonstrated a small increase in cardiac index without significant influence on dP/dt or on left ventricular end diastolic pressure or volume."	0
Pregnant patients: 600 mg (one 600 mg tablet) taken with ritonavir 100 mg twice daily and with food.	0
The pharmacokinetics of acetylsalicylic acid was not characterized.	0
"Hepatotoxicity: Hepatic failure, sometimes fatal, has been reported in patients treated with CYMBALTA."	0
Dabigatran is metabolized to four different acyl glucuronides and both the glucuronides and dabigatran have similar pharmacological activity.	0
The difference between sertraline hydrochloride and placebo in reduction from baseline in the number of full panic attacks was approximately 2 panic attacks per week in both studies.	0
"If trazodone is used with a CYP3A4 inhibitor such as REYATAZ, the combination should be used with caution and a lower dose of trazodone should be considered."	1
Tipranavir is a CYP 3A substrate and a P-gp substrate.	0
"Renal impairment: Because renal excretion of unchanged zaleplon accounts for less than 1% of the administered dose, the pharmacokinetics of zaleplon are not altered in patients with renal insufficiency."	0
Pharmacokinetics of losartan and its active metabolite were generally similar across the studied age groups and similar to historical pharmacokinetic data in adults.	0
"Thus, although no death has been reported to result directly from THIOLA<U+00AE> treatment, a fatal outcome from THIOLA<U+00AE> is possible, as has been reported with d-penicillamine therapy from such complications as aplastic anemia, agranulocytosis, thrombocytopenia, Goodpasture<U+2019>s syndrome or myasthenia gravis."	0
These hematomas may result in long-term or permanent paralysis.	0
"Excretion: LIPITOR and its metabolites are eliminated primarily in bile following hepatic and/or extra-hepatic metabolism; however, the drug does not appear to undergo enterohepatic recirculation."	0
Use PROZAC with caution in combination with other drugs that cause QT prolongation.	0
Results of in vitro studies demonstrate that duloxetine does not inhibit CYP2C19 activity at therapeutic concentrations.	0
"Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8 fold increase in plasma AUC of the TCA)."	0
"): See WARNINGS AND PRECAUTIONS (5.9, 5.11)."	0
Apixaban has a total clearance of approximately 3.3 L/hour and an apparent half-life of approximately 12 hours following oral administration.	0
"On a mg/kg (quinapril/hydrochlorothiazide) basis, the doses used were up to 188/94 times (in rats) and 0.6/0.3 times (in rabbits) the maximum recommended human dose."	0
"Initiate Remodulin at a recommended dose of 10 % of the current Flolan dose , and then escalate as the Flolan dose is decreased ( see Table 2 for recommended dose titrations ) ."	0
The efficacy of Celexa as a treatment for depression was established in two placebo-controlled studies (of 4 to 6 weeks in duration) in adult outpatients (ages 18-66) meeting DSM-III or DSM-III-R criteria for major depression.	0
"In healthy volunteers and in patients, abnormalities in atrioventricular (AV) conduction were asymptomatic and generally limited to first-degree AV block."	0
Duloxetine is a moderate inhibitor of CYP2D6.	0
It exerts its diuretic effect on the distal renal tubule to inhibit the reabsorption of sodium in exchange for potassium and hydrogen.	0
"Digoxin: When telmisartan was co-administered with digoxin, median increases in digoxin peak plasma concentration (49%) and in trough concentration (20%) were observed."	1
Electrophysiologic Effects: NORVASC does not change sinoatrial nodal function or atrioventricular conduction in intact animals or man.	0
"Cardiac Electrophysiology In a randomized, positive- and placebo-controlled, parallel-group study, healthy subjects received either Letairis 10 mg daily followed by a single dose of 40 mg, placebo followed by a single dose of moxifloxacin 400 mg, or placebo alone."	0
Dosage must be individualized and may be increased after at least 2 weeks.	0
The body<U+2019>s handling of digoxin can be affected by many different patient-specific factors.	0
The oxidative metabolites are further metabolized by conjugation via glucuronidation and sulfation.	0
"Although there is no systematic evidence that stimulants cause aggressive behavior or hostility, patients beginning treatment for ADHD should be monitored for the appearance of or worsening of aggressive behavior or hostility."	0
MULTAQ is contraindicated in women who are or may become pregnant.	0
"If signs of hepatocellular damage occur, rifampin should be withdrawn."	0
Plasma drug levels may not reflect the severity of the poisoning.	0
Anafranil is contraindicated in patients with a history of hypersensitivity to Anafranil or other tricyclic antidepressants.	0
"Because of the very low dose of HCTZ employed, this may be less likely with ZIAC."	0
Patients receiving other drugs that interfere with hemostasis should be carefully monitored when BRINTELLIX is initiated or discontinued.	0
"Concomitant use of salmeterol and REYATAZ may result in increased risk of cardiovascular adverse reactions associated with salmeterol, including QT prolongation, palpitations, and sinus tachycardia."	0
Discontinue MAXALT if these disturbances occur.	0
"The absorption and metabolism are rapid, with peak plasma concentrations(Cmax) of the active metabolite occurring approximately 30minutes after dosing."	0
The maximum recommended dose of TWYNSTA tablets is 80/10 mg once daily.	0
Interference with Laboratory Tests ROZEREM is not known to interfere with commonly used clinical laboratory tests.	0
"Administration of ADASUVE resulted in rapid absorption of loxapine, with a median time of maximum plasma concentration (Tmax) of 2 minutes."	0
"Gender In a population analysis, the clearance rate for teriflunomide is 23% less in females than in males."	0
This unloading of the heart reduces myocardial energy consumption and oxygen requirements and probably accounts for the effectiveness of CALAN in chronic stable effort angina.	0
"Following an oral dose of 14C-labeled candesartan cilexetil, approximately 33% of radioactivity is recovered in urine and approximately 67% in feces."	0
Leukopenia and/or agranulocytosis and convulsive seizures have been reported but are infrequent.	0
"Management of some adverse reactions may require dose interruption, dose reduction, or permanent discontinuation of TRISENOX."	0
"Families and caregivers of patients being treated with drugs inhibiting the reuptake of norepinephrine and/or serotonin for major depressive disorder or other indications, both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to health care providers."	0
"Therefore, inhibitors of these isoenzymes may reduce sildenafil clearance and inducers of these isoenzymes may increase sildenafil clearance."	0
"Other strong CYP450 enzyme inducers, e.g., rifampicin, phenytoin, phenobarbital, and St. John<U+2019>s wort, may also reduce AUC of fingolimod and fingolimod-phosphate."	1
"Irbesartan Angiotensin II is a potent vasoconstrictor formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II)."	0
Monitoring of the serum potassium level is essential because mild hyperkalemia is not usually associated with an abnormal ECG.	0
"In two well-controlled studies of patients with obstructive airway disease treated with nicardipine capsules, no evidence of increased bronchospasm was seen."	0
Compared to normal subjects the total plasma clearance of losartan in patients with hepatic insufficiency was about 50% lower and the oral bioavailability was about 2-times higher.	0
"Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior."	0
Absorption Risperidone is well absorbed.	0
Monitor for signs or symptoms of relapse in patients with cavitary lesions or bilateral disease.	0
Fluconazole is cleared primarily by renal excretion as unchanged drug.	0
Patients should be advised to remain under the care of a physician when using CRIXIVAN and should not modify or discontinue treatment without first consulting the physician.	0
"In volunteers with mild to moderate (CLcr = 30 to 60 mL/min), moderate to severe (CLcr = 10 to 29 mL/min) or severe (receiving hemodialysis) renal impairment (N = 10 each group), the pharmacokinetics and protein binding of 200 mg sertraline per day maintained for 21 days were not altered compared to age-matched volunteers (N = 12) with no renal impairment."	0
"However, ondansetron mean plasma clearance was reduced by about 41% in patients with severe renal impairment (creatinine clearance < 30 mL/min)."	0
A small number of patients (29) ranging in age from 1 day to 6 months have been treated safely with DIFLUCAN.	0
ELIQUIS should be restarted after the surgical or other procedures as soon as adequate hemostasis has been established.	0
Carbamazepine: Elevated carbamazepine levels and symptoms of toxicity have been reported with the coadministration of immediate-release fluvoxamine maleate tablets and carbamazepine.	1
Hemodialysis has been shown to reduce penicillin G serum levels.	0
The consumption of alcohol during treatment with WELLBUTRIN XL should be minimized or avoided.	0
"Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)."	0
Anticoagulant therapy may be continued after cardioversion according to usual medical practice for the treatment of people with AF.	0
Notable requirements of the Letairis REMS program include the following: Prescribers must be certified with the program by enrolling and completing training.	0
Human pharmacokinetic studies with an oral formulation of treprostinil ( treprostinil diethanolamine ) indicated that co-administration of the cytochrome P450 ( CYP ) 2C8 enzyme inhibitor gemfibrozil increases exposure ( both Cmax and AUC ) to treprostinil .	1
The increase in Cmax for candesartan was 56% in patients with mild hepatic impairment and 73% in patients with moderate hepatic impairment.	0
"Anticoagulants:apixaban <U+2191> anticoagulant Concomitant use of apixaban and PREZISTA/ritonavir is not recommended. dabigatran etexilate The combination of PREZISTA/ritonavir and dabigatran etexilate is not recommended in specific renal impairment groups, depending on the indication."	0
"Based on preclinical studies, the 4'-hydroxyphenyl metabolite is approximately 13times more potent than carvedilol for <U+03B2>-blockade."	0
The use of Savella within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated.	0
The 0.4% solution (4 mg/mL) can be given at a rate of 15 to 60 mL/hr (0.25 to 1 mL/min).	0
Hepatic insufficiency The pharmacokinetics of irbesartan following repeated oral administration were not significantly affected in patients with mild to moderate cirrhosis of the liver.	0
"For children aged about 2 years and greater, with normal renal function, doses normalized for body surface area are appropriate for both initial and incremental dosing."	0
"When drug treatment was interrupted or discontinued in these patients, the transaminase levels usually fell slowly to pretreatment levels."	0
"These lists are not exhaustive, and the prescriber should consider the effects on CYP 3A4 of other agents being considered for concomitant use with dihydroergotamine."	0
"Whether increased levels of bradykinin, a potent vasodepressor peptide, play a role in the therapeutic effects of PRINIVIL remains to be elucidated."	0
Increases in serum uric acid and decreases in serum potassium are dose-related over the 15-50 mg/day range and beyond.	0
"MAO inhibitors, including NARDIL, are contraindicated in patients receiving guanethidine."	0
The incidence of epistaxis was also higher in REVATIO-treated patients with a concomitant oral vitamin K antagonist (9% versus 2% in those not treated with concomitant vitamin K antagonist).	0
Intraoperative Floppy Iris Syndrome (IFIS) has been observed during cataract surgery in some patients treated with alpha-1 blockers.	0
"Although, like other dihydropyridine calcium channel blockers, nisoldipine has negative inotropic effects in vitro, studies conducted in intact anesthetized animals have shown that the vasodilating effect occurs at doses lower than those that affect cardiac contractility."	0
Monitor ECG for excessive increase in QTc.	0
Monitoring Liver Function: Abnormalities of liver function have not been reported to date.	0
Discontinuation of Treatment with Lexapro: A gradual reduction in dose rather than abrupt cessation is recommended whenever possible (5.3).	0
Use the same FDA authorized test to consistently monitor molecular response levels while on and off treatment.	0
"<U+2022>Hepatic Impairment: Recommended adjustments for patients with mild, moderate, or severe hepatic impairment."	0
The effect of drugs that induce or inhibit other P450 enzymes on the exposure to zolpidem is not known.	0
"These reactions include: photosensitivity, hypoglycemia, portal hypertension and pancreatitis."	0
"Inducers of CYP2B6 Ritonavir and Lopinavir: In a healthy volunteer study, ritonavir 100 mg twice daily reduced the AUC and Cmax of bupropion by 22% and 21%, respectively."	1
"Sildenafil is only about 10-fold as potent for PDE-5 compared to PDE6, an enzyme found in the retina and involved in the phototransduction pathway of the retina."	0
"If a patient requires TIKOSYN and anti-ulcer therapy, it is suggested that omeprazole, ranitidine, or antacids (aluminum and magnesium hydroxides) be used as alternatives to cimetidine, as these agents have no effect on the pharmacokinetic profile of TIKOSYN."	0
Male rats treated with 5 and 10 mg/kg/day had an increased incidence of hepatocellular adenomas.	0
The differences in half-life for bupropion and the other metabolites in the 2 groups were minimal.	0
"Differentiation syndrome has been observed with and without concomitant hyperleukocytosis, and it has occurred as early as day 1 of induction to as late as thesecond month induction therapy."	0
"Two receptor subtypes, ETA and ETB, mediate the effects of ET-1 in the vascular smooth muscle and endothelium."	0
"Anesthetics: The depression of cardiac contractility, conductivity, and automaticity as well as the vascular dilation associated with anesthetics may be potentiated by calcium channel blockers."	0
"Chlorpromazine, clozapine, haloperidol, mesoridazine, phenothiazines, pimozide, sertindole, thioridazine ziprasidone Potential for serious and/or life threatening reactions such as cardiac arrhythmias."	0
"In turn, neither warfarin nor diazepam altered the binding of quetiapine."	0
There is limited information available on the use of ORAP in children under 12 years of age.	0
"Should symptoms persist, use slow IV infusion with patient flat in bed: 25 to 50 mg (1-2 mL) in 500 to 1000 mL of saline."	0
ApolipoproteinB also falls during treatment with MEVACOR.	0
"Information in the table applies to LEXIVA with or without ritonavir, unless otherwise indicated."	0
CYP3A4 Inducers: Avoid concomitant strong CYP3A4 inducers during ZYTIGA treatment.	0
Long-term effects of methamphetamine in children have not been established.	0
"A possible interaction resulting in acute renal failure has been reported in a few patients on DYAZIDE when treated with indomethacin, a nonsteroidal anti-inflammatory agent."	0
"In a separate study, five healthy adults were administered one million units of penicillin G intravenously, either as a bolus over 4 minutes or as an infusion over 60 minutes."	0
"Amnesia, anxiety and other neuro-psychiatric symptoms may also occur unpredictably."	0
"Concomitant administration of both a CYP2C9 inhibitor ( such as fluconazole or amiodarone ) and a strong CYP3A inhibitor ( e.g. , ketoconazole , itraconazole ) or a moderate CYP3A inhibitor ( e.g. , amprenavir , erythromycin , fluconazole , diltiazem ) with Tracleer will likely lead to large increases in plasma concentrations of bosentan ."	1
Lidocaine is incompatible with the following due to precipitate formation (includes but is not limited to): Amphotericin Cephazolin sodium Phenytoin sodium Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.	0
"Measurements of cardiac function in patients with normal ventricular function have generally found a small increase in cardiac index without major effects on ejection fraction, left ventricular end diastolic pressure (LVEDP), or volume (LVEDV)."	0
Paroxetine: Coadministration of single dose of eszopiclone and paroxetine produced no pharmacokinetic or pharmacodynamic interaction.	0
"While the presence of food in the gastrointestinal tract reduces systemic bioavailability, the lipid-lowering effects of the drug are similar whether taken with or 1 hour prior to meals."	1
"These reports included dizziness and light-headedness, but not syncope."	0
Such patients should be followed closely for the first two weeks of treatment and whenever the dose of ACCUPRIL and/or diuretic is increased.	0
"In a long-term trial in pediatric patients with PAH, an increase in mortality with increasing REVATIO dose was observed."	0
Doxepin increases systemic exposure of ramelteon; patients should be closely monitored when ramelteon is coadministered with doxepin.	1
"Therefore, dosage adjustment is not necessary for either drug when coadministered."	0
"If there is severe vomiting, abdominal pain or gastrointestinal bleeding, potassium citrate extended-release tablets should be discontinued immediately and the possibility of bowel perforation or obstruction investigated."	0
"Critical manifestations of overdose include: cardiac dysrhythmias, severe hypotension, convulsions, and CNS depression, including coma."	0
The effect was present for at least 7 days after the last dose of bupropion.	0
This sequence of events may account for two clinical findings reported to occur after several weeks of nightly use of rapidly eliminated benzodiazepine hypnotics: 1) increased wakefulness during the last third of the night and 2) the appearance of increased daytime anxiety after 10 days of continuous treatment.	0
The highest dofetilide dose administered for 24 months was 10 mg/kg/day to rats and 20 mg/kg/day to mice.	0
Dosage adjustment of the antidiabetic drug may be required when coadministered with hydrochlorothiazide.	0
"Therefore, clinical evaluation for tics and Tourette<U+2019>s syndrome in children and their families should precede use of stimulant medications."	0
"Consequently, it is recommended that nefazodone not be used in combination with carbamazepine."	0
"However, this co-administration of intramuscular lorazepam and intramuscular olanzapine for injection added to the somnolence observed with either drug alone."	0
"Additionally, no dosage adjustment is required for diazepam, lithium, atenolol, tolbutamide, digoxin, and drugs metabolized by CYP3A4, when ZOLOFT is administered concomitantly."	0
"Concomitant use of fluconazole and erythromycin has the potential to increase the risk of cardiotoxicity (prolonged QT interval, torsade de pointes) and consequently sudden heart death."	0
"Based on the assumption that the relationship between paroxetine<U+2019>s in vitro Ki and its lack of effect on terfenadine<U+2019>s in vivo clearance predicts its effect on other CYP3A4 substrates, paroxetine<U+2019>s extent of inhibition of CYP3A4 activity is not likely to be of clinical significance."	0
Sertraline Concomitant administration of zolpidem and sertraline increases exposure to zolpidem.	1
The dynamic component of BPH is associated with an increase in smooth muscle tone in the prostate and bladder neck.	0
Monitor for signs and symptoms of heart failure.	0
"If agitation is present, it may be increased with NARDIL."	0
"Abrupt withdrawal of beta blockade might precipitate a thyroid storm; therefore, patients suspected of developing thyrotoxicosis from whom TENORMIN therapy is to be withdrawn should be monitored closely."	0
"In several well-controlled studies , guanfacine was administered together with diuretics with no drug interactions reported ."	0
Chronic abusive use can lead to marked tolerance and psychological dependence with varying degrees of abnormal behavior.	0
The bottle should be shaken vigorously for at least 30 seconds to ensure the oral suspension is well mixed.	0
Salicylate metabolism is saturable and total body clearance decreases at higher serum concentrations due to the limited ability of the liver to form both salicyluric acid and phenolic glucuronide.	0
The hydrochlorothiazide component of ACCURETIC may decrease serum PBI levels without signs of thyroid disturbance.	0
Titration of dose or discontinuance of diethylpropion hydrochloride may be necessary.	0
The DIAMOND CHF and MI trials examined mortality in patients with structural heart disease (ejection fraction <U+2264>35%).	0
Animal data have suggested the possibility of interaction between perindopril and gentamicin.	0
"With greater impairment, however, peak and trough lisinopril levels increase, time to peak concentration increases and time to attain steady state is prolonged."	0
Change in Cmax See Sections 5.1 and 7 for clinical significance.	0
"If concomitant treatment with sumatriptan and an SSRI (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline, citalopram) is clinically warranted, appropriate observation of the patient is advised."	0
Monitor these patients and adjust the dose of the concomitant drug(s) metabolized by CYP1A2 as required.	0
"In healthy volunteers, plasma concentrations of this metabolite are approximately 40% of those seen for sildenafil, so that the metabolite accounts for about 20% of sildenafil's pharmacologic effects."	0
The pharmacokinetic profile of bisoprolol fumarate has been examined following single doses and at steady state.	0
"Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) including selective Cyclooxygenase-2 inhibitors (COX-2 inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors with agents that affect the RAAS, including aliskiren, may result in deterioration of renal function, including possible acute renal failure."	0
"The combination may result in increased risk of cardiovascular adverse events associated with salmeterol, including QT prolongation, palpitations and sinus tachycardia."	0
"CNS In patients with CNS depression, early intubation is advised because of the potential for abrupt deterioration."	0
Screening Patients for Bipolar Disorder: A major depressive episode may be the initial presentation of bipolar disorder.	0
"In Regimen A, each patient received a loading dose of 15 mg/kg of quinidine base (that is, 24 mg/kg of quinidine gluconate) in 250 mL of normal saline infused over 4 hours."	0
"Tasigna is an inhibitor of CYP3A4, CYP2C8, CYP2C9, and CYP2D6."	0
"Although trough citalopram plasma levels were unaffected, given the enzyme-inducing properties of carbamazepine, the possibility that carbamazepine might increase the clearance of citalopram should be considered if the two drugs are coadministered."	1
"Hydrochlorothiazide Thiazides should be used with caution in patients with impaired hepatic function or progressive liver disease, since minor alterations of fluid and electrolyte balance may precipitate hepatic coma."	0
"The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine; cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide)."	0
Monitor renal function periodically in patients receiving azilsartan and NSAID therapy .	0
This was expected because zaleplon is primarily metabolized and renal excretion of unchanged zaleplon accounts for less than 1% of the administered dose.	0
Patients should avoid grapefruit juice because it may inhibit the metabolism of pimozide by CYP 3A4.	1
"Patients receiving coadministration of ACE inhibitor and mTOR inhibitor (e.g.,temsirolimus, sirolimus, everolimus) therapy may be at increased risk for angioedema."	0
It does not require antithrombin III for antithrombotic activity.	0
"PDE5 inhibitor Sildenafilb (Revatio<U+00AE>) when used for the treatment of pulmonary arterial hypertension (PAH) Potential for sildenafil-associated adverse events, including visual abnormalities, hypotension, prolonged erection, and syncope."	0
Tadalafil: no more than 10mg every 72hours.	0
"A mass balance study using 14C-sevelamer hydrochloride, in 16 healthy male and female volunteers showed that sevelamer hydrochloride is not systemically absorbed."	0
"Another ACE inhibitor, captopril, has been shown to cause agranulocytosis and bone marrow depression rarely in patients with uncomplicated hypertension, but more frequently in patients with renal impairment, especially if they also have a collagen vascular disease, such as systemic lupus erythematosus or scleroderma."	0
Avoid use of ADCIRCA during the initiation of ritonavir .	0
Effects on male fertility have not been determined.	0
Patients should be advised of the following issues and asked to alert their prescriber if these occur while taking Nardil.	0
The administration of Meperidine Hydrochloride Injection may result in severe hypotension in the postoperative patient or any individual whose ability to maintain blood pressure has been compromised by a depleted blood volume or the administration of drugs such as the phenothiazines or certain anesthetics.	0
Both the risk of developing the syndrome and the likelihood that it will become irreversible are believed to increase as the duration of treatment and the total cumulative dose of antipsychotic drugs administered to the patient increase.	0
Methamphetamine should not be given to patients who are in an agitated state or who have a history of drug abuse.	0
"Perphenazine is extensively metabolized in the liver to a number of metabolites by sulfoxidation, hydroxylation, dealkylation, and glucuronidation."	0
"Acetohydroxamic acid should not be used in: patients whose physical state and disease are amenable to definitive surgery and appropriate antimicrobial agents patients whose urine is infected by non-urease producing organisms patients whose urinary infections can be controlled by culture-specific oral antimicrobial agents patients whose renal function is poor (i.e., serum creatinine more than 2.5 mg/dl and/or creatinine clearance less than 20 ml/min) female patients who do not evidence a satisfactory method of contraception patients who are pregnant Acetohydroxamic acid may cause fetal harm when administered to a pregnant woman."	0
Pregnant Women NORVIR oral solution is not recommended during pregnancy due to its ethanol content.	0
"In more than half of the reported cases, treatment with PIs was continued or reintroduced if treatment had been discontinued."	0
"Strong CYP3A4 inhibitors: Simvastatin, like several other inhibitors of HMG-CoA reductase, is a substrate of CYP3A4."	0
Fluconazole doses >200 mg/day are not recommended.	0
"When used concomitantly, titrate anesthetics and calcium blockers slowly."	0
"The interaction between CMI and other highly protein-bound drugs has not been fully evaluated, but may be important."	0
PROCARDIA regularly reduces arterial pressure at rest and at a given level of exercise by dilating peripheral arterioles and reducing the total peripheral resistance (afterload) against which the heart works.	0
"No significant accumulation of atenolol occurs until creatinine clearance falls below 35 mL/min/1.73m2 (normal range is 100-150 mL/min/1.73m2); therefore, the following maximum dosages are recommended for patients with renal impairment."	0
"However, at steady state, approximately dose-proportional changes with respect to AUC (area under the curve), peak, and minimum clozapine plasma concentrations were observed after administration of 37.5, 75, and 150 mg twice daily."	0
At higher doses (<U+2265> 20 mg) bisoprolol fumarate also inhibits beta2-adrenoreceptors located in bronchial and vascular musculature.	0
Avoid concomitant administration of drugs that can lead to electrolyte abnormalities.	0
"HALCION is contraindicated with ketoconzaole, itraconazole, nefazodone, and several HIV protease inhibitors."	0
"The following dose adjustments are recommended for use of tadalafil (Adcirca<U+00AE>) with ritonavir: Co-administration of ADCIRCA in patients on ritonavir: In patients receiving ritonavir for at least one week, start ADCIRCA at 20 mg once daily."	0
"VIRACEPT should not be used in patients with either moderate or severe hepatic impairment (Child-Pugh B or C, score greater than or equal to 7)."	0
Other Potent Inhibitors of CYP3A Tadalafil is metabolized predominantly by CYP3A in the liver.	0
In children an initial dose of 10 mg/kg/day is recommended.	0
The terminal elimination half-life of paliperidone is approximately 23 hours.	0
"If digoxin treatment is continued, halve the dose of digoxin, monitor serum levels closely, and observe for toxicity."	1
"In patients who develop an allergic reaction to Catapres-TTS, substitution of oral clonidine hydrochloride may also elicit an allergic reaction (including generalized rash, urticaria, or angioedema)."	0
"The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine; cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide)."	0
Reports of tubulointerstitial nephritis with medullary calcification and cortical atrophy have been observed in patients with asymptomatic severe leukocyturia (>100 cells/ high power field).	0
Fluconazole treated patients who are concomitantly treated with drugs with a narrow therapeutic window metabolized through CYP2C9 and CYP3A4 should be monitored.	0
"Before initiating NARDIL after using other serotoninergic agents, a sufficient amount of time must be allowed for clearance of the serotoninergic agent and its active metabolites."	0
Lithium levels should be monitored when these drugs are administered concomitantly.	0
The mixture should be taken immediately (within 15 minutes) and should not be stored for future use.	0
"Non-steroidal Anti-Inflammatory Agents, including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors) In patients who are elderly, volume-depleted (including those on diuretic therapy), or who have compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including azilsartan, may result in deterioration of renal function, including possible acute renal failure."	0
"Efficacy of diethylpropion with other anorectic agents has not been studied and the combined use may have the potential for serious cardiac problems; therefore, the concomitant use with other anorectic agents is contraindicated."	0
Fluconazole (strong CYP2C9 inhibitor): The AUC0-inf and Cmax of ramelteon was increased by approximately 150% when ROZEREM was coadministered with fluconazole.	1
"Labor and Delivery<U+2013> Quinine is said to be oxytocic in humans, but there are no adequate data as to quinidine's effect (if any) on human labor and delivery."	0
The majority of the children had hypertension associated with renal and urogenital disease.	0
"Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium."	0
Frequent monitoring of trough blood levels of cyclosporine and tacrolimus is recommended and adjust the dose when appropriate.	0
"Effect on Driving Performance In a clinical study in healthy subjects, BRINTELLIX did not impair driving performance, or have adverse psychomotor or cognitive effects following single and multiple doses of 10 mg/day."	0
"Information for Patients: The patient should be informed that methamphetamine may impair the ability to engage in potentially hazardous activities, such as, operating machinery or driving a motor vehicle."	0
MICARDIS tablets may be administered with other antihypertensive agents.	0
"Nevertheless, caution is indicated in the co-administration of TCAs with any of the SSRIs and also in switching from one class to the other."	0
CYP2C19 Inhibitors - Celexa 20 mg/day is the maximum recommended dose for patients taking concomitant CYP2C19 inhibitors because of the risk of QT prolongation.	1
"Although a causal link between the emergence of such symptoms and the emergence of suicidal impulses has not been established, there is a concern that such symptoms may represent precursors to emerging suicidality."	0
Specific Populations Geriatric Patients The mechanism for elimination and results from population pharmacokinetics suggest that dose adjustment would not be necessary in elderly patients.	0
Described regimens have generally been similar to the regimen described just above for the treatment of symptomatic atrial fibrillation/flutter.	0
Consider the potential for drug interactions prior to and during VIRACEPT therapy; review concomitant medications during VIRACEPT therapy; and monitor for the adverse reactions associated with the concomitant medications.	0
"Signs and symptoms associated with more severe and/or acute cases have included hallucination, syncope, seizure, coma, respiratory arrest, and death."	0
Ketoconazole <U+2191> indinavir concentration Dose reduction of CRIXIVAN to 600 mg every 8 hours should be considered.	1
"Coadministration of amiodarone with HARVONI is not recommended; if coadministration is required, cardiac monitoring is recommended digoxin <U+2191> digoxin Coadministration of HARVONI with digoxin may increase the concentration of digoxin."	0
"Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, coma), autonomic instability (e.g., tachycardia, labile blood pressure, hyperthermia), neuromuscular aberrations (e.g., hyperreflexia, incoordination) and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)."	0
Hearing or visual impairment: Seek medical attention if sudden decrease or loss of vision or hearing occurs.	0
Sotalol can cause life threatening ventricular tachycardia associated with QT interval prolongation Do not initiate sotalol therapy if the baseline QTc is longer than 450 ms.	0
Supplemental doses should not be given to patients after dialysis.	0
"Do not administer Letairis to a pregnant female because it may cause fetal harm (4.1, 5.1, 8.1)."	0
The use of psychotropic drugs that interfere with serotonin reuptake is associated with the occurrence of upper gastrointestinal bleeding and concurrent use of an NSAID or aspirin may potentiate this risk of bleeding.	0
"Potassium supplementation , either in the form of medication or as a diet rich in potassium , should not ordinarily be given in association with ALDACTONE therapy ."	0
Therapy with nortriptyline hydrochloride oral solution USP may be resumed 24 hours after the last dose of linezolid or intravenous methylene blue.	0
"Inhibition of ACE results in decreased plasma angiotensin II, which leads to decreased vasopressor activity and to decreased aldosterone secretion."	0
"Increased incidences of testicular atrophy and epididymal oligospermia and a reduction in testicular weight were, however, observed in other studies in rats."	0
PEDIATRIC USE: Safety and effectiveness below the age of 9 have not been established.	0
Figure 3: Effect of Specific Populations on the Pharmacokinetics of Apixaban * ESRD subjects treated with intermittent hemodialysis; reported PK findings are following single dose of apixaban post hemodialysis.	0
Moderate (less than 3X ULN) elevations of serum transaminases have been reported following therapy with simvastatin.	0
"Calcium acetate, when taken with meals, combines with dietary phosphate to form an insoluble calcium-phosphate complex, which is excreted in the feces, resulting in decreased serum phosphorus concentrations."	0
Renal Impairment The usual regimens of therapy with AVALIDE may be followed as long as the patient's creatinine clearance is >30 mL/min.	0
"Administration of CMI has been reported to increase the plasma levels of phenobarbital, if given concomitantly."	1
"As with other serotonin reuptake inhibitors, an interaction between paroxetine and tryptophan may occur when they are coadministered."	0
Warfarin: Plasma concentrations increased and prothrombin times prolonged; monitor prothrombin time and adjust warfarin dose accordingly (5.9).	1
"Serotonin syndrome (including altered mental status, autonomic instability, and neuromuscular symptoms) has been described following the concomitant use of 5-HT3 receptor antagonists and other serotonergic drugs, including selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs)."	0
"Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients whose depression is persistently worse, or who are experiencing emergent suicidality or symptoms that might be precursors to worsening depression or suicidality, especially if these symptoms are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
Serious and/or life-threatening peripheral ischemia has been associated with the coadministration of DIHYDROERGOTAMINE with potent CYP 3A4 inhibitors including protease inhibitors and macrolide antibiotics.	0
"In some cases, a patient already receiving PRISTIQ therapy may require urgent treatment with linezolid or intravenous methylene blue."	0
"Although, in most patients, the hypotensive effect of PROCARDIA is modest and well tolerated, occasional patients have had excessive and poorly tolerated hypotension."	0
"Atorvastatin can be administered as a single dose at any time of the day, with or without food."	0
"Given the primary CNS effects of paliperidone , INVEGA<U+00AE> should be used with caution in combination with other centrally acting drugs and alcohol."	0
Neonates born to mothers who are receiving TENORMIN at parturition or breast-feeding may be at risk for hypoglycemia and bradycardia.	0
"The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents."	0
"Within the physiologic pH range, amlodipine is an ionized compound (pKa=8.6), and its kinetic interaction with the calcium channel receptor is characterized by a gradual rate of association and dissociation with the receptor binding site, resulting in a gradual onset of effect."	0
Periodic liver chemistry tests should be performed during Marplan therapy; use of the drug should be discontinued at the first sign of hepatic dysfunction or jaundice.	0
The clinical relevance of this increase in ETP is unknown.	0
"Contraction stress testing (CST), a non-stress test (NST), or biophysical profiling (BPP) may be appropriate, depending upon the week of pregnancy."	0
MINIPRESS was not mutagenic in in vivo genetic toxicology studies.	0
"For patients new to methylphenidate: Begin treatment with Focalin XR at 5 mg/day for pediatrics and 10 mg/day for adults, titrating the dose weekly in 5 mg increments for pediatrics and in 10 mg increments for adults."	0
"Tell patients to promptly report any indication of infection (e.g., sore throat, fever) which could be a sign of neutropenia."	0
ZIAC may potentiate the action of other antihypertensive agents used concomitantly.	0
"Before administering TRISENOX, assess the QT interval, correct electrolyte abnormalities, and consider discontinuing drugs known to prolong QT interval."	0
"Activation of mania or hypomania has also been reported in a small proportion of patients with affective disorder treated with marketed tricyclic antidepressants, which are closely related to Anafranil."	0
LEXIVA: Dose reduction of ketoconazole or itraconazole may be needed for patients receiving more than 400mg ketoconazole or itraconazole per day.	1
Clinically significant bradycardia has been reported in breast-fed infants.	0
"Of the total number of patients in clinical studies of TIKOSYN, 46% were 65 to 89 years old."	0
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) The concurrent use of aspirin with other NSAIDs may increase bleeding or lead to decreased renal function.	0
"Since verapamil is highly metabolized by the liver, it should be administered cautiously to patients with impaired hepatic function."	0
The usual regimens of therapy with DUTOPROL may be followed as long as the patient<U+2019>s creatinine clearance is > 30 mL/min.	0
Population pharmacokinetics analysis in HCV-infected subjects indicated that cirrhosis (including decompensated cirrhosis) had no clinically relevant effect on the exposure of ledipasvir.	0
Hypokalemia should be corrected before initiation of TIKOSYN therapy.	0
Reduction of oxygen utilization: CALAN regularly reduces the total peripheral resistance (afterload) against which the heart works both at rest and at a given level of exercise by dilating peripheral arterioles.	0
Patients receiving rifabutin and fluconazole concomitantly should be carefully monitored.	0
"If estazolam is given concomitantly with other drugs acting on the central nervous system, careful consideration should be given to the pharmacology of all agents."	0
"In MS studies, there was no clinically relevant prolongation of the QT interval, but patients at risk for QT prolongation were not included in clinical studies."	0
"Hypersensitivity to desvenlafaxine succinate, venlafaxine hydrochloride or to any excipients in the PRISTIQ formulation."	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP should not be administered."	0
Check for leaks by squeezing the inner bag firmly; if any leaks are found or sterility is suspect then the solution should be discarded.	0
"Because of the long half-life of fluoxetine and its metabolites, this washout period may range from one to several weeks depending on the dose of fluoxetine and other individual patient variables."	0
"Hepatic microsomal enzyme inducing agents, such as carbamazepine, were found to significantly increase the clearance of thiothixene."	1
Therapy with Anafranil may be resumed 24 hours after the last dose of linezolid or intravenous methylene blue.	0
Hyperkalemia occurs commonly (about 10%) when amiloride is used without a kaliuretic diuretic.	0
"Examples: Diltiazem, atazanavir, erythromycin, fluconazole, verapamil Strong CYP3A4 Inducers Clinical Impact: Concomitant use of LATUDA with strong CYP3A4 inducers decreased the exposure of lurasidone compared to the use of LATUDA alone."	1
"DAFNE Study DAFNE was a dose-response study in patients with recurrent AF, evaluating the effect of dronedarone in comparison with placebo in maintaining sinus rhythm."	0
"As the blood pressure approaches goal, increase the dose by less than doubling and lengthen the time between dose adjustments to every 5-10 minutes."	0
The potential risk of possible serious adverse effects such as valvular heart disease and pulmonary hypertension should be assessed carefully against the potential benefit of weight loss.	0
1645 <U+2013>22 <U+2013>30 +7.2 <U+2013>34 <U+2013>26 <U+2013>14 20 mg b.i.d.	0
"Thioridazine hydrochloride tablets may cause somnolence, postural hypotension, motor and sensory instability, which may lead to falls and, consequently, fractures or other injuries."	0
"Such individuals are referred to as <U+201C>poor metabolizers<U+201D> of drugs such as debrisoquin, dextromethorphan, and the TCAs."	0
C. difficile produces toxins A and B which contribute to the development of CDAD.	0
"(7.6) Concomitant administration of Remodulin with diuretics, antihypertensive agents or other vasodilators may increase the risk of symptomatic hypotension."	0
"Since patients with hepatic impairment have decreased clearance of amlodipine, start amlodipine or add amlodipine at 2.5 mg in patients with hepatic impairment."	0
"For children who develop intolerance or toxicity and cannot continue with APTIVUS 14 mg/kg with 6 mg/kg ritonavir, physicians may consider decreasing the dose to APTIVUS 12 mg/kg with 5 mg/kg ritonavir (or APTIVUS 290 mg/m2 co-administered with 115 mg/m2 ritonavir) taken twice daily provided their virus is not resistant to multiple protease inhibitors."	0
"Due to its alpha1-adrenergic receptor antagonism, FANAPT has the potential to enhance the effect of certain antihypertensive agents."	0
"However, the combination of triamterene and hydrochlorothiazide given twice daily also appeared to produce an increased frequency of elevation in serum BUN and creatinine levels."	0
"In the randomized medullary thyroid cancer (MTC) study, ischemic cerebrovascular events occurred more frequently with CAPRELSA compared to placebo (1.3% compared to 0%)."	0
"The antihypertensive effect of angiotensin II receptor antagonists, including candesartan may be attenuated by NSAIDs including selective COX-2 inhibitors."	0
"Periodic BUN and creatinine determinations should be made especially in elderly patients, patients with suspected or confirmed hepatic disease or renal insufficiencies."	0
"Syncope was reported in 3.9% and 1.9% of subjects, respectively."	0
Thus Remodulin is not expected to alter the pharmacokinetics of compounds metabolized by CYP enzymes.	0
"Therefore, the use of PRADAXA is contraindicated in patients with mechanical prosthetic valves."	0
"In asthmatic patients, a dose of TENORMIN producing a greater effect on resting heart rate than propranolol resulted in much less increase in airway resistance."	0
"Hypokalemia can sensitize or exaggerate the response of the heart to the toxic effects of digitalis (e.g., increased ventricular irritability)."	0
The extent of interaction and potentiation of effects depend on the variability of effect on CYP3A4.	0
"Tacrine: In a study of 13 healthy, male volunteers, a single 40 mg dose of tacrine added to immediate-release fluvoxamine maleate tablets 100 mg/day administered at steady-state was associated with 5- and 8-fold increases in tacrine Cmax and AUC, respectively, compared to the administration of tacrine alone."	1
The concomitant administration of other drugs that inhibit the activity of P450 2D6 may acutely increase plasma concentrations of antipsychotics.	1
The average volume of distribution is 53 to 93 liters.	0
"Study 2 was a 20-week, multicenter, flexible dose study that compared sertraline hydrochloride (50 to 200 mg/day) to placebo."	0
"To reduce the risk of respiratory depression, proper dosing and titration of Meperidine Hydrochloride Injection are essential."	0
Most patients taking REYATAZ experience asymptomatic elevations in indirect (unconjugated) bilirubin related to inhibition of UDP-glucuronosyl transferase (UGT).	0
"Excitation, seizures, delirium, hyperpyrexia, circulatory collapse, coma, and death have been reported in patients receiving MAOI therapy who have been given a single dose of meperidine."	0
Experimental data suggest that amlodipine binds to both dihydropyridine and nondihydropyridine binding sites.	0
"(7.1) Coadministration of antiplatelet agents, thrombolytics, heparin, aspirin, and chronic NSAID use increases the risk of bleeding."	0
Nelfinavir is metabolized by CYP3A and CYP2C19.	0
Patients who develop angioedema after treatment with ROZEREM should not be rechallenged with the drug.	0
"Nefazodone is a potent inhibitor of CYP 3A4, and its concomitant use with ORAP is also contraindicated."	0
"Antiarrhythmics : The metabolism of quinidine , procainamide , flecainide can be inhibited by amiodarone ."	1
Concomitant use of CRIXIVAN with lovastatin or simvastatin is contraindicated due to an increased risk of myopathy including rhabdomyolysis.	0
"The major metabolite is N-desmethyl rosuvastatin, which is formed principally by cytochrome P450 \2C9, and in vitro studies have demonstrated that N-desmethyl rosuvastatin has approximately one-sixth to one-half the HMG<U+2011>CoA reductase inhibitory activity of the parent compound."	0
"Intervention Avoid concomitant use of EMEND Examples rifampin, carbamazepine, phenytoin"	0
"When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus."	0
"These decreases were observed within the first few weeks of treatment with Letairis, and stabilized thereafter."	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
Lipid disorders should be managed as clinically appropriate.	0
There is no general agreement about specific pharmacological treatment regimens for uncomplicated NMS.	0
Steady-state concentrations of asenapine are reached within 3 days of twice daily dosing.	0
"Other Concomitant Drug Therapy: When using olanzapine in combination with lithium or valproate, refer to the Drug Interactions sections of the package insert for those products."	0
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.	0
"It may be advisable to eliminate the diuretic ( except in patients with heart failure ) , reduce the diuretic dose or increase salt intake cautiously before initiating therapy with VASOTEC in patients at risk for excessive hypotension who are able to tolerate such adjustments ( see PRECAUTIONS , Drug Interactions and ADVERSE REACTIONS ) ."	0
"In patients with renal disease, chlorthalidone or related drugs may precipitate azotemia."	0
Clinical trials with TARKA have explored only once-a-day doses.	0
Cationic exchange resins such as sodium polystyrene sulfonate may be orally or rectally administered.	0
"Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of other drugs that raise serum potassium levels."	0
"In general, patients with bronchospastic diseases should not receive <U+03B2>-blockers."	0
"If hyperkalemia is present, triamterene and hydrochlorothiazide should be discontinued immediately and a thiazide alone should be substituted."	0
Standardized susceptibility test procedures require the use of laboratory control microorganisms.	0
"Overall, these studies demonstrated a superiority of Zaleplon 10 mg and 20 mg over placebo in reducing LPS on the first 2 nights of treatment."	0
The mechanism of this effect has not been established.	0
"Endothelin receptor antagonist:bosentan <U+2191> bosentan Co-administration of bosentan in patients on PREZISTA/ritonavir: In patients who have been receiving PREZISTA/ritonavir for at least 10 days, start bosentan at 62.5 mg once daily or every other day based upon individual tolerability."	0
"Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother."	0
"In addition, one nonstudy participant reportedly experienced a convulsion (type not documented) following a multiple-drug overdose."	0
"Prothrombin time was increased by 5%, the clinical significance of which is unknown."	0
"If sertraline is administered to patients with liver impairment, a lower or less frequent dose should be used."	0
In vivo studies have revealed no effect of ziprasidone on the pharmacokinetics of estrogen or progesterone components.	0
The rate of ISTH major bleeding was 2.8% per year with apixaban versus 0.6% per year with placebo in patients receiving single antiplatelet therapy and was 5.9% per year with apixaban versus 2.5% per year with placebo in those receiving dual antiplatelet therapy.	0
"Caution is indicated in treating patients with known liver disease, and periodic monitoring of hepatic enzyme levels is recommended in such patients."	0
"An opioid antagonist, such as naloxone, must be available for reversal of opioid-induced respiratory depression in the neonate."	0
"If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus."	0
Consider alternatives to REYATAZ in patients at high risk for renal disease or with preexisting renal disease.	0
PDE5 INHIBITORS SildenafilVardenafilTadalafil <U+2191> PDE5 Inhibitors Concomitant use of PDE5 inhibitors and VIRACEPT should be undertaken with caution.	0
"Total radioactivity measurement following short IV administration in healthy volunteers suggests the presence of other unidentified metabolites, which attain higher concentrations than those of diltiazem and are more slowly eliminated; half-life of total radioactivity is about 20 hours compared to 2 to 5 hours for diltiazem."	0
"If additional control is required, the addition of a second antihypertensive drug is recommended."	0
Drug Interaction Studies: Effects of other drugs on the exposure of asenapine are summarized in Figure 1.	0
"However, during chronic administration this relationship may disappear."	0
The recommended initial dose of Tenex ( guanfacine hydrochloride ) when given alone or in combination with another antihypertensive drug is 1 mg daily given at bedtime to minimize somnolence .	0
There was no effect of bisoprolol fumarate on prothrombin times in patients on stable doses of warfarin.	0
"Beta-blockers may mask tachycardia occurring with hypoglycemia, but other manifestations such as dizziness and sweating may not be significantly affected."	0
"In the randomized MTC study in which 90% of the patients enrolled had prior thyroidectomy, increased dosing of thyroid replacement therapy was required in 49% of CAPRELSA-treated patients compared to 17% of placebo-treated patients."	0
"ACE is a peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor, angiotensin II."	0
"Aldosterone plasma concentrations generally decline following irbesartan administration, but serum potassium levels are not significantly affected at recommended doses."	0
Elimination of amlodipine from the plasma is biphasic with a terminal elimination half-life of about 30 to 50 hours.	0
Metoprolol apparent oral clearance (CL/F) increased linearly with body weight.	0
"In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin."	0
Hepatic impairment: Zaleplon is metabolized primarily by the liver and undergoes significant presystemic metabolism.	0
"Attention Deficit Disorder with Hyperactivity: For treatment of children 6 years or older with a behavioral syndrome characterized by moderate to severe distractibility, short attention span, hyperactivity, emotional lability and impulsivity: an initial dose of 5 mg DESOXYN once or twice a day is recommended."	0
Total daily dose should not exceed 50mg. Concomitant administration with a diuretic can be expected to produce additive effects and exaggerate the orthostatic component of carvedilol action.	0
"Some baseline characteristics, including hemorrhagic and lacunar stroke on study entry, were associated with a higher incidence of hemorrhagic stroke in the atorvastatin group."	0
"In such patients, thiazides may precipitate azotemia."	0
"Because nisoldipine is extensively metabolized by the liver and, in patients with cirrhosis, it reaches blood concentrations about 5 times those in normals, SULAR should be administered cautiously in patients with severe hepatic dysfunction."	0
"If patients experience symptoms that may be associated with altered electrolyte balance, such as excessive or prolonged diarrhea, sweating, or vomiting or loss of appetite or thirst, these conditions should immediately be reported to their health care provider."	0
"Steady-state, therefore, should be achieved after 2 to 3 weeks in older patients."	0
It is recommended that serum lithium levels be monitored frequently if enalapril is administered concomitantly with lithium .	0
Nursing Mothers Thiazides are excreted in human milk.	0
"Patients whose renal function may depend in part on the activity of the RAAS ( e.g. , patients with renal artery stenosis , severe heart failure , post-myocardial infarction or volume depletion ) or patients receiving ARB , ACEI or nonsteroidal anti-inflammatory drug ( NSAID ) , including selective Cyclooxygenase-2 inhibitors ( COX-2 inhibitors ) , therapy may be at particular risk for developing acute renal failure on Tekturna see Warnings and Precautions ( 5.2 Drug Interactions ( 7 ) , and Use in Specific Populations ( 8.7 ) and Clinical Studies ( 14.3 ) ."	0
Check the container for minute leaks prior to use by squeezing the bag firmly; ensure that the seal is intact.	0
"In non-AIDS patients, side effects possibly related to fluconazole treatment were reported in fewer patients aged 65 and older (9%, n =339) than for younger patients (14%, n=2240)."	0
Plasma protein binding in humans is approximately 87%.	0
"AGGRASTAT is contraindicated in patients with: Severe hypersensitivity reaction to AGGRASTAT (i.e., anaphylactic reactions)."	0
"Conversely, at least 7 days should be allowed after stopping PRISTIQ before starting an MAOI intended to treat psychiatric disorders."	0
Do not administer Silenor if patient is currently on MAOIs or has used MAOIs within the past two weeks.	0
Mothers should be instructed to discontinue nursing if they are receiving CRIXIVAN.	0
"Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death."	0
"Daily treatment with any acid-suppressing medications over a long period of time (e.g., longer than 3 years) may lead to malabsorption of cyanocobalamin (vitamin B-12) caused by hypo- or achlorhydria."	1
Tirofiban is not highly bound to plasma proteins and protein binding is concentration independent over the range of 0.01 to 25 mcg/mL.	0
"In some assays, spironolactone, canrenone and potassium canrenoate may be falsely detected as digoxin, at levels up to 0.5 ng/mL."	0
"Thus, it is difficult to predict the net effect of APTIVUS administered with ritonavir on oral bioavailability and plasma concentrations of drugs that are dual substrates of CYP 3A and P-gp."	0
"In vitro, desvenlafaxine does not inhibit or induce the CYP3A4 isozyme."	0
"Drugs Highly Bound to Plasma Protein: Because paroxetine is highly bound to plasma protein, administration of PEXEVA<U+00AE> (paroxetine mesylate) to a patient taking another drug that is highly protein-bound may cause increased free concentrations of the other drug, potentially resulting in adverse events."	1
"Because animal reproduction studies are not always predictive of human response, rifabutin should be used in pregnant women only if the potential benefit justifies the potential risk to the fetus."	0
The use of nortriptyline hydrochloride in schizophrenic patients may result in an exacerbation of the psychosis or may activate latent schizophrenic symptoms.	0
Pediatric Use Safety and effectiveness in pediatric patients have not been established.	0
"Response during the single-blind phase was defined as a decrease in the YBOCS score of <U+2265> 25% compared to baseline and a CGI-I of 1 (very much improved), 2 (much improved) or 3 (minimally improved)."	0
Such monitoring should include daily observation by families and caregivers.	0
The use of MAOIs intended to treat psychiatric disorders with PRISTIQ or within 7 days of stopping treatment with PRISTIQ is contraindicated because of an increased risk of serotonin syndrome.	0
"Letairis is contraindicated in patients with Idiopathic Pulmonary Fibrosis (IPF), including IPF patients with pulmonary hypertension (WHO Group 3)."	0
The length of this interval may also be determined by evidence of bone marrow recovery based on successive bone marrow studies.	0
Sildenafil and its major circulating N-desmethyl metabolite are both approximately 96% bound to plasma proteins.	0
"Assuming normal hepatic blood flow and negligible renal clearance of zaleplon, the estimated hepatic extraction ratio of zaleplon is approximately 0.7, indicating that zaleplon is subject to high first-pass metabolism."	0
Olmesartan blocks the vasoconstrictor effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in vascular smooth muscle.	0
Intravenous sotalol has not been studied in children.	0
"Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice."	0
CYP3A induction-mediated effect of bosentan on other drugs .	0
Initial dose: Initiate intravenous infusion of Cleviprex at 1- 2 mg/hour.	0
Rifampin enhances the metabolism of concurrently administered DIFLUCAN.	1
"As with other drugs that cause Torsade de Pointes, TIKOSYN was associated with a greater risk of Torsade de Pointes in female patients than in male patients."	0
"Surgery and Anesthesia In patients undergoing surgery or during anesthesia with agents that produce hypotension, ramipril may block angiotensin II formation that would otherwise occur secondary to compensatory renin release."	0
Atrioventricular block can occur in patients without preexisting conduction defects.	0
"In clinical trials, hyperkalemia (serum potassium <U+2265>5.8 mmol/L) occurred in approximately 2% of patients receiving quinapril."	0
"One such standardized procedure3,4 that has been recommended for use with disks to test the susceptibility of microorganisms to rifampin uses the 5 mcg rifampin disk."	0
"Monitor patients closely for respiratory depression, especially within the first 24 to 72 hours of initiating therapy with and following dosage increases of Meperidine Hydrochloride Injection."	0
Benicar doses of 2.5 mg to 40 mg inhibit the pressor effects of angiotensin I infusion.	0
"The risk of myopathy, including rhabdomyolysis, may be increased when HIV protease inhibitors, including REYATAZ, are used in combination with these drugs."	0
Approximately 90% is bound to plasma proteins.	0
"It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months."	0
"Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, coma), autonomic instability (e.g., tachycardia, labile blood pressure, hyperthermia), neuromuscular aberrations (e.g., hyperreflexia, incoordination, rigidity), and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)."	0
"Metabolism: Loxapine is metabolized extensively in the liver following oral administration, with multiple metabolites formed."	0
"There have been reports of serious, sometimes fatal, reactions (including hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations of vital signs, and mental status changes that include extreme agitation and confusion progressing to delirium and coma) in patients receiving fluoxetine (Prozac<U+00AE>, Lilly) in combination with a monoamine oxidase inhibitor (MAOI), and in patients who have recently discontinued fluoxetine and are then started on a MAOI."	0
"Avoid co-administration of CYP 3A inducers ( e.g. , rifampin , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine , St.   John 's   Wort ) with SAMSCA , as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment ."	1
Teriflunomide is the principal active metabolite of leflunomide and is responsible for leflunomide's activity in vivo.	0
"Cimetidine: A study in six healthy volunteers has shown a significant increase in peak diltiazem plasma levels (58%) and area under the curve (53%) after a 1-week course of cimetidine at 1200 mg per day and a single dose of diltiazem 60 mg. Ranitidine produced smaller, nonsignificant increases."	1
"A List of MAO Inhibitors by Generic Name Follows: pargyline hydrochloridepargyline hydrochloride and methylclothiazidefurazolidoneisocarboxazidprocarbazinetranylcypromine NARDIL should also not be used in combination with buspirone HCl, since several cases of elevated blood pressure have been reported in patients taking MAO inhibitors who were then given buspirone HCl."	0
REYATAZ/ritonavir: Use vardenafil with caution at reduced doses of no more than 2.5 mg every 72 hours with increased monitoring for adverse reactions.	1
"Due to the increased risk of myopathy, including rhabdomyolysis, associated with the 80-mg dose of ZOCOR, patients unable to achieve their LDL-C goal utilizing the 40-mg dose of ZOCOR should not be titrated to the 80-mg dose, but should be placed on alternative LDL-C-lowering treatment(s) that provides greater LDL-C lowering."	0
Water balance is maintained by various regulatory mechanisms.	0
Total daily dose should not exceed 8 mg. (2.1) The recommended dose of ROZEREM is 8 mg taken within 30 minutes of going to bed.	0
"In a double-blind, placebo-controlled study, 132 boys 10-17years of age (mean age 12.7yrs) with heterozygous familial hypercholesterolemia (heFH) were randomized to lovastatin (n=67) or placebo (n=65) for 48weeks."	0
"The improvement in time to termination of exercise utilizing a Bruce exercise protocol, measured at trough, for placebo, 60 mg, 120 mg, 240 mg, 360 mg, and 480 mg was 29, 40, 56, 51, 69, and 68 seconds, respectively."	0
"<U+2022>Therapy-Naive Adults: LEXIVA 1,400mg twice daily; LEXIVA 1,400mg once daily plus ritonavir 200mg once daily; LEXIVA 1,400mg once daily plus ritonavir 100mg once daily; LEXIVA 700mg twice daily plus ritonavir 100mg twice daily."	0
"The patient should be monitored for symptoms of serotonin syndrome for 5 days or until 24 hours after the last dose of linezolid or intravenous methylene blue, whichever comes first."	0
"Systematic evaluation of the efficacy of paroxetine has shown that efficacy is maintained for periods of up to 1 year with doses that averaged about 30 mg. Usual Initial Dosage: PEXEVA<U+00AE> (paroxetine mesylate) should be administered as a single daily dose with or without food, usually in the morning."	0
"Most of the unbound fraction is not ionized and, therefore, diffuses freely into tissues."	0
"Eplerenone is cleared predominantly by cytochrome P450 (CYP) 3A4 metabolism, with an elimination half-life of 3 to 6 hours."	0
"Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7)."	0
"Inhibitors of CYP3A (e.g., ketoconazole, saquinavir) increase blood levels of eplerenone."	1
"(see WARNINGS) Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"Oral contraceptives/estrogen:ethinyl estradiol, norethindrone <U+2193> ethinyl estradiol<U+2193> norethindrone Effective alternative contraceptive method or barrier method of contraception is recommended Co-administration with PREZISTA/ritonavir may result in an increase in PDE-5 inhibitor-associated adverse events, including hypotension, syncope, visual disturbances and priapism."	0
Use a specific reversal agent (idarucizumab) in case of emergency surgery or urgent procedures when reversal of the anticoagulant effect of dabigatran is needed.	0
"Autoimmune disorders (such as Graves' disease, polymyositis, and Guillain-Barr<U+00E9> syndrome) have also been reported to occur in the setting of immune reconstitution; however, the time to onset is more variable, and can occur many months after initiation of antiretroviral treatment."	0
"Consideration should be given to dose reduction or discontinuation of CYMBALTA in patients who experience symptomatic orthostatic hypotension, falls and/or syncope during CYMBALTA therapy."	0
"Study 3 was a 12-week fixed-dose study, including sertraline hydrochloride doses of 50, 100, and 200 mg/day."	0
Priapism: Cases of painful and prolonged penile erections and priapism have been reported with methylphenidate products.	0
There were no other restrictions with regard to the timing of meals in these trials.	0
Metabolism/Elimination Bicalutamide undergoes stereospecific metabolism.	0
"However, Cmax, Cmin, and AUC of m-chlorophenylpiperazine were increased by 23%, 54%, and 28%, respectively."	0
The following dosage schedule is provided as a guideline only.	0
"Plasma concentrations of losartan were about twice as high in female hypertensives as male hypertensives, but concentrations of the active metabolite were similar in males and females."	0
Dosages above 8 mg should be administered with careful blood pressure monitoring and dose titration.	0
The possible combined hypotensive effects of NARDIL and spinal anesthesia should be kept in mind.	0
"Doses up to 400 mg/day may be used, based on medical judgment of the patient's response to therapy."	0
Estazolam tablets have been found to be equivalent in absorption to an orally administered solution of estazolam.	0
Discontinue ULORIC if serious skin reactions are suspected.	0
"Since the highest recommended pimozide dose (10 mg) has not been evaluated in combination with sertraline, the effect on QT interval and PK parameters at doses higher than 2 mg at this time are not known."	0
"Compliance with the full course of therapy must be emphasized, and the importance of not missing any doses must be stressed."	0
The magnitude of interaction could be higher at the recommended repaglinide dose.	0
Dose to be repeated no earlier than 3 days.	0
Treatment includes administration of oxygen and discontinuation of lidocaine hydrochloride administration and where necessary administration of dantrolene sodium.	0
"To avoid interruptions in drug delivery, the patient should have access to a backup infusion pump and intravenous infusion sets."	0
Relatively weak binding of risperidone to the enzyme suggests this is unlikely.	0
This should include measurement of blood pressure just prior to the next dose (trough blood pressure) to ensure that the treatment effect is present for a full 24 hours.	0
Dosing recommendations for this combination have not been established.	0
"There were 3 subjects with subtype 4r, 2 of whom experienced virologic relapse, and both had a combination of 2 pretreatment NS5A resistance-associated polymorphisms (L28M/V+L30R)."	0
"The management of NMS should include 1) immediate discontinuation of antipsychotic drugs and other drugs not essential to concurrent therapy, 2) intensive symptomatic treatment and medical monitoring, and 3) treatment of any concomitant serious medical problems for which specific treatments are available."	0
Hydrochlorothiazide may alter glucose tolerance and raise serum levels of cholesterol and triglycerides.	0
"In a study of 19 healthy male subjects, which included 6 slow and 13 rapid hydroxylators of debrisoquin, a single 25 mg oral dose of thioridazine produced a 2.4-fold higher Cmax and a 4.5-fold higher AUC for thioridazine in the slow hydroxylators compared to rapid hydroxylators."	1
"In a single and multiple dose absorption, distribution, metabolism, and excretion (ADME) study, using 3H labeled drug, temazepam was well absorbed and found to have minimal (8%) first pass metabolism."	0
"Cmax and AUC of atorvastatin are approximately 16-fold and 11-fold increased, respectively, in patients with Childs-Pugh B disease."	0
"Steady state plasma levels of mirtazapine are attained within 5 days, with about 50% accumulation (accumulation ratio = 1.5)."	0
"Serious adverse cardiac events, including acute myocardial infarction, life-threatening disturbances of cardiac rhythm, and death have been reported to have occurred following the administration of dihydroergotamine mesylate injection."	0
This combination may be used by reducing the dosage of cyclosporine depending on cyclosporine concentration.	1
"Usual Initial Dosage: PEXEVA<U+00AE> (paroxetine mesylate) should be administered as a single daily dose with or without food, usually in the morning."	0
"In studies of oral sotalol, the incidence of bradycardia (as determined by the investigators) in the supraventricular arrhythmia population treated with oral sotalol was 13% and led to discontinuation in 2.4%."	0
The cumulative rates correct the crude rate of 0.7% (25 of 3519 patients) for the variable duration of exposure in clinical trials.	0
Bupropion inhibits the reuptake of dopamine and norepinephrine.	0
"The management of NMS should include 1) immediate discontinuation of antipsychotic drugs and other drugs not essential to concurrent therapy, 2) intensive symptomatic treatment and medical monitoring and 3) treatment of any concomitant serious medical problems for which specific treatments are available."	0
"The maximum recommended dose in patients with severe renal impairment (24-hr CrCl less than 30 mL/min, C-G) or end-stage renal disease (ESRD) is 25 mg every day or 50 mg every other day."	0
Average AUC values were similar in subjects with mild hepatic impairment and healthy subjects (< 5% difference).	0
"Adults <U+2014> Sudden deaths, stroke, and myocardial infarction have been reported in adults taking atomoxetine at usual doses for ADHD."	0
"If tolerance develops, the recommended dose should not be exceeded in an attempt to increase the effect; rather, the drug should be discontinued."	0
"Specific Populations Race: Population pharmacokinetics analysis in HCV-infected subjects indicated that race had no clinically relevant effect on the exposure of ledipasvir, sofosbuvir, and GS-331007."	0
The anticoagulant effect of warfarin was not significantly changed by trandolapril.	0
Keep the dispenser in the refrigerator until administered to the patient.	0
A lower starting dose or slower titration may be used.	0
Downward adjustment of SURMONTIL dosage may be required if cimetidine therapy is initiated; upward adjustment if cimetidine therapy is discontinued.	1
"Careful Monitoring Required: Close monitoring of the following indices <U+2500> urine flow, cardiac output and blood pressure <U+2500> during dopamine infusion is necessary as in the case of any adrenergic agent."	0
Administer over a period of 10-20 minutes at a rate that is comfortable for the patient.	0
Linear dose-proportional pharmacokinetics were demonstrated in a single dose study in which the Cmax and area under the plasma concentration time curve (AUC) of sertraline were proportional to dose over a range of 50 to 200 mg.	0
Use Marplan with caution in hyperthyroid patients because of their increased sensitivity to pressor amines.	0
Adjust the dosing interval based on creatinine clearance.	0
Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide.	0
"REYATAZ is contraindicated: <U+2022>in patients with previously demonstrated clinically significant hypersensitivity (eg, Stevens-Johnson syndrome, erythema multiforme, or toxic skin eruptions) to any of the components of REYATAZ capsules or REYATAZ oral powder."	0
Similar events were also observed in postmarketing reports.	0
The primary treatment is to discontinue hydrochlorothiazide as rapidly as possible.	0
"A first acute major coronary event was defined as myocardial infarction (54 participants on MEVACOR, 94 on placebo) or unstable angina (54 vs. 80) or sudden cardiac death (8 vs. 9)."	0
"The primary endpoint was the first occurrence of cardiovascular death, nonfatal stroke, or nonfatal myocardial infarction."	0
"Grapefruit juice was administered TID for 2 days, and 200 mL together with single dose lovastatin and 30 and 90 minutes following single dose lovastatin on Day 3."	0
"When duloxetine was administered (at a dose of 60 mg twice daily) in conjunction with a single 50 mg dose of desipramine, a CYP2D6 substrate, the AUC of desipramine increased 3-fold."	1
Ten percent of the parent amlodipine compound and 60% of the metabolites of amlodipine are excreted in the urine.	0
Hypokalemia or hypomagnesemia may occur with concomitant administration of potassium-depleting diuretics.	0
"There have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins, including atorvastatin."	0
"While the recommended therapeutic dose range is 10 to 80mg/day, linearity of inhibitory activity in the general circulation was established by a single dose study employing lovastatin tablet dosages from 60 to as high as 120mg. With a once-a-day dosing regimen, plasma concentrations of total inhibitors over a dosing interval achieved a steady state between the second and third days of therapy and were about 1.5 times those following a single dose."	0
A single dose should rarely exceed 30 mg. Avoid co-administration of nifedipine with grapefruit juice.	0
Absorption and distribution The absolute oral bioavailability of PRISTIQ after oral administration is about 80%.	0
"Signs and symptoms associated with more severe and/or acute cases have included hallucination, syncope, seizure, coma, respiratory arrest, and death."	0
The use of MAOIs intended to treat psychiatric disorders with Lexapro or within 14 days of stopping treatment with Lexapro is contraindicated because of an increased risk of serotonin syndrome.	0
"However, clinical monitoring is recommended as the dose of methadone during maintenance therapy may need to be adjusted in some patients."	0
There was no evidence of genotoxicity in the Ames test for mutagenicity or mouse micronucleus test for clastogenicity.	0
Negative inotropic effects can be detected in vitro but such effects have not been seen in intact animals at therapeutic doses.	0
TIKOSYN should be used with particular caution in these patients.	0
"The urinary excretion of ramipril, ramiprilat, and their metabolites is reduced in patients with impaired renal function."	0
The recommended dosing range is 10 to 40mg/day; the maximum recommended dose is 40mg/day.	0
"Therefore, close monitoring of liver function is recommended."	0
Most of these have been observed in the setting of congestive heart failure or ischemia and their relationship to mexiletine hydrochloride has not been established.	0
Concomitant use of paroxetine with other drugs metabolized by cytochrome CYP2D6 has not been formally studied but may require lower doses than usually prescribed for either paroxetine or the other drug.	1
These data indicate that renal clearance is the major elimination pathway for GS-331007.	0
Use in Pregnancy: There are no adequate and well-controlled studies of DIFLUCAN in pregnant women.	0
"Since sotalol is not subject to first-pass metabolism, patients with hepatic impairment show no alteration in clearance of sotalol."	0
Increase to 40 mg once daily based upon individual tolerability.	0
"If hypotension or excessive depression of cardiac conductivity (such as prolongation of the PR interval and QRS complex and the appearance of aggravation of arrhythmias) is seen, administration of Lidocaine Hydrochloride Injection, USP should be discontinued."	0
Steady-state concentrations are attained within 3-4 days of dosing.	0
"However, 40 mg three times a day may be warranted in patients who may have an increased response to verapamil (eg, decreased hepatic function, elderly, etc)."	0
"The antihypertensive effect of VASOTEC is augmented by antihypertensive agents that cause renin release ( e.g. , diuretics ) ."	0
Unchanged sertraline was not detectable in the urine.	0
Patients receiving 50 mg of hydrochlorothiazide who become hypokalemic may be transferred to this 75 mg/50 mg product directly.	0
"5-mg in Low Body Weight Patients - In patients with stable coronary artery disease, mean platelet inhibition in subjects <60kg taking 5-mg prasugrel was similar to that of subjects <U+2265>60kg taking 10-mg prasugrel."	0
"Lithium: As with other serotonergic drugs, lithium may enhance the serotonergic effects of fluvoxamine and, therefore, the combination should be used with caution."	0
Postural hypotension with or without syncope may occur.	0
The loading dose may not be appropriate for those with low systolic blood pressure (SBP) <110 mm Hg or for patients recently treated with afterload reducers.	0
"Examples: phenytoin, fosphenytoin Drugs that Prolong the QTc Interval Clinical Impact: The risk of QTc prolongation and/or ventricular arrhythmias (e.g., TdP) is increased with concomitant use of other drugs which prolong the QTc interval."	0
NOTE: PROSTIN VR PEDIATRIC Sterile Solution must be diluted before it is administered.	0
Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin alone.	1
"Frequent communication is important among the prescriber, other members of the healthcare team, the patient, and the caregiver/family during periods of changing analgesic requirements, including initial titration."	0
Fluvastatin sodium extended-release tablets were not evaluated in patients with renal impairment.	0
Pharmacokinetic/pharmacodynamic interaction studies have been conducted with treprostinil administered subcutaneously (Remodulin) and orally (treprostinil diethanolamine).	0
The (<U+2013>) enantiomer has an elimination half-life that is approximately twice as long as the (+) enantiomer and therefore achieves plasma levels that are about 3 times as high as that of the (+) enantiomer.	0
Steady-state drug exposure based on AUC0-24 was about 8 times greater than would have been predicted from single-dose data in these subjects.	0
"During initial titration, Anafranil should be given in divided doses with meals to reduce gastrointestinal side effects."	0
Use of PDE5 inhibitors for erectile dysfunction: LEXIVA: Sildenafil: 25mg every 48hours.	0
"Redosing in Adults Although the effectiveness of a second dose or subsequent doses has not been established in placebo-controlled trials, if the migraine headache returns, a second dose may be administered 2 hours after the first dose."	0
Coadministration should be done in a setting which ensures close clinical monitoring and appropriate medical management in case of respiratory depression and/or prolonged sedation.	0
The following adverse reactions have been identified during post-approval use of PURIXAN.	0
Required components of the EXTRANEAL REMS Program include the following: Dialysis clinic staff must be trained about the risk of undetected hypoglycemia resulting from a drug-device interactions involving EXTRANEAL in order to manage the treatment of patients prescribed EXTRANEAL.	0
Wean the patient off of the opioid to allow adrenal function to recover and continue corticosteroid treatment until adrenal function recovers.	0
Serotonin release by platelets plays an important role in hemostasis.	0
Ramelteon should not be used in combination with LUVOX CR Capsules.	0
"In patients with hepatic cirrhosis, the influence of verapamil on digoxin kinetics is magnified."	0
No increase in mortality was observed in patients taking digoxin as concomitant medication.	0
Outcome Classification (%) on CGI-Global Improvement Item for Completers in Study 1 Outcome Classification Placebo (n=74) Paroxetine 20 mg Paroxetine 40 mg Paroxetine 60 mg (n=75) (n=66) (n=66) Worse 14% 7% 7% 3% No Change 44% 35% 22% 19% Minimally Improved 24% 33% 29% 34% Much Improved 11% 18% 22% 24% Very Much Improved 7% 7% 20% 20% Subgroup analyses did not indicate that there were any differences in treatment outcomes as a function of age or gender.	0
Drug fever has been reported with PURIXAN.	0
Approximately 7% of the normal population has a genetic code that leads to reduced levels of activity of CYP2D6.	0
"CADUET therapy should be discontinued if myopathy is diagnosed or suspected (5.1, 8.5)."	0
"Benzodiazepines interact at GABAA sites, and opioids interact primarily at mu receptors."	0
There is a literature report of reversible reduction in the ability of human sperm obtained from a limited number of infertile men taking recommended doses of nifedipine to bind to and fertilize an ovum in vitro.	0
Gender Gender has no clinically significant influence on fingolimod and fingolimod-phosphate pharmacokinetics.	0
A study of outpatients with major depressive disorder who had responded to paroxetine (HDRS total score <8) during an initial 8-week open-treatment phase and were then randomized to continuation on paroxetine or placebo for 1 year demonstrated a significantly lower relapse rate for patients taking paroxetine (15%) compared to those on placebo (39%).	0
O-demethylation and hydroxylation at the 3-oxopiperidinyl moiety are the major sites of biotransformation.	0
Sudden deaths have been reported in patients receiving Tasigna (5.3).	0
"Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide."	0
Patients should always be started on the 1 mg capsules of MINIPRESS.	0
No dosage adjustment is necessary in patients with hepatic insufficiency.	0
"However, another HMG<U+2011>CoA reductase inhibitor has been found to produce a less than two-second increase in prothrombin time in healthy volunteers receiving low doses of warfarin."	0
"Signs and symptoms are usually intermittent and mild; however, very rare sequelae include digital ulceration and/or soft tissue breakdown."	0
These hemodynamic effects are accompanied by an increase in the left ventricular ejection fraction and a decrease in end-systolic and end-diastolic dimensions.	0
Observe for signs and symptoms of hypotension (5.2) Monitor carefully in patients with impaired hepatic (5.4) or renal function (5.5) Avoid concomitant use of an ACE inhibitor and angiotensin receptor blocker (5.6) Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.	0
"Serotonin Syndrome The development of a potentially life-threatening serotonin syndrome has been reported with SNRIs and SSRIs, including Anafranil, alone but particularly with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, and St. John's Wort) and with drugs that impair metabolism of serotonin (in particular, MAOIs, both those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue)."	0
NARDIL may cause excessive stimulation in schizophrenic patients; in manic-depressive states it may result in a swing from a depressive to a manic phase.	0
"Antihypertensive agents clonidine, guanfacine, or moxonidine: Beta blockers also increase the risk of clonidine-, guanfacine-, or moxonidine-withdrawal rebound hypertension."	0
"Monitor for lactic acidosis in patients at risk (5.5) Monitor for electrolyte, fluid, and nutrition imbalances (5.7) Only use glucose-specific monitors and test strips to measure blood glucose levels in patients using EXTRANEAL (icodextrin) Peritoneal Dialysis Solution."	0
Use with ethanol causes additive psychomotor impairment (7.1) Rifampicin: Combination use may decrease exposure and effects of LUNESTA (7.2) Ketoconazole: Combination use increases exposure and effect of LUNESTA.	0
"Experience in over 1400 patients in a non-comparative clinical trial has shown that concomitant administration of PROCARDIA and beta-blocking agents is usually well tolerated, but there have been occasional literature reports suggesting that the combination may increase the likelihood of congestive heart failure, severe hypotension, or exacerbation of angina."	0
"The antihypertensive effect of angiotensin II receptor antagonists, including telmisartan may be attenuated by NSAIDs including selective COX-2 inhibitors."	0
"Because Marplan lowers the convulsive threshold in some animal experiments, suitable precautions should be taken if epileptic patients are treated."	0
"Therefore, eating and drinking should be avoided for 10 minutes after administration."	0
This magnitude of change in tenofovir exposure does not reflect the approximately 60<U+2013>80% increase caused by the effects of an HIV PI/ritonavir and the effect of food.	0
Similar proportions of older patients (2.4%) and younger patients (1.5%) discontinued fluconazole therapy because of side effects.	0
No dose adjustment is recommended for drugs metabolized by CYP2D6.	0
"The risk of hypokalemia may be increased in patients with cirrhosis, brisk diuresis, or with concomitant use of drugs that lower serum potassium."	0
A gradual dose reduction is recommended (5.7).	0
Anagrelide Patients taking aspirin in combination with anagrelide are at an increased risk of bleeding.	0
"Candesartan cilexetil given to pregnant rabbits at an oral dose of 3 mg/kg/day (approximately 1.7 times the MRHD on a mg/m2 basis) caused maternal toxicity (decreased body weight and death) but, in surviving dams, had no adverse effects on fetal survival, fetal weight, or external, visceral, or skeletal development."	0
"In patients with severe hepatic impairment (Child-Pugh score of 10 or greater), clearance is reduced 2-fold to 3-fold and apparent volume of distribution is increased with a resultant increase in half-life to 20 hours."	0
"However, several possible mechanisms have been proposed: (1) competitive antagonism of catecholamines at peripheral (especially cardiac) adrenergic neuron sites, leading to decreased cardiac output; (2) a central effect leading to reduced sympathetic outflow to the periphery; and (3) suppression of renin activity."	0
"Use of sympathomimetics and compounds such as guanethidine, methyldopa, methylphenidate, reserpine, epinephrine, norepinephrine, phenylalanine, dopamine, levodopa, tyrosine, and tryptophan with Marplan may precipitate hypertension, headache, and related symptoms."	0
Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.	1
"The most important reaction associated with NARDIL administration is the occurrence of hypertensive crises, which have sometimes been fatal."	0
Some of the patients were treated with IMURAN as monotherapy and some had received concomitant treatment with a TNF<U+03B1> blocker at or prior to diagnosis.	0
7.6 Effect of Cytochrome P450 Inhibitors and Inducers on Treprostinil .	0
Treatment should be continued until clinical parameters or laboratory tests indicate that active fungal infection has subsided.	0
The 50 mg dose is both a starting dose and the therapeutic dose.	0
"Drugs that slow heart rate : Concomitant use of drugs with depressant effects on the sinus and AV node ( e.g. , digoxin , beta blockers , verapamil , diltiazem , ivabradine , clonidine ) can potentiate the electrophysiologic and hemodynamic effects of amiodarone , resulting in bradycardia , sinus arrest , and AV block ."	0
"Cimetidine is secreted in human milk and, as a general rule, nursing should not be undertaken while a patient is on a drug."	0
"Angina: The recommended dose of amlodipine for chronic stable or vasospastic angina is 5<U+2013>10 mg, with the lower dose suggested in the elderly and in patients with hepatic insufficiency."	0
"In adult clinical trials where EM/PM status was available, the mean heart rate increase in PM patients was significantly higher than in EM patients (11beats/minute versus 7.5beats/minute)."	0
"Given the likelihood that a proportion of patients exposed chronically to antipsychotics will develop tardive dyskinesia, it is advised that all patients in whom chronic use is contemplated be given, if possible, full information about this risk."	0
"Signs and symptoms of hyponatremia include headache, difficulty concentrating, memory impairment, confusion, weakness, and unsteadiness, which may lead to falls."	0
"In general, avoid combined use of RAS inhibitors."	0
Falsely elevated glucose levels may be measured up to two weeks following cessation of EXTRANEAL therapy.	0
"As doses of CARDIZEM CD were increased, overall angina frequency was decreased."	0
"While these reactions are generally self-limiting, there have been reports of serious discontinuation symptoms."	0
80 mg single dose 15.3 5.0 Grapefruit Juice (low dose) 16 8 oz (about 250 mL) of single-strengthSingle-strength: one can of frozen concentrate diluted with 3 cans of water.	0
Replacement therapy: May be substituted for titrated components.	0
Imipramine <U+2014> Single doses of olanzapine did not affect the pharmacokinetics of imipramine or its active metabolite desipramine.	0
The mechanism of this interaction is unknown.	0
"In the clinical trials, 44% of patients with newly-diagnosed low-risk APL treated with TRISENOX in combination with tretinoin experienced elevated aspartate aminotransferase (AST), alkaline phosphatase, and/or serum bilirubin."	0
"Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including enalapril, may result in deterioration of renal function, including possible acute renal failure."	0
Adults should take LEXIVA oral suspension without food.	0
"Because of the long half-life of amiodarone and its metabolite desethylamiodarone , the potential for adverse reactions or interactions , as well as observed adverse effects , can persist following amiodarone withdrawal ."	0
"Since carvedilol undergoes substantial oxidative metabolism, the metabolism and pharmacokinetics of carvedilol may be affected by induction or inhibition of cytochrome P450 enzymes."	0
"Acidic food or juice (e.g., orange juice, apple juice, or apple sauce) are not recommended for mixing VIRACEPT Oral Powder because the combination may result in a bitter taste."	0
"When given IV, dilute to at least 1 mg/mL and administer at a rate of 1 mg per 2 minutes."	0
Iloperidone doses should be reduced by one-half when administered with fluoxetine.	1
"Warning signs or symptoms of fluid and electrolyte imbalance include dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia, and gastrointestinal disturbances such as nausea and vomiting."	0
"Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders."	0
There was no significant pharmacokinetic interaction between fluconazole and azithromycin.	0
The latter decrease may result in a small increase of serum potassium.	0
"Hepatitis C virus (HCV): Direct-Acting Antivirals: For contraindicated HCV Direct-Acting Antivirals,. atorvastatin, pravastatin, rosuvastatin <U+2191> HMG-CoA reductase inhibitors Co-administration of PREZISTA/ritonavir with HMG-Co A reductase inhibitors may lead to adverse events such as myopathy."	0
"Rare cases have also been reported in association with the use of injectable dihydroergotamine mesylate; however, in those cases, patients also received drugs known to be associated with cardiac valvular fibrosis."	0
"Coadministration of inhibitors of the uptake transporter ( rifampin , cyclosporine ) or efflux transporter ( ritonavir ) may increase the systemic exposure to valsartan ."	1
"In a patient who requires more urgent treatment of a psychiatric condition, other interventions, including hospitalization, should be considered."	0
Female rats given the highest dose (270mg/kg/day) had a slightly higher incidence of pancreatic acinar adenoma.	0
"In a controlled clinical study for renal protection in type2 diabetic patients with proteinuria, 248 patients (33%) were 65 years and over."	0
Screening Patients for Bipolar Disorder: A major depressive episode may be the initial presentation of bipolar disorder.	0
"Some of the adverse effects of loxapine may be related to the antagonism of histamine H1 (somnolence), muscarinic M1 (anticholinergic), and adrenergic <U+03B1>2 (orthostatic hypotension) receptors (Ki values of 15 nM, 117 nM and 250 nM, respectively)."	0
Elevations in BUN and creatinine levels may be more frequent in patients receiving divided dose diuretic therapy.	0
"Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death."	0
"Nebivolol is metabolized by a number of routes, including glucuronidation and hydroxylation by CYP2D6."	0
"Limit fluvastatin dose to 20 mg (2.5, 7.2) Concomitant lipid-lowering therapies: Use with fibrates or lipid-modifying doses (<U+2265> 1 g/day) of niacin increases the risk of adverse skeletal muscle effects."	0
"<U+2022> Dosing modifications: may be required for concomitant therapy ( 2.3, 2.4, 2.5, 2.6), renal impairment (2.7), and hepatic impairment (2.8)."	0
Co-administration of APTIVUS/ritonavir in patients on bosentan: Discontinue use of bosentan at least 36 hours prior to initiation of APTIVUS/ritonavir.	0
"The recommended dosage of DIFLUCAN for esophageal candidiasis is 200 mg on the first day, followed by 100 mg once daily."	0
Another study at a 400 mg and 800 mg daily dose of fluconazole demonstrated that DIFLUCAN taken in doses of 400 mg per day or greater significantly increases plasma levels of terfenadine when taken concomitantly.	1
"A separate retrospective cohort study from the United States (United Healthcare data) evaluated 5,956 infants of mothers dispensed antidepressants during the first trimester (n = 815 for paroxetine)."	0
Dosage reduction may be necessary in the event of severe toxicities or QTc interval prolongation.	0
"Buspirone <U+2013> In a study of steady-state pharmacokinetics in healthy volunteers, coadministration of buspirone (2.5 or 5 mg BID) with nefazodone (250 mg BID) resulted in marked increases in plasma buspirone concentrations (increases up to 20 fold in Cmax and up to 50 fold in AUC) and statistically significant decreases (about 50%) in plasma concentrations of the buspirone metabolite 1-pyrimidinylpiperazine."	1
Blood pressure should be measured prior to initiating treatment and periodically measured throughout treatment.	0
Thiazides affect renal tubular mechanisms of electrolyte reabsorption and increase excretion of sodium and chloride in approximately equivalent amounts.	0
An inadequate period of treatment may lead to recurrence of active infection.	0
"In multiple dose studies in hypertensive patients, there were no clinically important effects on fasting triglycerides, total cholesterol, HDL-cholesterol, or fasting glucose concentrations."	0
Radiolabel mass balance studies indicate that the main route of excretion is via the kidneys.	0
"At recommended doses atenolol does not potentiate insulin-induced hypoglycemia and, unlike nonselective beta blockers, does not delay recovery of blood glucose to normal levels."	0
Advise patients to report signs and symptoms of bleeding and medically manage as needed.	0
"For a child aged 1 week, the initial starting oral dose should be multiplied by 0.3; the starting dose would be (30 <U+00D7> 0.3) = 9 mg/m2."	0
No postural effect on blood pressure was apparent and there was no evidence of tolerance to the antihypertensive effect of SULAR in patients treated for up to one year.	0
"Dual blockade of the RAS with angiotensin-receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
These effects have been partially additive to the effects of thiazide diuretics in some clinical studies.	0
"The pooled analyses of placebo-controlled trials in adults with MDD or other psychiatric disorders included a total of 295 short-term trials (median duration of 2 months) of 11 antidepressant drugs in over 77,000 patients."	0
Studies of the mutagenic potential of triamterene and hydrochlorothiazide have not been performed.	0
"Angiotensin II is the principal pressor agent of the renin-angiotensin system, with effects that include vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation, and renal reabsorption of sodium."	0
Conduction in the AV node is also prolonged.	0
"Furthermore, whenever one of these drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant agent may be required."	0
Follow patients closely for signs of respiratory depression and sedation.	0
There was no evidence of mutagenic potential when dihydroergotamine mesylate was tested in the presence or absence of metabolic activation in two gene mutation assays (the Ames test and the in vitro mammalian Chinese hamster V79/HGPRT assay) and in an assay for DNA damage (the rat hepatocyte unscheduled DNA synthesis test).	0
"Severe interactions with such drugs can result in, for example, severe hypotension, cardiac failure, severe bradycardia, sinus pause, sinoatrial block, atrioventricular block, and/or cardiac arrest."	0
"Abnormal thinking, behavioral changes, complex behaviors: May include ""sleep-driving"" and hallucinations."	0
"When switching to a TID regimen of nicardipine capsules, administer the first dose 1 hour prior to discontinuation of the infusion."	0
The apparent half-life of risperidone was 3 hours (CV=30%) in extensive metabolizers and 20 hours (CV=40%) in poor metabolizers.	0
"These interactions may lead to: Clinically significant adverse reactions, potentially leading to severe, life threatening, or fatal events from greater exposures of concomitant medications."	0
"Metabolism and Elimination Vortioxetine is extensively metabolized primarily through oxidation via cytochrome P450 isozymes CYP2D6, CYP3A4/5,CYP2C19, CYP2C9, CYP2A6, CYP2C8 and CYP2B6 and subsequent glucuronic acid conjugation."	0
"Quinapril was also negative in the following genetic toxicology studies: in vitro mammalian cell point mutation, sister chromatid exchange in cultured mammalian cells, micronucleus test with mice, in vitro chromosome aberration with V79 cultured lung cells, and in an in vivo cytogenetic study with rat bone marrow."	0
Administer Cleviprex by a central line or a peripheral line.	0
"Tricyclic Antidepressants (TCAs): Significantly increased plasma TCA levels have been reported with the coadministration of immediate-release fluvoxamine maleate tablets and amitriptyline, clomipramine or imipramine."	1
"At the first signs or symptoms of heart failure, discontinuation of ZIAC should be considered."	0
"However, because both of these compounds have CNS effects, an additive pharmacodynamic effect is possible."	0
It is eliminated predominantly via urine (75%) with 15% in feces.	0
Monitor hepatic function tests monthly or as clinically indicated.	0
Some patients required either initiation or dose adjustments of insulin or oral hypoglycemic agents for the treatment of these events.	0
"Monoamine Oxidase Inhibitors<U+2013> See CONTRAINDICATIONS, WARNINGS, andDOSAGE AND ADMINISTRATION."	0
"In the CYMBALTA clinical trials database, three CYMBALTA-treated patients had liver injury as manifested by ALT and total bilirubin elevations, with evidence of obstruction."	0
There was a significant regression of carotid lesions in patients receiving lovastatin alone compared to those receiving placebo alone (p=0.001).	0
"Adverse experiences, consisting primarily of headache, nausea, sweating, and dizziness, have been reported when tryptophan was administered to patients taking paroxetine."	0
"Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed."	0
The potential drug-drug interactions must be considered prior to and during therapy.	0
"Severe hyperthermia and seizures, sometimes fatal, have been reported in association with the combined use of tricyclic antidepressants and MAOIs."	0
The recommended dose of Savella is 100 mg/day (50 mg twice daily).	0
"Since NEXTERONE contains dextrose , patients with allergy to corn or corn products are at risk for allergic reaction ."	0
The elimination half-life of nifedipine is approximately two hours.	0
Dronedarone and its N-debutyl active metabolite accounted for less than 15% of the resultant radioactivity in the plasma.	0
Long-Term Suppression of Growth: monitor height and weight in pediatric patients at appropriate intervals.	0
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.	0
Calcium excretion is decreased by thiazides.	0
"Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death."	0
"See Drug Interactions (7) for instructions concerning coadministration of acid-reducing medications (eg, H2RA or PPIs), and other antiretroviral drugs (eg, efavirenz, tenofovir DF, and didanosine). c In treatment-experienced patients, REYATAZ capsules must be administered with ritonavir."	0
"In the DIAMOND trials, 1252 patients were treated with TIKOSYN and diuretics concomitantly, of whom 493 died compared to 508 deaths among the 1248 patients receiving placebo and diuretics."	0
"PDE5 Inhibitors Sildenafil (Revatio<U+00AE>) [for treatment of pulmonary arterial hypertension]See Drug Interactions, Table 6 for coadministration of sildenafil and tadalafil when dosed for erectile dysfunction."	0
"Treatment with LUVOX CR Capsules and any concomitant serotonergic agents should be discontinued immediately if the above events occur, and supportive symptomatic treatment should be initiated."	0
"If a ventricular pacemaker is operative, patients with second or third degree heart block may be treated with mexiletine hydrochloride if continuously monitored."	0
"Among these are tricyclic antidepressants and selective serotonin reuptake inhibitors, e.g., fluoxetine, sertraline and paroxetine."	0
"Drugs that inhibit CYP2D6 such as quinidine, fluoxetine, paroxetine, and propafenone are likely to increase metoprolol concentration."	1
Drug-drug interactions can be pharmacodynamic (combined pharmacologic effects) or pharmacokinetic (alteration of plasma levels).	0
The possibility of exacerbation of hypotensive effects with TARKA may be minimized by either discontinuing the diuretic or cautiously increasing salt intake prior to initiation of treatment with TARKA.	0
"Prophylaxis of gout flares-co-administration of colchicine in patients on ritonavir: If the original colchicine regimen was 0.6 mg twice a day, the regimen should be adjusted to 0.3 mg once a day."	0
"If acceptable alternatives to linezolid or intravenous methylene blue treatment are not available and the potential benefits of linezolid or intravenous methylene blue treatment are judged to outweigh the risks of serotonin syndrome in a particular patient, Savella should be stopped promptly, and linezolid or intravenous methylene blue can be administered."	0
"Drugs Highly Bound to Plasma Protein Because paroxetine is highly bound to plasma protein, administration of paroxetine to a patient taking another drug that is highly protein bound may cause increased free concentrations of the other drug, potentially resulting in adverse events."	1
This interference with reuptake of norepinephrine and/or serotonin is believed by some to underlie the antidepressant activity of amitriptyline.	0
Diltiazem produces relaxation of coronary vascular smooth muscle and dilation of both large and small coronary arteries at drug levels that cause little or no negative inotropic effect.	0
Paliperidone has no affinity for cholinergic muscarinic or <U+03B2>1- and <U+03B2>2-adrenergic receptors.	0
"Plasma concentrations, half-life, and clearance of olanzapine may vary between individuals on the basis of smoking status, gender, and age."	0
"If the platelet count decreases to <90,000/mm3, monitor platelet counts to exclude pseudothrombocytopenia."	0
Thiazide diuretics have been reported to cause exacerbation or activation of systemic lupus erythematosus.	0
"Clozapine demonstrated binding affinity to the following receptors: histamine H1 (Ki 1.1 nM), adrenergic <U+03B1>1A (Ki 1.6 nM), serotonin 5-HT6 (Ki 4 nM), serotonin 5-HT2A (Ki 5.4 nM), muscarinic M1 (Ki 6.2 nM), serotonin 5-HT7 (Ki 6.3 nM), serotonin 5-HT2C (Ki 9.4 nM), dopamine D4 (Ki 24 nM), adrenergic <U+03B1>2A (Ki 90 nM), serotonin 5-HT3 (Ki 95 nM), serotonin 5-HT1A (Ki 120 nM), dopamine D2 (Ki 160 nM), dopamine D1 (Ki 270 nM), dopamine D5 (Ki 454 nM), and dopamine D3 (Ki 555 nM)."	0
"In patients with the sick sinus syndrome, quinidine can cause marked sinus node depression and bradycardia."	0
"Preclinical data also suggest that Tracleer , similar to other endothelin receptor antagonists , may have an adverse effect on spermatogenesis see Adverse Reactions ( 6.1 ) , Nonclinical Toxicology ( 13.1 ) ."	0
"Hyperkalemia Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) can increase the risk of hyperkalemia."	0
Individualization of drug dosage should be based on therapeutic response.	0
Developmental changes in pediatric renal function were factored into Table 3.	0
"For patients who experience a sustained increase in blood pressure while receiving Savella, either reduce the dose or discontinue treatment with Savella if clinically warranted."	0
Cardiovascular A maximal limb-lead QRS duration of <U+2265> 0.10 seconds has been associated with an increased incidence of seizures.	0
"FANAPT functions as an antagonist at the dopamine D2, D3, serotonin 5-HT1A and norepinephrine <U+03B1>1/<U+03B1>2C receptors."	0
"In addition, pravastatin reduces VLDL and TG and increases HDL-C. General Absorption:Pravastatin sodiumis administered orally in the active form."	0
"Effient can cause significant, sometimes fatal, bleeding (5.1, 5.2, 6.1)."	0
"For a patient taking AUBAGIO, the dose of rosuvastatin should not exceed 10 mg once daily."	1
Stomatitis - The first small ulceration or persistent spot soreness around the oral cavity is a signal for cessation of therapy.	0
"6.Ventricular arrhythmias have been rarely associated with the use of macrolide antibiotics in patients with prolonged QT intervals, as might be produced by ORAP."	0
NORVASC is contraindicated in patients with known sensitivity to amlodipine.	0
"Unlike conventional alpha-blockers, the antihypertensive action of prazosin is usually not accompanied by a reflex tachycardia."	0
"Given these considerations, antipsychotics should be prescribed in a manner that is most likely to minimize the occurrence of tardive dyskinesia."	0
"In some patients, potassium citrate extended-release tablets cause a transient reduction in urinary calcium."	0
Caution should be used when treating Chinese patients with simvastatin in doses exceeding 20mg/day coadministered with lipid-modifying doses of niacin-containing products.	0
"Following discontinuation of an infusion of AGGRASTAT 0.10 mcg/kg/min, ex vivo platelet aggregation returns to near baseline in 4 to 8 hours in approximately 90% of patients with coronary artery disease."	0
The incidence of hyperkalemia leading to drug discontinuation in ATACAND-treated patients was 2.4% compared with 0.6% in placebo-treated patients.	0
"If acceptable alternatives to linezolid or intravenous methylene blue treatment are not available and the potential benefits of linezolid or intravenous methylene blue treatment are judged to outweigh the risks of serotonin syndrome in a particular patient, SURMONTIL should be stopped promptly, and linezolid or intravenous methylene blue can be administered."	0
Baseline genotypic testing is recommended for dose selection.	0
"Should a vasoconstrictor be required, the most suitable are levarterenol and phenylephrine."	0
"RE-ALIGN was terminated early due to the occurrence of significantly more thromboembolic events (valve thrombosis, stroke, transient ischemic attack, and myocardial infarction) and an excess of major bleeding (predominantly post-operative pericardial effusions requiring intervention for hemodynamic compromise) in the PRADAXA treatment arm as compared to the warfarin treatment arm."	0
"Until data on possible interactions between verapamil and disopyramide are obtained, disopyramide should not be administered within 48 hours before or 24 hours after verapamil administration."	0
"Compounds which inhibit DNA, RNA and protein synthesis might be expected to have adverse effects on peri- and postnatal development."	0
PERSANTINE tablets do not influence prothrombin time or activity measurements when administered with warfarin.	0
"Effect of Atorvastatin on the Pharmacokinetics of Co-administered Drugs Atorvastatin Co-administered drug and dosing regimen Drug/Dose (mg) Change in AUC Change in Cmax 80 mg QD for 15 days Antipyrine, 600 mg SD <U+2191> 3% <U+2193> 11% 80 mg QD for 14 days Digoxin 0.25 mg QD, 20 days <U+2191> 15% <U+2191> 20 % 40 mg QD for 22 days Oral contraceptive QD, 2 months <U+2013> norethindrone 1mg<U+2013> ethinyl estradiol 35 <U+00B5>g <U+2191> 28%<U+2191> 19% <U+2191> 23%<U+2191> 30% 10 mg, SD Tipranavir 500 mg BID/ritonavir 200 mg BID, 7 days No change No change 10 mg QD for 4 days Fosamprenavir 1400 mg BID, 14 days <U+2193> 27% <U+2193> 18% 10 mg QD for 4 days Fosamprenavir 700 mg BID/ritonavir 100 mg BID, 14 days No change No change"	0
"In view of the retinal degeneration seen in rats, eye examinations were performed during clinical trials in 908 patients before, and periodically after, the start of clonidine therapy."	0
Lithium - generally should not be given with diuretics.	0
"Rifampin has been shown to be active against most strains of the following microorganisms, both in vitro and in clinical infections as described in the INDICATIONS AND USAGE section."	0
Coadministration of triazolam or orally administered midazolam with REYATAZ may cause large increases in the concentration of these benzodiazepines.	1
"Patients should be advised that taking nefazodone hydrochloride tablets can cause mild pupillary dilation, which in susceptible individuals, can lead to an episode of angle-closure glaucoma."	0
"Although the role of atomoxetine in these adult cases is also unknown, adults have a greater likelihood than children of having serious structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, coronary artery disease, or other serious cardiac problems."	0
"Prompt reduction in dosage or temporary withdrawal of the drug may be necessary if there is a rapid fall in or persistently low leukocyte count, or other evidence of bone marrow depression."	0
CYP2D6 Polymorphism No dose adjustments are necessary for patients who are CYP2D6 poor metabolizers.	0
There is limited experience with short-duration therapy with beta-blockers as a treatment for Cleviprex-induced tachycardia.	0
"No statistically significant differences were observed for Cmax, Tmax, half-life, and AUC between the first and last day of drug administration when baseline concentration adjustments were made."	0
A 10 mg dose of REVATIO injection is predicted to provide pharmacological effect of sildenafil and its N-desmethyl metabolite equivalent to that of a 20 mg oral dose.	0
"Panic Disorder The effectiveness of paroxetine in the treatment of panic disorder was demonstrated in three 10- to 12-week multicenter, placebo-controlled studies of adult outpatients (Studies 1 to 3)."	0
Coadministration with amiodarone may result in serious symptomatic bradycardia.	0
"In an analysis of the supraventricular arrhythmia and DIAMOND patient populations, the concomitant administration of verapamil with dofetilide was associated with a higher occurrence of Torsade de Pointes."	0
"Following an initial more rapid distribution phase, the terminal half-life of asenapine is approximately 24 hours."	0
"LEXIVA/ritonavir and coadministration of colchicine: Treatment of gout flares: 0.6mg (1 tablet) x 1 dose, followed by 0.3mg (half tablet) 1 hour later."	0
"5 (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity."	0
"This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function."	0
Institute appropriate therapeutic countermeasures as clinically indicated.	0
"Conversely, at least 14 days should be allowed after stopping NORPRAMIN before starting an MAOI intended to treat psychiatric disorders."	0
Avoid co<U+2011>administration of verapamil and ivabradine.	0
Clinical studies of nortriptyline hydrochloride did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
"In addition, in vitro studies have shown ketoconazole, a potent inhibitor of CYP3A4 activity, to be at least 100 times more potent than paroxetine as an inhibitor of the metabolism of several substrates for this enzyme, including terfenadine, astemizole, cisapride, triazolam, and cyclosporine."	0
CYP3A Inducers No information is available on the quantitative effects of CYP3A inducers on amlodipine.	0
"Although beta-adrenergic receptor blockade is useful in the treatment of angina, hypertension, and heart failure there are situations in which sympathetic stimulation is vital."	0
"In Study 1, involving n = 251 randomized patients; sertraline hydrochloride treatment was initiated at 50 mg/day and administered daily throughout the menstrual cycle."	0
"Avoid the use of strong CYP3A4 inducers (e.g., rifampin, phenytoin, carbamazepine, rifabutin, rifapentine, phenobarbital, St. John's wort) if possible."	0
In vitro studies showed minimal inhibitory effect of desvenlafaxine on the CYP2D6 isoenzyme.	0
"Total plasma clearance of candesartan is 0.37 mL/min/kg, with a renal clearance of 0.19 mL/min/kg."	0
"At all doses, the rebound effect appeared to resolve by the second night following withdrawal."	0
"Should urinary flow begin to decrease in the absence of hypotension, reduction of dopamine dosage should be considered."	0
Do not substitute ONIVYDE for other drugs containing irinotecan HCl.	0
Most antidepressant drugs have a lag period of ten days to four weeks before a therapeutic response is noted.	0
Lamotrigine: Multiple oral doses of bupropion had no statistically significant effects on the single-dose pharmacokinetics of lamotrigine in 12 healthy volunteers.	0
Albuterol (or other beta2 agonists) - Action of albuterol on cardiovascular system can be potentiated.	0
Appropriate laboratory testing should be conducted prior to initiating therapy with PREZISTA/ritonavir and patients should be monitored during treatment.	0
Both of these metabolites can be further metabolized to R(-)-amphetamine.	0
"There are, however, no adequate and well-controlled studies in pregnant women."	0
"There were no adverse effects on fertility or reproduction in rats at doses up to 100 mg/kg/day (60 and 10 times the maximum daily human dose when based on mg/kg and mg/m2, respectively)."	0
"Additionally, in a study comparing 14-day dosing with WELLBUTRIN XL 300 mg once daily to the sustained-release formulation of bupropion at 150 mg 2 times daily, equivalence was demonstrated for peak plasma concentration and area under the curve for bupropion and the three metabolites."	0
REYATAZ/ritonavir <U+2191> lurasidone REYATAZ/ritonavir Use of lurasidone is contraindicated.	0
"Patients with bone marrow depression or who have previously demonstrated a hypersensitivity reaction (e.g., blood dyscrasias, jaundice) with a phenothiazine should not receive any phenothiazine, including chlorpromazine, unless in the judgment of the physician the potential benefits of treatment outweigh the possible hazard."	0
"These complications have varied in severity; while in some cases symptoms have been self-limited, in other cases neonates have required intensive care unit support and prolonged hospitalization."	0
Metabolism and Elimination - Prasugrel is not detected in plasma following oral administration.	0
The incidence of rhabdomyolysis (defined as myopathy with a CK>40timesULN) in patients on 80mg/day was approximately 0.4% compared with 0% for patients on 20mg/day.	0
Monitor patients receiving RIFADIN for signs and/or symptoms of hypersensitivity reactions.	0
"CYP1A2 Inhibitors Concomitant use of CLOZARIL and CYP1A2 inhibitors can increase plasma levels of clozapine, potentially resulting in adverse reactions."	1
Persistence of Resistance-Associated Substitutions No data are available on the persistence of ledipasvir or sofosbuvir resistance-associated substitutions.	0
"In clinical trials, potassium levels were generally maintained above 3.6<U+2013>4.0 mEq/L."	0
"At endpoint, 76% of patients receiving paroxetine 40 mg/day were free of panic attacks, compared to 44% of placebo-treated patients."	0
"Immunosuppressants: Cyclosporine, tacrolimus, sirolimus <U+2191>Immunosuppressants Therapeutic concentration monitoring is recommended for immunosuppressant agents."	0
"Quinidine clearance typically proceeds at 3<U+2013>5 mL/min/kg in adults, but clearance in pediatric patients may be twice or three times as rapid."	0
"Pediatric Patients: The pharmacokinetics of ledipasvir, sofosbuvir, and GS-331007 were determined in 100 pediatric subjects 12 years of age and older infected with HCV genotype 1 receiving a daily dose of HARVONI (90 mg ledipasvir and 400 mg sofosbuvir)."	0
Initiate sotalol only in a facility that can provide ECG monitoring and in the presence of personnel trained in the management of serious ventricular arrhythmias.	0
The presence of hypokalemia and hypomagnesemia may further prolong the QT interval [see Warnings and Precautions (5.	0
"Therefore, coadministration of PEXEVA<U+00AE> (paroxetine mesylate) with other drugs that are metabolized by this isozyme, including certain drugs effective in the treatment of MDD (eg, nortriptyline, amitriptyline, imipramine, desipramine, and fluoxetine), phenothiazines, risperidone, and Type 1C antiarrhythmics (eg, propafenone, flecainide, and encainide), or that inhibit this enzyme (eg, quinidine), should be approached with caution."	0
The half-life of salicylic acid is 1.71 hours.	0
"Since the mechanisms of these reactions are not fully understood, it seems prudent, in general, to avoid this combination of selegiline and tricyclic antidepressants as well as selegiline and selective serotonin reuptake inhibitors."	0
"Interrupt CAPRELSA for the following: Corrected QT interval, Fridericia (QTcF) greater than 500 ms: Resume at a reduced dose when the QTcF returns to less than 450 ms. CTCAE Grade 3 or greater toxicity: Resume at a reduced dose when the toxicity resolves or improves to CTCAE Grade 1."	0
"In view of the testicular changes observed in animals, 105 patients on long term MINIPRESS therapy were monitored for 17-ketosteroid excretion and no changes indicating a drug effect were observed."	0
Neither of these differences is clinically significant.	0
"See also Contraindications (4), Clinical Pharmacology (12.3)."	0
"Others <U+2191> other protease inhibitor Although not studied, the coadministration of REYATAZ/ritonavir and an additional protease inhibitor would be expected to increase exposure to the other protease inhibitor."	1
"Altered anticoagulant effects, including increased bleeding, have been reported when SSRIs or SNRIs are coadministered with warfarin."	0
Families and caregivers should be advised of the need for close observation and communication with the prescriber.	0
"When such patients are treated with ACCURETIC, renal function should be monitored during the first few weeks of therapy."	0
The effects of coadministered drugs on the pharmacokinetics of apixaban are summarized in Figure 2.	0
The recommended usual starting dose is 10 or 20mg once a day in the evening.	0
"More severe and/or acute cases have been associated with hallucination, syncope, seizure, coma, respiratory arrest, and death."	0
"While in vitro studies indicate that CYP2D6 and CYP3A4 may be minimally involved in paliperidone metabolism, in vivo studies do not show decreased elimination by these isozymes and they contribute to only a small fraction of total body clearance."	0
The clearance of perindoprilat and its metabolites is almost exclusively renal.	0
Patients receiving warfarin therapy should be carefully monitored when PEXEVA<U+00AE> (paroxetine mesylate) is initiated or discontinued.	0
"Solid oral dosage forms of potassium chloride can produce ulcerative and/or stenotic lesions of the gastrointestinal tract, particularly when the drug remains in contact with the gastrointestinal mucosa for a prolonged period of time."	0
Fingolimod and fingolimod-phosphate exposure were consistent with those from previous studies.	0
"Closely monitor blood pressure, renal function and electrolytes in patients on ACCURETIC and other agents that affect the RAS."	0
"Before attributing fever to PURIXAN, every attempt should be made to exclude more common causes of pyrexia, such as sepsis, in patients with acute leukemia."	0
In this trial the overall frequency of adverse events in the CARDIZEM CD treatment group was the same as the placebo group.	0
"No dose adjustment of FETZIMA is needed when co-administered with inhibitors of CYP2C8 , CYP2C19, CYP2D6, CYP2J2, P-glycoprotein, BCRP, OATP1B1, OATP1B3, OAT1, OAT3, or OCT2."	0
The effects (if any) of coadministration of other <U+00DF><U+2013>blockers on quinidine pharmacokinetics have not been adequately studied.	0
Connect the catheter tip of the syringe to a 16 French (or larger) tube.	0
"After coadministration of a radioactive intravenous dose of nicardipine with an oral 30 mg dose given every 8 hours, 49% of the radioactivity was recovered in the urine and 43% in the feces within 96 hours."	0
"Respiratory depression is the chief risk for elderly patients treated with opioids, and has occurred after large initial doses were administered to patients who were not opioid-tolerant or when opioids were co-administered with other agents that depress respiration."	0
Other symptomatic and supportive measures may be desirable in particular cases.	0
"In the majority of patients, these events were mild to moderate and were self-limiting and did not require medical intervention."	0
Antidiabetic drugs (oral agents and insulin) - dosage adjustment of the antidiabetic drug may be required.	0
Gender: A study in healthy subjects comparing the pharmacokinetics in males and females showed no meaningful difference.	0
"If the two drugs are coadministered, the beta blocker should be withdrawn several days before the gradual withdrawal of clonidine."	0
"Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group."	0
Benicar may be administered with or without food.	0
Sinus Node Disease and AV Block: Digoxin use can exacerbate the condition and may cause advanced or complete heart block.	0
Patients who are not growing or gaining weight as expected may need to have their treatment interrupted.	0
"Combination of Protease Inhibitors: Atorvastatin AUC was significantly increased with concomitant administration of atorvastatin with several combinations of HIV protease inhibitors, as well as with the hepatitis C protease inhibitor telaprevir, compared to that of atorvastatin alone."	1
"In this study with a demonstrated ability to detect small effects, the upper bound of the 90% confidence interval (CI) for the largest placebo-adjusted, baseline-corrected QTc based on individual correction method was below 10 milliseconds, the threshold for regulatory concern."	0
"Vasodilation, inhibition of platelet aggregation, and stimulation of intestinal and uterine smooth muscle are among the most notable of these effects."	0
Coadministration of REYATAZ/ritonavir with clarithromycin has not been studied.	0
Zolpidem did not accumulate in young adults following nightly dosing with 20 mg zolpidem tartrate tablets for 2 weeks.	0
"Therefore, monitor vital signs carefully when using nicardipine, particularly in combination with a beta-blocker, in patients with CHF or significant left ventricular dysfunction."	0
"Preparation and Administration (2.3, 2.4) EMEND capsules and EMEND for oral suspension can be administered with or without food."	0
Premedication Administer a corticosteroid and an anti-emetic 30 minutes prior to ONIVYDE infusion.	0
"Coadministration of REYATAZ or REYATAZ/ritonavir with other hormonal contraceptives (eg, contraceptive patch, contraceptive vaginal ring, or injectable contraceptives) or oral contraceptives containing progestogens other than norethindrone or norgestimate, or less than 25 mcg of ethinyl estradiol, has not been studied; therefore, alternative methods of contraception are recommended."	0
Studies in female rats at daily dietary doses up to 5.5 times (55 mg/kg/day) the maximum recommended human dose did not show impaired fertility.	0
HIV-1 CCR5 antagonist: Maraviroc <U+2191> Maraviroc Maraviroc dose should be 150 mg twice daily when coadministered with INVIRASE/ritonavir.	0
An additional 100mg/day (300mg total) of ritonavir is recommended when efavirenz is administered with LEXIVA/ritonavir once daily.	0
"Both free and clot-bound thrombin, and thrombin-induced platelet aggregation are inhibited by the active moieties."	0
"If symptoms persist for 2-3 days after trial with oral therapy, give 25 to 50 mg (1-2 mL) IM."	0
It is generally believed (though not established in controlled trials) that treating such an episode with an antidepressant alone may increase the likelihood of precipitation of a mixed/manic episode in patients at risk for bipolar disorder.	0
"In isolated cases , intravenous administration of LASIX within 24 hours of taking chloral hydrate may lead to flushing , sweating attacks , restlessness , nausea , increase in blood pressure and tachycardia ."	0
"In these patients, the mean volume of distribution of the central compartment (Vc) of nesiritide was estimated to be 0.073 L/kg, the mean steady-state volume of distribution (Vss) was 0.19 L/kg, and the mean clearance (CL) was approximately 9.2 mL/min/kg."	0
"Triglycerides, HDL cholesterol, and albumin did not change."	0
Drugs Metabolized by CYP2B6 - Prasugrel is a weak inhibitor of CYP2B6.	0
"In study 2, a 4-week, placebo-controlled trial in depressed patients, of whom 85% met criteria for melancholia, the initial dose was 20 mg/day, followed by titration to the maximum tolerated dose or a maximum dose of 80 mg/day."	0
"Corticosteroids, ACTH <U+2013> Intensified electrolyte depletion, particularly hypokalemia."	0
"Studies with phendimetrazine tartrate sustained release have not been performed to evaluate carcinogenic potential, mutagenic potential or effects on fertility."	0
"Because of the risk of embryo-fetal toxicity, females can only receive Letairis through a restricted program called the Letairis REMS program."	0
"In treatment-experienced adult patients: Whenever an H2RA is given to a patient receiving REYATAZ with ritonavir, the H2RA dose should not exceed a dose comparable to famotidine 20 mg twice daily, and the REYATAZ and ritonavir doses should be administered simultaneously with, and/or at least 10 hours after, the dose of the H2RA."	1
These patients were excluded from clinical studies during the product's premarketing testing.	0
Placebo 33 <U+2013>2 <U+2013>1 <U+2013>1 0 +1 +9 MEVACOR 10 mg q.p.m.	0
Rifabutin induces CYP3A enzymes and therefore may reduce the plasma concentrations of drugs metabolized by those enzymes.	1
Hemodynamics: Cleviprex causes a dose-dependent decrease in systemic vascular resistance.	0
HIV-1 CCR5 <U+2013> antagonist: maraviroc <U+2191> maraviroc See the complete prescribing information for maraviroc for details on co-administration of maraviroc and ritonavir-containing protease inhibitors.	0
The physician should switch to a more suitable site as soon as possible and the infusion site in use should be continuously monitored for free flow.	0
Patients who require a large reduction in LDL-C (more than 45%) may be started at 40 mg once daily.	0
"Following intravenous administration of metoprolol, the urinary recovery of unchanged drug is approximately 10%."	0
The clinical effect is hypothesized as being due to potentiation of adrenergic synapses by blocking uptake of norepinephrine at nerve endings.	0
"If these occur, the infusion should be discontinued and restarted at another site."	0
Concomitant medication usage must be reviewed.2.	0
Co-administration of SAMSCA and ketoconazole 200 mg daily results in a 5-fold increase in exposure to tolvaptan .	1
Metoprolol pharmacokinetics have not been investigated in patients < 6 years of age.	0
"After oral administration, about 81% of the dose is slowly excreted in the urine as inactive metabolites."	0
Clinically significant adverse reactions from greater exposures of INVIRASE/ritonavir.	0
Saquinavir/ritonavir prolongs the PR interval in a dose-dependent fashion.	0
Begin infusion with 0.05 to 0.1 micrograms alprostadil per kilogram of body weight per minute.	0
"Diazepam<U+2014> Under steady-state conditions, diazepam does not appear to affect paroxetine kinetics."	0
Patients with AIDS and cryptococcal meningitis or recurrent oropharyngeal candidiasis usually require maintenance therapy to prevent relapse.	0
"Coadministration of inhibitors of the uptake transporter ( rifampin , cyclosporine ) or efflux transporter ( ritonavir ) may increase the systemic exposure to valsartan ."	1
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.	0
"In patients with creatinine clearance <40 mL/min/1.73 m2, peak levels of ramiprilat are approximately doubled, and trough levels may be as much as quintupled."	0
"Clinically significant interactions have been reported with inhibitors of CYP3A4 (e.g. erythromycin, ritonavir) causing elevation of plasma levels of verapamil while inducers of CYP3A4 (e.g. rifampin) have caused a lowering of plasma levels of verapamil."	1
The safety and efficacy of doses above 40mg daily have not been studied in children.	0
"In subjects with ESRD, relative to subjects with normal renal function, sofosbuvir and GS-331007 AUC0<U+2013>inf was 28% and 1280% higher when sofosbuvir was dosed 1 hour before hemodialysis compared with 60% and 2070% higher when sofosbuvir was dosed 1 hour after hemodialysis, respectively."	0
"However, there is substantial evidence from placebo-controlled maintenance trials in adults with depression that the use of antidepressants can delay the recurrence of depression."	0
"Under steady-state conditions for duloxetine (20 mg qhs) and temazepam (30 mg qhs), the pharmacokinetics of duloxetine were not affected by co-administration."	0
"Maintenance therapy should be at the lowest effective dose, and the dose given can be lowered decrementally with changes of 0.5mg/kg or approximately 25mg daily every 4weeks while other therapy is kept constant."	0
"Should convulsions persist despite ventilatory support, small doses of anticonvulsant drugs may be used intravenously."	0
Amiloride HCl should be administered with food.	0
The oral bioavailability of lisinopril in patients with acute myocardial infarction is similar to that in healthy volunteers.	0
Metabolites are excreted in the urine in the form of conjugates and in the feces unconjugated.	0
"Oral contraceptives: In a study of concurrent administration of an oral contraceptive during 6 days of administration of MAXALT (10-30 mg/day) in healthy female volunteers (n=18), rizatriptan did not affect plasma concentrations of ethinyl estradiol or norethindrone."	0
"NORVIR should be used with caution in patients with underlying structural heart disease, preexisting conduction system abnormalities, ischemic heart disease, cardiomyopathies, as these patients may be at increased risk for developing cardiac conduction abnormalities."	0
"After a single IV administration, the total body clearance of teriflunomide is 30.5 mL/h."	0
"In clinical trials, however, no significant increases in blood pressure response or in the incidence of orthostatic hypotension were found in women."	0
These adverse outcomes are usually associated with use of these drugs in the second and third trimester of pregnancy.	0
"Clinical Trials In clinical trials, extended-release oral isosorbide dinitrate has been administered in a variety of regimens, with total daily doses ranging from 40 to 160 mg. A controlled trial using a single 40 mg sustained-release oral dose of isosorbide dinitrate (dilatrate<U+00AE>-SR) has demonstrated effective reductions in exercise-related angina for up to 8 hours."	0
"Coadministration of a single dose of fluconazole (100 mg) with a single dose of terbinafine resulted in a 52% and 69% increase in terbinafine Cmax and AUC, respectively."	1
"Because beta1-selectivity is not absolute, use the lowest possible dose of TOPROL-XL."	0
Other fibrates: Caution should be used when prescribing with simvastatin.	0
"In transplant patients, consider the risk that the reduced immunosuppression represents to the graft."	0
Hyperuricemia: Hyperuricemia or acute gout may be precipitated in certain patients receiving thiazide diuretics.	0
"ND 31 ledipasvir 0.65 (0.56, 0.76) 0.41 (0.36, 0.48) NA ND 400 single dose 17 sofosbuvir 0.23 (0.19, 0.29) 0.28 (0.24, 0.32) NA GS-331007 1.23 (1.14, 1.34) 0.95 (0.88, 1.03) NA Simeprevir 150 once daily 30 once daily ND 22 ledipasvir 1.81 (1.69, 2.94) 1.92 (1.77, 2.07) NA Tacrolimus 5 single dose ND 400 single dose 16 sofosbuvir 0.97 (0.65, 1.43) 1.13 (0.81, 1.57) NA GS-331007 0.97 (0.83, 1.14) 1.00 (0.87, 1.13)"	0
"Angiotensin II is the principal pressor agent of the renin-angiotensin system, with effects that include vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation and renal reabsorption of sodium."	0
The risk of accumulation of toxic blood levels of AHA seems to be greater than the chances for a beneficial effect in such patients.	0
Do not coadminister aliskiren with AVALIDE in patients with diabetes.	0
"The pooled analyses of placebo-controlled trials of nine antidepressant drugs (SSRIs) and others) in children and adolescents with MDD, Obsessive compulsive disorder (OCD), or other psychiatric disorders included a total of 24 short-term trials of 9 antidepressant drugs in over 4400 patients."	0
"Such symptoms should be reported to the patient's prescriber or health professional, especially if they are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
Concomitant allopurinol and PURIXAN can result in a significant increase in bone marrow toxicity.	0
A study that compared patients with normal hepatic function to patients with cirrhosis found an increase in half-life and a 69% increase in bioavailability in the hepatically impaired patients.	0
"When the etiology of these signs and symptoms is not obvious, measurement of serum digoxin levels may be helpful."	0
"The major biotransformation pathways are oxidative N-dealkylation, hydroxylation of norbornane ring, and S-oxidation."	0
"Telmisartan As the majority of telmisartan is eliminated by biliary excretion, patients with biliary obstructive disorders or hepatic insufficiency can be expected to have reduced clearance."	0
In vitro studies with human liver microsomes indicate that the biotransformation of estazolam to the major circulating metabolite 4-hydroxy-estazolam is mediated by cytochrome P450 3A (CYP3A).	0
"When chlorpromazine is administered concomitantly, about 1/4 to 1/2 the usual dosage of such agents is required."	0
The effect of paroxetine on cimetidine<U+2019>s pharmacokinetics was not studied.	0
"Sildenafil <U+2191> sildenafil concentration(only the use of sildenafil at doses used for treatment of erectile dysfunction has been studied with CRIXIVAN) May result in an increase in PDE5 inhibitor-associated adverse events, including hypotension, syncope, visual disturbances, and priapism."	0
"Drugs that induce CYP3A4 activity would be expected to increase the clearance of indinavir, resulting in lowered plasma concentrations of indinavir."	1
"Catecholamine-depleting drugs (eg, reserpine, monoamine oxidase (MAO) inhibitors) may have an additive effect when given with beta-blocking agents."	0
Clomipramine hydrochloride is not approved for use in pediatric patients except for patients with obsessive compulsive disorder (OCD).	0
"Clinical pharmacology studies were conducted to assess the effect of tadalafil on the potentiation of the blood pressure lowering effects of selected antihypertensive medications ( amlodipine , angiotensin II receptor blockers , bendroflumethiazide , enalapril , and metoprolol ) ."	0
"If concomitant use of ZOLOFT with other serotonergic drugs is clinically warranted, inform patients of the increased risk for serotonin syndrome and monitor for symptoms."	0
"While INVEGA<U+00AE> can be taken without regard to food, the presence of food at the time of INVEGA<U+00AE> administration may increase exposure to paliperidone."	1
Reports suggest that diethylpropion hydrochloride may increase convulsions in some epileptics.	0
Dosing in pediatric patients is based on the patient's body weight.	0
"If blood pressure is not adequately controlled with ACCUPRIL monotherapy, a diuretic may be added."	0
"In a study of fluvoxamine maleate tablets at 50 and 100 mg comparing elderly (ages 66-73) and young subjects (ages 19-35), mean maximum plasma concentrations in the elderly were 40% higher."	0
No fetal or neonatal abnormalities have been reported with the use of prazosin.2 There are no adequate and well controlled studies which establish the safety of MINIPRESS in pregnant women.	0
Inhibition of CYP2D6 by paroxetine may lead to reduced plasma concentrations of an active metabolite (endoxifen) and hence reduced efficacy of tamoxifen.	1
Prophylaxis of DVT following hip or knee replacement surgery: The recommended dose is 2.5 mg orally twice daily.	0
There are no known clinically relevant inhibitors or inducers of aldehyde oxidase.	0
"Observe patients treated with TOPROL-XL plus a catecholamine depletor for evidence of hypotension or marked bradycardia, which may produce vertigo, syncope, or postural hypotension."	0
At least 14 days should elapse between discontinuation of an MAOI intended to treat psychiatric disorders and initiation of therapy with Lexapro.	0
Total amounts of ethanol and propylene glycol from all medicines that are to be given to infants should be taken into account in order to avoid toxicity from these excipients.	0
CYP2D6 enzyme inhibitors may increase nebivolol levels (7.1) Reserpine or clonidine may produce excessive reduction of sympathetic activity.	0
All reports with methylene blue that provided information on the route of administration involved intravenous administration in the dose range of 1 mg/kg to 8 mg/kg.	0
"Similarly, St. John<U+2019>s wort, a CYP3A4 inducer, may also decrease the blood levels of zolpidem."	1
"Zanaflex can cause sedation, which may interfere with everyday activity."	0
"In hypertensive patients with unilateral or bilateral renal artery stenosis, increases in blood urea nitrogen and serum creatinine may occur."	0
"In patients with hepatic cirrhosis, the influence of verapamil on digoxin kinetics is magnified."	0
"Table 5: Sevelamer Drug Interactions Oral drugs for which sevelamer did not alter the pharmacokinetics when administered concomitantly Digoxin Enalapril Iron Metoprolol Warfarin Oral drugs that have demonstrated interaction with sevelamer and are to be dosed separately from Renvela Dosing Recommendations Ciprofloxacin Take at least 2 hours before or 6 hours after sevelamer Mycophenolate mofetil Take at least 2 hours before sevelamer For oral medication where a reduction in the bioavailability of that medication would have a clinically significant effect on its safety or efficacy, consider separation of the timing of administration and/or monitor clinical responses or blood levels of the concomitant medication."	0
"PATIENTS WITH BRONCHOSPASTIC DISEASES SHOULD, IN GENERAL, NOT RECEIVE BETA-BLOCKERS."	0
"Nevertheless, female rats administered pimozide had prolonged estrus cycles, an effect also produced by other antipsychotic drugs."	0
Physicians should carefully consider benefit versus risk when treating less severe disorders.	0
"After an initial priming of 10 sprays , each metered spray of NitroMist delivers 33 mg of solution containing 400 mcg of nitroglycerin ."	0
"To minimize dose-independent side effects, it is usually appropriate to begin combination therapy only after a patient has failed to achieve the desired effect with monotherapy."	0
"HMG-CoA Reductase inhibitors: lovastatin, simvastatin CONTRAINDICATED due to an increased risk for serious reactions such as myopathy including rhabdomyolysis."	0
Sudden cessation may result in marked hypotension.	0
"Use with organic nitrates or riociguat (4) History of hypersensitivity reaction to sildenafil or any component of the tablet, injection, or oral suspension (4)"	0
Potassium supplementation should not be used with DYAZIDE except in severe cases of hypokalemia.	0
"Lower starting and maintenance doses of other CYP3A4 substrates ( e.g. , atorvastatin ) may be required as amiodarone may increase the plasma concentration of these drugs ."	1
The presence of phenothiazines may produce false-positive phenylketonuria (PKU) test results.	0
Steady-state concentrations are attained within3 to 4 days of dosing.	0
APTIVUS co-administered with ritonavir capsules or solution can be taken with or without meals APTIVUS co-administered with ritonavir tablets must only be taken with meals APTIVUS may be administered as either capsules or oral solution to either pediatric or adult patients.	0
"Therapeutic effects appear to be the same for elderly (<U+2265>65 years of age) and younger adult patients given the same daily dosages, with no increase in adverse events in elderly patients."	0
Average sildenafil AUC was increased by 340% following coadministration of sildenafil and indinavir compared to historical data following administration of sildenafil alone.	1
"In general, avoid combined use of RAS inhibitors."	0
"Similarly, protease inhibitor drugs are also inhibitors of CYP 3A4, and thus ORAP is contraindicated in patients receiving protease inhibitors such as ritonavir, saquinovir, indinavir, and nelfinavir."	0
"ELIQUIS increases the risk of bleeding and can cause serious, potentially fatal, bleeding."	0
"In other premarketing oral sotalol studies, new or worsened heart failure occurred in 3% of patients and led to discontinuation in approximately 1% of patients receiving sotalol."	0
"Focalin XR is contraindicated during treatment with monoamine oxidase inhibitors, and also within a minimum of 14 days following discontinuation of treatment with a monoamine oxidase inhibitor (hypertensive crises may result)."	0
The risks of secondary lung cancer from treatment appear to be multiplied by tobacco use.	0
"Early morning awakening, a particular problem in the geriatric patient, was significantly reduced."	0
Reconstituted solutions can be used immediately.	0
Gender: There is no significant difference in the pharmacokinetics of Zaleplon in men and women.	0
DYAZIDE is a diuretic/antihypertensive drug product that combines natriuretic and antikaliuretic effects.	0
Epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an NSAID or aspirin may potentiate this risk of bleeding.	0
"Drugs that interfere with serotonin reuptake inhibition, including ZOLOFT, increase the risk of bleeding events."	0
"Antipsychotic treatment itself, however, may suppress (or partially suppress) the signs and symptoms of the syndrome and thereby may possibly mask the underlying disease process."	0
Use with caution in patients with a known sulfonamide allergy.	0
These differences can be almost entirely explained by differences in weight.	0
"To minimize the risk of peripheral venous irritation, consider changing the site of the drug infusion every 12 hours."	0
Select doses of amlodipine and atorvastatin independently.	0
Pravastatin undergoes extensive first-pass extraction in the liver (extraction ratio 0.66).	0
In patients with these risk factors it is recommended that renal function be monitored during up-titration of carvedilol and the drug discontinued or dosage reduced if worsening of renal function occurs.	0
"Metabolism CARDURA is extensively metabolized in the liver, mainly by O-demethylation of the quinazoline nucleus or hydroxylation of the benzodioxan moiety."	0
Clevidipine and its major dihydropyridine metabolite do not have the potential for blocking or inducing any CYP enzyme.	0
"In multiple dose studies in hypertensive patients, there were no clinically important effects on fasting triglycerides, total cholesterol, HDL-cholesterol, or fasting glucose concentrations."	0
"Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death."	0
"In subsequent cycles, patients were dosed in the range of 50 to 150 mg/day on the basis of clinical response and toleration."	0
"When used in combination with other anticancer drugs, the Matulane dose should be appropriately reduced, eg, in the MOPP regimen, the Matulane dose is 100 mg/m2 daily for 14 days."	0
"Paroxetine was significantly better than placebo in improvement of the HDRS sub-factor scores, including the depressed mood item, sleep disturbance factor, and anxiety factor."	0
False positive test results may be expected for several days following discontinuation of desvenlafaxine therapy.	0
"The usual dose of DYAZIDE is 1 or 2 capsules given once daily, with appropriate monitoring of serum potassium and of the clinical effect."	0
"Drug interactions have also been noted with cimetidine, fluconazole, cyclosporine, rifampin, and caffeine."	0
"HIV-1-Antiviral Agents: CCR5 co-receptor antagonists maraviroc <U+2191> maraviroc When used in combination with PREZISTA/ritonavir, the dose of maraviroc should be 150 mg twice daily."	0
"Thiazides affect the renal tubular mechanisms of electrolyte reabsorption, directly increasing excretion of sodium and chloride in approximately equivalent amounts."	0
Orally disintegrating tablets are packaged in a blister within an outer aluminum pouch and patients should not remove the blister from the outer pouch until just prior to dosing.	0
"When using ZYPREXA and fluoxetine in combination, also refer to the Drug Interactions section of the package insert for Symbyax."	0
"Monitoring: Monitor blood pressure and heart rate during infusion, and until vital signs stabilize."	0
Monitor patients for the development of hyperkalemia until the effect of INSPRA is established.	0
"Therefore, when INSPRA and NSAIDs are used concomitantly, monitor blood pressure and serum potassium levels."	0
"Gastrointestinal Adverse Reactions: Can produce ulcerative and/or stenotic lesions of the gastrointestinal tract, particularly when in prolonged contact with the gastrointestinal mucosa."	0
Some opacity of the container plastic due to moisture absorption during the sterilization process may be observed.	0
"The metabolism of digoxin is not dependent on the cytochrome P-450 system, and digoxin is not known to induce or inhibit the cytochrome P-450 system."	0
"Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including PRINIVIL."	0
"In a placebo controlled comparison of approximately equipotent oral doses of several beta blockers, TENORMIN produced a significantly smaller decrease of FEV1 than nonselective beta blockers such as propranolol and, unlike those agents, did not inhibit bronchodilation in response to isoproterenol."	0
"Systemic exposures of abiraterone in patients with metastatic CRPC, after repeated dosing of abiraterone acetate were similar when abiraterone acetate was taken with low-fat meals for 7 days and increased approximately 2-fold when taken with high-fat meals for 7 days compared to when taken at least 2 hours after a meal and at least 1 hour before a meal for 7 days."	1
The clinical consequences of this finding have not been established.	0
"Since the intended effect of ROZEREM is to promote sleep, patients should be cautioned not to consume alcohol when using ROZEREM."	0
"Among fibromyalgia patients who were normotensive at baseline, an analysis of the blood pressure findings demonstrated a substantially higher proportion of Savella-treated patients had a hypertensive blood pressure measurement at the Week 4, 50 mg BID steady state visit (17.7% [n=21/119]) and the Week 7, 100 mg BID steady state visit (14.3% [n=15/105]) as compared to placebo-treated patients (3.7% [n=2/54] and 0% [0/49] at the Week 4 and Week 7 visits, respectively)."	0
"Following a single oral dose of [14C]-labeled vortioxetine, approximately 59% and 26% of the administered radioactivity was recovered in the urine and feces, respectively as metabolites."	0
"At steady state, when the CYP2D6 pathway is essentially saturated, paroxetine clearance is governed by alternative P450 isozymes that, unlike CYP2D6, show no evidence of saturation."	0
"It is prudent, if COREG is used, to use the smallest effective dose, so that inhibition of endogenous or exogenous <U+03B2>-agonists is minimized."	0
"Thus, metabolic interactions between nefazodone and drugs metabolized by this isozyme are unlikely."	0
"Hypertoxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy."	0
Concomitant administration of strong CYP3A4 inhibitors.	0
"HMG-CoA Reductase Inhibitors Lovastatin, simvastatin Potential for myopathy including rhabdomyolysis."	0
"Exacerbated bradycardia in sick sinus syndrome<U+2014>In patients with the sick sinus syndrome, quinidine has been associated with marked sinus node depression and bradycardia."	0
ZOLOFT may increase phenytoin concentrations.	1
"In patients undergoing knee replacement surgery, the recommended duration of treatment is 12 days."	0
"Amlodipine inhibits calcium ion influx across cell membranes selectively, with a greater effect on vascular smooth muscle cells than on cardiac muscle cells."	0
"Adverse reactions after discontinuation of CYMBALTA, after abrupt or tapered discontinuation, include: dizziness, headache, nausea, diarrhea, paresthesia, irritability, vomiting, insomnia, anxiety, hyperhidrosis, and fatigue."	0
"Fluconazole increases the AUC of saquinavir by approximately 50%, Cmax by approximately 55%, and decreases clearance of saquinavir by approximately 50% due to inhibition of saquinavir's hepatic metabolism by CYP3A4 and inhibition of P-glycoprotein."	1
The CNS depressant effects of Zanaflex and alcohol are additive.	0
The reconstituted oral suspension should only be administered using the oral dispenser supplied with each pack.	0
Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents.	0
This drug should not be used for treating rheumatoid arthritis in pregnant women.	0
"Hepatic Impairment In a study in adult subjects with moderate hepatic impairment (Child-Pugh class B), the plasma concentrations of free paliperidone were similar to those of healthy subjects, although total paliperidone exposure decreased because of a decrease in protein binding."	0
Removal of angiotensin II negative feedback on renin secretion leads to increased plasma renin activity.	0
"The lowest dose, corresponding to an average daily dose of 0.07mg/kg, did not appear to offer consistent antihypertensive efficacy."	0
Refer to complete directions accompanying set.	0
Myocardial Infarction Anafranil is contraindicated during the acute recovery period after a myocardial infarction.	0
The half-life in anuric patients is prolonged to 3.5 to 5 days.	0
"A causal relationship between these events and thioridazine therapy has not been established but, given the ability of thioridazine to prolong the QTc interval, such a relationship is possible."	0
Caution is to be exercised in prescribing phendimetrazine tartrate for patients with even mild hypertension.	0
"In a pharmacokinetic interaction study, coadministration of multiple dose hydrochlorothiazide to healthy volunteers receiving fluconazole increased plasma concentrations of fluconazole by 40%."	1
"Furthermore, in vitro studies in human liver microsomes showed that iloperidone does not have enzyme inducing properties, specifically for the following cytochrome P450 isozymes: CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP3A4 and CYP3A5."	0
The major metabolite was the O-conjugate of temazepam (90%); the O-conjugate of N-desmethyl temazepam was a minor metabolite (7%).	0
Maintain lower doses if higher doses are not tolerated.	0
It has also been studied in transient insomnia (n=264).	0
The highest dose tested in rats was 640 mg/kg/day; at this dose a statistically significant increased incidence of thyroid adenomas was seen only in male rats.	0
"CYP2A6, CYP2B6, CYP3A4 and CYP3A5 appeared to contribute to the formation of R(-)-amphetamine from N-desmethylselegiline."	0
"Patients who were responders during the 10-week double-blind phase and during a 3-month double-blind extension phase were randomized to either paroxetine (10, 20, or 40 mg/day) or placebo in a 3-month double-blind relapse prevention phase."	0
Rare isolates of staphylococci that contains genes for <U+03B2>-lactamase production may not produce a positive induced <U+03B2>-lactamase test.	0
"Accordingly, such patients should not be considered for re-treatment."	0
Peak plasma concentrations of ramiprilat are reached 2<U+2013>4 hours after drug intake.	0
"(See clonidine, guanfacine, and moxonidine below.)"	0
"The mean sertraline hydrochloride dose for completers was 146 mg/day and 151 mg/day, respectively for Studies 1 and 2."	0
"Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide."	0
"The following dose adjustments are recommended for use of tadalafil (Adcirca) with APTIVUS/ritonavir: Co-administration of tadalafil (Adcirca) in patients on APTIVUS/ritonavir: In patients receiving APTIVUS/ritonavir for at least one week, start Adcirca at 20 mg once daily."	0
Maintenance Treatment It is generally agreed that acute episodes of major depressive disorder require several months or longer of sustained pharmacological therapy beyond response to the acute episode.	0
The exposures of GS-331007 and ledipasvir were not altered in the presence of either meal type.	0
There are no adequate and well-controlled studies of RIFADIN in pregnant women.	0
"The major compounds present in feces are unchanged abiraterone acetate and abiraterone (approximately 55% and 22% of the administered dose, respectively)."	0
The effects of propranolol on paroxetine have not been evaluated.	0
No formal clinical or pharmacokinetic studies have been conducted in patients with renal impairment.	0
"Drugs that Interfere with Hemostasis (NSAIDs, Aspirin, Warfarin, etc."	0
ADMINISTRATION OF METHAMPHETAMINE FOR PROLONGED PERIODS OF TIME IN OBESITY MAY LEAD TO DRUG DEPENDENCE AND MUST BE AVOIDED.	0
Vardenafil: no more than 2.5mg every 72hours.	0
StavudineStudy conducted in HIV-positive subjects.	0
It is presumed that the toxicity results from cumulative dopamine agonist effects.	0
"Do not use in patients with congenital long QT syndrome, those with refractory hypokalemia or hypomagnesemia, and in combination with drugs that both increase saquinavir plasma concentrations and prolong the QT interval."	0
Activation of mania/hypomania has also been reported in a small proportion of patients with major affective disorder who were treated with other marketed antidepressants.	0
TOPROL-XL was also shown to delay the increase in left ventricular end-systolic and end-diastolic volumes after 6 months of treatment.	0
"Among these 8 patients, 5 initially developed these abnormalities within the first year."	0
The incidence of syncopal episodes is approximately 1% in patients given an initial dose of 2 mg or greater.	0
"In patients with end-stage renal disease, chronic hemodialysis or continuous ambulatory peritoneal dialysis have little effect on the elimination of quinapril and quinaprilat."	0
"Following dermal application of EMSAM to humans, 25% to 30% of theselegilinecontent on average is delivered systemically over 24 hours (range approximately 10% to 40%)."	0
"History of a serious hypersensitivity reaction to PRADAXA (e.g., anaphylactic reaction or anaphylactic shock)."	0
"Whenever possible, use of IMURAN in pregnant patients should be avoided."	0
The plasma elimination half-life of perphenazine was independent of dose and ranged between 9 and 12 hours.	0
Gradually increase the dosage at weekly intervals until optimum clinical response has been obtained or there is an unacceptable bradycardia.	0
Bisoprolol is eliminated equally by renal and nonrenal pathways with about 50% of the dose appearing unchanged in the urine and the remainder in the form of inactive metabolites.	0
There are no specific laboratory tests recommended.	0
"When neuraxial anesthesia (spinal/epidural anesthesia) or spinal puncture is employed, patients treated with anticoagulant agents are at risk of developing an epidural or spinal hematoma which can result in long-term or permanent paralysis."	0
Decreasing or discontinuing Vitamin D therapy is recommended as well.	0
The rate of debrisoquin hydroxylation is felt to depend on the level of cytochrome P450 2D6 isozyme activity.	0
"Among Dosage Forms Tablets 60% to 80% 62.5 125 250 500 Solution 70% to 85% 62.5 125 250 500 Capsules 90% to 100% 50 100 200 400 Injection/IV 100% 50 100 200 400 In some patients, orally administered digoxin is converted to inactive reduction products (e.g., dihydrodigoxin) by colonic bacteria in the gut."	0
"The pharmacokinetics of perphenazine covary with the hydroxylation of debrisoquine which is mediated by cytochrome P450 2D6 (CYP 2D6) and thus is subject to genetic polymorphism<U+2014>i.e., 7% to 10% of Caucasians and a low percentage of Asians have little or no activity and are called <U+201C>poor metabolizers.<U+201D> Poor metabolizers of CYP 2D6 will metabolize perphenazine more slowly and will experience higher concentrations compared with normal or <U+201C>extensive<U+201D> metabolizers."	0
"Therapy with any combination of quinapril and hydrochlorothiazide will be associated with both sets of dose-independent side effects, but regimens that combine low doses of hydrochlorothiazide with quinapril produce minimal effects on serum potassium."	0
There has been a report of increased quinidine levels during verapamil therapy.	1
Varying degrees of cross-resistance among protease inhibitors have been observed.	0
GI motility agent Cisapride Potential for cardiac arrhythmias.	0
"DEMSER may have additive sedative effects with alcohol and other CNS depressants , e.g. , hypnotics , sedatives , and tranquilizers ."	0
In vivo drug-drug interaction studies conducted in healthy volunteer subjects showed that terbinafine does not affect the clearance of antipyrine or digoxin.	0
"Dipyridamole Dipyridamole inhibits the uptake of adenosine into platelets, endothelial cells and erythrocytes in vitro and in vivo ; the inhibition occurs in a dose-dependent manner at therapeutic concentrations (0.5<U+2013>1.9 <U+00B5>g/mL)."	0
"Clinical studies have shown that desvenlafaxine (100 mg daily) does not have a clinically relevant effect on tamoxifen and aripiprazole, compounds that are metabolized by a combination of both CYP2D6 and CYP3A4 enzymes (Figure 2)."	0
"Although, like other members of its class, PROCARDIA decreases sinoatrial node function and atrioventricular conduction in isolated myocardial preparations, such effects have not been seen in studies in intact animals or in man."	0
It is recommended that REYATAZ be given (with food) 2 h before or 1 h after didanosine buffered formulations.	0
Patients should be monitored for the emergence of serotonin syndrome.	0
"In patients who experience symptoms or signs suggestive of non-coronary vasospasm reaction following the use of any 5-HT1 agonist, the suspected vasospasm reaction should be ruled out before receiving additional MAXALT doses."	0
The possibility of hypotensive effects with ACCUPRIL may be minimized by either discontinuing the diuretic or cautiously increasing salt intake prior to initiation of treatment with ACCUPRIL.	0
Administer as a single daily peritoneal dialysis (PD) exchange for the long dwell.	0
ACEON may increase serum potassium because of its potential to decrease aldosterone production.	0
"If a clinically significant decrease in hemoglobin is observed and other causes have been excluded, consider discontinuing Letairis."	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
Based on a finding of substantial interactions of fluvoxamine with certain of these drugs.	0
"Use the reconstituted solution within 24 hours, as NATRECOR<U+00AE> contains no antimicrobial preservative."	0
"Although not specifically studied, fluconazole has the potential to increase the systemic exposure of other NSAIDs that are metabolized by CYP2C9 (e.g., naproxen, lornoxicam, meloxicam, diclofenac)."	1
"Food has complex effects on tizanidine pharmacokinetics, which differ with the different formulations."	0
Patients who have serum ALT greater than three times the reference range with serum total bilirubin greater than two times the reference range without alternative etiologies are at risk for severe drug-induced liver injury and should not be restarted on ULORIC.	0
Avoid use of aliskiren with TARKA in patients with renal impairment (GFR <60 ml/min).	0
"Effect of Co-administered Drugs on the Pharmacokinetics of Atorvastatin Co-administered drug and dosing regimen Atorvastatin Dose (mg) Change in AUC Change in Cmax See Warnings and Precautions (5.1) and Drug Interactions (7) for clinical significance.Cyclosporine 5.2 mg/kg/day, stable dose 10 mg QD for 28 days <U+2191> 870% <U+2191>1070% Tipranavir 500 mg BID/ritonavir 200 mg BID, 7 days 10 mg, SD <U+2191> 940% <U+2191> 860% Telaprevir 750 mg q8h, 10 days 20 mg, SD <U+2191> 790% <U+2191> 1060%, The dose of saquinavir plus ritonavir in this study is not the clinically used dose."	0
"No additional dose adjustment is required for concomitant use of substrates of CYP3A4, 1A2, 2A6, 2C8, 2C9, and 2C19 isozymes, and P-glycoprotein transporter."	0
"Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8 fold increase in plasma AUC of the TCA)."	0
Interaction with Food Patients should avoid grapefruit juice because it may inhibit the metabolism of pimozide by CYP 3A4.	1
"Limit dosage and duration of concomitant use of benzodiazepines and opioids, and monitor patients closely for respiratory depression and sedation."	0
<U+2022> Cardiac conduction abnormalities: PR interval prolongation may occur in some patients.	0
"Heart Failure The pharmacokinetics of eplerenone 50 mg was evaluated in 8 patients with heart failure (NYHA classification II<U+2013>IV) and 8 matched (gender, age, weight) healthy controls."	0
Fluid retention (with or without transient worsening heart failure symptoms) should be treated by an increase in the dose of diuretics.	0
Renal Impairment APTIVUS pharmacokinetics have not been studied in patients with renal dysfunction.	0
"There have been reports of serious reactions (including hyperthermia, rigidity, myoclonic movements and death) when serotoninergic drugs (e.g., dexfenfluramine, fluoxetine, fluvoxamine, paroxetine, sertraline, citalopram, venlafaxine) have been combined with an MAO inhibitor."	0
"Antimycobacterials Rifampin Rifampin substantially decreases plasma concentrations of atazanavir, which may result in loss of therapeutic effect and development of resistance."	1
Pharmacokinetics in Pediatric Cancer Patients 1 Month to 18 Years of Age a Population PK (Pharmacokinetic) Patients: 64% cancer patients and 36% surgery patients.	0
"Infants with histories of in utero exposure to an angiotensinII receptor antagonist should be closely observed for hypotension, oliguria, and hyperkalemia."	0
"Terbinafine,an allylamine antifungal, inhibits biosynthesis of ergosterol, an essential component of fungal cell membrane, via inhibition of squaleneepoxidaseenzyme."	0
No changes were observed in the degree of anticoagulation.	0
Varying degrees of cross-resistance among HIV-1 protease inhibitors have been observed.	0
Venlafaxine and ODV do not possess monoamine oxidase (MAO) inhibitory activity.	0
"The compound is distributed throughout body water, and there is no known binding to any tissue."	0
"Trandolapril, as an ACE inhibitor, may cause excessive hypotension in patients with congestive heart failure."	0
<U+2022>Cyclosporine or digoxin levels may increase.	1
"After chronic dosing of 80 mg three times a day sildenafil to healthy volunteers, the largest mean change from baseline in supine systolic and supine diastolic blood pressures was a decrease of 9.0 mmHg and 8.4 mmHg, respectively."	0
"Relapse during the double-blind phase was defined as an increase of <U+2265> 2 points compared to baseline on the CGI-Severity of Illness scale to a score of <U+2265> 4, or withdrawal due to lack of efficacy."	0
"Electrolyte disturbances such as hypokalemia, hypomagnesemia and hypocalcemia should be corrected prior to initiation of and during VFEND therapy."	0
"Administration of NitroMist is contraindicated in patients who are using a selective inhibitor of cyclic guanosine monophosphate ( cGMP ) - specific phosphodiesterase type 5 ( PDE5 ) , as PDE5 inhibitors such as sildenafil , vardenafil , and tadalafil have been shown to potentiate the hypotensive effects of organic nitrates see DRUG INTERACTIONS ( 7.1 ) ."	0
"Withdrawal-Emergent Anxiety and Insomnia During nightly use for an extended period, pharmacodynamic tolerance or adaptation to some effects of hypnotics may develop."	0
COREG should be discontinued over 1 to 2 weeks whenever possible.	0
"Following administration of 40 mg of LATUDA, the mean (%CV) elimination half-life was 18 (7) hours."	0
At least 14 days should elapse between discontinuation of an MAOI intended to treat psychiatric disorders and initiation of therapy with CYMBALTA.	0
"The use of an LC/MS/MS method may be the better option according to the good results it provides, especially in term of specificity and limit of quantization."	0
Drug Interactions In vivo Sevelamer carbonate has been studied in human drug-drug interaction studies (9.6 grams once daily with a meal) with warfarin and digoxin.	0
"If leukopenia occurs, hospitalization of the patient may be needed for appropriate treatment to prevent systemic infection."	0
Coadministration with other CYP3A substrates may require a dose adjustment or additional monitoring.	0
Absorption and Distribution Venlafaxine is well absorbed and extensively metabolized in the liver.	0
The decline in plasma concentration following a dose of PERSANTINE tablets fits a two-compartment model.	0
"Chronically administered beta-blocking therapy should not be routinely withdrawn prior to major surgery; however, the impaired ability of the heart to respond to reflex adrenergic stimuli may augment the risks of general anesthesia and surgical procedures."	0
"Ritonavir also appears to induce CYP3A, CYP1A2, CYP2C9, CYP2C19, and CYP2B6 as well as other enzymes, including glucuronosyl transferase."	0
Tell patients not to use potassium supplements or salt substitutes containing potassium without consulting their physician.	0
"Penicillin G is highly active in vitro against streptococci (groups A, B, C, G, H, L, and M), and Neisseria meningitidis."	0
Fluconazole inhibits the metabolism of carbamazepine and an increase in serum carbamazepine of 30% has been observed.	1
Relapse in the treatment of active pulmonary tuberculosis: Do not use as a once-weekly continuation phase regimen with isoniazid in HIV-infected patients.	0
"Inhibitors of CYP1A2 Fluvoxamine: Fluvoxamine, a CYP1A2 inhibitor, decreases the clearance of olanzapine."	1
The risk of myopathy is increased by high levels of statin activity in plasma.	0
"Marplan appears to have varying effects in epileptic patients; while some have a decrease in frequency of seizures, others have more seizures."	0
"Further decreases in trough supine diastolic blood pressure were obtained in non-black patients with higher doses, and no further response was seen with doses above 4 mg (up to 16 mg)."	0
Dosage should be started with one tablet (10mg) of Marplan twice daily.	0
HCV Antiviral Agents Protease Inhibitors: boceprevir <U+2193> atazanavir<U+2193> ritonavir Concomitant administration of boceprevir and atazanavir/ritonavir resulted in reduced steady-state exposures to atazanavir and ritonavir.	1
"In STEMI patients presenting within 12 hours of symptom onset, the loading dose of Effient was administered at the time of diagnosis, although most received Effient at the time of PCI."	0
Male Children(N = 7) Female Children(N = 3) AUC 0-12 (ng<U+2022>h/mL/kg) 95.8 (83.9) 293.5 (233) Cmax (ng/mL/kg) 9.1 (7.6) 28.1 (21.1) Cmin (ng/mL/kg) 6.6 (6.1) 21.2 (17.6) A cross study comparison (healthy subjects vs. patients with hepatic dysfunction) suggested a 30% decrease in fluvoxamine clearance in association with hepatic dysfunction.	0
Figure represents total unmetabolized acid and lactone.	0
"In patients using cardiac glycosides (digoxin and others), plasma levels of calcium, potassium and magnesium must be carefully monitored."	0
"A hydroxylated derivative of the side chain, present in plasma at concentrations approximately equal to the parent compound, appears to be the only active metabolite, and has about 10% of the activity of the parent compound."	0
"Institute appropriate measures such as fluid and electrolyte management, protein supplementation, antibacterial treatment of C. difficile, and surgical evaluation as clinically indicated."	0
"The PA, AH, and HV intervals* or the functional and effective refractory periods of the atrium were not prolonged."	0
"Table4: Efficacy Outcomes within Demographic Subgroups Primary Composite Endpoint ESRD No. of Patients LosartanEvent Rate% PlaceboEvent Rate% Hazard Ratio(95% CI) LosartanEvent Rate% PlaceboEvent Rate% Hazard Ratio(95% CI) Overall Results 1513 43.5 47.1 0.839 (0.721, 0.977) 19.6 25.5 0.714 (0.576, 0.885) Age <65 years 1005 44.1 49.0 0.784 (0.653, 0.941) 21.1 28.5 0.670 (0.521, 0.863) <U+2265>65 years 508 42.3 43.5 0.978 (0.749, 1.277) 16.5 19.6 0.847 (0.560, 1.281) Gender Female 557 47.8 54.1 0.762 (0.603, 0.962) 22.8 32.8 0.601 (0.436, 0.828) Male 956 40.9 43.3 0.892 (0.733, 1.085) 17.5 21.5 0.809 (0.605, 1.081) Race Asian 252 41.9 54.8 0.655 (0.453, 0.947) 18.8 27.4 0.625 (0.367, 1.066) Black 230 40.0 39.0 0.983 (0.647, 1.495) 17.6 21.0 0.831 (0.456, 1.516) Hispanic 277 55.0 54.0 1.003 (0.728, 1.380) 30.0 28.5 1.024 (0.661, 1.586) White 735 40.5 43.2 0.809 (0.645, 1.013) 16.2 23.9 0.596 (0.427, 0.831) Image of Figure 1 Image of Figure 2 Image of Figure 3 Image of Figure 4"	0
At least 14 days should elapse between discontinuation of an MAO inhibitor and initiation of treatment with bupropion hydrochloride.	0
"If combination therapy is needed, careful consideration should be given to the pharmacology of all agents to be used."	0
Therapy with any combination of trandolapril and verapamil will thus be associated with both sets of dose-independent hazards.	0
"In a separate study, when a single oral 300 mg dose of phenytoin was administered at paroxetine steady state (30 mg once daily for 14 days), phenytoin AUC was slightly reduced (12% on average) compared to phenytoin administered alone."	1
"Its action is, therefore, independent of the pathways for angiotensin II synthesis."	0
Coadministration of HARVONI with simeprevir is not recommended.	0
Average steady-state fluoxetine concentrations are approximately 50%lower following the once-weekly regimen compared with the once-daily regimen.	0
"While a specific study with pimozide and fluoxetine has not been conducted, the potential for drug interactions or QTprolongation warrants restricting the concurrent use of pimozide and PROZAC."	0
"In patients with underlying hepatitis B or C, cirrhosis, chronic alcoholism and/or other underlying liver abnormalities, there have been reports of worsening liver disease."	0
"In a controlled study, a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone."	0
The mechanism of this effect has not been established.	0
"This absolute difference in rates, 0.68%, is statistically significant at the P < 0.05 level."	0
"Hypersensitivity, including anaphylaxis, has been reported with lidocaine-containing solutions."	0
"Certain circumstances may increase the risk of Torsades de pointes and/or sudden death in association with the use of drugs that prolong the QTc interval, including 1) bradycardia, 2) hypokalemia, 3) concomitant use of other drugs that prolong the QTc interval, 4) presence of congenital prolongation of the QT interval, and 5) for thioridazine in particular, its use in patients with reduced activity of P450 2D6 or its coadministration with drugs that may inhibit P450 2D6 or by some other mechanism interfere with the clearance of thioridazine."	0
Triamterene given twice daily increased serum potassium levels in a dose related fashion.	0
The one subject who did not achieve SVR12 had subtype 6l.	0
The information available on ORAP from foreign marketing experience and from U.S. clinical trials indicates that ORAP has a side effect profile similar to that of other antipsychotic drugs.	0
"Absorption The pharmacokinetic properties of ledipasvir, sofosbuvir, and the predominant circulating metabolite GS-331007 have been evaluated in healthy adult subjects and in subjects with chronic hepatitis C. Following oral administration of HARVONI, ledipasvir median peak concentrations were observed 4 to 4.5 hours post-dose."	0
"Immune reconstitution syndrome has been reported in HIV-infected patients treated with combination antiretroviral therapy, including NORVIR."	0
"CYP 3A Inducers Avoid co-administration of CYP 3A inducers (e.g., rifampin, rifabutin, rifapentin, barbiturates, phenytoin, carbamazepine, St. John's Wort) with SAMSCA, as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment."	1
Hypersensitivity reactions may occur in patients receiving rifamycins.	0
"There is also an AT2 receptor in many tissues, but it is not involved in cardiovascular homeostasis."	0
"Also, some patients fail to respond to drug therapy or may respond only temporarily."	0
"Therefore, disopyramide should not be administered within 48 hours before or 24 hours after verapamil administration."	0
"Symptomatic hypotension is most likely to occur in patients who have been volume and/or salt depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting."	0
Less than one-third of ziprasidone metabolic clearance is mediated by cytochrome P450 catalyzed oxidation.	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP has not been studied."	0
"ZOCOR should be used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) in these patients or if such treatments are unavailable."	0
"These interactions may lead to: <U+2022>clinically significant adverse reactions potentially leading to severe, life-threatening, or fatal events from greater exposures of concomitant medications."	0
"To prepare quinidine for infusion, the contents of the supplied vial (80 mg/mL) should be diluted to 50 mL (16 mg/mL) with 5% dextrose."	0
Temporary peripheral intravenous infusion may be used until central access is established.	0
"This action results in reduced sympathetic outflow from the central nervous system and in decreases in peripheral resistance, renal vascular resistance, heart rate, and blood pressure."	0
For further details see complete prescribing information for Crixivan<U+00AE> (indinavir).	0
These patients presented with abdominal pain (with or without nausea or vomiting); in some cases there was no prior history of facial angioedema and C-1 esterase levels were normal.	0
"Therefore, monitor blood pressure if EMSAM is used with any of the following drugs: buspirone, amphetamines, and cold products or weight-reducing preparations that contain sympathomimetic amines (e.g., pseudoephedrine, phenylephrine, phenylpropanolamine, and ephedrine)."	0
"As in adults, both children and adolescents exhibited nonlinear multiple-dose pharmacokinetics."	0
Carcinogenicity studies were conducted in mice and rats.	0
"There are, however, no adequate and well controlled studies in pregnant women."	0
"If the patient is under anesthesia, a short-acting muscle relaxant (succinylcholine) may be used."	0
Several unconjugated metabolites possess pharmacological activity but are present in the plasma at very low levels.	0
Intervention: Monitor tacrolimus whole blood trough concentrations.	0
All reports with methylene blue that provided information on the route of administration involved intravenous administration in the dose range of 1mg/kg to 8mg/kg.	0
"The following serious adverse reactions are described elsewhere in the prescribing information: Myelosuppression Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice."	0
"In animals, the ortho-hydroxy metabolite undergoes further glucuronidation."	0
Inducers of CYP1A2 or Glucuronyl Transferase <U+2014> Omeprazole and rifampin may cause an increase in olanzapine clearance.	1
Active liver diseases or unexplained transaminase elevations are contraindications to the use of simvastatin.	0
Intravenous infusion should be terminated as soon as the patient<U+2019>s basic cardiac rhythm appears to be stable or at the earliest signs of toxicity.	0
The mean steady-state peak:trough ratio for an INVEGA<U+00AE> dose of 9 mg was 1.7 with a range of 1.2<U+2013>3.1.	0
"The volume of distribution of 3HQ appears to be larger than that of quinidine, and the elimination half<U+2013>life of 3HQ is about 12 hours."	0
"For these patients, a reduction in the quantity of concurrently administered lipids may be necessary to compensate for the amount of lipid infused as part of the Cleviprex formulation."	0
Concomitant use of other highly protein-bound drugs can increase the concentration of PROZAC.	1
"In both studies, Cmax, Tmax, and t<U+00BD>values were similar in older and younger subjects."	0
The single-dose pharmacokinetics of desvenlafaxine are linear and dose-proportional in a dose range of 50 to 600 mg per day.	0
"In actual salt depletion, appropriate replacement is the therapy of choice."	0
"In a study of radiolabeled sertraline involving two healthy male subjects, sertraline accounted for less than 5% of the plasma radioactivity."	0
In vitro studies indicate irbesartan is oxidized primarily by CYP2C9; metabolism by CYP3A4 is negligible.	0
It is unknown if the risk for myopathy with coadministration of simvastatin with lipid-modifying doses of niacin-containing products observed in Chinese patients applies to other Asian patients.	0
Postural hypotension may be relieved by having the patient lie down until blood pressure returns to normal.	0
"The exact length of time may vary and is dependent upon the particular MAO inhibitor being used, the length of time it has been administered, and the dosage involved."	0
"Tryptophan: As with other serotonin reuptake inhibitors, an interaction between paroxetine and tryptophan may occur when they are coadministered."	0
"Plasma concentrations of fluoxetine were higher than those predicted by single-dose studies, because fluoxetine's metabolism is not proportional to dose."	0
"In clinical trials with angina patients alone, NORVASC therapy did not alter electrocardiographic intervals or produce higher degrees of AV blocks."	0
"Initiation of INVIRASE/ritonavir, a CYP3A inhibitor, in patients receiving medications metabolized by CYP3A or initiation of medications metabolized by CYP3A in patients already receiving INVIRASE/ritonavir, may increase plasma concentrations of medications metabolized by CYP3A."	1
"Signs and symptoms of toxicity develop rapidly after tricyclic antidepressant overdose, therefore, hospital monitoring is required as soon as possible."	0
Discontinue ALTACE if patient develops jaundice or marked elevations of hepatic enzymes.	0
Peak serum levels occur generally six to eight hours (range 4 to 12 hours) after dosing.	0
"If no response is obtained by then, continued administration is unlikely to help."	0
ZYTIGA decreased serum testosterone and other androgens in patients in the placebo-controlled clinical trial.	0
"For young infants (less than 6 months) who cannot eat solid food or drink from a cup, REYATAZ oral powder should be mixed with infant formula and given using an oral dosing syringe."	0
"Promptly evaluate any signs or symptoms of blood loss if patients are treated concomitantly with aspirin, other platelet aggregation inhibitors, or NSAIDs [see Warnings and Precautions (5.2)]."	0
"Food slightly reduces the bioavailability of telmisartan, with a reduction in the area under the plasma concentration-time curve (AUC) of about 6% with the 40 mg tablet and about 20% after a 160 mg dose."	1
The usual dosage range is 20 to 40 mg per day administered in a single daily dose.	0
Consider reducing the CLOZARIL dose.	0
"Dipyridamole inhibits the uptake of adenosine into platelets, endothelial cells and erythrocytes in vitro and in vivo; the inhibition occurs in a dose-dependent manner at therapeutic concentrations (0.5<U+2013>1.9 <U+03BC>g/mL)."	0
"Corticosteroid, ACTH <U+2013> intensified electrolyte depletion, particularly hypokalemia."	0
GFR (mL/min/1.73 m 2 ) = (k x Height)/Scr.	0
"CYP3A Inhibitors: In post-MI HFrEF patients do not exceed 25 mg once daily when used with moderate CYP3A inhibitors (e.g., verapamil, erythromycin, saquinavir, fluconazole)."	1
"Dobutamine Hydrochloride in 5 %   Dextrose Injection solutions may exhibit a pink color that , if present , will increase with time ."	0
"HMG-CoA reductase inhibitors: Atorvastatina <U+2191>Atorvastatin For contraindicated HMG-CoA reductase inhibitors (lovastatin, simvastatin),."	0
"However, prior to initiating treatment with an antidepressant, patients with depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression."	0
"The pressor response to an angiotensin I infusion is reduced by perindopril, but this effect is not as persistent as the effect on ACE; there is about 35% inhibition at 24 hours after a 12 mg dose."	0
"In actual salt depletion, appropriate replacement is the therapy of choice."	0
"In vitro studies demonstrated that drugs metabolized by other CYP isozymes, including 1A1, 1A2, 2C9, 2C19, and 3A4, are only weak inhibitors of risperidone metabolism."	0
The efficacy of paroxetine as a treatment for major depressive disorder has been established in 6 placebo-controlled studies of patients with major depressive disorder (aged 18 to 73).	0
BYSTOLIC has not been studied in patients with severe hepatic impairment.	0
Mexiletine was found to be non-mutagenic in the Ames test.	0
"Serious exfoliative cutaneous reactions, such as Stevens-Johnson syndrome, have been reported during treatment with VFEND."	0
No evidence of impaired fertility was observed in a study performed in male and female rats at oral dosages of up to 100 mg/kg/day.	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction with antidepressants compared to placebo in adults aged 65 and older.	0
Potassium chloride is contraindicated in patients on triamterene or amiloride.	0
"In rats, however, doses as low as 1/3 the oral MRDHD (1/15 the MRDHD on a mg/m2 basis) of clonidine were associated with increased resorptions in a study in which dams were treated continuously from 2 months prior to mating."	0
RAS blockade has been shown to lead to abnormal kidney development in very young mice.	0
"Patients whose blood pressures are adequately controlled with 50 mg of hydrochlorothiazide daily, but who experience significant potassium loss with this regimen, may achieve similar blood pressure control without electrolyte disturbance if they are switched to ZIAC."	0
"Study outcome was assessed by the Clinician-Administered PTSD Scale Part 2 (CAPS) which is a multi-item instrument that measures the three PTSD diagnostic symptom clusters of reexperiencing/intrusion, avoidance/numbing, and hyperarousal as well as the patient-rated Impact of Event Scale (IES) which measures intrusion and avoidance symptoms."	0
"In general, avoid combined use of RAS inhibitors."	0
"Following the initial dose and with each dose increase of CARDURA, monitor blood pressure for at least 6 hours following administration."	0
Patients who were responders on paroxetine during the 3-month double-blind phase and a 6-month extension on open-label paroxetine (20 to 60 mg/day) were randomized to either paroxetine or placebo in a 6-month double-blind relapse prevention phase.	0
"In the large majority of these trials, active agents were no more effective than placebo after 24 hours (or less) of continuous therapy."	0
Mothers taking amphetamines should be advised to refrain from nursing.	0
"In general, elderly patients present higher atenolol plasma levels with total clearance values about 50% lower than younger subjects."	0
"The precise means by which this inhibition relieves angina has not been fully determined, but includes at least the following two mechanisms: PROCARDIA dilates the main coronary arteries and coronary arterioles, both in normal and ischemic regions, and is a potent inhibitor of coronary artery spasm, whether spontaneous or ergonovine-induced."	0
"Thereafter, patients may benefit from doses above 60mg once daily."	0
"After once-daily dosing, steady-state plasma concentrations of ramiprilat are reached by the fourth dose."	0
"EMSAM has the capacity to inhibit intestinal MAO, which is responsible for the catabolism of tyramine in food and beverages."	0
"The erections resolved in cases in which follow-up information was available, some following discontinuation of STRATTERA."	0
Ivabradine: Concurrent use of diltiazem increases exposure to ivabradine and may exacerbate bradycardia and conduction disturbances.	0
"Many drugs, including most drugs effective in the treatment of major depressive disorder (paroxetine, other SSRIs and many tricyclics), are metabolized by the cytochrome P450 isozyme CYP2D6."	0
"In the controlled clinical trials establishing the antidepressant efficacy of nefazodone, the effective dose range was generally 300 to 600 mg/day."	0
"Due to the more limited data available for EMSAM 9mg per 24 hours and the results from the Phase I tyramine challenge study in fed volunteers administered EMSAM 12mg per 24 hours, patients receiving these doses should follow Dietary Modifications Required for Patients Taking EMSAM 9mg per 24 hours and 12mg per 24 hours below."	0
)-Serotonin release by platelets plays an important role in hemostasis.	0
"To prepare infusion solutions, dilute 1 mL of PROSTIN VR PEDIATRIC Sterile Solution with Sodium Chloride Injection USP or Dextrose Injection USP."	0
"In clinical trials of ZIAC, mean changes in serum potassium for patients treated with ZIAC 2.5/6.25 mg, 5/6.25 mg or 10/6.25 mg or placebo were less than <U+00B1> 0.1 mEq/L."	0
"Drugs that require metabolic activation by CYP2D6 to be effective (e.g., tamoxifen), theoretically could have reduced efficacy when administered concomitantly with inhibitors of CYP2D6 such as bupropion."	0
"Neonates exposed to antipsychotic drugs, during the third trimester of pregnancy are at risk for extrapyramidal and/or withdrawal symptoms following delivery."	0
Such patients should be followed closely for the first 2 weeks of treatment and whenever the dosage of quinapril or diuretic is increased.	0
"Tissue culture experiments indicate that approximately 1/3 of human breast cancers are prolactin-dependent in vitro, a factor of potential importance if the prescribing of these drugs is contemplated in a patient with a previously detected breast cancer."	0
Its mechanism of action in man is not known.	0
The lack of a drug interaction following single-dose administration does not predict the absence of an effect following chronic administration.	0
Meperidine appears in the milk of nursing mothers receiving the drug.	0
"If neurological compromise is noted, urgent treatment is necessary."	0
Tasigna must be taken on an empty stomach.	0
Coadministration of INVIRASE/ritonavir is contraindicated with drugs that are CYP3A substrates for which increased plasma levels may result in serious or life-threatening reactions.	1
Cleviprex is a single-use parenteral product.	0
"When necessary, another antihypertensive agent may be added gradually beginning with 50 percent of the usual recommended starting dose to avoid an excessive fall in blood pressure."	0
The mechanism of action of aripiprazole in the treatment of schizophrenia and bipolar I disorder is unknown.	0
Intestinal angioedema has been reported in patients treated with ACE inhibitors.	0
Extent of absorption increases in proportion to LIPITOR dose.	0
Monitor blood pressure closely during NATRECOR<U+00AE> administration.	0
"Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function."	0
"In a subset of patients who have been treated with bicalutamide and an LHRH agonist, and who discontinue bicalutamide therapy due to progressive advanced prostate cancer, a reduction in Prostate Specific Antigen (PSA) and/or clinical improvement (antiandrogen withdrawal phenomenon) may be observed."	0
"After multiple dosing, mean steady-state plasma levels of desalkyl-flurazepam were higher in elderly male subjects (81 ng/mL) compared with younger male subjects (53 ng/mL), while values were similar between elderly female subjects (85 ng/mL) and younger female subjects (86 ng/mL)."	0
Intervention: LATUDA should not be used concomitantly with strong CYP3A4 inducers.	0
Dopamine Hydrochloride in 5% Dextrose Injection should be infused into a large vein whenever possible to prevent the infiltration of perivascular tissue adjacent to the infusion site.	0
"These effects could be more pronounced with concomitant use of Meperidine Hydrochloride Injection and CYP2B6 and CYP3A4 inhibitors, particularly when an inhibitor is added after a stable dose of Meperidine Hydrochloride Injection is achieved."	0
Metabolism and Pharmacokinetics More than 50% of a dose of pimozide is absorbed after oral administration.	0
Mexiletine did not impair fertility in the rat.	0
"use of indwelling epiduralcatheters . concomitant use of other drugs that affect hemostasis , such as nnon-steroidal anti-inflammatory drugs ( NSAIDs ) , platelet inhibitors , other anticoagulants . a history of traumatic or repeated epidural or spinal punctures . a history of spinal deformity or spinal surgery . optimal timing between the administration of XXARELTOand neuraxial procedures is not known . see Warnings and Precautions ( 5.2 , 5.3 ) and Adverse Reactions ( 6.2 ) ."	0
"The patient's ophthalmologist should be prepared for possible modifications to the surgical technique, such as the utilization of iris hooks, iris dilator rings, or viscoelastic substances."	0
A significantly lower systemic clearance and higher area under the curve (AUC) were observed.	0
Patients should be advised of the following issues and asked to alert their prescriber if these occur while taking nefazodone hydrochloride tablets.	0
The metabolites undergo further metabolism to yield over 30 uncharacterized metabolites.	0
"Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down."	0
Epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an NSAID or aspirin may potentiate this risk of bleeding.	0
"Patients whose renal function may depend on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, post- myocardial infarction, or volume depletion) may be at particular risk of developing acute renal failure on Lotensin."	0
Hydrochlorothiazide is well absorbed (65%-75%) following oral administration.	0
Stop ADCIRCA at least 24hours prior to starting LEXIVA.	0
"Diethylpropion hydrochloride should not be used in combination with other anorectic agents, including prescribed drugs, over-the-counter preparations, and herbal products."	0
"A study in healthy volunteers showed that the concomitant administration of flecainide and verapamil may have additive effects on myocardial contractility, AV conduction, and repolarization."	0
"In patients who are receiving BYSTOLIC and clonidine, discontinue BYSTOLIC for several days before the gradual tapering of clonidine."	0
CYP1A2 Isozyme <U+2013> Nefazodone and its metabolites have been shown in vitro not to inhibit CYP1A2.	0
"The recommended initial dose of intravenous sotalol is 75 mg infused over 5 hours, once or twice daily based on creatinine clearance."	0
The beneficial effects of lisinopril in hypertension and heart failure appear to result primarily from suppression of the renin-angiotensin-aldosterone system.	0
"In the Familial Atherosclerosis Treatment Study (FATS), either lovastatin or niacin in combination with a bile acid sequestrant for 2.5years in hyperlipidemic subjects significantly reduced the frequency of progression and increased the frequency of regression of coronary atherosclerotic lesions by QCA compared to diet and, in some cases, low-dose resin."	0
"Therefore, when amiloride HCl and non-steroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained."	0
Marplan should therefore be used with caution in diabetics using these drugs.	0
"In a number of cases, it appears possible that the cerebrovascular events were primary, the D.H.E.45<U+00AE> (dihydroergotamine mesylate) Injection, USP having been administered in the incorrect belief that the symptoms experienced were a consequence of migraine, when they were not."	0
Results of in vitro studies demonstrate that duloxetine does not inhibit CYP2C19 activity at therapeutic concentrations.	0
Rash occurred more commonly in treatment-experienced subjects receiving regimens containing PREZISTA/ritonavir + raltegravir compared to subjects receiving PREZISTA/ritonavir without raltegravir or raltegravir without PREZISTA/ritonavir.	0
"Amlodipine (5 to 10 mg per day) has been studied in a placebo-controlled trial of 1153 patients with NYHA Class III or IV heart failure on stable doses of ACE inhibitor, digoxin, and diuretics."	0
"Effusions were severe (Grade 3 or 4) in 0.7% and 0.4% of patients receiving Tasigna 300 mg twice daily and 400 mg twice daily, respectively, and in no patients receiving imatinib."	0
Less than 10% of the orally administered eszopiclone dose is excreted in the urine as parent drug.	0
Dose to be repeated no earlier than 3 days.	0
Median peak plasma concentration of GS-331007 was observed between 3.5 to 4 hours post-dose.	0
"In hypertensive patients, angiotensin II receptor inhibition following chronic administration of irbesartan causes a 1.5-fold to 2-fold rise in angiotensin II plasma concentration and a 2-fold to 3-fold increase in plasma renin levels."	0
"Oxidation of the bupropion side chain results in the formation of a glycine conjugate of meta-chlorobenzoic acid, which is then excreted as the major urinary metabolite."	0
<U+2022>loss of therapeutic effect of REYATAZ with ritonavir and possible development of resistance.	0
"Metabolism and Elimination: Although the metabolism and elimination of IM ziprasidone have not been systematically evaluated, the intramuscular route of administration would not be expected to alter the metabolic pathways."	0
"No overall differences in safety, effect on QTc, or effectiveness were observed between elderly and younger patients."	0
Administration of fluvoxamine maleate 100 mg daily for 18 days (N = 8) did not significantly affect the pharmacokinetics of a 1.25 mg single intravenous dose of digoxin.	0
"Coadministration of inhibitors of the uptake transporter ( rifampin , cyclosporine ) or efflux transporter ( ritonavir ) may increase the systemic exposure to valsartan ."	1
"In EM individuals treated with paroxetine or fluoxetine, the AUC of atomoxetine is approximately 6-to8-fold and Css, max is about 3-to4-fold greater than atomoxetine alone."	1
"Patients should be advised that taking Norpramin can cause mild pupillary dilation, which in susceptible individuals, can lead to an episode of angle closure glaucoma."	0
Both the Class III and beta-blocking effects of sotalol were linearly related with the plasma concentrations.	0
The esterification of fluphenazine markedly prolongs the drug's duration of effect without unduly attenuating its beneficial action.	0
In vitro studies in animals also suggest that paroxetine is a potent and highly selective inhibitor of neuronal serotonin reuptake and has only very weak effects on norepinephrine and dopamine neuronal reuptake.	0
The mechanism through which perindoprilat lowers blood pressure is believed to be primarily inhibition of ACE activity.	0
Agents that are extensively metabolized by CYP3A and have high first pass metabolism appear to be the most susceptible to large increases in AUC (greater than 3-fold) when co-administered with ritonavir.	1
Potassium Supplements: A patient receiving losartan potassium tablets should be told not to use potassium supplements or salt substitutes containing potassium without consulting the prescribing physician.	0
"Although an antihypertensive effect was observed 24 hours after dosing with recommended single daily doses, the effect was more consistent and the mean effect was considerably larger in some studies with doses of 20 mg or more than with lower doses."	0
Appropriate doses of the combinations with respect to safety and efficacy have not been established.	0
Thiazides may decrease arterial responsiveness to norepinephrine.	0
"Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed."	0
This metabolite has antibacterial activity.	0
"Likewise, hydrochlorothiazide had no effect on the pharmacokinetics of carvedilol."	0
Alcohol: Sedative effects may be increased with doxepin.	0
Approximately 93% of circulating amlodipine is bound to plasma proteins in hypertensive patients.	0
Blood pressure should be closely monitored when amlodipine is co-administered with CYP3A inducers.	0
Analyses for gender effects on outcome did not suggest any differential responsiveness on the basis of sex.	0
"Subsequently, the physician may continue decreasing the dose, but at a more gradual rate."	0
Coadministration of INVIRASE/ritonavir in patients on bosentan: Discontinue use of bosentan at least 36 hours prior to initiation of INVIRASE/ritonavir.	0
"The frequency of gastrointestinal lesions with wax-matrix potassium chloride products is estimated at one per 100,000 patient-years."	0
"However, a chloro-benzene derivative of acetohydroxamic acid caused significant liver dysfunction in an unrelated study."	0
"As with adults, the starting dose is 25 mg daily and should be gradually increased (also given in divided doses with meals to reduce gastrointestinal side effects) during the first 2 weeks, as tolerated, up to a daily maximum of 3 mg/kg or 100 mg, whichever is smaller."	0
The duration of activity following intramuscular administration may last up to 12 hours.	0
"Binding of trandolaprilat is concentration-dependent, varying from 65% at 1000 ng/mL to 94% at 0.1 ng/mL, indicating saturation of binding with increasing concentration."	0
"There have been postmarketing reports of hepatic dysfunction, including some fatalities."	0
Adjust dosage according to blood pressure goals.	0
Total plasma clearance of telmisartan is >800 mL/min.	0
Lorazepam: Coadministration of single doses of eszopiclone and lorazepam did not have clinically relevant effects on the pharmacodynamics or pharmacokinetics of either drug.	0
"Diuretic dose may need to be adjusted to help minimize hypovolemia, which may contribute to hypotension."	0
"DMI is pharmacologically active, but its effects on OCD behaviors are unknown."	0
"If signs or symptoms consistent with CLE or SLE are noted in patients receiving PROTONIX, discontinue the drug and refer the patient to the appropriate specialist for evaluation."	0
Do not start nortriptyline hydrochloride oral solution USP in a patient who is being treated with linezolid or intravenous methylene blue because there is increased risk of serotonin syndrome.	0
Time of administration (AM versus PM) did not affect the pharmacokinetics of venlafaxine and ODV from the 75 mg venlafaxine hydrochloride extended-release capsule.	0
"In patients taking potent inhibitors of CYP3A such as ketoconazole , and itraconazole , avoid use of ADCIRCA see Warnings and Precautions ( 5.2 ) and Clinical Pharmacology ( 12.3 ) ."	0
"These data indicate that biliary excretion of unchanged ledipasvir is a major route of elimination, with renal excretion being a minor pathway (approximately 1%)."	0
Clonidine stimulates alpha-adrenoreceptors in the brain stem.	0
"Confirmatory tests, such as gas chromatography/mass spectrometry, will distinguish sertraline from benzodiazepines."	0
"No single dose of the H2RA should exceed a dose comparable to famotidine 20 mg, and the total daily dose should not exceed a dose comparable to famotidine 40 mg."	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP should not be administered to patients with hemiplegic or basilar migraine."	0
"The risk of fracture was increased in patients who received high-dose, defined as multiple daily doses, and long-term PPI therapy (a year or longer)."	0
Single doses of 20 mg of ACCUPRIL provide over 80% inhibition of plasma ACE for 24 hours.	0
At least 14 days should elapse between discontinuation of an MAOI intended to treat psychiatric disorders and initiation of therapy with NORPRAMIN.	0
DIFLUCAN (fluconazole) is contraindicated in patients who have shown hypersensitivity to fluconazole or to any of its excipients.	0
"The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine; cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide)."	0
Monitor these electrolytes periodically during therapy [see Warnings and Precautions (5.	0
Concomitant administration of a heparin infusion through a separate catheter is acceptable.	0
"Electrolyte abnormalities: Tasigna can cause hypophosphatemia, hypokalemia, hyperkalemia, hypocalcemia, and hyponatremia."	0
Imperfect osteogenesis and embryotoxicity were also reported in pregnant rabbits given rifampin at oral doses up to 200 mg/kg/day (about 3 times the maximum recommended human dose based on body surface area comparisons).	0
Careful dose titration is advised when treating patients with more than mild renal impairment.	0
Peripheral Vascular Disease: Beta-blockers can precipitate or aggravate symptoms of arterial insufficiency in patients with peripheral vascular disease.	0
"Therefore, ZOLOFT should be used with caution in patients with risk factors for QTc prolongation."	0
Pharmacokinetic studies showed that ZYPREXA tablets and ZYPREXA ZYDIS (olanzapine orally disintegrating tablets) dosage forms of olanzapine are bioequivalent.	0
The metabolites are inactive.	0
Read circulars for lithium preparations before use of such concomitant therapy.	0
"Perindopril is extensively metabolized following oral administration, with only 4 to 12% of the dose recovered unchanged in the urine."	0
"CNS Drugs - Given the primary CNS effects of citalopram, caution should be used when it is taken in combination with other centrally acting drugs."	0
"During the administration of Dobutamine Hydrochloride in 5 %   Dextrose Injection , as with any adrenergic agent , ECG and blood pressure should be continuously monitored ."	0
"If it is employed, serum electrolytes must be frequently monitored."	0
"The following symptoms, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, have been reported in adult and pediatric patients being treated with drugs inhibiting the reuptake of norepinephrine and/or serotonin for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric."	0
"Following intravenous administration, clearance of nifedipine was decreased by 33% in elderly healthy subjects relative to young healthy subjects."	0
"Drugs Metabolized by CYP2D6 Bupropion and its metabolites (erythrohydrobupropion, threohydrobupropion, hydroxybupropion) are CYP2D6 inhibitors."	0
CYP1A2 may contribute to a much lesser extent.	0
"Thiazides have also been shown to increase the paralyzing effect of nondepolarizing muscle relaxants such as tubocurarine (an effect attributed to potassium loss); consequently, caution should be observed in patients undergoing surgery."	0
Open-angle glaucoma is not a risk factor for angle closure glaucoma.	0
"Transition from Flolan to Remodulin is accomplished by initiating the infusion of Remodulin and increasing it , while simultaneously reducing the dose of intravenous Flolan ."	0
Interstitial Lung Disease and Eosinophilic Pneumonia: Can occur (5.10).	0
"Because both CMI and its active metabolite, DMI, have long elimination half-lives, the prescriber should take into consideration the fact that steady-state plasma levels may not be achieved until 2 to 3 weeks after dosage change."	0
GlimepirideGlipizideGlyburidePioglitazone <U+2194> Glimepiride (CYP 2C9)<U+2194> Glipizide (CYP 2C9)<U+2194> Glyburide (CYP 2C9)<U+2195> Pioglitazone (CYP 2C8 and CYP 3A4) Repaglinide <U+2195> Repaglinide (CYP 2C8 and CYP 3A4) Tolbutamide <U+2194> Tolbutamide (CYP 2C9) The effect of TPV/ritonavir on CYP 2C8 substrate is not known.	0
"Prior to initiation of TOPROL-XL, stabilize the dose of other heart failure drug therapy."	0
"There is limited general clinical experience with doses above 360 mg, but doses to 540 mg have been studied in clinical trials."	0
"Coadministration of antiplatelet agents, thrombolytics, heparin, aspirin, and chronic NSAID use increases the risk of bleeding."	0
Symptoms associated with discontinuation of Lexapro and other SSRIs and SNRIs have been reported.	0
Some patients required either initiation or dose adjustments of insulin or oral hypoglycemic agents for treatment of these events.	0
Administer Savella in two divided doses per day (2.1).	0
"When Tenex is used with other centrally active depressants ( such as phenothiazines , barbiturates , or benzodiazepines ) , the potential for additive sedative effects should be considered ."	0
Reduced hepatic function - Citalopram oral clearance was reduced by 37% and half-life was doubled in patients with reduced hepatic function compared to normal subjects.	0
"Reports usually indicate that LASIX ototoxicity is associated with rapid injection , severe renal impairment , the use of higher than recommended doses , hypoproteinemia or concomitant therapy with aminoglycoside antibiotics , ethacrynic acid , or other ototoxic drugs ."	0
There may be circumstances when it is necessary to initiate treatment with an MAOI such as linezolid or intravenous methylene blue in a patient taking CYMBALTA.	0
"If concomitant use of Savella with other serotonergic drugs is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome, particularly during treatment and dose increases (5.2)."	0
Caution is advised in administering LUVOX CR Capsules to patients with diseases or conditions that could affect hemodynamic responses or metabolism.	0
"Renvela is contraindicated in patients with known hypersensitivity to sevelamer carbonate, sevelamer hydrochloride, or to any of the excipients."	0
Such concomitant therapy can be associated with rapid increases in serum potassium levels.	0
"Digoxin<U+2013>In a placebo-controlled trial in normal volunteers, administration of sertraline for 17 days (including 200 mg/day for the last 10 days) did not change serum digoxin levels or digoxin renal clearance."	0
"Other complex behaviors (e.g., preparing and eating food, making phone calls, or having sex) have been reported in patients who are not fully awake after taking a hypnotic."	0
Apixaban is a selective inhibitor of FXa.	0
It should be considered only in light of the complete history and evaluation of the child.	0
"Ordinarily, triamterene does not entirely compensate for the kaliuretic effect of hydrochlorothiazide and some patients may remain hypokalemic while receiving triamterene and hydrochlorothiazide."	0
Dosing recommendations in subjects with severe renal impairment are based on pharmacokinetic modeling.	0
"Two long-term (maximum dosing duration of 18 or 24 months) rat studies and one long-term (maximum dosing duration of 18 months) mouse study, each employing dose levels as high as 300 mg/kg/day or 150 times the maximum recommended human antihypertensive dose1, did not indicate a carcinogenic potential of atenolol."	0
"The reported rate in the United States is about 1 case of liver failure resulting in death or transplant per 250,000 to 300,000 patient-years of nefazodone hydrochloride treatment."	0
Didanosine (EC) <U+2193> Didanosine Clinical relevance of reduction in didanosine levels not established.	0
"), not over 40 mg/day; 5-12 years (or 50-100 lbs."	0
"As with hydrochlorothiazide, triamterene may reduce glomerular filtration and renal plasma flow."	0
"At steady state of ritonavir ( about 1 week ) , the exposure to tadalafil is similar as in the absence of ritonavir see Dosage and Administration ( 2.3 ) , Warnings and Precautions ( 5.2 ) , and Clinical Pharmacology ( 12.3 ) ."	0
"Cardiac and Arterial Vascular Occlusive Events: Cardiovascular events including ischemic heart disease, peripheral arterial occlusive disease and ischemic cerebrovascular events have been reported in patients with newly diagnosed Ph+CML receiving Tasigna."	0
COREG has no intrinsic sympathomimetic activity.	0
"On a body-weight basis, these doses are 600times (in mice) and 100times (in rats) the Maximum Recommended Human Dose (MRHD) for the hydrochlorothiazide component of DYAZIDE at 50mg/day (or 1.0mg/kg/day based on 50-kg individuals)."	0
Lamotrigine <U+2193> lamotrigine Coadministration of lamotrigine and REYATAZ with ritonavir may decrease lamotrigine plasma concentrations.	1
Monitoring for adverse events and toxicity related to voriconazole is started within 24 h after the last dose of fluconazole.	0
"The 6.8 mL and 8 mL darunavir dose should be taken as two (3.4 mL or 4 mL respectively) administrations with the included oral dosing syringe (675 mg) with ritonavir 1.25 mL (100 mg) Greater than or equal to 40 kg PREZISTA 800 mg with ritonavir 100 mg PREZISTA 8 mL (800 mg) with ritonavir 1.25 mL (100 mg) Dosing Recommendations for Treatment-Experienced Pediatric Patients with At Least One Darunavir Resistance Associated Substitutions Pediatric patients weighing at least 10 kg but less than 15 kg The weight-based dose in antiretroviral treatment-experienced pediatric patients with at least one darunavir resistance associated substitution is PREZISTA 20 mg/kg twice daily with ritonavir 3 mg/kg twice daily using the following table: Table 4: Recommended Dose for Pediatric Patients Weighing 10 kg to Less Than 15 kg Who are Treatment-Experienced with At Least One Darunavir Resistance Associated Substitutiondarunavir resistance associated substitutions: V11I, V32I, L33F, I47V, I50V, I54M, I54L, T74P, L76V, I84V and L89V Body weight (kg) Formulation: PREZISTA oral suspension (100 mg/mL) and ritonavir oral solution (80 mg/mL) Dose: twice daily with food Greater than or equal to 10 kg to less than 11 kg PREZISTA 2 mL (200 mg) with ritonavir 0.4 mL (32 mg) Greater than or equal to 11 kg to less than 12 kg PREZISTA 2.2 mL (220 mg) with ritonavir 0.4 mL (32 mg) Greater than or equal to 12 kg to less than 13 kg PREZISTA 2.4 mL (240 mg) with ritonavir 0.5 mL (40 mg) Greater than or equal to 13 kg to less than 14 kg PREZISTA 2.6 mL (260 mg) with ritonavir 0.5 mL (40 mg) Greater than or equal to 14 kg to less than 15 kg PREZISTA 2.8 mL (280 mg) with ritonavir 0.6 mL (48 mg) Pediatric patients weighing at least 15 kg Pediatric patients weighing at least 15 kg can be dosed with PREZISTA oral tablet(s) or suspension using the following table: Table 5: Recommended Dose for Pediatric Patients Weighing At Least 15 kg Who are Treatment-Experienced with At Least One Darunavir Resistance Associated Substitutiondarunavir resistance associated substitutions: V11I, V32I, L33F, I47V, I50V, I54M, I54L, T74P, L76V, I84V and L89V Body weight (kg) Formulation: PREZISTA tablet(s) and ritonavir tablets, capsules (100 mg) or oral solution (80 mg/mL) Formulation: PREZISTA oral suspension (100 mg/mL) and ritonavir oral solution (80 mg/mL) Dose: twice daily with food Dose: twice daily with food Greater than or equal to 15 kg to less than 30 kg PREZISTA 375 mg with ritonavir 0.6 mL (48 mg) PREZISTA 3.8 mL (375 mg)The 375 mg and 450 mg dose using darunavir tablets for this weight group is rounded up to 3.8 mL and 4.6 mL for suspension dosing convenience. with ritonavir 0.6 mL (48 mg) Greater than or equal to 30 kg to less than 40 kg PREZISTA 450 mg with ritonavir 0.75 mL (60 mg) PREZISTA 4.6 mL (450 mg) with ritonavir 0.75 mL (60 mg) Greater than or equal to 40 kg PREZISTA 600 mg with ritonavir 100 mg PREZISTA 6 mL (600 mg) with ritonavir 1.25 mL (100 mg) The use of PREZISTA/ritonavir in pediatric patients below 3 years of age is not recommended."	0
"Therefore, epileptics receiving diethylpropion hydrochloride should be carefully monitored."	0
The risk of seizures may be increased when maprotiline is taken concomitantly with phenothiazines or when the dosage of benzodiazepines is rapidly tapered in patients receiving maprotiline.	0
Baseline tests are unnecessary in pediatric patients unless a complicating condition is known or clinically suspected.	0
Anyone considering the use of Marplan in a child or adolescent must balance the potential risks with the clinical need.	0
"Families and caregivers of patients should be advised to look for the emergence of such symptoms on a day-to-day basis, since changes may be abrupt."	0
Tumor lysis syndrome: Tumor lysis syndrome cases have been reported in Tasigna treated patients with resistant or intolerant CML.	0
"In the 35-night study, there was a worsening in sleep on the first night off for both the 10-mg and 20-mg groups compared to placebo, but not to baseline."	0
"Coadministration of ritonavir with these drugs may result in an increase in PDE5 inhibitor associated adverse events, including hypotension, syncope, visual changes, and prolonged erection."	0
Do not start LUVOX CR Capsules in a patient who is being treated with linezolid or intravenous methylene blue because there is an increased risk of serotonin syndrome.	0
No major effects on cardiac conduction have been observed.	0
Benazepril and benazeprilat are cleared predominantly by renal excretion.	0
Do not use PROZAC in combination with thioridazine or pimozide.	0
Dosage adjustment of saquinavir may be necessary.	0
"Psychiatric Follow-up Since overdosage is often deliberate, patients may attempt suicide by other means during the recovery phase."	0
"When pregnancy is detected, discontinue ACCURETIC as soon as possible."	0
Patients receiving ACE inhibitors who develop jaundice should discontinue the ACE inhibitor and receive appropriate medical follow-up.	0
"Adults and Pediatric Patients 12 Years of Age and Older The recommended oral dosage of EMEND capsules, dexamethasone, and a 5-HT3 antagonist in adults and pediatric patients 12 years of age and older who can swallow oral capsules, for the prevention of nausea and vomiting associated with administration of HEC or MEC is shown in Table 1 or Table 2, respectively."	0
Dose adjustment for valproate is not recommended.	0
In Vitro Susceptibility Test Quality Control Ranges for Penicillin Organism(ATTC #) MIC range mcg/mL Disk Diffusion range (mm) Staphylococcus aureus (29213) 0.25 <U+2212> 2 Not applicable Staphylococcus aureus (25923) Not applicable 26 <U+2212> 37 Streptococcus pneumoniae (49619) 0.25 <U+2212> 1 24 <U+2212> 30 Neisseria gonorrhoeae (49226) 0.25 <U+2013> 1Using agar dilution method only.	0
An increase in heart rate is a normal response to vasodilation and decrease in blood pressure; in some patients these increases in heart rate may be pronounced.	0
For Helicobacter pylori eradication take ACIPHEX delayed-release tablets with food.	0
"Subgroup analyses generally did not indicate differences in treatment outcomes as a function of age, race, or gender."	0
The absolute bioavailability of nisoldipine is about 5%.	0
"The changes in diastolic blood pressure, measured at trough, for placebo, 90 mg, 180 mg, 360 mg, and 540 mg were <U+2013>2.9, <U+2013>4.5, <U+2013>6.1, <U+2013>9.5, and <U+2013>10.5 mm Hg, respectively."	0
In vitro studies in animals also suggest that paroxetine is a potent and highly selective inhibitor of neuronal serotonin reuptake and has only very weak effects on norepinephrine and dopamine neuronal reuptake.	0
The latter routes become more important with renal impairment.	0
Both the sedative and anticholinergic effects of the major tranquilizers are also additive to those of NORPRAMIN.	0
Reports of elevated theophylline levels associated with treatment with paroxetine have been reported.	1
Poor adherence to therapy is associated with high relapse rate.	0
"Table 2: Examples of CYP450 Interactions with Warfarin Enzyme Inhibitors Inducers CYP2C9 amiodarone, capecitabine, cotrimoxazole, etravirine, fluconazole, fluvastatin, fluvoxamine, metronidazole, miconazole, oxandrolone, sulfinpyrazone, tigecycline, voriconazole, zafirlukast aprepitant, bosentan, carbamazepine, phenobarbital, rifampin CYP1A2 acyclovir, allopurinol, caffeine, cimetidine, ciprofloxacin, disulfiram, enoxacin, famotidine, fluvoxamine, methoxsalen, mexiletine, norfloxacin, oral contraceptives, phenylpropanolamine, propafenone, propranolol, terbinafine, thiabendazole, ticlopidine, verapamil, zileuton montelukast, moricizine, omeprazole, phenobarbital, phenytoin, cigarette smoking CYP3A4 alprazolam, amiodarone, amlodipine, amprenavir, aprepitant, atorvastatin, atazanavir, bicalutamide, cilostazol, cimetidine, ciprofloxacin, clarithromycin, conivaptan, cyclosporine, darunavir/ritonavir, diltiazem, erythromycin, fluconazole, fluoxetine, fluvoxamine, fosamprenavir, imatinib, indinavir, isoniazid, itraconazole, ketoconazole, lopinavir/ritonavir, nefazodone, nelfinavir, nilotinib, oral contraceptives, posaconazole, ranitidine, ranolazine, ritonavir, saquinavir, telithromycin, tipranavir, voriconazole, zileuton armodafinil, amprenavir, aprepitant, bosentan, carbamazepine, efavirenz, etravirine, modafinil, nafcillin, phenytoin, pioglitazone, prednisone, rifampin, rufinamide Examples of drugs known to increase the risk of bleeding are presented in Table 3."	0
Plasma concentrations are linearly related to the administered dose.	0
"In a formal study, benzodiazepines were shown not to affect mexiletine plasma concentrations."	0
Total body clearance of mirtazapine was reduced approximately 30% in patients with moderate (Clcr=11<U+2013>39 mL/min/1.73 m2) and approximately 50% in patients with severe (Clcr=<10 mL/min/1.73 m2) renal impairment when compared to normal subjects.	0
Initiate telmisartan at low doses and titrate slowly in these patients.	0
"Potent Inducers of CYP3A For patients chronically taking potent inducers of CYP3A, such as rifampin, avoid use of ADCIRCA [see Warnings and Precautions (5.2) and Clinical Pharmacology (12.3)]."	0
Lipid disorders should be managed as clinically appropriate; taking into account any potential drug-drug interactions.	0
"Liver Disease <U+2014> As might be predicted from its primary site of metabolism, liver impairment can affect the elimination of fluoxetine."	0
Due to the increased systemic exposure to nefazodone seen in single-dose studies in elderly patients.	0
"Neither the rare postmarketing reports, nor the association of PDE-5 inhibitor use and NAION in the observational studies, substantiate a causal relationship between PDE-5 inhibitor use and NAION."	0
Patients being treated with voriconazole are likely to be treated concomitantly with nephrotoxic medications and have concurrent conditions that may result in decreased renal function.	0
"Compared with control subjects, steady state AUC and Cmax were increased by 38% and 24%, respectively, in patients with severe renal impairment and were decreased by 26% and 3%, respectively, in patients undergoing hemodialysis."	0
Half-life of verapamil may increase during titration.	0
"In humans, unchanged citalopram is the predominant compound in plasma."	0
"Adults and Pediatric Patients 12 Years and Older 125 mg orally 80 mg orally 80 mg orally Dexamethasone Adults 12 mg orally none none Pediatric Patients 12 Years and Older If a corticosteroid, such as dexamethasone, is co-administered, administer 50% of the recommended corticosteroid dose on Days 1 through 4.Administer dexamethasone 30 minutes prior to chemotherapy treatment on Day 1."	0
Hypotension that occurs as a result of this mechanism can be corrected by volume expansion.	0
The absolute bioavailability of apixaban is approximately 50% for doses up to 10 mg of ELIQUIS.	0
Valproate Repeated oral doses of risperidone (4 mg once daily) did not affect the pre-dose or average plasma concentrations and exposure (AUC) of valproate (1000 mg/day in three divided doses) compared to placebo (n=21).	0
"In one study the OR was 2.5 (95% confidence interval, 1.0 to 6.0, 7 exposed infants) and in the other study the OR was 3.3 (95% confidence interval, 1.3 to 8.8, 6 exposed infants)."	0
"In clinical studies to date, prazosin hydrochloride has not increased plasma renin activity."	0
"Excretion: A mean of 15% of radioactivity of orally administered, single 32 mg 14C-labeled pitavastatin dose was excreted in urine, whereas a mean of 79% of the dose was excreted in feces within 7 days."	0
Acceleration of ventricular rate may occur in patients with atrial fibrillation or flutter treated with lidocaine.	0
Cyclosporine: Combination increases fluvastatin exposure.	1
HIV-1 protease inhibitor: Fosamprenavir <U+2193> Saquinavir No dose adjustment required for INVIRASE/ritonavir.	0
"Because the potential for HIV cross-resistance among protease inhibitors has not been fully explored, it is unknown what effect therapy with LEXIVA will have on the activity of subsequently administered protease inhibitors."	0
"In the Asymptomatic Carotid Artery Progression Study (ACAPS), the effect of therapy with lovastatin on carotid atherosclerosis was assessed by B<U+2011>mode ultrasonography in hyperlipidemic patients with early carotid lesions and without known coronary heart disease at baseline."	0
"Alcohol In an in vitro study, alcohol interacted with the extended-release properties of FETZIMA."	0
Irbesartan is a specific competitive antagonist of AT1 receptors with a much greater affinity (more than 8500-fold) for the AT1 receptor than for the AT2 receptor and no agonist activity.	0
"Dual Blockade of the Renin-Angiotensin System (RAS): Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
Propranolol and Other Beta-Blockers: Coadministration of immediate-release fluvoxamine maleate tablets 100 mg per day and propranolol 160 mg per day in normal volunteers resulted in a mean five-fold increase (range 2 to 17) in minimum propranolol plasma concentrations.	1
Whether any of the symptoms described above represent such a conversion is unknown.	0
"Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function."	0
Approximately 97% of either quinapril or quinaprilat circulating in plasma is bound to proteins.	0
"Therefore, specific recommendations cannot be made for the use of Anafranil in pediatric patients under the age of 10."	0
"Oral Administration, Monotherapy <U+2014> Olanzapine is well absorbed and reaches peak concentrations in approximately 6 hours following an oral dose."	0
Digoxin: Administration of immediate-release fluvoxamine maleate tablets 100 mg daily for 18 days (N=8) did not significantly affect the pharmacokinetics of a 1.25 mg single intravenous dose of digoxin.	0
"Methamphetamine should be administered at the lowest effective dosage, and dosage should be individually adjusted."	0
"Blockade of the AT1 receptor removes the negative feedback of angiotensin II on renin secretion, but the resulting increased plasma renin activity and circulating angiotensin II do not overcome the effects of irbesartan on blood pressure."	0
Nevirapine <U+2193> indinavir concentration Indinavir concentrations may be decreased in the presence of nevirapine.	1
Nicardipine produces significant decreases in systemic vascular resistance.	0
"In a modified two-litter reproduction study, there was no remarkable gross pathology and no altered fertility or gestation among rats fed isosorbide dinitrate at 25 or 100 mg/kg/day."	0
These amines exist in a protonated form in the intestine and interact with phosphate molecules through ionic and hydrogen bonding.	0
These patients should be presumed to be at increased risk for liver injury if nefazodone hydrochloride is reintroduced.	0
"All patients receiving chlorthalidone should be observed for clinical signs of fluid or electrolyte imbalance: namely, hyponatremia, hypochloremic alkalosis and hypokalemia."	0
"Based on efficacy and tolerability dosing may be titrated according to the following schedule: Day 1: 12.5 mg once Days 2-3: 25 mg/day (12.5 mg twice daily) Days 4-7: 50 mg/day (25 mg twice daily) After Day 7: 100 mg/day (50 mg twice daily) Based on individual patient response, the dose may be increased to 200 mg/day (100 mg twice daily)."	0
"Initial dose: 6 mg, once daily for adults (2.1) and 3 mg, once daily for the elderly."	0
"Following multiple oral dosing of quinapril, there is an effective accumulation half-life of quinaprilat of approximately 3 hours, and peak plasma quinaprilat concentrations are observed approximately 2 hours postdose."	0
"In the placebo-controlled studies, there was an increased incidence of peripheral edema in patients treated with doses of 5 or 10 mg Letairis compared to placebo."	0
The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for Meperidine Hydrochloride Injection and any potential adverse effects on the breastfed infant from Meperidine Hydrochloride Injection or from the underlying maternal condition.	0
The clinical relevance of reduced MPA exposure on organ rejection has not been established in transplant patients receiving PROTONIX and MMF.	0
The cleavage of the dabigatran etexilate by esterase-catalyzed hydrolysis to the active principal dabigatran is the predominant metabolic reaction.	0
Patients may develop redistribution/accumulation of body fat or immune reconstitution syndrome.	0
Hypertensive crises during NARDIL therapy may also be caused by the ingestion of foods with a high concentration of tyramine or dopamine.	0
"Drugs that inhibit the renin-angiotensin-aldosterone system (RAAS) including angiotensin converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), spironolactone, eplerenone, or aliskiren produce potassium retention by inhibiting aldosterone production."	0
"The frequencies of these alleles in Caucasians are approximately 11% and 7% for CYP2C9*2 and CYP2C9*3, respectively."	0
Inhibition of these enzymes may increase the plasma concentration of bosentan [see Pharmacokinetics (12.3)].	0
"Co-administration of a cytochrome P450 ( CYP ) 2C8 enzyme inhibitor ( e.g. , gemfibrozil ) increases exposure ( both Cmax and AUC ) to treprostinil ."	1
Monitor renal function periodically in patients receiving trandolapril and NSAID therapy.	0
"Atenolol, in addition to its effects on survival, has shown other clinical benefits including reduced frequency of ventricular premature beats, reduced chest pain, and reduced enzyme elevation."	0
"While taking <U+03B2>-blockers, patients with a history of severe anaphylactic reactions to a variety of allergens may be more reactive to repeated accidental, diagnostic, or therapeutic challenge."	0
Sensitivity reactions may occur in patients with a history of allergy or bronchial asthma.	0
"The mean plasma half-life of fluvoxamine at steady state after multiple oral doses of 100 mg/day in healthy, young volunteers was 15.6 hours."	0
Dose reduction of LUNESTA is needed (7.2) Ethanol: An additive effect on psychomotor performance was seen with coadministration of eszopiclone and ethanol.	0
"More frequent INR monitoring should be performed when starting or stopping other drugs, including botanicals, or when changing dosages of other drugs, including drugs intended for short-term use (e.g., antibiotics, antifungals, corticosteroids)."	0
Blood counts usually return to normal within a month of discontinuation.	0
This condition can lead to permanent impotence if not promptly treated.	0
"Available data from clinical trials of quinapril are insufficient to show that, in patients without prior reactions to other ACE inhibitors, quinapril does not cause agranulocytosis at similar rates."	0
"When used to treat erectile dysfunction, non-arteritic anterior ischemic optic neuropathy (NAION), a cause of decreased vision including permanent loss of vision, has been reported postmarketing in temporal association with the use of phosphodiesterase type 5 (PDE-5) inhibitors, including sildenafil."	0
"Because these events have been reported voluntarily during clinical practice, estimates of frequency cannot be made and a causal relationship between protease-inhibitor therapy and these events has not been established."	0
"If a strong CYP3A4 inducer must be co-administered, increase the ZYTIGA dosing frequency."	1
See prescribing information for tacrolimus.	0
"Beta blockers , including BREVIBLOC , have been reported to cause hyperkalemic renal tubular acidosis ."	0
"Antikaliuretic therapy should be instituted only with caution in severely ill patients in whom respiratory or metabolic acidosis may occur, such as patients with cardiopulmonary disease or poorly controlled diabetes."	0
Steady state plasma levels of amlodipine are reached after 7 to 8 days of consecutive daily dosing.	0
"Adolescents (ages 13 to 17 years) <U+2014> In clinical studies, most adolescents were nonsmokers and this population had a lower average body weight, which resulted in higher average olanzapine exposure compared to adults."	0
"In mice, no increased incidence of any tumor type was observed."	0
"In these studies, sertraline hydrochloride was shown to be significantly more effective than placebo on change from baseline in panic attack frequency and on the Clinical Global Impression Severity of Illness and Global Improvement scores."	0
"Inducers of CYP2B6 Ritonavir, Lopinavir, and Efavirenz: Concomitant treatment with these drugs can decrease bupropion and hydroxybupropion exposure."	1
"Subsequently, the physician may continue decreasing the dose but at a more gradual rate."	0
Antidepressants: tricyclic antidepressants <U+2191> tricyclic antidepressants Coadministration with REYATAZ has the potential to produce serious and/or life-threatening adverse events and has not been studied.	0
"Because beta-blocker withdrawal has been associated with an increased risk of MI and chest pain, patients already on beta-blockers should generally continue treatment throughout the perioperative period."	0
Monitor serum creatinine both during and after NATRECOR<U+00AE> administration.	0
"Use of potassium-sparing diuretics (spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes concomitantly with ACE inhibitors can increase the risk of hyperkalemia."	0
The clearance of penicillin G in normal individuals is predominantly via the kidney.	0
"In patients undergoing surgery or during anesthesia with agents that produce hypotension, quinapril will block the angiotensin II formation that could otherwise occur secondary to compensatory renin release."	0
The recommended daily maintenance doses for each age group are given in Table 2 below.	0
"Sumatriptan - There have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of a SSRI and sumatriptan."	0
AVALIDE may be substituted for the titrated components.	0
"Subsequently, weight gain rebounds and at about 3years of treatment, patients treated with STRATTERA have gained 17.9kg on average, 0.5kg more than predicted by their baseline data."	0
Recommended Dose: Newly diagnosed Ph+ CML-CP: 300 mg orally twicedaily.	0
The mean elimination half-life (+SD) of bupropion 21 (<U+00B1>9) hours.	0
Lithium: Reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists including telmisartan.	1
"In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers."	0
"Several well-controlled, randomized trials studied the use of immediate-release nifedipine in patients who had just sustained myocardial infarctions."	0
Precipitation of rifampin from the infusion solution may occur beyond this time.	0
"Drugs Metabolized by P450 2D6 The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the caucasian population (about 7-10% of caucasians are so called <U+201C>poor metabolizers<U+201D>); reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African, and other populations are not yet available."	0
"However, small increases in the QTc interval (i.e., <10 ms) due to abiraterone acetate cannot be excluded due to study design limitations."	0
"In general, avoid combined use of RAS inhibitors."	0
Clinically significant adverse reactions from greater exposures of VIRACEPT.	0
Triamterene does not affect calcium excretion.	0
Irbesartan does not inhibit ACE or renin or affect other hormone receptors or ion channels known to be involved in the cardiovascular regulation of blood pressure and sodium homeostasis.	0
"Drugs that slow heart rate : Concomitant use of drugs with depressant effects on the sinus and AV node ( e.g. , digoxin , beta blockers , verapamil , diltiazem , ivabradine , clonidine ) can potentiate the electrophysiologic and hemodynamic effects of amiodarone , resulting in bradycardia , sinus arrest , and AV block ."	0
"Antihypertensive agents clonidine, guanfacine, or moxonidine: Beta blockers also increase the risk of clonidine-, guanfacine-, or moxonidine-withdrawal rebound hypertension."	0
Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.	0
Testing for the target serum uric acid level of less than 6 mg/dL may be performed as early as two weeks after initiating ULORIC therapy.	0
"Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."	1
"The mean <U+03B2>-phase serum half-life of penicillin G administered by the intravenous route in ten patients with normal renal function was 42 minutes, with a range of 31<U+2013>50 minutes."	0
Other CNS-Active Drugs <U+2013> The use of nefazodone in combination with other CNS-active drugs has not been systematically evaluated.	0
"Prothrombin complex concentrates, or recombinant Factor VIIa may be considered but their use has not been evaluated in clinical trials."	0
"Hyponatremia: Hyponatremia may occur as a result of treatment with SSRIs and SNRIs, including PEXEVA<U+00AE> (paroxetine mesylate)."	0
"Based on the mechanism of action of SNRIs and SSRIs, including paroxetine hydrochloride, and the potential for serotonin syndrome, caution is advised when paroxetine is coadministered with other drugs that may affect the serotonergic neurotransmitter systems, such as triptans, lithium, fentanyl, tramadol, or St. John<U+2019>s wort."	0
Monitor for signs of myopathy in patients receiving the combination of HMG-CoA reductase inhibitors (statins) and fibrates.	0
Discontinuation of PRISTIQ should be considered in patients with symptomatic hyponatremia and appropriate medical intervention should be instituted.	0
Effectiveness was similar for male and female patients.	0
"Consistent with its high degree of plasma protein<U+2011>binding, carvedilol does not appear to be cleared significantly by hemodialysis."	0
"If therapy is to be discontinued in patients receiving a beta-blocker and clonidine concurrently, the beta-blocker should be withdrawn several days before the gradual discontinuation of CATAPRES tablets."	0
Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have.	0
"In a formal, single-dose interaction study (n = 6 males) the clearance of mexiletine was decreased by 38% following the coadministration of fluvoxamine, an inhibitor of CYP1A2."	1
"It is converted, in part, to an active carboxylic acid metabolite that is responsible for most of the angiotensinII receptor antagonism that follows losartan treatment."	0
VKORC1 and CYP2C9 gene variants generally explain the largest proportion of known variability in warfarin dose requirements.	0
The AUC and Cmax for both verapamil and norverapamil are increased when 240 mg of controlled release verapamil is administered concomitantly with 4 mg trandolapril.	0
An excessive rise in blood pressure following discontinuation of CATAPRES tablets therapy can be reversed by administration of oral clonidine hydrochloride or by intravenous phentolamine.	0
Do not co-administer aliskiren with Benicar in patients with diabetes.	0
"Patients should be instructed to notify their physician immediately if they experience any of the following: rash, fever, or swollen lymph nodes, loss of appetite, malaise, nausea and vomiting, darkened urine, yellowish discoloration of the skin and eyes, cough, shortness of breath, wheezing and pain or swelling of the joints."	0
Renal function has returned to baseline when carvedilol was stopped.	0
"In plasma, risperidone is bound to albumin and <U+03B1>1-acid glycoprotein."	0
"In neonates and young infants, and in individuals with impaired kidney function, excretion is considerably delayed."	0
"There were differences in absolute risk of suicidality across the different indications, with the highest incidence in MDD."	0
It also stimulates aldosterone secretion by the adrenal cortex.	0
It is recommended that INR (international normalized ratio) be monitored.	0
Peak plasma concentrations are achieved within approximately 1 hour after oral administration.	0
"Food does not appear to affect the systemic bioavailability of fluoxetine, although it may delay its absorption by 1to 2hours, which is probably not clinically significant."	1
Caution should be exercised when TENORMIN is administered during pregnancy or to a woman who is breast-feeding.	0
"The blood level decline of the parent drug was biphasic with the short half-life ranging from 0.4 to 0.6 hours and the terminal half-life from 3.5 to 18.4 hours (mean 8.8 hours), depending on the study population and method of determination."	0
"Based on a population analysis of teriflunomide in healthy volunteers and MS patients, median t1/2 was approximately 18 and 19 days after repeated doses of 7 mg and 14 mg respectively."	0
Resume treatment at 400 mg oncedaily if serum lipase or amylase returns to less than or equal to Grade 1 Elevated bilirubin greater than or equal to Grade 3 1.	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP, nursing should not be undertaken with the use of D.H.E."	0
"If a dose of PRADAXA is not taken at the scheduled time, the dose should be taken as soon as possible on the same day; the missed dose should be skipped if it cannot be taken at least 6 hours before the next scheduled dose."	0
"When amiloride HCl is used concomitantly with a thiazide diuretic in patients without these complications, the risk of hyperkalemia is reduced to about 1-2 percent."	0
Rifampin is known to induce certain cytochrome P-450 enzymes.	0
"Chlorthalidone should be used with caution in patients with impaired hepatic function or progressive liver disease, because minor alterations of fluid and electrolyte balance may precipitate hepatic coma."	0
"Patients taking a concomitant neprilysin inhibitor (e.g., sacubitril) may be at increased risk for angioedema."	0
"If the diuretic cannot be discontinued, an initial dose of 5 mg ACCUPRIL should be used with careful medical supervision for several hours and until blood pressure has stabilized."	0
This effect is most pronounced on the diastolic blood pressure.	0
"Closely monitor blood pressure, renal function, and electrolytes in patients on AVALIDE and other agents that affect the RAS."	0
"Small droplets are acceptable, but if solution flows past the frangible prior to use, do not use and discard the units."	0
"Nevertheless, caution is indicated in the co-administration of TCAs with sertraline hydrochloride, because sertraline may inhibit TCA metabolism."	1
"ACE is a peptidyl dipeptidase that catalyzes conversion of the inactive decapeptide, angiotensin I, to the vasoconstrictor, angiotensin II."	0
NATRECOR<U+00AE> may cause hypotension.	0
"Do not administer PRINIVIL within 36 hours of switching to or from sacubitril/valsartan, a product containing a neprilysin inhibitor."	0
Monitor renal function periodically in patients treated with PRINIVIL.	0
"In those patients requiring maintenance therapy, the recommended adult oral dose is 400 mg at bedtime."	0
Strong CYP3A inhibitors may increase exposure to doxazosin.	1
"One to three subjects were infected with the other subtypes 6l, 6m, 6p, 6q, or 6r."	0
This is more likely to occur in patients with pre-existing renal impairment.	0
"Apixaban inhibits free and clot-bound FXa, and prothrombinase activity."	0
"Beta-blockers including metoprolol, may exacerbate the rebound hypertension that can follow the withdrawal of clonidine."	0
"If propranolol or metoprolol is coadministered with fluvoxamine maleate tablets, a reduction in the initial beta-blocker dose and more cautious dose titration are recommended."	1
"The primary P450 enzymes responsible for the metabolism of both R(+) and S(-)-carvedilol in human liver microsomes were CYP2D6 and CYP2C9 and to a lesser extent CYP3A4, 2C19, 1A2, and 2E1."	0
9.Fill the dispenser with the prescribed dose shown above in Table 3.	0
Aspirin Absorption Peak plasma levels of aspirin are achieved 0.63 hours (0.5<U+2013>1 hour) after administration of a 50 mg aspirin daily dose from AGGRENOX (given as 25 mg BID).	0
"Therefore, when amiloride HCl is given with other diuretics to such patients, careful monitoring of serum electrolytes and BUN levels is important."	0
"Fingolimod is metabolized by sphingosine kinase to the active metabolite, fingolimod-phosphate."	0
Prescribers should consult the complete prescribing information for ritonavir when using ritonavir.	0
"Analyses of seventeen placebo-controlled trials (modal duration of 10 weeks), largely in patients taking atypical antipsychotic drugs, revealed a risk of death in drug-treated patients of between 1.6 to 1.7 times the risk of death in placebo-treated patients."	0
Doses of MYCOBUTIN may be administered mixed with foods such as applesauce.	0
Co-administration of voriconazole and ritonavir doses of 400 mg every 12 hours or greater is contraindicated.	0
Anticoagulant: warfarin <U+2191><U+2193> warfarin Initial frequent monitoring of the INR during ritonavir and warfarin co-administration is recommended.	0
"Prior to Tasigna administration and periodically, monitor for hypokalemia or hypomagnesemia and correct deficiencies (5.2)."	0
"There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on suicide."	0
This explains how fluoxetine achieves a steady-state concentration rather than increasing without limit.	0
LASIX can increase the risk of cephalosporin-induced nephrotoxicity even in the setting of minor or transient renal impairment .	0
Non-Steroidal Anti-inflammatory Drugs (NSAIDs) and COX-2 inhibitors: Increased risk of renal impairment.	0
Results of in vitro studies demonstrate that duloxetine does not inhibit or induce CYP3A activity.	0
The concomitant use of benzodiazepines and opioids increases the risk of respiratory depression because of actions at different receptor sites in the CNS that control respiration.	0
"In adults, symptomatic response to therapy with ACIPHEX does not preclude the presence of gastric malignancy."	0
"During dynamic exercise, increases in diastolic pressure are inhibited, while maximum achievable systolic pressure is usually reduced."	0
"However, the pharmacodynamic effect increased by 190% (QTc increase over time) and by 84% (maximum QTc increase)."	0
"Selegiline is metabolized initially via N-dealkylation or N-depropargylation to form N-desmethylselegiline or R(-)-methamphetamine, respectively."	0
Severe hypertension is likely to require higher doses.	0
"In the presence of seizures, the drug should be discontinued."	0
Valproate <U+2014> Olanzapine (10mg daily for 2 weeks) did not affect the steady state plasma concentrations of valproate.	0
"Dosage of the drugs mentioned above and other similarly metabolized drugs, particularly those of low therapeutic ratio or in patients with renal and/or hepatic impairment, may require adjustment when starting or stopping the concomitant administration of cimetidine to maintain optimum therapeutic blood levels."	0
Do not administer Dobutamine Hydrochloride in 5 %   Dextrose Injection simultaneously with solutions containing sodium bicarbonate or strong alkaline solutions .	0
"In rodents, the metabolic fate of AHA is well known; 55% is excreted unchanged in urine, 25% is excreted as acetamide or acetate and 7% is excreted by the lungs as carbon dioxide."	0
Dose reduction of CRIXIVAN to 600 mg every 8 hours is recommended when administering itraconazole 200 mg twice daily concurrently.	1
There is no information about the effectiveness of hemodialysis in removing dofetilide from plasma.	0
"In elderly subjects, mean plasma concentrations at steady state are increased, in part attributed to lower creatinine clearance."	0
Combination use with CYP3A4 inducer may decrease the exposure and effects of LUNESTA.	0
"Before prescribing PREZISTA, children weighing greater than or equal to 15 kg should be assessed for the ability to swallow tablets."	0
The onset of symptoms can occur within minutes to hours of receiving a new or a greater dose of a serotonergic medication.	0
"In addition, concentrations of the active metabolite 14-OH clarithromycin are significantly reduced; consider alternative therapy for indications other than infections due to Mycobacterium avium complex."	1
Concomitant administration of diazepam (15 mg) had a minimal effect on plasma levels of mirtazapine (15 mg) in 12 healthy subjects.	0
Apixaban is a substrate of both CYP3A4 and P-gp.	0
No accumulation of unchanged drug appeared after 14 or 21 days.	0
Immediately evaluate any new onset behavioral changes.	0
Rilpivirine is not expected to affect the plasma concentrations of Aptivus/ritonavir.	0
Paliperidone is also not expected to have enzyme inducing properties.	0
"Use of a final filter is recommended during administration of all parenteral solutions, where possible."	0
"Hypersensitivity to voriconazole or its excipients (4) Coadministration with terfenadine, astemizole, cisapride, pimozide or quinidine, sirolimus due to risk of serious adverse reactions (4, 7) Coadministration with rifampin, carbamazepine, long-acting barbiturates, efavirenz, ritonavir, rifabutin, ergot alkaloids, and St. John's Wort due to risk of loss of efficacy (4, 7)"	0
Dosage should be individualized according to the needs and responses of the patient.	0
"Metabolism and Excretion Following the rapid and complete conversion of olmesartan medoxomil to olmesartan during absorption, there is virtually no further metabolism of olmesartan."	0
"Periodic CK determinations may be considered in patients starting therapy with ZOCOR or whose dose is being increased, but there is no assurance that such monitoring will prevent myopathy."	0
It may be useful to monitor renal function.	0
"However, since the renal clearance of tipranavir is negligible, a decrease in total body clearance is not expected in patients with renal insufficiency."	0
"There has been a long-standing concern, however, that antidepressants may have a role in inducing worsening of depression and the emergence of suicidality in certain patients during the early phases of treatment."	0
"Potassium citrate extended-release tablets are contraindicated: In patients with hyperkalemia (or who have conditions pre-disposing them to hyperkalemia), as a further rise in serum potassium concentration may produce cardiac arrest."	0
Consideration should be given to the similarity of the adverse effects of lidocaine and mexiletine and the possibility that they may be additive.	0
"Monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors, especially during the initial few months of drug therapy and at times of dosage changes."	0
Approximately 64% of a 30-mg oral solution dose of paroxetine was excreted in the urine with 2% as the parent compound and 62% as metabolites over a 10-day post-dosing period.	0
The 10-mg/kg/day dose in rats is approximately 2.8 times the maximum recommended daily human dose (MRHD) of 32 mg on a mg/m2 basis (comparison assumes human body weight of 50 kg).	0
The metabolism of paroxetine is accomplished in part by CYP2D6.	0
Use of LEXIVA with ritonavir at higher-than-recommended dosages may result in transaminase elevations and should not be used.	0
"Reduced renal function - In patients with mild to moderate renal function impairment, oral clearance of citalopram was reduced by 17% compared to normal subjects."	0
"Lovastatin undergoes extensive first-pass extraction in the liver, its primary site of action, with subsequent excretion of drug equivalents in the bile."	0
"The recommended starting dose is 100 mg at bedtime, with weekly increases of 50 mg as tolerated to maximum therapeutic benefit, not to exceed 300 mg per day."	0
"In such patients, periodic blood elevations are recommended."	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction with antidepressants compared to placebo in adults age 65 and older.	0
Must not be administered by intramuscular or subcutaneous route.	0
There was no evidence of impaired fertility when dipyridamole was administered to male and female rats at oral doses up to 500 mg/kg/day (about 12 times the MRHD on a mg/m2 basis).	0
"Distribution: Pitavastatin is more than 99% protein bound in human plasma, mainly to albumin and alpha 1-acid glycoprotein, and the mean volume of distribution is approximately 148 L. Association of pitavastatin and/or its metabolites with the blood cells is minimal."	0
EMSAM had no clinically relevant effect on pharmacokinetics of these drugs.	0
"Oral Contraceptives There was an increase in mean ethinylestradiol Cmax and AUC0<U+2013>24 (1.58- and 1.54-fold, respectively) and levonorgestrel Cmax and AUC0<U+2013>24 (1.33- and 1.41-fold, respectively) following repeated doses of teriflunomide."	1
"Mean terminal half-life was slightly reduced in pediatric patients (range, 2.5 to 3 hours) in comparison with adults (range, 3 to 3.5 hours)."	0
"Studies have indicated that 2.4 mg is the maximum effective daily dose, but doses as high as this have rarely been employed."	0
Coadministration of terfenadine is contraindicated in patients receiving DIFLUCAN (fluconazole) at multiple doses of 400 mg or higher based upon results of a multiple dose interaction study.	0
FANAPT has no appreciable affinity (Ki >1000 nM) for cholinergic muscarinic receptors.	0
Adenosine: Dipyridamole has been reported to increase the plasma levels and cardiovascular effects of adenosine.	0
"Although clarithromycin is a combined P-gp and strong CYP3A4 inhibitor, pharmacokinetic data suggest that no dose adjustment is necessary with concomitant administration with ELIQUIS."	0
PRIFTIN is only recommended for the treatment of active pulmonary tuberculosis caused by drug-susceptible organisms as part of regimens consisting of a 2 month initial phase followed by a 4 month continuation phase.	0
Doses above 0.61 mg/kg (or in excess of 40 mg) have not been studied in pediatric patients.	0
"Skin reactions ranging from mild to severe, including Stevens-Johnson Syndrome, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms and acute generalized exanthematous pustulosis, have been reported."	0
"The beta-blocking effects of sotalol may be useful in controlling heart rate in AFIB associated with thyrotoxicosis, but no study has been conducted to evaluate this."	0
A blood/plasma ratio of approximately 0.25 indicates poor drug penetration into red blood cells.	0
"When paroxetine is withdrawn from the combination therapy, the iloperidone dose should be returned to the previous level."	0
Dose adjustments may be required based on potassium levels.	0
ACCUPRIL is contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an ACE inhibitor.	0
"In a study where propranolol (80mg twice daily) was dosed orally for 18days, the established steady-state plasma concentrations of propranolol were unaltered during coadministration with paroxetine (30mg once daily) for the final 10days."	0
Symptoms such as these may be associated with an increased risk for suicidal thinking and behavior and indicate a need for very close monitoring and possibly changes in the medication.	0
Nisoldipine is a member of the dihydropyridine class of calcium channel antagonists (calcium ion antagonists or slow channel blockers) that inhibit the transmembrane influx of calcium into vascular smooth muscle and cardiac muscle.	0
"Abbreviations: AUC, area under the curve; Cmax, peak plasma concentrations; OH, hydroxyl * Data for 2-OH desipramine were not plotted to enhance clarity; the fold change and 90% CI for Cmax and AUC of 2-OH desipramine were 6.6 (5.5, 7.9) and 4.4 (3.8, 5.0), respectively."	0
"These doses, in some studies, have been reported to cause skeletal abnormalities."	0
"Patients receiving concomitant ACE inhibitor and mTOR (mammalian target of rapamycin) inhibitor (e.g., temsirolimus, sirolimus, everolimus) therapy may be at increased risk for angioedema."	0
"Although PROCARDIA has been used safely in patients with renal dysfunction and has been reported to exert a beneficial effect, in certain cases, rare, reversible elevations in BUN and serum creatinine have been reported in patients with pre-existing chronic renal insufficiency."	0
Experience with ACEON is limited in the elderly at doses exceeding 8 mg.	0
"Positive test results were obtained only in the in vitro CHO Sister Chromatid Exchange (clastogenicity) and in the Mouse Lymphoma Cell (mutagenicity) assays, using concentrations of hydrochlorothiazide from 43 to 1300 mcg/mL, and in the Aspergillus nidulans non-disjunction assay at an unspecified concentration."	0
Symptoms have not been relieved by antihistamines in these situations.	0
"Both alcohol and tadalafil , a PDE5 inhibitor , act as mild vasodilators ."	0
"Examples: propafenone, flecainide, atomoxetine, desipramine, dextromethorphan, metoprolol, nebivolol, perphenazine, thoridazine, tolterodine, venlafaxine Phenytoin Clinical Impact: Phenytoin is a narrow therapeutic index drug."	0
Safety and effectiveness in pediatric patients have not been established.	0
Animal and human studies have not shown any adverse effects of dofetilide on conduction velocity.	0
Such reports were concentrated in patients receiving rapidly increased high doses in one study; the phenomenon has not been a cause of safety concern in large clinical trials.	0
"Venlafaxine and ODV have no significant affinity for muscarinic-cholinergic, H1-histaminergic, or <U+03B1>1-adrenergic receptors in vitro."	0
"During premarket evaluation, seizure was identified as the most significant risk of Anafranil use."	0
"Accordingly, caution should be exercised when rauwolfia is used concomitantly with an MAO inhibitor, including NARDIL."	0
"If blood pressure is not controlled by ATACAND alone, a diuretic may be added."	0
"In patients whose renal function may depend on the activity of the renin-angiotensin-aldosterone system (e.g., patients with severe congestive heart failure or renal dysfunction), treatment with angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death."	0
Alternate antimycobacterial agents such as rifabutin should be considered.	0
"Absorption and Distribution REVATIO is rapidly absorbed after oral administration, with a mean absolute bioavailability of 41% (25<U+2013>63%)."	0
"Because substances in grapefruit juice may inhibit the metabolism of pimozide by CYP 3A4, patients should be advised to avoid grapefruit juice."	1
Mean ETP levels continued to increase and exceeded pre-apixaban levels reaching a maximum (34%-51% increase over pre-apixaban levels) at 21 hours after initiating PCC and remained elevated (21%-27% increase) at the end of the study (69 hours after initiation of PCC).	0
"In such situations, they must be used cautiously."	0
Some patients required hospitalization for additional management and some had complications.	0
Triamterene and hydrochlorothiazide should be used during pregnancy only if the potential benefit justifies the risk to the fetus.	0
"For all female patients, Letairis is available only through a restricted program called the Letairis Risk Evaluation and Mitigation Strategy (REMS) (5.2)."	0
"Furthermore, whenever one of these other drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant may be required."	0
"While serious, life-threatening, or fatal respiratory depression can occur at any time during the use of Meperidine Hydrochloride Injection, the risk is greatest during the initiation of therapy or following a dosage increase."	0
Anaphylactoid reactions have also been reported in patients undergoing low-density lipoprotein apheresis with dextran sulfate absorption.	0
ECG monitoring should be considered in patients with preexisting conduction system disease or when administered with other drugs that may prolong the PR interval.	0
A causal relationship between protease inhibitor therapy and these events has not been established.	0
Geriatric Patients It is not necessary to adjust the dose in the elderly.	0
"Therefore, coadministration of paroxetine with other drugs that are metabolized by this isozyme, including certain drugs effective in the treatment of major depressive disorder (e.g., nortriptyline, amitriptyline, imipramine, desipramine, and fluoxetine), phenothiazines, risperidone,and Type 1C antiarrhythmics (e.g., propafenone, flecainide, and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution."	0
"Use the supplied calibrated dropper to measure the amount of ZOLOFT oral solution needed Note: The supplied calibrated dropper has 25 mg and 50 mg graduation marks only Mix with 4 ounces (1/2 cup) of water, ginger ale, lemon/lime soda, lemonade or orange juice ONLY."	0
"If doses in excess of 50 mcg/kg/min are required, check urine output frequently."	0
Aggression: Monitor forappearance of or worsening of aggressive behavior or hostility.	0
Long-term studies were conducted with oral trandolapril administered by gavage to mice (78 weeks) and rats (104 and 106 weeks).	0
"In short-term controlled studies (up to 9weeks), STRATTERA-treated patients lost an average of 0.4kg and gained an average of 0.9cm, compared to a gain of 1.5kg and 1.1cm in the placebo-treated patients."	0
Benzodiazepines interact at GABAA sites and opioids interact primarily at mu receptors.	0
"Asenapine has no appreciable affinity for muscarinic cholinergic receptors (e.g., Ki value of 8128 nM for M1)."	0
Usual regimens of therapy with ALTACE may be followed in patients with estimated creatinine clearance >40 mL/min.	0
The effects of food on the bioavailability of paroxetine were studied in subjects administered a single dose with and without food.	0
Prompt medical or surgical treatments may need to be considered if the intraocular pressure remains uncontrolled.	0
"Because these events have been reported voluntarily during clinical practice, estimates of frequency cannot be made and a causal relationship between protease inhibitor therapy and these events has not been established.Consider monitoring for hyperglycemia, new onset diabetes mellitus, or an exacerbation of diabetes mellitus in patients treated with NORVIR."	0
"Pharmacokinetic studies revealed a decreased clearance in the elderly, and a lower starting dose is recommended; there were, however, no overall differences in the adverse event profile between elderly and younger patients, and effectiveness was similar in younger and older patients."	0
"Marplan should not be used in combination with buspirone HCL (Buspar<U+00AE>, Bristol Myers Squibb); several cases of elevated blood pressure have been reported in patients taking MAO inhibitors who were then given buspirone HCL."	0
"Under steady-state conditions for duloxetine (60 mg Q 12 hours) and lorazepam (2 mg Q 12 hours), the pharmacokinetics of duloxetine were not affected by co-administration."	0
Similar results were obtained in patients receiving amlodipine and concomitant beta-blockers.	0
Women of childbearing age should be advised to avoid becoming pregnant.	0
This dose may be adjusted up to a maximum of 450 mg every 12 hours to achieve the desired response.	0
"If this occurs, patients should contact their physician as soon as possible."	0
Intramuscular Administration <U+2014> ZYPREXA IntraMuscular results in rapid absorption with peak plasma concentrations occurring within 15 to 45 minutes.	0
The blood levels of fingolimod and fingolimod-phosphate are increased by 1.7-fold when used concomitantly with ketoconazole.	1
"Do not use dilatrate<U+00AE>-SR in patients who are taking certain drugs for erectile dysfunction (phosphodiesterase inhibitors), such as sildenafil, tadalafil, vardenafil, or avanafil."	0
Prescribing rifampin in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.	0
"A starting dose of 0.1 micrograms per kilogram of body weight per minute is the recommended starting dose based on clinical studies; however, adequate clinical response has been reported using a starting dose of 0.05 micrograms per kilogram of body weight per minute."	0
For detailed instructions regarding dose selection.	0
The recommendations for the PREZISTA/ritonavir dosage regimens were based on pediatric clinical trial data and population pharmacokinetic modeling and simulation.	0
"Following oral doses of 50 mg or 100 mg, both beta-blocking and antihypertensive effects persist for at least 24 hours."	0
Usually the patient becomes quiet and cooperative within 24 to 48 hours and oral doses may be substituted.	0
"Therefore, the combination should be administered with caution, especially in the elderly."	0
About 3% to 4% is excreted in the urine as unchanged drug.	0
VASOTEC is contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an angiotensin converting enzyme inhibitor and in patients with hereditary or idiopathic angioedema .	0
"The risk of myopathy and rhabdomyolysis increases when fluconazole is coadministered with HMG-CoA reductase inhibitors metabolized through CYP3A4, such as atorvastatin and simvastatin, or through CYP2C9, such as fluvastatin."	0
Maintenance dose: Most patients will achieve the desired therapeutic response at approximately 4-6 mg/hour.	0
Nevirapine <U+2193> nelfinavir (Cmin) Concentrations of nelfinavir were decreased when coadministered with nevirapine.	1
"In this study, these effects were shown to persist at the last observation at 4 weeks after discontinuation of LAMISIL Tablets."	0
Co-administration of the CYP2C8 enzyme inducer rifampin decreases exposure to treprostinil .	1
Discuss treatment options with women planning to become pregnant.	0
"The largest increases in serum potassium, BUN and creatinine in this study were observed with 50 mg of triamterene given twice daily, the largest dose tested."	0
"In such cases, discontinue ACEON treatment immediately and observe until the swelling disappears."	0
"Patients continuing on TIKOSYN after successful electrical cardioversion should continue to be monitored by electrocardiography for 12 hours post cardioversion, or a minimum of 3 days after initiation of TIKOSYN therapy, whichever is greater."	0
Like other antiarrhythmics mexiletine hydrochloride can cause worsening of arrhythmias.	0
"In replication competent virus assays, the EC50 value of sofosbuvir against genotype 1a was 30 nM."	0
Iloperidone doses should be reduced by one-half when administered with paroxetine.	1
"Serotonin Syndrome: Serotonin syndrome has been reported with SSRIs and SNRIs, including Lexapro, both when taken alone, but especially when co-administered with other serotonergic agents (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John's Wort)."	0
Amlodipine Amlodipine is a dihydropyridine calcium channel blocker that inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle.	0
Triamterene is primarily metabolized to the sulfate conjugate of hydroxytriamterene.	0
Safety and effectiveness in the pediatric population other than pediatric patients with OCD have not been established.	0
"Hemodynamics: Following administration of therapeutic doses to patients with hypertension, NORVASC produces vasodilation resulting in a reduction of supine and standing blood pressures."	0
No effect on AV nodal conduction following TIKOSYN treatment was noted in normal volunteers and in patients with 1st degree heart block.	0
These events have occurred as both new onset and an exacerbation of existing autoimmune disease.	0
A study involving haloperidol and zolpidem revealed no effect of haloperidol on the pharmacokinetics or pharmacodynamics of zolpidem.	0
Effects of Concomitant Medications The co-administration of NATRECOR<U+00AE> with enalapril did not have significant effects on the PK of NATRECOR<U+00AE>.	0
Administration of phenytoin to patients receiving dopamine HCl has been reported to lead to hypotension and bradycardia.	0
"Changes observed in these clotting tests at the expected therapeutic dose, however, are small, subject to a high degree of variability, and not useful in monitoring the anticoagulation effect of apixaban."	0
Closely monitor for signs of hyperkalemia with periodic blood tests and ECGs.	0
No significant pharmacokinetic changes have been observed when tacrolimus is given intravenously.	0
Male patients with a history of obstructive uropathies may experience higher rates of genitourinary adverse events (5.11).	0
Doses greater than 0.2 mg/kg/day or 10 mg/day are not recommended.	0
"In patients known to be hypersensitive to amphetamine, or other components of DESOXYN."	0
Taking COREG with food should minimize the risk of orthostatic hypotension.	0
The triamterene and hydrochlorothiazide components of this product are well absorbed and are bioequivalent to liquid preparations of the individual components administered orally.	0
"Terbinafine clearance is increased 100% by rifampin, a CYP450 enzyme inducer, and decreased 33% by cimetidine, a CYP450 enzyme inhibitor."	1
"In more seriously ill patients, begin infusion of dopamine hydrochloride at doses of 5 mcg/kg/min and increase gradually, using 5 to 10 mcg/kg/min increments, up to a rate of 20 to 50 mcg/kg/min as needed."	0
Consumption of food immediately prior to sublingual administration decreased asenapine exposure by 20%; consumption of food 4 hours after sublingual administration decreased asenapine exposure by about 10%.	1
Inosine monophosphate dehydrogenase (IMDH) is required for one of the metabolic pathways of azathioprine.	0
"In such patients, consider an increase in dosage or twice daily administration."	0
"Hypersensitivity reactions, including anaphylactic reactions, have been reported with lidocaine."	0
A multiple-dose study was conducted to assess the effect of fluoxetine 20 mg BID on the pharmacokinetics of estazolam 2 mg QHS after seven days.	0
Food thus decreases verapamil bioavailability and the time to peak plasma concentration for both verapamil and norverapamil are delayed by approximately 7 hours.	1
"Overall, the two higher doses (25 to 50mg in patients <50kg; 50 to 100mg in patients <U+2265>50kg) reduced diastolic blood pressure by 5 to 6mmHg more than the lowest dose used (2.5mg in patients <50kg; 5mg in patients <U+2265>50kg)."	0
"If concomitant use of PRISTIQ with other serotonergic drugs is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome, particularly during treatment initiation and dose increases (5.2)."	0
"Both sofosbuvir and ledipasvir were fully active against substitutions associated with resistance to other classes of direct-acting antivirals with different mechanisms of action, such as NS5B non-nucleoside inhibitors and NS3 protease inhibitors."	0
"PMs treated for at least twoyears gained an average of 2.4kg and 1.1cm less than predicted, while EMs gained an average of 0.2kg and 0.4cm less than predicted."	0
Alcohol There was no significant difference between oral aripiprazole co-administered with ethanol and placebo co-administered with ethanol on performance of gross motor skills or stimulus response in healthy subjects.	0
ZDV glucuronide concentrations were unaltered.	0
"Blood levels of fingolimod-phosphate decline in parallel with those of fingolimod in the terminal phase, yielding similar half-lives for both."	0
Hypersensitivity reactions: Serious reactions have been reported.	0
Cases of life-threatening hepatic failure have been reported in patients treated with nefazodone hydrochloride tablets.	0
Dosage should be initiated at a low level and increased according to clinical response and any evidence of intolerance.	0
"Coadministration of AVALIDE with potassium sparing diuretics, potassium supplements, potassium-containing salt substitutes or other drugs that raise serum potassium levels may result in hyperkalemia, sometimes severe."	0
The following dose equivalency scheme should generally provide equivalent exposure in pediatric and adult patients: Pediatric Patients Adults 3 mg/kg 100 mg 6 mg/kg 200 mg 12Some older children may have clearances similar to that of adults.	0
"It is suggested that in patients receiving dopamine HCl, alternatives to phenytoin should be considered if anticonvulsant therapy is needed."	0
Clarithromycin Atorvastatin AUC was significantly increased with concomitant administration of LIPITOR 80 mg with clarithromycin (500 mg twice daily) compared to that of LIPITOR alone.	1
"During induction therapy, monitor coagulation studies, blood counts, and chemistries at least 2-3 times per week through recovery."	0
"CYP 3A inhibitors can lead to a marked increase in tolvaptan concentrations [see Dosage and Administration (2.3), Drug Interactions (7.1)]."	1
Reduce ONIVYDE dose for Grade 3-4 neutropenia or neutropenic fever following recovery in subsequent cycles.	0
"The pharmacokinetics of sofosbuvir were studied in HCV-negative subjects with mild (eGFR between 50 to less than 80 mL/min/1.73 m2), moderate (eGFR between 30 to less than 50 mL/min/1.73 m2), severe renal impairment (eGFR less than 30 mL/min/1.73 m2), and subjects with ESRD requiring hemodialysis following a single 400 mg dose of sofosbuvir."	0
"PRIFTIN may produce a red-orange discoloration of body tissues and/or fluids (e.g., skin, teeth, tongue, urine, feces, saliva, sputum, tears, sweat, and cerebrospinal fluid)."	0
The half-life of zidovudine was likewise prolonged by approximately 128% following combination therapy with fluconazole.	1
There was no significant change in average heart rate among patients treated with INSPRA in the combined clinical studies.	0
"PATIENTS WITH BRONCHOSPASTIC PULMONARY DISEASE SHOULD, IN GENERAL, NOT RECEIVE BETA-BLOCKERS."	0
"These effects appear to be due to the inhibition of CYP3A4 by nefazodone because, in the same study, nefazodone had no significant effect on the plasma concentrations of pravastatin, which is not metabolized by CYP3A4 to a clinically significant extent."	0
"After at least 10 days following the initiation of PREZISTA/ritonavir, resume bosentan at 62.5 mg once daily or every other day based upon individual tolerability."	0
"The incidence, magnitude, and clinical significance of similar phenomena in patients receiving ISDN have not been studied."	0
"Like other ACE inhibitors, ALTACE, has been only rarely associated with hypotension in uncomplicated hypertensive patients."	0
There does not appear to be a benefit of stopping alpha-1 blocker therapy prior to cataract surgery.	0
"Coadministration of VFEND with ergot alkaloids (ergotamine and dihydroergotamine) is contraindicated because VFEND may increase the plasma concentration of ergot alkaloids, which may lead to ergotism."	0
"In patients not taking digoxin, no difference in risk of sudden death was observed in the dronedarone versus placebo groups."	0
Echocardiogram during and after treatment could be useful for detecting any valvular disorders which may occur.	0
Elderly patients have been found to have 2 to 3 fold higher plasma concentrations (Cmax and AUC) than young subjects.	0
"It is thus essential to monitor serum potassium levels carefully in any patient receiving amiloride, particularly when it is first introduced, at the time of diuretic dosage adjustments, and during any illness that could affect renal function."	0
"Sudden death, stroke and myocardial infarction have been reported in adults with CNS stimulant treatment at recommended doses."	0
There are no adequate and well-controlled studies in pregnant women; this drug should be used in pregnancy only if the potential benefit justifies the potential risk to the fetus.	0
"Modest accumulation of olmesartan was observed in the elderly with repeated dosing; AUCss, was 33% higher in elderly patients, corresponding to an approximate 30% reduction in CLR."	0
"Given the primary CNS effects of Anafranil, caution is advised in using it concomitantly with other CNS-active drugs."	0
Avoid sudden large dose reductions.	0
"In a large U.S. post-marketing study, angioedema (defined as reports of angio, face, larynx, tongue, or throat edema) was reported in 3/1523 (0.20%) Black patients and in 8/8680 (0.09%) non-Black patients."	0
This small change in antipyrine half-life reflects a clinically insignificant change in hepatic metabolism.	0
Co-administration of CMI with phenobarbital increases plasma concentrations of phenobarbital.	1
PREZISTA/ritonavir is not recommended for use in patients with severe hepatic impairment.	0
WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning.	0
"Dose adjustment is not recommended for risperidone when co-administered with ranitidine, cimetidine, amitriptyline, or erythromycin."	0
Clinical experience in children is limited.	0
Renal Disease: Cumulative effects of the thiazides may develop in patients with impaired renal function.	0
Limit the dose of ULORIC to 40 mg once daily in patients with severe renal impairment.	0
Sofosbuvir is not a substrate for CYP and UGT1A1 enzymes.	0
"Such symptoms should be reported to the patient's prescriber or health professional, especially if they are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
Premenopausal women who have not undergone a hysterectomy or oophorectomy must use effective contraception while using MULTAQ.	0
Neither quinapril nor quinaprilat were mutagenic in the Ames bacterial assay with or without metabolic activation.	0
At least 14 days should elapse between discontinuation of an MAOI intended to treat psychiatric disorders and initiation of therapy with PRISTIQ.	0
"In general, the weight and height gain of pediatric patients treated with STRATTERA lags behind that predicted by normative population data for about the first 9-12months of treatment."	0
In animal studies this was manifested as reduced prostate and seminal vesicle weights.	0
"Decreased exposure of some antiretroviral drugs (e.g., rilpivirine, atazanavir, and nelfinavir) when used concomitantly with rabeprazole may reduce antiviral effect and promote the development of drug resistance."	0
Patients receiving warfarin therapy should be carefully monitored when fluoxetine is initiated or discontinued.	0
"In hemodynamic studies, NORVASC has not been associated with a negative inotropic effect when administered in the therapeutic dose range to intact animals and man, even when co-administered with beta-blockers to man."	0
Anaphylactoid Reactions Anaphylactoid Reactions During Desensitization: Two patients undergoing desensitizing treatment with Hymenoptera venom while receiving ACE inhibitors sustained life-threatening anaphylactoid reactions.	0
"As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals."	0
The rate and extent of quinapril absorption are diminished moderately (approximately 25<U+2013>30%) when ACCUPRIL tablets are administered during a high-fat meal.	1
"Avoid concomitant administration of XARELTO with known combined P-gp and strong CYP3A4 inhibitors ( e.g. , ketoconazole and ritonavir ) see Warnings and Precautions ( 5.6 ) and Clinical Pharmacology ( 12.3 ) ."	0
If an alternate etiology is not found do not restart ZOCOR.	0
"When involvement of the tongue, glottis, or larynx appears likely to cause airway obstruction, administer appropriate therapy, such as subcutaneous epinephrine solution 1:1000 (0.3 to 0.5 mL), promptly."	0
"Strains with chromosomally mediated resistance can be detected only by agar dilution or disk diffusion susceptibility test methods.2 Isolates with zone diameters <U+2264>19 mm generally produced <U+03B2>-lactamase.2,4 <U+2264>0.06 0.12 <U+2013> 1 <U+2265>2 <U+2265>47 27 <U+2212> 46 <U+2264>26 Listeria Monocytogenes <U+2264>2The current absence of resistant isolates precludes defining results other than ""Susceptible""."	0
GI motility agents:cisapride CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias.	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy."	0
No teratogenic effects of ACCURETIC were seen in studies of pregnant rats and rabbits.	0
"An 18-month toxicity study in rats, at a low multiple (6-fold) of the maximum recommended human dose, and not the maximum tolerated dose, did not suggest a tumorigenic potential."	0
"Chronic Insomnia Non-elderly patients: Adult outpatients with chronic insomnia were evaluated in three double-blind, parallel-group outpatient studies, one of 2 weeks duration and two of 4 weeks duration, that compared the effects of Zaleplon at doses of 5 mg (in two studies), 10 mg, and 20 mg with placebo on a subjective measure of time to sleep onset (TSO)."	0
Only two metabolites (1-oxo-estazolam & 4-hydroxy-estazolam) were detected in human plasma up to 18 hrs.	0
"Based on the assumption that the relationship between paroxetine<U+2019>s in vitro Ki and its lack of effect on terfenadine<U+2019>s in vivo clearance predicts its effect on other CYP3A4 substrates, paroxetine<U+2019>s extent of inhibition of CYP3A4 activity is not likely to be of clinical significance."	0
"If one elects to use isosorbide dinitrate in these conditions, careful clinical or hemodynamic monitoring must be used to avoid the hazards of hypotension and tachycardia."	0
"If further titration is required, 12.5 mg increments should be utilized."	0
There was also no evidence of tachyphylaxis to the hemodynamic effects of NATRECOR<U+00AE> in the clinical trials.	0
The untoward reactions have reverted to normal following cessation of treatment.	0
Alteration in dose or regimen may be recommended based on drug interaction studies or predicted interaction for magnitude of interaction.	0
Treatment course to be repeated no earlier than 3 days.	0
A gradual reduction in dosage rather than abrupt cessation is recommended whenever possible.	0
"As HARVONI contains ledipasvir and sofosbuvir, any interactions that have been identified with these agents individually may occur with HARVONI."	0
"In addition, blood pressure reductions in both treatment groups were consistent between Black and non-Black patients."	0
Concomitant use of Pimozide and Celexa or Lexapro is contraindicated.	0
"Reports usually indicate that LASIX ototoxicity is associated with rapid injection , severe renal impairment , the use of higher than recommended doses , hypoproteinemia or concomitant therapy with aminoglycoside antibiotics , ethacrynic acid , or other ototoxic drugs ."	0
"Triamterene is not a competitive antagonist of the mineralocorticoids and its potassium-conserving effect is observed in patients with Addison's disease, i.e., without aldosterone."	0
Aprepitant acts as a moderate inhibitor of CYP3A4 when administered as a 3-day regimen (125-mg/80-mg/80-mg) and can increase plasma concentrations of concomitant drugs that are substrates for CYP3A4.	1
Special Populations Hepatic Dysfunction : Avoid aspirin in patients with severe hepatic insufficiency.	0
"Angioedema , including laryngeal edema , may occur at any time during treatment with angiotensin converting enzyme inhibitors , including enalapril ."	0
Intervention: An alternative confirmatory method should be considered to verify positive results.	0
"Because CYP 3A4 inhibition elevates the serum levels of DIHYDROERGOTAMINE, the risk for vasospasm leading to cerebral ischemia and/or ischemia of the extremities is increased."	0
No changes in doses of either nefazodone or desipramine are necessary when the two drugs are given concomitantly.	0
"Drug Interactions Hydrochlorothiazide Alcohol, barbiturates, or narcotics: Potentiation of orthostatic hypotension may occur."	0
"Increased doses of quetiapine up to 5 fold may be required to maintain control of symptoms of schizophrenia in patients receiving quetiapine and phenytoin, or other known potent CYP3A4 inducers."	1
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.	0
"In hypertensive patients with normal renal function, therapeutic doses of NORVASC resulted in a decrease in renal vascular resistance and an increase in glomerular filtration rate and effective renal plasma flow without change in filtration fraction or proteinuria."	0
The increases were not associated with jaundice or other clinical signs or symptoms.	0
Atorvastatin had no clinically significant effect on prothrombin time when administered to patients receiving chronic warfarin treatment.	0
"Increased risk of suicidal ideation, thinking, and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder (MDD) and other psychiatric disorders (5.1)."	0
"Approximately 95% and 93% of paroxetine is bound to plasma protein at 100 ng/mL and 400 ng/mL, respectively."	0
"The rate of hydrochlorothiazide absorption was reduced by 12% when ACCURETIC tablets were administered with a high-fat meal, while the extent of absorption was not significantly affected."	1
"Nitritoid reactions (symptoms include facial flushing, nausea, vomiting, and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy."	0
"Patients should also be cautioned not to take concomitant medications, whether prescription or over-the-counter drugs such as cold, hay fever, or weight-reducing preparations, without the advice of a physician."	0
"Clinical Worsening/Suicide Risk: Monitor for clinical worsening, suicidality and unusual change in behavior, especially, during the initial few months of therapy or at times of dose changes (5.1)."	0
There is no information on the presence of dofetilide in breast milk.	0
NATRECOR<U+00AE> (nesiritide) is for intravenous (IV) use only.	0
"If concomitant use is necessary, consider increasing the Meperidine Hydrochloride Injection dosage until stable drug effects are achieved."	0
The no-effect dose for rat pup mortality was 1.3 times the human dose on a mg/m2 basis.	0
Trandolapril Component Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.	0
"In a biochemical assay, GS-461203 inhibited the polymerase activity of the recombinant NS5B from HCV genotypes 1b and 4a with IC50 values of 3.3 and 2.7 microM, respectively."	0
"Impact of Dabigatran on Other Drugs In clinical studies exploring CYP3A4, CYP2C9, P-gp and other pathways, dabigatran did not meaningfully alter the pharmacokinetics of amiodarone, atorvastatin, clarithromycin, diclofenac, clopidogrel, digoxin, pantoprazole, or ranitidine."	0
Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity.	1
"ECGs should be obtained at baseline, 7 days after initiation and periodically thereafter, as well as following dose adjustments."	0
Do not co-administer aliskiren with Benicar in patients with diabetes (4).	0
The administration of guanfacine concomitantly with a known microsomal enzyme inducer ( phenobarbital or phenytoin ) to two patients with renal impairment reportedly resulted in significant reductions in elimination half-life and plasma concentration .	1
"HMG-CoA Reductase Inhibitors: rosuvastatin <U+2191> rosuvastatin Coadministration of HARVONI with rosuvastatin may significantly increase the concentration of rosuvastatin which is associated with increased risk of myopathy, including rhabdomyolysis."	1
A causal relationship with ULORIC has not been established.	0
Procedures for proper handling and disposal of anticancer drugs should be considered.	0
"While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition."	0
"In the event of an erection that persists longer than 4 hours, the patient should seek immediate medical assistance."	0
"For patients with diseases, conditions, or medications that could exacerbate these effects, complete fall risk assessments when initiating antipsychotic treatment and recurrently for patients on long-term antipsychotic therapy."	0
"If the level of pain increases after dosage stabilization, attempt to identify the source of increased pain before increasing the Meperidine Hydrochloride Injection dosage."	0
The maximum recommended dose for BPH is 8 mg once daily.	0
"In patients with creatinine clearance 10-30 mL/min, reduce the initial dose of PRINIVIL to half of the usual recommended dose (i.e., hypertension, 5 mg; heart failure or acute MI, 2.5 mg)."	0
It is also not known whether isocarboxazid can cause embryo/fetal harm when administered to a pregnant woman or can affect reproductive capacity.	0
Increased cyclosporine levels have been associated with nephrotoxicity.	0
"In patients with definite or suspected acute myocardial infarction, treatment with TENORMIN I.V."	0
"Amlodipine inhibits calcium ion influx across cell membranes selectively, with a greater effect on vascular smooth muscle cells than on cardiac muscle cells."	0
The elimination half life of trandolapril is about 6 hours.	0
may be stored refrigerated at 2<U+00B0>C to 8<U+00B0>C (36<U+00B0>F to 46<U+00B0>F) before use as long as the total time of refrigerated storage and infusion does not exceed 48 hours.	0
Angle Closure Glaucoma: Angle closure glaucoma has occurred in patients with untreated anatomically narrow angles treated with antidepressants.	0
"In a second study, 15 subjects consumed one 8oz glass of single-strength grapefruit juice (one can of frozen concentrate diluted with 3cans of water) with breakfast for 3 consecutive days and a single dose of 40mg lovastatin in the evening of the third day."	0
"In patients taking coumarin anticoagulants and CRESTOR concomitantly, INR should be determined before starting CRESTOR and frequently enough during early therapy to ensure that no significant alteration of INR occurs."	0
"Patients receiving antihypertensive drugs, beta-adrenergic blockers, and nitrates should be observed for possible additive hypotensive effects."	0
AHA does not acidify urine directly nor does it have a direct antibacterial effect.	0
"Patients with severe liver disease, however, may require lower doses and must be monitored closely."	0
One study at a 200 mg daily dose of fluconazole failed to demonstrate a prolongation in QTc interval.	0
Drug interaction studies have indicated that the maximum concentrations of metoprolol and propanolol are increased after the administration of verapamil.	1
These rates were not different statistically.	0
Drugs That Induce CYP3A4 Rifampin: CYP3A4 is ordinarily a minor metabolizing enzyme of zaleplon.	0
The recommended usual dosage range of Isoptin-SR for hypertension is 120 to 480 mg per day administered in a single dose or two divided doses.	0
Administration of eszopiclone 3 mg to a patient taking another drug that is highly protein-bound would not be expected to cause an alteration in the free concentration of either drug.	0
Monitor toxicity when administering lidocaine with CYP1A2 and/or CYP3A4 inhibitors.	1
"In these subjects (N=8), the clearance of diazepam was reduced by 65% and that of N-desmethyldiazepam to a level that was too low to measure over the course of the 2-week-long study."	1
"If acceptable alternatives to linezolid or intravenous methylene blue treatment are not available and the potential benefits of linezolid or intravenous methylene blue treatment are judged to outweigh the risks of serotonin syndrome in a particular patient, PEXEVA<U+00AE> should be stopped promptly, and linezolid or intravenous methylene blue can be administered."	0
"When duloxetine 60mg was co-administered with fluvoxamine 100mg, a potent CYP1A2 inhibitor, to male subjects (n=14) duloxetine AUC was increased approximately 6-fold, the Cmax was increased about 2.5-fold, and duloxetine t1/2 was increased approximately 3-fold."	1
Hyperuricemia may occur or frank gout may be precipitated in certain patients receiving thiazide therapy.	0
Dose to be repeated no earlier than 3days.	0
"When concomitant treatment with a <U+03B2>-blocker and clonidine is to be terminated, the <U+03B2>-blocker should be discontinued first."	0
"It is present in effective concentrations in many organs and body fluids, including cerebrospinal fluid."	0
Patients with hemophilia: There have been reports of spontaneous bleeding in patients with hemophilia A and B treated with protease inhibitors.	0
"Clonidine may potentiate the CNS-depressive effects of alcohol, barbiturates or other sedating drugs."	0
Both the recommended starting dosage and therapeutic range in patients with mild hepatic impairment (Child Pugh scores 5 or 6) are half the recommended daily dosage.	0
"A comparison of single-dose and multiple-dose administration of clozapine demonstrated that the elimination half-life increased significantly after multiple dosing relative to that after single-dose administration, suggesting the possibility of concentration-dependent pharmacokinetics."	0
Known hypersensitivity to escitalopram or citalopram or any of the inactive ingredients (4.3).	0
Drugs that inhibit CYP2D6 can be expected to increase plasma levels of nebivolol.	1
"In two additional placebo-controlled PTSD trials, the difference in response to treatment between patients receiving sertraline hydrochloride and patients receiving placebo was not statistically significant."	0
"STRATTERA capsules are not intended to be opened, they should be taken whole."	0
Do not co-administer aliskiren with ACEON in patients with diabetes.	0
"In particular, caution should be used when treating Chinese patients with simvastatin doses exceeding 20mg/day coadministered with lipid-modifying doses of niacin-containing products."	0
The concomitant use of venlafaxine hydrochloride extended-release with tryptophan supplements is not recommended.	0
"In an uncontrolled compassionate use program (n=3920), cases of rash, some of which were severe, accompanied by myalgia, fever, erythema, desquamation, and mucosal erosions were reported."	0
It is generally believed (though not established in controlled trials) that treating such an episode with an antidepressant alone may increase the likelihood of precipitation of a mixed/manic episode in patients at risk for bipolar disorder.	0
The antihypertensive effect of losartan was studied in one trial enrolling 177hypertensive pediatric patients aged 6 to 16years old.	0
"Daily dosage may be doubled up 16 mg once daily, as needed, to achieve the desired reduction in blood pressure."	0
"Patients receiving triamterene and hydrochlorothiazide should be carefully monitored for fluid or electrolyte imbalances, i.e., hyponatremia, hypochloremic alkalosis, hypokalemia and hypomagnesemia."	0
"Following oral administration of REMERON (mirtazapine) Tablets 20 mg/day for 7 days to subjects of varying ages (range, 25<U+2013>74), oral clearance of mirtazapine was reduced in the elderly compared to the younger subjects."	0
Caution should be used when prescribing with pravastatin sodium.	0
"No dose adjustment is necessary in patients with renal impairment, since less than 10% of the orally administered eszopiclone dose is excreted in the urine as parent drug."	0
It is not a disclosure of all possible adverse or intended effects.	0
"Duloxetine comprises about 3% of the total radiolabeled material in the plasma, indicating that it undergoes extensive metabolism to numerous metabolites."	0
"At endpoint, 33% of the paroxetine-treated patients showed a reduction to 0 or 1 panic attacks compared to 14% of placebo patients."	0
"Heart Failure Post-Myocardial Infarction In patients with heart failure post-myocardial infarction who are currently being treated with a diuretic, symptomatic hypotension occasionally can occur following the initial dose of ALTACE."	0
"Thus, these two agents should not be coadministered."	0
The latter consist of those few that are truly idiosyncratic in nature or those that occur with such low frequency that a dose relationship may be difficult to discern.	0
The peak plasma concentration at steady-state is 1.98 <U+00B5>g/mL (1.01<U+2013>3.99 <U+00B5>g/mL) and the steady-state trough concentration is 0.53 <U+00B5>g/mL (0.18<U+2013>1.01 <U+00B5>g/mL).	0
Volume and/or salt depletion should be corrected before initiating treatment with trandolapril.	0
"Activated oral charcoal reduces absorption of apixaban, thereby lowering apixaban plasma concentration."	1
CYMBALTA has not been systematically evaluated in patients with a recent history of myocardial infarction or unstable coronary artery disease.	0
"The incidence of abnormal renal function (e.g., creatinine increase) leading to drug discontinuation in ATACAND-treated patients was 6.3% compared with 2.9% in placebo-treated patients."	0
Hydrochlorothiazide 12.5mg daily should be added and/or the dose of losartan potassium tablets should be increased to 100mg once daily followed by an increase in hydrochlorothiazide to 25mg once daily based on blood pressure response.	0
Lotensin is not recommended in pediatric patients less than 6 years of age or in pediatricpatients with GFR less than 30 mL/min/1.73m<U+00B2>.	0
"Review the continued need for the other antiarrhythmic agent after the effects of amiodarone have been established , and attempt discontinuation see Clinical Pharmacology ( 12.3 ) ."	0
Paroxetine should be used cautiously in patients with a history of seizures.	0
Rare case reports have suggested possible additive effects of pimozide and fluoxetine leading to bradycardia.	0
Drugs that inhibit the renin-angiotensin system can cause hyperkalemia.Concomitant use of ATACAND with drugs that increase potassium levels may increase the risk of hyperkalemia.	0
Frequent monitoring of trough blood levels of cyclosporine and tacrolimus is recommended when co-administering nicardipine.	0
Food does not affect its bioavailability.	0
Drugs that act directly on the renin-angiotensin system (RAS) can have effects on the development of immature kidneys.	0
Semen studies in man (four schizophrenics and nine normal volunteers) revealed no significant changes in sperm morphology.	0
"In the presence of AV block, beta-blockade may prevent the necessary facilitating effect of sympathetic activity on conduction."	0
Risk of falling also appeared to be proportional to a patient's underlying risk for falls and appeared to increase steadily with age.	0
At 100mg/kg/day only a decrease in the number of corpora lutea/female was observed.	0
Use in combination with other anorectic agents is contraindicated.	0
Do not up-titrate NATRECOR<U+00AE> more frequently than every 3 hours.	0
"Drugs Dependent on Gastric pH for Absorption (e.g., ir on salts, erlotinib, dasatinib, nilotinib, mycophenol ate mofetil, ketoconazole , itraconazole ) Clinical Impact: Rabeprazole can reduce the absorption of other drugs due to its effect on reducing intragastric acidity."	1
"However, in some patients with severe left ventricular dysfunction, it may have a negative inotropic effect and could lead to worsened failure."	0
"While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition."	0
Dextromethorphan: A study in healthy volunteers showed that changes in the pharmacokinetics of dextromethorphan (80 mg dose) when a 3 mg dose of iloperidone was co-administered resulted in a 17% increase in total exposure and a 26% increase in the maximum plasma concentrations (Cmax)of dextromethorphan.	1
"Electrolyte Disorders: Toxicity is increased by hypokalemia, hypomagnesemia, and hypercalcemia."	0
"Avoid the administration of Tasigna with agents that are strong CYP3A4 inhibitors [see Boxed Warning, Dosage and Administration (2."	0
"In many cases, this hyponatremia appears to be the result of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)."	0
"After intravenous (IV) administration the volume of distribution at steady state is about 1400 L. Metabolism Dronedarone is extensively metabolized, mainly by CYP3A."	0
***Most patients heal within 4 weeks; some patients may require additional therapy to achieve healing.	0
Savella should be prescribed with care in patients with a history of a seizure disorder.	0
"Lorazepam <U+2013> When lorazepam (2 mg BID) and nefazodone (200 mg BID) were coadministered to steady state, there was no change in any pharmacokinetic parameter for either drug compared to each drug administered alone."	0
Patients with Hepatic Impairment: The pharmacokinetics of ledipasvir were studied with a single dose of 90 mg ledipasvir in HCV negative subjects with severe hepatic impairment (Child-Pugh Class C).	0
"In vitro metabolic studies indicate that verapamil is metabolized by cytochrome P450 including CYP3A4, CYP1A2, CYP2C8, CYP2C9 and CYP2C18."	0
"The use of DIFLUCAN in children with cryptococcal meningitis, Candida esophagitis, or systemic Candida infections is supported by the efficacy shown for these indications in adults and by the results from several small noncomparative pediatric clinical studies."	0
[See Warnings and Precautions (5.1) and Clinical Pharmacology (12.2)].	0
"In clinical trials of bisoprolol/hydrochlorothiazide combination therapy using bisoprolol doses of 2.5 to 20 mg and hydrochlorothiazide doses of 6.25 to 25 mg, the antihypertensive effects increased with increasing doses of either component."	0
The recommended dosage of LEXIVA in patients aged at least 4weeks to 18years should be calculated based on body weight (kg) and should not exceed the recommended adult dose (Table 1).	0
"Administration of NitroMist is contraindicated in patients who are using a selective inhibitor of cyclic guanosine monophosphate ( cGMP ) - specific phosphodiesterase type 5 ( PDE5 ) , as PDE5 inhibitors such as sildenafil , vardenafil , and tadalafil have been shown to potentiate the hypotensive effects of organic nitrates see DRUG INTERACTIONS ( 7.1 ) ."	0
Stability studies indicate that the suspension is stable when stored at room temperature (25<U+00B1>3<U+00B0>C) or in a refrigerator (2<U+2013>8<U+00B0>C) for four weeks.	0
"Drug dosage, rather than systemic drug concentration, correlates better with LDL-C reduction."	0
"Co-administration of SAMSCA with 400mg ketoconazole daily or with other strong CYP 3A inhibitors (e.g., clarithromycin, itraconazole, telithromycin, saquinavir, nelfinavir, ritonavir and nefazodone) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure."	1
"As with other ACE inhibitors, periodic monitoring of white blood cell counts in patients with collagen vascular disease and/or renal disease should be considered."	0
No clinically significant differences were observed in the pharmacokinetics or pharmacodynamics of alcohol or the pharmacokinetics of selegiline during co-administration.	0
Titrate slowly in patients with severe renal impairment.	0
"Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan."	1
"Early recognition of premonitory signs, assurance of adequate oxygenation and (where necessary) establishment of artificial airway with ventilatory support are essential to management of the problem."	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy."	0
The serum half-life of penicillin G correlates inversely with age and clearance of creatinine and ranges from 3.2 hours in infants 0 to 6 days of age to 1.4 hours in infants 14 days of age or older.	0
"Also, bleeding and/or increased prothrombin time have been reported in a few patients taking coumarin anticoagulants concomitantly with lovastatin."	0
"There have been reports of increased bleeding, including spontaneous skin hematomas and hemarthrosis in patients with hemophilia type A and B treated with PIs."	0
"In most cases, elevated serum potassium levels were isolated values, which resolved despite continued therapy."	0
"On the other hand, the pharmacokinetics and pharmacodynamics of quinidine in human infants have not been adequately studied, and neonates' reduced protein binding of quinidine may increase their risk of toxicity at low total serum levels."	0
This could further confound the ability to assess potential interactions and effects on anticoagulation.	0
"The extent of protein binding of the hydroxybupropion metabolite is similar to that for bupropion, whereas the extent of protein binding of the threohydrobupropion metabolite is about half that of bupropion."	0
Symptomatic response to treatment with cimetidine does not preclude the presence of a gastric malignancy.	0
The coadministration of REYATAZ and buprenorphine without ritonavir is not recommended.	0
Corresponding multiples of the MRHD are 100 (mice) and 4 (rats) on the basis of body weight and 9.4 (mice) and 0.8 (rats) on the basis of body surface area.	0
"In adult placebo-controlled clinical trials, 6/1697 (0.35%) of atomoxetine patients versus 4/1560 (0.26%) of placebo-treated patients spontaneously reported treatment emergent hostility-related adverse events (overall risk ratio of 1.38 [95% C.I."	0
"In humans, two inhibitors of P4503A4 have been studied."	0
Clinical experience with Lexapro in patients with certain concomitant systemic illnesses is limited.	0
Use of a dose titration schedule may help to reduce treatment-emergent adverse events while maintaining appropriate ritonavir plasma levels.	0
GS-461203 is neither an inhibitor of human DNA and RNA polymerases nor an inhibitor of mitochondrial RNA polymerase.	0
"Assess each patient's risk prior to prescribing Meperidine Hydrochloride Injection, and monitor all patients regularly for the development of these behaviors and conditions."	0
Irinotecan HCl can cause severe and fatal interstitial lungdisease (ILD).	0
"CYP2D6 mediated oxidation appears to be a minor metabolic pathway invivo, because the clearance of olanzapine is not reduced in subjects who are deficient in this enzyme."	0
The possibility of an interaction cannot be excluded with these drugs.	0
Abrupt cessation of administration following prolonged high dosage results in extreme fatigue and depression.	0
The dosage of PROCARDIA needed to suppress angina and that can be tolerated by the patient must be established by titration.	0
Such coadministration is not recommended.	0
"Ifblood pressure is not controlled with Lotensin alone, a low dose of diuretic may beadded."	0
"Chronically administered beta-blocking therapy should not be routinely withdrawn prior to major surgery, however the impaired ability of the heart to respond to reflex adrenergic stimuli may augment the risks of general anesthesia and surgical procedures."	0
"Cases of myopathy, including rhabdomyolysis, have been reported with simvastatin coadministered with colchicine, and caution should be exercised when prescribing simvastatin with colchicine."	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy."	0
Antipsychotics Lurasidone Potential for serious and/or life-threatening reactions if REYATAZ is coadministered with ritonavir.	0
The risks of using Anafranil in combination with other drugs have not been systematically evaluated.	0
WARNING: SUICIDALITY and ANTIDEPRESSANTS See full prescribing information for complete boxed warning.	0
The mean volume of distribution (VDss) is estimated at 0.35 L/kg.	0
"The risk of myopathy is also increased by the following lipid-lowering drugs that are not strong CYP3A4 inhibitors, but which can cause myopathy when given alone."	0
Advise women of the potential risk to a fetus and to avoid pregnancy during and for four months following treatment with CAPRELSA.	0
"Patients taking APTIVUS oral solution should be advised not to take supplemental vitamin E greater than a standard multivitamin as APTIVUS oral solution contains 116 IU/mL of vitamin E which is higher than the Reference Daily Intake (adults 30 IU, pediatrics approximately 10 IU)."	0
"Inhaled/Nasal Steroids: Fluticasone <U+2191> Fluticasone Concomitant use of fluticasone propionate and APTIVUS/ritonavir may increase plasma concentrations of fluticasone propionate, resulting in significantly reduced serum cortisol concentrations."	1
"Advise patients and tell them to immediately report any signs or symptoms suggesting angioedema (swelling of face, extremities, eyes, lips, tongue, difficulty in swallowing or breathing) and to stop taking the drug until they have consulted with their physician."	0
"Careful supervision is required during withdrawal from abusive use, since severe depression may occur."	0
"If such symptoms occur, diuretics should be increased and the carvedilol dose should not be advanced until clinical stability resumes."	0
"If concomitant treatment of Lexapro with a triptan is clinically warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases."	0
"ORAP should be administered cautiously to patients with impairment of liver or kidney function, because it is metabolized by the liver and excreted by the kidneys."	0
"Also, these infants may experience symptoms of withdrawal as demonstrated by dysphoria, including agitation and significant lassitude."	0
The presence of food did not affect the peak concentration or area under the curve of bupropion.	0
The pharmacokinetics of LATUDA is dose-proportional within a total daily dose range of 20 mg to 160 mg. Steady-state concentrations of LATUDA are reached within 7 days of starting LATUDA.	0
Rifampin significantly increased pitavastatin exposure.	1
The safety and efficacy of combinations of REVATIO with VIAGRA or other PDE-5 inhibitors have not been studied.	0
Figure 3: Effect of Specific Populations on the Pharmacokinetics of Apixaban * ESRD subjects treated with intermittent hemodialysis; reported PK findings are following single dose of apixaban post hemodialysis.	0
Peak plasma concentrations of both active and total inhibitors were attained within 2 to 4hours of dose administration.	0
No reports involved the administration of methylene blue by other routes (such as oral tablets or local tissue injection) or at lower doses.	0
"Geriatric: In a pharmacokinetic study which compared healthy young and elderly (<U+2265>65years) volunteers, pitavastatin Cmax and AUC were 10 and 30% higher, respectively, in the elderly."	0
Limit the dose of simvastatin in patients on verapamil to 10 mg daily.	1
"Adverse reactions such as hypotension, bradycardia, or excessive drowsiness can occur when Zanaflex is taken with other CYP1A2 inhibitors, such as zileuton, fluoroquinolones other than ciprofloxacin (which is contraindicated), antiarrythmics (amiodarone, mexiletine, propafenone), cimetidine, famotidine, oral contraceptives, acyclovir, and ticlopidine )."	0
"A dose of 500 mg/m2 every eight hours has been studied in uncontrolled studies of 70 children, 3 to 18 years of age."	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP, like other ergot alkaloids, may cause vasospastic reactions other than coronary artery vasospasm."	0
Central nervous system adverse reactions are associated with venous plasma levels above 6.0 <U+03BC>g free base per mL.	0
Renin-angiotensin-aldosterone system inhibitors: Monitor for hyperkalemia (7.2) Nonsteroidal anti-inflammatory drugs: Monitor for hyperkalemia (7.3) Use with triamterene or amiloride can produce severe hyperkalemia.	0
Plasma protein binding of duloxetine is not affected by renal or hepatic impairment.	0
INVEGA<U+00AE> has not been studied in patients with severe hepatic impairment.	0
"Total plasma and renal clearances are in the range of 157 to 176 mL/min and 3.0 to 3.5 mL/min, respectively."	0
The harmonic mean apparent half-life of flurazepam is 2.3 hours.	0
"The concomitant use of Meperidine Hydrochloride Injection and CYP3A4 inhibitors, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g. ketoconazole), and protease inhibitors (e.g., ritonavir), or CYP2B6 can increase the plasma concentration of meperidine, resulting in increased or prolonged opioid effects."	1
ACE inhibitor-induced cough should be considered in the differential diagnosis of cough.	0
"Following oral administration of 10 mg of apixaban as 2 crushed 5 mg tablets suspended in 30 mL of water, exposure was similar to that after oral administration of 2 intact 5 mg tablets."	0
"For information regarding clinical recommendations, see Table 9 in PRECAUTIONS."	0
Potassium retention associated with the use of an antikaliuretic agent is accentuated in the presence of renal impairment and may result in the rapid development of hyperkalemia.	0
"This variant of small pupil syndrome is characterized by the combination of a flaccid iris that billows in response to intraoperative irrigation currents, progressive intraoperative miosis despite preoperative dilation with standard mydriatic drugs, and potential prolapse of the iris toward the phacoemulsification incisions."	0
These adverse effects do not appear to have resulted from intrauterine drug exposure that has been limited to the first trimester.	0
<U+2022> Hemodialysis: Steady-state plasma concentrations of rosuvastatin in patients on chronic hemodialysis were approximately 50% greater compared with healthy volunteer subjects with normal renal function.	0
"Add 75 mL of Ora-Plus<U+00AE>* oral suspending vehicle to an amber polyethylene terephthalate(PET) bottle containing fifteen Lotensin 20 mg tablets, and shake for at least two minutes."	0
A major depressive episode may be the initial presentation of bipolar disorder.	0
"If serotonin syndrome occurs, consider discontinuation of ZOLOFT and/or concomitant serotonergic drugs."	0
"Hormonal contraceptives , including oral , injectable , transdermal , and implantable contraceptives should not be used as the sole means of contraception because these may not be effective in patients receiving Tracleer see Drug Interactions ( 7.2 ) ."	0
"PHOSLYRA contains maltitol (1 g per 5 mL) and may induce a laxative effect, especially if taken with other products containing maltitol."	0
Donotexceed8mg/day Paroxetine 10mg/day 4mg/day 1.3 - Re-evaluatedosing.	1
"Similar signs have been reported in some patients on the combination of selegiline (10 mg a day) and selective serotonin reuptake inhibitors including fluoxetine, sertraline and paroxetine."	0
Monitor these patients and adjust the dose of the concomitant drug(s) which are OAT3 substrates as required.	0
Concomitant use of ciprofoxacin and Zanaflex is contraindicated.	0
"The following symptoms, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric."	0
Hypertension The recommended initial dose is 4 mg once a day.	0
Titrate the dosage of Meperidine Hydrochloride Injection slowly in geriatric patients and monitor closely for signs of central nervous system and respiratory depression.	0
"Co-administration of SAMSCA with 400 mg ketoconazole daily or with other strong CYP 3A inhibitors ( e.g. , clarithromycin , itraconazole , telithromycin , saquinavir , nelfinavir , ritonavir and nefazodone ) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure ."	1
"Therefore, patients being treated with NARDIL should avoid high protein food that has undergone protein breakdown by aging, fermentation, pickling, smoking, or bacterial contamination."	0
"Such drugs include specific antidepressants, phenothiazines, carbamazepine, and Type 1C antiarrhythmics (e.g., propafenone, flecainide, and encainide)."	0
This results in a mean increase in olanzapine Cmax following fluvoxamine of 54% in female nonsmokers and 77% in male smokers.	1
"By decreasing the influx of calcium, CALAN prolongs the effective refractory period within the AV node and slows AV conduction in a rate-related manner."	0
"Impact of Dabigatran on Other Drugs In clinical studies exploring CYP3A4, CYP2C9, P-gp and other pathways, dabigatran did not meaningfully alter the pharmacokinetics of amiodarone, atorvastatin, clarithromycin, diclofenac, clopidogrel, digoxin, pantoprazole, or ranitidine."	0
"Other postmarketing reports indicate that elevated transaminases, bilirubin, and alkaline phosphatase have occurred in patients with chronic liver disease or cirrhosis."	0
"In patients able to swallow, the maintenance infusion was discontinued, and eight<U+2013>hourly oral quinine sulfate was administered to provide approximately as much daily quinine base as the patient had been receiving quinidine base (for example, each adult patient received 650 mg of quinine sulfate every eight hours)."	0
Serotonin release by platelets plays an important role in hemostasis.	0
Renal Impairment Phendimetrazine tartrate extended-release capsules were not studied in patients with renal impairment.	0
"There was considerable variation in risk of suicidality among drugs, but a tendency toward an increase in the younger patients for almost all drugs studied."	0
"The patient's surgeon should be prepared for possible modifications to their surgical technique, such as the utilization of iris hooks, iris dilator rings, or viscoelastic substances."	0
Metabolism of nebivolol is decreased in patients with moderate hepatic impairment.	0
7.Mix the EMEND suspension gently by swirling 20 times; then gently invert the mixing cup 5 times.	0
"There has been no long-term use of Benicar in patients with unilateral or bilateral renal artery stenosis, but similar results may be expected."	0
"In arandomized trial in patients with newly diagnosed Ph+ CML in chronic phase comparing Tasigna and imatinib,Grade 3 or 4 hemorrhage occurred in 1.1% of patients in the Tasigna 300 mg twice daily arm, in 1.8% patients in the Tasigna 400 mg twice daily arm, and 0.4% of patients in the imatinib arm."	0
The patient should be advised that the reliability of oral or other systemic hormonal contraceptives may be affected; consideration should be given to using alternative contraceptive measures.	0
"Serious reactions may also occur when MAO inhibitors are given with serotoninergic drugs (e.g., dexfenfluramine, fluoxetine, fluvoxamine, paroxetine, sertraline, citalopram, venlafaxine)."	0
Use caution in patients with severe renal impairment (2.3).	0
"For patients without renal or hepatic impairment: Treatment of gout-flares <U+2013> co-administration of colchicine in patients on PREZISTA/ritonavir: 0.6 mg (1 tablet) <U+00D7> 1 dose, followed by 0.3 mg (half tablet) 1 hour later."	0
These pharmacokinetic differences may result in clinically significant differences when switching administration of tablet and capsules and when switching administration between the fed or fasted state.	0
"Patients who were titrated to 100 mg/day received 50 mg/day for the first 3 days of the cycle, then 100 mg/day for the remainder of the cycle."	0
"Drugs that lower the seizure threshold, including MAO inhibitors, should not be used with Amipaque<U+00AE> (metrizamide, Sanofi Winthrop Pharmaceuticals)."	0
"600 once daily, 10 days 1000 three times daily, 10 days 20 After morning dose No significant change 0.67 (0.61, 0.74) 0.61 (0.49, 0.76) After afternoon dose No significant change 0.63 (0.54, 0.74) 0.48 (0.43, 0.53) After evening dose 0.71 (0.57, 0.89) 0.54 (0.46, 0.63) 0.43 (0.37, 0.50) Fluconazole 400 once daily, 8 days 1000 three times daily, 7 days 11 0.87(0.72, 1.05) 0.76(0.59, 0.98) 0.90(0.72, 1.12) Grapefruit Juice 8 oz."	0
"The following symptoms, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric."	0
"The most common non-functional alleles associated with reduced levels of TPMT activity are TPMT*2, TPMT*3A and TPMT*3C."	0
Treatment with dofetilide must therefore be started only in patients placed for a minimum of three days in a facility that can provide electrocardiographic monitoring and in the presence of personnel trained in the management of serious ventricular arrhythmias.	0
"If symptomatic hypotension develops, a dose reduction or discontinuation of ACCUPRIL or concomitant diuretic may be necessary."	0
This diagnosis should be considered if clinical symptoms consistent with cyanocobalamin deficiency are observed in patients treated with ACIPHEX.	0
All changes in the lipid measurements (TableIV) in MEVACOR treated patients were dose-related and significantly different from placebo (p<U+2264>0.001).	0
There may be quantitative differences between various established methods for aPTT assessment.	0
Binding to serum proteins has been reported to be approximately 40% to 68%.	0
CNS toxicity has been reported when bupropion was coadministered with levodopa or amantadine.	0
Nursing Mothers: The use of IMURAN in nursing mothers is not recommended.	0
"Thus, olanzapine is unlikely to cause clinically important drug interactions mediated by these enzymes."	0
"Redistribution/accumulation of body fat including central obesity, dorsocervical fat enlargement (""buffalo hump""), peripheral wasting, facial wasting, breast enlargement, and ""cushingoid appearance"" have been observed in patients receiving antiretroviral therapy."	0
Physical incompatibility (precipitate) was observed with undiluted (5 mg/mL) and diluted (1 mg/mL in normal saline) diltiazem hydrochloride and rifampin (6 mg/mL in normal saline) during simulated Y-site administration.	0
Discontinuation of CYMBALTA should be considered in patients with symptomatic hyponatremia and appropriate medical intervention should be instituted.	0
"In both situations, the conservative treatment program should be continued."	0
CDAD must be considered in all patients who present with diarrhea following antibacterial use.	0
"The 24-hour AUC for ramiprilat, however, is dose-proportional over the 2.5 mg<U+2013>20 mg dose range."	0
"A marked potentiating effect on these drugs has been reported, resulting in hypotension."	0
"If traumatic puncture occurs, delay the administration of ELIQUIS for 48 hours."	0
A potentially fatal symptom complex sometimes referred to as Neuroleptic Malignant Syndrome (NMS) has been reported in association with antipsychotic drugs.	0
"Most quinidine is eliminated hepatically via the action of cytochrome P450IIIA4; there are several different hydroxylated metabolites, and some of these have antiarrhythmic activity."	0
P-gp inhibition and impaired renal function are the major independent factors that result in increased exposure to dabigatran.	0
No dosage adjustment is required for nefazodone.	0
"Cyclosporine ( CYP3A substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine ."	0
Perform serial ultrasound examinations to assess the intra-amniotic environment.	0
"This incidence is greater in patients with renal impairment, diabetes mellitus (with or without recognized renal insufficiency), and in the elderly."	0
"A patient Medication Guide about <U+201C>Antidepressant Medications, Depression and Other Serious Mental Illness, and Suicidal Thoughts and Actions<U+201D> is available for Marplan."	0
This effect may be more frequent in patients who have also consumed alcohol.	0
"Following intravenous administrations of citalopram, the fraction of drug recovered in the urine as citalopram and DCT was about 10% and 5%, respectively."	0
There was no evidence of hypersensitivity.	0
The influence of moderate hepatic impairment (Child-Pugh Class B) or severe hepatic impairment (Child-Pugh Class C) on the multiple-dose pharmacokinetics of tipranavir administered with ritonavir has not been evaluated.	0
"When co-administering telmisartan and ramipril, the response may be greater because of the possibly additive pharmacodynamic effects of the combined drugs, and also because of the increased exposure to ramipril and ramiprilat in the presence of telmisartan."	0
"Strong CYP3A4 inducers include carbamazepine, phenytoin, St. John<U+2019>s wort, and rifampin."	0
Hydrochlorothiazide is a benzothiadiazine diuretic.	0
APTIVUS should be used with caution in patients with a known sulfonamide allergy.	0
"If a patient develops skeletal pain and radiologic findings compatible with fluorosis or periostitis, voriconazole should be discontinued."	0
Monitor serum potassium in such patients.	0
Administer REVATIO doses 4<U+2013>6 hours apart.	0
"The risk of hypotension may be increased by the concomitant use of NATRECOR<U+00AE> with drugs affecting the renin-angiotensin system (i.e., angiotensin receptor blockers and/or angiotensin-converting enzyme inhibitors) or other afterload reducers."	0
"In addition, discontinuation of a concomitantly used cytochrome P450 3A4 inducer may result in an increase in meperidine plasma concentration."	0
"For patients receiving ELIQUIS 5 mg or 10 mg twice daily, the dose of ELIQUIS should be decreased by 50% when coadministered with drugs that are combined P-gp and strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, ritonavir)."	1
"As a result of FXa inhibition, apixaban prolongs clotting tests such as prothrombin time (PT), INR, and activated partial thromboplastin time (aPTT)."	0
Assess serum potassium periodically thereafter.	0
"Monoamine Oxidase Inhibitors Adverse reactions, some of which are serious or fatal, can develop in patients who use MAOIs or who have recently been discontinued from an MAOI and started on a serotonergic antidepressant(s) or who have recently had SSRI or SNRI therapy discontinued prior to initiation of an MAOI."	0
"The effect of sofosbuvir 400 mg (maximum recommended dosage) and 1200 mg (three times the maximum recommended dosage) on QTc interval was evaluated in a randomized, single-dose, placebo-, and active-controlled (moxifloxacin 400 mg) four period crossover thorough QT trial in 59 healthy subjects."	0
<U+2022>REYATAZ capsules without ritonavir are not recommended for treatment-experienced adult or pediatric patients with prior virologic failure.	0
"If these agents are to be administered concurrently, cyclosporine concentrations should be monitored, especially when diltiazem therapy is initiated, adjusted, or discontinued."	0
"Since the half-life of sotalol decreases with decreasing age (below about 2 years), time to steady-state will also increase."	0
Ziprasidone's antagonism of <U+03B1>1-adrenergic receptors may explain the orthostatic hypotension observed with this drug.	0
"Based on pharmacokinetic studies, no dosage adjustment of ZOLOFT is necessary when used in combination with cimetidine."	0
The possibility of hypotensive effects with Lotensin can be minimized by either discontinuing or decreasing the dose of diuretic prior to initiation of treatment with Lotensin.	0
Dose changes should occur at intervals of at least 1 week.	0
"Conjugates with glucuronic acid and sulfate predominate, and major metabolites have been isolated and identified."	0
"In short-term child and adolescent registration studies, 1.8% (6/340) of STRATTERA-treated patients experienced orthostatic hypotension compared with 0.5% (1/207) of placebo-treated patients."	0
"Treatment of patients requiring as much as 300 mg should generally be initiated in hospitals, where regular visits by the physician, skilled nursing care, and frequent electrocardiograms (ECGs) are available."	0
Anaphylactoid reactions have also been reported in patients undergoing low-density lipoprotein apheresis with dextran sulfate absorption.	0
"The pooled analyses of placebo-controlled trials in adults with MDD or other psychiatric disorders included a total of 295 short-term trials (median duration of 2 months) of 11 antidepressant drugs in over 77,000 patients."	0
"Coadministration of AVAPRO with other drugs that raise serum potassium levels may result in hyperkalemia, sometimes severe."	0
"Kaplan-Meier curve for the primary composite endpoint of doubling of serum creatinine, end stage renal disease (need for dialysis or transplantation) or death."	0
Taking Savella with food may improve the tolerability of the drug.	0
It is estimated that 9-19% of an administered dose is absorbed.	0
Study 1 was an 8-week study with flexible dosing of sertraline hydrochloride in a range of 50 to 200 mg/day; the mean dose for completers was 145 mg/day.	0
The effect of oral contraceptives on the pharmacokinetics of D.H.E.	0
"Several cases of hepatocellular injury related to verapamil have been proven by rechallenge; half of these had clinical symptoms (malaise, fever, and/or right upper quadrant pain) in addition to elevations of SGOT, SGPT, and alkaline phosphatase."	0
Potassium levels should be within the normal range prior to administration of TIKOSYN and maintained in the normal range during administration of TIKOSYN.	0
"A marked response was seen within 2weeks, and the maximum therapeutic response occurred within 4<U+2013>6weeks."	0
"If the original regimen was 0.6mg once a day, the regimen should be adjusted to 0.3mg once every other day."	0
Variability in Metabolism <U+2014> A subset (about7%) of the population has reduced activity of the drug metabolizing enzyme cytochrome P4502D6(CYP2D6).	0
"Metabolism and Elimination: Clevidipine is rapidly metabolized by hydrolysis of the ester linkage, primarily by esterases in the blood and extravascular tissues, making its elimination unlikely to be affected by hepatic or renal dysfunction."	0
Patients with signs or symptoms of clinical hepatitis should discontinue APTIVUS/ritonavir treatment and seek medical evaluation.	0
"Evaluation of electrocardiograms of 1153 patients who received nefazodone in 6 to 8 week, double-blind, placebo-controlled trials did not indicate that nefazodone is associated with the development of clinically important ECG abnormalities."	0
"Immunosuppressants: cyclosporine, sirolimus, tacrolimus <U+2191> immunosuppressants Therapeutic concentration monitoring is recommended for these immunosuppressants when coadministered with REYATAZ."	0
"Because treatment with MYCOBUTIN Capsules may be associated with neutropenia, and more rarely thrombocytopenia, physicians should consider obtaining hematologic studies periodically in patients receiving prophylaxis with MYCOBUTIN."	0
The mean serum elimination half-life of pimozide in schizophrenic patients was approximately 55 hours.	0
Higher-than-approved dose combinations of LEXIVA plus ritonavir are not recommended due to an increased risk of transaminase elevations.	0
These recommendations are based on either drug interaction studies or predicted interactions due to the expected magnitude of interaction and potential for serious adverse events or loss of efficacy.	0
Patients should be advised of the potential development of complications and to report promptly the occurrence of any symptom or sign of them.	0
"In patients <U+2265>75 years of age, Effient is generally not recommended, because of the increased risk of fatal and intracranial bleeding and uncertain benefit, except in high-risk situations (patients with diabetes or a history of prior MI) where its effect appears to be greater and its use may be considered."	0
The resulting increased plasma renin activity and aldosterone circulating levels do not overcome the effects of eplerenone.	0
Fluid and Electrolyte Balance: Excess administration of potassium-free solutions may result in significant hypokalemia.	0
The management of patients undergoing major surgery who are being treated with beta-blockers is controversial.	0
"Concomitant use of paroxetine with risperidone, a CYP2D6 substrate, has also been evaluated."	0
"There were differences in absolute risk of suicidality across the different indications, with the highest incidence in MDD."	0
These adverse outcomes are usually associated with use of these drugs in the second and third trimester of pregnancy.	0
"5-HT3 antagonist Adults and Pediatric Patients 12 Years and Older See the selected 5-HT3 antagonist prescribing information for recommended dosage none none Pediatric Patients 6 Months to less than 12 Years of Age or Pediatric and Adult Patients Unable to Swallow Capsules The recommended dose of EMEND for oral suspension to be administered with a 5-HT3 antagonist, with or without a corticosteroid, for the prevention of nausea and vomiting associated with administration of HEC or MEC is specified in Table 3."	0
Adolescents (10-17 years of age) with HeFH: starting dose is 10mg/day; maximum recommended dose is 40 mg/day.	0
"APTIVUS/ritonavir should be used with caution in patients who may be at risk of increased bleeding from trauma, surgery or other medical conditions, or who are receiving medications known to increase the risk of bleeding such as antiplatelet agents and anticoagulants, or who are taking supplemental high doses of vitamin E. In rats, tipranavir treatment alone induced dose-dependent changes in coagulation parameters, bleeding events and death."	0
INVIRASE and ritonavir should be taken within 2 hours after a meal.	0
Marked hypercalcemia may be evidence of hidden hyperparathyroidism.	0
"Antiarrhythmics Amiodarone, quinidine Potential for serious and/or life-threatening cardiac arrhythmia."	0
"Mild to moderate peripheral edema, typically associated with arterial vasodilation and not due to left ventricular dysfunction, occurs in about one in ten patients treated with PROCARDIA (nifedipine)."	0
"However, it is reassuring that in two large placebo-controlled mortality studies in patients with significant heart disease (DIAMOND CHF/MI), there were no more deaths in TIKOSYN-treated patients than in patients given placebo."	0
"Caution should be exercised when administering DYAZIDE to patients with diabetes, since thiazides may cause hyperglycemia, glycosuria, and alter insulin requirements in diabetes."	0
"Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy."	0
All reports with methylene blue that provided information on the route of administration involved intravenous administration in the dose range of 1 mg/kg to 8 mg/kg.	0
Clinical studies of ACCUPRIL did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
"Based on the patient's physical activity level, attack frequency, and sublingual nitroglycerin consumption, the dose of PROCARDIA may be increased from 10 mg t.i.d. to 20 mg t.i.d. and then to 30 mg t.i.d. over a three-day period."	0
Prescribing recommendations for interacting agents are summarized in Table1.	0
<U+2022>Diabetes: Monitor glucose as <U+03B2>-blockers may mask symptoms of hypoglycemia or worsen hyperglycemia.	0
"Patients whose renal function may depend in part on the activity of the RAAS ( e.g. , patients with renal artery stenosis , severe heart failure , post-myocardial infarction or volume depletion ) or patients receiving ARB , ACEI or nonsteroidal anti-inflammatory drug ( NSAID ) , including selective Cyclooxygenase-2 inhibitors ( COX-2 inhibitors ) , therapy may be at particular risk for developing acute renal failure on Tekturna see Warnings and Precautions ( 5.2 Drug Interactions ( 7 ) , and Use in Specific Populations ( 8.7 ) and Clinical Studies ( 14.3 ) ."	0
"Distribution and Protein Binding Abiraterone is highly bound (>99%) to the human plasma proteins, albumin and alpha-1 acid glycoprotein."	0
"In the blood, approximately 75% of the drug is bound to plasma proteins."	0
Refer to the quetiapine prescribing information for recommendations on adverse reaction monitoring.	0
"Coadministration of CRIXIVAN with these medications is expected to substantially increase plasma concentrations of sildenafil, tadalafil, and vardenafil and may result in an increase in adverse events, including hypotension, visual changes, and priapism, which have been associated with sildenafil, tadalafil, and vardenafil."	1
Regimens of therapy with ACCURETIC need not take account of renal function as long as the patient's creatinine clearance is >30 mL/min/1.73 m2 (serum creatinine roughly <U+2264>3 mg/dL or 265 <U+00B5>mol/L).	0
"Rapid intravenous injection increases the incidence of adverse reactions; severe respiratory depression, apnea, hypotension, peripheral circulatory collapse and cardiac arrest have occurred."	0
Hypertension was defined as mean systolic blood pressure (SBP) <U+2265>140 mmHg and change from baseline in mean SBP <U+2265>10 mmHg or mean diastolic blood pressure (DBP) <U+2265>90 mmHg and change from baseline in mean DBP <U+2265>5 mmHg for the 12-hour period post AM study drug measurement at that visit.	0
"A significant beta-blocking effect of TENORMIN, as measured by reduction of exercise tachycardia, is apparent within one hour following oral administration of a single dose."	0
"The maximally tolerated dosages (270mg/kg/day in rats, 200mg/kg/day in mice) provided systemic exposures for losartan and its pharmacologically active metabolite that were approximately 160- and 90-times (rats) and 30- and 15-times (mice) the exposure of a 50kg human given 100mg per day."	0
"Alternatively, ELIQUIS tablets may be crushed and suspended in 60 mL of water or D5W and promptly delivered through a nasogastric tube."	0
"There have been rare reports of rhabdomyolysis involving patients receiving the combination of nefazodone and either simvastatin or lovastatin, also a substrate of CYP3A4."	0
In treatment-experienced adult patients: Coadministration of REYATAZ with efavirenz in treatment-experienced patients is not recommended due to decreased atazanavir exposure.	1
One fatal case of possible fentanyl fluconazole interaction was reported.	0
Cyclic GMP serves as a second messenger to dilate veins and arteries.	0
Avoid use ofaliskiren with Benicar in patients with renal impairment (GFR <60 ml/min).	0
"PROZACWeekly capsules, a delayed-release formulation, contain enteric-coated pellets that resist dissolution until reaching a segment of the gastrointestinal tract where the pHexceeds5.5."	0
"Prophylaxis of gout flares: Co-administration of colchicine in patients on CRIXIVAN:If the original colchicine regimen was 0.6 mg twice a day, the regimen should be adjusted to 0.3 mg once a day.If the original colchicine regimen was 0.6 mg once a day, the regimen should be adjusted to 0.3 mg once every other day."	0
An in vivo study showed a clinically meaningful increase in levomilnacipran exposure when FETZIMA was co-administered with the CYP3A4 inhibitor ketoconazole.	1
Avoid digoxin in patients with myocarditis.	0
"Nisoldipine pharmacokinetics are independent of the dose across the clinical dosage range of 17 to 51 mg, with plasma concentrations proportional to dose."	0
Coadministration of tadalafil ( 40 mg once daily ) for 10 days did not significantly alter digoxin pharmacokinetics in healthy subjects see Clinical Pharmacology ( 12.3 ) .	0
"Pooled analyses of short-term placebo-controlled trials of drugs used to treat depression (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18-24) with major depressive disorder (MDD) and other psychiatric disorders."	0
Patients are individually titrated to a dose that allows transition from Flolan therapy to Remodulin while balancing prostacyclin-limiting adverse events .	0
"Mycobacterial growth in the presence of drug, of at least 1% of the growth in the control culture, indicates resistance."	0
Lithium toxicity has been reported in patients receiving lithium concomitantly with diuretics and ACE inhibitors.	0
"Drugs That Inhibit CYP3A4 CYP3A4 is a minor metabolic pathway for the elimination of zaleplon because the sum of desethylzaleplon (formed via CYP3A4 in vitro) and its metabolites, 5-oxo-desethylzaleplon and 5-oxo-desethylzaleplon glucuronide, account for only 9% of the urinary recovery of a zaleplon dose."	0
Increased risk of suicidal ideation in children or adolescents (5.1) No suicides occurred in clinical trials (5.1) Patients started on therapy should be monitored closely (5.1)	0
4.ORAP is contraindicated in patients with severe toxic central nervous system depression or comatose states from any cause.	0
"This recommendation is based on several studies in which the mean Cmax, T1/2, and AUC were significantly increased when compared to results in young adults."	0
Propranolol and thioridazine should not be coadministered.	0
Stop Adcirca at least 24 hours prior to starting APTIVUS/ritonavir.	0
"Due to the dual interaction mechanism of rifampin, simultaneous co-administration of LIPITOR with rifampin is recommended, as delayed administration of LIPITOR after administration of rifampin has been associated with a significant reduction in atorvastatin plasma concentrations."	1
The selectivity of selegiline for MAO B may not be absolute even at the recommended daily dose of 10 mg a day.	0
"At 20 mg, there appeared to be both objective (polysomnographic) and subjective (diary) evidence of rebound insomnia on the first night after discontinuation of treatment with Zaleplon."	0
"CrCl <30 mL/min with concomitant use of P-gp inhibitors: Avoid co-administration Treatment of DVT and PE Reduction in the Risk of Recurrence of DVT and PE CrCl >30 mL/min: 150 mg twice daily CrCl <U+2264>30 mL/min or on dialysis: Dosing recommendations cannot be provided CrCl <50 mL/min with concomitant use of P-gp inhibitors: Avoid co-administration Prophylaxis of DVT and PE Following Hip Replacement Surgery CrCl >30 mL/min: 110 mg for first day, then 220 mg once daily CrCl <U+2264>30 mL/min or on dialysis: Dosing recommendations cannot be provided CrCl <50 mL/min with concomitant use of P-gp inhibitors: Avoid co-administration Reduction of Risk of Stroke and Systemic Embolism in Non-valvular Atrial Fibrillation For patients with creatinine clearance (CrCl) >30 mL/min, the recommended dose of PRADAXA is 150 mg taken orally, twice daily."	0
It may be necessary to adjust the dosages of these drugs if they are given concurrently with rifampin.	0
Selegiline is extensively metabolized by several CYP450-dependent enzyme systems.	0
Pediatric Use: Safety and effectiveness for use as an anorectic agent in children below the age of 12 years have not been established.	0
"The recommended starting dose of Focalin XR for patients who are not currently taking dexmethylphenidate or racemic methylphenidate, or for patients who are on stimulants other than methylphenidate, is 5 mg/day for pediatric patients and 10 mg/day for adult patients."	0
Another study using a crossover design in 10 subjects investigated tyramine pressor doses after administration of EMSAM 6mg per 24 hours or tranylcypromine 30mg per day for 10 days.	0
"When pregnancy is detected, discontinue PRINIVIL as soon as possible."	0
"For patients receiving ELIQUIS at a dose of 2.5 mg twice daily, avoid coadministration with combined P-gp and strong CYP3A4 inhibitors."	0
The maximum dose studied was 120 mg per day.	0
"Postmarketing cases of symptomatic bradycardia , some requiring pacemaker insertion and at least one fatal , have been reported when ledipasvir/sofosbuvir or sofosbuvir with simeprevir were initiated in patients on amiodarone ."	0
"<U+2022>Coadministration of thioridazine, tizanidine, pimozide, alosetron, or ramelteon (4)."	0
"Methotrexate Clinical Impact: Concomitant use of PPIs with methotrexate (primarily at high dose) may elevate and prolong serum concentrations of methotrexate and/or its metabolite hydroxymethotrexate, possibly leading to methotrexate toxicities."	1
"In actual salt depletion, appropriate replacement is the therapy of choice."	0
"Therefore, as patient age increases, a lower dose of warfarin is usually required to produce a therapeutic level of anticoagulation."	0
Renal impairment The pharmacokinetics of irbesartan is not altered in patients with renal impairment or in patients on hemodialysis.	0
"Redistribution/accumulation of body fat including central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, and <U+201C>cushingoid appearance<U+201D> have been observed in patients receiving antiretroviral therapy."	0
Ritonavir should be taken at the same time as INVIRASE.	0
"Thus, this study suggests that drugs which inhibit CYP2D6, such as certain SSRIs, including fluoxetine, will produce elevated plasma levels of thioridazine."	1
"Gastric Malignancy: In adults, symptomatic response to therapy with rabeprazole does not preclude the presence of gastric malignancy."	0
"<U+2022>Prior to mixing, tap the packet to settle the powder."	0
Stop Adcirca at least 24 hours prior to starting INVIRASE/ritonavir.	0
"This effect may lead to more rapid absorption and an increase in the systemic exposure of diltiazem, and associated dose-related adverse reactions."	0
Serum potassium should be monitored frequently.	0
"If a decision is made to increase the dose beyond 60mg once daily, increase dose in increments of 30mg once daily."	0
A fifth study of similar design utilized a higher dose (up to 50 mg) per day and also showed effectiveness.	0
"Due to the need for co-administration of APTIVUS with ritonavir, please refer to the ritonavir prescribing information."	0
"Based on in vivo abundance of excretory metabolites, less than one-third of ziprasidone metabolic clearance is mediated by cytochrome P450 catalyzed oxidation and approximately two-thirds via reduction."	0
The increase in urinary pH also decreases calcium ion activity by increasing calcium complexation to dissociated anions.	0
Trandolapril does not alter the effect of verapamil on intra-cardiac conduction.	0
The author judged that the patient died from fentanyl intoxication.	0
Similar ranges of fluoxetine and norfluoxetine plasma concentrations were observed in another study in 94pediatric patients (ages8 to<18) diagnosed with Major Depressive Disorder.	0
"Given twice daily, dabigatran<U+2019>s accumulation factor is approximately two."	0
Significant levels of losartan and its active metabolite were shown to be present in rat fetal plasma during late gestation and in rat milk.	0
There was insufficient information to determine the effect of race or age on outcome in these studies.	0
"The mean terminal half-life is approximately 66 hours, and steady-state plasma concentrations are typically achieved within two weeks of dosing."	0
"Given twice daily, dabigatran<U+2019>s accumulation factor is approximately two."	0
Temporary discontinuation of TRISENOX may be required.	0
"Therefore, do not administer NATRECOR<U+00AE> through a central heparin-coated catheter."	0
A single-dose interaction study with zolpidem tartrate 10 mg and fluoxetine 20 mg at steady-state levels in male volunteers did not demonstrate any clinically significant pharmacokinetic or pharmacodynamic interactions.	0
Amlodipine is a peripheral arterial vasodilator that acts directly on vascular smooth muscle to cause a reduction in peripheral vascular resistance and reduction in blood pressure.	0
"For MAXALT-MLT Orally Disintegrating Tablets, administration with liquid is not necessary."	0
"Limit the daily dose of lovastatin to 40 mg. Lower starting and maintenance doses of other CYP3A4 substrates (e.g., atorvastatin) may be required as verapamil may increase the plasma concentration of these drugs."	1
"Kaplan-Meier estimates of the primary endpoint of time to cardiovascular death, nonfatal stroke, or nonfatal myocardial infarction in the groups treated with losartan potassium tablets and atenolol."	0
Fertility of male or female rats (evaluated at dose levels as high as 200 mg/kg/day or 100 times the maximum recommended human dose) was unaffected by atenolol administration.	0
Dose escalation above 100 mg per day is not recommended.	0
Ritonavir may increase plasma levels of carbamazepine.	1
"Conversely, adverse effects could result from displacement of paroxetine by other highly bound drugs."	0
For information regarding clinical recommendations.	0
Clinically significant bradycardia has been reported in breast-fed infants.	0
Use in pediatric population is not recommended.	0
The mean age was 67 with 5704 (62%) age <U+2265>65.	0
High doses of ketoconazole or itraconazole (greater than 200 mg per day) are not recommended.	0
"Although dose appears to be a predictor of seizure, there is a confounding of dose and duration of exposure, making it difficult to assess independently the effect of either factor alone."	0
The optimum duration of maintenance IMURAN has not been determined.	0
Potentiation occurs with ganglionic or peripheral adrenergic blocking drugs.	0
Concomitant use of VYVANSE with MAOI drugs is contraindicated.	0
"Examples: other SSRIs, SNRIs, triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, St. John's Wort Drugs that Interfere with Hemostasis (antiplatelet agents and anticoagulants) Clinical Impact: The concurrent use of an antiplatelet agent or anticoagulant with ZOLOFT may potentiate the risk of bleeding."	0
"The pooled analyses of placebo-controlled trials in children and adolescents with MDD, obsessive compulsive disorder (OCD), or other psychiatric disorders included a total of 24 short-term trials of 9 antidepressant drugs in over 4400 patients."	0
"More severe hypercalcemia (Ca >12 mg/dL) is associated with confusion, delirium, stupor and coma."	0
"Prescriptions for nefazodone hydrochloride tablets should be written for the smallest quantity of tablets consistent with good patient management, in order to reduce the risk of overdose."	0
Hypotensive side effects have occurred in hypertensive as well as normotensive and hypotensive patients.	0
Concomitant use of drugs affecting hemostasis increases the risk of bleeding.	0
"If the serum potassium exceeds 6.5 mEq/liter, more vigorous therapy is required."	0
The effect of paroxetine on the pharmacokinetics of atomoxetine has been evaluated when both drugs were at steady state.	0
"Accordingly, patients should be advised to avoid diazepam and other similar drugs while taking REMERON."	0
"Pharmacokinetic studies document no clinically relevant interactions with other agents given concomitantly, including thiazide diuretics and cimetidine."	0
"While the principal mechanism of perindopril in blood pressure reduction is believed to be through the renin-angiotensin-aldosterone system, ACE inhibitors have some effect even in apparent low-renin hypertension."	0
"Maalox TC<U+00AE> 30 mL QD, 17 days 10 mg QD for 15 days <U+2193> 33% <U+2193> 34% Efavirenz 600 mg QD, 14 days 10 mg for 3 days <U+2193> 41% <U+2193> 1% Rifampin 600 mg QD, 7 days (co-administered) Due to the dual interaction mechanism of rifampin, simultaneous co-administration of atorvastatin with rifampin is recommended, as delayed administration of atorvastatin after administration of rifampin has been associated with a significant reduction in atorvastatin plasma concentrations."	1
The concomitant administration of amiodarone or other CYP2C9 inhibitors such as fluconazole with COREG may enhance the <U+03B2>-blocking activity resulting in further slowing of the heart rate or cardiac conduction.	0
"Due to the <U+03B1>1-receptor blocking activity of carvedilol, blood pressure is lowered more in the standing than in the supine position, and symptoms of postural hypotension (1.8%), including rare instances of syncope, can occur."	0
"Instruct patients to report to their physician any new numbness, pain, skin color change, or sensitivity to temperature in fingers or toes."	0
"Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders."	0
"The extrapyramidal symptoms which can occur secondary to chlorpromazine may be confused with the central nervous system signs of an undiagnosed primary disease responsible for the vomiting, e.g., Reye<U+2019>s syndrome or other encephalopathy."	0
Such an increased risk may result also from the additive effect of coadministering thioridazine with other agents that prolong the QTc interval.	0
"Based on individual patient response, the dose may be increased to 100 mg/day (50 mg twice daily)."	0
Do NOT administer unless solution is clear and container is undamaged.	0
"Nelfinavir <U+2191> indinavir concentration The appropriate doses for this combination, with respect to efficacy and safety, have not been established."	0
"In vitro studies of human hepatic microsomes showed that treprostinil does not inhibit cytochrome P450 (CYP) isoenzymes CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1 and CYP3A."	0
"The potential benefit of this drug, if used during pregnancy, lactation, or in women of childbearing age, should be weighed against the possible hazard to the mother or fetus."	0
There are reports of deaths attributed to hepatic necrosis associated with the administration of mercaptopurine.	0
"Although both doses were effective, the effect was greater and more consistent for the 20-mg dose."	0
Vasodilation effects may be more common in patients with hypotension or on antihypertensive therapy.	0
"Risk factors for bleeding include the use of other drugs that increase the risk of bleeding (e.g., anticoagulants, antiplatelet agents, heparin, anagrelide, fibrinolytic therapy, and chronic use of NSAIDs)."	0
"In patients who do require chronic treatment, the smallest dose and the shortest duration of treatment producing a satisfactory clinical response should be sought."	0
This is more likely to occur in patients with pre-existing renal impairment.	0
"TIKOSYN has been used safely in conjunction with pacemakers (53 patients in DIAMOND studies, 136 in trials in patients with ventricular and supraventricular arrhythmias)."	0
"Following administration of a crushed 5 mg ELIQUIS tablet that was suspended in 60 mL D5W and delivered through a nasogastric tube (NGT), exposure was similar to that seen in other clinical trials involving healthy volunteers receiving a single oral 5 mg tablet dose."	0
"Redistribution/accumulation of body fat including central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, and ""cushingoid appearance"" have been observed in patients receiving antiretroviral therapy."	0
PRINIVIL should be promptly discontinued and appropriate therapy and monitoring should be provided until complete and sustained resolution of signs and symptoms of angioedema has occurred.	0
"Additional risk factors for bleeding include: body weight <60kg; propensity to bleed; concomitant use of medications that increase the risk of bleeding (e.g., warfarin, heparin, fibrinolytic therapy, chronic use of non-steroidal anti-inflammatory drugs [NSAIDs])."	0
Torsades de pointes has been reported rarely post-marketing.	0
"When a single oral 30-mg dose of paroxetine was administered at phenytoin steady state (300mg once daily for 14days), paroxetine AUC and T<U+00BD> were reduced (by an average of 50% and 35%, respectively) compared to paroxetine administered alone."	1
"When central nervous system active agents are used, consideration must always be given to the possibility of adverse interactions with alcohol."	0
Smoking - Pharmacokinetics of prasugrel's active metabolite are similar in smokers and nonsmokers.	0
Zolpidem tartrate was evaluated in healthy volunteers in single-dose interaction studies for several CNS drugs.	0
"The drugs for which this potential interaction is of greatest concern are those metabolized primarily by 2D6 and which have a narrow therapeutic index, e.g., the tricyclic antidepressant drugs effective in the treatment of major depressive disorder and the Type 1C antiarrhythmics propafenone and flecainide."	0
Initiate intravenous infusions of FLOLAN at 2ng/kg/min.	0
Elderly No dosage adjustment is recommended based on age alone.	0
Ziprasidone's antagonism of histamine H 1 receptors may explain the somnolence observed with this drug.	0
Careful observation for digital changes is necessary during treatment with ADHD stimulants.	0
Maintenance therapy may be given on a once-daily schedule for patient convenience and compliance.	0
It is not known whether these effects on fertility are reversible.	0
"Amlodipine has no clinically relevant effects on the pharmacokinetics or pharmacodynamics of the following: atorvastatin, digoxin, warfarin."	0
"Reports usually indicate that LASIX ototoxicity is associated with rapid injection , severe renal impairment , the use of higher than recommended doses , hypoproteinemia or concomitant therapy with aminoglycoside antibiotics , ethacrynic acid , or other ototoxic drugs ."	0
All of these might affect the enteric coating.	0
A central venous catheter is not required.	0
"Dronedarone is metabolized by CYP 3A and is a moderate inhibitor of CYP 3A and CYP 2D6 and has potentially important pharmacodynamic interactions (7) Class I or III Antiarrhythmics: contraindicated (4, 7.1) Digoxin: Consider discontinuation or halve dose of digoxin before treatment and monitor digoxin levels (7.1, 7.3) Calcium channel blockers (CCB): Initiate CCB with low dose and increase after ECG verification of tolerability (7.1,7.2, 7.3) Beta-blockers: May provoke excessive bradycardia."	0
Prothrombin times should be closely monitored in patients already receiving coumarin anticoagulants who are started on bicalutamide and adjustment of the anticoagulant dose may be necessary.	0
Resume treatment at a 50% reduced dose of the withheld drug(s) when TB is less than 1.5 times the ULN and AP/AST are less than 3 times the ULN.	0
Initial therapy with TWYNSTA is not recommended in patients <U+2265>75 years old or with hepatic impairment.	0
"When discontinuing chronically administered TOPROL-XL, particularly in patients with ischemic heart disease, the dosage should be gradually reduced over a period of 1 - 2 weeks and the patient should be carefully monitored."	0
Decreases in left ventricular end-diastolic pressure were also observed.	0
Safety and effectiveness of rifabutin for prophylaxis of MAC in children have not been established.	0
Carbohydrate in the form of dextrose may aid in minimizing liver glycogen depletion and exerts a protein-sparing action.	0
"Digoxin has a narrow therapeutic index, increased monitoring of serum digoxin concentrations and for potential signs and symptoms of clinical toxicity is necessary when initiating, adjusting, or discontinuing drugs that may interact with digoxin."	0
There is no evidence that doses higher than 60mg confer additional significant benefit and the higher dose is clearly less well tolerated.	0
The pharmacokinetics of trimipramine were not substantially altered in the elderly.	0
No pharmacokinetic drug-drug interaction studies were conducted with Persantine<U+00AE> (dipyridamole USP) tablets.	0
Avoid grapefruit products since they may also increase serum concentrations of nilotinib.	0
"Changes in pharmacokinetics of tizanidine when administered with ciprofloxacin resulted in significantly decreased blood pressure, increased drowsiness, and increased psychomotor impairment sSee Contraindications (4) and Clinical Pharmacology (12.3) ] Because of potential drug interactions, concomitant use of Zanaflex with other CYP1A2 inhibitors, such as zileuton, fluoroquinolones other than strong CYP1A2 inhibitors (which are contraindicated), antiarrythmics (amiodarone, mexiletine, propafenone, and verapamil), cimetidine, famotidine, oral contraceptives, acyclovir, and ticlopidine) should be avoided."	0
Families and caregivers should be advised of the need for close observation and communication with the prescriber.	0
"Therefore , the expected clinical effects of SAMSCA in the presence of rifampin and other inducers ( e.g. , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine and St.   John 's   Wort ) may not be observed at the usual dose levels of SAMSCA ."	0
DUTOPROL may be administered with other antihypertensive agents.	0
"Intervention Vinblastine, vincristine, or ifosfamide or other chemotherapeutic agents Monitor for chemotherapeutic-related adverse reactions."	0
"In 353 of these 908 patients, the eye examinations were carried out over periods of 24 months or longer."	0
"Fluvoxamine (strong CYP1A2 inhibitor): AUC0-inf for ramelteon increased approximately 190-fold, and the Cmax increased approximately 70-fold upon coadministration of fluvoxamine and ROZEREM, compared to ROZEREM administered alone."	1
Consider the possibility of angiotensin converting enzyme inhibitor induced-cough in the differential diagnosis of cough.	0
"Due to the potential for coadministration of carbamazepine to result in insufficient plasma nefazodone and hydroxynefazodone concentrations for achieving an antidepressant effect for nefazodone, it is recommended that nefazodone not be used in combination with carbamazepine."	1
"SULAR is an extended release dosage form and tablets should be swallowed whole, not bitten, divided or crushed."	0
Mean weight-normalized clearance and volume of distribution values in these pediatric surgical patients were similar to those previously reported for young adults.	0
"For patients for whom tolerability is a concern, a lower starting dose may be considered."	0
Selegiline should not be used at daily doses exceeding those recommended (10 mg/day) because of the risks associated with non-selective inhibition of MAO.	0
"When the treatment is withdrawn, urinary citrate begins to decline toward the pre-treatment level on the first day."	0
"In three randomized controlled clinical trials involving 854 patients who had undergone surgical placement of a prosthetic heart valve, PERSANTINE tablets, in combination with warfarin, decreased the incidence of postoperative thromboembolic events by 62 to 91% compared to warfarin treatment alone."	0
"In addition to the active carboxylic acid metabolite, several inactive metabolites are formed."	0
"While there are no adequate and well-controlled studies with procarbazine hydrochloride in pregnant women, there are case reports of malformations in the offspring of women who were exposed to procarbazine hydrochloride in combination with other antineoplastic agents during pregnancy."	0
"For patients receiving a thienopyridine within 3days prior to CABG, the frequencies of TIMI Major or Minor bleeding were 26.7% (12 of 45patients) in the Effient group, compared with 5.0% (3 of 60patients) in the clopidogrel group."	0
Patients with hyperkalemia (or who have conditions predisposing them to hyperkalemia).	0
The effect of paroxetine on phenobarbital pharmacokinetics was not studied.	0
"All patients taking chlorthalidone should be observed for clinical signs of electrolyte imbalance, including dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia, palpitations and gastrointestinal disturbances, such as nausea and vomiting."	0
"Potent Inducers of CYP3A For patients chronically taking potent inducers of CYP3A, such as rifampin, avoid use of ADCIRCA [see Warnings and Precautions (5.2) and Clinical Pharmacology (12.3)]."	0
"Mean peak plasma concentrations were 42.9 [95% CI 33.8, 54.4] ng/mL at 10 minutes after intravenous infusion and 31.9 [95% CI 26.3, 38.6] ng/mL at 41 minutes after intramuscular injection."	0
"With concomitant use, changes in exposure were observed both for telaprevir and certain protease inhibitors used for the treatment of HIV-1 infection or telaprevir."	0
Postural hypotension and tachycardia have been reported in combination therapy with intravenously administered digoxin (1 mg).	0
"The usefulness and safety of dosages exceeding 480 mg/day have not been established; therefore, this daily dosage should not be exceeded."	0
Colesevelam hydrochloride Concurrent administration of bile acid sequestering agent colesevelam hydrochloride reduces the systemic exposure and peak plasma concentration of olmesartan.	1
"Because PROCARDIA decreases peripheral vascular resistance, careful monitoring of blood pressure during the initial administration and titration of PROCARDIA is suggested."	0
Hypomagnesemia: Reported rarely with prolonged treatment with PPIs (5.8).	0
"Carcinogenesis, Mutagenesis, Impairment of Fertility No information is available."	0
MINIPRESS should be used during pregnancy only if the potential benefit justifies the potential risk to the mother and fetus.	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
THIOLA<U+00AE> dosage should be readjusted depending on the urinary cystine value.	0
A dose of 800 mg at bedtime is the preferred regimen for most patients based upon convenience and reduced potential for drug interactions.	0
"In an intravenous perinatal study in rats at 5, 20, and 40 mg/kg, dystocia and prolongation of parturition were observed in a few dams at 20 mg/kg (approximately 5<U+2013>15<U+00D7> the recommended human dose) and 40 mg/kg, but not at 5 mg/kg."	0
Weekly Dosing <U+2014> Administration of PROZACWeekly once weekly results in increased fluctuation between peak and trough concentrations of fluoxetine and norfluoxetine compared with once-daily dosing [for fluoxetine:24%(daily) to 164%(weekly) and for norfluoxetine:17%(daily) to 43%(weekly)].	0
"In patients who discontinue Tasigna therapy, assess BCR-ABL transcript levels monthly for one year, then every 6 weeks for the second year, and every 12 weeks thereafter during treatment discontinuation."	0
LEXIVA may be less effective due to decreased amprenavir plasma concentrations in patients taking these agents concomitantly.	0
Thioridazine See CONTRAINDICATIONS and WARNINGS.	0
Indication Dose Hypertension (2.2) 150 to 300 mg once daily Diabetic Nephropathy (2.3) 300 mg once daily AVAPRO may be administered with other antihypertensive agents and with or without food.	0
"An in vivo study suggests that drugs which inhibit CYP2D6, such as paroxetine, will elevate plasma levels of thioridazine."	1
"Adults: In man, absorption of metoprolol is rapid and complete."	0
"Discontinuation of Effient: Premature discontinuation increases risk of stent thrombosis, MI, and death (5.3)."	0
"Limit the daily dose of lovastatin to 40 mg. Lower starting and maintenance doses of other CYP3A4 substrates (e.g., atorvastatin) may be required as amiodarone may increase the plasma concentration of these drugs."	1
"Based on mean AUC data, approximately 40% to 50% higher plasma concentrations of carvedilol were observed in subjects with hypertension and moderate to severe renal impairment compared with a control group of subjects with hypertension and normal renal function."	0
"Use of EMEND with strong or moderate CYP3A4 inhibitors (e.g., ketoconazole, diltiazem) may increase plasma concentrations of aprepitant and result in an increased risk of adverse reactions related to EMEND."	0
"After administration of a radio labeled dose of zaleplon, 70% of the administered dose is recovered in urine within 48 hours (71% recovered within 6 days), almost all as zaleplon metabolites and their glucuronides."	0
"COREG has little effect on plasma catecholamines, plasma aldosterone, or electrolyte levels, but it does significantly reduce plasma renin activity when given for at least 4weeks."	0
"In vitro data in human plasma indicate that CARDURA has no effect on protein binding of digoxin, warfarin, phenytoin, or indomethacin."	0
"Concomitant use of glycosides, clonidine, and diltiazem and verapamil with beta-blockers can increase the risk of bradycardia."	0
Note : This equation cannot be used for estimating creatinine clearance in infants or pediatric patients.	0
Initiation of quetiapine in patients taking INVIRASE with ritonavir: Refer to the quetiapine prescribing information for initial dosing and titration of quetiapine.	0
"If use of the combination drug product is deemed essential, the patient should stop nursing."	0
"Sirolimus, Tacrolimus, and Other CYP3A Substrates with Narrow Therapeutic Range Dronedarone can increase plasma concentrations of tacrolimus, sirolimus, and other CYP 3A substrates with a narrow therapeutic range when given orally."	1
Inhibitors of renal cationic secretion are contraindicated with TIKOSYN.	0
Interactions with Investigations of Neuroendocrine Tumors Clinical Impact : Serum chromogranin A (CgA) levels increase secondary to PPI-induced decreases in gastric acidity.	0
<U+2022> Gemfibrozil: Combination should be avoided.	0
"While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, paroxetine, and fluvoxamine, inhibit P450 2D6, they may vary in the extent of inhibition."	0
"TIKOSYN (dofetilide) increases the monophasic action potential duration in a predictable, concentration-dependent manner, primarily due to delayed repolarization."	0
"During clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal anti-inflammatory drugs , corticosteroids , and other medications ."	0
Table 18 Summary of Effect of Coadministered Drugs on Exposure to Active Moiety (Risperidone + 9-Hydroxy-Risperidone) in Healthy Subjects or Patients with Schizophrenia CoadministeredDrug DosingSchedule EffectonActiveMoiety(Risperidone+9-Hydroxy-Risperidone(Ratio*) RisperidoneDoseRecommendation CoadministeredDrug Risperidone AUC Cmax Enzyme(CYP2D6)Inhibitors Fluoxetine 20mg/day 2or3mgtwicedaily 1.4 1.5 Re-evaluatedosing.	0
Thyroid Supplement Thyroid Treatment of hypothyroidism in patients taking digoxin may increase the dose requirements of digoxin.	1
"No dose adjustment is necessary in patients with this degree of abnormal liver function, but continued monitoring of liver function tests for further elevations is recommended."	0
"On initiation of carbamazepine, the dose of INVEGA<U+00AE> should be re-evaluated and increased if necessary."	1
"Patients with tight aortic stenosis may be at greater risk for such an event, as the unloading effect of PROCARDIA would be expected to be of less benefit to these patients, owing to their fixed impedance to flow across the aortic valve."	0
"Metabolism Ramipril is almost completely metabolized to ramiprilat, which has about 6 times the ACE inhibitory activity of ramipril, and to the diketopiperazine ester, the diketopiperazine acid, and the glucuronides of ramipril and ramiprilat, all of which are inactive."	0
"Patients should be cautioned about the risk of serotonin syndrome with the concomitant use of paroxetine and triptans, tramadol, or other serotonergic agents."	0
"Hypoxia, Hypercapnia, Acidosis: These conditions, which may also reduce the effectiveness and/or increase the incidence of adverse effects of dopamine, must be identified and corrected prior to, or concurrently with, administration of dopamine HCl."	0
Do not add supplementary medication to the bag.	0
"In these situations, consider an alternative nonserotonergic drug or an alternative drug that does not inhibit CYP2D6."	0
"When discontinuing chronically administered TOPROL-XL, particularly in patients with ischemic heart disease, gradually reduce the dosage over a period of 1 - 2 weeks and monitor the patient."	0
"Appropriate diluents are saline, 5% dextrose in water (D5W), or Ringer's lactate."	0
"The necessary interdose interval for dilatrate<U+00AE>-SR has not been clearly identified, but it must be greater than 18 hours."	0
"In the case of intolerable dyspnea requiring discontinuation of BRILINTA , consider prescribing another antiplatelet agent ."	0
See the complete prescribing information for ritonavir for information on drug interactions with ritonavir.	0
"Via this mechanism, platelet aggregation is inhibited in response to various stimuli such as platelet activating factor (PAF), collagen and adenosine diphosphate (ADP)."	0
Caution should be used when prescribing with LIPITOR (7).	0
"If Tasigna must be administered to patients with hepatic impairment, consider the following dose reduction: Table 4: Dose Adjustments for Hepatic Impairment (At Baseline) Newly diagnosed Ph+ CML in chronic phase at 300 mg twicedaily Mild, Moderate, or Severe* An initial dosing regimen of 200 mg twicedaily followed by dose escalation to 300 mg twicedaily based on tolerability Resistant or intolerant Ph+ CML in chronic phase or accelerated phase at 400 mg twicedaily Mild or Moderate* An initial dosing regimen of 300 mg twicedaily followed by dose escalation to 400 mg twicedaily based on tolerability Severe* A starting dose of 200 mg twicedaily followed by a sequential dose escalation to 300 mg twicedaily and then to 400 mg twicedaily based on tolerability *Mild=mild hepatic impairment (Child-Pugh Class A); Moderate=moderate hepatic impairment (Child-Pugh Class B); Severe=severe hepatic impairment (Child-Pugh Class C) [see Warnings and Precautions (5."	0
Do not co-administer aliskiren with ACCUPRIL in patients with diabetes.	0
"Fetal testing may be appropriate, based on the week of pregnancy."	0
The overall prevalence of sulfite sensitivity in the general population is unknown and probably low.	0
"In normal Purkinje fibers, it reduces the slope of phase<U+2013>4 depolarization, shifting the threshold voltage upward toward zero."	0
Paliperidone is a centrally active dopamine Type 2 (D2) antagonist and with predominant serotonin Type 2 (5HT2A) activity.	0
"No trials specifically examining potential drug interactions with NATRECOR<U+00AE> were conducted, although many concomitant drugs (including IV nitroglycerin) were used in clinical trials."	0
All patients undergoing treatment with NARDIL should be closely followed for symptoms of postural hypotension.	0
"Thienopyridines, including Effient, increase the risk of bleeding."	0
Oral administration of nitroglycerin markedly decreases the first-pass metabolism of dihydroergotamine and subsequently increases its oral bioavailability .	1
"In the plasma, olanzapine accounted for only 12% of the AUC for total radioactivity, indicating significant exposure to metabolites."	0
The preferred route of administration for PROSTIN VR PEDIATRIC Sterile Solution is continuous intravenous infusion into a large vein.	0
"Ketoconazole: Co-administration of ketoconazole (200 mg twice daily for 4 days), a potent inhibitor of CYP3A4, with a 3 mg single dose of iloperidone to 19 healthy volunteers, ages 18 to 45 years, increased the area under the curve (AUC) of iloperidone and its metabolites P88 and P95 by 57%, 55% and 35%, respectively."	1
"Patients receiving these drugs should be observed for signs of reduced thiothixene effectiveness4,5."	0
Such elevations have sometimes been transient and may disappear even with continued verapamil treatment.	0
"Suspect bleeding in any patient who is hypotensive and has recently undergone coronary angiography, PCI, CABG, or other surgical procedures even if the patient does not have overt signs of bleeding."	0
"Although this is not conclusive evidence that STRATTERA causes aggressive behavior or hostility, these behaviors were more frequently observed in clinical trials among children, adolescents, and adults treated with STRATTERA compared to placebo."	0
<U+03B2>-blockers may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics.	0
HIV integrase inhibitor: Dolutegravira LEXIVA/ritonavir: <U+2193>Dolutegravir The recommended dose of dolutegravir is 50 mg twice daily when coadministered with LEXIVA/ritonavir.	0
Oral Pharmacokinetics Ziprasidone's activity is primarily due to the parent drug.	0
"Combination of NSAIDs, e.g., indomethacin, with potassium-sparing diuretics has been associated with severe hyperkalemia."	0
"Clozapine is a substrate for many cytochrome P450 isozymes, in particular CYP1A2, CYP2D6, and CYP3A4."	0
"While nisoldipine, like other dihydropyridines, exhibits a mild diuretic effect, most of the antihypertensive activity is attributed to its effect on peripheral vascular resistance."	0
"Cessation of Therapy with TENORMIN Patients with coronary artery disease, who are being treated with TENORMIN, should be advised against abrupt discontinuation of therapy."	0
Hypersensitivity reactions may occur in patients receiving PRIFTIN.	0
"Dabigatran Verapamil, a P-gp inhibitor, increases exposure to dabigatran (a thrombin inhibitor) when administered concomitantly; however, no dose adjustment of dabigatran is required when administered with verapamil."	1
Patients requiring larger blood pressure reductions may be started on TWYNSTA 80/5 mg once daily.	0
"Propensity to bleed (e.g., recent trauma, recent surgery, recent or recurrent gastrointestinal (GI) bleeding, active peptic ulcer disease, severe hepatic impairment, or moderate to severe renal impairment)."	0
Simvastatin therapy has not been associated with bleeding or with changes in prothrombin time in patients not taking anticoagulants.	0
"As a result of FXa inhibition, apixaban prolongs clotting tests such as prothrombin time (PT), INR, and activated partial thromboplastin time (aPTT)."	0
The Pulvule and PROZACWeekly capsule dosage forms of fluoxetine are bioequivalent.	0
The cumulative frequency of nephrolithiasis is substantially higher in pediatric patients (29%) than in adult patients (12.4%; range across individual trials: 4.7% to 34.4%).	0
"The mean elimination half-life of mirtazapine after oral administration ranges from approximately 20 to 40 hours across age and gender subgroups, with females of all ages exhibiting significantly longer elimination half-lives than males (mean half-life of 37 hours for females vs. 26 hours for males)."	0
"PPIs, including ACIPHEX delayed-release tablets, are contraindicated in patients receiving rilpivirine-containing products (4,7)."	0
"Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit."	0
"The effect of amlodipine on the pharmacokinetics of atorvastatin showed no effect on the Cmax: 91% (90% confidence interval: 80 to 103%), but the AUC of atorvastatin increased by 18% (90% confidence interval: 109 to 127%) in the presence of amlodipine, which is not clinically meaningful."	0
"Vortioxetine binds to 5-HT3 (Ki=3.7 nM), 5-HT1A (Ki=15 nM), 5-HT7 (Ki=19 nM), 5-HT1D (Ki=54 nM), and 5-HT1B (Ki=33 nM), receptors and is a 5-HT3, 5-HT1D, and 5-HT7 receptor antagonist, 5-HT1B receptor partial agonist, and 5-HT1A receptor agonist."	0
"In hypertensive patients with normal renal function, therapeutic doses of amlodipine resulted in a decrease in renal vascular resistance and an increase in glomerular filtration rate and effective renal plasma flow without change in filtration fraction or proteinuria."	0
The elimination of the major metabolites of bupropion may be reduced by impaired renal function.	0
"Reduced cytochrome P450 2D6 isozyme activity drugs that inhibit this isozyme (e.g., fluoxetine and paroxetine) and certain other drugs (e.g., fluvoxamine, propranolol, and pindolol) appear to appreciably inhibit the metabolism of thioridazine."	1
The effective antihypertensive oral dose in pediatric patients ages 6<U+2013>17 years is 2.5 mg to 5 mg once daily.	0
"Therefore, patients being treated with NARDIL should not take sympathomimetic drugs (including amphetamines, cocaine, methylphenidate, dopamine, epinephrine, and norepinephrine) or related compounds (including methyldopa, L-dopa, L-tryptophan, L-tyrosine, and phenylalanine)."	0
"In some cases, the angioedema was diagnosed by procedures including abdominal CT scan or ultrasound, or at surgery, and symptoms resolved after stopping the ACE inhibitor."	0
"However, when genotypic testing is not feasible, PREZISTA 600 mg taken with ritonavir 100 mg twice daily is recommended."	0
"Three metabolites are active: hydroxybupropion, which is formed via hydroxylation of the tert-butyl group of bupropion, and the amino-alcohol isomers threohydrobupropion and erythrohydrobupropion, which are formed via reduction of the carbonyl group."	0
"Benign Prostatic Hyperplasia (BPH) The symptoms associated with benign prostatic hyperplasia (BPH), such as urinary frequency, nocturia, weak stream, hesitancy, and incomplete emptying are related to two components, anatomical (static) and functional (dynamic)."	0
"A similar excretion profile would be expected for eszopiclone, the S-isomer of racemic zopiclone."	0
"In patients who have atrial fibrillation with rapid ventricular response , a digitalis preparation should be used prior to institution of therapy with Dobutamine in D5W ."	0
Refer to the quetiapine prescribing information for recommendations on adverse reaction monitoring.	0
"If CRIXIVAN with or without ritonavir is co-administered with parenteral midazolam, it should be done in a setting which ensures close clinical monitoring and appropriate medical management in case of respiratory depression and/or prolonged sedation."	0
CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.	1
Caution should be used in prescribing DIFLUCAN to patients with hypersensitivity to other azoles.	0
"Extra vigilance is warranted in patients with chronic hepatitis B or hepatitis C co-infection, as these patients have an increased risk of hepatotoxicity."	0
"If amiloride HCl is given to these patients, frequent monitoring of acid-base balance is necessary."	0
Hydrochlorothiazide crosses the placenta freely but not the blood-brain barrier.	0
"Because Anafranil is highly bound to serum protein, the administration of Anafranil to patients taking other drugs that are highly bound to protein (e.g., warfarin, digoxin) may cause an increase in plasma concentrations of these drugs, potentially resulting in adverse effects."	1
Amiloride HCl should not be used in the presence of elevated serum potassium levels (greater than 5.5 mEq per liter).	0
"At 4-week intervals, either the dose of Letairis or tadalafil can be increased, as needed and tolerated, to Letairis 10 mg or tadalafil 40 mg. Do not split, crush, or chew tablets."	0
The risk of TdP can be reduced by adjustment of the sotalol dose according to creatinine clearance and by monitoring the ECG for excessive increases in QTc.	0
Absorption and Distribution The absolute oral bioavailability of paliperidone following INVEGA<U+00AE> administration is 28%.	0
"If pulmonary toxicity is confirmed, MULTAQ should be discontinued."	0
"Treatment-emergent NS5B substitutions L159 (n=1) and V321 (n=2) previously associated with sofosbuvir failure were detected in the Phase 3 trials (ION-3, ION-1, and ION-2)."	0
Caution should be exercised in such individuals.	0
"The increased filtered load of citrate may play some role, however, as in small comparisons of oral citrate and oral bicarbonate, citrate had a greater effect on urinary citrate."	0
Concomitant use of Tasigna with medicinal products and herbal preparations that are potent inducers of CYP3A4 is likely to reduce exposure to nilotinib to a clinically relevant extent.	1
Prasugrel is an inhibitor of platelet activation and aggregation through the irreversible binding of its active metabolite to the P2Y12 class of ADPreceptors on platelets.	0
"The plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decrease by concomitant administration with hepatic enzyme inducers (e.g., barbiturates, phenytoin), and adjustment of the dosage of imipramine may therefore be necessary."	1
"If irritation is a problem, dilute injection with saline or 2% procaine; mixing with other agents in the syringe is not recommended."	0
Ledipasvir and sofosbuvir are substrates of drug transporters P-gp and BCRP while GS-331007 is not.	0
"If the original colchicine regimen was 0.6 mg once a day, the regimen should be adjusted to 0.3 mg once every other day."	1
"In a double-blind, placebo-controlled study, 54 girls 10-17years of age who were at least 1year post-menarche with heFH were randomized to lovastatin (n=35) or placebo (n=19) for 24weeks."	0
"Atropine exerts a more potent and prolonged effect on heart, intestine and bronchial muscle than scopolamine, but its action on the iris, ciliary body and certain secretory glands is weaker than that of scopolamine."	0
"Patients in Study 1 met DSM-III-R criteria for Late Luteal Phase Dysphoric Disorder (LLPDD), the clinical entity now referred to as Premenstrual Dysphoric Disorder (PMDD) in DSM-IV."	0
Achieve stable INR prior to starting CRESTOR.	0
"These increases usually have accompanied vigorous fluid elimination, especially when diuretic therapy was used in seriously ill patients, such as those who had hepatic cirrhosis with ascites and metabolic alkalosis, or those with resistant edema."	0
It has also been demonstrated in rats that candesartan passes across the placental barrier and is distributed in the fetus.	0
"Marplan should be used cautiously in hyperactive or agitated patients, as well as in schizophrenic patients, because it may cause excessive stimulation."	0
"90 once daily 400 once daily 15 1.79 (1.56, 2.04) 1.98 (1.77, 2.23) 2.63 (2.32, 2.97) No effect on the pharmacokinetic parameters of the following coadministered drugs was observed with ledipasvir or sofosbuvir: abacavir, cyclosporine, darunavir/ritonavir, dolutegravir, efavirenz, emtricitabine, lamivudine, methadone, or rilpivirine."	0
"The risk of myopathy, including rhabdomyolysis, is increased by concomitant administration of amiodarone, dronedarone, ranolazine, or calcium channel blockers such as verapamil, diltiazem, or amlodipine."	0
"Angioedema related to previous treatment with an ACE inhibitor, or a history of hereditary or idiopathic angioedema (4.0, 5.1) Do not co-administer aliskiren with ACEON in patients with diabetes (4.0, 7.8)"	0
Such doses also slightly increase cardiac output and decrease central venous pressure.	0
Development of cataracts due to verapamil has not been reported in man.	0
"In patients with severe hepatic impairment, a total daily dose of 8 mg should not be exceeded."	0
Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy.	0
"Upon evidence of hematologic or other toxicity , the drug should be discontinued until there has been satisfactory recovery."	0
HIV-1-Antiviral Agents: HIV-Protease Inhibitors (PIs) indinavir <U+2191> darunavir<U+2191> indinavir The appropriate dose of indinavir in combination with PREZISTA/ritonavir has not been established.	0
"Concomitant use of dilatrate<U+00AE>-SR with riociguat, a soluble guanylate cyclase stimulator, is contraindicated."	0
The reporting rate of SJS associated with CYMBALTA use exceeds the general population background incidence rate for this serious skin reaction (1 to 2 cases per million person years).	0
"Drugs that slow heart rate : Concomitant use of drugs with depressant effects on the sinus and AV node ( e.g. , digoxin , beta blockers , verapamil , diltiazem , ivabradine , clonidine ) can potentiate the electrophysiologic and hemodynamic effects of amiodarone , resulting in bradycardia , sinus arrest , and AV block ."	0
"Drugs metabolized by CYP3A4 (midazolam) In vitro, desvenlafaxine does not inhibit or induce the CYP3A4 isozyme."	0
"<U+2022>History of serious hypersensitivity reaction (e.g., Stevens-Johnson syndrome, anaphylactic reaction, angioedema) to any component of this medication or other medications containing carvedilol."	0
"Tryptophan may enhance the serotonergic effects of fluvoxamine, and the combination should, therefore, be used with caution."	0
1 Preparation Withdraw the calculated volume of ONIVYDE from the vial.	0
Milk of lactating rats contains radioactivity following administration of 14C lisinopril.	0
"Reduce the CLOZARIL dose to one-third of the original dose when CLOZARIL is coadministered with strong CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin, or enoxacin)."	1
"Because of similar pharmacological properties, it is reasonable to expect similar risk with the concomitant use of other CNS depressant drugs with opioid analgesics."	0
The physician who elects to use Lexapro for extended periods should periodically re-evaluate the long-term usefulness of the drug for the individual patient.	0
"A dosage of 400 mg once daily may be used, based on medical judgment of the patient's response to therapy."	0
Consider monitoring clinical responses or blood levels of concomitant medications that have a narrow therapeutic range.	0
"However, co-administration of duloxetine (60 or 120mg) with warfarin (2-9mg), a highly protein-bound drug, did not result in significant changes in INR and in the pharmacokinetics of either total S-or total R-warfarin (protein bound plus free drug)."	0
"In patients with hypertension, ACCUPRIL 10<U+2013>40 mg was similar in effectiveness to captopril, enalapril, propranolol, and thiazide diuretics."	0
The degree of serum protein binding of nifedipine is high (92<U+2013>98%).	0
The dose-response relationship of triamterene was also evaluated in patients rendered hypokalemic by hydrochlorothiazide given 25 mg twice daily.	0
"Do not split, crush, or chew tablets (2.1)."	0
Peak blood levels are reached between two (2) and four (4) hours after ingestion.	0
The change in heart rate is greater with immediate release nisoldipine preparations.	0
Irreversible lesions occurred in the reproductive tract of male rats after dosing in toxicity studies for 2 to 52 weeks.	0
"Patients should be observed for clinical signs of fluid or electrolyte imbalance; i.e., hyponatremia, hypochloremic alkalosis, and hypokalemia."	0
No suicides occurred in these trials.	0
"Acidifying agents (e.g., ascorbic acid) decrease blood levels, while alkalinizing agents (e.g., sodium bicarbonate) increase blood levels."	1
"Hepatic Impairment <U+2014> Although the presence of hepatic impairment may be expected to reduce the clearance of olanzapine, a study of the effect of impaired liver function in subjects (n=6) with clinically significant (Childs Pugh ClassificationA andB) cirrhosis revealed little effect on the pharmacokinetics of olanzapine."	0
Study 2 was a flexible-dose study comparing paroxetine (20 mg to 50 mg daily) and placebo.	0
"There is also an AT2 receptor in many tissues, but it is not involved in cardiovascular homeostasis."	0
"In some cases, hyperbilirubinemia resulting from competition between rifampin and bilirubin for excretory pathways of the liver at the cell level can occur in the early days of treatment."	0
Concomitant nifedipine or hydrochlorothiazide had no effect on irbesartan pharmacokinetics.	0
"If hyperkalemia is suspected, (warning signs include paresthesias, muscular weakness, fatigue, flaccid paralysis of the extremities, bradycardia and shock) an electrocardiogram (ECG) should be obtained."	0
"When equal daily doses of venlafaxine were administered as either an immediate-release tablet or the extended-release capsule, the exposure to both venlafaxine and ODV was similar for the two treatments, and the fluctuation in plasma concentrations was slightly lower with the venlafaxine hydrochloride extended-release capsule."	0
No patient discontinued due to increases or decreases in serum potassium.	0
"The latter represents absorbed drug equivalents excreted in bile, as well as any unabsorbed drug."	0
"Gold: Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including VASOTEC. mTOR (mammalian target of rapamycin) inhibitors: Patients receiving coadministration of ACE inhibitor and mTOR inhibitor (e.g., temsirolimus, sirolimus, everolimus) therapy may be at increased risk for angioedema (see WARNINGS)."	0
"ACCURETIC and lithium should be coadministered with caution, and frequent monitoring of serum lithium levels is recommended."	0
There were a total of 12 trials (11 in ADHD and 1 in enuresis) involving over 2200 patients (including 1357 patients receiving STRATTERA and 851 receiving placebo).	0
Monitor electrolytes more frequently in patients who must receive concomitant use of these drugs and TRISENOX.	0
Figure 1 Clinical studies have shown that desvenlafaxine does not have a clinically relevant effect on CYP2D6 metabolism at the dose of 100 mg daily (Figure 2).	0
The extent of interaction and potentiation of effects depend on the variability of effect on CYP 3A4.	0
"Citalopram has no or very low affinity for 5-HT1A, 5-HT2A, dopamine D1 and D2, <U+03B1>1-, <U+03B1>2-, and <U+03B2>-adrenergic, histamine H1, gamma aminobutyric acid (GABA), muscarinic cholinergic, and benzodiazepine receptors."	0
"Following five consecutive nightly doses at bedtime of oral zolpidem tartrate 10 mg in the presence of sertraline 50 mg (17 consecutive daily doses, at 7:00 am, in healthy female volunteers), zolpidem Cmax was significantly higher (43%) and Tmax was significantly decreased (-53%)."	1
Concomitant administration of LIPITOR with strong inhibitors of CYP 3A4 can lead to increases in plasma concentrations of atorvastatin.	1
"When coadministered with tenofovir DF in adults, it is recommended that REYATAZ 300 mg be given with ritonavir 100 mg and tenofovir DF 300 mg (all as a single daily dose with food)."	0
"Patients should be advised to be alert for signs of liver dysfunction (jaundice, anorexia, gastrointestinal complaints, malaise, etc.) and to report them to their doctor immediately if they occur."	0
Stop ADCIRCA at least 24 hours prior to starting ritonavir.	0
Screening Patients for Bipolar Disorder: A major depressive episode may be the initial presentation of bipolar disorder.	0
Phenytoin interferes directly with renal action of LASIX .	0
"There are no quantifiable metabolites circulating in plasma, but 5 metabolites have been identified in urine."	0
"In these patients, REYATAZ must be administered with ritonavir."	0
"This study showed a trend towards an increased risk for cardiovascular malformations for paroxetine (risk of 1.5%) compared to other antidepressants (risk of 1%), for an OR of 1.5 (95% confidence interval 0.8 to 2.9)."	0
"Coadministration of isoniazid increased the maximum plasma concentration of triazolam by 20%, decreased clearance by 42%, and increased half-life by 31%."	1
This inhibition of coronary spasm is responsible for the effectiveness of amlodipine in vasospastic (Prinzmetal's or variant) angina.	0
"Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs, warfarin, and other anti-coagulants may add to this risk."	0
Unscheduled DNA synthesis in the testis of rabbits and decreased fertility in male mice treated with procarbazine hydrochloride have been reported.	0
"Specifically, it interacts with bacterial RNA polymerase but does not inhibit the mammalian enzyme."	0
"In healthy subjects who had received EMSAM 6mg per 24 hours for 10 days, single dose administration with levothyroxine (150 mcg) did not alter the pharmacokinetics of either selegiline or levothyroxine."	0
"AHA was teratogenic (retarded and/or clubbed rear leg at 750 mg/kg and above and exencephaly and encephalocele at 1,500 mg/kg) when given intraperitoneally to rats."	0
"Effient can be administered with aspirin (75-mg to 325-mg per day), heparin, GPIIb/IIIa inhibitors, statins, digoxin, and drugs that elevate gastric pH, including proton pump inhibitors and H2 blockers."	0
See Table 5 for use of HARVONI with certain HIV antiretroviral regimens.	0
Serotonergic Drugs	0
"Digoxin - In subjects who had received 21 days of 40 mg/day Celexa, combined administration of Celexa and digoxin (single dose of 1 mg) did not significantly affect the pharmacokinetics of either citalopram or digoxin."	0
The concomitant use of VIRACEPT and certain other drugs may result in known or potentially significant drug interactions.	0
"When half-lives are long, the drug or metabolites may accumulate during periods of nightly administration and be associated with impairments of cognitive and motor performance during waking hours; the possibility of interaction with other psychoactive drugs or alcohol will be enhanced."	0
These studies have revealed no evidence of teratogenic effects.	0
"If concomitant use of paroxetine with a triptan is warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases."	0
"Given these considerations, antipsychotic drugs should be prescribed in a manner that is most likely to minimize the occurrence of tardive dyskinesia."	0
Some degree of metabolism of icodextrin occurs intraperitoneally with a progressive rise in the concentration of the smaller polymers in the dialysate during the 12-hour dwell.	0
"Ketoconazole: In healthy subjects receiving ketoconazole, a CYP3A4 inhibitor, at 400 mg oncedaily for 6 days, systemic exposure (AUC) to nilotinib was increased approximately 3-fold."	1
"Always dilute to 1 mg/mL, i.e., 1 mL (25 mg) mixed with 24 mL of saline."	0
Triamterene's onset and duration of activity is similar to hydrochlorothiazide.	0
Data from a drug-drug interaction study involving 10 mg of amlodipine and 80 mg of atorvastatin in healthy subjects indicate that the pharmacokinetics of amlodipine are not altered when the drugs are co-administered.	0
"Tricyclic Antidepressants (TCAs) <U+2014> In 2studies, previously stable plasma levels of imipramine and desipramine have increased greater than 2- to 10-fold when fluoxetine has been administered in combination."	1
"Pregnancy: Female patients of childbearing age should be told about the consequences of second- and third-trimester exposure to drugs that act on the renin-angiotensin system, and they should also be told that these consequences do not appear to have resulted from intrauterine drug exposure that has been limited to the first trimester."	0
"Clinical monitoring of carbamazepine concentrations and its dose titration is recommended to achieve the desired clinical response. phenobarbital, phenytoin <U+2194> darunavir<U+2193> phenytoin<U+2193> phenobarbital Phenytoin and phenobarbital levels should be monitored when co-administering with PREZISTA/ritonavir."	0
"Withdrawal adverse reactions include rebound hypertension, tachycardia, and hypertonia."	0
"Therefore, dofetilide should only be administered to pregnant women where the benefit to the patient justifies the potential risk to the fetus."	0
"The antihypertensive effect of ACE inhibitors, including perindopril, may be attenuated by NSAIDs including selective COX-2 inhibitors."	0
Agranulocytosis did occur during quinapril treatment in one patient with a history of neutropenia during previous captopril therapy.	0
Fluconazole can increase halofantrine plasma concentration due to an inhibitory effect on CYP3A4.	1
"Exacerbations of angina pectoris and, in some instances, myocardial infarction or ventricular arrhythmia, have been observed in patients with coronary artery disease following abrupt cessation of therapy with beta-blockers."	0
Maximum concentrations (Cmax) of apixaban appear 3 to 4 hours after oral administration of ELIQUIS.	0
HMG-CoA reductase inhibitors : Atorvastatin <U+2191> Atorvastatin Titrate atorvastatin dose carefully and use the lowest dose necessary; do not exceed atorvastatin 20 mg/day.	1
Coadministration of oral midazolam with CRIXIVAN is CONTRAINDICATED.	0
Renal Impairment Pharmacokinetic studies in elderly patients and patients with renal impairment have shown no significant alterations compared to younger patients with normal renal function.	0
"Whether this represents coronary steal in these patients, or is the result of increased heart rate and decreased diastolic pressure, is not clear.)"	0
"Good clinical judgment suggests, however, that patients who are dependent on sympathetic stimulation for maintenance of adequate cardiac output and blood pressure are not good candidates for beta blockade."	0
Neither food nor the race of the patient influences the pharmacokinetics of clonidine.	0
The combination INVIRASE/ritonavir is a potent inhibitor of CYP3A and may significantly increase the exposure of drugs primarily metabolized by CYP3A.	1
"XARELTO should not be used in patients with CrCl 15 to 80 mL/min who are receiving concomitant combined P-gp and moderate CYP3A4 inhibitors ( e.g. , erythromycin ) unless the potential benefit justifies the potential risk see Warnings and Precautions ( 5.4 ) and Clinical Pharmacology ( 12.3 ) ."	0
Hormonal Contraceptives: Use another means of birth control.	0
"Cortical proliferation of the long bones, first observed in dogs, has also been observed in infants during long-term infusions of alprostadil."	0
The apparent plasma clearance is approximately 10 L/hr.	0
16 Benefit versus risk must be weighed carefully before use of IMURAN in patients of reproductive potential.	0
No increased activity of the renin-angiotensin-aldosterone axis has been observed.	0
"Surgery <U+2013> Prior to elective surgery with general anesthetics, therapy with Anafranil should be discontinued for as long as is clinically feasible, and the anesthetist should be advised."	0
"However, sinus bradycardia, defined as heart rate <U+2264> 50 bpm and a decrease of at least 15 bpm from baseline, was observed in 1.5% of nefazodone-treated patients compared to 0.4% of placebo-treated patients (p <U+2264> 0.05)."	0
Adjust the dosage to obtain an appropriate balance between management of pain and opioid-related adverse reactions.	0
"Bronchospastic Disease: PATIENTS WITH BRONCHOSPASTIC DISEASES SHOULD, IN GENERAL, NOT RECEIVE BETA-BLOCKERS."	0
Limited data available on lidocaine<U+2019>s effects on the breastfed child have not revealed a consistent pattern of associated adverse events.	0
Limit dosages and durations to the minimum required.	0
"The development of a potentially life-threatening serotonin syndrome has been reported with SNRIs and SSRIs, including Savella, alone but particularly with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John's Wort) and with drugs that impair metabolism of serotonin (in particular MAOIs, both those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue)."	0
"Proton-pump inhibitors (e.g., omeprazole) Proton-pump inhibitor doses comparable to omeprazole 20 mg or lower can be administered simultaneously with HARVONI under fasted conditions."	1
"The exposure of the hydroxybupropion metabolite was decreased by 78%, the threohydrobupropion decreased by 50%, and the erythrohydrobupropion decreased by 68%."	0
It also has several other activities including 5-HT3 receptor antagonism and 5-HT1A receptor agonism.	0
"Drugs that slow heart rate : Concomitant use of drugs with depressant effects on the sinus and AV node ( e.g. , digoxin , beta blockers , verapamil , diltiazem , ivabradine , clonidine ) can potentiate the electrophysiologic and hemodynamic effects of amiodarone , resulting in bradycardia , sinus arrest , and AV block ."	0
"There have been reports of increased bleeding, including spontaneous skin hematomas and hemarthrosis, in patients with hemophilia type A and B treated with protease inhibitors."	0
"Based on drug interaction studies in healthy patients, ULORIC does not have clinically significant interactions with colchicine, naproxen, indomethacin, hydrochlorothiazide, warfarin or desipramine."	0
"Renal Insufficiency Patients with severe renal impairment (Clcr=10 to 30 mL/min/1.73 m2, n=8) had a 25% lower mean oral clearance than normal subjects (Clcr > 80 mL/min/1.73 m2, n=8), but plasma quetiapine concentrations in the subjects with renal insufficiency were within the range of concentrations seen in normal subjects receiving the same dose."	0
Maximum dose: Most patients were treated with maximum doses of 16 mg/hour or less.There is limited short-term experience with doses up to 32 mg/hour.	0
False-positive urine immunoassay screening tests for phencyclidine (PCP) and amphetamine have been reported in patients taking desvenlafaxine.	0
"If azotemia increases, discontinue DYAZIDE."	0
"Ledipasvir had median EC50 values ranging between 0.002 nM to 0.16 nM against 11 genotype 4 subtypes (4a, 4d, 4n, 4r, 4o, 4c, 4f, 4k, 4l, 4m and 4t)."	0
Dipyridamole is highly bound to plasma proteins.	0
"Consider the use of liquid potassium in patients with dysphagia, swallowing disorders, or severe gastrointestinal motility disorders."	0
Standard penicillin powder should provide MIC values provided below.	0
The suspension and tablet are similar in their bioavailability with respect to both losartan and the active metabolite.	0
Advise females of reproductive potential of the potential risk to a fetus and to use effective contraception.	0
"Following a single 15-mg oral dose of REMERON, the oral clearance of mirtazapine was decreased by approximately 30% in hepatically impaired patients compared to subjects with normal hepatic function."	0
"OCD is a chronic condition, and it is reasonable to consider continuation for a responding patient."	0
"Bioavailability studies have demonstrated that the total absorption relative to the drug in a 20% alcoholic solution is 90%, resulting in peak levels approximately 65% of that of the drug in solution."	0
"A linear relationship, including the lowest range of renal function, is found between the serum elimination rate constant and renal function as measured by creatinine clearance."	0
"While these studies provide some reassurance that selegiline is not mutagenic or clastogenic, they are not definitive because of methodological limitations."	0
"PATIENTS WITH BRONCHOSPASTIC DISEASE SHOULD, IN GENERAL, NOT RECEIVE BETA BLOCKERS."	0
"In contrast, the metabolite P95 only shows affinity for 5-HT2A (Ki value of 3.91) and the NE<U+03B1>1A, NE<U+03B1>1B, NE<U+03B1>1D, and NE<U+03B1>2 C receptors (Ki values of 4.7, 2.7, 8.8, and 4.7 nM respectively)."	0
"However, decreases in exposure were as much as 56% and 66%, respectively, in individual subjects."	0
"Vinca Alkaloids(CYP3A4 Inhibition) Not Studied In Vivo or In Vitro, but Drug Plasma Exposure Likely to be Increased Frequent monitoring for adverse events and toxicity (i.e., neurotoxicity) related to vinca alkaloids."	1
"Unlike propranolol or metoprolol, but like nadolol, TENORMIN undergoes little or no metabolism by the liver, and the absorbed portion is eliminated primarily by renal excretion."	0
"Sedative/Hypnotics Triazolam, orally administered midazolam Potential for serious and/or life threatening reactions such as prolonged or increased sedation or respiratory depression."	0
BYSTOLIC has not been studied in patients with severe hepatic impairment and therefore it is not recommended in that population.	0
Evidence of slow oxidative metabolism via an unknown mechanism has been observed.	0
"In vitro studies show that the effects of nisoldipine on contractile processes are selective, with greater potency on vascular smooth muscle than on cardiac muscle."	0
"Because duloxetine is highly bound to plasma protein, administration of CYMBALTA to a patient taking another drug that is highly protein bound may cause increased free concentrations of the other drug, potentially resulting in adverse reactions."	1
Increase the dose of the withheld drug(s) back to the recommended dosage after 7 days on the reduced dose in the absence of worsening of hepatotoxicity.	0
Expert consultation is advised for patients who have confirmed renal laboratory abnormalities while taking REYATAZ.	0
TARKA has not been evaluated in subjects with impaired hepatic function.	0
Patients taking digoxin should be monitored appropriately.	0
VIRACEPT should not be used in patients with either moderate or severe hepatic impairment.	0
"TTP is a serious condition that can be fatal and requires urgent treatment, including plasmapheresis (plasma exchange)."	0
Drugs that may cause orthostatic hypotension: An additive effect may be observed when co-administered with INVEGA<U+00AE>.	0
"Clinical manifestations of NMS are hyperpyrexia, muscle rigidity, altered mental status, and evidence of autonomic instability (irregular pulse or blood pressure, tachycardia, diaphoresis, and cardiac dysrhythmias)."	0
TIKOSYN is metabolized to a small degree by the CYP3A4 isoenzyme of the cytochrome P450 system and an inhibitor of this system could increase systemic dofetilide exposure.	1
"Angina: The recommended dose for chronic stable or vasospastic angina is 5<U+2013>10 mg, with the lower dose suggested in the elderly and in patients with hepatic insufficiency."	0
Hypotension: Correct volume or salt depletion prior to administration.	0
"In patients with symptomatic hyponatremia, discontinue ZOLOFT and institute appropriate medical intervention."	0
"Atorvastatin: Atorvastatin and its metabolites are eliminated primarily in bile following hepatic and/or extra-hepatic metabolism; however, the drug does not appear to undergo enterohepatic recirculation."	0
"However, the tested fluvoxamine dose was suboptimal."	0
Triple combination of ATACAND with an ACE-inhibitor and a mineralocorticoid receptor antagonist is generally not recommended.	0
"Furthermore, whenever one of these other drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant may be required."	0
"However, it is presumed that this action is mediated by noradrenergic and/or dopaminergic mechanisms."	0
The effect of epoprostenol on heart rate in animals varies with dose.	0
"At a dose of 30 mg once a day for 8 weeks, no evidence of enzyme induction was found in man."	0
In long-term follow-up studies (without placebo control) the effect of losartan appeared to be maintained for up to a year.	0
Drug Interaction B ile acid sequestering agent colesevelam Concomitant administration of 40 mg olmesartan medoxomil and 3750 mg colesevelam hydrochloride in healthy subjects resulted in 28% reduction in Cmax and 39% reduction in AUC of olmesartan.	1
A lower starting dose is recommended in patients with hepatic impairment (at baseline).	0
"The magnitude of blood pressure reduction is related to the degree of hypertension; thus hypertensive individuals experience an antihypertensive effect, whereas there is only a modest fall in blood pressure in normotensives."	0
The recommended dose is 300 mg once daily.	0
Preliminary clinical data suggest that the incidence of nephrolithiasis is higher in patients receiving indinavir in combination with ritonavir than those receiving CRIXIVAN 800 mg q8h.	0
"Evaluate for bipolar disorder prior to stimulant use (5.4) Suppression of Growth: Monitor height and weight in pediatric patients during treatment (5.5) Peripheral Vasculopathy, including Raynaud's phenomenon: Stimulants are associated with peripheral vasculopathy, including Raynaud's phenomenon."	0
WARNING: QT PROLONGATION AND SUDDEN DEATHS See full prescribing information for complete boxed warning.	0
.	0
Patients should be warned against eating the foods listed under CONTRAINDICATIONS while on Marplan therapy and should also be told not to drink alcoholic beverages.	0
"Prompt cessation of therapy is recommended if any one of the following occurs: Central nervous system signs or symptoms such as paresthesias, neuropathies or confusion."	0
"Pre-existing glaucoma is almost always open-angle glaucoma because angle-closure glaucoma, when diagnosed, can be treated definitively with iridectomy."	0
"To make 200 mL of a suspension at 1.0 mg/mL, add 10 mL of Purified Water USP to a polyethylene terephthalate (PET) bottle containing ten 20-mg tablets of PRINIVIL and shake for at least one minute."	0
"Concomitant administration of both a CYP2C9 inhibitor ( such as fluconazole or amiodarone ) and a strong CYP3A inhibitor ( e.g. , ketoconazole , itraconazole ) or a moderate CYP3A inhibitor ( e.g. , amprenavir , erythromycin , fluconazole , diltiazem ) with Tracleer will likely lead to large increases in plasma concentrations of bosentan ."	1
Renal excretion accounts for about 27% of total clearance.	0
Starting nortriptyline hydrochloride oral solution USP in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome.	0
There may be circumstances when it is necessary to initiate treatment with a MAOI such as linezolid or intravenous methylene blue in a patient taking PEXEVA<U+00AE>.	0
Convulsions (seizures) did not occur in mexiletine controlled clinical trials.	0
Inform patients taking ADCIRCA not to take CIALIS or other PDE5 inhibitors .	0
The elimination half-life of lidocaine following an intravenous bolus injection is typically 1.5 to 2.0 hours.	0
"Doses of bisoprolol fumarate ranged from 5 to 60 mg, atenolol from 50 to 200 mg, metoprolol from 100 to 200 mg, and propranolol from 40 to 80 mg."	0
Maintenance dose: The desired therapeutic response for most patients occurs at doses of 4-6 mg/hour.	0
"The drug also accumulates in red blood cells, so that whole blood levels are 1.6 to 1.8 times those measured in plasma."	0
"Since the exposure of nilotinib is reduced in patients with total gastrectomy, perform more frequent monitoring of these patients."	0
"Pharmacokinetics in Healthy Adult Subjects Administered a Single Dose of ADASUVE 10 mg Parameter Healthy Subjects ADASUVE 10 mg (N=114) AUC0-2h (ng<U+2022>h/mL), mean <U+00B1> SD 66.7 <U+00B1> 18.2 AUCinf (ng<U+2022>h/mL), mean <U+00B1> SD 188 <U+00B1> 47 Cmax (ng/mL), mean <U+00B1> SD 257 <U+00B1> 219 Tmax (minutes), median (25%, 75%) 1.13 (1, 2) Half-life(h), mean <U+00B1> SD 7.61 <U+00B1> 1.87 Figure 8."	0
"It is cleared from the plasma largely by renal excretion, with about 65% of an administered dose appearing in urine and about 25% in feces, both largely as unchanged tirofiban."	0
"MAO inhibitors, including NARDIL, potentiate hexobarbital hypnosis in animals."	0
The volume of distribution of dabigatran is 50 to 70 L. Dabigatran pharmacokinetics are dose proportional after single doses of 10 to 400 mg.	0
Case reports and epidemiological studies (case-control and cohort design) have demonstrated an association between use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding.	0
"Each vial (25 mg) must be diluted with 240 mL of compatible intravenous fluid, resulting in 250 mL of solution at a concentration of 0.1 mg/mL."	0
Oral Contraceptives: Values for norethindrone and ethinyl estradiol may be increased (7.9).	1
"Examples of MAOIs include selegiline, tranylcypromine, isocarboxazid, phenelzine, linezolid, methylene blue."	0
"In general, beta-blocking agents should be avoided in patients with overt congestive failure."	0
Patients with a history of angioedema unrelated to ACE inhibitor therapy may be at increased risk of angioedema while receiving an ACE inhibitor.	0
NORVIR is contraindicated with drugs that are potent CYP3A inducers where significantly reduced lopinavir plasma concentrations may be associated with the potential for loss of virologic response and possible resistance and cross-resistance.	0
Intervention: LATUDA should not be used concomitantly with strong CYP3A4 inhibitors.	0
"Cardiovascular Electrophysiology At a dose 2.5 times the maximum recommended dose, levomilnacipran does not prolong QTc to any clinically relevant extent."	0
Longer-term efficacy of PRISTIQ (50<U+2013>400 mg) was established in two maintenance trials.	0
"Based on observations in patients in a state of alcoholic delirium it has been suggested that high intravenous doses of clonidine may increase the arrhythmogenic potential (QT-prolongation, ventricular fibrillation) of high intravenous doses of haloperidol."	0
Dose reduction of methadone may be needed Fentanyl (CYP3A4 Inhibition) Increased Reduction in the dose of fentanyl and other long-acting opiates metabolized by CYP3A4 should be considered when coadministered with VFEND.	1
Discontinue CAPRELSA treatment in patients with RPLS.	0
A clinical study has shown that PRISTIQ does not increase the impairment of mental and motor skills caused by ethanol.	0
"There were no clinically significant changes in blood pressure during pseudoephedrine administration alone, or in combination with EMSAM."	0
"If the antiretroviral regimen must be withheld for a prolonged period, consideration should be given to initiating a revised regimen that does not include a CYP3A or P-gp inhibitor."	0
A higher dose of potassium citrate extended-release tablets may therefore be required to produce a satisfactory citraturic response.	0
BSA was the most important covariate and more relevant than age for the pharmacokinetics of sotalol.	0
"If bupropion is used concomitantly with a CYP inducer, it may be necessary to increase the dose of bupropion, but the maximum recommended dose should not be exceeded."	1
Geriatric: Plasma levels of fluvastatin are not significantly different in patients age > 65 years compared to patients age 21 to 49 years.	0
The mean time from onset of pain to entry was 5.0 <U+00B1> 2.7 hours in both groups.	0
"Measure blood pressure and heart rate prior to initiating treatment with Savella and monitor periodically throughout treatment (5.3, 5.4)."	0
Figure 22 Effects of intrinsic factors on aripiprazole pharmacokinetics Figure 23: Effects of intrinsic factors on dehydro-aripiprazole pharmacokinetics: Figure 22 Figure 23	0
"Levomilnacipran binds with high affinity to the human serotonin (5-HT) and norepinephrine (NE) transporters (Ki = 11 and 91 nM, respectively) and potently inhibits 5-HT and NE reuptake (IC50 = 16-19 and 11 nM, respectively)."	0
"Concomitant use of paroxetine with risperidone, a CYP2D6 substrate has also been evaluated."	0
"Patients should be advised to report promptly unexplained muscle pain, tenderness, or weakness, particularly if accompanied by malaise or fever or if muscle signs and symptoms persist after discontinuing CADUET."	0
"In ESPS2 patients, with creatinine clearances ranging from about 15 mL/min to >100 mL/min, no changes were observed in the pharmacokinetics of dipyridamole or its glucuronide metabolite if data were corrected for differences in age."	0
AGGRENOX capsules are not interchangeable with the individual components of aspirin and dipyridamole tablets.	0
At concentrations of 1 to 4 micrograms of free base per milliliter 60 to 80 percent of lidocaine is protein bound.	0
Patients at risk for osteoporosis-related fractures should be managed according to established treatment guidelines.	0
"This fact must be considered in assessing the estimates of the pharmacokinetic parameters presented below, as these were obtained in individuals exposed to doses of 150 mg."	0
"Of the patients still taking study medication, the mean doses of losartan potassium tablets and atenolol were both about 80mg/day, and 15% were taking atenolol or losartan as monotherapy, while 77% were also receiving hydrochlorothiazide (at a mean dose of 20mg/day in each group)."	0
Category C. Reproduction studies performed in rats and rabbits at oral doses up to 8 times the maximum human dose did not reveal evidence of teratogenicity.	0
"Steady-state AUCs, Cmax, and Cminplasma concentrations showed no evidence of pravastatin accumulation following once or twice daily administration of pravastatin sodium tablets."	0
The dosage should be reduced in patients with reduced renal function.	0
"Prophylaxis of gout flares: If the original regimen was 0.6 mg twice a day, the regimen should be adjusted to 0.3 mg once a day."	0
Savella has not been systematically evaluated in patients with a cardiac rhythm disorder.	0
"A third study, also flexible-dose comparing paroxetine (20 mg to 50 mg daily), did not demonstrate statistically significant superiority of paroxetine over placebo on the Hamilton Rating Scale for Anxiety (HAM-A) total score, the primary outcome."	0
"DEMSER may add to the sedative effects of alcohol and other CNS depressants , e.g. , hypnotics , sedatives , and tranquilizers ."	0
"In a separate study, when a single oral 300 mg dose of phenytoin was administered at paroxetine steady state (30 mg qd for 14 days), phenytoin AUC was slightly reduced (12% on average) compared to phenytoin administered alone."	1
"In a single study, rats given high intraperitoneal doses of an MAO inhibitor plus disulfiram experienced severe toxicity, including convulsions and death."	0
ADP induced platelet aggregation was higher up to 2 hours following 60 mg loading dose of prasugrel in stable patients more than 1 year after an ACS who were co-administered morphine.	0
"Conversion of losartan to its active metabolite after intravenous administration is not affected by ketoconazole, an inhibitor of P4503A4."	0
There have been no clinical studies to evaluate the effect of race on the pharmacokinetics of REMERON.	0
Dose titration of the calcium channel blocker should be considered.	0
"As with all drugs effective in the treatment of MDD, the full effect may be delayed."	0
"Generally, histological findings were observed without organ involvement."	0
Monoamine oxidases contribute partially to the metabolism of the active metabolite of dronedarone.	0
The Potential Effect of Other Drugs on AUBAGIO Potent CYP and transporter inducers: Rifampin did not affect the pharmacokinetics of teriflunomide.	0
No dose adjustment is required based on race/ethnicity.	0
Hypokalemia and hypomagnesemia can provoke ventricular arrhythmias or sensitize or exaggerate the response of the heart to the toxic effects of digitalis.	0
"In a longer-term study, patients meeting DSM-III-R criteria for PTSD who had responded during a 24-week open trial on sertraline hydrochloride 50 to 200 mg/day (N=96) were randomized to continuation of sertraline hydrochloride or to substitution of placebo for up to 28 weeks of observation for relapse."	0
"Therefore, caution should be exercised when coumarin anticoagulants are given in conjunction with CRESTOR."	0
Treatment should begin with the intravenous administration of 5 mg TENORMIN over 5minutes followed by another 5 mg intravenous injection 10 minutes later.	0
"Another patient receiving protriptyline and selegiline developed tremors, agitation, and restlessness followed by unresponsiveness and death two weeks after selegiline was added."	0
"In addition, urinary citrate and/or pH should be measured every four months."	0
"Similarly, there are no animal data as to quinidine's potential to impair fertility."	0
Either tachycardia or bradycardia may be present and can be associated with constricting chest pain.	0
Tissue distribution studies in dogs and monkeys showed a concentration of clonidine in the choroid.	0
Age appears to have a significant effect on the pharmacokinetics of nifedipine.	0
Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have.	0
Maintain adequate hydration and correct uric acid levels prior to initiating therapy with Tasigna.	0
A causal relationship has not been established.	0
"Because of its relative beta1 selectivity, however, TENORMIN may be used with caution in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment."	0
"The following complications, though rare, have been reported during d-penicillamine therapy and could occur during THIOLA<U+00AE> treatment."	0
"Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, chronic kidney disease, severe congestive heart failure, post-myocardial infarction or volume depletion) may be at particular risk of developing acute renal failure on PRINIVIL."	0
"The angioedema was diagnosed by procedures including abdominal CT scan or ultrasound, or at surgery, and symptoms resolved after stopping the ACE inhibitor."	0
Cimetidine increased AUC by about 30% but caused no change in Cmax.	1
The changes induced by beta-blockade with all agents were reversed by bronchodilator therapy.	0
Avoid coadministration of diltiazem with rifampin or any known CYP3A4 inducer.	0
"To reduce the abuse of CNS stimulants including VYVANSE, assess the risk of abuse, prior to prescribing."	0
"In depressed patients, the possibility of suicide should always be considered and adequate precautions taken."	0
Theophylline<U+2014> Reports of elevated theophylline levels associated with paroxetine treatment have been reported.	1
"Eplerenone has been shown to produce sustained increases in plasma renin and serum aldosterone, consistent with inhibition of the negative regulatory feedback of aldosterone on renin secretion."	0
"Use of PDE5 inhibitors for erectile dysfunction: Sildenafil at a single dose not exceeding 25 mg in 48 hours, vardenafil at a single dose not exceeding 2.5 mg in 24 hours, or tadalafil at a single dose not exceeding 10 mg dose in 72 hours, is recommended."	1
"Following remission, maintenance medication may be required for a longer period of time at the lowest dose that will maintain remission."	0
"As with other ACE inhibitors, periodic monitoring of white blood cell counts in patients with collagen vascular disease and/or renal disease should be considered."	0
"The serum half-life of digoxin in pediatric patients is reported to be 18 to 36 hours, and in adults it is typically 36 to 48 hours."	0
Patients should be advised of the following issues and asked to alert their prescriber if these occur while taking NORPRAMIN.	0
The pharmacokinetics of quinapril and quinaprilat are linear over a single-dose range of 5- to 80-mg doses and 40- to 160-mg in multiple daily doses.	0
Calcium Channel Blockers: DiltiazemFelodipineNicardipineNisoldipineVerapamil Combination with APTIVUS/ritonavir not studied.	0
"The recommended starting dose is 4 to 8 mg. For those greater than 50 kg, the dose range is 4 to 32 mg per day."	0
"), verapamil and norverapamil levels were noted in the cerebrospinal fluid with estimated partition coefficient of 0.06 for verapamil and 0.04 for norverapamil."	0
"However, prior to initiating treatment with an antidepressant, patients with depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression."	0
"Sedative/hypnotics: Parenteral midazolam <U+2191> midazolam For contraindicated sedative/hypnotics,.Co-administration should be done in a setting which ensures close clinical monitoring and appropriate medical management in case of respiratory depression and/or prolonged sedation."	0
"Drug Interaction Studies Telmisartan Ramipril and Ramiprilat: Co-administration of telmisartan 80 mg once daily and ramipril 10 mg once daily to healthy subjects increases steady-state Cmax and AUC of ramipril 2.3- and 2.1-fold, respectively, and Cmax and AUC of ramiprilat 2.4- and 1.5-fold, respectively."	1
Inhaled/nasal steroid: fluticasone REYATAZ <U+2191> fluticasone Concomitant use of fluticasone propionate and REYATAZ (without ritonavir) may increase plasma concentrations of fluticasone propionate.	1
Hyperpolarization-Activated Cyclic Nucleotide-Gated Channel Blocker Ivabradine can increase the risk of bradycardia.	0
Postnatal development at the highest dose tested in dams could not be evaluated because of the lack of surviving pups.	0
"Drug Class Drugs within class that are contraindicated with REYATAZ Clinical Comment Alpha 1-Adrenoreceptor Antagonist Alfuzosin Potential for increased alfuzosin concentrations, which can result in hypotension."	0
"Telmisartan Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II)."	0
"Hemodynamics: In a study of systemic hemodynamic function measured invasively in 12 patients with a mean LV ejection fraction of 37% and ventricular tachycardia (9 sustained and 3 non-sustained), a median dose of 160 mg twice daily of sotalol produced a 28% reduction in heart rate and a 24% decrease in cardiac index at 2 hours post-dosing at steady-state."	0
A gradual reduction in the dose rather than abrupt cessation is recommended whenever possible.	0
Thrombotic thrombocytopenic purpura (TTP): TTP has been reported with Effient (5.4).	0
"Mean arterial pressure, mean pulmonary artery pressure and stroke work index did not significantly change."	0
Absorption Olmesartan medoxomil is rapidly and completely bioactivated by ester hydrolysis to olmesartan during absorption from the gastrointestinal tract.	0
Patients not improved after 12weeks can be considered refractory.	0
No dose adjustment is required based on race/ethnicity.	0
"There has been a long-standing concern, however, that antidepressants may have a role in inducing worsening of depression and the emergence of suicidality in certain patients during the early phases of treatment."	0
CYP2D6 Poor Metabolizers A subset (3%<U+2013>10%) of the population has reduced activity of CYP2D6 (CYP2D6 poor metabolizers).	0
"The features seen in these infants include: brachycephaly, abnormal facies, abnormal calvarial development, cleft palate, femoral bowing, thin ribs and long bones, arthrogryposis, and congenital heart disease."	0
The following table compensates for dead space in the infusion set.	0
"In a patient who requires more urgent treatment of a psychiatric condition, other interventions, including hospitalization, should be considered."	0
Whether any of the symptoms described above represent such a conversion is unknown.	0
"The patient should be fully instructed on the need for compliance with the recommended dosing of TIKOSYN and the potential for drug interactions, and the need for periodic monitoring of QTc and renal function to minimize the risk of serious abnormal rhythms."	0
Lithium <U+2013> Generally should not be given with diuretics.	0
"Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including enalapril, may result in deterioration of renal function, including possible acute renal failure."	0
Dosage adjustment of methadone may be necessary.	0
Sildenafil Monitor for hypotension when sildenafil is co-administered with amlodipine.	0
Patients should be monitored for these symptoms when discontinuing treatment with LUVOX CR Capsules.	0
"CNS vascular lesions, characterized by perivascular hemorrhages, edema, and mononuclear cell infiltration of perivascular spaces, have been observed in dogs treated with other statins."	0
REYATAZ oral powder is for use in treatment-naive or treatment-experienced pediatric patients who are at least 3 months of age and weighing at least 5 kg.	0
"Because it is known that the risk of myopathy during treatment with HMG-CoA reductase inhibitors is increased with concurrent administration of other fibrates, LIVALO should be administered with caution when used concomitantly with other fibrates."	0
"Sertraline hydrochloride was initiated at 25 mg/day for the first week, and patients were then dosed in the range of 50 to 200 mg/day on the basis of clinical response and toleration."	0
"Since initiation of GILENYA treatment results in decreased heart rate and may prolong the QT interval, patients on QT prolonging drugs with a known risk of torsades de pointes (e.g., citalopram, chlorpromazine, haloperidol, methadone, erythromycin) should be monitored overnight with continuous ECG in a medical facility."	0
"Acute hemolytic anemia, including cases resulting in death, has been reported in patients treated with CRIXIVAN."	0
"Although not studied in vitro or in vivo, concomitant administration of fluconazole with pimozide may result in inhibition of pimozide metabolism."	1
"These effects may also occur if you drink alcohol, stand for long periods of time, exercise, or if the weather is hot."	0
"In this crossover steady state study, the pharmacokinetics of propafenone were unaffected in either phenotype by the coadministration of mexiletine."	0
"In post-MI HFrEF patients receiving a moderate CYP3A inhibitor (e.g., erythromycin, saquinavir, verapamil, and fluconazole), do not exceed 25 mg once daily."	1
"Alternative corticosteroids including beclomethasone and prednisolone (for which PK and/or PD are less affected by strong CYP3A inhibitors relative to other steroids) should be considered, particularly for long term use."	0
"(Note: All patients receiving theophylline should be monitored appropriately, regardless of concomitant drug therapy.)"	0
"Detoxification of patients, including withdrawal of the overused drugs, and treatment of withdrawal symptoms (which often includes a transient worsening of headache) may be necessary."	0
These studies have also shown that concurrent use of an NSAID or aspirin may potentiate this risk of bleeding.	0
"P-gp inducers rifampin: Avoid coadministration with PRADAXA (5.5) P-gp inhibitors in patients with CrCl 30-50 mL/min: Reduce dose or avoid (7) P-gp inhibitors in patients with CrCl <30 mL/min: Not recommended (7) The concomitant use of PRADAXA with P-gp inducers (e.g., rifampin) reduces exposure to dabigatran and should generally be avoided."	1
"Thyrotoxicosis: Beta-adrenergic blockade may mask certain clinical signs of hyperthyroidism, such as tachycardia."	0
Consider dose reduction when using with bupropion.	0
"CYP 3A Inducers Avoid co-administration of CYP 3A inducers (e.g., rifampin, rifabutin, rifapentin, barbiturates, phenytoin, carbamazepine, St. John's Wort) with SAMSCA, as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment."	1
AHA is a known inhibitor of DNA synthesis and also chelates metals - notably iron.	0
The pharmacokinetics of clonidine is dose-proportional in the range of 100 to 600 <U+00B5>g.	0
Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs): efavirenz <U+2193> atazanavir Efavirenz decreases atazanavir exposure.	1
"When an oral antihypertensive agent is being instituted, consider the lag time of onset of the oral agent<U+2019>s effect."	0
Theophylline Verapamil therapy may inhibit the clearance and increase the plasma levels of theophylline.	1
Use of EMSAM with these drugs is contraindicated.	0
Alcohol: Causes additive psychomotor impairment; should not be used in combination.	0
"Actions at receptors other than D2, 5-HT1A, and 5-HT2A may explain some of the other adverse reactions of aripiprazole (e.g., the orthostatic hypotension observed with aripiprazole may be explained by its antagonist activity at adrenergic alpha1 receptors)."	0
See full prescribing information for a list of clinically important drug interactions (7).	0
Seizures: Prescribe with care in patients with a history of seizure (5.4).	0
This drug should also be used with caution in patients with hypovolemia and shock and all forms of heart block.	0
"The angioedema was diagnosed by procedures including abdominal CT scan or ultrasound, or at surgery, and symptoms resolved after stopping the ACE inhibitor."	0
"Skeletal muscle relaxants, nondepolarizing (e.g., tubocurarine) - possible increased responsiveness to the muscle relaxant."	0
NORPRAMIN therapy in patients with manic-depressive illness may induce a hypomanic state after the depressive phase terminates.	0
"Rock the vial gently so that all surfaces, including the stopper, are in contact with the diluent to ensure complete reconstitution."	0
Stop ADCIRCA at least 24 hours prior to starting ritonavir .	0
There were no significant differences in the rates of these endpoints between the losartan potassium tablets and atenolol groups.	0
Olmesartan pharmacokinetics have not been investigated in pediatric patients less than 1 year of age.	0
"However, prior to initiating treatment with an antidepressant, patients with depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression."	0
"Data from in vitro studies of benzodiazepines other than triazolam suggest a possible drug interaction with triazolam for the following: ergotamine, cyclosporine, amiodarone, nicardipine, and nifedipine."	0
Physicians using this drug should be very familiar with this risk as well as with the mutagenic potential to both men and women and with possible hematologic toxicities.	0
The mechanism of action of loxapine in the treatment of agitation associated with bipolar I disorder is unknown.	0
Do not use CYMBALTA within 14 days of stopping an MAOI intended to treat psychiatric disorders.	0
"Because dopamine is metabolized by monoamine oxidase (MAO), inhibition of this enzyme prolongs and potentiates the effect of dopamine."	0
"Based on animal data with irinotecan HCl andthe mechanism of action ofONIVYDE, ONIVYDE can cause fetal harm when administered to a pregnant woman."	0
"Upon multiple dosing, lisinopril exhibits an effective half-life of 12 hours."	0
"Withhold Tasigna, and monitor hepatic transaminases2."	0
"However, its efficacy in schizophrenia and bipolar depression could be mediated through a combination of central dopamine D2 and serotonin Type 2 (5HT2A) receptor antagonism."	0
<U+2022>CNS Depressants: Downward dose adjustment may be necessary due to additive effects.	1
"Although some serious heart problems alone carry an increased risk of sudden death, stimulant products generally should not be used in children or adolescents with known serious structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious cardiac problems that may place them at increased vulnerability to the sympathomimetic effects of a stimulant drug."	0
Trandolapril and trandolaprilat concentrations increase in patients with impaired liver function.	0
Avoid the use of live attenuated vaccines during and for 2 months after treatment with GILENYA because of the risk of infection.	0
"Concomitant use of riociguat, a guanylate cyclase stimulator."	0
DHEA and androstenedione are androgens and are precursors of testosterone.	0
"In patients receiving concurrent therapy with clonidine, if therapy is to be discontinued, it is suggested that ZIAC be discontinued for several days before the withdrawal of clonidine."	0
"Gastrointestinal (GI) Side Effects GI side effects include stomach pain, heartburn, nausea, vomiting, and gross GI bleeding."	0
Hepatic Impairment No dosage adjustment is necessary in patients with hepatic impairment.	0
There is no evidence that bicalutamide induces hepatic enzymes.	0
"When these symptoms are associated with acute stress reactions, treatment with DESOXYN tablets is usually not indicated."	0
"Because beta1-selectivity is not absolute, use the lowest possible dose of DUTOPROL."	0
"Inhibition of ACE results in decreased plasma angiotensin II, which leads to decreased vasopressor activity and to decreased aldosterone secretion."	0
There have been reports that erythromycin and telithromycin may increase concentrations of verapamil.	1
Do not exceed 8 mg/day Enzyme (CYP3A/PgP inducers)Inducers Carbamazepine 573 <U+00B1> 168 mg/day 3 mg twice daily 0.51 0.55 Titrate dose upwards.	1
The pharmacokinetics of losartan and its active metabolite were also determined after IV doses of each component separately in healthy volunteers.	0
"In a patient who requires more urgent treatment of a psychiatric condition, other interventions, including hospitalization, should be considered."	0
Triazolam and orally administered midazolam are extensively metabolized by CYP3A4.	0
"While taking beta-blockers, patients with a history of severe anaphylactic reactions to a variety of allergens may be more reactive to repeated challenge and may be unresponsive to the usual doses of epinephrine used to treat an allergic reaction."	0
Twice-daily dosing offers no advantage over the same total dose given once daily.	0
"When MICROZIDE and non-steroidal anti-inflammatory agents are used concomitantly, the patients should be observed closely to determine if the desired effect of the diuretic is obtained."	0
"Use caution when concomitant use with drugs that affect Hemostasis (NSAIDs, Aspirin, Warfarin) (7.6)."	0
ANTIMYCOBACTERIAL Rifabutin <U+2191> rifabutin<U+2193> nelfinavir (750 mg TID)<U+2194> nelfinavir (1250 mg BID) It is recommended that the dose of rifabutin be reduced to one-half the usual dose when administered with VIRACEPT; 1250 mg BID is the preferred dose of VIRACEPT when coadministered with rifabutin.	1
"Possible fluid and electrolyte imbalance may be indicated by such warning signs as: dry mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pain or cramps, muscular fatigue, hypotension, oliguria, tachycardia, and gastrointestinal symptoms."	0
Table 2: Recommended Starting Dosage and Titration Increment Based on Pediatric Patient's Body Surface Area (m2) BSA (m2) Starting Dose Per Meal/Snack Titration Increases/Decreases Per Dose <U+2265>0.75 to <1.2 0.8 g Titrate by 0.4 g <U+2265>1.2 1.6 g Titrate by 0.8 g Dose Titration for Pediatric Patients Taking Renvela.	0
"Prasugrel is not an inhibitor of Pgp, as digoxin clearance was not affected by prasugrel coadministration."	0
Appropriate doses of the combination with respect to safety and efficacy have not been established.	0
"While the bioavailability of benazepril is not affected by food, time to peak plasma concentrations of benazeprilat is delayed to 2 to 4 hours."	0
"When symptomatic hypotension occurs, discontinue NATRECOR<U+00AE>."	0
Patients with cardiovascular disease should be given nortriptyline hydrochloride only under close supervision because of the tendency of the drug to produce sinus tachycardia and to prolong the conduction time.	0
"The Potential Effect of AUBAGIO on Other Drugs CYP2C8 Substrates There was an increase in mean repaglinide Cmax and AUC (1.7- and 2.4-fold, respectively), following repeated doses of teriflunomide and a single dose of 0.25 mg repaglinide, suggesting that teriflunomide is an inhibitor of CYP2C8 in vivo."	1
"Because of its very short half-life, studies focused on decreasing sleep latency, with less attention to duration of sleep and number of awakenings, for which consistent differences from placebo were not demonstrated."	0
Hypertension: The mechanism of the antihypertensive effects of beta-blocking agents has not been elucidated.	0
Dose can be increased at 2-week intervals up to 40 mg. (2.1) The dose of BYSTOLIC must be individualized to the needs of the patient.	0
"There has been a long-standing concern, however, that antidepressants may have a role in inducing worsening of depression and the emergence of suicidality in certain patients during the early phases of treatment."	0
"When paroxetine is withdrawn from the combination therapy, the iloperidone dose should be returned to the previous level."	0
The convenience and efficacy of the single dose oral tablet of fluconazole regimen for the treatment of vaginal yeast infections should be weighed against the acceptability of a higher incidence of drug related adverse events with DIFLUCAN (26%) versus intravaginal agents (16%) in U.S. comparative clinical studies.	0
Intestinal angioedema should be included in the differential diagnosis of patients on ACE inhibitors presenting with abdominal pain.	0
Measure serum creatinine and calculate an estimated creatinine clearance in order to establish the appropriate dosing interval for sotalol.	0
"Co-administration of a cytochrome P450 ( CYP ) 2C8 enzyme inhibitor ( e.g. , gemfibrozil ) increases exposure ( both Cmax and AUC ) to treprostinil ."	1
Cholestyramine and Colestipol Resins- Both cholestyramine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract.	1
"In Study1, for patients who completed to week12, 69% of paroxetine-treated patients compared to 29% of placebo-treated patients were CGI Improvement responders."	0
"REVATIO 20 mgthree times a day(n = 65) mPAP = mean pulmonary arterial pressure; PVR= pulmonary vascular resistance; SVR = systemic vascular resistance; RAP = right atrial pressure; CO = cardiac output; HR = heart rate mPAP (mmHg) 0.6 (-0.8, 2.0) -2.1 (-4.3, 0.0) PVR (dyn<U+2219>s/cm5) 49 (-54, 153) -122 (-217, -27) SVR (dyn<U+2219>s/cm5) -78 (-197, 41) -167 (-307, -26) RAP (mmHg) 0.3 (-0.9, 1.5) -0.8 (-1.9, 0.3) CO (L/min) -0.1 (-0.4, 0.2) 0.4 (0.1, 0.7) HR (beats/min) -1.3 (-4.1, 1.4) -3.7 (-5.9, -1.4) In another study evaluating lower doses of sildenafil 1 mg, 5 mg and 20 mg [Study 3 in Clinical Studies (14)], there were no significant differences in the effects on hemodynamic variables between doses."	0
Thiazides may cause intermittent and slight elevation of serum calcium in the absence of known disorders of calcium metabolism.	0
Meperidine Hydrochloride administered by the intravenous route via a compatible infusion device is not recommended for use in individuals younger than 19 years of age.	0
"These includedcases of cardiovascular events including ischemic heart disease-related cardiac events (5.0% and 9.4% in the Tasigna300 mg and 400 mg twice daily arms respectively, and 2.5% in the imatinib arm), peripheral arterial occlusive disease (3.6% and 2.9% in the Tasigna300 mg and 400 mg twice dailyarms respectively, and 0% in the imatinib arm), and ischemic cerebrovascular events (1.4% and 3.2% in the Tasigna300 mg and 400 mg twice dailyarms respectively, and 0.7% in the imatinib arm)."	0
"Olanzapine is an antagonist with moderate affinity binding for serotonin5HT3 (Ki=57nM) and muscarinicM1-5 (Ki=73, 96, 132, 32, and 48nM, respectively)."	0
"Occasional cases of exacerbation of angina pectoris, arrhythmias and, in some cases, myocardial infarction have been reported after abrupt discontinuation of beta-blocker therapy."	0
"Where patients are participating in activities requiring complete mental alertness (e.g., driving) it is advisable to administer the phenothiazines cautiously and to increase the dosage gradually."	0
"In drug-drug interaction studies, sildenafil (25 mg, 50 mg, or 100 mg) and the alpha-blocker doxazosin (4 mg or 8 mg) were administered simultaneously to patients with benign prostatic hyperplasia (BPH) stabilized on doxazosin therapy."	0
"The primary endpoint was the first occurrence of stroke, myocardial infarction or cardiovascular death, analyzed using an intention-to-treat (ITT) approach."	0
Diazepam <U+2014> The co-administration of diazepam with olanzapine potentiated the orthostatic hypotension observed with olanzapine.	0
"Acetohydroxamic acid has been evaluated clinically in patients with urea-splitting urinary infections, often accompanied by struvite stone disease, that were recalcitrant to other forms of medical and surgical management."	0
Cyclosporine: A prospective study in renal transplant patients (N=11) showed on an average of 40% increase in trough cyclosporine levels when concomitantly treated with amlodipine.	1
Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy.	0
Clinical studies of nisoldipine did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
Patients usually do not require doses in excess of 50 mg hydrochlorothiazide daily when used concomitantly with other antihypertensive agents.	0
"Pooled analyses of short-term placebo-controlled trials of antidepressant drugs (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18 to 24) with major depressive disorder (MDD) and other psychiatric disorders."	0
"There have been reports of hepatic failure, sometimes fatal, in patients treated with CYMBALTA."	0
Relapse rates among subjects without baseline NS5A polymorphisms at resistance-associated positions were 5% (8/167) after 8 weeks and 1% (3/306) after 12 weeks treatment with HARVONI.	0
"Adverse reactions reported in a limited number of patients with asthma, reactive airway disease, or obstructive airway disease were similar to reactions in other patients treated with nicardipine capsules."	0
The dose of IMURAN should not be increased to toxic levels because of threatened rejection.	0
"However, due to the potential for serotonin syndrome, caution is advised when paroxetine is coadministered with lithium."	0
"Patients should be instructed to report promptly the occurrence of headache or other unusual symptoms, i.e., palpitation and/or tachycardia, a sense of constriction in the throat or chest, sweating, dizziness, neck stiffness, nausea, or vomiting."	0
"Concomitant administration of intravenous nicardipine and tacrolimus may result in elevated plasma tacrolimus levels through nicardipine inhibition of hepatic microsomal enzymes, including CYP3A4."	1
"All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases."	0
"In occasional susceptible patients or in those receiving anticholinergic drugs (including antiparkinsonism agents) in addition, the atropine-like effects may become more pronounced (e.g., paralytic ileus)."	0
"If acceptable alternatives to linezolid or intravenous methylene blue treatment are not available and the potential benefits of linezolid or intravenous methylene blue treatment are judged to outweigh the risks of serotonin syndrome in a particular patient, NORPRAMIN should be stopped promptly, and linezolid or intravenous methylene blue can be administered."	0
"This dosage may be increased to 10 mg per day, if necessary."	0
"The strictest supervision, and preferably hospitalization, are required."	0
"The combined analysis of two unblinded, multicenter trials (a single dose and a multiple dose study) with 59 children, aged between 3 days and 12 years, showed the pharmacokinetics of sotalol to be first order."	0
Virus from three of these 7 subjects also had baseline NS5A polymorphisms at resistance-associated positions.	0
"If VFEND is continued despite the occurrence of phototoxicity-related lesions, dermatologic evaluation should be performed on a systematic and regular basis to allow early detection and management of premalignant lesions."	0
"Amiodarone is a substrate for CYP3A and CYP2C8, so inhibitors and inducers affect amiodarone exposure (7) Amiodarone inhibits p-glycoprotein and CYP1A2, CYP2C9, CYP2D6, and CYP3A, increasing exposure to other drugs (7) Drugs prolonging the QT interval: Co-administration of drugs prolonging the QT interval (such as class I and III antiarrhythmics, lithium, certain phenothiazines, tricyclic antidepressants, certain fluoroquinolone and macrolide antibiotics, azole antifungals, halogenated inhalation anesthetic agents) increases the risk of Torsade de Pointes."	0
The 4 studies of losartan monotherapy included a total of 1075 patients randomized to several doses of losartan and 334 to placebo.	0
"Moreover, as noted with alprazolam, the effect of fluvoxamine may even be more pronounced when it is administered at higher doses."	0
Coadministration is not recommended.Liver function should be monitored frequently if this combination is prescribed.	0
"Discontinuing Effient, particularly in the first few weeks after acute coronary syndrome, increases the risk of subsequent cardiovascular events."	0
"CYP 3A Inducers Avoid co-administration of CYP 3A inducers (e.g., rifampin, rifabutin, rifapentin, barbiturates, phenytoin, carbamazepine, St. John's Wort) with SAMSCA, as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment."	1
"Following oral doses of 12.5-100 mg, 55%-77% of the administered dose appears in urine and greater than 95% of the absorbed dose is excreted in urine as unchanged drug."	0
Studies were conducted with and without concomitant administration of food.	0
"A three<U+2011>year, double-blind, placebo-controlled study in hypercholesterolemic patients to assess the effect of lovastatin on the human lens demonstrated that there were no clinically or statistically significant differences between the lovastatin and placebo groups in the incidence, type or progression of lenticular opacities."	0
LEXIVA: A dosage reduction of rifabutin by at least half the recommended dose is required.	1
The use of anorectic agents for longer than three months was associated with a 23-fold increase in the risk of developing pulmonary hypertension.	0
"Should treatment with any HMG-CoA reductase inhibitor (a lipid lowering agent) be needed to treat lipid elevations, evaluate the potential for a drug-drug interaction before initiating therapyas certain HMG-CoA reductase inhibitors are metabolized by the CYP3A4 pathway."	0
No reports involved the administration of methylene blue by other routes (such as oral tablets or local tissue injection) or at lower doses.	0
Initial blood levels following parenteral administration are high but transient.	0
There was no statistically significant change in the urinary dextromethorphan/dextrorphan ratio.	0
"The hematologic status as indicated by hemoglobin, hematocrit, white blood count (WBC), differential, reticulocytes and platelets should be monitored closely - at least every 3 or 4 days."	0
"Postmarketing cases of symptomatic bradycardia , some requiring pacemaker insertion and at least one fatal , have been reported when ledipasvir/sofosbuvir or sofosbuvir with simeprevir were initiated in patients on amiodarone ."	0
Digoxin absorption may also be affected by various concomitant therapy modulating gastric pH and P-glycoprotein.	0
"Changes in pharmacokinetics of tizanidine when administered with fluvoxamine resulted in significantly decreased blood pressure, increased drowsiness, and increased psychomotor impairment."	0
"At low concentrations (<100 <U+00B5>g/mL), approximately 90% of salicylic acid is bound to albumin."	0
"In a patient who requires more urgent treatment of a psychiatric condition, other interventions, including hospitalization, should be considered."	0
"Avoid co-administration of CYP 3A inducers ( e.g. , rifampin , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine , St.   John 's   Wort ) with SAMSCA , as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment ."	1
"In human studies, cimetidine has been shown to have no effect on spermatogenesis, sperm count, motility, morphology or in vitro fertilizing capacity."	0
"No significant interactions were shown with tolbutamide (250 mg) or warfarin (40 mg), both of which are metabolized by CYP2C9."	0
"Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit."	0
Starting PRISTIQ in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome.	0
"In patients with creatinine clearance <U+2264>60 mL/min, give 25 mcg/kg within 5 minutes and then 0.075 mcg/kg/min."	0
"Although hepatocellular neoplasia (exclusively adenomas) in the rat study was limited to triamterene-exposed males, incidence was not dose dependent and there was no statistically significant difference from control incidence at any dose level."	0
The full antihypertensive effect of COREG is seen within 7 to 14days.	0
Steady-state plasma concentrations are typically achieved after 3 days of dosing.	0
"In general , avoid combined use of aliskiren with ACE inhibitors or ARBs , particularly in patients with creatinine clearance ( CrCl ) less than 60 mL/min see Contraindications ( 4 ) , Drug Interactions ( 7 ) and Clinical Studies ( 14.3 ) ."	0
Studies conducted with food are most relevant to clinical practice since tyramine typically will be consumed in food.	0
; Enterobacter aerogenes (formerly Aerobacter aerogenes) and Alcaligenes faecalis.	0
The once-daily administration of up to 80 mg telmisartan to healthy subjects did not influence plasma aldosterone concentrations.	0
"Angioedema Head and Neck Angioedema Angioedema of the face, extremities, lips, tongue, glottis, and/or larynx including some fatal reactions, have occured in patients treated with Lotensin."	0
"When the urine pH is less than 7, about 20% of administered quinidine appears unchanged in the urine, but this fraction drops to as little as 5% when the urine is more alkaline."	0
"In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including perindopril, may result in deterioration of renal function, including possible acute renal failure."	0
"PDE5 inhibitors , including ADCIRCA , and alpha adrenergic blocking agents are vasodilators with blood pressure lowering effects ."	0
Norepinephrine Dopamine Neuromuscular Blocking Agents Succinylcholine May cause sudden extrusion of potassium from muscle cells causing arrhythmias in patients taking digoxin.	0
Drugs that inhibit the renin-angiotensin system can cause hyperkalemia.	0
"When deciding among the alternative treatments available for depression, the prescriber should consider the risk of hepatic failure associated with nefazodone hydrochloride treatment."	0
"Patients with creatinine clearance of 30 to 60 mL/min. and patients with hepatic functional impairment had about a 2-fold increase in plasma concentrations (AUC, Cmax)."	0
ALTACE treatment usually can be continued following restoration of blood pressure and volume.	0
"It is recommended that blood glucose be monitored when carvedilol dosing is initiated, adjusted, or discontinued."	0
Patients who are currently tolerating the 80-mg dose of ZOCOR who need to be initiated on an interacting drug that is contraindicated or is associated with a dose cap for simvastatin should be switched to an alternative statin with less potential for the drug-drug interaction.	0
Whether any of these symptoms described above represent such a conversion is unknown.	0
"In infants with restricted pulmonary blood flow, measure efficacy of PROSTIN VR PEDIATRIC by monitoring improvement in blood oxygenation."	0
Ensure that the patient eats or drinks all the food or beverage that contains the powder.	0
Intervention: Temporarily stop treatment with ACIPHEX delayed-release tablets at least 14 days before assessing to allow gastrin levels to return to baseline.	0
"Cytochrome P450: Coadministration of Tracleer with drugs metabolized by CYP2C9 and CYP3A can increase exposure to Tracleer and/or the coadministered drug (4.2, 4.3, 7.1) Hormonal contraceptives: Tracleer use decreases contraceptive exposure and reduces effectiveness (7.2)."	1
BYSTOLIC is contraindicated in the following conditions: Severe bradycardia Heart block greater than first degree Patients with cardiogenic shock Decompensated cardiac failure Sick sinus syndrome (unless a permanent pacemaker is in place) Patients with severe hepatic impairment (Child-Pugh >B) Patients who are hypersensitive to any component of this product.	0
The administration of other potassium-sparing antihypertensives with NSAIDs has been shown to reduce the antihypertensive effect in some patients and result in severe hyperkalemia in patients with impaired renal function.	0
"Adult patients: 600 mg twice-day with meals (2.3) Pediatrics patients: The recommended twice daily dose for children greater than one month of age is based on body surface area and should not exceed 600 mg twice daily with meals (2.4) NORVIR oral solution should not be administered to neonates before a postmenstrual age (first day of the mother<U+2019>s last menstrual period to birth plus the time elapsed after birth) of 44 weeks has been attained (2.4, 5.2) NORVIR oral powder can only be used for dosing increments of 100 mg (2.4) Instructions for Use should be followed for preparation and administration of NORVIR oral powder (2.5) Dose modification for NORVIR is necessary when used with other protease inhibitors (2.6) NORVIR must be used in combination with other antiretroviral agents."	0
"However, any such finding must be considered to suggest a possible risk of long term use of the drug."	0
"Extravasation: Dopamine Hydrochloride in 5% Dextrose Injection, USP should be infused into a large vein whenever possible to prevent the possibility of infiltration of perivascular tissue adjacent to the infusion site."	0
"No cross-resistance with other chemotherapeutic agents, radiotherapy or steroids has been demonstrated."	0
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS See full prescribing information for complete boxed warning.	0
"In one such trial, however, subjects receiving nitroglycerin had less exercise tolerance at the end of the daily interdosing interval than the parallel group receiving placebo."	0
Triglyceride and cholesterol testing should be performed prior to initiating APTIVUS/ritonavir therapy and at periodic intervals during therapy.	0
The concomitant use of PRADAXA and P-gp inhibitors in patients with CrCl <50 mL/min should be avoided.	0
Protein binding may be greatly reduced in patients with renal or hepatic impairment.	0
"When taken with Silenor, the sedative effects of alcoholic beverages, sedating antihistamines, and other CNS depressants may be potentiated."	0
"Patients receiving IMURAN and allopurinol concomitantly should have a dose reduction of IMURAN, to approximately 1/3 to 1/4 the usual dose."	1
"Biotransformation includes oxidative N-dealkylation, ring hydroxylation, cleavage of the amide linkage, and conjugation."	0
Absorption Absorption of BYSTOLIC is similar to an oral solution.	0
"However, there is substantial evidence from placebo-controlled maintenance trials in adults with depression that the use of antidepressants can delay the recurrence of depression."	0
"In patients with CrCl <U+2265>50 mL/min who have concomitant administration of P-gp inhibitors such as dronedarone or systemic ketoconazole, it may be helpful to separate the timing of administration of dabigatran and the P-gp inhibitor by several hours."	0
"Malignant disease progression, high WBC counts and/or dehydration were present in the majority of these cases."	0
"In patients who do require chronic treatment, the smallest dose and the shortest duration of treatment producing a satisfactory clinical response should be sought."	0
Hyperbilirubinemia has occurred during treatment with CRIXIVAN.	0
Use with caution in patients with a known sulfonamide allergy.	0
"In general, use caution when selecting a dosage for an elderly patient, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function and of concomitant disease or other drug therapy."	0
"Monitor serum transaminase levels, alkaline phosphatase, and bilirubin levels at weekly intervals when first beginning therapy and at monthly intervals thereafter."	0
DOSAGE MUST BE INDIVIDUALIZED AND MONITORED DURING UP-TITRATION.	0
"Worsening angina and acute myocardial infarction can develop after starting or increasing the dose of amlodipine, particularly in patients with severe obstructive coronary artery disease."	0
"Adults <U+2014> For most patients, initiate CYMBALTA 60mg once daily."	0
See CLINICAL PHARMACOLOGY<U+2013>Pediatrics; see also DOSAGE AND ADMINISTRATION.	0
"Monitor the INR in patients on chronic warfarin therapy in the 2-week period, particularly at 7 to 10 days, following initiation of the 3-day regimen of EMEND with each chemotherapy cycle, or following administration of a single 40-mg dose of EMEND for the prevention of postoperative nausea and vomiting."	0
Complete blood counts should be performed every 2 weeks for the first 2 months and then monthly thereafter.	0
"Table 4: Summary of Torsade de Pointes in Patients Randomized to Dofetilide by Dose; Patients with Supraventricular Arrhythmias TIKOSYN Dose <250 mcg BID 250 mcg BID >250<U+2013>500 mcg BID >500 mcg BID All Doses Number of Patients 217 388 703 38 1346 Torsade de Pointes 0 1 (0.3%) 6 (0.9%) 4 (10.5%) 11 (0.8%) As shown in Table 5, the rate of TdP was reduced when patients were dosed according to their renal function."	0
"In patients with sinus bradycardia or incomplete heart block, the administration of Lidocaine Hydrochloride Injection, USP intravenously or the elimination of ventricular ectopic beats without prior acceleration in heart rate may promote more frequent and serious ventricular arrhythmias or complete heart block."	0
"Poor metabolizers demonstrate higher plasma concentrations of antipsychotic drugs at usual doses, which may correlate with emergence of side effects."	0
"Recommended starting dose: 2 mg; dose can be repeated at 6 to 8 hour intervals, up to a maximum of 3 doses in 24 hours ( 2.1) Dosage can be increased by 2 mg to 4 mg per dose, with 1 to 4 days between increases; total daily dose should not exceed 36 mg ( 2.1) Tizanidine pharmacokinetics differs between tablets and capsules, and when taken with or without food."	0
Coadministration of VIRACEPT is contraindicated with drugs that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events.	1
Digitalis glycosides: Risk of bradycardia (7) Anticholinesterases: Prolongs neuromuscular blockade (7) Antihypertensive agents: Risk of rebound hypertension (7) Sympathomimetic drugs: Dose adjustment needed (7) Vasoconstrictive and positive inotropic effect substances: Avoid concomitant use (7)	0
"Atropine readily crosses the placental barrier and enters the fetal circulation, but is not found in amniotic fluid."	0
Do not administer ONIVYDE to patients with bowel obstruction.	0
Race: Pharmacokinetic differences due to race have not been studied.	0
Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy.	0
"A clinically significant fluvoxamine interaction is possible with drugs having a narrow therapeutic ratio such as pimozide, warfarin, theophylline, certain benzodiazepines, omeprazole, and phenytoin."	0
These risk differences (drug-placebo difference in the number of cases of suicidality per 1000 patients treated) are provided in Table1.	0
"The ONTARGET trial enrolled 25,620 patients <U+2265>55 years old with atherosclerotic disease or diabetes with end-organ damage, randomizing them to telmisartan only, ramipril only, or the combination, and followed them for a median of 56 months."	0
(7.4) Monitor digoxin levels with initiation of or any change in BRILINTA.	0
Concomitant use of drugs that are known combined P-gp and strong CYP3A4 inhibitors increases rivaroxaban exposure and may increase bleeding risk see Drug Interactions ( 7.2 ) .	1
Increased plasma concentrations of paroxetine occur in patients with severe renal impairment (creatinine clearance <30 ml/min) or severe hepatic impairment.	0
Sofosbuvir is approximately 61<U+2013>65% bound to human plasma proteins and the binding is independent of drug concentration over the range of 1 <U+00B5>g/mL to 20 <U+00B5>g/mL.	0
These have generally occurred in patients with advanced HIV-1 disease taking multiple concomitant medications.	0
Patients receiving ACE inhibitors who develop jaundice or marked elevations of hepatic enzymes should discontinue the ACE inhibitor and receive appropriate medical follow-up.	0
"Either correct this condition prior to administration of TWYNSTA tablets, or start treatment under close medical supervision with a reduced dose."	0
"Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with NORPRAMIN and should counsel them in its appropriate use."	0
"Approximately 20% of the dose is excreted in the urine, with approximately 66% being eliminated in the feces."	0
"Metabolism After oral administration, dabigatran etexilate is converted to dabigatran."	0
"If fluvoxamine and mexiletine are coadministered, serum mexiletine levels should be monitored."	0
Figure 1: Mean QTc-Concentration Relationship in Young Volunteers Over 24 Days Note: The range of dofetilide plasma concentrations achieved with the 500 mcg BID dose adjusted for creatinine clearance is 1<U+2013>3.5 ng/mL.	0
The co-administration of LIPITOR with cyclosporine should be avoided.	0
"Patients and physicians should be aware, however, that oligohydramnios may not appear until after the fetus has sustained irreversible injury."	0
"In subjects with creatinine clearance less than 40 mL/min, the plasma half-life of bisoprolol fumarate is increased up to threefold, as compared to healthy subjects."	0
"Combined Effects <U+2014> The combined effects of age, smoking, and gender could lead to substantial pharmacokinetic differences in populations."	0
"Sexual Dysfunction <U+2013> The rate of sexual dysfunction in male patients with OCD who were treated with Anafranil in the premarketing experience was markedly increased compared with placebo controls (i.e., 42% experienced ejaculatory failure and 20% experienced impotence, compared with 2.0% and 2.6%, respectively, in the placebo group)."	0
"Although a causal link between the emergence of such symptoms and either the worsening of depression and/or the emergence of suicidal impulses has not been established, there is concern that such symptoms may represent precursors to emerging suicidality."	0
"Hypoglycemic Drugs<U+2013>In a placebo-controlled trial in normal volunteers, administration of sertraline for 22 days (including 200 mg/day for the final 13 days) caused a statistically significant 16% decrease from baseline in the clearance of tolbutamide following an intravenous 1000 mg dose."	1
"Non-steroidal Anti-Inflammatory Agents, including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors) In patients who are elderly, volume-depleted (including those on diuretic therapy), or who have compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including azilsartan, may result in deterioration of renal function, including possible acute renal failure."	0
Dosage increase of methadone may be considered.	1
Divided daily dosing is recommended for pediatric patients under age 10.	0
Nursing Mothers It is not known whether isosorbide dinitrate is excreted in human milk.	0
Cimetidine has demonstrated a weak antiandrogenic effect.	0
"While healing with cimetidine tablets often occurs during the first week or two, treatment should be continued for 4 to 6 weeks unless healing has been demonstrated by endoscopic examination."	0
"The primary plasma metabolites are (S)-zopiclone-N-oxide and (S)-N-desmethyl zopiclone; the latter compound binds to GABA receptors with substantially lower potency than eszopiclone, and the former compound shows no significant binding to this receptor."	0
Patients should be warned that while taking this drug their response to alcoholic beverages may be exaggerated.	0
The clinical significance of these findings is unknown.	0
"In such patients, it is recommended that carvedilol be used with caution."	0
Co-administration of nifedipine with grapefruit juice resulted in approximately a doubling in nifedipine AUC and Cmax with no change in half-life.	1
"In treatment-experienced patients, treatment history, genotypic and/or phenotypic testing is recommended to assess drug susceptibility of the HIV-1 virus."	0
Propranolol or metoprolol: Reduce dose if coadministered and titrate more cautiously (7.3).	1
Increased Blood Pressure and Heart Rate: have been reported.	0
Candidemia in non-neutropenic patients and other deep tissue Candida infections See Table 1.	0
Safety of doses above 120 mg once daily has not been adequately evaluated.	0
Consult the labeling of all concurrently used drugs to obtain further information about interactions with COUMADIN or adverse reactions pertaining to bleeding.	0
"There is no consistent signal of increased incidence of QTc outliers, either absolute or change from baseline, associated with fingolimod treatment."	0
"Hydrochlorothiazide When plasma levels have been followed for at least 24 hours, the plasma half-life has been observed to vary between 5.6 and 14.8 hours."	0
Serum levels of several tricyclic antidepressants have been reported to be significantly increased when cimetidine is administered concurrently.	1
These admixtures are stable for 48 hours if they are not used immediately.	0
"See ADVERSE REACTIONS, Post-Marketing Experience."	0
"Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapy, including APTIVUS."	0
Smokers had a 25% increase in the metabolism of fluvoxamine compared to nonsmokers.	0
"Initiation of quetiapine in patients taking PREZISTA with ritonavir: Refer to the quetiapine prescribing information for initial dosing and titration of quetiapine. risperidone, thioridazine <U+2191> antipsychotics A dose decrease may be needed for these drugs when co-administered with PREZISTA/ritonavir. carvedilol, metoprolol, timolol <U+2191> beta-blockers Clinical monitoring of patients is recommended."	0
Pediatric patients should take LEXIVA oral suspension with food.	0
Clozapine Chronic administration of clozapine with risperidone may decrease the clearance of risperidone.	1
"For subjects with CLcr of <30 mL/min, the dose of clarithromycin should be reduced by 75%."	1
Anaphylactoid Reactions During Dialysis Sudden and potentially life threatening anaphylactoid reactions have occurred in some patients dialyzed with high-flux membranes and treated concomitantly with an ACE inhibitor.	0
Safety and effectiveness in the pediatric population have not been established.	0
Excessive alkali therapy is not advisable.	0
"Patients with a heart rate of < 50 bpm or systolic blood pressure <100mmHg, or with other contraindications to beta blockade were excluded."	0
"In patients who are currently being treated with a diuretic , symptomatic hypotension occasionally may occur following the initial dose of VASOTEC ."	0
"Vasodilatory symptoms often do not require treatment, but it may be useful to separate the time of dosing of COREG from that of the ACE inhibitor or to reduce temporarily the dose of the ACE inhibitor."	0
Approximately 2% of patients in the mexiletine compassionate use program had elevations of SGOT greater than or equal to three times the upper limit of normal.	0
No reports involved the administration of methylene blue by other routes (such as oral tablets or local tissue injection) or at lower doses.	0
Clinical experience with CYMBALTA in patients with concomitant systemic illnesses is limited.	0
"As a result, the dose of triamterene required is not proportionally related to the level of mineralocorticoid activity, but is dictated by the response of the individual patients, and the kaliuretic effect of concomitantly administered drugs."	0
"Catecholamine depleting drugs (e.g., reserpine, monoamine oxidase (MAO) inhibitors) may have an additive effect when given with beta-blocking agents."	0
Race No dosage adjustment is recommended based on race.	0
Fluvoxamine (strong CYP1A2 inhibitor): Increases AUC for ramelteon and should not be used in combination.	1
The absolute bioavailability of sublingual asenapine at 5 mg is 35%.	0
In most patients no benefit has been associated with using two RAS inhibitors concomitantly.	0
Patients with impaired liver function should be given rifampin only in cases of necessity and then with caution and under strict medical supervision.	0
"During isometric or dynamic exercise, verapamil does not alter systolic cardiac function in patients with normal ventricular function."	0
This reaction may interfere with absorption of AHA and with iron.	1
It would also be possible for risperidone to interfere with metabolism of other drugs metabolized by CYP 2D6.	1
Warning Cases of life-threatening hepatic failure have been reported in patients treated with nefazodone hydrochloride tablets.	0
It is not a monoamine oxidase inhibitor and it does not act primarily by stimulation of the central nervous system.	0
"Myelosuppression Withhold or dose-reduce Tasigna for hematological toxicities (neutropenia, thrombocytopenia) that are not related to underlying leukemia (Table 2)."	0
An example of a proton pump inhibitor is omeprazole.	0
Histamine-2 Receptor Antagonists: The pharmacokinetics of nebivolol (5 mg single dose) were not affected by the co-administration of ranitidine (150 mg twice daily).	0
HCV Products: simeprevir <U+2191> ledipasvir<U+2191> simeprevir Concentrations of ledipasvir and simeprevir are increased when simeprevir is coadministered with ledipasvir.	1
Approximately 70% of an administered dose is excreted as metabolites in the urine and 16% or more in the feces within 5 days.	0
Ondansetron does not alter the respiratory depressant effects produced by alfentanil or the degree of neuromuscular blockade produced by atracurium.	0
This category also provides a buffer zone that prevents small-uncontrolled technical factors from causing major discrepancies in interpretation.	0
The starting dose of PURIXAN in multi-agent combination chemotherapy maintenance regimens is 1.5 to 2.5 mg/kg (50 to 75 mg/m2) as a single daily dose.	0
"The combination may result in increased risk of cardiovascular adverse events associated with salmeterol, including QT prolongation, palpitations and sinus tachycardia."	0
"Prolongation of the PR interval is also significant, but less closely correlated with plasma levels."	0
These increases were almost always reversible upon discontinuation of the ACE inhibitor and/or diuretic therapy.	0
See CLINICAL PHARMACOLOGY for dosing information in patients with renal failure.	0
Interpretation involves correlation of the diameter obtained in the disk test with the MIC for rifampin.	0
Rosuvastatin dose should not exceed 10 mg/day.	0
Nucleoside Reverse Transcriptase Inhibitors: Abacavir <U+2193> Abacavir AUC by approximately 40% Clinical relevance of reduction in abacavir levels not established.	0
Buprenorphine/naloxone <U+2194> Buprenorphine<U+2193> Tipranavir APTIVUS/ritonavir did not result in changes in the clinical efficacy of buprenorphine/naloxone.	0
The potential for a pharmacokinetic interaction exists with the co-administration of CYP2D6 inhibitors which may increase the risk with increased exposure to DESOXYN.	1
"The safety and efficacy of PRADAXA in patients with bileaflet mechanical prosthetic heart valves was evaluated in the RE-ALIGN trial, in which patients with bileaflet mechanical prosthetic heart valves (recently implanted or implanted more than three months prior to enrollment) were randomized to dose adjusted warfarin or 150, 220, or 300 mg of PRADAXA twice a day."	0
The bolus dose should be repeated if infusion is not initiated within 15 minutes of the initial bolus dose.	0
"Using an Emax model, the maximum effect is a 30% reduction in exercise heart rate, which is attributed to beta1-blockade."	0
"Pediatric Pharmacokinetics<U+2013>Sertraline pharmacokinetics were evaluated in a group of 61 pediatric patients (29 aged 6 to 12 years, 32 aged 13 to 17 years) with a DSM-III-R diagnosis of major depressive disorder or obsessive-compulsive disorder."	0
A minor decrease in the amount of drug excreted unchanged in the urine suggests that there was little effect on the CYP metabolism or bioavailability of paliperidone during carbamazepine co-administration.	0
"In hypertensive patients, decreases in blood pressure below normal are unusual."	0
"Prescriptions for Savella should be written for the smallest quantity of tablets consistent with good patient management, in order to reduce the risk of overdose."	0
"If these signs or symptoms occur, discontinue RIFADIN and administer supportive measures."	0
"Alteration of pH may affect absorption of certain drugs (e.g., ketoconazole)."	0
"If CDAD is suspected or confirmed, discontinue antibacterial use not directed against C. difficile if possible."	0
"Because of its relative beta1 cardio-selectivity, however, metoprolol succinate extended release/hydrochlorothiazide may be used in patients with bronchospastic disease who do not respond to, or cannot tolerate, other antihypertensive treatment."	0
All of the patients in this study received a starting dose of 20mg of simvastatin; 37% were titrated to 40mg.	0
An increase in mammary neoplasms has been found in rodents after chronic administration of neuroleptic drugs.	0
Limit the total dose of atropine sulfate to 0.03 mg/kg to 0.04 mg/kg.	0
"In the clinical trials of patients with newly-diagnosed low-risk APL treated with TRISENOX in combination with tretinoin, 11% experienced QTc prolongation > 450 msec for men and > 460 msec for women throughout the treatment cycles."	0
"If trazodone is used with a CYP 3A4 inhibitor such as APTIVUS/ritonavir, the combination should be used with caution and a lower dose of trazodone should be considered."	1
CYP2D6 Inhibitors - Concomitant use may increase atomoxetine steady-state plasma concentrations in EMs.	1
Methadone: Administration of indinavir (800 mg every 8 hours) with methadone (20 mg to 60 mg daily) for one week in subjects on methadone maintenance resulted in no change in methadone AUC.	0
"If needed, a cation exchange resin such as sodium polystyrene sulfonate may be given orally or by enema."	0
"Distribution: Asenapine is rapidly distributed and has a large volume of distribution (approximately 20 - 25 L/kg), indicating extensive extravascular distribution."	0
"Injection in Dextrose Injection USP, Sodium Chloride Injection USP, or Sodium Chloride and Dextrose Injection may be used."	0
"When DEMSER is used preoperatively , alone or especially in combination with alpha-adrenergic blocking drugs , adequate intravascular volume must be maintained intraoperatively ( especially after tumor removal ) and postoperatively to avoid hypotension and decreased perfusion of vital organs resulting from vasodilatation and expanded volume capacity ."	0
"In many cases, medical follow-up information was limited."	0
Caution must be exercised whenever quinidine is prescribed together with drugs metabolized by cytochrome P450IID6.	0
"In patients with severe heart failure whose renal function may depend on the activity of the renin-angiotensin-aldosterone system, treatment with ACE inhibitors, including ACCUPRIL, may be associated with oliguria and/or progressive azotemia and rarely acute renal failure and/or death."	0
LASIX has a tendency to antagonize the skeletal muscle relaxing effect of tubocurarine and may potentiate the action of succinylcholine .	0
10 mg/day is the recommended dose for most elderly patients and patients with hepatic impairment.	0
Co-administration of Tracleer in Patients on Ritonavir .	0
Patients with underlying hepatitis B or C viral infections or marked elevations in transaminases before treatment may be at increased risk for developing further transaminase elevations or hepatic decompensation.	0
Correct hypokalemia or hypomagnesemia prior to initiating saquinavir/ritonavir and monitor these electrolytes periodically during therapy.	0
"In healthy volunteers receiving 4 mg pitavastatin, the percent change from baseline for LDL-C following evening dosing was slightly greater than that following morning dosing."	0
"Because of significant negative inotropic and chronotropic effects in patients treated with <U+03B2>-blockers and calcium channel blockers of the verapamil and diltiazem type, monitor the ECG and blood pressure in patients treated concomitantly with these agents."	0
"In the dronedarone 400 mg twice-daily group, there was no apparent effect on heart rate; a moderate heart rate lowering effect (about 4 bpm) was noted at 800 mg twice daily."	0
The effect of sildenafil on epoprostenol pharmacokinetics is not known.	0
"Hypertension For patients with hypertension and renal impairment, the recommended initial dose is 1.25 mg ALTACE once daily."	0
"Based upon a pharmacokinetic study in healthy volunteers, a 5mg dose of intramuscular olanzapine for injection produces, on average, a maximum plasma concentration approximately 5 times higher than the maximum plasma concentration produced by a 5mg dose of oral olanzapine."	0
Patients with impaired liver function may require a lower starting dose and slower titration ( 5.15 ).	0
The recommended dose of PREZISTA/ritonavir for pediatric patients (3 to less than 18 years of age and weighing at least 10 kg is based on body weight and should not exceed the recommended adult dose.	0
"MEVACOR significantly decreased plasma levels of total<U+2011>C, LDL<U+2011>C and apolipoproteinB."	0
"The undiluted PROSTIN VR PEDIATRIC Sterile Solution should then be added to the intravenous infusion solution, avoiding direct contact of the undiluted solution with the walls of the volumetric infusion chamber."	0
"This dose may improve symptoms of heart failure, but increases in exercise duration have generally required higher doses."	0
"Continually reevaluate patients receiving Meperidine Hydrochloride Injection to assess the maintenance of pain control and the relative incidence of adverse reactions, as well as monitoring for the development of addiction, abuse, or misuse."	0
These studies have also shown that concurrent use of an NSAID or aspirin may potentiate this risk of bleeding.	0
"Avoid use of strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin) [see Clinical Pharmacology (12.3) ]."	0
Exclude pregnancy before the initiation of treatment with Letairis.	0
"If concomitant use of paroxetine with a triptan is clinically warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases."	0
"Concomitant potassium supplementation in the form of medication, potassium-containing salt substitute or potassium-enriched diets should also not be used."	0
Serious Cardiovascular Reactions: Sudden death has been reported in association with CNS stimulant treatment at recommended doses in pediatric patients with structural cardiac abnormalities or other serious heart problems.	0
TENORETIC should not be given to patients with untreated pheochromocytoma.	0
No significant differences in the lipid-lowering effects were observed between the two administrations.	0
"ANTIFUNGALS Fluconazole 200 mg QD <U+00D7> 2 weeks 300 mg QD <U+00D7> 2 weeks HIV-infected patients (12) <U+2191> AUC by 82%,<U+2191> Cmax by 88% <U+2194> Monitor for rifabutin associated adverse events."	0
"During the initial phase of combination antiretroviral treatment, patients whose immune system responds may develop an inflammatory response to indolent or residual opportunistic infections (such as Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia [PCP], or tuberculosis), which may necessitate further evaluation and treatment."	0
"Reduced cytochrome P450 2D6 isozyme activity, drugs which inhibit this isozyme (e.g., fluoxetine and paroxetine), and certain other drugs (e.g., fluvoxamine, propranolol, and pindolol) appear to appreciably inhibit the metabolism of thioridazine."	1
"Hydrochlorothiazide was not genotoxic in in vitro assays using strains TA 98, TA 100, TA 1535, TA 1537, and TA 1538 of Salmonella typhimurium (the Ames test); in the Chinese hamster ovary (CHO) test for chromosomal aberrations; or in vivo assays using mouse germinal cell chromosomes, Chinese hamster bone marrow chromosomes, and the Drosophila sex-linked recessive lethal trait gene."	0
"Thioridazine administration produces a dose-related prolongation of the QTc interval, which is associated with serious ventricular arrhythmias, such as torsades de pointes-type arrhythmias, and sudden death."	0
Teratogenic effects: Pregnancy Category C. Methamphetamine has been shown to have teratogenic and embryocidal effects in mammals given high multiples of the human dose.	0
"If, during the cardiovascular evaluation, the patient's medical history or electrocardiographic investigations reveal findings indicative of or consistent with coronary artery vasospasm or myocardial ischemia, D.H.E."	0
Tablets may be crushed and added to semi-solid food.	0
Blockade of the alpha1 receptor decreases urethral resistance and may relieve the obstruction and BPH symptoms and improve urine flow.	0
"After at least 10days following the initiation of LEXIVA, resume bosentan at 62.5mg once daily or every other day based upon individual tolerability."	0
Simvastatin is metabolized by the cytochrome P450 isoform 3A4.	0
"Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)."	0
"In patients with renal disease, plasma concentrations of hydrochlorothiazide are increased and the elimination half-life is prolonged."	0
"For Grade 3 to 4 bilirubin or hepatic transaminase elevations, dosing should be withheld, and may be resumed at 400 mg oncedaily."	0
Sotalol crosses the blood brain barrier poorly.	0
"Due to the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, use of the 80-mg dose of ZOCOR should be restricted to patients who have been taking simvastatin 80mg chronically (e.g., for 12months or more) without evidence of muscle toxicity."	0
Bupropion and its metabolites exhibit linear kinetics following chronic administration of 300 to 450 mg/day.	0
"In healthy adults, LUNESTA does not accumulate with once-daily administration, and its exposure is dose-proportional over the range of 1 to 6 mg. Absorption and Distribution Eszopiclone is rapidly absorbed following oral administration."	0
Isolated reports have associated porphyria exacerbation with rifampin administration.	0
"CYP2C9, a polymorphic enzyme, is likely to be the principal form of human liver CYP450 that modulates the in vivo anticoagulant activity of warfarin."	0
The least amount feasible should be prescribed or dispensed at one time in order to minimize the possibility of overdosage.	0
Inhibition of ACE results in decreased plasma angiotensin II which leads to decreased vasopressor activity and to decreased aldosterone secretion.	0
"Therefore, these tests should be performed before the morning dose of rifampin."	0
"For patients who cannot swallow oral capsules, EMEND for oral suspension can be used instead of EMEND capsules as shown in Table 3."	0
"Verapamil administered concomitantly with oral antihypertensive agents (e.g., vasodilators, angiotensin-converting enzyme inhibitors, diuretics, beta-blockers) will usually have an additive effect on lowering blood pressure."	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
See prescribing information for warfarin.	0
"Proton Pump Inhibitors: Omeprazole <U+2193> Omeprazole, <U+2194> Tipranavir Dosage of omeprazole may need to be increased when co-administered with APTIVUS and ritonavir."	1
"PDE5 inhibitor:RevatioRegistered trademark of Pfizer, Inc. (sildenafil) [for treatment of pulmonary arterial hypertension] A safe and effective dose has not been established when used with CRIXIVAN."	0
"Higher plasma concentrations of the active nortriptyline metabolite, 10-hydroxynortriptyline, have also been reported in elderly patients."	0
Cardiac Electrophysiology Thorough QT studies have been conducted for ledipasvir and sofosbuvir.	0
"Hyperpyrexia, not associated with the above symptom complex, has been reported with other antipsychotic drugs."	0
"In most patients, however, use of quinidine is associated with an increase in sinus rate."	0
"Specifically, one to two weeks should be allowed to elapse before one concludes that an increase in tic manifestations is a function of the underlying disease syndrome rather than a response to drug withdrawal."	0
"Hydrochlorothiazide Hypersensitivity reactions to hydrochlorothiazide may occur in patients with or without a history of allergy or bronchial asthma, but are more likely in patients with such a history."	0
"Although the prevalence of the syndrome appears to be highest among the elderly, especially elderly women, it is impossible to rely upon prevalence estimates to predict, at the inception of antipsychotic treatment, which patients are likely to develop the syndrome."	0
"In clinical studies in which NORVASC was administered in combination with beta-blockers to patients with either hypertension or angina, no adverse effects on electrocardiographic parameters were observed."	0
Similar results may be anticipated in patients treated with Benicar.	0
A similar phenomenon has been seen with several other dihydropyridine calcium channel blockers.	0
There are no adequate and well-controlled studies in pregnant women.	0
All three compounds show CNS depressant activity.	0
Drugs That Inhibit Aldehyde Oxidase The aldehyde oxidase enzyme system is less well studied than the cytochrome P450 enzyme system.	0
"Since pimozide is partly metabolized via CYP 3A4, it should not be administered concomitantly with inhibitors of this metabolic system, such as azole antifungal agents and protease inhibitor drugs."	0
"Avoid the use of preparations, such as decongestants and local anesthetics, that contain any sympathomimetic amine (e.g., epinephrine, norepinephrine), since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines."	0
"An interaction study demonstrated that co-administration of bosentan and a combination oral hormonal contraceptive produced average decreases of norethindrone and ethinyl estradiol levels of 14 % and 31 % , respectively ."	1
Atropine may cause inspissation of bronchial secretions and formation of viscid plugs in patients with chronic lung disease.	0
"The concomitant use of paroxetine with other SSRIs, SNRIs, or tryptophan is not recommended."	0
"Since there is little clinical experience, the concomitant administration of paroxetine and warfarin should be undertaken with caution."	0
"During infusion of the intravenous formulation of voriconazole in healthy subjects, anaphylactoid-type reactions, including flushing, fever, sweating, tachycardia, chest tightness, dyspnea, faintness, nausea, pruritus and rash, have occurred uncommonly."	0
Concomitant use of Zanaflex with oral contraceptives is not recommended.	0
"In normal subjects treated for 7 days with four times the recommended dosage, there was no evidence of altered systemic bioavailability, rate of elimination, or accumulation."	0
"Concomitant use of Meperidine Hydrochloride Injection with a CYP3A4 inhibitor, such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), may increase plasma concentrations of meperidine and prolong opioid adverse reactions, which may cause potentially fatal respiratory depression , particularly when an inhibitor is added after a stable dose of Meperidine Hydrochloride Injection is achieved."	0
However it is proposed that the efficacy of FANAPTis mediated through a combination of dopamine type 2 (D2) and serotonin type 2 (5-HT2) antagonisms.	0
"Due to the risk to the patient and the community, discontinuation of Silenor should be strongly considered for patients who report a ""sleep-driving"" episode."	0
Alternative antiretroviral therapy to REYATAZ may be considered if jaundice or scleral icterus associated with bilirubin elevations presents cosmetic concerns for patients.	0
"Although any chloride deficit is generally mild and usually does not require specific treatment except under extraordinary circumstances (as in liver disease or renal disease), chloride replacement may be required in the treatment of metabolic alkalosis."	0
"Avoid co-administration of CYP 3A inducers ( e.g. , rifampin , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine , St.   John 's   Wort ) with SAMSCA , as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment ."	1
EXTRANEAL is contraindicated in patients with severe lactic acidosis.	0
"Patients with underlying chronic hepatitis, cirrhosis, or in patients who have pre-treatment elevations of transaminases should be monitored for elevation in serum liver biochemistries, especially during the first several months of PREZISTA/ritonavir treatment."	0
There may be circumstances when it is necessary to initiate treatment with an MAOI such as linezolid or intravenous methylene blue in a patient taking NORPRAMIN.	0
Hypertension Initiate with 150/12.5 mg. Titrate to 300/12.5 mg then 300/25 mg if needed.	0
The more potent warfarin S-enantiomer is metabolized by CYP2C9 while the R-enantiomer is metabolized by CYP1A2 and 3A4.	0
"Because quinapril and hydrochlorothiazide are secreted in human milk, caution should be exercised when ACCURETIC is administered to a nursing woman."	0
Consider the potential for drug interactions prior to and during CRIXIVAN therapy; review concomitant medications during CRIXIVAN therapy; and monitor for the adverse reactions associated with the concomitant medications.	0
"Dosage may be titrated upward until blood pressure is controlled or to a maximum total daily dose of 5 mg. Heart Failure Post-Myocardial Infarction For patients with heart failure and renal impairment, the recommended initial dose is 1.25 mg ALTACE once daily."	0
"For the tablet, AUC was slightly increased when drug was administered with food but the Cmax was 25% greater, while the time to reach peak plasma concentration (Tmax) decreased from 8 hours post-dosing to 5.5 hours."	1
"However, during nightly use for an extended period, pharmacodynamic tolerance or adaptation to some effects of benzodiazepine hypnotics may develop."	0
"In the CHARM program (heart failure patients), hypotension was reported in 18.8% of patients on ATACAND versus 9.8% of patients on placebo."	0
"Treatment of Deep Venous Thrombosis and Pulmonary Embolism For patients with CrCl >30 mL/min, the recommended dose of PRADAXA is 150 mg taken orally, twice daily, after 5-10 days of parenteral anticoagulation."	0
"Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary)."	0
"By whole body autoradiography, radioactivity was found in the placenta following administration of labeled drug to pregnant rats, but none was found in the fetuses."	0
"As with tricyclic antidepressants to which it is closely related, Anafranil may precipitate an acute psychotic episode in patients with unrecognized schizophrenia."	0
"Concomitant use of strong CYP3A4 inhibitors: Reduce quetiapine dose to one sixth when coadministered with strong CYP3A4 inhibitors (e.g. ketoconazole, ritonavir) (2.5, 7.1, 12.3) Concomitant use of strong CYP3A4 inducers: Increase quetiapine dose up to 5 fold when used in combination with a chronic treatment (more than 7 to 14 days) of potent CYP3A4 inducers (e.g. phenytoin, rifampin, St. John<U+2019>s wort) (2.6, 7.1, 12.3) Discontinuation of strong CYP3A4 inducers: Reduce quetiapine dose by 5 fold within 7 to 14 days of discontinuation of CYP3A4 inducers (2.6, 7.1, 12.3) The risks of using quetiapine in combination with other drugs have not been extensively evaluated in systematic studies."	1
PREZISTA must be co-administered with ritonavir to exert its therapeutic effect.	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older.	0
"Therefore, start with a low initial dose of amlodipine."	0
"Examples: aspirin, clopidogrel, heparin, warfarin Drugs Highly Bound to Plasma Protein Clinical Impact: ZOLOFT is highly bound to plasma protein."	0
Digoxin may cause severe sinus bradycardia or sinoatrial block particularly in patients with pre-existing sinus node disease and may cause advanced or complete heart block in patients with pre-existing incomplete AV block.	0
The pupillary dilation that occurs following use of many antidepressant drugs including SURMONTIL may trigger an angle closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy.	0
The plasma protein binding of desvenlafaxine is low (30%) and is independent of drug concentration.	0
Bradycardia has been reported with the coadministration of fluvoxamine maleate and diltiazem.	0
"Monitor liver function before and during therapy, especially in patients with underlying chronic hepatitis, cirrhosis, or in patients who have pre-treatment elevations of transaminases."	0
"There are, however, no adequate and well-controlled studies in pregnant women."	0
The risk of administering methylene blue by non-intravenous routes (such as oral tablets or by local injection) or in intravenous doses much lower than 1 mg/kg with PRISTIQ is unclear.	0
"Patients with moderate or severe (Child-Pugh Class B or C) hepatic impairment (4.1, 5.1) Use with drugs highly dependent on CYP 3A for clearance or are potent CYP 3A inducers (4.2, 5.3, 7) APTIVUS is contraindicated in patients with moderate or severe (Child-Pugh Class B or C, respectively) hepatic impairment."	0
Additional risk factors for bleeding include: body weight <60kg; propensity to bleed; concomitant use of medications that increase the risk of bleeding (5.1).	0
"In addition, interactions with coadministered drugs can alter the serum concentration and activity of quinidine, leading either to toxicity or to lack of efficacy if the dose of quinidine is not appropriately modified."	0
"Hepatic Impairment Because of the rapid rate at which lidocaine is metabolized, any condition that affects liver function may alter lidocaine kinetics."	0
"This finding is consistent with the inhibition of PDE6, which is involved in phototransduction in the retina."	0
"Tamoxifen: Some studies have shown that the efficacy of tamoxifen, as measured by the risk of breast cancer relapse/mortality, may be reduced when co-prescribed with paroxetine as a result of paroxetine<U+2019>s irreversible inhibition of CYP2D6."	0
"Before therapy with NATRECOR<U+00AE> is instituted, careful inquiry should be made to determine whether the patient has had a previous hypersensitivity reaction to other recombinant peptides."	0
"In a randomized, double-blind, placebo-controlled, 4-way parallel, active-comparator study with moxifloxacin in 174 healthy participants, LIVALO was not associated with clinically meaningful prolongation of the QTc interval or heart rate at daily doses up to 16 mg (4 times the recommended maximum daily dose)."	0
"The pooled analyses of placebo-controlled studies in children and adolescents with MDD, obsessive compulsive disorder (OCD), or other psychiatric disorders included a total of 24 short-term studies of 9 antidepressant drugs in over 4,400 patients."	0
"The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Centers for Disease Control and Prevention recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH resistance is very low."	0
Postmarketing reports indicate that STRATTERA can cause severe liver injury.	0
Early drug discontinuation in these patients is advisable.	0
Cumulative effects of the drug may develop in patients with impaired renal function.	0
A dose proportional relationship has been established for the area under the plasma concentration/time curve over the 15 mg to 30 mg dose range.	0
"Multiple oral doses of ramipril of 2.0 mg or more cause plasma ACE activity to fall by more than 90% 4 hours after dosing, with over 80% inhibition of ACE activity remaining 24 hours after dosing."	0
Coadministration with aliskiren in patients with diabetes.	0
Hyperphosphatemia also plays a role in the development of secondary hyperparathyroidism in patients with ESRD.	0
"Combined administration of a single dose of ritonavir (600 mg), both a CYP3A4 substrate and a potent inhibitor of CYP3A4, and escitalopram (20 mg) did not affect the pharmacokinetics of either ritonavir or escitalopram."	0
Valvular heart disease associated with the use of some anorectic agents such as fenfluramine and dexfenfluramine has been reported.	0
See prescribing information for nelfinavir.	0
"It is recommended that COREG be started at 6.25mg twice daily and increased after 3 to 10days, based on tolerability, to 12.5mg twice daily, then again to the target dose of 25mg twice daily."	0
"Known hypersensitivity to sevelamer carbonate, sevelamer hydrochloride, or to any of the excipients."	0
"When the two drugs were taken concomitantly, decreased concentrations of atovaquone and increased concentrations of rifampin were observed."	1
PRINIVIL is contraindicated in patients with: a history of angioedema or hypersensitivity related to previous treatment with an angiotensin converting enzyme inhibitor hereditary or idiopathic angioedema.	0
"If the patient is hypertensive or recently post-myocardial infarction, ALTACE can also be given as a divided dose."	0
"Serious, life-threatening, or fatal respiratory depression may occur with use of Meperidine Hydrochloride Injection."	0
"The ability to predict the occurrence of seizures in subjects exposed to doses of CMI greater than 250 mg is limited, given that the plasma concentration of CMI may be dose-dependent and may vary among subjects given the same dose."	0
Serum levels of haloperidol are increased when quinidine is coadministered.	1
"Initiate with low dose and increase after ECG verification of tolerability (7.1, 7.3) CYP3A inducers: Avoid concomitant use (7.2) Grapefruit juice: Avoid concomitant use (7.2) Statins: Avoid simvastatin doses greater than 10 mg daily."	0
"Plasma TCA concentrations may need to be monitored, and the dose of TCA may need to be reduced, if a TCA is co-administered with sertraline hydrochloride."	1
"Of the 1,986 simvastatin treated patients in 4S with normal liver function tests (LFTs) at baseline, 8 (0.4%) developed consecutive LFT elevations to >3X ULN and/or were discontinued due to transaminase elevations during the 5.4 years (median follow-up) of the study."	0
"Due to the chronic nature of GERD, there may be a potential for prolonged administration of PROTONIX."	0
Concomitant administration of tolvaptan with furosemide or hydrochlorothiazide results in a 24 hour urine volume/excretion rate that is similar to the rate after tolvaptan administration alone .	0
"Because of the risk of unrecognized hypoglycemia that could result from a drug-device interaction, EXTRANEAL is available only through a restricted program ( 5.2 )."	0
"Intravenous hydrocortisone or prednisolone have been used to treat severe reactions, with the addition of intravenous chlorpromazine in those cases exhibiting hypertension and hyperpyrexia."	0
A differential diagnosis should be made between respiratory distress syndrome (hyaline membrane disease) and cyanotic heart disease (restricted pulmonary blood flow).	0
"Because nicardipine is extensively metabolized by the liver, plasma concentrations are influenced by changes in hepatic function."	0
"TENORMIN is contraindicated in sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure."	0
Larger effects were recorded among patients receiving concomitant nitrates.	0
"Specific Populations Renal Impairment <U+2014> Because olanzapine is highly metabolized before excretion and only 7% of the drug is excreted unchanged, renal dysfunction alone is unlikely to have a major impact on the pharmacokinetics of olanzapine."	0
"Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs."	0
"Concomitant administration of both a CYP2C9 inhibitor ( such as fluconazole or amiodarone ) and a strong CYP3A inhibitor ( e.g. , ketoconazole , itraconazole ) or a moderate CYP3A inhibitor ( e.g. , amprenavir , erythromycin , fluconazole , diltiazem ) with Tracleer will likely lead to large increases in plasma concentrations of bosentan ."	1
"ELIQUIS can cause serious, potentially fatal, bleeding."	0
There are no adequate and well-controlled studies in pregnant women.	0
Plasma concentrations are linearly related to the administered dose.	0
Approximately 2% of fluvoxamine was excreted in urine unchanged.	0
Other severe or life-threatening (grade 3-4) nonhematologic reactions Temporarily withhold TRISENOX and tretinoin.	0
ACE inhibitors have been associated with a syndrome that starts with cholestatic jaundice and progresses to fulminant hepatic necrosis and (sometimes) death.	0
The total ROZEREM dose should not exceed 8 mg per day.	0
No relationship has been established between the plasma concentration of verapamil and reduction in blood pressure.	0
Drug-Drug Interactions In vitro drug interaction studies reveal that paroxetine inhibits CYP2D6.	0
Use of PDE5 inhibitors for pulmonary arterial hypertension (PAH): Use of REVATIO<U+00AE> (sildenafil) for the treatment of pulmonary hypertension (PAH) is contraindicated with REYATAZ.	0
"If intolerable symptoms occur following a decrease in the dose or upon discontinuation of treatment, then resuming the previously prescribed dose may be considered."	0
Hypertension The mechanism of action of CARDURA is selective blockade of the alpha1 (postjunctional) subtype of adrenergic receptors.	0
An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy.	0
Advise patients subject to spontaneous hypoglycemia and diabetic patients receiving insulin or oral hypoglycemic agents about these possibilities.	0
"Quetiapine is an antagonist at multiple neurotransmitter receptors in the brain: serotonin 5HT1A and 5HT2 (IC50s=717 & 148nM, respectively), dopamine D1 and D2 (IC50s=1268 & 329nM, respectively), histamine H1 (IC50=30nM), and adrenergic <U+03B1>1 and <U+03B1>2receptors (IC50s=94 & 271nM, respectively)."	0
Discontinue or replace with an alternative drug that does not prolong the QT/QTc interval while patient is using TRISENOX.	0
Maintenance therapy is in the range of 50 to 150 mg/day.	0
STRATTERA is contraindicated in patients known to be hypersensitive to atomoxetine or other constituents of the product.	0
"For patients taking warfarin, carefully monitor the international normalized ratio."	0
The following doses are for administration of the drug as a single agent.	0
Combined P-gp and strong CYP3A4 inducers decrease exposure to rivaroxaban and may increase the risk of thromboembolic events .	0
"<U+00A7> No dose adjustment is recommended for nonvalvular atrial fibrillation patients unless at least 2 of the following patient characteristics (age greater than or equal to 80 years, body weight less than or equal to 60 kg, or serum creatinine greater than or equal to 1.5 mg/dL) are present."	0
The concomitant use of PRISTIQ with other desvenlafaxine-containing products or venlafaxine will increase desvenlafaxine blood levels and increase dose-related adverse reactions.	1
"Focalin XR capsules may be swallowed whole, or capsule contents can be sprinkled on applesauce."	0
PROCARDIA is rapidly and fully absorbed after oral administration.	0
Hemophilia: Spontaneous bleeding may occur and additional factor VII may be required.	0
"If the 75 mg dose of intravenous sotalol does not reduce the frequency of relapses of life threatening ventricular arrhythmias or symptomatic AFIB/AFL and is tolerated without excessive (i.e., to >500 ms) QTc prolongation, increase the dose to 112.5 mg infused over 5 hours, once or twice daily depending upon the creatinine clearance."	0
Inhibition of CYP17 by abiraterone can also result in increased mineralocorticoid production by the adrenals.	0
"The clinician should, nevertheless, be aware of the possibility of emergent symptoms of serotonin syndrome with such use."	0
"Digoxin Concentrations Decreased Acarbose, Activated Charcoal, Albuterol, Antacids, certain cancer chemotherapy or radiation therapy, Cholestyramine, Colestipol, Exenatide, Kaolin-pectin, Meals High in Bran, Metoclopramide, Miglitol, Neomycin, Penicillamine, Phenytoin, Rifampin, St. John<U+2019>s Wort, Sucralfate, Sulfasalazine Measure serum digoxin concentrations before initiating concomitant drugs."	1
"Careful follow-up of weight and height in children ages 7 to 10 years who were randomized to either methylphenidate or nonmedication treatment groups over 14 months, as well as in naturalistic subgroups of newly methylphenidate-treated and nonmedication treated children over 36 months (to the ages of 10 to 13 years), suggests that consistently medicated children (i.e., treatment for 7 days per week throughout the year) have a temporary slowing in growth rate (on average, a total of about 2 cm less growth in height and 2.7 kg less growth in weight over 3 years), without evidence of growth rebound during this period of development."	0
"Other drugs that are specific substrates, inhibitors, or inducers of this enzyme system may have a significant impact on the efficacy and side effect profile of diltiazem."	0
"Efficacy was assessed with the Daily Record of Severity of Problems (DRSP), a patient-rated instrument that mirrors the diagnostic criteria for PMDD as identified in the DSM-IV, and includes assessments for mood, physical symptoms, and other symptoms."	0
"It is believed that platelet reactivity and interaction with prosthetic cardiac valve surfaces, resulting in abnormally shortened platelet survival time, is a significant factor in thromboembolic complications occurring in connection with prosthetic heart valve replacement."	0
"Administration of NitroMist is contraindicated in patients who are using a selective inhibitor of cyclic guanosine monophosphate ( cGMP ) - specific phosphodiesterase type 5 ( PDE5 ) , as PDE5 inhibitors such as sildenafil , vardenafil , and tadalafil have been shown to potentiate the hypotensive effects of organic nitrates see DRUG INTERACTIONS ( 7.1 ) ."	0
The recommended dose of NATRECOR<U+00AE> is an IV bolus of 2 mcg/kg followed by a continuous infusion of 0.01 mcg/kg/min.	0
"In the first 2 weeks post-MI careful dose titration is especially important, particularly in patients with markedly impaired ventricular function."	0
"The reservoir should be made of polyvinyl chloride, polypropylene, or glass."	0
"Peak plasma concentrations are observed within 1-5 hours of dosing, and range from 70-490 ng/mL following oral doses of 12.5-100 mg."	0
Protriptyline hydrochloride is an antidepressant agent.	0
Reduce dose or suspend use of MYCOBUTIN if toxicity is suspected.	0
"Avoid use of strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin) [see Clinical Pharmacology (12.3) ]."	0
"Renvela contains sevelamer carbonate, a non-absorbed phosphate binding cross-linked polymer, free of metal and calcium."	0
The concomitant use of ZOLOFT with another drug that is highly bound to plasma protein may increase free concentrations of ZOLOFT or other tightly-bound drugs in plasma.	1
Do not administer or dilute reconstituted solutions of FLOLAN with other parenteral solutions or medications.	0
Known hypersensitivity to digoxin or other forms of digitalis.	0
The effect of mild renal impairment on pitavastatin exposure has not been studied.	0
"In an analysis of patients from all placebo-controlled trials, patients treated with CYMBALTA reported a higher rate of falls compared to patients treated with placebo."	0
Fluvoxamine increased mean alosetron plasma concentrations (AUC) approximately 6-fold and prolonged the half-life by approximately 3-fold.	1
EMEND is contraindicated in patients: who are hypersensitive to any component of the product.	0
"If priapism (painful erection greater than 6 hours in duration) is not treated immediately, penile tissue damage and permanent loss of potency could result."	0
"The clearance in young smoking males, for example, may be 3 times higher than that in elderly nonsmoking females."	0
"Withdrawal symptoms have been observed in clinical trials following discontinuation of milnacipran, as with other serotonin and norepinephrine re-uptake inhibitors (SNRIs) and selective serotonin re-uptake inhibitors (SSRIs)."	0
Antihypertensive Drugs and Pressor Agents - Possible effects on blood pressure.	0
"Concomitant administration of both a CYP2C9 inhibitor ( such as fluconazole or amiodarone ) and a strong CYP3A inhibitor ( e.g. , ketoconazole , itraconazole ) or a moderate CYP3A inhibitor ( e.g. , amprenavir , erythromycin , fluconazole , diltiazem ) with Tracleer will likely lead to large increases in plasma concentrations of bosentan ."	1
Pulmonary edema: Discontinue therapy if pulmonary edema occurs.	0
Efficacy in the elderly has not been demonstrated in placebo-controlled trials.	0
Severe diarrhea occurred in 13% of patients receiving ONIVYDE in combination with fluorouracil and leucovorin.	0
"If adrenal insufficiency is diagnosed, treat with physiologic replacement doses of corticosteroids."	0
LIVALO had no significant pharmacokinetic interaction with R- and S- warfarin.	0
"Since uncorrected hyperkalemia may be fatal, serum potassium levels must be monitored at frequent intervals especially in patients first receiving DYAZIDE, when dosages are changed, or with any illness that may influence renal function."	0
"NURSING MOTHERS: Because THIOLA<U+00AE> may be excreted in milk and because of the potential serious adverse reactions of nursing infants from THIOLA<U+00AE>, mothers taking THIOLA<U+00AE> should not nurse their infants."	0
Consider the potential for drug interactions prior to and during INVIRASE/ritonavir therapy; review concomitant medications during INVIRASE/ritonavir therapy; and monitor for adverse reactions associated with concomitant medications.	0
"In particular, patients should be urged to report, immediately, any severe headache or other atypical or unusual symptoms not previously experienced."	0
"Contains one or more components that inhibit CYP3A4 and can increase plasma concentrations of atorvastatin, especially with excessive grapefruit juice consumption (> 1.2 liters per day)."	1
Important Limitation: Doses in excess of 5 mg daily have not been studied in pediatric patients.	0
"Therefore, after initial titration, it may be appropriate to wait 2 to 3 weeks between further dosage adjustments."	0
Drug Interactions Eszopiclone is metabolized by CYP3A4 and CYP2E1 via demethylation and oxidation.	0
"In a study where paroxetine (30 mg once daily) was dosed orally for 4 weeks, steady-state plasma concentrations of paroxetine were increased by approximately 50% during coadministration with oral cimetidine (300 mg three times daily) for the final week."	1
<U+2022> Pretreatment testing: Renal laboratory testing should be performed in all patients prior to initiation of REYATAZ and continued during treatment with REYATAZ.	0
Do not administer TRISENOX to patients with ventricular arrhythmia or prolonged QTcF.	0
The kinetics of the components are unchanged by their co-administration as AGGRENOX.	0
"Dual Blockade of the Renin-Angiotensin-Aldosterone System (RAAS): The concomitant use of aliskiren with other agents acting on the RAAS such as ACEIs or ARBs is associated with an increased risk of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
Chest pain may be precipitated or aggravated in patients with underlying coronary artery disease who are receiving dipyridamole.	0
Do not use BYSTOLIC with other <U+03B2>-blockers.	0
"Clarithromycin 500 twice daily, 7 days 800 three times daily, 7 days 12 1.19(1.02, 1.39) 1.47(1.30, 1.65) 1.97(1.58, 2.46)n=11 Efavirenz 200 once daily, 14 days 800 three times daily, 14 days 20 No significant change No significant change -- Ethinyl Estradiol(ORTHO-NOVUM 1/35)Registered trademark of Ortho Pharmaceutical Corporation."	0
Patients receiving ACE inhibitors who develop jaundice or marked elevations of hepatic enzymes should discontinue the ACE inhibitor and receive appropriate medical treatment.	0
"The same study showed a decreased clearance of desmethylsertraline in older males, but not in older females."	0
Therapy should be initiated with the 10 mg capsule.	0
Clinical monitoring of patients is recommended.	0
"It is advisable, therefore, to observe patients closely for atypical responses."	0
"More common than loss of consciousness are the symptoms often associated with lowering of the blood pressure, namely, dizziness and lightheadedness."	0
"For patients chronically taking potent inducers of CYP3A , such as rifampin , avoid use of ADCIRCA see Warnings and Precautions ( 5.2 ) and Clinical Pharmacology ( 12.3 ) ."	0
"Coadministration of LEXIVA and drugs that induce CYP3A4, such as rifampin, may decrease amprenavir concentrations and reduce its therapeutic effect."	1
"The antihypertensive effects of these agents are additive, and studies have shown that there is no interference with bioavailability when these agents are given together in the single combination tablet."	0
"The patient should be told that rifampin may produce a discoloration (yellow, orange, red, brown) of the teeth, urine, sweat, sputum, and tears, and the patient should be forewarned of this."	0
Tasigna has been shown to prolong cardiac ventricular repolarization as measured by the QT interval on the surface ECG in a concentration-dependent manner.	0
"The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine; cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type IC antiarrhythmics propafenone and flecainide)."	0
Studies of carcinogenesis in rats (24 months) and mice (18 months) did not demonstrate any tumorigenic potential.	0
"Therefore, caution should be applied and the lowest dose necessary should be used.Saquinavir 400 mg BID/ ritonavir 400mg BID, 15 days 40 mg QD for 4 days <U+2191> 3.9 fold <U+2191> 4.3 fold Clarithromycin 500 mg BID, 9 days 80 mg QD for 8 days <U+2191> 4.4 fold <U+2191> 5.4 fold Darunavir 300 mg BID/ritonavir 100 mg BID, 9 days 10 mg QD for 4 days <U+2191> 3.4 fold <U+2191> 2.25 fold Itraconazole 200 mg QD, 4 days 40 mg SD <U+2191> 3.3 fold <U+2191> 20% Fosamprenavir 700 mg BID/ritonavir 100 mg BID, 14 days 10 mg QD for 4 days <U+2191> 2.53 fold <U+2191> 2.84 fold Fosamprenavir 1400 mg BID, 14 days 10 mg QD for 4 days <U+2191> 2.3 fold <U+2191> 4.04 fold Nelfinavir 1250 mg BID, 14 days 10 mg QD for 28 days <U+2191> 74% <U+2191> 2.2 fold Grapefruit Juice, 240 mL QD Greater increases in AUC (up to 2.5 fold) and/or Cmax (up to 71%) have been reported with excessive grapefruit consumption (<U+2265> 750 mL <U+2013> 1.2 liters per day)."	1
"In addition, certain drugs inhibit the activity of the isozyme and make normal metabolizers resemble poor metabolizers."	0
"It should be noted that in other studies in pediatric populations, at doses of 10 mg/kg body weight, mean peak serum concentrations of 3.5 mcg/mL to 15 mcg/mL have been reported."	0
"In patients with hypertension, quinapril 10 to 40 mg was similar in effectiveness to captopril, enalapril, propranolol, and thiazide diuretics."	0
"If MAS occurs, or is suspected, discontinue mercaptopurine."	0
Maintenance Treatment Generalized anxiety disorder is recognized as a chronic condition.	0
"Rare cases of liver failure have also been reported, including a case that resulted in a liver transplant."	0
"While there was no statistically significant difference between amlodipine and placebo in the primary endpoint of all-cause mortality (95% confidence limits from 8% reduction to 29% increase on amlodipine), there were more reports of pulmonary edema in the patients on amlodipine."	0
"If a patient receiving clonidine is also taking neuroleptics, orthostatic regulation disturbances (e.g., orthostatic hypotension, dizziness, fatigue) may be induced or exacerbated."	0
"Avoid use with strong inducers of CYP3A (e.g., rifampin, phenytoin, carbamazepine and phenobarbital) [see Clinical Pharmacology (12.3) ]."	0
"The risk differences (drug vs placebo), however, were relatively stable with age strada and across indications."	0
"Plasma concentrations of ramipril and ramiprilat increase with increased dose, but are not strictly dose-proportional."	0
"Benzodiazepines (e.g., lorazepam) The intensity of sedation was greater with the combination of oral aripiprazole and lorazepam as compared to that observed with aripiprazole alone."	0
Multiple doses of lisinopril in rats do not result in accumulation in any tissues.	0
"Signs and symptoms associated with more severe and/or acute cases have included hallucination, syncope, seizure, coma, respiratory arrest, and death."	0
"Nevertheless, periodic determination of serum electrolytes should be performed in patients who may be at risk for the development of hypokalemia."	0
NORVIR should be started at no less than 300 mg twice daily and increased at 2 to 3 day intervals by 100 mg twice daily.	0
"By a mechanism that is not understood, quinidine potentiates the anticoagulatory action of warfarin, and the anticoagulant dosage may need to be reduced."	0
The possibility of hypotensive effects with enalapril can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with enalapril .	0
It is eliminated primarily as unchanged drug in the urine.	0
"Therefore, when the concurrent use of a H2 blocker is necessary, it may be administered approximately 10 hours before and approximately 2 hours after the dose of Tasigna."	0
WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning.	0
"In 1 study, daily dosing of paroxetine (20 mg once daily) under steady-state conditions increased single dose desipramine (100 mg) Cmax, AUC, and T<U+00BD> by an average of approximately 2-, 5-, and 3-fold, respectively."	1
"Seizures: Prescribe with care in patients with a history of seizure disorder (5.10) Blood Pressure: Monitor blood pressure prior to initiating treatment and periodically throughout treatment (5.11) Inhibitors of CYP1A2 or Thioridazine: Should not administer with CYMBALTA (5.12) Hyponatremia: Cases of hyponatremia have been reported (5.13) Glucose Control in Diabetes: In diabetic peripheral neuropathic pain patients, small increases in fasting blood glucose, and HbA1c have been observed (5.14) Conditions that Slow Gastric Emptying: Use cautiously in these patients (5.14) Urinary Hesitation and Retention (5.15) Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs."	0
Avoid use of ABILIFY MAINTENA in combination with carbamazepine and other inducers of CYP3A4 for greater than 14days.	0
"Teratogenic Effects: Epidemiological studies have shown that infants exposed to paroxetine in the first trimester of pregnancy have an increased risk of congenital malformations, particularly cardiovascular malformations."	0
Treatment should not exceed a few weeks in duration.	0
Monitor for worsening renal function in patients with renal impairment (5.4).	0
"Nitritoid reactions (symptoms include facial flushing, nausea, vomiting, and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy."	0
"Instruct patients to inform their healthcare provider if they are taking, or plan to take serotonergic medications."	0
"Because any psychoactive drug may impair judgment, thinking, or motor skills, however, patients should be cautioned about operating hazardous machinery, including automobiles, until they are reasonably certain that BRINTELLIX therapy does not affect their ability to engage in such activities."	0
Such concomitant administration should not be undertaken.	0
Absorption Zaleplon is rapidly and almost completely absorbed following oral administration.	0
"Experience with potassium citrate extended-release tablets is limited, but a similar frequency of gastrointestinal lesions should be anticipated."	0
"When mild vasodilators are taken in combination, blood pressurelowering effects of each individual compound may be increased."	0
"In a clinical pharmacokinetic interaction study of healthy subjects pretreated with a strong CYP3A4 inducer (rifampin, 600 mg daily for 6 days) followed by a single dose of abiraterone acetate 1,000 mg, the mean plasma AUC<U+221E> of abiraterone was decreased by 55%."	1
"Verapamil has a negative inotropic effect which, in most patients, is compensated by its afterload reduction (decreased systemic vascular resistance) properties without a net impairment of ventricular performance."	0
Strategies to reduce these risks include prescribing the drug in the smallest appropriate quantity.	0
"Patients taking concomitant mammalian target of rapamycin (mTOR) inhibitor (e.g., temsirolimus) therapy or a neprilysin inhibitor may be at increased risk for angioedema."	0
It should be noted that CYMBALTA is not approved for use in treating bipolar depression.	0
Pancreatitis and elevated serum lipase: Monitor serum lipase monthly or as clinically indicated.	0
Approximately 90% of an administered dose of lidocaine hydrochloride is metabolized in the liver.	0
"However, neurogenic tumors were noted in the offspring of rats given intravenous injections of 125 mg/kg of procarbazine hydrochloride on day 22 of gestation."	0
These studies indicate that the reduction reaction is mediated primarily by chemical reduction by glutathione as well as by enzymatic reduction by aldehyde oxidase and the subsequent methylation is mediated by thiol methyltransferase.	0
"Since visual disorders may be part of a migraine attack, a causal relationship between these events and the use of 5-HT1 agonists have not been clearly established."	0
"Beta-adrenergic blockade may mask clinical signs of hyperthyroidism, such as tachycardia."	0
"Sinus bradycardia (<50 bpm), sick sinus syndrome or second or third degree AV block unless a functioning pacemaker is present Congenital or acquired long QT syndromes, QT interval >450 ms Cardiogenic shock, uncontrolled heart failure Creatinine clearance <40 mL/min Serum potassium <4 meq/L Bronchial asthma or related bronchospastic conditions Known hypersensitivity to sotalol Sinus bradycardia (<50 bpm), sick sinus syndrome or 2nd and 3rd degree AV block unless a functioning pacemaker is present (4) Congenital or acquired long QT syndromes, QT interval >450 ms (4) Cardiogenic shock, uncontrolled heart failure (4) Creatinine clearance <40 mL/min (4) Serum potassium <4 meq/L (4) Bronchial asthma or related bronchospastic conditions (4) Known hypersensitivity to sotalol (4)"	0
Store reconstituted suspension between 86<U+00B0>F (30<U+00B0>C) and 41<U+00B0>F (5<U+00B0>C) and discard unused portion after 2 weeks.	0
"However, the ranges of AUC values were similar for both groups."	0
No formal clinical or pharmacokinetic studies have been conducted in patients with hepatic impairment.	0
"Despite the higher plasma concentration of nisoldipine in the elderly, there was no consistent difference in their blood pressure response except that the lowest clinical dose was somewhat more effective than in non-elderly patients."	0
"In the perinatal/postnatal studies, there was an increased incidence of stillbirths at doses of 20 times the human dose or greater."	0
It should be noted that Lexapro is not approved for use in treating bipolar depression.	0
"Patients on diuretics, and especially those started recently, may occasionally experience an excessive reduction of blood pressure after initiation of ACEON therapy."	0
The higher blood levels in PMs lead to a higher rate of some adverse effects of STRATTERA.	0
Ambrisentan does not inhibit or induce drug metabolizing enzymes at clinically relevant concentrations.	0
"The mode of therapy, frequency of treatment, exchange volume, duration of dwell, and length of dialysis should be initiated and supervised by the prescribing physician experienced in the treatment of end-stage renal disease with peritoneal dialysis."	0
"Concurrent administration of cimetidine and mexiletine has been reported to increase, decrease, or leave unchanged mexiletine plasma levels; therefore patients should be followed carefully during concurrent therapy."	1
Mean digoxin AUC at steady state decreased by 15% in the presence of paroxetine.	1
"In patients with active urinary tract infection (with either urea-splitting or other organisms, in association with either calcium or struvite stones)."	0
"If treatment includes transfer to an oral antihypertensive agent other than nicardipine capsules, initiate oral therapy upon discontinuation of nicardipine hydrochloride injection."	0
Treatment of familial Mediterranean fever (FMF) coadministration of colchicine in patients on INVIRASE/ritonavir: Maximum daily dose of 0.6 mg (may be given as 0.3 mg twice a day).	0
Strong CYP3A inducers substantially reduce ticagrelor exposure and so decrease the efficacy of ticagrelor .	1
"Clinical trials conducted during the investigational phase of this drug suggest that syncopal episodes can be minimized by limiting the initial dose of the drug to 1 mg, by subsequently increasing the dosage slowly, and by introducing any additional antihypertensive drugs into the patient's regimen with caution."	0
Prime the IV tubing with 5 mL of the solution for infusion prior to connecting to the patient's vascular access port and prior to administering the bolus or starting the infusion.	0
"When alprazolam (1 mg BID) and nefazodone (200 mg BID) were coadministered, steady-state peak concentrations, AUC and half-life values for alprazolam increased by approximately 2 fold."	1
"While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, paroxetine, and fluvoxamine, inhibit P450 2D6, they may vary in the extent of inhibition."	0
No dosage adjustment is necessary in patients with mild to severe renal impairment unless a patient with renal impairment is also volume depleted.	0
Ketoconazole 200 mg administered with tolvaptan increased tolvaptan exposure by 5-fold .	1
Atorvastatin is contraindicated in patients with active liver disease.	0
"In a meta-analysis of paroxetine from 4 studies done in healthy volunteers following multiple dosing of 20 mg/day to 40 mg/day, males did not exhibit a significantly lower Cmax or AUC than females."	0
"Amiodarone is a substrate for CYP3A and CYP2C8, so inhibitors and inducers affect amiodarone exposure (7) Amiodarone inhibits p-glycoprotein and CYP1A2, CYP2C9, CYP2D6, and CYP3A, increasing exposure to other drugs (7) Drugs prolonging the QT interval: Co-administration of drugs prolonging the QT interval (such as class I and III antiarrhythmics, lithium, certain phenothiazines, tricyclic antidepressants, certain fluoroquinolone and macrolide antibiotics, azole antifungals, halogenated inhalation anesthetic agents) increases the risk of Torsade de Pointes."	0
"The antihypertensive effect of angiotensin II receptor antagonists, including olmesartan medoxomil may be attenuated by NSAIDs including selective COX-2 inhibitors."	0
Dipyridamole has been associated with elevated hepatic enzymes.	0
"In the CAPRICORN trial of survivors of an acute myocardial infarction, hypotension or postural hypotension occurred in 20.2% of subjects receiving COREG compared with 12.6% of placebo subjects."	0
"Indirectly, the diuretic action of hydrochlorothiazide reduces plasma volume, with consequent increases in plasma renin activity, increases in aldosterone secretion, increases in urinary potassium loss, and decreases in serum potassium."	0
"Table 5: Incidence of Torsade de Pointes Before and After Introduction of Dosing According to Renal Function Total Before After Population: n/N % n/N % n/N % Supraventricular Arrhythmias 11/1346 (0.8%) 6/193 (3.1%) 5/1153 (0.4%) DIAMOND CHF 25/762 (3.3%) 7/148 (4.7%) 18/614 (2.9%) DIAMOND MI 7/749 (0.9%) 3/101 (3.0%) 4/648 (0.6%) DIAMOND AF 4/249 (1.6%) 0/43 (0%) 4/206 (1.9%) The majority of the episodes of TdP occurred within the first three days of TIKOSYN therapy (10/11 events in the studies of patients with supraventricular arrhythmias; 19/25 and 4/7 events in DIAMOND CHF and DIAMOND MI, respectively; 2/4 events in the DIAMOND AF subpopulation)."	0
"Contains one or more components that inhibit CYP 3A4 and can increase plasma concentrations of atorvastatin, especially with excessive grapefruit juice consumption (>1.2 liters per day)."	1
"Dose increments should be 0.5mg/kg daily, up to a maximum dose of 2.5mg/kg per day."	0
"Angioedema, including laryngeal edema, can occur with treatment with ACE inhibitors, especially following the first dose."	0
"Premature discontinuation of any oral anticoagulant , including XARELTO , increases the risk of thrombotic events ."	0
Digoxin In the ANDROMEDA (patients with recently decompensated heart failure) and PALLAS (patients with permanent AF) trials baseline use of digoxin was associated with an increased risk of arrhythmic or sudden death in dronedarone-treated patients compared to placebo.	0
Monitor blood pressure and heart rate both during and after the infusion to avoid tachycardia or too rapid or excessive reduction in either systolic or diastolic blood pressure.	0
"Thus, REYATAZ and didanosine EC should be administered at different times."	0
Do not co-administer aliskiren with ATACAND in patients with diabetes (4).	0
Use absolute neutrophil count to guide dosing.	0
"P-gp Inhibitors Reduction in the dose of SAMSCA may be required in patients concomitantly treated with P-gp inhibitors, such as e.g., cyclosporine, based on clinical response [see Dose and Administration (2.3) and Warnings and Precautions (5.5)]."	0
Resistance In Cell Culture HCV replicons with reduced susceptibility to ledipasvir have been selected in cell culture for genotypes 1a and 1b.	0
"Impaired renal function decreases elimination of lisinopril, which is excreted principally through the kidneys, but this decrease becomes clinically important only when the glomerular filtration rate is below 30 mL/min."	0
REYATAZ should be administered 2 hours before or 1 hour after these medications.	0
Verapamil crosses the placental barrier and can be detected in umbilical vein blood at delivery.	0
"High therapeutic concentrations of sulfamethazine (100 mcg/mL), warfarin (10 mcg/mL), and carbamazepine (10mcg/mL) caused only a slight increase in the free fraction of risperidone at 10 ng/mL and 9-hydroxyrisperidone at 50 ng/mL, changes of unknown clinical significance."	0
LUVOX CR should be discontinued before initiating treatment with the MAOI.	0
Ergotamine is known to precipitate angina pectoris.	0
Chlorthalidone and related drugs may decrease serum PBI levels without signs of thyroid disturbance.	0
"Exposures of aripiprazole and dehydro-aripiprazole in specific populations are summarized in Figure 22 and Figure 23, respectively."	0
Chlorpromazine may counteract the antihypertensive effect of guanethidine and related compounds.	0
Levomilnacipran did not inhibit monoamine oxidase (MAO).	0
Abdominal roentogenogram (KUB) is advised on a yearly basis to monitor the size and appearance/disappearance of stone(s).	0
"Sedative/Psychomotor Effects Studies involving the exposure of normal subjects to single fixed doses of Zaleplon (10 mg or 20 mg) with structured assessments of sedation and psychomotor function (eg, reaction time and subjective ratings of alertness) at fixed times after dosing (eg, 1, 2, 3, 4, 5, 8, and 10 hours) generally revealed the expected sedation and impairment of psychomotor function at 1 hour, the time of peak exposure to zaleplon, for both doses."	0
"Subtypes 6a and 6h had median EC50 values of 0.55 and 0.17 nM, respectively."	0
"Intrauterine exposure to thiazide diuretics is associated with fetal or neonatal jaundice, thrombocytopenia, and possibly other adverse reactions that occurred in adults."	0
Constant rate of infusion may result in toxic accumulation of lidocaine.	0
"<U+2195> Voriconazole (not studied) Due to multiple enzymes involved with voriconazole metabolism, it is difficult to predict the interaction."	0
HIV Antiretrovirals: Regimens containing tenofovir DF without an HIV protease inhibitor/ritonavir or cobicistat tenofovir Monitor for tenofovir-associated adverse reactions in patients receiving HARVONI concomitantly with a regimen containing tenofovir DF without an HIV protease inhibitor/ritonavir or cobicistat.	0
"Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide."	0
Cardiac Electrophysiology No prolongation of the QTc interval was observed with dabigatran etexilate at doses up to 600 mg.	0
False Positive Urine Tests for THC Clinical Impact: There have been reports of false positive urine screening tests for tetrahydrocannabinol (THC) in patients receiving PPIs.	0
Avoid co-administration of nifedipine with phenytoin or any known CYP3A4 inducer or consider an alternative antihypertensive therapy.	0
"When mice were treated for up to 18 months with pimozide, pituitary gland changes developed in females only."	0
"Total excretion of radioactivity in urine and feces combined was approximately 89%, with about 80% recovered in feces and 9% recovered in urine, after a single dose of [14C]-labeled LATUDA."	0
Exposure to dabigatran increases with severity of renal function impairment (Table 8).	0
"Of the more severe side effects that have been reported with any consistency, hypomania has been the most common."	0
"Avoid concomitant use of XARELTO with drugs that are combined P-gp and strong CYP3A4 inducers ( e.g. , carbamazepine , phenytoin , rifampin , St.   John 's   wort ) see Warnings and Precautions ( 5.6 ) and Clinical Pharmacology ( 12.3 ) ."	0
"Hypersensitivity to LEXIVA or amprenavir (e.g., Stevens-Johnson syndrome)."	0
Hemophilia: Spontaneous bleeding may occur and additional factor VII may be required.	0
The half-life of dabigatran in healthy subjects is 12 to 17 hours.	0
"This concentration range covers the same increased sildenafil exposure observed in specifically-designed drug interaction studies with CYP3A inhibitors (except for potent inhibitors such as ketoconazole, itraconazole, and ritonavir)."	1
"Patients on oral contraceptives were excluded from these trials; therefore, the efficacy of sertraline in combination with oral contraceptives for the treatment of PMDD is unknown."	0
Prostatic carcinoma is known to be androgen sensitive and responds to treatment that counteracts the effect of androgen and/or removes the source of androgen.	0
Administer the bolus dose within 5 minutes via a syringe or IV pump.	0
"However, there is substantial evidence from placebo-controlled maintenance trials in adults with depression that the use of antidepressants can delay the recurrence of depression."	0
"Cholesterol and triglyceride levels should be monitored prior to initiating combination dosing regimen of INVIRASE with ritonavir, and at periodic intervals while on such therapy."	0
Beta-blocker use for this purpose is not recommended.	0
Animal reproduction studies to determine the potential for fetal harm by triamterene and hydrochlorothiazide have not been conducted.	0
"Conversely, some botanicals may decrease the effects of COUMADIN (e.g., co-enzyme Q10, St. John<U+2019>s wort, ginseng)."	0
"TIKOSYN does not increase the electrical energy required to convert electrically induced ventricular fibrillation, and it significantly reduces the defibrillation threshold in patients with ventricular tachycardia and ventricular fibrillation undergoing implantation of a cardioverter-defibrillator device."	0
"Despite apparent lower toxicity of THIOLA<U+2122>, THIOLA<U+00AE> may potentially cause all the serious adverse reactions reported for d-penicillamine."	0
"During marketing of immediate-release fluvoxamine maleate tablets and other SSRIs and SNRIs (serotonin and norepinephrine reuptake inhibitors), there have been spontaneous reports of adverse reactions occurring upon discontinuation of these drugs, particularly when abrupt, including the following: dysphoric mood, irritability, agitation, dizziness, sensory disturbances (e.g., paresthesias, such as electric shock sensations), anxiety, confusion, headache, lethargy, emotional lability, insomnia, and hypomania."	0
"If significant hematologic changes are observed, the patient should be carefully evaluated, and, if warranted, mexiletine should be discontinued."	0
"In patients with moderate renal impairment (CrCl 30-50 mL/min), reduce the dose of PRADAXA to 75 mg twice daily when administered concomitantly with the P-gp inhibitors dronedarone or systemic ketoconazole."	1
The clinical impact of this potential decrease is unknown.	0
"Patients taking concomitant mTOR inhibitor (e.g., temsirolimus, sirolimus, everolimus) therapy may be at increased risk for angioedema."	0
Adult recommended starting dose: 5 mg once daily with maximum dose 10 mg once daily.	0
Concomitant use with beta blockers can increase the risk of bradycardia.	0
"With coadministration of the two drugs there were significant increases in the steady-state Cmax and AUC of carbamazepine (23% and 23%, respectively), while the steady-state Cmax and the AUC of the carbamazepine metabolite, 10,11 epoxycarbamazepine, decreased by 21% and 20%, respectively."	1
New onset or worsening of heart failure has been reported during treatment with MULTAQ in the postmarketing setting.	0
Coadministration of phenytoin with a dose bioequivalent to 34 mg SULAR tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels.	1
"These bleeding and thromboembolic events were seen both in patients who were initiated on PRADAXA post-operatively within three days of mechanical bileaflet valve implantation, as well as in patients whose valves had been implanted more than three months prior to enrollment."	0
"If hyperkalemia develops, this drug should be discontinued and a thiazide alone should be substituted."	0
Atazanavir: See prescribing information for atazanavir for dosing information.	0
Consult the labeling of concomitantly used drugs to obtain further information about interactions with PPIs.	0
"In patients 1 month to 4 months of age, a longer half-life was observed due to the higher volume of distribution in this age group."	0
ZIAC should be used with caution in patients with impaired hepatic function or progressive liver disease.	0
"MULTAQ doubles the risk of death in these patients (4, 5.1, 14.3)."	0
The use of HMG-CoA reductase inhibitors that are CYP3A4 substrates in combination with verapamil has been associated with reports of myopathy/rhabdomyolysis.	0
"In a drug interaction study, when MAXALT 10 mg was administered to subjects (n=12) receiving concomitant therapy with the selective, reversible MAO-A inhibitor, moclobemide 150 mg t.i.d., there were mean increases in rizatriptan AUC and Cmax of 119% and 41% respectively; and the AUC of the active N-monodesmethyl metabolite of rizatriptan was increased more than 400%."	1
"Reproduction studies performed with mexiletine in rats, mice and rabbits at doses up to four times the maximum human oral dose (24 mg/kg in a 50 kg patient) revealed no evidence of teratogenicity or impaired fertility but did show an increase in fetal resorption."	0
"Triazolam and its metabolites, principally as conjugated glucuronides, which are presumably inactive, are excreted primarily in the urine."	0
Untreated acute angle-closure glaucoma can lead to permanent vision loss.	0
They can precipitate hepatic coma in patients with severe liver disease.	0
"In the same patients, these reactions were avoided when ACE inhibitors were temporarily withheld, but they reappeared upon inadvertent rechallenge."	0
Known hypersensitivity reaction to PROCARDIA.	0
Ergot drugs are known to inhibit prolactin.	0
Families and caregivers should be advised of the need for close observation and communication with the prescriber.	0
Heart rate was decreased by 4<U+2013>6 bpm in studies in patients.	0
Avoid concomitant use of PURIXAN and allopurinol.	0
Adults with such abnormalities should also generally not be treated with stimulant drugs.	0
This may result in loss of therapeutic effect to PREZISTA.	0
Treatment with losartan potassium tablets resulted in a 16%risk reduction in this endpoint.	0
"Citalopram is metabolized to demethylcitalopram (DCT), didemethylcitalopram (DDCT), citalopram-N-oxide, and a deaminated propionic acid derivative."	0
PROCARDIA should be used during breast-feeding only if the potential benefit justifies the potential risk.	0
"Inhibition of CYP3A4 by CRIXIVAN can result in elevated plasma concentrations of the following drugs, potentially causing serious and/or life-threatening reactions: Table 7: Drug Interactions With Crixivan: Contraindicated Drugs Drug Class Drugs Within Class That Are Contraindicated With CRIXIVAN Alpha 1-adrenoreceptor antagonist alfuzosin Antiarrhythmics amiodarone Antipsychotics lurasidone, pimozide Ergot derivatives dihydroergotamine, ergonovine, ergotamine, methylergonovine GI motility agents cisapride HMG-CoA Reductase Inhibitors lovastatin, simvastatin PDE5 Inhibitors RevatioRegistered trademark of Pfizer, Inc. (sildenafil) [for treatment of pulmonary arterial hypertension] Sedative/hypnotics oral midazolam, triazolam, alprazolam"	1
"Irbesartan was neither metabolized by, nor did it substantially induce or inhibit, isoenzymes commonly associated with drug metabolism (1A1, 1A2, 2A6, 2B6, 2D6, 2E1)."	0
"For children who can swallow tablets, the usual recommended starting dose of Benicar is 10 mg once daily for patients who weigh20 to <35 kg (44 to 77 lb), or 20 mg once daily for patients who weigh<U+2265>35 kg."	0
Steady-state serum digoxin concentrations will be achieved in approximately five half-lives of the drug for the individual patient.	0
Table 1 provides recommended starting doses of Renvela for adult patients not taking a phosphate binder.	0
Propranolol and thioridazine should not be coadministered.	0
"Salicylic acid is primarily conjugated in the liver to form salicyluric acid, a phenolic glucuronide, an acyl glucuronide, and a number of minor metabolites."	0
<U+2022>REYATAZ 300 mg with ritonavir 100 mg once daily (all as a single dose with food) if taken with an H2RA.	0
"During post-marketing experience toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms, and acute generalized exanthematous pustulosis have been reported."	0
The resulting solution may be stored for up to 24 hours at room temperature or up to 48 hours at 4<U+00B0>C (40<U+00B0>F).	0
"Based on published literature, the annual incidence of NAION is 2.5<U+2013>11.8 cases per 100,000 males aged <U+2265> 50 per year in the general population."	0
"<U+2022> Mixing with a beverage such as milk or water in a small drinking cup: Using a spoon, mix the recommended number of REYATAZ oral powder packets with a minimum of 30 mL of the beverage."	0
"Substantial intercurrent ethanol use was present in each of these cases, and this may have contributed to the abnormalities seen."	0
"Developmental toxicity studies were performed in rabbits (at doses up to 240 mg/kg/day), dogs (at doses up to 80 mg/kg/day), and rats (at doses up to 640 mg/kg/day)."	0
Trimethoprim 160 mg in combination with 800 mg sulfamethoxazole co-administered BID with TIKOSYN (500 mcg BID) for 4 days has been shown to increase dofetilide AUC by 103% and Cmax by 93%.	1
The plastic may be somewhat opaque because of moisture absorption during sterilization; the opacity will diminish gradually.	0
"Use of REVATIO, particularly chronic use, is not recommended in children."	0
"Hence, caution should be exercised when bicalutamide is co-administered with CYP 3A4 substrates."	0
Severe respiratory depression and respiratory arrest have been reported when a patient was given a phenothiazine and a concomitant high dose of a barbiturate.	0
As in adults the following precautionary measures should be considered when initiating sotalol treatment in children: initiation of treatment in the hospital after appropriate clinical assessment; individualized regimen as appropriate; gradual increase of doses if required; careful assessment of therapeutic response and tolerability; and frequent monitoring of the QTc interval and heart rate.	0
CALAN may shorten the antegrade effective refractory period of the accessory bypass tract.	0
Monitor serum lithium levels during concomitant use.	0
"In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen were observed."	0
"Patients with low or absent TPMT activity are at an increased risk of developing severe, life-threatening myelotoxicity from IMURAN if conventional doses are given."	0
Patients should remain under the care of a physician when using CRIXIVAN.	0
Dosage in Resistant or Intolerant Ph+ CML-CP and CML-AP The recommended dose of Tasigna (nilotinib) is 400 mg orally twicedaily.	0
"Because of the potential effect of duloxetine on platelets, patients receiving warfarin therapy should be carefully monitored when duloxetine is initiated or discontinued."	0
"COREG is rapidly and extensively absorbed following oral administration, with absolute bioavailability of approximately 25% to 35% due to a significant degree of first-pass metabolism."	0
CNS stimulants have been associated with weight loss and slowing of growth rate in pediatric patients.	0
Metabolism and Excretion The mechanism of elimination of nesiritide has not been studied specifically in humans.	0
"Syncope and orthostatic hypotension tend to occur within the first week of therapy but can occur at any time during CYMBALTA treatment, particularly after dose increases."	0
"Trandolapril is de-esterified to its diacid metabolite, trandolaprilat."	0
In vitro studies indicate that ambrisentan is a substrate of P-gp.	0
Clonidine therapy can then be discontinued several days later by gradually decreasing the dosage.	0
"As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals."	0
A decision to use ORAP chronically in Tourette<U+2019>s Disorder is one that deserves full consideration by the patient (or patient<U+2019>s family) as well as by the treating physician.	0
<U+2022>The concomitant use of REYATAZ/ritonavir and certain other medications may result in known or potentially significant drug interactions.	0
"When prescribing these drugs to patients already receiving antipsychotic therapy, close monitoring is essential and dose reduction may become necessary to avoid toxicity."	0
"For pediatric patients, the modified Schwartz equation may be used as listed below."	0
"Patients with heart failure given ACCUPRIL commonly have some reduction in blood pressure, but discontinuation of therapy because of continuing symptomatic hypotension usually is not necessary when dosing instructions are followed."	0
Cyclosporine : Avoid coadministration of cyclosporine with aliskiren see Warnings and Precautions ( 5.7 ) and Clinical Pharmacology ( 12.3 ) .	0
Administer sotalol twice daily in patients with a creatinine clearance >60 mL/min or once daily) in patients with a creatinine clearance between 40 and 60 mL/min.	0
Paralytic ileus may occur in patients taking tricyclic antidepressants in combination with anticholinergic type drugs.	0
"There are, however, no adequate and well-controlled studies in pregnant women."	0
"If improvement is not observed after appropriate dosage adjustment over a 1-month period, the drug should be discontinued."	0
"Plasma TCA concentrations may need to be monitored, and the dose of TCA may need to be reduced, if a TCA is coadministered with paroxetine."	1
As in adults sotalol should be used with particular caution in children if the QTc is greater than 500 ms on therapy and serious consideration should be given to reducing the dose or discontinuing therapy when QTc exceeds 550 ms.	0
The pharmacodynamics of Lamisil Tablets is unknown.	0
"Children and Adolescents At steady-state the pharmacokinetics of the parent compound, in children and adolescents (10 to 17 years of age), were similar to adults."	0
Consideration should be given to not using STRATTERA in adults with clinically significant cardiac abnormalities.	0
"If the container has frangible(s), inspect that they are positioned correctly and are not broken."	0
Initiation of quetiapine in patients taking VIRACEPT: Refer to the quetiapine prescribing information for initial dosing and titration of quetiapine.	0
Mothers whose embryos and fetuses are exposed to an angiotensinII receptor antagonist only during the first trimester should be so informed.	0
Induction or exacerbation of angina has been seen in less than 1% of coronary artery disease patients treated with nicardipine.	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
"As with other oral P2Y12 inhibitors, co-administration of opioid agonists delay and reduce the absorption of prasugrel's active metabolite presumably because of slowed gastric emptying."	1
Coadministration of paroxetine with SAPHRIS caused a two-fold increase in the maximum plasma concentrations and systemic exposure of paroxetine.	1
"In clinical pharmacology studies, both sofosbuvir and the inactive metabolite GS-331007 were monitored for purposes of pharmacokinetic analyses."	0
Serum lithium levels should be monitored frequently if INSPRA is administered concomitantly with lithium.	0
BRILINTA increases serum concentrations of simvastatin and lovastatin because these drugs are metabolized by CYP3A4 .	1
"However, chronic verapamil treatment can increase serum digoxin levels by 50% to 75% during the first week of therapy, and this can result in digitalis toxicity."	1
"The dose of Catapres<U+00AE> (clonidine hydrochloride, USP) tablets must be adjusted according to the patient's individual blood pressure response."	0
"Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8-fold increase in plasma AUC of the TCA)."	0
"However, in U.S. clinical trials, the incidence of treatment-related increases in uric acid was higher during therapy with HCTZ 25 mg (25%) than with B/H 6.25 mg (10%)."	0
This metabolite is further metabolized by glucuronidation or oxidation to the corresponding pyridine derivative.	0
The parent compound doxazosin is primarily responsible for the antihypertensive activity.	0
"In a pharmacokinetic study, 40 healthy female subjects received fluvoxamine in escalating doses from 50 to 200 mg/day for 16 days with coadministration of alosetron 1 mg on the last day."	0
The drug is highly bound to plasma protein.	0
"Meperidine Hydrochloride Injection should not be used in pregnant women prior to the labor period, unless in the judgment of the physician the potential benefits outweigh the possible hazards, because safe use in pregnancy prior to labor has not been established relative to possible adverse effects on fetal development."	0
"The effect may be mediated by the known inhibition of cimetidine on hepatic cytochrome P-450, the enzyme system probably responsible for the first-pass metabolism of nifedipine."	1
Serious Cardiovascular Events: Sudden death has been reported in association with CNS stimulant treatment at usual doses in children and adolescents with structural cardiac abnormalities or other serious heart problems.	0
"While a 120mg/day dose was shown to be effective, there is no evidence that doses greater than 60mg/day confer any additional benefits."	0
"Furthermore, in vitro studies in human liver microsomes showed that iloperidone does not have enzyme inducing properties, specifically for the following cytochrome P450 isozymes: CYP1A2, CYP2C8, CYP2C9, CYP2C19, CYP3A4 and CYP3A5."	0
The risk of toxic reactions to this drug may be greater in patients with impaired renal function.	0
"For intravenous administration, but may also be administered via subcutaneous, intramuscular or via an endotracheal tube (2.1, 2.3)."	0
Effient is contraindicated in patients with a history of prior transient ischemic attack (TIA) or stroke.	0
The exact mechanism of action is unknown.	0
"There are, however, no adequate and well-controlled studies in pregnant women."	0
"In a study of 25 healthy volunteers with co-administration of verapamil with sirolimus, whole blood sirolimus Cmax and AUC were increased 130% and 120%, respectively."	1
"When administered to neonates, indinavir caused an exacerbation of the transient physiologic hyperbilirubinemia seen in this species after birth; serum bilirubin values were approximately fourfold above controls at 160 mg/kg twice daily."	0
Doses of NARDIL in pregnant mice well exceeding the maximum recommended human dose have caused a significant decrease in the number of viable offspring per mouse.	0
"In hypertensive patients, angiotensin II receptor inhibition following chronic administration of irbesartan causes a 1.5-fold to 2-fold rise in angiotensin II plasma concentration and a 2-fold to 3-fold increase in plasma renin levels."	0
DYAZIDE should not be used in patients with pre-existing elevated serum potassium.	0
"Carcinogenesis, Mutagenesis, Impairment of Fertility: See WARNINGS section."	0
Excretion: Excretion occurs mainly in the first 24 hours.	0
"There have been rare postmarketing reports of fatal and non-fatal hepatic failure in patients taking statins, including simvastatin."	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction with antidepressants compared to placebo in adults aged 65 and older.	0
Increased plasma concentrations of paroxetine occur in subjects with renal and hepatic impairment.	0
All reports with methylene blue that provided information on the route of administration involved intravenous administration in the dose range of 1 mg/kg to 8 mg/kg.	0
See prescribing information for nelfinavir.	0
12 IMURAN is teratogenic in rabbits and mice when given in doses equivalent to the human dose (5mg/kg daily).	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older.	0
75 mg of intravenous sotalol is approximately equal to 80 mg of oral sotalol (2.2) Initiation of Therapy Calculate creatinine clearance to determine dosing interval (2.1) Starting adult dose is 75 mg administered twice daily.	0
Zanaflex use has been associated with hallucinations.	0
The reproductive performance of the untreated offspring was not assessed.	0
Usage in Nursing Mothers: Amphetamines are excreted in human milk.	0
"Effect of Coadministered Drugs on Pharmacokinetics of Apixaban The effects of level of renal impairment, age, body weight, and level of hepatic impairment on the pharmacokinetics of apixaban are summarized in Figure 3."	0
Less than 0.1% of patients discontinued therapy due to hyperkalemia.	0
ULORIC is contraindicated in patients being treated with azathioprine or mercaptopurine.	0
"STRATTERA should not be taken with an MAOI, or within 2weeks after discontinuing an MAOI."	0
Oral lesions resemble thrush rather than antifolic ulcerations.	0
"During Marplan therapy, it appears that some patients are particularly vulnerable to the effects of sympathomimetics when the activity of metabolizing enzymes is inhibited."	0
"New onset diabetes mellitus, exacerbation of pre-existing diabetes mellitus, and hyperglycemia have been reported during postmarketing surveillance in HIV-infected patients receiving protease inhibitor (PI) therapy."	0
"Active internal bleeding or a history of bleeding diathesis, major surgical procedure or severe physical trauma within the previous month."	0
The risk of dofetilide induced ventricular arrhythmia was assessed in three ways in clinical studies: 1) by description of the QT interval and its relation to the dose and plasma concentration of dofetilide; 2) by observing the frequency of TdP in TIKOSYN-treated patients according to dose; 3) by observing the overall mortality rate in patients with atrial fibrillation and in patients with structural heart disease.	0
"In clinical trials, 16-23% of patients treated with TRISENOX for APL developed differentiation syndrome."	0
"This pharmacodynamic behavior is consistent with a short in vivo half-life and rapid clearance in humans, as suggested by the results of animal and in vitro studies."	0
"In a pooled data base of four placebo-controlled AFIB/AFL and PSVT studies, new or worsening heart failure occurred during therapy with oral sotalol in 5 (1.2%) of 415 patients."	0
Distribution Quetiapine is widely distributed throughout the body with an apparent volume of distribution of 10<U+00B1>4 L/kg.	0
"In patients with hypertension, there is little change in cardiac output."	0
"If coadministration is necessary, reduce the quetiapine dose to 1/6 of the current dose and monitor for quetiapine-associated adverse reactions."	1
The pharmacologic profile of both drugs and the clinical experience suggest beneficial interactions.	0
"PDE5 Inhibitors Sildenafil (Revatio<U+00AE>)[for treatment of pulmonary arterial hypertension] Increased potential for sildenafil-associated adverse events (which include visual disturbances, hypotension, prolonged erection, and syncope)."	0
"If concomitant treatment with venlafaxine hydrochloride extended-release and these drugs is clinically warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases."	0
Venlafaxine hydrochloride extended-release is not indicated for weight loss alone or in combination with other products.	0
Adjustment of warfarin dosage may be needed.	0
Theophylline plasma levels returned to pre-mexiletine values within 48 hours after discontinuing mexiletine.	0
A longer period for monitoring respiratory and other opiate-associated adverse events may be necessary.	0
"Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma."	0
"If adrenal insufficiency is suspected, confirm the diagnosis with diagnostic testing as soon as possible."	0
"Switching from Warfarin to XARELTO - When switching patients from warfarin to XARELTO , discontinue warfarin and start XARELTO as soon as the International Normalized Ratio ( INR ) is below 3.0 to avoid periods of inadequate anticoagulation ."	0
Caution should be exercised if CRIXIVAN is used concurrently with atorvastatin or rosuvastatin.	0
"At the top of the chart, identify which dose in mcg/kg will be used for this patient."	0
Pharmacodynamic effects of haloperidol were generally not altered significantly.	0
Do not use EXTRANEAL if the frangible(s) are broken or leaks are suspected as sterility may be impaired.	0
Impact of Vortioxetine on PK of Other Drugs Figure2.jpg	0
The concomitant use of Anafranil with MAOIs intended to treat psychiatric disordersis contraindicated.	0
"Neonates with a history of in utero exposure to TARKA: If oliguria or hypotension occurs, direct attention toward support of blood pressure and renal perfusion."	0
NOTE: The calibrated oral syringe supplied with the 60 mL bottle of digoxin oral solution is not appropriate to measure doses below 0.1 mL.	0
TIKOSYN is also contraindicated in patients with a known hypersensitivity to the drug.	0
IT SHOULD THUS BE TRIED ONLY IN WEIGHT REDUCTION PROGRAMS FOR PATIENTS IN WHOM ALTERNATIVE THERAPY HAS BEEN INEFFECTIVE.	0
These hematomas may result in long-term or permanent paralysis.	0
"Signs and symptoms including respiratory compromise, urticaria, and angioedema of the throat and tongue have been reported."	0
"Caution should be used in administering Anafranil to patients with a history of seizures or other predisposing factors, e.g., brain damage of varying etiology, alcoholism, and concomitant use with other drugs that lower the seizure threshold."	0
"In addition, no dose adjustment of guanfacine or venlafaxine is needed when VYVANSE is co-administered."	0
"Consequently, most patients, depending on tolerability and the need for further clinical effect, should have their dose increased."	0
"Assessing Cardiovascular Status in Patients being Treated with Atomoxetine Children, adolescents, or adults who are being considered for treatment with atomoxetine should have a careful history (including assessment for a family history of sudden death or ventricular arrhythmia) and physical exam to assess for the presence of cardiac disease, and should receive further cardiac evaluation if findings suggest such disease (e.g., electrocardiogram and echocardiogram)."	0
Titrate to 40 mg daily based on blood pressure response.	0
"Cyanocobalamin ( V itamin B-12) Deficiency: Daily long-term use (e.g., longer than 3 years) may lead to malabsorption or a deficiency of cyanocobalamin (5.7)."	1
"If it is necessary to initiate treatment with an MAOI such as linezolid or intravenous methylene blue in a patient taking ZOLOFT, discontinue ZOLOFT before initiating treatment with the MAOI."	0
Rifabutin should be used in pregnant women only if the potential benefit justifies the potential risk to the fetus.	0
Doses above 30mg/day in children and 40mg/day in adults have not been studied.	0
Digoxin Clinical Impact: Potential for increased exposure of digoxin.	1
Digoxin had no effects on the pharmacokinetics of nefazodone and its active metabolites.	0
"A significant reduction in number of corpora lutea with consequent reduction in implantations and live fetuses was, however, observed at 1250 mg/kg (more than 30 times the MRHD on a mg/m2 basis)."	0
Discontinue corrective measures for hypokalemia immediately if laboratory determinations reveal an abnormal elevation of serum potassium.	0
"Shifts in acid-base balance alter the ratio of extracellular/intracellular potassium, and the development of acidosis may be associated with rapid increases in serum potassium levels."	0
"Drugs which lower the seizure threshold, including phenothiazine derivatives, should not be used with metrizamide."	0
"Prescriptions for LUVOX CR Capsules should be written for the smallest quantity of capsules consistent with good patient management, in order to reduce the risk of overdose."	0
Increased metoprolol plasma levels have been associated with decreased cardioselectivity.	0
"Immunosuppressants:cyclosporine,tacrolimus,sirolimus(rapamycin) <U+2191> immunosuppressants Therapeutic concentration monitoring is recommended for immunosuppressant agents when co-administered with ritonavir."	0
It should be noted that PRISTIQ is not approved for use in treating bipolar depression.	0
All reports with methylene blue that provided information on the route of administration involved intravenous administration in the dose range of 1 mg/kg to 8 mg/kg.	0
"Doses of 0.8 mg/kg/day (9.4 mg/m2/day) in rabbits, 1000 mg/kg/day (7000 mg/m2/day) in rats, and 25 mg/kg/day (295 mg/m2/day) in cynomolgus monkeys did not produce teratogenic effects."	0
"Special attention should be given to accurate calculation of the dose of NORVIR, transcription of the medication order, dispensing information and dosing instructions to minimize the risk for medication errors, and overdose."	0
"Patients may wish to be examined to determine whether they are susceptible to angle closure, and have a prophylactic procedure (e.g., iridectomy), if they are susceptible."	0
"Because escitalopram is extensively metabolized, excretion of unchanged drug in urine is a minor route of elimination."	0
"A variety of antiarrhythmics such as quinidine or propranolol were also added, sometimes with improved control of ventricular ectopy."	0
Aspirin Tadalafil (10 mg and 20 mg once daily) does not potentiate the increase in bleeding time caused by aspirin [see Clinical Pharmacology (12.3)].	0
Embryo-fetal toxicity: PURIXAN can cause fetal harm.	0
<U+2022>Coadministration of LEXIVA with drugs that induce CYP3A4 may decrease amprenavir (active metabolite) concentrations leading to potential loss of virologic activity.	0
A recent CBC should be available before initiating treatment with GILENYA.	0
"Amiodarone has the potential for interactions with drugs or substances that may be substrates , inhibitors or inducers of CYP450 enzymes ( e.g. , inhibitors such as protease inhibitors , grapefruit juice , certain fluoroquinolone and macrolide antibiotics , azole antifungals and inducers such as St.   John s Wort ) or P-glycoprotein ."	0
The target dose of paroxetine in the treatment of PD is 40 mg/day.	0
"Use of EMEND with strong CYP3A4 inducers (e.g., rifampin) may result in a reduction in aprepitant plasma concentrations and decreased efficacy of EMEND."	1
Pregnancy (4.1) Idiopathic Pulmonary Fibrosis (4.2) Letairis may cause fetal harm when administered to a pregnant female.	0
"In subjects who had received EMSAM 6mg per 24 hours for 9 days, co-administration with PPA (25mg every 4 hours for 24 hours) did not affect the pharmacokinetics of PPA."	0
"In this study, patients receiving paroxetine experienced a mean reduction of approximately 7 points on the YBOCS total score, which was significantly greater than the mean reduction of approximately 4 points in placebo-treated patients."	0
"Fingolimod did not induce mRNA or activity of the different CYP enzymes and MDR1 with respect to the vehicle control; therefore, no clinically relevant induction of the tested CYP enzymes or MDR1 by fingolimod are expected at therapeutic concentrations."	0
There are no data on the effect of losartan potassium tablets on blood pressure in pediatric patients under the age of 6 or in pediatric patients with glomerular filtration rate <30mL/min/1.73m2.	0
Tuberculosis in HIV-positive patients is common and may present with atypical or extrapulmonary findings.	0
"If trazodone is used with a CYP3A4 inhibitor such as LEXIVA, the combination should be used with caution and a lower dose of trazodone should be considered."	1
It is generally believed (though not established in controlled studies) that treating such an episode with an antidepressant alone may increase the likelihood of precipitation of a mixed/manic episode in patients at risk for bipolar disorder.	0
"Hence, concomitant use of these medications is contraindicated."	0
The long-term maintenance effects of paroxetine in OCD were demonstrated in a long-term extension to Study 1.	0
"Patients unhealed at 4 weeks, or those with persistent symptoms, have been shown to benefit from 2 to 4 weeks of continued therapy."	0
Most of the difference was attributed to mortality in days 0-1 (TENORMIN - 121 deaths; control - 171 deaths).	0
5-HT3 antagonist Pediatric Patients 6 Months to Less than12 Years or Pediatric and Adult Patients Unable to Swallow Capsules See selected 5-HT3 antagonist prescribing information for the recommended dosage none none none The recommended oral dosage of EMEND capsules in adults is 40 mg within 3 hours prior to induction of anesthesia.	0
"In patients with impaired renal function, Marplan should be used cautiously to prevent accumulation."	0
"However, in vivo data to address this question are limited."	0
Prompt medical or surgical treatments may need to be considered if the intraocular pressure remains uncontrolled.	0
"Its action is, therefore, independent of the pathways for angiotensin II synthesis."	0
THIOLA<U+00AE> is an active reducing agent which undergoes thiol-disulfide exchange with cystine to form a mixed disulfide of Thiola-cysteine.	0
Drugs that inhibit the RAS can cause hyperkalemia.	0
"Thus, the potential for drug interactions with ziprasidone due to displacement is minimal."	0
"The concomitant use of protease inhibitors may require at least a 50% reduction in rifabutin dose, and depending on the protease inhibitor, an adjustment of the antiviral drug dose."	1
"In patients who do not respond to these doses with adequate arterial pressures or urine flow, additional increments of dopamine may be given in an effort to produce an appropriate arterial pressure and central perfusion."	0
"After prescribing, keep careful prescription records, educate patients about abuse, monitor for signs of abuse and overdose, and re-evaluate the need for VYVANSE use."	0
"If patients develop acute pulmonary edema during initiation of therapy with Letairis, consider underlying pulmonary veno-occlusive disease and discontinue treatment if necessary (5.4)."	0
Norverapamil can reach steady-state plasma concentrations approximately equal to those of verapamil itself.	0
"The apparent volume of distribution averages about 1640L. Duloxetine is highly bound (>90%) to proteins in human plasma, binding primarily to albumin and <U+03B1>1-acid glycoprotein."	0
Sertraline hydrochloride was statistically significantly more effective than placebo as measured by the LSAS and the percentage of responders.	0
This risk of bleeding should be weighed against the urgency of intervention.	0
Single dose vials must be diluted before use (2.2).	0
Patients with these diagnoses were systematically excluded from clinical studies during the product<U+2019>s premarketing testing.	0
"Over the course of a typical 10-week controlled trial, the rate of death in drug-treated patients was about 4.5%, compared to a rate of about 2.6% in the placebo group."	0
"If the mixture is not consumed immediately, it must be stored under refrigeration, but storage must not exceed 6 hours."	0
"Removal of ACCUPRIL, which crosses the placenta, from the neonatal circulation is not significantly accelerated by these means."	0
"However, coadministration of escitalopram (20 mg) and ritonavir (600 mg), a potent inhibitor of CYP3A4, did not significantly affect the pharmacokinetics of escitalopram."	0
"If an elevated VMA is found, prazosin should be discontinued and the patient retested after a month."	0
Dose reduction of atazanavir is not recommended since long-term efficacy of reduced doses has not been established.	0
Atorvastatin AUC was significantly increased with concomitant administration of atorvastatin 10 mg and cyclosporine 5.2 mg/kg/day compared to that of atorvastatin alone.	1
NSAIDS use may lead to increased risk of renal impairment and loss of antihypertensive effect (7.6). mTOR inhibitor or neprilysin inhibitor use may increase angioedema risk (7.7).	0
"If clinically warranted, consider initiating VYVANSE with lower doses, monitoring patients for the emergence of serotonin syndrome during drug initiation or titration, and informing patients of the increased risk for serotonin syndrome."	0
"In two long-term studies, depressed patients who had responded to Celexa during an initial 6 or 8 weeks of acute treatment (fixed doses of 20 or 40 mg/day in one study and flexible doses of 20-60 mg/day in the second study) were randomized to continuation of Celexa or to placebo."	0
"Coadministration of HARVONI with rosuvastatin is not recommended.atorvastatin<U+2191> atorvastatinCoadministration of HARVONI with atorvastatin may be associated with increased risk of myopathy, including rhabdomyolysis."	0
"In general, maximum effects for any given dosage will be apparent during the first 48 hours of therapy."	0
"However, it has been proposed that the therapeutic efficacy of clozapine in schizophrenia is mediated through antagonism of the dopamine type 2 (D2) and the serotonin type 2A (5-HT2A) receptors."	0
"In an ambulatory blood pressure monitoring study, a substantially higher proportion of Savella-treated patients experienced clinically significant blood pressure and heart rate elevations as compared with placebo-treated patients."	0
This information is intended to aid in the safe and effective use of this medication.	0
"Hydrochlorothiazide Sulfonamide or sulfonamide derivative drugs, such as hydrochlorothiazide, can cause an idiosyncratic reaction, resulting in transient myopia and/or acute angle-closure glaucoma."	0
Symptoms include acute onset of decreased visual acuity or ocular pain and typically occur within hours to weeks of drug initiation.	0
The primary circulating metabolite is the inactive irbesartan glucuronide conjugate (approximately 6%).	0
"Fluctuations in INR values may occur in patients receiving warfarin concomitant with HCV treatment, including treatment with HARVONI."	0
Probenecid blocks the renal tubular secretion of penicillin.	1
"Atorvastatin Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis Cyclosporine, HIV protease inhibitors (tipranavir plus ritonavir), hepatitis C protease inhibitor (telaprevir) Avoid atorvastatin HIV protease inhibitor (lopinavir plus ritonavir) Use with caution and lowest dose necessary Clarithromycin, itraconazole,HIV protease inhibitors (saquinavir plus ritonavirUse with caution and with the lowest dose necessary (12.3), darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir) Do not exceed 20 mg atorvastatin daily HIV protease inhibitor (nelfinavir)Hepatitis C protease inhibitor (boceprevir) Do not exceed 40 mg atorvastatin daily Cases of myopathy, including rhabdomyolysis, have been reported with atorvastatin co-administered with colchicine, and caution should be exercised when prescribing atorvastatin with colchicine."	0
"When switching from drugs with prolonged immune effects, such as natalizumab, teriflunomide or mitoxantrone, the duration and mode of action of these drugs must be considered to avoid unintended additive immunosuppressive effects when initiating GILENYA."	0
"In clinical trials, hyperkalemia (serum potassium <U+2265>5.8 mmol/L) occurred in approximately 2% of patients receiving ACCUPRIL."	0
Abnormal Bleeding: Savella may increase the risk of bleeding events.	0
"Combined P-gp and strong CYP3A4 inhibitors and inducers: Avoid concomitant use (7.2, 7.3) Anticoagulants: Avoid concomitant use (7.4) Rivaroxaban is a substrate of CYP3A4/5, CYP2J2, and the P-gp and ATP-binding cassette G2 (ABCG2) transporters."	0
Discoloration of body fluids: May permanently stain contact lenses or dentures red-orange.	0
"<U+03B2>-adrenergic blockade may mask clinical signs of hyperthyroidism, such as tachycardia."	0
Postulated relationship between elimination rate of benzodiazepine hypnotics and their profile of common untoward effects: The type and duration of hypnotic effects and the profile of unwanted effects during administration of benzodiazepine drugs may be influenced by the biologic half-life of administered drug and any active metabolites formed.	0
"Mean doses (mg/kg) for these children were: 18.5 (range 15.0 to 25.0) for infants 1 year of age, 8.6 (range 4.4 to 18.8) for children 2 to 10 years of age, and 4.0 (range 2.8 to 5.4) for adolescents 14 to 16 years of age."	0
Strong CYP3A4 inhibitors such as ketoconazole: Do not exceed 80 mg once daily (7).	1
Patients receiving digoxin should have their serum electrolytes and renal function (serum creatinine concentrations) assessed periodically; the frequency of assessments will depend on the clinical setting.	0
"Although it blocks the increase in this exchange that is stimulated by mineralocorticoids (chiefly aldosterone), it is not a competitive antagonist of aldosterone and its activity can be demonstrated in adrenalectomized rats and patients with Addison<U+2019>s disease."	0
PREZISTA should be taken with ritonavir and with food.	0
There may be circumstances when it is necessary to initiate treatment with an MAOI such as linezolid or intravenous methylene blue in a patient taking Savella.	0
Studies 1 and 2 were 10-week flexible dose studies.	0
"Obtain ECGs to monitor the QTc at baseline, seven days after initiation, and periodically thereafter, and following any dose adjustments (5.2, 5.3, 5.7, 5."	0
The safety of doses above 120mg/day has not been adequately evaluated.	0
This study also suggested an increased risk of overall major congenital malformations including cardiovascular defects for paroxetine (4% risk) compared to other (2% risk) antidepressants (OR 1.8; 95% confidence interval 1.2 to 2.8).	0
Cases with serum sodium lower than 110 mmol/L have been reported.	0
"Following oral administration of perphenazine tablets, mean peak plasma perphenazine concentrations were observed between 1 to 3 hours."	0
"Initial effects on cardiac output, stroke volume index, and systemic vascular resistance were small and variable."	0
Observe for signs and symptoms of hypotension.	0
One patient in clinical trials with atorvastatin developed jaundice.	0
"Use of PEXEVA<U+00AE> With Other MAOIs, Such as Linezolid or Methylene Blue: Do not start PEXEVA<U+00AE> in a patient who is being treated with linezolid or intravenous methylene blue because there is increased risk of serotonin syndrome."	0
"In patients with CHD or at high risk of CHD, ZOCOR can be started simultaneously with diet."	0
"Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE inhibitor therapy including ALTACE."	0
Downward dose adjustments of these drugs may be required when given concomitantly with methylphenidate.	0
Mirtazapine did not cause relevant changes in the pharmacokinetics of cimetidine.	0
"Angiotensin II is the principal pressor agent of the renin-angiotensin system, with effects that include vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation, and renal reabsorption of sodium."	0
"(CV 10%), 30.7 ng/mL (CV 67%), and 21 hours (CV 32%), respectively."	0
It should be noted that ultrafiltration does not solve all interference problems with alternative medicines.	0
"The effects of the initial intravenous dose must be monitored and the dose titrated either upward or downward, if needed, based on clinical effect, QT interval, or adverse reactions."	0
"Because elderly patients are more likely to have decreased renal function, care should be taken to adjust dose based on creatinine clearance."	0
"Abrupt withdrawal of beta blockade might precipitate a thyroid storm; therefore, patients suspected of developing thyrotoxicosis from whom TENORETIC therapy is to be withdrawn should be monitored closely."	0
"The use of PRADAXA for the prophylaxis of thromboembolic events in patients with atrial fibrillation in the setting of other forms of valvular heart disease, including the presence of a bioprosthetic heart valve, has not been studied and is not recommended."	0
"Atomoxetine did not affect the binding of warfarin, acetylsalicylic acid, phenytoin, or diazepam to human albumin."	0
"Normal sinus rhythm is usually not affected, but in patients with sick sinus syndrome, CALAN may interfere with sinus-node impulse generation and may induce sinus arrest or sinoatrial block."	0
"Potassium alkali are advantageous over sodium alkali, because they do not cause hypercalciuria and are less likely to cause the complication of calcium stones."	0
"For the same dose, PMs attain a 5-fold higher Cmax and 10-fold higher AUC of d-nebivolol than do EMs. d-Nebivolol accumulates about 1.5-fold with repeated once-daily dosing in EMs."	0
Atenolol can cause fetal harm when administered to a pregnant woman.	0
This is due to lack of specificity of the screening tests.	0
"Due to the narrow therapeutic index of pimozide and its known ability to prolong the QT interval, concomitant use of pimozide and paroxetine is contraindicated."	0
"In two studies, following the administration of 2 mg orally once daily, the mean accumulation ratios (steady-state AUC vs. first-dose AUC) were 1.2 and 1.7."	0
"Drugs that slow heart rate : Concomitant use of drugs with depressant effects on the sinus and AV node ( e.g. , digoxin , beta blockers , verapamil , diltiazem , ivabradine , clonidine ) can potentiate the electrophysiologic and hemodynamic effects of amiodarone , resulting in bradycardia , sinus arrest , and AV block ."	0
(The dosage reported for phentolamine is 5 mg intravenously.)	0
Digoxin may produce false positive ST-T changes on the electrocardiogram during exercise testing that may be indistinguishable from those of ischemia.	0
"As a consequence of inhibiting the renin-angiotensin-aldosterone system, anticipate changes in renal function in susceptible individuals."	0
"Known hypersensitivity (e.g., anaphylaxis or angioedema) to telmisartan or any other component of this product (4) Do not co-administer aliskiren with MICARDIS in patients with diabetes (4)"	0
False positive test results may be expected for several days following discontinuation of desvenlafaxine therapy.	0
Figure 1: The Impact of Coadministered Drugs on the Pharmacokinetics of Dronedarone and Recommendations for Dronedarone Coadministration or Dose Adjustment Figure 2: The Impact of Dronedarone on Coadministered Drugs and Recommendations for Dose Adjustment of Coadministered Drug Figure 1 Figure 2	0
"Life-threatening respiratory depression is more likely to occur in elderly, cachectic, or debilitated patients because they may have altered pharmacokinetics or altered clearance compared to younger, healthier patients."	0
MAO Inhibitors: Serious side effects and even death have been reported following the concomitant use of certain drugs with MAO inhibitors.	0
At least 61% of the oral dose is eliminated unchanged within 24 hours.	0
Advise women to avoid becoming pregnant while receiving PURIXAN.	0
Hepatic transaminase elevations that occur with hyperbilirubinemia should be evaluated for alternative etiologies.	0
Patients should be instructed to report promptly the occurrence of headache or other unusual symptoms.	0
"Families and caregivers of pediatric patients being treated with STRATTERA should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to healthcare providers."	0
Do not restart ULORIC if liver injury is confirmed and no alternate etiology can be found.	0
Tilt-table testing (60 degrees) was not able to induce orthostatic hypotension.	0
"Concentrations of thioridazine and its two active metabolites, mesoridazine and sulforidazine, increased 3-fold following coadministration of fluvoxamine."	1
Maximum IM Dosage: Patients up to 5 years (or 50 lbs.	0
"However, as with all CNS-active drugs, patients should be advised to avoid alcohol consumption while taking PRISTIQ."	0
"Patients taking concomitant mammalian target of rapamycin (mTOR inhibitor) (e.g., temsirolimus) therapy or a neprilysin inhibitor may be at increased risk for angioedema."	0
(Occasional patients have developed increased angina upon receiving nicardipine capsules.	0
"Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide."	0
"This contrasts with the effect of nonselective beta-blockers, which completely reverse the vasodilating effects of epinephrine."	0
"If the decision has been made to discontinue treatment, medication should be tapered, as rapidly as is feasible, but with recognition that abrupt discontinuation can be associated with certain symptoms."	0
"Also, patients taking diuretics or who are otherwise volume-depleted may be at greater risk."	0
Pamelor is not a monoamine oxidase inhibitor.	0
"Because it is known that the risk of myopathy during treatment with HMG-CoA reductase inhibitors is increased with concurrent administration of other fibrates, fluvastatin sodium should be administered with caution when used concomitantly with other fibrates."	0
"Consider initiating TOPROL-XL therapy at doses lower than those recommended for a given indication; gradually increase dosage to optimize therapy, while monitoring closely for adverse events."	0
"Perindopril has been studied in relatively few black patients, usually a low-renin population, and the average response of diastolic blood pressure to perindopril was about half the response seen in nonblack patients, a finding consistent with previous experience of other ACE inhibitors."	0
"Therefore, PRIFTIN may increase the metabolism of other coadministered drugs that are metabolized by these enzymes."	0
Maintenance Therapy: Long-term maintenance of efficacy was demonstrated in a 3-month relapse prevention trial.	0
"The combination of MAO inhibitors and tryptophan has been reported to cause behavioral and neurologic symptoms, including disorientation, confusion, amnesia, delirium, agitation, hypomanic signs, ataxia, myoclonus, hyperreflexia, shivering, ocular oscillations, and Babinski signs."	0
"However, the maximum concentration of fluvastatin sodium extended-release tablets seen after a high fat meal is less than the peak concentration following a single dose or twice daily dose of the 40 mg fluvastatin capsule."	0
Monitor patients who take Zanaflex with another CNS depressant for symptoms of excess sedation.	0
Maintenance Therapy: There is no body of evidence available to answer the question of how long the patient treated with paroxetine should remain on it.	0
A population PK analyses concluded that coadministration of lurasidone has minimal effect on lithium and valproate exposure when it is coadministered with lithium 300-2400 mg/day or valproate 300-2000 mg/day.	0
The recommended dose for this combination is INVIRASE 1000 mg plus lopinavir/ritonavir 400/100 mg bid.	0
The goal of this initial titration phase is to minimize side effects by permitting tolerance to side effects to develop or allowing the patient time to adapt if tolerance does not develop.	0
The maximal effect occurred within 1-4 hours post-dosing.	0
Blood glucose monitoring devices using glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ) or glucose-dye-oxidoreductase (GDO)-based methods must not be used.	0
"Unlike propranolol and metoprolol, which undergo hepatic metabolism, atenolol is eliminated primarily by renal excretion."	0
"For all patients: Serum potassium >5.5 mEq/L at initiation (4) Creatinine clearance <U+2264>30 mL/min (4) Concomitant use with strong CYP3A inhibitors (4, 7.1) For the treatment of hypertension: Type 2 diabetes with microalbuminuria (4) Serum creatinine >2.0 mg/dL in males, >1.8 mg/dL in females (4) Creatinine clearance <50 mL/min (4) Concomitant use of potassium supplements or potassium-sparing diuretics (4) For All Patients INSPRA is contraindicated in all patients with: serum potassium >5.5 mEq/L at initiation, creatinine clearance <U+2264>30 mL/min, or concomitant administration of strong CYP3A inhibitors (e.g., ketoconazole, itraconazole, nefazodone, troleandomycin, clarithromycin, ritonavir, and nelfinavir)."	0
Dosage may be adjusted in increments of 10 mg or 20 mg at approximately weekly intervals up to maximum dose of 70 mg/day.	0
"For the induction cycle, the recommended dose of TRISENOX is 0.15 mg/kg intravenously daily until bone marrow remission or up to a maximum of 60 days."	0
"Drugs that Induce CYP3A4 (Rifampicin) Racemic zopiclone exposure was decreased 80% by concomitant use of rifampicin, a potent inducer of CYP3A4."	1
"In general, the dose of digoxin used should be determined on clinical grounds."	0
WARNING: BLEEDING RISK See full prescribing information for complete boxed warning.	0
"If hypotension does occur, place the patient in the supine position and, if necessary, give an intravenous infusion of normal saline."	0
"The clinician should, nevertheless, be aware of the possibility of emergent symptoms of serotonin syndrome with such use."	0
"The cause of the decrease in hemoglobin is unknown, but it does not appear to result from hemorrhage or hemolysis."	0
"Other HIV protease inhibitors, except atazanavir As coadministration with PREZISTA/ritonavir has not been studied, coadministration is not recommended."	0
"When a daily dose of 20 mg/day was reached, patients were continued on this dose for 1 week before treatment was stopped."	0
"Clinical Trials Controlled Trials Supporting Effectiveness Zaleplon (typically administered in doses of 5 mg, 10 mg, or 20 mg) has been studied in patients with chronic insomnia (n = 3,435) in 12 placebo- and active-drug-controlled trials."	0
"The antihypertensive effect of ACE inhibitors, including benazepril, may be attenuated by NSAIDs."	0
Emergent Cardiovascular Symptoms <U+2013> Patients should undergo prompt cardiac evaluation.	0
Physicians should consider that the lowest available dose of LUVOX CR Capsules may not be appropriate for pediatric patients na<U+00EF>ve to fluvoxamine maleate.	0
"Consider alternatives to fluticasone propionate, particularly for long-term use."	0
Prevention of hypokalemia: Typical dose is 20 mEq per day.	0
The pharmacokinetics of quinapril and quinaprilat are linear over a single-dose range of 5<U+2013>80 mg doses and 40<U+2013>160 mg in multiple daily doses.	0
Neonates receiving PROSTIN VR PEDIATRIC at recommended doses for more than 120 hours should be closely monitored for evidence of antral hyperplasia and gastric outlet obstruction.	0
Consider holding tretinoin if symptoms are severe.	0
"If baseline QT interval < 450 msec, an on-treatment ECG should be performed after 3-4 days of therapy."	0
Monoamine Oxidase Inhibitors See CONTRAINDICATIONS and WARNINGS.	0
"Of the total number of patients receiving losartan potassium tablets in controlled clinical studies for hypertension, 391 patients (19%) were 65 years and over, while 37 patients (2%) were 75 years and over."	0
There were no gender differences in the pharmacokinetics of DCT and DDCT.	0
"Bacteriostatic antibacterials (i.e., chloramphenicol, erythromycins, sulfonamides or tetracyclines) may antagonize the bactericidal effect of penicillin, and concurrent use of these drugs should be avoided."	0
"For inadequate blood pressure response, dosing may be increased to a maximum of 25 mg twice daily."	0
"Given the primary CNS effects of FANAPT, caution should be used when it is taken in combination with other centrally acting drugs and alcohol."	0
These doses are up to 2.4 (mouse) and 3.9 (rat) times the maximum recommended human dose (MRHD) for MDD and GAD on a mg/m2 basis.	0
Vitamin K promotes the biosynthesis of <U+03B3>-carboxyglutamic acid residues in the proteins that are essential for biological activity.	0
"Hypokalemia may develop, especially with brisk diuresis when severe cirrhosis is present, during concomitant use of corticosteroid or adrenocorticotropic hormone (ACTH) or after prolonged therapy."	0
Lithium <U+2014> Multiple doses of olanzapine (10mg for 8 days) did not influence the kinetics of lithium.	0
"Additionally, higher than expected tricyclic antidepressant levels have been observed when they are begun in patients already taking cimetidine."	1
Diabetes and Hypoglycemia: May mask tachycardia occurring with hypoglycemia.	0
<U+2022> Other Potentially Important Drug Interactions.	0
"Blockade of the angiotensin II receptor inhibits the negative regulatory feedback of angiotensin II on renin secretion, but the resulting increased plasma renin activity and angiotensin II circulating levels do not overcome the effect of telmisartan on blood pressure."	0
CYMBALTA can be given without regard to meals.	0
Appearance of myasthenic syndrome or myasthenia gravis requires cessation of treatment.	0
"This preferential effect is not absolute, however, and at higher doses, TENORMIN inhibits beta2-adrenoreceptors, chiefly located in the bronchial and vascular musculature."	0
"Because of possible hypotensive effects, reserve parenteral administration for bedfast patients or for acute ambulatory cases, and keep patient lying down for at least 1/2 hour after injection."	0
The discontinuation rate due to rash in subjects using PREZISTA/ritonavir was 0.5%.	0
The recommended initial dose for treating heart failure is 4 mg once daily.	0
Digoxin responses are normal in patients with compensated thyroid disease.	0
"Hypokalemia may develop especially with brisk diuresis, when severe cirrhosis is present, or during concomitant use of corticosteroids or ACTH."	0
The volume of distribution of dabigatran is 50 to 70 L. Dabigatran pharmacokinetics are dose proportional after single doses of 10 to 400 mg.	0
Doses beyond 34 mg once daily are not recommended.	0
"Cases of Stevens-Johnson syndrome, erythema multiforme, and toxic skin eruptions, including drug rash, eosinophilia, and systemic symptoms (DRESS) syndrome, have been reported in patients receiving REYATAZ."	0
<U+2022>Patients with cardiogenic shock or who have decompensated heart failure requiring the use of intravenous inotropic therapy.	0
Evidence gathered in preclinical studies suggests that mirtazapine enhances central noradrenergic and serotonergic activity.	0
REMS: CAPRELSA is available only through a restricted distribution program called the CAPRELSA REMS Program.	0
"In a longer-term study, patients meeting DSM-III-R criteria for Panic Disorder who had responded during a 52-week open trial on Sertraline hydrochloride 50-200 mg/day (n=183) were randomized to continuation of Sertraline hydrochloride or to substitution of placebo for up to 28 weeks of observation for discontinuation due to relapse or insufficient clinical response."	0
"The variant alleles, CYP2C9*2 and CYP2C9*3, result in decreased in vitro CYP2C9 enzymatic 7-hydroxylation of S-warfarin."	0
Recommended dose of ONIVYDE is 70 mg/m 2 intravenous infusion over 90 minutes every two weeks.	0
Voriconazole also significantly increases efavirenz plasma concentrations.	1
"Telmisartan As a consequence of inhibiting the renin-angiotensin-aldosterone system, anticipate changes in renal function in susceptible individuals."	0
Ccr is corrected to 1.73 m 2 body surface area.	0
"Anaphylactoid and Possibly Related Reactions Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors, including trandolapril may be subject to a variety of adverse reactions, some of them serious."	0
"When adding a diuretic or other antihypertensive agent, the dose of MINIPRESS should be reduced to 1 mg or 2 mg three times a day and retitration then carried out."	1
"In patients with sick sinus syndrome, diltiazem significantly prolongs sinus cycle length (up to 50% in some cases)."	0
Stop the infusion immediately if signs of hypersensitivity develop.	0
Monitor cholesterol and triglycerides prior to therapy and periodically thereafter.	0
No reports involved the administration of methylene blue by other routes (such as oral tablets or local tissue injection) or at lower doses.	0
Coadministration of aspirin and nitroglycerin has been reported to result in increased nitroglycerin maximum concentrations by as much as 67 % and AUC by 73 % when administered as a single dose .	1
"Race Pharmacokinetic analysis showed that race (White, n = 466; Black, n = 97; Hispanic, n = 39; Other, n = 33) had no apparent effect on the pharmacokinetics of PRISTIQ."	0
Therapeutic levels of rifampin have been shown to inhibit standard microbiological assays for serum folate and vitamin B12.	0
The mechanism of this syndrome is not understood.	0
"In the vast majority of instances, these enzyme increases were not associated with other clinical findings suggestive of hepatic injury; moreover, none were jaundiced."	0
"Co-administration of nifedipine with phenytoin, an inducer of CYP3A4, lowers the systemic exposure to nifedipine by approximately 70%."	1
Penicillin blood levels may be prolonged by concurrent administration of probenecid which blocks the renal tubular secretion of penicillins.	1
Specific Populations Pediatric Irbesartan-hydrochlorothiazide pharmacokinetics have not been investigated in patients <18 years of age.	0
"Therefore, expect an increased risk for hemorrhagic complications, particularly for patients with other risk factors for bleeding."	0
"Liver Disease<U+2013>As might be predicted from its primary site of metabolism, liver impairment can affect the elimination of sertraline."	0
"Patients should be advised to notify their physician if they develop a rash, hives, or a related allergic phenomenon."	0
Monitor toxicity when coadministering these medications.	0
Consider additional follow-up and diagnostic testing in adult patients who have a suboptimal response or an early symptomatic relapse after completing treatment with a PPI.	0
"New-onset diabetes mellitus, exacerbation of preexisting diabetes mellitus, and hyperglycemia have been reported during postmarketing surveillance in HIV-infected patients receiving protease inhibitor therapy."	0
"Therapeutic effects of quinapril appear to be the same for elderly (<U+2265>65 years of age) and younger adult patients given the same daily dosages, with no increase in adverse events in elderly patients."	0
"Vortioxetine and its metabolites are unlikely to inhibit the following CYP enzymes and transporter based on in vitro data: CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, CYP3A4/5, and P-gp."	0
"Above this glomerular filtration rate, the elimination half-life is little changed."	0
"In a randomized, double-blind, placebo- and positive-controlled three-period crossover thorough QTc study in 54 healthy adult subjects, there was a positive relationship between the length of the rate-adjusted QTc interval and serum sertraline concentration."	0
THIOLA<U+00AE> may be begun at a dosage of 800 mg/day in adult patients with cystine stones.	0
"The bleeding risk is highest initially, as shown in Figure 1 (events through 450days; inset shows events through 7days)."	0
"Of the most frequently reported (>1%) side effects, rash, vomiting, and diarrhea occurred in greater proportions of older patients."	0
Rash: Discontinue and initiate appropriate treatment if severe skin reaction occurs or is suspected.	0
Add 100 mL of Ora-Sweet<U+00AE>* and 50 mL of Ora-Plus<U+00AE>* to the suspension and shake well for at least 1 minute.	0
This is most likely to occur within the first few weeks of treatment.	0
The drug produces diuresis with increased excretion of sodium and chloride.	0
"The pharmacokinetics of estazolam (Cmax and AUC) were not affected during multiple-dose fluoxetine, suggesting no clinically significant pharmacokinetic interaction."	0
Treatment of familial Mediterranean fever (FMF): Maximum daily dose of 0.6mg (may be given as 0.3mg twice a day).	0
"While no in vivo drug-drug interaction studies were conducted between estazolam and inducers of CYP3A, compounds that are potent CYP3A inhibitors (such as carbamazepine, phenytoin, rifampin, and barbiturates) would be expected to decrease estazolam concentrations."	1
Individual patients may respond to higher doses of up to 480 mg once daily.	0
"Acute Liver Injury In postmarketing experience abnormal liver function tests have been reported, some in the first few weeks of therapy with mexiletine hydrochloride."	0
Use caution when administering CLOZARIL concomitantly with drugs that are inducers or inhibitors of these enzymes.	0
"Give low doses of beta-blockers initially, and increase only after ECG verification of good tolerability."	1
Insulin or oral hypoglycemic medication requirements in diabetes mellitus may be altered in association with the use of phendimetrazine and the concomitant dietary regimen.	0
The effect of theophylline on the pharmacokinetics of citalopram was not evaluated.	0
The increase in AUC for candesartan was 30% in patients with mild hepatic impairment (Child-Pugh A) and 145% in patients with moderate hepatic impairment (Child-Pugh B).	0
<U+2022> Gender: There were no differences in plasma concentrations of rosuvastatin between men and women.	0
"For patients chronically taking potent inducers of CYP3A , such as rifampin , avoid use of ADCIRCA see Warnings and Precautions ( 5.2 ) and Clinical Pharmacology ( 12.3 ) ."	0
No dosing adjustment is required in patients with mild hepatic impairment.	0
"As urinary pH rises above 6.5, the renal clearance of free salicylate increases from <5% to >80%."	0
Drug-Drug Interaction Studies The in vivo assessments of effect of other drugs on the pharmacokinetics of quetiapine are summarized in Table 17.	0
"Therefore , the expected clinical effects of SAMSCA in the presence of rifampin and other inducers ( e.g. , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine and St.   John 's   Wort ) may not be observed at the usual dose levels of SAMSCA ."	0
Intestinal Angioedema Intestinal angioedema has occurred in patients treated with ACE inhibitors.	0
"Antiarrhythmics: amiodarone Effect on amiodarone, ledipasvir, and sofosbuvir concentrations unknown Coadministration of amiodarone with HARVONI may result in serious symptomatic bradycardia."	0
"In patients with pre-existing severe liver disease, hepatic encephalopathy, manifested by tremors, confusion, and coma, and increased jaundice, have been reported in association with diuretics, including amiloride HCl."	0
Patients whose serum creatinine is greater than 1.8 mg/dl should take no more than 1.0 gm/day; such patients should be dosed at q-12-h intervals.	0
"In patients whose renal function may depend on the activity of the renin-angiotensin-aldosterone system (e.g., patients with severe congestive heart failure), treatment with angiotensin converting enzyme inhibitors has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death."	0
"Accordingly, dosage selection must be based upon clinical assessment and ultimately therapeutic drug level monitoring of the patient."	0
Conduction disturbance (rarely with hemodynamic compromise) has been observed when COREG is coadministered with diltiazem.	0
"Exercise, both prior to and immediately following intramuscular administration of atropine, significantly increases the absorption of atropine due to increased perfusion in the muscle and significantly decreases the clearance of atropine."	0
Co-administration of ritonavir and rivaroxaban may lead to risk of increased bleeding.	0
"If a dose of CYMBALTA is missed, take the missed dose as soon as it is remembered."	0
Instruct patients or caregivers to immediately take the dose after mixing.	0
Treatment of familial Mediterranean fever (FMF)<U+2013> coadministration of colchicine in patients on VIRACEPT: Maximum daily dose of 0.6 mg (may be given as 0.3 mg twice a day).	1
"However, there are no clinical data with this dose adjustment in patients receiving strong CYP3A4 inhibitors."	0
The last two complications may occur with or without preceding exacerbation of the angina pectoris.	0
"Patients may wish to be examined to determine whether they are susceptible to angle closure, and have a prophylactic procedure (e.g., iridectomy), if they are susceptible."	0
"If this is not possible, sample at least 6 hours or later after the last dose, regardless of the route of administration or the formulation used."	0
Children (5 years and older) <U+2265> 15 kg to < 40 kg 20 mg Once daily for up to 8 weeks <U+2265> 40 kg 40 mg Maintenance of Healing of Erosive Esophagitis Adults 40 mg Once dailyControlled studies did not extend beyond 12 months Pathological Hypersecretory Conditions Including Zollinger-Ellison Syndrome Adults 40 mg Twice dailyDosage regimens should be adjusted to individual patient needs and should continue for as long as clinically indicated.	0
A QRS duration of <U+2265> 0.16 seconds has been associated with an increased incidence of ventricular dysrhythmias.	0
Fatalities associated with jaundice have occurred in patients with liver disease and in patients taking rifampin with other hepatotoxic agents.	0
Intervention Initiate with lower doses and monitor patients for signs and symptoms of serotonin syndrome particularly during VYVANSE initiation and after a dosage increase.	0
"PDE5 inhibitors , including ADCIRCA , are mild systemic vasodilators ."	0
"During dialysis, perindopril is removed with the same clearance as in patients with normal renal function."	0
Store the pouch at room temperature [between 68<U+00B0>F-77<U+00B0>F (20<U+00B0>C-25<U+00B0>C)].	0
The physician may consider the value of liver function testing.	0
Resume within 2 weeks at prior dose if ANC greater than 1.0 x 109/L and platelets greater than 50 x 109/L3.	0
", The effects of atazanavir/ritonavir on ledipasvir and sofosbuvir are similar with or without the presence of emtricitabine/tenofovir DF."	0
These data indicate that fluoxetine's extent of inhibition of CYP3A4 activity is not likely to be of clinical significance.	0
"Quinapril hydrochloride was not carcinogenic in mice or rats when given in doses up to 75 or 100 mg/kg/day (50 to 60 times the maximum human daily dose, respectively, on an mg/kg basis and 3.8 to 10 times the maximum human daily dose when based on an mg/m2 basis) for 104 weeks."	0
Special Populations Gender Dronedarone exposures are on average 30% higher in females than in males.	0
There were no significant differences in plasma protein binding observed between the two groups.	0
INTEGRILIN should be given concomitantly with heparin dosed to achieve the following parameters : .	0
"In a study of intra-arterially administered nicardipine, the degree of vasodilation and the resultant decrease in blood pressure were more prominent in hypertensive patients than in normotensive volunteers."	0
Single 40 mg dose of EMEND No dosage adjustment of oral dexamethasone needed Methylprednisolone Clinical Impact Increased methylprednisolone exposure.	1
"Therapy with TIKOSYN must be initiated (and, if necessary, re-initiated) in a setting that provides continuous electrocardiographic (ECG) monitoring and in the presence of personnel trained in the management of serious ventricular arrhythmias."	0
"Ergot derivatives dihydroergotamine, ergotamine, methylergonovine Potential for serious and/or life-threatening events such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues."	0
<U+2022>Add a small amount of vehicle to the required number of ATACAND tablets (five 32 mg tablets) and grind into a smooth paste using a mortar and pestle.	0
"As soon as possible and when indicated, patients should be changed to an oral antiarrhythmic agent for maintenance therapy."	0
Test serum lipase levels monthly or as clinically indicated.	0
Rare reports of cyanocobalamin deficiency occurring with acid-suppressing therapy have been reported in the literature.	0
Nortriptyline hydrochloride oral solution USP should be discontinued before initiating treatment with the MAOI.	0
<U+2022>REYATAZ capsules and oral powder must be taken with food.	0
"Adverse events and discontinuations, however, were dose-related."	0
"Delavirdine 400 mg TID 300 mg QD HIV-infected patients (7) <U+2191> AUC by 230%,<U+2191> Cmax by 128% <U+2193> AUC by 80%,<U+2193> Cmax by 75%,<U+2193> Cmin by 17% CONTRAINDICATED Didanosine 167 or 250 mg BID <U+00D7> 12 days 300 or 600 mg QD <U+00D7> 1 HIV-infected patients (11) <U+2194> <U+2194> Fosamprenavir/ ritonavir 700 mg BID plus ritonavir 100 mg BID <U+00D7> 2 weeks 150 mg every other day <U+00D7> 2 weeks Healthy subjects (15) <U+2194> AUCcompared to rifabutin 300 mg QD alone <U+2193> Cmax by 15% <U+2191> AUC by 35%compared to historical control (fosamprenavir/ritonavir 700/100 mg BID),<U+2191> Cmax by 36%,<U+2191> Cmin by 36%, Reduce rifabutin dose by at least 75% (to a maximum 150 mg every other day or three times per week) when given with fosamprenavir/ritonavir combination."	1
"Study 3 was a 12-week study comparing fixed paroxetine doses of 20, 40, or 60mg/day with placebo."	0
Hydrochlorothiazide is eliminated primarily by renal pathways.	0
It is also unknown if the risk for myopathy with coadministration of simvastatin with lipid-modifying doses of niacin-containing products observed in Chinese patients applies to other Asian patients.	0
No pharmacodynamic effects of either histamine H2 receptor antagonist were observed.	0
"In patients with end-stage renal disease, chronic hemodialysis or continuous ambulatory peritoneal dialysis has little effect on the elimination of quinapril and quinaprilat."	0
Chronic or overuse of laxatives may reduce serum potassium levels by promoting excessive potassium loss from the intestinal tract; laxatives may interfere with the potassium-retaining effects of triamterene.	0
Avoid doses greater than 10 mg once daily of simvastatin.	1
"By comparison, a group of 22 separately studied adults between 18 and 45 years of age (11 male, 11 female) received 30 days of 200 mg/day sertraline and exhibited a mean sertraline AUC (0 to 24 hr) of 2570 ng-hr/mL, mean Cmax of 142 ng/mL, and mean half-life of 27.2 hr."	0
Digitalis glycosides: Risk of bradycardia (7) Anticholinesterases: Prolongs neuromuscular blockade (7) Antihypertensive agents: Risk of rebound hypertension (7) Sympathomimetic drugs: Dose adjustment needed (7) Vasoconstrictive and positive inotropic effect substances: Avoid concomitant use (7)	0
Anaphylactoid reactions have been reported in patients dialyzed with high-flux membranes and treated concomitantly with an ACE inhibitor.	0
"This suggests that fluvoxamine is metabolized, at least in part, by CYP2D6."	0
"HALCION Tablets 0.5 mg, in two separate studies, did not affect the prothrombin times or plasma warfarin levels in male volunteers administered sodium warfarin orally."	0
"If laryngeal stridor or angioedema of the face, tongue, or glottis occurs, discontinue treatment with ALTACE and institute appropriate therapy immediately."	0
Higher relapse rates may occur in patients with cavitary pulmonary lesions and/or positive sputum cultures after the initial phase of active tuberculosis treatment and in patients with evidence of bilateral pulmonary disease.	0
"Intervention No dosage adjustment needed Examples ondansetron, granisetron, dolasetron Aprepitant is a CYP3A4 substrate."	0
Nonteratogenic effects: Infants born to mothers dependent on amphetamines have an increased risk of premature delivery and low birth weight.	0
Angiotensin II also stimulates aldosterone secretion by the adrenal cortex.	0
Caution should be exercised when TENORETIC is administered during pregnancy or to a woman who is breast-feeding.	0
"Avoid use with strong inducers of CYP3A (e.g., rifampin, phenytoin, carbamazepine and phenobarbital) [see Clinical Pharmacology (12.3) ]."	0
"In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including quinapril, may result in deterioration of renal function, including possible acute renal failure."	0
"Amiloride HCl, one 5 mg tablet daily, should be added to the usual antihypertensive or diuretic dosage of a kaliuretic diuretic."	0
"Proton pump inhibitor: omeprazole <U+2193> omeprazole<U+2194> darunavir When omeprazole is co-administered with PREZISTA/ritonavir, monitor patients for decreased efficacy of omeprazole."	0
There is no need to adjust single dose therapy for vaginal candidiasis because of impaired renal function.	0
Patients with pre-existing conduction abnormalities or left ventricular dysfunction are particularly susceptible.	0
"(7.6) Concomitant administration of Remodulin with diuretics, antihypertensive agents or other vasodilators may increase the risk of symptomatic hypotension."	0
Use of HARVONI with amiodarone is not recommended.	0
Lexapro has not been systematically evaluated in patients with a recent history of myocardial infarction or unstable heart disease.	0
Plasma S-(-) verapamil Cmax and AUC were both increased 50%.	0
The pharmacokinetics of ambrisentan (S-ambrisentan) in healthy subjects is dose proportional.	0
"Drug Interactions The pharmacokinetics of benazepril are not affected by the following drugs: hydrochlorothiazide, furosemide, chlorthalidone, digoxin, propranolol, atenolol, nifedipine, amlodipine, naproxen, acetylsalicylic acid, or cimetidine."	0
"DYAZIDE is contraindicated in patients with anuria, acute and chronic renal insufficiency, or significant renal impairment."	0
Alcohol: Alcohol increases the rate at which CARDIZEM CD releases diltiazem in vitro.	1
Do not co-administer these drugs with NATRECOR<U+00AE> through the same IV catheter.	0
The concomitant use of rifampin and halothane should be avoided.	0
"There are, however, no adequate and well-controlled studies in pregnant women."	0
"In clinical trials, one ClassIII patient's death was judged attributable to the interruption of FLOLAN."	0
Monitor for signs and symptoms of TB relapse in these patients.	0
"From this reaction, a water-soluble mixed disulfide is formed and the amount of sparingly soluble cystine is reduced."	0
All inhibitory effects of selegiline and N-desmethylselegiline occurred at concentrations that are several orders of magnitude higher than concentrations seen clinically (highest predose concentration observed at a dose of 12mg per 24 hours at steady-state was 0.046mcM).	0
"There were differences in absolute risk of suicidality across the different indications, with the highest incidence in MDD."	0
"Nonsteroidal anti-inflammatory drugs - In some patients, the administration of a nonsteroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium sparing, and thiazide diuretics."	0
"Bleeding events related to SSRIs and SNRIs use have ranged from ecchymoses, hematomas, epistaxis, and petechiae to life-threatening hemorrhages."	0
"APTIVUS, co-administered with 200 mg of ritonavir, has been associated with reports of both fatal and non-fatal intracranial hemorrhage (ICH)."	0
"If signs or symptoms of spinal hematoma are suspected, initiate urgent diagnosis and treatment including consideration for spinal cord decompression even though such treatment may not prevent or reverse neurological sequelae."	0
"The plasma protein binding of nisoldipine is very high, with less than 1% unbound over the plasma concentration range of 100 ng/mL to 10 mcg/mL."	0
"Neonatal opioid withdrawal syndrome presents as irritability, hyperactivity and abnormal sleep pattern, high pitched cry, tremor, vomiting, diarrhea and failure to gain weight."	0
Digitalis glycosides: Risk of bradycardia (7) Anticholinesterases: Prolongs neuromuscular blockade (7) Antihypertensive agents: Risk of rebound hypertension (7) Sympathomimetic drugs: Dose adjustment needed (7) Vasoconstrictive and positive inotropic effect substances: Avoid concomitant use (7)	0
"In multiple-dose regimens, the total exposure to ramiprilat (AUC) in these patients is 3<U+2013>4 times as large as it is in patients with normal renal function who receive similar doses."	0
Patients treated with dronedarone should undergo monitoring of cardiac rhythm no less often than every 3 months.	0
<U+2022> Concomitant Illness: Use caution in patients with diseases or conditions that affect hemodynamic responses or metabolism.	0
The mean plasma loxapine concentrations following administration of ADASUVE were linear over the clinical dose range.	0
"The measured levels of DLIS (as digoxin equivalents) are usually low (0.2 to 0.4 ng/mL), but sometimes they reach levels that would be considered therapeutic or even toxic."	0
"Safe use of NORPRAMIN during pregnancy and lactation has not been established; therefore, if it is to be given to pregnant patients, nursing mothers, or women of childbearing potential, the possible benefits must be weighed against the possible hazards to mother and child."	0
No hypertensive crises were reported in any patient receiving EMSAM.	0
"Administration of iloperidone with a standard high-fat meal did not significantly affect the Cmax or AUC of iloperidone, P88, or P95, but delayed Tmax by 1 hour for iloperidone, 2 hours for P88 and 6 hours for P95."	1
ATACAND can cause symptomatic hypotension.	0
Concomitant use of proton pump inhibitors and VIRACEPT may lead to a loss of virologic response and development of resistance.	0
Specific Population Studies Renal or Hepatic Impairment No specific pharmacokinetic studies were conducted to investigate the effects of renal or hepatic impairment on the pharmacokinetics of clozapine.	0
"WARNING: QT PROLONGATION, TORSADES DE POINTES, AND SUDDEN DEATH See full prescribing information for complete boxed warning."	0
Such monitoring should include daily observation by families and caregivers.	0
"Under the auspices of the National Toxicology Program, rats and mice received hydrochlorothiazide in their feed for 2 years, at doses up to 600 mg/kg/day in mice and up to 100 mg/kg/day in rats."	0
"Other Agents Commonly Used Anticonvulsants: CarbamazepinePhenobarbitalPhenytoin <U+2193> Tipranavir Caution should be used when prescribing carbamazepine, phenobarbital and/or phenytoin."	0
The amlodipine component of CADUET inhibits the transmembrane influx of calcium ions into vascular smooth muscle and cardiac muscle.	0
"Because of underreporting, it is impossible to provide an accurate estimate of the true incidence of these reactions."	0
"Data from several studies, ie, TIMI-II, ISIS-2, currently do not suggest any clinical interaction between aspirin and beta blockers in the acute myocardial infarction setting."	0
Ziprasidone at a dose of 40 mg twice daily administered concomitantly with lithium at a dose of 450 mg twice daily for 7 days did not affect the steady-state level or renal clearance of lithium.	0
"Patients at increased risk may be prescribed opioids such as Meperidine Hydrochloride Injection, but use in such patients necessitates intensive counseling about the risks and proper use of Meperidine Hydrochloride Injection along with intensive monitoring for signs of addiction, abuse, and misuse."	0
"NATRECOR<U+00AE> binds to heparin and therefore could bind to the heparin lining of a heparin-coated catheter, decreasing the amount of NATRECOR<U+00AE> delivered to the patient for some period of time."	0
"Like other slow-channel blockers, PROCARDIA exerts a negative inotropic effect on isolated myocardial tissue."	0
Amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats.	0
The complete text of the Medication Guide is reprinted at the end of this document.	0
Prophylaxis of Deep Vein Thrombosis and Pulmonary Embolism Following Hip Replacement Surgery Dosing recommendations for patients with CrCl <U+2264>30 mL/min or on dialysis cannot be provided.	0
Thiazides and triamterene have been shown to cross the placental barrier and appear in cord blood.	0
Caution should be exercised when DIFLUCAN is administered to a nursing woman.	0
Case reports and epidemiological studies (case-control and cohort design) have demonstrated an association between use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding.	0
"Quinidine is also contraindicated in patients who, like those with myasthenia gravis, might be adversely affected by an anticholinergic agent."	0
"In patients with impaired hepatic function or progressive liver disease, minor alterations in fluid and electrolyte balance may precipitate hepatic coma."	0
"Site-directed mutagenesis of the Y93H in both genotypes 1a and 1b, as well as the Q30E substitution in genotype 1a, conferred high levels of reduced susceptibility to ledipasvir (fold change in EC50 greater than 1000-fold)."	0
Selegiline should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.	0
"As noted above (CLINICAL PHARMACOLOGY), multiple studies with ISDN and other nitrates have shown that maintenance of continuous 24-hour plasma levels results in refractory tolerance."	0
"Drugs That Interfere With Hemostasis (e.g., NSAIDs, Aspirin, and Warfarin) Serotonin release by platelets plays an important role in hemostasis."	0
"In a controlled study of healthy volunteers, after paroxetine was titrated to 60 mg daily, co-administration of a single dose of 2 mg pimozide was associated with mean increases in pimozide AUC of 151% and Cmax of 62%, compared to pimozide administered alone."	1
"Nitritoid reactions ( symptoms include facial flushing , nausea , vomiting and hypotension ) have been reported rarely in patients on therapy with injectable gold ( sodium aurothiomalate ) and concomitant ACE inhibitor therapy including VASOTEC ."	0
Consider withholding or discontinuing therapy in patients who develop a clinically significant decrease in renal function on Lotensin.	0
Duration of diuretic activity and effective dosage range of the hydrochlorothiazide and triamterene components of DYAZIDE are similar.	0
"Angiotensin II is the principal pressor agent of the renin-angiotensin system, with effects that include vasoconstriction, stimulation of synthesis and release of aldosterone, cardiac stimulation, and renal reabsorption of sodium."	0
"In a study of elderly (62<U+2013>83 years old) versus younger subjects (21<U+2013>41 years old) who received HALCION at the same dose levels (0.125 mg and 0.25 mg), the elderly experienced both greater sedation and impairment of psychomotor performance."	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction with antidepressants compared to placebo in adults aged 65 and older.	0
"This effect may reduce the efficacy of standard doses of such drugs, which include itraconazole, clarithromycin, and saquinavir."	1
Digoxin can precipitate vasoconstriction and may promote production of pro-inflammatory cytokines.	0
Inhibitors of CYP3A4 and P-gp increase exposure to apixaban and increase the risk of bleeding.	1
"The once-daily administration of up to 16 mg of candesartan cilexetil to healthy subjects did not influence plasma aldosterone concentrations, but a decrease in the plasma concentration of aldosterone was observed when 32 mg of candesartan cilexetil was administered to hypertensive patients."	0
"<U+2022> Hepatic Impairment: In patients with chronic alcohol liver disease, plasma concentrations of rosuvastatin were modestly increased."	0
TIKOSYN is also contraindicated in patients with severe renal impairment (calculated creatinine clearance <20 mL/min).	0
CAPRELSA has not been studied in patients with ventricular arrhythmias or recent myocardial infarction.	0
"Less than 5% of a 2 mg dose of estazolam was excreted unchanged in the urine, with only 4% of the dose appearing in the feces."	0
Pediatric Amlodipine: Sixty-two hypertensive patients aged 6 to 17 years received doses of amlodipine between 1.25 mg and 20 mg. Weight-adjusted clearance and volume of distribution were similar to values in adults.	0
Lexapro should also not be started in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue.	0
Triamterene is rapidly absorbed following oral administration.	0
Advise pregnant women of the potential risk to a fetus.	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP should be discontinued immediately if signs or symptoms of vasoconstriction develop."	0
Complex behaviors have been reported with the use of ROZEREM.	0
"Check serum potassium and serum creatinine within 3<U+2013>7 days of a patient initating a moderate CYP3A inhibitor ACE inhibitors, angiotensin-II blockers or non-steroidal-anti-inflammatories."	0
"Renal Function CrCl (mL/min) Increase in AUC Increase in Cmax t1/2 (h) Normal <U+2265> 80 1x 1x 13 Mild 50-80 1.5x 1.1x 15 Moderate 30-50 3.2x 1.7x 18 Severe+ 15-30 6.3x 2.1x 27 Hepatic Impairment Administration of PRADAXA in patients with moderate hepatic impairment (Child-Pugh B) showed a large inter-subject variability, but no evidence of a consistent change in exposure or pharmacodynamics."	0
The patient should be cautioned about concomitant use of alcohol or other CNS-active drugs and diethylpropion hydrochloride.	0
Less than 2% of a dose of LIPITOR is recovered in urine following oral administration.	0
"While none of the drugs studied for drug interactions significantly affected the pharmacokinetics of fluvoxamine, an in vivo study of fluvoxamine single-dose pharmacokinetics in 13 PM subjects demonstrated altered pharmacokinetic properties compared to 16 ""extensive metabolizers"" (EM): mean Cmax, AUC, and half-life were increased by 52%, 200%, and 62%, respectively, in the PM compared to the EM group."	0
"Increase dose as tolerated to 40 mg daily (2.2) Acute Myocardial Infarction (MI): Give 5 mg within 24 hours of MI followed by 5 mg after 24 hours, then 10 mg once daily (2.3) Renal Impairment: For patients with creatinine clearance 10-30 mL/min, halve the usual initial dose."	0
"The risk of post-transplant lymphomas may be increased in patients who receive aggressive treatment with immunosuppressive drugs, including IMURAN."	0
The pharmacokinetics of atropine is nonlinear after intravenous administration of 0.5 to 4 mg. Atropine's plasma protein binding is about 44% and saturable in the 2-20 <U+03BC>g/mL concentration range.	0
Renal Impairment There is limited information on the pharmacokinetics of bupropion in patients with renal impairment.	0
"The incidence of Grade 3 or 4 late onset diarrhea was 9% in patients receiving ONIVYDE/5-FU/LV, compared to 4% in patients receiving 5-FU/LV."	0
The effect of theophylline on the pharmacokinetics of citalopram was not evaluated.	0
Follow the suspension preparation instructions below to administer Benicar as a suspension.	0
"In a study in which pregnant monkeys (both treated and control) had high rates of abortion and mortality, the only surviving fetus from a group exposed to a maternal dose of 100 mg nisoldipine/kg/day (about 30 times the MRHD when compared on a mg/m2 basis) presented with forelimb and vertebral abnormalities not previously seen in control monkeys of the same strain."	0
"There are scattered reports of infusion rates in neonates up to 125 mcg/kg/min, but most reports in pediatric patients describe dosing that is similar (on a mcg/kg/min basis) to that used in adults."	0
Anaphylactoid Reactions During Membrane Exposure Anaphylactoid reactions have been reported in patients dialyzed with high-flux membranes and treated concomitantly with an ACE inhibitor.	0
Gemfibrozil significantly increased rosuvastatin exposure.	1
"In humans, hemodynamic changes due to epoprostenol (e.g., increased heart rate, facial flushing) returned to baseline within 10 minutes of termination of 60-minute infusions of 1 to 16 ng/kg/min."	0
"In embryo-fetal development studies of dihydroergotamine mesylate nasal spray, intranasal administration to pregnant rats throughout the period of organogenesis resulted in decreased fetal body weights and/or skeletal ossification at doses of 0.16 mg/day (associated with maternal plasma dihydroergotamine exposures [AUC] approximately 0.4-1.2 times the exposures in humans receiving the MRDD of 4 mg) or greater."	0
"The patient should be monitored for symptoms of serotonin syndrome for 7 days or until 24 hours after the last dose of linezolid or intravenous methylene blue, whichever comes first."	0
DIFLUCAN can be taken with or without food.	0
This will deliver a NATRECOR<U+00AE> infusion dose of 0.01 mcg/kg/min.	0
"Most of the antihypertensive effect is present within 2 weeks, and maximal blood pressure reduction is generally obtained within 4 to 6 weeks of treatment with ATACAND."	0
"If omeprazole or another proton pump inhibitor is taken concomitantly with INVIRASE/ritonavir, caution is advised and monitoring for potential saquinavir toxicities is recommended, particularly gastrointestinal symptoms, increased triglycerides, deep vein thrombosis, and QT prolongation."	0
There was no effect on serum uric acid during chronic oral administration and no uricosuric effect.	0
The terminal elimination half-life of irbesartan averages 11 to 15 hours.	0
"Treatment of P. falciparum malaria<U+2014>Two regimens have each been shown to be effective, with or without concomitant exchange transfusion."	0
Continue optimum dosage for 2 weeks; then gradually reduce dosage to the lowest effective maintenance level.	0
"Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior."	0
"Symptomatic hypotension is most likely to occur in patients who have been volume- and/or salt-depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea, or vomiting."	0
Dopamine HCl should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.	0
Pharmacokinetic data were significantly more variable in subjects with moderate hepatic impairment.	0
"If a hypertensive crisis occurs, NARDIL should be discontinued immediately and therapy to lower blood pressure should be instituted immediately."	0
"However, concomitant use of CLOZARIL and strong CYP3A4 inducers is not recommended."	0
"This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function."	0
<U+2022> Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.	0
Both the risk of developing tardive dyskinesia and the likelihood that it will become irreversible are believed to increase as the duration of treatment and the total cumulative dose of antipsychotic drugs administered to the patient increase.	0
"Since PRIFTIN is highly bound to albumin, drug displacement interactions may also occur."	0
Both CYP3A4 and CYP2D6 are responsible for iloperidone metabolism.	0
"Moreover, higher doses should ordinarily be avoided because of the increased risk of side effects."	0
"The most consistent, dose-related toxicity of PURIXAN is bone marrow suppression, manifested by anemia, leukopenia, thrombocytopenia, or any combination of these."	0
"Dihydroergotamine possesses oxytocic properties and, therefore, should not be administered during pregnancy."	0
Nefazodone hydrochloride tablets are contraindicated in patients who were withdrawn from nefazodone because of evidence of liver injury.	0
A significant difference from placebo was observed only for the 40 mg/day group.	0
"The corresponding dose of intravenous sotalol is, therefore, slightly less than that of the oral dose."	0
There was no induction or inhibition of 3A4.	0
Monitor renal function periodically in patients receiving telmisartan and NSAID therapy.	0
"However, due to the potential for serotonin syndrome, caution is advised when paroxetine is coadministered with lithium."	0
"If concomitant use of nortriptyline hydrochloride oral solution USP with other serotonergic drugs, including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, tryptophan, and St. John's Wort is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome, particularly during treatment initiation and dose increases."	0
"Under fed conditions, nebivolol glucuronides are slightly reduced."	0
"As with other <U+03B2>-blockers, when discontinuation of BYSTOLIC is planned, carefully observe and advise patients to minimize physical activity."	0
Substitute non-enzymeinducing therapies at least 2 weeks prior to initiation of ONIVYDE therapy.	0
Intravenous sodium bicarbonate should be used to maintain the serum pH in the range of 7.45 to 7.55.	0
The mean terminal elimination half-life (t1/2) of nesiritide is approximately 18 minutes and was associated with approximately 2/3 of the area-under-the-curve (AUC).	0
Do not co-administer aliskiren with TWYNSTA in patients with diabetes.	0
"On a once-daily dosing schedule, the concentration of digoxin will be 10% to 25% lower when sampled at 24 versus 8 hours, depending upon the patient<U+2019>s renal function."	0
"Patients should be cautioned about the risk of bleeding associated with the concomitant use of PEXEVA<U+00AE> (paroxetine mesylate) and NSAIDs, aspirin, or other drugs that affect coagulation."	0
"There were differences in absolute risk of suicidality across the different indications, with the highest incidence in MDD."	0
The maximum recommended dose in patients with moderate renal impairment is 50 mg per day.	0
Clinical studies of TENORMIN did not include sufficient number of patients aged 65 and over to determine whether they respond differently from younger subjects.	0
Children <1 year of age must not receive Benicar for hypertension (5.2).	0
Elevation of blood levels of haloperidol and clozapine has been observed in patients receiving concomitant fluoxetine.	1
The pharmacokinetic profile of AMBIEN is characterized by rapid absorption from the gastrointestinal tract and a short elimination half-life (T1/ 2) in healthy subjects.	0
"In vivo, abiraterone acetate is converted to abiraterone."	0
Drug Interactions When given concurrently the following drugs may interact with thiazide diuretics.	0
These reactions are more likely to occur in individuals with a history of sensitivity to recombinant peptides.	0
Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have.	0
"If the reticulocyte count exceeds 6%, a reduced dosage should be entertained."	0
"Amiodarone is a substrate for CYP3A and CYP2C8, so inhibitors and inducers affect amiodarone exposure (7) Amiodarone inhibits p-glycoprotein and CYP1A2, CYP2C9, CYP2D6, and CYP3A, increasing exposure to other drugs (7) Drugs prolonging the QT interval: Co-administration of drugs prolonging the QT interval (such as class I and III antiarrhythmics, lithium, certain phenothiazines, tricyclic antidepressants, certain fluoroquinolone and macrolide antibiotics, azole antifungals, halogenated inhalation anesthetic agents) increases the risk of Torsade de Pointes."	0
"Immediately following the bolus dose administration, administer the maintenance infusion from the 100 mL premixed vial or 250 mL premixed bag via an IV pump."	0
"Impact of Other Drugs on Vortioxetine PK Figure1.jpg No dose adjustment for the comedications is needed when BRINTELLIX is coadministered with a substrate of CYP1A2 (e.g., duloxetine), CYP2A6, CYP2B6 (e.g., bupropion), CYP2C8 (e.g., repaglinide), CYP2C9 (e.g., S-warfarin), CYP2C19 (e.g., diazepam), CYP2D6 (e.g., venlafaxine), CYP3A4/5 (e.g., budesonide), and P-gp (e.g., digoxin)."	0
Theophylline - Combined administration of Celexa (40 mg/day for 21 days) and the CYP1A2 substrate theophylline (single dose of 300 mg) did not affect the pharmacokinetics of theophylline.	0
Select route of administration according to severity of patient<U+2019>s condition and increase dosage gradually as required.	0
Reduction in the risk of recurrent DVT and PE following initial therapy: The recommended dose is 2.5 mg taken orally twice daily.	0
PRINIVIL is not recommended in pediatric patients <6 years or in pediatric patients with glomerular filtration rate <30 mL/min/1.73 m2.	0
"In contrast, if half-lives are short, drug and metabolites will be cleared before the next dose is ingested, and carry-over effects related to excessive sedation or CNS depression should be minimal or absent."	0
"Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma."	0
"In addition, do not start desvenlafaxine in a patient who is being treated with linezolid or intravenous methylene blue."	0
Starting Dose for Pediatric Patients Not Taking a Phosphate Binder.	0
Evaluation of patients with hypertension or heart failure should always include assessment of renal function.	0
Patients should have a careful history and physical exam to assess for presence of cardiovascular disease.	0
"Monitor closely for HMG-CoA reductase inhibitor-associated adverse reactions, such as myopathy and rhabdomyolysis."	0
"Since ORAP is partly metabolized via CYP 3A4, it should not be administered concomitantly with inhibitors of this metabolic system, such as azole antifungal agents and protease inhibitor drugs."	0
Thiazides are excreted in human breast milk.	0
Monitor patients receiving MYCOBUTIN therapy for signs and/or symptoms of hypersensitivity reactions.	0
AHA is well absorbed from the gastrointestinal tract after oral administration; peak blood levels occur from 0.25 to 1 hour after dosing.	0
"The NTP, however, found equivocal evidence for hepatocarcinogenicity in male mice."	0
Patients with a previous history of pancreatitis may be at greater risk of elevated serum lipase.	0
Large veins of the antecubital fossa are preferred to veins of the dorsum of the hand or ankle.	0
Most patients require 15-20 mL with each meal.	0
The administration of guanfacine concomitantly with a known microsomal enzyme inducer ( phenobarbital or phenytoin ) to two patients with renal impairment reportedly resulted in significant reductions in elimination half-life and plasma concentration .	1
These risk differences (drug-placebo difference in the number of cases of suicidality per 1000 patients treated) are provided in Table 1.	0
Absolute bioavailability has been estimated to be between 64% and 90%.	0
"Patients treated with Celexa showed significantly greater improvement than placebo patients on the HAMD total score, HAMD item 1, and the CGI Severity score."	0
"In contrast, when the first90 mgonce-weekly dose and the last 20 mgonce-daily dose were separated by 1week, Cmax values were similar."	0
The total daily dose may be given in two divided doses daily.	0
Fertility of male or female rats (evaluated at dose levels as high as 200 mg/kg/day or 100 times the maximum recommended human dose1) was unaffected by atenolol administration.	0
"In post-myocardial infarction patients , doubling of serum creatinine was observed in 4.2 % of valsartan-treated patients and 3.4 % of captopril-treated patients ."	0
Anaphylactic Reactions: Patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction.	0
Concomitant administration of pimozide and sertraline should be contraindicated.	0
This may result in loss of therapeutic effect and development of resistance.	0
Rifampin is contraindicated in patients who are also receiving ritonavir-boosted saquinavir due to an increased risk of severe hepatocellular toxicity.	0
"Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors ( COX-2 Inhibitors ) : In patients who are elderly , volume-depleted ( including those on diuretic therapy ) , or with compromised renal function , coadministration of NSAIDs , including selective COX-2 inhibitors , with angiotensin II receptor antagonists , including valsartan , may result in deterioration of renal function , including possible acute renal failure ."	0
"<U+2022> Abnormal Bleeding: May increase bleeding risk, especially when used with NSAIDs, aspirin, warfarin, or other drugs that affect coagulation (5.11)."	0
"(7.5) Strong CYP3A inhibitors substantially increase ticagrelor exposure and so increase the risk of dyspnea, bleeding, and other adverse events."	0
"Angioedema Angioedema of the face, extremities, lips, tongue, glottis, and larynx has been reported in patients treated with ACE inhibitors including trandolapril."	0
"Food and Beverages to Avoid and Those which are Acceptable All other vegetables Dairy Aged cheeses Processed cheeses, mozzarella, ricotta cheese, cottage cheese, and yogurt Beverages All varieties of tap beer and beers that have not been pasteurized so as to allow for ongoing fermentation Concomitant use of alcohol with EMSAM is not recommended."	0
This resulted in increases in steady state atomoxetine AUC values that were 6- to 8-fold greater and in atomoxetine Cmax values that were 3- to 4-fold greater than when atomoxetine was given alone.	1
"Although disturbances such as galactorrhea, amenorrhea, gynecomastia and impotence have been reported, the clinical significance of elevated serum prolactin levels is unknown for most patients."	0
Serotonin release by platelets plays an important role in hemostasis.	0
Dosage should be increased more gradually in elderly patients.	0
Fluconazole (strong CYP2C9 inhibitor): Increases systemic exposure of ramelteon; administer with caution.	1
Patients (or their families if the patient is incompetent) should be advised not to exceed the daily recommended dose of 10 mg.	0
Intervention 3-day EMEND regimen Reduce the dose of intravenous methylprednisolone by approximately 25% Reduce the dose of oral methylprednisolone by approximately 50% Single 40 mg dose of EMEND No dosage adjustment of methylprednisolone needed Chemotherapeutic agents that are metabolized by CYP3A4 Clinical Impact Increased exposure of the chemotherapeutic agent may increase the risk of adverse reactions.	1
Lidocaine hydrochloride exerts its antiarrhythmic effect by raising the electrical stimulation threshold of the ventricle during diastole.	0
"Use of PDE-5 inhibitors for erectile dysfunction: Sildenafil at a single dose not exceeding 25 mg in 48 hours, vardenafil at a single dose not exceeding 2.5 mg dose in 72 hours, or tadalafil at a single dose not exceeding 10 mg dose in 72 hours can be used with increased monitoring for PDE-5 inhibitor-associated adverse events."	0
"These lesions are caused by a high local concentration of potassium ions in the region of the dissolving tablets, which injured the bowel."	0
"Pediatrics: Pharmacokinetic samples were collected from 74 cancer patients 6 to 48 months of age, who received a dose of 0.15 mg/kg of intravenous ondansetron every 4 hours for 3 doses during a safety and efficacy trial."	0
"If the combination is nevertheless considered necessary, a dose reduction of fluticasone propionate with close monitoring of local and systemic effects is recommended.A switch to a corticosteroid which is not a substrate for CYP3A (e.g., beclomethasone) should be considered."	1
"Patients who were responders during the 10-week double-blind phase and during a 3-month double-blind extension phase were randomized to either paroxetine (10, 20, or 40 mg/day) or placebo in a 3-month double-blind relapse prevention phase."	0
Opioids: Buprenorphine <U+2191> buprenorphine<U+2191> norbuprenorphine Coadministration of buprenorphine and REYATAZ with or without ritonavir increases the plasma concentration of buprenorphine and norbuprenorphine.	1
Darunavir and ritonavir are metabolized by CYP3A.	0
COREG should be taken with food to slow the rate of absorption and reduce the incidence of orthostatic effects.	0
Digoxin does not affect BREVIBLOC pharmacokinetics .	0
Use PROTONIX with caution in transplant patients receiving MMF.See the prescribing information for other drugs dependent on gastric pH for absorption.	0
The amount of vitamin K in food may affect therapy with COUMADIN.	0
"Like other agents that are metabolized by CYP2D6, paroxetine may significantly inhibit the activity of this isozyme."	0
Verapamil significantly counteracted the effects of quinidine on AV conduction.	0
Exchange transfusions or dialysis may be required as a means of reversing hypotension and/or substituting for disordered renal function.	0
Patients assigned to STRATTERA in the maintenance phase were generally continued on the same dose used to achieve a response in the open label phase.	0
Simultaneous use of combined P-gp and strong CYP3A4 inducers reduces blood levels of apixaban: Avoid concomitant use.	1
LEXIVA should be given with ritonavir when coadministered with maraviroc.	0
"Clonidine: Because Savella inhibits norepinephrine reuptake, co-administration with clonidine may inhibit clonidine's anti-hypertensive effect."	0
"Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit."	0
Treatment with Savella should not be resumed unless another cause can be established.	0
"In clinical trials, sotalol was not administered to patients previously treated with oral amiodarone for >1 month in the previous three months."	0
Benzodiazepine hypnotics have a spectrum of half-lives from short (< 4 hours) to long (> 20 hours).	0
Gender Plasma concentrations of telmisartan are generally 2 to 3 times higher in females than in males.	0
"Thiazides cross the placenta, and use of thiazides during pregnancy is associated with a risk of fetal or neonatal jaundice, thrombocytopenia, and possibly other adverse reactions that have occurred in adults."	0
"The plasma protein binding of vortioxetine in humans is 98%, independent of plasma concentrations."	0
Avoid concomitant use of aliskiren with ACCURETIC in patients with renal impairment (GFR <60 mL/min/1.73 m2).	0
"Class Ia antiarrhythmic drugs, such as disopyramide, quinidine and procainamide and other Class III drugs (e.g., amiodarone) are not recommended as concomitant therapy with intravenous sotalol because of their potential to prolong refractoriness."	0
Savella should also not be started in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue.	0
"Coadministration of voriconazole with REYATAZ (without ritonavir) may affect atazanavir concentrations; however, no data are available."	0
"Endothelin receptor antagonists: Bosentan <U+2191> Bosentan Coadministration of bosentan in patients on INVIRASE/ritonavir: In patients who have been receiving INVIRASE/ritonavir for at least 10 days, start bosentan at 62.5 mg once daily or every other day based upon individual tolerability."	0
"Excretion After oral administration of ramipril, about 60% of the parent drug and its metabolites are eliminated in the urine, and about 40% is found in the feces."	0
"These interactions may lead to: Clinically significant adverse reactions, potentially leading to severe, life-threatening, or fatal events from greater exposures of concomitant medications."	0
"If the decision has been made to discontinue treatment, medication should be tapered, as rapidly as is feasible, but with recognition that abrupt discontinuation can be associated with certain symptoms."	0
"Because the study was designed to achieve equal blood pressure control in both groups, other antihypertensive agents (diuretics, calcium-channel blockers, alpha- or beta-blockers, and centrallyacting agents) could be added as needed in both groups."	0
"Cimetidine is reported to reduce hepatic metabolism of certain tricyclic antidepressants, thereby delaying elimination and increasing steady-state concentrations of these drugs."	1
"When the CYP3A4 inhibitor is withdrawn from the combination therapy, the iloperidone dose should be returned to the previous level."	0
"Clinical pharmacology studies have been conducted with coadministration of tadalafil with doxazosin , alfuzosin or tamsulosin see Warnings and Precautions ( 5.1 ) and Clinical Pharmacology ( 12.2 ) ."	0
The pharmacokinetic profiles of indinavir at this dose were not comparable to profiles previously observed in adults receiving the recommended dose.	0
"Although there are no data on pharmacokinetic drug interactions between ondansetron and tramadol, data from two small studies indicate that concomitant use of ondansetron may result in reduced analgesic activity of tramadol."	0
Body Weight - The mean exposure(AUC) to the active metabolite is approximately 30 to 40% higher in subjects with a body weight of <60kg than in those weighing <U+2265>60kg.	0
"Angioedema or a history of hereditary or idiopathic angioedema (4) Hypersensitivity (4) Coadministration of aliskiren with PRINIVIL in patients with diabetes (4, 7.4) PRINIVIL is contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril)."	0
"However, thioridazine has been shown to prolong the QTc interval in a dose dependent fashion."	0
"No clinically significant drug-drug pharmacokinetic interactions were observed when eplerenone was administered with cisapride, cyclosporine, digoxin, glyburide, midazolam, oral contraceptives (norethindrone/ethinyl estradiol), simvastatin, or warfarin."	0
"These include the intravenous administration of calcium chloride solution, sodium bicarbonate solution, and/or the oral or parenteral administration of glucose with a rapid-acting insulin preparation."	0
"Beta-Blockers In clinical trials, bradycardia was more frequently observed when dronedarone was given in combination with beta-blockers."	0
"Aripiprazole exhibits high affinity for dopamine D2 and D3 (Kis 0.34 and 0.8 nM respectively), serotonin 5-HT1A and 5-HT2A receptors (Kis 1.7 and 3.4 nM respectively), moderate affinity for dopamine D4, serotonin 5-HT2C and 5-HT7, alpha1-adrenergic and histamine H1 receptors (Kis 44 nM, 15 nM, 39 nM, 57 nM, and 61 nM, respectively), and moderate affinity for the serotonin reuptake site (Ki 98 nM)."	0
Coadministration of ACCUPRIL with other drugs that raise serum potassium levels may result in hyperkalemia.	0
"Pregnancy Category B: Studies in which hydrochlorothiazide was orally administered to pregnant mice and rats during their respective periods of major organogenesis at doses up to 3000 and 1000 mg hydrochlorothiazide/kg, respectively, provided no evidence of harm to the fetus."	0
"On termination of the infusion, nicardipine concentrations decrease rapidly, with at least a 50% decrease during the first two hours post-infusion."	0
The therapeutic dosages most commonly employed have ranged from 6 mg to 15 mg daily given in divided doses.	0
"Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan."	1
"Nonsteroidal Anti-Inflammatory Drugs ( NSAIDs ) including selective Cyclooxygenase-2 inhibitors ( COX-2 inhibitors ) : In patients who are elderly , volume-depleted ( including those on diuretic therapy ) , or with compromised renal function , coadministration of NSAIDs , including selective COX-2 inhibitors with agents that affect the RAAS , including aliskiren , may result in deterioration of renal function , including possible acute renal failure ."	0
"Penetration in the eye, brain, cerebrospinal fluid (CSF) or prostate is poor in the absence of inflammation."	0
Diuretic agents reduce the renal clearance of lithium and greatly increase the risk of lithium toxicity.	1
"Once the patient has clinically improved and can tolerate medication given by mouth, the oral tablet form or oral suspension form of VFEND may be utilized."	0
Some patients required either initiation or dose adjustments of insulin or oral hypoglycemic agents for treatment of these events.	0
Matulane should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.	0
Metabolic toxicities associated with excessive electrolyte changes caused by hydrochlorothiazide have been shown to be dose-related.	0
REVATIO Injection: Predictions based on a pharmacokinetic model suggest that drug-drug interactions with CYP3A inhibitors will be less than those observed after oral sildenafil administration.	0
Discontinue if these events occur (5.14) See Table 7 for a listing of drugs that may significantly alter voriconazole concentrations.	0
"Pharmacodynamic drug interaction studies with aspirin, clopidogrel, aspirin and clopidogrel, prasugrel, enoxaparin, and naproxen were conducted."	0
"Following abrupt cessation of therapy with beta-blocking agents, exacerbations of angina pectoris and myocardial infarction have occurred."	0
"Signs and symptoms are usually intermittent and mild; however, very rare sequelae include digital ulceration and/or soft tissue breakdown."	0
Discontinuation symptoms have been systematically evaluated in patients taking CYMBALTA.	0
Hemodialysis in ESRD subjects: Systemic exposure to apixaban administered as a single 5 mg dose in ESRD subjects dosed immediately after the completion of a 4-hour hemodialysis session (post-dialysis) is 36% higher when compared to subjects with normal renal function (Figure 3).	0
"If the baseline QT is greater than 450 ms (JT >330 ms if QRS over 100 ms), sotalol is not recommended."	0
"Myelosuppression can be exacerbated by coadministration with drugs that inhibit TPMT (e.g., olsalazine, mesalamine, or sulfasalazine) or drugs whose primary or secondary toxicity is myelosuppression."	0
P-gp inhibition and impaired renal function are the major independent factors that result in increased exposure to dabigatran.	0
The systemic exposure of apixaban is 14% lower on dialysis when compared to not on dialysis.	0
Distribution Irbesartan Irbesartan is 90% bound to serum proteins (primarily albumin and <U+03B1>1-acid glycoprotein) with negligible binding to cellular components of blood.	0
The ability of estazolam to induce human hepatic enzyme systems has not been determined.	0
"In a pooled analysis of multiple short-term, placebo-controlled studies, such symptoms occurred in about 0.1% (4 patients with events out of 3482 exposed to methylphenidate or amphetamine for several weeks at usual doses) of stimulant-treated patients compared to 0 in placebo-treated patients."	0
Combined P-gp and strong CYP3A4 inhibitors increase exposure to rivaroxaban and may increase the risk of bleeding .	0
"Peripheral Vasculopathy, including Raynaud<U+2019>s phenomenon: Stimulants, including DESOXYN, used to treat ADHD are associated with peripheral vasculopathy, including Raynaud<U+2019>s phenomenon."	0
"Because elderly patients are more likely to have decreased renal function with a reduced creatinine clearance, care must be taken in dose selection."	0
Over-the-counter drug preparations which contain antihistamines or sympathomimetic drugs should also be avoided.	0
Intervention: Rilpivirine-containing products: Concomitant use with PROTONIX is contraindicated.	0
Families and caregivers should be advised of the need for close observation and communication with the prescriber.	0
Clinically-Significant Drug Interactions with ZOLOFT Monoamine Oxidase Inhibitors (MAOIs) Clinical Impact: The concomitant use of SSRIs including ZOLOFT and MAOIs increases the risk of serotonin syndrome.	0
"In patients with concomitant congestive heart failure, with or without associated renal insufficiency, ACE inhibitor therapy may cause excessive hypotension, which may be associated with oliguria or azotemia, and, rarely, with acute renal failure and death."	0
"Therefore, if theophylline is coadministered with fluvoxamine maleate, its dose should be reduced to one-third of the usual daily maintenance dose and plasma concentrations of theophylline should be monitored."	1
An increase in mammary neoplasms has been found in rodents after chronic administration of antipsychotic drugs.	0
"After at least one week following the initiation of ritonavir , resume ADCIRCA at 20 mg once daily ."	0
This property accounts for the ability of CALAN to slow the ventricular rate in patients with chronic atrial flutter or atrial fibrillation.	0
"Because the goal of treatment is symptomatic improvement, the patient<U+2019>s view of the need for treatment and assessment of response are critical in evaluating the impact of therapy and weighing its benefits against the risks."	0
"In studies in which dipyridamole was administered in the feed to mice (up to 111 weeks in males and females) and rats (up to 128 weeks in males and up to 142 weeks in females), there was no evidence of drug-related carcinogenesis."	0
Discontinue PREZISTA/ritonavir immediately if signs or symptoms of severe skin reactions develop.	0
"Consequently, CMI and DMI may accumulate, and this accumulation may increase the incidence of any dose- or plasma-concentration-dependent adverse reactions, in particular seizures."	0
In vitro studies have shown that paliperidone is a P-gp substrate.	0
Change the infusion site every 12 hours if administered via peripheral vein.	0
The low systemic availability is attributed to presystemic clearance in gastrointestinal mucosa and/or hepatic first-pass metabolism.	0
Reconstitution and Dilution Instructions for FLOLAN Using STERILE DILUENT for FLOLAN or pH 12 STERILE DILUENT for FLOLAN.	0
"When taken with meals high in bran fiber, however, the amount absorbed from an oral dose may be reduced."	1
"After doses of 0.1 to 0.2 mg/kg, steady state peak plasma concentrations of lisinopril occurred within 6 hours and the extent of absorption based on urinary recovery was about 28%."	0
Heart failure with reduced ejection fraction.	0
Closely monitor potassium in patients receiving concomitant NSAID therapy.	0
"STRATTERA should not be used in patients with severe cardiac or vascular disorders whose condition would be expected to deteriorate if they experience increases in blood pressure or heart rate that could be clinically important (for example, 15 to 20 mm Hg in blood pressure or 20 beats per minute in heart rate)."	0
Use effective alternative or back-up methods of contraception.	0
"Concomitant administration of Remodulin with diuretics , antihypertensive agents or other vasodilators may increase the risk of symptomatic hypotension ."	0
Sotalol does not bind to plasma proteins and is not metabolized.	0
The in vivo inversion of S-ambrisentan to R-ambrisentan is negligible.	0
"In a gender-balanced pharmacodynamic study (n = 56), ondansetron 4 mg administered intravenously or intramuscularly was dynamically similar in the prevention of nausea and vomiting using the ipecacuanha model of emesis."	0
"In addition, there should be an interval of least 10 days between discontinuation of Marplan and initiation or fluoxetine or other SSRIs."	0
"Because the risk for myopathy is dose-related, Chinese patients should not receive simvastatin 80 mg coadministered with lipid-modifying doses of niacin-containing products."	0
"Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with nortriptyline hydrochloride and should counsel them in its appropriate use."	0
There may be circumstances when it is necessary to initiate treatment with an MAOI such as linezolid or intravenous methylene blue in a patient taking LUVOX CR.	0
Therapeutic concentrations of rifampin have been shown to inhibit standard microbiological assays for serum folate and Vitamin B12.	0
"Excessive consumption of alcohol in combination with nortriptyline therapy may have a potentiating effect, which may lead to the danger of increased suicidal attempts or overdosage, especially in patients with histories of emotional disturbances or suicidal ideation."	0
"Chlorpromazine should be administered cautiously to persons with cardiovascular, liver or renal disease."	0
"Male patients are more prone to genitourinary adverse effects, such as dysuria or urinary retention, and may experience testicular pain or ejaculation disorders."	0
"Because of the rapid biotransformation of verapamil during its first pass through the portal circulation, absolute bioavailability ranges from 20% to 35%."	0
"Significant elevation in blood pressure, including hypertensive crisis with acute impairment of organ systems, has been reported on rare occasions in patients with and without a history of hypertension receiving 5-HT1 agonists, including MAXALT."	0
The percent of dose excreted unchanged in urine is about 55% for bisoprolol and about 60% for hydrochlorothiazide.	0
"After a single 90 mg dose of [14C]-ledipasvir in healthy subjects, the blood to plasma ratio of 14C-radioactivity ranged between 0.51 and 0.66."	0
"In diabetic patients, hyperkalemia has been reported with the use of all potassium-conserving diuretics, including amiloride HCl, even in patients without evidence of diabetic nephropathy."	0
No clinically significant effect was observed for enfuvirtide when coadministered with INVIRASE/ritonavir.	0
"However, during nightly use for an extended period pharmacodynamic tolerance or adaptation to some effects of benzodiazepine hypnotics may develop."	0
"Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders."	0
"When clinically significant drug interactions are expected, separate dosing from PHOSLYRA, or consider monitoring blood levels of the drug."	0
Amlodipine does not change sinoatrial nodal function or atrioventricular conduction in intact animals or man.	0
"In such patients, renal function should be monitored during the first few weeks of therapy."	0
"Since proton pump inhibitors affect pH of the upper GI tract for an extended period, separation of doses may not eliminate the interaction."	0
"Hepatic Insufficiency Telmisartan: In patients with hepatic insufficiency, plasma concentrations of telmisartan are increased, and absolute bioavailability approaches 100%."	0
Steady-state concentrations are achieved within one to three days of dosing.	0
"Assessment of patients' medication history should include all over-the-counter, prescription, and herbal/natural preparations with emphasis on preparations that may affect the pharmacokinetics of TIKOSYN such as cimetidine, trimethoprim alone or in combination with sulfamethoxazole, prochlorperazine, megestrol, ketoconazole, dolutegravir, hydrochlorothiazide (alone or in combinations such as with triamterene), other cardiovascular drugs (especially verapamil <U+2013> see CONTRAINDICATIONS ), phenothiazines, and tricyclic antidepressants."	0
The decrement in urinary cystine produced by THIOLA<U+00AE> is generally proportional to the dose.	0
"Paroxetine: Co-administration of paroxetine (20 mg/day for 5 to 8 days), a potent inhibitor of CYP2D6, with multiple doses of iloperidone (8 or 12 mg twice daily) to patients with schizophrenia ages 18 to 65 years resulted in increased mean steady-state peak concentrations of iloperidone and its metabolite P88, by about 1.6-fold, and decreased mean steady-state peak concentrations of its metabolite P95 by one-half."	1
"This has been uncommon in patients with less serious arrhythmias (frequent premature beats or nonsustained ventricular tachycardia: see ADVERSE REACTIONS ), but is of greater concern in patients with life-threatening arrhythmias such as sustained ventricular tachycardia."	0
"Pancreatitis has been observed in patients receiving NORVIR therapy, including those who developed hypertriglyceridemia."	0
These increases in plasma concentration would decrease the cardioselectivity of metoprolol.	0
"Dose adjustment may be necessary for drugs that are CYP3A4 substrates,especially those that have narrow therapeutic indices (e.g., alfentanil, cyclosporine, dihydroergotamine, ergotamine, fentanyl, sirolimus and tacrolimus) when coadministered with Tasigna."	0
"In a dedicated drug interaction trial, co-administration of ketoconazole, a strong inhibitor of CYP3A4, had no clinically meaningful effect on the pharmacokinetics of abiraterone."	0
"Similarly, PMs of CYP2D6 have higher exposure to iloperidone compared with EMsand PMs should have their dose reduced by one-half."	0
"There have been rare reports of serious adverse events in connection with the coadministration of dihydroergotamine and potent CYP 3A4 inhibitors, such as protease inhibitors and macrolide antibiotics, resulting in vasospasm that led to cerebral ischemia and/or and ischemia of the extremities."	0
"Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary)."	0
Do not use desvenlafaxine within 14 days of stopping an MAOI intended to treat psychiatric disorders.	0
The addition of verapamil to high-dose beta-blockers induced modest negative inotropic and chronotropic effects that were not severe enough to limit short-term (48 hours) combination therapy in this study.	0
<U+2020> Results reflect CrCl of 15 mL/min based on regression analysis.	0
Misidentification of Digoxin Toxicity: Signs and symptoms of digoxin toxicity may be mistaken for worsening symptoms of congestive heart failure.	0
"Most adverse effects responded well to dose reduction, and only rarely did verapamil use have to be discontinued."	0
There is no information regarding cross-sensitivity between VFEND (voriconazole) and other azole antifungal agents.	0
"Certain calcium channel antagonists (nifedipine, isradipine, amlodipine, verapamil, and felodipine) are metabolized by CYP3A4."	0
"Dilutional hyponatremia may occur in edematous patients in hot weather; appropriate therapy is water restriction rather than salt administration, except in rare instances when the hyponatremia is life threatening."	0
Icodextrin undergoes renal elimination in direct proportion to the level of residual renal function.	0
Known hypersensitivity to chlorthalidone or other sulfonamide-derived drugs.	0
There are no clinical studies establishing the benefits or risks of combined use of ECT and fluvoxamine maleate.	0
"In early dose titration with verapamil, a relationship exists between verapamil plasma concentration and prolongation of the PR interval."	0
"Paroxetine distributes throughout the body, including the CNS, with only 1% remaining in the plasma."	0
"Therefore falsely elevated glucose levels may be measured up to two weeks following cessation of EXTRANEAL (icodextrin) therapy when GDH-PQQ, GDO, and GDH-FAD-based blood glucose monitors and test strips are used."	0
"Some have been characterized by coma, severe respiratory depression, cyanosis, and hypotension, and have resembled the syndrome of acute narcotic overdose."	0
Therapy with prazosin was continued for as long as 14 weeks.1 Prazosin has also been used alone or in combination with other hypotensive agents in severe hypertension of pregnancy by other investigators.	0
Use of quinidine has been associated with QT prolongation and rare occurrences of torsades de pointes.	0
Approximately 85% of males with sexual dysfunction chose to continue treatment.	0
"These interactions may lead to: Clinically significant adverse reactions, potentially leading to severe, life-threatening, or fatal events from greater exposures of concomitant medications."	0
"Gender Atorvastatin: Plasma concentrations of atorvastatin in women differ from those in men (approximately 20% higher for Cmax and 10% lower for AUC); however, there is no clinically significant difference in LDL-C reduction with atorvastatin between men and women."	0
Following oral administration about 40% to 60% of the absorbed dose is recovered in the urine as unchanged drug in 24 hours.	0
"There is a direct relationship between renal function, as measured by serum creatinine or creatinine clearance, and the elimination rate of sotalol."	0
Immunosuppressant/neoplastic: everolimus Co-administration of everolimus and PREZISTA/ritonavir is not recommended.	0
Alcohol: Alcohol ingestion may exacerbate the potential sedative effects of PRUDOXIN Cream.	0
"Several published observational studies suggest that PPI therapy may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist, or spine."	0
"If hypotension occurs and is considered to bedue to this mechanism, it can be corrected by volume expansion Neuromuscular Transmission )."	0
"As a result, the expression of LDL-receptors followed by the uptake of LDL from blood to liver is accelerated and then the plasma TC decreases."	0
Careful monitoring for abnormal prolongation of the PR interval or other signs of excessive pharmacologic effects should be carried out.	0
"At steady state, Cmax was 19% lower and AUC was 26% lower in Blacks."	0
Impairment of fertility was not evaluated for D.H.E.	0
"Watch for anaphylactoid reactions, including angioedema (5.1) Monitor renal function during therapy (5.8) Assess for hypotension and hyperkalemia (5.2, 5.6) Presumably because angiotensin-converting enzyme inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including ACEON) may be subject to a variety of adverse events, some of them serious."	0
Peripheral vascular disease (PVD).	0
The concomitant use of ADASUVE and other anticholinergic drugs can increase the risk of anticholinergic adverse reactions including exacerbation of glaucoma and urinary retention.	0
"The co-administration of NATRECOR<U+00AE> with nitroprusside, milrinone, or IV ACE inhibitors has not been evaluated."	0
"Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders."	0
Coumarin anticoagulants: Concomitant use with ZOCOR prolongs INR.	0
"Triamterene and quinidine have similar fluorescence spectra; thus, DYAZIDE will interfere with the fluorescent measurement of quinidine."	0
"The plasma elimination half-life is 9-12 hours and is slightly longer in elderly patients, in part because of decreased renal function."	0
"This reaction has been largely limited to patients in whom disorders characterized by hyperkinetic symptoms coexist with, but are obscured by, depressive affect; hypomania usually appeared as depression improved."	0
The risk of myopathy during treatment with HMG-CoA reductase inhibitors is increased with concurrent administration of other fibrates.	0
"In two sleep laboratory studies involving 14- and 28-nightly doses of Zaleplon (5 mg and 10 mg in one study and 10 mg and 20 mg in the second) and structured assessments of daytime anxiety, no increases in daytime anxiety were detected."	0
Doses should be individualized according to the recommended goal of therapy.	0
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.	0
14 There have been two published reports of abnormal physical findings.	0
"In healthy young adult male and female patients who received maximal doses of MAXALT (10 mg every 2 hours for 3 doses), slight increases in blood pressure (approximately 2-3 mmHg) were observed."	0
"Overuse of acute migraine drugs (e.g., ergotamine, triptans, opioids, or a combination of drugs for 10 or more days per month) may lead to exacerbation of headache (medication overuse headache)."	0
"In hospitalized patients under close observation, the dose may be increased in 10 mg increments over four- to six-hour periods as required to control pain and arrhythmias due to ischemia."	0
An additive adverse effect on psychomotor performance between alcohol and oral zolpidem was demonstrated.	0
"If this drug is used during pregnancy or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus."	0
Untreated acute angle-closure glaucoma can lead to permanent vision loss.	0
"Because there were too few events among those participants with age as their only risk factor in this study, the effect of MEVACOR on outcomes could not be adequately assessed in this subgroup."	0
Onset of action is rapid after an intravenous bolus with a duration of action of approximately 15 to 20 minutes.	0
Anti-gout: colchicine <U+2191> colchicine Concomitant administration with colchicine is contraindicated in patients with renal and/or hepatic impairment.	0
"Race In an analysis of data on all subjects participating in Phase 1 studies of eszopiclone, the pharmacokinetics for all races studied appeared similar."	0
Cholestyramine and colestipol resins - Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.	1
"Female children showed significantly higher AUC (0-12) and Cmax compared to male children and, therefore, lower doses of fluvoxamine maleate tablets may produce therapeutic benefit."	0
"ALTACE is contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril)."	0
The enteric coating delays the onset of absorption of fluoxetine 1to 2hours relative to the immediate-release formulations.	0
Endothelin-1 (ET-1) is a potent autocrine and paracrine peptide.	0
"Relative to subjects with normal hepatic function, the sofosbuvir AUC0<U+2013>24 were 126% and 143% higher in moderate and severe hepatic impairment, while the GS-331007 AUC0<U+2013>24 were 18% and 9% higher, respectively."	0
Avoid food 2 hours before and 1 hour after taking the dose (5.9).	0
"(5.7, 7, 12.3) Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Increased risk of renal impairment and loss of antihypertensive effect."	0
Among other populations the prevalence is not known.	0
The absolute bioavailability has not been determined.	0
Orig Submission\Source\eliquis-pkplot-pop-fig3.jpg	0
"In vitro metabolic studies indicate that verapamil is metabolized by cytochrome P450 CYP3A4, CYP1A2, CYP2C8, CYP2C9, and CYP2C18."	0
"The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents."	0
Co-administration with vitamin E significantly increased these effects.	0
"When co-administering telmisartan and ramipril, the response may be greater because of the possibly additive pharmacodynamic effects of the combined drugs, and also because of the increased exposure to ramipril and ramiprilat in the presence of telmisartan."	0
"Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs."	0
"Single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85% and 43%, respectively."	1
"Periodic routine evaluation of all patients, however, is appropriate."	0
Metabolism Irbesartan is an orally active agent that does not require biotransformation into an active form.	0
"At a dose three times the maximum recommended dose, sofosbuvir does not prolong QTc to any clinically relevant extent."	0
"Based on in vitro studies, LATUDA is not a substrate of CYP1A1, CYP1A2, CYP2A6, CYP4A11, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6 or CYP2E1 enzymes."	0
Concurrent use of phenothiazines may antagonize the anorectic effect of diethylpropion.	0
"Table 1: Estimate the Loading Dose Age Oral Loading Dose, mcg/kg Premature 20 to 30 Full-Term 25 to 35 1 to 24 months 35 to 60 2 to 5 years 30 to 45 5 to 10 years 20 to 35 Over 10 years 10 to 15 More gradual attainment of digoxin levels can also be accomplished by beginning an appropriate maintenance dose."	0
Quantitative methods that require measurement of zone diameters also provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds.	0
"For the treatment of candidemia and disseminated Candida infections, daily doses of 6<U+2013>12 mg/kg/day have been used in an open, noncomparative study of a small number of children."	0
"Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother."	0
"Inhibitors of the OATP1B1 (e.g., cyclosporine) can increase the bioavailability of atorvastatin."	1
Concurrent use of ketoconazole and rifampin has resulted in decreased serum concentrations of both drugs.	1
"When pregnancy is detected, discontinue MICARDIS as soon as possible."	0
"For EXTRANEAL in UltraBag, inspect the tubing and drain container for presence of solution."	0
"The AUC for dextrorphan, the active metabolite of dextromethorphan, increased approximately 1.3 fold."	1
Patients with esophageal candidiasis should be treated for a minimum of three weeks and for at least two weeks following resolution of symptoms.	0
"Increased risk of suicidal thinking and behavior in children, adolescents and young adults taking antidepressants (5.1)."	0
The recommended starting dose of ONIVYDE in patients known to be homozygous for the UGT1A1*28 allele is 50 mg/m 2administered by intravenous infusion over 90 minutes.	0
FLOLAN is contraindicated in patients with heart failure caused by reduced left ventricular ejection fraction.	0
Subsequent dose adjustment of either drug should be based on clinical assessment.	0
CARDIZEM undergoes extensive metabolism in which only 2% to 4% of the unchanged drug appears in the urine.	0
"Invitro binding studies indicate that losartan is a reversible, competitive inhibitor of the AT1 receptor."	0
"It is generally agreed, however, that pharmacological treatment of ADHD may be needed for extended periods."	0
Whether any of the symptoms described above represent such a conversion is unknown.	0
"Patients receiving immunosuppressive therapy, including mercaptopurine, are at an increased risk of developing lymphoproliferative disorders and other malignancies, notably skin cancers (melanoma and non-melanoma), sarcomas (Kaposi's and non-Kaposi's) and uterine cervical cancer in situ."	0
The majority of PPI-induced lupus erythematous cases were CLE.	0
The liver is the primary site of action and the principal site of cholesterol synthesis and LDL clearance.	0
"Premature infants, or infants with impaired renal function, may be more likely to develop adverse effects."	0
The significance of this is unclear since there are few correlations between plasma levels and clinical findings.	0
"As with any antiarrhythmic drug, clinical and electrocardiographic evaluation (including Holter monitoring if necessary for evaluation) are needed to determine whether the desired antiarrhythmic effect has been obtained and to guide titration and dose adjustment."	0
Anyone considering the use of SURMONTIL in a child or adolescent must balance the potential risks with the clinical need.	0
"If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus."	0
Peak plasma concentrations of 1 mcg/mL appear within 2 hours after a single 250 mg dose; the AUC is approximately 4.56 mcg.h/mL.	0
"Symptomatic hypotension is possible, particularly in patients with severe aortic stenosis."	0
"Mean dofetilide AUCs(0<U+2013>24hr) at these doses were about 26 and 10 times, respectively, the maximum likely human AUC."	0
"Generally, swallow ALTACE capsules whole."	0
Table 17: The Effect of Other Drugs on the Pharmacokinetics of Quetiapine Coadministered drug Dose schedules Effect on quetiapine pharmacokinetics Coadministered drug Quetiapine Phenytoin 100 mg three times daily 250 mg three times daily 5 fold Increase in oral clearance Divalproex 500 mg twice daily 150 mg twice daily 17% increase mean max plasma concentration at steady state.	1
Initial dose: Initiate the intravenous infusion of Cleviprex at 1-2 mg/hour.	0
Concomitant administration of fluconazole with amiodarone may increase QT prolongation.	0
"Amiodarone has the potential for interactions with drugs or substances that may be substrates , inhibitors or inducers of CYP450 enzymes ( e.g. , inhibitors such as protease inhibitors , grapefruit juice , certain fluoroquinolone and macrolide antibiotics , azole antifungals and inducers such as St.   John s Wort ) or P-glycoprotein ."	0
"In animal models, nicardipine produced relaxation of coronary vascular smooth muscle at drug levels which cause little or no negative inotropic effect."	0
"Because of the potential effect of duloxetine on platelets, patients receiving warfarin therapy should be carefully monitored when duloxetine is initiated or discontinued."	0
Resume treatment at 400 mg oncedaily if bilirubin returns to less than or equal to Grade 1 Elevated hepatic transaminasesgreater than or equal to Grade 3 1.	0
"Narcotic Analgesics: Combinations with APTIVUS/ritonavir not studied Dosage increase and long-term use of meperidine are not recommended due to increased concentrations of the metabolite normeperidine which has both analgesic activity and CNS stimulant activity (e.g., seizures)."	1
"Dopamine exhibits an inotropic action on the myocardium, resulting in increased cardiac output."	0
Adults: The usual initial dosage is 25 to 100 mg daily in a single dose.	0
"Concomitant administration of atorvastatin with inducers of CYP3A4 (e.g., efavirenz, rifampin) can lead to variable reductions in plasma concentrations of atorvastatin."	1
"If concomitant use of SURMONTIL with other serotonergic drugs, including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, tryptophan, and St. John<U+2019>s wort is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome, particularly during treatment initiation and dose increases."	0
Patients who experience a stroke or TIA while on Effient generally should have therapy discontinued.	0
"In patients with renal insufficiency, the elimination half-life of quinaprilat increases as creatinine clearance decreases."	0
Administration of rifampin with drugs that undergo biotransformation through these metabolic pathways may accelerate elimination of coadministered drugs.	0
"Interstitial lung disease (ILD), including fatalities: investigate unexplained non-specific respiratory signs and symptoms."	0
The terminal half-life of verapamil is 6-11 hours.	0
Repeated daily doses of 10-mg do not lead to accumulation of the active metabolite.	0
"There has been no known use of irbesartan in patients with unilateral or bilateral renal artery stenosis, but a similar effect should be anticipated."	0
"Monitor serum potassium and adjust dosages accordingly (2.1) If serum potassium concentration is less than 2.5 mEq/L, use intravenous potassium instead of oral supplementation (2.1) Take with meals and with a glass of water or other liquid."	0
The tablets should be swallowed whole with water.	0
In none of these trials did immediate-release nifedipine appear to provide any benefit.	0
"Anticonvulsants: Carbamazepine, phenobarbital, phenytoin Phenytoina LEXIVA: <U+2193>Amprenavir LEXIVA/ritonavir: <U+2191>Amprenavir <U+2193>Phenytoin Use with caution."	0
"In patients with thyroid disease or those taking thyroid medication, because of the possibility of cardiovascular toxicity, including arrhythmias."	0
It should be noted that nortriptyline hydrochloride is not approved for use in treating bipolar depression.	0
"Consider changing the therapeutic regimen, including possibly discontinuing ZOLOFT, in patients whose depression is persistently worse, or who are experiencing emergent suicidal thoughts or behaviors."	0
Reduced aldosterone secretion by quinapril may result in a small increase in serum potassium.	0
"May result in an increase in PDE5 inhibitor-associated adverse events, including hypotension, syncope, visual disturbances, and priapism."	0
The International Agency for Research on Cancer (IARC) considers that there is <U+201C>sufficient evidence<U+201D> for the human carcinogenicity of procarbazine hydrochloride when it is given in intensive regimens which include other antineoplastic agents but that there is inadequate evidence of carcinogenicity in humans given procarbazine hydrochloride alone.	0
"The hepatotoxicity has been associated in some cases with anorexia, diarrhea, jaundice and ascites."	0
"The clearance of benzodiazepines is accelerated in smokers compared to nonsmokers, and there is evidence that this occurs with estazolam."	0
"<U+2022>REYATAZ is contraindicated in patients with previously demonstrated hypersensitivity (eg, Stevens-Johnson syndrome, erythema multiforme, or toxic skin eruptions) to any of the components of this product."	0
Reduce ELIQUIS dose or avoid coadministration.	0
"Monitor blood pressure and heart rate continually during infusion, and then until vital signs are stable."	0
"In subjects with hepatic impairment, clearance of racemic citalopram was decreased and plasma concentrations were increased."	1
"Penicillins bind to serum proteins, mainly albumin."	0
"In patients who are elderly , volume-depleted ( including those on diuretic therapy ) , or with compromised renal function , coadministration of NSAIDs , including selective COX-2 inhibitors , with ACE inhibitors , including enalapril , may result in deterioration of renal function , including possible acute renal failure ."	0
"Cimetidine In a study assessing disposition of Sertraline hydrochloride (100 mg) on the second of 8 days of cimetidine administration (800 mg daily), there were increases in Sertraline hydrochloride mean AUC (50%), Cmax (24%) and half-life (26%) compared to the placebo group."	1
Intervention: LATUDA dose should be reduced to half of the original level when used concomitantly with moderate inhibitors of CYP3A4.	1
"Presumably caused by inhibition of the degradation of endogenous bradykinin, persistent nonproductive cough has been reported with all ACE inhibitors, always resolving after discontinuation of therapy."	0
Anaphylactoid Reactions During Dialysis: Sudden and potentially life-threatening anaphylactoid reactions have occurred in some patients dialyzed with high-flux membranes and treated concomitantly with an ACE inhibitor.	0
"Bioavailability is approximately 65%, reflecting first-pass metabolism of doxazosin by the liver."	0
The overall prevalence of sulfite sensitivity in the general population is unknown and probably low.	0
Serum determinations of electrolytes should be performed and are particularly important if the patient is vomiting excessively or receiving fluids parenterally.	0
"Additional pharmacologic effects of epoprostenol in animals include bronchodilation, inhibition of gastric acid secretion, and decreased gastric emptying."	0
Periodically reassess to determine the continued need for maintenance treatment and the appropriate dose for such treatment.	0
Monitor cholesterol and triglycerides prior to therapy and periodically thereafter.	0
Heart failure may not be reversible upon stopping CAPRELSA.	0
AGGRENOX can be administered with or without food.	0
There is no evidence that MYCOBUTIN is an effective prophylaxis against M. tuberculosis.	0
PROCARDIA capsules should not be used for the control of essential hypertension.	0
"Sympathetic stimulation is necessary in supporting circulatory function in congestive heart failure, and beta blockade carries the potential hazard of further depressing myocardial contractility and precipitating more severe failure."	0
"This may be of clinical importance, because the plasma concentrations of the metabolites are as high or higher than those of bupropion."	0
The use of therapeutic doses of digoxin may cause prolongation of the PR interval and depression of the ST segment on the electrocardiogram.	0
About 70% of an administered dose of verapamil is excreted as metabolites in the urine.	0
"The metabolites are excreted primarily by the kidney, and excretion is essentially complete within 24 hours after administration."	0
Safety and effectiveness in pediatric patients have not been established.	0
"Non-steroidal Anti-Inflammatory Agents, including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors) In patients who are elderly, volume-depleted (including those on diuretic therapy), or who have compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including azilsartan, may result in deterioration of renal function, including possible acute renal failure."	0
Each packet of REYATAZ oral powder contains 35 mg of phenylalanine.	0
"Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk."	0
"Coadministration of ranitidine increased the maximum plasma concentration of triazolam by 30%, increased the area under the concentration curve by 27%, and increased half-life by 3.3%."	1
"In addition, pharmacokinetic studies in children have established a dose proportionality between children and adults."	0
"Corticosteroids, ACTH<U+2014>intensified electrolyte depletion, particularly hypokalemia."	0
Metabolism <U+2014> Fluoxetine is extensively metabolized in the liver to norfluoxetine and a number of other unidentified metabolites.	0
Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide.	0
"Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination) seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)."	0
"Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium."	0
"ALDACTONE , when used with ACE inhibitors or indomethacin , even in the presence of a diuretic , has been associated with severe hyperkalemia ."	0
Excretion Irbesartan and its metabolites are excreted by both biliary and renal routes.	0
Renal Dysfunction : No study has been conducted with AGGRENOX in patients with renal dysfunction.	0
"After stopping a CYP3A4 or CYP2B6 inhibitor, as the effects of the inhibitor decline, the meperidine plasma concentration will decrease , resulting in decreased opioid efficacy or a withdrawal syndrome in patients who had developed physical dependence to oxycodone."	1
"Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with Marplan and should counsel them in its appropriate use."	0
Strong CYP3A4 Inducers: Avoid the use of strong CYP3A4 inducers if possible.	0
88 <U+2013>34 <U+2013>42 +8 <U+2013>44 <U+2013>37 <U+2013>31 <U+2013>27 Cholestyramine 12 g b.i.d.	0
Tipranavir contains a sulfonamide moiety.	0
"Therefore, dosage of anticonvulsants, including barbiturates, should not be reduced if chlorpromazine is started."	0
Determination of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals.	0
It is recommended that ROZEREM not be taken with or immediately after a high-fat meal.	0
"Paroxetine, the active ingredient in PEXEVA<U+00AE> (paroxetine mesylate), is also the active ingredient of Paxil<U+00AE>."	0
Only limited clinical experience exists in use of nicardipine for patients with hypertension from pheochromocytoma.	0
"Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue TOPROL-XL therapy abruptly even in patients treated only for hypertension (5.1)."	0
"The average risk of suicidal ideation in patients receiving STRATTERA was 0.4% (5/1357 patients), compared to none in placebo-treated patients (851 patients)."	0
"The AUC and Cmax of midazolam decreased by approximately 31% and 16%, respectively."	1
"<U+2022>Coadministration with alfuzosin, triazolam, orally administered midazolam, ergot derivatives, rifampin, irinotecan, lurasidone (if REYATAZ is coadministered with ritonavir), lovastatin, simvastatin, indinavir, cisapride, pimozide, St. John<U+2019>s wort, nevirapine, elbasvir/grazoprevir, and sildenafil when dosed as REVATIO<U+00AE>."	0
"Thus, an interaction between iloperidone and other CYP2D6 substrates is unlikely."	0
"As with all alpha-blockers, MINIPRESS may cause syncope with sudden loss of consciousness."	0
The Rotachrom<U+00AE> Heparin chromogenic assay was used to measure the effect of apixaban on FXa activity in humans during the apixaban development program.	0
<U+2022> Phenylketonuria: REYATAZ oral powder contains phenylalanine which can be harmful to patients with phenylketonuria.	0
"Also, patients with migraine may be at increased risk of certain cerebrovascular events (e.g., stroke, hemorrhage, transient ischemic attack)."	0
"Reproduction studies have been performed in pregnant rabbits and rats at daily doses up to 200 and 300 mg/kg, respectively (approximately 6 and 5 times, respectively, the maximum human daily dose on a mg/m2 basis)."	0
"Inhaled/nasal steroids: Fluticasone Budesonide <U+2191> Fluticasone Concomitant use of fluticasone propionate and INVIRASE/ritonavir may increase plasma concentrations of fluticasone propionate, resulting in significantly reduced serum cortisol concentrations."	1
"The side effects of irbesartan are generally rare and apparently independent of dose; those of hydrochlorothiazide are a mixture of dose-dependent (primarily hypokalemia) and dose-independent phenomena (e.g., pancreatitis), the former much more common than the latter."	0
"For stroke or TIA patients for whom aspirin is indicated to prevent recurrent myocardial infarction (MI) or angina pectoris, the aspirin in this product may not provide adequate treatment for the cardiac indications."	0
"Patients may wish to be examined to determine whether they are susceptible to angle closure, and have a prophylactic procedure (e.g., iridectomy), if they are susceptible."	0
The formula was based on height in cm and Scr in mg/dL where k is a constant.	0
The half-life may be prolonged two-fold or more in patients with liver dysfunction.	0
There was a clear dose-dependent effect on PR-interval with an increase of +5 ms at 400 mg twice daily and up to +50 ms at 1600 mg twice daily.	0
Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have.	0
It is desirable to monitor TCA plasma levels whenever an agent of the tricyclic antidepressant class including Anafranil is going to be co-administered with another drug known to be an inhibitor of P450 2D6 (and/or P450 1A2).	0
MULTAQ is contraindicated in patients with symptomatic heart failure with recent decompensation requiring hospitalization or NYHA Class IV heart failure.	0
"Laboratory Tests: Complete Blood Count (CBC) Monitoring: Patients on IMURAN should have complete blood counts, including platelet counts, weekly during the first month, twice monthly for the second and third months of treatment, then monthly or more frequently if dosage alterations or other therapy changes are necessary."	0
"During marketing of milnacipran, and other SNRIs and SSRIs, there have been spontaneous reports of adverse events indicative of withdrawal and physical dependence occurring upon discontinuation of these drugs, particularly when discontinuation is abrupt."	0
Anyone considering the use of NARDIL in a child or adolescent must balance the potential risks with the clinical need.	0
"Some of the possible effects are small, so anticipatory dose adjustment might not be required, but others should be considered before initial dosing."	0
The risk of these events may be increased by the postoperative use of indwelling epidural catheters or the concomitant use of medicinal products affecting hemostasis.	0
"When administered concurrently, the following drugs may interact with thiazide diuretics."	0
"The recommended approach is to: estimate the patient<U+2019>s daily maintenance dose adjust the estimate to account for patient-specific factors choose a dosing regimen decide whether to initiate therapy with a loading dose monitor the patient for toxicity and for therapeutic effect adjust the dose Dose titration may be accomplished by either of two general approaches that differ in dosage and frequency of administration, but reach the same total amount of digoxin accumulated in the body."	0
"CALAN exerts antihypertensive effects by decreasing systemic vascular resistance, usually without orthostatic decreases in blood pressure or reflex tachycardia; bradycardia (rate less than 50 beats/min) is uncommon (1.4%)."	0
"When higher doses of NATRECOR<U+00AE> were infused, the duration of hypotension was sometimes several hours."	0
"If <U+03B2>-blocking therapy is withdrawn prior to major surgery, the impaired ability of the heart to respond to reflex adrenergic stimuli may augment the risks of general anesthesia and surgical procedures."	0
Olmesartan was distributed to milk at low levels in rats.	0
Careful monitoring and dose adjustment may be necessary; consider initiating nifedipine at the lowest dose available if given concomitantly with these medications.	0
Geriatrics: A reduction in clearance and increase in elimination half-life are seen in patients over 75 years of age.	0
"Indication Initial Dose Titration Schedule Recommended Dose Maximum Dose ADHD (Adult and Pediatric patients) (2.2) 30 mg every morning 10 mg or 20 mg weekly 30 mg to 70 mg per day 70 mg per day BED (Adult patients) (2.3) 30 mg every morning 20 mg weekly 50 mg to 70 mg per day 70 mg per day Prior to treatment, assess for presence of cardiac disease (2.4) Severe renal impairment: Maximum dose is 50 mg/day (2.5) End stage renal disease (ESRD): Maximum dose is 30 mg/day (2.5) Prior to treating children, adolescents, and adults with CNS stimulants, including VYVANSE, assess for the presence of cardiac disease (e.g., a careful history, family history of sudden death or ventricular arrhythmia, and physical exam)."	0
"Obtain ECGs to monitor the QTc at baseline, seven days after initiation, and periodically thereafter, and following any dose adjustments ( 5.2 , 5.3 , 5.7 , 5.15 )."	0
Clinical studies have demonstrated no clinically significant pharmacokinetic interaction between PRISTIQ and strong CYP 3A4 inhibitors (Figure 1).	0
Such findings have emerged during the course of treatment with hypnotic drugs.	0
Hold the syringe attached to the tubing as high as possible while giving PROTONIX For Delayed-Release Oral Suspension to prevent any bending of the tubing.	0
"Long-term studies have not been conducted with DYAZIDE (the triamterene/hydrochlorothiazide combination), or with triamterene alone."	0
"Avoid the concurrent use of calcium supplements, including calcium-based nonprescription antacids, with PHOSLYRA."	0
Anyone considering the use of STRATTERA in a child or adolescent must balance this risk with the clinical need.	0
"Following oral doses of 12.5 to 100 mg, 55% to 77% of the administered dose appears in urine and greater than 95% of the absorbed dose is excreted in urine as unchanged drug."	0
Levomilnacipran concentration was not significantly affected when FETZIMA was administered with food.	0
"As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals."	0
"Furthermore, in a randomized crossover study with 12 healthy volunteers it was shown that fluconazole delayed the elimination of fentanyl significantly."	1
The pharmacologic activity of estazolam is primarily from the parent drug.	0
"Atropine Sulfate Injection, USP in clinical doses counteracts the peripheral dilatation and abrupt decrease in blood pressure produced by choline esters."	0
Refer to the quetiapine prescribing information for recommendations on adverse reaction monitoring.	0
It is not known whether rifabutin is excreted in human milk.	0
"If , after five days , an adequate diuretic response to ALDACTONE has not occurred , a second diuretic that acts more proximally in the renal tubule may be added to the regimen ."	0
(median) Placebo 1663 +0.7 +0.4 +2.0 +0.2 +0.6 +4 MEVACOR 20 mg q.p.m.	0
"Removal of quinapril, which crosses the placenta, from the neonatal circulation is not significantly accelerated by these means."	0
"Selective Serotonin-Reuptake Inhibitors: Combination with APTIVUS/ritonavir not studied Antidepressants have a wide therapeutic index, but doses may need to be adjusted upon initiation of APTIVUS/ritonavir therapy."	0
Opioids cross the placenta and may produce respiratory depression and psycho-physiologic effects in neonates.	0
The agar proportion method (CDC or CLSI(1) M24-A) utilizes Middlebrook 7H10 medium impregnated with rifampin at a final concentration of 1.0 mcg/mL to determine drug resistance.	0
The half-life is markedly longer in the elderly compared to younger subjects.	0
Dosing recommendations for patients with a CrCl <U+2264>30 mL/min or on dialysis cannot be provided.	0
Cholestyramine and Colestipol Resin<U+2014>absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.	1
"Elimination Following a single 90 mg oral dose of [14C]-ledipasvir, mean total recovery of the [14C]-radioactivity in feces and urine was approximately 87%, with most of the radioactive dose recovered from feces (approximately 86%)."	0
<U+2022> Concomitant lipid-lowering therapies: use with fibrates or lipid-modifying doses (<U+2265> 1 g/day) of niacin increases the risk of adverse skeletal muscle effects.	0
"The decrease in blood pressure was most notable approximately 1<U+2013>2 hours after dosing, and was not different from placebo at 8 hours."	0
"Closely monitor INR if a concomitant drug is a CYP2C9, 1A2, and/or 3A4 inhibitor or inducer."	0
Patients who have difficulty swallowing PREZISTA tablets can use the 100 mg per mL PREZISTA oral suspension.	0
Reduce rifabutin dose or suspend MYCOBUTIN use if toxicity is suspected.	0
"Because it is possible that CYMBALTA and alcohol may interact to cause liver injury or that CYMBALTA may aggravate pre-existing liver disease, CYMBALTA should not be prescribed to patients with substantial alcohol use or evidence of chronic liver disease."	0
"Eszopiclone did not show any inhibitory potential on CYP450 1A2, 2A6, 2C9, 2C19, 2D6, 2E1, and 3A4 in cryopreserved human hepatocytes."	0
"Physicians should discuss with patients the risk of taking Anafranil while engaging in activities in which sudden loss of consciousness could result in serious injury to the patient or others, e.g., the operation of complex machinery, driving, swimming, climbing."	0
"The pharmacokinetic characteristics of olanzapine were similar in patients with severe renal impairment and normal subjects, indicating that dosage adjustment based upon the degree of renal impairment is not required."	0
"Data from other beta blocker trials suggest that if there is any question concerning the use of IV beta blocker or clinical estimate that there is a contraindication, the IV beta blocker may be eliminated and patients fulfilling the safety criteria may be given TENORMIN Tablets 50 mg twice daily or 100 mg once a day for at least seven days (if the IV dosing is excluded)."	0
"Although there was a dose-related increase in the number of tumors in mice, there was no drug-related increase in the number of mice with tumors."	0
"Zanaflex Capsules and Zanaflex tablets are bioequivalent to each other under fasting conditions (more than 3 hours after a meal), but not under fed conditions (within 30 minutes of a meal)."	0
"Heart Failure Amlodipine: In patients with moderate to severe heart failure, the increase in AUC for amlodipine was similar to that seen in the elderly and in patients with hepatic insufficiency."	0
"In extremely acidic conditions, CYMBALTA, unprotected by the enteric coating, may undergo hydrolysis to form naphthol."	0
Anticoagulants: Potentiation of warfarin-type (CYP2C9 and CYP3A substrate) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding.	0
<U+2022> Distribution: Mean volume of distribution at steady-state of rosuvastatin is approximately 134 liters.	0
"There is a median 2 hour lag until absorption begins (Tlag), with maximal plasma concentrations (Cmax) of duloxetine occurring 6 hours post dose."	0
Oral Contraceptives or Patch Contraceptives: ethinyl estradiol <U+2193> ethinyl estradiol Alternate methods of contraception should be considered.	0
Dosage reduction of zidovudine may be considered.	1
Concomitant Use with Other Cardiovascular Agents: Sublingual NTG: May be taken as required to abort acute anginal attacks during CARDIZEM CD (diltiazem hydrochloride) therapy.	0
Serotonin release by platelets plays an important role in hemostasis.	0
Treatment-related increases over controls in the incidence of supernumerary ribs (at exposures at or below those in humans) and of cervical ribs (at exposures comparable to or slightly greater than those in humans) were seen in rats.	0
Dosing APTIVUS 500 mg with 200 mg ritonavir capsules twice daily for greater than 2 weeks and without meal restriction produced the pharmacokinetic parameters for male and female HIV-1 positive patients presented in Table 5.	0
"Aspirin Aspirin inhibits platelet aggregation by irreversible inhibition of platelet cyclooxygenase and thus inhibits the generation of thromboxane A2, a powerful inducer of platelet aggregation and vasoconstriction."	0
"Patients with underlying structural heart disease, pre-existing conduction system abnormalities, cardiomyopathies and ischemic heart disease may be at increased risk for developing cardiac conduction abnormalities."	0
Initiate FLOLAN in a setting with adequate personnel and equipment for physiologic monitoring and emergency care.	0
Nefazodone hydrochloride tablets are not approved for use in pediatric patients.	0
WARNING: SUICIDAL THOUGHTS AND BEHAVIORS See full prescribing information for complete boxed warning.	0
"Dose proportional increases in plasma bisoprolol concentrations are observed between the 2.5 and 5, as well as between the 5 and 10 mg doses."	0
"If renal function deteriorates, adjust dose as described in Initiation of TIKOSYN Therapy, Step 3."	0
"In humans, selegiline is approximately 90% bound to plasma protein over a 2 to 500ng per mL concentration range."	0
"Because renal elimination is not an important pathway, bioavailability and pharmacokinetics of SULAR were not significantly different in patients with various degrees of renal impairment."	0
"In vivo studies The effects of other drugs on sildenafil pharmacokinetics and the effects of sildenafil on the exposure to other drugs are shown in Figure 7 and Figure 8, respectively."	0
"After 7 days, the recommended dose of INVIRASE is 1000-mg twice daily with ritonavir 100-mg twice daily."	0
Digoxin concentrations are increased by about 15% when digoxin and carvedilol are administered concomitantly.	1
"Redistribution/accumulation of body fat, including central obesity, dorsocervical fat enlargement (buffalo hump), peripheral wasting, facial wasting, breast enlargement, and ""cushingoid appearance"" have been observed in patients receiving antiretroviral therapy."	0
Both optical isomers of verapamil are similarly affected.	0
"No dose adjustment of alprazolam, ibuprofen, levothyroxine, olanzapine, risperdione, warfarin, or strong CYP3A4 inhibitors (e.g., ketoconazole) is necessary when these drugs are used in combination with EMSAM."	0
Renal Impairment The pharmacokinetics of eplerenone was evaluated in patients with varying degrees of renal impairment and in patients undergoing hemodialysis.	0
"Overall, no significant differences in the overall antihypertensive effect of losartan were detected when the patients were analyzed according to age (<,<U+2265>12years old) or gender."	0
"Sulfonylurea Oral Hypoglycemics(CYP2C9 Inhibition) Not Studied In Vivo or In Vitro, but Drug Plasma Exposure Likely to be Increased Frequent monitoring of blood glucose and for signs and symptoms of hypoglycemia."	1
"Adverse experiences were similar to those observed in the adult population, and included leukopenia, neutropenia, and rash."	0
"Therefore, EXTREME CAUTION should be exercised when administering dopamine HCl to patients receiving cyclopropane or halogenated hydrocarbon anesthetics."	0
"For patients with severe renal impairment (CrCl 15-30 mL/min), the recommended dose of PRADAXA is 75 mg twice daily."	0
The median EC50 values of ledipasvir against chimeric replicons encoding NS5A sequences from clinical isolates from treatment-na<U+00C3><U+00AF>ve HCV-infected subjects were 0. 02 nM for genotype 1a (range 0.007-1.0 nM; N=23) and 0.006 nM for genotype 1b (range 0.002-1.0 nM; N=34).	0
"Inject slowly, deep into upper outer quadrant of buttock."	0
"Patients receiving antihypertensive drugs, beta-adrenergic blockers, and nitrates should be observed for possible additive hypotensive effects."	0
Symptoms include acute onset of decreased visual acuity or ocular pain and typically occur within hours to weeks of drug initiation.	0
Mild hepatic impairment does not require a dose modification.	0
Dofetilide is metabolized to a small extent by the CYP3A4 isoenzyme of the cytochrome P450 system.	0
Clinical studies have not shown any drug interactions between bicalutamide and LHRH analogs (goserelin or leuprolide).	0
"Race <U+2014> Invivo studies have shown that exposures are similar among Japanese, Chinese and Caucasians, especially after normalization for body weight differences."	0
"When the renin-angiotensin-aldosterone system is inhibited by quinapril, changes in renal function may be anticipated in susceptible individuals."	0
"Patients with involvement of the tongue, glottis or larynx are likely to experience airway obstruction, especially those with a history of airway surgery."	0
A cardiology consult is recommended if drug discontinuation or interruption is being considered on the basis of ECG assessment.	0
The contents should be mixed until completely dispersed.	0
This was associated with an increase in adverse reactions of Zanaflex.	0
Its mean terminal half-life after a single dose was 8.6days and after multiple dosing was 9.3days.	0
Information for VYVANSE chewable tablets: VYVANSE chewable tablets must be chewed thoroughly before swallowing.	0
Irbesartan is excreted in the milk of lactating rats.	0
At least 1 week should be allowed after stopping nefazodone before starting an MAOI.	0
"In patients with cirrhosis of the liver, AUC values of nefazodone and HO-NEF were increased by approximately 25%."	0
"Intracranial Hemorrhage In European Stroke Prevention Study-2 (ESPS2), the incidence of intracranial hemorrhage was 0.6% in the AGGRENOX group, 0.5% in the extended-release dipyridamole (ER-DP) group, 0.4% in the aspirin (ASA) group and 0.4% in the placebo groups."	0
"There were no fetal effects at 5 or 10 mg/kg; increases in fetal anatomical variants (supernumerary ribs, renal pelvis dilation) and delays in ossification were observed at 25 and 50 mg/kg and higher doses."	0
"Serum Potassium: In hypertensive patients, greater than 20% increases in serum potassium were observed in 4.4% of Diovan-treated patients compared to 2.9% of placebo-treated patients."	0
Sotalol does not have partial agonist or membrane stabilizing activity.	0
Patients with mild renal functional impairment should not receive this drug without frequent and continuing monitoring of serum electrolytes.	0
It is strongly recommended that the physician contact the local poison control center for specific pediatric treatment.	0
"After an intravenous dose, approximately 28% of total body clearance was via the renal route, and 72% by the hepatic route."	0
Antidepressant Trazodone Increased trazodone concentrations can result in potentially life threatening cardiac arrhythmia.	1
Treatment with an MAOI should not be initiated within 2weeks after discontinuing STRATTERA.	0
The recommended starting dose is 30 mg once daily in the morning in patients ages 6 and above.	0
"In pooled analyses of placebo-controlled trials of antidepressant drugs (SSRIs and other antidepressant classes) that included approximately 77,000 adult patients and over 4,400 pediatric patients, the incidence of suicidal thoughts and behaviors in pediatric and young adult patients was greater in antidepressant-treated patients than in placebo-treated patients."	0
For all patients: Measure serum potassium before starting INSPRA and periodically thereafter.	0
Digoxin is contraindicated in patients with a known hypersensitivity to digoxin or other forms of digitalis.	0
Storage of this drug in the home must be supervised responsibly.	0
"Drugs that slow heart rate : Concomitant use of drugs with depressant effects on the sinus and AV node ( e.g. , digoxin , beta blockers , verapamil , diltiazem , ivabradine , clonidine ) can potentiate the electrophysiologic and hemodynamic effects of amiodarone , resulting in bradycardia , sinus arrest , and AV block ."	0
"For optimal absorption, CRIXIVAN should be administered without food but with water 1 hour before or 2 hours after a meal."	0
"In addition, resistance to rifampin has been determined to occur as single-step mutations of the DNA-dependent RNA polymerase."	0
"In instances where swelling is confined to the face and lips, the condition generally resolves without treatment; antihistamines may be useful in relieving symptoms."	0
"Duloxetine undergoes extensive metabolism, but the major circulating metabolites have not been shown to contribute significantly to the pharmacologic activity of duloxetine."	0
Recommended adult oral dosage: 300 mg 4 times a day with meals and at bedtime.	0
"Should arterial pressure fall significantly, decrease the rate of infusion immediately."	0
"The use of potassium citrate extended-release tablets in patients with chronic renal failure, or any other condition which impairs potassium excretion such as severe myocardial damage or heart failure, should be avoided."	0
"The principal metabolites are polar and conjugated products of oxidation and methylation, which are readily cleared."	0
Racemic citalopram did not alter the mean AUC or Cmax of pimozide.	0
"Distribution Telmisartan Telmisartan is highly bound to plasma proteins (>99.5%), mainly albumin and <U+03B1>1 - acid glycoprotein."	0
Concomitant administration of ACE inhibitors with potassium-sparing diuretics has been associated with severe hyperkalemia.	0
"Following any dose reduction for QT prolongation or any dose interruption greater than 2 weeks, conduct QT assessments as described above."	0
"Elimination Total plasma and renal clearances are in the range of 157 to 176 mL/min and 3.0 to 3.5 mL/min, respectively."	0
"Co-administration of PREZISTA and ritonavir with drugs that are primarily metabolized by CYP3A and CYP2D6, or are transported by P-gp may result in increased plasma concentrations of such drugs, which could increase or prolong their therapeutic effect and adverse events."	1
Benazeprilat has much greater ACE inhibitory activity than does benazepril.	0
"Benzodiazepines Triazolam, orally administered midazolama Triazolam and orally administered midazolam are extensively metabolized by CYP3A4."	0
"In addition, olanzapine is not removed by dialysis."	0
"These elevations frequently occurred in association with identifiable clinical events and therapeutic measures such as congestive heart failure, acute myocardial infarction, blood transfusions and other medications."	0
"CNS stimulants (amphetamines and methylphenidate-containing products), including VYVANSE, have a high potential for abuse and dependence."	0
"Prevent pregnancy during treatment and for one month after stopping treatment by using acceptable methods of contraception (2.2, 8.6)."	0
"Distribution The in vitro human plasma protein binding of nebivolol is approximately 98%, mostly to albumin, and is independent of nebivolol concentrations."	0
Patients should be advised of the following issues and asked to alert their prescriber if these occur while taking SURMONTIL.	0
"Neither losartan nor its active metabolite inhibits ACE (kininaseII, the enzyme that converts angiotensinI to angiotensinII and degrades bradykinin); nor do they bind to or block other hormone receptors or ion channels known to be important in cardiovascular regulation."	0
The absolute bioavailability of apixaban is approximately 50% for doses up to 10 mg of ELIQUIS.	0
Co-administration of PREZISTA/ritonavir in patients on tadalafil: Avoid use of tadalafil during the initiation of PREZISTA/ritonavir.	0
"If patients beginning treatment with REYATAZ/ritonavir have been titrated to a stable dose of carbamazepine, a dose reduction for carbamazepine may be necessary. phenytoin, phenobarbital <U+2193> atazanavir<U+2193> phenytoin<U+2193> phenobarbital Plasma concentrations of atazanavir may be decreased when phenytoin or phenobarbital is administered with REYATAZ without ritonavir."	1
"If a diuretic is also used, it may increase the risk of lithium toxicity."	0
The physician who elects to use STRATTERA for extended periods should periodically reevaluate the long-term usefulness of the drug for the individual patient.	0
"<U+2212> <U+2212> <U+2212> <U+2212> <U+2212> Streptococcus pneumoniae (meningitis) <U+2264>0.06 <U+2212> <U+2265>0.12 <U+2212> <U+2212> <U+2212> Streptococcus pneumoniae (non-meningitis) <U+2264>2 4 <U+2265>8 <U+2212> <U+2212> <U+2212> Streptococcus spp., Beta-hemolytic GroupSusceptibility testing of penicillins for treatment of <U+03B2>-hemolytic streptococcal infections need not be performed routinely, because non-susceptible isolates are extremely rare in any <U+03B2>-hemolytic streptococcus and have not been reported from Streptococcus pyogenes."	0
The usual starting dose is 50mg of losartan potassium tablets once daily.	0
"Patients with pre-existing liver dysfunction, including chronic active hepatitis B or C, have an increased risk for liver function abnormalities including severe hepatic adverse events."	0
"While taking beta-blockers, patients with a history of severe anaphylactic reaction to a variety of allergens may be more reactive to repeated challenge, either accidental, diagnostic, or therapeutic."	0
It is desirable to monitor TCA plasma levels whenever a TCA is going to be co-administered with another drug known to be an inhibitor of P450 2D6.	0
"It is recommended that in patients taking anticoagulants, prothrombin time be determined before starting lovastatin and frequently enough during early therapy to insure that no significant alteration of prothrombin time occurs."	0
Single and multiple doses of 10 mg or more of Lotensin cause inhibition of plasma ACE activity by at least 80% - 90% for at least 24 hours after dosing.	0
Electroconvulsive Therapy (ECT) There are no clinical studies of the combined use of ECT and paroxetine.	0
Population Pharmacokinetics Analysis A population pharmacokinetics evaluation performed in MS patients did not provide evidence for a significant effect of fluoxetine and paroxetine (strong CYP2D6 inhibitors) on fingolimod or fingolimod-phosphate predose concentrations.	0
"Do not administer Tasigna to patients with hypokalemia, hypomagnesemia, or long QT syndrome (4, 5.2)."	0
Resume within 2 weeks at prior dose if QTcF returns to less than 450 msec and to within 20 msec of baseline.3.	0
"In these sleep laboratory studies, REM sleep was essentially unchanged and slow wave sleep was decreased."	0
"This effect, and the related increase in effective refractory period, is observed in the atria and ventricles in both resting and paced electrophysiology studies."	0
Moderate Hepatic Impairment (Child-Pugh Score Ranging from 7 to 9) LEXIVA should be used with caution at a reduced dosage of 700mg twice daily without ritonavir (therapy-naive) or 450mg twice daily plus ritonavir 100mg once daily (therapy-naive or protease inhibitor-experienced).	0
"If serious hypokalemia (serum potassium less than 3.0mEq/L) is demonstrated by repeat serum potassium determinations, DYAZIDE should be discontinued and potassium chloride supplementation initiated."	0
Experimental data suggest that amlodipine binds to both dihydropyridine and nondihydropyridine binding sites.	0
"If a patient requires antipsychotic drug treatment after recovery from NMS, the potential reintroduction of drug therapy should be carefully considered."	0
"Several possible mechanisms have been proposed and include: (1) competitive antagonism of catecholamines at peripheral (especially cardiac) adrenergic neuron sites, leading to decreased cardiac output, (2) a central effect leading to reduced sympathetic outflow to the periphery, and (3) suppression of renin activity."	0
"In one study, daily dosing of paroxetine 20 mg in patients stabilized on risperidone (4 to 8 mg/day) increased mean plasma concentrations of risperidone approximately 4-fold, decreased 9-hydroxyrisperidone concentrations approximately 10%, and increased concentrations of the active moiety (the sum of risperidone plus 9-hydroxyrisperidone) approximately 1.4-fold."	1
"In a single-dose study in normal volunteers, losartan had no effects on glomerular filtration rate, renal plasma flow or filtration fraction."	0
Drugs That Can Prolong the QT/QTc Interval Concomitant use of these drugs and TRISENOX may increase the risk of serious QT/QTc interval prolongation.	0
"Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients whose depression is persistently worse, or who are experiencing emergent suicidality or symptoms that might be precursors to worsening depression or suicidality, especially if these symptoms are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
"20 mg/day is the maximum recommended dose for hepatically impaired patients , due to the risk of QT prolongation."	0
Injection 5-10 mg given over 5 minutes plus TENORMIN Tablets 50 mg every 12 hours orally on the first study day (the first oral dose administered about 15 minutes after the IV dose) followed by either TENORMIN Tablets 100 mg once daily or TENORMIN Tablets 50 mg twice daily on days 2-7.	0
Similar results have been reported with MICARDIS.	0
Co-administration of APTIVUS/ritonavir and drugs that inhibit P-gp may increase tipranavir plasma concentrations.	1
Do not use Lexapro within 14 days of stopping an MAOI intended to treat psychiatric disorders.	0
An anticoagulation effect generally occurs within 24 hours after warfarin administration.	0
300/100 + 200/300 once daily	0
Improvement may be sustained when the drug is either temporarily or permanently discontinued.	0
"In dogs, doses of 20 mg/kg were also associated with hepatic changes; however, these changes were reversible with continued dosing."	0
Do not co-administer aliskiren with ALTACE in patients with diabetes.	0
All of zaleplon's metabolites are pharmacologically inactive.	0
"For this reason, CYMBALTA should not be prescribed for patients with substantial alcohol use."	0
A rise in plasma pH may cause a decrease in plasma potassium concentration and an increase in the intracellular potassium concentration.	0
Flush the catheter between administration of NATRECOR<U+00AE> and incompatible drugs.	0
"The exact mechanism of the antidepressant action of desvenlafaxine is unknown, but is thought to be related to the potentiation of serotonin and norepinephrine in the central nervous system, through inhibition of their reuptake."	0
A study in patients with mild or moderate renal impairment has not been conducted.	0
"Consequently, concomitant use of paroxetine with tryptophan is not recommended."	0
Protamine sulfate and vitamin K are not expected to affect the anticoagulant activity of apixaban.	0
"Nevertheless, caution is indicated in the co-administration of TCAs with any of the SSRIs."	0
"In this study, there was a slight potentiation of the propranolol-induced reduction in heart rate and reduction in the exercise diastolic pressure."	0
"Concomitant use of paroxetine with risperidone, a CYP2D6 substrate has also been evaluated."	0
Neither clinical studies nor epidemiologic studies conducted to date have shown an association between chronic administration of these drugs and mammary tumorigenesis.	0
"At the dose of 120 mg twice daily (2.67 times the maximum recommended dosage), ledipasvir does not prolong QTc interval to any clinically relevant extent."	0
Each gram of VIRACEPT powder contains 11.2 mg phenylalanine.	0
Effect of AUBAGIO on CYP1A2 substrates Teriflunomide may be a weak inducer of CYP1A2 in vivo.	0
The clinical situation dictates the procedures to be employed.	0
The elimination half-life of midazolam and triazolam also increased (1.5- to 2.5-fold) during coadministration with diltiazem.	1
Inflammation also enhances its penetration into the pericardial fluid.	0
"Extended-release capsule Since the product is an extended-release dosage form, limit to one extended-release capsule (105 mg phendimetrazine tartrate) in the morning (30 to 60 minutes before morning meal)."	0
Selegiline is contraindicated for use with meperidine.	0
"In man, blood pressure is lowered in both the supine and standing positions."	0
TENORETIC should be reinstated if withdrawal symptoms occur.	0
Chronic administration of BRINTELLIX is unlikely to induce the metabolism of drugs metabolized by these CYP isoforms.	0
Many patients do not show a clinical response until treatment at 60 mg has been continued for at least 4 weeks.	0
"Lithium toxicity has been reported in patients receiving lithium concomitantly with drugs, which cause elimination of sodium, including ACE inhibitors."	0
"Rare postmarketing cases of priapism, defined as painful and nonpainful penile erection lasting more than 4 hours, have been reported for pediatric and adult patients treated with STRATTERA."	0
"However, clinical monitoring of the platelet and white cell count is recommended."	0
"The 2-mononitrate has been less well studied, but it appears to participate in the same metabolic pathways with a half-life of about 2 hours."	0
"When co-administering NORVIR with other protease inhibitors, see the full prescribing information for that protease inhibitor including contraindication information."	0
"Additionally, EXTRANEAL results in an increased ultrafiltration volume per gram of absorbed carbohydrate compared to hyperosmolar glucose solutions."	0
Neither risperidone nor 9-hydroxyrisperidone displaces each other from plasma binding sites.	0
"In common with other phenothiazines, thioridazine is contraindicated in severe central nervous system depression or comatose states from any cause including drug induced central nervous system depression."	0
"Following oral administration in patients with mild to moderate alcoholic cirrhosis, plasma concentrations of trandolapril and trandolaprilat were, respectively, 9-fold and 2-fold greater than in normal subjects, but inhibition of ACE activity was not affected."	0
"Dual Blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"When decision-making is to be guided by serum digoxin levels, the clinician must consider the possibility of reported concentrations that have been falsely elevated by endogenous digoxin-like immunoreactive substances."	0
Prospective phenotyping of elderly patients prior to antipsychotic treatment may identify those at risk for adverse events.	0
There were an insufficient number of women greater than age 65 years in the two trials to evaluate the elderly.	0
The relationship between inhibition of platelet aggregation and clinical activity has not been established.	0
"More than two 5 mg tablets usually are not needed, and there is little controlled experience with such doses."	0
"There were suicides in the adult studies, but the number was not sufficient to reach any conclusion about antidepressant drug effect on suicide."	0
Diazepam: May potentiate orthostatic hypotension.	0
Patients should use the lowest dose and shortest duration of PPI therapy appropriate to the condition being treated.	0
Clinically significant hypotension (decreases in both systolic and diastolic pressure) has been reported with concomitant administration of either fluvoxamine or ciprofloxacin and single doses of 4 mg of Zanaflex.	0
"Co-administration of INVEGA<U+00AE> 6 mg once daily with carbamazepine, a strong inducer of both CYP3A4 and P-glycoprotein (P-gp), at 200 mg twice daily caused a decrease of approximately 37% in the mean steady-state Cmax and AUC of paliperidone."	1
"In addition, studies in healthy volunteers have shown that TIKOSYN does not affect the pharmacokinetics or pharmacodynamics of warfarin, or the pharmacokinetics of propranolol (40 mg twice daily), phenytoin, theophylline, or oral contraceptives."	0
"Intestinal reabsorption is reduced by deacetylation, and elimination is facilitated."	0
There were insufficient elderly patients to conduct subgroup analyses on the basis of age.	0
Adjustments should be made at intervals of 4 weeks or more.	0
DeWitte et al reported pancytopenia and severe immune deficiency in a preterm infant whose mother received 125mg azathioprine and 12.5mg prednisone daily.	0
Monoamine Oxidase Inhibitors (MAOIs) <U+2014> The use of MAOIs intended to treat psychiatric disorders with CYMBALTA or within 5 days of stopping treatment with CYMBALTA is contraindicated because of an increased risk of serotonin syndrome.	0
"The responder rate 3 weeks after vaccination, defined as seroconversion or a <U+2265>4-fold increase in antibody directed against tetanus toxoid was 40% for GILENYA 0.5 mg and 61% in the placebo group."	0
Use in Hepatic Impairment: Initiate with 8 mg ATACAND in patients with moderate hepatic insufficiency.	0
Race There is no race effect on the pharmacokinetics of quetiapine.	0
"The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents."	0
Pediatric patients (3 to less than 18 years of age and weighing at least 10 kg): dosage of PREZISTA and ritonavir is based on body weight and should not exceed the adult dose.	0
The effectiveness of paroxetine in the treatment of obsessive compulsive disorder (OCD) was demonstrated in two 12-week multicenter placebo-controlled studies of adult outpatients (Studies 1 and 2).	0
"Following EXTRANEAL use, inspect the drained fluid for the presence of fibrin or cloudiness, which may indicate the presence of peritonitis."	0
The effect of paroxetine on cimetidine's pharmacokinetics was not studied.	0
ANTIGOUT Colchicine <U+2191> colchicines Patients with renal or hepatic impairment should not be given colchicine with VIRACEPT due to the risk of colchicine toxicity.	0
"Following administration of abiraterone acetate, the pharmacokinetics of abiraterone and abiraterone acetate have been studied in healthy subjects and in patients with metastatic CRPC."	0
"Prophylaxis of gout-flares <U+2013>coadministration of colchicine in patients on VIRACEPT: If the original colchicine regimen was 0.6 mg twice a day, the regimen should be adjusted to 0.3 mg once a day.If the original colchicine regimen was 0.6 mg once a day, the regimen should be adjusted to 0.3 mg once every other day."	1
"Since the concomitant administration of warfarin with amiodarone increases the INR by 100 % after 3 to 4 days , reduce the dose of the anticoagulant by one-third to one-half , and monitor INR closely ."	0
"Fluvoxamine is a potent inhibitor of CYP1A2, and tizanidine is a CYP1A2 substrate."	0
"Electrocardiographic assessment: Prior to administration of the first dose, the QTc must be determined using an average of 5<U+2013>10 beats."	0
This combination may be used but the incidence of CNS related undesirable effects should be borne in mind.	0
"Consider alternatives to fluticasone propionate, particularly for long-term use."	0
"In dose-response (fixed-dose) studies (pediatric from 10 to 30 mg/day and adult from 20 to 40 mg/day), all doses were effective vs. placebo."	0
(tadalafil) with CRIXIVAN:Co-administration of Adcirca in patients on CRIXIVAN or co-administration of CRIXIVAN in patients on Adcirca:Start at or adjust Adcirca to 20 mg once daily.	0
The dose of COREG should not be increased until symptoms of worsening heart failure or vasodilation have been stabilized.	0
"The effects of nesiritide on PCWP, cardiac index (CI), and systolic blood pressure (SBP) were not significantly different in patients with chronic renal impairment (baseline serum creatinine ranging from 2 mg/dL to 4.3 mg/dL), and patients with normal renal function."	0
Patients with a preexisting low WBC or a history of drug induced leukopenia/neutropenia should have their complete blood count (CBC) monitored frequently during the first few months of therapy and should discontinue Chlorpromazine Hydrochloride Injection USP at the first sign of a decline in WBC in the absence of other causative factors.	0
"Under clinical conditions, paroxetine concentrations would normally be less than 400 ng/mL."	0
"Drugs That Interfere With Hemostasis (e.g., NSAIDs, Aspirin, and Warfarin): Serotonin release by platelets plays an important role in hemostasis."	0
Blood pressure usually returns to pretreatment levels rapidly when the drug is discontinued or the dosage is reduced.	0
"Studies to evaluate the potential for EMSAM to inhibit tyramine metabolism have been conducted and, overall, the data for EMSAM 6mg per 24 hours support a recommendation that a modified diet is not required at this dose."	0
Other Antihypertensive Drugs- additive effect or potentiation.	0
"Inhibition of these enzymes may result in increased plasma levels of certain drugs, including cyclosporine and tacrolimus."	1
"The combination may result in increased risk of cardiovascular adverse events associated with salmeterol, including QT prolongation, palpitations, and sinus tachycardia."	0
Parenteral drug products should be inspected visually for particulate matter and discoloration whenever solution and container permit prior to administration.	0
Hyponatremia: Can occur in association with SIADH (5.6).	0
This metabolite has a phosphodiesterase selectivity profile similar to sildenafil and an in vitro potency for PDE-5 approximately 50% of the parent drug.	0
"In patients who are intravascularly volume-depleted (e.g., those treated with diuretics), symptomatic hypotension may occur after initiation of therapy with losartan potassium tablets."	0
"Based upon the pharmacodynamic and pharmacokinetic profile of ziprasidone, possible interactions could be anticipated: Approximately two-thirds of ziprasidone is metabolized via a combination of chemical reduction by glutathione and enzymatic reduction by aldehyde oxidase."	0
Patients should not consume alcohol with Silenor.	0
The concomitant use of benzodiazepines and opioids increases the risk of respiratory depression because of actions at different receptor sites in the CNS that control respiration.	0
"Treatment with isosorbide dinitrate may be associated with lightheadedness on standing, especially just after rising from a recumbent or seated position."	0
These lesions consisted of vacuolation of epididymal tubular epithelium at 50 mg/kg/day and atrophic changes in the seminiferous tubules of the testes with arrested spermatogenesis at 25 mg/kg/day (9.8 and 4.9 times the MRHD for MDD and GAD; 8.2 and 4.1 times the MRHD for OCD and PD on a mg/m2 basis).	0
Figure 21: The effects of oral aripiprazole on pharmacokinetics of other drugs Figure19 Figure 20 Figure 21 Studies in Specific Populations No specific pharmacokinetic studies have been performed with ABILIFY MAINTENA in specific populations.	0
"Coadministration of antiplatelet agents, fibrinolytics, heparin, aspirin, and chronic NSAID use increases the risk of bleeding."	0
"Autoimmune disorders (such as Graves' disease, polymyositis, and Guillain-Barr<U+00E9> syndrome) have also been reported to occur in the setting of immune reconstitution; however, the time to onset is more variable, and can occur many months after initiation of treatment."	0
Certain drugs which inhibit this metabolic pathway can raise the plasma levels of simvastatin and may increase the risk of myopathy.	0
Avoid the use of agents that prolong the QT interval.	0
The maximum recommended dose in patients with a calculated creatinine clearance greater than 60 mL/min is 500 mcg BID; doses greater than 500 mcg BID have been associated with an increased incidence of Torsade de Pointes.	0
Antimycobacterial:rifampin <U+2193> ritonavir May lead to loss of virologic response.	0
"If neurological compromise is noted, urgent treatment is necessary."	0
"A food-effect study involving administration of PRISTIQ to healthy subjects under fasting and fed conditions (high-fat meal, 800 to 1000 calories) indicated that desvenlafaxine Cmax was increased about 16% in the fed state, while the AUCs were similar."	1
Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.	0
O:\E-Submissions\PBO\PRODUCTS\Eliquis 202155\08.	0
"Neprilysin Inhibitor Trandolapril component Patients taking concomitant neprilysin inhibitors (e.g., sacubitril) may be at increased risk for angioedema."	0
"This inhibition results in an increase in local concentrations of adenosine which acts on the platelet A2-receptor thereby stimulating platelet adenylate cyclase and increasing platelet cyclic-3',5'-adenosine monophosphate (cAMP) levels."	0
May lead to loss of virologic response.a Increased risk of transaminase elevations.	0
"At the highest dose tested, no pups born alive survived to Day 4 postpartum."	0
Several LC/MS/MS methods are available that may provide less susceptibility to DLIS interference.	0
"One such standardized procedure 2, 4 requires the use of standardized inoculum concentrations."	0
"Volume Depletion or Renal Artery Stenosis Blood pressure decreases associated with any dose of ALTACE depend, in part, on the presence or absence of volume depletion (e.g., past and current diuretic use) or the presence or absence of renal artery stenosis."	0
The pharmacological activity of the (+)- and (-)- paliperidone enantiomers is qualitatively and quantitatively similar in vitro.	0
Intravenous sotalol is a racemic mixture of d- and l-sotalol.	0
These increases should be considered when selecting an oral contraceptive for a woman taking LIPITOR.	0
Refer to the quetiapine prescribing information for recommendations on adverse reaction monitoring.	0
"Concomitant use with SSRIs, SNRIs or Tryptophan is not recommended (7.2)."	0
The recommended dosage is 25 mcg/kg administered intravenously within 5 minutes and then 0.15 mcg/kg/min for up to 18 hours.	0
Lower dosages are also recommended for outpatients as compared to hospitalized patients who will be under close supervision.	0
"However, dose adjustment may be required because of age-related decreases in creatinine clearance."	0
"Severe and life-threatening skin reactions, including 1case of Stevens-Johnson syndrome among 700subjects treated with LEXIVA in clinical trials."	0
Average normal adult daily requirement ranges from two to three liters (1.0 to 1.5 liters each for insensible water loss due to perspiration and urine production).	0
Human Data Women receiving mercaptopurine in the first trimester of pregnancy have an increased incidence of abortion; the risk of malformation in offspring surviving first trimester exposure is not known.	0
Acetylsalicylic acid did not alter the clearance ( pharmacokinetics ) of iloprost .	0
Do not administer injectable drugs that contain sodium metabisulfite in the same infusion line as NATRECOR<U+00AE>.	0
Steady-state drug exposure based on AUC0-24 was about 8 times greater than would have been predicted from single-dose data in these subjects.	0
"On average, both lorazepam alone and lorazepam with fluvoxamine produced substantial decrements in cognitive functioning; however, the coadministration of fluvoxamine and lorazepam did not produce larger mean decrements compared to lorazepam alone."	0
Hypersensitivity to atomoxetine or other constituents of product.	0
MISUSE OF METHAMPHETAMINE MAY CAUSE SUDDEN DEATH AND SERIOUS CARDIOVASCULAR ADVERSE EVENTS.	0
Concomitant administration of atorvastatin with strong inhibitors of CYP3A4 can lead to increases in plasma concentrations of atorvastatin.	1
<U+2022>Administer the entire dosage of REYATAZ oral powder (mixed in the food or beverage) within one hour of preparation (may leave the mixture at room temperature during this one hour period).	0
"In the event of an erection that persists longer than 4 hours, seek immediate medical assistance."	0
Review medications taken by patients prior to prescribing NORVIR or when prescribing other medications to patients already taking NORVIR.	0
"In patients with ischemic heart disease or cerebrovascular disease, an excessive fall in blood pressure could result in a myocardial infarction or a cerebrovascular accident."	0
Case reports and epidemiological studies (case-control and cohort design) have demonstrated an association between use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding.	0
"The Perpetrator and Dabigatran Etexilate Dose and Dosing Frequency are given as well as the Time of Perpetrator Dosing in Relation to Dabigatran Etexilate Dose (Time Difference) Figure 3.1 Figure 3.2 In RE-LY, dabigatran plasma samples were also collected."	0
This diagnosis should be considered for diarrhea that does not improve.	0
Marplan should be used in women who are nursing only if clearly needed.	0
"Serotonergic drugs include selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake inhibitors (SNRIs), tricyclic antidepressants (TCAs), triptans, 5-HT3 receptor antagonists, drugs that affect the serotonergic neurotransmitter system (e.g., mirtazapine, trazodone, tramadol), and drugs that impair metabolism of serotonin (including MAO inhibitors, both those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue)."	0
Zaleplon has a short half-life and no active metabolites.	0
"CNS depressants, including alcohol: Possible adverse additive CNS-depressant effects (5.1, 7.1) Imipramine: Decreased alertness observed (7.1) Chlorpromazine: Impaired alertness and psychomotor performance observed (7.1) Rifampin: Combination use may decrease effect (7.2) Ketoconazole: Combination use may increase effect (7.2) Co-administration of zolpidem with other CNS depressants increases the risk of CNS depression."	0
Paroxetine is extensively metabolized after oral administration.	0
"For patients with diseases, conditions, or medications that could exacerbate these effects, complete fall risk assessments when initiating antipsychotic treatment and recurrently for patients on long-term antipsychotic therapy."	0
"Because ACCUPRIL is secreted in human milk, caution should be exercised when this drug is administered to a nursing woman."	0
Inspect the patient connector to ensure the pull ring is attached.	0
"If angina markedly worsens or acute coronary ischemia develops, promptly reinstate DUTOPROL, and take measures appropriate for the management of unstable angina."	0
"Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide."	0
This is especially important for young children.	0
"Bone Fracture: Long-term and multiple daily dose PPI therapy may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist or spine."	0
"In a placebo-controlled study in 1272 MS patients (of whom 425 received fingolimod 0.5 mg daily and 418 received placebo), 18% (N=78) of patients on fingolimod 0.5 mg reached a nadir of <200 cells/mcL on at least 1 occasion."	0
"There have been reports of cardiac events, including torsade de pointes, in patients to whom fluconazole and cisapride were coadministered."	0
"During isometric or dynamic exercise, CALAN does not alter systolic cardiac function in patients with normal ventricular function."	0
"Consider monitoring white blood cell counts in patients with collagen-vascular disease, especially if the disease is associated with impaired renal function."	0
Savella is not approved for use in the treatment of major depressive disorder.	0
The risk of skeletal muscle effects may be enhanced when atorvastatin is used in combination with niacin; consider a reduction in atorvastatin dosage in this setting.	0
Patients with neutropenia should be carefully monitored for fever or other symptoms or signs of infection and treated promptly if such symptoms or signs occur.	0
ELIQUIS should be discontinued at least 48 hours prior to elective surgery or invasive procedures with a moderate or high risk of unacceptable or clinically significant bleeding.	0
"Following oral administration of 10 mg of apixaban as 2 crushed 5 mg tablets mixed with 30 g of applesauce, the Cmax and AUC were 20% and 16% lower, respectively, when compared to administration of 2 intact 5 mg tablets."	0
The patient should be informed that the response to alcohol may be exaggerated.	0
Co-administration of a single dose of INVEGA<U+00AE> 12 mg with divalproex sodium extended-release tablets (two 500 mg tablets once daily) resulted in an increase of approximately 50% in the Cmax and AUC of paliperidone.	1
The effect that symptomatic suppression has upon the long-term course of the syndrome is unknown.	0
"If FETZIMA is taken with alcohol, a pronounced accelerated drug release may occur."	0
"Also, pimozide, at a dose about 15 times that given humans, caused an increase in the number of benign tumors of the pituitary gland in female mice."	0
Vasodilation reactions: Monitor blood pressure and symptoms regularly during initiation and after dose change.	0
"The Reduction of Endpoints in NIDDM with the AngiotensinII Receptor Antagonist Losartan(RENAAL) study was a randomized, placebo-controlled, double-blind, multicenter study conducted worldwide in 1513 patients with type2 diabetes with nephropathy (defined as serum creatinine 1.3 to 3.0mg/dl in females or males <U+2264>60kg and 1.5 to 3.0mg/dl in males >60kg and proteinuria [urinary albumin to creatinine ratio <U+2265>300mg/g])."	0
"As a result, serum digoxin levels may be as much as doubled."	1
"In infants with restricted pulmonary blood flow, about 50% responded to alprostadil infusion with at least a 10 torr increase in blood pO2 (mean increase about 14 torr and mean increase in oxygen saturation about 23%)."	0
Consider additional follow-up and diagnostic testing.	0
Do not mix TRISENOX with other medications.	0
"Because the MRHD for MDD is slightly less than that for OCD (50 mg vs 60 mg), the doses used in these carcinogenicity studies were only 2.0 (mouse) and 3.2 (rat) times the MRHD for OCD."	0
"Very rarely, and again by mechanisms not understood, quinidine levels are decreased by coadministration of nifedipine."	1
"Concomitant use of monoamine oxidase inhibitors (MAOIs), or use within 14 days of stopping MAOIs (4, 7.1) Concomitant use of pimozide (4, 7.1) Known hypersensitivity to sertraline or excipients (4, 5.4) ZOLOFT oral solution only: Concomitant use of disulfiram (4)"	0
Table 6<U+2003>Impact of Renal Impairment on Dabigatran Pharmacokinetics +Patients with severe renal impairment were not studied in RE-LY and RE-COVER.	0
"In a CYP2C8 drug-drug interaction trial in healthy subjects, the AUC of pioglitazone (CYP2C8 substrate) was increased by 46% when pioglitazone was given together with a single dose of 1,000 mg abiraterone acetate."	1
"On a twice-daily dosing schedule, there will be only minor differences in serum digoxin concentrations whether sampling is done at 8 or 12 hours after a dose."	0
The long-term clinical impact of the emergence or persistence of virus containing ledipasvir or sofosbuvir resistance-associated substitutions is unknown.	0
"During the TIKOSYN clinical development program, the risk of Torsade de Pointes in females was approximately 3 times the risk in males."	0
"At these doses, which are multiples of the MRHD equal to 3,000 for mice and 1,000 for rats, based on body weight, and equal to 282 for mice and 206 for rats, based on body surface area, there was no evidence of harm to the fetus."	0
"Evaluation of electrocardiograms of 682 patients who received paroxetine in double-blind, placebo-controlled trials, however, did not indicate that paroxetine is associated with the development of significant ECG abnormalities."	0
Such treatment should be limited to those patients for whom it is essential.	0
"However, co-administration of duloxetine with aluminum- and magnesium-containing antacids (51 mEq) or duloxetine with famotidine, had no significant effect on the rate or extent of duloxetine absorption after administration of a 40 mg oral dose."	0
"Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan."	1
"Furthermore, 1.9% (4/210) of Savella-treated and 0.9% (1/111) of placebo patients discontinued treatment for increases in blood pressure."	0
Amlodipine Amlodipine is extensively (about 90%) converted to inactive metabolites via hepatic metabolism with 10% of the parent compound and 60% of the metabolites excreted in the urine.	0
The possibility of rapid emergence of resistant meningococci restricts the use of RIFADIN to short-term treatment of the asymptomatic carrier state.	0
"The clinical relevance of these interactions and subsequent dose modifications should be judged in light of the population studied, severity of the disease, patient's drug profile, and the likely impact on the risk/benefit ratio."	0
"In the same study, approximately 2% of patients treated with ALTACE and hydrochlorothiazide for up to 56 weeks had abnormally high potassium values and an increase from baseline of 0.75 mEq/L or greater; and approximately 2% had abnormally low values and decreases from baseline of 0.75 mEq/L or greater."	0
Coadministration of REYATAZ/ritonavir in adult patients on bosentan: Discontinue bosentan at least 36 hours before starting REYATAZ/ritonavir.	0
"Monitor serum electrolytes (sodium, potassium, chloride and carbon dioxide), serum creatinine and complete blood counts every four months and more frequently in patients with cardiac disease, renal disease or acidosis."	0
Pediatric dose recommendations that are both reliably effective and below thresholds of concern for QT and PR interval prolongation could not be determined.	0
"Hyperkalemia: Patients with decreased renal function, diabetes, proteinuria or patients who are taking ACEs and ARBs, NSAIDs or moderate CYP3A inhibitors are at increased risk."	0
Dipyridamole exposure (Cmax and AUC) at steady-state were similar with or without omeprazole co-administration.	0
"Hence, doses of ketoconazole or itraconazole >200 mg/day are not recommended."	0
Patients with hepatic impairment The recommended dose in patients with moderate to severe hepatic impairment is 50 mg per day.	0
EMSAM should not be used in patients less than 18 years of age.	0
Avoid use with strong CYP3A inhibitors or CYP3A inducers.	0
"An encephalopathic syndrome (characterized by weakness, lethargy, fever, tremulousness and confusion, extrapyramidal symptoms, leukocytosis, elevated serum enzymes, BUN and FBS) has occurred in a few patients treated with lithium plus an antipsychotic."	0
The potentiation resulted from a CNS pharmacodynamic interaction; zaleplon did not affect the pharmacokinetics of ethanol.	0
"Promethazine: Coadministration of a single dose of zaleplon and promethazine (10 and 25 mg, respectively) resulted in a 15% decrease in maximal plasma concentrations of zaleplon, but no change in the area under the plasma concentration-time curve."	1
Coadministration of triazolam or orally administered midazolam with INVIRASE/ritonavir may cause large increases in the concentration of these benzodiazepines.	1
The 2 and 5 mg capsules are not indicated for initial therapy.	0
"Nonetheless, at this time, it is recommended that plasma lithium levels be monitored following initiation of sertraline hydrochloride therapy with appropriate adjustments to the lithium dose."	0
Zaleplon does not accumulate with once-daily administration and its pharmacokinetics are dose proportional in the therapeutic range.	0
"Since only a minimal amount of clonidine is removed during routine hemodialysis, there is no need to give supplemental clonidine following dialysis."	0
"Metabolism and Excretion Sildenafil is cleared predominantly by the CYP3A (major route) and cytochrome P450 2C9 (CYP2C9, minor route) hepatic microsomal isoenzymes."	0
LUNESTA should be used with caution in patients with hepatic impairment.	0
Need to evaluate for co-morbid diagnoses: Reevaluate if insomnia persists after 7 to 10 days of treatment.	0
"The following symptoms, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric."	0
"The recommended initial dose for elderly or debilitated patients is 100 mg/day, administered in two divided doses (BID)."	0
Anticoagulant: Warfarin Concentrations of warfarin may be affected.	0
"Therefore, concomitant use of Zanaflex with fluvoxamine or with ciprofloxacin, potent inhibitors of CYP1A2, is contraindicated."	0
"CYP3A4 Interactions: Aprepitant is a substrate, weak-to-moderate inhibitor and inducer of CYP3A4; See Full Prescribing Information for recommendations regarding contraindications, risk of adverse reactions, and dosage adjustments of EMEND and concomitant drugs."	0
"Importantly, it may take two weeks or longer to achieve this extent of accumulation at constant dosing because of the relatively long elimination half-lives of CMI and DMI."	0
"Drugs predominantly metabolized by the CYP450 2D6 isozyme include the following drug classes: tricyclic antidepressants, selective serotonin reuptake inhibitors, beta-blockers, antiarrhythmics class 1C (e.g., flecainide and propafenone) and monoamine oxidase inhibitors Type B. Coadministration of Lamisil Tablets should be done with careful monitoring and may require a reduction in dose of the 2D6-metabolized drug."	1
"The common complications of hyperparathyroidism such as renal lithiasis, bone resorption and peptic ulceration have not been seen."	0
No dosage adjustment is required for patients with mild to moderate renal impairment.	0
"The mechanism of these reactions is unclear, but may be related to a preexisting hyperphenylalaninemia."	0
"Do not administer Lotensin within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor."	0
"Premature discontinuation of any oral anticoagulant , including XARELTO , in the absence of adequate alternative anticoagulation increases the risk of thrombotic events ."	0
Concomitant use of bupropion with other drugs metabolized by CYP2D6 has not been formally studied.	0
"If neurological compromise is noted, urgent diagnosis and treatment is necessary."	0
Digoxin and verapamil use may be rarely associated with ventricular fibrillation when combined with Adenocard (see Warnings ).	0
"On the left side of the chart, locate the patient<U+2019>s weight in kilograms."	0
Pour another 10 mL of formula into the medicine cup to rinse off remaining REYATAZ oral powder in cup.	0
Monitor blood pressure and symptoms regularly during initiation and after dose change.	0
Potassium levels should be within the normal range prior to administration of MULTAQ and maintained in the normal range during administration of MULTAQ.	0
"Two-year feeding studies in mice and rats, conducted under the auspices of the National Toxicology Program (NTP), treated mice and rats with doses of hydrochlorothiazide up to 600 and 100 mg/kg/day, respectively."	0
No significant drug interactions were reported in studies in which Benicar was co-administered with digoxin or warfarin in healthy volunteers.	0
"However, when given by itself, atropine does not exert a striking or uniform effect on blood vessels or blood pressure."	0
The oral-dose plasma clearance of zaleplon is about 3 L/h/kg and the IV zaleplon plasma clearance is approximately 1 L/h/kg.	0
Protein binding is independent of total drug concentrations.	0
PROZAC is primarily metabolized by CYP2D6.	0
"When nicardipine capsules (20or 30 mg TID) were given to hypertensive patients with impaired renal function, mean plasma concentrations, AUC, and Cmax were approximately two-fold higher than in healthy controls."	0
This effect occurred at a dose of 1 mg/kg/day or approximately one-sixth of the MRHD on an mg/m2 basis.	0
"Co-administration of SAMSCA with 400mg ketoconazole daily or with other strong CYP 3A inhibitors (e.g., clarithromycin, itraconazole, telithromycin, saquinavir, nelfinavir, ritonavir and nefazodone) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure."	1
Perform serial ultrasound examinations to assess the intra-amniotic environment.	0
"Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function."	0
Pulmonary vasodilators may significantly worsen the cardiovascular status of patients with pulmonary veno-occlusive disease (PVOD).	0
A patient who becomes hypotensive at this dose may be switched to 1.25 mg twice daily.	0
"These studies uncovered no evidence of a carcinogenic potential of hydrochlorothiazide in rats or female mice, but there was equivocal evidence of hepatocarcinogenicity in male mice."	0
Co-administration of PREZISTA/ritonavir in patients on bosentan: Discontinue use of bosentan at least 36 hours prior to initiation of PREZISTA/ritonavir.	0
Studies 1 and 2 were 12-week flexible dose studies.	0
Duloxetine is in a class of drugs known to affect urethral resistance.	0
Protein binding was similar (92%-94%) between healthy controls and ESRD subjects during the on-dialysis and off-dialysis periods.	0
Studies in animals demonstrate that the acute toxicity of bupropion is enhanced by the MAO inhibitor phenelzine.	0
"In a fertility and general reproductive performance study in rats, both males and females, treated with 75 mg/kg (225 times the usual maximum recommended human dose), demonstrated decreased fertility, while those treated with 25 mg/kg (75 times the usual maximum recommended human dose) did not."	0
Lisinopril absorption is not influenced by the presence of food in the gastrointestinal tract.	0
"Reduction in the dose of SAMSCA may be required in patients concomitantly treated with P-gp inhibitors , such as e.g. , cyclosporine , based on clinical response see Dose and Administration ( 2.3 ) and Warnings and Precautions ( 5.5 ) ."	0
Stop tadalafil at least 24 hours prior to starting PREZISTA/ritonavir.	0
"In vitro, quetiapine did not affect the binding of warfarin or diazepam to human serum albumin."	0
"At clinically relevant concentrations, in vitro studies indicate that estazolam (0.6<U+00B5>M) was not inhibitory towards the major cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A."	0
Staggered administration (12 hours apart) of atazanavir/ritonavir + emtricitabine/tenofovir DF or darunavir/ritonavir + emtricitabine/tenofovir DF and HARVONI provided similar results.	0
The need for a fourth drug should be reassessed when the results of susceptibility testing are known.	0
Lithium - generally should not be given with diuretics.	0
"Like other calcium channel antagonists, diltiazem decreases sinoatrial and atrioventricular conduction in isolated tissues and has a negative inotropic effect in isolated preparations."	0
"With a dosing regimen of NATRECOR<U+00AE> of 2 mcg/kg IV bolus followed by an intravenous infusion dose of 0.01 mcg/kg/min, Table 4 and Figure 3 summarize the changes in the VMAC trial in PCWP and other measures during the first 3 hours."	0
"This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function."	0
Renvela is contraindicated in patients with bowel obstruction.	0
"Such adverse experiences have not been reported in the literature, despite a long history of use of verapamil in Europe in the treatment of cardiac side effects of beta-adrenergic agonist agents used to treat premature labor."	0
The safe use of triamterene and hydrochlorothiazide in pregnancy has not been established since there are no adequate and well-controlled studies with triamterene and hydrochlorothiazide in pregnant women.	0
"Sevelamer did not alter the pharmacokinetics of digoxin, enalapril, iron, metoprolol and warfarin."	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
These deaths may have been the result of an effect of ORAP upon the heart.	0
"Because of the long half lives of fluoxetine and its active metabolite, at least five weeks (perhaps longer, especially if fluoxetine has been prescribed chronically and/or at higher doses) should elapse between discontinuation of fluoxetine and initiation of treatment with selegiline."	0
"AGGRASTAT inhibits platelet function, as demonstrated by its ability to inhibit ex vivo adenosine phosphate (ADP)-induced platelet aggregation and prolong bleeding time in healthy subjects and patients with coronary artery disease."	0
"MACROLIDE ANTIBIOTIC Azithromycin <U+2191> azithromycin Dose adjustment of azithromycin is not recommended, but close monitoring for known side effects such as liver enzyme abnormalities and hearing impairment is warranted."	0
Cases of acute angle-closure glaucoma have been reported with hydrochlorothiazide.	0
"There was no clinically significant change in visual acuity in the patients who had new opacities reported nor was any patient, including those with opacities noted at baseline, discontinued from therapy because of a decrease in visual acuity."	0
The safety of single doses over 120mg and total daily doses above 150mg have not been systematically evaluated.	0
"Increased Risk of Bleeding: Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), other antiplatelet drugs, warfarin, and other anticoagulants may increase this risk."	0
Gender The pharmacokinetics of eszopiclone in men and women are similar.	0
"Conversely, at least 14 days should be allowed after stopping nortriptyline hydrochloride oral solution USP before starting an MAOI intended to treat psychiatric disorders."	0
Savella inhibits the reuptake of norepinephrine.	0
"In some patients with compromised renal function (e.g., elderly patients or patients who are volume-depleted, including those on diuretic therapy) who are being treated with non-steroidal anti-inflammatory drugs, including selective COX-2 inhibitors, the co-administration of angiotensin II receptor antagonists or ACE inhibitors may result in a further deterioration of renal function, including possible acute renal failure."	0
A specific antidote for rivaroxaban is not available .	0
"After oral administration of radiolabeled dabigatran, 7% of radioactivity is recovered in urine and 86% in feces."	0
"Severe skin reactions, including erythema multiforme and Stevens-Johnson Syndrome (SJS), can occur with CYMBALTA."	0
Moderate or weak CYP1A2 inhibitors include oral contraceptives and caffeine.	0
"See PRECAUTIONS, Drug Interactions, for information on co-administration of PROCARDIA with beta blockers or long-acting nitrates."	0
"Clinical drug interaction studies have been performed with substrates of CYP2D6 and show that paroxetine can inhibit the metabolism of drugs metabolized by CYP2D6 including desipramine, risperidone, and atomoxetine."	1
"As in the case of other phenothiazines, thioridazine is capable of potentiating central nervous system depressants (e.g., alcohol, anesthetics, barbiturates, narcotics, opiates, other psychoactive drugs, etc.) as well as atropine and phosphorus insecticides."	0
It is not known if phendimetrazine tartrate is excreted in human milk.	0
Isosorbide dinitrate should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.	0
"<U+2022>Determine the number of packets (3, 4, 5 or 6 packets) that are needed."	0
"If concomitant use of such agents is indicated, they should be used with caution and with appropriate monitoring of serum potassium."	0
Gradually reduce the dosage rather than stopping ZOLOFT abruptly whenever possible.	0
"Subjects receiving nefazodone 250 mg BID and buspirone 5 mg BID experienced lightheadedness, asthenia, dizziness, and somnolence, adverse events also observed with either drug alone."	0
"17, 18, 19 Because of the potential for tumorigenicity shown for azathioprine, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother."	0
The extent to which SSRI TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.	0
"4-hydroxy-estazolam is the major metabolite in plasma, with concentrations approaching 12% of those of the parent eight hours after administration."	0
The mean plasma concentrations in patients with creatinine clearance below 30 mL/min. were approximately 4 times greater than seen in normal volunteers.	0
"In animal models, atorvastatin lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA reductase and cholesterol synthesis in the liver and by increasing the number of hepatic LDL receptors on the cell surface to enhance uptake and catabolism of LDL; atorvastatin also reduces LDL production and the number of LDL particles."	0
Midazolam is extensively metabolized by CYP3A4.	0
"This variant of small pupil syndrome is characterized by the combination of a flaccid iris that billows in response to intraoperative irrigation currents, progressive intraoperative miosis despite preoperative dilation with standard mydriatic drugs, and potential prolapse of the iris toward the phacoemulsification incisions."	0
DYAZIDE should be used during pregnancy only if the potential benefit justifies the risk to the fetus.	0
"Pooled analyses of short-term placebo-controlled trials of antidepressant drugs (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and behaviour (suicidality) in children, adolescents, and young adults (ages 18-24) with major depressive disorder (MDD) and other psychiatric disorders."	0
Treatment Related Malignancies: Agressive and fatal causes of hepatosplenic T-cell lymphoma have occurred.	0
The interaction was pharmacodynamic with no alteration of the pharmacokinetics of either drug.	0
"Because of the relative beta1-selectivity of bisoprolol fumarate, ZIAC may be used with caution in patients with bronchospastic disease who do not respond to, or who cannot tolerate other antihypertensive treatment."	0
"In case of hypotension or tachycardia, discontinue infusion."	0
The terminal half-life is approximately 15 minutes.	0
"Dual Blockade of the Renin-Angiotensin System (RAS): Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"Centrally-Acting Drugs and Alcohol Given the primary CNS effects of risperidone, caution should be used when risperidone is taken in combination with other centrally-acting drugs and alcohol."	0
"Response during the single-blind phase was defined by having a decrease of <U+2265>2 points compared to baseline on the CGI-Severity of Illness scale, to a score of <U+2264>3."	0
Consideration should be given to the type or dose of contraceptives used in combination with AUBAGIO.	0
"Potassium-sparing diuretics (e.g., spironolactone, triamterene, or amiloride), potassium supplements, or potassium-containing salt substitutes may lead to significant increases in serum potassium."	0
"Because increase in QT interval and the risk of ventricular arrhythmias are directly related to plasma concentrations of dofetilide, dosage adjustment based on calculated creatinine clearance is critically important."	0
"Because of probable underreporting, it is impossible to provide an accurate estimate of the true incidence of these reactions."	0
Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.	1
The contractile processes of cardiac muscle and vascular smooth muscle are dependent upon the movement of extracellular calcium ions into these cells through specific ion channels.	0
"In vitro studies suggested that CYP2C8, CYP2C19, CYP2D6, and CYP2J2 had minimal contributions to metabolism of levomilnacipran."	0
"When pregnancy is detected, discontinue PRINIVIL as soon as possible (5.1)."	0
Pregnancy: Teratogenic Effects: Pregnancy Category D. See WARNINGS section.	0
"Triamterene was not mutagenic in bacteria ( S. typhimurium strains TA 98, TA 100, TA 1535 or TA 1537) with or without metabolic activation."	0
"If a gout flare occurs during treatment, ULORIC need not be discontinued."	0
Treat pre-existing hypertension and other cardiovascular disease before starting therapy with Savella.	0
Body surface area can be calculated as follows: aptivus-formula	0
"Following a single dose of INSPRA 100 mg and CYP3A inhibitor ketoconazole 200 mg twice a day, eplerone's Cmax was 1.7-fold and AUC was 5.4-fold compared with eplerone alone."	0
<U+2022>when coadministered with drugs that strongly induce CYP3A and may lead to lower exposure and loss of efficacy of REYATAZ.	1
The influence of hepatic or renal impairment on the pharmacokinetics of estazolam has not been studied.	0
"The corresponding values for Cmaxwere 42.4 (CV 54%) and 18.6 ng/mL (CV 100%) for children and adolescents, respectively."	0
"Patients with renal impairment The maximum recommended dose in patients with moderate renal impairment (24-hr creatinine clearance [CrCl] = 30 to 50 mL/min, Cockcroft-Gault [C-G]) is 50 mg per day."	0
The dose of FANAPT should be reduced in patients co-administered a strong CYP2D6 or CYP3A4 inhibitor.	1
"In two of the 8 hepatically impaired patients, AUC and Cmax were 3 times higher than those observed typically in healthy subjects."	0
"Animal studies using tritium<U+2011>labeled epoprostenol have indicated a high clearance (93mL/kg/min), small volume of distribution (357mL/kg), and a short half<U+2011>life (2.7minutes)."	0
"Apixaban has no direct effect on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin."	0
"In the orthopedic hip surgery patients, limited clinical data with P-gp inhibitors is available."	0
Transdermally absorbed selegiline (via EMSAM) is not metabolized in human skin and does not undergo extensive first-pass metabolism.	0
Patients should be advised of the increased risk of myopathy including rhabdomyolysis with the 80-mg dose.	0
"Do not use ADCIRCA in patients who are using a GC stimulator , such as riociguat ."	0
"FANAPT exhibits high (nM) affinity binding to serotonin 5-HT2A dopamine D2 and D3 receptors, and norepinephrine NE<U+03B1>1 receptors (Ki values of 5.6, 6.3, 7.1, and 0.36 nM, respectively)."	0
Acute Interstitial Nephritis: Observed in patients taking PPIs (5.3).	0
Starting PEXEVA<U+00AE> in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome.	0
Plasma levels of both doxepin and desmethyldoxepin are highly variable and are poorly correlated with dosage.	0
"Because telmisartan does not inhibit ACE (kininase II), it does not affect the response to bradykinin."	0
The vasodilating effects of isosorbide dinitrate may be additive with those of other vasodilators.	0
Patients with persistent hyperkalemia may require dialysis.	0
"Severe skin reactions, including toxic epidermal necrolysis and Stevens-Johnson syndrome, some fatal."	0
"Telmisartan The ONTARGET trial enrolled 25,620 patients >55 years old with atherosclerotic disease or diabetes with end-organ damage, randomized them to telmisartan only, ramipril only, or the combination, and followed them for a median of 56 months."	0
Dilutions in dextrose 5% for injection (D5W) are stable at room temperature for up to 8 hours and should be prepared and used within this time.	0
Assess renal function prior to initiation of treatment with PRADAXA.	0
Amiodarone is also a potential source of large amounts of inorganic iodine and can cause either hypothyroidism or hyperthyroidism .	0
"When pregnancy is detected, losartan potassium tablets should be discontinued as soon as possible."	0
8.Clinical drug interaction studies have demonstrated that pimozide is also metabolized by CYP 2D6.	0
"Metabolism of a number of medications, including antipsychotics, antidepressants, <U+03B2>-blockers, and antiarrhythmics, occurs through the cytochrome P450 2D6 isoenzyme (debrisoquine hydroxylase)."	0
"Presumably because ACE inhibitors affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving ACE inhibitors (including ACCUPRIL) may be subject to a variety of adverse reactions, some of them serious."	0
"MAO in the gastrointestinal tract (primarily type A) provides protection from exogenous amines with vasopressor actions, such as tyramine, which if absorbed intact can cause a hypertensive crisis, the so-called <U+201C>cheese reaction<U+201D>."	0
"Clinical Worsening and Suicide Risk: Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down."	0
The end result of these biochemical processes is a reduction of the plasma cholesterol concentration.	0
These changes were rarely associated with significant clinical symptoms.	0
Phenobarbital<U+2014> Phenobarbital induces many cytochrome P450 (oxidative) enzymes.	0
Metabolites are formed by N-dealkylation and N-oxidation.	0
Activated partial thromboplastin times ( APTT ) should be monitored in patients receiving heparin and intravenous nitroglycerin .	0
The oral dose of 40 mg is sufficient to assess the effect of metabolic inhibition.	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy observed in this population."	0
Hyponatremia and hypochloremia may occur when amiloride HCl is used with other diuretics and increases in BUN levels have been reported.	0
"Ideally, periodic skin examinations should be performed by appropriately qualified individuals (e.g., dermatologists)."	0
Check with your physician if you have any questions.	0
Nicardipine is highly protein bound (greater than 95%) in human plasma over a wide concentration range.	0
"As with outpatients, start with low doses and increase dosage gradually."	0
Drugs that Cause QT Interval Prolongation Use caution when administering concomitant medications that prolong the QT interval or inhibit the metabolism of clozapine.	0
Sensitivity reactions to thiazides may occur in patients with or without a history of allergy or bronchial asthma.	0
Periodic serum transaminase testing has not been proven to prevent serious injury but it is generally believed that early detection of drug-induced hepatic injury along with immediate withdrawal of the suspect drug enhances the likelihood for recovery.	0
Discontinue Meperidine Hydrochloride Injection if serotonin syndrome is suspected.	0
Coadministration with diazepam is generally not advisable (5.9).	0
QTc Prolongation greater than 450 msec for men or greater than 460 msec for women: Withhold treatment with TRISENOX and any medication known to prolong the QTc interval.	0
"Rifampicin: In healthy subjects receiving the CYP3A4 inducer, rifampicin, at 600 mg daily for 12 days, systemic exposure (AUC) to nilotinib was decreased approximately 80%."	1
Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients (5.1) Closely monitor for clinical worsening and emergence of suicidal thoughts and behaviors (5.1)	0
"Drug Interactions In vitro studies with human hepatic microsomes showed that abiraterone has the potential to inhibit CYP1A2, CYP2D6, CYP2C8 and to a lesser extent CYP2C9, CYP2C19 and CYP3A4/5."	0
"Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide."	0
Antipsychotics:lurasidone pimozide CONTRAINDICATED due to potential for serious and/or life-threatening reactions.	0
Treatment with PRISTIQ and any concomitant serotonergic agents should be discontinued immediately if the above events occur and supportive symptomatic treatment should be initiated.	0
"Coadministration of fibrinolytics, anticoagulants and antiplatelet agents, increases the risk of bleeding."	0
"Patient age was the most important determinant of warfarin requirement in these patients, with a progressively lower warfarin requirement with increasing age."	0
Monitor patients receiving Meperidine Hydrochloride Injection and any CYP3A4 inhibitor or inducer.	0
250 mL 2 0.05 100 mL 5 0.02 50 mL 10 0.01 25 mL 20 0.005	0
Paroxetine hydrochloride is completely absorbed after oral dosing of a solution of the hydrochloride salt.	0
Adjustment of the dosage of maprotiline hydrochloride may therefore be necessary in such cases.	0
Absolute bioavailability has been estimated to be between 64% and 90%.	0
"There is also an AT2 receptor found in many tissues, but AT2 is not known to be associated with cardiovascular homeostasis."	0
"For the treatment of esophageal candidiasis, the recommended dosage of DIFLUCAN in children is 6 mg/kg on the first day, followed by 3 mg/kg once daily."	0
"If the drug has a short elimination half-life, it is possible that a relative deficiency of the drug or its active metabolites (i.e., in relationship to the receptor site) may occur at some point in the interval between each night<U+2019>s use."	0
"The most common ECG changes were PVCs, ST-T wave changes, and intraventricular conduction abnormalities."	0
The mechanism of action of quetiapine is unknown.	0
Patients should be closely monitored when ROZEREM is coadministered with doxepin.	0
"Avoid use of strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin) [see Clinical Pharmacology (12.3) ]."	0
"In patients with more severe renal impairment, loop diuretics are preferred to thiazides, so DUTOPROL is not recommended."	0
Dosages greater than 20 mEq per day should be divided such that no more than 20 mEq is given in a single dose.	0
The half-life of dabigatran in healthy subjects is 12 to 17 hours.	0
Effient may be administered with or without food.	0
Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.	1
"ECG intervals (PR, QRS, and QT) were not affected by concurrent mexiletine and digoxin, diuretics, or propranolol."	0
"In studies conducted in healthy subjects, apixaban did not meaningfully alter the pharmacokinetics of digoxin, naproxen, atenolol, prasugrel, or acetylsalicylic acid."	0
"A greater blood pressure reduction and an increase in side effects may be observed in the elderly (i.e., > 65 years) with hydrochlorothiazide."	0
Symptoms such as these may be associated with an increased risk for suicidal thinking and behavior and indicate a need for very close monitoring and possibly changes in the medication.	0
"Whether this effect plays any role in classical effort angina is not clear, but studies of exercise tolerance have not shown an increase in the maximum exercise rate<U+2013>pressure product, a widely accepted measure of oxygen utilization."	0
"In studies in normal subjects , there was no pharmacodynamic interaction between intravenous iloprost and either nifedipine , diltiazem , or captopril ."	0
There are no studies of the coadministration of thioridazine and other drugs that prolong the QTc interval.	0
"In patients at risk for excessive hypotension , therapy should be started under very close medical supervision and such patients should be followed closely for the first two weeks of treatment and whenever the dose of enalapril and/or diuretic is increased ."	0
"Adjust dosage to individual and the severity of his condition, recognizing that the milligram for milligram potency relationship among all dosage forms has not been precisely established clinically."	0
MYCOBUTIN Capsules are contraindicated in patients who have had clinically significant hypersensitivity to rifabutin or to any other rifamycins.	0
"Asenapine is highly bound (95%) to plasma proteins, including albumin and <U+03B1>1-acid glycoprotein."	0
"At steady-state, in comparison to a single dose, the peak concentration of terbinafine is 25% higher and plasma AUC increases by a factor of 2.5; the increase in plasma AUC is consistent with an effective half-life of ~36 hours."	0
"There has been a long-standing concern, however, that antidepressants may have a role in inducing worsening of depression and the emergence of suicidality in certain patients during the early phases of treatment."	0
"When multiple doses of LIPITOR and digoxin were co-administered, steady state plasma digoxin concentrations increased by approximately 20%."	1
"Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients whose depression is persistently worse, or who are experiencing emergent suicidality or symptoms that might be precursors to worsening depression or suicidality, especially if these symptoms are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
"Over 21 days, 60.1% of the administered dose is excreted via feces (37.5%) and urine (22.6%)."	0
"Warning signs or symptoms of fluid and electrolyte imbalance include: dryness of mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia and gastrointestinal disturbances such as nausea and vomiting."	0
ACE inhibitor-induced cough should be considered in the differential diagnosis of cough.	0
"Iloperidone doses should be reduced by about one-half when administered with ketoconazole or other strong inhibitors of CYP3A4 (e.g., itraconazole)."	1
"Because these events have been reported voluntarily during clinical practice, estimates of frequency cannot be made and causal relationships between protease inhibitor therapy and these events have not been established."	0
"Patients treated with TENORMIN plus a catecholamine depletor should therefore be closely observed for evidence of hypotension and/or marked bradycardia which may produce vertigo, syncope, or postural hypotension."	0
"Following a single dose administration of ABILIFY MAINTENA in the deltoid and gluteal muscle, the extent of absorption (AUCt, AUC<U+221E>) of aripiprazole was similar for both injection sites, but the rate of absorption (Cmax) was 31% higher following administration to the deltoid compared to the gluteal site."	0
"There have been rare postmarketing reports describing patients with weakness, hyperreflexia, and incoordination following the use of an SSRI and sumatriptan."	0
"Ketoconazole did not affect the conversion of losartan to the active metabolite after intravenous administration of losartan, and erythromycin had no clinically significant effect after oral administration."	0
"Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin converting enzyme (ACE, kininase II)."	0
Epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an NSAID or aspirin may potentiate this risk of bleeding.	0
"However, some patients may require treatment despite the presence of the syndrome."	0
"Likewise, the single-dose pharmacokinetics of fingolimod and fingolimod-phosphate and the steady-state pharmacokinetics of both atenolol and diltiazem were unchanged during the coadministration of the latter 2 drugs individually with fingolimod."	0
Beta-blocking drugs may potentiate the rebound hypertension sometimes observed after discontinuation of clonidine.	0
"Antifungal: Ketoconazole, itraconazole <U+2194> Saquinavir<U+2194> Ritonavir<U+2191> Ketoconazole When INVIRASE/ritonavir and ketoconazole are coadministered, plasma concentrations of ketoconazole are increased."	1
"If concomitant use of Anafranil with other serotonergic drugs, including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, tryptophan, and St. John<U+2019>s Wort is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome, particularly during treatment initiation and dose increases."	0
"Therefore, in patients taking fluconazole, therapy should be limited to fluvastatin 20 mg twice daily."	0
At least 36 hours should be allowed between dose increments to attain steady-state plasma concentrations of sotalol in patients with age-adjusted normal renal function.	0
"Risperidone has low to moderate affinity (Ki of 47 to 253 nM) for the serotonin 5HT1C, 5HT1D, and 5HT1A receptors, weak affinity (Ki of 620 to 800 nM) for the dopamine D1 and haloperidol-sensitive sigma site, and no affinity (when tested at concentrations >10-5 M) for cholinergic muscarinic or <U+03B2>1 and <U+03B2>2 adrenergic receptors."	0
The lowest DUTOPROL tablet available is 25/12.5 mg. A 50/6.25 mg dose can be achieved by splitting the 100/12.5 mg tablet.	0
<U+2022> Seizures: Avoid administering fluvoxamine in patients with unstable epilepsy; monitor patients with controlled epilepsy; discontinue treatment if seizures occur or frequency increases (5.13).	0
"In addition, corneal deposits have been observed in some patients during routine ophthalmologic surveillance of HIV-positive pediatric patients receiving MYCOBUTIN as part of a multiple-drug regimen for MAC prophylaxis."	0
"The majority of patients presented with rash; however, arthralgia and cytopenia were also reported."	0
"When concomitant administration of either of these two drugs is initiated, the dose of mexiletine should be slowly titrated to desired effect."	0
"There was considerable variation in risk of suicidality among drugs, but a tendency toward an increase in the younger patients for almost all drugs studied."	0
"For most patients, the recommended starting dose is 5 mg once daily, with or without food, as monotherapy or in combination with other agents."	0
Both black patients (usually a predominantly low renin group) and non-black patients respond to 2 to 4 mg of trandolapril.	0
"Due to the increased risk of myopathy, including rhabdomyolysis, use of the 80-mg dose of ZOCOR should be restricted to patients who have been taking simvastatin 80 mg chronically (e.g., for 12months or more) without evidence of muscle toxicity."	0
Disconnect ULTRABAG from transfer set and apply MINICAP.	0
"STRATTERA should be used with caution in any condition that may predispose patients to hypotension, or conditions associated with abrupt heart rate or blood pressure changes."	0
The safe use of NARDIL during pregnancy or lactation has not been established.	0
These drugs and other contraindicated drugs (which may lead to reduced efficacy of darunavir) are listed in Table 6.	0
"The angioedema was diagnosed by procedures including abdominal CT scan or ultrasound, or at surgery, and symptoms resolved after stopping the ACE inhibitor."	0
"Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements, and/or potassium-containing salt substitutes, which should be used cautiously, if at all, with trandolapril."	0
The risk of skeletal muscle effects may be enhanced when CRESTOR is used in combination with lipid-modifying doses (<U+2265>1g/day) of niacin; caution should be used when prescribing with CRESTOR.	0
"Before initiating TIKOSYN therapy, previous antiarrhythmic therapy should be withdrawn under careful monitoring for a minimum of three (3) plasma half-lives."	0
"If concomitant treatment of Savella with a triptan is clinically warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases."	0
Patients taking digoxin should be monitored appropriately when simvastatin is initiated.	0
Administration of doses ranging from five to ten times greater (on a mg/kg basis) than the daily recommended therapeutic dose has resulted in embryo and fetal lethality.	0
"The interaction with high dose fentanyl appears to be due to the combination of PROCARDIA and a beta blocker, but the possibility that it may occur with PROCARDIA alone, with low doses of fentanyl, in other surgical procedures, or with other narcotic analgesics cannot be ruled out."	0
"By pharmacokinetic mechanisms that are not well understood, quinidine levels are increased by coadministration of amiodarone or cimetidine."	1
Some patients have required medical therapy in the emergency department.	0
These risk differences (drug-placebo difference in the number of cases of suicidality per 1000 patients treated) are provided in Table 1.	0
"If alternative treatments cannot be used, consider a dose reduction of the concomitant CYP2D6 substrate drug."	1
The mechanism of mood elevation by tricyclic antidepressants is at present unknown.	0
Antipsychotics: See WARNINGS AND PRECAUTIONS (5.2).	0
"Labor and Delivery: In obstetrics, if vasopressor drugs are used to correct hypotension or are added to a local anesthetic solution the interaction with some oxytocic drugs may cause severe hypertension."	0
"Although a weaker enzyme inducer than rifampin, rifabutin may be expected to have some effect on those drugs as well."	0
Approximately 70% of the administered dose is eliminated in the urine.	0
"On the final day of sertraline 200 mg/day, the 6 to 12 year old group exhibited a mean sertraline AUC (0 to 24 hr) of 3107 ng-hr/mL, mean Cmax of 165 ng/mL, and mean half-life of 26.2 hr."	0
The effects of quinapril on long-term mortality in heart failure have not been evaluated.	0
Loxapine exposure in the first 2 hours after administration (AUC0-2h) was 66.7 ng<U+2022>h/mL for the 10 mg dose.	0
The N1-hydroxyethyl-flurazepam was measurable only during the early hours after a 30 mg dose and was not detectable after 24 hours.	0
The effects of age upon the metabolism of fluoxetine have been investigated in 260elderly but otherwise healthy depressed patients (<U+2265>60years of age) who received 20mg fluoxetine for 6weeks.	0
Excessive hypotension is rare in patients with uncomplicated hypertension treated with ACCUPRIL alone.	0
Reduce the starting dose to 200 mg in patients with moderate to severe renal impairment and monitor QT interval frequently.	0
"When co-administration is required, the daily dose of ketoconazole or itraconazole should not exceed 200 mg with monitoring for increased antifungal adverse events. voriconazole <U+2193> voriconazole(not studied) Voriconazole is not recommended for patients receiving PREZISTA/ritonavir unless an assessment comparing predicted benefit to risk ratio justifies the use of voriconazole."	0
.	0
"In patients with AFIB and sinus node dysfunction, sotalol increases the risk of Torsade de Pointes, especially after cardioversion."	0
Long-term maintenance effects of paroxetine in panic disorder were demonstrated in an extension to Study 1.	0
Combined P-gp and strong CYP3A4 inducers decrease exposure to rivaroxaban and may increase the risk of thromboembolic events .	0
The concomitant use of LUVOX CR Capsules with MAOIs intended to treat psychiatric disorders is contraindicated.	0
"Therefore, an increase or decrease in the metabolism of CYP3A substrates (e.g., oral contraceptives and other steroidal agents) resulting from induction or inhibition is not anticipated, although clinical studies have not been performed."	0
"As individual monotherapy, quinapril is an effective treatment of hypertension in once-daily doses of 10 to 80 mg and hydrochlorothiazide is effective in doses of 12.5 to 50 mg."	0
"Increased AST/ALT monitoring should be considered in patients with underlying chronic hepatitis, cirrhosis, or in patients who have pre-treatment elevations of transaminases, especially during the first several months of PREZISTA/ritonavir treatment."	0
"Pediatric use information for patients ages 7 to 17 years is approved for Eli Lilly and Company, Inc.'s CYMBALTA <U+00AE> (duloxetine) delayed-release capsules."	0
Potential additive effects when used in combination with CNS depressants or sedating antihistamines.	0
"Renal Impairment: With perindopril doses of 2 mg to 4 mg, perindoprilat AUC increases with decreasing renal function."	0
"Second, co-administration of known enzyme inducers (e.g., carbamazepine, phenytoin, rifampin, and phenobarbital) with risperidone may cause a decrease in the combined plasma concentrations of risperidone and 9-hydroxyrisperidone."	1
"Conversely, 5% of patients receiving Anafranil and 1% receiving placebo had weight losses of at least 7% of their initial body weight."	0
"When treatment was maintained beyond 3months, worsening heart failure was reported less frequently in subjects treated with carvedilol than with placebo."	0
A causal relationship between protease inhibitors and these events has not been established.	0
A starting dose not exceeding 8.5 mg daily is recommended in these patient groups.	0
Benazepril and benazeprilat inhibit angiotensin-converting enzyme (ACE) in human subjects and animals.	0
"Diethylpropion hydrochloride controlled-release: One controlled-release 75 mg tablet daily, swallowed whole, in midmorning."	0
"In some cases, diabetic ketoacidosis has occurred."	0
"Triamterene and hydrochlorothiazide is contraindicated in patients with anuria, acute and chronic renal insufficiency or significant renal impairment."	0
The response was maintained during continuation of therapy.	0
Atorvastatin: Atorvastatin is extensively metabolized to ortho- and parahydroxylated derivatives and various beta-oxidation products.	0
"Specific Populations Renal Impairment: In patients with moderate to severe renal impairment (CLCr 10 to 40 mL/min), AUC and Cmax increased approximately 1.2 fold after administration of a single dose of 40 mg fluvastatin compared to healthy volunteers."	0
"In patients taking the HIV protease inhibitor lopinavir plus ritonavir, caution should be used when prescribing LIPITOR and the lowest dose necessary should be used."	1
Elimination of mirtazapine is correlated with creatinine clearance.	0
The mean systemic exposure (AUC) was approximately 13% higher in male volunteers compared to female volunteers.	0
No clinical drug interaction studies were conducted.	0
"Elevations of serum potassium have been observed in some patients treated with ACE inhibitors, including ACEON."	0
"For co-administration of clarithromycin and PREZISTA/ritonavir in patients with renal impairment, the following dose adjustments should be considered: For subjects with CLcr of 30<U+2013>60 mL/min, the dose of clarithromycin should be reduced by 50%."	1
For all other indications ACIPHEX delayed-release tablets can be taken with or without food.	0
Loss of therapeutic effect of NORVIR and possible development of resistance.	0
<U+2022> Concomitant lipid-lowering therapies: use with fibrates or lipid-modifying doses (<U+2265> 1 g/day) of niacin increases the risk of adverse skeletal muscle effects.	0
These patients should be carefully monitored for abnormal prolongation of the PR interval or other signs of overdosage.	0
The drug-placebo differences in the number of cases of suicidal thoughts and behaviors per 1000 patients treated are provided in Table 2.	0
"Anticoagulants Ten patients who were stabilized on oral anticoagulants were given guanfacine, 1 - 2 mg/day, for 4 weeks."	0
Potential for Other Drugs to Affect CYMBALTA CYP1A2 Inhibitors <U+2014> Co-administration of CYMBALTA with potent CYP1A2 inhibitors should be avoided.	0
Plasma concentrations of total radioactivity (lovastatin plus 14C<U+2011>metabolites) peaked at 2hours and declined rapidly to about 10% of peak by 24hours postdose.	0
Bleeding and/or increased prothrombin times have been reported in patients taking coumarin anticoagulants concomitantly with other HMG-CoA reductase inhibitors.	0
Caution is advisable in using paroxetine in patients with diseases or conditions that could affect metabolism or hemodynamic responses.	0
"During clinical studies, NATRECOR<U+00AE> was administered concomitantly with other medications, including: diuretics, digoxin, oral ACE inhibitors, anticoagulants, oral nitrates, statins, class III antiarrhythmic agents, beta-blockers, dobutamine, calcium channel blockers, angiotensin II receptor antagonists, and dopamine."	0
"Lidocaine Hydrochloride Injection, USP should be used with caution in patients with digitalis toxicity accompanied by atrioventricular block."	0
"In a clinical study of 15 male subjects (ages 19 to 35 years) who were extensive metabolizers of CYP2D6, bupropion given as 150 mg twice daily followed by a single dose of 50 mg desipramine increased the Cmax, AUC, and T1/2 of desipramine by an average of approximately 2-, 5-, and 2-fold, respectively."	1
Positive test results were also obtained in the Aspergillus nidulans nondisjunction assay using an unspecified concentration of hydrochlorothiazide.	0
"For the combined amino-alcohol isomers threohydrobupropion and erythrohydrobupropion, the mean Cmax was approximately 31% lower."	0
Figure 3 Figure 3 Prasugrel is a prodrug and is rapidly metabolized to a pharmacologically active metabolite and inactive metabolites.	0
"Herbal Supplements: St. John<U+2019>s wort (Hypericum perforatum) <U+2193> ledipasvir<U+2193> sofosbuvir<U+2193> GS-331007 Coadministration of HARVONI with St. John<U+2019>s wort, a P-gp inducer is not recommended."	0
A gradual reduction in the dose rather than abrupt cessation is recommended whenever possible.	0
"Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death."	0
"Use with caution in persons who will be exposed to extreme heat, organophosphorus insecticides and in persons receiving atropine or related drugs."	0
Silenor is contraindicated in individuals with untreated narrow angle glaucoma or severe urinary retention.	0
<U+2022>The concomitant use of LEXIVA with ritonavir and certain other drugs may result in known or potentially significant drug interactions.	0
"Fourteen tyramine challenge studies including 214 healthy subjects (age range 18 to 65; 31 subjects greater than 50 years of age) were conducted to determine the pressor effects of oral tyramine with concurrent EMSAM treatment (6mg per 24 hours to 12mg per 24 hours), measured as the dose of tyramine required to raise systolic blood pressure by 30mmHg (TYR30)."	0
"However, in clinical trials with bicalutamide as a single agent for prostate cancer, rises in serum testosterone and estradiol have been noted."	0
INVIRASE when administered with ritonavir is contraindicated in patients with severe hepatic impairment.	0
"Studies of binding of zaleplon to recombinant GABAA receptors (<U+03B1>1<U+03B2>1<U+03B3>2 [omega-1] and <U+03B1>2<U+03B2>1<U+03B3>2 [omega-2]) have shown that zaleplon has a low affinity for these receptors, with preferential binding to the omega-1 receptor."	0
Reduction of the dose of MYCOBUTIN may also be needed for patients receiving concomitant treatment with certain other drugs.	0
"Healthcare providers should temporarily stop PROTONIX treatment at least 14 days before assessing CgA levels and consider repeating the test if initial CgA levels are high. for monitoring), the same commercial laboratory should be used for testing, as reference ranges between tests may vary."	0
Dosage adjustment is recommended in renally impaired patients.	0
Triptans There have been rare postmarketing reports of serotonin syndrome with the use of an SSRI and a triptan.	0
"TWYNSTA tablets are contraindicated in patients with known hypersensitivity (e.g., anaphylaxis or angioedema) to telmisartan, amlodipine, or any other component of this product."	0
"In Clinical Trials In a pooled analysis of subjects who received HARVONI in Phase 3 trials, 37 subjects (29 with genotype 1a and 8 with genotype 1b) qualified for resistance analysis due to virologic failure (35 with virologic relapse, 2 with breakthrough on-treatment due to documented non-adherence)."	0
Appropriate management of maternal hypertension during pregnancy is important to optimize outcomes for both mother and fetus.	0
"In clinical experience with 4,954 patients, 87(1.8%) developed congestive heart failure or pulmonary edema."	0
"CAPRELSA is not recommended for use in patients with moderate and severe hepatic impairment, as safety and efficacy have not been established."	0
"The risk differences (drug vs placebo), however, were relatively stable within age strata and across indications."	0
PREZISTA/ritonavir in pediatric patients below 3 years of age is not recommended in view of toxicity and mortality observed in juvenile rats dosed with darunavir (from 20 mg/kg to 1000 mg/kg) up to days 23 to 26 of age.	0
"In a study in which normal male subjects (n = 15) received 30 mg tablets daily for 30 days, steady-state paroxetine concentrations were achieved by approximately 10 days for most subjects, although it may take substantially longer in an occasional patient."	0
"Patients, including children, should avoid exposure to direct sunlight during VFEND treatment and should use measures such as protective clothing and sunscreen with high sun protection factor (SPF)."	0
Co-administration of SAMSCA with moderate CYP3A inhibitors should therefore generally be avoided see Dosage and Administration ( 2.3 ) and Warnings and Precautions ( 5.5 ) .	0
Atorvastatin (Hyperlipidemia) Hyperlipidemia and Mixed Dyslipidemia: The recommended starting dose of atorvastatin is 10 or 20 mg once daily.	0
It is 83% bound to plasma proteins at therapeutic concentrations.	0
Caution should be exercised when administering maprotiline to hyperthyroid patients or those on thyroid medication because of the possibility of enhanced potential for cardiovascular toxicity of maprotiline.	0
"Maximum plasma concentrations at steady state occurred within 3 to 8 hours of dosing and reached concentrations averaging 88, 283 and 546 ng/mL, respectively."	0
Acute studies with clonidine hydrochloride in humans have demonstrated a moderate reduction (15% to 20%) of cardiac output in the supine position with no change in the peripheral resistance: at a 45<U+00B0> tilt there is a smaller reduction in cardiac output and a decrease of peripheral resistance.	0
"Patients suspected of developing thyrotoxicosis should be managed carefully to avoid abrupt withdrawal of beta<U+2014>blockade, which might precipitate a thyroid storm."	0
Follow patients for signs and symptoms of respiratory depression and sedation.	0
The majority of reported cases have occurred in patients with Crohn's disease or ulcerative colitis and the majority were in adolescent and young adult males.	0
"Since the modified release characteristics of Focalin XR are pH dependent, the coadministration of antacids or acid suppressants could alter the release of dexmethylphenidate."	0
"No dose adjustment for EMSAM is needed when EMSAM is used concomitantly with alcohol, alprazolam, ibuprofen, olanzapine, risperidone, levothyroxine, and CYP3A4 inhibitors (e.g., ketoconazole)."	0
"Drugs Tightly Bound to Plasma Proteins <U+2014> Because fluoxetine is tightly bound to plasma proteins, the administration of fluoxetine to a patient taking another drug that is tightly bound to protein (e.g., Coumadin, digitoxin) may cause a shift in plasma concentrations potentially resulting in an adverse effect."	0
Calculation of the creatinine clearance for all patients must precede administration of the first dose of dofetilide.	0
"Secondary pathways involve oxidation, N-acetylation and sulfate conjugation."	0
"Since the Class III potency in children is not very different from that in adults, reaching plasma concentrations that occur within the adult dose range is an appropriate guide."	0
"Additionally, difficulty in restarting and maintaining the heartbeat has been reported with <U+03B2>-blockers."	0
Monoamine Oxidase Inhibitors (MAOIs)	0
"The pharmacokinetics of trandolapril and trandolaprilat are not altered when trandolapril is administered in combination with verapamil, compared to monotherapy."	0
Safety and effectiveness in the pediatric population have not been established.	0
"IMURAN is usually given as a single daily dose on the day of, and in a minority of cases 1 to 3days before, transplantation."	0
Inducers of CYP1A2 <U+2014> Carbamazepine therapy (200mgbid) causes an approximately 50% increase in the clearance of olanzapine.	1
"If a hypertensive crisis occurs, Marplan should be discontinued, and therapy to lower blood pressure should be instituted immediately."	0
"Serum protein binding of trandolapril is about 80%, and is independent of concentration."	0
Impact of amlodipine on other drugs Amlodipine is a weak inhibitor of CYP3A and may increase exposure to CYP3A substrates.	1
"Antiviral Activity In HCV replicon assays, the EC50 values of ledipasvir against full-length replicons from genotypes 1a and 1b were 0.031 nM and 0.004 nM, respectively."	0
Satisfactory control can be achieved in most patients by 200 to 300 mg given every eight hours with food or antacid.	0
"Table 8 Drug Interactions: Changes in Pharmacokinetic Parameters for Coadministered Drug in the Presence of Ledipasvir, Sofosbuvir, or HARVONIAll interaction studies conducted in healthy volunteers."	0
"If it is not possible to discontinue the diuretic, the starting dose of TARKA should be reduced."	0
Twoadult atomoxetine subjects and no placebo subjects discontinued from controlled clinical trials because of urinary retention.	0
Warfarin - A significant prolongation of the bleeding time was observed when prasugrel was coadministered with 15-mg of warfarin.	0
NORVIR oral solution contains the excipients ethanol (approx.	0
Inhibitors of CYP3A cause increased exposure.	1
Acceleration of ventricular rate and/or ventricular fibrillation has been reported in patients with atrial flutter or atrial fibrillation and a coexisting accessory AV pathway following administration of verapamil.	0
"Histamine H2-receptor antagonists: Cimetidine, famotidine, nizatidine, ranitidinea LEXIVA: <U+2193>Amprenavir LEXIVA/ritonavir: Interaction not evaluated Use with caution."	0
Lower doses than usually prescribed for either the antipsychotic or the other drug may be required.	0
"If the dose of simvastatin is changed or discontinued, the same procedure should be repeated."	0
"When meperidine hydrochloride is given parenterally, especially intravenously, the patient should be lying down."	0
Additional fluids should be consumed if there is excessive sweating or intestinal fluid loss.	0
"AGGRENOX increases the risk of bleeding (5.1) Avoid use in patients with severe hepatic or renal insufficiency (5.2, 5.3) Can cause fetal harm when administered to a pregnant woman, especially in the third trimester (5.4) AGGRENOX increases the risk of bleeding."	0
"IN PATIENTS WITHOUT A HISTORY OF CARDIAC FAILURE, continued depression of the myocardium with beta-blocking agents over a period of time can, in some cases, lead to cardiac failure."	0
"Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of other drugs that raise serum potassium levels."	0
"However, the effects of zaleplon on inhibition of enzymes involved in the metabolism of other drugs have not been studied."	0
"If treatment with such a medicinal product is discontinued, it may be necessary to reduce the mirtazapine dose."	0
"Compared to normal subjects, patients with creatinine clearance <40 mL/min/1.73 m2 had higher peak and trough ramiprilat levels and slightly longer times to peak concentrations."	0
"In a dedicated drug interaction trial, co-administration of rifampin, a strong CYP3A4 inducer, decreased exposure of abiraterone by 55%."	1
This risk is expected to increase with fluoxetine-induced inhibition of thioridazine metabolism.	1
Shake the container for at least 1 minute and allow the suspension to stand for at least 1 minute.	0
Focalin XR is for oral administration once daily in the morning.	0
"The two main circulating metabolites of abiraterone in human plasma are abiraterone sulphate (inactive) and N-oxide abiraterone sulphate (inactive), which account for about 43% of exposure each."	0
"In a similarly designed trial, the Monitored Atherosclerosis Regression Study (MARS), patients were treated with diet and either lovastatin 80mg daily or placebo."	0
"Geriatric <U+2014> In a study involving 24 healthy subjects, the mean elimination half-life of olanzapine was about 1.5 times greater in elderly (<U+2265>65 years) than in nonelderly subjects (<65 years)."	0
"In healthy subjects with CYP2D6 extensive metabolizer phenotype, coadministration of quinidine 100 mg and immediate release metoprolol 200 mg tripled the concentration of S<U+2014>metoprolol and doubled the metoprolol elimination half<U+2014>life."	1
For Control of Hypertension: The adult initial dose of MICROZIDE is one capsule given once daily whether given alone or in combination with other antihypertensives.	0
Advise patients of potential risk to a fetus and to use effective contraception.	0
"Serum creatinine levels should be closely monitored in these patients, and if increases occur, consideration should be given to changing to oral voriconazole therapy."	0
Consult the full prescribing information prior to and during treatment for potential drug interactions.	0
Patients with Wolff-Parkinson-White syndrome who develop atrial fibrillation are at high risk of ventricular fibrillation.	0
Women who discontinued antidepressant medication during pregnancy showed a significant increase in relapse of their major depression compared to those women who remained on antidepressant medication throughout pregnancy.	0
"During the initial phase of combination antiretroviral treatment, patients whose immune systems respond may develop an inflammatory response to indolent or residual opportunistic infections (such as Mycobacterium avium infection, cytomegalovirus, Pneumocystis jirovecii pneumonia [PCP], or tuberculosis), which may necessitate further evaluation and treatment."	0
"Antialcoholics:disulfiram/ metronidazole Ritonavir formulations contain ethanol, which can produce disulfiram-like reactions when co-administered with disulfiram or other drugs that produce this reaction (e.g.,metronidazole)."	0
Concomitant use increases the risk of bradycardia.	0
Patients receiving PRISTIQ should have regular monitoring of blood pressure since increases in blood pressure were observed in clinical studies.	0
"Ledipasvir is an inhibitor of transporters OATP1B1, OATP1B3, and BSEP only at concentrations exceeding those achieved in clinic."	0
"After a single dose, the glucuronide represents approximately 11% of the measured radioactivity in plasma."	0
The main route of excretion is the kidney.	0
"In these studies, paroxetine was shown to be significantly more effective than placebo in treating panic disorder by at least 2 out of 3 measures of panic attack frequency and on the Clinical Global Impression Severity of Illness score."	0
This reduction in clearance is variable and was not consistent with an increase in half-life.	0
"Monitor blood glucose and adjust insulin, if needed."	0
Acute renal failure has been observed in patients undergoing treatment with VFEND.	0
Consult the full prescribing information prior to and during treatment for potential drug interactions.	0
Experience in the use of sotalol to treat ventricular arrhythmias in the early phase of recovery from acute MI is limited.	0
Ledipasvir is an inhibitor of drug transporter P-gp and breast cancer resistance protein (BCRP) and may increase intestinal absorption of coadministered substrates for these transporters.	1
"If it is necessary to continue the diuretic, provide close medical supervision after the initial dose for at least two hours and until blood pressure has stabilized for at least an additional hour (see WARNINGS and DOSAGE AND ADMINISTRATION )."	0
"Families and caregivers of patients should be advised to look for the emergence of such symptoms on a day-to-day basis, since changes may be abrupt."	0
"Following administration of 40 mg of LATUDA, the mean (%CV) apparent clearance was 3902 (18.0) mL/min."	0
"A transient hypotensive response is not a contraindication to further treatment, which usually can be continued without difficulty once the blood pressure has stabilized."	0
"Thus, fluvoxamine had nonlinear pharmacokinetics over this dose range, i.e., higher doses of fluvoxamine maleate produced disproportionately higher concentrations than predicted from the lower dose."	0
EXTRANEAL is an isosmotic peritoneal dialysis solution containing glucose polymers (icodextrin) as the primary osmotic agent.	0
The decision to inform patients and/or their guardians must obviously take into account the clinical circumstances and the competency of the patient to understand the information provided.	0
"The efficacy of paroxetine in the treatment of major depressive disorder, obsessive compulsive disorder (OCD), panic disorder (PD), and generalized anxiety disorder (GAD) is presumed to be linked to potentiation of serotonergic activity in the central nervous system resulting from inhibition of neuronal reuptake of serotonin (5-hydroxy-tryptamine, 5-HT)."	0
Dextrose injected parenterally undergoes oxidation to carbon dioxide and water.	0
The pharmacokinetics of metoprolol were similar to those described previously in adults.	0
"Non-steroidal Anti-inflammatory Drugs<U+2014>the diuretic, natriuretic, and antihypertensive effects of thiazide diuretics may be reduced by concurrent administration of nonsteroidal anti-inflammatory agents."	0
Monitor hepatic laboratory tests prior to therapy and during treatment.	0
Dephosphorylation results in the formation of nucleoside metabolite GS-331007 that cannot be efficiently rephosphorylated and lacks anti-HCV activity in vitro.	0
"Fluoxetine and other SSRIs should therefore not be used in combination with Marplan, or within 14 days of discontinuing therapy with Marplan."	0
Plasma concentrations may not necessarily be predictive of clinical response.	0
"After at least one week following the initiation of PREZISTA/ritonavir, resume tadalafil at 20 mg once daily."	0
"Both of these situations have resulted in unrecognized hypoglycemia, which has led to loss of consciousness, coma, permanent neurological damage, and death."	0
Digoxin can potentiate the electrophysiologic effects of dronedarone (such as decreased AV-node conduction).	0
Peak serum concentrations in healthy adults and pediatric populations vary widely from individual to individual.	0
Marplan should not be administered in combination with any SSRI.	0
At least 14 days should elapse between discontinuation of an MAOI intended to treatpsychiatric disorders and initiation of therapy with Anafranil.	0
Combined administration of racemic citalopram (40 mg/day for 21 days) and the CYP1A2 substrate theophylline (single dose of 300 mg) did not affect the pharmacokinetics of theophylline.	0
Patients receiving both drugs must be monitored carefully.	0
"In industrial workers who have had long-term exposure to unknown (presumably high) doses of organic nitrates, tolerance clearly occurs."	0
"Since quetiapine is extensively metabolized by the liver, higher plasma levels are expected in the hepatically impaired population, and dosage adjustment may be needed."	0
"Steady-state conditions for carbamazepine, nefazodone, and several of their metabolites were achieved by day 5 of coadministration."	0
"In the unusual case that there is no appropriate alternative to therapy with drugs affecting the renin-angiotensin system for a particular patient, apprise the mother of the potential risk to the fetus."	0
"The possibility of a suicidal attempt by a depressed patient remains after the initiation of treatment; in this regard, it is important that the least possible quantity of drug be dispensed at any given time."	0
"Discontinuation: May result in symptoms, including dizziness, headache, nausea, diarrhea, paresthesia, irritability, vomiting, insomnia, anxiety, hyperhidrosis, and fatigue (5.7) Activation of mania or hypomania has occurred (5.8) Angle-Closure Glaucoma: Angle-closure glaucoma has occurred in patients with untreated anatomically narrow angles treated with antidepressants."	0
"Disulfiram/Metronidazole Combination with TPV/ritonavir not studied APTIVUS capsules contain alcohol that can produce disulfiram-like reactions when co-administered with disulfiram or other drugs which produce this reaction (e.g., metronidazole)."	0
"If signs and symptoms of tardive dyskinesia appear in a patient on antipsychotics, drug discontinuation should be considered."	0
Animal reproduction studies have yielded inconclusive results.	0
"If concomitant therapy is necessary, the patient should be observed for symptoms of myopathy and rhabdomyolysis and creatinine kinase should be monitored."	0
"Metoprolol has no intrinsic sympathomimetic activity, and membrane-stabilizing activity is detectable only at plasma concentrations much greater than required for beta-blockade."	0
Exchange transfusions or dialysis may be required as a means of reversing hypotension and/or substituting for disordered renal function.	0
Other studies in patients have provided evidence of a reduction in plasma renin activity and in the excretion of aldosterone and catecholamines.	0
Intravenous infusion of iloprost had no effect on the pharmacokinetics of digoxin.	0
Chlorpromazine may lower the convulsive threshold; dosage adjustments of anticonvulsants may be necessary.	0
"(A) PREMATURE DISCONTINUATION OF ELIQUIS INCREASES THE RISK OF THROMBOTIC EVENTS: Premature discontinuation of any oral anticoagulant, including ELIQUIS, increases the risk of thrombotic events."	0
This is due to lack of specificity of the screening tests.	0
"Particular caution should be used when prescribing sildenafil, tadalafil, or vardenafil in patients receiving indinavir."	0
A single tonic convulsion was seen in each of 2 male dogs (one treated at 10 mg/kg/day and one at 120 mg/kg/day) in a 2-year study.	0
Additional clinical experience may reveal other drugs affected by the concomitant administration of cimetidine.	0
"Treatment with Anafranil should be initiated at a dosage of 25 mg daily and gradually increased, as tolerated, to approximately 100 mg during the first 2 weeks."	0
"If the original regimen was 0.6 mg once a day, the regimen should be adjusted to 0.3 mg once every other day."	0
Combination therapy with cyclophosphamide and fluconazole results in an increase in serum bilirubin and serum creatinine.	0
"Hallucinations, as well as behavioral changes such as bizarre behavior, agitation and mania have been reported with ROZEREM use."	0
Pediatrics: The pharmacokinetic profile of TOPROL-XL was studied in 120 pediatric hypertensive patients (6-17 years of age) receiving doses ranging from 12.5 to 200 mg once daily.	0
"Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan."	1
"Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary)."	0
The usual adult dose is 100 to 200 mg per day.	0
Geriatric The pharmacokinetics of olmesartan were studied in the elderly (<U+2265>65 years).	0
"In such cases, therefore, more frequent dosing may be required to achieve or maintain the desired hypotensive response."	0
"Rifampin and Other CYP 3A Inducers Avoid rifampin or other CYP 3A inducers such as phenobarbital, carbamazepine, phenytoin, and St. John's wort because they decrease exposure to dronedarone significantly."	1
Chronic hypercalcemia may lead to vascular calcification and other soft-tissue calcification.	0
Active pulmonary tuberculosis: PRIFTIN should be used in regimens consisting of an initial 2 month phase followed by a 4 month continuation phase.	0
The bioavailability of NORVASC is not altered by the presence of food.	0
Beta-blockers should be withdrawn only after a gradual reduction in dose.	0
"During post-marketing surveillance, there have been rare cases of QT prolongation and torsade de pointes in patients taking fluconazole."	0
"Seizures: During premarketing testing, seizures occurred in 0.1% of paroxetine-treated patients, a rate similar to that associated with other drugs effective in the treatment of MDD."	0
The recommended dose of ELIQUIS is 2.5 mg twice daily in patients with at least two of the following characteristics: age greater than or equal to 80 years body weight less than or equal to 60 kg serum creatinine greater than or equal to 1.5 mg/dL The recommended dose of ELIQUIS is 2.5 mg taken orally twice daily.	0
"Based on drug interaction studies conducted with the components of HARVONI (ledipasvir or sofosbuvir) or HARVONI, no clinically significant drug interactions have been either observed or are expected when HARVONI is used with the following drugs individually : abacavir, atazanavir/ritonavir, cyclosporine, darunavir/ritonavir, efavirenz, emtricitabine, lamivudine, methadone, oral contraceptives, pravastatin, raltegravir, rilpivirine, tacrolimus, tenofovir disoproxil fumarate, or verapamil."	0
"No pharmacodynamic interactions were observed with aspirin, clopidogrel, or prasugrel."	0
Nefazodone has been shown in vitro to be an inhibitor of CYP3A4.	0
"Atorvastatin The risk of myopathy during treatment with statins is increased with concurrent administration of fibric acid derivatives, lipid-modifying doses of niacin, cyclosporine, or strong CYP3A4 inhibitors (e.g., clarithromycin, HIV protease inhibitors, and itraconazole)."	0
The amount of triamterene added to 50 mg of hydrochlorothiazide in triamterene and hydrochlorothiazide 75 mg/50 mg tablets was determined from steady-state dose-response evaluations in which various doses of liquid preparations of triamterene were administered to hypertensive persons who developed hypokalemia with hydrochlorothiazide (50 mg given once daily).	0
"In healthy volunteers who were extensive metabolizers of CYP2D6, paroxetine 20 mg daily was given in combination with 20 mg atomoxetine every 12 hours."	0
"Demographic Effects : There were no clinically significant differences in loxapine pharmacokinetics following administration of ADASUVE in subgroups based on age, weight, body mass index, gender, or race."	0
The TRISENOX vial is single-dose and does not contain any preservatives.	0
There are no adequate and well-controlled studies in pregnant women.	0
Prophylaxis of Deep Vein Thrombosis and Pulmonary Embolism Following Hip Replacement Surgery Avoid use of PRADAXA and concomitant P-gp inhibitors in patients with CrCl <50 mL/min.	0
MAXALT treatment should be discontinued if serotonin syndrome is suspected.	0
Patients should be warned against interruption or discontinuation of therapy without the physician's advice.	0
"While early pain relief with either 800 mg at bedtime or 1600 mg at bedtime is equivalent in all patients, 1600 mg at bedtime provides an appropriate alternative when it is important to ensure healing within 4 weeks for this subpopulation."	0
Monitor serum lithium levels during concurrent use.	0
A gradual withdrawal is recommended in any case.	0
Approximately 45% of desvenlafaxine is excreted unchanged in urine at 72 hours after oral administration.	0
It is recommended that patients being placed on peritoneal dialysis should be appropriately trained in a program that is under supervision of a physician.	0
"Because of the pharmacologic similarity of maprotiline hydrochloride to the tricyclic antidepressants, the plasma concentration of maprotiline may be increased when the drug is given concomitantly with hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by concomitant administration with hepatic enzyme inducers (e.g., barbiturates, phenytoin), as has occurred with tricyclic antidepressants."	1
Thiazides may decrease urinary calcium excretion.	0
Discontinuation of Lexapro should be considered in patients with symptomatic hyponatremia and appropriate medical intervention should be instituted.	0
Increase subsequent IM doses gradually over several days<U+2013>up to 400 mg q4-6h in exceptionally severe cases<U+2013>until patient is controlled.	0
"Intervention Initiate with lower doses and monitor patients for signs and symptoms of serotonin syndrome, particularly during VYVANSE initiation or dosage increase."	0
The usual regimens of therapy with DUTOPROL may be followed in patients with mild hepatic impairment.	0
Racemic citalopram did not alter the mean AUC or Cmax of pimozide.	0
"Patients should avoid engaging in hazardous activities, such as operating a motor vehicle or heavy machinery, at night after taking Silenor, and should be cautioned about potential impairment in the performance of such activities that may occur the day following ingestion."	0
Caution is indicated in administering REMERON to patients with compromised hepatic function.	0
<U+2022>Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.	0
"Because olmesartan medoxomil does not inhibit ACE (kininase II), it does not affect the response to bradykinin."	0
"It can rarely be determined with certainty whether a particular instance of the abnormal behaviors listed above is drug induced, spontaneous in origin, or a result of an underlying psychiatric or physical disorder."	0
"If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be informed of the potential hazard to the fetus."	0
Ranitidine 150 mg twice daily did not interact significantly with nisoldipine (AUC was decreased by 15 - 20%).	1
Dosage and frequency of administration should be adjusted according to the severity of the symptoms and response of the patient.	0
"Administer atropine, if not contraindicated, for early diarrhea of any severity."	0
"Irbesartan is a specific competitive antagonist of AT1 receptors with a much greater affinity (more than 8500-fold) for the AT1 receptor than for the AT2 receptor, and no agonist activity."	0
"Pressor amines (e.g., norepinephrine)<U+2013>possible decreased response to pressor amines but not sufficient to preclude their use."	0
"Clinical manifestations of NMS are hyperpyrexia, muscle rigidity, altered mental status and evidence of autonomic instability (irregular pulse or blood pressure, tachycardia, diaphoresis and cardiac dysrhythmias)."	0
Screening Patients for Bipolar Disorder <U+2014> A major depressive episode may be the initial presentation of bipolar disorder.	0
"Episodes of dizziness or fluid retention during initiation of COREG can generally be managed without discontinuation of treatment and do not preclude subsequent successful titration of, or a favorable response to, carvedilol."	0
No unusual age-related adverse events were identified in this population.	0
ONIVYDE can cause severe or life-threatening neutropenia and fatal neutropenic sepsis.	0
Patients should be instructed to take rifampin either 1 hour before or 2 hours after a meal with a full glass of water.	0
There is no gender effect on the pharmacokinetics and pharmacodynamics (heart rate changes) of atropine.	0
"Pediatric Hypertensive Patients <U+2265> 6 Years of age: A pediatric clinical hypertension study in patients 6 to 16 years of age did not meet its primary endpoint (dose response for reduction in SBP); however, some other endpoints demonstrated effectiveness."	0
EMEND for oral suspension should be prepared by healthcare provider.	0
"IMNM is characterized by: proximal muscle weakness and elevated serum creatine kinase, which persist despite discontinuation of statin treatment; muscle biopsy showing necrotizing myopathy without significant inflammation; improvement with immunosuppressive agents."	0
"Ergot Derivatives Dihydroergotamine, ergotamine, methylergonovine Potential for serious and/or life threatening reactions such as ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues."	0
Increases in the concentration of midazolam are expected to be significantly higher with oral than parenteral administration.	0
Approximately 7% of the normal population has a genetic code that leads to reduced levels of activity of CYP2D6 enzyme.	0
"Because GDH-PQQ, GDO, and GDH-FAD-based blood glucose monitors may be used in hospital settings, it is important that the health care providers of all peritoneal dialysis patients using EXTRANEAL (icodextrin) carefully review the product information of the blood glucose testing system, including that of test strips, to determine if the system is appropriate for use with EXTRANEAL (icodextrin)."	0
"The magnitude of the effect on renal elimination by cimetidine, trimethoprim, and ketoconazole (all contraindicated concomitant uses with dofetilide) suggests that all renal cation transport inhibitors should be contraindicated."	0
"However, patients subject to spontaneous hypoglycemia, or diabetic patients receiving insulin or oral hypoglycemic agents, should be cautioned about these possibilities."	0
Although the results of a clinical study did not indicate a safety problem associated with the administration of D.H.E.	0
"Even in the absence of overt angina pectoris, when discontinuation of TENORETIC is planned, the patient should be carefully observed and should be advised to limit physical activity to a minimum."	0
"Likewise, they should inform their physicians and their dentist about the use of Marplan."	0
"(7.1) Coadministration of antiplatelet agents, thrombolytics, heparin, aspirin, and chronic NSAID use increases the risk of bleeding."	0
"Cmax and AUC are approximately 16-fold and 11-fold increased, respectively, in patients with Childs-Pugh B disease."	0
Cholestyramine and colestipol resins <U+2013> Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.	1
"Thereafter, the dosage may be increased gradually over the next several weeks up to a daily maximum of 3 mg/kg or 200 mg, whichever is smaller."	0
"In clinical trials, COREG caused bradycardia in about 2% of hypertensive subjects, 9% of subjects with heart failure, and 6.5% of subjects with myocardial infarction and left ventricular dysfunction."	0
The clinical significance of this change is unknown.	0
"The use of the P-gp inhibitors verapamil, amiodarone, quinidine, clarithromycin, and ticagrelor does not require a dose adjustment of PRADAXA."	0
"Most patients have required dosages of 20, 40, or 80 mg/day, given as a single dose or in two equally divided doses."	0
"Whether the increased risk observed was due to Parkinson's disease or other factors, such as drugs used to treat Parkinson's disease, is unclear."	0
"Hepatic injury can occur with any dosage, but seems to occur with greater frequency when the recommended dosage is exceeded."	0
The potential benefits should clearly outweigh possible hazards.	0
The ability of potassium citrate extended-release tablets to increase urinary citrate may be attenuated by bacterial enzymatic degradation of citrate.	0
"If possible, Effient should be discontinued at least 7days prior to CABG."	0
Diuretics: Possibility of excessive hypotension (7.1).	0
"Therefore, monitor digoxin levels when initiating, adjusting, and discontinuing telmisartan for the purpose of keeping the digoxin level within the therapeutic range."	0
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.	0
"Storage and Administration Limits for Reconstituted FLOLAN When Using STERILE DILUENT for FLOLAN When Using pH 12 STERILE DILUENT for FLOLAN Stability When used at room temperature, (15<U+00B0>C to 25<U+00B0>C; 59<U+00B0>F to 77<U+00B0>F) reconstituted solutions: are stable for up to 8 hours following reconstitution or removal from refrigerated storage."	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older.	0
Drug Interactions CNS-depressants Co-administration of zolpidem with other CNS depressants increases the risk of CNS depression.	0
"In the pooled analysis of the Phase 3 trials, 23% (370/1589) of subjects' virus had baseline NS5A polymorphisms at resistance-associated positions (any change from reference at NS5A amino acid positions 24, 28, 30, 31, 58, 92, or 93) identified by population or deep sequencing."	0
"In some cases, a patient already receiving Savella therapy may require urgent treatment with linezolid or intravenous methylene blue."	0
"As a result, certain antibiotics may increase the absorption of digoxin in such patients."	1
"Nevertheless, if a decision is made to increase the dose beyond 60mg once daily, increase dose in increments of 30mg once daily."	0
Taking the larger portion of the oral daily dose at bedtime may minimize transient adjustment effects of dry mouth and drowsiness.	0
"Although quinapril monotherapy is somewhat less effective in blacks than in non-blacks, the efficacy of combination therapy appears to be independent of race."	0
Erythromycin significantly increased pitavastatin exposure.	1
An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy.	0
"Approximately 73% and 20% of the dose was recovered in the urine and feces, respectively."	0
Bone marrow suppression may be increased when PURIXAN is combined with other drugs whose primary or secondary toxicity is myelosuppression.	0
"After single or multiple doses above 20 mg, fluvastatin exhibits saturable first-pass metabolism resulting in more than dose proportional plasma fluvastatin concentrations."	0
"The recommended starting dose for PRINIVIL, when used with diuretics and (usually) digitalis as adjunctive therapy is 5 mg once daily."	0
Use the dose necessary based on patient response once the need for combination product is established.	0
A causal relationship with PREZISTA/ritonavir therapy has not been established.	0
"Atorvastatin: Renal disease has no influence on the plasma concentrations or LDL-C reduction of atorvastatin; thus, dose adjustment of atorvastatin in patients with renal dysfunction is not necessary."	0
Consider discontinuing Zanaflex in patients who develop hallucinations.	0
Zaleplon was rapidly absorbed with a time to peak concentration (tmax) of approximately 1 hour and a terminal-phase elimination half-life (t1/2) of approximately 1 hour.	0
"Hypokalemia may develop, especially with brisk diuresis when severe cirrhosis is present, during concomitant use of corticosteroids or adrenocorticotropic hormone (ACTH) or after prolonged therapy."	0
Monitor heart rate in patients on amiodarone and concomitant drugs that slow heart rate.	0
"Other drugs that are relatively less potent inhibitors of CYP 3A4 should also be avoided, in view of the risks: e.g."	0
"Hepatotoxicity, defined by 1 or more of the following: Total bilirubin (TB) greater than 3 times the upper limit of normal (ULN) Aspartate aminotransferase (AST) greater than 5 times the ULN Alkaline phosphatase (AP) greater than 5 times the ULN Withhold treatment with TRISENOX and/or tretinoin."	0
"Administration of an antacid (aluminum hydroxide/magnesium hydroxide/simethicone) to healthy subjects, 2 hours before or 2 hours after a single 400 mg dose of Tasigna did not alter nilotinib pharmacokinetics."	0
"If such symptoms occur, consideration should be given to a possible causal role of the stimulant, and discontinuation of treatment may be appropriate."	0
"In patients with underlying hepatitis B or C, cirrhosis, chronic alcoholism and/or other underlying liver abnormalities there have been reports of worsening liver disease."	0
The systemic availability and half-life of metoprolol in patients with renal failure do not differ to a clinically significant degree from those in normal subjects.	0
"Appropriate supportive care has not been studied, but it seems reasonable to treat this as a nitrate overdose, with elevation of the extremities and with central volume expansion."	0
Prescribing recommendations for interacting agents are summarized in Table 2.	0
The risk of myopathy/rhabdomyolysis is increased with concomitant administration of cyclosporine.	0
"Due to an increased risk of myopathy/rhabdomyolysis when HMG-CoA reductase inhibitors are coadministered with gemfibrozil, concomitant administration of pravastatin sodium with gemfibrozil should be avoided."	0
Concomitant use of paroxetine with other drugs metabolized by cytochrome CYP2D6 has not been formally studied but may require lower doses than usually prescribed for either paroxetine or the other drug.	1
"Both isomers have similar Class III antiarrhythmic effects, while the l-isomer is responsible for virtually all of the beta-blocking activity."	0
CABG or other surgical procedure.	0
The effect of food on the pharmacokinetics of CARDURA was examined in a crossover study with twelve hypertensive subjects.	0
Patients on moderate CYP3A inhibitors that cannot be avoided should have their dose of eplerenone reduced.	1
Effects of Other Drugs on Sildenafil Pharmacokinetics Figure 8 Effects of Sildenafil on Other Drugs Figure 7 Figure 8 CYP3A Inhibitors and Beta Blockers Population pharmacokinetic analysis of data from patients in clinical trials indicated an approximately 30% reduction in sildenafil clearance when it was co-administered with mild/moderate CYP3A inhibitors and an approximately 34% reductions in sildenafil clearance when co-administered with beta-blockers.	1
"Withhold Tasigna, and perform an analysis of serum potassium and magnesium, and if below lower limit of normal, correct with supplements to within normal limits."	0
"Because of the potential for serious adverse reactions in nursing infants from chlorthalidone, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother."	0
ZOLOFT should be prescribed with caution in patients with a seizure disorder.	0
"The initial dose is usually 3 to 5mg/kg daily, beginning at the time of transplant."	0
"The multiple-dose pharmacokinetics of quetiapine are dose-proportional within the proposed clinical dose range, and quetiapine accumulation is predictable upon multiple dosing."	0
Discontinue DYAZIDE and substitute a thiazide diuretic alone until potassium levels return to normal.	0
There are no adequate and well-controlled studies in pregnant or breastfeeding women.	0
"The valsartan-atenolol combination was more antihypertensive than either component , but it did not lower the heart rate more than atenolol alone ."	0
"ACE is identical to kininase II, an enzyme that degrades bradykinin."	0
Consider the benefits and risks before neuraxial intervention in patients anticoagulated or to be anticoagulated.	0
"The geometric means of pravastatin Cma xand AUC following a 20 mg dose in the fasted state were 26.5 ng/mL and 59.8 ng*hr/mL, respectively."	0
"In post marketing experience there were cases reported of QT prolongation in patients who overdosed on quetiapine , in patients with concomitant illness, and in patients taking medicines known to cause electrolyte imbalance or increase QT interval."	0
Discontinuation: Reduce dose gradually whenever possible (2.1).	0
"Other Dosing Considerations <U+2022>When administered without ritonavir, the adult regimen of LEXIVA tablets 1,400mg twice daily may be used for pediatric patients weighing at least 47kg."	0
These effects would be expected to be additive to the anticoagulant effects of COUMADIN.	0
"In the placebo-controlled clinical trials of adults with fibromyalgia, among the patients who had a history of depression at treatment initiation, the incidence of suicidal ideation was 0.5% in patients treated with placebo, 0% in patients treated with Savella 100 mg/day, and 1.3% in patients treated with Savella 200 mg/day."	0
"These can include but are not limited to severe rash or rash accompanied with fever, general malaise, fatigue, muscle or joint aches, blisters, oral lesions, conjunctivitis, hepatitis and/or eosinophilia."	0
"If the angina worsens or acute coronary insufficiency develops, it is recommended that COREG be promptly reinstituted, at least temporarily."	0
"The volume of distribution of quinidine is typically 2<U+2013>3 L/kg in healthy young adults, but this may be reduced to as little as 0.5 L/kg in patients with congestive heart failure, or increased to 3<U+2013>5 L/kg in patients with cirrhosis of the liver."	0
Prophylactic therapy may be beneficial for up to six months.	0
"Zaleplon is metabolized to a lesser extent by cytochrome P450 (CYP) 3A4 to form desethyl zaleplon, which is quickly converted, presumably by aldehyde oxidase, to 5-oxo-desethylzaleplon."	0
Monitor serum electrolytes during therapy with BREVIBLOC .	0
Hypersensitivity to any component of this medication.	0
"Severe, chronic diarrhea with substantial weight loss has been reported in patients taking olmesartan months to years after drug initiation."	0
Patients with emerging symptoms suggestive of cardiac disease should undergo a prompt cardiac evaluation.	0
"Although clarithromycin is a combined P-gp and strong CYP3A4 inhibitor, pharmacokinetic data suggest that no dose adjustment is necessary with concomitant administration with ELIQUIS."	0
The daily dose of DIFLUCAN for the treatment of infections other than vaginal candidiasis should be based on the infecting organism and the patient's response to therapy.	0
Anaphylactoid Reactions During Desensitization Two patients undergoing desensitizing treatment with hymenoptera venom while receiving ACE inhibitors sustained life-threatening anaphylactoid reactions.	0
Both CYP1A2 and CYP2D6 catalyze the oxidation of the naphthyl ring in vitro.	0
"Because of the potential for additive or synergistic depressant effects on the SA and AV nodes, however, Adenocard should be used with caution in the presence of these agents."	0
In vitro testing for Neisseria meningitidis isolates: Dilution Techniques: Quantitative methods that are used to determine minimum inhibitory concentrations provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds.	0
Lorazepam (IM): Increased somnolence with IM olanzapine.	0
All dosages are based on the patient's actual weight.	0
Clinical hepatitis and hepatic decompensation including some fatalities.	0
"5-HT1 agonists, including MAXALT, may cause non-coronary vasospastic reactions, such as peripheral vascular ischemia, gastrointestinal vascular ischemia and infarction (presenting with abdominal pain and bloody diarrhea), splenic infarction, and Raynaud's syndrome."	0
"This may be increased gradually in a few days to 200 mg/day, depending upon individual response and tolerance."	0
Nephrolithiasis/urolithiasis has occurred with CRIXIVAN therapy.	0
"When dosing intermittently, patients not responding to a 50 mg dosage may benefit from increasing the dosage up to a maximum of 100 mg per day during the next menstrual cycle (and subsequent cycles) as follows: 50 mg per day during the first 3 days of dosing followed by 100 mg per day during the remaining days in the dosing cycle."	0
"Paroxetine distributes throughout the body, including the CNS, with only 1% remaining in the plasma."	0
"Selegiline shows greater affinity for MAO-B; however, as selegiline concentration increases, this selectivity is lost with resulting dose-related inhibition of MAO-A."	0
Starting CYMBALTA in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome.	0
"Dosage may be increased at daily (eg, patients with unstable angina) or weekly intervals until optimum clinical response is obtained."	0
The 25 mg dose is available for discontinuing therapy.	0
Some MAO inhibitors have contributed to hypoglycemic episodes in diabetic patients receiving insulin or glycemic agents.	0
Renal laboratory testing should be performed in all patients prior to initiation of REYATAZ and continued during treatment with REYATAZ.	0
"Because it includes a thiazide, ZIAC should be discontinued before carrying out tests for parathyroid function."	0
Allow diluted solution to come to room temperature prior to administration.	0
REYATAZ capsules do not contain phenylalanine.	0
"These patients should be monitored closely for the onset or increase in severity of the common adverse events (dry mouth, somnolence, asthenia and dizziness) as indicators of potential overdose."	0
"Serotonin Syndrome: The development of a potentially life-threatening serotonin syndrome has been reported with SNRIs and SSRIs, including PEXEVA<U+00AE>, alone but particularly with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John's Wort) and with drugs that impair metabolism of serotonin (in particular, MAOIs, both those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue)."	0
Intervention: Pimozide is contraindicated for use with sertraline.	0
"Iloperidone is not a substrate for CYP1A1, CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, or CYP2E1 enzymes."	0
"Therefore, if the use of mexiletine hydrochloride is deemed essential, an alternative method of infant feeding should be considered."	0
"Opioid analgesics, including Meperidine Hydrochloride Injection, can prolong labor through actions which temporarily reduce the strength, duration, and frequency of uterine contractions."	0
"Of the 29 genotype 1a virologic failure subjects, 55% (16/29) of subjects had virus with emergent NS5A resistance-associated substitutions K24R, M28T/V, Q30R/H/K/L, L31M, or Y93H/N at failure."	0
"To minimize the risk of these reactions, particularly in patients who have been receiving high doses (20 to 28 mg daily) for long periods of time (9 weeks or more) or who may be on concomitant treatment with narcotics, the dose should be decreased slowly (2 to 4 mg per day)."	0
"Pharmacodynamics Blood pressure lowering drugs (e.g., diuretics, antihypertensive agents, or vasodilators): Risk of increased reduction in blood pressure (7.1) Remodulin inhibits platelet aggregation."	0
"Assessing Cardiovascular Status in Patients being Treated with Stimulant Medications: Children, adolescents, or adults who are being considered for treatment with stimulant medications should have a careful history (including assessment for a family history of sudden death or ventricular arrhythmia) and physical exam to assess for the presence of cardiac disease, and should receive further cardiac evaluation if findings suggest such disease (e.g., electrocardiogram and echocardiogram)."	0
"Because of its CNS depressant effect, chlorpromazine should be used with caution in patients with chronic respiratory disorders such as severe asthma, emphysema and acute respiratory infections, particularly in children (1 to 12 years of age)."	0
Metoprolol crosses the blood-brain barrier and has been reported in the CSF in a concentration 78% of the simultaneous plasma concentration.	0
"Mixing REYATAZ oral powder with a beverage (milk, infant formula, or water) may be used for infants who can drink from a cup."	0
Dosage adjustment of alfentanil may be necessary.	0
"However, peak anticoagulant effect may be delayed 72 to 96 hours."	0
Gender Plasma concentrations of telmisartan are generally 2 to 3 times higher in females than in males.	0
"Change in Cmax Cyclosporine <U+2013> stable dose required (75mg <U+2013> 200mgBID) 10mg QD for 10days <U+2191> 7.1-foldClinically significant <U+2191> 11-fold Atazanavir/ritonavir combination 300mg/100mgQD for 8days 10mg <U+2191> 3.1-fold <U+2191> 7-fold Lopinavir/ritonavir combination 400mg/100mgBID for 17days 20mgQD for 7days <U+2191> 2.1-fold <U+2191> 5-fold Gemfibrozil 600mgBID for 7days 80mg <U+2191> 1.9-fold <U+2191> 2.2-fold Eltrombopag 75 mg QD, 5 days 10 mg <U+2191> 1.6-fold <U+2191> 2-fold Darunavir 600 mg/ritonavir 100 mg BID, 7 days 10 mg QD for 7 days <U+2191> 1.5-fold <U+2191> 2.4-fold Tipranavir/ritonavir combination 500mg/200mgBID for 11days 10mg <U+2191> 26% <U+2191> 2.2-fold Dronedarone 400 mg BID 10 mg <U+2191> 1.4-fold Itraconazole 200 mg QD, 5 days 10 mg or 80mg <U+2191> 39% <U+2191> 28% <U+2191> 36% <U+2191> 15% Ezetimibe 10 mg QD, 14 days 10 mg QD for 14 days <U+2191> 1.2-fold Fosamprenavir/ritonavir 700mg/100mgBID for 7days 10mg <U+2191> 8% <U+2191> 45% Fenofibrate 67mgTID for 7days 10mg <U+2194> <U+2191> 21% Rifampicin 450 mg QD, 7 days 20 mg <U+2194> Aluminum & magnesium hydroxide combination antacid Administered simultaneouslyAdministered 2hours apart 40mg40mg <U+2193> 54% <U+2193> 22% <U+2193> 50% <U+2193> 16% Ketoconazole 200mgBID for 7days 80mg <U+2191> 2% <U+2193> 5% Fluconazole 200mg QD for 11days 80mg <U+2191> 14% <U+2191> 9% Erythromycin 500mgQID for 7days 80mg <U+2193> 20% <U+2193> 31% Table 5."	0
"At steady state, the effective half-life of trandolaprilat is 22.5 hours."	0
"Monitor patients closely when coadministering Tasigna with drugs that have a narrow therapeutic indexand are substrates for CYP2B6,CYP2C8, or CYP2C9 enzymes."	0
"Due to the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of thioridazine, thioridazine should not be administered with fluoxetine or within a minimum of 5weeks after fluoxetine has been discontinued."	0
"In a third crossover study, tyramine without food was administered to 12 subjects."	0
We do not know if CRIXIVAN can be passed to your baby in your breast milk and whether it could harm your baby.	0
Oral Contraceptives/Estrogens: Ethinyl estradiol <U+2193> Ethinyl estradiol concentrations by 50% Alternative methods of nonhormonal contraception should be used when estrogen based oral contraceptives are co-administered with APTIVUS and 200 mg of ritonavir.	0
"ZIAC is contraindicated in patients in cardiogenic shock, overt cardiac failure, second or third degree AV block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs."	0
"Co-administration of FANAPT with known strong inhibitors of CYP2D6 like fluoxetine results in a 2.3-fold increase in iloperidone plasma exposure, andtherefore one-half of the FANAPT dose should be administered."	1
"This discontinuation-emergent effect was mild, had the characteristics of the return of the symptoms of chronic insomnia, and appeared to resolve by the second night after zaleplon discontinuation."	0
<U+2022> Hepatotoxicity: Patients with hepatitis B or C infection are at risk of increased transaminases or hepatic decompensation.	0
Monitor for quinidine adverse effects and adjust the dose accordingly.	0
"The pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, were similar in extensive and poor metabolizers, with an overall mean elimination half-life of about 20 hours."	0
"When the CYP2D6 inhibitor is withdrawn from the combination therapy, iloperidone dose could then be increased to the previous level."	1
"Patients may wish to be examined to determine whether they are susceptible to angle closure, and have a prophylactic procedure (e.g., iridectomy), if they are susceptible."	0
"Paroxetine was significantly better than placebo in improvement of the HDRS sub-factor scores, including the depressed mood item, sleep disturbance factor, and anxiety factor."	0
"In the 7-week, double-blind, placebo-controlled study of Focalin XR, the mean weight gain was greater for patients receiving placebo (+0.4 kg) than for patients receiving Focalin XR (-0.5 kg)."	0
Shake the closed bottle vigorously for about 1 minute.	0
Patients with Coronary Artery Disease: Limit the total dose to 0.03mg/kg to 0.04 mg/kg.	0
"Concomitant use of drugs that increase bleeding risk, antibiotics, antifungals, botanical (herbal) products, and inhibitors and inducers of CYP2C9, 1A2, or 3A4 (7)."	0
PROCARDIA is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac muscle and smooth muscle.	0
"In addition, in vitro studies have shown ketoconazole, a potent inhibitor of CYP3A4 activity, to be at least 100 times more potent than paroxetine as an inhibitor of the metabolism of several substrates for this enzyme, including terfenadine, astemizole, cisapride, triazolam, and cyclosporine."	0
"Monitor blood pressure , renal function , and electrolytes in patients taking aliskiren and other agents that affect the RAAS see Warnings and Precautions ( 5.4 , 5.5 , 5.6 ) ."	0
Lithium <U+2013> In 13 healthy subjects the coadministration of nefazodone (200 mg BID) with lithium (500 mg BID) for 5 days (steady-state conditions) was found to be well tolerated.	0
"Effect on Antibody Response GILENYA reduces the immune response to vaccination, as evaluated in 2 studies."	0
"Potent Inducers of CYP3A : Avoid use of ADCIRCA in patients chronically taking potent inducers of CYP3A ( e.g. , rifampin ) ."	0
"Therefore, false positive results may occur in screening tests for pheochromocytoma in patients who are being treated with prazosin."	0
"Nevertheless, caution is indicated in the coadministration of TCAs with any of the SSRIs and also in switching from one class to the other."	0
Discontinuation: Withdrawal symptoms have been reported in patients when discontinuing treatment with Savella.	0
"Posaconazole 200 mg QD <U+00D7> 10 days 300 mg QD <U+00D7> 17 days Healthy subjects (8) <U+2191> AUC by 72%,<U+2191> Cmax by 31% <U+2193> AUC by 49%,<U+2193> Cmax by 43% If co-administration of these two drugs cannot be avoided, patients should be monitored for adverse events associated with rifabutin administration, and lack of posaconazole efficacy."	0
Atenolol and chlorthalidone have been used singly and concomitantly for the treatment of hypertension.	0
"Quetiapine exposure is increased by the prototype CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, indinavir, ritonavir, nefazodone, etc. and decreased by the prototype CYP3A4 inducers (e..g, phenytoin, carbamazepine, rifampin, avasimibe, St. John<U+2019>s wort etc."	1
In schizophrenic patients activation of the psychosis may occur and require reduction of dosage or the addition of a major tranquilizer to the therapeutic regimen.	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
"Pimozide <U+2013> See CONTRAINDICATIONS, WARNINGS, and PRECAUTIONS, Pharmacokinetics of Nefazodone in <U+2018>Poor Metabolizers<U+2019> and Potential Interaction With Drugs That Inhibit and/or Are Metabolized by Cytochrome P450 Isozymes."	0
"The duration of the inhibitory effect was related to dose, with doses of Benicar >40 mg giving >90% inhibition at 24 hours."	0
Peak concentrations from once-weekly doses of PROZACWeekly capsules of fluoxetine are in the range of the average concentration for 20 mg once-daily dosing.	0
"Therefore , when ALDACTONE and NSAIDs are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained ."	0
STRATTERA may be taken with or without food.	0
<U+2022>LEXIVA should be discontinued for severe skin reactions including Stevens-Johnson syndrome.	0
"Because the effects of extended-release oral isosorbide dinitrate are so difficult to terminate rapidly, this formulation is not recommended in these settings."	0
"In addition, at least 14 days must elapse after stopping ZOLOFT before starting an MAOI antidepressant."	0
"Blockade of the angiotensin II receptor inhibits the negative regulatory feedback of angiotensin II on renin secretion, but the resulting increased plasma renin activity and circulating angiotensin II levels do not overcome the effect of olmesartan on blood pressure."	0
"Should aminosalicylate derivatives and PURIXAN be coadministered, use the lowest possible doses of each drug and closely monitor the patient for bone marrow suppression."	1
"If acute signs or symptoms of cardiovascular events occur, advise patients to seek immediate medical attention."	0
"Exchange resins, such as sodium polystyrene sulfonate, whether administered orally or rectally, reduce serum potassium levels by sodium replacement of the potassium; fluid retention may occur in some patients because of the increased sodium intake."	0
Citalopram did not alter the mean AUC or Cmax of pimozide.	0
Use of BRILINTA with aspirin maintenance doses above 100 mg reduced the effectiveness of BRILINTA see Warnings and Precautions ( 5.2 ) and Clinical Studies ( 14.1 ) .	0
Hydrochlorothiazide Hydrochlorothiazide crosses the placental but not the blood-brain barrier and is excreted in breast milk.	0
"Outpatients and Office Patients <U+2014>Initially, 75 mg/day in divided doses, increased to 150 mg/day."	0
"In general , avoid combined use of aliskiren with ACE inhibitors or ARBs , particularly in patients with CrCl less than 60 mL/min ."	0
Human pharmacokinetic studies with an oral formulation of treprostinil ( treprostinil diethanolamine ) indicated that co-administration of the cytochrome P450 ( CYP ) 2C8 enzyme inhibitor gemfibrozil increases exposure ( both Cmax and AUC ) to treprostinil .	1
Therapy with SURMONTIL may be resumed 24 hours after the last dose of linezolid or intravenous methylene blue.	0
"Each subject received ~1000 mg elemental calcium from each dose of the following study medications: 30 mL PHOSLYRA (test), 6 calcium acetate gelcaps (reference), or 5 calcium citrate caplets (positive control) in three periods."	0
"Co-administration of SAMSCA with 400 mg ketoconazole daily or with other strong CYP 3A inhibitors ( e.g. , clarithromycin , itraconazole , telithromycin , saquinavir , nelfinavir , ritonavir and nefazodone ) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure ."	1
This represents a rate of about 3 to 4 times the estimated background rate of liver failure.	0
"Hyponatremia may occur as a result of treatment with SSRIs and SNRIs, including LUVOX CR Capsules."	0
Because of the potential for these serious adverse events in nursing infants exposed to D.H.E.	0
"However, prior to initiating treatment with an antidepressant, patients with depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression."	0
A pronounced food-effect is observed when SULAR is administered with a high-fat meal resulting in an increased peak concentration (Cmax) of up to 245%.	1
"During or within 14 days following the administration of monoamine oxidase inhibitors, hypertensive crises may result."	0
"In a limited number of patients studied, perindopril clearance by dialysis ranged from about 40 to 80 mL/min."	0
Antiepileptics: carbamazepine <U+2193> atazanavir<U+2191> carbamazepine Plasma concentrations of atazanavir may be decreased when carbamazepine is administered with REYATAZ without ritonavir.	1
Treat mild hypercalcemia by reducing or interrupting PHOSLYRA and Vitamin D. Severe hypercalcemia may require hemodialyis and discontinuation of PHOSLYRA.	0
Dihydroergotamine mesylate should not be used by nursing mothers.	0
The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.	0
"Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs, warfarin, and other anti-coagulants may add to this risk."	0
"Because of the limited experience with systematically monitored patients receiving Marplan at the higher end of the currently recommended dose range of up to 60mg/day, caution is indicated in patients for whom a dose of 40mg/day is exceeded."	0
Olanzapine's antagonism of adrenergic<U+03B1>1 receptors may explain the orthostatic hypotension observed with this drug.	0
"In a case-control epidemiological study, the use of anorectic agents, including phendimetrazine tartrate, was associated with an increased risk of developing pulmonary hypertension, a rare, but often fatal disorder."	0
A pooled analysis of the vital signs monitored during placebo-controlled premarketing studies revealed that 5.1% of nefazodone patients compared to 2.5% of placebo patients (p <U+2264> 0.01) met criteria for a potentially important decrease in blood pressure at some time during treatment (systolic blood pressure <U+2264> 90 mmHg and a change from baseline of <U+2265> 20 mmHg).	0
Rifapentine is an inducer of cytochromes P4503A4 and P4502C8/9.	0
No treatment-related external or visceral changes were observed in rats.	0
The safety and effectiveness in pediatric patients below the age of 10 have not been established.	0
Increase the dose of ONIVYDE to 70mg/m 2 as tolerated in subsequent cycles.	0
Effect of AUBAGIO on organic anion transporter 3 (OAT3) substrates Teriflunomide inhibits the activity of OAT3 in vivo.	0
"Pulmonary hypertension, advanced arteriosclerosis, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma, severe hypertension."	0
"Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature."	0
NARDIL should be used with caution in diabetes mellitus; increased insulin sensitivity may occur.	0
"Bupropion, levodopa, and amantadine have dopamine agonist effects."	0
"At steady state, mean values of Cmax, Tmax, Cmin, and T<U+00BD> were 61.7 ng/mL (CV 45%), 5.2 hr."	0
"CADUET: Following oral administration of CADUET, peak plasma concentrations of amlodipine and atorvastatin are seen at 6 to 12 hours and 1 to 2 hours post dosing, respectively."	0
Atorvastatin and atorvastatin-metabolites are substrates of the OATP1B1 transporter.	0
"At 40 and 160 mg the bioavailability was 42% and 58%, respectively."	0
CAPRELSA increased plasma concentrations of metformin that is transported by the organic cation transporter type 2 (OCT2).	1
"Maternal weight gain was impaired at all dose levels (approximately 0.25 to 4 times the 400 mg clinical dose based on BSA), and abortions occurred at 75 mg/kg (approximately 4 times the 400 mg clinical dose based on BSA); no adverse fetal effects were observed."	0
Thiazides and triamterene in combination have not been studied in nursing mothers.	0
HIV-1 protease inhibitor: Indinavir <U+2191> Saquinavir<U+2191> Indinavir Low dose ritonavir increases the concentration of indinavir Appropriate doses of the combination of indinavir and INVIRASE/ritonavir with respect to safety and efficacy have not been established.	1
The mechanism of this syndrome is not understood.	0
"Intravenous administration is usually preferred, but subcutaneous, intramuscular, and endotracheal administration are possible."	0
"To minimize CNS depression and possible potentiation, barbiturates, antihistamines, narcotics, hypotensive agents or phenothiazines should be used with caution."	0
Steady state will be attained after approximately 5 days in subjects with normal renal function.	0
"Discontinuation of CYP1A2 or CYP3A4 Inducers: Consider reducing CLOZARIL dose when CYP1A2 inducers (e.g., tobacco smoke) or CYP3A4 inducers (e.g., carbamazepine) are discontinued."	1
CYP2D6 Substrates: Avoid co-administration of ZYTIGA with CYP2D6 substrates that have a narrow therapeutic index.	0
"Rifampin, an inducer of drug metabolism, decreased the concentrations of losartan and its active metabolite."	1
"Subsequent dose adjustments may be necessary during coadministration, and should be based on clinical assessment."	0
Switching between the intravenous and oral formulations is appropriate because of the high bioavailability of the oral formulation in adults.	0
Triamterene appears in animal milk; this may occur in humans.	0
SURMONTIL should be discontinued before initiating treatment with the MAOI.	0
"Because of the uncontrolled nature of many of the studies, it is impossible to provide a precise estimate of the extent of risk imposed by treatment with Anafranil."	0
"Serious Skin Reactions: Postmarketing reports of serious skin and hypersensitivity reactions, including Stevens-Johnson Syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) and toxic epidermal necrolysis (TEN) have been reported in patients taking ULORIC."	0
Steady state concentrations for the typical subject were attained by the fourth dose for both sites of administration.	0
"There may also be lowering of the R wave and increased depth of the S wave, widening and even disappearance of the P wave, progressive widening of the QRS complex, prolongation of the PR interval, and ST depression."	0
Dose escalation above 100 mg per day is not recommended.	0
"Therefore , the expected clinical effects of SAMSCA in the presence of rifampin and other inducers ( e.g. , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine and St.   John 's   Wort ) may not be observed at the usual dose levels of SAMSCA ."	0
Less than 0.1% of patients discontinued therapy due to hyperkalemia.	0
"In the VMAC trial, in patients given the recommended dose (2 mcg/kg bolus followed by a 0.01 mcg/kg/min infusion) or the adjustable dose, the incidence of symptomatic hypotension in the first 24 hours was similar for NATRECOR<U+00AE> (4%) and IV nitroglycerin (5%)."	0
"If short-term treatment with strong CYP3A4 inhibitors is unavoidable, therapy with simvastatin must be suspended during the course of treatment."	0
"Some patients with hypertension or heart failure with no apparent preexisting renal vascular disease have developed increases in blood urea and serum creatinine, usually minor and transient, especially when ACCUPRIL has been given concomitantly with a diuretic."	0
"Inhibition of CYP3A4 by aprepitant could result in elevated plasma concentrations of this drug which is a CYP3A4 substrate, potentially causing serious or life-threatening reactions, such as QT prolongation, a known adverse reaction of pimozide."	1
The large free fraction suggests that eszopiclone disposition should not be affected by drug-drug interactions caused by protein binding.	0
"Tardive dyskinesia, a syndrome consisting of potentially irreversible, involuntary, dyskinetic movements, may develop in patients treated with antipsychotic drugs."	0
"Accordingly, prothrombin time should be carefully monitored when sertraline hydrochloride therapy is initiated or stopped."	0
Atropine also may lessen the degree of partial heart block when vagal activity is an etiologic factor.	0
"Fluvoxamine should be avoided in patients with unstable epilepsy, and patients with controlled epilepsy should be carefully monitored."	0
LUVOX CR Capsules and tizanidine should not be used together.	0
Recommended maintenance doses based upon lean body weight and renal function are listed in Table 3.	0
Coadministration of buprenorphine and REYATAZ without ritonavir may decrease atazanavir plasma concentrations.	1
Avoid use of PRADAXA and P-gp inhibitors in patients with CrCl <50 mL/min.	0
"Verapamil has a negative inotropic effect, which in most patients is compensated by its afterload reduction (decreased systemic vascular resistance) properties without a net impairment of ventricular performance."	0
"The effect of Lidocaine Hydrochloride Injection, USP for the management of cardiac arrhythmias is potentiated with the simultaneous or prior administration of propranolol."	0
"Major Surgery: Avoid initiation of high-dose extended-release metoprolol in patients undergoing non-cardiac surgery because it has been associated with bradycardia, hypotension, stroke and death."	0
"Obtain Thyroid-stimulating hormone (TSH) at baseline, at 2<U+2013>4 weeks and 8<U+2013>12 weeks after starting treatment with CAPRELSA, and every 3 months thereafter."	0
"Dosage adjustments should be made to maintain the patient on the lowest effective dosage, and patients should be periodically reassessed to determine the need for continued treatment."	0
"Because coronary artery disease is common and may be unrecognized in patients receiving sotalol, abrupt discontinuation in patients with arrhythmias may unmask latent coronary insufficiency."	0
"Start sotalol therapy only if the baseline QT interval is <450 ms. During initiation and titration, monitor the QT interval after the completion of each infusion If the QT interval prolongs to 500 ms or greater, reduce the dose, decrease the infusion rate, or discontinue the drug."	0
Administration of a single dose of nisoldipine leads to decreased systemic vascular resistance and blood pressure with a transient increase in heart rate.	0
"In both Studies 2 and 3, the mean paroxetine dose for completers at endpoint was approximately 40 mg/day of paroxetine."	0
Dr ugs t hat a c t di rect ly on t he re nin - angio te ns i n sys te m c an c ause in j u r y and dea t h t o t he d e v e loping fet us.	0
"Atropine-induced parasympathetic inhibition may be preceded by a transient phase of stimulation, especially on the heart where small doses first slow the rate before characteristic tachycardia develops due to paralysis of vagal control."	0
<U+2022>Review ritonavir contraindications when used in combination.	0
"Even in patients without overt coronary artery disease, it may be advisable to taper therapy with ZIAC (bisoprolol fumarate and hydrochlorothiazide) over approximately 1 week with the patient under careful observation."	0
Antipsychotic: Quetiapine <U+2191> Quetiapine Initiation of INVIRASE with ritonavir in patients taking quetiapine: Consider alternative antiretroviral therapy to avoid increases in quetiapine drug exposures.	1
"If no hypotension occurs, give 25 to 50 mg q3-4h prn, until vomiting stops."	0
Inhibition of XO by ULORIC may cause increased plasma concentrations of these drugs leading to toxicity.	0
"Cases of myopathy, including rhabdomyolysis, have been reported with HMG-CoA reductase inhibitors coadministered with colchicine, and caution should be exercised when prescribing LIVALO with colchicine."	0
"There have been postmarketing reports of fatal and non-fatal hepatic failure in patients taking ULORIC, although the reports contain insufficient information necessary to establish the probable cause."	0
"Peak serum concentrations of 10.7 <U+00B1> 3.7 and 11.5 <U+00B1> 5.1 mcg/mL were obtained 1 hour after preprandial ingestion of the drug suspension and the applesauce mixture, respectively."	0
Abrupt withdrawal of beta-blockade may precipitate a thyroid storm.	0
Late evening medication should be avoided because of the resulting insomnia.	0
Clevidipine is a dihydropyridine L-type calcium channel blocker.	0
"For adults, if only serum creatinine concentrations (Scr) are available, a Ccr (corrected to 70 kg body weight) may be estimated in men as (140 <U+2013> Age)/Scr."	0
"Therefore, ZYTIGA must be taken on an empty stomach, either one hour before or two hours after a meal."	0
"If the antihypertensive effect measured at trough using once-a-day dosing is inadequate, a twice-a-day regimen at the same total daily dose or an increase in dose may give a more satisfactory response."	0
"PDE5 inhibitors: Concomitant use contraindicated (4.1, 7.1) Antihypertensives: Possible additive hypotensive effects (7.2) Aspirin: increased nitroglycerin levels (7.3) Tissue-type plasminogen activator (t-PA): decreased thrombolytic effect (7.4) Heparin: anticoagulant effect of heparin may be reduced."	0
"Delayed-Release Tablets Oral Swallowed whole, with or without food For Delayed-Release Oral Suspension Oral Administered in 1 teaspoonful of applesauce or apple juice approximately 30 minutes prior to a meal For Delayed-Release Oral Suspension Nasogastric tube See instructions below Take a missed dose as soon as possible."	0
"Amiodarone inhibits peripheral conversion of thyroxine ( T4 ) to triiodothyronine ( T3 ) and may cause increased T4 levels , decreased T3 levels , and increased levels of inactive reverse T3 ( rT3 ) in clinically euthyroid patients ."	1
In such patients an increase in dosage or twice daily administration may be warranted.	0
Patients with severe hepatic impairment were not studied.	0
Hypersensitivity: Serious hypersensitivity/allergic reactions have been reported.	0
"While the inhibition of cAMP-PDE is weak, therapeutic levels of dipyridamole inhibit cyclic-3',5'-guanosine monophosphate-PDE (cGMP-PDE), thereby augmenting the increase in cGMP produced by EDRF (endothelium-derived relaxing factor, now identified as nitric oxide)."	0
Severe toxicity has also been reported in patients receiving the combination of tricyclic antidepressants and selegiline and selective serotonin reuptake inhibitors and selegiline.	0
Increased monitoring for adverse events is warranted in patients receiving this combination and further dose reduction of rifabutin may be necessary. rifapentine <U+2193> darunavir Co-administration of PREZISTA/ritonavir with rifapentine is not recommended.	0
Use of PDE-5 inhibitors for pulmonary arterial hypertension (PAH): Co-administration of PREZISTA/ritonavir and sildenafil for treatment of pulmonary arterial hypertension is contraindicated.	0
Withdraw 3mL and add to sufficient sterile diluent to make a total of 100mL.	0
The initial clinical effect may occur within four to seven days and occurs within two weeks in over 80% of responders.	0
Inclusion in the study required a baseline LDL<U+2011>C level of 160-400mg/dL and a parental history of familial hypercholesterolemia.	0
"Remodulin can be administered without further dilution for subcutaneous administration , or diluted for intravenous infusion with Sterile Diluent for Remodulin or similar approved high-pH glycine diluent ( e.g. Sterile Diluent for Flolan or Sterile Diluent for Epoprostenol Sodium ) , Sterile Water for Injection , or 0.9 %   Sodium Chloride Injection prior to administration ."	0
"Clinical studies have shown that with co-administration of bicalutamide, mean midazolam (a CYP 3A4 substrate) levels may be increased 1.5-fold (for Cmax) and 1.9-fold (for AUC)."	1
Systemic lupus erythematosus (SLE) is less commonly reported than CLE in patients receiving PPIs.	0
"There was considerable variation in risk of suicidality among drugs, but a tendency toward an increase in the younger patients for almost all drugs studied."	0
The mechanisms of the antihypertensive effects of beta-blocking agents have not been established.	0
It causes excitation-contraction uncoupling in various myocardial tissues without changes in the configuration of the action potential.	0
"Compared with healthy subjects, patients with severe liver impairment (cirrhosis) exhibit a 4- to 7-fold increase in carvedilol levels."	0
"With chronic dosing, however, there is substantial inhibition of angiotensin II levels at 24 hours by doses of 20 to 80 mg. Administration of 10 to 80 mg of quinapril to patients with mild to severe hypertension results in a reduction of sitting and standing blood pressure to about the same extent with minimal effect on heart rate."	0
"Hydrochlorothiazide had no adverse effects on the fertility of mice and rats of either sex in studies wherein these species were exposed, via their diets, to doses of up to 100 and 4 mg/kg/day, respectively, prior to mating and throughout gestation."	0
Plasma phenytoin concentrations should be monitored and phenytoin dose should be increased as appropriate.	1
Intraoperative Floppy Iris Syndrome (IFIS) has been observed during cataract surgery in some patients treated with alpha-1 blockers (COREG is an alpha/beta blocker).	0
"For CrCl <15 mL/min, no recommendations can be made."	0
"Chlorpromazine may cause somnolence, postural hypotension, motor and sensory instability, which may lead to falls and, consequently, fractures or other injuries."	0
This is of potential consequence when drug discontinuation is required or when drugs are prescribed that might interact with fluoxetine and norfluoxetine following the discontinuation of PROZAC.	0
"In a study of 19 healthy male subjects, which included 6 slow and 13 rapid hydroxylators of debrisoquin, a single 25 mg oral dose of thioridazine produced a 2.4-fold higher Cmax and a 4.5-fold higher AUC for thioridazine in the slow hydroxylators compared to rapid hydroxylators."	0
Drugs metabolized by CYP2C8 and OAT3 transporters: Monitor patients because teriflunomide may increase exposure of these drugs (7) Teriflunomide may increase exposure of ethinylestradiol and levonorgestrel.	1
"Suicide is a known risk of depression and certain other psychiatric disorders, and these disorders themselves are the strongest predictors of suicide."	0
"Charcoal: The pharmacokinetics of nebivolol (10 mg single dose) were not affected by repeated co-administration (4, 8, 12, 16, 22, 28, 36, and 48 hours after nebivolol administration) of activated charcoal (Actidose-Aqua<U+00AE>)."	0
Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses.	0
"Dosage reduction for midazolam should be considered, especially if more than a single dose of midazolam is administered."	1
"Significantly increased plasma TCA levels have been reported with the coadministration of fluvoxamine maleate and amitriptyline, clomipramine or imipramine."	1
The drug and applesauce mixture should not be stored for future use.	0
"Such symptoms should be reported to the patient's prescriber or health professional, especially if they are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
Discard unused portion 12 hours after stopper puncture.	0
"It also binds with moderate affinity to the human <U+03B1>2C adrenergic receptors (Ki=11 nM), is a partial agonist at serotonin 5-HT1A (Ki=6.4 nM) receptors, and is an antagonist at the <U+03B1>2A adrenergic receptors (Ki=41 nM)."	0
"After gluteal administration, the mean apparent aripiprazole terminal elimination half-life was 29.9 days and 46.5 days after multiple injections for every 4-week injection of ABILIFY MAINTENA 300 mg and 400 mg, respectively."	0
"The effect of quinapril in hypertension appears to result primarily from the inhibition of circulating and tissue ACE activity, thereby reducing angiotensin II formation."	0
The R (active) isomer also undergoes glucuronidation but is predominantly oxidized to an inactive metabolite followed by glucuronidation.	0
"Maalox TC<U+00AE> 30 mL QD, 17 days 10 mg QD for 15 days <U+2193> 33% <U+2193> 34% Efavirenz 600 mg QD, 14 days 10 mg for 3 days <U+2193> 41% <U+2193> 1% Rifampin 600 mg QD, 7 days (co-administered)Because of the dual interaction mechanism of rifampin, simultaneous co-administration of atorvastatin with rifampin is recommended, as delayed administration of atorvastatin after administration of rifampin has been associated with a significant reduction in atorvastatin plasma concentrations."	1
Relapsed or refractory APL: Induction: 0.15 mg/kg intravenously daily until bone marrow remission.	0
"At the end of study or at the last visit before a primary endpoint, the mean blood pressures were 144.1/81.3mmHg for the group treated with losartan potassium tablets and 145.4/80.9mmHg for the group treated with atenolol [the difference in systolic blood pressure (SBP) of 1.3mmHg was significant (p<0.001), while the difference of 0.4mmHg in diastolic blood pressure (DBP) was not significant (p=0.098)]."	0
The clinical benefits of these properties have not yet been demonstrated.	0
"IV administration of cardiodepressant calcium-channel antagonists ( e.g. , verapamil ) and BREVIBLOC in close proximity ( i.e. , while cardiac effects from the other are still present ) , fatal cardiac arrests have occurred in patients receiving BREVIBLOC and intravenous verapamil ."	0
The iloperidone metabolite P95 represents 47.9% of the AUC of iloperidone and its metabolites in plasma at steady-state for extensive metabolizers (EM) and 25% for poor metabolizers (PM).	0
"In patients with at least 2 of the following characteristics: age greater than or equal to 80 years, body weight less than or equal to 60 kg, or serum creatinine greater than or equal to 1.5 mg/dL, the recommended dose is 2.5 mg orally twice daily."	0
"Calculation of creatinine clearance: Prior to the administration of the first dose, the patient's creatinine clearance must be calculated using the following formula: creatinine clearance (male) = (140-age) <U+00D7> actual body weight in kg 72 <U+00D7> serum creatinine (mg/dL) creatinine clearance (female) = (140-age) <U+00D7> actual body weight in kg <U+00D7> 0.85 72 <U+00D7> serum creatinine (mg/dL) When serum creatinine is given in <U+00B5>mol/L, divide the value by 88.4 (1 mg/dL = 88.4 <U+00B5>mol/L)."	0
"Given the primary CNS effects of escitalopram, caution should be used when it is taken in combination with other centrally acting drugs."	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP may cause coronary artery vasospasm; patients who experience signs or symptoms suggestive of angina following its administration should, therefore, be evaluated for the presence of CAD or a predisposition to variant angina before receiving additional doses."	0
The increase in atorvastatin exposure when used clinically is likely to be higher than what was observed in this study.	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP should not be given to patients with ischemic heart disease (angina pectoris, history of myocardial infarction, or documented silent ischemia) or to patients who have clinical symptoms or findings consistent with coronary artery vasospasm including Prinzmetal's variant angina."	0
Paliperidone is a weak inhibitor of P-glycoprotein (P-gp) at high concentrations.	0
Reproduction studies in rats at 20 times the expected maximum daily dose for humans showed no evidence of impaired fertility.	0
Fluoxetine After multiple doses of zolpidem tartrate and fluoxetine an increase in the zolpidem half-life (17%) was observed.	1
"After single doses of losartan administered orally, about 4% of the dose is excreted unchanged in the urine and about 6% is excreted in urine as active metabolite."	0
"Pediatrics In Study 1116, the presence of NS5A and NS5B resistance-associated polymorphisms did not impact treatment outcome; all pediatric subjects 12 years of age and older with baseline NS5A or NS5B nucleoside inhibitor resistance-associated polymorphisms (18%; 17/96) achieved SVR following 12 weeks treatment with HARVONI."	0
The pharmacokinetics of iloperidone is more than dose proportional.	0
A dose of 100mg inhibits the pressor effect by about 85% at peak with 25-40% inhibition persisting for 24hours.	0
"Further information, including a listing of blood glucose monitor compatibility information provided by the manufacturers of blood glucose monitors, is available by visiting www.glucosesafety.com or by calling Baxter Renal Clinical Help Line 1-888-RENAL-HELP."	0
Verapamil is approximately 90% bound to plasma proteins.	0
"Therefore, when DUTOPROL and non-steroidal anti- inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained."	0
"The findings from these studies are summarized below: A study based on Swedish national registry data demonstrated that infants exposed to paroxetine during pregnancy (n = 815) had an increased risk of cardiovascular malformations (2% risk in paroxetine-exposed infants) compared to the entire registry population (1% risk), for an odds ratio (OR) of 1.8 (95% confidence interval 1.1 to 2.8)."	0
Maintenance doses of aspirin above 100 mg reduce the effectiveness of BRILINTA and should be avoided .	0
"Concomitant administration of CRESTOR with medications that are inhibitors of these transporter proteins (e.g. cyclosporine, certain HIV protease inhibitors) may result in increased rosuvastatin plasma concentrations and an increased risk of myopathy."	0
Heart Failure: Worsening cardiac failure may occur.	0
"Caution should be used when prescribing other fibrates with simvastatin, as these agents can cause myopathy when given alone and the risk is increased when they are coadministered."	0
Feeding tubes composed of silicone or polyvinyl chloride (PVC) can be used.	0
"Because amiloride HCl is not metabolized by the liver, drug accumulation is not anticipated in patients with hepatic dysfunction, but accumulation can occur if the hepatorenal syndrome develops."	0
"In the rabbit study, increases in total resorptions and % post-implantation loss, and a decrease in the number of live fetuses per dam occurred at the highest dose tested."	0
The recommended dose is 2.5 mg or 10 mg administered as an intravenous bolus injection three times a day.	0
Marplan should not be used in patients with severe impairment of renal function.	0
Hold the EMEND for oral suspension pouch upright and shake the contents to the bottom before opening the pouch.	0
A causal relationship between PI therapy and these episodes has not been established.	0
Absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins.	1
Elderly outpatients with chronic insomnia were also evaluated in a 2-night sleep laboratory study involving doses of 5 mg and 10 mg.	0
"The most prominent effect is the negative chronotropic effect, giving a reduction in resting and exercise heart rate."	0
Valproic acid may be less effective due to decreased valproic acid plasma concentration in patients taking APTIVUS concomitantly.	1
Pregnancy/Non-Teratogenic Effects Thiazides cross the placental barrier and appear in cord blood.	0
Therapy with NORPRAMIN may be resumed 24 hours after the last dose of linezolid or intravenous methylene blue.	0
The recommended dosages are outlined in Table 1.	0
Only use glucose-specific monitors and test strips to measure blood glucose levels in patients using EXTRANEAL (icodextrin) Peritoneal Dialysis Solution.	0
"However, it is expected that such coadministration would produce additive prolongation of the QTc interval and, thus, such use is contraindicated."	0
"For patients who do not achieve a serum uric acid (sUA) less than 6 mg/dL after 2 weeks with 40 mg, ULORIC 80 mg is recommended."	0
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.	0
"Serious reactions, including elevated blood pressure and tachyarrhythmia, have been reported in patients with pheochromocytoma or a history of pheochromocytoma who received STRATTERA."	0
.	0
"Patients should be advised that taking SURMONTIL can cause mild pupillary dilation, which in susceptible individuals, can lead to an episode of angle closure glaucoma."	0
Reconstitution Tap the bottle to release the powder.	0
"Monitor the following laboratory tests in patients receiving PURIXAN: Complete blood counts (CBCs), transaminases, and bilirubin."	0
Effectiveness is well sustained during continued use.	0
Permanently discontinue CAPRELSA for severe skin reactions and refer the patient for urgent medical evaluation.	0
"Concomitant use of lidocaine with propofol, a hypnotic agent and CYP3A4 inhibitor, may increase lidocaine plasma levels by reducing lidocaine clearance."	1
"Metabolism and Elimination Following absorption, venlafaxine undergoes extensive presystemic metabolism in the liver, primarily to ODV, but also to N-desmethylvenlafaxine, N,O-didesmethylvenlafaxine, and other minor metabolites."	0
Enterohepatic recycling is suggested by secondary peaking of plasma doxazosin concentrations.	0
"In a patient who requires more urgent treatment of a psychiatric condition, other interventions, including hospitalization, should be considered."	0
Dihydroergotamine-induced intrauterine growth retardation has been attributed to reduced uteroplacental blood flow resulting from prolonged vasoconstriction of the uterine vessels and/or increased myometrial tone.	0
"However, coadministration of citalopram and the potent CYP3A4 inhibitor ketoconazole did not significantly affect the pharmacokinetics of citalopram."	0
Swallow the capsules whole with water.	0
"Autoimmune disorders (such as Graves<U+2019> disease, polymyositis, and Guillain-Barr<U+00E9> syndrome) have also been reported to occur in the setting of immune reconstitution, however, the time to onset is more variable, and can occur many months after initiation of treatment."	0
Studies at clinically relevant doses in humans have demonstrated that paroxetine blocks the uptake of serotonin into human platelets.	0
"CYP2B6, CYP2C9, CYP3A4 and CYP3A5 appeared to be the major contributing enzymes in the formation of R(-)-methamphetamine from selegiline, with CYP2A6 having a minor role."	0
"For pediatric patients with known or suspected renal dysfunction, lower starting doses should be considered combined with frequent monitoring of digoxin levels."	0
"Chlorpromazine prolongs and intensifies the action of CNS depressants such as anesthetics, barbiturates and narcotics."	0
"While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition."	0
"Similarly, at least 1week should elapse between the discontinuation of Marplan and initiation of another MAO inhibitor or dibenzazepine-related entity, or the readministration of Marplan."	0
"There is evidence that treatment with phenytoin leads to decrease intestinal absorption of LASIX , and consequently to lower peak serum furosemide concentrations ."	1
"Nitritoid reactions ( symptoms include facial flushing , nausea , vomiting and hypotension ) have been reported rarely in patients on therapy with injectable gold ( sodium aurothiomalate ) and concomitant ACE inhibitor therapy including VASOTEC ."	0
"Hydrochlorothiazide After oral administration of hydrochlorothiazide, diuresis begins within 2 hours, peaks in about 4 hours and lasts about 6 to 12 hours."	0
Diltiazem: Bradycardia with coadministration (7.3).	0
"Take CYMBALTA once daily, with or without food."	0
Dosing every 12 hours results in trough plasma concentrations which are approximately one-half of those at peak.	0
Absorption:Iloperidone is well absorbed after administration of the tablet with peak plasma concentrations occurring within 2 to 4 hours; while the relative bioavailability of the tablet formulation compared to oral solution is 96%.	0
May result in significantly reduced serum cortisol concentrations.	0
APTIVUS must be co-administered with ritonavir to exert its therapeutic effect.	0
Most patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy.	0
Verapamil has been given concomitantly with short- and long-acting nitrates without any undesirable drug interactions.	0
Convulsions were reported in patients with and without a prior history of seizures.	0
"Zanaflex should be used with caution in patients with renal insufficiency (creatinine clearance < 25 mL/min), as clearance is reduced by more than 50%."	0
Tolerance has not been observed to develop in long term therapy.	0
The risks of using clomipramine in combination with other drugs have not been systematically evaluated.	0
"P-gp Inhibitors The dose of SAMSCA may have to be reduced when SAMSCA is co-administered with P-gp inhibitors, e.g., cyclosporine [see Dosage and Administration (2.3), Drug Interactions (7.1)]."	0
ACCURETIC should be used cautiously in patients receiving concomitant therapy with other antihypertensives.	0
"A patient Medication Guide about <U+201C>Antidepressant Medicines, Depression and other Serious Mental Illness, and Suicidal Thoughts or Actions<U+201D> is available for clomipramine hydrochloride."	0
"By this endpoint, significant slowing of disease was seen, with regression in 23% of patients treated with lovastatin compared to 11% of placebo patients."	0
Anaphylactoid reactions have also been reported in patients undergoing low-density lipoprotein apheresis with dextran sulfate absorption.	0
"Continued depression of the myocardium with beta-blockers can, in some patients, precipitate cardiac failure."	0
"Excretion Risperidone and its metabolites are eliminated via the urine and, to a much lesser extent, via the feces."	0
"If oligohydramnios is observed, discontinue TARKA, unless it is considered lifesaving for the mother."	0
"If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and should not be longer than 24 hours at 2<U+00B0> to 8<U+00B0>C (36<U+00B0> to 46<U+00B0>F)."	0
"Abiraterone is a substrate of CYP3A4, in vitro."	0
Coadministration of phenytoin or phenobarbital and REYATAZ without ritonavir is not recommended.	0
"Its metabolite, salicylic acid, is highly bound to plasma proteins, but its binding is concentration-dependent (nonlinear)."	0
"Cases of hepatosplenic T-cell lymphoma have been reported in patients treated with mercaptopurine for inflammatory bowel disease (IBD), an unapproved use."	0
"Absorption: Following oral administration, peak concentrations (Cmax) of telmisartan are reached in 0.5 to 1 hour after dosing."	0
Responses to postganglionic cholinergic nerve stimulation also may be inhibited by atropine but this occurs less readily than with responses to injected (exogenous) choline esters.	0
Rifampin reduced plasma concentrations of carvedilol by about 70%.	1
"Dosage can then be increased by increments of up to 20mg/week, if needed and tolerated, to a maximum recommended dosage of 60mg/day."	0
"Protect the patient<U+2019>s airway, establish an intravenous line and initiate gastric decontamination."	0
Renal insufficiency The pharmacokinetics of irbesartan were not altered in patients with renal impairment or in patients on hemodialysis.	0
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.	0
Distribution Clozapine is approximately 97% bound to serum proteins.	0
"If community rates of INH resistance are currently less than 4%, an initial treatment regimen with less than four drugs may be considered."	0
The increase in atorvastatin exposure when used clinically is likely to be higher than what was observed in this study.	0
"If it is not possible to discontinue the interacting drug, perform cardiac monitoring frequently."	0
"The co-administration of alcohol (i.e., ethanol) with olanzapine potentiated the orthostatic hypotension observed with olanzapine."	0
"Ziprasidone is primarily cleared via three metabolic routes to yield four major circulating metabolites, benzisothiazole (BITP) sulphoxide, BITP-sulphone, ziprasidone sulphoxide, and S-methyldihydroziprasidone."	0
Discontinuation of cimetidine in well controlled patients receiving tricyclic antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants.	1
"A patient Medication Guide about <U+201C>Antidepressant Medicines, Depression and other Serious Mental Illness, and Suicidal Thoughts or Actions<U+201D> is available for PEXEVA<U+00AE> (paroxetine mesylate)."	0
"In a 4-week, placebo-controlled trial of VYVANSE in patients ages 6 to 12 years old with ADHD, there was a dose-related decrease in weight in the VYVANSE groups compared to weight gain in the placebo group."	0
"Patients with coronary artery disease, who are being treated with COREG, should be advised against abrupt discontinuation of therapy."	0
"In patients with severe renal tubular acidosis or chronic diarrheal syndrome where urinary citrate may be very low (<100 mg/day), potassium citrate extended-release tablets may be relatively ineffective in raising urinary citrate."	0
Please note that aspirin is not to be administered concomitantly with coumarin anticoagulants.	0
REVATIO Injection: The pharmacokinetic profile of REVATIO has been characterized following intravenous administration.	0
"In patients with chronic stable angina, intravenous administration of 10 mg did not significantly alter A-H and H-V conduction and sinus node recovery time after pacing."	0
The absolute oral bioavailability of perindopril is about 75%.	0
"It inhibits the activity of such diverse agents as histamine, 5-hydroxytryptamine, and acetylcholine."	0
"Serious hemorrhagic events, including fatalities, occurred in patients treated with CAPRELSA."	0
"Therefore, monitor serum lithium levels during concomitant use."	0
Protease Inhibitors and Reverse Transcriptase Inhibitors.	0
"The usual dose of Triamterene and Hydrochlorothiazide Tablets 75 mg/50 mg is one tablet daily, with appropriate monitoring of serum potassium."	0
"In rabbits, at a maternal dose of 240 mg/kg/day, no drug was detected in fetal plasma 1 hour after dosing."	0
It is important to increase dosage until symptoms are controlled.	0
Anaphylactoid Reactions During Membrane Exposure Anaphylactoid reactions have been reported in patients dialyzed with high-flux membranes and treated concomitantly with an ACE inhibitor.	0
Zanaflex can cause anaphylaxis.	0
"For patients chronically taking potent inducers of CYP3A , such as rifampin , avoid use of ADCIRCA see Drug Interactions ( 7.2 ) and Clinical Pharmacology ( 12.3 ) ."	0
The CLOZARIL dose should be increased to the original dose when coadministration of strong CYP1A2 inhibitors is discontinued.	1
Switching from ELIQUIS to anticoagulants other than warfarin (oral or parenteral): Discontinue ELIQUIS and begin taking the new anticoagulant other than warfarin at the usual time of the next dose of ELIQUIS.	0
"If BREVIBLOC is used in the setting of pheochromocytoma , give it in combination with an alpha-blocker , and only after the alpha-blocker has been initiated ."	0
"Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders."	0
"It is unaltered AHA in the urine that provides the therapeutic effect, but the precise concentration of AHA in urine that is necessary to inhibit urease is incompletely delineated."	0
The possibility of this happening can be minimized by allowing a washout period before initiating nefazodone therapy and by reducing the initial dose of nefazodone.	0
Doses in excess of 5 mg daily have not been studied in pediatric patients.	0
"In patients with an activated renin-angiotensin system, such as volume- or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of therapy with MICARDIS."	0
"In plasma, terbinafine is greater than 99% bound to plasma proteins and there are no specific binding sites."	0
Twelve metabolites have been identified in plasma; all except norverapamil are present in trace amounts only.	0
Inhaled beta agonist: Salmeterol <U+2191> salmeterol Coadministration of salmeterol with REYATAZ is not recommended.	0
"Rarely, patients, usually those receiving a beta blocker, have developed heart failure after beginning PROCARDIA."	0
"Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapy, including PREZISTA."	0
"Renal Impairment: Renal disease has no influence on the plasma concentrations or LDL-C reduction of LIPITOR; thus, dose adjustment in patients with renal dysfunction is not necessary."	0
"Effect of Food In healthy adults a high-fat/heavy meal prolonged the absorption of zaleplon compared to the fasted state, delaying tmax by approximately 2 hours and reducing Cmax by approximately 35%."	1
Plasma levels of t-PA are reduced when coadministered with nitroglycerin .	1
These reactions have also been reported in patients who have recently discontinued that drug and have been started on an MAOI.	0
Approximately 25% of an orally administered apixaban dose is recovered in urine and feces as metabolites.	0
Cmax and AUC are each 4-fold greater in patients with Childs-Pugh A disease.	0
SULAR is substrate of CYP3A4 and coadministration of SULAR with any known inducer or inhibitor of CYP3A4 should be avoided in general.	0
Sinus bradycardia resulting in hospitalization and pacemaker insertion has been reported in association with the use of clonidine concomitantly with diltiazem or verapamil.	0
The evidence for efficacy of mercaptopurine in children with ALL is derived from the published literature and clinical experience.	0
"Therefore, concomitant use of these medications is contraindicated."	0
Electroconvulsive Therapy (ECT)<U+2014> There are no clinical studies of the combined use of ECT and paroxetine.	0
IV IV OralAdult patients who weigh less than 40 kg should receive half of the oral maintenance dose.	0
Patients in all studies had moderate to severe OCD (DSM-IIIR) with mean baseline ratings on the Yale Brown Obsessive Compulsive Scale (YBOCS) total score ranging from 23 to 26.	0
Treatment of familial Mediterranean fever <U+2013> co-administration of colchicine in patients on PREZISTA/ritonavir: maximum daily dose of 0.6 mg (may be given as 0.3 mg twice a day).	0
"Plasma concentrations of angiotensin I and angiotensin II, and plasma renin activity (PRA), increased in a dose-dependent manner after single and repeated administration of candesartan cilexetil to healthy subjects, hypertensive, and heart failure patients."	0
There was essentially no change in average heart rate in losartan-treated patients in controlled trials.	0
"Ziprasidone at a dose of 20 mg twice daily did not affect the pharmacokinetics of concomitantly administered oral contraceptives, ethinyl estradiol (0.03 mg) and levonorgestrel (0.15 mg)."	0
"Lotensin is contraindicated inpatients: who are hypersensitive to benazepril or to any other ACEinhibitor with a history of angioedema with or without previous ACE inhibitortreatment Lotensin is contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril)."	0
"Based on drug interaction studies conducted with INVIRASE/ritonavir, no clinically significant effect was observed for saquinavir when coadministered with fosamprenavir."	0
"Single doses of cholestyramine and colestipol resins bind the hydrochlorothiazide and reduce its absorption in the gastrointestinal tract by up to 85 percent and 43 percent, respectively."	1
"In addition, the mean protein binding was found to be lower in the severe hepatic impairment group compared to the normal hepatic function group, which resulted in a two-fold increase in the fraction of free drug in patients with severe hepatic impairment."	0
Dosing in pediatric patients less than 6 kg is not recommended.	0
"In the subgroup of Black patients (n=533; 6% of the LIFE study patients), there were 29 primary endpoints among 263 patients on atenolol (11%, 26 per 1000 patient-years) and 46 primary endpoints among 270 patients (17%, 42 per 1000 patient-years) on losartan potassium tablets."	0
Elimination/Excretion Levomilnacipran and its metabolites are eliminated primarily by renal excretion.	0
The use of alcohol and other CNS depressants may increase the risk of such behaviors.	0
"Based on findings from animal studies and its mechanism of action, Tasigna can cause fetal harm when administered to a pregnant woman."	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
Subgroup analyses did not indicate that there were any differences in treatment outcomes as a function of age or gender.	0
"During initiation of therapy, the patient should be cautioned to avoid situations such as driving or hazardous tasks, where injury could result should syncope occur."	0
Benazepril is almost completely metabolized to benazeprilat by cleavage of the ester group (primarily in liver).	0
Refer to the quetiapine prescribing information for recommendations on adverse reaction monitoring.	0
Monitoring frequency can be reduced to monthly during continued use if no clinically significant changes are noted.	0
Absorption and Distribution Paroxetine hydrochloride is completely absorbed after oral dosing of a solution of the hydrochloride salt.	0
Excessive doses can result in hypotension.	0
No significant interactions were found between nisoldipine and warfarin of digoxin.	0
Combination of these drugs with simvastatin is contraindicated.	0
Tadalafil is also marketed as CIALIS .	0
"In adult placebo-controlled clinical trials across indications from baseline to endpoint, CYMBALTA treatment was associated with mean increases of 0.5mm Hg in systolic blood pressure and 0.8mm Hg in diastolic blood pressure compared to mean decreases of 0.6mm Hg systolic and 0.3mm Hg diastolic in placebo-treated patients."	0
"Co-administration of verapamil with everolimus in 16 healthy volunteers increased the Cmax and AUC of everolimus by 130% and 250%, respectively."	1
Insulin: Patients with insulin-dependent diabetes may require modification of insulin dosage following initiation of treatment with EXTRANEAL.	0
"Therefore, caution should be exercised when using these combinations and the patients should be carefully monitored."	0
"Nevertheless, caution is indicated in the co-administration of TCAs with any of the SSRIs and also in switching from one class to the other."	0
"In steady-state dose proportionality studies involving elderly and nonelderly patients, at doses of 20 mg to 40 mg daily for the elderly and 20 mg to 50 mg daily for the nonelderly, some nonlinearity was observed in both populations, again reflecting a saturable metabolic pathway."	0
"However, the syndrome can develop, although much less commonly, after relatively brief treatment periods at low doses."	0
"Like all ACE inhibitors, trandolaprilat also has a prolonged terminal elimination phase, involving a small fraction of administered drug, probably representing binding to plasma and tissue ACE."	0
"In hemodynamic studies, TIKOSYN had no effect on cardiac output, cardiac index, stroke volume index, or systemic vascular resistance in patients with ventricular tachycardia, mild to moderate congestive heart failure or angina, and either normal or low left ventricular ejection fraction."	0
The enantiomer ratios of the two isomers of fluvastatin in hepatic impairment patients were comparable to those observed in healthy subjects.	0
Geriatric Pharmacokinetics <U+2014> The disposition of single doses of fluoxetine in healthy elderly subjects (>65years of age) did not differ significantly from that in younger normal subjects.	0
Careful monitoring of serum theophylline concentrations in patients receiving DIFLUCAN and theophylline is recommended.	0
"Dual Blockade of the Renin-Angiotensin System (RAS): Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"<U+2022> ACIPHEX is contraindicated in patients with known hypersensitivity to rabeprazole, substituted benzimidazoles, or to any component of the formulation."	0
Discontinuation of LUVOX CR Capsules should be considered in patients with symptomatic hyponatremia and appropriate medical intervention should be instituted.	0
"Potential of Fingolimod and Fingolimod-phosphate to Induce its Own and/or the Metabolism of Comedications Fingolimod was examined for its potential to induce human CYP3A4, CYP1A2, CYP4F2, and MDR1 (P-glycoprotein) mRNA and CYP3A, CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, and CYP4F2 activity in primary human hepatocytes."	0
"Angle Closure Glaucoma: Avoid use of antidepressants, including ZOLOFT, in patients with untreated anatomically narrow angles."	0
"Patients and physicians should be aware, however, that oligohydramnios may not appear until after the fetus has sustained irreversible injury."	0
Dosing adjustments in patients with mild to moderate renal impairment are not necessary.	0
Warfarin: Multiple oral doses of Zaleplon (20 mg q24h for 13 days) did not affect the pharmacokinetics of warfarin (R+)- or (S-)-enantiomers or the pharmacodynamics (prothrombin time) following a single 25-mg oral dose of warfarin.	0
"No evidence of a mutagenic potential of atenolol was uncovered in the dominant lethal test (mouse), in vivo cytogenetics test (Chinese hamster) or Ames test (S typhimurium)."	0
Total daily dose should not exceed 6 mg. (2.3) Should not be taken within 3 hours of a meal.	0
"Following administration of non-liposomal irinotecan (i.e., irinotecan HCl), patients receiving concomitant ketoconazole, a CYP3A4 andUGT1A1 inhibitor, have increased exposure to irinotecan and its active metabolite SN-38."	1
"Immune System Effects on Immune Cell Numbers in the Blood In a study in which 12 subjects received GILENYA 0.5 mg daily, the lymphocyte count decreased to approximately 60% of baseline within 4 to 6 hours after the first dose."	0
Patients should be cautioned about potential additive effects of Silenor used in combination with CNS depressants or sedating antihistamines.	0
"Absorption After oral administration of therapeutic doses, peak plasma levels of CARDURA occur at about 2<U+2013>3 hours."	0
Reduce dose of digoxin by half or discontinue digoxin.	0
The recommended starting dose of ULORIC is 40 mg once daily.	0
"The concomitant administration of quinidine and nortriptyline may result in a significantly longer plasma half-life, higher AUC, and lower clearance of nortriptyline."	1
"Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including telmisartan, may result in deterioration of renal function, including possible acute renal failure."	0
Effect of AUBAGIO on oral contraceptives AUBAGIO may increase the systemic exposures of ethinylestradiol and levonorgestrel.	1
Sample Dilutions and Infusion Rates to Provide a Dosage of 0.1 Micrograms per Kilogram of Body Weight per Minute Add 1 ampoule (500 micrograms) alprostadil to: Approximate Concentration of resulting solution (micrograms/mL) Infusion rate (mL/min per kg of body weight) Example: To provide 0.1 micrograms/kilogram of body weight per minute to an infant weighing 2.8 kilograms using a solution of 1 ampoule PROSTIN VR PEDIATRIC in 100 mL of saline or dextrose: INFUSION RATE = 0.02 mL/min per kg <U+00D7> 2.8 kg = 0.056 mL/min or 3.36 mL/hr.	0
Leukopenia does not correlate with therapeutic effect; therefore the dose should not be increased intentionally to lower the white blood cell count.	0
The mean baseline LDL<U+2011>C value was 253.1mg/dL (range: 171-379mg/dL) in the MEVACOR group compared to 248.2mg/dL (range: 158.5-413.5mg/dL) in the placebo group.	0
"Select a concentration for the solution of FLOLAN that is compatible with the infusion pump being used with respect to minimum and maximum flow rates, reservoir capacity, and the infusion pump criteria listed below."	0
Patients with a history of a clinically significant low WBC or drug induced leukopenia/neutropenia should have their complete blood count (CBC) monitored frequently during the first few months of therapy and discontinuation of ORAP should be considered at the first sign of a clinically significant decline in WBC in the absence of other causative factors.	0
"In patients with known or suspected pheochromocytoma, initiate an <U+03B1>-blocker prior to the use of any <U+03B2>-blocker."	0
"Other Agents Antiarrhythmics:bepridil, lidocaine(systemic) and quinidine <U+2191> antiarrhythmic agents concentration Caution is warranted and therapeutic concentration monitoring is recommended for antiarrhythmics when coadministered with CRIXIVAN."	0
"There has been a long-standing concern, however, that antidepressants may have a role in inducing worsening of depression and the emergence of suicidality in certain patients during the early phases of treatment."	0
Patients should be advised of the following issues and asked to alert their prescribers if these occur while taking nortriptyline hydrochloride.	0
Children(N = 10) Adolescent (N = 17) Adolescent (N = 13) Adult (N = 16) AUC 0-12 (ng<U+2022>h/mL/kg) 155.1 (160.9) 43.9 (27.9) 69.6 (46.6) 59.4 (40.9) Cmax (ng/mL/kg) 14.8 (14.9) 4.2 (2.6) 6.7 (4.2) 5.7 (3.9) Cmin (ng/mL/kg) 11 (11.9) 2.9 (2) 4.8 (3.8) 4.6 (3.2) TABLE 5 COMPARISON OF MEAN (SD) FLUVOXAMINE PHARMACOKINETIC PARAMETERS BETWEEN MALE AND FEMALE CHILDREN (6 TO 11 YEARS) Pharmacokinetic Parameter (body weight corrected) Dose = 200 mg/day (100 mg b.i.d.)	0
"To minimize dose-independent hazards, it is usually appropriate to begin therapy with TARKA only after a patient has either (a) failed to achieve the desired antihypertensive effect with one or the other monotherapy at its respective maximally recommended dose and shortest dosing interval, or (b) the dose of one or the other monotherapy cannot be increased further because of dose-limiting side effects."	0
"Symptoms include unexplained fever, dyspnea, hypoxia, pulmonary infiltrates, pleural or pericardial effusion, weight gain, peripheral edema, hypotension, renal insufficiency, hepatopathy and multi-organ dysfunction."	0
Specific Populations Renal Insufficiency Telmisartan: No dosage adjustment is necessary in patients with decreased renal function.	0
"The mechanism by which fingolimod exerts therapeutic effects in multiple sclerosis is unknown, but may involve reduction of lymphocyte migration into the central nervous system."	0
No formal studies have been performed in patients with severe hepatic impairment and nebivolol should be contraindicated for these patients.	0
Nisoldipine is relatively well absorbed into the systemic circulation with 87% of the radiolabeled drug recovered in urine and feces.	0
"Antagonism of some of these receptors is thought to be associated with various sedative, cardiovascular, anticholinergic, and extrapyramidal effects of some psychotropic drugs."	0
"Selegiline (the drug substance of EMSAM) is an irreversible inhibitor of monoamine oxidase (MAO), a ubiquitous intracellular enzyme."	0
There is no clinical experience to reverse bleeding with the use of 4-factor PCC products in individuals who have received ELIQUIS.	0
"General Anesthetics <U+2013> Little is known about the potential for interaction between nefazodone and general anesthetics; therefore, prior to elective surgery, nefazodone hydrochloride should be discontinued for as long as clinically feasible."	0
Gender A single-dose study involving 12 healthy male and 12 healthy female volunteers revealed no sex-related differences in the pharmacokinetic parameters of bupropion.	0
"Trandolapril Component Following oral administration of trandolapril, the absolute bioavailability of trandolapril is approximately 10% as trandolapril and 70% as trandolaprilat."	0
"Antiarrhythmic Amiodarone, dronedarone, flecainide, propafenone, quinidine Potential for cardiac arrhythmias."	0
NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7).	0
"Furthermore, whenever one of these other drugs is withdrawn from cotherapy, an increased dose of tricyclic antidepressant may be required."	0
Maximum observed plasma concentrations are reached within 30 to 120 minutes (median 60 minutes) of oral dosing in the fasted state.	0
Meperidine is contraindicated in patients who are receiving monoamine oxidase (MAO) inhibitors or those who have recently received such agents.	0
The safety of nefazodone in long-term use is supported by data from both double-blind and open-label trials involving more than 250 patients treated for at least one year.	0
"Surgery/Anesthesia: In patients undergoing major surgery or during anesthesia with agents that produce hypotension, PRINIVIL may block angiotensin II formation secondary to compensatory renin release."	0
Elimination of ziprasidone is mainly via hepatic metabolism with a mean terminal half-life of about 7 hours within the proposed clinical dose range.	0
"The duration of separation depends upon the absorption characteristics of the medication concomitantly administered, such as the time to reach peak systemic levels and whether the drug is an immediate-release or an extended-release product."	0
Steady-state concentrations of 9-hydroxyrisperidone are reached in 5-6 days (measured in extensive metabolizers).	0
Coadministration of losartan and phenobarbital led to a reduction of about 20% in the AUC of losartan and that of its active metabolite.	1
"In these studies, there was no evidence of worsening of heart failure based on measures of exercise tolerance, NYHA classification, symptoms, or LVEF."	0
"Reduction in the risk of myocardial infarction, stroke, or death from cardiovascular causes: 2.5 mg once daily for 1 week, 5 mg once daily for 3 weeks, and increased as tolerated to a maintenance dose of 10 mg once daily (2.2)."	0
"However, norepinephrine may still be used effectively."	0
No further down titration of TIKOSYN based on QTc is recommended.	0
This diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.	0
Hormonal contraceptives: ethinyl estradiol and norgestimate or norethindrone <U+2193> ethinyl estradiol<U+2191> norgestimatec <U+2191> ethinyl estradiol<U+2191> norethindroned Use with caution if coadministration of REYATAZ or REYATAZ/ritonavir with oral contraceptives is considered.	0
"In the presence of inflammation, levels of penicillin in abscesses, middle ear, pleural, peritoneal and synovial fluids are sufficient to inhibit most susceptible bacteria."	0
"New onset diabetes mellitus, exacerbation of pre-existing diabetes mellitus, and hyperglycemia have been reported during postmarketing surveillance in HIV-infected patients receiving protease inhibitor therapy."	0
Do not use MAOIs intended to treat psychiatric disorders with desvenlafaxine or within 7 days of stopping treatment with desvenlafaxine.	0
"Because chlorpromazine can suppress the cough reflex, aspiration of vomitus is possible."	0
Fluvoxamine maleate is extensively metabolized by the liver; the main metabolic routes are oxidative demethylation and deamination.	0
The pharmacokinetics are linear over the clinical dosing range.	0
"Studies of Lidocaine Hydrochloride Injection, USP in animals to evaluate the carcinogenic and mutagenic potential or the effect on fertility have not been conducted."	0
Treatment and Reduction in the Risk of Recurrence of Deep Venous Thrombosis and Pulmonary Embolism Dosing recommendations for patients with CrCl <U+2264>30 mL/min cannot be provided.	0
Its diuretic action commences a mean of 2.6 hours after dosing and continues for up to 72 hours.	0
Pregnancy Category D Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.	0
"In patients with acute myocardial infarction, cardiac failure which is not promptly and effectively controlled by 80 mg of intravenous furosemide or equivalent therapy is a contraindication to beta-blocker treatment."	0
"Once-daily regimens, and regimens with one daily interdosing interval of at least 14 hours (e.g., a regimen providing doses at 0800, 1400 and 1800 hours), have shown efficacy after the first dose of each day that was similar to that shown in the single dose studies cited above."	0
"The pooled analyses of placebo-controlled trials in children and adolescents with MDD, obsessive compulsive disorder (OCD), or other psychiatric disorders included a total of 24 short-term trials of 9 antidepressant drugs in over 4400 patients."	0
Epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an NSAID or aspirin may potentiate this risk of bleeding.	0
"In rats, given 200 mg/kg/day, (about 6 times the recommended human daily dose based on body surface area comparisons), there was a decrease in fetal viability."	0
"The dose of MAXALT should be adjusted in propranolol-treated patients, as propranolol has been shown to increase the plasma AUC of rizatriptan by 70%."	1
"In a dose proportionality study involving fluvoxamine maleate at 100, 200 and 300 mg/day for 10 consecutive days in 30 normal volunteers, steady state was achieved after about a week of dosing."	0
These recommendations are based on either drug interaction studies or predicted interactions due to the expected magnitude of interaction and potential for serious adverse events or loss of efficacy.	0
The lack of a drug interaction following single-dose administration does not predict the complete absence of a pharmacodynamic effect following chronic administration.	0
"A few cases of accelerated growth of lung carcinoma have been reported in man, but a causal relationship with the drug has not been established."	0
"Because its use and safety have not been evaluated in other childhood disorders, ORAP is not recommended for use in any condition other than Tourette<U+2019>s Disorder."	0
"Consult the full prescribing information prior to and during treatment for potential drug interactions (5.1, 7.3) QT and PR interval prolongations have been observed in a healthy volunteer study."	0
Triptans - There have been rare post marketing reports of serotonin hydrochloride syndrome with use of an SNRI or an SSRI and a triptan.	0
"Overall, 72% of patients received the 100-mg daily dose more than 50% of the time they were on study drug."	0
Apixaban is a substrate of transport proteins: P-gp and breast cancer resistance protein.	0
"Prior to initiation of PURIXAN and on each visit to the clinic, train patients or caregivers on proper handling, storage, administration, disposal and clean-up of accidental spillage of the medication."	0
"In these patients, lipid disorders should be managed as clinically appropriate."	0
Coadministration of fluconazole and astemizole is contraindicated.	0
"Caution must be exercised if the concomitant use of fluconazole and amiodarone is necessary, notably with high-dose fluconazole (800 mg)."	0
Both elevation and lowering of blood sugar levels have been reported.	0
"Although 60 - 80% of an oral dose undergoes urinary excretion, only traces of unchanged nisoldipine are found in urine."	0
Dose reduction of NSAIDs may be needed.	1
"For ADASUVE, the order of metabolites observed in humans (based on systemic exposure) was 8-OH-loxapine >> loxapine N-oxide, 7-OH-loxapine > amoxapine."	0
Study 1 was an 8-week study comparing fixed paroxetine doses of 20 mg or 40 mg/day with placebo.	0
Fluvoxamine and thioridazine should not be coadministered.	0
The induced alkaline load in turn increases urinary pH and raises urinary citrate by augmenting citrate clearance without measurably altering ultrafilterable serum citrate.	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy."	0
Patients using estrogens as hormone replacement therapy should be clinically monitored for signs of estrogen deficiency.	0
"Published data are inadequate to determine whether chronic use of amphetamines may cause a similar suppression of growth, however, it is anticipated that they likely have this effect as well."	0
"Following oral administration of Accupril (quinapril monotherapy) tablets, peak plasma quinapril concentrations are observed within 1 hour."	0
"If an allergic reaction to NATRECOR<U+00AE> occurs, discontinue the drug."	0
"Although these results suggest no adjustments in warfarin dosage are required when nefazodone is administered to patients stabilized on warfarin, such patients should be monitored as required by standard medical practices."	0
"As with other drugs having efficacy in bipolar disorder, the mechanism of action of ziprasidone in bipolar disorder is unknown."	0
A causal relationship has not been established.	0
Simultaneous administration of sucralfate and LASIX tablets may reduce the natriuretic and antihypertensive effects of LASIX .	0
"In the rabbit, maternal toxicity, mortality, decreased weight gain, and embryotoxicity including increased resorptions were dose-related."	0
Calcium excretion is decreased by thiazide-like drugs.	0
"Factors that can increase the risk of developing epidural or spinal hematomas in these patients include: use of indwelling epidural catheters<U+2003><U+2022> concomitant use of other drugs that affect hemostasis, such as non-steroidal anti-inflammatory drugs (NSAIDs), platelet inhibitors, other anticoagulants<U+2003><U+2022> a history of traumatic or repeated epidural or spinal punctures<U+2003><U+2022> a history of spinal deformity or spinal surgery<U+2003><U+2022> optimal timing between the administration of PRADAXA and neuraxial procedures is not known."	0
"In adult placebo-controlled studies using a fixed dose design, there was evidence of a dose response relationship for ALT and AST elevation of >3 times the upper limit of normal and >5 times the upper limit of normal, respectively."	0
Midazolam (a sensitive CYP 3A4 substrate):A study in patients with schizophrenia showed a less than 50% increase in midazolam total exposure at iloperidone steady state (14 days of oral dosing at up to 10 mg iloperidone twice daily) and no effect on midazolam Cmax.	1
There is little experience with infusion durations beyond 72 hours at any dose.	0
"For a gradual blood pressure reduction the rate can be increased every 15 minutes, for a rapid reduction, every 5 minutes (2.4)."	0
The use of thiazides and triamterene in pregnant women requires that the anticipated benefits be weighed against possible hazards to the fetus.	0
TPMT TESTING CANNOT SUBSTITUTE FOR COMPLETE BLOOD COUNT (CBC) MONITORING IN PATIENTS RECEIVING IMURAN.	0
"Zaleplon was not distinguishable from placebo at doses of 5 mg, 10 mg, or 20 mg on this measure, nor was Zaleplon distinguishable from placebo on spontaneously reported withdrawal-emergent adverse events."	0
"Active Liver Disease, Which May Include Unexplained Persistent Elevations in Hepatic Transaminase Levels Pregnancy Lactation Active liver disease (4) Pregnancy (4) Lactation (4)"	0
"Triamterene and hydrochlorothiazide should be used with caution in patients with impaired hepatic function or progressive liver disease, since minor alterations of fluid and electrolyte balance may precipitate hepatic coma."	0
Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate.	0
"Avoid administration of NATRECOR<U+00AE> in patients suspected of having, or known to have, low cardiac filling pressures."	0
"MEVACOR is a specific inhibitor of HMG<U+2011>CoA reductase, the enzyme which catalyzes the conversion of HMG<U+2011>CoA to mevalonate."	0
"Based on efficacy and tolerability, dosing may be titrated according to the following schedule (2.1): Day 1: 12.5 mg once Days 2-3: 25 mg/day (12.5 mg twice daily) Days 4-7: 50 mg/day (25 mg twice daily) After Day 7: 100 mg/day (50 mg twice daily) Recommended dose is 100 mg/day (2.1)."	0
Metabolism and Excretion The mean elimination half-life is approximately 21 hours (CV 32%) after oral dosing of 30 mg tablets daily for 30 days of paroxetine.	0
Pharmacokinetics of sertraline and N-desmethylsertraline were unaffected by zolpidem.	0
"With chronic once daily oral administration, antihypertensive effectiveness is maintained for at least 24 hours."	0
AVALIDE may be administered with other antihypertensive agents.	0
Selegiline hydrochloride is contraindicated in patients with a known hypersensitivity to this drug.	0
Aprepitant acts as a weak inhibitor when administered as a single 40-mg dose and has not been shown to alter the plasma concentrations of concomitant drugs that are primarily metabolized through CYP3A4.	0
IMMUNOSUPPRESSANTS CyclosporineTacrolimusSirolimus <U+2191> immuno-suppressants<U+2191> nelfinavir Concentrations of these immunosuppressants and nelfinavir may be increased by coadministration of these agents with nelfinavir.	1
"IMNM is characterized by: proximal muscle weakness and elevated serum creatine kinase, which persist despite discontinuation of statin treatment; muscle biopsy showing necrotizing myopathy without significant inflammation; improvement with immunosuppressive agents."	0
The number of tablets and volume of vehicle specified below will yield 160 mL of a 1 mg/mL suspension.	0
Class I or Class III antiarrhythmic agents should be withheld for at least three half-lives prior to dosing with TIKOSYN.	0
The use of MAOIs intended to treat psychiatric disorders with nortriptyline hydrochloride oral solution USP or within 14 days of stopping treatment with nortriptyline hydrochloride oral solution USP is contraindicated because of an increased risk of serotonin syndrome.	0
An initial dose of 5 mg should be given to patients who are concomitantly being treated with cimetidine.	0
The results suggest that the use of sertraline in patients with liver disease must be approached with caution.	0
"There were differences in absolute risk of suicidality across the different indications, with the highest incidence in MDD."	0
"When maximum response is obtained, the dose may be maintained at 1 to 2 mg/kg/day."	0
Maximum concentrations (Cmax) of apixaban appear 3 to 4 hours after oral administration of ELIQUIS.	0
"Other organisms susceptible to penicillin G are N. gonorrhoeae, Corynebacterium diphtheriae, Bacillus anthracis, Clostridium spp, Actinomyces species, ""Spirillum minus"", Streptobacillus moniliformis, Listeria monocytogenes and Leptospira spp; Treponema pallidum is extremely sensitive to the bactericidal action of penicillin G. Some species of gram-negative bacilli were previously considered susceptible to very high intravenous doses of penicillin G (up to 80 million units/day) including some strains of Escherichia coli, Proteus mirabilis, Salmonella spp."	0
Consider the potential for drug interactions prior to and during therapy with LEXIVA/ritonavir; review concomitant medications during therapy with LEXIVA/ritonavir; and monitor for the adverse reactions associated with the concomitant medications.	0
This finding should be given special consideration when the patient is young and chronic use of pimozide is anticipated.	0
"Risk factors for the development of hyperkalemia include renal insufficiency, diabetes mellitus, and the concomitant use of potassium-sparing diuretics, potassium supplements and/or potassium-containing salt substitutes."	0
"Maintenance and digitalization doses should be reduced when verapamil is administered, and the patient should be reassessed to avoid over- or under-digitalization."	1
GI Motility Agent Cisapride Potential for cardiac arrhythmias.	0
Trandolapril can cause symptomatic hypotension.	0
Choose an appropriate oral contraceptive (7) Drugs metabolized by CYP1A2: Monitor patients because teriflunomide may decrease exposure of these drugs (7) Warfarin: Monitor INR as teriflunomide may decrease INR (7) Drugs metabolized by BCRP and OATP1B1/B3 transporters: Monitor patients because teriflunomide may increase exposure of these drugs (7) Rosuvastatin: The dose of rosuvastatin should not exceed 10 mg once daily in patients taking AUBAGIO (7) Effect of AUBAGIO on CYP2C8 substrates Teriflunomide is an inhibitor of CYP2C8 in vivo.	1
"Administration of reserpine during therapy with a tricyclic antidepressant has been shown to produce a ""stimulating"" effect in some depressed patients."	0
Peak plasma concentrations are reached within about 2 hours following an oral dose.	0
"Therefore, it is desirable to maintain normal serum potassium and magnesium concentrations in patients being treated with digoxin."	0
"Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8 fold increase in plasma AUC of the TCA)."	0
Caution patients without overt coronary artery disease against interruption or abrupt discontinuation of therapy.	0
A further phenomenon of toxicity common to many hydrazine derivatives is hemolysis and the appearance of Heinz-Ehrlich inclusion bodies in erythrocytes.	0
"Norfluoxetine, however, appears to have linear pharmacokinetics."	0
"Although such an interaction has not been reported to date with amoxapine, specific interaction studies have not been done, and the possibility should be considered."	0
"If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus."	0
Study 2 was a 12-week flexible-dose study comparing paroxetine (10 to 60 mg daily) and placebo.	0
Cross-sensitivity between this and other dibenzazepines is a possibility.	0
"Phendimetrazine tartrate, a phenylalkylamine sympathomimetic amine has pharmacological activity similar to amphetamines."	0
Monitor renal function periodically in patients receiving quinapril and NSAID therapy.	0
"In a pooled survival analysis of patients in the supraventricular arrhythmia population (low prevalence of structural heart disease), deaths occurred in 0.9% (12/1346) of patients receiving TIKOSYN and 0.4% (3/677) in the placebo group."	0
In vitro studies have shown that CYP3A4 and CYP2E1 enzymes are involved in the metabolism of eszopiclone.	0
"During the clinical development program (N=3063), hepatitis was reported in 0.5% of patients receiving combination therapy with PREZISTA/ritonavir."	0
Use aseptic technique and discard any unused product within 12 hours of stopper puncture.	0
"The pooled analyses of placebo-controlled trials in children and adolescents with MDD, obsessive compulsive disorder (OCD), or other psychiatric disorders included a total of 24 short-term trials of 9 antidepressant drugs in over 4400 patients."	0
Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses.	0
"The mean placebo-subtracted reductions in supine systolic and diastolic blood pressure at trough, 24 hours post-dose, in these studies, are shown below."	0
"If indinavir and didanosine are administered concomitantly, they should be administered at least one hour apart on an empty stomach (consult the manufacturer's product circular for didanosine)."	0
"Due to this risk, thioridazine is indicated only for schizophrenic patients who have not been responsive to or cannot tolerate other antipsychotic agents."	0
"Hyponatremia may occur as a result of treatment with SSRIs and SNRIs, including Savella."	0
Data on other hemodynamic measures for the REVATIO 20 mg three times a day and placebo dosing regimens is displayed in Table 3.	0
Alteration in dose or avoidance of the combination may be recommended depending on the interaction.	0
Do not coadminister aliskiren with Edarbi in patients with diabetes .	0
Combined fluoxetine plus norfluoxetine plasma concentrations were 209.3<U+00B1>85.7ng/mL at the end of 6weeks.	0
"If AF is detected discontinue MULTAQ or cardiovert (5.2) Ensure appropriate antithrombotic therapy prior to and throughout MULTAQ use (5.3) Liver injury: if hepatic injury is suspected, discontinue MULTAQ (5.5) If pulmonary toxicity is confirmed, discontinue treatment (5.6) Hypokalemia and hypomagnesemia: Maintain potassium and magnesium levels within the normal range (5.7) Renal Impairment: Monitor renal function periodically (5.9) Teratogen: Women of childbearing potential should use effective contraception while using MULTAQ (5.10) MULTAQ is contraindicated in patients with NYHA Class IV heart failure or symptomatic heart failure with recent decompensation requiring hospitalization because it doubles the risk of death."	0
"However, if deemed necessary, use with caution and at lowest effective dose."	0
"In many cases, this hyponatremia appears to be the result of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)."	0
"In man, the Class II (beta-blockade) electrophysiological effects of sotalol are manifested by increased sinus cycle length (slowed heart rate), decreased AV nodal conduction and increased AV nodal refractoriness."	0
The preservative sodium metabisulfite is incompatible with NATRECOR<U+00AE>.	0
"In patients requiring hydrochlorothiazide therapy and in whom hypokalemia cannot be risked, therapy may be initiated with 37.5 mg/25 mg of triamterene and hydrochlorothiazide."	0
"Caution is to be exercised in prescribing diethylpropion hydrochloride for patients with hypertension or with symptomatic cardiovascular disease, including arrhythmias."	0
In vitro studies in animals also suggest that sertraline is a potent and selective inhibitor of neuronal serotonin reuptake and has only very weak effects on norepinephrine and dopamine neuronal reuptake.	0
Do not abruptly discontinue Meperidine Hydrochloride Injection in a physically-dependent patient.	0
Combined P-gp and strong CYP3A4 inhibitors increase exposure to rivaroxaban and may increase the risk of bleeding .	0
Cardiac Electrophysiology No prolongation of the QTc interval was observed with dabigatran etexilate at doses up to 600 mg.	0
"Thioridazine <U+2014> Thioridazine should not be administered with PROZAC or within a minimum of 5weeks after PROZAC has been discontinued, because of the risk of QT Prolongation."	0
"Based on the mechanism of action of desvenlafaxine and the potential for serotonin syndrome, caution is advised when desvenlafaxine is co-administered with other drugs that may affect the serotonergic neurotransmitter systems."	0
"At steady state, elderly subjects had increases in Cmax (22%) and AUC (45%) compared with younger subjects (18 to 45 years)."	0
Some patients may respond to the starting dose.	0
"When the CYP2D6 inhibitor is withdrawn from the combination therapy, iloperidone dose could then be increased to previous levels."	1
Adjust the rate of infusion as needed to maintain desired response.	0
Alter the infusion by 1- to 2-ng/kg/min increments at intervals sufficient to allow assessment of clinical response.	0
"When potassium citrate extended-release tablets are given orally, the metabolism of absorbed citrate produces an alkaline load."	0
"The pharmacokinetics of orally administered telmisartan are nonlinear over the dose range 20 to 160 mg, with greater than proportional increases of plasma concentrations (Cmax and AUC) with increasing doses."	0
"Paroxetine and Ketoconazole: Co-administration of paroxetine (20 mg once daily for 10 days), a CYP2D6 inhibitor, and ketoconazole (200 mg twice daily) with multiple doses of iloperidone (8 or 12 mg twice daily) to patients with schizophrenia ages 18 to 65 years resulted in a 1.4-fold increase in steady-state concentrations of iloperidone and its metabolite P88 and a 1.4-fold decrease in the P95 in the presence of paroxetine."	1
"However, these effects on heart rate and blood pressure were not seen in another study after the coadministration with inhaled dose of albuterol (200-800 mcg) and atomoxetine (80 mg QD for 5 days) in 21 healthy Asian subjects who were excluded for poor metabolizer status."	0
Fluconazole should be administered with caution to patients with these potentially proarrhythmic conditions.	0
Avoid use with strong CYP3A inhibitors or CYP3A inducers.	0
Do not use aliskiren with ARBs or ACEIs in patients with diabetes see Warnings and Precautions ( 5.2 ) and Clinical Studies ( 14.3 ) .	0
"ACE is identical to kininase, an enzyme that degrades bradykinin."	0
"Digoxin : In patients receiving digoxin therapy , administration of oral amiodarone results in an increase in serum digoxin concentration ."	1
"Following oral administration of AVAPRO, peak plasma concentrations of irbesartan are attained at 1.5 to 2 hours after dosing."	0
A causal relationship has not been established.	0
Use BRILINTA with a daily maintenance dose of aspirin of 75-100 mg .	0
Effects of REVATIO on Hemodynamic Measures Patients on all REVATIO doses achieved a statistically significant reduction in mean pulmonary arterial pressure (mPAP) compared to those on placebo in a study with no background vasodilators [Study 1 in Clinical Studies (14)].	0
The Ames and Alkaline Elution assays reveal no potential for mutagenesis.	0
The median time to onset of rash was 53 days and the median duration of rash was 22 days.	0
"Press the bottle adaptor into the neck of the bottle (as shown on Figure 5, below)."	0
Fertility was impaired in male rats given 160 mg/kg (32 times the recommended human daily dose).	0
"Co-administration of lovastatin and SAMSCA increases the exposure to lovastatin and its active metabolite lovastatin - hydroxyacid by factors of 1.4 and 1.3 , respectively ."	1
Long-acting beta-adrenoceptor agonist: salmeterol <U+2191> salmeterol Concurrent administration of salmeterol and ritonavir is not recommended.	0
"The intravenous administration of these solutions can cause fluid and/or solute overloading resulting in dilution of serum electrolyte concentrations, overhydration, congested states or pulmonary edema."	0
"Limit LIVALO to 1 mg once daily (2.3, 7.2) Rifampin: Combination increases pitavastatin exposure."	1
"When amitriptyline hydrochloride is given with anticholinergic agents or sympathomimetic drugs, including epinephrine combined with local anesthetics, close supervision and careful adjustment of dosages are required."	0
Fluoxetine binds to these and other membrane receptors from brain tissue much less potently invitro than do the tricyclic drugs.	0
No dose adjustment is necessary in patients with mild to moderate hepatic impairment.	0
"If the initial dose is well tolerated, ACCUPRIL may be administered the following day as a twice daily regimen."	0
"The mechanism of action of FANAPT, as with other drugs having efficacy in schizophrenia, is unknown."	0
"If signs or symptoms of hypothyroidism occur, examine thyroid hormone levels and adjust thyroid replacement therapy accordingly."	0
"Pooled analyses of short-term placebo-controlled trials of antidepressant drugs (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18-24) with major depressive disorder (MDD) and other psychiatric disorders."	0
Paralytic ileus may occur in patients taking tricyclic antidepressants in combination with anticholinergic drugs.	0
Enhanced marrow suppression has been noted in some patients also receiving trimethoprim-sulfamethoxazole.	0
"Once treatment with INSPRA has begun, adjust the dose based on the serum potassium level as shown in Table 1."	0
"Most notably, it is commonly seen in alcoholics and in patients with diabetes mellitus or hypercalcemia."	0
No adjustment of dosage for such patients is recommended.	0
ACEON is not recommended in patients with creatinine clearance <30 mL/min.	0
"Monitor patients frequently for signs and symptoms of neurological impairment (e.g., numbness or weakness of the legs, or bowel or bladder dysfunction)."	0
"Telmisartan In patients with an activated renin-angiotensin system, such as volume- or salt-depleted patients (e.g., those being treated with high doses of diuretics), symptomatic hypotension may occur after initiation of therapy with TWYNSTA tablets."	0
Reproduction studies in animals were not adequate to assess all aspects of fertility.	0
"In poor CYP 2D6 metabolizers, ORAP doses should not exceed 4 mg/day, and doses should not be increased earlier than 14 days."	0
This diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.	0
"Quinidine is contraindicated in patients who are known to be allergic to it, or who have developed thrombocytopenic purpura during prior therapy with quinidine or quinine."	0
"As usual for patients with increased risk for skin cancer, exposure to sunlight and ultraviolet light should be limited by wearing protective clothing and using a sunscreen with a high protection factor."	0
"Drug Interactions In vivo In a study of 15 healthy subjects, a co-administered single dose of 4 calcium acetate tablets (approximately 2.7 g) decreased the bioavailability of ciprofloxacin by approximately 50%."	1
"As is the case with tricyclic antidepressants to which Anafranil is closely related, leukocyte and differential blood counts should be obtained in patients who develop fever and sore throat during treatment with Anafranil."	0
"Thus, an interaction between iloperidone and other CYP3A4 substrates is unlikely."	0
"With constant infusion, blood pressure begins to fall within minutes."	0
Lexapro is not approved for use in pediatric patients less than 12 years of age (5.1).	0
"Because not all commercially available dosage forms of triazolam permit sufficient dosage reduction, coadministration of triazolam with nefazodone should be avoided for most patients, including the elderly."	1
This test is a more specific measure of the effect of dabigatran than activated partial thromboplastin time (aPTT).	0
"When phenytoin, carbamazepine, or another inducer of hepatic metabolism (such as rifampicin) is added to mirtazapine therapy, the mirtazapine dose may have to be increased."	1
"In a longer-term trial, 566 patients meeting DSM-IV criteria for Generalized Anxiety Disorder, who had responded during a single-blind, 8-week acute treatment phase with 20 to 50 mg/day of paroxetine, were randomized to continuation of paroxetine at their same dose, or to placebo, for up to 24 weeks of observation for relapse."	0
"The risk of fracture was increased in patients who received high-dose, defined as multiple daily doses, and long-term PPI therapy (a year or longer)."	0
"), not over 75 mg/day except in severe cases."	0
"In such patients, thiazides may precipitate azotemia."	0
Do not use SAMSCA with strong inhibitors of CYP 3A [see Contraindications (4.4)] and avoid concomitant use with moderate CYP 3A inhibitors.	0
Verapamil may inhibit the clearance and increase the plasma levels of theophylline.	1
Tadalafil ( 10 mg and 20 mg once daily ) does not potentiate the increase in bleeding time caused by aspirin see Clinical Pharmacology ( 12.3 ) .	0
"TENORMIN may be used alone or concomitantly with other antihypertensive agents including thiazide-type diuretics, hydralazine, prazosin, and alpha-methyldopa."	0
Patients allergic to sulfonamides may also be allergic to LASIX .	0
Any chloride deficit is generally mild and usually does not require specific treatment except under extraordinary circumstances (as in liver disease or renal disease).	0
"In patients with hypertension receiving a moderate CYP3A inhibitor, initiate at 25 mg once daily."	0
"The concomitant use of PRADAXA with P-gp inducers (e.g., rifampin) reduces exposure to dabigatran and should generally be avoided."	1
Whether any of the symptoms described above represent such a conversion is unknown.	0
Elimination half-life may be prolonged in the elderly.	0
"In both Studies 2 and 3, the mean paroxetine dose for completers at endpoint was approximately 40 mg/day of paroxetine."	0
Steady-state concentrations of levomilnacipran are predictable from single-dose data.	0
Penicillin G is actively secreted into the bile resulting in levels at least 10 times those achieved simultaneously in serum.	0
The potential for increased sedation when Tenex is given with other CNS-depressant drugs should be appreciated .	0
A no effect level for embryo-fetal toxicity was not established in rats.	0
"The magnitude of the impact of this factor is small in comparison to the overall variability between individuals, and therefore dose modification is not routinely recommended."	0
"Benzodiazepines : Alprazolam, clorazepate, diazepam, flurazepam <U+2191> Benzodiazepines Clinical significance is unknown."	0
"A third study, also flexible-dose comparing paroxetine (20 mg to 50 mg daily), did not demonstrate statistically significant superiority of paroxetine over placebo on the Hamilton Rating Scale for Anxiety (HAM-A) total score, the primary outcome."	0
"In vitro studies suggest the importance of LIPITOR metabolism by cytochrome P450 3A4, consistent with increased plasma concentrations of LIPITOR in humans following co-administration with erythromycin, a known inhibitor of this isozyme."	1
CMI is extensively biotransformed to DMI and other metabolites and their glucuronide conjugates.	0
Single doses greater than 16 mg have not been studied.	0
"Caution is indicated in the coadministration of tricyclic antidepressants (TCAs) with paroxetine, because paroxetine may inhibit TCA metabolism."	1
"Male and female rats exposed to the highest tested concentration received triamterene at about 25 and 30 mg/kg/day, respectively."	0
Manage hypothyroidism by reducing the dose of or discontinuing NEXTERONE and considering the need for thyroid hormone supplement .	0
"If serious liver injury with clinical symptoms and/or hyperbilirubinemia or jaundice occurs during treatment with ZOCOR, promptly interrupt therapy."	0
Cutaneous and Systemic Lupus Erythematosus: Mostly cutaneous; new onset or exacerbation of existing disease; discontinue PROTONIX and refer to specialist for evaluation.	0
You should always add a total of 90 mL of water irrespective of the dose prescribed.	0
"Altered anticoagulant effects, including increased bleeding, have been reported when SSRIs and SNRIs are co-administered with warfarin."	0
Cases of nephrolithiasis were reported during postmarketing surveillance in HIV-1-infected patients receiving LEXIVA.	0
"If excessive hypotension occurs, place the patient in a supine position and, if necessary, treat with intravenous infusion of physiological saline."	0
Co-administration of PREZISTA/ritonavir with other drugs can alter the concentrations of other drugs and other drugs may alter the concentrations of darunavir.	0
"For maximum therapeutic effect, the dosage of Marplan must be individually adjusted on the basis of careful observation of the patient."	0
The effect of either agent on the other's inhibition of platelet reactivity has not been evaluated.	0
"Elimination: Following administration of 14C-quazepam, 31% of the dose appeared in the urine and 23% in the feces over five days; only trace amounts of unchanged drug were present in the urine."	0
"As with any effective diuretic , electrolyte depletion may occur during LASIX therapy , especially in patients receiving higher doses and a restricted salt intake ."	0
Furosemide : Oral coadministration of aliskiren and furosemide reduced exposure to furosemide .	1
Clarithromycin: combination increases exposure.	1
<U+2022>Both digitalis glycosides and <U+03B2>-blockers slow atrioventricular conduction and decrease heart rate.	0
Neuromuscular Blocking Agents Clinical data and animal studies suggest that verapamil may potentiate the activity of neuromuscular blocking agents (curare-like and depolarizing).	0
<U+2022>Verapamil- or diltiazem-type calcium channel blockers may affect ECG and/or blood pressure.	0
Dosage adjustment of 50 mg every other day is recommended in patients with severe renal impairment or ESRD.	0
Most such studies have observed progressive increases in bioavailability during chronic therapy; it is not known whether similar increases in bioavailability appear during the course of chronic therapy with dilatrate<U+00AE>-SR sustained release capsules.	0
This is consistent with the recommendation by the U.S. Public Health Service Centers for Disease Control and Prevention that HIV-infected mothers not breast-feed their infants to avoid risking postnatal transmission of HIV.	0
There was also no mutagenic response in vitro or in vivo in mammalian cell assays or in vitro in bacteria.	0
"Eight subjects from this study, with a mean tyramine pressor dose of 64mg at 90 days, were subsequently administered tyramine with food, resulting in a mean pressor dose of 172mg (2.7 times the mean pressor dose observed without food, p less than 0.003)."	0
"Body weight REYATAZ Daily Dosage Ritonavir Daily Dosage Treatment-Naive and Treatment-Experiencedc Less than 15 kg Capsules not recommended N/A At least 15 kg to less than 35 kg 200 mg 100 mg At least 35 kg 300 mg 100 mg Treatment-Naive, at least 13 years old and cannot tolerate ritonavirc At least 40 kg 400 mg N/A When transitioning between formulations, a change in dose may be needed."	0
"When dispensing dose(s) to the patient or caregiver, instruct them to refrigerate the oral dosing dispenser(s) until they are ready to administer the dose."	0
Lidocaine hydrochloride is contraindicated in patients with a history of hypersensitivity to local anesthetics of the amide type.	0
Treatment-Na<U+00EF>ve Adult Patients The recommended oral dose of PREZISTA is 800 mg (one 800 mg tablet or 8 mL of the oral suspension) taken with ritonavir 100 mg (one 100 mg tablet or capsule or 1.25 mL of a 80 mg per mL ritonavir oral solution) once daily and with food.	0
Concomitant use of pimozide and paroxetine or other strong CYP 2D6 inhibitors are contraindicated.	0
Pulmonary hypertension secondary to sickle cell disease: REVATIO may cause serious vaso-occlusive crises.	0
"In combination with amitriptyline, clonidine hydrochloride administration led to the development of corneal lesions in rats within 5 days."	0
"In arriving at a diagnosis, it is important to identify cases where the clinical presentation includes both serious medical illness (e.g., pneumonia, systemic infection, etc.) and untreated or inadequately treated extrapyramidal signs and symptoms (EPS)."	0
"In the presence of these methylxanthines , larger doses of adenosine may be required or adenosine may not be effective ."	0
"Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs."	0
The co-administration of atorvastatin with cyclosporine should be avoided.	0
"The common complications of hyperparathyroidism such as renal lithiasis, bone resorption, and peptic ulceration have not been seen."	0
In some cases ZIAC therapy can be continued while heart failure is treated with other drugs.	0
The recommended pediatric dose of APTIVUS is 14 mg/kg with 6 mg/kg ritonavir (or 375 mg/m2 co-administered with ritonavir 150 mg/m2) taken twice daily not to exceed a maximum dose of APTIVUS 500 mg co-administered with ritonavir 200 mg twice daily.	0
Desvenlafaxine also lacked monoamine oxidase (MAO) inhibitory activity.	0
Accumulation of atenolol and prolongation of its half-life were studied in subjects with creatinine clearance between 5 and 105 mL/min.	0
See WARNINGS - Pregnancy and Fetal Injury.	0
Peripheral Vascular Disease: Can aggravate symptoms of arterial insufficiency.	0
Dosing recommendations cannot be provided for patients with severe hepatic insufficiency.	0
"There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on suicide."	0
"Based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron, concomitant use of apomorphine with ondansetron is contraindicated."	0
The use of any form of nitroglycerin during the early days of acute myocardial infarction requires particular attention to hemodynamic monitoring and clinical status.	0
"In instances where swelling is confined to the face and lips, the condition generally resolves without treatment; antihistamines may be useful in relieving symptoms."	0
These reported anomalies are similar to those seen in animal studies.	0
"Complex behaviors such as ""sleep-driving"" (i.e., driving while not fully awake after ingestion of a hypnotic) and other complex behaviors (e.g., preparing and eating food, making phone calls, or having sex), with amnesia for the event, have been reported in association with hypnotic use."	0
The effect of amounts of grapefruit juice between those used in these two studies on lovastatin pharmacokinetics has not been studied.	0
"Exposure increases in a dose-related manner and following three days of intramuscular dosing, little accumulation is observed."	0
"When administered during the last few weeks of pregnancy, rifampin can cause post-natal hemorrhages in the mother and infant for which treatment with vitamin K may be indicated."	0
"Prescribers should ask patients about the development of new or increased gambling urges, sexual urges or other urges while being treated with selegiline."	0
"In vitro studies in human liver microsomes showed that iloperidone does not substantially inhibit the metabolism of drugs metabolized by the following cytochrome P450 isozymes: CYP1A1, CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, or CYP2E1."	0
Phenothiazines can produce alpha-adrenergic blockade.	0
"15,000ng/mLa Dissolve contents of one 1.5<U+2011>mg vial with 5mL of sterile diluent."	0
"Proarrhythmic effects<U+2014>Like many other drugs (including all other class 1a antiarrhythmics), quinidine prolongs the QTc interval, and this can lead to torsades de pointes, a life<U+2013>threatening ventricular arrhythmia."	0
No dosage adjustment is required for fluvoxamine maleate tablets.	0
"In addition, sudden, unexpected deaths have occurred in patients taking high doses of ORAP for conditions other than Tourette<U+2019>s Disorder."	0
"While this interaction has not been formally studied, it is recommended that theophylline levels be monitored when these drugs are concurrently administered."	0
Concomitant treatment with drugs which are inhibitors of CYP1A2 and/or CYP3A4 has the potential to increase lidocaine plasma levels by decreasing lidocaine clearance and thereby prolonging the elimination half-life.	1
"Centrally-acting drugs: Due to CNS effects, use caution in combination."	0
"Heart failure, including fatalities, occurred in patients treated with CAPRELSA."	0
Concomitant administration of CARDURA with a PDE-5 inhibitor can result in additive blood pressure lowering effects and symptomatic hypotension.	0
"Conversely, on discontinuation of carbamazepine, the dose of INVEGA<U+00AE> should be re-evaluated and decreased if necessary."	1
"The predominant species was asenapine N+-glucuronide; others included N-desmethylasenapine, N-desmethylasenapine N-carbamoyl glucuronide, and unchanged asenapine in smaller amounts."	0
Treatment with LEXIVA should be discontinued for severe or life-threatening rashes and for moderate rashes accompanied by systemic symptoms.	0
"Heart failure and atrial arrhythmias resulting from hypermetabolic or hyperdynamic states (e.g., hyperthyroidism, hypoxia, or arteriovenous shunt) are best treated by addressing the underlying condition."	0
"Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue therapy with COREG abruptly even in patients treated only for hypertension or heart failure."	0
Anaphylactoid reactions have also been reported in patients undergoing low-density lipoprotein apheresis with dextran sulfate absorption.	0
Monitor INR frequently until stable upon initiation or alteration of ZOCOR therapy.	0
Maximum reductions in blood pressure usually occur 2<U+2013>6 hours after dosing and are associated with a small increase in standing heart rate.	0
"It was not possible in this meta-analysis to determine the extent to which cardiovascular malformations might have contributed to overall malformations, nor was it possible to determine whether any specific types of cardiovascular malformations contributed to all cardiovascular malformations."	0
"The major metabolite in blood was N1-desalkyl-flurazepam, which reached steady-state (plateau) levels after 7 to 10 days of dosing, at levels approximately 5- to 6-fold greater than the 24-hour levels observed on Day 1."	0
"While blood pressure was reduced in all racial subgroups examined, too few non-White patients were enrolled to compare the dose-response of losartan in the non-White subgroup."	0
"Effect on Cardiac Repolarization The effect of vortioxetine 10 mg and 40 mg administered once daily on QTc interval was evaluated in a randomized, double-blind, placebo-, and active-controlled (moxifloxacin 400 mg), four-treatment-arm parallel study in 340 male subjects."	0
"Antiarrhythmics Amiodarone, bepridil, flecainide, propafenone, quinidine Potential for serious and/or life-threatening reactions such as cardiac arrhythmias secondary to increases in plasma concentrations of antiarrhythmics."	1
Antianginal Ranolazine Potential for serious and/or life-threatening reactions.	0
The cortical proliferation in infants regressed after withdrawal of the drug.	0
"Benzodiazepines, including flurazepam, produce additive CNS depressant effects when co-administered with ethanol or other CNS depressants (e.g., psychotropic medications, anticonvulsants, antihistamines)."	0
"Treatment with Tasigna can cause Grade 3/4 thrombocytopenia, neutropenia and anemia."	0
No evidence of stomach neoplasia was observed at lower doses (up to 58 mg/kg/day).	0
Patients receiving sertraline hydrochloride continuation treatment experienced a statistically significantly lower relapse rate over this 24-week study than patients randomized to placebo substitution.	0
Reduced testicular weight and increased incidence of testicular atrophy were also consistent findings in dogs and mice.	0
The major route of elimination of pimozide and its metabolites is through the kidney.	0
"Based on the finding of dose-dependent prolongations of QT and PR intervals in healthy volunteers receiving INVIRASE/ritonavir, additive effects on QT and/or PR interval prolongation may occur with certain members of the following drug classes: antiarrhythmics class IA or class III, neuroleptics, antidepressive agents, PDE5 inhibitors (when used for pulmonary arterial hypertension), antimicrobials, antihistaminics and others."	0
"As a result, and as seen in clinical studies, the half-life of dofetilide is longer in patients with lower creatinine clearances."	0
Dabigatran is subject to conjugation forming pharmacologically active acyl glucuronides.	0
"While the mean changes alone would not be expected to have short-term consequences, all patients should be monitored for larger changes in heart rate and blood pressure."	0
"The differences were most striking in males, with a 40% lower clearance in elderly males compared to younger males, while the clearance in elderly females was only 10% lower compared to younger females."	0
"Caution is indicated in patients known to have reduced levels of cytochrome P450 2D6 activity and those receiving concomitant drugs known to inhibit this cytochrome P450 isoenzyme (e.g., quinidine)."	0
Excessive use of caffeine in any form should be avoided in patients receiving Marplan.	0
"In one study of eight elderly subjects (> 70 years), the means for Cmax, T1/2, and AUC significantly increased by 50% (255 vs. 384 ng/mL), 32% (2.2 vs. 2.9 hr), and 64% (955 vs. 1,562 ng<U+2219>hr/mL), respectively, as compared to younger adults (20 to 40 years) following a single 20 mg oral dose."	0
Consider discontinuing in patients with symptomatic hyponatremia (5.14).	0
Caution should be exercised when MINIPRESS is administered to a nursing woman.	0
"In a subsequent 24-month study, there were no differences between the rats receiving 150 mg/kg/day and the untreated controls."	0
Labetolol blunts the reflex tachycardia produced by nitroglycerin without preventing its hypotensive effects .	0
ACCUPRIL treatment did not affect the pharmacokinetics of digoxin.	0
"Because sleep disturbances may be the presenting manifestation of a physical and/or psychiatric disorder, symptomatic treatment of insomnia should be initiated only after careful evaluation of the patient."	0
"The favorable effects of losartan potassium tablets were seen in patients also taking other anti-hypertensive medications (angiotensinII receptor antagonists and angiotensin converting enzyme inhibitors were not allowed), oral hypoglycemic agents and lipid-lowering agents."	0
"Rarely, the dose-independent hazards of trandolapril are serious."	0
Some patients may require 90 to 120 mg at these intervals or up to 120 mg daily.	0
The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline .	0
"DRESS typically presents with eosinophilia, fever, rash, and/or lymphadenopathy in association with other organ involvement, such as hepatitis, nephritis, hematologic abnormalities, myocarditis, or myositis, sometimes resembling an acute viral infection."	0
"Drowsiness was significantly increased, and performance on the psychomotor task was significantly impaired."	0
Selegiline did not induce mutations or chromosomal damage when tested in the bacterial mutation assay in Salmonella typhimurium and in an in vivo chromosomal aberration assay.	0
"Since there have been isolated reports of patients with elevated digoxin levels, and since there is a possible interaction between digoxin and nifedipine, it is recommended that digoxin levels be monitored when initiating, adjusting, and discontinuing nifedipine to avoid possible over- or under-digitalization."	0
"Pressor Amines (e.g., Norepinephrine)- possible decreased response to pressor amines but not sufficient to preclude their use."	0
"In controlled adult clinical trials, rash (all grades, all causality) was observed in 10% of females and in 8% of males receiving APTIVUS/ritonavir through 48 weeks of treatment."	0
"Peak plasma concentrations are observed within 1 to 5 hours of dosing, and range from 70 to 490 ng/mL following oral doses of 12.5 to 100 mg."	0
"PDE5 inhibitors: sildenafil, tadalafil, vardenafil <U+2191> sildenafil<U+2191> tadalafil<U+2191> vardenafil Coadministration with REYATAZ has not been studied but may result in an increase in PDE5 inhibitor-associated adverse reactions, including hypotension, syncope, visual disturbances, and priapism."	0
Maintenance Therapy: Long-term maintenance of efficacy was demonstrated in a 6-month relapse prevention trial.	0
"If radiation or a chemotherapeutic agent known to have marrow-depressant activity has been used, an interval of one month or longer without such therapy is recommended before starting treatment with Matulane."	0
Consider alternatives in patients at high risk for renal disease or with preexisting renal disease.	0
"Serotonergic Drugs: See CONTRAINDICATIONS, WARNINGS, and DOSAGE AND ADMINISTRATION."	0
The complete text of the Medication Guide is reprinted at the end of this document.	0
"In other studies, verapamil did not generally induce significant negative inotropic, chronotropic, or dromotropic effects in patients with preserved left ventricular function receiving low or moderate doses of propranolol (less than or equal to 320 mg/day); in some patients, however, combined therapy did produce such effects."	0
"Oligohydramnios has also been reported, presumably resulting from decreased fetal renal function; oligohydramnios in this setting has been associated with fetal limb contractures, craniofacial deformation, and hypoplastic lung development."	0
"There have been reports of increased bleeding, including spontaneous skin hematomas and hemarthrosis, in patients with hemophilia type A and B treated with protease inhibitors."	0
Favorable effects were maintained for up to two years of open label therapy.	0
"Transporter Interaction: In vitro studies indicated that loxapine was not a substrate for p-glycoprotein (P-gp): however, loxapine inhibited P-gp."	0
"After stopping a CYP3A4 or CYP2B6 inducer, as the effects of the inducer decline, the meperidine plasma concentration will increase , which could increase or prolong both the therapeutic effects and adverse reactions, and may cause serious respiratory depression."	1
No correlation was observed between plasma clearance of eplerenone and creatinine clearance.	0
Advise pregnant women of the potential risk to a fetus.	0
"In an 87 patient 4-week double-blind, placebo controlled, parallel group trial, patients who received MICROZIDE had reductions in seated systolic and diastolic blood pressure that were significantly greater than those seen in patients who received placebo."	0
Patients already using Focalin (dexmethylphenidate) immediate release: switch to the same daily dose of Focalin XR.	0
"The effect of ramipril on hypertension appears to result at least in part from inhibition of both tissue and circulating ACE activity, thereby reducing angiotensin II formation in tissue and plasma."	0
There are no adequate and well-controlled studies of the use of AGGRENOX in pregnant women.	0
No dose adjustment for patients with normal renal function is necessary.	0
ULORIC should not be restarted in these patients without another explanation for the liver test abnormalities.	0
The range of estimates for the mean elimination half-life of estazolam varied from 10 to 24 hours.	0
ADCIRCA is contraindicated in patients with a known serious hypersensitivity to tadalafil ( ADCIRCA or CIALIS ) .	0
"Vasoconstrictive and positive inotropic agents : Because of the risk of reducing cardiac contractility in presence of high systemic vascular resistance , do not use BREVIBLOC to control tachycardia in patients receiving drugs that are vasoconstrictive and have positive inotropic effects , such as epinephrine , norepinephrine , and dopamine ."	0
Patients should continue to be monitored in this way for a minimum of three days.	0
Beta-Blockers and Other CYP2D6 Substrates Dronedarone increased the exposure of propranolol and metoprolol.	1
It is desirable to monitor TCA plasma levels whenever a TCA is going to be co-administered with another drug known to be an inhibitor of P450 2D6.	0
Over 85% of an intravenous dose is excreted in urine within 24 hours compared with approximately 50% for an oral dose.	0
Coadministration is not recommended.Increased concentrations of indinavir may result in nephrolithiasis.	1
It should be noted that nefazodone hydrochloride tablets are not approved for use in treating bipolar depression.	0
"In children 2 years of age and older, the recommended oral dose of VIRACEPT Oral Powder or 250 mg tablets is 45 to 55 mg/kg twice daily or 25 to 35 mg/kg three times daily."	0
The concomitant use of hydrochlorothiazide (alone or in combinations such as with triamterene) with TIKOSYN is contraindicated because this has been shown to significantly increase dofetilide plasma concentrations and QT interval prolongation.	0
"In addition, the active metabolite showed no evidence of genotoxicity in the microbial mutagenesis, invitro alkaline elution, and invitro chromosomal aberration assays."	0
"To minimize the risk of induced arrhythmia, patients initiated or re-initiated on intravenous sotalol, and patients who are converted from intravenous to oral administration should be hospitalized in a facility that can provide cardiac resuscitation, continuous electrocardiographic monitoring and calculations of creatinine clearance."	0
Variable results on clearance have been obtained in acute studies of healthy volunteers; clearance of verapamil was either reduced or unchanged.	0
The concomitant use of CYMBALTA with MAOIs intended to treat psychiatric disorders is contraindicated.	0
"A dosage of 12 mg/kg once daily may be used, based on medical judgment of the patient's response to therapy."	0
RIFADIN should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.	0
Such increases may increase the risk of a hypertensive crisis when carbamazepine is used with EMSAM at any dose.	0
Monitor renal function periodically in patients receiving ramipril and NSAID therapy.	0
PREZISTA must be co-administered with ritonavir and food to achieve the desired antiviral effect.	0
Screening Patients for Bipolar Disorder <U+2013> A major depressive episode may be the initial presentation of bipolar disorder.	0
"Based on the assumption that the relationship between paroxetine's in vitro K i and its lack of effect on terfenadine's in vivo clearance predicts its effect on other 3A4 substrates, paroxetine's extent of inhibition of CYP3A4 activity is not likely to be of clinical significance."	0
Geriatric Use: Clinical studies of dopamine injection did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
Amiodarone: The risk of myopathy/rhabdomyolysis is increased when amiodarone is used concomitantly with a closely related member of the HMG<U+2011>CoA reductase inhibitor class.	0
Indwelling epidural or intrathecal catheters should not be removed earlier than 24 hours after the last administration of ELIQUIS.	0
The absolute oral bioavailability of risperidone is 70% (CV=25%).	0
"This is consistent with the half-lives of the affected vitamin K-dependent clotting factors and anticoagulation proteins: Factor II - 60 hours, VII - 4 to 6 hours, IX - 24 hours, X - 48 to 72 hours, and proteins C and S are approximately 8 hours and 30 hours, respectively."	0
"Hepatic Disease d-Nebivolol peak plasma concentration increased 3-fold, exposure (AUC) increased 10-fold, and the apparent clearance decreased by 86% in patients with moderate hepatic impairment (Child-Pugh Class B)."	0
"At that dose, daily systemic exposure in rats was approximately 1.3 times higher than daily systemic exposure in humans."	0
Safety and effectiveness in pediatric patients have not been established.	0
.	0
Eplerenone is not removed by hemodialysis.	0
"Patients taking concomitant mTOR inhibitor (e.g., temsirolimus) therapy or a neprilysin inhibitor may be at increased risk for angioedema."	0
Hepatotoxicity: Monitor transaminases and bilirubin.	0
"<U+2022>When pregnancy is detected, discontinue ATACAND as soon as possible."	0
"Following intravenous administration, clonidine displays biphasic disposition with a distribution half-life of about 20 minutes and an elimination half-life ranging from 12 to 16 hours."	0
"However, a 3-fold increase in plasma exposure to tacrolimus in a renal transplant patient (CYP3A5 non-expresser) upon initiation of amlodipine for the treatment of post-transplant hypertension resulting in reduction of tacrolimus dose has been reported."	1
"Phylogenetic analysis of HCV sequences from genotype 6-infected subjects in ELECTRON-2 identified 7 HCV genotype 6 subtypes (6a, 6e, 6l, 6m, 6p, 6q, and 6r)."	0
"However, due to the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of thioridazine, paroxetine, and thioridazine should not be coadministered."	0
Most patients receiving the combination of two drugs that inhibit the renin-angiotensin system do not obtain any additional benefit compared to monotherapy.	0
"In studies conducted in healthy subjects, apixaban did not meaningfully alter the pharmacokinetics of digoxin, naproxen, atenolol, prasugrel, or acetylsalicylic acid."	0
"However, such usage has been very limited."	0
"Patients resistant or intolerant to prior treatment which included imatinib must reinitiate Tasigna therapy within 4 weeks of a loss of MMRor confirmed loss of MR4.0 (two consecutive measures separated by at least 4 weeks showing loss of MR4.0, corresponding to = BCR-ABL/ABL <U+2264>0.01%IS)."	0
"Treatment-emergent NS5A resistance-associated substitutions K24R, M28T, Q30R/H/K, L31V, H58D/P, and/or Y93H/C were detected in 14/17 (82%) genotype 1a virologic failure subjects, and R30Q, L31M, and/or Y93H/N were detected in 6/7 (86%) genotype 1b virologic failure subjects."	0
The complete text of the Medication Guide is reprinted at the end of this document.	0
"In animal models, S-norfluoxetine is a potent and selective inhibitor of serotonin uptake and has activity essentially equivalent to R- or S-fluoxetine."	0
Homozygous Familial Hypercholesterolemia: The dosage range of atorvastatin in patients with HoFH is 10 to 80 mg daily.	0
Sotalol is not recommended in patients with a creatinine clearance <40 mL/min.	0
"Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular changes (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)."	0
"If co-administered with CYP 3A inducers, the dose of SAMSCA may need to be increased [see Dosage and Administration (2.3), Drug Interactions (7.1)]."	0
The effects of food on the bioavailability of the sertraline tablet and oral concentrate were studied in subjects administered a single dose with and without food.	0
Carbamazepine <U+2013> The coadministration of nefazodone (200 mg BID) for 5 days to 12 healthy subjects on carbamazepine who had achieved steady state (200 mg BID) was found to be well tolerated.	0
"(CV 10%), 30.7 ng/mL (CV 67%), and 21 hours (CV 32%), respectively."	0
Coadministration of fluticasone propionate and REYATAZ/ritonavir is not recommended unless the potential benefit to the patient outweighs the risk of systemic corticosteroid side effects.	0
"DYAZIDE should not be given to patients receiving other potassium-sparing agents such as spironolactone, amiloride, or other formulations containing triamterene."	0
Advise females of reproductive potential to use effective contraceptionduring treatment with ONIVYDE and for one month following the final dose.	0
The times to peak concentrations for the erythrohydrobupropion and threohydrobupropion metabolites are similar to that of hydroxybupropion.	0
The recommended dose of isoniazid is 15 mg/kg (rounded to the nearest 50 mg or 100mg) up to a maximum of 900 mg once-weekly for 12 weeks.	0
"To lessen the likelihood of adverse reactions related to cumulative drug effect, patients with a history of long-term therapy with chlorpromazine and/or other antipsychotics should be evaluated periodically to decide whether the maintenance dosage could be lowered or drug therapy discontinued."	0
Maximum antihypertensive effects are attained within 2 to 4 weeks after a change in dose.	0
Olanzapine's antagonism of histamineH1 receptors may explain the somnolence observed with this drug.	0
Patients receiving warfarin therapy should be carefully monitored when FETZIMA is initiated or discontinued.	0
Ask patients to report pregnancies to their physicians as soon as possible.	0
"Potential outcomes include death, stroke, myocardial infarction, aortic dissection, ophthalmological complications, eclampsia, pulmonary edema, and renal failure."	0
"Coadministration of enoxaparin, warfarin, aspirin, clopidogrel and chronic NSAID use may increase the risk of bleeding [see Clinical Pharmacology (12.3)]."	0
Advise both patients and caregivers about the risks of respiratory depression and sedation when Meperidine Hydrochloride Injection is used with benzodiazepines or other CNS depressants (including alcohol and illicit drugs).	0
The administration of meperidine or other narcotics may obscure the diagnosis or clinical course in patients with acute abdominal conditions.	0
Discontinuation of fluvoxamine may produce opioid withdrawal (5.9).	0
Safety for the use of chlorpromazine during pregnancy has not been established.	0
"In a separate experiment, fertility of female rats appeared to be affected at dose levels of 500 to 2000 <U+00B5>g/kg (10 to 40 times the oral MRDHD on a mg/kg basis; 2 to 8 times the MRDHD on a mg/m2 basis)."	0
"At steady state, when the CYP2D6 pathway is essentially saturated, paroxetine clearance is governed by alternative P450 isozymes that, unlike CYP2D6, show no evidence of saturation."	0
"Biotransformation of citalopram is mainly hepatic, with a mean terminal half-life of about 35 hours."	0
"If priapism is not treated immediately, penile tissue damage and permanent loss of potency could result."	0
"In patients with renal disease, thiazides may precipitate azotemia."	0
"Co-administration of substrates of CYP2D6 with ritonavir could result in increases (up to 2-fold) in the AUC of the other agent, possibly requiring a proportional dosage reduction."	1
Closely monitored clinical experience with LUVOX CR Capsules in patients with concomitant systemic illness is limited.	0
Duloxetine delayed-release capsules have an enteric coating that resists dissolution until reaching a segment of the gastrointestinal tract where the pH exceeds 5.5.	0
"Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients whose depression is persistently worse, or who are experiencing emergent suicidality or symptoms that might be precursors to worsening depression or suicidality, especially if these symptoms are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
"Cyanocobalamin (Vitamin B-12) Deficiency: Daily long-term use (e.g., longer than 3 years) may lead to malabsorption or a deficiency of cyanocobalamin."	0
"Before prescribing REVATIO, carefully consider whether patients with certain underlying conditions could be adversely affected by such vasodilatory effects (e.g., patients on antihypertensive therapy or with resting hypotension [BP less than 90/50], fluid depletion, severe left ventricular outflow obstruction, or autonomic dysfunction)."	0
Concomitant administration of MINIPRESS with a phosphodiesterase-5 (PDE-5) inhibitor can result in additive blood pressure lowering effects and symptomatic hypotension.	0
"Symptomatic hypotension is most likely to occur in patients who have been volume or salt-depleted as a result of prolonged diuretic therapy, dietary salt restriction, dialysis, diarrhea or vomiting."	0
"Slowing of the pulse rate has been observed in most patients given clonidine, but the drug does not alter normal hemodynamic response to exercise."	0
Test bilirubin and hepatic transaminases levels monthly or as clinically indicated [see Warnings and Precautions (5.	0
ULORIC is recommended at 40 mg or 80 mg once daily.	0
For details on preparation see Full Prescribing Information.	0
"Accordingly, serum electrolytes must be frequently monitored if DYAZIDE is used in diabetic patients."	0
"In patients at risk of excessive hypotension, therapy with ACCURETIC should be started under close medical supervision."	0
"Warfarin and Other Drugs That Interfere With Hemostasis (NSAIDs, Aspirin, etc."	0
Clinical studies of MYCOBUTIN did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
The mean baseline blood pressures were 152/82mmHg for losartan potassium tablets plus conventional antihypertensive therapy and 153/82mmHg for placebo plus conventional antihypertensive therapy.	0
Monitor for hypotension when Zanaflex is used in patients receiving concurrent antihypertensive therapy.	0
Absorption of icodextrin from the peritoneal cavity follows zero-order kinetics consistent with convective transport via peritoneal lymphatic pathways.	0
"Combined P-gp and strong CYP3A4 inhibitors and inducers: Avoid concomitant use (7.2, 7.3) Anticoagulants: Avoid concomitant use (7.4) Rivaroxaban is a substrate of CYP3A4/5, CYP2J2, and the P-gp and ATP-binding cassette G2 (ABCG2) transporters."	0
"Since there is little clinical experience, the concurrent administration of paroxetine and digoxin should be undertaken with caution."	0
Thrombocytopenia may be immunologic in origin or occur on an idiosyncratic basis.	0
"New onset diabetes mellitus, exacerbation of pre-existing diabetes mellitus and hyperglycemia have been reported during post-marketing surveillance in HIV-infected patients receiving protease inhibitor therapy."	0
The alpha half-life (the initial decline following peak concentration) is approximately 40 minutes.	0
"Mammary gland tumors in female mice were also increased, but these tumors are expected in rodents treated with antipsychotic drugs which elevate prolactin levels."	0
"Similar electrophysiologic effects were seen with single IV doses, which could be blunted in patients pre-treated with beta-blockers."	0
"MAO inhibitors inhibit the destruction of serotonin and norepinephrine, which are believed to be released from tissue stores by rauwolfia alkaloids."	0
"Give a low dose of beta-blockers initially, and increase only after ECG verification of good tolerability."	0
One patient receiving Savella 100 mg/day (0.2%) had an increase in ALT greater than 5 times the upper limit of normal but did not exceed 10 times the upper limit of normal.	0
"Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)."	0
It is recommended that MYCOBUTIN Capsules be administered at a dose of 300 mg once daily.	0
Pharmacogenomics Individuals with genetic variations resulting in poor CYP 2D6 metabolism (approximately 5 to 10% of the population) exhibit higher pimozide concentrations than extensive CYP 2D6 metabolizers.	0
The antihypertensive effect of aliskiren may be attenuated by NSAIDs .	0
"Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk."	0
Anticoagulants : Potentiation of warfarin - type ( CYP2C9 and CYP3A substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .	0
Relapse during the double-blind phase was defined as the following conditions being met on three consecutive visits: (1) CGI-I <U+2265> 3; (2) meets DSM-III-R criteria for Panic Disorder; (3) number of panic attacks greater than at baseline.	0
"Study 1, a dose-range finding study where patients were treated with fixed doses of 20, 40, or 60 mg of paroxetine/day demonstrated that daily doses of paroxetine 40 and 60 mg are effective in the treatment of OCD."	0
N-dealkylation and beta-oxidation of the side-chain also occurs.	0
Steady-state plasma levels of amlodipine are reached after 7 to 8 days of consecutive daily dosing.	0
ACEON treatment can usually be continued following restoration of volume and blood pressure.	0
"For initiation of treatment, 30 mg/m2 three times a day (90 mg/m2 total daily dose) is approximately equivalent to the initial 160 mg total oral daily dose for adults."	0
A 50% dosage reduction of dexamethasone is recommended to account for a drug interaction with EMEND.	1
The mean plasma half-life of chlorthalidone is about 40 to 60 hours.	0
These risk differences (drug-placebo difference in the number of cases of suicidality per 1000 patients treated) are provided in Table 1.	0
Blood pressure should be carefully monitored during surgery and additional measures to control blood pressure should be available if required.	0
"To open, tear the overwrap down at the slit and remove the solution container."	0
Response rates are greater at higher doses.	0
"In a pooled analysis of multiple short-term, placebo-controlled studies, such symptoms occurred in about 0.1% (4 patients with events out of 3,482 exposed to methylphenidate or amphetamine for several weeks at usual doses) of stimulant-treated patients compared to 0 in placebo-treated patients."	0
Embryo-fetal toxicity: Can cause fetal harm.	0
Patients should be informed that CRIXIVAN should be stored and used in the original container and the desiccant should remain in the bottle.	0
An induced <U+03B2>-lactamase test should be performed on all S. aureus isolates for which the penicillin MIC is <U+2264>0.12 mcg/mL or zone diameter is <U+2265>29 mm before reporting as penicillin susceptible.	0
The total weekly dosage should not exceed 6 mL.	0
"The prescriber or health professional should instruct patients, their families, and their caregivers to read the Medication Guide and should assist them in understanding its contents."	0
PEDIATRIC PATIENTS 6 YEARS OF AGE AND OLDER The recommended starting dose for pediatric patients is 0.2 mg/kg once per day.	0
"Published data are inadequate to determine whether chronic use of amphetamines may cause a similar suppression of growth, however, it is anticipated that they likely have this effect as well."	0
Patients should be informed that all types of side effects associated with the use of antipsychotics may be associated with the use of ORAP.	0
"After tablet ingestion, the peak serum concentration (Cmax) is reached after 3 to 4 hours."	0
"In a 10-day study with daily administration of EMSAM to healthy male and female volunteers, steady-state selegiline plasma concentrations indicated selegiline concentration-time profiles were comparable when EMSAM is applied to the upper torso or upper thigh, and absorption from these two sites of administration was equivalent."	0
Perform sampling of serum concentrations just before the next scheduled dose of the drug.	0
"In patients who are currently being treated with a diuretic, symptomatic hypotension occasionally can occur following the initial dose of ACCUPRIL."	0
Co-administration of multiple doses of 10 mg of verapamil with 80 mg simvastatin resulted in exposure to simvastatin 2.5-fold that following simvastatin alone.	1
"The relative importance of preload reduction, afterload reduction, and coronary dilatation remains undefined."	0
"Rare instances of severe liver injury, including hepatic necrosis, have been reported in association with mexiletine treatment."	0
"Prior to initiating treatment with a stimulant, patients with comorbid depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression."	0
FANAPT should not be used with any other drugs that prolong the QT interval.	0
"Amiodarone is a substrate for CYP3A and CYP2C8, so inhibitors and inducers affect amiodarone exposure (7) Amiodarone inhibits p-glycoprotein and CYP1A2, CYP2C9, CYP2D6, and CYP3A, increasing exposure to other drugs (7) Drugs prolonging the QT interval: Co-administration of drugs prolonging the QT interval (such as class I and III antiarrhythmics, lithium, certain phenothiazines, tricyclic antidepressants, certain fluoroquinolone and macrolide antibiotics, azole antifungals, halogenated inhalation anesthetic agents) increases the risk of Torsade de Pointes."	0
"In two clinical studies, one in normal volunteers and the other in hypercholesterolemic patients, simvastatin 20-40mg/day modestly potentiated the effect of coumarin anticoagulants: the prothrombin time, reported as International Normalized Ratio (INR), increased from a baseline of 1.7 to 1.8 and from 2.6 to 3.4 in the volunteer and patient studies, respectively."	0
There is no clinical experience to reverse bleeding with the use of 4-factor PCC products in individuals who have received ELIQUIS.	0
"Aspirin is contraindicated in patients with known allergy to nonsteroidal anti-inflammatory drug (NSAID) products and in patients with the syndrome of asthma, rhinitis, and nasal polyps."	0
"Because of significant inotropic and chronotropic effects in patients treated with beta-blockers and calcium channel blockers of the verapamil and diltiazem type, caution should be exercised in patients treated with these agents concomitantly."	0
"Table 8<U+2003><U+2022>Impact of Renal Impairment on Dabigatran Pharmacokinetics +Patients with severe renal impairment were not studied in RE-LY, RE-COVER and RE-NOVATE II."	0
"Losartan potassium tablets have been shown to produce adverse effects in rat fetuses and neonates, including decreased body weight, delayed physical and behavioral development, mortality and renal toxicity."	0
"In Regimen B, each patient received a loading dose of 6.25 mg/kg of quinidine base (that is, 10 mg/kg of quinidine gluconate) in approximately 5 mL/kg of normal saline over 1<U+2013>2 hours."	0
PREZISTA should be used with caution in patients with a known sulfonamide allergy.	0
"Patients taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive crisis."	0
Patients were dosed in a range of 10 to 60 mg/day in the clinical trials demonstrating the effectiveness of paroxetine.	0
"In controlled hypertension trials, treatment with quinapril alone resulted in mean increases in potassium of 0.07 mmol/L."	0
"Cleviprex is contraindicated in patients with defective lipid metabolism such as pathologic hyperlipemia, lipoid nephrosis, or acute pancreatitis if it is accompanied by hyperlipidemia."	0
Observe newborns for signs of neonatal opioid withdrawal syndrome and manage accordingly.	0
Warfarin <U+2013> There were no effects on the prothrombin or bleeding times or upon the pharmacokinetics of R-warfarin when nefazodone (200 mg BID) was administered for 1 week to subjects who had been pretreated for 2 weeks with warfarin.	0
There are no clinical studies of the combined use of ECT and nefazodone.	0
"If symptoms of urinary hesitation develop during treatment with CYMBALTA, consideration should be given to the possibility that they might be drug-related."	0
Administration of REYATAZ and infant formula using an infant bottle is not recommended because full dose may not be delivered.	0
"After oral administration in fed conditions, peak plasma concentrations of dronedarone and the main circulating active metabolite (N-debutyl metabolite) are reached within 3 to 6 hours."	0
"Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients whose depression is persistently worse, or who are experiencing emergent suicidality or symptoms that might be precursors to worsening depression or suicidality, especially if these symptoms are severe, abrupt in onset or were not part of the patient<U+2019>s presenting symptoms."	0
"There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on suicide."	0
"Symptomatic hypotension is most likely to occur in patients who are salt- or volume-depleted as a result of prolonged treatment with diuretics, dietary salt restriction, dialysis, diarrhea, or vomiting."	0
This diagnosis should be considered for diarrhea that does not improve.	0
The mixture of drug and applesauce should be consumed immediately in its entirety.	0
"Prescriptions for MARPLAN should be written for the smallest quantity of tablets consistent with good patient management, in order to reduce the risk of overdose A major depressive episode may be the initial presentation of bipolar disorder."	0
Single Dose Vials Dilution Single dose vials must be diluted before infusion.	0
"Drugs that slow heart rate : Concomitant use of drugs with depressant effects on the sinus and AV node ( e.g. , digoxin , beta blockers , verapamil , diltiazem , ivabradine , clonidine ) can potentiate the electrophysiologic and hemodynamic effects of amiodarone , resulting in bradycardia , sinus arrest , and AV block ."	0
"When drainage complete, close transfer set."	0
CADUET may be used to provide additional therapy for patients already on one of its components.	0
"In some cases, a patient already receiving PEXEVA<U+00AE> therapy may require urgent treatment with linezolid or intravenous methylene blue."	0
Families and caregivers should be advised of the need for close observation and communication with the prescriber.	0
Whether any of the symptoms described above represent such a conversion is unknown.	0
"Patients with severe hypertension may require doses up to 32 mg/hour, but there is limited experience at this dose rate."	0
CADUET may be substituted for its individually titrated components.	0
"In patients with PAH, this can lead to vasodilation of the pulmonary vascular bed and, to a lesser degree, vasodilatation in the systemic circulation."	0
Pregnancy Category D. See WARNINGS section.	0
Such reactions may occur when these drugs are given concurrently or in close proximity.	0
"Following an intravenous dose of 14C-labeled candesartan, approximately 59% of radioactivity is recovered in urine and approximately 36% in feces."	0
"The volume of distribution of losartan and the active metabolite is about 34liters and 12liters, respectively."	0
"A linear relationship between mean QTc increase and dofetilide dose was also seen in patients with renal impairment, in patients with ischemic heart disease, and in patients with supraventricular and ventricular arrhythmias."	0
"However, the risk of developing coronary heart disease is continuous and graded over the range of cholesterol levels and many coronary events do occur in patients with total cholesterol (total<U+2011>C) and LDL<U+2011>C in the lower end of this range."	0
"Pediatric: Apparent oral clearance of atorvastatin in pediatric subjects appeared similar to that of adults when scaled allometrically by body weight as the body weight was the only significant covariate in atorvastatin population PK model with data including pediatric HeFH patients (ages 10 years to 17 years of age, n=29) in an open-label, 8-week study."	0
"In patients with sinus bradycardia or incomplete heart block, the administration of lidocaine hydrochloride intravenously for the elimination of ventricular ectopic beats without prior acceleration in heart r ate (e.g., by isoproterenol or by electric pacing) may promote more frequent and serious ventricular arrhythmias or complete heart block."	0
"Because of the risk of QT prolongation, Torsades de pointes, and sudden death, CAPRELSA is available only through a restricted distribution program called the CAPRELSA REMS Program."	0
"Vasoconstrictive and positive inotropic agents : Because of the risk of reducing cardiac contractility in presence of high systemic vascular resistance , do not use BREVIBLOC to control tachycardia in patients receiving drugs that are vasoconstrictive and have positive inotropic effects , such as epinephrine , norepinephrine , and dopamine ."	0
"There has been a long-standing concern, however, that antidepressants may have a role in inducing worsening of depression and the emergence of suicidality in certain patients during the early phases of treatment."	0
"It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months."	0
Patients should be followed closely for the first two weeks of treatment and whenever the dose of ACEON and/or diuretic is increased.	0
"Elderly: Plasma concentrations of both perindopril and perindoprilat in elderly patients (greater than 70 years) are approximately twice those observed in younger patients, reflecting both increased conversion of perindopril to perindoprilat and decreased renal excretion of perindoprilat."	0
The Risk Reduction is adjusted for baseline Framingham risk score and level of electrocardiographic left ventricular hypertrophy.	0
"40 mg SD <U+2191> 30% <U+2191> 2.7 fold Rifampin 600 mg QD, 5 days (doses separated) 40 mg SD <U+2193> 80% <U+2193> 40% Gemfibrozil 600mg BID, 7 days 40mg SD <U+2191> 35% <U+2193> Less than 1% Fenofibrate 160mg QD, 7 days 40mg SD <U+2191> 3% <U+2191> 2% Boceprevir 800 mg TID, 7 days 40 mg SD <U+2191>2.30 fold <U+2191>2.66 fold TABLE 4."	0
Calcium Channel Blockers Calcium channel blockers with depressant effects on the sinus and AV nodes could potentiate dronedarone's effects on conduction.	0
"Limit the daily dose of lovastatin to 40 mg. Lower starting and maintenance doses of other CYP3A4 substrates (e.g., atorvastatin) may be required as verapamil may increase the plasma concentration of these drugs."	1
"The average steady-state concentrations of fluoxetine in these children were 2-fold higher than in adolescents (171and 86ng/mL, respectively)."	0
Place the cap on the dispenser until it clicks.	0
"Many potent anesthetic drugs, neuromuscular blocking agents and possibly amide local anesthetics may serve as triggering agents for the fulminant hypermetabolic process termed malignant hyperthermia."	0
Measure serum transaminase levels and bilirubin at the initiation of VFEND therapy and monitor at least weekly for the first month of treatment.	0
Intervention 3-day EMEND regimen Reduce the dose of oral dexamethasone by approximately 50%.	0
"SINCE ORAL ABSORPTION IS RAPID AND ALMOST COMPLETE, THE DAILY DOSE OF DIFLUCAN (FLUCONAZOLE) IS THE SAME FOR ORAL (TABLETS AND SUSPENSION) AND INTRAVENOUS ADMINISTRATION."	0
"St. John's wort (Hypericum perforatum, standardized to 0.3 % hypericin) 300 three times daily with meals, 14 days 800 three times daily 8 Not Available 0.46(0.34, 0.58)95% CI."	0
"Following the initial phase, treatment should be continued with rifampin and isoniazid (e.g., RIFAMATE<U+00AE>) for at least 4 months."	0
Patients should be maintained on lower doses if higher doses are not tolerated.	0
"In contrast, if half-lives are shorter, drug (and, where appropriate, its active metabolites) will be cleared before the next dose is ingested, and carry over effects related to excessive sedation or CNS depression should be minimal or absent."	0
The dose of TIKOSYN must be individualized according to calculated creatinine clearance and QTc.	0
"The PK effect of co-administration of NATRECOR<U+00AE> with other IV vasodilators such as nitroglycerin, nitroprusside, milrinone, or IV ACE inhibitors has not been evaluated."	0
Electroconvulsive Therapy (ECT) - There are no clinical studies of the combined use of electroconvulsive therapy (ECT) and Celexa.	0
"Patients taking thioridazine who experience symptoms that may be associated with the occurrence of Torsades de pointes (e.g., dizziness, palpitations, or syncope) may warrant further cardiac evaluation; in particular, Holter monitoring should be considered."	0
"In 30 hypertensive patients with normal renal function treated for 8 weeks with telmisartan 80 mg or telmisartan 80 mg in combination with hydrochlorothiazide 12.5 mg, there were no clinically significant changes from baseline in renal blood flow, glomerular filtration rate, filtration fraction, renovascular resistance, or creatinine clearance."	0
Clozapine: See WARNINGS AND PRECAUTIONS (5.9).	0
Growth <U+2013> Height and weight should be monitored in pediatric patients.	0
"The dosage of mexiletine hydrochloride must be individualized on the basis of response and tolerance, both of which are dose-related."	0
"However, some patients may require treatment despite the presence of the syndrome."	0
Duloxetine is a moderate inhibitor of CYP2D6 (7.9).	0
Hemodynamics and Myocardial Metabolism: Verapamil reduces afterload and myocardial contractility.	0
The plasma elimination half-life has been reported to be 6 to 15 hours.	0
"ACE is identical to kininase II, an enzyme that degrades bradykinin."	0
Adequate clinical and laboratory facilities should be available to patients for proper monitoring of treatment.	0
The no-effect dose for rat pup mortality was not determined.	0
The minimal effective once daily dose was 1.0 mg in non-black patients and 2.0 mg in black patients.	0
Patients with clinically significant neutropenia should be carefully monitored for fever or other symptoms or signs of infection and treated promptly if such symptoms or signs occur.	0
Both digoxin and beta blockers slow atrioventricular conduction and decrease heart rate.	0
Treat pre-existing tachyarrhythmias and other cardiac disease before starting therapy with Savella.	0
"Co-administration of a cytochrome P450 ( CYP ) 2C8 enzyme inhibitor ( e.g. , gemfibrozil ) increases exposure ( both Cmax and AUC ) to treprostinil ."	1
Irbesartan is metabolized via glucuronide conjugation and oxidation.	0
The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline .	0
"Caution is advised in patients with history of urinary retention because of the drug<U+2019>s anticholinergic properties; hyperthyroid patients or those on thyroid medication because of the possibility of cardiovascular toxicity; patients with a history of seizure disorder, because this drug has been shown to lower the seizure threshold; patients receiving guanethidine or similar agents, since SURMONTIL (trimipramine maleate) may block the pharmacologic effects of these drugs."	0
"No pharmacodynamic interactions were observed with aspirin, clopidogrel, or prasugrel."	0
Increased monitoring for adverse events including neutropenia and liver enzyme levels is warranted in patients receiving the combination.	0
In vitro studies using human liver microsomes indicated that CYP3A4 and CYP2C19 are the primary isozymes involved in the N-demethylation of citalopram.	0
"Thus, the net pharmacodynamic activities were essentially the same."	0
These antiviral drugs must not be coadministered with rifampin.	0
"In Study 1, Grade 3 or 4 diarrhea occurred in 13% receiving ONIVYDE/5-FU/LVcompared to 4%receiving 5-FU/LV."	0
Use caution and closely monitor for toxicities when administering CAPRELSA with digoxin.	0
"When Tenex is used with other centrally active depressants ( such as phenothiazines , barbiturates , or benzodiazepines ) , the potential for additive sedative effects should be considered ."	0
Consider the potential for drug interactions prior to and during APTIVUS/ritonavir therapy; review concomitant medications during APTIVUS/ritonavir therapy; and monitor for the adverse reactions associated with the concomitant medications.	0
"Limit the daily dose of lovastatin to 40 mg. Lower starting and maintenance doses of other CYP3A4 substrates (e.g., atorvastatin) may be required as amiodarone may increase the plasma concentration of these drugs."	1
"Clinical Worsening and Suicide Risk: Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down."	0
"Metoprolol is metabolized predominantly by CYP2D6, an enzyme that is absent in about 8% of Caucasians (poor metabolizers) and about 2% of most other populations."	0
"In a clinical study conducted in type2 diabetic patients with proteinuria, the incidence of hyperkalemia was higher in the group treated with losartan potassium tablets as compared to the placebo group; however, few patients discontinued therapy due to hyperkalemia."	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
It is generally believed (though not established in controlled trials) that treating such an episode with an antidepressant alone may increase the likelihood of precipitation of a mixed/manic episode in patients at risk for bipolar disorder.	0
"Under clinical conditions, paroxetine concentrations would normally be less than 400 ng/mL."	0
"General Severe hypotension, particularly with upright posture, may occur with even small doses of isosorbide dinitrate."	0
"Ritonavir has been shown to increase triglycerides, cholesterol, SGOT (AST), SGPT (ALT), GGT, CPK, and uric acid."	0
"To be sure that ramipril is not lost when such a mixture is used, consume the mixture in its entirety."	0
The postulated mechanism of maprotiline is that it acts primarily by potentiation of central adrenergic synapses by blocking reuptake of norepinephrine at nerve endings.	0
"The risk differences (drug vs placebo), however, were relatively stable within age strata and across indications."	0
The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.	0
Do not use in patients with congenital long QT syndrome.	0
"Based on a case report in one patient receiving combination therapy with all-trans-retinoid acid (an acid form of vitamin A) and fluconazole, CNS related undesirable effects have developed in the form of pseudotumour cerebri, which disappeared after discontinuation of fluconazole treatment."	0
The ratio of pitavastatin Cmax between patients with moderate hepatic impairment (Child-Pugh B disease) and healthy volunteers was 2.7.	0
"If the dose is increased to 20 mg, this should occur after a minimum of one week."	0
"<U+2022>Heart failure: Start at 3.125mg twice daily and increase to 6.25, 12.5, and then 25mg twice daily over intervals of at least 2 weeks."	0
"Since atenolol is excreted via the kidneys, dosage should be adjusted in cases of severe impairment of renal function."	0
The clinical effect and safety profile observed in poor metabolizers were similar to those of extensive metabolizers.	0
Likewise the administration of benazepril does not substantially affect the pharmacokinetics of these medications (cimetidine kinetics were not studied).	0
"An isolated report showing a moderate rise in bilirubin and/or transaminase level is not in itself an indication for interrupting treatment; rather, the decision should be made after repeating the tests, noting trends in the levels, and considering them in conjunction with the patient's clinical condition."	0
Monitor such patients for hypotension and marked bradycardia which may produce syncope.	0
"Do not administer Tasigna to patients with hypokalemia, hypomagnesemia, or long QT syndrome ( 4 , 5.2 )."	0
Safety and effectiveness in the pediatric population below the age of 12 years have not been established.	0
"Pimozide - In a controlled study, a single dose of pimozide 2 mg co-administered with citalopram 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone."	0
"Because <U+03B1>1<U+2013>acid glycoprotein levels are increased in response to stress, serum levels of total quinidine may be greatly increased in settings such as acute myocardial infarction, even though the serum content of unbound (active) drug may remain normal."	0
"Avoid initiation of a high-dose regimen of extended-release metoprolol in patients undergoing non-cardiac surgery, since such use in patients with cardiovascular risk factors has been associated with bradycardia, hypotension, stroke and death."	0
"The risk for these events was highest during the first 30days of dosing, corresponding to the up<U+2011>titration period and was a cause for discontinuation of therapy in 0.7% of subjects receiving COREG, compared with 0.4% of placebo subjects."	0
"Tricyclic antidepressants : Amitriptyline, clomipramine, imipramine, maprotiline <U+2191> Tricyclics Therapeutic concentration monitoring is recommended for tricyclic antidepressants when coadministered with INVIRASE/ritonavir."	0
WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning.	0
Concomitant administration of warfarin (2 to 9 mg once daily) under steady state conditions with duloxetine 60 or 120 mg once daily for up to 14 days in healthy subjects (n=15) did not significantly change INR from baseline (mean INR changes ranged from 0.05 to +0.07).	0
Observational studies have demonstrated that concomitant use of opioid analgesics and benzodiazepines increases the risk of drug-related mortality compared to use of opioid analgesics alone.	0
"Monitor BCR-ABL transcript levels and complete blood count with differential in patients who have discontinued Tasigna therapy monthly for one year, then every 6 weeks for the second year, and every 12 weeks thereafter."	0
"Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan."	1
"Careful patient observation is advised (4.2, 5.2, 7.3)."	0
"Following the initial dose of ACCUPRIL, the patient should be observed under medical supervision for at least two hours for the presence of hypotension or orthostatis and, if present, until blood pressure stabilizes."	0
"In healthy subjects, no significant change in nilotinib pharmacokinetics was observed when a single 400 mg dose of Tasigna was administered 10 hours after and 2 hours before famotidine (an H2 blocker)."	0
Amiodarone is an antiarrhythmic agent with negative chronotropic properties that may be additive to those seen with beta blockers.	0
"When maximum response is attained, the dose may be maintained at 50 mg per square meter of body surface per day."	0
"Anesthetic:meperidine <U+2193> meperidine/ <U+2191>normeperidine (metabolite) Dosage increase and long-term use of meperidine with ritonavir are not recommended due to the increased concentrations of the metabolite normeperidine which has both analgesic activity and CNS stimulant activity (e.g.,seizures)."	0
Phylogenetic analysis of HCV sequences from genotype 5-infected subjects in Study 1119 showed almost all were subtype 5a (N=39) with one subject not having a subtype identified at screening or by analysis.	0
"With multiple-dose twice-daily dosing, steady-state is attained within 3 days."	0
<U+2022>Severe bradycardia (unless permanent pacemaker in place).	0
"The coadministration of triazolam and nefazodone causes a significant increase in the plasma level of triazolam , and a 75% reduction in the initial triazolam dosage is recommended if the two drugs are to be given together."	1
"Reported cases of liver injury occurred within 120 days of initiation of atomoxetine in the majority of cases and some patients presented with markedly elevated liver enzymes [>20 X upper limit of normal (ULN)], and jaundice with significantly elevated bilirubin levels (>2 X ULN), followed by recovery upon atomoxetine discontinuation."	0
"Meperidine Hydrochloride Injection is not recommended for use in pregnant women during or immediately prior to labor, when other analgesic techniques are more appropriate."	0
"Myopathy and Rhabdomyolysis: Advise patients to promptly report to their physician unexplained and/or persistent muscle pain, tenderness, or weakness."	0
These effects are probably due to increased hepatic blood flow.	0
Increase the respiridone dose up to double the patient's usual dose.	0
"Separately prepare a 50/50 volumetric mixture of Ora-Plus<U+2122> Trademark of Paddock Laboratories, Inc. and Ora-SweetSF<U+2122>."	0
"Based on clinical studies, the average prescribed adult daily dose of sevelamer carbonate is approximately 7.2 g per day."	0
"In hypertensive patients with normal renal function treated with ALTACE alone for up to 56 weeks, approximately 4% of patients during the trial had an abnormally high serum potassium and an increase from baseline greater than 0.75 mEq/L, and none of the patients had an abnormally low potassium and a decrease from baseline greater than 0.75 mEq/L."	0
"Patients taking Verapamil, Diltiazem, or Dronedarone The dose of ZOCOR should not exceed 10mg/day."	1
Do not use Effient in patients with active pathological bleeding or a history of transient ischemic attack or stroke.	0
"Should treatment with any of these agents be required, therapy with Tasigna should be interrupted."	0
"Since the clearance exceeds hepatic blood flow, considerable extrahepatic metabolism must also occur."	0
Only clear solutions without particles should be used.	0
Antipsychotics: Quetiapine <U+2191> Quetiapine Initiation of APTIVUS with ritonavir in patients taking quetiapine: Consider alternative antiretroviral therapy to avoid increases in quetiapine exposures.	1
"The desvenlafaxine volume of distribution at steady-state following intravenous administration is 3.4 L/kg, indicating distribution into nonvascular compartments."	0
Patients with hypokalemia and advanced cardiac failure are at an increased risk for the occurrence of life-threatening ventricular arrhythmias and torsades de pointes.	0
"Although a causal link between the emergence of such symptoms and either the worsening of depression and/or the emergence of suicidal impulses has not been established, there is concern that such symptoms may represent precursors to emerging suicidality."	0
"The risk of torsade de pointes is related to the extent of QTc prolongation, concomitant administration of QTc prolonging drugs, a history of torsade de pointes, pre-existing QTc interval prolongation, congestive heart failure, administration of potassium-wasting diuretics, or other conditions that result in hypokalemia or hypomagnesemia."	0
"Medication overuse headache may present as migraine-like daily headaches, or as a marked increase in frequency of migraine attacks."	0
"Hepatotoxicity: Tasigna may result in elevations in bilirubin, AST/ALT, and alkaline phosphatase."	0
"Therefore, if concomitant use of such agents is indicated, monitor the patient's serum potassium frequently."	0
Myocardial infarction and ventricular arrhythmias may occur with or without preceding exacerbation of the angina pectoris.	0
"For patients who develop a QTc greater than 500 msec, immediately withhold treatment with TRISENOX and any medication known to prolong the QTc interval."	0
"Advise patients taking COUMADIN to eat a normal, balanced diet maintaining a consistent amount of vitamin K. Patients taking COUMADIN should avoid drastic changes in dietary habits, such as eating large amounts of green leafy vegetables."	0
"When pemphigus-type reactions develop, THIOLA<U+00AE> therapy should be stopped."	0
No normal pharmacokinetic studies have been carried out in hypertensive patients with impaired liver function.	0
"In a14-day study of 0.5, 1.25, or 5 mg/day, fingolimodwas not associated with impaired oxygenation or oxygen desaturation with exercise or an increase in airway responsiveness to methacholine."	0
Known hypersensitivity to any component of this drug.	0
"In a controlled clinical trial in children and adolescents (10 to 17 years of age), 46 outpatients received Anafranil for up to 8 weeks."	0
"Non-Steroidal Anti-Inflammatory Agents including Selective Cyclooxygenase-2 Inhibitors ( COX-2 Inhibitors ) : In patients who are elderly , volume-depleted ( including those on diuretic therapy ) , or with compromised renal function , coadministration of NSAIDs , including selective COX-2 inhibitors , with angiotensin II receptor antagonists , including valsartan , may result in deterioration of renal function , including possible acute renal failure ."	0
For the treatment hypertension: Initiate therapy at 1 mg once daily.	0
Discontinuation Syndrome: Taper dose when possible and monitor for discontinuation symptoms (5.7).	0
"Families and caregivers of patients being treated with antidepressants for major depressive disorder or other indications, both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to health care providers."	0
All pediatric patients with a glomerular filtration rate less than 30 ml/min/1.73m2 should not receive ATACAND since ATACAND has not been studied in this population.	0
"The side effects , the former much more common than the latter."	0
"Therefore, coadministration of paroxetine with other drugs that are metabolized by this isozyme, including certain drugs effective in the treatment of major depressive disorder (e.g., nortriptyline, amitriptyline, imipramine, desipramine, and fluoxetine), phenothiazines, risperidone,and Type 1C antiarrhythmics (e.g., propafenone, flecainide, and encainide), or that inhibit this enzyme (e.g., quinidine), should be approached with caution."	0
"In sleep laboratory studies, HALCION Tablets significantly decreased sleep latency, increased the duration of sleep, and decreased the number of nocturnal awakenings."	0
"Although not approved for this purpose, PROCARDIA and other immediate-release nifedipine capsules have been used (orally and sublingually) for acute reduction of blood pressure."	0
Only 0.5% of the oral dose was excreted as unchanged bupropion.	0
"In this study, renal clearance was reduced by 55-85% for both losartan and its active metabolite in patients with mild or moderate renal insufficiency."	0
Do not use unless solution is clear and package is undamaged.	0
"Serotonergic Drugs-SeeCONTRAINDICATIONS, WARNINGS, and DOSAGE AND ADMINISTRATION."	0
"Closely monitor blood pressure, renal function and electrolytes in patients on ALTACE and other agents that affect the RAS."	0
"In the RE-LY trial, the median (10th to 90th percentile) trough ECT in patients receiving the 150 mg dose was 63 (44 to 103) seconds."	0
Monitor serum creatinine both during and after therapy has been completed.	0
"Concomitant use of allopurinol with PURIXAN inhibits the first-pass oxidative metabolism of mercaptopurine by xanthine oxidase, leading to mercaptopurine toxicity (bone marrow suppression, nausea, vomiting)."	1
Patients should be treated for a minimum of 14 days and for at least 7 days following resolution of symptoms.	0
Both digitalis glycosides and <U+03B2>-blockers slow atrioventricular conduction and decrease heart rate.	0
Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide.	0
"Other strong inhibitors of CYP3A4 (e.g., itraconazole, clarithromycin, nefazodone, troleandomycin, ritonavir, nelfinavir) would be expected to behave similarly."	0
"However, acute hypotension is unlikely (5.4)."	0
"If hypotension occurs, correct by volume expansion."	0
Most (about 70%) of the duloxetine dose appears in the urine as metabolites of duloxetine; about 20% is excreted in the feces.	0
The effects of paroxetine on diazepam were not evaluated.	0
"Use with Other Agents Affecting Myelopoesis: Drugs which may affect leukocyte production, including co-trimoxazole, may lead to exaggerated leukopenia, especially in renal transplant recipients."	0
"Benicar contains olmesartan, a drug that inhibits the renin-angiotensin system (RAS)."	0
The glass should be rinsed with water and the rinse swallowed to ensure the entire dose is consumed.	0
Clinical relevance of reduction in zidovudine levels not established.	0
Such patients merit closer monitoring for skeletal muscle effects.	0
An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy.	0
"In this clinical trial, there was limited (2.3%) use of dual antiplatelet therapy with ELIQUIS."	0
"Eplerenone is not an inhibitor of CYP1A2, CYP3A4, CYP2C19, CYP2C9, or CYP2D6."	0
"In most patients, nicardipine hydrochloride injection can safely be used concomitantly with beta-blockers."	0
"Marked increase in serum creatinine, pre-renal azotemia and acute renal failure, often in the setting of heart failure or hypovolemia, have been reported in patients taking MULTAQ."	0
Monitor cyclosporine drug levels and renal function in patients taking both drugs.	0
Epidemiological studies of case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding.	0
Maintenance Therapy: Systematic evaluation of continuing paroxetine for periods of up to 24 weeks in patients with GAD who had responded while taking paroxetine during an 8-week acute treatment phase has demonstrated a benefit of such maintenance.	0
"The following symptoms have been reported with STRATTERA: anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania and mania."	0
The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.	0
Concomitant use of fluvoxamine and Zanaflex is contraindicated.	0
CNS Depressants: Additive CNS-depressant effects with combination use.	0
"Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients who may experience worsening depressive symptoms, or who are experiencing emergent suicidality or symptoms that might be precursors to worsening depression or suicidality, especially if these symptoms are severe or abrupt in onset, or were not part of the patient's presenting symptoms."	0
"Renal Impairment Mild or moderate renal impairment does not affect lidocaine kinetics; while in patients with severe renal dysfunction, lidocaine clearance is decreased by half and the accumulation of GX increased 1.5-fold."	0
"Patients with risk factors for acute pancreatitis (e.g., recent chemotherapy, hematopoietic stem cell transplantation [HSCT]) should be monitored for the development of pancreatitis during VFEND treatment."	0
"Closely observe infants with histories of in utero exposure to TARKA for hypotension, oliguria, and hyperkalemia."	0
"Increases in ALT were more frequently observed in the patients treated with Savella 100 mg/day (6%) and Savella 200 mg/day (7%), compared to the patients treated with placebo (3%)."	0
"In patients with CrCl <U+2265>50 mL/min who have concomitant administration of P-gp inhibitors such as dronedarone or systemic ketoconazole, it may be helpful to separate the timing of administration of dabigatran and the P-gp inhibitor by several hours."	0
TENORMIN may aggravate peripheral arterial circulatory disorders.	0
Hydrochlorothiazide is a diuretic and antihypertensive agent.	0
"In patients, the concomitant administration of digoxin with dofetilide was associated with a higher occurrence of Torsade de Pointes."	0
Do not use LUVOX CR Capsules within 14 days of stopping an MAOI intended to treat psychiatric disorders.	0
"The physician should initiate dosage at a low level and increase it gradually, noting carefully the clinical response and any evidence of intolerance."	0
Careful monitoring of cyclosporine concentrations and serum creatinine is recommended in patients receiving DIFLUCAN and cyclosporine.	0
Doxazosin and prazosin have similar abilities to antagonize phenylephrine.	0
The safety and effectiveness of TIKOSYN in children (<18 years old) has not been established.	0
Open-angle glaucoma is not a risk factor for angle closure glaucoma.	0
This may be accomplished by reducing the dosage from 0.1 to 0.05 to 0.025 to 0.01 micrograms per kilogram of body weight per minute.	0
The bioavailability of CMI from capsules is not significantly affected by food.	0
These events have occurred as both new onset and an exacerbation of existing autoimmune disease.	0
Intravenous nitroglycerin reduces the anticoagulant effect of heparin .	0
Didanosine <U+2194> nelfinavir There was no change in nelfinavir concentration when coadministered with didanosine.	0
"Carbamazepine: Concomitant administration of diltiazem with carbamazepine has been reported to result in elevated serum levels of carbamazepine (40% to 72% increase), resulting in toxicity in some cases."	1
"Renal laboratory testing (including serum creatinine, estimated creatinine clearance, and urinalysis with microscopic examination) should be conducted in all patients prior to initiating therapy with REYATAZ and continued during treatment with REYATAZ."	0
Additive effects on QT and/or PR interval prolongation may occur with INVIRASE.	0
Minimal conversion of losartan to the active metabolite (less than 1% of the dose compared to 14% of the dose in normal subjects) was seen in about one percent of individuals studied.	0
"Concomitant administration of MINIPRESS with a PDE-5 inhibitor can result in additive blood pressure lowering effects and symptomatic hypotension; therefore, PDE-5 inhibitor therapy should be initiated at the lowest dose in patients taking MINIPRESS."	0
"The mechanism through which atenolol improves survival in patients with definite or suspected acute myocardial infarction is unknown, as is the case for other beta blockers in the postinfarction setting."	0
Consideration should be given to using a lower dose of zolpidem when a potent CYP3A4 inhibitor and zolpidem are given together.	1
Drug/Laboratory Test Interactions - Thiazides should be discontinued before carrying out tests for parathyroid function.	0
"Olanzapine binds with high affinity to the following receptors: serotonin5HT2A/2C, 5HT6 (Ki=4, 11, and 5nM, respectively), dopamineD1-4 (Ki=11-31nM), histamineH1 (Ki=7nM), and adrenergic<U+03B1>1 receptors (Ki=19nM)."	0
"Altered anticoagulant effects, including increased bleeding, have been reported when SSRIs and SNRIs are co-administered with warfarin."	0
"Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with SURMONTIL and should counsel them in its appropriate use."	0
There are no specific laboratory tests recommended.	0
Measurement of MIC or minimum bactericidal concentrations (MBC) and achieved antimicrobial compound concentrations may be appropriate to guide therapy in some infections.	0
"Cytochrome P450: Coadministration of Tracleer with drugs metabolized by CYP2C9 and CYP3A can increase exposure to Tracleer and/or the coadministered drug (4.2, 4.3, 7.1) Hormonal contraceptives: Tracleer use decreases contraceptive exposure and reduces effectiveness (7.2)."	1
"After an oral radiolabeled dose of trandolapril, excretion of trandolapril and metabolites account for 33% of the dose in the urine and about 66% in the feces."	0
The k is 0.55 for pediatric patients and adolescent girls and 0.7 for adolescent boys.	0
"After titration, the total daily dose may be given once daily at bedtime to minimize daytime sedation."	0
"This regimen of grapefruit juice resulted in a mean increase in the plasma concentration (as measured by the area under the concentration-time curve) of active and total HMG<U+2011>CoA reductase inhibitory activity [using an enzyme inhibition assay both before (for active inhibitors) and after (for total inhibitors) base hydrolysis] of 1.34<U+2011>fold and 1.36<U+2011>fold, respectively, and of lovastatin and its <U+03B2><U+2011>hydroxyacid metabolite [measured using a chemical assay <U+2014> liquid chromatography/tandem mass spectrometry <U+2014> different from that used in the first study] of 1.94<U+2011>fold and 1.57<U+2011>fold, respectively."	1
"Once the pull ring has been removed, do not reuse the solution or container."	0
<U+2022>Observe for signs and symptoms of hypotension (5.3).	0
Apomorphine <U+2013> profound hypotension and loss of consciousness.	0
"Strong CYP3A4/P-glycoprotein (P-gp) inducers: It may be necessary to increase the dose of INVEGA<U+00AE> when a strong inducer of both CYP3A4 and P-gp (e.g., carbamazepine) is co-administered."	1
"Limit LIVALO to 2 mg once daily (2.4, 7.3) Concomitant lipid-lowering therapies: Use with fibrates or lipid-modifying doses (<U+2265>1 g/day) of niacin increases the risk of adverse skeletal muscle effects."	0
"When the QTc normalizes, resume TRISENOX at a reduced dose."	0
Use of PRISTIQ with other MAOIs such as Linezolid or Methylene Blue Do not start PRISTIQ in a patient who is being treated with linezolid or intravenous methylene blue because there is increased risk of serotonin syndrome.	0
Doses above 0.6 mg/kg (or in excess of 40 mg daily) havenot been studied in pediatricpatients.	0
"Blockade of the AT1 receptor removes the negative feedback of angiotensin II on renin secretion, but the resulting increased plasma renin activity and circulating angiotensin II do not overcome the effects of irbesartan on blood pressure."	0
"Unlike Torsade de Pointes, the incidence of other ventricular arrhythmias was similar in female patients receiving TIKOSYN and patients receiving placebo."	0
Liver Function Tests: Occasional elevations (greater than 150%) of liver chemistries occurred in Diovan-treated patients.	0
Aripiprazole also does not undergo direct glucuronidation.	0
Lower starting and maintenance doses should be used in cirrhotic patients.	0
"Avoid co-administration of abiraterone acetate with substrates of CYP2D6 with a narrow therapeutic index (e.g., thioridazine)."	0
"Reproduction studies have been performed in rats at doses as high as 20times the MRHD on the basis of body weight, and 6times the human dose on the basis of body surface area without evidence of harm to the fetus due to triamterene."	0
"Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with PEXEVA<U+00AE> (paroxetine mesylate) and should counsel them in its appropriate use."	0
"Concurrent use of hydrochlorothiazide with amphotericin B or corticosteroids or corticotropin (ACTH) may intensify electrolyte imbalance, particularly hypokalemia, although the presence of triamterene minimizes the hypokalemic effect."	0
Steady-state levels measured prior to the morning dose on a one dosage regimen are summarized as follows: Average Minimum Concentration 95% Confidence Limits Regimen ng/mL ng/mL 50 mg <U+00D7> 3 daily 238 181<U+2013>295	0
"Concomitant administration of duloxetine 40mg twice daily with fluvoxamine 100mg, a potent CYP1A2 inhibitor, to CYP2D6 poor metabolizer subjects (n=14) resulted in a 6-fold increase in duloxetine AUC and Cmax."	1
Mix well and infuse at a rate allowing for complete infusion within 3 hours.	0
Antipsychotics:quetiapine <U+2191> quetiapine Initiation of NORVIR in patients taking quetiapine: Consider alternative antiretroviral therapy to avoid increases in quetiapine exposures.	1
Nilotinib inhibits human P-glycoprotein (P-gp).	0
"Hepatic transaminase elevations exceeding 5 times the upper limit of normal, clinical hepatitis, and jaundice have occurred in patients receiving NORVIR alone or in combination with other antiretroviral drugs."	0
"Hyperkalemia is more likely to occur in patients with renal impairment and diabetes (even without evidence of renal impairment), and in the elderly or severely ill."	0
AVOID INJECTING UNDILUTED CHLORPROMAZINE HYDROCHLORIDE INJECTION INTO VEIN.	0
"In a study in subjects with stable atherosclerosis, the mean exposure (AUC) to the active metabolite of prasugrel in subjects <U+2265>75years old taking a 5-mg maintenance dose was approximately half that seen in subjects 45 to 64 years old taking a 10-mg maintenance dose."	0
"Cyclosporine or Danazol: The risk of myopathy, including rhabdomyolysis is increased by concomitant administration of cyclosporine or danazol."	0
"Treatment should be continued for longer if the patient is still sputum or culture positive, if resistant organisms are present, or if the patient is HIV positive."	0
Initiate loperamide for late onset diarrhea of any severity.	0
"Such symptoms should be reported to the patient<U+2019>s prescriber or health professional, especially if they are severe, abrupt in onset, or were not part of the patient<U+2019>s presenting symptoms."	0
The terminal elimination half-life of irbesartan averaged 11 to 15 hours.	0
In vitro studies indicate that risperidone is a relatively weak inhibitor of CYP 2D6.	0
"Calcium channel blockers:diltiazem, nifedipine, verapamil <U+2191> calcium channel blockers Caution is warranted and clinical monitoring of patients is recommended."	0
An individual who is stable on a given dosage regimen of a TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy.	0
"Use in Renal Dysfunction: Relatively oliguric patients, especially those with tubular necrosis in the immediate postcadaveric transplant period, may have delayed clearance of IMURAN or its metabolites, may be particularly sensitive to this drug, and are usually given lower doses."	0
Advise pregnant women of the potential risk to a fetus.	0
The total patient-years is a summation of each patient<U+2019>s duration of exposure expressed in years.	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy."	0
"Antipsychotic treatment itself, however, may suppress (or partially suppress) the signs and symptoms of the syndrome and thereby may possibly mask the underlying process."	0
"Bronchodilators, including beta2<U+2014>agonists, should be readily available or administered concomitantly."	0
Potential risk for nevirapine-associated adverse reactions due to increased nevirapine exposures.	1
"), not over 75 mg/day except in unmanageable cases."	0
Plasma protein binding is constant over the concentration range achieved with recommended doses.	0
Food Effect Food does not affect either the rate or extent of absorption of risperidone.	0
Dilutional hyponatremia may occur in edematous patients in hot weather; appropriate therapy is water restriction rather than administration of salt except in rare instances when the hyponatremia is life-threatening.	0
"These studies uncovered no evidence of carcinogenic potential of hydrochlorothiazide in rats or female mice, but there was equivocal evidence of hepatocarcinogenicity in male mice."	0
"Hepatocellular liver injury, including acute liver failure requiring transplant, has been reported in patients treated with MULTAQ in the postmarketing setting."	0
Hepatic Transaminitis: Monitor liver enzymes before and during treatment (5.2).	0
"When lovastatin was given under fasting conditions, plasma concentrations of total inhibitors were on average about two-thirds those found when lovastatin was administered immediately after a standard test meal."	0
Severe hypersensitivity reaction: Permanently discontinueONIVYDE for severe hypersensitivity reactions.	0
Carbamazepine: Increased risk of hyponatremia.	0
There have been no reported cases from spontaneous reports of drug interaction between SSRI's and D.H.E.	0
"Tenex , like other orally active central 2-adrenergic agonists , causes sedation or drowsiness , especially when beginning therapy ."	0
Distribution Dabigatran is approximately 35% bound to human plasma proteins.	0
"In patients with heart failure and renal impairment, the recommended initial dose of ACCUPRIL is 5 mg in patients with a creatinine clearance above 30 mL/min and 2.5 mg in patients with a creatinine clearance of 10 to 30 mL/min."	0
"When rifampin is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed."	0
Inhalation Anesthetics Animal experiments have shown that inhalation anesthetics depress cardiovascular activity by decreasing the inward movement of calcium ions.	0
Table2 shows the results for the primary composite endpoint and the individual endpoints.	0
"Because of their noradrenergic effect, SNRIs including Savella, can affect urethral resistance and micturition."	0
In clinical pharmacology studies ADCIRCA potentiated the hypotensive effect of nitrates [see Clinical Pharmacology (12.2)].	0
"The use of the P-gp inhibitors verapamil, amiodarone, quinidine, clarithromycin, and ticagrelor does not require a dose adjustment of PRADAXA."	0
"Race/ethnicity In healthy black subjects, irbesartan AUC values are approximately 25% greater than whites; there is no difference in Cmax values."	0
"In addition, in vitro addition of quinidine to the serum of pregnant women reduces the activity of pseudocholinesterase, an enzyme that is essential to the metabolism of succinylcholine."	1
"The risk of differences (drug vs placebo), however, were relatively stable within age strata and across indications."	0
"The maximum mean (upper 1-sided, 95% CI) increase in baseline-adjusted QTc intervals based on individual correction method (QTcI) was 7.5 (11.7) ms and 4.6 (9.5) ms, for the 120 mg and 600 mg dose groups respectively, observed at 2 to 4 hours after dosing."	0
"Severe liver dysfunction prolongs the elimination half-life of verapamil to about 14 to 16 hours; hence, approximately 30% of the dose given to patients with normal liver function should be administered to these patients."	0
"CYMBALTA should be discontinued at the first appearance of blisters, peeling rash, mucosal erosions, or any other sign of hypersensitivity if no other etiology can be identified."	0
"When Tenex is used with other centrally active depressants ( such as phenothiazines , barbiturates , or benzodiazepines ) , the potential for additive sedative effects should be considered ."	0
"Interaction with Methotrexate: Concomitant use with PPIs may elevate and/or prolong serum concentrations of methotrexate and/or its metabolite, possibly leading to toxicity."	1
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction with antidepressants compared to placebo in adults aged 65 and older.	0
"The principal metabolites are polar and conjugated products of oxidation and methylation, which are readily cleared."	0
"Guanethidine or similarly acting compounds; thyroid medication; alcohol, barbiturates and other CNS depressants; and disulfiram."	0
Losartan inhibits the pressor effect of angiotensinII (as well as angiotensinI) infusions.	0
"If hyperkalemia is present, DYAZIDE should be discontinued immediately and a thiazide alone should be substituted."	0
Acidifying Agents Lower blood levels and efficacy of amphetamines.	1
"Combined P-gp and strong CYP3A4 inhibitors and inducers: Avoid concomitant use (7.2, 7.3) Anticoagulants: Avoid concomitant use (7.4) Rivaroxaban is a substrate of CYP3A4/5, CYP2J2, and the P-gp and ATP-binding cassette G2 (ABCG2) transporters."	0
Amlodipine does not change sinoatrial nodal function or atrioventricular conduction in intact animals or man.	0
"Plasma protein binding of dofetilide is 60<U+2013>70%, is independent of plasma concentration, and is unaffected by renal impairment."	0
Clozapine: Clozapine levels may be increased and produce orthostatic hypotension or seizures (5.9).	0
"However, the syndrome can develop, although much less commonly, after relatively brief treatment periods at low doses."	0
"Anyone considering the use of nortriptyline hydrochloride or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need."	0
No clinically significant change in CD4 cell counts or viral loads were noted.	0
All reports with methylene blue that provided information on the route of administration involved intravenous administration in the dose range of 1 mg/kg to 8 mg/kg.	0
Olanzapine's antagonism of muscarinicM1-5 receptors may explain its anticholinergic-like effects.	0
"Chest pain, acute myocardial infarction, and even sudden death have occurred during temporary withdrawal of nitrates from these workers demonstrating the existence of true physical dependence."	0
Recent studies indicate that regimens using twice-weekly doses of rifampin 600 mg plus isoniazid 15 mg/kg are much better tolerated.	0
"For other substrates of BCRP (e.g., mitoxantrone) and drugs in the OATP family (e.g., methotrexate, rifampin), especially HMG-Co reductase inhibitors (e.g., atorvastatin, nateglinide, pravastatin, repaglinide, and simvastatin), consider reducing the dose of these drugs and monitor patients closely for signs and symptoms of increased exposures to the drugs while patients are taking AUBAGIO."	1
The mean half-life of perindopril associated with most of its elimination is approximately 0.8 to 1 hours.	0
"Based on this finding, it is likely that other inhibitors of both CYP2C9 and CYP3A4 (e.g., ketoconazole, amiodarone) may also lead to a substantial increase in the systemic exposure (Cmax and AUC) of terbinafine when concomitantly administered."	1
"If excessive hypotension occurs, the patient should be placed in the supine position and, if necessary, receive an intravenous infusion of normal saline."	0
There is no body of evidence available from controlled trials to indicate how long the depressed patient should be treated with nefazodone.	0
Safety and effectiveness in the pediatric population have not been established.	0
"However, on the basis of available data, no dosage adjustment for ondansetron is recommended for patients on these drugs."	0
Reconstituted vials of NATRECOR<U+00AE> may be stored at 2 to 25<U+00B0>C (36 to 77<U+00B0>F) for up to 24 hours.	0
"In patients with renal insufficiency, the elimination half-life of quinaprilat increases as creatinine clearance decreases."	0
"New onset diabetes mellitus, exacerbation of pre-existing diabetes mellitus, and hyperglycemia have been reported during postmarketing surveillance in HIV-1-infected patients receiving protease inhibitor therapy."	0
"However, it has been proposed that this drug's efficacy in schizophrenia is mediated through a combination of dopamine type 2 (D 2) and serotonin type 2 (5HT 2) antagonism."	0
"In published placebo-controlled trials comparing 12.5 mg of hydrochlorothiazide to 25 mg, the 12.5 mg dose preserved most of the placebo-corrected blood pressure reduction seen with 25 mg."	0
"The reported clearance rate of dopamine in critically ill infants and children has ranged from 46 to 168mL/kg/min, with the higher values seen in the younger patients."	0
The likelihood of such reactions to discontinuation of clonidine therapy appears to be greater after administration of higher doses or continuation of concomitant beta-blocker treatment and special caution is therefore advised in these situations.	0
"Beta-blockers may mask some of the manifestations of hypoglycemia, particularly tachycardia."	0
"Although the role of stimulants in these adult cases is also unknown, adults have a greater likelihood than children of having serious structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, coronary artery disease, or other serious cardiac problems."	0
Drug/Laboratory Test Interactions Chlorthalidone and related drugs may decrease serum PBI levels without signs of thyroid disturbance.	0
"Avoid co-administration of CYP 3A inducers ( e.g. , rifampin , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine , St.   John 's   Wort ) with SAMSCA , as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment ."	1
Patients should be instructed not to discontinue therapy without consulting their physician.	0
Administration of 20 mg/day Lexapro for 21 days in healthy volunteers resulted in a 50% increase in Cmax and 82% increase in AUC of the beta-adrenergic blocker metoprolol (given in a single dose of 100 mg).	1
Concurrent use of mexiletine and theophylline may lead to increased plasma theophylline levels.	1
Exposure in elderly patients is 30-40% higher as compared to adults.	0
"Aldosterone plasma concentrations generally decline following irbesartan administration, but serum potassium levels are not significantly affected at recommended doses."	0
Hepatic and renal evaluation are indicated prior to beginning therapy.	0
Prazosin causes a decrease in total peripheral resistance and was originally thought to have a direct relaxant action on vascular smooth muscle.	0
"Hepatic Insufficiency Increases in AUC0- <U+221E> and Cmax were observed in patients with moderate hepatic impairment compared to those in matched controls, with an increase in AUC of about 60%."	0
"Following an initial more rapid distribution phase, the mean terminal half-life is approximately 24 hrs."	0
Co-administration of Ritonavir in Patients on Tracleer .	0
"Telmisartan Hyperkalemia may occur in patients on ARBs, particularly in patients with advanced renal impairment, heart failure, on renal replacement therapy, or on potassium supplements, potassium-sparing diuretics, potassium-containing salt substitutes or other drugs that increase potassium levels."	0
"Subsequently, the health care provider may continue decreasing the dose but at a more gradual rate."	0
"ECG monitoring is recommended if therapy is initiated in patients with congestive heart failure, bradyarrhythmias, hepatic impairment and electrolyte abnormalities."	0
"In an in vivo, nonrandomized, interaction study, subjects (n=6) in need of treatment with an antipsychotic and antidepressant drug, showed that mirtazapine (30 mg daily) at steady state did not influence the pharmacokinetics of risperidone (up to 3 mg b.i.d."	0
"These cases have presented as hepatitis with abdominal pain, hepatomegaly, and elevation of transaminase levels to more than twenty times the upper limit of normal with or without jaundice, reflecting a mixed or hepatocellular pattern of liver injury."	0
"After oral administration of dabigatran etexilate in healthy volunteers, Cmax occurs at 1 hour post-administration in the fasted state."	0
"Response during the single-blind phase was defined by having a decrease of <U+2265>2 points compared to baseline on the CGI-Severity of Illness scale, to a score of <U+2264>3."	0
Embryo-Fetal Toxicity: Can cause fetal harm.	0
<U+2022>Carbamazepine and other enzyme inducers decrease plasma concentrations of risperidone.	1
"There is no evidence that higher doses confer additional benefit, even in patients who do not respond to a 60mg dose, and higher doses are associated with a higher rate of adverse reactions."	0
Abrupt withdrawal of <U+03B2>-blockade may be followed by an exacerbation of the symptoms of hyperthyroidism or may precipitate thyroid storm.	0
Inhibition of CYP2D6 by paroxetine may lead to reduced plasma concentrations of an active metabolite (endoxifen) and hence reduced efficacy of tamoxifen.	0
Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide.	0
"Relative to subjects with normal renal function (eGFR >80 mL/min/1.73m2), the sofosbuvir AUC0<U+2013>inf was 61%, 107%, and 171% higher in mild, moderate, and severe renal impairment, while the GS-331007 AUC0<U+2013>inf was 55%, 88%, and 451% higher, respectively."	0
Fluconazole may enhance the serum concentration of methadone.	1
"In the unusual case that there is no appropriate alternative to therapy with drugs affecting the renin-angiotensin system for a particular patient, apprise the mother of the potential risk to the fetus."	0
The plasma levels achieved are proportional to the dose given.	0
"Aripiprazole is not a substrate of CYP1A1, CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, or CYP2E1 enzymes."	0
In vitro studies suggest that doxazosin is a substrate of CYP 3A4.	0
"In these trials, the coumarin anticoagulant was begun between 24 hours and 4 days postoperatively, and the Persantine<U+00AE> (dipyridamole USP) tablets were begun between 24 hours and 10 days postoperatively."	0
Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses.	0
"Since paroxetine exhibits nonlinear pharmacokinetics, the results of this study may not address the case where the 2 drugs are both being chronically dosed."	0
The altered pharmacokinetics may necessitate dosage adjustment of the affected drug or discontinuation of treatment.	0
It is generally believed (though not established in controlled trials) that treating such an episode with an antidepressant alone may increase the likelihood of precipitation of a mixed/manic episode in patients at risk for bipolar disorder.	0
"This should include laboratory evaluation, particularly serum creatinine."	0
"Serious reactions have been precipitated with concomitant use, including coma, severe hypertension or hypotension, severe respiratory depression, convulsions, malignant hyperpyrexia, excitation, peripheral vascular collapse, and death."	0
"Signs of excessive depression of cardiac conductivity, such as prolongation of the PR interval, widening of the QRS interval and the appearance or aggravation of arrhythmias, should be followed by prompt cessation of the intravenous infusion of this agent."	0
"Attention must be given to other factors that may precipitate hepatic coma, such as blood in the gastrointestinal tract or pre-existing potassium depletion."	0
The E237G substitution was detected in 3 subjects infected with HCV GT1a in the SOLAR-1 and SOLAR-2 trials.	0
Hang solution container and place the drainage container below the level of the abdomen.	0
"During the clinical development program (n=3063), severe skin reactions, accompanied by fever and/or elevations of transaminases in some cases, have been reported in 0.4% of subjects."	0
"Interference with Cognitive and Motor Performance: Any psychoactive drug may impair judgment, thinking, or motor skills."	0
Abnormalities included skeletal malformations and visceral anomalies.	0
"No effect was observed on the pharmacokinetics of pravastatin or its 3<U+03B1>-hydroxy isomeric metabolite (SQ 31,906)."	0
The estimated AUC accumulation ratio is approximately 30 after repeated doses of 7 or 14 mg. Absorption Median time to reach maximum plasma concentrations is between 1 to 4 hours post dose following oral administration of teriflunomide.	0
"FANAPT exhibits high (nM) affinity binding to serotonin 5-HT2A dopamine D2 and D3 receptors, and norepinephrine NE<U+03B1>1 receptors (Ki values of 5.6, 6.3, 7.1, and 0.36 nM, respectively)."	0
"Confirmatory tests, such as gas chromatography/mass spectrometry, will distinguish desvenlafaxine from PCP and amphetamine."	0
"In vitro, desvenlafaxine does not inhibit CYP1A2, 2A6, 2C8, 2C9, and 2C19, isozymes, and P-glycoprotein transporter and would not be expected to affect the pharmacokinetics of drugs that are substrates of these CYP isozymes and transporter."	0
"In addition, the growth of young dogs and rats has been retarded by doses exceeding the maximum human dose."	0
Co-administration of APTIVUS can alter the concentrations of other drugs and other drugs may alter the concentration of tipranavir.	0
Patients should be monitored for the emergence of serotonin syndrome.	0
"Prescriptions for nortriptyline hydrochloride should be written for the smallest quantity of solution consistent with good patient management, in order to reduce the risk of overdose."	0
"In rare instances, hemoperfusion may be beneficial in acute refractory cardiovascular instability in patients with acute toxicity."	0
Apnea is experienced by about 10 to 12% of neonates with congenital heart defects treated with PROSTIN VR PEDIATRIC Sterile Solution.	0
"The primary endpoint of the study was the time to first occurrence of any one of the following events: doubling of serum creatinine, end-stage renal disease (ESRD) (need for dialysis or transplantation), or death."	0
Concomitant use of CRIXIVAN and St. John's wort (Hypericum perforatum) or products containing St. John's wort is not recommended.	0
"Verapamil should be avoided in patients with severe left ventricular dysfunction (eg, ejection fraction less than 30%) or moderate to severe symptoms of cardiac failure and in patients with any degree of ventricular dysfunction if they are receiving a beta-adrenergic blocker."	0
"Coronary Artery Disease: Dipyridamole has a vasodilatory effect and should be used with caution in patients with severe coronary artery disease (e.g., unstable angina or recently sustained myocardial infarction)."	0
"Drugs that slow heart rate : Concomitant use of drugs with depressant effects on the sinus and AV node ( e.g. , digoxin , beta blockers , verapamil , diltiazem , ivabradine , clonidine ) can potentiate the electrophysiologic and hemodynamic effects of amiodarone , resulting in bradycardia , sinus arrest , and AV block ."	0
The median EC50 value for subtype 4b was 199.6 nM (range 0.66<U+2013>1799 nM; N=3); the two 4b isolates with EC50 values greater than 100 nM had NS5A resistance-associated polymorphisms L30S+M31M+P58S+Y93H.	0
"If alprazolam is coadministered with nefazodone, a 50% reduction in the initial alprazolam dosage is recommended."	1
Digitalis Glycosides: Digoxin <U+2191> Digoxin Increases in serum digoxin concentration were greater in female subjects as compared to male subjects when digoxin was coadministered with INVIRASE/ritonavir.	1
Maintain serum potassium levels of 4 mEq/L or higher (within normal range) and maintain serum magnesium and calcium levels within normal ranges to reduce the risk of QT prolongation.	0
"Patients should be cautioned to contact their physician if they experience any of the following symptoms of potassium loss: excess thirst, tiredness, drowsiness, restlessness, muscle pains or cramps, nausea, vomiting or increased heart rate or pulse."	0
Children < 1 year of age must not receive ATACAND.	0
Rare occurrences of convulsions (including grand mal seizures) following nefazodone administration have been reported since market introduction.	0
Patients should be monitored for these symptoms when discontinuing treatment with Lexapro.	0
"Anticonvulsants:divalproex, lamotrigine, phenytoin <U+2193> anticonvulsants A dose increase may be needed for these drugs when co-administered with ritonavir and therapeutic concentration monitoring is recommended for these anticonvulsants, if available."	1
"In any case , both heparin and INTEGRILIN should be discontinued and sheath hemostasis should be achieved at least 2 to 4 hours before hospital discharge ."	0
"All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases."	0
"Should the patient<U+2019>s condition require, the frequency of dosing may be increased to every 8 hours or even further with caution."	0
"Because of the potassium-sparing properties of angiotensin-converting enzyme (ACE) inhibitors, triamterene and hydrochlorothiazide should be used cautiously, if at all, with these agents."	0
Clinical Worsening/Suicide Risk: Monitor for clinical worsening and suicide risk (5.1).	0
Clostridium difficile - Associated Diarrhea: PPI therapy may be associated with increased risk of (5.4).	0
Several well-controlled clinical trials have used exercise testing to assess the antianginal efficacy of continuously-delivered nitrates.	0
There are no adequate and well controlled studies in pregnant women.	0
"Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death."	0
"In open, noncomparative studies of small numbers of patients, doses of up to 400 mg daily have been used."	0
The exact mechanism of the antihypertensive effect of hydrochlorothiazide is not known.	0
"A three-drug regimen consisting of rifampin, isoniazid, and pyrazinamide (e.g., RIFATER<U+00AE>) is recommended in the initial phase of short-course therapy which is usually continued for 2 months."	0
Administration of a high fat meal delayed the absorption (Tmax: 6h) and increased the bioavailability of the extended-release tablet by approximately 50%.	0
"The dosage may be increased to 10 mg per day, if necessary."	0
Olanzapine <U+2014> Fluoxetine (60mg single dose or 60 mg daily dose for 8 days) causes a small (mean 16%) increase in the maximum concentration of olanzapine and a small (mean 16%) decrease in olanzapine clearance.	1
"If acceptable alternatives to linezolid or intravenous methylene blue treatment are not available and the potential benefits of linezolid or intravenous methylene blue treatment are judged to outweigh the risks of serotonin syndrome in a particular patient, Anafranil should be stopped promptly, and linezolid or intravenous methylene blue can be administered."	0
"In particular, there are no studies that directly evaluate the effects of long term Anafranil use on the growth, development, and maturation of children and adolescents."	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older.	0
Use of tadalafil for erectile dysfunction: Tadalafil dose should not exceed a maximum of 10 mg in a 72-hour period in patients receiving concomitant CRIXIVAN therapy.	1
No CNS lesions have been observed in mice after chronic treatment for up to 2 years at doses up to 400 mg/kg/day or in rats at doses up to 100 mg/kg/day.	0
"Other reported clinical experience indicates that, as with other tricyclic antidepressants, hepatic adverse events (characterized mainly by jaundice and elevated liver enzymes) are observed very rarely in geriatric patients and deaths associated with cholestatic liver damage have been reported in isolated instances."	0
"Monitor fluid status to avoid hyper- or hypovolemia and potentially severe consequences including congestive heart failure, volume depletion, and hypovolemic shock."	0
"Because candesartan does not inhibit ACE (kininase II), it does not affect the response to bradykinin."	0
"Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs."	0
Information is not available regarding tipranavir or boceprevir exposure with concomitant use.	0
The absolute bioavailability of clonidine on oral administration is 70% to 80%.	0
"In addition, MEVACOR produced increases of variable magnitude in HDL<U+2011>C, and modestly decreased VLDL<U+2011>C and plasma TG."	0
"However, the clinical significance of in vitro data is unknown."	0
Steady state interactions of rabeprazole and warfarin have not been adequately evaluated in patients.	0
The recommended initial dosage of ACCUPRIL in elderly patients is 10 mg given once daily followed by titration (as described above) to the optimal response.	0
Less serious hypokalemia should be evaluated with regard to other coexisting conditions and treated accordingly.	0
Cyclosporine: A pharmacokinetic interaction between diltiazem and cyclosporine has been observed during studies involving renal and cardiac transplant patients.	0
"If angina markedly worsens or acute coronary insufficiency develops, TOPROL-XL administration should be reinstated promptly, at least temporarily, and other measures appropriate for the management of unstable angina should be taken."	0
Cumulative effects of the drug may develop in patients with impaired renal function.	0
CALAN decreases the frequency of episodes of paroxysmal supraventricular tachycardia.	0
"Beta-blockade may mask some important premonitory signs of acute hypoglycemia (e.g., tachycardia) in patients with diabetes (especially labile diabetes) or with a history of episodes of spontaneous hypoglycemia."	0
"Aggressive behavior or hostility is often observed in children and adolescents with ADHD, and has been reported in clinical trials and the post marketing experience of some medications indicated for the treatment of ADHD."	0
"In general, particular care should be taken in treating ADHD in patients with comorbid bipolar disorder because of concern for possible induction of a mixed/manic episode in patients at risk for bipolar disorder."	0
Should not be taken with or immediately after a high-fat meal.	0
"In a separate study, one case of uveitis was associated with increased serum rifabutin levels following co-administration of rifabutin (300 mg QD) with itraconazole (600<U+2013>900 mg QD)."	1
"In the randomized trial in patients with newly diagnosed Ph+CML in chronic phase, severe (Grade 3 or 4) fluid retention occurred in 3.9% and 2.9% of patients receiving Tasigna 300 mg twice daily and 400 mg twice daily, respectively, and in 2.5% of patients receiving imatinib."	0
Anti-gout Colchicinea Potential for serious and/or life-threatening reactions in patients with renal and/or hepatic impairment.	0
Geriatric Patients Telmisartan: The pharmacokinetics of telmisartan do not differ between the elderly and those younger than 65 years.	0
"PDE5 inhibitors such as sildenafil, vardenafil, and tadalafil have been shown to potentiate the hypotensive effects of organic nitrates."	0
"Approximately 87% of a venlafaxine dose is recovered in the urine within 48 hours as unchanged venlafaxine (5%), unconjugated ODV (29%), conjugated ODV (26%), or other minor inactive metabolites (27%)."	0
"The multiple-dose pharmacokinetics of ziprasidone are dose-proportional within the proposed clinical dose range, and ziprasidone accumulation is predictable with multiple dosing."	0
<U+2022>Pediatric Patients (aged at least 4 weeks to 18years): Dosage should be calculated based on body weight (kg) and should not exceed adult dose.	0
The antihypertensive effect is reached at plasma concentrations between about 0.2 and 2.0 ng/mL in patients with normal excretory function.	0
"HMG-CoA reductase inhibitors: atorvastatin, rosuvastatin <U+2191> atorvastatin<U+2191> rosuvastatin Titrate atorvastatin dose carefully and use the lowest necessary dose."	0
Amiloride HCl was devoid of mutagenic activity in various strains of Salmonella typhimurium with or without a mammalian liver microsomal activation system (Ames test).	0
"Because of its beta1-selectivity, this is less likely with bisoprolol fumarate."	0
Monitor electrolytes and blood chemistry periodically and take appropriate clinical action.	0
The bioavailability of amlodipine is not altered by the presence of food.	0
It is recommended that the international normalized ratio (INR) be monitored when warfarin is combined with PREZISTA/ritonavir.	0
Table 34: Clinically Important Drug Interactions with LATUDA Strong CYP3A4 Inhibitors Clinical Impact: Concomitant use of LATUDA with strong CYP3A4 inhibitors increased the exposure of lurasidone compared to the use of LATUDA alone.	1
"P-glycoprotein (e.g., digoxin) Coadministration of tadalafil (40 mg once daily) for 10 days did not significantly alter digoxin pharmacokinetics in healthy subjects [see Clinical Pharmacology (12.3)]."	0
The minimum recommended Lockout Interval is 5 minutes.	0
Telmisartan is metabolized by conjugation to form a pharmacologically inactive acylglucuronide; the glucuronide of the parent compound is the only metabolite that has been identified in human plasma and urine.	0
Other antihypertensive drugs - additive effect or potentiation.	0
Dose to be repeated no earlier than 3 days.	0
"Because quinidine may be absorbed to PVC tubing, tubing length should be minimized."	0
The duration of an appropriate washout period which should intervene before switching from one selective serotonin reuptake inhibitor (SSRI) to another has not been established.	0
Citrate also inhibits the spontaneous nucleation of calcium oxalate and calcium phosphate (brushite).	0
"Paliperidone is not a substrate of CYP1A2, CYP2A6, CYP2C9, and CYP2C19, so that an interaction with inhibitors or inducers of these isozymes is unlikely."	0
"Asenapine exhibits high affinity for serotonin 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT5A, 5-HT6, and 5-HT7 receptors (Ki values of 2.5, 2.7, 0.07, 0.18, 0.03, 1.6, 0.25, and 0.11nM, respectively), dopamine D2A, D2B, D3, D4, and D1 receptors (Ki values of 1.3, 1.4, 0.42, 1.1, and 1.4 nM, respectively), <U+03B1>1A, <U+03B1>2A, <U+03B1>2B, and <U+03B1>2C -adrenergic receptors (Ki values of 1.2, 1.2, 0.33 and 1.2 nM, respectively), and histamine H1 receptors (Ki value 1.0 nM), and moderate affinity for H2 receptors (Ki value of 6.2 nM)."	0
"Ten patients who were stabilized on oral anticoagulants were given guanfacine , 1 - 2 mg/day , for 4 weeks ."	0
"Epoprostenol is metabolized to 2 primary metabolites: 6<U+2011>keto-PGF1<U+03B1> (formed by spontaneous degradation) and 6,15-diketo-13,14-dihydro-PGF1<U+03B1> (enzymatically formed), both of which have pharmacological activity orders of magnitude less than epoprostenol in animal test systems."	0
"In all three species, no treatment-related effects on embryonic/fetal survival or fetal weights were observed."	0
A flexible-dose trial of Lexapro (10 to 20 mg/day) demonstrated the effectiveness of Lexapro.	0
"If a concomitant transaminase increase occurs, evaluate for alternative etiologies."	0
"Hypertension: 50 mg once daily, alone or combined with other antihypertensive agents."	0
LASIX may decrease arterial responsiveness to norepinephrine .	0
Tell patients planning to undergo major surgery and/ or general or spinal anesthesia to inform their physicians that they are taking an ACE inhibitor.	0
"If angina markedly worsens or acute coronary ischemia develops, promptly reinstate TOPROL-XL, and take measures appropriate for the management of unstable angina."	0
"All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases."	0
"Signs and symptoms associated with more severe and/or acute cases have included hallucination, syncope, seizure, coma, respiratory arrest, and death."	0
Rechallenge with mexiletine in several cases was negative.	0
Anyone considering the use of Anafranil in a child or adolescent must balance the potential risks with the clinical need.	0
Women of childbearing potential should be advised to avoid becoming pregnant.	0
BREVIBLOC is not compatible with Sodium Bicarbonate ( 5 % ) solution ( limited stability ) or furosemide ( precipitation ) .	0
Clinical data and animal studies suggest that verapamil may potentiate the activity of neuromuscular blocking agents (curare-like and depolarizing).	0
An agent to reverse the anti-factor Xa activity of apixaban is available.	0
Individualize dosing based on the severity of hypertension and the response of the patient during dosing.	0
Known hypersensitivity to any rifamycin (4.1) PRIFTIN is contraindicated in patients with a history of hypersensitivity to rifamycins.	0
"In both studies, patients receiving continued Celexa treatment experienced significantly lower relapse rates over the subsequent 6 months compared to those receiving placebo."	0
Diabetes mellitus which has been latent may become manifest during thiazide administration.	0
Cholestyramine and colestipol: Reduced absorption of thiazides.	1
"Similar effects have been reported with losartan potassium tablets; in some patients, these effects were reversible upon discontinuation of therapy."	0
"Following either oral or intravenous administration of 14C-labeled irbesartan, about 20% of radioactivity is recovered in the urine and the remainder in the feces, as irbesartan or irbesartan glucuronide."	0
90% confidence intervals (CI) were within the range of 80 to 125% with the exception of the upper 90% CI limit for Cmax which was 126.5%.	0
Elderly patients and those with hepatic impairment have been observed to have a decreased clearance of fluvoxamine maleate.	0
An 18% increase in mean pulmonary artery pressure was seen following dosing with another 5-HT1 agonist in a study evaluating subjects undergoing cardiac catheterization.	0
"For adult patients weighing less than 40 kg, the oral maintenance dose may be increased from 100 mg every 12 hours to 150 mg every 12 hours."	0
"However, simultaneous administration of cimetidine tablets and antacids is not recommended, since antacids have been reported to interfere with the absorption of cimetidine."	1
"Angioedema of the face, extremities, lips, tongue, glottis, and larynx has been reported in patients treated with ACE inhibitors and has been seen in 0.1% of patients receiving ACCUPRIL."	0
There are no dosage adjustments for postpartum patients.	0
"No interaction studies have been performed with oral contraceptives containing other progestagens; however, an effect of fingolimod on their exposure is not expected."	0
There is limited experience with short-term dosing as high as 32 mg/hour.	0
Drug Interactions The risk of myopathy and rhabdomyolysis is increased by high levels of statin activity in plasma.	0
"In schizophrenic patients with epilepsy, anticonvulsant medication should be maintained during treatment with thioridazine."	0
"Because many drugs are excreted in human milk, caution should be exercised when nefazodone is administered to a nursing woman."	0
Nonselective beta-blockers may potentiate insulin-induced hypoglycemia and delay recovery of serum glucose levels.	0
The clinical relevance of in vitro susceptibility test results for mycobacterial species other than M tuberculosis using either the radiometric or the proportion method has not been determined.	0
"If the initial dose of 2.5 mg ALTACE cannot be tolerated, use an initial dose of 1.25 mg ALTACE to avoid excessive hypotension."	0
"If blood pressure is not controlled with VASOTEC alone , a diuretic may be added ."	0
"In patients undergoing hip replacement surgery, the recommended duration of treatment is 35 days."	0
"In healthy subjects, coadministration of a single 400 mg dose of Tasigna with multiple doses of esomeprazole (a proton-pump inhibitor) at 40 mg daily decreased the nilotinib AUC by 34%."	1
"If coadministration is necessary, reduce the quetiapine dose to 1/6 of the current dose and monitor for quetiapine-associated adverse reactions."	1
"If anticholinergic effects are seen, the dose of procyclidine should be reduced."	0
Hepatic impairment is likely to decrease clearance and increase exposure level of lidocaine.	0
"Orthostatic hypotension, falls and syncope have been reported with therapeutic doses of CYMBALTA."	0
"In general, discontinuation events occurred more frequently with longer duration of therapy."	0
Many of these patients had reported previous similar skin reactions to allopurinol.	0
Skeletal muscle relaxants: Possible increased responsiveness to muscle relaxants such as curare derivatives.	0
"In patients who are elderly , volume-depleted ( including those on diuretic therapy ) , or with compromised renal function , coadministration of NSAIDs , including selective COX-2 inhibitors , with ACE inhibitors , including enalapril , may result in deterioration of renal function , including possible acute renal failure ."	0
"Adult outpatients with chronic insomnia were evaluated in six double-blind, parallel-group sleep laboratory studies that varied in duration from a single night up to 35 nights."	0
"In such patients, dialysis must be stopped immediately, and aggressive therapy for anaphylactoid reactions must be initiated."	0
Hyperkalemia has been reported in diabetic patients with the use of potassium-sparing agents even in the absence of apparent renal impairment.	0
"Drugs Metabolized by P450 2D6 <U+2013> The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the Caucasian population (about 7% to 10% of Caucasians are so-called <U+201C>poor metabolizers<U+201D>); reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are not yet available."	0
"Focalin XR should not be used in children under 6 years of age, since safety and efficacy in this age group have not been established."	0
"Following oral administration, the apparent mean terminal elimination half-life of carvedilol generally ranges from 7 to 10hours."	0
"While this interaction has not been formally studied, it is recommended that theophylline levels be monitored when these drugs are concurrently administered."	0
"In patients with a history of urinary retention or glaucoma, because of the anticholinergic properties of the drug."	0
"However, there is substantial evidence from placebo-controlled maintenance trials in adults with depression that the use of antidepressants can delay the recurrence of depression."	0
"Hepatic clearance of quinidine is significantly reduced during coadministration of verapamil, with corresponding increases in serum levels and half<U+2013>life."	1
Minimum Inhibitory Concentration (MIC) No formal clinical drug interaction studies have been performed.	0
Prompt medical or surgical treatments may need to be considered if the intraocular pressure remains uncontrolled.	0
02 nM for genotype 1a (range 0.007<U+2013>1.0 nM; N=23) and 0.006 nM for genotype 1b (range 0.002<U+2013>1.0 nM; N=34).	0
"Furthermore, in a series of clinical drug interaction studies, coadministration of BRINTELLIX with substrates for CYP2B6 (e.g., bupropion), CYP2C9 (e.g., warfarin), and CYP2C19 (e.g., diazepam), had no clinical meaningful effect on the pharmacokinetics of these substrates (Figure 2)."	0
Herbal Products: St. John's wort (hypericum perforatum) <U+2193> Saquinavir Herbal products containing St. John's wort should not be used concomitantly with INVIRASE/ritonavir because coadministration may lead to loss of virologic response and possible resistance to INVIRASE or to the class of protease inhibitors.	0
"If interruption of treatment with Tasigna is not possible, patients who require treatment with a drug that prolongs QT or strongly inhibits CYP3A4 should be closely monitored for prolongation of the QT interval [see Boxed Warning, Dosage and Administration (2."	0
The pharmacokinetics in heart failure patients is similar to that in healthy elderly volunteers.	0
Candesartan does not bind to or block other hormone receptors or ion channels known to be important in cardiovascular regulation.	0
"Although carvedilol is metabolized primarily by the liver, plasma concentrations of carvedilol have been reported to be increased in patients with renal impairment."	0
Interference with adequate oral electrolyte intake will also contribute to hypokalemia.	0
"Of the 8,037 patients with suspected acute myocardial infarction randomized to TENORMIN in the ISIS-1 trial, 33% (2,644) were 65 years of age and older."	0
"In some cases, a patient already receiving LUVOX CR therapy may require urgent treatment with linezolid or intravenous methylene blue."	0
"Breaking, chewing, or emptying the contents of the capsule can result in increased exposure."	0
"New onset diabetes mellitus, exacerbation of pre-existing diabetes mellitus and hyperglycemia have been reported during post-marketing surveillance in HIV-infected patients receiving protease inhibitor therapy."	0
"In a CYP2C8 drug-drug interaction trial in healthy subjects, the AUC of pioglitazone was increased by 46% when pioglitazone was given together with a single dose of 1,000 mg abiraterone acetate."	1
"In immunocompromised patients, decreased gastric acidity, including that produced by acid-suppressing agents such as cimetidine, may increase the possibility of a hyperinfection of strongyloidiasis."	0
HCV protease inhibitor: Paritaprevir (coformulated with ritonavir and ombitasvir and coadministered with dasabuvir) LEXIVA: <U+2191>Amprenavir (predicted) <U+2191> or <U+2194>Paritaprevir (predicted) LEXIVA/ritonavir: <U+2191> or <U+2194>Amprenavir (predicted) <U+2191>Paritaprevir (predicted) Appropriate doses of the combinations with respect to safety and efficacy have not been established.	0
The coadministration of fluconazole at doses lower than 400 mg/day with terfenadine should be carefully monitored.	0
"Non-valvular Atrial Fibrillation: For patients with CrCl >30 mL/min: 150 mg orally, twice daily (2.1) For patients with CrCl 15-30 mL/min: 75 mg orally, twice daily (2.1) Treatment of DVT and PE: For patients with CrCl >30 mL/min: 150 mg orally, twice daily after 5-10 days of parenteral anticoagulation (2.1) Reduction in the Risk of Recurrence of DVT and PE: For patients with CrCl >30 mL/min: 150 mg orally, twice daily after previous treatment (2.1) Prophylaxis of DVT and PE Following Hip Replacement Surgery: For patients with CrCl >30 mL/min: 110 mg orally first day, then 220 mg once daily (2.1) Review recommendations for converting to or from other oral or parenteral anticoagulants (2.4, 2.5) Temporarily discontinue PRADAXA before invasive or surgical procedures when possible, then restart promptly (2.6) Indication Dosage Reduction in Risk of Stroke and Systemic Embolism in Non-valvular AF CrCl >30 mL/min: 150 mg twice daily CrCl 15 to 30 mL/min: 75 mg twice daily CrCl <15 mL/min or on dialysis: Dosing recommendations cannot be provided CrCl 30 to 50 mL/min with concomitant use of P-gp inhibitors: Reduce dose to 75 mg twice daily if given with P-gp inhibitors dronedarone or systemic ketoconazole."	0
At least 14 days should elapse between discontinuation of an MAOI and initiation of therapy with nefazodone.	0
Exposures in pediatric subjects were similar to those observed in adults.	0
Concomitant use of DESOXYN with MAOI drugs is contraindicated.	0
Do not divide the 40 mg PROTONIX For Delayed-Release Oral Suspension packet to create a 20 mg dosage for pediatric patients who are unable to take the tablet formulation.	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy."	0
A crossover study in nine healthy males comparing single doses of thioridazine 10 mg and 50 mg with placebo demonstrated a dose related prolongation of the QTc interval.	0
TRISENOX is contraindicated in patients who are hypersensitive to arsenic.	0
"TRISENOX can cause QT interval prolongation and ventricular arrhythmia, which can be fatal."	0
"<U+03B2>-Blockers:metoprolol, timolol <U+2191> beta-blockers Caution is warranted and clinical monitoring of patients is recommended."	0
Interrupt CAPRELSA for acute or worsening pulmonary symptoms.	0
Diarrhea - Frequent bowel movements or watery stools.	0
Antiparasitic:quinine <U+2191> quinine A dose decrease of quinine may be needed when co-administered with ritonavir.	1
Dosage reduction is recommended in patients with reduced TPMT activity.	0
The effect of paroxetine on phenobarbital pharmacokinetics was not studied.	0
Antidepressants increased the risk of suicidal thoughts and behavior in pediatric and young adult patients in short-term studies.	0
Therapy with LUVOX CR may be resumed 24 hours after the last dose of linezolid or intravenous methylene blue.	0
"However, the relationship to PROCARDIA therapy is uncertain."	0
"If DYAZIDE is employed, frequent evaluations of acid/base balance and serum electrolytes are necessary."	0
"Bupropion is extensively metabolized in the liver to active metabolites, which are further metabolized and subsequently excreted by the kidneys."	0
"Pregnancy Category C At oral doses 35 and 150 times the daily Maximum Recommended Human Dose (MRHD), isosorbide dinitrate has been shown to cause a dose related increase in embryotoxicity (increase in mummified pups) in rabbits."	0
It does not act primarily by stimulation of the central nervous system and is not a monoamine oxidase inhibitor.	0
"If diuretic therapy cannot be altered, provide close medical supervision with the first dose of ACEON, for at least two hours and until blood pressure has stabilized for another hour."	0
"In the extension phase of these studies, which lasted up to 52 weeks, mean fasting blood glucose increased by 12mg/dL in the CYMBALTA group and decreased by 11.5mg/dL in the routine care group."	0
"Do not use Effient in patients with active bleeding, prior TIA or stroke."	0
"The target dose is 32 mg once daily, which is achieved by doubling the dose at approximately 2-week intervals, as tolerated by the patient."	0
"Given the substantially lower antepartum exposures observed and the limited data in this patient population, indinavir use is not recommended in HIV-infected pregnant patients."	0
"Compared with carvedilol, the 3 active metabolites exhibit weak vasodilating activity."	0
Diltiazem 10 120 mg BID for 14 days 20 mg 3.57 MEVACOR has been shown to reduce total<U+2011>C and LDL<U+2011>C in heterozygous familial and non-familial forms of primary hypercholesterolemia and in mixed hyperlipidemia.	0
Impaired Hepatic Function: Thiazides should be used with caution in patients with impaired hepatic function.	0
Irbesartan is excreted in the milk of lactating rats.	0
"Desipramine <U+2013> When nefazodone (150 mg BID) and desipramine (75 mg QD) were administered together there were no changes in the pharmacokinetics of desipramine or its metabolite, 2-hydroxy desipramine."	0
"INVIRASE/ritonavir is a potent inhibitor of CYP3A, significantly increasing the exposure of drugs primarily metabolized by CYP3A."	1
"Intervention Avoid concomitant use of EMEND Examples Moderate inhibitor: diltiazem Strong inhibitors: ketoconazole, itraconazole, nefazodone, troleandomycin, clarithromycin, ritonavir, nelfinavir Strong CYP3A4 Inducers Clinical Impact Substantially decreased exposure of aprepitant in patients chronically taking a strong CYP3A4 inducer may decrease the efficacy of EMEND."	0
"The mean heart rate increase in extensive metabolizer (EM) patients was 5.0 beats/minute, and in poor metabolizer (PM) patients 9.4 beats/minute."	0
"Therefore, tenofovir exposure is approximately 130% higher when administered as tenofovir DF + atazanavir/ritonavir + HARVONI or tenofovir DF + darunavir/ritonavir + HARVONI and with food as compared to the tenofovir exposure observed following fasted administration of tenofovir DF-based regimens that do not contain an HIV PI/ritonavir and HARVONI."	1
Nifedipine is transferred through breast milk.	0
"Examples of some of the more potent CYP 3A4 inhibitors include: anti-fungals ketoconazole and itraconazole, the protease inhibitors ritonavir, nelfinavir, and indinavir, and macrolide antibiotics erythromycin, clarithromycin, and troleandomycin."	0
"Controlled studies in small numbers of patients suggest that the concomitant use of CALAN and oral beta-adrenergic blocking agents may be beneficial in certain patients with chronic stable angina or hypertension, but available information is not sufficient to predict with confidence the effects of concurrent treatment in patients with left ventricular dysfunction or cardiac conduction abnormalities."	0
"In heart failure trials, greater than 50% increases in creatinine were observed in 3.9% of Diovan-treated patients compared to 0.9% of placebo-treated patients."	0
"Based on recovery of quinapril and its metabolites in urine, the extent of absorption is at least 60%."	0
Do not administer bolus injections of FLOLAN.	0
Paliperidone is not expected to cause clinically important pharmacokinetic interactions with drugs that are metabolized by cytochrome P450 isozymes.	0
These oxidative metabolites are then converted to glucuronides and eliminated in urine.	0
"There was considerable variation in risk of suicidality among drugs, but a tendency toward an increase in the younger patients for almost all drugs studied."	0
"Concomitant administration of duloxetine 40 mg twice daily with fluvoxamine 100 mg, a potent CYP1A2 inhibitor, to CYP2D6 poor metabolizer subjects (n=14) resulted in a 6-fold increase in duloxetine AUC and Cmax."	1
Individualize dosage depending on the blood pressure to be obtained and the response of the patient.	0
"Co-administered Drug Dose of Co-administered Drug (mg) Ledipasvir Dose(mg) Sofosbuvir Dose(mg) N Mean Ratio (90% CI) of Ledipasvir, Sofosbuvir, and GS-331007 PK With/Without Coadministered DrugNo Effect=1.00 Cmax AUC Cmin NA = not available/not applicable, ND = not dosed."	0
"Data on the long-term effects of STRATTERA on growth come from open-label studies, and weight and height changes are compared to normative population data."	0
Evaluate liver function tests at start of and during voriconazole therapy (5.2) Visual Disturbances (including optic neuritis and papilledema): Monitor visual function if treatment continues beyond 28 days (5.3) Embryo-Fetal Toxicity: Do not administer to pregnant women unless the benefit to the mother outweighs the risk to the fetus.	0
They should be informed of the danger of infection while receiving IMURAN and asked to report signs and symptoms of infection to their physician.	0
"Absorption Quetiapine fumarate is rapidly absorbed after oral administration, reaching peak plasma concentrations in 1.5 hours."	0
Lovastatin is a substrate for cytochrome P450 isoform3A4 (CYP3A4).	0
It has been reported that discontinuation of immunosuppression may provide partial regression of the lymphoproliferative disorder.	0
Peripheral edema is a known clinical consequence of PAH and worsening PAH and is also a known effect of Tracleer and other endothelin receptor antagonists .	0
"In vitro studies have shown that levomilnacipran is not an inhibitor of CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, P-gp, OATP1B1, OATP1B3, OAT1, OAT3, or OCT2."	0
Only prescribers and pharmacies certified with the program are able to prescribe and dispense CAPRELSA.	0
"Although ALTACE was antihypertensive in all races studied, Black hypertensive patients (usually a low-renin hypertensive population) had a blood pressure lowering response to monotherapy, albeit a smaller average response, than non-Black patients."	0
"If laryngeal stridor or angioedema of the face, tongue, or glottis occurs, treatment with ACCURETIC should be discontinued immediately, the patient treated in accordance with accepted medical care, and carefully observed until the swelling disappears."	0
"For oral medications where a reduction in the bioavailability of that medication would have a clinically significant effect on its safety or efficacy, consider separation of the timing of the administration of the two drugs."	0
"Therefore, risperidone is not expected to substantially inhibit the clearance of drugs that are metabolized by this enzymatic pathway."	0
Lexapro is contraindicated in patients with a hypersensitivity to escitalopram or citalopram or any of the inactive ingredients in Lexapro.	0
Metabolism and Elimination Biotransformation and disposition of duloxetine in humans have been determined following oral administration of 14C-labeled duloxetine.	0
Patients may develop new onset diabetes mellitus or hyperglycemia.	0
"In a 12-week study of 161 patients with non-insulin-dependent (type 2) diabetes mellitus and hypertension, there was no change in the level of HbA1c."	0
"Patients with severe neutropenia (absolute neutrophil count <1000/mm3) should discontinue Chlorpromazine Hydrochloride Injection, USP and have their WBC followed until recovery."	0
A substantial increase in the exposure to tolvaptan would be expected when SAMSCA is co-administered with moderate CYP 3A inhibitors.	1
"When a single oral 30 mg dose of paroxetine was administered at phenobarbital steady state (100 mg qd for 14 days), paroxetine AUC and T 1/2 were reduced (by an average of 25% and 38%, respectively) compared to paroxetine administered alone."	1
Other studies do not show a significant statistical association.	0
Dexmethylphenidate is metabolized primarily to d-ritalinic acid by de-esterification and not through oxidative pathways.	0
"Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients whose depression is persistently worse, or who are experiencing emergent suicidality or symptoms that might be precursors to worsening depression or suicidality, especially if these symptoms are severe, abrupt in onset, or were not part of the patient<U+2019>s presenting symptoms."	0
Only very small increases in blood levels of larger polymers were observed.	0
"Consequently, Tracleer is not expected to increase the plasma concentrations of drugs metabolized by these enzymes."	0
"Although a causal link between the emergence of such symptoms and either the worsening of depression and/or the emergence of suicidal impulses has not been established, there is concern that such symptoms may represent precursors to emerging suicidality."	0
Empty granules into a small cup or teaspoon containing one teaspoon of apple juice.	0
Rheumatoid Arthritis: IMURAN is usually given on a daily basis.	0
"Lotensin can cause symptomatic hypotension, sometimes complicated by oliguria, progressive azotemia, acute renal failure, or death."	0
"However, prior to initiating treatment with an antidepressant, patients with depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression."	0
"Fourteen additional minor metabolites have been isolated from urine, indicating that epoprostenol is extensively metabolized in humans."	0
Refer to the quetiapine prescribing information for recommendations on adverse reaction monitoring.	0
Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.	0
"In most patients, including those with organic cardiac disease, the negative inotropic action of CALAN is countered by reduction of afterload, and cardiac index is usually not reduced."	0
"Dosing in Low Weight Patients Compared to patients weighing <U+2265>60kg, patients weighing <60kg have an increased exposure to the active metabolite of prasugrel and an increased risk of bleeding on a 10-mg once daily maintenance dose."	0
Do not administer CAPRELSA to patients with a recent history of hemoptysis of <U+2265>1/2 teaspoon of red blood.	0
"After one week at the starting dose, increase dose (if tolerated) toward a target dose of 5 mg twice daily, with dosage increases being about 3 weeks apart."	0
Cases of second or third degree atrioventricular block have been reported rarely.	0
The recommended starting dose of Renvela is 0.8 to 1.6 g taken orally with meals based on serum phosphorus level.	0
"In some patients, additional factor VIII was required."	0
Titrate the atorvastatin and rosuvastatin doses carefully and use the lowest necessary dose with CRIXIVAN.	1
Patients should be instructed NOT to double the next dose if a dose is missed.	0
"Chronic animal studies showed occasional occurrence of hepatic congestion, fatty infiltration, or increased serum liver enzymes at the highest dose of 60 mg/kg/day."	0
"The plasma protein binding of risperidone is 90%, and that of its major metabolite, 9-hydroxyrisperidone, is 77%."	0
The recommended dosage of NORVIR in pediatric patients older than 1 month is 350 to 400 mg per m2 twice daily by mouth to be taken with meals and should not exceed 600 mg twice daily.	0
Hepatic Impairment: The bioavailability of perindoprilat is increased in patients with impaired hepatic function.	0
Safe Handling Procedures TRISENOX is a cytotoxic drug.	0
Dose adjustment of lamotrigine may be required when coadministered with REYATAZ and ritonavir.	0
"It is recommended that patients in whom an abnormal liver test has occurred, or who have signs of symptoms suggesting liver dysfunction, be carefully evaluated."	0
Atazanavir is a weak inhibitor of CYP2C8.	0
Total exposure (AUC) is decreased by 25%.	0
Individually titrate Meperidine Hydrochloride Injection to a dose that provides adequate analgesia and minimizes adverse reactions.	0
"Co-administration of TIKOSYN with verapamil resulted in increases in dofetilide peak plasma levels of 42%, although overall exposure to dofetilide was not significantly increased."	1
"The management of NMS should include, 1) immediate discontinuation of antipsychotic drugs and other drugs not essential to concurrent therapy, 2) intensive symptomatic treatment and medical monitoring, and 3) treatment of any concomitant serious medical problems for which specific treatments are available."	0
Central Nervous System <U+2013> More than 30 cases of hyperthermia have been recorded by nondomestic postmarketing surveillance systems.	0
"Although viral suppression was observed in some of the 32 children who were followed on this regimen through 24 weeks, a substantially higher rate of nephrolithiasis was reported when compared to adult historical data."	0
The majority of the sofosbuvir dose recovered in urine was GS-331007 (78%) while 3.5% was recovered as sofosbuvir.	0
Tolerance to the anorectic effect of phendimetrazine develops within a few weeks.	0
The recommended Lockout Interval is 6 to 10 minutes.	0
Posttraumatic Stress Disorder (PTSD)<U+2013>The effectiveness of sertraline in the treatment of PTSD was established in two multicenter placebo-controlled studies (Studies 1 to 2) of adult outpatients who met DSM-III-R criteria for PTSD.	0
Sixty-two hypertensive patients aged 6 to 17 years received doses of NORVASC between 1.25 mg and 20 mg. Weight-adjusted clearance and volume of distribution were similar to values in adults.	0
Emergent Psychotic or Manic Symptoms <U+2013> Consider discontinuing treatment if such new symptoms occur.	0
Similar outcomes have been reported with losartan potassium tablets.	0
"Duration of therapy should be based on the severity of the patient's underlying disease, recovery from immunosuppression, and clinical response."	0
"However, clinical experience in patients aged above 65 years is limited."	0
GILENYA reduces the immune response to vaccination.	0
There was not sufficient evidence in this study to suggest a greater benefit for the 40 mg/day dose compared to the 20 mg/day dose.	0
CYP2C9 is thought to be of primary importance in the O-methylation pathway of S(-)-carvedilol.	0
Use caution when administering WELLBUTRIN XL concomitantly with these drugs.	0
Azoospermia and antifertility effects associated with procarbazine hydrochloride administration in combination with other chemotherapeutic agents for treating Hodgkin's disease have been reported in human clinical studies.	0
"For the treatment of tuberculosis, rifampin is usually administered on a daily basis."	0
Patients with a history of seizures were excluded from clinical studies.	0
"<U+2022> When pregnancy is detected, discontinue ATACAND as soon as possible."	0
A Patient Package Insert (PPI) for CRIXIVAN is available for patient information.	0
"(7.1, 7.2) Patients receiving more than 40 mg per day of simvastatin or lovastatin may be at increased risk of statin-related adverse effects."	0
"Antiarrhythmics: amiodarone, bepridil, lidocaine (systemic), quinidine <U+2191> amiodarone, bepridil, lidocaine (systemic), quinidine Coadministration with REYATAZ has the potential to produce serious and/or life-threatening adverse events and has not been studied."	0
"Gender: In a pharmacokinetic study which compared healthy male and female volunteers, pitavastatin Cmax and AUC were 60 and 54% higher, respectively in females."	0
The disposition of a single dose paliperidone 3 mg extended-release tablet was studied in adult subjects with varying degrees of renal function.	0
"<U+2022> Race: A population pharmacokinetic analysis revealed no clinically relevant differences in pharmacokinetics among Caucasian, Hispanic, and Black or Afro-Caribbean groups."	0
"Amiodarone is a substrate for CYP3A and CYP2C8, so inhibitors and inducers affect amiodarone exposure (7) Amiodarone inhibits p-glycoprotein and CYP1A2, CYP2C9, CYP2D6, and CYP3A, increasing exposure to other drugs (7) Drugs prolonging the QT interval: Co-administration of drugs prolonging the QT interval (such as class I and III antiarrhythmics, lithium, certain phenothiazines, tricyclic antidepressants, certain fluoroquinolone and macrolide antibiotics, azole antifungals, halogenated inhalation anesthetic agents) increases the risk of Torsade de Pointes."	0
"For treatment of hyperuricemia in patients with gout, ULORIC is recommended at 40 mg or 80 mg once daily."	0
Inhibition of CYP2D6 by paroxetine may lead to reduced plasma concentrations of an active metabolite (endoxifen) and hence reduced efficacy of tamoxifen.	1
"Beta blockers may mask tachycardia occurring with hypoglycemia, but other manifestations such as dizziness and sweating may not be significantly affected."	0
Further increments of 0.1 mg per day may be made at weekly intervals if necessary until the desired response is achieved.	0
"Use with caution in patients with hypertension, tachycardia, or cardiovascular or cerebrovascular disease."	0
"In general , avoid combined use of aliskiren with ACE inhibitors or ARBs , particularly in patients with creatinine clearance ( CrCl ) less than 60 mL/min see Contraindications ( 4 ) , Drug Interactions ( 7 ) and Clinical Studies ( 14.3 ) ."	0
Occasionally a large dose may cause atrioventricular (A-V) block and nodal rhythm.	0
Anti-infective Agents Therapy with rifampin may markedly reduce oral verapamil bioavailability.	1
<U+2022>Efficacy and safety of REYATAZ with ritonavir when ritonavir is administered in doses greater than 100 mg once daily have not been established.	0
See full prescribing information for a list of clinically important drug interactions (7)	0
Patients should be periodically reassessed to determine the need for continued treatment.	0
"The parent compound, benazepril, was not detected in the dialysate."	0
"Because digoxin slows sinoatrial and AV conduction, the drug commonly prolongs the PR interval."	0
"Angiotensin II is formed from angiotensin I in a reaction catalyzed by angiotensin-converting enzyme (ACE, kininase II)."	0
A causal relationship between protease inhibitor therapy and these episodes has not been established.	0
"In a 10-week pediatric OCD study, 2 out of 57 patients (4%) treated with fluvoxamine experienced manic reactions, compared to none of 63 placebo patients."	0
"Adolescent and Geriatric Patients<U+2014>Initially, a dose of 50 mg/day is recommended, with gradual increments up to 100 mg/day, depending upon patient response and tolerance."	0
Each vial is for single use only; discard any unused diluent or unused reconstituted solution.	0
Families and caregivers should be advised of the need for close observation and communication with the prescriber.	0
"If LUVOX CR Capsules are to be administered together with a drug that is eliminated via oxidative metabolism and has a narrow therapeutic window, plasma levels and/or pharmacodynamic effects of the latter drug should be monitored closely, at least until steady-state conditions are reached."	0
Bradycardia and heart block can occur and the left ventricular end diastolic pressure can rise when beta-blockers are administered with verapamil or diltiazem.	0
"5-HT3 antagonist Adults and Pediatric Patients 12 Years and Older See selected 5-HT3 antagonist prescribing information for the recommended dosage none none none Table 2: Recommended Dosing for the Prevention of Nausea and Vomiting Associated with MEC Population Day 1 Day 2 Day 3 EMEND capsulesAdminister EMEND capsules 1 hour prior to chemotherapy treatment on Days 1, 2, and 3."	0
"In most patients, treatment of hypomagnesemia required magnesium replacement and discontinuation of the PPI."	0
"Seizures: There is some clinical evidence that stimulants may lower the convulsive threshold in patients with prior history of seizures, in patients with prior EEG abnormalities in absence of seizures, and, very rarely, in patients without a history of seizures and no prior EEG evidence of seizures."	0
Safety and effectiveness in pediatric patients have not been established.	0
Each bottle will deliver 35 mL of suspension.	0
Such monitoring should include daily observation by families and caregivers.	0
Olanzapine displays linear kinetics over the clinical dosing range.	0
"While no in vivo drug-drug interaction studies were conducted between estazolam and inhibitors/inducers of CYP3A, compounds that are potent CYP3A inhibitors (such as ketoconazole, itraconazole, nefazodone, fluvoxamine, and erythromycin) would be expected to increase plasma estazolam concentrations and CYP3A inducers (such as carbamazepine, phenytoin, rifampin and barbiturates) would be expected to decrease estazolam concentrations."	1
Patients should be monitored for these symptoms when discontinuing treatment.	0
Atenolol crosses the placental barrier and appears in cord blood.	0
"In volunteers with varying degrees of renal impairment and patients with arrhythmias, the clearance of dofetilide decreases with decreasing creatinine clearance."	0
"In healthy patients undergoing abdominal surgery, nicardipine hydrochloride injection (10 mg over 20 minutes) increased GFR with no change in RPF when compared with placebo."	0
"Marplan should not be used in combination with antihypertensive agents, including thiazide diuretics."	0
Some cases presented with features resembling neuroleptic malignant syndrome.	0
No effects at therapeutic doses on beta2-adrenoreceptor density have been observed.	0
"Bleeding events related to SSRIs and SNRIs have ranged from ecchymosis, hematoma, epistaxis, and petechiae to life-threatening hemorrhages."	0
"This suggests that an interaction of iloperidone with inhibitors or inducers of these enzymes, or other factors, like smoking, is unlikely."	0
The increased risk of malignancy following therapy with IMURAN should be explained to the patient.	0
"Hypotension  Patients on Diuretic Therapy: Patients on diuretics and especially those in whom diuretic therapy was recently instituted, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with enalapril."	0
"Colchicine: Cases of myopathy, including rhabdomyolysis, have been reported with lovastatin coadministered with colchicine."	0
"Following oral administration, terbinafine is well absorbed (>70%) and the bioavailability of Lamisil Tablets as a result of first-pass metabolism is approximately 40%."	0
"These include aspirin and other antiplatelet agents, other anticoagulants, heparin, thrombolytic agents, selective serotonin reuptake inhibitors, serotonin norepinephrine reuptake inhibitors, and nonsteroidal anti-inflammatory drugs (NSAIDs)."	0
Human pharmacokinetic studies with an oral formulation of treprostinil ( treprostinil diethanolamine ) indicated that co-administration of the cytochrome P450 ( CYP ) 2C8 enzyme inhibitor gemfibrozil increases exposure ( both Cmax and AUC ) to treprostinil .	1
It should be noted that Nardil is not approved for use in treating bipolar depression.	0
Grapefruit juice may increase plasma levels of verapamil.	1
"MEVACOR reduced the risk of a first acute major coronary event, the primary efficacy endpoint, by 37% (MEVACOR 3.5%, placebo 5.5%; p<0.001; Figure1)."	0
"Physicians should be aware that interaction studies with medications other than those listed in the CLINICAL PHARMACOLOGY section have not been conducted, but such interactions may occur."	0
Antimalarial:artemether/lumefantrine <U+2193> artemether<U+2193> dihydroartemisinin<U+2191> lumefantrine<U+2194> darunavir The combination of PREZISTA/ritonavir and artemether/lumefantrine can be used without dose adjustments.	0
"Because these events were reported voluntarily during clinical practice, estimates of frequency cannot be made."	0
Add 190mL of the 50/50 Ora-Plus<U+2122>/Ora-SweetSF<U+2122> mixture to the tablet and water slurry in the PET bottle and shake for 1minute to disperse the ingredients.	0
"Drugs that cause QT prolongation include: specific antipsychotics (e.g., ziprasidone, iloperidone, chlorpromazine, thioridazine, mesoridazine, droperidol, and pimozide), specific antibiotics (e.g., erythromycin, gatifloxacin, moxifloxacin, sparfloxacin), Class 1A antiarrhythmics (e.g., quinidine, procainamide) or Class III antiarrhythmics (e.g., amiodarone, sotalol), and others (e.g., pentamidine, levomethadyl acetate, methadone, halofantrine, mefloquine, dolasetron mesylate, probucol or tacrolimus)."	0
"In clinical studies with PREZISTA/ritonavir, the incidence and severity of rash were similar in subjects with or without a history of sulfonamide allergy."	0
PDE-5 inhibitor sildenafil for treatment of pulmonary arterial hypertension A safe and effective dose for the treatment of pulmonary arterial hypertension has not been established with PREZISTA/ritonavir.	0
No adjustment of dosage on the basis of race is needed.	0
Caution is therefore advised when administering non-steroidal anti-inflammatory agents with triamterene and hydrochlorothiazide.	0
Warn patients not to interrupt therapy without their physician<U+2019>s advice.	0
Ketoconazole (strong CYP3A4 inhibitor): The AUC0-inf and Cmax of ramelteon increased by approximately 84% and 36% upon coadministration of ketoconazole with ROZEREM.	1
Susceptibility test results obtained by the two different methods can only be compared if the appropriate rifampin concentration is used for each test method as indicated above.	0
"If no chemotherapy is given on Days 2 and 3, administer EMEND capsules in the morning."	0
Rheumatoid Arthritis Information is available on the risk of malignancy with the use of IMURAN in rheumatoid arthritis.	0
The risk of administering methylene blue by non-intravenous routes (such as oral tablets or by local injection) or in intravenous doses much lower than 1 mg/kg with SURMONTIL is unclear.	0
Dose adjustment of warfarin may be needed to maintain target INR range.	0
Avoid the use of strong CYP3A4 inducers because they may decrease CAPRELSA exposure.	1
"Caution: When administering lidocaine hydrochloride by continuous infusion, it is advisable to closely monitor the infusion rate."	0
"Fluoxetine: Co-administration of fluoxetine (20 mg twice daily for 21 days), a potent inhibitor of CYP2D6, with a single 3 mg dose of iloperidone to 23 healthy volunteers, ages 29 to 44 years, who were classified as CYP2D6 extensive metabolizers, increased the AUC of iloperidone and its metabolite P88, by about 2- to 3-fold, and decreased the AUC of its metabolite P95 by one-half."	1
Concomitant use of paroxetine with other drugs metabolized by cytochrome CYP2D6 has not been formally studied but may require lower doses than usually prescribed for either paroxetine or the other drug.	1
"Some patients given selegiline may experience an exacerbation of levodopa associated side effects, presumably due to the increased amounts of dopamine reaction with super sensitive, post-synaptic receptors."	0
"Therefore, STRATTERA should not be taken by patients with pheochromocytoma or a history of pheochromocytoma."	0
"To reduce this risk, consider coverage with another anticoagulant if ELIQUIS is discontinued for a reason other than pathological bleeding or completion of a course of therapy."	0
"Beta-Blockers In a study where propranolol (80 mg twice daily) was dosed orally for 18 days, the established steady-state plasma concentrations of propranolol were unaltered during coadministration with paroxetine (30 mg once daily) for the final 10 days."	0
"Optimally effective dosages of DEMSER usually are between 2.0 and 3.0 g/day , and the dose should be titrated by monitoring clinical symptoms and catecholamine excretion ."	0
It may be necessary to decrease the dose of verapamil and/or the dose of the neuromuscular blocking agent when the drugs are used concomitantly.	1
"Sudden cessation of clonidine treatment has, in some cases, resulted in symptoms such as nervousness, agitation, headache, and tremor accompanied or followed by a rapid rise in blood pressure and elevated catecholamine concentrations in the plasma."	0
"However, the prescriber should be aware that thioridazine has not been systematically evaluated in controlled trials in treatment refractory schizophrenic patients and its efficacy in such patients is unknown."	0
"Ergot derivatives Dihydroergotamine, ergonovine, ergotamine, methylergonovine Potential for acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues."	0
TENORMIN also differs from propranolol in that only a small amount (6%-16%) is bound to proteins in the plasma.	0
"To minimize the potential for next day effects, Silenor should not be taken within 3 hours of a meal."	0
This is more likely to occur in patients with pre-existing renal impairment.	0
"If the drug has a short half-life of elimination, it is possible that a relative deficiency of the drug or its active metabolites (ie, in relationship to the receptor site) may occur at some point in the interval between each night's use."	0
"In controlled hypertension trials, treatment with ACCUPRIL alone resulted in mean increases in potassium of 0.07 mmol/L."	0
There is insufficient data for dosage recommendation in patients with a creatinine clearance less than 10 mL/min.	0
"However, prior to initiating treatment with an antidepressant, patients with depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression."	0
It is desirable to monitor TCA plasma levels whenever a TCA is going to be co-administered with another drug known to be an inhibitor of P450 2D6.	0
Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.	0
LDL is formed from very low-density lipoprotein (VLDL) and is catabolized predominantly by the high affinity LDL receptor.	0
Avoid concomitant use of aliskiren with cyclosporine or itraconazole see Drug Interactions ( 7 ) .	0
Inhibitors or inducers of CYP4F2 and possibly other CYP4F isozymes might alter the exposure of fingolimod or fingolimod-phosphate.	0
"The combination may result in increased risk of cardiovascular adverse events associated with salmeterol, including QT prolongation, palpitations and sinus tachycardia."	0
"The Perpetrator and Dabigatran Etexilate Dose and Dosing Frequency are given as well as the Time of Perpetrator Dosing in Relation to Dabigatran Etexilate Dose (Time Difference) Figure 3.2<U+2003><U+2022>Effect of Non-P-gp Inhibitor or Inducer, Other Drugs, on Peak and Total Exposure to Dabigatran (Cmax and AUC)."	0
"Wide distribution occurs in body tissues including lungs, heart, brain, and liver."	0
Excessive reduction of blood pressure was rarely seen in patients with uncomplicated hypertension treated with irbesartan alone (<0.1%) or with irbesartan-hydrochlorothiazide (approximately 1%).	0
This does not affect the solution quality or safety and may often leave a slight amount of moisture within the overwrap.	0
The effects of propranolol on paroxetine have not been evaluated.	0
"Use with Diuretics in Adults If blood pressure is not controlled with PRINIVIL alone, a low dose of a diuretic may be added (e.g., hydrochlorothiazide 12.5 mg)."	0
"Endothelin-receptor antagonists: Bosentan <U+2191>Bosentan Coadministration of bosentan in patients on LEXIVA: In patients who have been receiving LEXIVA for at least 10days, start bosentan at 62.5mg once daily or every other day based upon individual tolerability."	0
AHA chelates with dietary iron within the gut.	0
"Drug interactions In vitro data indicate that amlodipine has no effect on the human plasma protein binding of digoxin, phenytoin, warfarin, and indomethacin."	0
"Drugs with a narrow therapeutic index represent the greatest concern (e.g., flecainide, propafenone, vinblastine, and TCAs)."	0
Antidiabetic drugs (oral agents and insulin) <U+2013> Dosage adjustment of the antidiabetic drug may be required.	0
Serum potassium should be maintained within the normal range before TIKOSYN treatment is initiated and should be maintained within the normal range while the patient remains on TIKOSYN therapy.	0
"Pimozide is metabolized by the CYP3A4 isozyme and it has been demonstrated that ketoconazole, a potent inhibitor of CYP3A4, blocks the metabolism of this drug, resulting in increased plasma concentrations of parent drug."	0
There is only minimal metabolism by the cytochrome P450 system.	0
Mirtazapine did not significantly affect the pharmacokinetics of phenytoin.	0
Imipramine: Coadministration of single doses of Zaleplon 20 mg and imipramine 75 mg produced additive effects on decreased alertness and impaired psychomotor performance for 2 to 4 hours after administration.	0
"Therefore, growth should be monitored during treatment with stimulants, and patients who are not growing or gaining height or weight as expected may need to have their treatment interrupted."	0
Exposure was increased 2-fold in severely impaired patients compared with the healthy volunteers.	0
Monitor patients for changes in clinical effect and adjust therapy based on clinical response.	0
Patients requiring treatment with medications with the potential to increase the QT interval and concomitant INVIRASE/ritonavir: Such combinations should only be used where no alternative therapy is available and the potential benefits outweigh the potential risks.	0
Dofetilide has been shown to adversely affect in utero growth and survival of rats and mice when orally administered during organogenesis at doses of 2 or more mg/kg/day.	0
Pediatric The pharmacokinetics of risperidone and 9-hydroxyrisperidone in children were similar to those in adults after correcting for the difference in body weight.	0
"Chronically administered beta-blocking therapy should not be routinely withdrawn prior to major surgery, however the impaired ability of the heart to respond to reflex adrenergic stimuli may augment the risks of general anesthesia and surgical procedures."	0
"The coadministration of a potent CYP3A4 enzyme inducer, although not posing a safety concern, thus could lead to ineffectiveness of zaleplon."	0
Sildenafil: The co-administration of nebivolol and sildenafil decreased AUC and Cmax of sildenafil by 21 and 23% respectively.	1
"There was considerable variation in risk of suicidality among drugs, but a tendency toward an increase in the younger patients for almost all drugs studied."	0
"When administered with a thiazide or loop diuretic, amiloride HCl has been shown to decrease the enhanced urinary excretion of magnesium which occurs when a thiazide or loop diuretic is used alone."	0
"Adults and Pediatric Patients 12 Years and Older 125 mg orally 80 mg orally 80 mg orally none Dexamethasone Adults 12 mg orally 8 mg orally 8 mg orally 8 mg orally Pediatric Patients 12 Years and Older If a corticosteroid, such as dexamethasone, is co-administered, administer 50% of the recommended corticosteroid dose on Days 1 through 4.Administer dexamethasone 30 minutes prior to chemotherapy treatment on Day 1 and in the morning on Days 2 through 4."	0
"Thioridazine has been shown to prolong the QTc interval in a dose related manner, and drugs with this potential, including thioridazine, have been associated with Torsades de pointes type arrhythmias and sudden death."	0
"Concomitant use of lidocaineat steady-state concentrations of the CYP1A2 inhibitor fluvoxamine increases intravenous lidocaine plasma AUC and Cmax by 71% and 22%, and decreases MEGX AUC and Cmax by 54% and 65%."	1
.	0
The absolute bioavailability of pitavastatin oral solution is 51%.	0
"If it is not possible to discontinue the diuretic, the starting dose of quinapril should be reduced."	1
"Thus, terbinafine may convert extensive CYP2D6 metabolizers to poor metabolizer status."	0
HIV Antiviral Agents: Protease Inhibitors Indinavir <U+2191> nelfinavir<U+2191> indinavir Concentrations of both indinavir and nelfinavir were increased when the two agents were coadministered.	1
"If opioid use is required for a prolonged period in a pregnant woman, advise the patient of the risk of neonatal opioid withdrawal syndrome and ensure that appropriate treatment will be available."	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy."	0
"Treatment of these patients with digoxin leads to greater slowing of conduction in the atrioventricular node than in accessory pathways, and the risks of rapid ventricular response leading to ventricular fibrillation are thereby increased."	0
"Concomitant administration of ULORIC with XO substrate drugs, azathioprine or mercaptopurine could increase plasma concentrations of these drugs resulting in severe toxicity."	1
Do not coadminister aliskiren with Lotensin in patients with diabetes.	0
"The risk differences (drug vs placebo), however, were relatively stable within age strata and across indications."	0
"The primary biotransformation pathway to minor metabolites of teriflunomide is hydrolysis, with oxidation being a minor pathway."	0
"When iron administration is indicated, intramuscular iron is probably the product of choice."	0
Nisoldipine was fetotoxic but not teratogenic in rats and rabbits at doses resulting in maternal toxicity (reduced maternal body weight gain).	0
Switching from anticoagulants other than warfarin (oral or parenteral) to ELIQUIS: Discontinue the anticoagulant other than warfarin and begin taking ELIQUIS at the usual time of the next dose of the anticoagulant other than warfarin.	0
"The incidence of non-fatal hemorrhagic stroke was significantly higher in the atorvastatin group (38, 1.6%) as compared to the placebo group (16, 0.7%)."	0
Removal of angiotensin II negative feedback on renin secretion leads to increased plasma renin activity.	0
The oral bioavailability of dabigatran etexilate increases by 75% when the pellets are taken without the capsule shell compared to the intact capsule formulation.	0
Monitor renal function periodically in patients receiving aliskiren and NSAID therapy .	0
"CYP3A4, CYP2C9, and CYP2C19 inhibitors and inducers: Adjust VFEND dosage and monitor for adverse reactions or lack of efficacy (4, 7) VFEND may increase the concentrations and activity of drugs that are CYP3A4, CYP2C9 and CYP2C19 substrates."	1
"The coadministration of the two drugs significantly reduced the steady-state Cmax and AUC of nefazodone by 86% and 93%, respectively."	0
"Neither clinical studies nor epidemiologic studies conducted to date, however, have shown an association between chronic administration of these drugs and mammary tumorigenesis; the available evidence is considered too limited to be conclusive at this time."	0
"A third (24 month) rat study, employing doses of 500 and 1,500 mg/kg/day (250 and 750 times the maximum recommended human antihypertensive dose1) resulted in increased incidences of benign adrenal medullary tumors in males and females, mammary fibroadenomas in females, and anterior pituitary adenomas and thyroid parafollicular cell carcinomas in males."	0
"Amiodarone has the potential for interactions with drugs or substances that may be substrates , inhibitors or inducers of CYP450 enzymes ( e.g. , inhibitors such as protease inhibitors , grapefruit juice , certain fluoroquinolone and macrolide antibiotics , azole antifungals and inducers such as St.   John s Wort ) or P-glycoprotein ."	0
Add 30 mL of Sodium Citrate and Citric Acid Oral Solution or Cytra-2 diluent and 160 mL of Ora-Sweet SF<U+2122> to the concentrate in the PET bottle and gently shake for several seconds to disperse the ingredients.	0
For patients with hepatic impairment CAPRELSA is not recommended for use in patients with moderate and severe hepatic impairment.	0
"The clinician should, nevertheless, be aware of the possibility of emergent symptoms of serotonin syndrome with such use."	0
"Coadministration of voriconazole and low-dose ritonavir (100 mg q12h) should be avoided, unless an assessment of the benefit/risk to the patient justifies the use of voriconazole."	0
Chlorthalidone is a long-acting oral diuretic with antihypertensive activity.	0
The single- and multiple-dose pharmacokinetics of citalopram are linear and dose-proportional in a dose range of 10-60 mg/day.	0
"Statins, like atorvastatin, and some other lipid-lowering therapies, have been associated with biochemical abnormalities of liver function."	0
Therapeutic concentration monitoring of digoxin is recommended when coadministered with HARVONI.	0
"The average time course for effects on aPTT, following approved dosing regimens in patients with various degrees of renal impairment is shown in Figure 2."	0
Estimation of the incidence of torsades in patients with therapeutic levels of quinidine is not possible from the available data.	0
The effects of race on pharmacokinetic characteristics in other ethnic groups have not been well characterized.	0
K-TAB should not be taken on an empty stomach because of its potential for gastric irritation.	0
There may be circumstances when it is necessary to initiate treatment with an MAOI such as linezolid or intravenous methylene blue in a patient taking nortriptyline hydrochloride oral solution USP.	0
"CARDIZEM CD decreases vascular resistance, increases cardiac output (by increasing stroke volume), and produces a slight decrease or no change in heart rate."	0
"Therefore, concomitant use of these drugs is contraindicated."	0
"Sinus bradycardia occurred in 11% of the patients, second-degree AV block in 4% and sinus arrest in 2%."	0
"In a dose proportionality study involving multiple CMI doses, steady-state plasma concentrations (Css) and area-under-plasma-concentration-time curves (AUC) of CMI and CMI's major active metabolite, desmethylclomipramine (DMI), were not proportional to dose over the ranges evaluated, i.e., between 25 to 100 mg/day and between 25 to 150 mg/day, although Css and AUC are approximately linearly related to dose between 100 to 150 mg/day."	0
"There were, however, no apparent differences between men and women in effectiveness or adverse effects."	0
Therefore GILENYA may be taken without regard to meals.	0
Drug Interactions Chlorthalidone may add to or potentiate the action of other antihypertensive drugs.	0
Mexiletine: The effect of steady-state fluvoxamine (50 mg given twice daily for 7 days) on the single dose pharmacokinetics of mexiletine (200 mg) was evaluated in 6 healthy Japanese males.	0
Combined therapy should usually be avoided in patients with atrioventricular conduction abnormalities and those with depressed left ventricular function.	0
Do not rechallenge if such reactions occur.	0
Several guidelines on this subject have been published.1-6 There is no general agreement that all of the procedures recommended in the guidelines are necessary or appropriate.	0
A single 360 mg dose of the capsule results in detectable plasma levels within 2 hours and peak plasma levels between 10 and 14 hours; absorption occurs throughout the dosing interval.	0
The use of alcohol with this drug should be avoided due to possible additive effects and hypotension.	0
"In these studies, the effectiveness of paroxetine compared to placebo was evaluated on the basis of (1) the proportion of responders, as defined by a Clinical Global Impression (CGI) Improvement score of 1 (very much improved) or 2 (much improved), and (2) change from baseline in the Liebowitz Social Anxiety Scale (LSAS)."	0
Concomitant use in patients taking pimozide is contraindicated.	0
"Similar findings were observed in the RE-LY, RE-COVER and RE-NOVATE II trials."	0
NATRECOR<U+00AE> is contraindicated in patients with: Persistent systolic blood pressure <100 mm Hg prior to therapy because of an increased risk of symptomatic hypotension Known hypersensitivity to any of its components Cardiogenic shock Persistent systolic blood pressure <100 mm Hg prior to therapy because of an increased risk of symptomatic hypotension.	0
The pupillary dilation that occurs following use of many antidepressant drugs including nortriptyline hydrochloride oral solution USP may trigger an angle-closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy.	0
"It is not known whether simvastatin is excreted into human milk; however, a small amount of another drug in this class does pass into breast milk."	0
"Before initiating stimulant therapy, obtain a detailed psychiatric history for patients with comorbid depressive symptoms, in order to determine risk for Bipolar Disorder."	0
"In contrast, Cmax and AUC of telmisartan decrease by 31% and 16%, respectively."	0
"This effect is maximal at about 2 to 4 hours, and persists for at least 24 hours."	0
"Although clarithromycin is a combined P-gp and strong CYP3A4 inhibitor , pharmacokinetic data suggests that no precautions are necessary with concomitant administration with XARELTO as the change in exposure is unlikely to affect the bleeding risk see Clinical Pharmacology ( 12.3 ) ."	0
"Dosage should be initiated at a low level and increased gradually, noting carefully the clinical response and any evidence of intolerance."	0
"Study 2 was a 6-week fixed-dose study, including sertraline hydrochloride doses of 50, 100, and 200 mg/day."	0
"In some patients with complete heart block, the idioventricular rate may be accelerated by atropine; in others, the rate is stabilized."	0
"Serious adverse events include tetany, arrhythmias, and seizures."	0
Zolpidem tartrate had no effect on digoxin pharmacokinetics and did not affect prothrombin time when given with warfarin in healthy subjects.	0
"In a multiclinic trial, average dose of THIOLA<U+00AE> was about 1000 mg/day."	0
NARDIL should be discontinued at least 10 days prior to elective surgery.	0
"VFEND tablets contain lactose and should not be given to patients with rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption."	0
"Caution is advised in using duloxetine in patients with conditions that may slow gastric emptying (e.g., some diabetics)."	0
Co-administration of ADCIRCA in Patients on Ritonavir .	0
Gender and Race The influence of gender and race on the pharmacokinetics of icodextrin and its metabolites was not assessed.	0
"Macrolide antibiotics are inhibitors of CYP 3A4, and thus could potentially impede pimozide metabolism."	1
The latter results in diuresis and natriuresis and may be associated with a small increase of serum potassium.	0
Diethylpropion hydrochloride is not recommended for patients who used any anorectic agents within the prior year.	0
"Sotalol has not been studied with other drugs that prolong the QT interval, such as antiarrhythmics, some phenothiazines, tricyclic antidepressants, and certain oral macrolides."	0
Drugs which induce or inhibit hepatic microsomal enzymes may alter diltiazem disposition.	0
Adjust VYVANSE dosage accordingly.	0
Lisinopril can be removed by hemodialysis.	0
"Coadministration of antiplatelet agents, thrombolytics, heparin, aspirin, and chronic NSAID use increases the risk of bleeding."	0
The absolute bioavailability of fluvoxamine maleate is 53%.	0
"In some cases, a patient already receiving nortriptyline therapy may require urgent treatment with linezolid or intravenous methylene blue."	0
"The pooled analyses of placebo-controlled trials in adults with MDD or other psychiatric disorders included a total of 295 short-term trials (median duration of 2 months) of 11 antidepressant drugs in over 77,000 patients."	0
"Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) including selective Cyclooxygenase-2 inhibitors (COX-2 inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors with agents that affect the RAAS, including aliskiren, may result in deterioration of renal function, including possible acute renal failure."	0
"Trandolapril Component As with other ACE inhibitors, patients on diuretics, especially those on recently instituted diuretic therapy, may occasionally experience an excessive reduction of blood pressure after initiation of therapy with TARKA."	0
"Nicardipine does not induce or inhibit its own metabolism; however, nicardipine has been shown to inhibit certain cytochrome P450 enzymes (including CYP3A4, CYP2D6, CYP2C8, and CYP2C19)."	0
"For suppression of relapse of cryptococcal meningitis in children with AIDS, the recommended dose of DIFLUCAN is 6 mg/kg once daily."	0
No studies have been conducted in patients on dialysis.	0
Preserved Left Ventricular Systolic Function: Patients with heart failure with preserved left ventricular ejection fraction may be more susceptible to digoxin toxicity.	0
Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.	1
"Hypersensitivity reactions may include anaphylaxis, anaphylactic shock, angioedema, bronchospasm, acute interstitial nephritis, and urticaria."	0
"If that dose level, at steady state, does not reduce the frequency of early relapse of arrhythmia and is tolerated without excessive QTc prolongation (>520 ms), increase the dose to 160 mg orally once or twice a day (corresponding to 150 mg intravenous sotalol)."	0
"Valvulopathy has been very rarely reported with diethylpropion hydrochloride monotherapy, but the causal relationship remains uncertain."	0
"After oral administration, the concentration of (+)-nisoldipine, the active enantiomer, is about 6 times higher than the inactive (-) -nisoldipine enantiomer."	0
Absorption:Iloperidone is well absorbed after administration of the tablet with peak plasma concentrations occurring within 2 to 4 hours; while the relative bioavailability of the tablet formulation compared to oral solution is 96%.	0
"With known hypersensitivity to sertraline (e.g., anaphylaxis, angioedema)."	0
The mean half-life in cirrhotic patients of 9.9 hr (range: 4.1 to 25.8 hr) was greater than that observed in normal subjects of 2.2 hr (range: 1.6 to 2.4 hr).	0
"In a small number of patients with hypertrophic cardiomyopathy (IHSS), concomitant use of verapamil and quinidine resulted in significant hypotension."	0
"If the patient<U+2019>s clinical response necessitates a change from the calculated loading dose of digoxin, then calculation of the maintenance dose should be based upon the amount actually given as the loading dose."	0
"While there was no difference in the proportion of nefazodone and placebo patients having adverse events characterized as <U+2018>syncope<U+2019> (nefazodone, 0.2%; placebo, 0.3%), the rates for adverse events characterized as <U+2018>postural hypotension<U+2019> were as follows: nefazodone (2.8%), tricyclic antidepressants (10.9%), SSRI (1.1%), and placebo (0.8%)."	0
Patients with advanced HIV disease may be at increased risk of elevated triglycerides and pancreatitis.	0
"Caution patients that lightheadedness can occur, especially during the first few days of ACCUPRIL therapy, and that it should be reported to a physician."	0
A dose decrease of methamphetamine may be needed when co-administered with ritonavir.	1
"Fingolimod-phosphate was also examined for its potential to induce mRNA and/or activity of human CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP3A, CYP4F2, CYP4F3B, and CYP4F12."	0
Higher doses of irbesartan ameliorated the hypokalemic response to hydrochlorothiazide.	0
"If the decision has been made to discontinue treatment, medication should be tapered, as rapidly as is feasible, but with recognition that abrupt discontinuation can be associated with certain symptoms."	0
"ZOCOR dosage should not exceed 20 mg/day (or 40 mg/day for patients who have previously taken ZOCOR 80 mg/day chronically, e.g., for 12 months or more, without evidence of muscle toxicity) while taking lomitapide."	1
"The concomitant use of higher doses of atorvastatin with certain drugs such as cyclosporine and strong CYP3A4 inhibitors (e.g., clarithromycin, itraconazole, and HIV protease inhibitors) increases the risk of myopathy/rhabdomyolysis."	0
"Tissue culture experiments indicate that approximately one-third of human breast cancers are prolactin dependent in vitro, a factor of potential importance if the prescription of these drugs is contemplated in a patient with a previously detected breast cancer."	0
"Myopathy sometimes takes the form of rhabdomyolysis with or without acute renal failure secondary to myoglobinuria, and rare fatalities have occurred."	0
"At baseline, 1195 (13%) had diabetes, 1326 (14%) had isolated systolic hypertension, 1469 (16%) had coronary heart disease, and 728 (8%) had cerebrovascular disease."	0
Concomitant use of drugs that are known combined P-gp and strong CYP3A4 inhibitors increases rivaroxaban exposure and may increase bleeding risk see Drug Interactions ( 7.2 ) .	1
Silenor should be taken within 30 minutes of bedtime.	0
Simvastatin: Co-administration of multiple doses of 10 mg of amlodipine with 80 mg simvastatin resulted in a 77% increase in exposure to simvastatin compared to simvastatin alone.	1
There was no clinically significant alteration in the pharmacokinetics of dofetilide in volunteers with mild to moderate hepatic impairment (Child-Pugh Class A and B) compared to age- and weight-matched healthy volunteers.	0
In vivo mutagenicity studies were negative.	0
Focalin XR is contraindicated in patients with glaucoma.	0
"For a child aged 20 months, the dosing suggested for children with normal renal function aged 2 years or greater should be multiplied by about 0.97; the initial starting dose would be (30 <U+00D7> 0.97) = 29.1 mg/m2, administered orally three times daily."	0
"The mean terminal half-life (t1/2) was prolonged from 11.1 hours in the control subjects to approximately 13.5, 15.5, 17.6, and 22.8 hours in mild, moderate, severe renal impairment and ESRD subjects, respectively."	0
"(7.6) Concomitant administration of Remodulin with diuretics, antihypertensive agents or other vasodilators may increase the risk of symptomatic hypotension."	0
"The pooled analyses of placebo-controlled trials in adults with MDD or other psychiatric disorders included a total of 295 short-term trials (median duration of 2 months) of 11 antidepressant drugs in over 77,000 patients."	0
"Inhibition was complete (100%) 4 hours following oral doses of 150 mg or 300 mg and partial inhibition was sustained for 24 hours (60% and 40% at 300 mg and 150 mg, respectively)."	0
"In resistant cases of depression in adults, a dose of 2.5 mg/kg/day may have to be exceeded."	0
"Possible factors that may be involved include: (1) decreased heart rate, (2) decreased myocardial contractility, (3) diminution of tonic sympathetic outflow to the periphery from cerebral vasomotor centers, (4) suppression of renin activity and (5) vasodilation and decreased peripheral vascular resistance."	0
"Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8 fold increase in plasma AUC of the TCA)."	0
"Since the half-life of verapamil increases during chronic dosing, maximum response may be delayed."	0
Concomitant administration of CARDURA with a phosphodiesterase-5 (PDE-5) inhibitor can result in additive blood pressure lowering effects and symptomatic hypotension.	0
The dose can be stored at room temperature for up to 3 hours before use.	0
Drug-Drug Interactions Table 3: Effect of Coadministered Drugs on the Pharmacokinetics of Pravastatin Coadministered Drug and Dosing Regimen Pravastatin Dose (mg) Change in AUC Change in Cmax Cyclosporine 5 mg/kg single dose 40 mg single dose <U+2191>282% <U+2191>327% Clarithromycin 500 mg BID for 9 days 40 mg OD for 8 days <U+2191>110% <U+2191>128% Boceprevir 800 mg TID for 6 days 40 mg single dose <U+2191>63% <U+2191>49% Darunavir 600 mg BID/Ritonavir 100 mg BID for 7 days 40 mg single dose <U+2191>81% <U+2191>63% Colestipol 10 g single dose 20 mg single dose <U+2193>47% <U+2193>53% Cholestyramine 4 g single dose 20 mg single dose Administered simultaneously <U+2193>40% <U+2193>39% Administered 1 hour prior tocholestyramine <U+2191>12% <U+2191>30% Administered 4 hours aftercholestyramine <U+2193>12% <U+2193>6.8% Cholestyramine 24 g OD for 4 weeks 20 mg BID for 8 weeks <U+2193>51% <U+2191>4.9% 5 mg BID for 8 weeks <U+2193>38% <U+2191>23% 10 mg BID for 8 weeks <U+2193>18% <U+2193>33% Fluconazole 200 mg IV for 6 days 20 mg PO + 10 mg IV <U+2193>34% <U+2193>33% 200 mg PO for 6 days 20 mg PO + 10 mg IV <U+2193>16% <U+2193>16% Kaletra 400 mg/100 mg BID for 14 days 20 mg OD for 4 days <U+2191>33% <U+2191>26% Verapamil IR 120 mg for 1 day and Verapamil ER 480 mg for 3 days 40 mg single dose <U+2191>31% <U+2191>42% Cimetidine 300 mg QID for 3 days 20 mg single dose <U+2191>30% <U+2191>9.8% Antacids 15 mL QID for 3 days 20 mg single dose <U+2193>28% <U+2193>24% Digoxin 0.2 mg OD for 9 days 20 mg OD for 9 days <U+2191>23% <U+2191>26% Probucol 500 mg single dose 20 mg single dose <U+2191>14% <U+2191>24% Warfarin 5 mg OD for 6 days 20 mg BID for 6 days <U+2193>13% <U+2193>6.7% Itraconazole 200 mg OD for 30 days 40 mg OD for 30 days <U+2191>11% (compared to Day 1) <U+2191>17% (compared to Day 1) Gemfibrozil 600 mg single dose 20 mg single dose <U+2193>7.0% <U+2193>20% Aspirin 324 mg single dose 20 mg single dose <U+2191>4.7% <U+2191>8.9% Niacin 1 g single dose 20 mg single dose <U+2193>3.6% <U+2193>8.2% Diltiazem 20 mg single dose <U+2191>2.7% <U+2191>30% Grapefruit juice 40 mg single dose <U+2193>1.8% <U+2191>3.7% BID = twice daily; OD = once daily; QID = four times daily Table 4: Effect of Pravastatin on the Pharmacokinetics of Coadministered Drugs Pravastatin Dosing Regimen Name and Dose Change in AUC Change in Cmax 20 mg BID for 6 days Warfarin 5 mg OD for 6 days <U+2191>17% <U+2191>15% Change in mean prothrombin time <U+2191>0.4 sec 20 mg OD for 9 days Digoxin 0.2 mg OD for 9 days <U+2191>4.6% <U+2191>5.3% 20 mg BID for 4 weeks Antipyrine 1.2 g single dose <U+2191>3.0% Not Reported 10 mg BID for 4 weeks <U+2191>1.6% 5 mg BID for 4 weeks <U+2191>Less than1% 20 mg OD for 4 days Kaletra 400 mg/100 mg BID for 14 days No change No change BID = twice daily; OD = once daily	0
"Caution is advised in using CYMBALTA in patients with conditions that may slow gastric emptying (e.g., some diabetics)."	0
No initial dosage adjustments are considered necessary when these drugs are coadministered; any subsequent adjustments should be guided by clinical effect.	0
"Heparin - A single intravenous dose of unfractionated heparin(100U/kg) did not significantly alter coagulation or the prasugrel-mediated inhibition of platelet aggregation; however, bleeding time was increased compared with either drug alone."	0
"REVATIO is contraindicated in patients with: Concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension."	0
Patients with atrial fibrillation should be anticoagulated according to usual medical practice prior to electrical or pharmacological cardioversion.	0
Donepezil increases systemic exposure of ramelteon; patients should be closely monitored when ramelteon is coadministered with donepezil.	1
"Consider benefits and risks before use in patients for whom blood pressure increases may be problematic (5.3) Psychiatric Adverse Reactions: May cause psychotic or manic symptoms in patients with no prior history, or exacerbation of symptoms in patients with pre-existing psychosis."	0
"Therefore , the expected clinical effects of SAMSCA in the presence of rifampin and other inducers ( e.g. , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine and St.   John 's   Wort ) may not be observed at the usual dose levels of SAMSCA ."	0
"For the four dosing strengths, the antihypertensive effect of the combination is approximately additive to the individual components."	0
"Amiodarone is a substrate for CYP3A and CYP2C8, so inhibitors and inducers affect amiodarone exposure (7) Amiodarone inhibits p-glycoprotein and CYP1A2, CYP2C9, CYP2D6, and CYP3A, increasing exposure to other drugs (7) Drugs prolonging the QT interval: Co-administration of drugs prolonging the QT interval (such as class I and III antiarrhythmics, lithium, certain phenothiazines, tricyclic antidepressants, certain fluoroquinolone and macrolide antibiotics, azole antifungals, halogenated inhalation anesthetic agents) increases the risk of Torsade de Pointes."	0
This contraindication is often extended to other opioids.	0
"Subjects and Age Group N CL(L/h/kg) Vdss (L/kg) T<U+00BD> (h) Geometric Mean Mean Pediatric Cancer Patients4 to 18 years of age N = 21 0.599 1.9 2.8 Population PK Patientsa 1 month to 48 months of age N = 115 0.582 3.65 4.9 Based on the population pharmacokinetic analysis, cancer patients 6 to 48 months of age who receive a dose of 0.15 mg/kg of intravenous ondansetron every 4 hours for 3 doses would be expected to achieve a systemic exposure (AUC) consistent with the exposure achieved in previous pediatric studies in cancer patients (4 to 18 years of age) at similar doses."	0
"Information For Patients Patients should inform their doctor if they have: 1) had an allergic reaction to chlorthalidone or other diuretics or have asthma 2) kidney disease 3) liver disease 4) gout 5) systemic lupus erythematosus, or 6) been taking other drugs such as cortisone, digitalis, lithium carbonate, or drugs for diabetes."	0
Smoking No dosage adjustment is recommended based on smoking status.	0
"Olanzapine binds weakly to GABAA, BZD, and <U+03B2>-adrenergic receptors (Ki>10<U+03BC>M)."	0
"Positive test results were also obtained in the Aspergillus nidulans nondisjunction assay, using an unspecified concentration of hydrochlorothiazide."	0
An adjustment in the diltiazem dose may be warranted.	0
Thrombocytopenia: Discontinue AGGRASTAT and heparin.	0
One case of bradycardia and hypotension and a second case of orthostatic hypotension have been reported with the coadministration of fluvoxamine maleate and metoprolol.	0
"The 120 mg/kg dose resulted in a systemic exposure approximately 16 times the human plasma area-under-the-curve (AUC, 0<U+2013>24 hours) based on the maximum human dose of 80 mg/day."	0
"Pravastatin is a reversible inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme that catalyzes the conversion of HMG-CoA to mevalonate, an early and rate limiting step in the biosynthetic pathway for cholesterol."	0
"Potassium-sparing diuretics, potassium supplements or salt substitutes may lead to increases in serum potassium, and in heart failure patients, increases in serum creatinine (7) NSAID use may lead to increased risk of renal impairment and loss of antihypertensive effect (7) Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia (7) Lithium: Increases in serum lithium concentrations and lithium toxicity (7) In controlled clinical trials, clinically important changes in standard laboratory parameters were rarely associated with administration of Diovan."	1
The concomitant use of PEXEVA<U+00AE> with MAOIs intended to treat psychiatric disorders is contraindicated.	0
The effect of MEVACOR on lipids and lipoproteins and the safety profile of MEVACOR were similar to that demonstrated in studies in nondiabetics.	0
"Closely monitor all antidepressant-treated patients for clinical worsening, and for emergence of suicidal thoughts and behaviors."	0
"At steady-state, the mean plasma level of icodextrin plus its metabolites was about 5 g/L."	0
"In children, a Class III electrophysiological effect can be seen at daily doses of 210 mg/m2 body surface area (BSA)."	0
"For example, use one packet for doses of 100 mg and two packets for doses of 200 mg. Pour and mix the entire contents of each packet over soft food or liquid."	0
"If a patient requires antipsychotic drug treatment after recovery from NMS, the potential reintroduction of drug therapy should be carefully considered."	0
It has been shown to cross the blood-brain barrier in rats.	0
TENORMIN is contraindicated in those patients with a history of hypersensitivity to the atenolol or any of the drug product<U+2019>s components.	0
"* Ora-Sweet<U+00AE> and Ora-Plus<U+00AE> are registered trademarks of Paddock Laboratories, Inc."	0
"QT prolongation and proarrhythmia: Reduce dose, reduce rate of infusion, or discontinue (5.1) Bradycardia, AV block, hypotension, worsening heart failure: Reduce dose as needed (5.3, 5.4, 5.5."	0
"Suicide <U+2013> Since depression is a commonly associated feature of OCD, the risk of suicide must be considered."	0
Beta-adrenergic Blockers and Calcium Channel Blockers Additive effects on AV node conduction can result in complete heart block.	0
Reported cases were in children under the age of six or with a low body mass index.	0
"Based on clinical response, dosage adjustment of WELLBUTRIN XL may be necessary when coadministered with CYP2B6 inhibitors (e.g., ticlopidine or clopidogrel)."	0
Intervention Effective alternative or back-up methods of contraception (such as condoms and spermicides) should be used during treatment with EMEND and for 1 month following the last dose of EMEND.	0
"If Tasigna is administered with drugs that are substrates of P-gp, increased concentrations of the substrate drug are likely, and caution should be exercised."	1
The described mixtures can be pre-prepared and stored for up to 24 hours at room temperature or up to 48 hours under refrigeration.	0
None of these factors had a significant impact on sildenafil pharmacokinetics in patients with PAH.	0
Pediatric Use Safety and effectiveness in children have not been established.	0
Amphetamines have been reported to exacerbate motor and phonic tics and Tourette<U+2019>s syndrome.	0
"Of the 229 patients who had potassium depleting diuretics added to their concomitant medications in the DIAMOND trials, the patients on TIKOSYN had a non-significantly reduced relative risk for death of 0.68 (95% CI: 0.376, 1.230)."	0
"In studies of ACE inhibitors in patients with unilateral or bilateral renal artery stenosis, increases in serum creatinine or blood urea nitrogen (BUN) have been reported."	0
Limit pravastatin to 40 mg once daily for concomitant use with clarithromycin.	1
"In healthy subjects who received up to three times the recommended dose of estazolam, peak estazolam plasma concentrations occurred within two hours after dosing (range 0.5 to 6.0 hours) and were proportional to the administered dose, suggesting linear pharmacokinetics over the dosage range tested."	0
Ketoconazole and Other Strong CYP 3A Inhibitors SAMSCA is metabolized primarily by CYP 3A.	0
"Adult Patients: Following oral administration of PRINIVIL, peak serum concentrations of lisinopril occur within about 7 hours, although there was a trend to a small delay in time taken to reach peak serum concentrations in acute myocardial infarction patients."	0
"However, no change in the initial dosage of phenytoin is considered necessary and any subsequent adjustment of phenytoin dosage should be guided by usual clinical practices."	0
"Pimozide: In a controlled study of healthy volunteers, after paroxetine was titrated to 60 mg daily, coadministration of a single dose of 2 mg pimozide was associated with mean increases in pimozide AUC of 151% and Cmax of 62%, compared to pimozide administered alone."	1
"Following a single dose of 90 mg [14C]-ledipasvir, systemic exposure was almost exclusively to the parent drug (greater than 98%)."	0
"In a clinical study with radiolabeled clevidipine, 83% of the drug was excreted in urine and feces."	0
"With high dose methotrexate administration, consider a temporary withdrawal of ACIPHEX delayed-release tablets (5.9, 7)."	0
Social Anxiety Disorder <U+2013> The effectiveness of sertraline hydrochloride in the treatment of social anxiety disorder (also known as social phobia) was established in two multicenter placebo-controlled studies (Study 1 and 2) of adult outpatients who met DSM-IV criteria for social anxiety disorder.	0
Other Drugs Affecting Exposure to Tolvaptan CYP 3A Inhibitors Tolvaptan is a substrate of CYP 3A.	0
"Under these circumstances, phendimetrazine tartrate should be immediately discontinued, and the patient should be evaluated for the possible presence of pulmonary hypertension."	0
Therapy with medications that are predominantly metabolized by the CYP2D6 system and that have a relatively narrow therapeutic index should be initiated at the low end of the dose range if a patient is receiving fluoxetine concurrently or has taken it in the previous 5weeks.	1
Baseline cardiac evaluation should be considered to detect preexisting valvular heart diseases or pulmonary hypertension prior to initiation of phendimetrazine treatment.	0
"Caution is indicated in patients known to have reduced levels of CYP2D6 activity and those receiving concomitant drugs known to inhibit this cytochrome P450 isoenzyme (e.g., quinidine)."	0
Patients should be advised not to consume alcohol in combination with ROZEREM as alcohol and ROZEREM may have additive effects when used in conjunction.	0
"DUE TO THE POTENTIAL FOR SIGNIFICANT, POSSIBLY LIFE THREATENING, PROARRHYTHMIC EFFECTS WITH THIORIDAZINE TREATMENT, THIORIDAZINE SHOULD BE RESERVED FOR USE IN THE TREATMENT OF SCHIZOPHRENIC PATIENTS WHO FAIL TO SHOW AN ACCEPTABLE RESPONSE TO ADEQUATE COURSES OF TREATMENT WITH OTHER ANTIPSYCHOTIC DRUGS, EITHER BECAUSE OF INSUFFICIENT EFFECTIVENESS OR THE INABILITY TO ACHIEVE AN EFFECTIVE DOSE DUE TO INTOLERABLE ADVERSE EFFECTS FROM THOSE DRUGS."	0
"ACCUPRIL was an effective antihypertensive in all races studied, although it was somewhat less effective in blacks (usually a predominantly low renin group) than in nonblacks."	0
"The antihypertensive effect of angiotensin II receptor antagonists, including irbesartan, may be attenuated by NSAIDs including selective COX-2 inhibitors."	0
It is uncertain whether the co-administration of paroxetine and tamoxifen has a significant adverse effect on the efficacy of tamoxifen.	0
Food does not affect the bioavailability of apixaban.	0
"Following abrupt cessation of therapy with certain beta-blocking agents in patients with coronary artery disease, exacerbations of angina pectoris and, in some cases, myocardial infarction have been reported."	0
Antibacterial:clarithromycin <U+2194> darunavir<U+2191> clarithromycin No dose adjustment of the combination is required for patients with normal renal function.	0
"Hyperkalemia: Abnormal elevation of serum potassium levels (greater than or equal to 5.5mEq/liter) can occur with all potassium-sparing diuretic combinations, including DYAZIDE."	0
"If indicated, adequate anticonvulsant therapy should be maintained concomitantly."	0
The elimination of acetylsalicylic acid follows first-order kinetics with AGGRENOX and has a half-life of 0.33 hours.	0
The full therapeutic effect of INSPRA is apparent within 4 weeks.	0
Do not start Lexapro in a patient who is being treated with linezolid or intravenous methylene blue because there is an increased risk of serotonin syndrome.	0
"Absorption Following oral administration of abiraterone acetate to patients with metastatic CRPC, the median time to reach maximum plasma abiraterone concentrations is 2 hours."	0
Prescription should not depend solely on the presence of one or more of the behavioral characteristics.	0
Such monitoring should include daily observation by families and caregivers.	0
"As with all antidepressants, several weeks on treatment may be required to obtain the full antidepressant effect."	0
"It is generally agreed, however, that pharmacological treatment for acute episodes of depression should continue for up to 6 months or longer."	0
Avoid use of aliskiren with ACEON in patients with renal impairment (GFR <60 ml/min).	0
The cytochrome P450 isoenzymes are not involved in the metabolism of telmisartan.	0
Gender: Population pharmacokinetics analysis in HCV-infected subjects indicated that gender had no clinically relevant effect on the exposure of sofosbuvir and GS-331007.	0
Carcinoma of the prostate causes many of the symptoms associated with BPH and the two disorders frequently co-exist.	0
"Cimetidine 600 twice daily, 6 days 400 single dose 12 1.07(0.77, 1.49) 0.98(0.81, 1.19) 0.82(0.69, 0.99) Clarithromycin 500 q12h, 7 days 800 three times daily, 7 days 10 1.08 (0.85, 1.38) 1.19 (1.00, 1.42) 1.57(1.16, 2.12) Delavirdine 400 three times daily 400 three times daily, 7 days 28 0.64Relative to indinavir 800 mg three times daily alone."	0
The least amount feasible should be prescribed or dispensed at one time in order to minimize the possibility of overdosage.	0
There are no adequate and well-controlled studies in pregnant women.	0
REYATAZ increases tenofovir concentrations.	1
"Study outcome was assessed by the (a) Duke Brief Social Phobia Scale (BSPS), a multi-item clinician-rated instrument that measures fear, avoidance and physiologic response to social or performance situations, (b) the Marks Fear Questionnaire Social Phobia Subscale (FQ-SPS), a 5-item patient-rated instrument that measures change in the severity of phobic avoidance and distress, and (c) the CGI-I responder criterion of <U+2264> 2."	0
22 10 100 mg QD for 4 days 40 mg on Day 4 > 14.8 15.4 Grapefruit JuiceThe effect of amounts of grapefruit juice between those used in these two studies on lovastatin pharmacokinetics has not been studied.	0
"It is unknown whether the suicidality risk extends to longer-term use, ie, beyond several months."	0
"In infants treated with PROSTIN VR PEDIATRIC at the usual doses for 10 hours to 12 days and who died of causes unrelated to ductus structural weakness, tissue sections of the ductus and pulmonary arteries have shown intimal lacerations, a decrease in medial muscularity and disruption of the medial and internal elastic lamina."	0
"See Dosage and Administration (2.5 and 2.6), Contraindications (4.2) and Warnings and Precautions (5.2)."	0
The combinations of tipranavir/ritonavir or fosamprenavir/ritonavir produce little or no change in rosuvastatin exposure.	0
"The effect of verapamil on AV conduction and the SA node may cause asymptomatic first-degree AV block and transient bradycardia, sometimes accompanied by nodal escape rhythms."	0
No studies have been performed on the use of atenolol in the first trimester and the possibility of fetal injury cannot be excluded.	0
One patient among these 5 continued to have problems for at least 2 weeks following discontinuation of tizanidine.	0
Women who are pregnant or may become pregnant.	0
"Thereafter, each patient received a maintenance infusion of 12.5 <U+03BC>g/kg/min of base (that is, 20 <U+03BC>g/kg/min of quinidine gluconate)."	0
Angina Pectoris: Usual initial dosage is 100 mg once daily.	0
WARNING It is recommended that MATULANE be given only by or under the supervision of a physician experienced in the use of potent antineoplastic drugs.	0
It acts through the inhibition of biosynthesis of cell wall peptidoglycan rendering the cell wall osmotically unstable.	0
"The effect of dronedarone on 12-lead ECG parameters (heart rate, PR, and QTc) was investigated in healthy subjects following repeated oral doses up to 1600 mg once daily or 800 mg twice daily for 14 days and 1600 mg twice daily for 10 days."	0
Coadministration of carbamazepine and REYATAZ without ritonavir is not recommended.	0
ACE inhibitors have been associated with a higher rate of angioedema in Black than in non-Black patients.	0
"In the absence of such data, it is recommended that plasma valproate levels be monitored following initiation of sertraline hydrochloride therapy with appropriate adjustments to the valproate dose."	0
WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning.	0
"No clinically significant interactions have been noted, but until wider clinical experience is obtained, AHA should be used with caution in patients receiving other therapeutic agents."	0
Avoid concomitant use of XARELTO with drugs that are known combined P-gp and strong CYP3A4 inducers see Drug Interactions ( 7.3 ) .	0
Pediatricpatientsage6yearsandabovewithglomerularfiltrationrate (GFR) >30 mL/min/1.73 m2: Initiate with 0.2 mg/kg oncedaily.	0
The discontinuation of fluconazole presumably caused an enhanced CYP3A4 activity which led to increased metabolism of prednisone.	1
Saturation of this enzyme at clinical doses appears to account for the nonlinearity of paroxetine kinetics with increasing dose and increasing duration of treatment.	0
"Adjusted for duration of therapy, primary diagnosis, age, gender, and prevalence of structural heart disease, the point estimate of the hazard ratio for the pooled studies (TIKOSYN/placebo) was 1.1 (95% CI: 0.3, 4.3)."	0
"Closely monitor blood pressure, renal function and electrolytes in patients on AVAPRO and other agents that affect the RAS."	0
ELIQUIS should be discontinued at least 24 hours prior to elective surgery or invasive procedures with a low risk of bleeding or where the bleeding would be non-critical in location and easily controlled.	0
Concomitant use of carbamazepine and hydrochlorothiazide has been associated with the risk of symptomatic hyponatremia.	0
"There was considerable variation in risk among drugs, but a tendency toward an increase in the younger patients `for almost all drugs studied."	0
"The respiratory depressant effects of Meperidine Hydrochloride Injection and its capacity to elevate cerebrospinal fluid pressure may be markedly exaggerated in the presence of head injury, other intracranial lesions, or a preexisting increase in intracranial pressure."	0
Monoamine Oxidase Inhibitors (MAOIs)	0
"In general, dosages in the lower range are sufficient for most elderly patients."	0
Such monitoring should include daily observation by families and caregivers.	0
Elimination of paliperidone decreased with decreasing estimated creatinine clearance.	0
"Thus, the necessary interdosing interval sufficient to avoid tolerance remains unknown, but it must be greater than 18 hours."	0
"The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine; cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide)."	0
Fluvoxamine and thioridazine should not be coadministered.	0
The use of sotalol in conjunction with other drugs that prolong the QT interval has not been studied and is not recommended.	0
There was a case report that a liver-transplanted patient treated with prednisone developed acute adrenal cortex insufficiency when a three month therapy with fluconazole was discontinued.	0
Pharmacokinetic parameters by age group are presented in Table 6.	0
"Major Surgery: Avoid initiation of high-dose regimen of extended<U+2014> release metoprolol in patients undergoing non-cardiac surgery, since such use in patients with cardiovascular risk factors has been associated with bradycardia, hypotension, stroke and death."	0
Co-administration with other CYP3A substrates may require a dose adjustment or additional monitoring as shown in Table 5.	0
Assessment of the carcinogenic potential of selegiline in mice and rats is ongoing for all dosage forms.	0
The combined use of fluconazole with cisapride is contraindicated.	0
"Vasoconstrictive and positive inotropic agents : Because of the risk of reducing cardiac contractility in presence of high systemic vascular resistance , do not use BREVIBLOC to control tachycardia in patients receiving drugs that are vasoconstrictive and have positive inotropic effects , such as epinephrine , norepinephrine , and dopamine ."	0
Patients should be monitored for the emergence of serotonin syndrome.	0
"However, patients receiving infusions of FLOLAN in clinical trials were maintained on anticoagulants without evidence of increased bleeding."	0
LATUDA is not a clinically significant inhibitor of P-gp.	0
"Narcotic analgesic: Methadone <U+2193>Methadone Data suggest that the interaction is not clinically relevant; however, patients should be monitored for opiate withdrawal symptoms."	0
"In addition to pulmonary vascular smooth muscle and the corpus cavernosum, PDE-5 is also found in other tissues including vascular and visceral smooth muscle and in platelets."	0
"Therefore, in patients taking insulin or oral hypoglycemics, regular monitoring of blood glucose is recommended."	0
"Invasive AspergillosisIn a clinical study of invasive aspergillosis, the median duration of IV VFEND therapy was 10 days (range 2<U+2013>85 days)."	0
No teratogenicity was observed in either species.	0
Cases with serum sodium lower than 110 mmol/L have been reported.	0
"First, it increases the number of hepatic LDL receptors on the cell-surface to enhance uptake and catabolism of LDL."	0
"Nardil, as with other hydrazine derivatives, has been reported to induce pulmonary and vascular tumors in an uncontrolled lifetime study in mice."	0
"Upon the loss of MR4.0(corresponding to = BCR-ABL/ABL <U+2264>0.01%IS) during the treatment-free phase, monitor BCR-ABL transcript levels every 2 weeks until BCR-ABL levels remain lower than major molecular response (MMR, corresponding to MR3.0 or =BCR-ABL/ABL <U+2264>0.1%IS) for 4 consecutive measurements."	0
"Due to the need for co-administration of PREZISTA with ritonavir, please refer to ritonavir prescribing information for a description of ritonavir contraindications."	0
"If possible, discontinue PRADAXA 1 to 2 days (CrCl <U+2265>50 mL/min) or 3 to 5 days (CrCl <50 mL/min) before invasive or surgical procedures because of the increased risk of bleeding."	0
Mean peak plasma hydrochlorothiazide concentrations of 30 ng/mL occur approximately 2.5 hours following the administration of the combination.	0
"Therefore, avoid digoxin in patients with myocarditis."	0
Drug-Drug Interactions: Rosuvastatin clearance is not dependent on metabolism by cytochrome P450 3A4 to a clinically significant extent.	0
An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy.	0
"The only identified active metabolite, norfluoxetine, is formed by demethylation of fluoxetine."	0
"Its bone marrow suppressant effect is probably related to its ability to inhibit DNA synthesis, but anemia could also be related to depletion of iron stores."	0
"Effect of Coadministered Drugs on Pharmacokinetics of Apixaban The effects of level of renal impairment, age, body weight, and level of hepatic impairment on the pharmacokinetics of apixaban are summarized in Figure 3."	0
"Fluvoxamine has also been shown to inhibit P450 1A2, an isoform also involved in TCA metabolism."	1
PROSTIN VR PEDIATRIC should be infused for the shortest time and at the lowest dose that will produce the desired effects.	0
Nicardipine inhibits the transmembrane influx of calcium ions into cardiac muscle and smooth muscle without changing serum calcium concentrations.	0
Antipsychotics: Lurasidone POTENTIAL for serious and/or life-threatening reactions if LEXIVA is coadministered with ritonavir.	0
Gender There is no gender effect on the pharmacokinetics of quetiapine.	0
Avoid saquinavir/ritonavir in patients with long QT syndrome.	0
Antimycobacterials Rifampin May lead to loss of virologic response and possible resistance to APTIVUS or to the class of protease inhibitors or other co-administered antiretroviral agents.	0
Lithium - Coadministration of Celexa (40 mg/day for 10 days) and lithium (30 mmol/day for 5 days) had no significant effect on the pharmacokinetics of citalopram or lithium.	0
"After the first two weeks, these children should be dosed once daily."	0
Treatment with PEXEVA<U+00AE> and any concomitant serotonergic agents should be discontinued immediately if the above events occur and supportive symptomatic treatment should be initiated.	0
Coadministration of nefazodone potentiated the effects of triazolam on psychomotor performance tests.	0
"ZOCOR is contraindicated in the following conditions: Concomitant administration of strong CYP3A4 inhibitors (e.g., itraconazole, ketoconazole, posaconazole, voriconazole, HIV protease inhibitors, boceprevir, telaprevir, erythromycin, clarithromycin, telithromycin, nefazodone, and cobicistat-containing products)."	0
Do not take on an empty stomach because of its potential for gastric irritation.	0
"In volunteers with severe (CLcr less than 30 mL/min) renal impairment, sildenafil clearance was reduced, resulting in approximately doubling of AUC and Cmax compared to age-matched volunteers with no renal impairment."	0
"During consolidation, monitor at least weekly."	0
Patients receiving warfarin therapy should be carefully monitored when venlafaxine hydrochloride extended-release is initiated or discontinued.	0
"WARNING: (A) PREMATURE DISCONTINUATION OF PRADAXA INCREASES THE RISK OF THROMBOTIC EVENTS, and (B) SPINAL/EPIDURAL HEMATOMA See full prescribing information for complete boxed warning (A) PREMATURE DISCONTINUATION OF PRADAXA INCREASES THE RISK OF THROMBOTIC EVENTS: Premature discontinuation of any oral anticoagulant, including PRADAXA, increases the risk of thrombotic events."	0
"If treatment is to be discontinued, reduce the dosage gradually over a period of 1 - 2 weeks."	0
The efficacy of DIFLUCAN for the suppression of cryptococcal meningitis was successful in 4 of 5 children treated in a compassionate-use study of fluconazole for the treatment of life-threatening or serious mycosis.	0
Use of PDE-5 inhibitors for pulmonary arterial hypertension (PAH): Use of sildenafil (Revatio) is contraindicated when used for the treatment of pulmonary arterial hypertension (PAH).	0
"Altered anticoagulant effects, including increased bleeding, have been reported when SSRIs or SNRIs are coadministered with warfarin."	0
"Pre-existing glaucoma is almost always open-angle glaucoma because angle closure glaucoma, when diagnosed, can be treated definitively with iridectomy."	0
"Non-steroidal Anti-Inflammatory Agents, including Selective Cyclooxygenase-2 Inhibitors (COX-2 Inhibitors) In patients who are elderly, volume-depleted (including those on diuretic therapy), or who have compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists, including azilsartan, may result in deterioration of renal function, including possible acute renal failure."	0
"As an alternative to water, the entire contents of the sachet may be pre-mixed with a small amount of food or beverage and consumed immediately (within 30 minutes) as part of the meal."	0
"Substantial consumption of alcohol (e.g., 5 units or greater) in combination with ADCIRCA can increase the potential for orthostatic signs and symptoms, including increase in heart rate, decrease in standing blood pressure, dizziness, and headache."	0
"Pooled analyses of short-term placebo-controlled studies of antidepressant drugs (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18 to 24) with major depressive disorder (MDD) and other psychiatric disorders."	0
"Doses of 6.25mg twice daily, 12.5mg twice daily, and 25mg twice daily were associated with placebo<U+2011>corrected increases in EF of 5EF units, 6EF units, and 8EF units, respectively; each of these effects were nominally statistically significant."	0
"Hypertension Adults In multiple-dose studies with hypertensive patients, there were no clinically significant changes in metabolic function, including serum levels of total cholesterol, triglycerides, glucose, or uric acid."	0
Patients should be monitored for these symptoms when discontinuing treatment.	0
Combined administration of racemic citalopram (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate triazolam (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either citalopram or triazolam.	0
"In 12healthy subjects, combined administration of carvedilol (25mg once daily) and a single dose of glyburide did not result in a clinically relevant pharmacokinetic interaction for either compound."	0
"In a study of 13 healthy, male volunteers, a single 40 mg dose of tacrine added to fluvoxamine 100 mg/day administered at steady-state was associated with 5- and 8-fold increases in tacrine Cmax and AUC, respectively, compared to the administration of tacrine alone."	1
"The usual starting dose for adult schizophrenic patients is 50 mg to 100 mg three times a day, with a gradual increment to a maximum of 800 mg daily if necessary."	0
The S (inactive) isomer is metabolized primarily by glucuronidation.	0
Regimens containing tenofovir DF and an HIV protease inhibitor/ritonavir or cobicistat	0
"Until adequate numbers of patients with severe renal impairment have been evaluated during chronic treatment with Lexapro, however, it should be used with caution in such patients."	0
"Although the probability of developing hypokalemia is reduced with ZIAC because of the very low dose of HCTZ employed, periodic determination of serum electrolytes should be performed, and patients should be observed for signs of fluid or electrolyte disturbances, i.e., hyponatremia, hypochloremic alkalosis, hypokalemia, and hypomagnesemia."	0
"When coadministered with H2-receptor antagonists or proton-pump inhibitors, dose separation may be required."	0
Steady-state concentrations of venlafaxine and ODV in plasma are attained within 3 days of oral multiple-dose therapy.	0
"Neither ledipasvir nor sofosbuvir is a substrate for hepatic uptake transporters OCT1, OATP1B1, or OATP1B3."	0
Amoxapine is not a monoamine oxidase inhibitor.	0
"Considering the known proarrhythmic properties of mexiletine and the lack of evidence of improved survival for any antiarrhythmic drug in patients without life-threatening arrhythmias, the use of mexiletine as well as other antiarrhythmic agents should be reserved for patients with life-threatening ventricular arrhythmia."	0
The affinity of the FANAPT metabolite P88 is generally equal or less than that of the parent compound.	0
Loss of therapeutic effect of INVIRASE/ritonavir and possible development of resistance.	0
Oral administration of ACEON with food does not significantly lower the rate or extent of perindopril absorption relative to the fasted state.	0
Clozapine causes little or no prolactin elevation.	0
(Bottled and canned beers and wines contain little or no tyramine.)	0
No information regarding DIFLUCAN pharmacokinetics in full-term newborns is available.	0
Higher dosages of INSPRA are not recommended because they have no greater effect on blood pressure than 100 mg and are associated with an increased risk of hyperkalemia.	0
Monitor appropriately if concomitant treatment is clinically warranted (7.2).	0
In some patients jaundice has cleared following withdrawal of mercaptopurine and reappeared with rechallenge.	0
"Drugs Metabolized by P450 2D6 <U+2013> The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the Caucasian population (about 7% to 10% of Caucasians are so called <U+201C>poor metabolizers<U+201D>); reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are not yet available."	0
The effect of oral anticoagulants may be decreased when used concurrently with hydrochlorothiazide; dosage adjustments may be necessary.	0
Metabolism Amlodipine: Amlodipine is extensively (about 90%) converted to inactive metabolites via hepatic metabolism.	0
"PREZISTA co-administered with ritonavir is an inhibitor of CYP3A, CYP2D6, and P-gp."	0
Monitoring of saquinavir concentrations is recommended.	0
The length of follow-up in these trials varied from 1 to 2 years.	0
"In addition, steady state levels of racemic citalopram were not significantly different in poor metabolizers and extensive CYP2D6 metabolizers after multiple-dose administration of citalopram, suggesting that coadministration, with escitalopram, of a drug that inhibits CYP2D6, is unlikely to have clinically significant effects on escitalopram metabolism."	0
The combination may be substituted for the titrated individual components.	0
Consider the benefits and risks before neuraxial intervention in patients who are or who need to be anticoagulated (5.3).	0
"Lithium : Increases in serum lithium concentrations and lithium toxicity have been reported during concomitant administration of lithium with angiotensin II receptor antagonists , including Diovan ."	1
"The steady-state volume of distribution of dipyridamole is about 92 L. Approximately 99% of dipyridamole is bound to plasma proteins, predominantly to alpha 1-acid glycoprotein and albumin."	0
"In two similarly sized U.S. postmarketing trials that, combined, enrolled over 3,000 black patients and over 19,000 non-blacks, angioedema was reported in 0.30% and 0.55% of blacks (in study 1 and 2 respectively) and 0.39% and 0.17% of non-blacks."	0
"Toxicity may be manifest as central nervous system depression (sedation) or irritability (twitching), which may progress to frank convulsions accompanied by respiratory depression and/or arrest."	0
"When taken with Silenor, the sedative effects of sedating antihistamines and CNS depressants may be potentiated."	0
Embryofetal toxicity: Can cause fetal harm.	0
Antidiabetic Drugs (Oral Agents and Insulin)- dosage adjustment of the antidiabetic drug may be required.	0
"For patients who fail to achieve MMR after three months of treatment re initiation, BCR-ABL kinase domain mutation testing should be performed."	0
"Follow label recommendations for concomitant use of other statins with a CYP3A and P-gp inhibitor like dronedarone (7.3) CYP3A substrates with a narrow therapeutic index (e.g., sirolimus and tacrolimus): Monitor and adjust dosage of concomitant drug as needed when used with MULTAQ (7.3) Warfarin: Monitor INR after initiating dronedarone in patients taking warfarin."	0
"The combined use of nefazodone with terfenadine, astemizole, cisapride, or pimozide is contraindicated."	0
"Renal laboratory testing should include serum creatinine, estimated creatinine clearance, and urinalysis with microscopic examination."	0
Case reports and epidemiological studies (case-control and cohort design) have demonstrated an association between use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding.	0
"At the primary efficacy endpoint (nights 29 and 30) in a 35-night sleep laboratory study, polysomnographic recordings showed that wakefulness was not significantly longer with Zaleplon than with placebo during the last quarter of the night."	0
Both enantiomers of fluvastatin are metabolized in a similar manner.	0
Triazolam - Combined administration of Celexa (titrated to 40 mg/day for 28 days) and the CYP3A4 substrate triazolam (single dose of 0.25 mg) did not significantly affect the pharmacokinetics of either citalopram or triazolam.	0
"It causes a decrease in peripheral vascular resistance and a modest fall in blood pressure in normotensive individuals and, in exercise tolerance studies in patients with ischemic heart disease, reduces the heart rate-blood pressure product for any given workload."	0
"Following oral or intravenous administration of 14C-labeled irbesartan, more than 80% of the circulating plasma radioactivity is attributable to unchanged irbesartan."	0
Focalin XR should not be used in patients being treated (currently or within the preceding 2 weeks) with MAO Inhibitors [see Contraindications (4.	0
"There is no relevant effect of genetic variation in CYP2B6, CYP2C9, CYP2C19, or CYP3A5 on the pharmacokinetics of prasugrel's active metabolite or its inhibition of platelet aggregation."	0
"Also, latent diabetes mellitus may become manifest and diabetic patients given thiazides may require adjustment of their insulin dose."	0
Triamterene appears in animal milk and this may occur in humans.	0
"Losartan potassium was not carcinogenic when administered at maximally tolerated dosages to rats and mice for 105 and 92weeks, respectively."	0
"In addition, pimozide tablets, USP in common with other antipsychotic drugs, has various effects on other central nervous system receptor systems which are not fully characterized."	0
"Active internal bleeding, or history of bleeding diathesis, major surgical procedure or severe physical trauma within the previous month."	0
Triglyceride and cholesterol testing should be performed prior to initiating therapy with LEXIVA and at periodic intervals during therapy.	0
The reaction can recur within hours after re-challenge with a single dose of IMURAN.	0
Use with increased monitoring for adverse events.	0
"There have been reports of patients experiencing intense urges to gamble, increased sexual urges, and other intense urges and the inability to control these urges while taking one or more of the medications that increase central dopaminergic tone, that are generally used for the treatment of Parkinson<U+2019>s disease, including selegiline."	0
There was not sufficient evidence in this study to suggest a greater benefit for the 40 mg/day dose compared to the 20 mg/day dose.	0
Blood pressure reduction measured at trough was similar for both treatment groups but blood pressure was not measured at any other time of the day.	0
Concurrent administration of cimetidine and tricyclic antidepressants can produce clinically significant increases in the plasma concentrations of the tricyclic antidepressant.	1
"There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about the drug effect on suicide."	0
So giving iloperidone with inhibitors of both of its metabolic pathways did not add to the effect of either inhibitor given alone.	0
This natriuresis and diuresis is accompanied by a secondary loss of potassium and bicarbonate.	0
"In healthy subjects, the pharmacokinetic profile has been examined after single doses of up to 60 mg and once-daily administration at 15 mg and 30 mg for 10 days."	0
"200 mg q12h Scedosporiosis and Fusariosis 6 mg/kg q12h for the first 24 hours 4 mg/kg q12h 200 mg q12h If patient response is inadequate, the oral maintenance dose may be increased from 200 mg every 12 hours (similar to 3 mg/kg IV q12h) to 300 mg every 12 hours (similar to 4 mg/kg IV q12h)."	0
The possibility of hypotensive effects with PRINIVIL can be minimized by either decreasing or discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with PRINIVIL.	0
"Furthermore, whenever one of these other drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant may be required."	0
"During transfer to oral amiodarone, reduce the dose levels of previously administered agents by 30 to 50% several days after the addition of oral amiodarone."	1
"Psychosis, Confusion, and Other Neuropsychiatric Phenomena <U+2013> Patients treated with Anafranil have been reported to show a variety of neuropsychiatric signs and symptoms including delusions, hallucinations, psychotic episodes, confusion, and paranoia."	0
Several dozen cases have been reported in the world literature in patients who were taking angiotensin converting enzyme inhibitors.	0
Do not use if contamination is suspected.	0
Add 10 mL of Purified Water USP to an 8ounce (240mL) amber polyethylene terephthalate (PET) bottle containing ten 50mg losartan potassium tablets.	0
In vivo studies have shown that terbinafine is an inhibitor of the CYP450 2D6 isozyme.	0
"Correct imbalances of intravascular volume- or salt-depletion, before initiating therapy with TWYNSTA tablets."	0
Consider discontinuation of CAPRELSA in patients with heart failure.	0
"Adverse reactions have included restlessness, agitation, tremor, ataxia, gait disturbance, vertigo, and dizziness."	0
Co-administration of SAMSCA with digoxin increased digoxin AUC by 20 % and Cmax by 30 % .	1
Cobicistat is not interchangeable with ritonavir to increase systemic exposure of saquinavir.	0
Plasma levels of carvedilol average about 50% higher in the elderly compared with young subjects.	0
"Since both drugs exhibit nonlinear pharmacokinetics, the above studies may not address the case where the 2 drugs are both being chronically dosed."	0
Figure Figure Figure Figure Figure Figure Figure Figure Figure Figure EMEND capsules and EMEND for oral suspension can be administered with or without food.	0
"45<U+00AE> (dihydroergotamine mesylate) Injection USP, should not exceed the dosing guidelines and should not be used for chronic daily administration."	0
"In general, <U+03B2>-blockers may mask some of the manifestations of hypoglycemia, particularly tachycardia."	0
"In three clinical trials of CYMBALTA for the management of neuropathic pain associated with diabetic peripheral neuropathy, the mean duration of diabetes was approximately 12 years, the mean baseline fasting blood glucose was 176mg/dL, and the mean baseline hemoglobin A1c (HbA1c) was 7.8%."	0
"Dilutional hyponatremia may occur in edematous patients in hot weather; appropriate therapy is water restriction, rather than administration of salt, except in rare instances when the hyponatremia is life-threatening."	0
Most patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy.	0
Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have.	0
"When desvenlafaxine succinate was administered at a dose of 100 mg daily in conjunction with a single 50 mg dose of desipramine, a CYP2D6 substrate, the Cmax and AUC of desipramine increased approximately 25% and 17%, respectively."	1
Dopamine HCl at doses approaching maximal solubility showed no clear genotoxic potential in the Ames test.	0
"Calcium Channel Blockers, Dihydropyridine: e.g., felodipine, nifedipine, nicardipine <U+2191> dihydropyridine calcium channel blockers concentration Caution is warranted and clinical monitoring of patients is recommended."	0
"CARCINOGENESIS, MUTAGENESIS, IMPAIRMENT OF FERTILITY: Long-term carcino-genicity studies in animals have not been performed."	0
"In placebo-controlled clinical trials conducted with pediatric patients, the following adverse events were reported in at least 2% of pediatric patients treated with paroxetine and occurred at a rate at least twice that for pediatric patients receiving placebo: emotional lability (including self-harm, suicidal thoughts, attempted suicide, crying, and mood fluctuations), hostility, decreased appetite, tremor, sweating, hyperkinesia, and agitation."	0
Diltiazem: Bradycardia with coadministration (7.3).	0
Myelosuppression was generally reversible and usually managed by withholding Tasigna temporarily or dose reduction [see Dosage and Administration (2.	0
In vitro studies utilizing human liver microsomes demonstrated that several CYP450-dependent enzymes are involved in the metabolism of selegiline and its metabolites.	0
"Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients whose depression is persistently worse, or who are experiencing emergent suicidality or symptoms that might be precursors to worsening depression or suicidality, especially if these symptoms are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
STRATTERA increased the risk of suicidal ideation in short-term studies in children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD).	0
"Confirmatory tests, such as gas chromatography/mass spectrometry, will help distinguish ZOLOFT from benzodiazepines."	0
The low systemic availability is attributed to presystemic clearance in gastrointestinal mucosa and/or hepatic first-pass metabolism.	0
"Compared to normal subjects, the plasma concentrations of trandolapril and trandolaprilat are approximately 2-fold greater and renal clearance is reduced by about 85% in patients with creatinine clearance below 30 mL/min and in patients on hemodialysis."	0
"Serum cholesterol and triglycerides increase during normal pregnancy, and cholesterol or cholesterol derivatives are essential for fetal development."	0
"Based on the mechanism of action of venlafaxine hydrochloride extended-release and the potential for serotonin syndrome, caution is advised when venlafaxine hydrochloride extended-release is coadministered with other drugs that may affect the serotonergic neurotransmitter systems, such as triptans, SSRIs, other SNRIs, linezolid (an antibiotic which is a reversible non-selective MAOI), lithium, tramadol, or St. John<U+2019>s wort."	0
These effects may often be mitigated by reducing the dose of levodopa/carbidopa by approximately 10 to 30%.	1
A multiple-dose study has shown that there is no pharmacokinetic interaction between paroxetine and lithium carbonate.	0
Patients were dosed in a range of 20 to 50 mg/day in the clinical trials demonstrating the effectiveness of paroxetine in the treatment of MDD.	0
"Hepatic Effects: Postmarketing reports of hepatic failure, sometimes fatal."	0
Antiarrhythmic dronedarone Potential for serious and/or life-threatening reactions such as cardiac arrhythmias.	0
The interaction was pharmacodynamic; there was no alteration in the pharmacokinetics of either drug.	0
"When converting patients from warfarin therapy to PRADAXA, discontinue warfarin and start PRADAXA when the INR is below 2.0."	0
"For patients who have a negative cardiovascular evaluation, consideration should be given to administration of the first MAXALT dose in a medically-supervised setting and performing an electrocardiogram (ECG) immediately following MAXALT administration."	0
"This sequence of events may account for two clinical findings reported to occur after several weeks of nightly use of rapidly eliminated benzodiazepine hypnotics, namely, increased wakefulness during the last third of the night and increased daytime anxiety in selected patients."	0
Discontinuing Lexapro: A gradual dose reduction is recommended (2.4).	0
"The Benzodiazepine Withdrawal Symptom Questionnaire was used in several of these studies, both at baseline and then during days 1 and 2 following discontinuation."	0
"When used with a cold pack, reconstituted solutions: are stable for up to 24 hours use."	0
Reconstitute the lyophilized powder by transferring 10 mL of sterile water for injection to a vial containing 600 mg of rifampin for injection.	0
Difficulties with accommodation and blurring of vision have been reported with stimulant treatment.	0
"Changes observed in these clotting tests at the expected therapeutic dose, however, are small, subject to a high degree of variability, and not useful in monitoring the anticoagulation effect of apixaban."	0
<U+2022>Patients with severe hepatic impairment.	0
"In patients with permanent AF, MULTAQ doubles the risk of death, stroke, and hospitalization for heart failure."	0
"Co-administration of ATACAND with potassium sparing diuretics, potassium supplements, potassium-containing salt substitutes or other drugs that raise serum potassium levels may result in hyperkalemia."	0
Patients should be monitored for the emergence of serotonin syndrome.	0
"Since mexiletine hydrochloride is a substrate for the metabolic pathways involving CYP2D6 and CYP1A2 enzymes, inhibition or induction of either of these enzymes would be expected to alter mexiletine plasma concentrations."	0
"Pulmonary function studies have been conducted in healthy volunteers, asthmatics, and patients with chronic obstructive pulmonary disease (COPD)."	0
"Prophylaxis of gout-flares <U+2013> co-administration of colchicine in patients on PREZISTA/ritonavir: If the original regimen was 0.6 mg twice a day, the regimen should be adjusted to 0.3 mg once a day.If the original regimen was 0.6 mg once a day, the regimen should be adjusted to 0.3 mg once every other day."	0
"Examples: Rifampin, avasimibe, St. John<U+2019>s wort, phenytoin, carbamazepine Moderate CYP3A4 Inducers Clinical Impact: Concomitant use of LATUDA with moderate CYP3A4 inducers decreased the exposure of lurasidone compared to the use of LATUDA alone."	1
Tricyclic Antidepressants Clinical Impact May enhance the activity of tricyclic or sympathomimetic agents causing striking and sustained increases in the concentration of d-amphetamine in the brain; cardiovascular effects can be potentiated.	1
Verapamil was not mutagenic in the Ames test in 5 test strains at 3 mg per plate with or without metabolic activation.	0
"PDE5 inhibitors , including ADCIRCA , and alpha adrenergic blocking agents are both vasodilators with blood-pressure-lowering effects ."	0
Hydrochlorothiazide may raise the serum uric acid level due to reduced clearance of uric acid and may cause or exacerbate hyperuricemia and precipitate gout in susceptible patients.	0
"Figure 1 shows that the relationship in normal volunteers between dofetilide plasma concentrations and change in QTc is linear, with a positive slope of approximately 15<U+2013>25 msec/(ng/mL) after the first dose and approximately 10<U+2013>15 msec/(ng/mL) at Day 23 (reflecting a steady state of dosing)."	0
"Antihypertensive Agents <U+2014> Olanzapine, because of its potential for inducing hypotension, may enhance the effects of certain antihypertensive agents."	0
It should be noted that NORPRAMIN is not approved for use in treating bipolar depression.	0
"Although the acute intravenous administration of amlodipine decreases arterial blood pressure and increases heart rate in hemodynamic studies of patients with chronic stable angina, chronic oral administration of amlodipine in clinical trials did not lead to clinically significant changes in heart rate or blood pressures in normotensive patients with angina."	0
Patients with abnormal liver tests and/or liver disease or patients initiating treatment for active pulmonary tuberculosis should only be given PRIFTIN in cases of necessity and under strict medical supervision.	0
Patients with intermediate thiopurine S-methyl transferase (TPMT) activity may be at an increased risk of myelotoxicity if receiving conventional doses of IMURAN.	0
Potassium citrate extended-release tablets and the wax-matrix formulation of potassium chloride were indistinguishable but both were significantly more irritating than the wax-matrix placebo.	0
Grapefruit Juice Patients should avoid grapefruit juice beverages while taking MULTAQ because exposure to dronedarone is significantly increased.	1
Beta blockers may exacerbate the rebound hypertension which can follow the withdrawal of clonidine.	0
"In a single-dose crossover study in 45 healthy subjects administered 5 and 10 mg zolpidem tartrate tablets, the mean peak concentrations (Cma x) were 59 (range: 29 to 113) and 121 (range: 58 to 272) ng/mL, respectively, occurring at a mean time (Tma x) of 1.6 hours for both."	0
"The patient should be carefully monitored, since recurrences of NMS have been reported."	0
The concomitant use of Lexapro with MAOIs intended to treat psychiatric disorders is contraindicated.	0
"However, it has been reported that chlorpromazine may interfere with the metabolism of phenytoin and thus precipitate phenytoin toxicity."	1
"Nelfinavir 1250 mg BID <U+00D7> 7<U+2013>8 days 150 mg QD <U+00D7> 8 days HIV-infected patients (11) <U+2191> AUC by 83%, compared to rifabutin 300 mg QD alone <U+2191> Cmax by 19% <U+2194> Reduce rifabutin dose by 50% (to 150 mg QD) and increase the nelfinavir dose to 1250 mg BID Zidovudine 100 or 200 mg q4h 300 or 450 mg QD HIV-infected patients (16) <U+2194> <U+2193> AUC by 32%,<U+2193> Cmax by 48%, Because zidovudine levels remained within the therapeutic range during coadministration of rifabutin, dosage adjustments are not necessary."	1
"In patients up to 50 lbs., do not exceed 40 mg daily; 50 to 100 lbs., do not exceed 75 mg except in severe cases."	0
"Anyone considering the use of nefazodone hydrochloride tablets or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need."	0
Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment.	0
Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide.	0
Continue monitoring and increase digoxin dose by approximately 20% to 40% as necessary.	0
Steady-state plasma levels of sotalol and maximum QTc prolongation occur by 3 days.	0
CYP2D6 poor metabolizers - Citalopram steady state levels were not significantly different in poor metabolizers and extensive metabolizers of CYP2D6.	0
Loss of therapeutic effect of VIRACEPT and possible development of resistance.	0
Warfarin Preliminary data suggest that there may be a pharmacodynamic interaction (that causes an increased bleeding diathesis in the face of unaltered prothrombin time) between paroxetine and warfarin.	0
This is normal and does not affect solution quality or safety.	0
"Following a single 900 mg oral dose of rifampin in patients with varying degrees of renal insufficiency, the mean half-life increased from 3.6 hours in healthy adults to 5, 7.3, and 11 hours in patients with glomerular filtration rates of 30 to 50 mL/min, less than 30 mL/min, and in anuric patients, respectively."	0
"Signs and symptoms of these reactions may include hypotension, urticaria, angioedema, acute bronchospasm, conjunctivitis, thrombocytopenia, neutropenia or flu-like syndrome (weakness, fatigue, muscle pain, nausea, vomiting, headache, fever, chills, aches, rash, itching, sweats, dizziness, shortness of breath, chest pain, cough, syncope, palpitations)."	0
Vortioxetine potently and selectively inhibits reuptake of serotonin (IC50=5.4 nM).	0
These findings are attributed to drug exposure in late gestation and during lactation.	0
Initiate telmisartan at low doses and titrate slowly in these patients.	0
"For most patients, their maintenance dose was that associated with response during acute treatment."	0
Change dose in 1-to 2-ng/kg/min increments at intervals of at least 15 minutes based on clinical response.	0
"Effects of food and disease upon the absorption, distribution, metabolism and elimination of pimozide are not known."	0
"This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function."	0
The pharmacokinetics of the d and l enantiomers of sotalol are essentially identical.	0
"Co-administration of fusidic acid and INVIRASE/ritonavir can cause increased plasma concentrations of fusidic acid, saquinavir and ritonavir."	1
Co-administration of APTIVUS/ritonavir in patients on tadalafil (Adcirca): Avoid use of tadalafil (Adcirca) during the initiation of APTIVUS/ritonavir.	0
The 25 mg per day dose is intended for a gradual reduction in dose when discontinuing treatment or dosing in severe renal and end-stage renal disease patients (2.1).	0
There have been postmarketing reports of decreases in hemoglobin concentration and hematocrit that have resulted in anemia requiring transfusion.	0
"The results from in vitro human liver microsomal studies suggest that at therapeutic concentrations, estazolam has no significant inhibitory effect on the major human cytochrome P450 enzyme activities (i.e., CYP1A2, CYP2A6, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A)."	0
Terbinafine is an allylamine antifungal.	0
Atenolol is excreted in human breast milk at a ratio of 1.5 to 6.8 when compared to the concentration in plasma.	0
"In chronic studies (one year or more) of MINIPRESS in rats and dogs, testicular changes consisting of atrophy and necrosis occurred at 25 mg/kg/day (75 times the usual maximum recommended human dose)."	0
"If bleeding at access site can not be controlled with pressure , infusion of INTEGRILIN and heparin should be discontinued immediately ."	0
Patients randomized to paroxetine were significantly less likely to relapse than comparably treated patients who were randomized to placebo.	0
"Benzodiazepines: Alprazolam, clorazepate, diazepam, flurazepam <U+2191>Benzodiazepines For contraindicated sedative/hypnotics (midazolam, triazolam),."	0
"In addition, no dose adjustment for lithium, aspirin, and warfarin is necessary."	0
The antithrombotic action of AGGRENOX is the result of the additive antiplatelet effects of dipyridamole and aspirin.	0
The best available evidence of impending toxicity from very high doses of NORPRAMIN is prolongation of the QRS or QT intervals on the ECG.	0
"Co-administration of SAMSCA with 400mg ketoconazole daily or with other strong CYP 3A inhibitors (e.g., clarithromycin, itraconazole, telithromycin, saquinavir, nelfinavir, ritonavir and nefazodone) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure."	1
"In the absence of a functioning artificial pacemaker, quinidine is also contraindicated in any patient whose cardiac rhythm is dependent upon a junctional or idioventricular pacemaker, including patients in complete atrioventricular block."	0
"In controlled clinical trials, TENORMIN, given as a single daily oral dose, was an effective antihypertensive agent providing 24-hour reduction of blood pressure."	0
"The recommended starting dose for nefazodone hydrochloride tablets USP is 200 mg/day, administered in two divided doses (BID)."	0
Age did not influence the paliperidone exposure.	0
Hemorrhage: Hemorrhage from any site may occur.	0
The clinical significance of these changes is unknown.	0
There are no studies of the coadministration of thioridazine and other drugs that prolong the QTc interval.	0
"If clinically significant fluid retention develops, with or without associated weight gain, further evaluation should be undertaken to determine the cause, such as Letairis or underlying heart failure, and the possible need for specific treatment or discontinuation of Letairis therapy."	0
"If replacing clonidine by beta-blocker therapy, the introduction of beta blockers should be delayed for several days after clonidine administration has stopped."	0
The use of ORAP (pimozide) in the treatment of Tourette<U+2019>s Disorder involves different risk/benefit considerations than when antipsychotic drugs are used to treat other conditions.	0
Coronary artery vasospasm including Prinzmetal's angina.	0
"The risk of using higher daily doses of selegiline should be explained, and a brief description of the 'cheese reaction' provided."	0
"Should a dermatologic reaction persist, the drug should be discontinued."	0
"In HCV replicon assays, the EC50 values of sofosbuvir against full-length replicons from genotypes 1a, 1b, 2a, 3a, and 4a, and chimeric 1b replicons encoding NS5B from genotypes 2b, 5a, or 6a ranged from 14<U+2013>110 nM."	0
The cause of the increased sensitivity to the anticoagulant effects of warfarin in this age group is unknown but may be due to a combination of pharmacokinetic and pharmacodynamic factors.	0
A complaint of urinary retention or urinary hesitancy should be considered potentially related to atomoxetine.	0
"Therefore, Tasigna may alter serum concentration of other drugs (7.1) Nilotinib is a competitive inhibitor of CYP3A4, CYP2C8, CYP2C9, CYP2D6 and UGT1A1 in vitro, potentially increasing the concentrations of drugs eliminated by these enzymes."	1
The table shows the number of events for each component in two different ways.	0
Treatment with BRINTELLIX and any concomitant serotonergic agents should be discontinued immediately if serotonin syndrome occurs.	0
Discontinue or replace with an alternative drug that does not cause hepatotoxicity while the patient is using TRISENOX.	0
Focalin XR may be swallowed as whole capsules or alternatively may be administered by sprinkling the capsule contents on a small amount of applesauce.	0
The MIC values obtained should be interpreted according to the following criteria for Neisseria meningitidis	0
"Because hypotension caused by NATRECOR<U+00AE> may be prolonged (up to hours), a period of observation may be necessary before restarting the drug."	0
The absolute bioavailability of ambrisentan is not known.	0
It is metabolized in the liver where it is conjugated as a glucuronide and excreted with the bile.	0
"Angioedema associated with involvement of the tongue, glottis or larynx may be fatal."	0
"The highest dose administered in these studies (75 mg/kg/day) was, on a mg/m2 basis, about equivalent to the maximum recommended daily human oral dose (MRHD) in mice and about twice the MRHD in rats."	0
Therefore the initial dosage in the elderly should be reduced.	0
"Distribution:Iloperidone has an apparent clearance (clearance/bioavailability) of 47 to 102 L/h, with an apparent volume of distribution of 1340 to 2800 L. At therapeutic concentrations, the unbound fraction of iloperidone in plasma is ~3% and of each metabolite (P88 and P95) it is ~8%."	0
"As with other phenothiazine derivatives, chlorpromazine should be discontinued at least 48 hours before myelography, should not be resumed for at least 24 hours postprocedure, and should not be used for the control of nausea and vomiting occurring either prior to myelography or postprocedure with metrizamide."	0
Suicidality: Monitor for worsening of depressive symptoms and suicide risk (5.1).	0
The trough effect represents about 50% of the peak effect.	0
Specific Populations Renal Insufficiency No dosage adjustment is necessary in patients with decreased renal function.	0
Contact lenses or dentures may become permanently stained.	0
Hypersensitivity: Hypersensitivity including angioedema has been reported with Effient including in patients with a history of hypersensitivity reaction to other thienopyridines (5.5).	0
"Conversely, at least 14 days should be allowed after stopping WELLBUTRIN XL before starting an MAOI antidepressant."	0
Treatment-na<U+00EF>ve patients initiating treatment with INVIRASE/ritonavir: First 7 days of treatment: INVIRASE 500 mg twice daily with ritonavir 100 mg twice daily.	0
"Further evaluate patients who develop exertional chest pain, unexplained syncope, or arrhythmias during VYVANSE treatment."	0
"Effect of Food Relative to fasting conditions, the administration of a single dose of HARVONI with a moderate fat (~600 kcal, 25% to 30% fat) or high fat (~1000 kcal, 50% fat) meal increased sofosbuvir AUC0<U+2013>inf by approximately 2-fold, but did not significantly affect sofosbuvir Cmax."	1
Do not start NORPRAMIN in a patient who is being treated with linezolid or intravenous methylene blue because there is increased risk of serotonin syndrome.	0
"Angioedema of the face, extremities, lips, tongue, glottis, and larynx has been reported in patients treated with ACE inhibitors and has been seen in 0.1% of patients receiving quinapril."	0
Similar results may be anticipated in patients treated with telmisartan.	0
Treatment-na<U+00EF>ve adult patients and treatment-experienced adult patients with no darunavir resistance associated substitutions: 800 mg (one 800 mg tablet) taken with ritonavir 100 mg once daily and with food.	0
"In a small, prematurely terminated study of patients with pulmonary hypertension (PH) secondary to sickle cell disease, vaso-occlusive crises requiring hospitalization were more commonly reported by patients who received REVATIO than by those randomized to placebo."	0
"After further treatment with Savella 100 mg BID for two weeks, the mean increase from baseline in heart rate was 13 beats per minute."	0
"The most common adverse reaction (> 20% of patients) is myelosupression including anemia, neutropenia, lymphopenia and thrombocytopenia."	0
Refer to the package insert on lithium before use of such concomitant therapy.	0
Alprostadil must be infused continuously because it is very rapidly metabolized.	0
"Table 3: Drugs that Can Increase the Risk of Bleeding Drug Class Specific Drugs Anticoagulants argatroban, dabigatran, bivalirudin, desirudin, heparin, lepirudin Antiplatelet Agents aspirin, cilostazol, clopidogrel, dipyridamole, prasugrel, ticlopidine Nonsteroidal Anti-Inflammatory Agents celecoxib, diclofenac, diflunisal, fenoprofen, ibuprofen, indomethacin, ketoprofen, ketorolac, mefenamic acid, naproxen, oxaprozin, piroxicam, sulindac Serotonin Reuptake Inhibitors citalopram, desvenlafaxine, duloxetine, escitalopram, fluoxetine, fluvoxamine, milnacipran, paroxetine, sertraline, venlafaxine, vilazodone There have been reports of changes in INR in patients taking warfarin and antibiotics or antifungals, but clinical pharmacokinetic studies have not shown consistent effects of these agents on plasma concentrations of warfarin."	0
<U+2022>Combined P-gp and strong CYP3A4 inhibitors increase blood levels of apixaban.	1
"In the same patients, these reactions did not occur when ACE inhibitors were temporarily withheld, but they reappeared when the ACE inhibitors were inadvertently readministered."	0
"In humans, greater than 70% of a single dose of estazolam was recovered in the urine as metabolites."	0
"Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary)."	0
"However, in some patients with compensated cardiac failure, it may be necessary to utilize these agents."	0
Patients should be warned that imipramine pamoate may enhance the CNS depressant effects of alcohol.	0
Clinically significant drug-drug interactions of APTIVUS co-administered with ritonavir are summarized in Table 4 below.	0
"Zaleplon 10 mg, but not 5 mg, was superior to placebo in decreasing latency to persistent sleep (LPS), a polysomnographic measure of time to onset of sleep."	0
"Because of a possible causal relationship between these events and the concomitant administration of lithium and antipsychotics, patients receiving such combined therapy should be monitored closely for early evidence of neurologic toxicity and treatment discontinued promptly if such signs appear."	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy."	0
Hepatic impairment: Changes in anti-FXa activity were similar in patients with mild-to-moderate hepatic impairment and healthy subjects.	0
Consult the labeling of all concurrently used drugs to obtain further information about CYP450 interaction potential.	0
"Because digoxin<U+2019>s therapeutic and toxic effects are all largely mediated by intracellular calcium distribution, they are affected by abnormalities in serum calcium levels."	0
Warfarin is stereoselectively metabolized by hepatic cytochrome P-450 (CYP450) microsomal enzymes to inactive hydroxylated metabolites (predominant route) and by reductases to reduced metabolites (warfarin alcohols) with minimal anticoagulant activity.	0
No difference was observed between placebo and desvenlafaxine treatments for the QRS interval.	0
"Because of the verapamil component, TARKA is contraindicated in: Severe left ventricular dysfunction."	0
Emphasize the importance of compliance with therapy Rifapentine is an inducer of CYP450 enzymes.	0
"Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with Nardil and should counsel them in its appropriate use."	0
Patients should be seen at least monthly during therapy and should be specifically questioned concerning symptoms associated with adverse reactions.	0
"Eszopiclone is a nonbenzodiazepine hypnotic that is a pyrrolopyrazine derivative of the cyclopyrrolone class with a chemical structure unrelated to pyrazolopyrimidines, imidazopyridines, benzodiazepines, barbiturates, or other drugs with known hypnotic properties."	0
The complete text of the Medication Guide is reprinted at the end of this document.	0
"While the mechanism through which PRINIVIL lowers blood pressure is believed to be primarily suppression of the renin-angiotensin-aldosterone system, PRINIVIL is antihypertensive even in patients with low-renin hypertension."	0
Doses in excess of 5 mg daily have not been studied in pediatric patients.	0
Immediately evaluate any new onset behavioral changes.	0
(Figure 4) Figure 4 Remove the cap.	0
"For subtypes 6e, 6l, 6n, 6q, 6k and 6m, the median EC50 values ranged from 60.6 nM to 430.1 nM."	0
"Because of an increased risk of myopathy/rhabdomyolysis when HMG-CoA reductase inhibitors are co-administered with gemfibrozil, avoid concomitant administration of atorvastatin with gemfibrozil."	0
"Concomitant use of Meperidine Hydrochloride Injection with monoamine oxidase (MAO) inhibitors can result in coma, severe respiratory depression, cyanosis and hypotension."	0
"In three month controlled trials, elevations of SGOT greater than three times the upper limit of normal occurred in about 1% of both mexiletine-treated and control patients."	0
"Non<U+2013>interactions of quinidine with other drugs: Quinidine has no clinically significant effect on the pharmacokinetics of diltiazem, flecainide, mephenytoin, metoprolol, propafenone, propranolol, quinine, timolol, or tocainide."	0
"NARDIL should not be used in patients who are hypersensitive to the drug or its ingredients, with pheochromocytoma, congestive heart failure, severe renal impairment or renal disease, a history of liver disease, or abnormal liver function tests."	0
"Although a similar dosage reduction may be considered for elderly and/or renally-impaired patients being treated for indications other than hypertension, data are not available for these patient populations."	0
"It is recognized that drugs having a parasympathetic effect, including tricyclic antidepressants, may alter the ejaculatory response."	0
The adaptor is provided so that you can fill the oral syringe with medicine from the bottle.	0
The primary treatment is to discontinue hydrochlorothiazide as rapidly as possible.	0
The use of these microorganisms does not imply clinical efficacy ; they are used to control the technical aspects of the laboratory procedures.	0
"In a peri- and postnatal development study in Sprague-Dawley rats (oral doses of 4, 16, and 64 mg/kg or 4, 15, and 62 times the human therapeutic dose on a mg/m2 basis), an increase in the number of stillbirths and decreases in the number of pups per dam, pup survival, and pup body weight (at birth and throughout the lactation period) were observed at the two highest doses."	0
"Cleviprex is contraindicated in patients with: Allergy to soy or eggs (4.1) Defective lipid metabolism (4.2) Severe aortic stenosis (4.3) Cleviprex is contraindicated in patients with allergies to soybeans, soy products, eggs, or egg products."	0
"May be administered with or without food (2.1) When used for cardiovascular risk reduction, monitoring of blood pressure is recommended, and if appropriate, adjustment of medications that lower blood pressure may be necessary (2.2) Indication Starting Dose Dose Range Hypertension (2.1) 40 mg once daily 40 to 80 mg once daily Cardiovascular Risk Reduction (2.2) 80 mg once daily 80 mg once daily Dosage must be individualized."	0
Avoid concurrent use of XARELTO with other anticoagulants due to increased bleeding risk unless benefit outweighs risk .	0
Patients with ESRD retain phosphorus and can develop hyperphosphatemia.	0
It is not recommended to co-administer boceprevir with APTIVUS/ritonavir.	0
"To minimize the known dose-related tolerability and safety-related effects of the individual agents, consideration should be given to initiating treatment at less than their maximum doses."	0
"Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders."	0
"CYP 2D6 is subject to genetic polymorphism (about 6%-8% of Caucasians, and a very low percentage of Asians, have little or no activity and are ""poor metabolizers"") and to inhibition by a variety of substrates and some non-substrates, notably quinidine."	0
Relapsed or Refractory APL A treatment course including TRISENOX monotherapy for patients with relapsed or refractory APL consists of 1 induction cycle and 1 consolidation cycle.	0
"Following single oral administration of [14C] fingolimod, the major fingolimod-related components in blood, as judged from their contribution to the AUC up to 816 hours post-dose of total radiolabeled components, are fingolimod itself (23.3%), fingolimod-phosphate (10.3%), and inactive metabolites [M3 carboxylic acid metabolite (8.3%), M29 ceramide metabolite (8.9%), and M30 ceramide metabolite (7.3%)]."	0
"Excretion Plasma elimination of doxazosin is biphasic, with a terminal elimination half-life of about 22 hours."	0
"Patients may wish to be examined to determine whether they are susceptible to angle closure, and have a prophylactic procedure (e.g., iridectomy), if they are susceptible."	0
"Risk factors for the development of hyperkalemia include renal insufficiency , diabetes mellitus , and the concomitant use of potassium-sparing diuretics , potassium supplements and/or potassium-containing salt substitutes , which should be used cautiously , if at all , with VASOTEC ( see Drug Interactions ) ."	0
Etravirine and APTIVUS/ritonavir should not be coadministered.	0
Seizures: The threshold for seizures may be lowered.	0
The use of CYMBALTA within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated.	0
Triptans: There have been rare postmarketing reports of serotonin syndrome with use of an SSRI and a triptan.	0
"HMG-CoA Reductase Inhibitors <U+2013> When single 40 mg doses of simvastatin or atorvastatin, both substrates of CYP3A4, were given to healthy adult volunteers who had received nefazodone hydrochloride, 200 mg BID for 6 days, approximately 20 fold increases in plasma concentrations of simvastatin and simvastatin acid and 3 to 4 fold increases in plasma concentrations of atorvastatin and atorvastatin lactone were seen."	1
"Lovastatin is a lactone which is readily hydrolyzed in vivo to the corresponding <U+03B2><U+2011>hydroxyacid, a strong inhibitor of HMG<U+2011>CoA reductase."	0
"Drugs Metabolized by P450 2D6 <U+2013> The biochemical activity of the drug metabolizing isozyme cytochrome P450 2D6 (debrisoquin hydroxylase) is reduced in a subset of the Caucasian population (about 7% to 10% of Caucasians are so called <U+201C>poor metabolizers<U+201D>); reliable estimates of the prevalence of reduced P450 2D6 isozyme activity among Asian, African and other populations are not yet available."	0
Renal Impairment Amlodipine: The pharmacokinetics of amlodipine are not significantly influenced by renal impairment.	0
Possible increased responsiveness to the muscle relaxant may result.	0
"In patients whose renal function may depend on the activity of the renin-angiotensin-aldosterone system (e.g., patients with severe congestive heart failure), treatment with ACE inhibitors has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death."	0
"Aspirin may cause severe urticaria, angioedema or bronchospasm."	0
Patients with severely impaired renal function have been treated with cimetidine tablets.	0
The pharmacokinetics of eplerenone did not differ significantly between males and females.	0
"In the exceptional case where coadministration of triazolam with nefazodone may be considered appropriate, only the lowest possible dose of triazolam should be used."	1
The absolute bioavailability of atorvastatin (parent drug) is approximately 14% and the systemic availability of HMG-CoA reductase inhibitory activity is approximately 30%.	0
"The magnitude of reduction in blood pressure with amlodipine is also correlated with the height of pretreatment elevation; thus, individuals with moderate hypertension (diastolic pressure 105<U+2013>114 mmHg) had about a 50% greater response than patients with mild hypertension (diastolic pressure 90<U+2013>104 mmHg)."	0
The dose of REVATIO injection does not need to be adjusted for body weight.	0
"The pooled analysis of placebo-controlled trials in children and adolescents with MDD, obsessive compulsive disorder (OCD), or other psychiatric disorders including a total of 24 short-term trials of 9 antidepressant drugs in over 4400 patients."	0
Patients should use the lowest dose and shortest duration of PPI therapy appropriate to the condition being treated.	0
Potassium levels persistently above 6mEq/L require careful observation and treatment.	0
PEXEVA<U+00AE> (paroxetine mesylate) tablets are contraindicated in patients with a hypersensitivity to paroxetine or any of the inactive ingredients in PEXEVA<U+00AE> (paroxetine mesylate) tablets.	0
Population pharmacokinetic analyses found no difference in exposure or clearance of paliperidone between extensive metabolizers and poor metabolizers of CYP2D6 substrates.	0
"After at least one week following the initiation of INVIRASE/ritonavir, resume Adcirca at 20 mg once daily."	0
No metabolites have been identified that have antifungal activity similar to terbinafine.	0
Absorption/Distribution Epoprostenol is rapidly hydrolyzed at neutral pH in blood and is also subject to enzymatic degradation.	0
Close observation is especially important for patients already taking medications that are known to lower blood pressure.	0
"If it occurs, discontinue VYVANSE and initiate supportive treatment (4, 5.7, 10)."	0
<U+25CF> Patients resistant or intolerant to prior treatment that included imatinib with confirmed loss of MR4.0 (2 consecutive measures separated by at least 4 weeks showing loss of MR4.0) or loss of MMR must re-initiate treatment within 4 weeks at the dose level prior to discontinuation of therapy.	0
Only small amounts of unmetabolized triazolam appear in the urine.	0
"After mixing, a slight haze may appear, which is normal."	0
The elimination of warfarin is almost entirely by metabolism.	0
The exact mechanism of hydrochlorothiazide's antihypertensive action is not known although it may relate to the excretion and redistribution of body sodium.	0
STRATTERA use within 2 weeks after discontinuing MAOI or other drugs that affect brain monoamine concentrations.	0
"Prolongation of the QT interval can result in a type of ventricular tachycardia called torsade de pointes, which may result in syncope, seizure, and/or death."	0
The potential reproductive toxicity of isocarboxazid has not been adequately evaluated in animals.	0
"Patients and physicians should be aware, however, that oligohydramnios may not appear until after the fetus has sustained irreversible injury."	0
"There have been reports of agitation, hypertonia, hypotonia, tremor, somnolence, respiratory distress and feeding disorder in these neonates."	0
"Maximum antihypertensive effect is usually observed by 14 days of chronic therapy; therefore, schedule dosage adjustments accordingly."	0
"If differentiation syndrome is suspected, immediately initiate high-dose corticosteroid therapy and hemodynamic monitoring until resolution of signs and symptoms."	0
"Arteriolar relaxation reduces systemic vascular resistance, systolic arterial pressure, and mean arterial pressure (afterload)."	0
In vitro drug interaction studies reveal that paroxetine inhibits CYP2D6.	0
There have been rare postmarketing reports of serotonin syndrome with use of an SSRI and a triptan.	0
"Reduce rifabutin dosage further, as needed."	0
"Therefore, ULORIC may be used concomitantly with these medications."	0
Advise females and males of reproductive potential to use effective contraception during and after treatment with TRISENOX.	0
1/4 mg/lb body weight IM 1 to 2 hours before operation.	0
Other Drugs with No Interactions with Zolpidem A study involving cimetidine/zolpidem tartrate and ranitidine/zolpidem tartrate combinations revealed no effect of either drug on the pharmacokinetics or pharmacodynamics of zolpidem.	0
"Treatment of gout flares <U+2013>co- administration of colchicine in patients on VIRACEPT: 0.6 mg (1 tablet) <U+00D7> 1 dose, followed by 0.3 mg (half tablet) 1 hour later."	0
"Other studies have found varying results as to whether there was an increased risk of overall, cardiovascular, or specific congenital malformations."	0
Increase dose based on clinical response.	0
Dosage adjustment is therefore not needed in these patients.	0
For the treatment of duodenal ulcers take ACIPHEX delayed-release tablets after a meal.	0
"In most patients, treatment of hypomagnesemia required magnesium replacement and discontinuation of the PPI."	0
"When given together with thiazide-type diuretics, the blood pressure lowering effects of the two drugs are approximately additive."	0
Change in Cmax 40 mg QD for 5 days Phenytoin 300 mg QDConsidered clinically significant <U+2191>20% <U+2191>5% 40 mg b.i.d. for 21 days Glyburide 5 to 20 mg QD for 22 days <U+2191>70% <U+2191>50% 40 mg QD for 8 days Diclofenac 25 mg QD <U+2191>25% <U+2191>60% 40 mg QD for 8 days Warfarin 30 mg QD S-warfarin: <U+2191>7% S-warfarin: <U+2191>10% R-warfarin: no change R-warfarin: <U+2191>6%	0
Elimination of asenapine is primarily through direct glucuronidation by UGT1A4 and oxidative metabolism by cytochrome P450 isoenzymes (predominantly CYP1A2).	0
See CONTRAINDICATIONS and WARNINGS.	0
Teriparatide transiently increases serum calcium.	0
"PDE5 inhibitors: Concomitant use contraindicated (4.1, 7.1) Antihypertensives: Possible additive hypotensive effects (7.2) Aspirin: increased nitroglycerin levels (7.3) Tissue-type plasminogen activator (t-PA): decreased thrombolytic effect (7.4) Heparin: anticoagulant effect of heparin may be reduced."	0
There are no adequate and well-controlled studies in pregnant women.	0
The single dose pharmacokinetics of flurazepam were studied in 12 healthy geriatric subjects (aged 61 to 85 years).	0
"Because of its potent binding to ACE and slow dissociation from the enzyme, ramiprilat shows two elimination phases."	0
"400 single dose 10 0.65(0.53, 0.79) 0.73(0.60, 0.87) 0.90(0.71, 1.15) Isoniazid 300 once daily in the morning, 8 days 800 three times daily, 7 days 11 0.95(0.88, 1.03) 0.99(0.87, 1.13) 0.89(0.75, 1.06) Itraconazole 200 twice daily, 7 days 600 three times daily, 7 days 12 0.78 (0.69, 0.88) 0.99 (0.91, 1.06) 1.49 (1.28, 1.74) Ketoconazole 400 once daily,7 days 600 three times daily, 7 days 12 0.69 (0.61, 0.78) 0.80 (0.74, 0.87) 1.29 (1.11, 1.51) 400 once daily, 7 days 400 three times daily, 7 days 12 0.42 (0.37, 0.47) 0.44 (0.41, 0.48) 0.73 (0.62, 0.85) Methadone 20-60 once daily in the morning, 8 days 800 three times daily, 8 days 10 See text below for discussion of interaction."	0
"If short-acting benzodiazepines, which are metabolized by the cytochrome P450 system, are concomitantly administered with fluconazole, consideration should be given to decreasing the benzodiazepine dosage, and the patients should be appropriately monitored."	1
"Quinidine 200 single dose 400 single dose 10 0.96(0.79, 1.18) 1.07(0.89, 1.28) 0.93 (0.73, 1.19) Rifabutin 150 once daily in the morning, 10 days 800 three times daily, 10 days 14 0.80(0.72, 0.89) 0.68(0.60, 0.76) 0.60(0.51, 0.72) Rifabutin 300 once daily in the morning, 10 days 800 three times daily, 10 days 10 0.75(0.61, 0.91) 0.66(0.56, 0.77) 0.61(0.50, 0.75) Rifampin 600 once daily in the morning, 8 days 800 three times daily, 7 days 12 0.13(0.08, 0.22) 0.08(0.06, 0.11) Not Done Ritonavir 100 twice daily, 14 days 800 twice daily, 14 days 10, 16Comparison to historical data on 16 subjects receiving indinavir alone."	0
"LASIX combined with angiotensin converting enzyme inhibitors or angiotensin II receptor blockers may lead to severe hypotension and deterioration in renal function , including renal failure ."	0
The safety and efficacy of ELIQUIS have not been studied in patients with prosthetic heart valves.	0
"Urinary cystine should be measured at 1 month after THIOLA<U+00AE> treatment, and every 3 months thereafter."	0
Similar considerations may apply to patients with ischemic heart or cerebrovascular disease in whom an excessive fall in blood pressure could result in a myocardial infarction or a cerebrovascular accident.	0
"Additionally, paroxetine did not alter the pharmacokinetics of Zaleplon, reflecting the absence of a role of CYP2D6 in zaleplon's metabolism."	0
Data suggested that one in ten patients treated with digoxin will degrade 40% or more of the ingested dose.	0
"Clinical evidence indicates that the early high serum concentrations do not reflect the concentration of digoxin at its sites of action, but that with chronic use, the steady-state post-distribution serum concentrations are in equilibrium with tissue concentrations and correlate with pharmacologic effects."	0
"No clinically relevant differences were observed between desvenlafaxine treated and placebo-treated patients for QT, QTc, PR, and QRS intervals."	0
"As with other alpha-blockers, there is a potential for syncope, especially after the initial dose or after an increase in dosage strength."	0
"Dosage reductions of rifabutin by 75% are recommended (e.g., 150 mg every other day)."	1
Sympathomimetics Epinepherine Can increase the risk of cardiac arrhythmias.	0
Duloxetine does not inhibit monoamine oxidase (MAO).	0
An increase in the AUC of terbinafine of less than 20% is observed when LamisilTablets areadministered with food.	1
"In some patients with compromised renal function (e.g., elderly patients or patients who are volume-depleted, including those on diuretic therapy) who are being treated with non-steroidal anti-inflammatory drugs, including selective COX-2 inhibitors, the co-administration of angiotensin II receptor antagonists or ACE inhibitors may result in a further deterioration of renal function, including possible acute renal failure."	0
"If concomitant treatment of fluvoxamine with a triptan is clinically warranted, careful observation of the patient is advised, particularly during treatment initiation and dose increases."	0
The decision to inform patients and/or their guardians must obviously take into account the clinical circumstances and the competency of the patient to understand the information provided.	0
"In patients with hypertension taking a moderate CYP3A inhibitor, initiate at 25 mg once daily."	0
This increase is likely due to the fact that carbamazepine is a potent inducer of CYP1A2 activity.	0
"At these doses, which are multiples of the MRHD equal to 3000 for mice and 1000 for rats, based on body-weight, and equal to 282 for mice and 206 for rats, based on body-surface area, there was no evidence of harm to the fetus."	0
Avoid use of PRINIVIL in patients who are hemodynamically unstable after acute MI.	0
No dose adjustment is necessary when administering ULORIC in patients with mild or moderate renal impairment.	0
"Icodextrin is metabolized by alpha-amylase into oligosaccharides with a lower degree of polymerization (DP), including maltose (DP2), maltotriose (DP3), maltotetraose (DP4), and higher molecular weight species."	0
"Because of the small number of events, an excess mortality due to TIKOSYN cannot be ruled out with confidence in the pooled survival analysis of placebo-controlled trials in patients with supraventricular arrhythmias."	0
"Desvenlafaxine lacked significant affinity for numerous receptors, including muscarinic-cholinergic, H1-histaminergic, or <U+03B1>1-adrenergic receptors in vitro."	0
"While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition."	0
Verapamil therapy may increase serum levels of cyclosporine.	1
"Cases of dysphagia and esophageal tablet retention have been reported in association with use of the tablet formulation of sevelamer, some requiring hospitalization and intervention."	0
"If dosage must be increased, dividing the dose should be considered in order to achieve lower peak blood levels."	0
The mechanism for the induction of pituitary tumors in mice is not known.	0
"ALDACTONE ( 100 mg/kg/day ) , administered i.p. to female mice during a two-week cohabitation period with untreated males , decreased the number of mated mice that conceived ( effect shown to be caused by an inhibition of ovulation ) and decreased the number of implanted embryos in those that became pregnant ( effect shown to be caused by an inhibition of implantation ) , and at 200 mg/kg , also increased the latency period to mating ."	0
"Aerobic Gram-Negative Microorganisms: Neisseria meningitidis <U+201C>Other<U+201D> Microorganisms: Mycobacterium tuberculosis The following in vitro data are available, but their clinical significance is unknown."	0
Twenty-eight percent of these patients discontinued therapy.	0
Avoid use of aliskiren with TWYNSTA in patients with renal impairment (GFR <60 mL/min).	0
"In individual patients, these post-distribution serum concentrations may be useful in evaluating therapeutic and toxic effects."	0
"In some cases, diabetic ketoacidosis has occurred."	0
The maintenance dose of voriconazole should be increased when co-administered with phenytoin or efavirenz.	1
Midazolam (a sensitive CYP 3A4 substrate):A study in patients with schizophrenia showed a less than 50% increase in midazolam total exposure at iloperidone steady state (14 days of oral dosing at up to 10 mg iloperidone twice daily) and no effect on midazolam Cmax.	1
"Although some reports described dark urine and nonspecific prodromal symptoms (e.g., anorexia, malaise, and gastrointestinal symptoms), other reports did not describe the onset of clear prodromal symptoms prior to the onset of jaundice."	0
"Examples: Specific antipsychotics (e.g., ziprasidone, iloperidone, chlorpromazine, mesoridazine, droperidol); specific antibiotics (e.g., erythromycin, gatifloxacin, moxifloxacin, sparfloxacin); Class 1A antiarrhythmic medications (e.g., quinidine, procainamide); Class III antiarrhythmics (e.g., amiodarone, sotalol); and others (e.g., pentamidine, levomethadyl acetate, methadone, halofantrine, mefloquine, dolasetron mesylate, probucol or tacrolimus)."	0
<U+2022> Clinical Worsening/Suicide Risk: Monitor for clinical worsening of suicidal thoughts/behaviors especially during the initial months of therapy and at times of dose changes (5.1).	0
"Cross-reactivity and false-positive urine screening tests for opiates have been reported in patients receiving rifampin when using the KIMS (Kinetic Interaction of Microparticles in Solution) method (e.g., Abuscreen OnLine opiates assay; Roche Diagnostic Systems)."	0
The role of this enzyme in paroxetine metabolism also suggests potential drug-drug interactions.	0
Diuretic agents reduce the renal clearance of lithium and add a high risk of lithium toxicity.	1
"As a result, the systemic exposure of drugs metabolized by CYP3A4 (e.g., certain HMG-CoA reductase inhibitors) may be increased when coadministered with Tasigna."	1
"It has been reported that verapamil decreases neuromuscular transmission in patients with Duchenne's muscular dystrophy, and that verapamil prolongs recovery from the neuromuscular blocking agent vecuronium."	0
Coadministration of ACCURETIC with other drugs that raise serum potassium levels may result in hyperkalemia.	0
The affinity of the FANAPT metabolite P88 is generally equal or less than that of the parent compound.	0
"Compatability Nicardipine hydrochloride injection has been found compatible and stable in polyvinyl chloride containers for 24 hours at controlled room temperature with: Dextrose (5%) Injection, USPDextrose (5%) and Sodium Chloride (0.45%) Injection, USPDextrose (5%) and Sodium Chloride (0.9%) Injection, USPDextrose (5%) with 40 mEq Potassium, USPSodium Chloride (0.45%) Injection, USPSodium Chloride (0.9%) Injection, USP Nicardipine hydrochloride is not compatible with Sodium Bicarbonate (5%) Injection, USP or Lactated Ringer<U+2019>s Injection, USP."	0
Children and Adolescents (7 to 17 years of age) <U+2014> Initiate CYMBALTA at a dose of 30mg once daily for 2 weeks before considering an increase to 60mg.	0
"When CYMBALTA and ethanol were administered several hours apart so that peak concentrations of each would coincide, CYMBALTA did not increase the impairment of mental and motor skills caused by alcohol."	0
The mechanism of action of maprotiline is not precisely known.	0
"In a dose-response trial comparing three dose levels of sotalol, 80 mg, 120 mg, and 160 mg with placebo given q12h (or q24h in patients with a reduced renal creatinine clearance) for the prevention of recurrence of symptomatic atrial fibrillation (AFIB)/flutter (AFL), the mean ventricular rate during recurrence of AFIB/AFL was 125, 107, 110 and 99 beats/min in the placebo, 80 mg, 120 mg and 160 mg dose groups, respectively (p<0.017) for each sotalol dose group versus placebo)."	0
Amiloride HCl should be discontinued at least three days before glucose tolerance testing.	0
"Based on in vitro data, no interaction would be expected with drugs whose metabolism is dependent upon cytochrome P450 isoenzymes 1A1, 1A2, 2A6, 2B6, 2D6, 2E1, or 3A4."	0
The recommended starting dose of Silenor in elderly patients (<U+2265> 65 years old) is 3 mg once daily.	0
"In clinical studies, the majority of patients required 10 mg."	0
Administration of CRESTOR with food did not affect the AUC of rosuvastatin.	0
Patients with renal failure may therefore receive the usual initial dose.	0
"Among 10,867 patients treated with mexiletine in the compassionate use program, marked leukopenia (neutrophils less than 1000/mm3) or agranulocytosis were seen in 0.06% and milder depressions of leukocytes were seen in 0.08%, and thrombocytopenia was observed in 0.16%."	0
This encephalopathic syndrome may be similar to or the same as neuroleptic malignant syndrome (NMS).	0
Abrupt withdrawal of PRINIVIL has not been associated with a rapid increase in blood pressure or a significant increase in blood pressure compared to pretreatment levels.	0
"In the past, it was difficult to differentiate most cases of drug-induced hepatocellular jaundice from viral hepatitis although this is no longer true."	0
The contractile processes of cardiac muscle and vascular smooth muscle are dependent upon the movement of extracellular calcium ions into these cells through specific ion channels.	0
"In multiple-dose studies, 10 to 80 mg per day in single or divided doses lowered systolic and diastolic blood pressure throughout the dosing interval, with a trough effect of about 5 to 11/3 to 7 mm Hg."	0
"In subjects who had received EMSAM 6mg per 24 hours for 10 days, co-administration with risperidone (2mg per day for 7 days), a substrate for CYP2D6, did not affect the pharmacokinetics of selegiline or risperidone."	0
"No treatment-related effects on mating, fertility, or embryo survival were seen in female rats and no treatment-related effects on mating performance were seen in male rats at doses providing systemic exposure comparable to or slightly higher than that with the clinical dose."	0
Do not administer unless solution is clear and seal is intact.	0
The risk of skeletal muscle effects may be enhanced when LIVALO is used in combination with niacin; a reduction in LIVALO dosage should be considered in this setting.	0
Effects of Savella on blood pressure in patients with significant hypertension or cardiac disease have not been systematically evaluated.	0
"Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"The bioavailability of metoprolol shows a dose-related, although not directly proportional, increase with dose and is not significantly affected by food following TOPROL-XL administration."	0
Changes in plasma atropine levels following intramuscular administration (0.5 to 4mgdoses) and heart rate are closely overlapped but the time course of the changes in atropine levels and behavioral impairment indicates that pharmacokinetics is not the primary rate-limiting mechanism for the central nervous system effect of atropine.	0
"Dysrhythmias unresponsive to sodium bicarbonate therapy/hyperventilation may respond to lidocaine, bretylium or phenytoin."	0
"Liver function tests should be performed prior to initiating therapy with APTIVUS/ritonavir, and frequently throughout the duration of treatment."	0
"The plasma concentration of CMI has been reported to be increased by the concomitant administration of haloperidol; plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors (e.g., cimetidine, fluoxetine) and decreased by the concomitant administration of hepatic enzyme inducers (e.g., barbiturates, phenytoin), and such an effect may be anticipated with CMI as well."	1
Drug reactions with eosinophilia and systemic symptoms (DRESS) have been reported in patients taking mexiletine.	0
"If intolerable symptoms occur following a decrease in the dose or upon discontinuation of treatment, then resuming the previously prescribed dose may be considered."	0
"Following establishment of a new chronic infusion rate, measure standing and supine blood pressure for several hours."	0
"However, due to the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of thioridazine, paroxetine and thioridazine should not be coadministered."	0
"Twice-Daily Dosage Regimens by Weight for Protease Inhibitor-Naive Pediatric Patients (Aged 4Weeks and Older) and for Protease Inhibitor-Experienced Pediatric Patients (Aged 6Months and Older) Using LEXIVA Oral Suspension with Concurrent Ritonavir Weight Twice-Daily Dosage Regimen <11kg LEXIVA 45mg/kg plus ritonavir 7mg/kga 11kg - <15kg LEXIVA 30mg/kg plus ritonavir 3mg/kga 15kg - <20kg LEXIVA 23mg/kg plus ritonavir 3mg/kga <U+2265>20kg LEXIVA 18mg/kg plus ritonavir 3mg/kga a When dosing with ritonavir, do not exceed the adult dose of LEXIVA 700mg/ritonavir 100mg twice-daily dose."	0
<U+2022>It is preferable to mix REYATAZ oral powder with food such as applesauce or yogurt.	0
"If pulse rate drops below 55beats per minute, the dosage should be reduced."	0
MAO inhibitors: Silenor should not be administered in patients on MAOIs within the past two weeks.	0
Monitor calcium levels in patients with hypercalcemia receiving ACCURETIC.	0
Adjustment of adenosine dosage may be necessary.	0
Concomitant therapy with flecainide and verapamil may result in additive negative inotropic effect and prolongation of atrioventricular conduction.	0
The safety of doses above 120mg once daily has not been evaluated.	0
No dosage adjustment of SAPHRIS is necessary when administered concomitantly with paroxetine.	0
Both sildenafil and the active metabolite have terminal half-lives of about 4 hours.	0
Pregnancy/Teratogenic Effects PREGNANCY CATEGORY B: Reproduction studies have been performed in the rat and the rabbit at doses up to 420 times the human dose and have revealed no evidence of harm to the fetus due to chlorthalidone.	0
"The absolute bioavailability of lisinopril is reduced to about 16 percent in patients with stable NYHA Class II-IV congestive heart failure, and the volume of distribution appears to be slightly smaller than that in normal subjects."	0
Refer to the quetiapine prescribing information for recommendations on adverse reaction monitoring.	0
"In the long-term open-label extension of the two pivotal clinical studies, mean decreases from baseline (ranging from 0.9 to 1.2 g/dL) in hemoglobin concentrations persisted for up to 4 years of treatment."	0
"In some instances, the syndrome was followed by irreversible brain damage."	0
Renal Impairment No initial dosage adjustment is required for patients with mild or moderate renal impairment.	0
"If malignant hyperthermia develops, discontinue administration immediately and institute therapeutic countermeasures as clinically indicated."	0
NSAIDsNon-Steroidal Anti-Inflammatory Drug including. ibuprofen and diclofenac Increased Frequent monitoring for adverse events and toxicity related to NSAIDs.	0
DIFLUCAN increases the plasma concentrations of phenytoin.	1
The mean duration of PMDD symptoms for these patients was approximately 10.5 years in both studies.	0
"Such drugs include antidepressants (e.g., venlafaxine, nortriptyline, imipramine, desipramine, paroxetine, fluoxetine, and sertraline), antipsychotics (e.g. haloperidol, risperidone, and thioridazine), beta-blockers (e.g., metoprolol), and Type 1C antiarrhythmics (e.g."	0
Increase to 40 mg once daily based upon individual tolerability.	0
Figure 19: The effects of other drugs on aripiprazole pharmacokinetics Figure 20: The effects of other drugs on dehydro-aripiprazole pharmacokinetics The effects of ABILIFY on the exposures of other drugs are summarized in Figure 21.	0
This statement is included on the product's bottle label.	0
"After oral administration, the peak plasma concentration (Cmax) of olmesartan is reached after 1 to 2 hours."	0
"Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or direct renin inhibitors (such as aliskiren) is associated with increased risks of hypotension, syncope, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
LIPITOR is metabolized by cytochrome P450 3A4.	0
MEVACOR had no clinically important effect on glycemic control or on the dose requirement of oral hypoglycemic agents.	0
Administration of quinidine should (if possible) be avoided in lactating women who continue to nurse.	0
"There has been a long-standing concern, however, that antidepressants may have a role in inducing worsening of depression and the emergence of suicidality in certain patients during the early phases of treatment."	0
Dose reduction of CRIXIVAN to 600 mg every 8 hours is recommended when administering ketoconazole concurrently.	1
There is not sufficient evidence to suggest a greater benefit to doses higher than 20 mg/day.	0
"These infections may lead to serious, including fatal outcomes."	0
Terbinafine increases the clearance of cyclosporine by 15%.	1
No reports involved the administration of methylene blue by other routes (such as oral tablets or local tissue injection) or at lower doses.	0
See prescribing information for warfarin.	0
This binding is reversible and independent of plasma concentrations.	0
"The antihypertensive effect of angiotensin II receptor antagonists , including valsartan , may be attenuated by NSAIDs including selective COX-2 inhibitors ."	0
Nucleotide Reverse Transcriptase Inhibitors: tenofovir disoproxil fumarate (DF) <U+2193> atazanavir<U+2191> tenofovir Tenofovir DF may decrease the AUC and Cmin of atazanavir.	1
"Inhibitors of the OATP1B1 (e.g., cyclosporine) can increase the bioavailability of atorvastatin."	1
General Obtain an ECG and immediately initiate cardiac monitoring.	0
"An evaluation of visual function at doses up to 200 mg revealed no effects of REVATIO on visual acuity, intraocular pressure, or pupillometry."	0
"Concentrations of thioridazine and its two active metabolites, mesoridazine and sulforidazine, increased 3-fold following coadministration of fluvoxamine."	1
"Metoprolol succinate extended release/hydrochlorothiazide is contraindicated in patients in cardiogenic shock, overt cardiac failure , second or third degree AV block, marked sinus bradycardia, anuria, and hypersensitivity to either component of this product or to other sulfonamide-derived drugs."	0
"In all neonates, arterial pressure should be monitored intermittently by umbilical artery catheter, auscultation, or with a Doppler transducer."	0
"Benzodiazepines Clinical Impact Increased exposure to midazolam or other benzodiazepines metabolized via CYP3A4 (alprazolam, triazolam) may increase the risk of adverse reactions."	0
The usual maintenance dose range is 4 mg to 8 mg administered as a single daily dose or in two divided doses.	0
Families and caregivers should be advised of the need for close observation and communication with the prescriber.	0
"In nonpregnant rats dosed at 135mg/kg/day for 7days, systemic exposure (AUCs) for losartan and its active metabolite were approximately 66 and 26times the exposure achieved in man at the maximum recommended human daily dosage (100mg)."	0
"Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8 fold increase in plasma AUC of the TCA)."	0
"In child and adolescent registration studies, 0.2% (12/5596) of STRATTERA-treated patients experienced orthostatic hypotension and 0.8% (46/5596) experienced syncope."	0
Dermatological events may be transient and may disappear despite continued use of CARDIZEM.	0
"In patients with renal impairment (creatinine clearance less than or equal to 50 mL/min) or hepatic cirrhosis, the clearance of terbinafine is decreased by approximately 50% compared to normal volunteers."	0
"Use with Warfarin: Monitor for increases in INR and prothrombin time (5.2, 7)."	0
"In patients with hepatic insufficiency, verapamil clearance is decreased about 30% and the elimination half-life is prolonged up to 14 to 16 hours."	0
Dosage reduction and/or discontinuation of any diuretic and/or the ACE inhibitor may be required.	0
PRADAXA is contraindicated in patients with: Active pathological bleeding.	0
Endothelin receptor antagonist:Bosentan <U+2191> bosentan concentration Co-administration of bosentan in patients on CRIXIVAN or co-administration of CRIXIVAN in patients on bosentan: Start at or adjust bosentan to 62.5 mg once daily or every other day based upon individual tolerability.	0
Depression: Worsening of depression or suicidal thinking may occur.	0
Concurrent use of DEMSER with alcohol or other CNS depressants can increase their sedative effects .	0
The evidence supporting the conclusion that Anafranil is safe for use in children and adolescents is derived from relatively short term clinical studies and from extrapolation of experience gained with adult patients.	0
"Tipranavir trough concentrations at steady-state are about 70% lower than those on Day 1, presumably due to intestinal P-gp induction."	0
"Pimozide is extensively metabolized, primarily by N-dealkylation in the liver."	0
"Pimozide may be capable of potentiating CNS depressants, including analgesics, sedatives, anxiolytics, and alcohol."	0
"In order to assess effect on stone disease, urinary cystine analysis should be monitored frequently during the first 6 months when the optimum dose schedule is being determined, and at 6-month intervals thereafter."	0
"In general, patients who responded best had low pretreatment blood pO2 and were 4 days old or less."	0
"Intravenous solutions containing (non-concentrated) electrolytes VFEND I.V. can be infused at the same time as other intravenous solutions containing (non-concentrated) electrolytes, but must be infused through a separate line."	0
Negligible amounts of unchanged vortioxetine were excreted in the urine up to 48 hours.	0
Evaluate the bone marrow in patients with prolonged or repeated marrow suppression to assess leukemia status and marrow cellularity.	0
"Although it is generally recommended that antiplatelet therapy be administered promptly in the management of ACS because many cardiovascular events occur within hours of initial presentation, in a trial of 4033 NSTEMI patients, no clear benefit was observed when Effient loading dose was administered prior to diagnostic coronary angiography compared to at the time of PCI; however, risk of bleeding was increased with early administration in patients undergoing PCI or early CABG."	0
"Some patients not responding to a 20 mg dose may benefit from dose increases, in 10 mg/day increments, up to a maximum of 50 mg/day."	0
Concomitant administration of fluvastatin and phenytoin increased phenytoin exposures.	1
Patients should also be cautioned that taking alcohol can increase the chance of dizziness occurring.	0
For Obesity: One 5 mg tablet should be taken one-half hour before each meal.	0
These studies have also shown that concurrent use of an NSAID or aspirin may potentiate this risk of bleeding.	0
Safety and effectiveness in children have not been established by controlled clinical studies.	0
"Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed."	0
Monitor cholesterol and triglycerides prior to therapy and periodically thereafter.	0
"There is limited controlled experience regarding the optimal timing of switching from other drugs effective in the treatment of major depressive disorder, obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, premenstrual dysphoric disorder and social anxiety disorder to sertraline."	0
MAXALT should not be administered to patients with a history of stroke or transient ischemic attack.	0
Less than 5% of an eplerenone dose is recovered as unchanged drug in the urine and feces.	0
"Because of lipid load restrictions, no more than 1000 mL or an average of 21 mg/hour of Cleviprex infusion is recommended per 24 hour period."	0
Inhibitors of CYP2B6 Ticlopidine and Clopidogrel: Concomitant treatment with these drugs can increase bupropion exposures but decrease hydroxybupropion exposure.	1
"If bradycardia or hypotension requiring treatment or any other untoward effects occur, TENORMIN should be discontinued."	0
"Accordingly, pimozide should not be given with dofetilide, sotalol, quinidine, other Class Ia and III anti-arrhythmics, mesoridazine, thioridazine, chlorpromazine, droperidol, sparfloxacin, gatifloxacin, moxifloxacin, halofantrine, mefloquine, pentamidine, arsenic trioxide, levomethadyl acetate, dolasetron mesylate, probucol, tacrolimus, ziprasidone, or other drugs that have demonstrated QT prolongation as one of their pharmacodynamic effects."	0
"Of the randomized patients, 4963 (54%) were female and 533 (6%) were Black."	0
It is not intended that the suspension be further diluted with water or other vehicles.	0
"A gradual reduction in the dose, rather than abrupt cessation, is recommended whenever possible."	0
The effect of paroxetine on the pharmacokinetics of atomoxetine has been evaluated when both drugs were at steady state.	0
"In patients aged 65 years old and above, dronedarone exposures are 23% higher than in patients less than 65 years old."	0
Use with Warfarin: IMURAN may inhibit the anticoagulant effect of warfarin.	0
Inhibitors of these isozymes may increase the exposure of doxepin.	0
Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide.	0
"Because of the effect on the central nervous system, phendimetrazine may impair the ability of the patient to engage in potentially hazardous activities such as operating machinery or driving a motor vehicle; the patient should therefore be cautioned accordingly."	0
"Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure , reduce myocardial contractility , or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC s effects on blood pressure , contractility , and impulse propagation ."	0
Risperidone could be subject to two kinds of drug-drug interactions.	0
"Effect of amiodarone on other drugs Amiodarone and DEA are inhibitors of P-glycoprotein and certain CYP450 enzymes, including CYP1A2, CYP2C9, CYP2D6 and CYP3A [see Clinical Pharmacology (12.3)]."	0
Monitor renal function periodically in patients receiving candesartan and NSAID therapy.	0
"Therefore, growth should be monitored during treatment with stimulants, and patients who are not growing or gaining height or weight as expected may need to have their treatment interrupted."	0
Iloperidone doses should be reduced by one-half when administered with fluoxetine.	1
Lotensin attenuates potassium loss caused by thiazide-type diuretics.	0
The dose of SAMSCA may have to be increased [Dosage and Administration (2.3) and Warnings and Precautions (5.5)].	0
Disopyramide is a Type I antiarrhythmic drug with potent negative inotropic and chronotropic effects.	0
"An open-label, randomized, controlled trial has shown DIFLUCAN to be effective in the treatment of oropharyngeal candidiasis in children 6 months to 13 years of age."	0
"This preferential effect is not absolute, however, and at higher doses, atenolol inhibits beta2-adrenoreceptors, chiefly located in the bronchial and vascular musculature."	0
"Therefore, barbiturates should be given at a reduced dose with NARDIL."	1
"The doses of dronedarone in this study were 400, 600, and 800 mg twice a day."	0
"An in vitro enzyme inhibition study utilizing human liver microsomes showed that ziprasidone had little inhibitory effect on CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4, and thus would not likely interfere with the metabolism of drugs primarily metabolized by these enzymes."	0
Refer to the lurasidone prescribing information for concomitant use with moderate CYP3A4 inhibitors.	0
No activation of mania or hypomania was reported in the clinical trials evaluating effects of Savella in patients with fibromyalgia.	0
Drug/Laboratory Test Interactions: Literature reports suggest that amphetamines may be associated with significant elevation of plasma corticosteroids.	1
"No drug interaction studies have been conducted with TWYNSTA tablets and other drugs, although studies have been conducted with the individual amlodipine and telmisartan components of TWYNSTA tablets, as described below: Aliskiren: Do not co-administer aliskiren with TWYNSTA in patients with diabetes."	0
"Conversely, at least 5 days should be allowed after stopping Savella before starting a MAOI intended to treat psychiatric disorders."	0
"For inadequate response, increase to 50 mg twice daily."	0
Close supervision and careful adjustment of the dosage are required when Pamelor is used with other anticholinergic drugs and sympathomimetic drugs.	0
"Adults: To minimize the nausea and vomiting experienced by a high percentage of patients beginning Matulane therapy, single or divided doses of 2 to 4 mg/kg/day for the first week are recommended."	0
"Serious hemorrhagic events, including fatal events, have occurred in patients with CML treated with Tasigna."	0
"The bulk of the radioactive materials were recovered in the urine (mean 58.2% and 45.1% in EM and PM, respectively), with feces accounting for 19.9% (EM) to 22.1% (PM) of the dosed radioactivity."	0
"All patients should be warned that the following foods, beverages, and medications must be avoided while taking NARDIL, and for two weeks after discontinuing use."	0
"Mirtazapine is a potent antagonist of histamine (H1) receptors, a property that may explain its prominent sedative effects."	0
"Rare reports of fatalities in association with seizures have been reported by foreign postmarketing surveillance, but not in U.S. clinical trials."	0
"It is not possible to determine whether these reported events are related directly to the use of REVATIO, to the patient's underlying risk factors for hearing loss, a combination of these factors, or to other factors."	0
"Proton pump inhibitors: Omeprazole <U+2191> Saquinavir When INVIRASE/ritonavir is co-administered with omeprazole, saquinavir concentrations are increased significantly."	1
"In male mice receiving a mean dose of 163 mg nisoldipine/kg/day (16 times the MRHD of 60 mg/day on a mg/m2 basis), an increased frequency of stomach papilloma, but still within the historical range, was observed."	0
Plasma concentration of angiotensin II and plasma renin activity (PRA) increased in a dose-dependent manner after single administration of telmisartan to healthy subjects and repeated administration to hypertensive patients.	0
"Caution should be exercised in treating patients with pre-existing hypertension, cardiovascular, or cerebrovascular conditions that might be compromised by increases in blood pressure."	0
This test is not recommended for assessing the anticoagulant effect of apixaban.	0
Citalopram: Citalopram did not affect the pharmacokinetics of bupropion and its three metabolites.	0
Subsequent titration to higher or lower doses may be necessary.	0
The usual recommended starting dose of Benicar is 20 mg once daily when used as monotherapy in patients who are not volume-contracted.	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function, and of concomitant disease or other drug therapy."	0
"Total parenteral nutrition (TPN) VFEND I.V. can be infused at the same time as total parenteral nutrition, but must be infused in a separate line."	0
Tapering of the initial antidepressant may be necessary to minimize discontinuation symptoms.	0
Rifampin has been shown to produce liver dysfunction.	0
"The following symptoms, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric."	0
"For patients at high risk for a CHD event due to existing CHD, diabetes, peripheral vessel disease, history of stroke or other cerebrovascular disease, the recommended starting dose is 40mg/day."	0
Drug interaction studies Inhibitors of CYP3A4 (ketoconazole) CYP3A4 is a minor pathway for the metabolism of desvenlafaxine.	0
Oral contraceptives: Ethinylestradiol/norethindronea LEXIVA: <U+2193>Amprenavir <U+2193>Ethinyl estradiol LEXIVA/ritonavir: <U+2193>Ethinyl estradiol Alternative methods of non-hormonal contraception are recommended.	0
No clinically relevant differences in ledipasvir pharmacokinetics were observed between healthy subjects and subjects with severe renal impairment.	0
"Depending upon the patient<U+2019>s renal function, this will take between 1 and 3 weeks."	0
Concomitant administration of alcohol (equivalent to 60 g) had a minimal effect on plasma levels of mirtazapine (15 mg) in 6 healthy male subjects.	0
"However, 800 mg at bedtime is the dose of choice for most patients, as it provides a high healing rate (the difference between 800 mg at bedtime and 1600 mg at bedtime being small), maximal pain relief, a decreased potential for drug interactions and maximal patient convenience."	0
Prompt medical or surgical treatments may need to be considered if the intraocular pressure remains uncontrolled.	0
Atenolol<U+2013>Sertraline (100 mg) when administered to 10 healthy male subjects had no effect on the beta-adrenergic blocking ability of atenolol.	0
Caution should be exercised when INVIRASE/ritonavir and digoxin are coadministered; serum digoxin concentrations should be monitored and the dose of digoxin may need to be reduced when coadministered with INVIRASE/ritonavir.	1
Selegiline hydrochloride tablets USP are intended for administration to Parkinsonian patients receiving levodopa/carbidopa therapy who demonstrate a deteriorating response to this treatment.	0
Appropriate laboratory testing should be conducted prior to initiating therapy with LEXIVA and patients should be monitored closely during treatment.	0
Ledipasvir plasma exposure (AUC0<U+2013>inf) was similar in subjects with severe hepatic impairment and control subjects with normal hepatic function.	0
GI Motility Agent Cisapride Potential for serious and/or life-threatening reactions such as cardiac arrhythmias.	0
"In Study 1, the incidence of fatal neutropenic sepsis was 0.8% among patients receiving ONIVYDE, occurring in one of 117 patients in the ONIVYDEplus fluorouracil/leucovorin (ONIVYDE/5-FU/LV) arm and one of 147 patients receiving ONIVYDE as a single agent."	0
"In addition, there was no pharmacodynamic interaction as a result of coadministration of zaleplon and venlafaxine ER."	0
"Discontinue thienopyridines, including Effient, for active bleeding, elective surgery, stroke, or TIA."	0
"Alcohol<U+2013>Although sertraline did not potentiate the cognitive and psychomotor effects of alcohol in experiments with normal subjects, the concomitant use of sertraline and alcohol is not recommended."	0
"Calcium Channel Blockers Dronedarone increased the exposure of calcium channel blockers (verapamil, diltiazem or nifedipine)."	1
"The result is slowed conduction and reduced automaticity in all parts of the heart, with increase of the effective refractory period relative to the duration of the action potential in the atria, ventricles, and Purkinje tissues."	0
Such complications can arise immediately upon delivery.	0
"Other macrolides (e.g., erythromycin and azithromycin) have the potential to increase statin exposures while used in combination."	1
Monitor heart rate in patients receiving concomitant verapamil and clonidine.	0
"Initial, Target and Maximum Daily Dose (2.1) (Acute and Maintenance/Extended Treatment) Body Weight Initial Daily Dose Target Total Daily Dose Maximum Total Daily Dose Children and adolescents up to 70kg 0.5mg/kg 1.2mg/kg 1.4mg/kg Children and adolescents over 70kg and adults 40mg 80mg 100mg Dosing adjustment <U+2014> Hepatic Impairment, Strong CYP2D6 Inhibitor, and in patients known to be CYP2D6 poor metabolizers (PMs)."	0
"If concomitant use is warranted, carefully observe the patient, particularly during treatment initiation and dose adjustment."	0
"To reduce the possibility of venous thrombosis, phlebitis, local irritation, swelling, extravasation, and the rare occurrence of vascular impairment, administer drug through large peripheral veins or central veins rather than arteries or small peripheral veins, such as those on the dorsum of the hand or wrist."	0
Repeat at least twice more using the same amount of apple juice (10 mL or 2 teaspoonfuls) each time.	0
WARNING: (A) PREMATURE DISCONTINUATION OF ELIQUIS INCREASES THE RISK OF THROMBOTIC EVENTS(B) SPINAL/EPIDURAL HEMATOMA See full prescribing information for complete boxed warning.	0
"Two-year feeding studies in mice and rats, conducted under the auspices of the National Toxicology Program (NTP), treated mice and rats with doses of hydrochlorothiazide up to 600and 100mg/kg/day, respectively."	0
"Therefore, carefully monitor for rifabutin associated adverse events in those patients also receiving CYP3A inhibitors, which include fluconazole and clarithromycin."	0
SURMONTIL should be used with caution in patients with impaired liver function.	0
Individualize dosage depending on the blood pressure response of the patient and the goal blood pressure.	0
Pimozide Potential for serious and/or life-threatening reactions such as cardiac arrhythmias.	0
"In animal models, LIPITOR lowers plasma cholesterol and lipoprotein levels by inhibiting HMG-CoA reductase and cholesterol synthesis in the liver and by increasing the number of hepatic LDL receptors on the cell surface to enhance uptake and catabolism of LDL; LIPITOR also reduces LDL production and the number of LDL particles."	0
"Since there is little clinical experience, the concurrent administration of paroxetine and digoxin should be undertaken with caution."	0
Nicardipine has been shown to improve systolic shortening in both normal and hypokinetic segments of myocardial muscle.	0
"The intravenous vehicle, SBECD, is hemodialyzed with clearance of 55 mL/min."	0
"Active liver disease, which may include unexplained persistent elevations in hepatic transaminase levels."	0
STRATTERA can be discontinued without being tapered.	0
"Paroxetine, Fluoxetine, and Sertraline In a study of schizophrenic patients (n=14) who received clozapine under steady-state conditions, coadministration of paroxetine produced only minor changes in the levels of clozapine and its metabolites."	0
Patients receiving sertraline hydrochloride experienced a significantly greater reduction in panic attack frequency than patients receiving placebo.	0
"Systemic corticosteroid effects, including Cushing<U+2019>s syndrome and adrenal suppression, have been reported during postmarketing use in patients receiving ritonavir and inhaled or intranasally administered fluticasone propionate."	0
Meperidine should be used with caution in patients with atrial flutter and other supraventricular tachycardias because of a possible vagolytic action which may produce a significant increase in the ventricular response rate.	0
This hyperbilirubinemia is reversible upon discontinuation of REYATAZ.	0
"In another pharmacokinetic study, patients with severe renal impairment (glomerular filtration rate 15 <U+2013> 29 mL/min/1.73 m2) not receiving hemodialysis were administered a single dose of LIVALO 4 mg."	0
"Trandolapril Component After a single 2 mg dose of trandolapril, inhibition of ACE activity reaches a maximum (70-85%) at 4 hours with about 10% decline at 24 hours."	0
"Up to 75% of an oral dose of racemic zopiclone is excreted in the urine, primarily as metabolites."	0
"For treatment of hypertension and angina, when switching from immediate-release metoprolol to TOPROL-XL, use the same total daily dose of TOPROL-XL."	0
Coadministration of PRADAXA with a high-fat meal delays the time to Cmax by approximately 2 hours but has no effect on the bioavailability of dabigatran; PRADAXA may be administered with or without food.	1
Hydrochlorothiazide is a thiazide diuretic.	0
"The main metabolite, 9-hydroxyrisperidone, has similar pharmacological activity as risperidone."	0
"When a patient who has been taking meperidine hydrochloride regularly and may be physically dependent no longer requires therapy with Meperidine Hydrochloride Injection, taper the dose gradually, by 25% to 50% every 2 to 4 days, while monitoring carefully for signs and symptoms of withdrawal."	0
Do not use aspirin in children or teenagers with viral infections because of the risk of Reye syndrome.	0
Hormonal contraceptives : Tracleer use decreases contraceptive exposure and reduces effectiveness ( 7.2 ) .	1
"Drug Interactions (not described in Contraindications or Warnings and Precautions) include the following: Drugs Inhibiting or Metabolized by Cytochrome P450: Fluvoxamine inhibits several cytochrome P450 isoenzymes (CYP1A2, CYP2C9, CYP3A4, and CYP2C19)."	0
"The Losartan Intervention For Endpoint reduction in hypertension (LIFE) study was a multinational, double-blind study comparing losartan potassium tablets and atenolol in 9193 hypertensive patients with ECG-documented left ventricular hypertrophy."	0
Extended and frequent monitoring for opiate-associated adverse events may be necessary.	0
", The effects of HARVONI on atazanavir and ritonavir are similar with or without the presence of emtricitabine/tenofovir DF."	0
"For pediatric patients, pharmacokinetic and clinical data: <U+2022>do not support once-daily dosing of LEXIVA alone or in combination with ritonavir."	0
"For Grade 3 to 4 lipase elevations, dosing should be withheld, and may be resumed at 400 mg oncedaily."	0
"Altered anticoagulant effects, including increased bleeding, have been reported when SNRIs or SSRIs are coadministered with warfarin."	0
If hypotension occurs (systolic blood pressure <U+2264>100 mmHg) consider doses of 2.5 or 5 mg.	0
"No data are available on the use of LEXIVA/ritonavir with other hormonal therapies, such as hormone replacement therapy (HRT) for postmenopausal women."	0
"Following oral 14C-labeled losartan, about 35% of radioactivity is recovered in the urine and about 60% in the feces."	0
"In controlled trials of trandolapril, cough was present in 2% of trandolapril patients and 0% of patients given placebo."	0
Patients receiving continued REMERON treatment experienced significantly lower relapse rates over the subsequent 40 weeks compared to those receiving placebo.	0
Atazanavir is an inhibitor of CYP3A and UGT1A1.	0
Savella is not recommended for patients with end-stage renal disease.	0
Caution should be used when prescribing with CRESTOR.	0
"Ketoconazole and Other Potent CYP 3A Inhibitors Concomitant use of ketoconazole as well as other potent CYP 3A inhibitors such as itraconazole, voriconazole, ritonavir, clarithromycin, and nefazodone is contraindicated because exposure to dronedarone is significantly increased."	1
"First, inhibitors of CYP 2D6 interfere with conversion of risperidone to 9-hydroxyrisperidone."	0
The suppression of tics by ORAP requires a slow and gradual introduction of the drug.	0
"Several reports of possible interference with digoxin radioimmunoassay by ALDACTONE , or its metabolites , have appeared in the literature ."	0
Absorption The oral absorption of irbesartan is rapid and complete with an average absolute bioavailability of 60% to 80%.	0
"Dosing adjustment for use with a strong CYP2D6 inhibitor or in patients who are known to be CYP2D6 PMs <U+2014> In children and adolescents up to 70kg body weight administered strong CYP2D6 inhibitors, e.g.,paroxetine, fluoxetine, and quinidine, or in patients who are known to be CYP2D6 PMs, STRATTERA should be initiated at 0.5mg/kg/day and only increased to the usual target dose of 1.2mg/kg/day if symptoms fail to improve after 4weeks and the initial dose is well tolerated."	0
"Specific Populations Cirrhotics Based on published literature, the baseline corrected serum concentrations of potassium measured over 3 hours after administration in cirrhotic subjects who received an oral potassium load rose to approximately twice that of normal subjects who received the same load."	0
"Telmisartan is not expected to interact with drugs that inhibit cytochrome P450 enzymes; it is also not expected to interact with drugs metabolized by cytochrome P450 enzymes, except for possible inhibition of the metabolism of drugs metabolized by CYP2C19."	1
Cardiovascular Events: A higher rate of cardiovascular thromboembolic events was observed in patients treated with ULORIC than allopurinol in clinical trials.	0
Available data from clinical trials of trandolapril or TARKA are insufficient to show that trandolapril does not cause agranulocytosis at similar rates.	0
"In evaluating individual cases, consideration should be given to using lower initial doses of the concomitantly administered drugs, using conservative titration schedules, and monitoring of clinical status."	0
Case reports and epidemiological studies (case-control and cohort design) have demonstrated an association between use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding.	0
"Ordinarily, treatment with nefazodone hydrochloride tablets should not be initiated in individuals with active liver disease or with elevated baseline serum transaminases."	0
"In patients with acute myocardial infarction, particularly if they have ongoing ischemia, the use of inotropic drugs, such as digoxin, may result in undesirable increases in myocardial oxygen demand and ischemia."	0
"Verapamil Component Verapamil dilates the main coronary arteries and coronary arterioles, both in normal and ischemic regions, and is a potent inhibitor of coronary artery spasm."	0
"When possible, use a non-CYP3A4-metabolized statin together with diltiazem; otherwise, monitor for signs and symptoms of any statin-related adverse events, and adjust the doses accordingly."	0
"In a clinical trial in which 12,064 patients with a history of myocardial infarction were treated with ZOCOR (mean follow-up 6.7years), the incidence of myopathy (defined as unexplained muscle weakness or pain with a serum creatine kinase [CK]>10times upper limit of normal [ULN]) in patients on 80mg/day was approximately 0.9% compared with 0.02% for patients on 20mg/day."	0
Vardenafil <U+2191> vardenafil concentration Vardenafil dose should not exceed a maximum of 2.5 mg in a 24-hour period in patients receiving concomitant indinavir therapy.	1
"The use of higher ritonavir doses may alter the safety profile of atazanavir (cardiac effects, hyperbilirubinemia) and, therefore, is not recommended."	0
"Families and caregivers of patients should be advised to observe for the emergence of such symptoms on a day-to-day basis, since changes may be abrupt."	0
Monitoring of heart rate and QTc is most important.	0
Concomitant administration of clonidine with a <U+03B2>-blocker may cause hypotension and bradycardia.	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy."	0
"More gradual titration may be obtained by beginning an appropriate maintenance dose, thus allowing digoxin body stores to accumulate slowly."	0
"As with all drugs which exert an anticholinergic effect, and/or cause mydriasis, chlorpromazine should be used with caution in patients with glaucoma."	0
"Therefore, no dosage adjustment of either lithium or nefazodone is required when they are coadministered."	0
"For the active metabolite, norquetiapine, AUC and Cmax were 45% and 31% higher, respectively, in children and adolescents than in adults."	0
Increased resorptions were not associated with treatment at the same time or at higher dose levels (up to 3 times the oral MRDHD) when the dams were treated on gestation days 6 to 15.	0
"MAO exists as two isoenzymes, referred to as MAO-A and MAO-B."	0
"Younger subjects (18 to 40 years of age) tolerated CMI better and had significantly lower steady-state plasma concentrations, compared with subjects over 65 years of age."	0
A chemically similar drug in this class produced optic nerve degeneration (Wallerian degeneration of retinogeniculate fibers) in clinically normal dogs in a dose-dependent fashion at a dose that produced plasma drug levels about 30 times higher than the mean drug level in humans taking the highest recommended dose.	0
Dosage must be individualized and closely monitored during up-titration.	0
Coadministration of racemic citalopram (40 mg/day for 10 days) and lithium (30 mmol/day for 5 days) had no significant effect on the pharmacokinetics of citalopram or lithium.	0
A typical therapeutic concentration range is 2<U+2013>6 mg/L (6.2 <U+2013> 18.5 <U+03BC>mol/L).	0
"If symptoms of urinary hesitation develop during treatment with duloxetine, consideration should be given to the possibility that they might be drug-related."	0
"Fluid retention:Pericardial effusion, pleural effusion,and severe fluid retention have occurred in patients receiving Tasigna."	0
"Grapefruit juice, which has been shown to increase significantly the bioavailability of nisoldipine and other dihydropyridine type calcium channel blockers, should not be taken with SULAR."	1
"Up to 30% of a dose is excreted in the urine, with about half of this being unchanged drug."	0
In vitro data suggest that fluvoxamine is a relatively weak inhibitor of CYP2D6.	0
The usefulness and safety of narcotic antagonists in the treatment of these reactions is unknown.	0
"Since both drugs exhibit nonlinear pharmacokinetics, the above studies may not address the case where the 2 drugs are both being chronically dosed."	0
"In addition , nephrotoxicity of nephrotoxic drugs such as cisplatin may be enhanced if LASIX is not given in lower doses and with positive fluid balance when used to achieve forced diuresis during cisplatin treatment ."	0
"Metabolites found in plasma include 4-hydroxy duloxetine glucuronide and 5-hydroxy, 6-methoxy duloxetine sulfate."	0
"Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs."	0
No drug interaction study has been performed for the co-administration of CRIXIVAN with benzodiazepines.	0
"In poor CYP 2D6 metabolizers, ORAP doses should not exceed 0.05 mg/kg/day, and doses should not be increased earlier than 14 days."	0
Lipid determinations should be performed after 4 weeks of therapy and periodically thereafter.	0
Limited clinical studies have demonstrated a moderate but statistically significant decrease in platelet aggregation and an increase in bleeding time in some PROCARDIA patients.	0
Analyses for age and gender effects on outcome did not suggest any differential responsiveness on the basis of age or sex.	0
"Additionally, a Q30E substitution emerged in genotype 1a replicons."	0
"At later time points in 5-, 14-, and 28-night studies, a reduction in LPS from baseline was observed for all treatment groups, including the placebo group, and thus, a significant difference between Zaleplon and placebo was not seen beyond 2 nights."	0
"Pooled analyses of short-term placebo-controlled trials of antidepressant drugs (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18-24) with major depressive disorder (MDD) and other psychiatric disorders."	0
"Some serious hypersensitivity/allergic reactions may require treatment with epinephrine, oxygen, IV fluids, antihistamines, corticosteroids, pressor amines and airway management, as clinically indicated."	0
"Do not use in comatose states or in the presence of large amounts of central nervous system depressants (alcohol, barbiturates, narcotics, etc."	0
Co-administration of divalproex sodium increased Cmax and AUC of paliperidone by approximately 50%.	1
"Donepezil: The AUC0-inf and Cmax of ramelteon increased by approximately 100% and 87%, respectively upon coadministration of donepezil with ROZEREM."	1
"Prescriptions for Lexapro should be written for the smallest quantity of tablets consistent with good patient management, in order to reduce the risk of overdose."	0
Prepare fresh infusion solutions every 24 hours.	0
Spontaneous and ergonovine-induced coronary artery spasms are inhibited by diltiazem.	0
"Also, they should not be given cocaine or local anesthesia containing sympathomimetic vasoconstrictors."	0
"Intervention: Temporarily stop ACIPHEX delayed-release tablets treatment at least 14 days before assessing CgA levels and consider repeating the test if initial CgA levels are high. for monitoring), the same commercial laboratory should be used for testing, as reference ranges between tests may vary."	0
"The systemic exposure of 2 metabolites (M2 and M3) is increased by 3- and 13-fold, respectively."	0
"Specifically, two sudden deaths have been reported when clarithromycin was added to ongoing pimozide therapy."	0
"Pediatric Patients 6 Months to Less than12 Years or Pediatric and Adult Patients Unable to Swallow Capsules 3 mg/kg orally Maximum dose 125 mg 2 mg/kg orally Maximum dose 80 mg 2 mg/kg orally Maximum dose 80 mg none Dexamethasone Adults Unable to Swallow Capsules See Table 1 or 2 See Table 1 or 2 See Table 1 or 2 See Table 1 or 2 Pediatric Patients 6 Months to Less than12 Years or Pediatric Patients Unable to Swallow Capsules If a corticosteroid, such as dexamethasone, is co-administered, administer 50% of the recommended corticosteroid dose on Days 1 through 4.Administer dexamethasone 30 minutes prior to chemotherapy treatment on Day 1."	0
"Although mild vagal excitation occurs, the increased respiratory rate and (sometimes) increased depth of respiration produced by atropine are more probably the result of bronchiolar dilatation."	0
Antigout: colchicine <U+2191> colchicine The coadministration of REYATAZ with colchicine in patients with renal or hepatic impairment is not recommended.	0
Nisoldipine has no clinically important chronotropic effects.	0
Co-administration of multiple doses of 10 mg of verapamil with 80 mg simvastatin resulted in exposure to simvastatin 2.5-fold that following simvastatin alone.	1
"Although the causes of death were varied, most of the deaths appeared to be either cardiovascular (e.g., heart failure, sudden death) or infectious (e.g., pneumonia) in nature."	0
"2.ORAP should not be used in patients taking drugs that may, themselves, cause motor and phonic tics (e.g., pemoline, methylphenidate and amphetamines) until such patients have been withdrawn from these drugs to determine whether or not the drugs, rather than Tourette<U+2019>s Disorder, are responsible for the tics."	0
<U+2022>Label with an expiry date of 100 days and include the following instructions: Store at room temperature (below 30<U+00B0>C/86<U+00B0>F).	0
Concomitant administration of pimozide and sertraline should be contraindicated.	0
"Caution is indicated with the coadministration of fluvoxamine maleate tablets and TCAs; plasma TCA concentrations may need to be monitored, and the dose of TCA may need to be reduced."	1
"Because of its relative beta1-selectivity, however, TENORETIC may be used with caution in patients with bronchospastic disease who do not respond to or cannot tolerate, other antihypertensive treatment."	0
"To define the risk of hypertensive crises with use of EMSAM, several Phase I tyramine challenge studies were conducted both with and without food."	0
"Avoid a statin with drugs that may decrease the levels or activity of endogenous steroid hormones such as ketoconazole, spironolactone, and cimetidine."	0
Monitor for antidepressant response in patients on a stable dose of sertraline or paroxetine who start treatment with PREZISTA/ritonavir.	0
Lithium<U+2014> A multiple-dose study has shown that there is no pharmacokinetic interaction between paroxetine and lithium carbonate.	0
"From large, well-controlled studies of other nitrates, it is reasonable to believe that the maximal achievable daily duration of antianginal effect from isosorbide dinitrate is about 12 hours."	0
Plasma protein binding in humans is approximately 87%.	0
The extent to which SSRI-TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.	0
"The patient should also be warned about the possibility of hypotension and faintness, as well as drowsiness sufficient to impair performance of potentially hazardous tasks, such as driving a car or operating machinery."	0
Tolvaptan produces a greater 24 hour urine volume/excretion rate than does furosemide or hydrochlorothiazide .	0
"BRILINTA , like other antiplatelet agents , can cause significant , sometimes fatal bleeding ( 5.1 , 6.1 ) ."	0
Sotalol produces significant reductions in both systolic and diastolic blood pressures and may result in hypotension.	0
It is excreted rapidly and unchanged in the urine.	0
"When appropriate, hospitalization for the initial course of treatment should be considered."	0
"If blood pressure is not controlled with Edarbi alone , additional blood pressure reduction can be achieved by taking Edarbi with other antihypertensive agents ."	0
Antipsychotics Lurasidone Pimozide Potential for serious and/or life-threatening reactions.	0
"However, there were 16% and 32% increases in the AUC and Cmax, respectively, of the combined moieties of threohydrobupropion and erythrohydrobupropion."	0
The following have been observed in patients receiving NORVIR: The concomitant use of NORVIR and certain other drugs may result in known or potentially significant drug interactions.	0
"Extreme caution should be used when this drug is given to patients with any evidence of cardiovascular disease because of the possibility of conduction defects, arrhythmias, myocardial infarction, strokes, and tachycardia."	0
"Concomitant Strong CYP3A4 Inhibitors Avoid the concomitant use of strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole, clarithromycin, atazanavir, indinavir, nefazodone, nelfinavir, ritonavir, saquinavir, telithromycin, voriconazole)."	0
Clinical studies of diethylpropion hydrochloride did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
"In treatment-na<U+00EF>ve subjects whose virus had baseline NS5A polymorphisms at resistance-associated positions in Studies ION-1 and ION-3, relapse rates were 6% (3/48) after 8 weeks and 1% (1/113) after 12 weeks of treatment with HARVONI."	0
CRIXIVAN must be taken at intervals of 8 hours.	0
Data indicate that the metabolites have no more than 1/50 the potency of the parent compound at inhibiting serotonin uptake.	0
Cases of second and third degree heart block have been reported.	0
"At recommended therapeutic doses, dabigatran etexilate prolongs the coagulation markers such as aPTT, ECT, and TT."	0
"When 400 mg (8 times the recommended 50 mg dose) was administered, the Cmax and AUC of desipramine increased approximately 50% and 90%, respectively."	1
"In some cases, the angioedema was diagnosed by procedures including abdominal CT scan or ultrasound, or at surgery, and symptoms resolved after stopping the ACE inhibitor."	0
"Patients with a history of sick sinus syndrome , 2nd or 3rd degree AV block or bradycardia-related syncope not protected by a pacemaker were excluded from PLATO and PEGASUS and may be at increased risk of developing bradyarrhythmias with ticagrelor ."	0
"For these reasons, ORAP is contraindicated in patients receiving the macrolide antibiotics clarithromycin, erythromycin, azithromycin, dirithromycin, and troleandomycin."	0
Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy.	0
Clostridium difficile-Associated Diarrhea: PPI therapy may be associated with increased risk of Clostridium difficile-associated diarrhea.	0
Patients with underlying hepatitis B or C or marked elevations in transaminases prior to treatment may be at increased risk for developing or worsening of transaminase elevations.	0
Starting Dose: The starting dose of TIKOSYN is determined as follows: Calculated Creatinine Clearance TIKOSYN Dose >60 mL/min 500 mcg twice daily 40 <U+2013> 60 mL/min 250 mcg twice daily 20 <U+2013> <40 mL/min 125 mcg twice daily <20 mL/min Dofetilide is contraindicated in these patients Step 4.	0
Loss of therapeutic effect of PREZISTA/ritonavir and possible development of resistance.	0
"There is little information, however, in patients with severe congestive heart failure, and all calcium channel blockers should be used with caution in any patient with heart failure."	0
"On a body-weight basis, these doses are 600 times (in mice) and 100 times (in rats) the Maximum Recommended Human Dose (MRHD) for hydrochlorothiazide (50 mg/day or 1 mg/kg/day based on a 50 kg patient)."	0
Patients with severe hepatic impairment have not been studied.	0
"In animal models, both enantiomers are specific and potent serotonin uptake inhibitors with essentially equivalent pharmacologic activity."	0
"Consequently, it is recommended that nefazodone not be used in combination with either terfenadine, astemizole, cisapride, or pimozide."	0
"If such symptoms occur, discontinue Lexapro and initiate supportive treatment."	0
Tables 1 and 2 provide dosing guidelines for VIRACEPT tablets and powder based on age and body weight.	0
"Angioedema of the face, extremities, lips, tongue, glottis, and larynx has been reported in patients treated with ACE inhibitors."	0
Interference with Cognitive and Motor Performance: Use caution when operating machinery (5.8).	0
"TABLE 4: COMPARISON OF MEAN (SD) FLUVOXAMINE PHARMACOKINETIC PARAMETERS BETWEEN CHILDREN, ADOLESCENTS, AND ADULTS Pharmacokinetic Parameter (body weight corrected) Dose = 200 mg/day (100 mg b.i.d.)"	0
"In clinical trials that included electrocardiograms, asymptomatic first-degree AV block was observed in 5.9% of atazanavir-treated patients (n=920), 5.2% of lopinavir/ritonavir-treated patients (n=252), 10.4% of nelfinavir-treated patients (n=48), and 3.0% of efavirenz-treated patients (n=329)."	0
"DEMSER may add to the sedative effects of alcohol and other CNS depressants , e.g. , hypnotics , sedatives , and tranquilizers ."	0
Patients should have their blood pressure monitored continuously.	0
Studies in female rats at daily dietary doses up to 5.5 times (55 mg/kg/day) the maximum recommended human dose did not show impaired fertility.	0
Olmesartan passed across the placental barrier in rats and was distributed to the fetus.	0
"Rare, usually transient, but occasionally significant elevations of enzymes such as alkaline phosphatase, CPK, LDH, SGOT, and SGPT have been noted."	0
Tolazamide: A case of severe hypoglycemia has been reported.	0
"To monitor maternal-fetal outcomes of pregnant patients exposed to CRIXIVAN, an Antiretroviral Pregnancy Registry has been established."	0
The effects of gastrointestinal pH alterations on the absorption of dexmethylphenidate from Focalin XR have not been studied.	0
"In the same study, there was no significant change in 20 mg single dose pravastatin AUC and Cmax during diltiazem coadministration."	0
Both the parent and metabolite glucuronides are eliminated in the urine and feces.	0
Concurrent use of verapamil increases exposure to ivabradine and may exacerbate bradycardia and conduction disturbances.	0
Drugs that act directly on the renin-angiotensin aldosterone system (RAAS) can have effects on the development of immature kidneys.	0
Cimetidine (400 mg twice daily) causes a 23% increase in the plasma levels of d-nebivolol.	1
"Concomitant administration of VASOTEC with potassium supplements , potassium salt substitutes , or potassium-sparing diuretics may lead to increases of serum potassium ( see PRECAUTIONS ) ."	0
Cases with serum sodium lower than 110 mmol/L have been reported.	0
"Dosing of EMEND for oral suspension is based on weight, to a maximum of 125 mg on Day 1 and 80 mg on Days 2 and 3."	0
Digoxin <U+2191> digoxin Concomitant administration of ritonavir with digoxin may increase digoxin levels.	1
"If signs or symptoms of nephrolithiasis/urolithiasis occur, (including flank pain, with or without hematuria or microscopic hematuria), temporary interruption (e.g., 1-3 days) or discontinuation of therapy may be considered."	0
The major urinary metabolite is conjugated N1-hydroxyethyl-flurazepam which accounts for 22% to 55% of the dose.	0
"Whether increased levels of bradykinin, a potent vasodepressor peptide, play a role in the therapeutic effect of TARKA remains to be elucidated."	0
"In patients with moderate renal impairment (CrCl 30-50 mL/min), reduce the dose of PRADAXA to 75 mg twice daily when administered concomitantly with the P-gp inhibitors dronedarone or systemic ketoconazole."	1
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP, should not be used for chronic daily administration."	0
"In addition, do not start PRISTIQ in a patient who is being treated with linezolid or intravenous methylene blue (4.2)."	0
"Dizziness, lightheadedness, or fainting may occur, especially when rising from a lying or sitting position."	0
<U+2022> The following dose adjustments are recommended for use of tadalafil (ADCIRCA<U+2122>) with VIRACEPT: Coadministration of ADCIRCA in patients on VIRACEPT or coadministration of VIRACEPT in patients on ADCIRCA: Start at or adjust ADCIRCA to 20 mg once daily.	0
Plasma levels of icodextrin rose during the dwell and declined after the dwell was drained.	0
The plasma elimination half-life following single or multiple drug administration is approximately 3.0 to 4.5 hours.	0
"Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out."	0
"CYP3A4 inhibitors:Coadministration of ketoconazole, a potent inhibitor of cytochrome CYP3A4, resulted in significant increase in quetiapine exposure."	1
The oral absorption of irbesartan is rapid and complete with an average absolute bioavailability of 60% to 80%.	0
Lidocaine may cross the placental barrier.	0
Failure to correctly co-administer PREZISTA with ritonavir will result in plasma levels of darunavir that will be insufficient to achieve the desired antiviral effect and will alter some drug interactions.	1
Non-nucleoside reverse transcriptase inhibitor: Delavirdinea May lead to loss of virologic response and possible resistance to delavirdine.	0
"Hydrochlorothiazide was orally administered to pregnant mice and rats during respective periods of major organogenesis at doses up to 3000 and 1000 mg/kg/day, respectively."	0
"In normal volunteers, a dose of telmisartan 80 mg inhibited the pressor response to an intravenous infusion of angiotensin II by about 90% at peak plasma concentrations with approximately 40% inhibition persisting for 24 hours."	0
The steady-state Cmax and Cmin values were about 6 and 14 times what would be predicted from single-dose studies.	0
"The blood to plasma ratio for zaleplon is approximately 1, indicating that zaleplon is uniformly distributed throughout the blood with no extensive distribution into red blood cells."	0
Paroxetine: Coadministration of a single dose of Zaleplon 20 mg and paroxetine 20 mg daily for 7 days did not produce any interaction on psychomotor performance.	0
"Therefore, drug interactions mediated through effects on protein binding are not anticipated."	0
"The effect of quinapril in hypertension and in congestive heart failure (CHF) appears to result primarily from the inhibition of circulating and tissue ACE activity, thereby reducing angiotensin II formation."	0
Triamterene is a potassium-conserving (antikaliuretic) diuretic with relatively weak natriuretic properties.	0
"Signs and symptoms associated with more severe and/or acute cases have included hallucination, syncope, seizure, coma, respiratory arrest, and death."	0
The beta half-life (the terminal decline in plasma concentration) is approximately 10 hours.	0
"It has been suggested in regard to phenothiazines in general, that people who have demonstrated a hypersensitivity reaction (e.g., blood dyscrasias, jaundice) to one may be more prone to demonstrate a reaction to others."	0
"In extensive metabolizers (EMs), inhibitors of CYP2D6 (e.g., paroxetine, fluoxetine, and quinidine) increase atomoxetine steady-state plasma concentrations to exposures similar to those observed in poor metabolizers (PMs)."	1
Blood pressure should be followed closely in patients taking Marplan to detect any pressor response.	0
False-positive urine immunoassay screening tests for benzodiazepines have been reported in patients taking ZOLOFT.	0
"Anticoagulants and Antiplatelets Patients taking AGGRENOX in combination with anticoagulants, antiplatelets, or any substance impacting coagulation are at increased risk for bleeding."	0
"Because these events were reported voluntarily during clinical practice, estimates of frequency cannot be made."	0
"Possible contributing factors include use for extended periods of time, higher than recommended dose, and/or use in combination with other anorectic drugs."	0
In dogs intraduodenal doses of dipyridamole of 0.5 to 4.0 mg/kg produced dose-related decreases in systemic and coronary vascular resistance leading to decreases in systemic blood pressure and increases in coronary blood flow.	0
Continue high-dose steroids until signs and symptoms have abated for at least 3 days.	0
Results of a placebo-controlled trial in normal volunteers suggest that chronic administration of sertraline 200 mg/day does not produce clinically important inhibition of phenytoin metabolism.	0
No reports involved the administration of methylene blue by other routes (such as oral tablets or local tissue injection) or at lower doses.	0
"Viracept Oral Powder contains phenylalanine, a component of aspartame."	0
Vasodilators (peripheral): Intravenously administered Vincamine <U+2191> Vincamine Monitoring for vincamine toxicity is recommended.	0
Initiate intravenous sotalol therapy in the presence of personnel trained in the management of serious ventricular arrhythmias.	0
TWYNSTA Tablets The pharmacokinetics of amlodipine and telmisartan when combined are similar to the pharmacokinetics of amlodipine and telmisartan when administered separately.	0
"After a single 400 mg dose of [14C]-sofosbuvir in healthy subjects, the blood to plasma ratio of 14C-radioactivity was approximately 0.7."	0
HIV protease inhibitor: Atazanavira LEXIVA: Interaction has not been evaluated.	0
"Co-administration of SAMSCA with 400mg ketoconazole daily or with other strong CYP 3A inhibitors (e.g., clarithromycin, itraconazole, telithromycin, saquinavir, nelfinavir, ritonavir and nefazodone) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure."	1
"Marplan should not be administered together with, or in close proximity to, other MAO inhibitors or dibenzazepine-related entities."	0
This should be considered if determination of plasma corticosteroid levels is desired in a person receiving amphetamines.	0
Protriptyline has been found in some studies to have a more rapid onset of action than imipramine or amitriptyline.	0
"Because of the potential for tumorigenicity shown for procarbazine hydrochloride in animal studies, mothers should not nurse while receiving this drug."	0
"Intestinal MAO is predominantly type A, while in the brain both isoenzymes exist."	0
Contact local state professional licensing board or state controlled substances authority for information on how to prevent and detect abuse or diversion of this product.	0
"Alcohol - Although citalopram did not potentiate the cognitive and motor effects of alcohol in a clinical trial, as with other psychotropic medications, the use of alcohol by depressed patients taking Celexa is not recommended."	0
"Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior."	0
A high-tyramine meal is considered to contain up to 40mg of tyramine.	0
"Because HMG-CoA reductase inhibitors (statins) decrease cholesterol synthesis and possibly the synthesis of other biologically active substances derived from cholesterol, ZOCOR may cause fetal harm when administered to a pregnant woman."	0
"Angiotensin II also stimulates the secretion of aldosterone from the adrenal cortex, thereby facilitating renal sodium and fluid reabsorption."	0
Ethnicity - Exposure in subjects of African and Hispanic descent is similar to that in Caucasians.	0
Maximum platelet inhibition was about 80%.	0
There does not appear to be a benefit of stopping alpha-1 blocker therapy prior to cataract surgery.	0
"For the consolidation cycles, the recommended dose of TRISENOX is 0.15 mg/kg intravenously daily 5 days per week during weeks 1-4 of an 8-week cycle for a total of 4 cycles in combination with tretinoin."	0
"Therefore, drugs that affect CYP3A and/or P-gp may modify the pharmacokinetics of saquinavir."	0
"Therefore, an increase in the metabolism of CYP1A2 substrates (e.g., theophylline, caffeine) resulting from induction is not anticipated, although clinical studies of induction have not been performed."	0
"Following oral administration of 10 mg of apixaban as 2 crushed 5 mg tablets suspended in 30 mL of water, exposure was similar to that after oral administration of 2 intact 5 mg tablets."	0
"Thereafter, the dosage may be increased gradually over the next several weeks, up to a maximum of 250 mg daily."	0
The prescribed dose of NORVIR oral powder can be administered via a feeding tube after being mixed with water.	0
"Based on its mechanism of action, CAPRELSA can cause fetal harm when administered to a pregnant woman."	0
"In asthmatic patients, metoprolol reduces FEV1 and FVC significantly less than a nonselective beta-blocker, propranolol, at equivalent beta1-receptor blocking doses."	0
The NS5B S282T substitution associated with resistance to sofosbuvir was not detected in the baseline NS5B sequence of any subject in Phase 3 trials by population or deep nucleotide sequence analysis.	0
Shake the vial until all the powder is dissolved.	0
Whether antipsychotic drug products differ in their potential to cause tardive dyskinesia is unknown.	0
"In many cases, this hyponatremia appears to be the result of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)."	0
"Absorption In humans, CLOZARIL tablets (25 mg and 100 mg) are equally bioavailable relative to a CLOZARIL solution."	0
"<U+2022>when coadministered with ritonavir in patients receiving the antiarrhythmic agents, flecainide and propafenone."	0
"Literature suggests that concomitant use of PPIs with methotrexate (primarily at high dose; see methotrexate prescribing information) may elevate and prolong serum concentrationsof methotrexate and/or its metabolite, possibly leading to methotrexate toxicities."	1
Concomitant use of drugs labeled as having a strong inhibitory effect on CYP3A4 is contraindicated.	0
Increase to 40 mg once daily based upon individual tolerability.	0
"Therefore, when these drugs are administered concurrently, dosage adjustment of paroxetine after the 20 mg starting dose should be guided by clinical effect."	0
"There were significant reductions in systemic blood pressure, pulmonary artery pressure, pulmonary capillary wedge pressure, and heart rate."	0
Caution should be exercised when TENORMIN is administered to a nursing woman.	0
"In healthy subjects, prasugrel decreased exposure to hydroxybupropion, a CYP2B6-mediated metabolite of bupropion, by 23%, an amount not considered clinically significant."	1
Hepatic Impairment: The pharmacokinetics of AMBIEN in eight patients with chronic hepatic insufficiency were compared to results in healthy subjects.	0
"In the cases of prodrugs whose actions are actually mediated by P450IID6<U+2013>produced metabolites (for example, codeine and hydrocodone, whose analgesic and antitussive effects appear to be mediated by morphine and hydromorphone, respectively), it may not be possible to achieve the desired clinical benefits in poor metabolizers."	0
The mean dose for completers was 178 mg/day.	0
"Therefore, this combination provides a convenient formulation for the concomitant administration of these two entities."	0
"Particular caution should be used when prescribing sildenafil, tadalafil or vardenafil in patients receiving ritonavir."	0
<U+2022>Lithium: Increases in serum lithium concentrations and toxicity (7).	1
The impact of moderate (Child-Pugh Class B) or severe (Child-Pugh Class C) hepatic impairment on the pharmacokinetics of doxazosin is not known.	0
"In more than half of the cases, protease inhibitors was continued or reintroduced (5.5) Fat redistribution: observed with antiretroviral therapy (5.6) Immune reconstitution syndrome: reported with combination antiretroviral therapy, including VIRACEPT."	0
"Tasigna may result in hepatotoxicity as measured by elevations in bilirubin, AST/ALT, and alkaline phosphatase."	0
Plasma concentration of angiotensin II and plasma renin activity (PRA) increased in a dose-dependent manner after single administration of telmisartan to healthy subjects and repeated administration to hypertensive patients.	0
"Use with caution in combination with other drugs that prolong the QT interval (4.2, 5.11, 7.7, 7.8)."	0
Consider discontinuation of treatment in patients with newly diagnosed Ph+ CML-CP who have: <U+25CF> been treated with Tasigna for at least 3 years <U+25CF> maintaineda molecular response of at least MR4.0(corresponding to = BCR-ABL/ABL <U+2264>0.01% IS)for one year prior to discontinuation of therapy <U+25CF> achieved an MR4.5 for the last assessment taken immediately prior to discontinuation of therapy <U+25CF> been confirmed to express the typical BCR-ABL transcripts (e13a2/b2a2 or e14a2/b3a2) <U+25CF> no history of accelerated phase or blast crisis <U+25CF> no history of prior attempts of treatment-free remission discontinuation that resulted in relapse.	0
The same caution should be observed in patients with hepatic dysfunction secondary to congestive heart failure.	0
"Increased plasma concentrations of terfenadine, astemizole, cisapride, and pimozide are associated with QT prolongation and with rare cases of serious cardiovascular adverse events, including death, due principally to ventricular tachycardia of the torsade de pointes type."	0
"Dilute to 1 mg/mL, i.e., 1 mL (25 mg) mixed with 24 mL of saline."	0
"Tolerance to the antihypertensive effect may develop in some patients, necessitating a reevaluation of therapy."	0
"Patients with evidence of renal functional impairment (blood urea nitrogen [BUN] levels over 30 mg per 100 mL or serum creatinine levels over 1.5 mg per 100 mL) or diabetes mellitus should not receive the drug without careful, frequent and continuing monitoring of serum electrolytes, creatinine, and BUN levels."	0
Subsequent doses may be given by the same route if necessary.	0
GI motility agents: Cisapride POTENTIAL for serious and/or life-threatening reactions such as cardiac arrhythmias.	0
Careful monitoring of prothrombin time in patients receiving DIFLUCAN and coumarin-type anticoagulants is recommended.	0
"In patients without such a history, the incidence of stroke was 0.9% (0.2% ICH) and 1.0% (0.3% ICH) with Effient and clopidogrel, respectively."	0
These results should not be extrapolated to other P-gp inhibitors.	0
"Decreased exposure of some antiretroviral drugs (e.g., rilpivirine atazanavir, and nelfinavir) when used concomitantly with pantoprazole may reduce antiviral effect and promote the development of drug resistance."	0
"There is no known treatment for established cases of tardive dyskinesia, although the syndrome may remit, partially or completely, if antipsychotic treatment is withdrawn."	0
"Adults: 10 mg/kg, in a single daily administration, not to exceed 600 mg/day, oral or IV Pediatric Patients: 10<U+2013>20 mg/kg, not to exceed 600 mg/day, oral or IV It is recommended that oral rifampin be administered once daily, either 1 hour before or 2 hours after a meal with a full glass of water."	0
Avoid concomitant administration of voriconazole and fluconazole.	0
Pediatric Dosage Guidelines for Oral Solution NORVIR oral solution should not be administered to neonates before a postmenstrual age (first day of the mother<U+2019>s last menstrual period to birth plus the time elapsed after birth) of 44 weeks has been attained.	0
"Plasma concentrations of ramiprilat decline in a triphasic manner (initial rapid decline, apparent elimination phase, terminal elimination phase)."	0
The pharmacokinetics of losartan and its active metabolite are linear with oral losartan doses up to 200mg and do not change over time.	0
"Vagolysis<U+2014>Because quinidine opposes the atrial and A<U+2013>V nodal effects of vagal stimulation, physical or pharmacological vagal maneuvers undertaken to terminate paroxysmal supraventricular tachycardia may be ineffective in patients receiving quinidine."	0
Cleviprex gives no protection against the effects of abrupt beta-blocker withdrawal.	0
Patients should be advised of the following issues and asked to alert their prescriber if these occur while taking PEXEVA<U+00AE> (paroxetine mesylate).	0
Most cases were isolated single values that did not appear clinically relevant and were rarely a cause for withdrawal.	0
1646 <U+2013>24 <U+2013>34 +8.6 <U+2013>38 <U+2013>29 <U+2013>16 40 mg b.i.d.	0
Severe hypotension and/or increased fluid volume requirements have been reported in patients receiving PROCARDIA together with a beta-blocking agent who underwent coronary artery bypass surgery using high dose fentanyl anesthesia.	0
"DYAZIDE may produce an elevated blood urea nitrogen (BUN) level, creatinine level, or both."	0
The concomitant use of PRISTIQ with other desvenlafaxine-containing products or venlafaxine will increase desvenlafaxine blood levels and increase dose-related adverse reactions.	1
"Obtain a liver test panel (serum alanine aminotransferase [ALT], aspartate aminotransferase [AST], alkaline phosphatase, and total bilirubin) as a baseline before initiating ULORIC."	0
Monitor blood pressure and adjust dose accordingly.	0
"Cardiac Electrophysiology The effect of venlafaxine on the QT interval was evaluated in a randomized, double-blind, placebo- and positive-controlled three-period crossover thorough QT study in 54 healthy adult subjects."	0
"Electrolyte imbalance, often encountered in such conditions as heart failure, renal disease, or cirrhosis of the liver, may also be aggravated by diuretics and should be considered during therapy with DYAZIDE when using high doses for prolonged periods or in patients on a salt-restricted diet."	0
Patients 60 years or older appear to exhibit greater than expected INR response to the anticoagulant effects of warfarin.	0
"Any <U+03B2>-hemolytic streptococcal isolate found to be non-susceptible to penicillin should be re-identified, retested, and, if confirmed, submitted to a public health authority.2,4 <U+2264>0.12 <U+2212> <U+2212> <U+2265>24 <U+2212> <U+2212> Streptococcus spp., Viridans Group <U+2264>0.12 0.25<U+2013>2 <U+2265>4 <U+2212> <U+2212> <U+2212> Bacillus anthracis B. anthracis strains may contain inducible <U+03B2>-lactamases."	0
Prompt medical or surgical treatments may need to be considered if the intraocular pressure remains uncontrolled.	0
"When neuraxial anesthesia (spinal/epidural anesthesia) or spinal/epidural puncture is employed, patients treated with antithrombotic agents for prevention of thromboembolic complications are at risk of developing an epidural or spinal hematoma which can result in long-term or permanent paralysis."	0
Adjust dosage according to blood pressure response after 2<U+2013>4 weeks of treatment.	0
Both peak plasma levels (Cmax) and area under the curve (AUC) are dose proportional for doses of 25 mg to 100 mg and less than proportional at doses above 100 mg.	0
"Follow-up was at least 6 months, with a mean of about 14 months."	0
"Dosage adjustments for patients taking CYP2D6 inhibitors, CYP3A4 inhibitors, or CYP3A4 inducers for greater than 14 days"	0
"Teriflunomide, an immunomodulatory agent with anti-inflammatory properties, inhibits dihydroorotate dehydrogenase, a mitochondrial enzyme involved in de novo pyrimidine synthesis."	0
ROZEREM is not known to interfere with commonly used clinical laboratory tests.	0
Antihypertensive Agents: Enhanced antihypertensive effect.	0
"Interaction with Combined P-gp and Strong CYP3A4 Inhibitors Avoid concomitant administration of XARELTO with known combined P-gp and strong CYP3A4 inhibitors (e.g., ketoconazole and ritonavir) [see Warnings and Precautions (5.6) and Clinical Pharmacology (12.3)]."	0
"Chronically administered beta-blocking therapy should not be routinely withdrawn prior to major surgery, however, the impaired ability of the heart to respond to reflex adrenergic stimuli may augment the risks of general anesthesia and surgical procedures."	0
"If this drug is used during pregnancy or if the patient becomes pregnant while taking the drug, the patient should be informed of the potential hazard to the fetus"	0
It is recommended that liver enzyme tests be obtained prior to initiating therapy with atorvastatin and repeated as clinically indicated.	0
The intracellular concentration of potassium is approximately 150 to 160 mEq per liter.	0
Getting up slowly may help lessen the problem.	0
"The net effect will vary depending on the relative affinity of the co-administered drugs for CYP 3A and P-gp, and the extent of intestinal first-pass metabolism/efflux."	0
Refrigerate at 2<U+00B0>C to 8<U+00B0>C (36<U+00B0>F to 46<U+00B0>F) if not used immediately.	0
"Blood Urea Nitrogen (BUN): In heart failure trials, greater than 50% increases in BUN were observed in 16.6% of Diovan-treated patients compared to 6.3% of placebo-treated patients."	0
Dose conversion Dose (mg/hour) Dose (mL/hour) 1 2 2 4 4 8 6 12 8 16 10 20 12 24 14 28 16 32 18 36 20 40 22 44 24 48 26 52 28 56 30 60 32 64 Maintain aseptic technique while handling Cleviprex.	0
The concurrent administration of an MAO inhibitor and bupropion hydrochloride (Wellbutrin<U+00AE>) is contraindicated.	0
Apixaban is a substrate of both CYP3A4 and P-gp.	0
"Additionally, nebivolol did not significantly alter the protein binding of the following drugs: diazepam, digoxin, diphenylhydantoin, hydrochlorothiazide, imipramine, or warfarin at their therapeutic concentrations."	0
Specific Populations Renal Impairment:A single 20 mg oral dose of pravastatin was administered to 24 patients with varying degrees of renal impairment (as determined by creatinine clearance).	0
"The more concentrated 1600 mcg/mL or 3200 mcg/mL solutions, may be preferred in patients with fluid retention or when a slower rate of infusion is desired."	0
"Although it is not proven that the medications caused these events, these urges were reported to have stopped in some cases when the dose was reduced or the medication was stopped."	0
The AUC of the active N-monodesmethyl metabolite of rizatriptan was not affected by propranolol.	0
Cleviprex contains approximately 0.2 g of lipid per mL (2.0 kcal).	0
"This decrease in half-life, presumably due to enzyme induction by smoking, is consistent with other drugs with similar hepatic clearance characteristics."	0
"Doxepin, the active ingredient in Silenor, is an antidepressant at doses 10- to 100-fold higher than in Silenor."	0
Fluconazole is a potent CYP2C9 inhibitor and a moderate CYP3A4 inhibitor.	0
"There is evidence that patients with a history of hepatic encephalopathy due to cirrhosis have increased sensitivity to the CNS effects of chlorpromazine (i.e., impaired cerebration and abnormal slowing of the EEG)."	0
Very little warfarin is excreted unchanged in urine.	0
"The hazards of trandolapril are generally independent of dose; those of verapamil are a mixture of dose-dependent phenomena (primarily dizziness, AV block, constipation) and dose-independent phenomena, the former much more common than the latter."	0
Clinical use of verapamil in digitalized patients has shown the combination to be well tolerated if digoxin doses are properly adjusted.	0
Quinaprilat concentrations are reduced in patients with alcoholic cirrhosis due to impaired deesterification of quinapril.	0
"PROTONIX Delayed-Release Tablets Swallow PROTONIX Delayed-Release Tablets whole, with or without food in the stomach."	0
"Avoid concomitant use of XARELTO with drugs that are combined P-gp and strong CYP3A4 inducers ( e.g. , carbamazepine , phenytoin , rifampin , St.   John 's   wort ) see Warnings and Precautions ( 5.6 ) and Clinical Pharmacology ( 12.3 ) ."	0
Studies involving single 40 g doses of ethanol (oral administration in one study and intravenous in the other) and multiple dosing with fluvoxamine maleate (50 mg b.i.d.) revealed no effect of either drug on the pharmacokinetics or pharmacodynamics of the other.	0
"As peak olanzapine levels are not typically obtained until about 6 hours after dosing, charcoal may be a useful treatment for olanzapine overdose."	0
Amitriptyline inhibits the membrane pump mechanism responsible for uptake of norepinephrine and serotonin in adrenergic and serotonergic neurons.	0
There is a risk of ototoxic effects if cisplatin and LASIX are given concomitantly .	0
Monitor patients closely when CLOZARIL is coadministered with these inhibitors.	0
"Because the majority of these patients had confounding medical conditions and/or were receiving concomitant therapy(ies), a causal relationship between CRIXIVAN and these events has not been established."	0
Hepatic injury: DIFLUCAN should be administered with caution to patients with liver dysfunction.	0
The diagnostic evaluation of patients with this syndrome is complicated.	0
"There is little difference in relative bioavailability when PROCARDIA capsules are given orally and either swallowed whole, bitten and swallowed, or bitten and held sublingually."	0
<U+25CF>Simultaneous use of strong dual inducers of CYP3A4 and P-gp reduces blood levels of apixaban: Avoid concomitant use.	1
Loading doses for each age group are given in Table 1 below.	0
Study 3 was a 12-week study with flexible dosing of sertraline hydrochloride in a range of 50 to 200 mg/day; the mean dose for completers was 185 mg/day.	0
"Age, Gender, Race/Ethnicity Nesiritide clearance was not influenced significantly by age, gender, or race/ethnicity."	0
"Simvastatin occasionally causes myopathy manifested as muscle pain, tenderness or weakness with creatine kinase (CK) above tentimes the upper limit of normal (ULN)."	0
Protein binding of GS-331007 was minimal in human plasma.	0
Use a volumetric infusion pump to infuse intravenous sotalol at a constant rate.	0
Cases of lithium toxicity and increased serotonergic effects have been reported.	0
"Olmesartan medoxomil is not metabolized by the cytochrome P450 system and has no effects on P450 enzymes; thus, interactions with drugs that inhibit, induce, or are metabolized by those enzymes are not expected."	0
No evidence of carcinogenic potential was seen in mice dosed up to 25 mg/kg/day (85 mg/m2/day) or rats dosed up to 8 mg/kg/day (60 mg/m2/day).	0
"In a study of treatment-na<U+00EF>ve patients, 20.3% (21/100 PEY) experienced Grade 3 or 4 hepatic transaminase elevations while receiving APTIVUS/ritonavir 500 mg/200 mg through week 48."	0
"In treatment-experienced subjects in Study ION-2 whose virus had baseline NS5A polymorphisms at resistance-associated positions, relapse rates were 22% (5/23) after 12 weeks and 0% (0/19) after 24 weeks of treatment with HARVONI."	0
Increased tacrolimus levels have been associated with nephrotoxicity.	0
These events can occur in hypnotic-naive as well as in hypnotic-experienced persons.	0
"Warning signs or symptoms of fluid and electrolyte imbalance include dryness of the mouth, thirst, weakness, lethargy, drowsiness, restlessness, muscle pains or cramps, muscular fatigue, hypotension, oliguria, tachycardia, and gastrointestinal disturbances such as nausea and vomiting."	0
Patients taking Marplan should not undergo elective surgery requiring general anesthesia.	0
A causal relationship between protease inhibitor therapy and these events has not been established.	0
Endothelin receptor antagonists: Bosentan <U+2193> atazanavir<U+2191> bosentan Plasma concentrations of atazanavir may be decreased when bosentan is administered with REYATAZ without ritonavir.	1
"Physostigmine is not recommended except to treat life-threatening symptoms that have been unresponsive to other therapies, and then only in consultation with a poison control center."	0
Use of PDE5 inhibitors for the treatment of erectile dysfunction: It is recommended not to exceed the following doses: Sildenafil: 25 mg every 48 hours Tadalafil: 10 mg every 72 hours Vardenafil: 2.5 mg every 72 hours Use with increased monitoring for adverse events.	0
Diethylpropion hydrochloride is not recommended in patients with known heart murmur or valvular heart disease.	0
"Patients receiving coadministration of ACE inhibitor and mTOR (mammalian target of rapamycin) inhibitor (e.g., temsirolimus, sirolimus, everolimus) therapy or a neprilysin inhibitor may be at increased risk for angioedema."	0
An increase of less than 20% of the AUC of terbinafine was observed when LAMISIL Tablets were administered with food.	1
"Acute Hemodynamic Effects Acute intravenous infusions of FLOLAN for up to 15minutes in patients with idiopathic or heritable PAH or PAH/SSD produce dose<U+2011>related increases in cardiac index (CI) and stroke volume (SV) and dose<U+2011>related decreases in pulmonary vascular resistance (PVR), total pulmonary resistance (TPR), and mean systemic arterial pressure (SAPm)."	0
The absorption of hydrochlorothiazide is somewhat slower (1 to 2.5 hours) and more complete (50% to 80%).	0
Such patients may be unresponsive to the usual doses of epinephrine used to treat the allergic reaction.	0
Results of the interaction study with cisapride indicate that sertraline 200 mg (q.d.) induces the metabolism of cisapride (cisapride AUC and Cmax were reduced by about 35%).	1
Benicar tablets and the suspension formulation prepared from Benicar tablets are bioequivalent.	0
"When REYATAZ with ritonavir is coadministered with either phenytoin or phenobarbital, a dose adjustment of phenytoin or phenobarbital may be required."	0
Patients should be given the opportunity to discuss the contents of the Medication Guide and to obtain answers to any questions they may have.	0
"Where there is involvement of the tongue, glottis, or larynx likely to cause airway obstruction, administer appropriate therapy (e.g., subcutaneous epinephrine solution 1:1000 [0.3 mL to 0.5 mL]) promptly."	0
"In some cases, nephrolithiasis/urolithiasis has been associated with renal insufficiency or acute renal failure, pyelonephritis with or without bacteremia."	0
ECG monitoring is recommended in these patients.	0
Corticosteroid: Dexamethasone <U+2193>Amprenavir Use with caution.	0
LASIX has a tendency to antagonize the skeletal muscle relaxing effect of tubocurarine and may potentiate the action of succinylcholine .	0
"In patients with end-stage renal disease, exposure to the active metabolite (both Cmax and AUC (0-tlast)) was about half that in healthy controls and patients with moderate renal impairment."	0
"When drugs whose metabolism is P450IID6<U+2013>dependent are given to poor metabolizers, the serum levels achieved are higher, sometimes much higher, than the serum levels achieved when identical doses are given to extensive metabolizers."	0
Subjects with multiple NS5A polymorphisms at resistance-associated positions appeared to have higher relapse rates.	0
"Human BNP binds to the particulate guanylate cyclase receptor of vascular smooth muscle and endothelial cells, leading to increased intracellular concentrations of guanosine 3'5'-cyclic monophosphate (cGMP) and smooth muscle cell relaxation."	0
"The major metabolites of atropine are noratropine, atropin-n-oxide, tropine, and tropic acid."	0
Long-term maintenance effects of paroxetine in panic disorder were demonstrated in an extension to Study 1.	0
"Dosage adjustment of STRATTERA may be necessary when coadministered with potent CYP2D6 inhibitors (e.g., paroxetine, fluoxetine, and quinidine) or when administered to CYP2D6 PMs."	0
"There have been reports that an interaction exists when fluconazole is administered concomitantly with rifabutin, leading to increased serum levels of rifabutin up to 80%."	1
These data indicate that GILENYA is unlikely to reduce or increase the clearance of drugs cleared mainly by CYP3A4.	0
"In patients with hepatic insufficiency, metabolism is delayed and elimination half-life prolonged up to 14 to 16 hours ; the volume of distribution is increased and plasma clearance reduced to about 30% of normal."	0
The possibility of this complication may be reduced by remaining within the recommended limits of dosage.	0
"In ARISTOTLE, concomitant use of aspirin increased the bleeding risk on ELIQUIS from 1.8% per year to 3.4% per year and concomitant use of aspirin and warfarin increased the bleeding risk from 2.7% per year to 4.6% per year."	0
The change in furosemide clearance value is not likely to be clinically significant.	0
Dopamine should not be administered in the presence of uncorrected tachyarrhythmias or ventricular fibrillation.	0
"Oral voriconazole should be administered to these patients, unless an assessment of the benefit/risk to the patient justifies the use of intravenous voriconazole."	0
Multiple hepatic cytochrome P450 isoenzymes are involved in the oxidative biotransformation of a large number of structurally different drugs and endogenous compounds.	0
Saquinavir/ritonavir causes dose-dependent QT prolongation.	0
Persistent hyperkalemia may require dialysis.	0
"Because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to discontinue nursing or to discontinue hydrochlorothiazide, taking into account the importance of the drug to the mother."	0
"Potassium citrate extended-release tablets therapy does not alter the urinary saturation of calcium phosphate, since the effect of increased citrate complexation of calcium is opposed by the rise in pH-dependent dissociation of phosphate."	0
"Monitor blood cell counts periodically during treatment ( 2.2 ), ( 5.1 )."	0
Upward titration should be based on therapeutic efficacy and safety evaluated approximately eight hours after dosing.	0
"Itraconazole 200 mg QD 300 mg QD HIV-Infected patients (6) <U+2191>data from a case report <U+2193> AUC by 70%,<U+2193> Cmax by 75%, If co-administration of these two drugs cannot be avoided, patients should be monitored for adverse events associated with rifabutin administration, and lack of itraconazole efficacy."	0
The recommended dwell time is 8- to 16- hours.	0
"The incidence of these abnormalities was 0.2%, 0.2%, 0.6%, and 2.3% for 10, 20, 40, and 80 mg, respectively."	0
"Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapy, including LEXIVA."	0
"Generic Name Trademark (Manufacturer) Other MAO Inhibitors Furazolidone Furoxone<U+00AE> (Roberts Laboratories) Pargyline HCL Eutonyl<U+00AE> (Abbott Laboratories) Pargyline HCL and methyclothiazide Eutron<U+00AE> (Abbott Laboratories) Phenelzine sulfate Nardil<U+00AE> (Parke-Davis) Procarbazine Matulane<U+00AE> (Roche Laboratories) Tranylcypromine sulfate Parnate<U+00AE> (SmithKline Beecham Pharmaceuticals) Dibenzazepine-Related and Other Tricyclics Amitriptyline HCL Elavil<U+00AE> (Zeneca) Endep<U+00AE> (Roche Products) Perphenazine and amitriptyline HCL Etrafon<U+00AE> (Schering) Triavil<U+00AE> (Merck Sharp & Dohme) Clomipramine hydrochloride Anafranil<U+00AE> (Novartis) Desipramine HCL Norpramin<U+00AE> (Hoechst Marion Roussel) Pertofrane<U+00AE> (Rh<U+00F4>ne-Poulenc Rorer Pharmaceuticals) Imipramine HCL Janimine<U+00AE> (Abbott Laboratories) Tofranil<U+00AE> (Novartis) Nortriptyline HCL Aventyl<U+00AE> (Eli Lilly & Co.) Pamelor<U+00AE> (Novartis) Protripyline HCL Vivactil<U+00AE> (Merck Sharp & Dohme) Doxepin HCL Adapin<U+00AE> (Fisons) Sinequan<U+00AE> (Pfizer) Carbamazepine Tegretol<U+00AE> (Novartis) Cyclobenzaprine HCL Flexeril<U+00AE> (Merck Sharp & Dohme) Amoxapine Asendin<U+00AE> (Lederle) Maprotiline HCL Ludiomil<U+00AE> (Novartis) Trimipramine maleate Surmontil<U+00AE> (Wyeth-Ayerst Laboratories) The concurrent administration of a MAO inhibitor and buproprion hydrochloride (Wellbutrin<U+00AE>, and Zyban<U+00AE>, Glaxo Wellcome) is contraindicated."	0
"Within the physiologic pH range, amlodipine is an ionized compound (pKa=8.6), and its kinetic interaction with the calcium channel receptor is characterized by a gradual rate of association and dissociation with the receptor binding site, resulting in a gradual onset of effect."	0
"Diuretics The effectiveness of diuretics in patients with underlying renal or cardiovascular disease may be diminished by the concomitant administration of aspirin due to inhibition of renal prostaglandins, leading to decreased renal blood flow and salt and fluid retention."	0
The incidence of epistaxis was 13% in patients taking REVATIO with PAH secondary to CTD.	0
Monitor serum potassium in such patients.	0
"800 mcg/mL Dosing Chart for Dopamine (mL/hr) Infusion Rate Infusion rate (mcg/kg/min) Patient Body Weight (kg) 10 20 30 40 50 60 70 80 90 100 2.5 1.9 3.8 5.6 7.5 9.4 11.3 13.1 15 16.9 18.8 5 3.8 7.5 11.3 15 18.8 22.5 26.3 30 33.8 37.5 10 7.5 15 22.5 30 37.5 45 52.5 60 67.5 75 15 11.3 22.5 33.8 45 56.3 67.5 78.8 90 101.3 112.5 20 15 30 45 60 75 90 105 120 135 150 25 18.8 37.5 56.3 75 93.8 112.5 131.3 150 168.8 187.5 30 22.5 45 67.5 90 112.5 135 157.5 180 202.5 225 35 26.3 52.5 78.8 105 131.3 157.5 183.8 210 236.3 262.5 40 30 60 90 120 150 180 210 240 270 300 45 33.8 67.5 101.3 135 168.8 202.5 236.3 270 303.8 337.5 50 37.5 75 112.5 150 187.5 225 262.5 300 337.5 375 1600 mcg/mL Dosing Chart for Dopamine (mL/hr) Infusion Rate Infusion rate Patient Body Weight (kg) (mcg/kg/min) 10 20 30 40 50 60 70 80 90 100 2.5 0.9 1.9 2.8 3.8 4.7 5.6 6.6 7.5 8.4 9.4 5 1.9 3.8 5.6 7.5 9.4 11.3 13.1 15 16.9 18.8 10 3.8 7.5 11.3 15 18.8 22.5 26.3 30 33.8 37.5 15 5.6 11.3 16.9 22.5 28.1 33.8 39.4 45 50.6 56.3 20 7.5 15 22.5 30 37.5 45 52.5 60 67.5 75 25 9.4 18.8 28.1 37.5 46.9 56.3 65.6 75 84.4 93.8 30 11.3 22.5 33.8 45 56.3 67.5 78.8 90 101.3 112.5 35 13.1 26.3 39.4 52.5 65.6 78.8 91.9 105 118.1 131.3 40 15 30 45 60 75 90 105 120 135 150 45 16.9 33.8 50.6 67.5 84.4 101.3 118.1 135 151.9 168.8 50 18.8 37.5 56.3 75 93.8 112.5 131.3 150 168.8 187.5 3200 mcg/mL Dosing Chart for Dopamine (mL/hr) Infusion Rate Infusion rate Patient Body Weight (kg) (mcg/kg/min) 10 20 30 40 50 60 70 80 90 100 2.5 0.5 0.9 1.4 1.9 2.3 2.8 3.3 3.8 4.2 4.7 5 0.9 1.9 2.8 3.8 4.7 5.6 6.6 7.5 8.4 9.4 10 1.9 3.8 5.6 7.5 9.4 11.3 13.1 15 16.9 18.8 15 2.8 5.6 8.4 11.3 14.1 16.9 19.7 22.5 25.3 28.1 20 3.8 7.5 11.3 15 18.8 22.5 26.3 30 33.8 37.5 25 4.7 9.4 14.1 18.8 23.4 28.1 32.8 37.5 42.2 46.9 30 5.6 11.3 16.9 22.5 28.1 33.8 39.4 45 50.6 56.3 35 6.6 13.1 19.7 26.3 32.8 39.4 45.9 52.5 59.1 65.6 40 7.5 15 22.5 30 37.5 45 52.5 60 67.5 75 45 8.4 16.9 25.3 33.8 42.2 50.6 59.1 67.5 75.9 84.4 50 9.4 18.8 28.1 37.5 46.9 56.3 65.6 75 84.4 93.8 Parenteral drug products should be visually inspected for particulate matter and discoloration prior to administration, whenever solution and container permit."	0
Such an effect was observed in one study following the concomitant administration of verapamil and prazosin.	0
In vitro studies indicated that CYP3A4 and -2C19 are the primary enzymes involved in the metabolism of escitalopram.	0
Refer to the WARNINGS section for information regarding patients with hepatic insufficiency.	0
Administration of guanethidine to patients receiving an MAO inhibitor can produce moderate to severe hypertension due to release of catecholamines.	0
Paliperidone may antagonize the effect of levodopa and other dopamine agonists.	0
"If syncope occurs, the patient should be placed in the recumbent position and treated supportively as necessary."	0
Triglyceride and cholesterol testing should be performed prior to initiating NORVIR therapy and at periodic intervals during therapy.	0
Geriatrics The influence of age on the pharmacokinetics of icodextrin and its metabolites was not assessed.	0
"In vitro studies in human liver microsomes showed that iloperidone does not substantially inhibit the metabolism of drugs metabolized by the following cytochrome P450 isozymes: CYP1A1, CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, or CYP2E1."	0
"Verapamil was not mutagenic in the Ames test in 5 test strains at 3 mg per plate, with or without metabolic activation."	0
"In the LIFE study, Black patients with hypertension and left ventricular hypertrophy had a lower risk of stroke on atenolol than on losartan potassium tablets."	0
"In the U.S. multicenter dose-response study, 120 mg orally once or twice a day (corresponding to 112.5 mg intravenous sotalol) was found to be the most effective dose in prolonging the time to ECG-documented symptomatic recurrence of AFIB/AFL."	0
Inducers of CYP3A4 and P-gp decrease exposure to apixaban and increase the risk of stroke and other thromboembolic events.	0
"After taking Silenor, patients should confine their activities to those necessary to prepare for bed."	0
On Day 3 of coadministration a transient 2-fold increase in AUC was noted that was no longer evident by Day 7.	0
Geriatric Patients The pharmacokinetics of telmisartan do not differ between the elderly and those younger than 65 years.	0
There are no adequate or well-controlled studies in pregnant women.	0
Patients should be monitored for the emergence of serotonin syndrome.	0
Dosage reduction for INVEGA<U+00AE> should be considered when INVEGA<U+00AE> is co-administered with valproate after clinical assessment.	1
"For patients currently taking PRADAXA, wait 12 hours (CrCl <U+2265>30 mL/min) or 24 hours (CrCl <30 mL/min) after the last dose of PRADAXA before initiating treatment with a parenteral anticoagulant."	0
Increased serum lithium and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ACE inhibitor therapy.	1
Treatment-na<U+00EF>ve patients initiating treatment with INVIRASE/ritonavir should receive a reduced starting dose of INVIRASE 500-mg twice daily with ritonavir 100-mg twice daily for the first 7 days of treatment followed by INVIRASE/ritonavir 1000/100 mg twice daily due to potential for an increased risk of PR and QT interval prolongation with the standard 1000/100-mg twice daily dose.	0
"Therefore, respiratory status should be monitored throughout treatment, and PROSTIN VR PEDIATRIC should be used where ventilatory assistance is immediately available."	0
"Because azole antifungal agents are also inhibitors of the CYP 3A4 enzymes and thus may likewise impair pimozide metabolism, ORAP is contraindicated in patients receiving the azole antifungal agents itraconazole and ketoconazole."	0
"Absorption Bicalutamide is well-absorbed following oral administration, although the absolute bioavailability is unknown."	0
"To achieve the necessary nitrate-free interval with immediate-release oral ISDN, it appears that at least one of the daily interdose intervals must be at least 14 hours long."	0
"For further recommendations, please refer to current, official product monographs of the protease inhibitor or contact the specific manufacturer."	0
"Although Tourette's Disorder most often has its onset between the ages of 2 and 15 years, information on the use and efficacy of ORAP in patients less than 12 years of age is limited."	0
Androgen sensitive prostatic carcinoma responds to treatment that decreases androgen levels.	0
A dose decrease may be needed for these drugs when co-administered with ritonavir.	0
"Swallow tablets whole without crushing, chewing or sucking."	0
"In 1 study, daily dosing of paroxetine 20 mg in patients stabilized on risperidone (4 to 8 mg/day) increased mean plasma concentrations of risperidone approximately 4-fold, decreased 9-hydroxyrisperidone concentrations approximately 10%, and increased concentrations of the active moiety (the sum of risperidone plus 9-hydroxyrisperidone) approximately 1.4-fold."	1
Thiothixene possesses certain chemical and pharmacological similarities to the piperazine phenothiazines and differences from the aliphatic group of phenothiazines.	0
Discontinuing clopidogrel 75-mg and initiating a prasugrel 10-mg maintenance dose with or without a prasugrel 60-mg loading dose results in a decrease of 14 percentage points in maximum platelet aggregation (MPA) by Day 7.	0
Serotonergic Drugs: See WARNINGS AND PRECAUTIONS (5.2).	0
TABLE III: MEVACOR vs. Cholestyramine (Percent Change from Baseline After 12Weeks) TREATMENT N TOTAL-C(mean) LDL-C(mean) HDL-C(mean) LDL-C/HDL-C(mean) TOTAL-C/HDL-C(mean) VLDL-C(median) TG.	0
"Examples of such drugs include benzodiazepines (e.g., diazepam, lorazepam), or an ultrashort acting barbiturate (e.g., thiopental or thiamylal)."	0
"Available data from clinical studies of benzodiazepines other than triazolam suggest a possible drug interaction with triazolam for the following: fluvoxamine, diltiazem, and verapamil."	0
"As with other tricyclic antidepressants, dose selection for an elderly patient should usually be limited to the smallest effective total daily dose."	0
Titrate the dose every 2 to 3 weeks until an acceptable serum phosphorus level is reached.	0
"Concurrent use of PURIXAN and aminosalicylate derivatives (e.g., olsalazine, mesalamine, or sulfasalazine) may inhibit the TPMT enzyme, resulting in an increased risk of bone marrow suppression."	0
"As with other ACE inhibitors, periodic monitoring of white blood cell counts in patients with collagen-vascular disease and/or renal disease should be considered."	0
"However, receptor blockade is often accompanied by a series of secondary alterations in central dopamine metabolism and function which may contribute to both pimozide<U+2019>s therapeutic and untoward effects."	0
"Nitritoid reactions (symptoms include facial flushing, nausea, vomiting and hypotension) have been reported rarely in patients on therapy with injectable gold (sodium aurothiomalate) and concomitant ACE Inhibitor therapy including ACEON."	0
Warfarin shows a volume of distribution of about 0.14 L/kg.	0
"Vasoconstrictive and positive inotropic agents : Because of the risk of reducing cardiac contractility in presence of high systemic vascular resistance , do not use BREVIBLOC to control tachycardia in patients receiving drugs that are vasoconstrictive and have positive inotropic effects , such as epinephrine , norepinephrine , and dopamine ."	0
"Examples paroxetine and fluoxetine (also serotonergic drugs), quinidine, ritonavir Alkalinizing Agents Clinical Impact Urinary alkalinizing agents can increase blood levels and potentiate the action of amphetamine."	1
TIKOSYN should not be used in patients with a baseline QT interval or QTc >440 msec (500 msec in patients with ventricular conduction abnormalities).	0
Dosage must be adjusted to the individual needs of each patient.	0
No food should be consumed for at least 2hours before and for at least 1 hour after the dose is taken.	0
"In healthy, male, Caucasian patients (n=24), coadministration of the potent CYP3A4 inhibitor ketoconazole (200 mg b.i.d. for 6.5 days) increased the peak plasma levels and the AUC of a single 30-mg dose of mirtazapine by approximately 40% and 50%, respectively."	1
For patients with CLCR <30 mL/min the dose of clarithromycin should be decreased by 75%.	1
"Hydrochlorothiazide was not genotoxic in vitro in the Ames mutagenicity assay of Salmonella typhimurium strains TA 98, TA 100, TA 1535, TA 1537, and TA 1538 and in the Chinese Hamster Ovary (CHO) test for chromosomal aberrations, or in vivo in assays using mouse germinal cell chromosomes, Chinese hamster bone marrow chromosomes, and the Drosophila sex-linked recessive lethal trait gene."	0
"The beta-blocking effect of sotalol is non-cardioselective, half maximal at oral doses of about 80 mg/day and maximal at oral doses between 320 and 640 mg/day."	0
"These are described in greater detail below: Oral hypoglycemicsCoumarin-type anticoagulantsPhenytoinCyclosporineRifampinTheophyllineTerfenadineCisaprideAstemizoleRifabutinVoriconazoleTacrolimusShort-acting benzodiazepinesTofacitinibTriazolamOral ContraceptivesPimozideQuinidineHydrochlorothiazideAlfentanilAmiodaroneAmitriptyline, nortriptylineAmphotericin BAzithromycinCarbamazepineCalcium Channel BlockersCelecoxibCyclophosphamideFentanylHalofantrineHMG-CoA reductase inhibitorsLosartanMethadoneNon-steroidal anti-inflammatory drugsPrednisoneSaquinavirSirolimusVinca AlkaloidsVitamin AZidovudine Clinically significant hypoglycemia may be precipitated by the use of DIFLUCAN with oral hypoglycemic agents; one fatality has been reported from hypoglycemia in association with combined DIFLUCAN and glyburide use."	0
Agents with non-selective <U+03B2>-blocking activity may provoke chest pain in patients with Prinzmetal<U+2019>s variant angina.	0
Hypersensitivity to either drug in the preparation or to other sulfonamide-derived drugs is a contraindication.	0
"In patients with compromised circulation, persistent vasospasm may result in gangrene or death."	0
Thiazides have also been shown to increase the responsiveness to tubocurarine.	0
"Drugs Metabolized by Cytochrome CYP3A4 An in vivo interaction study involving the coadministration under steady-state conditions of paroxetine and terfenadine, a substrate for cytochrome CYP3A4, revealed no effect of paroxetine on terfenadine pharmacokinetics."	0
Lovastatin is metabolized by CYP3A4 but has no CYP3A4 inhibitory activity; therefore it is not expected to affect the plasma concentrations of other drugs metabolized by CYP3A4.	0
"ACCURETIC is contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril)."	0
Starting Savella in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome.	0
WARNING: DRUG DEPENDENCE See full prescribing information for complete boxed warning.	0
Adjustment of calcium channel blocker dosage may be needed.	0
There were insufficient elderly patients to conduct subgroup analyses on the basis of age.	0
The efficacy and safety of treatment with more than one dose of MAXALT within 24 hours in pediatric patients 6 to 17 years of age have not been established.	0
Mild Hepatic Impairment (Child-Pugh Score Ranging from 5 to 6) LEXIVA should be used with caution at a reduced dosage of 700mg twice daily without ritonavir (therapy-naive) or 700mg twice daily plus ritonavir 100mg once daily (therapy-naive or protease inhibitor-experienced).	0
"Although controlled clinical studies to establish pediatric dosing schedules have not been conducted, the American Heart Association<U+2019>s Standards and Guidelines recommends a bolus dose of 1 mg/kg followed by an infusion rate of 30 mcg/kg/min."	0
"Following a single oral dose of radiolabeled drug, approximately 32% of the dose was excreted in the feces and approximately 67% was excreted in the urine."	0
"Clinical evidence of oropharyngeal candidiasis generally resolves within several days, but treatment should be continued for at least 2 weeks to decrease the likelihood of relapse."	0
"Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary)."	0
It should be noted that MARPLAN is not approved for use in treating bipolar depression.	0
Anyone considering the use of NORPRAMIN in a child or adolescent must balance the potential risks with the clinical need.	0
The pharmacologic profile of both drugs and the clinical experience suggest beneficial interactions.	0
"<U+2022>Strong CYP Inducers: Consider increasing BRINTELLIX dose when a strong CYP inducer (e.g., rifampin, carbamazepine, or phenytoin) is coadministered for more than 14 days."	1
"For the consolidation cycle, the recommended dose of TRISENOX is 0.15 mg/kg intravenously daily for 25 doses over a period of up to 5 weeks."	0
"In cases where discontinuation was judged necessary, the condition usually cleared within 3 to 4 days of drug withdrawal."	0
"Unlike the latter, atropine in clinical doses does not depress the central nervous system but may stimulate the medulla and higher cerebral centers."	0
WARNING: Suicidality and Antidepressant Drugs See full prescribing information for complete boxed warning.	0
"Because coronary artery disease is common and may be unrecognized, it may be prudent not to discontinue TENORETIC therapy abruptly even in patients treated only for hypertension."	0
"If coadministration is necessary, reduce the quetiapine dose to 1/6 of the current dose and monitor for quetiapine-associated adverse reactions."	1
<U+2022> Monitor renal function (5.4) and potassium levels (5.5).	0
"Carbamazepine is contraindicated with MAOIs, including selegiline."	0
"Serious, sometimes fatal, central nervous system (CNS) toxicity referred to as the <U+201C>serotonin syndrome<U+201D> has been reported with the combination of nonselective MAOIs and serotonergic drugs."	0
"There is a risk of fetal or neonatal jaundice, thrombocytopenia, and possibly other adverse reactions that have occurred in adults."	0
"Thus, the dose of TCAs may need to be reduced and plasma TCA concentrations may need to be monitored temporarily when fluoxetine is coadministered or has been recently discontinued."	1
ZOCOR therapy should be discontinued immediately if myopathy is diagnosed or suspected.	0
The potential for cross-sensitivity between drugs in the sulfonamide class and fosamprenavir is unknown.	0
"Imipramine in combination with zolpidem produced no pharmacokinetic interaction other than a 20% decrease in peak levels of imipramine, but there was an additive effect of decreased alertness."	0
Mercaptopurine is immunosuppressive and may impair the immune response to infectious agents or vaccines.	0
"In patients receiving thiazides, sensitivity reactions may occur with or without a history of allergy or bronchial asthma."	0
Fingolimod 1.25 mg was associated with a 5-fold increase in the use of rescue short acting beta-agonists.	0
CALAN reduces afterload and myocardial contractility.	0
"Upon evidence of hematologic or other toxicity , the drug should be discontinued until there has been satisfactory recovery, based on clinical evaluation and appropriate laboratory tests."	0
Dosage reduction and/or discontinuation of the diuretic and/or VASOTEC may be required .	0
"If satisfactory response has not been achieved at 300 mg q8h, and the patient tolerates mexiletine well, a dose of 400 mg q8h may be tried."	0
"Strong inhibitors of CYP3A4 (e.g., itraconazole, ketoconazole, posaconazole, voriconazole, clarithromycin, telithromycin, HIV protease inhibitors, boceprevir, telaprevir, nefazodone, erythromycin, and cobicistat-containing products), and grapefruit juice increase the risk of myopathy by reducing the elimination of lovastatin."	1
The effect of nefazodone on labor and delivery in humans is unknown.	0
"The results of these studies indicated that sertraline did not increase plasma concentrations of terfenadine, carbamazepine, or cisapride."	0
Cleft palate was increased in a dose-dependent fashion in fetuses of pregnant mice treated at oral doses of 50 to 200 mg/kg (about 0.2 to 0.8 times the maximum recommended human dose based on body surface area comparisons).	0
The net renal clearance is about 1 mL/min/kg in healthy adults.	0
"Patients with end stage renal disease may develop hypercalcemia when treated with calcium, including calcium acetate (PHOSLYRA)."	0
"Hypomagnesemia, symptomatic and asymptomatic, has been reported rarely in patients treated with PPIs for at least three months, in most cases after a year of therapy."	0
"If coadministration of simvastatin with diltiazem is required, limit the daily doses of simvastatin to 10 mg and diltiazem to 240 mg."	0
"Increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ACE inhibitors during therapy with lithium; therefore, frequent monitoring of serum lithium levels is recommended."	1
Lithium: Increases in serum lithium concentrations and lithium toxicity.	1
"If a diuretic is also used, the risk of lithium toxicity may be increased."	0
EMEND capsules Swallow capsules whole.	0
Addition of a low dose of hydrochlorothiazide (12.5mg) to losartan 50mg once daily resulted in placebo-adjusted blood pressure reductions of 15.5/9.2mmHg.	0
<U+2022>The recommended oral dosage of REYATAZ depends on the treatment history of the patient and the use of other coadministered drugs.	0
It is recommended that INR (international normalized ratio) be monitored.	0
Patients with hepatitis B or C are at increased risk of transaminase elevations.	0
Inform patients that opioids could cause a rare but potentially life-threatening condition resulting from concomitant administration of serotonergic drugs.	0
"There are, however, no adequate and well-controlled studies in pregnant women."	0
"Phenytoin<U+2014> When a single oral 30 mg dose of paroxetine was administered at phenytoin steady state (300 mg qd for 14 days), paroxetine AUC and T 1/2 were reduced (by an average of 50% and 35%, respectively) compared to paroxetine administered alone."	1
"In high-dose methotrexate administration, a temporary withdrawal of the PPI may be considered in some patients."	0
"In addition, pooled analysis of bupropion pharmacokinetic data from 90 healthy male and 90 healthy female volunteers revealed no sex-related differences in the peak plasma concentrations of bupropion."	0
"At clinically relevant concentrations, clevidipine and its metabolites do not inhibit or induce any CYP450 enzymes."	0
Overestimating the Meperidine Hydrochloride Injection dosage when converting patients from another opioid product can result in a fatal overdose with the first dose.	0
"Total plasma clearance of olmesartan is 1.3 L/h, with a renal clearance of 0.6 L/h."	0
Losartan potassium was negative in the microbial mutagenesis and V-79 mammalian cell mutagenesis assays and in the invitro alkaline elution and invitro and invivo chromosomal aberration assays.	0
The intake of water several (2 or 5) minutes after asenapine administration resulted in decreased asenapine exposure.	1
"Overall, maximum plasma concentrations of olmesartan were similar in young adults and the elderly."	0
Heart failure post-myocardial infarction: Starting dose of 2.5 mg twice daily.	0
<U+2022>Drugs highly dependent on CYP3A4 for clearance and for which elevated plasma levels may result in serious and/or life-threatening events.	1
Hypertension Therapy in most patients should be initiated with a single daily dose of 15 mg.	0
"Initiate treatment at 5 mg once daily, with or without tadalafil 20 mg once daily."	0
"In a second healthy volunteer study, ritonavir 600 mg twice daily decreased the AUC and Cmax of bupropion by 66% and 62%, respectively."	1
The mean elimination half-life is approximately 21 hours (CV 32%) after oral dosing of 30 mg tablets of paroxetine daily for 30 days.	0
Increase the infusion rate by 2.5 mg/hr to a maximum of 15 mg/hr until desired blood pressure reduction is achieved.	0
"At the first sign or symptom of impending cardiac failure, patients should be treated appropriately according to currently recommended guidelines, and the response observed closely."	0
"In rodents, AHA shows a dose-related change in pharmacokinetics; with increasing dose, there is an increase in the half-life and an increase in the percent of the administered dose recovered in urine as unchanged AHA."	0
Tamoxifen is a pro-drug requiring metabolic activation by CYP2D6.	0
The recommended initial dose for patients not receiving a diuretic is 2.5 mg once a day.	0
An individual patient may experience both early and late-onset diarrhea.	0
The volume of distribution (Vss) is approximately 21 liters.	0
The mechanism and long-term consequences of these events are currently unknown.	0
"For patients expected to be on prolonged treatment or who take PPIs with medications such as digoxin or drugs that may cause hypomagnesemia (e.g., diuretics), health care professionals may consider monitoring magnesium levels prior to initiation of PPI treatment and periodically."	0
There are no specific laboratory tests recommended.	0
"Nevertheless, patients should be periodically reassessed to determine the need for maintenance treatment."	0
"Risk factors for the development of hyperkalemia include renal insufficiency , diabetes mellitus , and the concomitant use of potassium-sparing diuretics , potassium supplements and/or potassium-containing salt substitutes , which should be used cautiously , if at all , with VASOTEC ( see Drug Interactions ) ."	0
The incidence of hypokalemia with the bisoprolol fumarate and HCTZ 6.25 mg combination (B/H) is significantly lower than with HCTZ 25 mg.	0
"The mean oral clearance of ambrisentan is 38 mL/min and 19 mL/min in healthy subjects and in PAH patients, respectively."	0
The drug is contraindicated during the acute recovery period after a myocardial infarction.	0
Patients receiving warfarin therapy should be carefully monitored when sertraline hydrochloride is initiated or discontinued.	0
"Some patients, especially those with evidence of coronary artery spasm, respond only to higher doses, more frequent administration, or both."	0
Adjust dosage according to blood pressure response.	0
"It is not a monoamine oxidase inhibitor, and it does not act primarily by stimulation of the central nervous system."	0
There is a low incidence of altered liver function or jaundice in patients treated with Marplan.	0
Do not administer TRISENOX to patients with ventricular arrhythmia or prolonged QTc.	0
"NORVIR is contraindicated in patients with known hypersensitivity (e.g., toxic epidermal necrolysis (TEN) or Stevens-Johnson syndrome) to ritonavir or any of its ingredients."	0
Resulting oligohydramnios can be associated with fetal lung hypoplasia and skeletal deformations.	0
6.Pour the entire contents of the pouch into the 4.6 mL of water in the mixing cup and snap the lid shut.	0
Rare cases of rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported with atorvastatin and with other drugs in this class.	0
"Monitoring for adverse events and toxicity related to voriconazole is recommended; especially, if voriconazole is started within 24 h after the last dose of fluconazole."	0
"As illustrated by a mass balance study of a single 1 mg oral dose of 14C-risperidone administered as solution to three healthy male volunteers, total recovery of radioactivity at 1 week was 84%, including 70% in the urine and 14% in the feces."	0
Verapamil is not removed by hemodialysis.	0
These risk differences (drug-placebo difference in the number of cases of suicidality per 1000 patients treated) are provided in Table 1.	0
Do not routinely withdraw chronic beta blocker therapy prior to surgery.	0
Diazepam <U+2014> Olanzapine did not influence the pharmacokinetics of diazepam or its active metabolite N-desmethyldiazepam.	0
"Avoid co-administration of CYP 3A inducers ( e.g. , rifampin , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine , St.   John 's   Wort ) with SAMSCA , as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment ."	1
"Lurasidone <U+2191>Lurasidone LEXIVA: If coadministration is necessary, reduce the lurasidone dose."	1
Activation of Mania/Hypomania: Use cautiously in patients with Bipolar Disorder.	0
Starting treatment with the lowest available dose of hydrochlorothiazide (12.5 mg) is therefore recommended.	0
Dronedarone inhibits in vivo the tubular secretion of creatinine a substrate of the organic cation transporter (OCT2).	0
"While the preoperative use of DEMSER in patients with pheochromocytoma is thought to decrease intraoperative problems with blood pressure control , DEMSER does not eliminate the danger of hypertensive crises or arrhythmias during manipulation of the tumor , and the alpha-adrenergic blocking drug , phentolamine , may be needed ."	0
"As the management is complex and changing, it is recommended that the physician contact a poison control center for current information on treatment."	0
"If rapid titration is considered medically appropriate, administer a loading dose based upon projected peak digoxin body stores."	0
The highest daily adult dose of sevelamer carbonate studied was 14 grams in CKD patients on dialysis.	0
"Smoking Status <U+2014> Olanzapine clearance is about 40% higher in smokers than in nonsmokers, although dosage modifications are not routinely recommended."	0
Other antiretrovirals: See prescribing information.	0
"Following oral administration of CLOZARIL 100 mg twice daily, the average steady-state peak plasma concentration was 319 ng/mL (range: 102 to 771 ng/mL), occurring at the average of 2.5 hours (range: 1 to 6 hours) after dosing."	0
"A safe and effective dose of NORVIR oral solution in this patient population has not been established (2.4, 5.2) Hepatotoxicity: Fatalities have occurred."	0
Do not start Savella in a patient being treated with linezolid or intravenous methylene blue because there is increased risk of serotonin syndrome.	0
Known hypersensitivity to product components.	0
"Hepatic Impairment Pharmacokinetics of a 2 mg eszopiclone dose were assessed in 16 healthy volunteers and in 8subjects with mild, moderate, and severe liver disease."	0
The effect of Cleviprex appears to plateau at approximately 25% of baseline systolic pressure.	0
"Because LATUDA is not a substrate for CYP1A2, smoking is not expected to have an effect on the pharmacokinetics of LATUDA."	0
"Furthermore, whenever one of these other drugs is withdrawn from co-therapy, an increased dose of tricyclic antidepressant may be required."	0
Pharmacokinetic measures indicating the magnitude of these interactions are presented in Figure 1 (impact of coadministered drugs on dronedarone) and Figure 2 (impact of dronedarone on coadministered drugs).	0
"Food does not affect the Cmax of duloxetine, but delays the time to reach peak concentration from 6 to 10 hours and it marginally decreases the extent of absorption (AUC) by about 10%."	1
"In continued therapy, gradually reduce dosage to the lowest effective maintenance level, after symptoms have been controlled for a reasonable period."	0
These studies have also shown that concurrent use of an NSAID or aspirin may potentiate this risk of bleeding.	0
Paroxetine is extensively metabolized and the metabolites are considered to be inactive.	0
"5.6) Acute exacerbation of coronary artery disease upon cessation of therapy: Do not abruptly discontinue (5.8) Electrolyte disturbances must be corrected (5.9) Monitor serum glucose in diabetic patients as sotalol may mask symptoms of hypoglycemia, or worsen hyperglycemia (5.12) Sotalol can cause serious ventricular arrhythmias, primarily Torsade de Pointes (TdP) type ventricular tachycardia, a polymorphic ventricular tachycardia associated with QTc prolongation."	0
In vitro studies indicate that the formation of ODV is catalyzed by CYP2D6; this has been confirmed in a clinical study showing that patients with low CYP2D6 levels (poor metabolizers) had increased levels of venlafaxine and reduced levels of ODV compared to people with normal CYP2D6 levels (extensive metabolizers).	0
The combination of MAO inhibitors and dextromethorphan has been reported to cause brief episodes of psychosis or bizarre behavior.	0
The mechanism for this effect is unknown.	0
No reports involved the administration of methylene blue by other routes (such as oral tablets or local tissue injection) or at lower doses.	0
Prolonged erections and priapism have been reported with alpha-1 blockers including prazosin in post marketing experience.	0
"Abnormal Bleeding: Use caution in concomitant use with NSAIDs, aspirin, warfarin or other drugs that affect coagulation (5.7)."	0
"When chlorpromazine is used with cancer chemotherapeutic drugs, vomiting as a sign of the toxicity of these agents may be obscured by the antiemetic effects of chlorpromazine."	0
"Potassium supplementation in the form of medication, potassium-containing salt substitutes or a potassium-rich diet should not be used with amiloride HCl except in severe and/or refractory cases of hypokalemia."	0
Cmax and AUC are each 4-fold greater in patients with Childs-Pugh A disease.	0
"Olmesartan has more than a 12,500-fold greater affinity for the AT1 receptor than for the AT2 receptor."	0
"The pooled analyses of placebo-controlled trials in adults with MDD or other psychiatric disorders included a total of 295 short-term trials (median duration of 2 months) of 11 antidepressant drugs in over 77,000 patients."	0
"However, compounds which inhibit DNA, RNA and/or protein synthesis might be expected to have adverse effects on gametogenesis."	0
"Signs and symptoms of hypersensitivity reactions may include fever, rash, urticaria, angioedema, hypotension, acute bronchospasm, conjunctivitis, thrombocytopenia, neutropenia, elevated liver transaminases or flu-like syndrome (weakness, fatigue, muscle pain, nausea, vomiting, headache, chills, aches, itching, sweats, dizziness, shortness of breath, chest pain, cough, syncope, palpitations)."	0
"Cutaneous and Systemic Lupus Erythematosus: Mostly cutaneous, new onset or exacerbation of existing disease; discontinue ACIPHEX and refer to specialist for evaluation (5.6)."	0
No pharmacokinetic difference was observed in patients with mild to severe renal impairment in comparison with patients with normal renal function.	0
"The mean apparent volume of distribution for fluvoxamine is approximately 25 L/kg, suggesting extensive tissue distribution."	0
"Additional monitoring, and in some cases anticipatory dose adjustment, may be indicated around the time of various changes to the patient including: normal development through childhood; concomitant drug use should be considered when adjusting the estimated digoxin dose ; new co-administration of an antibiotic, especially if the patient had required high doses of digoxin in order to achieve modest serum concentrations, raising the suspicion that a substantial fraction of administered digoxin was being destroyed by colonic bacteria; and changes in renal function. right arrow down arrow"	0
There have been reports of uveitis in patients to whom fluconazole and rifabutin were coadministered.	0
"Serious cases of dysphagia, bowel obstruction, and perforation have been associated with sevelamer use, some requiring hospitalization and surgery."	0
Plasma concentrations correlate with effect in both young and elderly patients.	0
<U+2022> Severe Skin Reactions: Discontinue if severe rash develops.	0
"Co-administration with APTIVUS/ritonavir may result in an increase in PDE-5 inhibitor-associated adverse events, including hypotension, syncope, visual disturbances, and priapism."	0
It is desirable to monitor TCA plasma levels whenever a TCA is going to be co-administered with another drug known to be an inhibitor of P450 2D6.	0
"Tranquilizers/ Anti-depressants Due to metabolism via the CYP enzyme system, there have been reports that verapamil may increase the concentrations of buspirone, midazolam, almotriptan and imipramine."	1
"P-gp inducers rifampin: Avoid coadministration with PRADAXA (5.5) P-gp inhibitors in patients with CrCl 30-50 mL/min: Reduce dose or avoid (7) P-gp inhibitors in patients with CrCl <30 mL/min: Not recommended (7) The concomitant use of PRADAXA with P-gp inducers (e.g., rifampin) reduces exposure to dabigatran and should generally be avoided."	1
Do not co-administer aliskiren with ALTACE in patients with diabetes (4).	0
"As CYP 1A2 may also contribute to the metabolism of pimozide, prescribers should be aware of the theoretical potential for drug interactions with inhibitors of this enzymatic system."	0
"CYP 2D6 inhibitors: In healthy subjects, co-administration of pimozide 2 mg (single dose) and paroxetine 60 mg resulted in a 151% increase in pimozide AUC and a 62% increase in pimozide Cmax compared to pimozide administered alone."	1
Approximately 50% of the participants treated with MEVACOR were titrated to 40mg daily when their LDL<U+2011>C remained >110mg/dL at the 20<U+2011>mg starting dose.	0
"Abnormal thinking, behavioral changes, complex behaviors: May include ""Sleep-driving"" and hallucinations."	0
"Anti-infectives Clarithromycin, erythromycin, halofantrine, pentamidine Potential for serious and/or life-threatening cardiac arrhythmia."	0
"<U+2022>Hemophilia: Spontaneous bleeding may occur, and additional factor VIII may be required."	0
"Consideration should be given to changing the therapeutic regimen, including possibly discontinuing the medication, in patients whose depression is persistently worse, or who are experiencing emergent suicidality or symptoms that might be precursors to worsening depression or suicidality, especially if these symptoms are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
"Nadolol/Metoprolol: In a drug interactions study, effects of multiple doses of nadolol 80 mg or metoprolol 100 mg every 12 hours on the pharmacokinetics of a single dose of 10 mg rizatriptan were evaluated in healthy subjects (n=12)."	0
Paliperidone is metabolized to a limited extent by CYP2D6.	0
Anafranil should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.	0
"As with other dialysis solutions, blood concentrations of dialyzable drugs may be reduced by dialysis."	0
Inhibitors of the CYP3A4 isoenzyme could increase systemic dofetilide exposure.	1
AMBIEN is converted to inactive metabolites that are eliminated primarily by renal excretion.	0
"In a 24-month carcinogenicity study in rats, animals received up to 50 times the maximum recommended human dose."	0
"For more information specific to antibacterial agents (clarithromycin and amoxicillin) indicated for use in combination with ACIPHEX, refer to Warnings and Precautions sections of the corresponding prescribing information."	0
"These symptoms may also be accompanied by diarrhea, rash, fever, malaise, myalgias, elevations in liver enzymes, and occasionally, hypotension."	0
PDE-5 inhibitors Sildenafil (Revatio) [for treatment of pulmonary arterial hypertension] A safe and effective dose has not been established when used with APTIVUS/ritonavir.	0
Non-nucleoside reverse transcriptase inhibitor: Delavirdine <U+2191> Saquinavir Effect on delavirdine is not well established Appropriate doses of the combination with respect to safety and efficacy have not been established.	0
"There is increased potential for sildenafil-associated adverse events (which include visual disturbances, hypotension, prolonged erection, and syncope)."	0
"Fluconazole did not affect the fertility of male or female rats treated orally with daily doses of 5, 10, or 20 mg/kg or with parenteral doses of 5, 25, or 75 mg/kg, although the onset of parturition was slightly delayed at 20 mg/kg PO."	0
"Testing: In treatment-experienced patients, treatment history genotypic and/or phenotypic testing is recommended prior to initiation of therapy with PREZISTA/ritonavir to assess drug susceptibility of the HIV-1 virus (2.1, 12.4) Monitor serum liver chemistry tests before and during therapy with PREZISTA/ritonavir."	0
The recommended dose of ELIQUIS is 2.5 mg taken orally twice daily after at least 6 months of treatment for DVT or PE.	0
Do not administer Letairis to a pregnant female because it may cause fetal harm.	0
"Several published observational studies in adults suggest that PPI therapy may be associated with an increased risk for osteoporosis-related fractures of the hip, wrist, or spine."	0
"Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs."	0
"An infusion of quinidine must be delivered slowly, preferable under control of a volumetric pump, no faster than 0.25 mg/kg/min (that is, no faster than 1 mL/kg/hour)."	0
"As noted below, a substantial pharmacokinetic interaction has been observed for fluvoxamine in combination with alprazolam, a drug that is known to be metabolized by the CYP3A4 isozyme."	0
Urinary excretion of calcium and phosphorus were not significantly increased with PHOSLYRA compared to calcium acetate gelcaps.	0
Cytochrome P450 enzymes are believed to play a major role in the metabolism of nisoldipine.	0
An FDA-authorized test with a detection limit below MR4.5 must be used to determine eligibility for discontinuation.	0
"Note that in these studies, doses were modified by results of creatinine clearance measurement and in-hospital QTc prolongation."	0
"If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to a fetus."	0
Caution is recommended during coadministration of any of these drugs with triazolam.	0
This results in fungal cell death primarily due to the increased membrane permeability mediated by the accumulation of high concentrations of squalene but not due to ergosterol deficiency.	0
"PROCARDIA may be safely co-administered with nitrates, but there have been no controlled studies to evaluate the antianginal effectiveness of this combination."	0
Fluphenazine decanoate has activity at all levels of the central nervous system (CNS) as well as on multiple organ systems.	0
"Anyone considering the use of PEXEVA<U+00AE> (paroxetine mesylate) or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need."	0
Chronic administration of nisoldipine results in a sustained decrease in vascular resistance and small increases in stroke index and left ventricular ejection fraction.	0
Patients receiving REYATAZ and tenofovir DF should be monitored for tenofovir-associated adverse reactions.	0
"Study 1, a 6-week trial in which patients received fixed Celexa doses of 10, 20, 40, and 60 mg/day, showed that Celexa at doses of 40 and 60 mg/day was effective as measured by the Hamilton Depression Rating Scale (HAMD) total score, the HAMD depressed mood item (Item 1), the Montgomery Asberg Depression Rating Scale, and the Clinical Global Impression (CGI) Severity scale."	0
Distribution: Fluvastatin is 98% bound to plasma proteins.	0
"The antihypertensive effect of angiotensin II receptor antagonists, including losartan, may be attenuated by NSAIDs, including selective COX-2 inhibitors."	0
There is a 3 hour delay in absorption and a one-third increase in apparent clearance of duloxetine after an evening dose as compared to a morning dose.	0
"This rate is an underestimate because of under reporting, and the true risk could be considerably greater than this."	0
"Avoid use of strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin) [see Clinical Pharmacology (12.3) ]."	0
"The mean tyramine pressor doses (TYR30) after administration of EMSAM 6mg per 24 hours for 9 and 33 days were 292mg and 204mg, respectively."	0
"Renal Disease <U+2014> In depressed patients on dialysis(N=12), fluoxetine administered as 20mg once daily for 2months produced steady-state fluoxetine and norfluoxetine plasma concentrations comparable with those seen in patients with normal renal function."	0
Adults with such abnormalities should also generally not be treated with stimulant drugs.	0
"If acceptable alternatives to linezolid or intravenous methylene blue treatment are not available and the potential benefits of linezolid or intravenous methylene blue treatment are judged to outweigh the risks of serotonin syndrome in a particular patient, nortriptyline hydrochloride oral solution USP should be stopped promptly, and linezolid or intravenous methylene blue can be administered."	0
The absolute bioavailability of telmisartan is dose dependent.	0
Intramuscular Pharmacokinetics Systemic Bioavailability: The bioavailability of ziprasidone administered intramuscularly is 100%.	0
"General Dosing Guidelines Patients who take the 600 mg twice daily soft gel capsule NORVIR dose may experience more gastrointestinal side effects such as nausea, vomiting, abdominal pain or diarrhea when switching from the soft gel capsule to the tablet formulation because of greater maximum plasma concentration (Cmax) achieved with the tablet formulation relative to the soft gel capsule."	0
"Flurazepam, like other central nervous system agents of the 1,4-benzodiazepine class, presumably exerts its effects by binding to stereo-specific receptors at several sites within the central nervous system (CNS)."	0
Plasma levels are linearly related to dose over a dose range of 15 to 80 mg.	0
PROTONIX For Delayed-Release Oral Suspension - Oral Administration in Apple Juice Open packet.	0
Patients receiving amlodipine and telmisartan from separate tablets may instead receive TWYNSTA tablets containing the same component doses once daily.	0
"When treating pregnant women with paroxetine during the third trimester, the physician should carefully consider the potential risks and benefits of treatment."	0
"Carbamazepine, Phenobarbital, Phenytoin: While not systemically studied, these drugs may induce metabolism of bupropion and may decrease bupropion exposure."	1
"After 2 weeks of consecutive nightly administration, the drug's effect on total wake time is decreased, and the values recorded in the last third of the night approach baseline levels."	0
Use with caution due to possible cardiac arrhythmias.	0
"Warfarin is essentially completely absorbed after oral administration, with peak concentration generally attained within the first 4 hours."	0
"Tablets must be swallowed whole with fluid and not divided, crushed, chewed, or dissolved."	0
A single-dose interaction study with zolpidem tartrate 10 mg and itraconazole 200 mg at steady-state levels in male volunteers resulted in a 34% increase in AUC0<U+2013><U+221E> of zolpidem tartrate.	1
"The antihypertensive effect of ACE inhibitors, including quinapril may be attenuated by NSAIDs."	0
Lurasidone is an antagonist with high affinity binding at the dopamine D2 receptors (Ki of 1 nM) and the serotonin 5-HT2A (Ki of 0.5 nM) and 5-HT7 (Ki of 0.5 nM) receptors.	0
Verapamil is not removed by hemodialysis.	0
"After oral administration, peak plasma concentrations are reached in 2.5 to 4 hours, and steady-state plasma concentrations are attained within 2-3 days (i.e., after 5-6 doses when administered twice daily)."	0
Use caution; monitor plasma TCA levels; reduce TCA dose if indicated (7.2).	1
Inform patients taking REVATIO not to take VIAGRA or other PDE-5 inhibitors.	0
Discard the vial if a vacuum does not pull the diluent into the vial.	0
"Diovan may be given with other standard post-myocardial infarction treatment , including thrombolytics , aspirin , beta-blockers , and statins ."	0
Dosing Considerations <U+2022>LEXIVA tablets may be taken with or without food.	0
"Nonrenal clearance includes hepatic metabolism and, to a lesser extent, biliary excretion."	0
These effects are thought to be due to an inhibition or delay in implantation which is also observed in rodents administered other antipsychotic drugs.	0
ECG monitoring should be considered in these patients.	0
Abuse with diethylpropion hydrochloride during pregnancy may result in withdrawal symptoms in the human neonate.	0
Causal relationship and relevance for clonidine oral tablets have not been established.	0
"If APTIVUS is co-administered with parenteral midazolam, close clinical monitoring for respiratory depression and/or prolonged sedation should be exercised and dosage adjustments should be considered."	0
VYVANSE is contraindicated in patients with: Known hypersensitivity to amphetamine products or other ingredients of VYVANSE.	0
Amlodipine Amlodipine is extensively metabolized by the liver and the plasma elimination half-life (t1/2) is 56 hours in patients with impaired hepatic function.	0
"Marked first-degree block or progressive development to second- or third-degree AV block requires a reduction in dosage or, in rare instances, discontinuation of verapamil HCl and institution of appropriate therapy, depending on the clinical situation."	0
"Co-administration with anticoagulants, antiplatelets, or NSAIDs can increase risk of bleeding (7.1) Decreased renal function can occur with co-administration with NSAIDs (7.1) Adenosine Dipyridamole has been reported to increase the plasma levels and cardiovascular effects of adenosine."	0
Hypercalcemia may aggravate digitalis toxicity.	0
"Do not start CAPRELSA treatment in patients whose QTcF interval is greater than 450 ms. Do not administer CAPRELSA to patients who have a history of Torsades de pointes, congenital long QT syndrome, bradyarrhythmias or uncompensated heart failure."	0
The maximum recommended total daily dose in children and adolescents over 70kg and adults is 100mg.	0
"Notwithstanding the known pharmacokinetic differences between pediatric patients and adults, pediatric patients in these trials received the same doses (on a mg/kg basis) as adults."	0
In vitro data suggest that fluvoxamine is a relatively weak inhibitor of CYP2D6.	0
Nicardipine administered intravenously increased hepatic venous pressure gradient by 4 mmHg in cirrhotic patients at high doses (5 mg/20 min) in one study.	0
"Prevention of hypokalemia: Typical dose is 20 mEq per day (2.2) If serum potassium concentration is less than 2.5 mEq/L, use intravenous potassium instead of oral supplementation."	0
"Other Agents Antiarrhythmics: Amiodarone, lidocaine (systemic), and quinidine <U+2191>Antiarrhythmics For contraindicated antiarrhythmics (flecainide, propafenone),."	0
<U+2022>clinically significant adverse reactions from greater exposures of REYATAZ with ritonavir.	1
"However, there is substantial evidence from placebo-controlled maintenance trials in adults with depression that the use of antidepressants can delay the recurrence of depression."	0
"PDE5 inhibitors such as sildenafil, vardenafil, and tadalafil have been shown to potentiate the hypotensive effects of organic nitrates."	0
"In patients with baseline hepatic impairment, starting at the low end of the PURIXAN dose range should be considered and patients should be monitored for toxicity."	0
"Carvedilol 16% 14% Conivaptan 33% 43% Diltiazem 20% NA Indomethacin 40% NA Nefazodone 27% 15% Nifedipine 45% NA Propantheline 24% 24% Quinine NA 33% Rabeprazole 29% 19% Saquinavir 27% 49% Spironolactone 25% NA Telmisartan 20 to 49% NA Ticagrelor 31% 28% Tolvaptan 30% 20% Trimethoprim 22 to 28% NA Digoxin Concentrations Increased, but Magnitude is Unclear Alprazolam, Azithromycin, Cyclosporine, Diclofenac, Diphenoxylate, Epoprostenol, Esomeprazole, Ibuprofen, Ketoconazole, Lansoprazole, Metformin, Omeprazole Measure serum digoxin concentrations before initiating concomitant drugs."	1
"Blood glucose monitoring devices using glucose dehydrogenase pyrroloquinolinequinone (GDH-PQQ), glucose-dye-oxidoreductase (GDO), or some glucose dehydrogenase flavin-adenine dinucleotide (GDH-FAD)-based methods must not be used."	0
No initial dosage adjustment of paroxetine is considered necessary when coadministered with phenobarbital; any subsequent adjustment should be guided by clinical effect.	0
Store at 20<U+00B0> to 25<U+00B0>C (68<U+00B0> to 77<U+00B0>F).	0
"Do not administer ALTACE within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor (4)."	0
Clinically relevant transporter inhibition by ledipasvir in the systemic circulation is not expected due to its high protein binding.	0
Ventavis has the potential to increase the hypotensive effect of vasodilators and antihypertensive agents ( 7.2 ) .	0
Patients in all studies had moderate to severe OCD (DSM-III or DSM-III-R) with mean baseline ratings on the Yale<U+2013>Brown Obsessive-Compulsive Scale (YBOCS) total score ranging from 23 to 25.	0
"Cholestyramine and colestipol resins - Cholestyramine and colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent, respectively."	1
"Based on these findings, the GILENYA 0.5 mg dose is appropriate for use in patients with renal impairment."	0
Concomitant use can increase the risk of bradycardia.	0
"Carcinogenesis, Mutagenesis, Impairment of Fertility: Data are not available on long-term potential for carcinogenicity, mutagenicity, or impairment of fertility."	0
"In a controlled clinical study for the reduction in the combined risk of cardiovascular death, stroke and myocardial infarction in hypertensive patients with left ventricular hypertrophy, 2857 patients (62%) were 65 years and over, while 808 patients (18%) were 75 years and over."	0
Neutropenic fever/neutropenic sepsis was reported in 6% of Asian patients compared to1% of Whitepatients.	0
"Potassium-sparing diuretics (spironolactone, amiloride, triamterene, and others) can increase the risk of hyperkalemia."	0
"For women who intend to become pregnant or are in their first trimester of pregnancy, paroxetine should only be initiated after consideration of the other available treatment options."	0
Increasing the dose of Tasigna when coadministered with such agents is not likely to compensate for the loss of exposure.	0
Reduce paroxetine dose by half when paroxetine is used in combination with SAPHRIS.	1
"Also, use extra care during exercise or hot weather, or if standing for long periods."	0
Similar results were obtained in patients receiving NORVASC and concomitant beta-blockers.	0
"While none of the drugs studied for drug interactions significantly affected the pharmacokinetics of fluvoxamine, an in vivo study of fluvoxamine single-dose pharmacokinetics in 13 PM subjects demonstrated altered pharmacokinetic properties compared to 16 <U+201C>extensive metabolizers<U+201D> (EM): mean Cmax, AUC, and half-life were increased by 52%, 200%, and 62%, respectively, in the PM compared to the EM group."	0
PRISTIQ should also not be started in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue.	0
"In clinical studies in hypertensive patients with unilateral or bilateral renal artery stenosis, increases in blood urea nitrogen and serum creatinine have been observed in some patients following ACE inhibitor therapy."	0
Average trough concentrations are 76%lower for fluoxetine and 47%lower for norfluoxetine than the concentrations maintained by 20 mg once-daily dosing.	0
"No unchanged alprostadil has been found in the urine, and there is no evidence of tissue retention of alprostadil or its metabolites."	0
The mechanism of action of the antihypertensive response of BYSTOLIC has not been definitively established.	0
There may be quantitative differences between various established methods for aPTT assessment.	0
Patients should also take aspirin (75-mg to 325-mg) daily (2).	0
"In clinical trials, STRATTERA use was associated with an increased risk of mydriasis and therefore its use is not recommended in patients with narrow angle glaucoma."	0
"In addition, such patients may experience a worsening of psychiatric status."	0
PROCARDIA selectively inhibits calcium ion influx across the cell membrane of cardiac muscle and vascular smooth muscle without changing serum calcium concentrations.	0
An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy.	0
"Presumably due to the inhibition of the degradation of endogenous bradykinin, persistent nonproductive cough has been reported with all ACE inhibitors, resolving after discontinuation of therapy."	0
"In patients with liver dysfunction, a dosage adjustment may be required."	0
The beta-blocking effects also tended to be greater in the smaller children (BSA<0.33m2).	0
"The antihypertensive effect of ACE inhibitors, including trandolapril may be attenuated by NSAIDs."	0
"The monoamine oxidase inhibitory effects of Marplan may persist for a substantial period after discontinuation of the drug, and this should be borne in mind when another drug is prescribed following Marplan."	0
"If AGGRENOX is used during pregnancy, or if the patient becomes pregnant while taking AGGRENOX, inform the patient of the potential hazard to the fetus."	0
Thorough QTc Study ADASUVE did not prolong the QTc interval.	0
Avoid abrupt withdrawal of FLOLAN or sudden large reductions in infusion rates.	0
Do not coadminister aliskiren with AVAPRO in patients with diabetes.	0
The pharmacokinetics of amlodipine are not significantly influenced by renal impairment.	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP should be administered in a dose of 1 mL intravenously, intramuscularly or subcutaneously."	0
"Since PURIXAN is supplied with 1 mL and 5 mL oral dispensing syringes, provide appropriate instructions regarding which syringe to use and how to administer a specified dose."	0
Dose adjustment for digoxin is not recommended.	0
"Consider alternatives to fluticasone propionate, particularly for long-term use."	0
The cleavage of the dabigatran etexilate by esterase-catalyzed hydrolysis to the active principal dabigatran is the predominant metabolic reaction.	0
"There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on suicide."	0
Cimetidine increases nicardipine plasma levels (7.3).	1
"In a pooled analysis of multiple short-term, placebo-controlled studies, such symptoms occurred in about 0.2% (4 patients with reactions out of 1939 exposed to atomoxetine for several weeks at usual doses) of atomoxetine-treated patients compared to 0 out of 1056 placebo-treated patients."	0
Creatinine: Minor elevations in creatinine occurred in 0.8% of patients taking Diovan and 0.6% given placebo in controlled clinical trials of hypertensive patients.	0
"Identified metabolites of warfarin include dehydrowarfarin, two diastereoisomer alcohols, and 4<U+2032>-, 6-, 7-, 8-, and 10-hydroxywarfarin."	0
ULORIC is an XO inhibitor.	0
"Chronic verapamil treatment can increase serum digoxin levels by 50 to 75% during the first week of therapy, and this can result in digoxin toxicity."	1
"OTC Medications To Avoid Cold and cough preparations (including those containing dextromethorphan)Nasal decongestants (tablets, drops, or spray)Hay-fever medicationsSinus medicationsAsthma inhalant medicationsAntiappetite medicinesWeight-reducing preparations""Pep"" pillsL-tryptophan containing preparations Also, certain prescription drugs should be avoided."	0
"However, greater sensitivity of some older individual patients cannot be ruled out."	0
Imipramine and Other Tricyclic Antidepressants (TCAs) - In vitro studies suggest that citalopram is a relatively weak inhibitor of CYP2D6.	0
TENORMIN is an additional treatment to standard coronary care unit therapy.	0
This finding could not be explained on the basis of differences in the populations other than race or on any imbalances between treatment groups.	0
Marked decreases in hemoglobin (>15% decrease from baseline resulting in a value below the lower limit of normal) were observed in 7% of all patients receiving Letairis (and 10% of patients receiving 10 mg) compared to 4% of patients receiving placebo.	0
Dipyridamole can be dosed without restriction as long as there is no evidence of hepatic failure.	0
Consult the labeling of concomitantly used drugs to obtain further information about interactions with PPIs.	0
Phendimetrazine tartrate is contraindicated during pregnancy because weight loss offers no potential benefit to a pregnant woman and may result in fetal harm.	0
The maximum dose is not recommended to exceed three times the original dose.	0
Exacerbation of insomnia or the emergence of new cognitive or behavioral abnormalities may be the consequence of an unrecognized psychiatric or physical disorder.	0
"ACCURETIC can cause symptomatic hypotension, probably not more frequently than either monotherapy."	0
The conversion is likely through esterase activity (the esterases have not been identified) and is not CYP mediated.	0
"Canrenone , a major ( and active ) metabolite of ALDACTONE , appears in human breast milk ."	0
The potential for drug interactions with LEXIVA changes when LEXIVA is coadministered with the potent CYP3A4 inhibitor ritonavir.	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
Some of these reactions occurred in patients without known coronary artery disease (CAD).	0
History of thrombocytopenia with prior exposure to AGGRASTAT.	0
Patients should be asked to report pregnancies to their physicians as soon as possible.	0
"Reduced plasma concentrations of atazanavir are expected if proton-pump inhibitors, antacids, buffered medications, or H2-receptor antagonists are administered with REYATAZ."	1
Nefazodone has not been evaluated or used to any appreciable extent in patients with a recent history of myocardial infarction or unstable heart disease.	0
Cardiovascular Effects <U+2013> Modest orthostatic decreases in blood pressure and modest tachycardia were each seen in approximately 20% of patients taking Anafranil in clinical trials; but patients were frequently asymptomatic.	0
One patient developed psychosis in association with the hallucinations.	0
Reduction of diastolic pressure in these patients may worsen rather than improve myocardial oxygen balance.	0
Other drugs that are CYP3A substrates DapsoneDisopyramideQuinine Potential for serious and/or life-threatening cardiac arrhythmia.	0
Approximately 70% of circulating inhibitory activity for HMG-CoA reductase is attributed to active metabolites.	0
"The maximum early effect on exercise tolerance occurs with doses of 50 to 100 mg, but at these doses the effect at 24 hours is attenuated, averaging about 50% to 75% of that observed with once a day oral doses of 200 mg."	0
Reduced susceptibility to sofosbuvir was associated with the NS5B substitution S282T in all replicon genotypes examined.	0
Loss of therapeutic effect of APTIVUS/ritonavir and possible development of resistance.	0
"Nevertheless, the physician who elects to use Focalin XR for extended periods in patients with ADHD should periodically reevaluate the long-term usefulness of the drug for the individual patient with periods off medication to assess the patient<U+2019>s functioning without pharmacotherapy."	0
"In such patients, Meperidine Hydrochloride Injection must be used with extreme caution and only if its use is deemed essential."	0
Quetiapine has no appreciable affinity at cholinergic muscarinic and benzodiazepine receptors (IC50s > 5000 nM).	0
ACCURETIC should be used with caution in patients with severe renal disease.	0
"However, the QT effect was not systematically evaluated in a thorough QT study."	0
"The development of a potentially life-threatening serotonin syndrome has been reported with serotonin norepinephrine reuptake inhibitors (SNRIs) and SSRIs, including NORPRAMIN, alone but particularly with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, and St. John's Wort) and with drugs that impair metabolism of serotonin (in particular, MAOIs both those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue)."	0
"After oral administration, a 3-fold increase in mean Cmax and AUC values at steady-state is expected in poor metabolizers of CYP2D6 administered with strong CYP3A4 inhibitors."	0
Refer to the package insert for lithium preparations before use of such preparations with ZIAC.	0
Hyperuricemia or acute gout may be precipitated in certain patients receiving thiazide diuretics.	0
"Fluconazole increases Cmax and AUC of zidovudine by 84% and 74%, respectively, due to an approximately 45% decrease in oral zidovudine clearance."	1
"For patients currently receiving a parenteral anticoagulant, start PRADAXA 0 to 2 hours before the time that the next dose of the parenteral drug was to have been administered or at the time of discontinuation of a continuously administered parenteral drug (e.g., intravenous unfractionated heparin)."	0
An M289L substitution developed along with the S282T substitution in genotype 5 and 6 replicons.	0
Perindoprilat clearance by dialysis ranged from about 40 to 90 mL/min.	0
"Compared to healthy subjects with normal renal function, patients with severe renal impairment had 69% and 37% higher mean AUC and Cmaxvalues, respectively, and a 0.61 hour shorter t<U+00BD>for the inactive enzymatic ring hydroxylation metabolite (SQ 31,945)."	0
"Hypokalemia is uncommon with DYAZIDE; but, should it develop, corrective measures should be taken such as potassium supplementation or increased intake of potassium-rich foods."	0
"In a separate clinical pharmacokinetic interaction study of healthy subjects, co-administration of ketoconazole, a strong inhibitor of CYP3A4, had no clinically meaningful effect on the pharmacokinetics of abiraterone."	0
"Published observational studies suggest that PPI therapy like PROTONIX may be associated with an increased risk of Clostridium difficile associated diarrhea, especially in hospitalized patients."	0
"The clearest drug-effect associations were for sternebral and vertebral anomalies in both species; cleft palate, adactyly, levocardia, dilation of cerebral ventricles, hydroureter, hydronephroses, and unossified metacarpal in the rat; and increased incidence of unossified calcaneum in the mouse."	0
"When administered chronically, prepare FLOLAN in a drug delivery reservoir appropriate for the infusion pump with a total reservoir volume of at least 100 mL, using 2vials of Sterile Diluent for FLOLAN or 2 vials of pH 12 STERILE DILUENT for FLOLAN."	0
"Dual inhibition of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia."	0
Studies of the effects of DYAZIDE (the triamterene/hydrochlorothiazide combination) or of triamterene alone on animal reproductive function have not been conducted.	0
"Table3: Incidence of Primary Endpoint Events Incidence Risk Reduction 95% C.I. p-Value Losartan Placebo Primary Composite Endpoint 43.5% 47.1% 16.1% 2.3% to 27.9% 0.022 Doubling of Serum Creatinine, ESRD and Death Occurring as a First Event Doubling of Serum Creatinine 21.6% 26.0% ESRD 8.5% 8.5% Death 13.4% 12.6% Overall Incidence of Doubling of Serum Creatinine, ESRD and Death Doubling of Serum Creatinine 21.6% 26.0% 25.3% 7.8% to 39.4% 0.006 ESRD 19.6% 25.5% 28.6% 11.5% to 42.4% 0.002 Death 21.0% 20.3% -1.7% -26.9% to 18.6% 0.884 The secondary endpoints of the study were change in proteinuria, change in the rate of progression of renal disease, and the composite of morbidity and mortality from cardiovascular causes (hospitalization for heart failure, myocardial infarction, revascularization, stroke, hospitalization for unstable angina, or cardiovascular death)."	0
"Amiloride HCl has also been administered for 104 weeks to male and female rats at doses up to 6 and 8 mg/kg/day (15 and 20 times the maximum daily dose for humans, respectively) and showed no evidence of carcinogenicity."	0
"Vaccines: Avoid live attenuated vaccines during, and for 2 months after stopping GILENYA treatment."	0
"Peak plasma concentrations occur within 2-4 hours of dosing with 2.5 to 20 mg, and mean peak values range from 9.0 ng/mL at 2.5 mg to 70 ng/mL at 20 mg. Once-daily dosing with bisoprolol fumarate results in less than twofold intersubject variation in peak plasma concentrations."	0
"To maintain optimum therapeutic blood levels, dosages of drugs metabolized by these enzymes may require adjustment when starting or stopping concomitantly administered rifampin."	0
Mexiletine appears in human milk in concentrations similar to those observed in plasma.	0
Peripheral lymphocyte count increases are evident within days of stopping fingolimod treatment and typically normal counts are reached within 1 to 2 months.	0
The cytochrome P450 isoenzymes are not involved in the metabolism of telmisartan.	0
"Therefore , the expected clinical effects of SAMSCA in the presence of rifampin and other inducers ( e.g. , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine and St.   John 's   Wort ) may not be observed at the usual dose levels of SAMSCA ."	0
Use caution and closely monitor for toxicities when administering CAPRELSA with drugs that are transported by OCT2.	0
Trandolapril Component Trandolapril can attenuate potassium loss caused by thiazide diuretics and increase serum potassium when used alone.	0
"In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, coadministration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including lisinopril, may result in deterioration of renal function, including possible acute renal failure."	0
"In the RE-LY trial, the median (10th to 90th percentile) trough aPTT in patients receiving the 150 mg dose was 52 (40 to 76) seconds."	0
"Quinapril hydrochloride was not carcinogenic in mice or rats when given in doses up to 75 or 100 mg/kg/day (50 or 60 times the maximum human daily dose, respectively, on a mg/kg basis and 3.8 or 10 times the maximum human daily dose on a mg/m2 basis) for 104 weeks."	0
Do not take anything less than one capsule or chewable tablet per day.	0
Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses.	0
Amlodipine The apparent volume of distribution of amlodipine is 21 L/kg.	0
"Therefore, monitor serum lithium levels during concomitant use."	0
Dosage adjustments should be made if indicated by the patient's clinical condition.	0
"At concentrations of 2<U+2013>5 mg/L (6.5<U+2013>16.2 <U+03BC>mol/L), the fraction of quinidine bound to plasma proteins (mainly to <U+03B1>1<U+2013>acid glycoprotein and to albumin) is 80<U+2013>88% in adults and older children, but it is lower in pregnant women, and in infants and neonates it may be as low as 50<U+2013>70%."	0
"Therefore, the initial dose should be one TENORETIC 50 tablet given once a day."	0
Studies in rats indicate that quinapril and its metabolites do not cross the blood-brain barrier.	0
"If blood pressure is not controlled by Benicar alone, a diuretic may be added."	0
Animal studies demonstrated that lovastatin crosses the blood-brain and placental barriers.	0
Lisinopril inhibits angiotensin converting enzyme (ACE) in human subjects and animals.	0
Patients treated withACIPHEX delayed-release tablets and warfarin concomitantly may need to be monitored for increases in INR and prothrombin time.	0
These risk differences (drug-placebo difference in the number of cases of suicidality per 1000 patients treated) are provided in Table 1.	0
Patients initiating therapy with INVIRASE/ritonavir: An ECG should be performed prior to initiation of treatment.	0
Steady-state plasma levels of amlodipine are reached after 7 to 8 days of consecutive daily dosing.	0
"Effect of other drugs on bosentan Figure 1 Figure 2 Hormonal contraceptives, including oral, injectable, transdermal, and implantable forms, may not be reliable when Tracleer is co-administered."	0
"Antiarrhythmics : The metabolism of quinidine , procainamide , flecainide can be inhibited by amiodarone ."	1
"Wh e n p re gnan c y is d etecte d, dis c on t inue Lo te nsin as so o n as poss i bl e."	0
BRILINTA inhibits the P-glycoprotein transporter; monitor digoxin levels with initiation of or change in BRILINTA therapy [see Clinical Pharmacology (12.3) ].	0
"Since there are no clinical data on administration of REVATIO to patients with veno-occlusive disease, administration of REVATIO to such patients is not recommended."	0
Invitro studies suggest that coadministration of cytochromeP450 inhibitors to PMs will not increase the plasma concentrations of atomoxetine.	0
Evaluation of the hypertensive patients should also include assessment of the renal function.	0
There was no evidence of tolerance development in the sleep laboratory parameters when patients were given temazepam nightly for at least 2 weeks.	0
The bioavailability of oral sotalol is between 90% and 100%.	0
"A study of healthy volunteers showed that the concomitant administration of flecainide and verapamil may have additive effects on myocardial contractility, AV conduction, and repolarization."	0
"(these studies used both drugs at steady state) In healthy male patients (n=18), phenytoin (200 mg daily) increased mirtazapine (30 mg daily) clearance about 2-fold, resulting in a decrease in average plasma mirtazapine concentrations of 45%."	0
"These include the active ACE inhibitor, perindoprilat (hydrolyzed perindopril), perindopril and perindoprilat glucuronides, dehydrated perindopril and the diastereoisomers of dehydrated perindoprilat."	0
Initiate treatment at 5 mg once daily (2.1).	0
More than 50% of adult patients have been satisfactorily maintained on doses less than 20 mcg/kg/min.	0
Rosuvastatin is a substrate for certain transporter proteins including the hepatic uptake transporter organic anion-transporting polyprotein 1B1 (OATP1B1) and efflux transporter breast cancer resistance protein (BCRP).	0
"Redistribution/accumulation of body fat including central obesity, dorsocervical fat enlargement (buffalo hump), facial wasting, peripheral wasting, breast enlargement, and ""cushingoid appearance"" have been observed in patients receiving antiretroviral therapy."	0
Reduce the dose of or discontinue NATRECOR<U+00AE> in patients who develop hypotension.	0
"Metabolism and elimination Desvenlafaxine is primarily metabolized by conjugation (mediated by UGT isoforms) and, to a minor extent, through oxidative metabolism."	0
Ritonavir is required with several REYATAZ dosage regimens.	0
"In a clinical trial database in which 41,413 patients were treated with ZOCOR, 24,747 (approximately 60%) of whom were enrolled in studies with a median follow-up of at least 4 years, the incidence of myopathy was approximately 0.03% and 0.08% at 20 and 40 mg/day, respectively."	0
"Plasma TCA concentrations may need to be monitored and the dose of TCA may need to be reduced, if a TCA is coadministered with PEXEVA<U+00AE> (paroxetine mesylate)."	1
No adjustment of dosage on the basis of gender is needed.	0
Cyclosporine or Itraconazole: Avoid concomitant use.	0
Safety and effectiveness in pediatric patients have not been established.	0
High doses of THIOLA<U+00AE> in experimental animals have been shown to interfere with maintenance of pregnancy and viability of the fetus.	0
Sildenafil: The results of one published study in HIV-infected men (n=6) indicated that coadministration of indinavir (800 mg every 8 hours chronically) with a single 25-mg dose of sildenafil resulted in an 11% increase in average AUC0-8hr of indinavir and a 48% increase in average indinavir peak concentration (Cmax) compared to 800 mg every 8 hours alone.	1
Elevated cholesterol and/or triglyceride levels have been observed in some patients taking saquinavir in combination with ritonavir.	0
"A single-dose interaction study with zolpidem tartrate 5 mg and ketoconazole, a potent CYP3A4 inhibitor, given as 200 mg twice daily for 2 days increased Cmax of zolpidem (30%) and the total AUC of zolpidem (70%) compared to zolpidem alone and prolonged the elimination half-life (30 %) along with an increase in the pharmacodynamic effects of zolpidem."	1
"Following oral administration of irbesartan, peak plasma concentrations of irbesartan are attained at 1.5 to 2 hours after dosing."	0
Pregnancy: Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during therapy.	0
The risk of hyperkalaemia increase when eplerenone is used in combination with an ACE inhibitor and/or an ARB.	0
"Encapsulating peritoneal sclerosis (EPS), sometimes fatal, is a complication of peritoneal dialysis therapy and has been reported in patients using EXTRANEAL."	0
Nuceloside reverse transcriptase inhibitor: Didanosine <U+2193>Saquinavir Clinical significance unknown.	0
"Hypertoxin producing strains of C. difficile cause increased morbidity and mortality, as these infections can be refractory to antimicrobial therapy and may require colectomy."	0
"No adequate, well-controlled studies have been conducted in pregnant women."	0
Therapy of ventricular arrhythmias is often initiated with a single IV bolus of 1.0 to 1.5 mg/kg at a rate of 25 to 50 mg/min. of lidocaine hydrochloride injection.	0
Symptoms associated with discontinuation of other SSRIs or SNRIs have been reported.	0
Case reports and epidemiological studies (case-control and cohort design) have demonstrated an association between use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding.	0
"Surgery/Anesthesia In patients undergoing major surgery or during anesthesia with agents that produce hypotension, Lotensin may block angiotensin II formation secondary to compensatory renin release."	0
"Dose maybe titrated at 1 to 2 week intervals, up to 8 mg once daily."	0
Quinidine should be given to a pregnant woman only if clearly needed.	0
"Alcohol Both alcohol and tadalafil, a PDE5 inhibitor, act as mild vasodilators."	0
"Once a stable prothrombin time has been documented, prothrombin times can be monitored at the intervals usually recommended for patients on coumarin anticoagulants."	0
"Nevertheless, plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice."	0
Controlled clinical trials of fluconazole did not include sufficient numbers of patients aged 65 and older to evaluate whether they respond differently from younger patients in each indication.	0
Dose titration: Double the dose at short (90 second) intervals initially.	0
(Figure 2) Figure 2 Remove the cap.	0
Mechanism of Action Rifampin inhibits DNA-dependent RNA polymerase activity in susceptible Mycobacterium tuberculosis organisms.	0
The volume of distribution for telmisartan is approximately 500 liters indicating additional tissue binding.	0
ALDACTONE reduces the vascular responsiveness to norepinephrine .	0
Concomitant use with beta blockers can increase the risk of bradycardia.	0
"Therefore, paliperidone is not expected to inhibit clearance of drugs that are metabolized by these metabolic pathways in a clinically relevant manner."	0
Visual Disturbance: difficulties with accommodation and blurring of vision have been reported with stimulant treatment.	0
"Therefore, increased monitoring of digoxin is recommended when initiating, adjusting, or discontinuing COREG."	0
"While maximum plasma concentrations of losartan and its active metabolite are approximately equal, the AUC of the metabolite is about 4times as great as that of losartan."	0
"Angioedema Head and Neck Angioedema: Angioedema of the face, extremities, lips, tongue, glottis and/or larynx, including some fatal reactions, have occurred in patients treated with angiotensin converting enzyme inhibitors, including PRINIVIL, at any time during treatment."	0
"Postmarketing cases of symptomatic bradycardia , some requiring pacemaker insertion and at least one fatal , have been reported when ledipasvir/sofosbuvir or sofosbuvir with simeprevir were initiated in patients on amiodarone ."	0
"Therefore, apixaban is not expected to alter the metabolic clearance of coadministered drugs that are metabolized by these enzymes."	0
"Sertraline hydrochloride was shown to be significantly more effective than placebo on change from baseline to endpoint on the CAPS, IES and on the Clinical Global Impressions (CGI) Severity of Illness and Global Improvement scores."	0
Drug Interactions: Use with Allopurinol: One of the pathways for inactivation of azathioprine is inhibited by allopurinol.	1
"Patients who develop symptoms such as exertional chest pain, unexplained syncope, or other symptoms suggestive of cardiac disease during stimulant treatment should undergo a prompt cardiac evaluation."	0
The mechanism of this pharmacodynamic interaction is not known.	0
"Abiraterone acetate (ZYTIGA) is converted in vivo to abiraterone, an androgen biosynthesis inhibitor, that inhibits 17 <U+03B1>-hydroxylase/C17,20-lyase (CYP17)."	0
Pharmacies that dispense Letairis must be certified with the program and must dispense to female patients who are authorized to receive Letairis.	0
No increase in the risk of overall congenital malformations was seen in the paroxetine-exposed infants.	0
"Nisoldipine does not appear to have significant negative inotropic activity in intact animals or humans, and did not lead to worsening of clinical heart failure in three small studies of patients with asymptomatic and symptomatic left ventricular dysfunction."	0
Rare cases of rhabdomyolysis with acute renal failure secondary to myoglobinuria have been reported.	0
Monitor toxicity when coadministering lidocaine with propofol.	1
Some patients required either initiation or dose adjustments of insulin or oral hypoglycemic agents for treatment of these events.	0
Clinical studies of CRIXIVAN did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
"Combined administration of racemic citalopram (40 mg/day for 14 days) and carbamazepine (titrated to 400 mg/day for 35 days) did not significantly affect the pharmacokinetics of carbamazepine, a CYP3A4 substrate."	0
"Prescriptions for Nardil should be written for the smallest quantity of tablets consistent with good patient management, in order to reduce the risk of overdose."	0
Distribution:Approximately 50% of the circulating drug is bound to plasma proteins.	0
"When pregnancy is detected, discontinue Lotensin as soon as possible."	0
"Age per se does not significantly alter the pharmacokinetics of sotalol, but impaired renal function in geriatric patients can increase the terminal elimination half-life, resulting in increased drug accumulation."	0
Titrate at 4-week intervals as needed and tolerated (2.1).	0
Antipsychotics Lurasidone Potential for serious and/or life-threatening reactions.	0
"The S-enantiomer is rapidly cleared relative to the R-enantiomer, with the R-enantiomer accounting for about 99% of total steady-state plasma levels."	0
"After oral administration of HARVONI, sofosbuvir is rapidly absorbed and subject to extensive first-pass hepatic extraction."	0
The dosage of SULAR must be adjusted to each patient's needs.	0
The apparent absolute oral bioavailabilityis 93%.	0
"The desethylation is catalyzed primarily by CYP3A4 with minor contribution by CYP2C8, 2C19, 2D6, and 2J2."	0
"In vitro studies with human liver microsomes show that dofetilide can be metabolized by CYP3A4, but it has a low affinity for this isoenzyme."	0
"If intolerable symptoms occur following a decrease in the dose or upon discontinuation of treatment, then resuming the previously prescribed dose may be considered."	0
"Advise patients to seek prompt medical attention in the event of sudden decrease or loss of hearing while taking PDE-5 inhibitors, including REVATIO."	0
"Amiloride HCl exerts its potassium sparing effect through the inhibition of sodium reabsorption at the distal convoluted tubule, cortical collecting tubule and collecting duct; this decreases the net negative potential of the tubular lumen and reduces both potassium and hydrogen secretion and their subsequent excretion."	0
Consider ACE inhibitor-induced cough in the differential diagnosis of cough.	0
"For detailed instructions regarding dose selection, see DOSAGE AND ADMINISTRATION."	0
There was no significant difference in the frequency of sustained (3 consecutive visits) elevated blood pressure.	0
"In studies conducted under the auspices of the National Toxicology Program, groups of rats were fed diets containing 0, 150, 300 or 600 ppm triamterene, and groups of mice were fed diets containing 0, 100, 200 or 400 ppm triamterene."	0
In vitro experiments did not provide an indication of CYP induction by fingolimod-phosphate.	0
"Carvedilol is more than 98% bound to plasma proteins, primarily with albumin."	0
This may lead to loss of therapeutic effect and possible development of resistance to VIRACEPT or other coadministered antiretroviral agents.	0
Resting heart rate is usually slightly reduced by diltiazem.	0
Administration into an umbilical arterial catheter is not recommended.	0
Grapefruit juice caused a 25% increase in exposure.	1
"A double-blind, placebo-controlled ambulatory blood pressure monitoring (ABPM) study was conducted to evaluate the effects of milnacipran (up to 200 mg/day) on blood pressure in 321 fibromyalgia patients."	0
There are no controlled clinical data assessing the lens available for treatment beyond three years.	0
No available chemical assay is sufficiently sensitive and specific to assess the in vivo human pharmacokinetics of epoprostenol.	0
Response during the open phase was defined as having achieved a HAM-D 17 total score of <U+2264>8 and a CGI-Improvement score of 1 or 2 at 2 consecutive visits beginning with week 6 of the 8 to 12 weeks in the open-label phase of the study.	0
Thrombocytopenia : Discontinue INTEGRILIN and heparin .	0
"Use only a clear, essentially colorless solution."	0
Therefore concomitant use of Savella with epinephrine and norepinephrine may be associated with paroxysmal hypertension and possible arrhythmia.	0
The information below is obtained from studies with oral aripiprazole.	0
Systemic bioavailability of pravastatin administered following a bedtime dose was decreased 60% compared to that following an AM dose.	0
"In some cases, a patient already receiving Lexapro therapy may require urgent treatment with linezolid or intravenous methylene blue."	0
"Consequently, concentrations of S-norfluoxetine at steady state were lower."	0
"When pregnancy is detected, discontinue TARKA as soon as possible."	0
"In patients at risk of excessive hypotension, therapy with ACCUPRIL should be started under close medical supervision."	0
Psychotic Symptoms: may be exacerbated in patients withpsychotic disorders.	0
Suspect bleeding in any patient who is hypotensive and has recently undergone invasive or surgical procedures (5.1).	0
VFEND is contraindicated in patients with known hypersensitivity to voriconazole or its excipients.	0
"Following recovery to Grade 1 diarrhea, resume ONIVYDE at a reduced dose."	0
"It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months."	0
"Specific Populations Age Compared with non-elderly adults, subjects 65 years and older had an increase of 41% in total exposure (AUC) and a slightly prolonged elimination of eszopiclone (t1/2 approximately 9hours)."	0
"Renal Impairment An open, parallel-group single-center study compared dabigatran pharmacokinetics in healthy subjects and patients with mild to moderate renal impairment receiving a single dose of PRADAXA 150 mg."	0
In vitro inhibition of HMG-CoA reductase by ortho- and parahydroxylated metabolites is equivalent to that of atorvastatin.	0
Three patients (<0.1%) treated with valsartan discontinued treatment for elevated liver chemistries.	0
The use of MAOIs intended to treat psychiatric disorders with LUVOX CR Capsules or within 14 days of stopping treatment with LUVOX CR is contraindicated because of an increased risk of serotonin syndrome.	0
Administration of olmesartan at least 4 hours prior to colesevelam hydrochloride decreased the drug interaction effect.	0
"In patients classified as bipolar the rate of manic episodes was 1.6% for nefazodone, 5.1% for the combined tricyclic-treated groups, and 0% for placebo-treated patients."	0
Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses.	0
The dose of digoxin should be based on clinical assessment but individual patient factors should be taken into consideration.	0
Initial therapy may be administered in divided doses or a single daily dose.	0
Patients who re-initiate Tasigna therapy should have their BCR-ABL transcript levels monitored monthly until previous major molecular response or MR 4.0 is re-established and every 12 weeks thereafter.	0
"MINIPRESS has been shown to be associated with decreased litter size at birth, 1, 4, and 21 days of age in rats when given doses more than 225 times the usual maximum recommended human dose."	0
These drugs should be coadministered with caution and frequent monitoring of serum lithium levels is recommended.	0
This should be reflected in more cautious dosing.	0
"If potassium supplementation is used, careful monitoring of the serum potassium level is necessary."	0
PRINIVIL attenuates potassium loss caused by thiazide-type diuretics.	0
Safety and effectiveness in pediatric patients have not been established.	0
"Use a 60-inch microbore non-di-(2-ethylhexyl)phthalate (DEHP) extension set with proximal antisyphon valve, low-priming volume (0.9 mL), and in-line 0.22-micron filter."	0
"Avoid use with strong inducers of CYP3A (e.g., rifampin, phenytoin, carbamazepine and phenobarbital) [see Clinical Pharmacology (12.3) ]."	0
"In the absence of excessive hypotension or significant deterioration of renal function, the dose may be increased at weekly intervals based on clinical and hemodynamic response."	0
36 <U+2013>24 <U+2013>32 +2 <U+2013>32 <U+2013>24 <U+2013>6 MEVACOR was compared to cholestyramine in a randomized open parallel study.	0
"Patients taking Amiodarone, Amlodipine or Ranolazine The dose of ZOCOR should not exceed 20mg/day."	1
"Although a causal link between the emergence of such symptoms and either the worsening of depression and/or the emergence of suicidal impulses has not been established, there is concern that such symptoms may represent precursors to emerging suicidality."	0
Patients with myocardial infarction or stroke within six months prior to randomization were excluded.	0
"If dosage must be increased, dividing the dose should be considered in order to achieve lower peak blood levels."	0
"Limit dosage and duration of concomitant use of benzodiazepines and opioids, and follow patients closely for respiratory depression and sedation."	0
"Fluphenazine differs from other phenothiazine derivatives in several respects: it is more potent on a milligram basis, it has less potentiating effect on CNS depressants and anesthetics than do some of the phenothiazines and appears to be less sedating, and it is less likely than some of the older phenothiazines to produce hypotension (nevertheless, appropriate cautions should be observed, see PRECAUTIONS and ADVERSE REACTIONS )."	0
"Based on simulation, a 4.5-fold increase in mean Cmax and AUC values at steady-state is expected when extensive metabolizers of CYP2D6 are administered with both strong CYP2D6 and CYP3A4 inhibitors."	0
Candesartan and its inactive metabolite do not accumulate in serum upon repeated once-daily dosing.	0
"Completion of Therapy Following use, the drained fluid should be inspected for the presence of fibrin or cloudiness, which may indicate the presence of peritonitis."	0
"Overall, steady-state asenapine pharmacokinetics are similar to single-dose pharmacokinetics."	0
Inhaled beta agonist:Salmeterol <U+2191> salmeterol Concurrent administration of salmeterol with CRIXIVAN is not recommended.	0
Hypertensive episodes have been observed during surgery in patients taking desipramine hydrochloride.	0
The safety of REVATIO is unknown in patients with bleeding disorders or active peptic ulceration.	0
"AngiotensinII [formed from angiotensinI in a reaction catalyzed by angiotensin converting enzyme (ACE, kininaseII)], is a potent vasoconstrictor, the primary vasoactive hormone of the renin-angiotensin system and an important component in the pathophysiology of hypertension."	0
Angle Closure Glaucoma: The pupillary dilation that occurs following use of many antidepressant drugs including Lexapro may trigger an angle closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy.	0
"Digoxin : When MICARDIS was co-administered with digoxin, median increases in digoxin peak plasma concentration (49%) and in trough concentration (20%) were observed."	1
The effectiveness and safety of REVATIO in the treatment of PAH secondary to sickle cell anemia has not been established.	0
It is recommended that the standard loading dose regimens be used but that the maintenance dose be halved in patients with mild to moderate hepatic cirrhosis (Child-Pugh Class A and B) receiving VFEND.	0
"Although sotalol is usually well-tolerated, monitor hemodynamics in patients with marginal cardiac compensation as deterioration in cardiac performance may occur."	0
Dosage of methadone may need to be increased when coadministered with VIRACEPT.	1
Dosing of TOPROL-XL should be individualized.	0
See dilution instructions in DOSAGE AND ADMINISTRATION section.	0
"Patients who use GILENYA and systemic ketoconazole concomitantly should be closely monitored, as the risk of adverse reactions is greater."	0
It is unknown whether the risk of suicidal ideation in pediatric patients extends to longer-term use.	0
"There is increased potential for sildenafil-associated adverse events (which include visual disturbances, hypotension, prolonged erection, and syncope)."	0
"Population pharmacokinetic analysis of schizophrenic patients enrolled in controlled clinical trials has not revealed evidence of any clinically significant pharmacokinetic interactions with benztropine, propranolol, or lorazepam."	0
<U+03B2>-phase serum half-lives of one to two hours were observed in azotemic patients with serum creatinine concentrations <3 mg/100 mL and ranged as high as 20 hours in anuric patients.	0
Clinical use of verapamil in digitalized patients has shown the combination to be well tolerated if digoxin doses are properly adjusted.	0
"Drugs that slow heart rate : Concomitant use of drugs with depressant effects on the sinus and AV node ( e.g. , digoxin , beta blockers , verapamil , diltiazem , ivabradine , clonidine ) can potentiate the electrophysiologic and hemodynamic effects of amiodarone , resulting in bradycardia , sinus arrest , and AV block ."	0
"Overall, these studies demonstrated mirtazapine to be superior to placebo on at least 3 of the following 4 measures: 21-Item Hamilton Depression Rating Scale (HDRS) total score; HDRS Depressed Mood Item; CGI Severity score; and Montgomery and Asberg Depression Rating Scale (MADRS)."	0
"When fluoxetine is withdrawn from the combination therapy, the iloperidone dose should be returned to the previous level."	0
Female patients of childbearing age should be told about the consequences of exposure to TARKA during pregnancy.	0
Plasma concentrations of perindoprilat in patients with impaired liver function were about 50% higher than those observed in healthy subjects or hypertensive patients with normal liver function.	0
"In clinical trials with angina patients alone, amlodipine therapy did not alter electrocardiographic intervals or produce higher degrees of AV blocks."	0
Thirty-two percent of the subjects had subtype 6a and 24% had subtype 6e.	0
"Hence, it is not recommended to co-administer saquinavir and PREZISTA, with or without ritonavir."	0
"Make sure no air is in the dispenser - if air is present, remove."	0
The apparent elimination phase corresponds to the clearance of free ramiprilat and has a half-life of 9<U+2013>18 hours.	0
Adjust dose of INVEGA<U+00AE> if necessary based on clinical assessment.	0
Benzodiazepines: See WARNINGS AND PRECAUTIONS (5.9).	0
"In most patients (>90%), this CYP2D6 isozyme is saturated early during paroxetine dosing."	0
Blood pressure response increases over the 8.5 - 34 mg daily dose range but adverse event rates also increase.	0
Carefully monitor patients receiving the two drugs concomitantly.	0
False-positive test results may be expected for several days following discontinuation of ZOLOFT.	0
"Because proper pH is necessary for stability, do not administer PROTONIX For Delayed-Release Oral Suspension in liquids other than apple juice, or foods other than applesauce."	0
Cardioversion has been used safely and effectively after oral CALAN.	0
"Emergency resuscitative equipment and drugs must be immediately available to manage possible adverse reactions involving the cardiovascular, respiratory, or central nervous system."	0
Patients who were responders on paroxetine during the 3-month double-blind phase and a 6-month extension on open-label paroxetine (20 to 60 mg/day) were randomized to either paroxetine or placebo in a 6-month double-blind relapse prevention phase.	0
"In vitro, propranolol appears to be displaced from its binding sites by diltiazem."	1
"The development of a potentially life-threatening serotonin syndrome has been reported with SNRIs and SSRIs, including LUVOX CR Capsules, alone but particularly with concomitant use of serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John<U+2019>s Wort), and with drugs that impair metabolism of serotonin (in particular, MAOIs, both those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue)."	0
"Warfarin Clinical Impact: Increased INR and prothrombin time in patients receiving PPIs, including pantoprazole , and warfarin concomitantly."	0
"PROTONIX For Delayed-Release Oral Suspension - Nasogastric (NG) Tube or Gastrostomy Tube Administration For patients who have a nasogastric tube or gastrostomy tube in place, PROTONIX For Delayed-Release Oral Suspension can be given as follows: Remove the plunger from the barrel of a 2 ounce (60 mL) catheter-tip syringe."	0
The NATRECOR<U+00AE> bolus must be drawn from the prepared infusion bag.	0
"VASOTEC is contraindicated in combination with a neprilysin inhibitor ( e.g. , sacubitril ) ."	0
"The safety and efficacy of venlafaxine therapy in combination with weight loss agents, including phentermine, have not been established."	0
Begin consolidation 3 to 6 weeks after completion of induction therapy.	0
"Drug Interactions: When given concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics - potentiation of orthostatic hypotension may occur."	0
Study 2 was a flexible-dose study comparing paroxetine (20 to 60 mg daily) with clomipramine (25 to 250 mg daily).	0
"Quinidine/quinine therapy was continued for 72 hours or until parasitemia had decreased to 1% or less, whichever came first."	0
Patient management should include laboratory evaluation of renal (particularly serum creatinine) and hepatic function (particularly liver function tests and bilirubin).	0
"Nefazodone hydrochloride tablets are also contraindicated in patients who have demonstrated hypersensitivity to nefazodone hydrochloride, its inactive ingredients, or other phenylpiperazine antidepressants."	0
Prescribe the least amount feasible to avoid intentional overdose.	0
"Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death."	0
Consider the potential for drug interactions prior to and during PREZISTA/ritonavir therapy; review concomitant medications during PREZISTA/ritonavir therapy; and monitor for the adverse reactions associated with the concomitant drugs.	0
Hydrochlorothiazide may alter glucose tolerance and raise serum levels of cholesterol and triglycerides.	0
"Coadministration of grapefruit juice increased the maximum plasma concentration of triazolam by 25%, increased the area under the concentration curve by 48%, and increased half-life by 18%."	1
"After the loading dose, the daily dose (according to indication) should be based on the following table: Creatinine Clearance (mL/min) Percent of Recommended Dose >50 100% <U+2264>50 (no dialysis) 50% Regular dialysis 100% after each dialysis Patients on regular dialysis should receive 100% of the recommended dose after each dialysis; on non-dialysis days, patients should receive a reduced dose according to their creatinine clearance."	0
Intervention: Decrease the dosage of a CYP2D6 substrate if needed with concomitant ZOLOFT use.	1
"If used together, limit CRESTOR dose to 10mg once daily."	0
"In vitro studies have shown that sertraline has no significant affinity for adrenergic (alpha1, alpha2, beta), cholinergic, GABA, dopaminergic, histaminergic, serotonergic (5HT1A, 5HT1B, 5HT2), or benzodiazepine receptors; antagonism of such receptors has been hypothesized to be associated with various anticholinergic, sedative, and cardiovascular effects for other psychotropic drugs."	0
Inspect parenteral drug products for particulate matter and discoloration prior to administration whenever solution and container permit.	0
These recommendations assume the presence of normal renal function.	0
Selegiline does not accumulate in the skin.	0
"With inflamed meninges, the penetration of penicillin G into the CSF improves, such that the CSF/serum ratio is 2<U+2013>6%."	0
Signs and symptoms generally improve after reduction in dose or discontinuation of drug.	0
"Aspirin undergoes moderate hydrolysis to salicylic acid in the liver and the gastrointestinal wall, with 50%<U+2013>75% of an administered dose reaching the systemic circulation as intact aspirin."	0
"The apparent elimination half-life of fingolimod is unchanged in subjects with mild hepatic impairment, but is prolonged by about 50% in patients with moderate or severe hepatic impairment."	0
"Edema INITIATION: Adults, initially 30 to 60 mg daily or 60 mg on alternate days."	0
"Because many drugs are excreted in human milk and because of the potential for tumorigenicity and unknown cardiovascular effects in the infant, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother."	0
"Pooled analyses of short-term (6 to 18 weeks) placebo-controlled trials of STRATTERA in children and adolescents (a total of 12 trials involving over 2200 patients, including 11 trials in ADHD and 1 trial in enuresis) have revealed a greater risk of suicidal ideation early during treatment in those receiving STRATTERA compared to placebo."	0
The time to achieve steady state Pimozide concentrations is expected to be longer (approximately 2 weeks) in poor CYP 2D6 metabolizers because of the prolonged half-life.	0
"Amiodarone and DEA are inhibitors of P-glycoprotein and certain CYP450 enzymes , including CYP1A2 , CYP2C9 , CYP2D6 and CYP3A see Clinical Pharmacology ( 12.3 ) ."	0
"Attention should be paid to the fact that phenothiazines are capable of potentiating central nervous system depressants (e.g., anesthetics, opiates, alcohol, etc.) as well as atropine and phosphorus insecticides."	0
Epoprostenol has 2 major pharmacological actions: (1)direct vasodilation of pulmonary and systemic arterial vascular beds and (2)inhibition of platelet aggregation.	0
"Patients should be observed for signs of bradycardia or heart block, particularly when one agent is added to pre-existing treatment with the other."	0
"Therefore, fingolimod and fingolimod-phosphate are unlikely to reduce the clearance of drugs that are mainly cleared through metabolism by the major CYP isoenzymes described above."	0
"In instances where swelling is confined to the face and lips, the condition generally resolves without treatment; antihistamines may be useful in relieving symptoms."	0
There was an increased incidence of hepatocellular neoplasia (primarily adenomas) in male and female mice at the highest dosage level.	0
"If triamterene and hydrochlorothiazide is employed, frequent evaluations of acid/base balance and serum electrolytes are necessary."	0
"A daily dose of 30 mg/m2 of sotalol was administered in the single dose study and daily doses of 30, 90 and 210 mg/m2 were administered q8h in the multi-dose study."	0
"If patients are not adequately controlled by the use of DEMSER , an alpha-adrenergic blocking agent ( phenoxybenzamine ) should be added ."	0
"Severity of HF Nesiritide clearance was not influenced significantly by baseline endogenous hBNP concentration, severity of HF (as indicated by baseline PCWP, baseline CI, or New York Heart Association [NYHA] classification)."	0
"In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with angiotensin II receptor antagonists (including irbesartan) may result in deterioration of renal function, including possible acute renal failure."	0
It may be necessary to use lower doses of such drugs than usually prescribed.	0
"The treatment of potassium depletion, particularly in the presence of cardiac disease, renal disease, or acidosis, requires careful attention to acid-base balance, volume status, electrolytes, including magnesium, sodium, chloride, phosphate, and calcium, electrocardiograms, and the clinical status of the patient."	0
"Concomitant administration of VASOTEC with potassium supplements , potassium salt substitutes , or potassium-sparing diuretics may lead to increases of serum potassium ( see PRECAUTIONS ) ."	0
Further information is available at www.letairisrems.com or 1-866-664-5327.	0
"Vortioxetine binds with high affinity to the human serotonin transporter (Ki=1.6 nM), but not to the norepinephrine (Ki=113 nM) or dopamine (Ki>1000 nM) transporters."	0
Intervention Do not administer VYVANSE during or within 14 days following the administration of MAOI.	0
Thiothixene is an antipsychotic of the thioxanthene series.	0
"If full diagnostic facilities are not immediately available, cyanosis (pO2 less than 40 torr) and restricted pulmonary blood flow apparent on an X-ray are appropriate indicators of congenital heart defects."	0
"Marplan should not be administered in combination with sympathomimetics, including amphetamines, or with over-the-counter drugs such as cold, hay fever, or weight-reducing preparations that contain vasoconstrictors."	0
"If co-medication is considered necessary, monitoring of serum potassium is advisable."	0
Priapism has also appeared during a period of drug withdrawal (drug holidays or during discontinuation).	0
Mean plasma levels of temazepam (for days 2 to 7) were 260 <U+00B1> 210 ng/mL at 9 hours and 75 <U+00B1> 80 ng/mL at 24 hours after dosing.	0
"Neonatal opioid withdrawal syndrome, unlike opioid withdrawal syndrome in adults, may be life-threatening if not recognized and treated, and requires management according to protocols developed by neonatology experts."	0
Methamphetamine should not be used to combat fatigue or to replace rest in normal persons.	0
"There has been a long-standing concern, however, that antidepressants may have a role in inducing worsening of depression and the emergence of suicidality in certain patients during the early phases of treatment."	0
The pharmacologic activity and pharmacokinetics of the individual enantiomers have not been studied.	0
"Note that ALT may emanate from muscle, therefore ALT rising with CK may indicate myopathy."	0
"Ketoconazole at 400 mg daily (the maximum approved prescription dose) co-administered with TIKOSYN (500 mcg BID) for 7 days has been shown to increase dofetilide Cmax by 53% in males and 97% in females, and AUC by 41% in males and 69% in females."	1
"Conversely, adverse effects could result from displacement of nefazodone by other highly bound drugs."	0
LEXIVA should only be administered to infants born at 38weeks<U+2019> gestation or greater and who have attained a post-natal age of 28days.	0
"Warfarin reduces the regeneration of vitamin K from vitamin K epoxide in the vitamin K cycle through inhibition of VKOR, a multiprotein enzyme complex."	0
CADUET therapy should be discontinued if markedly elevated CPK levels occur or myopathy is diagnosed or suspected.	0
Observe newborns for symptoms of neonatal opioid withdrawal syndrome and manage accordingly.	0
"Prescriptions for Anafranil should be written for the smallest quantity of capsules consistent with good patient management, in order to reduce the risk of overdose."	0
Coadministration of buprenorphine and REYATAZ with ritonavir is not expected to decrease atazanavir plasma concentrations.	0
"After two to three days of selegiline treatment, an attempt may be made to reduce the dose of levodopa/carbidopa."	0
"For some patients, it may be desirable to start at 30mg once daily for 1 week, to allow patients to adjust to the medication before increasing to 60mg once daily."	0
The complete text of the Medication Guide is reprinted at the end of this document.	0
"Patients should be advised that taking Pexeva can cause mild pupillary dilation, which in susceptible individuals, can lead to an episode of angle closure glaucoma."	0
"In particular, triazolam produces additive CNS depressant effects when coadministered with other psychotropic medications, anticonvulsants, antihistamines, ethanol, and other drugs which themselves produce CNS depression."	0
Atropine disappears rapidly from the blood following injection and is distributed throughout the body.	0
Some patients may benefit from doses above 60mg once daily.	0
Concomitant administration of PRINIVIL and hydrochlorothiazide further reduced blood pressure in Black and non-Black patients and any racial difference in blood pressure response was no longer evident.	0
Evaluation of sofosbuvir in combination with ledipasvir showed no antagonistic effect in reducing HCV RNA levels in replicon cells.	0
Hepatitis C direct-acting antiviral elbasvir/grazoprevir Potential for the increased risk of alanine transaminase (ALT) elevations.	0
Anafranil should be discontinued before initiating treatment with theMAOI.	0
"In a multiple-dose study in the elderly at daily paroxetine doses of 20, 30, and 40mg, Cmin concentrations were about 70% to 80% greater than the respective Cmin concentrations in nonelderly subjects."	0
Dofetilide is eliminated in the kidney by cationic secretion.	0
"During the initial phase of combination antiretroviral treatment, patients whose immune system responds may develop an inflammatory response to indolent or residual opportunistic infections (such as Mycobacterium avium infection, cytomegalovirus, Pneumocystis jiroveci pneumonia, tuberculosis, or reactivation of herpes simplex and herpes zoster), which may necessitate further evaluation and treatment."	0
The red blood cell to plasma partitioning of dabigatran measured as total radioactivity is less than 0.3.	0
"If the combination is nevertheless considered necessary, monitoring of saquinavir concentrations is recommended."	0
"Peak concentrations of ramiprilat in these patients, however, are not different from those seen in subjects with normal hepatic function, and the effect of a given dose on plasma ACE activity does not vary with hepatic function."	0
Metabolism Nebivolol is predominantly metabolized via direct glucuronidation of parent and to a lesser extent via N-dealkylation and oxidation via cytochrome P450 2D6.	0
One study in six subjects demonstrated that the combination of furosemide and acetylsalicylic acid temporarily reduced creatinine clearance in patients with chronic renal insufficiency .	0
Highly variable results have been seen in the clinical development of all antidepressant drugs.	0
"Fingolimod-phosphate blocks the capacity of lymphocytes to egress from lymph nodes, reducing the number of lymphocytes in peripheral blood."	0
"To limit unwarranted exposure and risks, treatment with diethylpropion hydrochloride should be continued only if the patient has satisfactory weight loss within the first 4 weeks of treatment (e.g., weight loss of at least 4 pounds, or as determined by the physician and patient)."	0
"Ziprasidone functioned as an antagonist at the D 2, 5HT 2A, and 5HT 1D receptors, and as an agonist at the 5HT 1A receptor."	0
"Alternatively, consider the use of non-opioid analgesics in these patients."	0
Lovastatin therapy has not been associated with bleeding or with changes in prothrombin time in patients not taking anticoagulants.	0
"The AUC of hydroxybupropion was unchanged, whereas Cmax of hydroxybupropion was increased by 50%."	0
"IM: 25 to 50 mg (1-2 mL) given 3 or 4 times daily, usually in conjunction with barbiturates."	0
Patients unable to swallow the 250 or 625 mg tablets may dissolve the tablets in a small amount of water.	0
27% w/v).	0
"For the induction cycle, the recommended dose of TRISENOX is 0.15 mg/kg intravenously daily in combination with tretinoin until bone marrow remission and not to exceed 60 days."	0
Approximately 70% of the 3-hour effect on SBP reduction is reached within 15 minutes.	0
The common complications of hyperparathyroidism such as bone resorption and peptic ulceration have not been seen.	0
Heart Failure: The precise mechanism for the beneficial effects of beta-blockers in heart failure has not been elucidated.	0
The contribution of these activities to vortioxetine<U+2019>s antidepressant effect has not been established.	0
Onset of SLE typically occurred within days to years after initiating treatment primarily in patients ranging from young adults to the elderly.	0
Only trace (<1% of the dose) amounts of unchanged duloxetine are present in the urine.	0
"Offset of Effect: In most patients, full recovery of blood pressure is achieved in 5-15 minutes after the infusion is stopped."	0
"The usual dose of Triamterene and Hydrochlorothiazide Tablets 37.5 mg/25 mg is one or two tablets daily, given as a single dose, with appropriate monitoring of serum potassium."	0
"Concomitant administration of Remodulin with diuretics , antihypertensive agents or other vasodilators may increase the risk of symptomatic hypotension ."	0
Lidocaine toxicity is related to systemic blood levels.	0
Severe bone marrow suppression may also occur.	0
"Non- clinical studies have demonstrated that venlafaxine and its active metabolite, ODV, are potent and selective inhibitors of neuronal serotonin and norepinephrine reuptake and weak inhibitors of dopamine reuptake."	0
"In controlled studies, hypotension was observed in 0.6% of patients receiving any combination of trandolapril and verapamil HCl ER."	0
Hepatotoxicity: More patients treated with Savella than with placebo experienced mild elevations of ALT and AST.	0
"Rifampin is contraindicated in patients who are also receiving atazanavir, darunavir, fosamprenavir, saquinavir, or tipranavir due to the potential of rifampin to substantially decrease plasma concentrations of these antiviral drugs, which may result in loss of antiviral efficacy and/or development of viral resistance."	1
The ability of Silenor to induce CYP isozymes is not known.	0
The maximum dose of 600 mg twice daily should not be exceeded upon completion of the titration.	0
"The hydroxy metabolites have some pharmacologic activity, but do not circulate in the blood."	0
"The best predictor of this arrhythmia appears to be the length of the QTc interval, and quinidine should be used with extreme care in patients who have preexisting long<U+2013>QT syndromes, who have histories of torsades de pointes of any cause, or who have previously responded to quinidine (or other drugs that prolong ventricular repolarization) with marked lengthening of the QTc interval."	0
"In pregnant rats, increased fetal resorption (postimplantation loss) was observed at 100 mg/kg/day and decreased fetal weight was observed at both 30 and 100 mg/kg/day."	0
Sedative and tranquilizing properties are lacking.	0
"In the CHARM-Added program, where candesartan or placebo was given in addition to ACE inhibitors, the incidence of abnormal renal function (e.g., creatinine increase) was 15% in patients treated with ATACAND versus 9% in patients treated with placebo."	0
For patients with renal impairment the following dosage adjustments should be considered: For patients with CLCR 30 to 60 mL/min the dose of clarithromycin should be reduced by 50%.	1
"There are, however, no adequate and well-controlled studies in pregnant women."	0
If the dose is less than 1 mL round to the nearest 0.1 mL.	0
The iloperidone metabolite P95 represents 47.9% of the AUC of iloperidone and its metabolites in plasma at steady-state for extensive metabolizers (EM) and 25% for poor metabolizers (PM).	0
<U+2021> Dashed vertical lines illustrate pharmacokinetic changes that were used to inform dosing recommendations.	0
Doses less than 0.1 mL require appropriate methods or measuring devices designed to administer an accurate amount to the patient.	0
"Altered anticoagulant effects, including increased bleeding, have been reported when SSRIs or SNRIs are co-administered with warfarin."	0
"In adult placebo-controlled trials in any indication, for patients with normal and abnormal baseline ALT values, elevation of ALT >3 times the upper limit of normal occurred in 1.25% (144/11,496) of CYMBALTA-treated patients compared to 0.45% (39/8716) of placebo-treated patients."	0
"Fluoxetine <U+2013> When fluoxetine (20 mg QD) and nefazodone (200 mg BID) were administered at steady state there were no changes in the pharmacokinetic parameters for fluoxetine or its metabolite, norfluoxetine."	0
"Antipsychotic treatment itself, however, may suppress (or partially suppress) the signs and symptoms of the syndrome and thereby may possibly mask the underlying disease process."	0
Cimetidine has been shown to increase nicardipine plasma concentrations with oral nicardipine administration.	1
<U+03B2>-blockers can precipitate or aggravate symptoms of arterial insufficiency in patients with peripheral vascular disease.	0
Figure 1 Structural Formula The risk of bleeding is increased in patients receiving Effient who undergo CABG.	0
"In these patients, the onset of REM sleep occurred almost immediately after falling asleep."	0
"Whenever over-digitalization is suspected, the daily dose of digitalis should be reduced or temporarily discontinued."	1
One valsartan patient discontinued treatment for microcytic anemia.	0
"Avoid concomitant use of XARELTO with drugs that are combined P-gp and strong CYP3A4 inducers ( e.g. , carbamazepine , phenytoin , rifampin , St.   John 's   wort ) see Warnings and Precautions ( 5.6 ) and Clinical Pharmacology ( 12.3 ) ."	0
"Serotonin syndrome symptoms may include mental status changes (e.g., agitation, hallucinations, delirium, and coma), autonomic instability (e.g., tachycardia, labile blood pressure, dizziness, diaphoresis, flushing, hyperthermia), neuromuscular symptoms (e.g., tremor, rigidity, myoclonus, hyperreflexia, incoordination), seizures, and/or gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea)."	0
Patients with asymptomatic severe leukocyturia should be followed closely and monitored frequently with urinalyses.	0
Data from concomitant use of parenteral midazolam with other protease inhibitors suggest a possible 3-4 fold increase in midazolam plasma levels.	1
Close supervision and careful adjustment of dosage are required when clomipramine is administered with anticholinergic or sympathomimetic drugs.	0
"Consequently, it is recommended that fluvoxamine not be used in combination with pimozide."	0
"The pooled analyses of placebo-controlled trials in adults with MDD or other psychiatric disorders included a total of 295 short-term trials (median duration of 2 months) of 11 antidepressant drugs in over 77,000 patients."	0
"If concomitant use of CYMBALTA with other serotonergic drugs including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, buspirone, tryptophan, amphetamines, and St. John's Wort is clinically warranted, patients should be made aware of a potential increased risk for serotonin syndrome, particularly during treatment initiation and dose increases."	0
"Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit."	0
"Hematological reactions to ACE inhibitors are more likely to occur in patients with collagen-vascular disease (e.g., systemic lupus erythematosus, scleroderma) and renal impairment."	0
"Combined P-gp and strong CYP3A4 inhibitors and inducers: Avoid concomitant use (7.2, 7.3) Anticoagulants: Avoid concomitant use (7.4) Rivaroxaban is a substrate of CYP3A4/5, CYP2J2, and the P-gp and ATP-binding cassette G2 (ABCG2) transporters."	0
Do not restart MULTAQ in patients without another explanation for the observed liver injury.	0
Serum potassium should be monitored periodically in patients receiving Lotensin.	0
"Immunosuppression: Due to the immunosuppression associated with maintenance chemotherapy for ALL, response to all vaccines may be diminished and there is a risk of infection with live virus vaccines."	0
Consider additional follow-up and diagnostic testing in adult patients who have a suboptimal response or an early symptomatic relapse after completing treatment with a PPI.	0
"For recurrent toxicities, reduce the dose of CAPRELSA to 100 mg after resolution or improvement to CTCAE Grade 1 severity, if continued treatment is warranted."	0
Terbinafine decreases the clearance of caffeine by 19%.	1
"Potential to prolong the QT interval In a placebo controlled thorough QT study performed in healthy subjects, there was no evidence that teriflunomide caused QT interval prolongation of clinical significance (i.e., the upper bound of the 90% confidence interval for the largest placebo-adjusted, baseline-corrected QTc was below 10 ms)."	0
"In Vivo Studies The effects of other drugs on ambrisentan pharmacokinetics and the effects of ambrisentan on the exposure to other drugs are shown in Figure 2 and Figure 3, respectively."	0
FANAPT can be administered without regard to meals.	0
"The systemic clearance of selegiline after intravenous administration was 1.4 L per min, and the mean half-lives of selegiline and its three metabolites, R(-)-N-desmethylselegiline, R(-)-amphetamine, and R(-)-methamphetamine, ranged from 18 to 25 hours."	0
"In general, avoid combined use of RAS inhibitors."	0
"Carcinogenesis, Mutagenesis, Impairment of Fertility: Two-year feeding studies in mice and rats conducted under the auspices of the National Toxicology Program (NTP) uncovered no evidence of a carcinogenic potential of hydrochlorothiazide in female mice (at doses of up to approximately 600 mg/kg/day) or in male and female rats (at doses of approximately 100 mg/kg/day)."	0
"Additionally, in one controlled study in five normal subjects and seven patients, the clearance of caffeine was decreased 50% following the administration of mexiletine."	1
"CADUET is a combination of two drugs, a dihydropyridine calcium channel blocker (amlodipine) and an HMG-CoA reductase inhibitor (atorvastatin)."	0
Hepatic laboratory testing should be performed in patients with underlying liver disease prior to initiation of REYATAZ and continued during treatment with REYATAZ.	0
Drug Class/Drug Name Clinical Comment Alpha 1-adrenoreceptor antagonists: Alfuzosin Potentially increased alfuzosin concentrations can result in hypotension.	0
"When given to rats prior to mating, nifedipine caused reduced fertility at a dose approximately 5 times the maximum recommended human dose."	0
"The mechanism of action of REMERON (mirtazapine) Tablets, as with other drugs effective in the treatment of major depressive disorder, is unknown."	0
"Small, fragile, or elderly patients, or patients with hepatic insufficiency may be started on 2.5 mg once daily and this dose may be used when adding NORVASC to other antihypertensive therapy."	0
"Co-administration of EMEND with drugs that are inhibitors or inducers of CYP3A4 may result in increased or decreased plasma concentrations of aprepitant, respectively, as shown in Table 11."	1
"WARNING: DIFFERENTIATION SYNDROME AND CARDIAC CONDUCTION ABNORMALITIES Differentiation Syndrome: Patients with acute promyelocytic leukemia (APL) treated with TRISENOX have experienced symptoms of differentiation syndrome, which can be fatal if not treated."	0
Families and caregivers should be advised of the need for close observation and communication with the prescriber.	0
The major route of elimination is via the kidney where most of the drug and metabolites are excreted.	0
A press-in bottle adapter and two oral dispensing syringes (one 1 mL and one 5 mL) are provided.	0
Hydrochlorothiazide is contraindicated in patients with anuria.	0
"In the VMAC trial, in which the use of diuretics was not restricted, the mean change in volume status (output minus input) during the first 24 hours in the nitroglycerin and NATRECOR<U+00AE> groups was similar: 1279 <U+00B1> 1455 mL and 1257 <U+00B1> 1657 mL, respectively."	0
Monitor patients receiving PRIFTIN therapy for signs and/or symptoms of hypersensitivity reactions.	0
<U+2022> Metabolism: Rosuvastatin is not extensively metabolized; approximately 10% of a radiolabeled dose is recovered as metabolite.	0
Postmarketing cases of increased INR with or without bleeding events have been reported in warfarin-treated patients initiated on dronedarone.	0
"TARKA is contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril)."	0
Ex vivo studies have shown that approximately 93% of the circulating drug is bound to plasma proteins in hypertensive patients.	0
The most serious reactions to NARDIL involve changes in blood pressure.	0
"Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs."	0
"Warfarin - When immediate-release fluvoxamine maleate tablets (50 mg given three times daily) were administered concomitantly with warfarin for two weeks, warfarin plasma concentrations increased by 98% and prothrombin times were prolonged."	1
"Use In Patients With Renal Impairment: Since AHA is eliminated primarily by the kidneys, patients with significantly impaired renal function should be closely monitored, and a reduction of daily dose may be needed to avoid excessive drug accumulation."	0
"After at least one week following the initiation of APTIVUS/ritonavir, resume Adcirca at 20 mg once daily."	0
"Although the mechanism is not fully understood, cyclosporine has been shown to increase the AUC of HMG-CoA reductase inhibitors."	1
Treatment-experienced patients with chronic hepatitis B or hepatitis C co-infection or elevated transaminases are at approximately 2-fold risk for developing Grade 3 or 4 transaminase elevations or hepatic decompensation.	0
"Use of pimozide with EMEND is contraindicated due to the risk of significantly increased plasma concentrations of pimozide, potentially resulting in prolongation of the QT interval, a known adverse reaction of pimozide."	0
The effect of paroxetine on phenobarbital pharmacokinetics was not studied.	0
"Following recommended doses of HALCION, triazolam peak plasma levels in the range of 1 to 6 ng/mL are seen."	0
"Although the effects of combined use of nefazodone and MAOI have not been evaluated in humans or animals, because nefazodone is an inhibitor of both serotonin and norepinephrine reuptake, it is recommended that nefazodone not be used in combination with an MAOI, or within 14 days of discontinuing treatment with an MAOI."	0
Adolescents (12<U+2013>17 years of age) Paliperidone systemic exposure in adolescents weighing <U+2265> 51 kg (<U+2265> 112 lbs) was similar to that in adults.	0
Antihypertensive activity commences within 1 hour with peak effects usually achieved by 2 to 4 hours after dosing.	0
"Prophylaxis of gout flares: If the original regimen was 0.6mg twice a day, the regimen should be adjusted to 0.3mg once a day."	0
Verapamil does not interfere with ACE inhibition by trandolapril.	0
"In Study AI424-045, asymptomatic first-degree AV block was observed in 5% (6/118) of atazanavir/ritonavir-treated patients and 5% (6/116) of lopinavir/ritonavir-treated patients who had on-study electrocardiogram measurements."	0
"Hepatic reactions, including hepatitis and jaundice, have occurred among patients with no other identifiable risk factors."	0
"Another ACE inhibitor, captopril, has been shown to cause agranulocytosis and bone marrow depression rarely in patients with uncomplicated hypertension, but more frequently in patients with renal impairment, especially if they also have a collagen vascular disease, such as systemic lupus erythematosus or scleroderma."	0
Coadministration of LEXIVA in patients on bosentan: Discontinue use of bosentan at least 36hours prior to initiation of LEXIVA.	0
"Increased frequency of chromosomal aberrations was observed in vitro in lymphocytes obtained from patients treated with combinations of rifampin, isoniazid, and pyrazinamide and combinations of streptomycin, rifampin, isoniazid, and pyrazinamide."	0
Other drugs may compete with penicillin G for renal tubular secretion and thus prolong the serum half-life of penicillin.	0
Coadministration of VIRACEPT and drugs that inhibit CYP3A or CYP2C19 may increase nelfinavir plasma concentrations.	1
Periodic cardiovascular evaluation should be considered in intermittent long-term users of MAXALT who have cardiovascular risk factors.	0
A causal relationship has not been established.	0
Sudden death has been reported in children and adolescents with structural cardiac abnormalities and other serious heart problems taking CNS stimulants at recommended doses for ADHD.	0
"Patients with rheumatoid arthritis previously treated with alkylating agents (cyclophosphamide, chlorambucil, melphalan, or others) may have a prohibitive risk of malignancy if treated with IMURAN."	0
A limited number of patients (45 of 475 in controlled clinical trials) with preexisting first degree AV block were treated with mexiletine; none of these patients developed second or third degree AV block.	0
The elevated plasma alprazolam concentrations resulted in decreased psychomotor performance and memory.	1
"Simultaneous administration of tetracycline with ACCUPRIL reduced the absorption of tetracycline by approximately 28% to 37%, possibly due to the high magnesium content in ACCUPRIL tablets."	1
Rifampin is widely distributed throughout the body.	0
"If possible, reduce the dose of any concomitant diuretic as this may diminish the likelihood of hypotension."	0
"Such conditions include chronic renal failure, uncontrolled diabetes mellitus, acute dehydration, strenuous physical exercise in unconditioned individuals, adrenal insufficiency, extensive tissue breakdown (4) Patients for whom there is cause for arrest or delay in tablet passage through the gastrointestinal tract such as those suffering from delayed gastric emptying, esophageal compression, intestinal obstruction or stricture (4) Patients with peptic ulcer disease (4) Patients with active urinary tract infection (4) Patients with renal insufficiency (glomerular filtration rate of less than 0.7 ml/kg/min) (4)"	0
"(350 mg) with ritonavir 0.8 mL (64 mg) Greater than or equal to 11 kg to less than 12 kg PREZISTA 4 mL (385 mg) with ritonavir 0.8 mL (64 mg) Greater than or equal to 12 kg to less than 13 kg PREZISTA 4.2 mL (420 mg) with ritonavir 1 mL (80 mg) Greater than or equal to 13 kg to less than 14 kg PREZISTA 4.6 mL (455 mg) with ritonavir 1 mL (80 mg) Greater than or equal to 14 kg to less than 15 kg PREZISTA 5 mL (490 mg) with ritonavir 1.2 mL (96 mg) Pediatric patients weighing at least 15 kg Pediatric patients weighing at least 15 kg can be dosed with PREZISTA oral tablet(s) or suspension using the following table: Table 3: Recommended Dose for Pediatric Patients Weighing At Least 15 kg Who are Treatment-Na<U+00EF>ve or Treatment-Experienced with No Darunavir Resistance Associated Substitutionsdarunavir resistance associated substitutions: V11I, V32I, L33F, I47V, I50V, I54M, I54L, T74P, L76V, I84V and L89V Body weight (kg) Formulation: PREZISTA tablet(s) and ritonavir capsules or tablets (100 mg) Formulation: PREZISTA oral suspension (100 mg/mL) and ritonavir oral solution (80 mg/mL) Dose: once daily with food Dose: once daily with food Greater than or equal to 15 kg to less than 30 kg PREZISTA 600 mg with ritonavir 100 mg PREZISTA 6 mL (600 mg) with ritonavir 1.25 mL (100 mg) Greater than or equal to 30 kg to less than 40 kg PREZISTA 675 mg with ritonavir 100 mg PREZISTA 6.8 mLThe 675 mg dose using darunavir tablets for this weight group is rounded up to 6.8 mL for suspension dosing convenience."	0
The recommended dose of maraviroc is 150 mg twice daily when coadministered with LEXIVA/ritonavir.	0
Phenobarbital Phenobarbital induces many cytochrome P450 (oxidative) enzymes.	0
Gender No gender-related differences in pharmacokinetics were observed in healthy elderly (age 65 to 80 years) or in healthy young (age 18 to 40 years) subjects.	0
"To date, the only clinical effect noted has been hemolysis, with a decrease in the circulating red blood cells, hemoglobin and hematocrit."	0
Tricyclic Antidepressant Drugs Effective in the Treatment of Major Depressive Disorder(TCAs)<U+2013>The extent to which SSRI<U+2013>TCA interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the SSRI involved.	0
"In attempts to reduce the dosage of ORAP, consideration should be given to the possibility that increases of tic intensity and frequency may represent a transient, withdrawal-related phenomenon rather than a return of disease symptoms."	0
No dose adjustment is necessary for patients with mild-to-moderate hepatic impairment.	0
However it is proposed that the efficacy of FANAPTis mediated through a combination of dopamine type 2 (D2) and serotonin type 2 (5-HT2) antagonisms.	0
In patients with mild to moderate hypocitraturia (urinary citrate > 150 mg/day) therapy should be initiated at 30 mEq/day (15 mEq two times/day or 10 mEq three times/day within 30 minutes after meals or bedtime snack).	0
"Angina: CARDIZEM CD has been shown to produce increases in exercise tolerance, probably due to its ability to reduce myocardial oxygen demand."	0
The efficacy of Lexapro in the treatment of GAD beyond 8 weeks has not been systematically studied.	0
"During steady-state, the respective average increases above baseline of the QTc interval, in ms (%), were 2(+1%), 14(+4%) and 29(+7%) ms at the 3 dose levels."	0
Zaleplon is not recommended for use in patients with severe hepatic impairment.	0
"On average, the combination of irbesartan and hydrochlorothiazide had no effect on serum potassium."	0
Study 1 was an 8-week study with flexible dosing of sertraline hydrochloride in a range of 50 to 200 mg/day; the mean dose for completers was 186 mg/day.	0
"When pregnancy is detected, discontinue AVAPRO as soon as possible."	0
"Following chronic dosing, the mean steady-state plasma concentration of bupropion was reached within 8 days."	0
"Carvedilol is a basic, lipophilic compound with a steady-state volume of distribution of approximately 115L, indicating substantial distribution into extravascular tissues."	0
Pindolol and thioridazine should not be coadministered.	0
"Nefazodone should be used with caution in patients with known cardiovascular or cerebrovascular disease that could be exacerbated by hypotension (history of myocardial infarction, angina, or ischemic stroke) and conditions that would predispose patients to hypotension (dehydration, hypovolemia, and treatment with antihypertensive medication)."	0
Hypertensive crises have sometimes occurred during Marplan therapy after ingestion of foods with a high tyramine content.	0
Consider withholding or discontinuing therapy in patients who develop a clinically significant decrease in renal function on PRINIVIL.	0
"Marplan is not recommended for use in patients under 16years of age, as safety and effectiveness in pediatric populations have not been demonstrated."	0
Five of these 16 subjects' viruses also had baseline NS5A polymorphisms at resistance-associated amino acid positions.	0
These abnormalities resolved with temporary discontinuation of TRISENOX and/or tretinoin.	0
"The following symptoms, anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, and mania, have been reported in adult and pediatric patients being treated with antidepressants for major depressive disorder as well as for other indications, both psychiatric and nonpsychiatric."	0
"Substantial intercurrent ethanol use was present in each of these cases, and this may have contributed to the abnormalities seen."	0
"Tasigna is contraindicated in patients with hypokalemia, hypomagnesemia, or long QT syndrome."	0
Therapy should be discontinued immediately if palpitations or frequent headaches occur during Marplan therapy as these symptoms may be prodromal of a hypertensive crisis.	0
"Assays of serum quinidine levels are widely available, but the results of modern assays may not be consistent with results cited in the older medical literature."	0
"TIKOSYN (dofetilide) can cause serious ventricular arrhythmias, primarily Torsade de Pointes (TdP) type ventricular tachycardia, a polymorphic ventricular tachycardia associated with QT interval prolongation."	0
Ensure the patient transfer set is closed.	0
"Myelosuppression, defined by 1 or more of the following: absolute neutrophil count less than 1 Gi/L platelets less than 50 Gi/L lasting more than 5 weeks Consider reducing the dose of TRISENOX and tretinoin by 1 dose level."	0
The concomitant use of proton pump inhibitors with Tasigna is not recommended.	0
Recommended usual starting dose is 10 or 20mg once a day in the evening.	0
"Families and caregivers of patients being treated with antidepressants for major depressive disorder or other indications, both psychiatric and non-psychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to health care providers."	0
"<U+2022> Mixing with liquid infant formula using an oral dosing syringe and a small medicine cup: Using a spoon, mix the recommended number of REYATAZ oral powder packets with 10 mL of prepared liquid infant formula."	0
Patients should be monitored for the emergence of serotonin syndrome.	0
Some researchers have suggested that infants and young pediatric patients tolerate slightly higher serum concentrations than do adults.	0
"Consequently, no dose adjustment is required in patients with mild or moderate hepatic impairment."	0
Intracranial Hemorrhage: Both fatal and non-fatal intracranial hemorrhage have been reported.	0
"For both orally and intravenously administered drug, the duration of action is dose related and also bears a linear relationship to the logarithm of plasma TENORMIN concentration."	0
If prolonged hypotension occurs (systolic blood pressure <90 mmHg for more than 1 hour) discontinue PRINIVIL.	0
Aliskiren Do not co-administer aliskiren with ALTACE in patients with diabetes.	0
"To ensure adequate hydration, it is recommended that adults drink at least 1.5 liters (approximately 48 ounces) of liquids during the course of 24 hours."	0
There was no net effect on CYP 2C9 or hepatic P-gp at first dose or steady state.	0
"(e.g., famotidine) H2-receptor antagonists may be administered simultaneously with or 12 hours apart from HARVONI at a dose that does not exceed doses comparable to famotidine 40 mg twice daily."	1
Monitor heart rate in patients on amiodarone and concomitant drugs that slow heart rate.	0
"Because of the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of thioridazine, CYMBALTA and thioridazine should not be co-administered."	1
Withhold ONIVYDE for diarrhea of Grade 2-4 severity.	0
"Acute effects of thiazides are thought to result from a reduction in blood volume and cardiac output, secondary to a natriuretic effect, although a direct vasodilatory mechanism has also been proposed."	0
Chest pain may be aggravated in patients with underlying coronary artery disease who are receiving dipyridamole.	0
Do not combine Nicardipine Hydrochloride in 0.9% Sodium Chloride Injection with any product in the same intravenous line or premixed container.	0
"The predominant metabolite in urine (17% of the administered dose) has not been identified, but is likely to be a metabolite of 4-hydroxy-estazolam."	0
"Careful dosage instructions should be given to the patient, especially when IMURAN is being administered in the presence of impaired renal function or concomitantly with allopurinol."	0
"<U+2022>Fluoxetine, paroxetine, and other CYP 2D6 enzyme inhibitors increase plasma concentrations of risperidone."	1
The plasma elimination half-life has been reported to be 6-15 hours.	0
"The pharmacokinetics of Zaleplon in elderly subjects, including those over 75 years of age, are not significantly different from those in young healthy subjects."	0
"Pharmacokinetic interactions between nisoldipine and beta-blockers (atenolol, propranolol) were variable and not significant."	0
Consider the potential for drug interactions prior to and during REYATAZ/ritonavir therapy; review concomitant medications during REYATAZ/ritonavir therapy; and monitor for the adverse reactions associated with the concomitant medications.	0
Warfarin: Preliminary data suggest that there may be a pharmacodynamic interaction (that causes an increased bleeding diathesis in the face of unaltered prothrombin time) between paroxetine and warfarin.	0
Factors such as reduced creatinine clearance or certain dofetilide drug interactions will increase dofetilide plasma concentration.	0
"Measurement of potassium levels is appropriate especially in elderly patients, those receiving digitalis preparations for cardiac failure, patients whose dietary intake of potassium is abnormally low, or those suffering from gastrointestinal complaints."	0
"Patients with hepatic insufficiency due to cirrhosis: In these patients, the dosage of CRIXIVAN should be lowered because of decreased metabolism of CRIXIVAN."	0
"It was reported in 1.2% of 1,571 patients receiving ACCURETIC during clinical trials."	0
"In usual therapeutic doses, lidocaine hydrochloride produces no change in myocardial contractility, in systemic arterial pressure, or in absolute refractory period."	0
"However, there is substantial evidence from placebo-controlled maintenance trials in adults with depression that the use of antidepressants can delay the recurrence of depression."	0
Dosing with REYATAZ was often continued without interruption in patients who developed rash.	0
"Increased risk for bleeding: Increased risk for hemorrhagic complications, particularly for patients with other risk factors for bleeding."	0
It is generally agreed that acute episodes of major depressive disorder require several months or longer of sustained pharmacologic therapy.	0
"The total daily dosage ranges from 200 mg to 800 mg, divided into two to four doses."	0
MULTAQ offers no benefit in subjects in permanent AF.	0
Both digitalis glycosides and <U+03B2>-blockers slow atrioventricular conduction and decrease heart rate.	0
"Avoid co-administration of CYP 3A inducers ( e.g. , rifampin , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine , St.   John 's   Wort ) with SAMSCA , as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment ."	1
"Zidovudine 200 three times daily, 7 days 1000 three times daily, 7 days 12 0.89(0.73, 1.09) 1.17(1.07, 1.29) 1.51(0.71, 3.20)n=4 Zidovudine/Lamivudine Zidovudine 200/150 three times daily, 7 days 800 three times daily, 7 days 6, 7 1.23(0.74, 2.03) 1.39(1.02, 1.89) 1.08(0.77, 1.50)n=5, 5 Zidovudine/Lamivudine Lamivudine 200/150 three times daily, 7 days 800 three times daily, 7 days 6, 7 0.73(0.52, 1.02) 0.91(0.66, 1.26) 0.88(0.59, 1.33) Delavirdine: Delavirdine inhibits the metabolism of indinavir such that coadministration of 400-mg or 600-mg indinavir three times daily with 400-mg delavirdine three times daily alters indinavir AUC, Cmax and Cmin."	1
"In addition, valproic acid and lithium pre-dose serum concentrations collected from an adjunctive therapy study were comparable between asenapine-treated patients and placebo-treated patients indicating a lack of effect of asenapine on valproic and lithium plasma levels."	0
"Since these patients received multicombination therapy, it is difficult to determine to what extent procarbazine hydrochloride alone was involved in the male germ-cell damage."	0
Steady-state concentrations are achieved within 3 days.	0
"Because these events have been reported voluntarily during clinical practice, estimates of frequency cannot be made and a causal relationship between protease inhibitor therapy and these events has not been established."	0
Pregnancy Category D Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death.	0
The benefits of extended-release oral isosorbide dinitrate in patients with acute myocardial infarction or congestive heart failure have not been established.	0
"Such symptoms should be reported to the patient's prescriber or health professional, especially if they are severe, abrupt in onset, or were not part of the patient's presenting symptoms."	0
A pharmacokinetic interaction of ziprasidone with valproate is unlikely due to the lack of common metabolic pathways for the two drugs.	0
Seizures precede cardiac dysrhythmias and death in some patients.	0
Use low initial doses of WELLBUTRIN XL and increase the dose gradually.	0
The MICs should be determined using a standardized procedure.	0
"Because the relative potencies of paroxetine<U+2019>s major metabolites are at most 1/50 of the parent compound, they are essentially inactive."	0
"Factors that may be involved include: Decreased cardiac output, Inhibition of renin release by the kidneys, Diminution of tonic sympathetic outflow from vasomotor centers in the brain."	0
"With 5 mg BID doses of buspirone, slight increases in AUC were observed for nefazodone (23%) and its metabolites hydroxynefazodone (17%) and mCPP (9%)."	1
A 24-week open label study in 36 children between the ages of 2 and 12 demonstrated that pimozide has a similar safety profile in this age group as in older patients and there were no safety findings that would preclude its use in this age group.	0
Preliminary data suggest that there may be a pharmacodynamic interaction (that causes an increased bleeding diathesis in the face of unaltered prothrombin time) between paroxetine and warfarin.	0
<U+2022>do not support administration of LEXIVA alone or in combination with ritonavir for protease inhibitor<U+2011>experienced children younger than 6months.	0
"Some hypertensive patients with no apparent pre-existing renal vascular disease have developed increases in blood urea and serum creatinine, usually minor and transient, especially when ACE inhibitors have been given concomitantly with a diuretic."	0
"SSRIs and SNRIs, including Lexapro, may increase the risk of bleeding events."	0
Candesartan cilexetil pharmacokinetics have not been investigated in pediatric patients less than 1 year of age.	0
The cardiac malformations in the paroxetine-exposed infants were primarily ventricular septal defects (VSDs) and atrial septal defects (ASDs).	0
Instruct patients to immediately report if they experience any of the above signs or symptoms.	0
Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy.	0
The blood pressure effects could be clinically important in some PM patients.	0
These hematomas may result in long-term or permanent paralysis (5.3).	0
Herbal Products St. John<U+2019>s wort (Hypericum perforatum) Coadministration of St. John<U+2019>s wort and REYATAZ may result in loss of therapeutic effect and development of resistance.	0
Hepatotoxicity: Monitor for symptoms of liver injury and discontinue PRIFTIN if signs or symptoms or liver injury occur (5.1) Hypersensitivity: Discontinue PRIFTIN if signs or symptoms of hypersensitivity reaction occur.	0
Combined P-gp and strong CYP3A4 inducers decrease exposure to rivaroxaban and may increase the risk of thromboembolic events .	0
"Telmisartan is not metabolized by the cytochrome P450 system and had no effects in vitro on cytochrome P450 enzymes, except for some inhibition of CYP2C19."	0
The steady-state volume of distribution was determined to be 0.17 L/kg in arterial blood.	0
"Given these considerations, antipsychotics should be prescribed in a manner that is most likely to minimize the occurrence of tardive dyskinesia."	0
"The ratio of 2-hydroxydesipramine to desipramine may be increased in the elderly, most likely due to decreased renal elimination with aging."	0
"Patients should be instructed to report promptly the occurrence of any symptom or sign of these hematological abnormalities, such as fever, sore throat, chills, bleeding or easy bruisability."	0
"Non-nucleoside reverse transcriptase inhibitor: EfavirenzSee Pharmacokinetics, Drug Interactions (12.3), Table 6 and Table 7 for magnitude of interactions.,nevirapine <U+2193> Saquinavir<U+2194> Efavirenz Appropriate doses of the combination of efavirenz or nevirapine and INVIRASE/ritonavir with respect to safety and efficacy have not been established."	0
"Concentrations of thioridazine and its two active metabolites, mesoridazine and sulforidazine, increased 3-fold following coadministration of fluvoxamine."	1
"At concentrations covering several orders of magnitude, dofetilide blocks only IKr with no relevant block of the other repolarizing potassium currents (e.g., IKs, IK1)."	0
Caution is advised if patients receive large doses of ethchlorvynol concurrently.	0
"Also, patients taking diuretics or who are otherwise volume depleted may be at greater risk."	0
A population PK analyses concluded that coadministration of lithium 300-2400 mg/day or valproate 300-2000 mg/day with lurasidone for up to 6 weeks has minimal effect on lurasidone exposure.	0
"If LEXIVA is coadministered with ritonavir, reference should be made to the full prescribing information for ritonavir for additional contraindications."	0
Hypomagnesemia: Reported rarely with prolonged treatment with PPIs.	0
"There have been cases of increased liver enzymes and reports of severe liver injury, including fulminant hepatitis with milnacipran from foreign postmarketing experience."	0
PRIFTIN may reduce the effectiveness of hormonal contraceptives.	0
Ziprasidone is unlikely to interfere with the metabolism of drugs metabolized by cytochrome P450 enzymes.	0
Thioridazine hydrochloride tablet use should be avoided in combination with other drugs that are known to prolong the QTc interval and in patients with congenital long QT syndrome or a history of cardiac arrhythmias.	0
"If the angina worsens or acute coronary insufficiency develops, re-start BYSTOLIC promptly, at least temporarily."	0
Prescribe REVATIO with caution in these patients.	0
No suicides occurred in the short-term or longer-term (up to 1 year) fibromyalgia trials.	0
The use of TIKOSYN in conjunction with other drugs that prolong the QT interval has not been studied and is not recommended.	0
"A syringe with a fine hypodermic needle should be used, and the solution liberally infiltrated throughout the ischemic area."	0
"While these events are generally self-limiting, there have been reports of serious discontinuation symptoms."	0
In some cases fatalities have been observed.	0
Caution should be observed in administering DEMSER to patients receiving phenothiazines or haloperidol because the extrapyramidal effects of these drugs can be expected to be potentiated by inhibition of catecholamine synthesis .	0
Population pharmacokinetics analysis in HCV-infected subjects indicated that cirrhosis (including decompensated cirrhosis) had no clinically relevant effect on the exposure of sofosbuvir and GS-331007.	0
"Animal Data Mercaptopurine was embryo-lethal and teratogenic in several animal species (rat, mouse, rabbit, and hamster)."	0
"): Patients should be cautioned about concomitant use of paroxetine with NSAIDs, aspirin, or other drugs that affect coagulation since the combined use of psychotropic drugs that interfere with serotonin reuptake and these agents has been associated with an increased risk of bleeding."	0
Safety and effectiveness in children have not been established.	0
"In clinical studies, no differences in steady state serum citalopram levels were seen between men (N=237) and women (N=388)."	0
Possible exacerbation or activation of systemic lupus erythematosus by thiazides has been reported.	0
"These differences could result in a change in tolerability and control of symptoms ( 2.1, 12.3) To discontinue Zanaflex, decrease dose slowly to minimize the risk of withdrawal and rebound hypertension, tachycardia, and hypertonia ( 2.2) Zanaflex Capsules <U+00AE> or Zanaflex <U+00AE> tablets may be prescribed with or without food."	0
In some patients it may be necessary to administer higher doses more frequently.	0
"Use TWYNSTA tablets to provide additional blood pressure lowering for patients not adequately controlled with amlodipine (or another dihydropyridine calcium channel blocker) alone or with telmisartan (or another angiotensin receptor blocker) alone (2.3) Dosage may be increased after at least 2 weeks to a maximum dose of 80/10 mg once daily, usually by increasing one component at a time but both components can be raised to achieve more rapid control (2.1, 2.2) Majority of antihypertensive effect is attained within 2 weeks (2.1) Initiate with 40/5 mg or 80/5 mg once daily (2.4) Switch patients who experience dose-limiting adverse reactions on amlodipine to TWYNSTA tablets containing a lower dose of that component (2.3) Telmisartan is an effective treatment of hypertension in once daily doses of 20 to 80 mg while amlodipine is effective in doses of 2.5 to 10 mg."	0
No clinically significant pharmacokinetic interaction has been found between trandolapril (or its metabolites) and furosemide.	0
"The dose may be increased, beginning at 6 to 8weeks and thereafter by steps at 4-week intervals, if there are no serious toxicities and if initial response is unsatisfactory."	0
Plasma level may also be affected by certain concomitant drugs.	0
Sotalol can cause life threatening ventricular tachycardia associated with QT interval prolongation.	0
"Mean<U+00B1>SD steady-state plasma clearance of venlafaxine and ODV is 1.3<U+00B1>0.6 and 0.4<U+00B1>0.2 L/h/kg, respectively; apparent elimination half-life is 5<U+00B1>2 and 11<U+00B1>2 hours, respectively; and apparent (steady-state) volume of distribution is 7.5<U+00B1>3.7 and 5.7<U+00B1>1.8 L/kg, respectively."	0
Use of tadalafil for pulmonary arterial hypertension (PAH): The following dose adjustments are recommended for use of AdcircaRegistered trademark of Eli Lilly and Company.	0
Normotensive subjects experienced no clinically significant change in blood pressure (+1/-2 mmHg).	0
"AHA has been used concomitantly with insulin, oral and parenteral antibiotics, and progestational agents."	0
"Patients who are anticipated to have severe granulocytopenia (less than 500 neutrophils per cu mm) should start DIFLUCAN prophylaxis several days before the anticipated onset of neutropenia, and continue for 7 days after the neutrophil count rises above 1000 cells per cu mm."	0
Clinical studies of NARDIL did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
"Although there has been no systematic study of treatment of hypertensive crisis, phentolamine (available as Regitine<U+00AE>, Novartis) has been used and is recommended at a dosage of 5mg IV."	0
"The development of a potentially life-threatening serotonin syndrome has been reported with SNRIs and SSRIs, including SURMONTIL, alone, but particularly with concomitant use of other serotonergic drugs (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, and St. John<U+2019>s wort) and with drugs that impair metabolism of serotonin (in particular, MAOIs, both those intended to treat psychiatric disorders and also others, such as linezolid and intravenous methylene blue)."	0
"P-gp Inhibitors Reduction in the dose of SAMSCA may be required in patients concomitantly treated with P-gp inhibitors, such as e.g., cyclosporine, based on clinical response [see Dose and Administration (2.3) and Warnings and Precautions (5.5)]."	0
"Paroxetine metabolism is mediated in part by CYP2D6, and the metabolites are primarily excreted in the urine and to some extent in the feces."	0
Digoxin Concentrations Increased Greater than 50% Digoxin Serum Concentration Increase Digoxin AUC Increase Recommendations Amiodarone 70% NA Measure serum digoxin concentrations before initiating concomitant drugs.	1
"Higher degrees of AV block, however, were infrequently (0.8%) observed."	0
"Digoxin 0.25 mg QD, 20 days <U+2191> 15% <U+2191> 20 % 40 mg QD for 22 days Oral contraceptive QD, 2 months - norethindrone 1mg - ethinyl estradiol 35<U+00B5>g <U+2191> 28% <U+2191> 19% <U+2191> 23% <U+2191> 30% 10 mg, SD Tipranavir 500 mg BID/ritonavir 200 mg BID, 7 days No change No change 10 mg QD for 4 days Fosamprenavir 1400 mg BID, 14 days <U+2193> 27% <U+2193> 18% 10 mg QD for 4 days Fosamprenavir 700 mg BID/ritonavir 100 mg BID, 14 days No change No change"	0
The effect of paroxetine on labor and delivery in humans is unknown.	0
Prior to neuraxial intervention the physician should consider the potential benefit versus the risk in anticoagulated patients or in patients to be anticoagulated for thromboprophylaxis.	0
During these trials the appearance of new opacities was noted in both the lovastatin and placebo groups.	0
Systematic evaluation of the efficacy of nefazodone has shown that efficacy is maintained for periods of up to 36 weeks following 16 weeks of open-label acute treatment (treated for 52 weeks total) at dosages that averaged 438 mg/day.	0
"At clinically relevant concentrations, dofetilide has no effect on sodium channels (associated with Class I effect), adrenergic alpha-receptors, or adrenergic beta-receptors."	0
<U+201C>Coronary steal<U+201D> has not been observed during treatment with nicardipine (Coronary steal is the detrimental redistribution of coronary blood flow in patients with coronary artery disease from underperfused areas toward better perfused areas.)	0
Serum calcium concentration is not affected by amlodipine.	0
Administration Instruction s Swallow ACIPHEX delayed-release tablets whole.	0
"There have been rare reports of immune-mediated necrotizing myopathy (IMNM), an autoimmune myopathy, associated with statin use."	0
Treatment with antibacterial agents alters the normal flora of the colon leading to overgrowth of C. difficile.	0
"Although these events are generally self-limiting, some have been reported to be severe."	0
"The time course and dose dependence of this interaction have not been studied, and use within a few days of one another cannot be recommended."	0
"ACE inhibitors also inhibit the degradation of bradykinin, a reaction also catalyzed by ACE."	0
Eplerenone is not a substrate or an inhibitor of P-Glycoprotein at clinically relevant doses.	0
"Mirtazapine is a moderate peripheral <U+03B1>1<U+2013>adrenergic antagonist, a property that may explain the occasional orthostatic hypotension reported in association with its use."	0
"Initiate the dosing regimen for each patient individually, taking into account the patient's severity of pain, patient response, prior analgesic treatment experience, and risk factors for addiction, abuse, and misuse."	0
After initial titration some patients can be maintained adequately on a twice daily dosage regimen.	0
"Dual Blockade of the Renin-Angiotensin-Aldosterone System (RAAS): The concomitant use of aliskiren with other agents acting on the RAAS such as ACEIs or ARBs is associated with an increased risk of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"Second, rosuvastatin inhibits hepatic synthesis of VLDL, which reduces the total number of VLDL and LDL particles."	0
The intake of LASIX and sucralfate should be separated by at least two hours .	0
"When chlorpromazine is not being administered to reduce requirements of CNS depressants, it is best to stop such depressants before starting chlorpromazine treatment."	0
"At the first sign or symptom of impending cardiac failure, patients should be treated appropriately according to currently recommended guidelines, and the response observed closely."	0
INVIRASE must be administered in combination with ritonavir.	0
The combination may be used while taking increased consideration to the risk of increased serum bilirubin and serum creatinine.	0
"The terminal half-life of warfarin after a single dose is approximately 1 week; however, the effective half-life ranges from 20 to 60 hours, with a mean of about 40 hours."	0
"If this 25mg dose is used, assessment of efficacy must be made carefully."	0
Absorption and Distribution Mean peak plasma concentrations of eplerenone are reached approximately 1.5 to 2 hours following oral administration.	0
"Although the role of stimulants in these adult cases is also unknown, adults have a greater likelihood than children of having serious structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, coronary artery disease, or other serious cardiac problems."	0
"The oral bioavailability of dofetilide is >90%, with maximal plasma concentrations occurring at about 2<U+2013>3 hours in the fasted state."	0
"Since hepatic biotransformation is the predominant route for the disposition of nifedipine, the pharmacokinetics may be altered in patients with chronic liver disease."	0
Elderly patients may benefit from a lower initial dose.	0
"After multiple dosing, the major circulating metabolites were the 10-N-glucuronide, present at steady state at 44% of the concentration of olanzapine, and 4<U+2032>-N-desmethyl olanzapine, present at steady state at 31% of the concentration of olanzapine."	0
"After chronic dosing of 80 mg three times a day sildenafil to patients with PAH, lesser reductions than above in systolic and diastolic blood pressures were observed (a decrease in both of 2 mmHg)."	0
Laboratory Tests Periodic determination of serum electrolytes to detect possible electrolyte imbalance should be performed at appropriate intervals.	0
The serum digoxin concentrations should be monitored and used for titration of digoxin dose to obtain the desired clinical effect.	0
There was also a doubling of Cmin levels compared to healthy volunteers.	0
"Antifungals: ketoconazole, itraconazole REYATAZ/ritonavir: <U+2191> ketoconazole<U+2191> itraconazole Coadministration of ketoconazole has only been studied with REYATAZ without ritonavir (negligible increase in atazanavir AUC and Cmax)."	0
"However, most patients developed a mild reticulocytosis."	0
The last 2 complications may occur with or without preceding exacerbation of the angina pectoris.	0
"When VFEND is discontinued, cyclosporine concentrations must be frequently monitored and the dose increased as necessary."	1
"Thus , smaller doses of adenosine may be effective in the presence of dipyridamole ."	0
"Of particular importance, sufficient time must elapse before initiating TCA treatment in a patient being withdrawn from fluoxetine, given the long half-life of the parent and active metabolite (at least 5 weeks may be necessary)."	0
"Alcohol <U+2013> Although nefazodone did not potentiate the cognitive and psychomotor effects of alcohol in experiments with normal subjects, the concomitant use of nefazodone and alcohol in depressed patients is not advised."	0
"Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit."	0
Hypotension and reflex tachycardia are potential consequences of rapid upward titration of Cleviprex.	0
Alcohol Sildenafil (50 mg) did not potentiate the hypotensive effect of alcohol in healthy volunteers with mean maximum blood alcohol levels of 0.08%.	0
"If conversion to sinus rhythm has not been achieved after infusion of 10 mg/kg, then the infusion should be discontinued, and other means of conversion (eg, direct<U+2013>current cardioversion) should be considered."	0
Barbiturates Phenobarbital therapy may increase verapamil clearance.	1
Spironolactone and DLIS are much more extensively protein-bound than digoxin.	0
"Presumably because both drugs are metabolized by cyctochrome P450IIIA4, coadministration of quinidine causes variable slowing of the metabolism of nifedipine."	1
It is generally agreed that pharmacological treatment of ADHD may be needed for extended periods.	0
"If the dose is not administered immediately after measuring, store filled oral dosing dispenser(s) in the refrigerator [between 36<U+00B0>F-46<U+00B0>F (2<U+00B0>C-8<U+00B0>C)] for up to 72 hours prior to use."	0
Pediatrics ATACAND pharmacokinetics have not been determined in children with renal insufficiency.	0
"Reduce the dose of tofacitinib when given concomitantly with fluconazole (i.e., from 5 mg twice daily to 5 mg once daily as instructed in the XELJANZ<U+00AE> [tofacitinib] label)."	1
Higher doses of CARDIZEM CD may be needed in some patients.	0
Ketoconazole (strong CYP3A4 inhibitor): Increases AUC for ramelteon; administer with caution.	1
Cumulative drug effects may be observed in patients with impaired renal function.	0
"Pravastatin plasma concentrations, including area under the concentration-time curve (AUC), Cmax, and steady-state minimum (Cmin), are directly proportional to administered dose."	0
AVALIDE is not recommended as initial therapy in patients with intravascular volume depletion.	0
"Angiotensin converting enzyme is identical to kininase, an enzyme that degrades bradykinin."	0
Some patients responding to mexiletine may be transferred to a 12 hour dosage schedule to improve convenience and compliance.	0
PGP Inducers/Inhibitors: Drugs that induce or inhibit PGP have the potential to alter digoxin pharmacokinetics.	0
"As such, no clinically relevant interactions with drugs metabolized by these CYP enzymes would be expected."	0
Pediatric Use Safety and effectiveness in pediatric patients have not been established.	0
"Laboratory Tests: Infusion of dopamine suppresses pituitary secretion of thyroid<U+2019>stimulating hormone, growth hormone, and prolactin."	0
These patients presented with abdominal pain (with or without nausea or vomiting); in some cases there was no prior history of facial angioedema and C-1 esterase levels were normal.	0
"Concomitant Strong CYP3A4 Inducers Avoid the concomitant use of strong CYP3A4 inducers (e.g., dexamethasone, phenytoin, carbamazepine, rifampin, rifabutin, rifapentine, phenobarbital)."	0
Patients with AFIB/AFL associated with the sick sinus syndrome may be treated with sotalol if they have an implanted pacemaker for control of bradycardia symptoms.	0
"After oral administration of dabigatran etexilate in healthy volunteers, Cmax occurs at 1 hour post-administration in the fasted state."	0
It is not possible to say how important this is.	0
"The pooled analyses of short-term placebo-controlled trials of antidepressant drugs (SSRIs and others) showed that these drugs increase the risk of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults (ages 18-24) with major depressive disorder (MDD) and other psychiatric disorders."	0
"In the duloxetine clinical trials database, three duloxetine -treated patients had liver injury as manifested by ALT and total bilirubin elevations, with evidence of obstruction."	0
"Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior."	0
"In a controlled study of a single dose (2 mg) of pimozide, 200 mg sertraline (q.d.) co-administration to steady state was associated with a mean increase in pimozide AUC and Cmax of about 40%, but was not associated with any changes in EKG."	1
"For a selective serotonin reuptake inhibitor (SSRI), these reactions have included hyperthermia, rigidity, myoclonus, autonomic instability with possible rapid fluctuations of vital signs, and mental status changes that include extreme agitation progressing to delirium and coma."	0
Remodulin has not been studied in conjunction with Flolan or Tracleer ( bosentan ) .	0
The optimal dosing regimen for use of indinavir in pediatric patients has not been established.	0
"Pulse and blood pressure should be measured at baseline, following STRATTERA dose increases, and periodically while on therapy to detect possible clinically important increases."	0
The mechanism and long-term consequences of these events are currently unknown.	0
"ACE inhibitors also inhibit the degradation of bradykinin, a reaction also catalyzed by ACE."	0
Starting dose of Renvela is 0.8 or 1.6 grams administered orally three times per day with meals based on serum phosphorus levels for adult patients and based on body surface area (BSA) category for pediatric patients.	0
"For the same period, about 40 to 45% of the administered radioactivity was accounted for in feces, including 12 to 14% unchanged sertraline."	0
"If a change in skin color or temperature occurs and is thought to be the result of compromised circulation to the extremities, the benefits of continued dopamine infusion should be weighed against the risk of possible necrosis."	0
These studies did not show an increase in the risk of suicidal thoughts and behavior with antidepressant use in patients over age 24; there was a reduction in risk with antidepressant use in patients aged 65 and older.	0
"Therefore, early in the treatment phase during the dosage adjustment period, monitor serum calcium levels twice weekly."	0
No dosage adjustment is necessary in patients with compromised renal function.	0
"Figure 2<U+2003>Average Time Course for Effects of Dabigatran on aPTT, Following Approved PRADAXA Dosing Regimens in Patients with Various Degrees of Renal Impairment* *Simulations based on PK data from a study in subjects with renal impairment and PK/aPTT relationships derived from the RE-LY study; aPTT prolongation in RE-LY was measured centrally in citrate plasma using PTT Reagent Roche Diagnostics GmbH, Mannheim, Germany."	0
Treatment of familial Mediterranean fever (FMF): Co-administration of colchicine in patients on CRIXIVAN: Maximum daily dose of 0.6 mg (may be given as 0.3 mg twice a day).	0
Methadone: Coadministration may produce opioid intoxication.	0
The volume of distribution is 11 L after a single intravenous (IV) administration.	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP may be used to treat migraine headaches with an acceptable margin of cardiovascular safety."	0
Steady-state plasma fluvoxamine concentrations were 2-3 fold higher in children than in adolescents.	0
Nitrates Do not use ADCIRCA in patients who are using any form of organic nitrate [see Contraindications (4.1)].	0
"Discontinuation may be necessary for severe hematologic or other toxicity, even if rejection of the homograft may be a consequence of drug withdrawal."	0
"AGGRASTAT is a reversible antagonist of fibrinogen binding to the GP IIb/IIIa receptor, the major platelet surface receptor involved in platelet aggregation."	0
Telmisartan is not removed from blood by hemofiltration.	0
"35 mcg, 8 days 800 three times daily, 8 days 18 1.02(0.96, 1.09) 1.22(1.15, 1.30) 1.37(1.24, 1.51) Isoniazid 300 once daily in the morning, 8 days 800 three times daily, 8 days 11 1.34(1.12, 1.60) 1.12(1.03, 1.22) 1.00(0.92, 1.08) MethadoneStudy conducted in subjects on methadone maintenance."	0
Pediatric Patients: There is no pediatric experience with ZIAC.	0
"As with other antimuscarinic agents, the major action of atropine is a competitive or surmountable antagonism which can be overcome by increasing the concentration of acetylcholine at receptor sites of the effector organ (e.g., by using anticholinesterase agents which inhibit the enzymatic destruction of acetylcholine)."	0
The use of MAOIs intended to treat psychiatric disorders with Savella or within 5 days of stopping treatment with Savella is contraindicated because of an increased risk of serotonin syndrome.	0
"It is greater than 99% bound to plasma proteins, binding primarily to albumin and <U+03B1>1-acid glycoprotein."	0
"Consider this syndrome in any patient presenting with seizures, headache, visual disturbances, confusion or altered mental function."	0
Approximately 97% of either quinapril or quinaprilat circulating in plasma is bound to proteins.	0
"Marplan should not be used in patients with a history of liver disease, or in those with abnormal liver function tests."	0
AGGRENOX is not interchangeable with the individual components of aspirin and dipyridamole tablets.	0
Perindoprilat elimination is decreased in renally impaired patients.	0
A similar effect would be expected with eszopiclone.	0
Caution should be used when prescribing with simvastatin.	0
"PDE5 inhibitors: Concomitant use contraindicated (4.1, 7.1) Antihypertensives: Possible additive hypotensive effects (7.2) Aspirin: increased nitroglycerin levels (7.3) Tissue-type plasminogen activator (t-PA): decreased thrombolytic effect (7.4) Heparin: anticoagulant effect of heparin may be reduced."	0
"With this action, triamterene increases sodium excretion and reduces the excessive loss of potassium and hydrogen associated with hydrochlorothiazide."	0
Epidemiological studies of case-control and cohort design have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding.	0
"The following drug interactions may occur with potassium citrate: Potassium-sparing diuretics: concomitant administration should be avoided since the simultaneous administration of these agents can produce severe hyperkalemia (7.1) Drugs that slow gastrointestinal transit time: These agents (such as anticholinergics) can be expected to increase the gastrointestinal irritation produced by potassium salts (7.2) Potassium-sparing Diuretics: Concomitant administration of potassium citrate extended-release tablets and a potassium-sparing diuretic (such as triamterene, spironolactone or amiloride) should be avoided since the simultaneous administration of these agents can produce severe hyperkalemia."	0
"The systemic clearance of citalopram was 330 mL/min, with approximately 20% of that due to renal clearance."	0
"Interaction with Combined P-gp and Strong CYP3A4 Inhibitors Avoid concomitant administration of XARELTO with known combined P-gp and strong CYP3A4 inhibitors (e.g., ketoconazole and ritonavir) [see Warnings and Precautions (5.6) and Clinical Pharmacology (12.3)]."	0
"CYP3A4 Inducers: No information is available on the quantitative effects of CYP3A4 inducers (e.g., carbamazepine, phenobarbital, phenytoin, fosphenytoin, primidone, rifampicin, St. John<U+2019>s Wort) on amlodipine."	0
There is no body of evidence available from controlled trials to indicate how long the patient with ADHD should be treated with Focalin XR.	0
A similar analysis in adult patients treated with STRATTERA for either ADHD or major depressive disorder (MDD) did not reveal an increased risk of suicidal ideation or behavior in association with the use of STRATTERA.	0
"Electrophysiological Effects Dronedarone exhibits properties of all four Vaughn-Williams antiarrhythmic classes, although it is unclear which of these are important in producing dronedarone's clinical effects."	0
"Telmisartan In normal volunteers, a dose of telmisartan 80 mg inhibited the pressor response to an intravenous infusion of angiotensin II by about 90% at peak plasma concentrations with approximately 40% inhibition persisting for 24 hours."	0
"Clinical pharmacology studies have confirmed the beta-blocking activity of metoprolol in man, as shown by (1) reduction in heart rate and cardiac output at rest and upon exercise, (2) reduction of systolic blood pressure upon exercise, (3) inhibition of isoproterenol-induced tachycardia, and (4) reduction of reflex orthostatic tachycardia."	0
Warfarin (CYP2C9 Inhibition) Prothrombin Time Significantly Increased Monitor PT or other suitable anti-coagulation tests.	0
"If Tasigna is administered with drugs that inhibit P-gp, increased concentrations of nilotinib are likely, and caution should be exercised."	1
Phenylalanine can be harmful to patients with phenylketonuria.	0
"Lower starting and maintenance doses of other CYP3A4 substrates ( e.g. , atorvastatin ) may be required as amiodarone may increase the plasma concentration of these drugs ."	1
There may be circumstances when it is necessary to initiate treatment with an MAOI such as linezolid or intravenous methylene blue in a patient taking SURMONTIL.	0
The dose of TOPROL-XL should not be increased until symptoms of worsening heart failure have been stabilized.	0
The recommended initial dosage of CARDURA is 1 mg given once daily either in the morning or evening.	0
"Drugs Metabolized by CYP2D6 In vitro, bupropion and hydroxybupropion are CYP2D6 inhibitors."	0
Pediatric: Clinical studies to establish pediatric dosing schedules have not been conducted.	0
Discontinue mexiletine if DRESS is suspected.	0
"Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure."	0
"In more than half of the reported cases, treatment with protease inhibitors was continued or reintroduced."	0
Reserve concomitant prescribing of these drugs for use in patients for whom alternative treatment options are inadequate.	0
"Calcium channel antagonists : In patients with depressed myocardial function , use of BREVIBLOC with cardiodepressant calcium channel antagonists ( e.g. , verapamil ) can lead to fatal cardiac arrests ."	0
IV: 1 mg per fractional injection at 2-minute intervals and not exceeding recommended IM dosage.	0
"However, in patients with moderate hepatic impairment, there is no clear understanding of the impact of this degree of hepatic function impairment on the coagulation cascade and its relationship to efficacy and bleeding."	0
This combination may be used with a dosage adjustment of sirolimus depending on the effect/concentration measurements.	0
"However, age-related and other changes in adult renal function were not."	0
"If serotonin syndrome occurs, discontinue DESOXYN and the CYP2D6 inhibitor."	0
Diabetes and Hypoglycemia: Latent diabetes mellitus may become manifest and diabetic patients given thiazides may require adjustment of their insulin dose.	0
"In man, amoxapine serum concentration declines with a half-life of eight hours."	0
All reactions occurred in children 12 years of age or younger.	0
The dosage for prophylaxis of PSVT (non-digitalized patients) ranges from 240 to 480 mg/day in divided (t.i.d.	0
ACCURETIC is contraindicated in patients who are hypersensitive to quinapril or hydrochlorothiazide and in patients with a history of angioedema related to previous treatment with an ACE inhibitor.	0
"Therefore, due to significant drug-drug interactions between protease inhibitors and rifabutin, their concomitant use should be based on the overall assessment of the patient and a patient-specific drug profile."	0
"When discontinuing therapy, gradual dose reduction is recommended whenever possible to minimize discontinuation symptoms."	0
"In some of the cases, medical conditions and other factors were reported that may have played a role."	0
This diminution is not sufficient to preclude effectiveness of the pressor agent for therapeutic use.	0
Reproductive effects: Include decreased testosterone and increased prolactin levels.	0
"In particular, the combined use of nefazodone with triazolam should be avoided for most patients, including the elderly."	0
"There were differences in absolute risk of suicidality across the different indications, with the highest incidence in MDD."	0
"If either cyclosporine or tacrolimus is administered with nefazodone, blood concentrations of the immunosuppressive agent should be monitored and dosage adjusted accordingly."	0
"Penicillins are distributed in varying degrees into pleural, pericardial, peritoneal, ascitic, synovial, and interstitial fluids."	0
Sofosbuvir is extensively metabolized in the liver to form the pharmacologically active nucleoside analog triphosphate GS-461203.	0
"Transporter proteins: In vitro studies suggest LATUDA is not a substrate of OATP1B1 or OATP1B3, however, is probably a substrate of P-gp and BCRP."	0
"Since indomethacin and potassium-sparing diuretics, including amiloride HCl, may each be associated with increased serum potassium levels, the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently."	0
"Therefore, coadministration of WELLBUTRIN XL with drugs that are metabolized by CYP2D6 can increase the exposures of drugs that are substrates of CYP2D6."	1
Aggressive behavior or hostility is often observed in children and adolescents with ADHD.	0
"Telmisartan is not metabolized by the cytochrome P450 system and had no effects in vitro on cytochrome P450 enzymes, except for some inhibition of CYP2C19."	0
There are no empirical data on avoiding drug interactions between Renvela and most concomitant oral drugs.	0
"Foods and Beverages To Avoid Meat and Fish Pickled herring Liver Dry sausage (including Genoa salami, hard salami, pepperoni, and Lebanon bologna) Vegetables Broad bean pods (fava bean pods) Sauerkraut Dairy Products Cheese (cottage cheese and cream cheese are allowed) Yogurt Beverages Beer and wine Alcohol-free and reduced-alcohol beer and wine products Miscellaneous Yeast extract (including brewer's yeast in large quantities) Meat extract Excessive amounts of chocolate and caffeine Also, any spoiled or improperly refrigerated, handled, or stored protein-rich foods such as meats, fish, and dairy products, including foods that may have undergone protein changes by aging, pickling, fermentation, or smoking to improve flavor should be avoided."	0
Intraoperative Floppy Iris Syndrome (IFIS) has been observed during cataract surgery in some patients on or previously treated with alpha1 blockers.	0
Cholestyramine and Colestipol Resins- Both cholestyramine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract.	1
"Cerebral hemorrhage, subarachnoid hemorrhage, and stroke have occurred in patients treated with 5-HT1 agonists, and some have resulted in fatalities."	0
It is not known whether this drug is excreted in human milk.	0
"Consider periodic determinations of serum electrolytes to detect possible electrolyte imbalances, particularly in patients at risk."	0
"This is consistent with the interactions observed between nefazodone and triazolam, alprazolam, buspirone, atorvastatin, and simvastatin, drugs metabolized by this isozyme."	0
"In addition, certain drugs inhibit the activity of this isozyme and make normal metabolizers resemble poor metabolizers."	0
Geriatric use<U+2013> Safety and efficacy of quinidine in elderly patients has not been systematically studied.	0
"In cases of actual salt depletion, appropriate replacement is the therapy of choice."	0
"Worsening of insomnia, or the emergence of new cognitive or behavioral abnormalities, may be the result of an unrecognized underlying psychiatric or physical disorder and requires further evaluation of the patient."	0
"Population Subgroups: Factors or conditions altering metabolic capacity (e.g., liver disease, congestive heart failure [CHF], age, concomitant medications, etc.) or elimination may be expected to influence the degree and extent of accumulation of the active metabolites of bupropion."	0
"Because animal reproductive studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed."	0
Patients with mild renal functional impairment should not receive this drug without frequent and continuing monitoring of serum electrolytes.	0
Hypomagnesemia is common in most of the same conditions in which hypokalemia appears.	0
Measure blood pressure prior to initiating treatment and periodically monitor blood pressure throughout Savella treatment.	0
"Rarely, use of carvedilol in patients with heart failure has resulted in deterioration of renal function."	0
"Strong CYP3A inhibitors substantially increase ticagrelor exposure and so increase the risk of dyspnea , bleeding , and other adverse events ."	1
Drug Interactions: May interact with drugs metabolized by CYP450.	0
"These data suggest that there is no prominent effect of age on bupropion concentration; however, another single- and multiple-dose pharmacokinetic study suggested that the elderly are at increased risk for accumulation of bupropion and its metabolites."	0
"Drugs That Alter Renal Excretion Ibuprofen: Ibuprofen is known to affect renal function and, consequently, alter the renal excretion of other drugs."	0
This diagnosis should be considered if clinical symptoms consistent with cyanocobalamin deficiency are observed.	0
"If liver injury is detected, promptly interrupt ULORIC and assess patient for probable cause, then treat cause if possible, to resolution or stabilization."	0
"This hazard may be decreased if partial atrioventricular block is achieved prior to initiation of quinidine therapy, using conduction<U+2013>reducing drugs such as digitalis, verapamil, diltiazem, or a <U+00DF><U+2013>receptor blocking agent."	0
At 10weeks most features were normalized.	0
"Pharmacodynamics Blood pressure lowering drugs (e.g., diuretics, antihypertensive agents, or vasodilators): Risk of increased reduction in blood pressure (7.1) Remodulin inhibits platelet aggregation."	0
"Like the thiazide diuretics, chlorthalidone produces dose-related reductions in serum potassium levels, elevations in serum uric acid and blood glucose, and it can lead to decreased sodium and chloride levels."	0
"The occurrence of stupor, muscular rigidity, severe agitation, and elevated temperature has been reported in some patients receiving the combination of selegiline and meperidine."	0
Reproductive studies in animals and clinical experience to date have failed to show a teratogenic effect with thioridazine.	0
In vitro protein-binding studies have shown that bicalutamide can displace coumarin anticoagulants from binding sites.	0
"EXTRANEAL contains lactate which may contribute to worsening acidosis if conversion to bicarbonate is impaired and may be associated with hyperventilation, lethargy, hypotension or irregular heart rhythms."	0
The relevance of these findings to humans is unknown.	0
The recommended dosage of CRIXIVAN is 800 mg (usually two 400-mg capsules) orally every 8 hours.	0
"Avoid administration of CAPRELSA with anti-arrhythmic drugs (including but not limited to amiodarone, disopyramide, procainamide, sotalol, dofetilide) and other drugs that may prolong the QT interval (including but not limited to chloroquine, clarithromycin, dolasetron, granisetron, haloperidol, methadone, moxifloxacin, and pimozide)."	0
"If the QT interval prolongs to 500 ms or greater, the dose must be reduced, the duration of the infusion prolonged or the drug discontinued Adjust the dosing interval based on creatinine clearance WARNING: LIFE THREATENING PROARRHYTHMIA See full prescribing information for complete boxed warning."	0
"Similar findings, however, have been observed in normal or well-compensated patients with heart failure with agents possessing significant negative inotropic effects."	0
"It is mandatory to have emergency resuscitative equipment and drugs immediately available to manage adverse reactions involving cardiovascular, respiratory, or central nervous systems."	0
The absolute bioavailability of asenapine when swallowed is low (<2% with an oral tablet formulation).	0
"DEMSER may have additive sedative effects with alcohol and other CNS depressants , e.g. , hypnotics , sedatives , and tranquilizers ."	0
"The antihypertensive effect of ACE inhibitors, including quinapril may be attenuated by NSAIDs."	0
NORPRAMIN is contraindicated in the acute recovery period following myocardial infarction.	0
"Renal Impairment An open, parallel-group single-center study compared dabigatran pharmacokinetics in healthy subjects and patients with mild to moderate renal impairment receiving a single dose of PRADAXA 150 mg."	0
"In a longer-term study, patients meeting DSM-III-R criteria for OCD who had responded during a 52-week single-blind trial on sertraline 50 to 200 mg/day (n = 224) were randomized to continuation of sertraline or to substitution of placebo for up to 28 weeks of observation for discontinuation due to relapse or insufficient clinical response."	0
PERSANTINE tablets have been found to lengthen abnormally shortened platelet survival time in a dose-dependent manner.	0
Symptoms suggestive of angioedema or facial edema occurred in 0.13% of trandolapril-treated patients.	0
"The risk of hyperkalemia may be increased in patients with renal insufficiency, diabetes mellitus or with concomitant use of drugs that raise serum potassium."	0
"Concomitant therapy with beta-adrenergic blockers and verapamil may result in additive negative effects on heart rate, atrioventricular conduction and/or cardiac contractility."	0
"In subjects who had received 21 days of 40 mg/day racemic citalopram, combined administration of 400 mg twice a day cimetidine for 8 days resulted in an increase in citalopram AUC and Cmax of 43% and 39%, respectively."	1
"Peripheral Vasculopathy, including Raynaud<U+2019>s phenomenon: Stimulants used to treat ADHD are associated with peripheral vasculopathy, including Raynaud<U+2019>s phenomenon."	0
"In patients whose renal function may depend upon the activity of the renin-angiotensin-aldosterone system (e.g., patients with severe congestive heart failure), treatment with angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and rarely with acute renal failure and/or death."	0
"The objective of treatment with potassium citrate extended-release tablets is to provide potassium citrate extended-release tablets in sufficient dosage to restore normal urinary citrate (greater than 320 mg/day and as close to the normal mean of 640 mg/day as possible), and to increase urinary pH to a level of 6.0 or 7.0."	0
"Cases of serotonin syndrome, a potentially life-threatening condition, have been reported during concomitant use of Meperidine Hydrochloride Injection with serotonergic drugs."	0
Dosing must be individualized considering baseline and target blood pressure as well as experience with individual agents.	0
"Calcium excretion is decreased by thiazides, and pathologic changes in the parathyroid glands, with hypercalcemia and hypophosphatemia, have been observed in a few patients on prolonged thiazide therapy."	0
Monoamine Oxidase Inhibitors: See CONTRAINDICATIONS (4.1) and WARNINGS AND PRECAUTIONS (5.2).	0
"Therefore, no adjustment is necessary for oral dosing in patients with mild to severe renal impairment."	0
The following formula may be used to estimate creatinine clearance in children: K <U+00D7> linear length or height (cm) serum creatinine (mg/100 mL) (Where K=0.55 for children older than 1 year and 0.45 for infants.)	0
Antimycobacterial Agents Rifampin Plasma concentrations of nelfinavir can be reduced by concomitant use of rifampin.	1
So giving iloperidone with inhibitors of both of its metabolic pathways did not add to the effect of either inhibitor given alone.	0
"Drug Interactions (not described in Contraindications or Warnings and Precautions) include the following: Drugs Inhibiting or Metabolized by Cytochrome P450: Fluvoxamine inhibits several cytochrome P450 isoenzymes (CYP1A2, CYP2C9, CYP3A4, and CYP2C19) (7.1)."	0
Study 2 was a flexible-dose study comparing paroxetine (20 to 60 mg daily) with clomipramine (25 to 250 mg daily).	0
"Similarly, there were no changes in the pharmacokinetic parameters of nefazodone or HO-NEF; however, the mean AUC levels of the nefazodone metabolites mCPP and triazole-dione increased by 3 to 6 fold and 1.3 fold, respectively."	0
Antidiabetic drugs: Dosage adjustment of antidiabetic may be required.	0
"In order to allow the required volume of VFEND concentrate to be added, withdraw and discard at least an equal volume of diluent from the infusion bag or bottle to be used."	0
"In such patients, prothrombin time should be determined before starting simvastatin and frequently enough during early therapy to ensure that no significant alteration of prothrombin time occurs."	0
There are no adequate and well-controlled studies in pregnant women.	0
The effects of adenosine are antagonized by methylxanthines such as caffeine and theophylline .	0
"GI hemorrhage occurred in 2.9% and 5.1% of patients in the Tasigna 300 mg twice daily and 400 mg twice daily arms and in 1.4% of patients in the imatinib arm, respectively."	0
"Prophylaxis of gout flares: If the original regimen was 0.6mg twice a day, the regimen should be adjusted to 0.3mg twice a day or 0.6mg once a day."	0
Specific Populations Renal and Liver Disease: Increased plasma concentrations of paroxetine occur in subjects with renal and hepatic impairment.	0
Lipid intake restrictions may be necessary for patients with significant disorders of lipid metabolism.	0
"The exposure of eszopiclone was increased by coadministration of ketoconazole, a potent inhibitor of CYP3A4."	1
Other 5-HT3 Antagonists Clinical Impact No change in the exposure of the 5-HT3 antagonist.	0
"Thiazides affect the renal tubular mechanisms of electrolyte reabsorption, directly increasing excretion of sodium and chloride in approximately equivalent amounts."	0
"Myocardial ischemia, myocardial infarction, and Prinzmetal's angina: Perform cardiac evaluation in patients with multiple cardiovascular risk factors (5.1) Arrhythmias: Discontinue dosing if occurs (5.2) Chest/throat/neck/jaw pain, tightness, pressure, or heaviness; Generally not associated with myocardial ischemia; Evaluate patients at high risk (5.3) Cerebral hemorrhage, subarachnoid hemorrhage, and stroke: Discontinue dosing if occurs (5.4) Gastrointestinal ischemic events, peripheral vasospastic reactions: Discontinue dosing if occurs (5.5) Medication overuse headache: Detoxification may be necessary (5.6) Serotonin syndrome: Discontinue dosing if occurs (5.7) MAXALT should not be given to patients with ischemic or vasospastic coronary artery disease."	0
"Concomitant medications were grouped as ACE inhibitors, oral anticoagulants, calcium channel blockers, beta blockers, cardiac glycosides, inducers of CYP3A4, substrates and inhibitors of CYP3A4, substrates and inhibitors of P-glycoprotein, nitrates, sulphonylureas, loop diuretics, potassium sparing diuretics, thiazide diuretics, substrates and inhibitors of tubular organic cation transport, and QTc-prolonging drugs."	0
Some ACEON-treated patients have developed minor and transient increases in blood urea nitrogen and serum creatinine especially in those concomitantly treated with a diuretic.	0
"Some patients with paroxysmal and/or chronic atrial fibrillation or atrial flutter and a coexisting accessory AV pathway have developed increased antegrade conduction across the accessory pathway bypassing the AV node, producing a very rapid ventricular response or ventricular fibrillation after receiving intravenous verapamil (or digitalis)."	0
"Patients switching immediately (no washout period) from treatment with another ritonavir containing regimen or from a non-nucleoside reverse transcriptase inhibitor based regimen (not including delavirdine, rilpivirine) should initiate and continue INVIRASE at the standard recommended dose of 1000-mg twice daily with ritonavir 100-mg twice daily."	0
"A List of Dibenzazepine Derivative Drugs by Generic Name Follows: nortriptyline hydrochlorideamitriptyline hydrochlorideperphenazine and amitriptyline hydrochlorideclomipramine hydrochloridedesipramine hydrochlorideimipramine hydrochloridedoxepincarbamazepine cyclobenzaprine HClamoxapinemaprotiline HCltrimipramine maleateprotriptyline HClmirtazapine NARDIL should be used with caution in combination with antihypertensive drugs, including thiazide diuretics and <U+03B2>-blockers, since exaggerated hypotensive effects may result."	0
<U+2022>Extended treatment: Adjust dose to maintain lowest effective dose; reassess patients periodically (2.4).	0
In vitro binding studies show CARDIZEM is 70% to 80% bound to plasma proteins.	0
IM: 25 mg (1 mL) tid or qid until patient can take oral therapy.	0
"In these studies, paroxetine was shown to be significantly more effective than placebo in treating panic disorder by at least 2 out of 3 measures of panic attack frequency and on the Clinical Global Impression Severity of Illness score."	0
"No teratogenic effects were observed in studies performed in rats and mice at doses up to 100 mg/kg, which is 24 times the maximum recommended human daily dose (MRHD) on a mg/kg basis and 4 times (rats) and 2 times (mice) the MRHD on a mg/m2 basis."	0
Apixaban is a substrate of transport proteins: P-gp and breast cancer resistance protein.	0
"TOPROL-XL is contraindicated in severe bradycardia, second or third degree heart block, cardiogenic shock, decompensated cardiac failure, sick sinus syndrome (unless a permanent pacemaker is in place), and in patients who are hypersensitive to any component of this product."	0
"Amiodarone is metabolized to the active metabolite desethylamiodarone ( DEA ) by the cytochrome P450 ( CYP450 ) enzyme group , specifically CYP3A and CYP2C8 ."	0
A potentially fatal symptom complex sometimes referred to as Neuroleptic Malignant Syndrome (NMS) has been reported in association with antipsychotic drugs.	0
The trough effect represents about 50% of the peak effect.	0
"Patients with Hepatic Impairment - In patients with liver dysfunction, following administration of immediate-release fluvoxamine maleate tablets, fluvoxamine clearance was decreased by approximately 30%."	0
Losartan potassium tablets can be administered once or twice daily with total daily doses ranging from 25mg to 100mg.	0
"Figure 1: Acute Major Coronary Events (Primary Endpoint) In the Canadian Coronary Atherosclerosis Intervention Trial (CCAIT), the effect of therapy with lovastatin on coronary atherosclerosis was assessed by coronary angiography in hyperlipidemic patients."	0
"If the serum potassium level exceeds 6.5 mEq per liter, active measures should be taken to reduce it."	0
"Withdrawal symptoms can occur in breastfed infants when maternal administration of an opioid analgesic is stopped, or when breast-feeding is stopped."	0
The active metabolite is bound about 98% to human serum albumin.	0
Adjust dosage according to blood pressure goals.	0
"Co-administration of SAMSCA with 400 mg ketoconazole daily or with other strong CYP 3A inhibitors ( e.g. , clarithromycin , itraconazole , telithromycin , saquinavir , nelfinavir , ritonavir and nefazodone ) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure ."	1
"Concomitant use with triamterene and amiloride (4, 7.1)"	0
"In patients receiving nonselective monoamine oxidase (MAO) inhibitors in combination with serotoninergic agents (e.g., dexfenfluramine, fluoxetine, fluvoxamine, paroxetine, sertraline, citalopram, venlafaxine) there have been reports of serious, sometimes fatal, reactions."	0
"Pharmacodynamic Actions Pimozide tablets, USP is an orally active antipsychotic drug product which shares with other antipsychotics the ability to blockade dopaminergic receptors on neurons in the central nervous system."	0
Cases of cholestatic jaundice with minimal elevation of transaminase levels have also been reported.	0
The elimination of the parent drug takes place via hepatic metabolism of estazolam to hydroxylated and other metabolites that are eliminated largely in the urine both free and conjugated.	0
"However, patients receiving warfarin should have their PT and INR monitored when pitavastatin is added to their therapy."	0
Bicalutamide is a non-steroidal androgen receptor inhibitor.	0
"Therefore, particular care should be exercised when it is necessary to administer tricyclic antidepressants with sympathomimetic amines, local decongestants, local anesthetics containing epinephrine, atropine or drugs with an anticholinergic effect."	0
"Drug interaction was studied with several beta-blockers (propranolol, metoprolol, nadolol, and pindolol)."	0
A dosage of 25 mg or 50 mg per day is the initial therapeutic dosage.	0
The total daily dose should not exceed 36 mg.	0
"Further diagnostic evaluation may be warranted, and discontinuation of CRIXIVAN should be considered in all patients with severe leukocyturia."	0
Coadministration of CRIXIVAN and other drugs that inhibit CYP3A4 may decrease the clearance of indinavir and may result in increased plasma concentrations of indinavir.	1
"Dosage adjustments should be made to maintain the patient on the lowest effective dosage, and patients should be periodically reassessed to determine the need for continued treatment."	0
Patients with liver dysfunction should begin with a low dose of LUVOX CR Capsules and increase it slowly with careful monitoring.	0
No reports involved the administration of methylene blue by other routes (such as oral tablets or local tissue injection).	0
In vitro studies using human liver microsomes and recombinant enzymes indicate that CYP3A4 is the major CYP contributing to the oxidative metabolism of ziprasidone.	0
"Race: The results across pharmacokinetic studies in normal subjects showed no differences in apixaban pharmacokinetics among White/Caucasian, Asian, and Black/African American subjects."	0
Warfarin <U+2014> Warfarin (20mg single dose) did not affect olanzapine pharmacokinetics.	0
Mirtazapine is a potent antagonist of 5-HT2 and 5-HT3 receptors.	0
"Known hypersensitivity to amphetamine products or other ingredients in VYVANSE (4) Use with monoamine oxidase (MAO) inhibitor, or within 14 days of the last MAO inhibitor dose (4, 7.2)"	0
NA <U+2013> Not available/reported Antiarrhythmics Dofetilide Concomitant administration with digoxin was associated with a higher rate of torsades de pointes.	0
Thiazides should be used with caution in severe renal disease.	0
"In addition, in vitro data indicate that ramelteon does not cause false-positive results for benzodiazepines, opiates, barbiturates, cocaine, cannabinoids, or amphetamines in two standard urine drug screening methods in vitro."	0
Hemodialysis in ESRD subjects: Systemic exposure to apixaban administered as a single 5 mg dose in ESRD subjects dosed immediately after the completion of a 4-hour hemodialysis session (post-dialysis) is 36% higher when compared to subjects with normal renal function.	0
"In clinical studies in which amlodipine was administered in combination with beta-blockers to patients with either hypertension or angina, no adverse effects of electrocardiographic parameters were observed."	0
"Nonetheless, the emergence of any new behavioral sign or symptom of concern requires careful and immediate evaluation."	0
"The S-enantiomer of warfarin is mainly metabolized to 7-hydroxywarfarin by CYP2C9, a polymorphic enzyme."	0
"Furthermore, in those circumstances when the drugs have not been studied in the same controlled clinical trial(s), comparisons among the results of studies evaluating the effectiveness of different antidepressant drug products are inherently unreliable."	0
"Figure 1 PK Interactions between Levomilnacipran (LVM) and Other Drugs Figure 1 No dose adjustment of the concomitant medication is recommended when FETZIMA is administered with a substrate of CYP3A4, CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, P-gp, OATP1B1, OATP1B3, OAT1, OAT3, or OCT2."	0
"In a study of patients with impaired renal function (mean creatinine clearance of 19 mL/min), the half-life of hydrochlorothiazide elimination was lengthened to 21 hours."	0
The mean relative bioavailability of the extended-release tablet is approximately 29% (range: 9% to 66%) compared to that of the fluvastatin immediate-release capsule administered under fasting conditions.	0
A causal relationship between protease inhibitor therapy and these episodes has not been established.	0
"In that trial, 40 mg of dilatrate<U+00AE>-SR was administered twice daily in doses given 6 hours apart."	0
Coadministration of INVIRASE/ritonavir with CYP3A substrates for which increased plasma levels may result in serious or life-threatening reactions.	0
Monitor serum lithium levels during concurrent use.	0
"Apixaban is metabolized mainly via CYP3A4 with minor contributions from CYP1A2, 2C8, 2C9, 2C19, and 2J2."	0
The use of NORPRAMIN within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated.	0
Elevated blood pressure and heart rate: Savella may increase blood pressure and heart rate.	0
"In poor metabolizers and at higher doses, nebivolol inhibits both <U+03B2>1 - and <U+03B2>2 - adrenergic receptors."	0
"Nefazodone has been shown to have no genotoxic effects based on the following assays: bacterial mutation assays, a DNA repair assay in cultured rat hepatocytes, a mammalian mutation assay in Chinese hamster ovary cells, an in vivo cytogenetics assay in rat bone marrow cells, and a rat dominant lethal study."	0
Patients should be monitored for these symptoms when discontinuing treatment with Savella.	0
APTIVUS may be less effective due to decreased tipranavir plasma concentration in patients taking these agents concomitantly.	0
The ALTACE capsule can also be opened and the contents sprinkled on a small amount (about 4 oz.) of applesauce or mixed in 4 oz.	0
An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy.	0
"When used concomitantly, inhalation anesthetics and calcium antagonists, such as verapamil, should each be titrated carefully to avoid excessive cardiovascular depression."	0
"In clinical studies, sertraline hydrochloride was shown to induce hepatic enzymes minimally as determined by a small (5%) but statistically significant decrease in antipyrine half-life following administration of 200 mg/day for 21 days."	1
DUTOPROL may be administered with or without food.	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older.	0
The dose of verapamil must be individualized by titration.	0
"CYP17 catalyzes two sequential reactions: 1) the conversion of pregnenolone and progesterone to their 17<U+03B1>-hydroxy derivatives by 17<U+03B1>-hydroxylase activity and 2) the subsequent formation of dehydroepiandrosterone (DHEA) and androstenedione, respectively, by C17, 20 lyase activity."	0
Clinical studies have demonstrated no clinically significant pharmacokinetic interaction between PRISTIQ and strong CYP 3A4 inhibitors (Figure 1).	0
Active pathological bleeding (4) History of serious hypersensitivity reaction to PRADAXA (4) Mechanical prosthetic heart valve (4)	0
"Patients should be monitored for these symptoms when discontinuing treatment, regardless of the indication for which paroxetine is being prescribed."	0
"Until further data are obtained, combined therapy of verapamil and quinidine in patients with hypertrophic cardiomyopathy should probably be avoided."	0
The remaining oxidative metabolites do not add appreciably to irbesartan's pharmacologic activity.	0
Hydrochlorothiazide is excreted unchanged by the kidney.	0
Activated partial thromboplastin times (APTT) should be monitored in patients receiving heparin and intravenous nitroglycerin.	0
Intestinal Angioedema: Intestinal angioedema has occurred in patients treated with ACE inhibitors.	0
"Upon recovery to <U+2264> Grade 1, resume ONIVYDE at: First 50 mg/m 2 43 mg/m 2 Second 43 mg/m 2 35 mg/m 2 Third Discontinue ONIVYDE Discontinue ONIVYDE Interstitial Lung Disease First Discontinue ONIVYDE Discontinue ONIVYDE Anaph y lactic Reaction First Discontinue ONIVYDE Discontinue ONIVYDE <U+2020> NCI CTCAE v 4.0=National Cancer Institute Common Toxicity Criteria for Adverse Events version 4.0 For recommended dose modifications of fluorouracil (5-FU) or leucovorin (LV), refer to the Full Prescribing Information; refer to Clinical Studies ( 14)."	0
Statins: Diltiazem is an inhibitor of CYP3A4 and has been shown to increase significantly the AUC of some statins.	1
Hepatic Insufficiency: Elevations of hepatic enzymes and hepatic failure have been reported in association with dipyridamole administration.	0
Treatment of hypokalemia: Typical dose range is 40-100 mEq per day in divided doses.	0
"As with other <U+03B2>-blockers, if COREG is administered with calcium channel blockers of the verapamil or diltiazem type, it is recommended that ECG and blood pressure be monitored."	0
"There has been a long-standing concern, however, that antidepressants, including drugs that inhibit the reuptake of norepinephrine and/or serotonin, may have a role in inducing worsening of depression and the emergence of suicidality in certain patients during the early phases of treatment."	0
Avoid consumption of alcohol with CARDIZEM CD.	0
False positive test results may be expected for several days following discontinuation of venlafaxine therapy.	0
This drug has no recognized use in labor or delivery.	0
"Anti-gout: Colchicine <U+2191> Colchicine In patients with renal or hepatic impairment, coadministration of colchicine in patients on APTIVUS/ritonavir is contraindicated."	0
"Although the exact mechanisms of the antidepressant, central pain inhibitory and anxiolytic actions of duloxetine in humans are unknown, these actions are believed to be related to its potentiation of serotonergic and noradrenergic activity in the CNS."	0
Several patients had weight gains in excess of 25% of their initial body weight.	0
"Similarly, these compounds did not affect the binding of atomoxetine to human albumin."	0
Apixaban has a total clearance of approximately 3.3 L/hour and an apparent half-life of approximately 12 hours following oral administration.	0
Concomitant use of these agents with IMURAN should be done with caution.	0
"Skeletal Muscle Relaxants, Nondepolarizing (e.g., Tubocurarine)- possible increased responsiveness to the muscle relaxant."	0
"In patients with PAH, however, the ratio of the metabolite to sildenafil is higher."	0
In vitro penicillinase induction studies suggest that penicillin MICs may increase during therapy.	0
"Allergic reactions including urticaria, mild skin eruptions, bronchospasm, and angioedema have been reported."	0
Consider the possibility of associated pulmonary veno-occlusive disease in such patients.	0
Please refer to ritonavir prescribing information for additional information on precautionary measures.	0
"Agitation, marked anxiety, and tension (4.1) Known hypersensitivity to methylphenidate or product components (4.2) Glaucoma (4.3) History of motor tics or a family history or diagnosis of Tourette<U+2019>s syndrome(4.4) During, or within a minimum of 14 days following discontinuation of treatment with a monoamine oxidase inhibitor (MAOI) (4.5) Focalin XR is contraindicated in patients with marked anxiety, tension, and agitation, since the drug may aggravate these symptoms."	0
"Initiation of medications that inhibit or induce CYP3A may increase or decrease concentrations of REYATAZ with ritonavir, respectively."	1
This is accomplished via reductions in heart rate and systemic blood pressure at submaximal and maximal workloads.	0
"The primary metabolite in urine is a conjugate of 4-hydroxy-2,6-dimethylaniline."	0
When given concurrently the following drugs may interact with thiazide diuretics.	0
"In the same study, the combined urinary recoveries of CMI and DMI were only about 0.8% to 1.3% of the dose administered."	0
"Although a casual link between the emergence of such symptoms and either the worsening of depression and/or the emergence of suicidal impulses has not been established, there is concern that such symptoms may represent precursors to emerging suicidality."	0
Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus ( 5.1 ).	0
"There is a potential for increased risk of bleeding, particularly in patients maintained on anticoagulants (7.3)."	0
"While all the selective serotonin reuptake inhibitors (SSRIs), e.g., fluoxetine, sertraline, and paroxetine, inhibit P450 2D6, they may vary in the extent of inhibition."	0
HIV CCR5 co-receptor antagonist: Maraviroca LEXIVA/ritonavir: <U+2193>Amprenavir <U+2191>Maraviroc No dosage adjustment required for LEXIVA/ritonavir.	0
Inhaled/nasal steroid: Fluticasone LEXIVA: <U+2191>Fluticasone LEXIVA/ritonavir: <U+2191>Fluticasone Use with caution.	0
"Even in patients without preexisting cardiac disease, antimalarial use of quinidine has occasionally been associated with hypotension, QTc prolongation, and cinchonism; see Warnings."	0
"Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior."	0
"Lovastatin significantly slowed the progression of lesions as measured by the mean change per-patient in minimum lumen diameter (the primary endpoint) and percent diameter stenosis, and decreased the proportions of patients categorized with disease progression (33% vs. 50%) and with new lesions (16% vs. 32%)."	0
Removal of angiotensin II negative feedback on renin secretion leads to increased plasma renin activity (PRA).	0
The patient should be informed that the response to alcohol may be exaggerated.	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP."	0
"Do NOT add sodium bicarbonate or other alkalinizing substance, since dopamine is inactivated in alkaline solution."	0
"Hydrochlorothiazide was not genotoxic in in vitro assays using strains TA98, TA100, TA1535, TA1537, and TA1538 of Salmonella typhimurium (the Ames test); in the Chinese Hamster Ovary (CHO) test for chromosomal aberrations; or in in vivo assays using mouse germinal cell chromosomes, Chinese hamster bone marrow chromosomes, and the Drosophila sex-linked recessive lethal trait gene."	0
"Protein-bound drugs: Monitor for adverse reactions and reduce dosage of ZOLOFT or other protein-bound drugs (e.g., warfarin) as warranted."	1
Clinical Trials Major Depressive Disorder<U+2013>The efficacy of sertraline as a treatment for major depressive disorder was established in two placebo-controlled studies in adult outpatients meeting DSM-III criteria for major depressive disorder.	0
"Therefore, if concomitant use of such agents is indicated, monitor the patient<U+2019>s serum potassium frequently."	0
"Porphyria has been reported in patients receiving rifampin, attributed to induction of delta amino levulinic acid synthetase."	0
"Renal Impairment: The pharmacokinetics of zolpidem tartrate were studied in 11 patients with end-stage renal failure (mean ClCr = 6.5 <U+00B1> 1.5 mL/min) undergoing hemodialysis three times a week, who were dosed with zolpidem tartrate 10 mg orally each day for 14 or 21 days."	0
Hypertension: Most patients start at 5 mg once daily.	0
Approximately 7% of a Caucasian population are PMs.	0
"See Full Prescribing Information for dosing recommendations for patients switching immediately from treatment with another protease inhibitor taken with ritonavir or from a non-nucleoside reverse transcriptase inhibitor based regimen, without a wash-out period."	0
Concurrent use of verapamil increases exposure to ivabradine and may exacerbate bradycardia and conduction disturbances.	0
"Metabolism and Elimination <U+2014> Following a single oral dose of 14Clabeled olanzapine, 7% of the dose of olanzapine was recovered in the urine as unchanged drug, indicating that olanzapine is highly metabolized."	0
"Antiarrhythmics:disopyramide, lidocaine, mexiletine <U+2191> antiarrhythmics For contraindicated antiarrhythmics.Caution is warranted and therapeutic concentration monitoring is recommended for antiarrhythmics when co-administered with ritonavir, if available."	0
"In clinical trials of quinapril/hydrochlorothiazide combination therapy using quinapril doses of 2.5 to 40 mg and hydrochlorothiazide doses of 6.25 to 25 mg, the antihypertensive effects increased with increasing dose of either component."	0
"There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on suicide."	0
The initial step in triazolam metabolism is hydroxylation catalyzed by cytochrome P450 3A (CYP 3A).	0
Benzodiazepines <U+2014> The half-life of concurrently administered diazepam may be prolonged in some patients.	1
"About 37% of an orally administered dose was recovered in urine as benazeprilat (20%),benazeprilat glucuronide (8%), benazepril glucuronide (4%) and as trace amounts of benazepril."	0
Adults (over the age of 16 years ): INVIRASE 1000 mg twice daily (5 <U+00D7> 200 mg capsules or 2 <U+00D7> 500 mg tablets) in combination with ritonavir 100 mg twice daily.	0
Celexa 20 mg/day is the maximum recommended dose for patients taking concomitant cimetidine because of the risk of QT prolongation.	1
"A minimum weight gain, and no weight loss, is currently recommended for all pregnant women, including those who are already overweight or obese, due to obligatory weight gain that occurs in maternal tissues during pregnancy."	0
PDE5 inhibitors: Sildenafil (REVATIO) (for treatment of pulmonary arterial hypertension) A safe and effective dose has not been established when used with LEXIVA.	0
"Alprazolam - When immediate-release fluvoxamine maleate tablets (100 mg given once daily) and alprazolam (1 mg given 4 times per day) were coadministered to steady state, plasma concentrations and other pharmacokinetic parameters (AUC, Cmax, T<U+00BD>) of alprazolam were approximately twice those observed when alprazolam was administered alone; oral clearance was reduced by about 50%."	1
"Hyperkalemia is more likely to occur in patients with renal impairment, diabetes (even without evidence of renal impairment), or elderly or severely ill patients."	0
Add 15 mL of either sugar syrup or sorbitol syrup (for patients with Type 1 diabetes or glucose intolerance) OR 3 teaspoons of jam to the contents of INVIRASE capsules that are in the container.	0
No predictable antihypertensive effect has been demonstrated for triamterene.	0
"Dilutional hyponatremia is life-threatening and may occur in edematous patients in hot weather; appropriate therapy is water restriction rather than salt administration, except in rare instances when the hyponatremia is life-threatening."	0
Most patients receiving the combination of two RAS inhibitors do not obtain any additional benefit compared to monotherapy.	0
Patients in this study had moderate to severe OCD (DSM-III-R) with mean baseline ratings on the Children<U+2019>s Yale-Brown Obsessive-Compulsive Scale (CYBOCS) total score of 22.	0
Prescribers should consult the prescribing information of any drug which is co-prescribed with digoxin for potential drug interaction information.	0
"Drugs that inhibit CYP2D6 such as quinidine, fluoxetine, paroxetine, and propafenone are likely to increase metoprolol concentration."	1
"Pathologic changes in the parathyroid glands, with hypercalcemia and hypophosphatemia, have been observed in a few patients on prolonged thiazide therapy; however, the common complications of hyperparathyroidism such as renal lithiasis, bone resorption, and peptic ulceration have not been seen."	0
"In vitro studies have shown that R-bicalutamide is an inhibitor of CYP 3A4 with lesser inhibitory effects on CYP 2C9, 2C19 and 2D6 activity."	0
"In clinical trial and post-marketing experience, events of leukopenia/neutropenia and agranulocytosis have been reported temporally related to antipsychotic agents."	0
"In separate studies of patients receiving maintenance doses of warfarin, hydrochlorothiazide, or digoxin, irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin (prothrombin time) or the pharmacokinetics of digoxin."	0
"Efavirenz <U+2193> indinavir concentration The optimal dose of indinavir, when given in combination with efavirenz, is not known."	0
"Non-nucleoside reverse transcriptase inhibitor: Nevirapinea LEXIVA: <U+2193>Amprenavir <U+2191>Nevirapine LEXIVA/ritonavir: <U+2193>Amprenavir <U+2191>Nevirapine For contraindicated NNRTIs (delavirdine),."	0
The frequency of phototoxicity reactions is higher in the pediatric population.	0
"Therapy usually should be initiated with 17 mg orally once daily, then increased by 8.5 mg per week or longer intervals, to attain adequate control of blood pressure."	0
Amlodipine CYP3A Inhibitors Co-administration with CYP3A inhibitors (moderate and strong) results in increased systemic exposure to amlodipine and may require dose reduction.	1
"Neither clinical nor epidemiologic studies conducted to date, however, have shown an association between chronic administration of these drugs and mammary tumorigenesis; the available evidence is considered too limited to be conclusive at this time."	0
"Post-marketing cases of liver injury, including some fatalities, have been reported."	0
Amoxapine is an antidepressant with a mild sedative component to its action.	0
"Concomitant administration of sevelamer and mycophenolate mofetil in adult and pediatric patients decreased the mean MPA Cmax and AUC0<U+2013>12h by 36% and 26%, respectively."	1
It is not recommended to co-administer telaprevir with APTIVUS/ritonavir.	0
No dosage adjustment for patients with mild or moderate renal impairment.	0
The clinical significance of this finding is unknown.	0
"The renin-aldolsterone link is mediated by angiotensin, so coadministration of an ACE inhibitor tends to reverse the potassium loss associated with these diuretics."	0
The second trial demonstrated no statistically significant differences in the pharmacokinetics of bupropion and its active metabolites in 9 subjects with mild to moderate hepatic cirrhosis compared to 8 healthy volunteers.	0
"N-terminal pro-B-type natriuretic peptide (NT-proBNP) In AMBITION, the decrease in NT-proBNP in patients on Letairis plus tadalafil was observed early (Week 4) and was sustained, with a reduction of 63% on Letairis plus tadalafil, 50% on Letairis alone, and 41% on tadalafil alone at Week 24."	0
Administration of beta-blockers alone in the setting of pheochromocytoma has been associated with a paradoxical increase in blood pressure due to the attenuation of beta-mediated vasodilatation in skeletal muscle.	0
Avoid concomitant use of Savella in patients with substantial alcohol use or chronic liver disease (5.6).	0
The patient should be advised to observe caution when driving or engaging in any potentially hazardous activity.	0
No initial dosage adjustment of paroxetine is considered necessary when coadministered with phenobarbital; any subsequent adjustment should be guided by clinical effect.	0
Hormonal Contraceptives: Efficacy of contraceptives may be reduced during administration of and for 28 days following the last dose of EMEND.	0
"Co-administered amlodipine does not affect the exposure to atorvastatin, digoxin, ethanol and the warfarin prothrombin response time."	0
Fosamprenavir contains a sulfonamide moiety.	0
"However, the elimination half-lives of erythrohydrobupropion and threohydrobupropion are longer, approximately 33 (<U+00B1>10) and 37 (<U+00B1>13) hours, respectively and steady-state AUCs were 1.4 and 7 times that of bupropion, respectively."	0
85 <U+2013>27 <U+2013>32 +9 <U+2013>36 <U+2013>31 <U+2013>34 <U+2013>21 40 mg b.i.d.	0
"Coadministration of antiplatelet agents, thrombolytics, heparin, aspirin, and chronic NSAID use increases the risk of bleeding."	0
The estimates of apparent volume of distribution of prasugrel's active metabolite ranged from 44 to 68L and the estimates of apparent clearance ranged from 112 to 166L/hr in healthy subjects and patients with stable atherosclerosis.	0
"These doses, which also resulted in a high resorption rate in rats (63% of implantations versus 5% in controls), are, on a mg/m2 basis, about 66 and 44 times, respectively, the dose of aspirin contained in the maximum recommended daily human dose of AGGRENOX."	0
"In a longer-term study, patients meeting DSM-IV criteria for social anxiety disorder who had responded while assigned to sertraline hydrochloride (CGI-I of 1 or 2) during a 20-week placebo-controlled trial on sertraline hydrochloride 50 to 200 mg/day were randomized to continuation of sertraline hydrochloride or to substitution of placebo for up to 24 weeks of observation for relapse."	0
"Fetal testing may be appropriate, based on the week of pregnancy."	0
"After repeated dosing, the AUC and Cmax were approximately doubled in patients with severe renal impairment (creatinine clearance <30 mL/min/1.73m2) compared to patients with normal kidney function."	0
The elimination half-life (t1/2) of rosuvastatin is approximately 19 hours.	0
"During clinical development and post-marketing surveillance, there have been rare cases of arrhythmias, (including ventricular arrhythmias such as torsade de pointes), cardiac arrests and sudden deaths in patients taking voriconazole."	0
"Table2: Dose Adjustments for Adverse Reactions Adverse Reaction(s) Dose Modification Differentiation syndrome, defined by the presence of 2 or more of the following: Unexplained fever Dyspnea Pleural and/or pericardial effusion Pulmonary infiltrates Renal failure Hypotension Weight gain greater than 5 kg Temporarily withhold TRISENOX."	0
Triamterene and hydrochlorothiazide should not be used in the presence of elevated serum potassium levels (greater than or equal to 5.5 mEq/liter).	0
"<U+2022>History of cardiovascular disease (e.g., coronary artery disease, stroke, arrhythmias, congestive heart failure, uncontrolled hypertension, pulmonary hypertension) <U+2022>During or within 14 days following the administration of monoamine oxidase inhibitors <U+2022>Hyperthyroidism <U+2022>Glaucoma <U+2022>Agitated states <U+2022>History of drug abuse <U+2022>Pregnancy <U+2022>Nursing <U+2022>Use in combination with other anorectic agents or CNS stimulants <U+2022>Known hypersensitivity or idiosyncratic reactions to sympathomimetics."	0
Fosamprenavir/Ritonavir Coadministration of fosamprenavir/ritonavir with paroxetine significantly decreased plasma levels of paroxetine.	1
"In those patients who discontinued protease inhibitor therapy, hyperglycemia persisted in some cases."	0
"When plasma levels have been followed for at least 24 hours, the plasma half-life has been observed to vary between 4 to 15 hours."	0
"CYP2D6 substrates: Reduce dosage of drugs metabolized by CYP2D6 (7.1, 12.3) Table 5 includes clinically significant drug interactions with ZOLOFT."	1
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
Also inform patients not to take St. John<U+2019>s Wort since these agents may reduce the concentration of Tasigna.	1
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP may cause fetal harm when administered to a pregnant woman."	0
"Patients required intervention with a diuretic, fluid management, or, in some cases, hospitalization for decompensating heart failure."	0
Geriatric Use Clinical studies of Thalitone<U+00AE> did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
Drug-Drug Interaction Studies Fluvoxamine A pharmacokinetic study was conducted in 16 schizophrenic patients who received clozapine under steady-state conditions.	0
Dosing recommendations in subjects with severe renal impairment are based on pharmacokinetic modeling.	0
"The incidence was higher in patients presenting with sustained ventricular tachycardia/fibrillation (5%), or a prior history of heart failure (7%)."	0
The dose may be increased every third day to a maximum of 0.2 mg/kg not to exceed 10 mg/day.	0
"Consequently, it is recommended that LUVOX CR Capsules not be used in combination with alosetron."	0
"Similar findings, however, have been observed in normal or well-compensated patients with heart failure with agents possessing significant negative inotropic effects."	0
Subsequent dose adjustments should be made on the basis of clinical response.	0
Dipyridamole inhibits phosphodiesterase (PDE) in various tissues.	0
"While advice cannot be provided on the level of recovery of aPTT needed in any particular clinical setting, the curves can be used to estimate the time to get to a particular level of recovery, even when the time since the last dose of PRADAXA is not precisely known."	0
The blood level profile of flurazepam and its major metabolites was determined in man following the oral administration of 30 mg daily for 2 weeks.	0
Similar calculations should be made for increased doses as titration proceeds.	0
"If this drug is used during pregnancy or if the patient becomes pregnant while taking the drug, the patient should be apprised of the potential hazard to a fetus."	0
<U+2022>Bronchial asthma or related bronchospastic conditions.	0
"When rifampin is given concomitantly with either halothane or isoniazid, the potential for hepatotoxicity is increased."	0
Clostridium difficile-associated colitis: Evaluate if diarrhea occurs.	0
"Do not use Effient in patients with active pathological bleeding or a history of transient ischemic attack or stroke (4.1, 4.2)."	0
The use of potent CYP 3A4 inhibitors with dihydroergotamine should therefore be avoided.	0
"Patients taking concomitant mTOR inhibitor (e.g., temsirolimus) therapy or a neprilysin inhibitor may be at increased risk for angioedema."	0
"Inhibitors of this isoenzyme (e.g., macrolide antibiotics, azole antifungal agents, protease inhibitors, serotonin reuptake inhibitors, amiodarone, cannabinoids, diltiazem, grapefruit juice, nefazadone, norfloxacin, quinine, zafirlukast) should be cautiously co-administered with TIKOSYN as they can potentially increase dofetilide levels."	1
"Maintenance dose may be as low as one tablet, 15 mg, a day or every other day, and should be continued for as long as is required."	0
ACE inhibitors have been associated with a syndrome that starts with cholestatic jaundice or hepatitis and progresses to fulminant hepatic necrosis and sometimes death.	0
This influence may persist for 3weeks or longer after fluoxetine is discontinued.	0
Treatment with SURMONTIL and any concomitant serotonergic agents should be discontinued immediately if the above events occur and supportive symptomatic treatment should be initiated.	0
Dose adjustment of tacrolimus may be needed to maintain therapeutic drug concentrations.	0
Phenylalanine can be harmful to patients with phenylketonuria (PKU).	0
Steady state is attained within 5 days with once-daily dosing.	0
Caution should be used when prescribing VFEND to patients with hypersensitivity to other azoles.	0
Pharmacokinetic studies showed that Risperidone Orally Disintegrating Tablets and Risperidone Oral Solution are bioequivalent to Risperidone Tablets.	0
The mechanism of its clinical action in man is not well understood.	0
"Compared with placebo, losartan potassium tablets significantly reduced proteinuria by an average of 34%, an effect that was evident within 3 months of starting therapy, and significantly reduced the rate of decline in glomerular filtration rate during the study by 13%, as measured by the reciprocal of the serum creatinine concentration."	0
Plasma concentrations of sulfapyridine may be reduced following the concomitant administration of sulfasalazine and rifampin.	1
"In a human pharmacokinetic study conducted with bosentan ( 250 mg/day ) and an oral formulation of treprostinil ( treprostinil diethanolamine ) , no pharmacokinetic interactions between treprostinil and bosentan were observed ."	0
"Dihydroergotamine mesylate was clastogenic in two in vitro chromosomal aberration assays, the V79 Chinese hamster cell assay with metabolic activation and the cultured human peripheral blood lymphocyte assay."	0
.	0
Refer to VIREAD or TRUVADA prescribing information for recommendations on renal monitoring.	0
"However , Ventavis has the potential to increase the hypotensive effect of vasodilators and antihypertensive agents ."	0
"CLOZARIL also acts as an antagonist at adrenergic, cholinergic, histaminergic and other dopaminergic and serotonergic receptors."	0
"There are no adequate studies of dihydroergotamine in human pregnancy, but developmental toxicity has been demonstrated in experimental animals."	0
"A treatment regimen containing multiple immunosuppressants (including thiopurines) should therefore be used with caution as this could lead to lymphoproliferative disorders, some with reported fatalities."	0
"Families and caregivers of patients being treated with antidepressants for major depressive disorder or other indications, both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to health care providers."	0
"By inhibiting FXa, apixaban decreases thrombin generation and thrombus development."	0
"During this process, rifampin undergoes progressive deacetylation so that nearly all the drug in the bile is in this form in about 6 hours."	0
"In clinical studies, doses of 50 mg to 400 mg per day were shown to be effective, although no additional benefit was demonstrated at doses greater than 50 mg per day and adverse reactions and discontinuations were more frequent at higher doses."	0
"7.For ULTRABAG, follow the below steps: Clamp solution line and then break frangible near solution bag."	0
Steady<U+2011>state plasma concentrations of carvedilol and its enantiomers increased proportionally over the 6.25- to 50- mg dose range in subjects with heart failure.	0
"Changes in renal function, including acute renal failure, can be caused by drugs that inhibit the renin-angiotensin system."	0
Ledipasvir is subject to slow oxidative metabolism via an unknown mechanism.	0
Directions for method of administration for each dosage form are presented in Table 2.	0
"There are no adequate and well-controlled studies in pregnant women, and it is not known if dopamine HCl crosses the placental barrier."	0
"Fluvoxamine has also been shown to inhibit P450 1A2, an isoform also involved in TCA metabolism."	0
"Similarly, marked right-sided congestive heart failure can reduce hepatic metabolism and reduce the needed dose."	0
"Co-administration of VIRACEPT with other drugs (CYP3A substrates) can alter the concentration of these other drugs, and other drugs (inhibitors and/or inducers of CYP3A or CYP2C19) may alter the concentrations of nelfinavir."	0
"In patients with PAH, plasma ET-1 concentrations are increased as much as 10-fold and correlate with increased mean right atrial pressure and disease severity."	0
"Seizures should be controlled with benzodiazepines, or if these are ineffective, other anticonvulsants (e.g., phenobarbital, phenytoin)."	0
Digoxin Risperidone (0.25 mg twice daily) did not show a clinically relevant effect on the pharmacokinetics of digoxin.	0
"These data were combined with sequential pharmacokinetics data from 41 surgery patients 1 month to 24 months of age, who received a single dose of 0.1 mg/kg of intravenous ondansetron prior to surgery with general anesthesia, and a population pharmacokinetic analysis was performed on the combined data set."	0
Angioedema associated with laryngeal edema can be fatal.	0
Fluconazole should be discontinued in patients treated for superficial fungal infection who develop a rash that may be attributed to fluconazole.	0
WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning.	0
Take a missed dose as soon as it is remembered.	0
Reduce the dose of these substrates by up to one-half if co-administered with 400 mg of PRISTIQ.	0
"Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and young adults in short-term studies."	0
"In a male subject with mild Von Willebrand ( vW ) disease , intravenous infusion of dDAVP 2 hours after administration of oral tolvaptan did not produce the expected increases in vW Factor Antigen or Factor VIII activity ."	0
Physicians considering the use of indinavir in pediatric patients without other protease inhibitor options should be aware of the limited data available in this population and the increased risk of nephrolithiasis.	0
"With chronic once daily oral administration, antihypertensive effectiveness is maintained for at least 24 hours."	0
"This has been documented in vitro; however, the clinical significance of this interaction is not well-documented."	0
Coadministration of fluvoxamine maleate 100 mg per day with atenolol 100 mg per day (N = 6) did not affect the plasma concentrations of atenolol.	0
"Hemophilia: Spontaneous bleeding may occur, and additional factor VIII may be required (5.12) Clinical hepatitis and hepatic decompensation, including some fatalities, were reported with APTIVUS co-administered with 200 mg of ritonavir."	0
Drugs such as proton pump inhibitors that inhibit gastric acid secretion to elevate the gastric pH may decrease the solubility of nilotinib and reduce its bioavailability.	1
"For patients with possible depletion of intravascular volume (e.g., patients treated with diuretics, particularly those with impaired renal function), initiate ATACAND under close medical supervision and consider administration of a lower dose."	0
"A similar study reported a consistent result, with a risk estimate of 2.27 (95% CI 0.99, 5.20)."	0
"Losartan and its principal active metabolite block the vasoconstrictor and aldosterone-secreting effects of angiotensinII by selectively blocking the binding of angiotensinII to the AT1 receptor found in many tissues, (e.g., vascular smooth muscle, adrenal gland)."	0
Epidemiological studies of the case-control and cohort design that have demonstrated an association between use of psychotropic drugs that interfere with serotonin reuptake and the occurrence of upper gastrointestinal bleeding have also shown that concurrent use of an NSAID or aspirin may potentiate the risk of bleeding.	0
The mean duration of PTSD for these patients was 12 years (Studies 1 and 2 combined) and 44% of patients (169 of the 385 patients treated) had secondary depressive disorder.	0
The use of PRISTIQ within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated.	0
"Moreover, the effect of fluvoxamine may be even more pronounced when it is administered at higher doses."	0
"Respiratory depression, if not immediately recognized and treated, may lead to respiratory arrest and death."	0
Avoid use of PRADAXA and P-gp inhibitors in patients with severe renal impairment (CrCl 15-30 mL/min).	0
Only prescribers and pharmacies certified with the restricted distribution program are able to prescribe and dispense CAPRELSA.	0
The mechanism of the antihypertensive effect of thiazides is unknown.	0
"Do not coadminister aliskiren with angiotensin receptor blockers, ACE inhibitors, including Lotensin in patients with diabetes."	0
"In patients with liver cirrhosis given a dose bioequivalent to 8.5 mg SULAR, plasma concentrations of the parent compound were 4 to 5 times higher than those in healthy young subjects."	0
Administration of beta-blockers alone in the setting of pheochromocytoma has been associated with a paradoxical increase in blood pressure due to the attenuation of beta-mediated vasodilatation in skeletal muscle.	0
Hypertension Adult Patients: Administration of PRINIVIL to patients with hypertension results in a reduction of supine and standing blood pressure to about the same extent with no compensatory tachycardia.	0
"With continued daily dosing, the lymphocyte count continued to decrease over a 2-week period, reaching a nadir count of approximately 500 cells/mcL or approximately 30% of baseline."	0
"Although not measured directly, the difference between losartan potassium tablets and placebo is compelling because there is evidence that atenolol is itself effective (vs. placebo) in reducing cardiovascular events, including stroke, in hypertensive patients."	0
Individualize dosage and monitor during up-titration.	0
The patient should be cautioned accordingly.	0
Savella should be used with caution in these patients.	0
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
"If signs or symptoms of nephrolithiasis occur, temporary interruption or discontinuation of therapy may be considered."	0
"DMI also distributes into CSF, with a mean CSF/plasma ratio of 2.6."	0
Non-nucleoside Reverse Transcriptase Inhibitors Nevirapine Nevirapine substantially decreases atazanavir exposure which may result in loss of therapeutic effect and development of resistance.	1
The median duration of oral VFEND therapy was 76 days (range 2<U+2013>232 days).	0
"CRESTOR is a selective and competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme that converts 3<U+2011>hydroxy<U+2011>3<U+2011>methylglutaryl coenzyme A to mevalonate, a precursor of cholesterol."	0
"Eszopiclone is rapidly absorbed, with a time to peak concentration (tmax) of approximately 1 hour and a terminal-phase elimination half-life (t1/2) of approximately 6 hours."	0
"There was no apparent pharmacokinetic interaction between zaleplon and ibuprofen following single dose administration (10 mg and 600 mg, respectively) of each drug."	0
Changes in renal function including acute renal failure can be caused by drugs that inhibit the renin-angiotensin system.	0
Study 3 was not readily interpretable regarding a dose response relationship for effectiveness.	0
"All patients being treated with antidepressants for any indication should be monitored appropriately and observed closely for clinical worsening, suicidality, and unusual changes in behavior, especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases."	0
"In a few reported cases, co-administration of verapamil with aspirin has led to increased bleeding times greater than observed with aspirin alone."	0
Systemic doses slightly raise systolic and lower diastolic pressures and can produce significant postural hypotension.	0
NS5A resistance substitutions (Y93C or L28V) emerged in two of the genotype 4 relapse subjects post-treatment who also had NS5A polymorphisms pretreatment that were retained post-treatment.	0
Possible risk factors for leukopenia/neutropenia include preexisting low white blood cell count (WBC) and history of drug induced leukopenia/neutropenia.	0
Concomitant use of agents that attenuate alpha-adrenergic function with verapamil may result in a reduction in blood pressure that is excessive in some patients.	0
Initiation of quetiapine in patients taking APTIVUS with ritonavir: Refer to the quetiapine prescribing information for initial dosing and titration of quetiapine.	0
"In renal and cardiac transplant recipients, a reduction of cyclosporine dose ranging from 15% to 48% was necessary to maintain cyclosporine trough concentrations similar to those seen prior to the addition of diltiazem."	1
"Three of the trials were in elderly patients (n=1,019)."	0
"Evaluate cardiovascular status,monitor and manage cardiovascular risk factors during Tasigna therapy."	0
Acute renal failure has been reported in a few patients receiving indomethacin and formulations containing triamterene and hydrochlorothiazide.	0
Such patients may be unresponsive to the usual doses of epinephrine used to treat allergic reaction.	0
"Avoid concomitant administration of XARELTO with known combined P-gp and strong CYP3A4 inhibitors ( e.g. , ketoconazole and ritonavir ) see Warnings and Precautions ( 5.6 ) and Clinical Pharmacology ( 12.3 ) ."	0
Food does not affect the bioavailability of olmesartan.	0
"For patients currently using methylphenidate, the recommended starting dose of Focalin XR is half the total daily dose of racemic methylphenidate."	0
Rifampin has been reported to cross the placental barrier and appear in cord blood.	0
Dosage should be adjusted according to blood pressure response.	0
A close observation of affected patients is mandatory.	0
It is not clear whether this represents an interaction with TIKOSYN or the presence of more severe structural heart disease in patients on digoxin; structural heart disease is a known risk factor for arrhythmia.	0
No predictable antihypertensive effect has been demonstrated with triamterene.	0
"For patients requiring further reduction in blood pressure, the dose can be increased at 2-week intervals up to 40 mg. A more frequent dosing regimen is unlikely to be beneficial."	0
Metabolic profiles after intramuscular administration are qualitatively similar to metabolic profiles after oral administration.	0
"In special subacute hepatic studies, oral doses of 125 mg/kg and higher in rats were associated with histological changes in the liver which were reversible when the drug was discontinued."	0
Fingolimod and fingolimod-phosphate protein binding is not altered by renal or hepatic impairment.	0
"Reduce BRINTELLIX dose by half when a strong CYP2D6 inhibitor (e.g., bupropion, fluoxetine, paroxetine, quinidine) is coadministered."	1
"Coadministration of CRIXIVAN and drugs primarily metabolized by CYP3A4 may result in increased plasma concentrations of the other drug, which could increase or prolong its therapeutic and adverse effects."	1
Co-administration of fluticasone propionate and APTIVUS/ritonavir is not recommended unless the potential benefit to the patient outweighs the risk of systemic corticosteroid side effects.	0
"PDE5 inhibitors , including tadalafil , have mild systemic vasodilatory properties that may result in transient decreases in blood pressure ."	0
"After a single 50 mg oral dose, maximum plasma concentrations of CMI occur within 2 to 6 hours (mean, 4.7 hr) and range from 56 ng/mL to 154 ng/mL (mean, 92 ng/mL)."	0
"Attempts to overcome nitrate tolerance by dose escalation, even to doses far in excess of those used acutely, have consistently failed."	0
Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction with antidepressants compared to placebo in adults aged 65 and older.	0
Paroxetine hydrochloride is completely absorbed after oral dosing of a solution of the hydrochloride salt.	0
Specific Populations Geriatric: Plasma concentrations of LIPITOR are higher (approximately 40% for Cmax and 30% for AUC) in healthy elderly subjects (age <U+2265>65 years) than in young adults.	0
"Patients receiving the combination of telmisartan and ramipril did not obtain any additional benefit compared to monotherapy, but experienced an increased incidence of renal dysfunction (e.g., acute renal failure) compared with groups receiving telmisartan alone or ramipril alone."	0
The smallest children (BSA <0.33m2) showed a tendency for larger Class III effects (<U+0394>QTc) and an increased frequency of prolongations of the QTc interval as compared with the larger children (BSA <U+2265>0.33m2).	0
A 4 hour hemodialysis session removed approximately 18% of administered dose.	0
"When liver impairment is also present, further reductions in dosage may be necessary."	0
Exchange transfusions or dialysis may be required as a means of reversing hypotension and/or substituting for disordered renal function.	0
"In the PRAISE-2 study, 1654 patients with NYHA class III (80%) or IV (20%) heart failure without evidence of underlying ischemic disease, on stable doses of ACE inhibitor (99%), digitalis (99%), and diuretics (99%) were randomized 1:1 to receive placebo or amlodipine and followed for a mean of 33 months."	0
Lamisil Tablets can be taken with or without food.	0
"Concomitant Use with Dibenzazepine Derivative Drugs If the decision is made to administer NARDIL concurrently with other antidepressant drugs, or within less than 10 days after discontinuation of antidepressant therapy, the patient should be cautioned by the physician regarding the possibility of adverse drug interaction."	0
Saquinavir: See the prescribing information for saquinavir and monitor for potential saquinavir toxicities.	0
Patients with hemophilia may develop increased bleeding events.	0
"Standard therapy includes antibiotics, such as penicillin and gentamicin; vasopressors, such as dopamine and isoproterenol; cardiac glycosides; and diuretics, such as furosemide."	0
A beta2 agonist (bronchodilator) should be made available.	0
Sufficient time should be allowed to enable a slow circulation to carry the drug to the site of action.	0
"The mean maximal effect on blood pressure was a 35 mm Hg decrease in systolic blood pressure, a 20 mm Hg decrease in diastolic blood pressure, and a 4 beat/min decrease in heart rate."	0
"In this trial, patients with OCD assigned to paroxetine demonstrated a lower relapse rate compared to patients on placebo."	0
"Insulin requirements in diabetic patients may be increased, decreased or unchanged."	0
"When abnormal, the ECG in hyperkalemia is characterized primarily by tall, peaked T waves or elevations from previous tracings."	0
"Thus, SAMSCA and strong CYP 3A inhibitors should not be co-administered [see Dosage and Administration (2.3) and Contraindications (4.4)]."	0
"While the mechanism through which benazepril lowers blood pressure is believed to be primarily suppression of the renin-angiotensin-aldosterone system, benazepril has an antihypertensive effect even in patients with low-renin hypertension."	0
No dosage adjustment is necessary in patients with hepatic insufficiency.	0
Limited accumulation of irbesartan (<20%) is observed in plasma upon repeated once-daily dosing.	0
"This effect was not seen in idiopathic PAH (REVATIO 3%, placebo 2%) patients."	0
"In short-term clinical trials, there was no evidence of reduction in serum levels of vitamins."	0
Hypersensitivity to dipyridamole and any of the other components.	0
The usual initial monotherapy dose in clinical trials was 80 mg three times a day (240 mg/day).	0
The recommended dosage is 40mg/day in the evening.	0
"<U+2022> For information about contraindications of antibacterial agents (clarithromycin and amoxicillin) indicated in combination with ACIPHEX delayed-release tablets, refer to the Contraindications section of their package inserts."	0
"Mild hypercalcemia (10.5 to 11.9 mg/dL) may be asymptomatic or manifest as constipation, anorexia, nausea, and vomiting."	0
"When benzodiazepines and opioids are combined, the potential for benzodiazepines to significantly worsen opioid-related respiratory depression exists."	0
Co-administration of LIPITOR and an oral contraceptive increased AUC values for norethindrone and ethinyl estradiol.	1
"However, it is important to monitor serum potassium levels because hyperkalemia may not be associated with ECG changes."	0
A void food 2 hours before and 1 hour after taking the dose ( 5.9 ).	0
"Initiation of medications that inhibit or induce CYP3A may increase or decrease concentrations of VIRACEPT, respectively."	1
"Patients receiving the combination of MICARDIS and ramipril did not obtain any additional benefit compared to monotherapy, but experienced an increased incidence of renal dysfunction (e.g., acute renal failure) compared with groups receiving telmisartan alone or ramipril alone."	0
Limit the dose of simvastatin in patients on amlodipine to 20 mg daily.	1
"Although anticonvulsant effects of racemic citalopram have been observed in animal studies, Lexapro has not been systematically evaluated in patients with a seizure disorder."	0
"Patients whose blood pressures are adequately controlled with 25 mg of daily hydrochlorothiazide, but who experience significant potassium loss with this regimen, may achieve blood pressure control with less electrolyte disturbance if they are switched to ACCURETIC 10/12.5 or 20/12.5."	0
Both CYP3A4 and CYP2D6 are responsible for iloperidone metabolism.	0
"If symptoms occur, treatment should be discontinued immediately."	0
Hypotension has been observed during Marplan therapy.	0
"In adult clinical trials where EM/PM status was available, the mean change from baseline in diastolic blood pressure in PM patients was higher than in EM patients (4.21 versus 2.13 mm Hg) as was the mean change from baseline in systolic blood pressure (PM: 2.75 versus EM: 2.40mmHg)."	0
"When using PROZAC and olanzapine and in combination, also refer to the Drug Interactions section of the package insert for Symbyax."	0
LEXIVA and coadministration of colchicine: Treatment of gout flares: 1.2mg (2 tablets) x 1 dose.	0
Continue at 10-mg once daily with or without food.	0
"Risk factors for bleeding include the concomitant use of other drugs that increase the risk of bleeding (e.g., anti-platelet agents, heparin, fibrinolytic therapy, and chronic use of NSAIDs)."	0
"Skeletal Muscle Relaxants, Nondepolarizing (e.g., tubocurarine)<U+2014>possible increased responsiveness to the muscle relaxant."	0
Consider a lower (5-mg) maintenance dose.	0
"It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months."	0
Warfarin: Administration of BYSTOLIC (10 mg once daily for 10 days) led to no significant changes in the pharmacokinetics of nebivolol or R- or S-warfarin following a single 10 mg dose of warfarin.	0
REYATAZ oral powder contains phenylalanine (a component of aspartame).	0
"Amlodipine Following administration of therapeutic doses to patients with hypertension, amlodipine produces vasodilation resulting in a reduction of supine and standing blood pressures."	0
"The mean minimum plasma concentrations in renally impaired patients (creatinine clearance of 5 to 45 mL/min) after 4 and 6 weeks of treatment (50 mg b.i.d., N = 13) were comparable to each other, suggesting no accumulation of fluvoxamine in these patients."	0
"While most foods contain negligible amounts or no tyramine, certain food products may contain large amounts of tyramine that represent a potential risk for hypertensive crisis."	0
Phendimetrazine tartrate is not recommended for patients who used any anorectic agents within the prior year.	0
"Telmisartan Dual blockade of the RAS with angiotensin-receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy."	0
"Lidocaine is contraindicated in patients with Stokes-Adams syndrome, Wolff-Parkinson-White syndrome, or with severe degrees of sinoatrial, atrioventricular, or intraventricular block."	0
Coadministration of REYATAZ plus ritonavir with buprenorphine warrants clinical monitoring for sedation and cognitive effects.	0
"If such symptoms occur, discontinue Savella and initiate supportive treatment."	0
"The long elimination half-lives of fluoxetine and norfluoxetine assure that, even when dosing is stopped, active drug substance will persist in the body for weeks (primarily depending on individual patient characteristics, previous dosing regimen, and length of previous therapy at discontinuation)."	0
"While 4-hydroxy-estazolam and the lesser metabolite, 1-oxo-estazolam, have some pharmacologic activity, their low potencies and low concentrations preclude any significant contribution to the hypnotic effect of estazolam."	0
The use of ZOLOFT in patients with moderate (Child Pugh scores 7 to 9) or severe hepatic impairment (Child Pugh scores 10<U+2013>15) is not recommended.	0
"However, in vitro and in some patients, a negative inotropic effect has been observed."	0
The metabolism of estazolam to the major circulating metabolite 4-hydroxy-estazolam is catalyzed by CYP3A.	0
"These drugs include: aspirin, phenylbutazone, sulfonamides, indomethacin, thiazide diuretics, furosemide and ethacrynic acid."	0
Biliary excretion of unchanged ledipasvir is a major route of elimination.	0
"In those patients who discontinued protease-inhibitor therapy, hyperglycemia persisted in some cases."	0
Lower than usual dosages are recommended for elderly patients and adolescents.	0
"Do not administer ALTACE within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor."	0
"There have been reports of visual disturbances associated with the use of nefazodone, including blurred vision, scotoma, and visual trails."	0
Lithium A multiple-dose study has shown that there is no pharmacokinetic interaction between paroxetine and lithium carbonate.	0
Bupropion is a relatively weak inhibitor of the neuronal uptake of norepinephrine and dopamine and does not inhibit monoamine oxidase or the reuptake of serotonin.	0
Repeated administration of up to 80 mg Benicar had minimal influence on aldosterone levels and no effect on serum potassium.	0
Educate all patients to alert health care providers of this interaction whenever they are admitted to the hospital.	0
"Although uncommon, allergic reactions, including anaphylactic reactions, angioneurotic edema, urticaria, and rash, have been reported in patients taking STRATTERA."	0
An individual who is stable on a given dose of TCA may become abruptly toxic when given one of these inhibiting drugs as concomitant therapy.	0
Therapy with PRISTIQ may be resumed 24 hours after the last dose of linezolid or intravenous methylene blue.	0
Make sure the dispenser contains the prescribed dose.	0
"Rifampin has been reported to substantially decrease the plasma concentrations of the following antiviral drugs: atazanavir, darunavir, fosamprenavir, saquinavir, and tipranavir."	1
"In vitro apixaban studies at concentrations significantly greater than therapeutic exposures, no inhibitory effect on the activity of CYP1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2D6, CYP3A4/5, or CYP2C19, nor induction effect on the activity of CYP1A2, CYP2B6, or CYP3A4/5 were observed."	0
"However, <U+03B2>-lactamase testing of clinical isolates of B. anthracis is unreliable and should not be performed.3 <U+2264>0.12 <U+2212> <U+2265>0.25 <U+2212> <U+2212> <U+2212> Standardized susceptibility test procedures require the use of laboratory control microorganisms to monitor and ensure the accuracy and precision of the supplies and reagents used in the assay, and the techniques of the individuals performing the test."	0
<U+2022> Geriatric: There were no differences in plasma concentrations of rosuvastatin between the nonelderly and elderly populations (age <U+2265>65years).	0
"Generally, daily treatment with any acid-suppressing medications over a long period of time (e.g., longer than 3 years) may lead to malabsorption of cyanocobalamin (Vitamin B-12) caused by hypo- or achlorhydria."	0
"NATRECOR<U+00AE> is not recommended for patients for whom vasodilating agents are not appropriate, such as patients with significant valvular stenosis, restrictive or obstructive cardiomyopathy, constrictive pericarditis, pericardial tamponade, or other conditions in which cardiac output is dependent upon venous return, or for patients suspected to have low cardiac filling pressures."	0
It has not been determined if the safety and efficacy of treprostinil by the parenteral ( subcutaneously or intravenously ) route are altered by inhibitors or inducers of CYP2C8 see Warnings and Precautions ( 5.4 ) .	0
Reduce digoxin dose by approximately 30% to 50% or by modifying the dosing frequency and continue monitoring.	0
"Quinidine is gametocidal to Plasmodium vivax and P. malariae, but not to P. falciparum."	0
Hypertension: Initial dose is 2.5 mg to 20 mg once daily.	0
The initial dose should be approximately 1.0mg/kg (50 to 100mg) given as a single dose or on a twice-daily schedule.	0
"However, other published reports describe modest elevations (less than 2-fold) of clozapine and metabolite concentrations when clozapine was taken with paroxetine, fluoxetine, and sertraline."	1
"CYP3A4 inducers:Coadministration of quetiapine and phenytoin, a CYP3A4 inducer increased the mean oral clearance of quetiapine by 5-fold."	1
"ACE inhibitors have been associated with agranulocytosis and bone marrow depression, most frequently in patients with renal impairment, especially patients with a collagen vascular disease such as systemic lupus erythematosus or scleroderma."	0
"However, prior to initiating treatment with an antidepressant, patients with depression symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression."	0
"For adults and pediatric patients, subsequent dosages may be increased in case of an inadequate response in 25 to 50 mg per day increments once a week, depending on tolerability, up to a maximum of 200 mg per day."	0
Rate of Administration: Administration into an umbilical artery catheter is not recommended.	0
"If anticoagulation with PRADAXA is discontinued for a reason other than pathological bleeding or completion of a course of therapy, consider coverage with another anticoagulant."	0
Known hypersensitivity to any of the components in the formulation.	0
"Therefore, in patients taking clarithromycin, avoid atorvastatin doses >20 mg."	1
The administration of the recommended dose of NATRECOR<U+00AE> is a two step process: Step 1.	0
The drug should be used with caution in patients with impaired renal function.	0
Plasma atorvastatin concentrations are lower (approximately 30% for Cmax and AUC) following evening drug administration compared with morning.	0
"In patients taking the HIV protease inhibitors saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, or fosamprenavir plus ritonavir, the dose of atorvastatin should not exceed 20 mg."	1
"When patients were randomized to continue losartan at the two higher doses or to placebo after 3weeks of therapy, trough diastolic blood pressure rose in patients on placebo between 5 and 7mmHg more than patients randomized to continuing losartan."	0
The need for continued treatment should be reassessed periodically.	0
"Higher degrees of AV block, however, were infrequently (0.8%) observed."	0
Absorption of hydrochlorothiazide is reduced in patients with congestive heart failure.	0
"Hepatic Changes <U+2013> During premarketing testing, Anafranil was occasionally associated with elevations in SGOT and SGPT (pooled incidence of approximately 1% and 3%, respectively) of potential clinical importance (i.e., values greater than 3 times the upper limit of normal)."	0
"MAXALT is contraindicated in patients with: Ischemic coronary artery disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), or other significant underlying cardiovascular disease."	0
Fertility and reproductive performance were not affected in studies with male rats given oral doses of losartan potassium up to approximately 150mg/kg/day.	0
"It is also contraindicated in patients with glaucoma, advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism or known hypersensitivity or idiosyncrasy to sympathomimetic amines."	0
"CYP3A4 and CYP 2C19 inhibitors: Since CYP3A4 and CYP 2C19 are the primary enzymes involved in the metabolism of citalopram, it is expected that potent inhibitors of CYP3A4 (e.g., ketoconazole, itraconazole, and macrolide antibiotics) and potent inhibitors of CYP2C19 (e.g., omeprazole) might decrease the clearance of citalopram."	1
"Cases of myopathy, including rhabdomyolysis, have been reported with HMG<U+2011>CoA reductase inhibitors, including rosuvastatin, coadministered with colchicine, and caution should be exercised when prescribing CRESTOR with colchicine."	0
"Non-steroidal anti-inflammatory drugs - In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics."	0
The pharmacokinetics of paliperidone following INVEGA<U+00AE> administration are dose-proportional within the available dose range.	0
Eszopiclone is weakly bound to plasma protein (52-59%).	0
Intervention: Monitor phenytoin levels when initiating or titrating ZOLOFT.	0
Aripiprazole absorption into the systemic circulation is slow and prolonged following intramuscular injection due to low solubility of aripiprazole particles.	0
Outcome Classification (%) on CGI-Global Improvement Item for Completers in Study 1 Outcome Classification Placebo(n = 74) Paroxetine20 mg(n = 75) Paroxetine40 mg(n = 66) Paroxetine60 mg(n = 66) Worse 14% 7% 7% 3% No Change 44% 35% 22% 19% Minimally Improved 24% 33% 29% 34% Much Improved 11% 18% 22% 24% Very Much Improved 7% 7% 20% 20% Subgroup analyses did not indicate that there were any differences in treatment outcomes as a function of age or gender.	0
"Advise patients to seek immediate medical attention in the event of a sudden loss of vision in one or both eyes while taking PDE-5 inhibitors, including REVATIO."	0
"Patients in all studies had panic disorder (DSM-IIIR), with or without agoraphobia."	0
"If azotemia increases, triamterene and hydrochlorothiazide should be discontinued."	0
"The risk of myopathy, including rhabdomyolysis, is dose related."	0
"The active metabolite, perindoprilat, also exhibits multicompartment pharmacokinetics following the oral administration of ACEON."	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
"This effect can be minimized by reducing the MINIPRESS dose to 1 to 2 mg three times a day, by introducing additional antihypertensive drugs cautiously, and then by retitrating MINIPRESS based on clinical response."	0
"Antipsychotics: Quetiapine LEXIVA/ritonavir: <U+2191>Quetiapine For contraindicated antipsychotics (lurasidone, pimozide),."	0
The mean dose for completers was 70 mg/day.	0
Race The effects of race on fingolimod and fingolimod-phosphate pharmacokinetics cannot be adequately assessed due to a low number of non-white patients in the clinical program.	0
"In addition, do not start Lexapro in a patient who is being treated with linezolid or intravenous methylene blue (4.1)."	0
Paroxetine has not been evaluated or used to any appreciable extent in patients with a recent history of myocardial infarction or unstable heart disease.	0
"However, it is important to monitor serum potassium levels because mild hyperkalemia may not be associated with ECG changes."	0
There have been rare postmarketing reports of serotonin syndrome with use of an SSRI and a triptan.	0
Activation of mania or hypomania has been reported in a small proportion of patients with mood disorders who were treated with other marketed drugs effective in the treatment of major depressive disorder.	0
"Patients receiving doses of 40 and 60 mg paroxetine experienced a mean reduction of approximately 6 and 7 points, respectively, on the YBOCS total score which was significantly greater than the approximate 4-point reduction at 20 mg and a 3-point reduction in the placebo-treated patients."	0
The increased plasma concentrations most likely result from inhibition of CYP 3A4 related first-pass metabolism.	0
Radiolabeled trandolapril or its metabolites are secreted in rat milk.	0
"Until further data are available, verapamil should be administered cautiously to patients with impaired renal function."	0
Deaths may occur from overdosage with this class of drugs.	0
"The safe use of Lidocaine Hydrochloride Injection, USP requires careful ECG observation in an environment equipped and by persons trained for resuscitation."	0
Drug Interactions Concomitant use of dilatrate<U+00AE>-SR with phosphodiesterase inhibitors in any form is contraindicated.	0
Hyponatremia: Can occur in association with SIADH (5.9).	0
Concomitant use in patients taking pimozide is contraindicated.	0
"Hyperkalemia Abnormal elevation of serum potassium levels (greater than or equal to 5.5 mEq/liter) can occur with all potassium-conserving diuretic combinations, including triamterene and hydrochlorothiazide."	0
The risk of falling appears to be related to the degree of orthostatic decrease in blood pressure as well as other factors that may increase the underlying risk of falls.	0
"Ischemic cerebrovascular events, including fatalities, occurred in patients treated with CAPRELSA."	0
"Severe leukopenia, thrombocytopenia, anemias including macrocytic anemia, and/or pancytopenia may occur in patients being treated with IMURAN."	0
"Verapamil- or diltiazem-type calcium channel blockers may cause excessive reductions in heart rate, blood pressure, and cardiac contractility."	0
"Caution should be exercised when co-administering ritonavir with digoxin, with appropriate monitoring of serum digoxin levels."	0
"Safe use of nortriptyline hydrochloride oral solution USP during pregnancy and lactation has not been established; therefore, when the drug is administered to pregnant patients, nursing mothers, or women of childbearing potential, the potential benefits must be weighed against the possible hazards."	0
")Considered clinically significant 20 mg QD for 14 weeks <U+2191>90% <U+2191>30% Fluconazole 400 mg QD day 1,200 mg b.i.d. day 2 to 4 40 mg QD <U+2191>84% <U+2191>44% Cholestyramine 8 g QD 20 mg QD administered 4 hrs after a meal plus cholestyramine <U+2193>51% <U+2193>83% Rifampicin 600 mg QD for 6 days 20 mg QD <U+2193>53% <U+2193>42% Cimetidine 400 mg b.i.d. for 5 days, QD on Day 6 20 mg QD <U+2191>30% <U+2191>40% Ranitidine 150 mg b.i.d. for 5 days, QD on Day 6 20 mg QD <U+2191>10% <U+2191>50% Omeprazole 40 mg QD for 6 days 20 mg QD <U+2191>20% <U+2191>37% Phenytoin 300 mg QD 40 mg b.i.d. for 5 days <U+2191>40% <U+2191>27% Propranolol 40 mg b.i.d. for 3.5 days 40 mg QD <U+2193>5% No change Digoxin 0.1 to 0.5 mg QD for 3 weeks 40 mg QD No change <U+2191>11% Diclofenac 25 mg QD 40 mg QD for 8 days <U+2191>50% <U+2191>80% Glyburide 5 to 20 mg QD for 22 days 40 mg b.i.d. for 14 days <U+2191>51% <U+2191>44% Warfarin 30 mg QD 40 mg QD for 8 days <U+2191>30% <U+2191>67% Clopidogrel 300 mg loading dose on day 10, 75 mg QD on days 11 to 19 fluvastatin sodium extended-release tablets, 80 mg QD for 19 days <U+2193>2% <U+2191>27% Data from drug-drug interaction studies involving fluvastatin and coadministration of either gemfibrozil, tolbutamide or losartan indicate that the PK disposition of either gemfibrozil, tolbutamide or losartan is not significantly altered when coadministered with fluvastatin."	0
"Some azoles, including voriconazole, have been associated with prolongation of the QT interval on the electrocardiogram."	0
"Retrospective analysis of side effects in clinical trials showed that poor 2D6 metabolizers had a higher rate of dizziness during up-titration, presumably resulting from vasodilating effects of the higher concentrations of the <U+03B1>-blocking R(+) enantiomer."	0
"Serum digoxin concentrations are not significantly altered by large changes in fat tissue weight, so that its distribution space correlates with lean (i.e., ideal) body weight, not total body weight."	0
"Predisposing factors include advanced age (<U+2265>65), female gender, uncontrolled hypothyroidism, and renal impairment."	0
"In healthy subjects with CYP2D6 extensive metabolizer phenotype, coadministration of quinidine 100 mg and immediate-release metoprolol 200 mg tripled the concentration of S-metoprolol and doubled the metoprolol elimination half-life."	1
"Other signs of overdose may include: confusion, disturbed concentration, transient visual hallucinations, dilated pupils, agitation, hyperactive reflexes, stupor, drowsiness, muscle rigidity, vomiting, hypothermia, hyperpyrexia, or any of the symptoms listed under ADVERSE REACTIONS."	0
GI motility agent cisapride Potential for serious and/or life-threatening reactions such as cardiac arrhythmias.	0
"If nifedipine therapy is initiated in a patient currently receiving cimetidine, cautious titration is advised."	0
Monitor all patients for potential tachycardia and hypertension.	0
Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy.	0
Elderly patients may be at greater risk of developing hyponatremia with SSRIs and SNRIs.	0
Achieve stable INR prior to starting ZOCOR.	0
"In general, the maximum effect of any given dosage level will be apparent after 1 week of therapy."	0
The diuretic effects of chlorthalidone and the benzothiadiazine (thiazide) diuretics appear to arise from similar mechanisms and the maximal effect of chlorthalidone and the thiazides appear to be similar.	0
Patients receiving sertraline experienced a mean reduction of approximately 7 units on the CYBOCS total score which was significantly greater than the 3 unit reduction for placebo patients.	0
"Special populations Age In a study of healthy subjects administered doses of up to 300 mg, there was an approximate 32% increase in Cmax and a 55% increase in AUC in subjects older than 75 years of age (n = 17), compared with subjects 18 to 45 years of age (n = 16)."	0
"No consistent effects of INSPRA on heart rate, QRS duration, or PR or QT interval were observed in 147 normal subjects evaluated for electrocardiographic changes during pharmacokinetic studies."	0
Use in pulmonary veno-occlusive disease may cause pulmonary edema and is not recommended.	0
"Hypersensitivity reactions, including angioedema and anaphylactic reactions, have been observed in patients treated with methylphenidate."	0
"Hyperglycemia may occur, and the dosage of insulin or antidiabetic drugs may require adjustment."	0
Avoid use of Lotensin in patients who are hemodynamically unstable after acute MI.	0
Do not use a microwave oven to warm EXTRANEAL.	0
Tryptophan: Severe vomiting with coadministration (7.2).	0
"Interactions with other dihydropyridine calcium<U+2013>channel blockers have not been reported, but these agents (including felodipine, nicardipine, and nimodipine) are all dependent upon P450IIIA4 for metabolism, so similar interactions with quinidine should be anticipated."	0
"After absorption, rifampin is rapidly eliminated in the bile, and an enterohepatic circulation ensues."	0
Clinical data suggest a greater degree of LDL-lowering at any dose of drug in the elderly patient population compared to younger adults.	0
"The 6'- and 7'-hydroxy metabolites have demonstrated antioxidant properties at concentrations of 5 <U+00B5>M, in vitro."	0
"Placement or removal of an epidural catheter or lumbar puncture is best performed when the anticoagulant effect of dabigatran is low; however, the exact timing to reach a sufficiently low anticoagulant effect in each patient is not known."	0
"Following a single oral dose (40 mg tablet) of citalopram, peak blood levels occur at about 4 hours."	0
"In these studies, paroxetine was shown to be significantly more effective than placebo in treating major depressive disorder by at least 2 of the following measures: Hamilton Depression Rating Scale (HDRS), the Hamilton depressed mood item, and the Clinical Global Impression (CGI)-Severity of Illness."	0
Monitor renal function periodically in patients receiving olmesartan medoxomil and NSAID therapy.	0
"Approximately 50% of an oral dose is absorbed from the gastrointestinal tract, the remainder being excreted unchanged in the feces."	0
Increased monitoring for adverse events in patients receiving the combination is warranted.	0
"Pharmacokinetics The pharmacokinetics of zaleplon have been investigated in more than 500 healthy subjects (young and elderly), nursing mothers, and patients with hepatic disease or renal disease."	0
Clinical studies of RIFADIN did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects.	0
"Rhabdomyolysis has been observed in patients receiving HMG-CoA reductase inhibitors administered alone (at recommended dosages) and in particular, for certain drugs in this class, when given in combination with inhibitors of the CYP3A4 isozyme."	0
"Because of the risk of bleeding (including fatal bleeding) and uncertain effectiveness in patients <U+2265>75years of age, use of Effient is generally not recommended in these patients, except in high-risk situations (patients with diabetes or history of myocardial infarction) where its effect appears to be greater and its use may be considered."	0
"Increases in plasma levels of tricyclic antidepressants, and in the frequency and severity of side effects, particularly anticholinergic, have been reported when cimetidine was added to the drug regimen."	1
ORAP should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.	0
"In patients receiving ritonavir for at least one week , start ADCIRCA at 20 mg once daily ."	0
Heart Rate and Rhythm Fingolimod causes a transient reduction in heart rate and AV conduction at treatment initiation.	0
"In plasma, about 80% of the total amount is present as parent compound and 20% as monoglucuronide."	0
"In another placebo controlled trial in which sotalol was titrated to a dose between 160 and 320 mg/day in patients with chronic AFIB, the mean ventricular rate during recurrence of AFIB was 107 and 84 beats/min in the placebo and sotalol groups, respectively (p<0.001)."	0
Atropine is an antimuscarinic agent since it antagonizes the muscarine-like actions of acetylcholine and other choline esters.	0
"Renal Impairment: Due to the very small contribution (5%) of renal clearance to the overall clearance, renal impairment was not expected to significantly influence the total clearance of ondansetron."	0
A study observed a reduction in clearance and distribution volume as well as prolongation of T<U+00BD> of alfentanil following concomitant treatment with fluconazole.	1
"At least 3 liters of fluid (10-10 oz. glassfuls) should be provided, including two glasses with each meal and at bedtime."	0
"Other important considerations in the differential diagnosis include central anticholinergic toxicity, heat stroke, drug fever and primary central nervous system (CNS) pathology."	0
"However, skin eruptions progressing to erythema multiforme and/or exfoliative dermatitis have also been infrequently reported."	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP should not be taken within 24 hours of each other."	0
TENORETIC may be used with caution in diabetic patients.	0
It is generally believed (though not established in controlled trials) that treating such an episode with an antidepressant alone may increase the likelihood of precipitation of a mixed/manic episode in patients at risk for bipolar disorder.	0
"There was no net effect after first dose on CYP 1A2, but there was moderate induction at steady state."	0
"ACE is peptidyl dipeptidase that catalyzes the conversion of angiotensin I to the vasoconstrictor, angiotensin II."	0
SULAR should be taken on an empty stomach (1 hour before or 2 hours after a meal).	0
"Trandolapril component In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors, with ACE inhibitors, including trandolapril, may result in deterioration of renal function, including possible acute renal failure."	0
Serotonin release by platelets plays an important role in hemostasis.	0
Oral doses as high as 240-320 mg once or twice a day (corresponding to 225 to 300 mg intravenous sotalol) have been utilized in patients with refractory life-threatening arrhythmias.	0
Modest increases in mean trough cyclosporine concentrations were observed following initiation of carvedilol treatment in 21renal transplant subjects suffering from chronic vascular rejection.	1
"If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus."	0
"Drugs that slow heart rate : Concomitant use of drugs with depressant effects on the sinus and AV node ( e.g. , digoxin , beta blockers , verapamil , diltiazem , ivabradine , clonidine ) can potentiate the electrophysiologic and hemodynamic effects of amiodarone , resulting in bradycardia , sinus arrest , and AV block ."	0
The triamterene component of DYAZIDE exerts its diuretic effect on the distal renal tubule to inhibit the reabsorption of sodium in exchange for potassium and hydrogen ions.	0
"Adverse events of nausea, dizziness, hypotension, and syncope have been observed following coadministration of trazodone and ritonavir."	0
QT I nterval P rolongation: Table 1: Dose Adjustments for QT Prolongation ECGs with a QTcgreater than 480 msec 1.	0
Avoid use of aliskiren with PRINIVIL in patients with renal impairment (GFR <60 ml/min).	0
Biliary excretion contributes to the elimination of losartan and its metabolites.	0
"Hepatic Insufficiency: Following oral administration in patients with mild to moderate alcoholic cirrhosis of the liver, plasma concentrations of losartan and its active metabolite were, respectively, 5-times and about 1.7-times those in young male volunteers."	0
ACEON has been associated with hypotension in 0.3% of uncomplicated hypertensive patients in U.S. placebo-controlled trials.	0
"If the drug is given to overactive or agitated patients, increased anxiety and agitation may occur."	0
"IM: 12.5 to 25 mg (0.5-1 mL), 1 to 2 hours before operation."	0
"Severe or life-threatening diarrhea followed one of two patterns: late onset diarrhea (onset more than 24 hours followingchemotherapy)and early onset diarrhea (onset within 24 hours of chemotherapy, sometimes occurring with other symptoms of cholinergic reaction)."	0
"Dosage of amitriptyline/nortriptyline should be adjusted, if necessary."	0
Concomitant use with ondansetron is contraindicated.	0
"20-60 once daily in the morning, 8 days 800 three times daily, 8 days 12 0.93(0.84, 1.03) 0.96(0.86, 1.06) 1.06 (0.94, 1.19) Norethindrone(ORTHO-NOVUM 1/35) 1 mcg, 8 days 800 three times daily, 8 days 18 1.05(0.95, 1.16) 1.26(1.20, 1.31) 1.44(1.32, 1.57) Rifabutin150 mg once daily in the morning, 11 days + indinavir compared to 300 mg once daily in the morning, 11 days alone 150 once daily in the morning, 10 days 300 once daily in the morning, 10 days 800 three times daily, 10 days 800 three times daily, 10 days 14 10 1.29(1.05, 1.59) 2.34(1.64, 3.35) 1.54(1.33, 1.79) 2.73(1.99, 3.77) 1.99(1.71, 2.31)n=13 3.44(2.65, 4.46)n=9 Ritonavir 100 twice daily, 14 days 800 twice daily, 14 days 10, 4Parallel group design; n for coadministered drug + indinavir, n for coadministered drug alone."	0
"With drugs inhibiting CYP3A to a lesser, but still significant degree, estazolam should be used only with caution and consideration of appropriate dosage reduction."	1
"The Class III electrophysiological effects in man include prolongation of the atrial and ventricular monophasic action potentials, and effective refractory period prolongation of atrial muscle, ventricular muscle, and atrio-ventricular accessory pathways (where present) in both the anterograde and retrograde directions."	0
"In the RE-LY trial, the median (10th to 90th percentile) trough ECT in patients receiving the 150 mg dose was 63 (44 to 103) seconds."	0
"Therefore, venlafaxine hydrochloride extended-release provides a slower rate of absorption, but the same extent of absorption compared with the immediate-release tablet."	0
"Lapses in therapy should be avoided, and if thienopyridines must be temporarily discontinued because of an adverse event(s), they should be restarted as soon as possible."	0
Its action is therefore independent of the pathways for angiotensin II synthesis.	0
Tests in the offspring of the drug-treated rodents demonstrate decreased performance.	0
"3.Treatment of all patients requires constant evaluation of therapy in terms of blood volume, augmentation of cardiac contractility, urine flow, cardiac output, blood pressure, and distribution of peripheral perfusion."	0
Fluid retention may require intervention (5.3).	0
ROZEREM should not be used by patients with severe hepatic impairment.	0
"Specific Populations Geriatric - In a study of 32healthy subjects between the ages of 20 and 80years, age had no significant effect on pharmacokinetics of prasugrel's active metabolite or its inhibition of platelet aggregation."	0
The therapeutic doses most commonly employed have ranged from 0.2 mg to 0.6 mg per day given in divided doses.	0
Higher dosage of oral hypoglycemic agents may be required.	1
Avoid co-administration of verapamil and ivabradine.	0
"If oligohydramnios is observed, discontinue ACCUPRIL, unless it is considered life-saving for the mother."	0
"Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders."	0
"In some patients, the administration of a non-steroidal anti-inflammatory agent can reduce the diuretic, natriuretic, and antihypertensive effects of loop, potassium-sparing and thiazide diuretics."	0
"Using aseptic technique, reconstitute FLOLAN only with STERILE DILUENT for FLOLAN or pH 12 STERILE DILUENT for FLOLAN."	0
Rifampin has been observed to increase the requirements for anticoagulant drugs of the coumarin type.	0
The maximum dosage should not exceed 60 mg/day.	0
Figure 3 Effects of Ambrisentan on Other Drugs * Active metabolite of mycophenolate mofetil** GMR (95% CI) for INR Figure 2 Figure 3	0
Metabolism: LIPITOR is extensively metabolized to ortho- and parahydroxylated derivatives and various beta-oxidation products.	0
"In general, expect progressive increases in dose."	0
"Potassium : Concomitant use of valsartan with other agents that block the renin-angiotensin system , potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , salt substitutes containing potassium or other drugs that may increase potassium levels ( e.g. , heparin ) may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine ."	0
"45<U+00AE> (dihydroergotamine mesylate) Injection, USP to subjects already receiving propranolol, there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine."	0
Women of childbearing potential should avoid pregnancy.	0
"Additionally, in studies of another stimulant, there was slowing of the increase in height."	0
Concurrent administration of low-dose dopamine HCl and diuretic agents may produce an additive or potentiating effect on urine flow.	0
A drug interaction study of eplerenone with an NSAID has not been conducted.	0
"In contrast to the benzodiazepines, which non-selectively bind to and activate all BZ receptor subtypes, zolpidem in vitro binds the BZ1 receptor preferentially with a high affinity ratio of the <U+03B1>1/<U+03B1>5 subunits."	0
The inotropic effects of digoxin tend to appear at lower concentrations than the electrophysiological effects.	0
"Because of limited clinical experience in patients with preexisting conduction system disease (eg, marked first-degree AV block or second- or third-degree AV block)."	0
"Therefore, ACCURETIC may be administered without regard to food."	0
"Because of an increased risk for myopathy in Chinese patients taking simvastatin 40 mg coadministered with lipid-modifying doses (greater than or equal to 1g/day niacin) of niacin-containing products, caution should be used when treating Chinese patients with simvastatin doses exceeding 20 mg/day coadministered with lipid-modifying doses of niacin-containing products."	0
QT interval prolongation is directly related to dofetilide plasma concentration.	0
Open-angle glaucoma is not a risk factor for angle-closure glaucoma.	0
may be additive.	0
"After 4 weeks of APTIVUS/ritonavir 500/200 mg BID, the median plasma trough concentration of tipranavir was 43.9 <U+03BC>M for females and 31.1 <U+03BC>M for males."	0
Peak plasma levels of icodextrin plus its metabolites (median Cpeak 2.2 g/L) were observed at the end of the long dwell exchange (median Tmax = 13 hours).	0
Concurrent administration of SURMONTIL and electroshock therapy may increase the hazards of therapy.	0
Adjustment of dosage of NSAIDs may be needed.	0
"CYP 2D6, also called debrisoquin hydroxylase, is the enzyme responsible for metabolism of many neuroleptics, antidepressants, antiarrhythmics, and other drugs."	0
"In pharmacokinetic comparison between Caucasian volunteers and Japanese volunteers, there were no significant differences in Cmax and AUC."	0
"In patients taking the HIV protease inhibitor nelfinavir or the hepatitis C protease inhibitor boceprevir, the dose of atorvastatin should not exceed 40 mg and close clinical monitoring is recommended."	1
"In one study, concomitant administration of digoxin with simvastatin resulted in a slight elevation in digoxin concentrations in plasma."	1
At least two weeks should elapse between withdrawal of the MAO inhibitor and the initiation of guanethidine.	0
It is thought that these reactions may be mediated by accumulation of 5-HT (serotonin) consequent to MAO inhibition.	0
"If oliguria or hypotension occurs, direct attention toward support of blood pressure and renal perfusion."	0
Addition of a diuretic or other antihypertensive agent to MINIPRESS has been shown to cause an additive hypotensive effect.	0
"There were differences in absolute risk of suicidality across the different indications, with the highest incidence in MDD."	0
"The pharmacokinetics of digoxin are complex and dose determination should take into account patient-specific factors (age, lean body weight, renal function, etc."	0
Consider these risks when prescribing or dispensing Meperidine Hydrochloride Injection.	0
The largest incremental effect will likely be in the transition from monotherapy to 150/12.5 mg.	0
Requirements for insulin or oral hypoglycemics may be decreased.	0
"Distribution Telmisartan is highly bound to plasma proteins (>99.5%), mainly albumin and <U+03B1>1 - acid glycoprotein."	0
"In contrast, Cmax and AUC of telmisartan decrease by 31% and 16%, respectively."	0
"Metabolism: Fluvastatin is metabolized in the liver, primarily via hydroxylation of the indole ring at the 5 and 6 positions."	0
Hemiplegic or basilar migraine.	0
"Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior."	0
"In most cases, these were isolated values, which resolved despite continued therapy."	0
"In vitro studies suggest that ambrisentan is a substrate of the Organic Anion Transporting Polypeptides OATP1B1 and OATP1B3, and P-glycoprotein (P-gp)."	0
"Coadministration of VIRACEPT and drugs primarily metabolized by CYP3A (e.g., dihydropyridine calcium channel blockers, HMG-CoA reductase inhibitors, immunosuppressants and PDE5 inhibitors) may result in increased plasma concentrations of such drugs that could increase or prolong both its therapeutic and adverse effects."	1
Angioedema: Discontinue Lotensin and treat appropriately.	0
"The serum levels of quinidine cited in this package insert are those derived from specific assays, using either benzene extraction or (preferably) reverse<U+2013>phase high<U+2013>pressure liquid chromatography."	0
Occasionally it is necessary to lower the carvedilol dose or temporarily discontinue it.	0
"When phenytoin or other hepatic enzyme inducers such as rifampin and phenobarbital have been taken concurrently with mexiletine, lowered mexiletine plasma levels have been reported."	1
Additional food may be given after consumption of the entire mixture.	0
"Although food decreases the rate and extent of drug absorption by approximately 25% and 9%, respectively, as assessed by Cmax and AUC, LDL-C reduction is similar whether LIPITOR is given with or without food."	1
Paroxetine is extensively metabolized after oral administration.	0
LIVALO had no significant effect on prothrombin time (PT) and international normalized ratio (INR) when administered to patients receiving chronic warfarin treatment.	0
A routine dosage adjustment of zaleplon is not considered necessary.	0
"Pharmacologic activity at these receptors is hypothesized to be associated with the various anticholinergic, sedative, and cardiovascular effects seen with other psychotropic drugs."	0
Female rats given the highest dose level had an increased incidence of mesenteric lymph node hemangiomas and skin/subcutaneous lipomas.	0
CYP 450 Interactions: In vitro metabolism studies indicate that CYP 450 mediated drug interactions between valsartan and coadministered drugs are unlikely because of the low extent of metabolism [see Clinical Pharmacology (12.3)].	0
Dopamine hydrochloride should not be used in patients with pheochromocytoma.	0
"In a small number of patients with hypertrophic cardiomyopathy (IHSS), concomitant use of verapamil and quinidine resulted in significant hypotension."	0
"15 Tallent et al described an infant with a large myelomeningocele in the upper lumbar region, bilateral dislocated hips, and bilateral talipes equinovarus."	0
Coadministration of INVIRASE/ritonavir in patients on Adcirca: Avoid use of Adcirca during the initiation of INVIRASE/ritonavir.	0
Methamphetamine is not recommended for use as an anorectic agent in children under 12 years of age.	0
Please refer to the cobicistat full prescribing information for additional precautionary measures.	0
Cimetidine inhibits many cytochrome P450 (oxidative) enzymes.	0
Cationic exchange resins such as sodium polystyrene sulfonate may be orally or rectally administered.	0
The concomitant use of PRADAXA and P-gp inhibitors in patients with CrCl <50 mL/min should be avoided.	0
"Because ZOCOR does not undergo significant renal excretion, modification of dosage should not be necessary in patients with mild to moderate renal impairment."	0
If the serum potassium exceeds 6.5mEq/L more vigorous therapy is required.	0
The usual effective dose is 20 to 25 mg daily.	0
Patients who exhibit these signs or symptoms should be evaluated and NORVIR therapy should be discontinued if a diagnosis of pancreatitis is made.	0
"Adults: Sudden deaths, stroke, and myocardial infarction have been reported in adults taking stimulant drugs at usual doses for ADHD."	0
"In all subjects and at all doses, the mean elimination half-life appeared to be independent of the dose."	0
Long-term carcinogenicity studies and fertility studies have not been done.	0
Potent inhibition of CYP 2D6 and both hepatic and intestinal CYP 3A4/5 activities were observed after first dose and steady state.	0
"There were differences in absolute risk of suicidality across the different indications, with the highest incidence in MDD."	0
"When used concomitantly, inhalation anesthetics and calcium antagonists, such as verapamil, should be titrated carefully to avoid excessive cardiovascular depression."	0
The ratio of pitavastatin AUCinf between patients with moderate hepatic impairment and healthy volunteers was 3.8.	0
The risk of administering methylene blue by non-intravenous routes (such as oral tablets or by local injection) or in intravenous doses much lower than 1mg/kg with CYMBALTA is unclear.	0
Itraconazole : Avoid coadministration of itraconazole with aliskiren see Warnings and Precautions ( 5.7 ) and Clinical Pharmacology ( 12.3 ) .	0
"If patient becomes hypotensive at this dose, decrease dosage to 1.25 mg twice daily."	0
Lithium generally should not be given with diuretics because they reduce its renal clearance and add a high risk of lithium toxicity.	1
"The recommended initial dose is 75 mg once daily in patients with depletion of intravascular volume or salt (e.g., patients treated vigorously with diuretics or on hemodialysis)."	0
"In females, as in males, renal function was the single most important factor influencing dofetilide clearance."	0
The results of dog forelimb experiments demonstrate that the peripheral vasodilator effect of prazosin is confined mainly to the level of the resistance vessels (arterioles).	0
"In hypertensive patients, CARDIZEM CD produces antihypertensive effects both in the supine and standing positions."	0
"Patients in all studies had panic disorder (DSM-IIIR), with or without agoraphobia."	0
"Signs and symptoms of hyponatremia include headache, difficulty concentrating, memory impairment, confusion, weakness, and unsteadiness, which may lead to falls."	0
"When THIOLA<U+00AE> is given orally, up to 48% of dose appears in urine during the first 4 hours and up to 78% by 72 hours."	0
Treatment with APTIVUS co-administered with 200 mg of ritonavir has resulted in large increases in the concentration of total cholesterol and triglycerides.	0
"Therapy should be initiated with the lowest possible dose, then titrated according to individual patient response."	0
"6.For AMBU-FLEX II, continue with therapy set-up as instructed in user manual or directions accompanying tubing sets for automated peritoneal dialysis."	0
"The dosage of lovastatin (once daily in the evening) was 20mg for the first 4weeks, and 40mg thereafter."	0
"Because lithium may enhance the serotonergic effects of escitalopram, caution should be exercised when Lexapro and lithium are coadministered."	0
Effects of 4-factor PCCs on the pharmacodynamics of apixaban were studied in healthy subjects.	0
Dosing should be modified accordingly in the elderly patients.	0
"Appropriate supportive care for the severe hypotension has not been studied, but it seems reasonable to treat this as a nitrate overdose, with elevation of the extremities and with central volume expansion."	0
"The mean t1/2 changed from approximately 10 hours in healthy subjects and subjects with mild hepatic impairment to 13 and 14 hours in moderate and severe hepatic impairment, respectively."	0
"Cardiac Conduction Abnormalities: Arsenic trioxide can cause QTc interval prolongation, complete atrioventricular block, and a torsade de pointes-type ventricular arrhythmia, which can be fatal."	0
Substitute TWYNSTA for its individually titrated components for patients on amlodipine and telmisartan.	0
Atrioventricular block can occur in patients without preexisting conduction defects.	0
"When this occurs, its use should be discontinued; the maximum recommended dose should not be exceeded."	0
The orthostatic hypotension observed was greater with the combination as compared to that observed with lorazepam alone.	0
"Nilotinib has pH-dependent solubility, with decreased solubility at higher pH."	0
Nilotinib exposure is increased in patients with impaired hepatic function.	0
"The CYP450 inhibition and induction potential should be considered when starting, stopping, or changing dose of concomitant medications."	0
"However, prior to initiating treatment with an antidepressant, patients with depressive symptoms should be adequately screened to determine if they are at risk for bipolar disorder; such screening should include a detailed psychiatric history, including a family history of suicide, bipolar disorder, and depression."	0
Letairis is contraindicated in females who are pregnant.	0
"Cutaneous lupus erythematosus (CLE) and systemic lupus erythematosus (SLE) have been reported in patients taking PPIs, including pantoprazole sodium."	0
Preparation of Suspension (for 200 mL of a 2 mg/mL suspension) Add 50 mL of Purified Water to an amber polyethylene terephthalate (PET) bottle containing twenty Benicar20 mg tablets and allow tostand for a minimum of 5 minutes.	0
Hyperkalemic metabolic acidosis has been reported in patients given ALDACTONE concurrently with cholestyramine .	0
"The antihypertensive effect and or adverse effects of adding 4 mg of trandolapril once-a-day to a dose of 240mg Isoptin-SR administered twice-a-day has not been studied, nor have the effects of adding as little of 180 mg Isoptin-SR to 2 mg trandolapril administered twice-a-day been evaluated."	0
"The recommended dosage of DIFLUCAN for oropharyngeal candidiasis is 200 mg on the first day, followed by 100 mg once daily."	0
Echocardiogram during and after treatment could be useful for detecting any valvular disorders which may occur.	0
Patients taking NARDIL should not undergo elective surgery requiring general anesthesia.	0
Pediatric Patients: Pediatric patients 1 month of age or older: 10 mg/kg (not to exceed 600 mg per dose) every 12 hours for two days.	0
The incidence of myopathy with 80 mg (0.61%) was disproportionately higher than that observed at the lower doses.	0
"Like other peritoneal dialysis solutions, EXTRANEAL also contains electrolytes to help normalize electrolyte balance and lactate to help normalize acid-base status."	0
(B) SPINAL/EPIDURAL HEMATOMA: Epidural or spinal hematomas may occur in patients treated with PRADAXA who are receiving neuraxial anesthesia or undergoing spinal puncture.	0
"When administered concurrently the following drugs may interact with thiazide diuretics: Alcohol, barbiturates, or narcotics <U+2013> Potentiation of orthostatic hypotension may occur."	0
"Prescribers or other health professionals should inform patients, their families, and their caregivers about the benefits and risks associated with treatment with nefazodone hydrochloride tablets and should counsel them in its appropriate use."	0
A CBC and reticulocyte count are recommended at 3-month intervals for the duration of treatment.	0
EMEND for oral suspension The dose will be prepared by the healthcare provider and dispensed to the patient or caregiver in an oral dispenser.	0
"Treatment emergent psychotic or manic symptoms, e.g., hallucinations, delusional thinking, or mania in children and adolescents without a prior history of psychotic illness or mania can be caused by atomoxetine at usual doses."	0
"Overall, the data for EMSAM 6mg per 24 hours support a recommendation that a modified diet is not required at this dose."	0
High-dose treatment of both LASIX and these other drugs may result in elevated serum levels of these drugs and may potentiate their toxicity as well as the toxicity of LASIX.	0
Administer continuous chronic infusion of FLOLAN through a central venous catheter.	0
"In patients with progressive kidney disease, discontinuation of REYATAZ may be considered."	0
Study 3 was a 12-week flexible-dose study comparing paroxetine (10 to 60 mg daily) to placebo in patients concurrently receiving standardized cognitive behavioral therapy.	0
NATRECOR<U+00AE> may decrease renal function as judged by increases in serum creatinine.	0
GI Motility Agent Cisapride Potential for serious and/or life threatening reactions such as cardiac arrhythmias.	0
The terminal elimination half-life (T1/2) ranged from 6 to 8 hours.	0
33 <U+2013>16 <U+2013>21 +5 <U+2013>24 <U+2013>19 <U+2013>10 20 mg q.p.m.	0
FLOLAN is a potent inhibitor of platelet aggregation.	0
"The exposure of the hydroxybupropion metabolite was decreased by 23%, the threohydrobupropion decreased by 38%, and the erythrohydrobupropion decreased by 48%."	0
"Because many drugs are excreted in human milk, and because of the potential for serious adverse reactions in nursing infants from mercaptopurine, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother."	0
The elimination half-life of candesartan is approximately 9 hours.	0
Please refer to the nilotinib and dasatinib prescribing information for dosing instructions.	0
Plasma levels from topical application of PRUDOXIN Cream can result in CNS and other systemic side effects.	0
"Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death."	0
Continue to monitor QTc during dose escalations.	0
The usual Segment I fertility/reproduction studies in laboratory animals have not been carried out with procarbazine hydrochloride.	0
"Therefore, phentolamine should be given as soon as possible after the extravasation is noted."	0
The recommended starting dose of TOPROL-XL is 25 mg once daily for two weeks in patients with NYHA Class II heart failure and 12.5 mg once daily in patients with more severe heart failure.	0
Reliable dose response data for the effects of ORAP (pimozide) on tic manifestation in Tourette<U+2019>s Disorder patients below the age of twelve are not available.	0
In some cases diabetic ketoacidosis has occurred.	0
Hyperuricemia may occur or acute gout may be precipitated in certain patients receiving thiazide therapy.	0
Two pharmacokinetic studies with a combined oral contraceptive have been performed using multiple doses of fluconazole.	0
"Due to the narrow therapeutic index of pimozide and its known ability to prolong the QT interval, concomitant use of pimozide and paroxetine is contraindicated."	0
Dose to be repeated no earlier than three days.	0
Loss of therapeutic effect of CRIXIVAN and possible development of resistance.	0
Gender Evaluation of steady-state plasma tipranavir trough concentrations at 10-14 h after dosing from the controlled clinical trials 1182.12 and 1182.48 demonstrated that females generally had higher tipranavir concentrations than males.	0
Tacrolimus: A prospective study in healthy Chinese volunteers (N=9) with CYP3A5 expressers showed a 2.5- to 4-fold increase in tacrolimus exposure when concomitantly administered with amlodipine compared to tacrolimus alone.	1
<U+2022>Pediatric patients na<U+00EF>ve to fluvoxamine maleate: The lowest available dose of LUVOX CR Capsules may not be appropriate (2.2).	0
Cases with serum sodium lower than 110 mmol/L have been reported.	0
"<U+2022>Adults: Recommended starting dose is 100 mg at bedtime, with weekly increases of 50 mg as tolerated to maximum effect, not to exceed 300 mg/day (2.1)."	0
"See Drug Interactions (7) for instructions concerning coadministration of acid-reducing medications (eg, H2RA or PPIs), and other antiretroviral drugs (eg, efavirenz, tenofovir DF, and didanosine). b For pediatric patients at least 25 kg who cannot swallow REYATAZ capsules, 300 mg (6 packets) REYATAZ oral powder is taken once daily with food along with 100 mg ritonavir. c Only patients weighing 5 to less than 10 kg who do not tolerate the 200 mg (4 packets) dose of REYATAZ oral powder and have not previously taken an HIV protease inhibitor, may take 150 mg (3 packets) REYATAZ oral powder with close HIV viral load monitoring. d Each packet contains 50 mg of REYATAZ."	0
EMEND for oral suspension should be prepared by a healthcare provider.	0
"In many cases, this hyponatremia appears to be the result of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)."	0
"Peritoneal dialysis may affect a patient<U+2019>s protein, water-soluble vitamin, potassium, sodium, chloride, bicarbonate, and magnesium levels and volume status."	0
"There have been spontaneous reports of increase or decrease in prothrombin times in patients concomitantly taking oral terbinafine and warfarin, however, a causal relationship between LAMISIL Tablets and these changes has not been established."	0
Pimozide POTENTIAL for serious and/or life-threatening reactions such as cardiac arrhythmias.	0
Children 1 to < 6 years of age: The dose range is 0.05 to 0.4 mg/kg per day.	0
"Families and caregivers of patients being treated with antidepressants for major depressive disorder or other indications, both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to health care providers."	0
All of digoxin<U+2019>s actions are mediated through its effects on NaK<U+2013>ATPase.	0
"For patients switching from a regimen containing delavirdine or rilpivirine, the recommended dose is 500-mg twice daily with ritonavir 100-mg twice daily for the first 7 days of treatment."	0
A patient Medication Guide is available for DESOXYN.	0
"In these studies, paroxetine was shown to be significantly more effective than placebo in treating major depressive disorder by at least 2 of the following measures: Hamilton Depression Rating Scale (HDRS), the Hamilton depressed mood item, and the Clinical Global Impression (CGI)-Severity of Illness."	0
Chronic therapy with CARDIZEM CD produces no change or an increase in plasma catecholamines.	0
"Study 1, a dose-range finding study where patients were treated with fixed doses of 20, 40, or 60 mg of paroxetine/day demonstrated that daily doses of paroxetine 40 and 60 mg are effective in the treatment of OCD."	0
TARKA should not be administered to nursing mothers.	0
"Ergot derivatives: dihydroergotamine, ergonovine, ergotamine, methylergonovine CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues."	0
"If dose-related adverse reactions occur, make dose decreases gradually in 2-ng/kg/min decrements every 15 minutes or longer until the dose-limiting effects resolve."	0
The metabolites of carvedilol are excreted primarily via the bile into the feces.	0
"Severe Renal Impairment <U+2014> Avoid use in patients with severe renal impairment, GFR <30mL/min."	0
"Indication Starting Dosage Maximum Dosage MDD (2.1) 50 mg per day 200 mg per day OCD (2.1) 25 mg per day (ages 6<U+2013>12) 50 mg per day (ages <U+2265> 13) 200 mg per day PD, PTSD, SAD (2.1) 25 mg per day 200 mg per day PMDD (2.2) continuous dosing 50 mg per day 150 mg per day PMDD (2.2) intermittent dosing 50 mg per day during luteal phase only 100 mg per day during luteal phase only If inadequate response to starting dosage, titrate in 25<U+2013>50 mg per day increments once weekly in MDD, OCD, PD, PTSD, and SAD (2.1) See Full Prescribing Information for titration in PMDD (2.2) Hepatic impairment: Mild: Recommended starting and maximum dosage is half recommended dosage (2.4) Moderate or severe: Not recommended (2.4) When discontinuing ZOLOFT, reduce dose gradually (2.6, 5.4) Oral solution: Must be diluted before administration (2.7) The recommended initial dosage and maximum ZOLOFT dosage in patients with MDD, OCD, PD, PTSD, and SAD are displayed in Table 1 below."	0
"The influence of terbinafine on the pharmacokinetics of fluconazole, cotrimoxazole (trimethoprim and sulfamethoxazole), zidovudine or theophylline was not considered to be clinically significant."	0
"Rarely, ACE inhibitors have been associated with a syndrome that starts with cholestatic jaundice and progresses to fulminant hepatic necrosis and (sometimes) death."	0
"This may produce carbamazepine side effects such as diplopia, headache, ataxia, or dizziness."	0
"Carcinogenesis, mutagenesis, impairment of fertility <U+2014> Animal studies to evaluate quinidine's carcinogenic or mutagenic potential have not been performed."	0
Further glucuronidation results in urinary excretion of the parent drug and its metabolites.	0
"NORVIR oral powder should be mixed with soft food such as apple sauce or vanilla pudding, or mixed with liquid such as water, chocolate milk, or infant formula."	0
Obtain monthly pregnancy tests during treatment and 1 month after discontinuation of treatment.	0
"Moreover, the rise in urinary pH resulting from potassium citrate extended-release tablets therapy might promote further bacterial growth."	0
Heparin In vitro studies demonstrated no evidence of incompatibility of heparin with EXTRANEAL.	0
"Prior to initiating treatment with ZOLOFT or another antidepressant, screen patients for a personal or family history of bipolar disorder, mania, or hypomania."	0
Patients beginning treatment for ADHD should be monitored for the appearance or worsening of aggressive behavior or hostility.	0
"In a similar study conducted in women, the mean AUC for pravastatin was approximately 46% higher and the mean CUE approximately 18% lower in elderly women (65 to 78 years old) compared with younger women (18 to 38 years old)."	0
"The pharmacokinetics of candesartan were linear in the elderly, and candesartan and its inactive metabolite did not accumulate in the serum of these subjects upon repeated, once-daily administration."	0
"Standardized procedures are based on dilution method 1, 2, 3 (broth or agar dilution) or equivalent using standardized inoculum and concentrations of penicillin."	0
"In another formal study (n = 8 extensive and n = 7 poor metabolizers of CYP2D6), coadministration of propafenone did not alter the kinetics of mexiletine in the poor CYP2D6 metabolizer group."	0
Monitor plasma concentrations and adjust dosage appropriately.	0
Plasma clearance ranges from 500 to 700mL/min.	0
Increased frequency of monitoring of plasma levels of immunosuppressant drugs is recommended.	0
Patients should also check with their health care provider and/or pharmacist prior to taking a new over-the-counter preparation.	0
Therapy with rifampin may markedly reduce oral verapamil bioavailability.	1
"However, there was no impairment of mating performance or fertility, nor any harm to the fetus in these animals at doses 8 to 48 times the full therapeutic dose of cimetidine, as compared with controls."	0
"(For further information about the description of tardive dyskinesia and its clinical detection, please refer to the sections on Information for Patients and ADVERSE REACTIONS.)"	0
"Cardiovascular function, particularly arrhythmias and fluctuations in blood pressure, should be monitored."	0
Consolidation: 0.15 mg/kg intravenously daily for 25 doses over a period up to 5 weeks.	0
"In a human pharmacokinetic study conducted with sildenafil ( 60 mg/day ) and an oral formulation of treprostinil ( treprostinil diethanolamine ) , no pharmacokinetic interactions between treprostinil and sildenafil were observed ."	0
"However, due to the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of thioridazine, paroxetine and thioridazine should not be coadministered."	0
Swirl vial gently to completely dissolve the antibiotic.	0
"Drug interactions Sildenafil : When amlodipine and sildenafil were used in combination, each agent independently exerted its own blood pressure lowering effect."	0
"DIFLUCAN hepatotoxicity has usually, but not always, been reversible on discontinuation of therapy."	0
"The absolute bioavailabilities of ramipril and ramiprilat were 28% and 44%, respectively, when 5 mg of oral ramipril was compared with the same dose of ramipril given intravenously."	0
The absolute bioavailability of rosuvastatin is approximately 20%.	0
"For further information about the description of tardive dyskinesia and its clinical detection, please refer to the sections on PRECAUTIONS and ADVERSE REACTIONS."	0
Cyclosporine or Itraconazole: Avoid concomitant use.	0
"If hyperkalemia is suspected (warning signs include paresthesias, muscular weakness, fatigue, flaccid paralysis of the extremities, bradycardia, and shock), an electrocardiogram (ECG) should be obtained."	0
These changes are not due to changes in renal function.	0
"In patients taking AUBAGIO, exposure of drugs which are OAT3 substrates (e.g., cefaclor, cimetidine, ciprofloxacin, penicillin G, ketoprofen, furosemide, methotrexate, zidovudine) may be increased."	1
Fingolimod treatment is not associated with a decrease in cardiac output.	0
"After at least one week following the initiation of LEXIVA, resume ADCIRCA at 20mg once daily."	0
"Opioids: Limit dosage and duration, and follow patients closely for respiratory depression and sedation."	0
"Prescriptions for CYMBALTA should be written for the smallest quantity of capsules consistent with good patient management, in order to reduce the risk of overdose."	0
Careful observation for digital changes is necessary during treatment with ADHD stimulants.	0
"In depressed patients, the possibility of suicide should always be considered and adequate precautions taken."	0
"Clinically significant effects have been reported with the warfarin anticoagulants; therefore, close monitoring of prothrombin time is recommended, and adjustment of the anticoagulant dose may be necessary when cimetidine is administered concomitantly."	0
"In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy."	0
"Since there is little clinical experience, the concomitant administration of paroxetine and warfarin should be undertaken with caution."	0
"Consequently, it may be appropriate to titrate slowly following the initial dose of 100 mg in these patient groups."	0
"Trandolapril in doses of 0.8 mg/kg/day in rabbits, 100.0 mg/kg/day in rats, and 25 mg/kg/day in cynomolgus monkeys (10, 1250, and 312 times the maximum projected human dose, respectively, assuming a 50 kg woman) did not produce teratogenic effects."	0
Downward dose adjustment of QUAZEPAM and/or concomitant CNS depressants may be necessary because of additive effects.	1
Ambrisentan is a high-affinity (Ki=0.011 nM) ETA receptor antagonist with a high selectivity for the ETA versus ETB receptor (>4000-fold).	0
A variable effect has been seen when verapamil and atenolol were given together.	0
It has the potential to inhibit P-glycoprotein (P-gp) transport.	0
12 200 mg QD for 4 days 40 mg on Day 4 > 36Estimated minimum change.	0
"Meperidine Hydrochloride Injection, like other narcotics, may produce orthostatic hypotension in ambulatory patients."	0
"STRATTERA generally should not be used in children or adolescents with known serious structural cardiac abnormalities, cardiomyopathy, serious heart rhythm abnormalities, or other serious cardiac problems that may place them at increased vulnerability to its noradrenergic effects."	0
"However, the pharmacodynamic effect increased by 197% (QTc increase over time) and by 95% (maximum QTc increase)."	0
Take VYVANSE by mouth in the morning with or without food; avoid afternoon doses because of the potential for insomnia.	0
"Intervention: Mycophenolate mofetil (MMF): Co-administration of pantoprazole sodium in healthy subjects and in transplant patients receiving MMF has been reported to reduce the exposure to the active metabolite, mycophenolic acid (MPA), possibly due to a decrease in MMF solubility at an increased gastric pH."	1
The pharmacokinetics of olmesartan in patients undergoing hemodialysis has not been studied.	0
It does not require antithrombin III for antithrombotic activity.	0
The dialysis clearance of apixaban is approximately 18 mL/min.	0
"The serum protein binding of benazepril is about 96.7% and that of benazeprilat about 95.3%, as measured by equilibrium dialysis; on the basis of in vitro studies, the degree of protein binding should be unaffected by age, hepatic dysfunction, or concentration (over the concentration range of 0.24-23.6<U+00B5>mol/L)."	0
Counsel patients about potential effects on fertility.	0
The QT prolongation caused by other medicinal products (such as amiodarone) may be amplified via the inhibition of cytochrome P450 (CYP) 3A4.	0
Certain drugs or drug classes should not be coadministered with INVIRASE/ritonavir based on drug interaction studies or predicted drug interactions.	0
"Higher infusion rates, and therefore, more concentrated solutions may be necessary with long<U+2011>term administration of FLOLAN."	0
"The available knowledge concerning the relationship of fluvoxamine and the cytochrome P450 isoenzyme system has been obtained mostly from pharmacokinetic interaction studies conducted in healthy volunteers, but some preliminary in vitro data are also available."	0
"After multiple dosing with 150 mg/day, the accumulation factor for CMI is approximately 2.5 and for DMI is 4.6."	0
Triptans: There have been rare postmarketing reports of serotonin syndrome with use of an SSRI and a triptan.	0
"When co-administering NORVIR with other protease inhibitors, see the full prescribing information for that protease inhibitor including important Warnings and Precautions."	0
Females should practice additional methods of contraception and not rely on hormonal contraception alone when taking Tracleer [see Use in Specific Populations (8.3)].	0
"Thioridazine administration alone produces prolongation of the QTc interval, which is associated with serious ventricular arrhythmias, such as torsade de pointes-type arrhythmias, and sudden death."	0
"Do NOT add any alkalinizing substance, since dopamine is inactivated in alkaline solution."	0
"The half-life does not differ in patients with renal failure at doses not exceeding 600 mg daily, and consequently, no dosage adjustment is required."	0
Daily dosages of 360 and 480 mg have been used but there is no evidence that dosages beyond 360 mg provided added effect.	0
Clinical electroencephalogram (EEG) studies demonstrated that clozapine increases delta and theta activity and slows dominant alpha frequencies.	0
"If an optimal blood pressure response is not obtained with 37.5 mg/25 mg of triamterene and hydrochlorothiazide, the dose should be increased to two 37.5 mg/25 mg tablets daily as a single dose, or one 75 mg/50 mg tablet daily."	0
Prompt medical attention is required in the event of suspected priapism.	0
The maximum recommended dose should not exceed 3 times the original dose (2.7 and 7.3).	0
"Due to a possible additive effect with hypotensive agents, patients receiving these drugs should be observed closely for signs of excessive hypotension when thiothixene is added to their drug regimen6."	0
"At 40 and 160 mg the bioavailability was 42% and 58%, respectively."	0
"Rare reports of more severe liver injury, some fatal, have been recorded in foreign postmarketing experience."	0
Hypotension induced by isosorbide dinitrate may be accompanied by paradoxical bradycardia and increased angina pectoris.	0
"Serotonin Syndrome: Serotonin syndrome has been reported with SSRIs and SNRIs, including Savella, both when taken alone, but especially when co-administered with other serotonergic agents (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines and St. John's Wort)."	0
"INVIRASE is contraindicated in patients with clinically significant hypersensitivity (e.g., anaphylactic reaction, Stevens-Johnson syndrome) to saquinavir, saquinavir mesylate, or any of its ingredients."	0
"AUC was only slightly increased (6%) when drug was administered with food but the Cmax was 29% greater, while the time to reach peak plasma concentration decreased from 6.4 hours post-dosing to 4.9 hours."	1
"Calcium Channel Blockers:amlodipine, diltiazem, felodipine, nicardipine, nifedipine, verapamil <U+2191> calcium channel blockers Clinical monitoring of patients is recommended."	0
"Dabigatran and its acyl glucuronides are competitive, direct thrombin inhibitors."	0
This drug should be discontinued as soon as possible prior to elective surgery because of possible cardiovascular effects.	0
"In ARISTOTLE, concomitant use of aspirin increased the bleeding risk on ELIQUIS from 1.8% per year to 3.4% per year and concomitant use of aspirin and warfarin increased the bleeding risk from 2.7% per year to 4.6% per year."	0
Antihypertensive effects of losartan potassium tablets have been established in hypertensive pediatric patients aged 6 to 16years.	0
"Thiazides may precipitate azotemia in such patients, and the effects of repeated dosing may be cumulative."	0
"For complete CAPD and APD system preparation, see directions accompanying ancillary equipment."	0
In the Scandinavian Simvastatin Survival Study (4S).	0
"If fluvoxamine maleate tablets are to be administered together with a drug that is eliminated via oxidative metabolism and has a narrow therapeutic window, plasma levels and/or pharmacodynamic effects of the latter drug should be monitored closely, at least until steady-state conditions are reached."	0
"Because of the prolonged elimination half-life, a longer period of time is required to achieve an initial or new steady-state serum concentration in patients with renal impairment than in patients with normal renal function."	0
The effects of LUNESTA on sleep onset may be reduced if it is taken with or immediately after a high-fat/heavy meal.	0
"When nefazodone (200 mg BID) and cimetidine (300 mg QID) were coadministered for one week, no change in the steady-state pharmacokinetics of either nefazodone or cimetidine was observed compared to each dosed alone."	0
The time course of inhibition parallels the plasma concentration profile of the drug.	0
"In particular, patients should be instructed not to take foods such as cheese (particularly strong or aged varieties), sour cream, Chianti wine, sherry, beer (including non-alcoholic beer), liqueurs, pickled herring, anchovies, caviar, liver, canned figs, raisins, bananas or avocados (particularly if overripe), chocolate, soy sauce, sauerkraut, the pods of broad beans (fava beans), yeast extracts, yogurt, meat extracts, meat prepared with tenderizers, or dry sausage."	0
"CYP 2D6 inhibitors: In healthy subjects, co-administration of pimozide 2 mg (single dose) and paroxetine 60 mg resulted in a 151% increase in pimozide AUC and a 62% increase in pimozide Cmax compared to pimozide administered alone."	1
"At endpoint, 33% of the paroxetine-treated patients showed a reduction to 0 or 1 panic attacks compared to 14% of placebo patients."	0
"Corticosteroids, ACTH - Intensified electrolyte depletion, particularly hypokalemia."	0
The more prolonged terminal elimination phase probably represents a small fraction of dose saturably bound to ACE.	0
"Patients may develop new onset or exacerbations of diabetes mellitus, hyperglycemia (5.8), immune reconstitution syndrome (5.9), redistribution/accumulation of body fat (5.10), and elevated lipids."	0
Hydrochlorothiazide Hydrochlorothiazide is not metabolized but is eliminated rapidly by the kidney.	0
Exacerbation of insomnia and emergence of cognitive and behavioral abnormalities were seen with ROZEREM during the clinical development program.	0
"Avoid use of strong inhibitors of CYP3A (e.g., ketoconazole, itraconazole, voriconazole, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir and telithromycin) [see Clinical Pharmacology (12.3) ]."	0
Invasive aspergillosis and serious fungal infections due to Fusarium spp. and Scedosporium apiospermum See Table 1.	0
Reports from the laboratory providing results of the standard single-disk susceptibility test with a 5 mcg rifampin disk should be interpreted according to the following criteria for Neisseria meningitides: Zone Diameter (mm) Interpretation <U+2265> 20 (S) Susceptible 17 - 19 (I) Intermediate <U+2264> 16 (R) Resistant Interpretation should be as stated above for results using dilution techniques.	0
The effect of lovastatin on the progression of atherosclerosis in the coronary arteries has been corroborated by similar findings in another vasculature.	0
"For patients already taking ritonavir 100-mg twice daily as part of their antiretroviral regimen, no additional ritonavir is needed."	0
"BCRP and OATP1B1/1B3 Substrates There was an increase in mean rosuvastatin Cmax and AUC (2.65- and 2.51-fold, respectively), following repeated doses of teriflunomide , suggesting that teriflunomide is an inhibitor of BCRP transporter and organic anion transporting polypeptide 1B1 and 1B3 (OATP1B1/1B3)."	1
Continued administration of INVIRASE therapy following loss of viral suppression may increase the likelihood of cross resistance to other protease inhibitors.	0
"Immune reconstitution syndrome has been reported in patients treated with combination antiretroviral therapy, including REYATAZ."	0
"In patients being transferred to Marplan from another MAO inhibitor or from a dibenzazepine-related entity, a medication-free interval of at least 1 week should be allowed, after which Marplan therapy should be started using half the normal starting dosage for at least the first week of therapy."	0
Angle Closure Glaucoma: The pupillary dilation that occurs following use of many antidepressant drugs including Luvox CR may trigger an angle closure attack in a patient with anatomically narrow angles who does not have a patent iridectomy.	0
"It may be necessary to reduce the maintenance and digitalization doses when ALDACTONE is administered, and the patient should be carefully monitored to avoid over- or under-digitalization."	0
Other less potent CYP 3A4 inhibitors should be administered with caution.	0
There are no data to support dosing recommendations for pediatric patients with hepatic impairment.	0
"If hypotension occurs during the administration of NATRECOR<U+00AE>, reduce the dose of or discontinue NATRECOR<U+00AE> and initiate other measures to support blood pressure (IV fluids, changes in body position)."	0
"Increased risk of suicidal thinking and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder and other psychiatric disorders (5.1)."	0
"In multi-dose studies, steady-state levels of icodextrin were achieved within one week."	0
"Electrolyte and Fluid Balance Status: In published studies, clinically significant hypokalemia has been consistently less common in patients who received 12.5 mg of hydrochlorothiazide than in patients who received higher doses."	0
"Atrial arrhythmias associated with hypermetabolic states (e.g., hyperthyroidism) are particularly resistant to digoxin treatment."	0
Losartan potassium tablets are not recommended in pediatric patients <6years of age or in pediatric patients with glomerular filtration rate <30mL/min/1.73m2.	0
Food does not alter the pharmacokinetics of nebivolol.	0
"Renal clearance involves both glomerular filtration and active tubular secretion, moderated by (pH<U+2013>dependent) tubular reabsorption."	0
"Blockade of the renin-angiotensin system with ACE inhibitors, which inhibit the biosynthesis of angiotensin II from angiotensin I, is widely used in the treatment of hypertension."	0
The recommended starting dose is 0.20 mg/kg (oral suspension).	0
"In general, avoid combined use of RAS inhibitors."	0
Use of PDE5 inhibitors for erectile dysfunction: Use VIAGRA<U+00AE> (sildenafil) with caution at reduced doses of 25 mg every 48 hours with increased monitoring for adverse events.	1
The suspension should be stored at or below 25<U+00B0>C (77<U+00B0>F) and can be stored for up to four weeks.	0
"With the exception of one study (N = 153), the Phase III clinical development program was conducted without requiring a modified diet (N = 2,553, 1,606 at 6mg per 24 hours, and 947 at 9mg per 24 hours or 12mg per 24 hours)."	0
"In these rare cases, the mothers should be apprised of the potential hazards to their fetuses, and serial ultrasound examinations should be performed to assess the intra-amniotic environment."	0
"WARNING - MALIGNANCY Chronic immunosuppression with IMURAN, a purine antimetabolite increases risk of malignancy in humans."	0
Systemic/Inhaled/ Nasal/Ophthalmic Corticosteroids:e.g. betamethasone budesonide ciclesonide dexamethasone fluticasone methylprednisolone mometasone prednisone triamcinolone <U+2193> darunavir<U+2191> corticosteroids Co-administration of PREZISTA/ritonavir with systemic dexamethasone or other systemic corticosteroids that induce CYP3A may result in loss of therapeutic effect and development of resistance to darunavir.	0
For intravenous use: Cleviprex is intended for intravenous use.	0
"Because many drugs are excreted in human milk, a decision should be made to discontinue nursing, or to discontinue SULAR, taking into account the importance of the drug to the mother."	0
"Bleeding events related to SSRIs and SNRIs use have ranged from ecchymoses, hematomas, epistaxis, and petechiae to life-threatening hemorrhages."	0
Dilatation of the coronary arteries also occurs.	0
Hypomagnesemia can result in hypokalemia which appears difficult to treat despite potassium repletion.	0
Olanzapine: Coadministration of eszopiclone and olanzapine produced a decrease in DSST scores.	0
ONIVYDE is contraindicated in patients who have experienced a severe hypersensitivity reaction to ONIVYDE or irinotecan HCl.	0
"If asymptomatic elevations in AST or ALT greater than 10 times the upper limit of normal occur, APTIVUS/ritonavir therapy should be discontinued."	0
"Therefore, from a microbiological point of view, once reconstituted, the product should be used immediately."	0
"Positive direct Coombs Test with/without hemolytic anemia has been reported but a causal relationship between PROCARDIA administration and positivity of this laboratory test, including hemolysis, could not be determined."	0
Table1: Pharmacokinetic Parameters in Hypertensive Adults and Children Age6-16 Following Multiple Dosing Adults given 50mg once daily for 7daysN=12 Age6-16 given 0.7mg/kg once daily for 7daysN=25 Parent Active Metabolite Parent Active Metabolite AUC0-24 Mean <U+00B1> standard deviation(ng<U+2022>h/mL) 442 <U+00B1> 173 1685 <U+00B1> 452 368 <U+00B1> 169 1866 <U+00B1> 1076 CMAX (ng/mL) 224 <U+00B1> 82 212 <U+00B1> 73 141 <U+00B1> 88 222 <U+00B1> 127 T1/2 (h)Harmonic mean and standard deviation 2.1 <U+00B1> 0.70 7.4 <U+00B1> 2.4 2.3 <U+00B1> 0.8 5.6 <U+00B1> 1.2 TPEAK (h)Median 0.9 3.5 2.0 4.1 CLREN (mL/min) 56 <U+00B1> 23 20 <U+00B1> 3 53 <U+00B1> 33 17 <U+00B1> 8 The bioavailability of the suspension formulation was compared with losartan tablets in healthy adults.	0
"Therefore , concomitant use of Tracleer and cyclosporine A is contraindicated see Cytochrome P450 Drug Interactions ( 7.1 ) ."	0
"Table 16: Comparison of Cmax and Tmax Values for Venlafaxine and ODV Following Oral Administration of Venlafaxine hydrochloride Extended-Release and Venlafaxine hydrochloride Immediate-Release) Venlafaxine ODV Cmax (ng/mL) Tmax (h) Cmax (ng/mL) Tmax (h) Venlafaxine hydrochloride Extended-Release (150 mg once daily) 150 5.5 260 9 Venlafaxine hydrochloride Immediate-Release (75 mg twice daily) 225 2 290 3 Food did not affect the bioavailability of venlafaxine or its active metabolite, ODV."	0
"Because of the dual interaction mechanism of rifampin, simultaneous co-administration of atorvastatin with rifampin is recommended, as delayed administration of atorvastatin after administration of rifampin has been associated with a significant reduction in atorvastatin plasma concentrations."	1
"The usual starting dose of losartan potassium tablets is 50mg once daily, with 25mg used in patients with possible depletion of intravascular volume (e.g., patients treated with diuretics)."	0
"As in adults, fluoxetine and norfluoxetine accumulated extensively following multiple oral dosing; steady-state concentrations were achieved within 3to4weeks of daily dosing."	0
"There was no evidence of tumorigenicity in male C3Hf/DP mice or in similar studies in BALB/c mice, or in two year studies in Wistar rats."	0
"The mean steady state volume of distribution (Vss) for sildenafil is 105 L, indicating distribution into the tissues."	0
"Additionally, based on population pharmacokinetic analysis, no effects of sex, race, BMI, and smoking status on asenapine exposure were observed."	0
"Patients with symptomatic hypotension may require temporarily reducing the dose of ATACAND, diuretic or both, and volume repletion."	1
"Reproductive studies have been performed in the rat at doses up to 5 times the human dose and have revealed no evidence of impaired fertility or harm to the fetus due to Lidocaine Hydrochloride Injection, USP."	0
Whether the dose needed to induce remission is identical to the dose needed to maintain and/or sustain euthymia is unknown.	0
"Patients may improve the taste of NORVIR oral solution by mixing with chocolate milk, Ensure<U+00AE>, or Advera<U+00AE> within one hour of dosing."	0
Caution is warranted and therapeutic concentration monitoring of these drugs is recommended if they are used concomitantly with REYATAZ.	0
"Monitor patients closely for respiratory depression, especially within the first 24 to 72 hours of initiating therapy and following dosage increases with Oxycodone and Aspirin Tablets and adjust the dosage accordingly."	0
"Concomitant use of BREVIBLOC injection with other drugs that can lower blood pressure , reduce myocardial contractility , or interfere with sinus node function or electrical impulse propagation in the myocardium can exaggerate BREVIBLOC s effects on blood pressure , contractility , and impulse propagation ."	0
The risks of long-term infusion of PROSTIN VR PEDIATRIC should be weighed against the possible benefits that critically ill infants may derive from its administration.	0
"Hyperkalemia: In patients with impaired mechanisms for excreting potassium, potassium citrate extended-release tablets administration can produce hyperkalemia and cardiac arrest."	0
Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide.	0
The major biotransformation pathways for duloxetine involve oxidation of the naphthyl ring followed by conjugation and further oxidation.	0
"Upon dose reduction, drug interruption, or discontinuation, transaminase levels returned to or near pretreatment levels without sequelae."	0
Caution is advisable in using Lexapro in patients with diseases or conditions that produce altered metabolism or hemodynamic responses.	0
"After 4 weeks, dilatrate<U+00AE>-SR could not be distinguished from placebo."	0
"For patients with normal renal or hepatic function: Treatment of gout flares-co-administration of colchicine in patients on ritonavir: 0.6 mg (one tablet) for one dose, followed by 0.3 mg (half tablet) one hour later."	0
"Therefore, there is no apparent rationale, except for familiarity with use, for treating with anything other than a once daily at bedtime dosage regimen."	0
Remodulin dosage adjustment may be necessary if inhibitors or inducers of CYP2C8 are added or withdrawn .	0
Coadministration of ALTACE with other drugs that raise serum potassium levels may result in hyperkalemia.	0
These intervals should be at least 15minutes.	0
"LASIX may increase the ototoxic potential of aminoglycoside antibiotics , especially in the presence of impaired renal function ."	0
"On the basis of body-surface area, these doses are 56 times (in mice) and 21 times (in rats) the MRHD."	0
"Because many drugs are excreted in human milk, caution should be exercised when Lidocaine Hydrochloride Injection, USP is administered to a nursing woman."	0
A potentially fatal symptom complex sometimes referred to as Neuroleptic Malignant Syndrome (NMS) has been reported in association with antipsychotic drugs.	0
The elimination half-life (t1/2) of fluvastatin is approximately 3 hours.	0
3.Discard all the unused water remaining in the mixing cup.	0
"Dual blockade of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia."	0
"Losartan does not affect the response to bradykinin, whereas ACE inhibitors increase the response to bradykinin."	0
Intravenous sotalol is administered by a volumetric infusion pump over 5 hours at a constant infusion rate.	0
Potassium-sparing agents should generally not be used in patients with heart failure receiving VASOTEC .	0
Pharmacologically this action may potentiate or prolong neuronal activity since reuptake of these biogenic amines is important physiologically in terminating transmitting activity.	0
Concomitant use of tricyclic antidepressants with drugs that can inhibit cytochrome P450 2D6 may require lower doses than usually prescribed for either the tricyclic antidepressant or the other drug.	1
The possibility of exacerbation or activation of systemic lupus erythematosus has been reported with thiazide diuretics which are structurally related to chlorthalidone.	0
TTP can occur after a brief exposure (<2weeks).	0
Monitor lithium levels in patients receiving Avalide and lithium.	0
The rate of ISTH major bleeding was 2.8% per year with apixaban versus 0.6% per year with placebo in patients receiving single antiplatelet therapy and was 5.9% per year with apixaban versus 2.5% per year with placebo in those receiving dual antiplatelet therapy.	0
"STRATTERA should be discontinued in patients with jaundice or laboratory evidence of liver injury, and should not be restarted."	0
DIFLUCAN significantly increases cyclosporine levels in renal transplant patients with or without renal impairment.	1
Hepatic Impairment - Pharmacokinetics of prasugrel's active metabolite and inhibition of platelet aggregation were similar in patients with mild to moderate hepatic impairment compared to healthy subjects.	0
"The bulk of the radioactive materials were recovered in the urine (mean 58.2% and 45.1% in EM and PM, respectively), with feces accounting for 19.9% (EM) to 22.1% (PM) of the dosed radioactivity."	0
Abrupt withdrawal of <U+03B2>-blockers may be followed by an exacerbation of the symptoms of hyperthyroidism or may precipitate a thyroid storm.	0
Distribution: Clevidipine is >99.5% bound to proteins in plasma at 37<U+00B0>C.	0
The initial clinical effect may occur within one week.	0
"The patient should be cautioned not to increase dosage, except on advice of the physician."	0
Patients receiving warfarin therapy should be carefully monitored when paroxetine is initiated or discontinued.	0
"Concurrently, systemic vascular resistance and stroke volume showed non-significant increases of 25% and 8%, respectively."	0
"Do not coadminister aliskiren with VASOTEC in patients with diabetes ( see PRECAUTIONS , Drug Interactions ) ."	0
"Perform chemistry panels, including electrolytes, calcium, magnesium, liver enzymes, lipid profile, and glucoseprior to therapy and periodically."	0
There is no pharmacokinetic interaction between losartan and hydrochlorothiazide.	0
"A transient hypotensive response is not a contraindication to further doses; however, lower doses of verapamil HCl ER and/or trandolapril or reduced concomitant diuretic therapy should be considered."	0
"VASOTEC has been used concomitantly with beta adrenergic-blocking agents , methyldopa , nitrates , calcium-blocking agents , hydralazine , prazosin and digoxin without evidence of clinically significant adverse interactions ."	0
These values are similar to those obtained previously in adults.	0
Insulin requirements in diabetes mellitus may be altered in association with the use of methamphetamine and the concomitant dietary regimen.	0
"Symptomatic postural hypotension is infrequent, although it can occur in patients who are salt- and/or volume-depleted."	0
"The antihypertensive efficacy of SULAR was studied in 5 double-blind, placebo-controlled, randomized studies, in which over 600 patients were treated with SULAR as monotherapy and about 300 with placebo; 4 of the five studies compared 2 or 3 fixed doses while the fifth allowed titration from doses bioequivalent to 8.5 - 34 mg. Once daily administration of SULAR produced sustained reductions in systolic and diastolic blood pressures over the 24 hour dosing interval in both supine and standing positions."	0
"In more severely ill patients, dosage may be further increased gradually to 300 mg/day if necessary."	0
Antipsychotics PimozideLurasidone Potential for cardiac arrhythmias.Potential for serious and/or life-threatening reactions.	0
"Geriatric Patients Healthy elderly volunteers (65 years or over) had a reduced clearance of sildenafil, resulting in approximately 84% and 107% higher plasma concentrations of sildenafil and its active N-desmethyl metabolite, respectively, compared to those seen in healthy younger volunteers (18<U+2013>45 years)."	0
It may be necessary to increase dosage up to 90 mg per day to obtain sufficient MAO inhibition.	0
<U+2022>when coadministered with drugs that are highly dependent on cytochrome P450 3A4 (CYP3A4) for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events (Table 2).	1
"Hypotension: monitor for signs and symptoms of hypotension, in particular in patients receiving concurrent antihypertensives; Zanaflex should not be used with other <U+03B1> 2-adrenergic agonists ( 5.1, 7.7) Risk of liver injury: monitor ALTs; discontinue Zanaflex if liver injury occurs ( 5.2) Sedation: Zanaflex may interfere with everyday activities; sedative effects of Zanaflex, alcohol, and other CNS depressants are additive ( 5.3, 7.5, 7.6) Hallucinations: consider discontinuation of Zanaflex ( 5.4) Less potent inhibitors of CYP1A2: may cause hypotension, bradycardia, or excessive drowsiness, use caution if Zanaflex is used with less potent inhibitors of CYP1A2, e.g., zileuton, other fluoroquinolones, antiarrythmics , cimetidine, famotidine, oral contraceptives, acyclovir, and ticlopidine ( 5.5, 7.3, 12.3) Renal impairment (creatinine clearance < 25 mL/min): use Zanaflex with caution, and monitor closely for dry mouth, somnolence, asthenia and dizziness as indicators of potential overdose ( 5.7) Tizanidine is an <U+03B1> 2-adrenergic agonist that can produce hypotension."	0
"Symptomatic hypotension is possible with use of amlodipine, particularly in patients with severe aortic stenosis."	0
"Concomitant use of fibrinolytics, anticoagulants and antiplatelet drugs increases the risk of bleeding."	0
"No affinity [Ki greater than 10mcM] was noted at dopamine receptors, adrenergic <U+03B2>3, glutamate, muscarinic M1-M5, nicotinic, or rolipram receptor/sites."	0
"The clinician should, nevertheless, be aware of the possibility of emergent symptoms of serotonin syndrome with such use."	0
"Methadone: Significantly increased methadone (plasma level:dose) ratios have been reported when immediate-release fluvoxamine maleate tablets were administered to patients receiving maintenance methadone treatment, with symptoms of opioid intoxication in one patient."	0
For patients with CLCR less than 30 mL per min the dose of clarithromycin should be decreased by 75%.	1
"These phenomena are not well understood, but they are observed in animal models as well as in humans."	0
Lithium - generally should not be given with diuretics.	0
Read prescribing information for lithium preparations before use of such preparations with TENORETIC.	0
"Depending on the fraction of drug metabolized by P450 2D6, the increase in plasma concentration may be small, or quite large (8-fold increase in plasma AUC of the TCA)."	0
"In studies in man, peak plasma pravastatin concentrations occurred 1 to 1.5 hours upon oral administration."	0
The contractile processes of cardiac muscle and vascular smooth muscle are dependent upon the movement of extracellular calcium ions into these cells through specific ion channels.	0
Closely monitor symptoms of serotonin syndrome if BRINTELLIX is co-administered with other serotonergic drugs.	0
Serum and urine electrolyte determinations are particularly important when the patient is vomiting excessively or receiving parenteral fluids.	0
(7.2) Remodulin dosage adjustment may be necessary if inhibitors or inducers of CYP2C8 are added or withdrawn.	0
"For the diffusion technique, the 10 unit penicillin disk should provide the following zone diameters with the quality control strains: Table 2."	0
Concomitant PDE-5 inhibitors: Avoid use with Viagra or other PDE-5 inhibitors.	0
It is common to have medicine leftover in the cup.	0
"Twenty-five children in an unblinded, multicenter trial with supraventricular (SVT) and/or ventricular (VT) tachyarrhythmias, aged between 3 days and 12 years (mostly neonates and infants), received an ascending titration regimen with daily doses of 30, 90 and 210 mg/m2 with dosing every 8 hours for a total of 9 doses."	0
"Co-administration of a cytochrome P450 ( CYP ) 2C8 enzyme inhibitor ( e.g. , gemfibrozil ) increases exposure ( both Cmax and AUC ) to treprostinil ."	1
Steady-state concentrations are achieved within 3 days.	0
Localized and aneurysmal dilatations and vessel wall edema also were seen compared to a series of pathological specimens from infants not treated with PROSTIN VR PEDIATRIC.	0
"For optimal absorption, didanosine should be separated from APTIVUS/ritonavir dosing by at least 2 hours."	0
"For convenient therapy and to facilitate patient compliance, the total dosage requirement may be given at bedtime."	0
Refer to the lurasidone prescribing information for concomitant use with moderate CYP3A4 inhibitors.	0
"Patients should be cautioned about the risk of bleeding associated with the concomitant use of CYMBALTA and NSAIDs, aspirin, or other drugs that affect coagulation."	0
"History of ischemic heart disease or coronary artery vasospasm (4) History of stroke or transient ischemic attack (4) Peripheral vascular disease (4) Ischemic bowel disease (4) Uncontrolled hypertension (4) Recent (within 24 hours) use of another 5-HT1 agonist (e.g., another triptan), or of an ergotamine-containing medication (4) Hemiplegic or basilar migraine (4) MAO-A inhibitor used in the past 2 weeks (4) Hypersensitivity to MAXALT or MAXALT-MLT (4)"	0
Proton Pump Inhibitors Time to maximum concentration (Tmax) of amphetamine is decreased compared to when administered alone.	1
"In patients taking erythromycin, a dose of LIVALO 1 mg once daily should not be exceeded."	1
"Because thrombin (serine protease) enables the conversion of fibrinogen into fibrin during the coagulation cascade, its inhibition prevents the development of a thrombus."	0
Indication Starting dose Dose Range Adult Hypertension (2.1) 20 mg once daily 20 - 40 mg once daily Pediatric Hypertension (6 - 16 years) (2.2) 20 to <35 kg 10 mg once daily <U+2265>35 kg 20 mg once daily 20 to <35 kg 10 - 20 mg once daily <U+2265>35 kg20 - 40 mg once daily Benicar may be administered with or without food.	0
"The effects of intravenous atropine on heart rate (maximum heart rate) and saliva flow (minimum flow) after intravenous administration (rapid, constant infusion over 3 min.) are delayed by 7 to 8 minutes after drug administration and both effects are non-linearly related to the amount of drug in the peripheral compartment."	0
Patients who develop abnormally sustained or frequent and painful erections should seek immediate medical attention.	0
"While this interaction has not been formally studied, it is recommended that theophylline levels be monitored when these drugs are concurrently administered."	0
"Competitive in vitro ligand binding studies have also shown CARDIZEM binding is not altered by therapeutic concentrations of digoxin, hydrochlorothiazide, phenylbutazone, propranolol, salicylic acid, or warfarin."	0
Rifampin and Other CYP 3A Inducers Rifampin is an inducer of CYP 3A and P-gp.	0
"Figure 2: Effect of Coadministered Drugs on the Pharmacokinetics of Apixaban In dedicated studies conducted in healthy subjects, famotidine, atenolol, prasugrel, and enoxaparin did not meaningfully alter the pharmacokinetics of apixaban."	0
"However, this has not been investigated in human studies."	0
The recommended initial dose is 20 mg/day.	0
"Treatment of symptomatic atrial fibrillation/flutter<U+2014>A patient receiving an intravenous infusion of quinidine must be carefully monitored, with frequent or continuous electrocardiography and blood<U+2013>pressure measurement."	0
Stopping Effient increases the risk of subsequent cardiovascular events (5.3).	0
Hypertension Administration of CARDURA results in a reduction in systemic vascular resistance.	0
"Marked elevations of SGOT (> 1000 U/L) were seen before death in four patients with end-stage cardiac disease (severe congestive heart failure, cardiogenic shock)."	0
Acute exacerbation of coronary artery disease upon cessation of therapy: Do not abruptly discontinue (5.1) Diabetes: Monitor glucose as <U+03B2>-blockers may mask symptoms of hypoglycemia (5.5) Do not abruptly discontinue BYSTOLIC therapy in patients with coronary artery disease.	0
"The dietary administration of nefazodone to rats and mice for 2 years at daily doses of up to 200 mg/kg and 800 mg/kg, respectively, which are approximately 3 and 6 times, respectively, the maximum human daily dose on a mg/m2 basis, produced no increase in tumors."	0
Interference with adequate oral electrolyte intake will also contribute to hypokalemia.	0
"Lidocaine Hydrochloride Injection, USP should not be used in patients with STOKES-ADAMS syndrome, Wolff-Parkinson-White syndrome, or with severe degrees of sinoatrial, atrioventricular or intraventricular block."	0
"Rarely, prolonged daily use of other ergot alkaloid drugs has been associated with cardiac valvular fibrosis."	0
"The mechanism of action of bupropion is unknown, as is the case with other antidepressants."	0
Thus sertraline multiple dose pharmacokinetics appear to be unaffected by renal impairment.	0
"The precise mechanism of action of CALAN as an antianginal agent remains to be fully determined, but includes the following two mechanisms: Relaxation and prevention of coronary artery spasm: CALAN dilates the main coronary arteries and coronary arterioles, both in normal and ischemic regions, and is a potent inhibitor of coronary artery spasm, whether spontaneous or ergonovine-induced."	0
"However, at all doses studied, the mean antihypertensive effect was substantially smaller 24 hours after dosing than it was 6 hours after dosing."	0
The absolute bioavailability after a 10 mg oral dose of bisoprolol fumarate is about 80%.	0
Suspensions should be at room temperature before administering.	0
"Rare instances of hypertensive encephalopathy, cerebrovascular accidents and death have been reported after clonidine withdrawal."	0
The next dose of ELIQUIS should not be administered earlier than 5 hours after the removal of the catheter.	0
Clomipramine should not be used with MAO inhibitors.	0
The dose of MINIPRESS should be adjusted according to the patient's individual blood pressure response.	0
"Should treatment with any of these agents be required, interrupt therapy with Tasigna."	0
"The diuretic effects of chlorthalidone lead to decreased extracellular fluid volume, plasma volume, cardiac output, total exchangeable sodium, glomerular filtration rate, and renal plasma flow."	0
"Therapeutic concentration monitoring, if available, is recommended for antiarrhythmics."	0
"When administered concomitantly with propylene glycol, ethanol competitively inhibits the metabolism of propylene glycol, which may lead to elevated concentrations."	0
ORAP produces anticholinergic side effects and should be used with caution in individuals whose conditions may be aggravated by anticholinergic activity.	0
"Systemic exposure to tofacitinib is increased when tofacitinib is coadministered with fluconazole, a combined moderate CYP3A4 and potent CYP2C19 inhibitor."	1
"Suggested Regimen: 1.When appropriate, increase blood volume with whole blood or plasma until central venous pressure is 10 to 15 cm H2O or pulmonary wedge pressure is 14 to 18 mm Hg."	0
Delayed hematologic suppression may occur.	0
Gender Minor differences were observed in the pharmacokinetics of olmesartan in women compared to men.	0
The clearance of the primary dihydropyridine metabolite is 0.03 L/h/kg and the terminal half-life is approximately 9 hours.	0
"In most patients, the median time to detection of the transaminase elevation was about two months."	0
Inform patients taking ADCIRCA not to take CIALIS or other PDE5 inhibitors .	0
Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by rifampin or other antibacterial drugs in the future.	0
"Following a 14C-labelled oral dose of fluvoxamine maleate (5 mg), an average of 94% of drug-related products was recovered in the urine within 71 hours."	0
Approximately 80% of the administered radioactivity was recovered in urine and 11% in the feces.	0
"If propranolol or metoprolol is coadministered with LUVOX CR Capsules, a reduction in the initial beta-blocker dose and more cautious dose titration are recommended."	1
Do not use in combination with drugs that both increase saquinavir plasma concentrations and prolong the QT interval.	0
"To avoid improper insulin administration, educate all patients to alert health care providers of this interaction whenever they are admitted to the hospital."	0
Savella should be discontinued in patients who develop jaundice or other evidence of liver dysfunction.	0
"Because of the trandolapril component, TARKA is contraindicated in patients with a history of angioedema related to previous treatment with an angiotensin converting enzyme (ACE) inhibitor."	0
"Although in most patients the hypotensive effect of SULAR is modest and well tolerated, occasional patients have had excessive and poorly tolerated hypotension."	0
HIV Antiviral Agents Nucleoside Reverse Transcriptase Inhibitors (NRTIs): didanosine buffered formulationsenteric-coated (EC) capsules <U+2193> atazanavir<U+2193> didanosine Coadministration of REYATAZ with didanosine buffered tablets resulted in a marked decrease in atazanavir exposure.	1
"Thereafter, each patient received a maintenance regimen of 7.5 mg/kg of base (12 mg/kg of quinidine gluconate) infused over 4 hours every 8 hours, starting 8 hours after the beginning of the loading dose."	0
"CRIXIVAN may interact with some drugs; therefore, patients should be advised to report to their doctor the use of any other prescription, non-prescription medication or herbal products, particularly St. John's wort."	0
"Immunosuppressants : Cyclosporine, rapamycin <U+2191> Immunosuppressants Therapeutic concentration monitoring is recommended for immunosuppressant agents when coadministered with INVIRASE/ritonavir."	0
"Marplan (isocarboxazid) should not be administered in combination with any of the following: MAO inhibitors or dibenzazepine derivatives; sympathomimetics (including amphetamines); some central nervous system depressants (including narcotics and alcohol); antihypertensive, diuretic, antihistaminic, sedative or anesthetic drugs, buproprion HCL, buspirone HCL, dextromethorphan, cheese or other foods with a high tyramine content; or excessive quantities of caffeine."	0
Streptogramin antibiotics (quinupristin/dalfopristin) Streptogramin antibiotics such as quinupristin/dalfopristin inhibit CYP3A4; saquinavir concentrations may be increased Monitoring for saquinavir toxicity is recommended.	1
Table 6 Pharmacokinetic Properties of the Components of HARVONI in Pediatric Subjects 12 Years of Age and Older	0
"Consistent with in vitro results, a study in normal healthy volunteers showed that ziprasidone did not alter the metabolism of dextromethorphan, a CYP2D6 model substrate, to its major metabolite, dextrorphan."	0
"CYP2D6 substrates and inhibitors (e.g., paroxetine) SAPHRIS may enhance the inhibitory effects of paroxetine on its own metabolism."	1
"Effient can cause significant, sometimes fatal, bleeding."	0
"See PRECAUTIONS, Drug Interactions, below."	0
Other drugs that reduce blood pressure Alpha blockers.	0
"In controlled studies of SULAR in patients with angina this was seen about 1.5% of the time in patients given nisoldipine, compared with 0.9% in patients given placebo."	0
"Events reported upon discontinuation of treatment with paroxetine in the pediatric clinical trials that included a taper phase regimen, which occurred in at least 2% of patients who received paroxetine and which occurred at a rate at least twice that of placebo, were: emotional lability (including suicidal ideation, suicide attempt, mood changes, and tearfulness), nervousness, dizziness, nausea, and abdominal pain."	0
Thiazides should be used with caution in patients with impaired hepatic function.	0
"There have been rare reports of immune-mediated necrotizing myopathy (IMNM), an autoimmune myopathy, associated with statin use."	0
"Monitor patients frequently for signs and symptoms of neurological impairment and if observed, treat urgently."	0
Administration of MYCOBUTIN as a single agent to patients with active tuberculosis is likely to lead to the development of tuberculosis that is resistant both to MYCOBUTIN and to rifampin.	0
Patients receiving continued sertraline hydrochloride treatment experienced significantly lower relapse rates over the subsequent 28 weeks compared to those receiving placebo.	0
"In a trial of 12healthy subjects, combined oral administration of carvedilol 25mg once daily and torsemide 5mg once daily for 5days did not result in any significant differences in their pharmacokinetics compared with administration of the drugs alone."	0
"As with other 5-HT1 agonists, sensations of tightness, pain, pressure, and heaviness in the precordium, throat, neck and jaw commonly occur after treatment with MAXALT and are usually non-cardiac in origin."	0
Interactions with Investigations of Neuroendocrine Tumors Clinical Impact: CgA levels increase secondary to PPI-induced decreases in gastric acidity.	0
"Head and Neck Angioedema: Angioedema of the face, extremities, lips, tongue, glottis, or larynx has been reported in patients treated with ACE inhibitors, including ACEON (0.1% of patients treated with ACEON in U.S. clinical trials)."	0
The thiazides may decrease serum PBI levels without signs of thyroid disturbance.	0
"In patients with pheochromocytoma, an <U+03B1>-blocking agent should be initiated prior to the use of any <U+03B2>-blocking agent."	0
"Figure2: Inhibition (Mean<U+00B1>SD) of 20<U+03BC>M ADP-induced Platelet Aggregation(IPA) Measured by Light Transmission Aggregometry after Prasugrel 60-mg. Platelet aggregation gradually returns to baseline values over 5-9 days after discontinuation of prasugrel, this time course being a reflection of new platelet production rather than pharmacokinetics of prasugrel."	0
Recommended starting dose of ONIVYDE in patients homozygous for UGT1A1*28 is 50 mg/m 2 every two weeks.	0
"Therefore, in patients taking cyclosporine, therapy should be limited to fluvastatin 20 mg twice daily."	0
"The duration of separation depends upon the absorption characteristics of the medication concomitantly administered, such as the time to reach peak systemic levels and whether the drug is an immediate release or an extended release product."	0
"Limited information suggests there is no difference in the clearance of S-warfarin; however, there may be a slight decrease in the clearance of R-warfarin in the elderly as compared to the young."	0
"PDE5 inhibitors such as sildenafil, vardenafil, and tadalafil have been shown to potentiate the hypotensive effects of organic nitrates."	0
"The following dosage schedule, based on theoretical considerations rather than experimental data, is suggested for transferring patients from other Class I oral antiarrhythmic agents to mexiletine: mexiletine hydrochloride treatment may be initiated with a 200 mg dose, and titrated to response as described above, 6 to 12 hours after the last dose of quinidine sulfate, 3 to 6 hours after the last dose of procainamide, 6 to 12 hours after the last dose of disopryramide or 8 to 12 hours after the last dose of tocainide."	0
Absorption The relative bioavailability of levomilnacipran after administration of FETZIMA ER was 92% when compared to oral solution.	0
Immediate medical attention should be sought if signs or symptoms of prolonged penile erections or priapism are observed.	0
"Irrespective of the CYP3A5 genotype status, the possibility of an interaction cannot be excluded with these drugs."	0
"Absorption: Following sublingual administration, asenapine is rapidly absorbed with peak plasma concentrations occurring within 0.5 to 1.5 hours."	0
"Therefore , the expected clinical effects of SAMSCA in the presence of rifampin and other inducers ( e.g. , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine and St.   John 's   Wort ) may not be observed at the usual dose levels of SAMSCA ."	0
"Coadministration is not recommended.Coadministration of HARVONI with rifampin, a P-gp inducer, is not recommended."	0
"If coadministration is necessary, reduce the quetiapine dose to 1/6 of the current dose and monitor for quetiapine-associated adverse reactions."	1
Reductions of 18% in mean maximum plasma concentration (Cmax) and 12% in the area under the concentration-time curve (AUC) occurred when CARDURA was administered with food.	1
"In most patients studied, onset of antihypertensive activity was seen at one hour after oral administration of an individual dose of PRINIVIL, with peak reduction of blood pressure achieved by 6 hours."	0
Losartan did not affect the pharmacokinetics of oral or intravenous digoxin.	0
"Dilutional hyponatremia may occur in edematous patients in hot weather; appropriate therapy is water restriction, rather than administration of salt, except in rare instances when the hyponatremia is life threatening."	0
"Adults Candesartan cilexetil is rapidly and completely bioactivated by ester hydrolysis during absorption from the gastrointestinal tract to candesartan, a selective AT1 subtype angiotensin II receptor antagonist."	0
"If this is not possible, reduce the starting dose."	0
The role of this enzyme in paroxetine metabolism also suggests potential drug-drug interactions.	0
Risk factors for developing acute angle-closure glaucoma may include a history of sulfonamide or penicillin allergy.	0
Transient delirium has been reported in patients who were treated with one gram of ethchlorvynol and 75 mg to 150 mg of amitriptyline hydrochloride.	0
"Pheochromocytoma: If DUTOPROL is used in the setting of pheochromocytoma, it should be given in combination with an alpha blocker, and only after the alpha blocker has been initiated."	0
Mexiletine should be used with caution in patients with known seizure disorder.	0
This should be kept in mind if NARDIL is administered to diabetics.	0
The usual therapeutic effect is observed with oral doses of 80 to 160 mg once or twice a day (corresponding to 75 to 150 mg intravenous sotalol).	0
"Because NORVIR oral solution contains ethanol and propylene glycol, it is not recommended for use with polyurethane feeding tubes due to potential incompatibility."	0
Concomitant use of ORAP with paroxetine and other strong CYP 2D6 inhibitors is contraindicated.	0
"In patients with renal disease, thiazides may precipitate azotemia."	0
There is no measurable negative chronotropic effect.	0
"If oligohydramnios is observed, losartan potassium tablets should be discontinued unless they are considered life-saving for the mother."	0
HIV-1 Protease Inhibitor Atazanavir Potential for serious and/or life-threatening cardiac arrhythmia.	0
"If heart failure develops or worsens and requires hospitalization, discontinue MULTAQ."	0
Pediatric patients under 1 month of age: 5 mg/kg every 12 hours for two days.	0
A CRIXIVAN dose of 800 mg every 8 hours (with zidovudine 200 mg every 8 hours and lamivudine 150 mg twice a day) has been studied in 16 HIV-infected pregnant patients at 14 to 28 weeks of gestation at enrollment (study PACTG 358).	0
Tell female patients of childbearing age about the consequences of exposure to ACCURETIC during pregnancy.	0
"Quazepam, like other central nervous system agents of the 1,4-benzodiazepine class, presumably exerts its effects by binding to stereo-specific receptors at several sites within the central nervous system (CNS)."	0
Antiarrhythmics: amiodarone CONTRAINDICATED due to potential for serious and/or life-threatening reactions such as cardiac arrhythmias.	0
The radiometric broth method employs the BACTEC 460 machine to compare the growth index from untreated control cultures to cultures grown in the presence of 2.0 mcg/mL of rifampin.	0
"NOTE: If at any time after the second dose of TIKOSYN is given the QTc is greater than 500 msec (550 msec in patients with ventricular conduction abnormalities), TIKOSYN should be discontinued."	0
Angiotensin II also stimulates aldosterone secretion by the adrenal cortex.	0
Acidosis may be associated with rapid elevations in serum potassium levels.	0
"A related trivalent arsenic, sodium arsenite, produced teratogenicity when administered during gestation in mice at a dose approximately 5 times the projected human dose on a mg/m<U+00B2> basis and in hamsters at an intravenous dose approximately equivalent to the projected human daily dose on a mg/m<U+00B2> basis."	0
The average peak to trough concentration ratio was 2.	0
"In pediatric patients and in adult volunteers, absolute bioavailability of digoxin from the solution formulation is 70% to 85%, similar to that seen (in adults) with standard tablets (60% to 80%)."	0
"If excessive hypotension occurs, the patient should be placed immediately in a supine position and, if necessary, treated with an intravenous infusion of physiological saline."	0
Various degrees of cross-resistance among protease inhibitors have been observed.	0
Sofosbuvir was absorbed quickly and the peak median plasma concentration was observed ~0.8 to 1 hour post-dose.	0
Williamson and Karp described an infant born with preaxial polydactyly whose mother received azathioprine 200mg daily and prednisone 20mg every other day during pregnancy.	0
Monitor blood cell counts periodically during treatment.	0
"However, strong inhibitors of CYP3A (e.g., itraconazole, clarithromycin) may increase the plasma concentrations of amlodipine to a greater extent."	1
"Marked first-degree block or progressive development to second- or third-degree AV block requires a reduction in dosage or, in rare instances, discontinuation of verapamil HCl and institution of appropriate therapy depending upon the clinical situation."	0
"In arriving at a diagnosis, it is important to identify cases where the clinical presentation includes both serious medical illness (e.g., pneumonia, systemic infection, etc.) and untreated or inadequately treated extrapyramidal signs and symptoms (EPS)."	0
"Since beta1 selectivity is not absolute, the lowest possible dose of TENORMIN should be used with therapy initiated at 50 mg and a beta2-stimulating agent (bronchodilator) should be made available."	0
"Diltiazem significantly decreases the clearance and increases the t<U+00BD> of quinidine, but quinidine does not alter the kinetics of diltiazem."	1
"Pimozide and Celexa: In a controlled study, a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in QTc values of approximately 10 msec compared to pimozide given alone."	0
The terminal elimination phase has a prolonged half-life (>50 hours) and probably represents the binding/dissociation kinetics of the ramiprilat/ACE complex.	0
"Beta-adrenergic blockade may mask certain clinical signs (eg, tachycardia) of hyperthyroidism."	0
"Approximately 10% of the Caucasian population has reduced activity of this enzyme, so-called <U+201C>poor<U+201D> metabolizers."	0
"In many cases, this hyponatremia appears to be the result of the syndrome of inappropriate antidiuretic hormone secretion (SIADH)."	0
"CYP 3A Inducers Avoid co-administration of CYP 3A inducers (e.g., rifampin, rifabutin, rifapentin, barbiturates, phenytoin, carbamazepine, St. John's Wort) with SAMSCA, as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment."	1
Capsules should not be crushed or chewed.	0
Animal and human experiments indicate that metoprolol slows the sinus rate and decreases AV nodal conduction.	0
There is no information available for patients with end-stage renal disease requiring dialysis.	0
"No evidence of a mutagenic potential of atenolol was uncovered in the dominant lethal test (mouse), in vivo cytogenetics test (Chinese hamster) or Ames test (S typhimurium)."	0
"In contrast, if half-lives are short, the drug and metabolites will be cleared before the next dose is ingested, and carry-over effects related to excessive sedation or CNS depression should be minimal or absent."	0
Monitor appropriately.	0
"In patients <U+2265>75 years of age, Effient is generally not recommended, except in high-risk patients (diabetes or prior MI), where its use may be considered (8.5)."	0
"Avoid co-administration of CYP 3A inducers ( e.g. , rifampin , rifabutin , rifapentin , barbiturates , phenytoin , carbamazepine , St.   John 's   Wort ) with SAMSCA , as this can lead to a reduction in the plasma concentration of tolvaptan and decreased effectiveness of SAMSCA treatment ."	1
"Use in Adolescents and Children ROZEREM has been associated with an effect on reproductive hormones in adults, e.g., decreased testosterone levels and increased prolactin levels."	0
"For the metabolite hydroxybupropion, the mean Cmax was approximately 69% lower."	0
ANA) may be positive and elevated serological test results may take longer to resolve than clinical manifestations.	0
"As with other <U+03B2>-blockers, when discontinuation of COREG is planned, the patients should be carefully observed and advised to limit physical activity to a minimum."	0
The relationship between plasma metoprolol levels and reduction in exercise heart rate is independent of the pharmaceutical formulation.	0
"For additional information on management, see prescribing information for dantrolene sodium."	0
ENDOTHELIN RECEPTOR ANTAGONIST Bosentan <U+2191> bosentan Concentrations of bosentan may be increased when coadministered with VIRACEPT.	1
A single-dose pharmacokinetic study demonstrated that the disposition of bupropion and its metabolites in elderly subjects was similar to that in younger subjects.	0
"Caution is indicated with the coadministration of LUVOX CR Capsules and TCAs; plasma TCA concentrations may need to be monitored, and the dose of TCA may need to be reduced."	0
Lisinopril does not appear to be bound to other serum proteins.	0
"If hypotension occurs, the patient should be placed in the supine position and, if necessary, given an intravenous infusion of normal saline."	0
"Because of the potential for additive effects, slow titration is warranted in patients receiving CARDIZEM concomitantly with other agents known to affect cardiac contractility and/or conduction."	0
Angle Closure Glaucoma: Angle closure glaucoma has occurred in patients with untreated anatomically narrow angles treated with antidepressants.	0
"After coadministration of fluvoxamine for 14 days, mean trough concentrations of clozapine and its metabolites, N-desmethylclozapine and clozapine N-oxide, were elevated about 3-fold compared to baseline steady-state concentrations."	1
"When the dosing requirement is complete, the unused portion should be discarded in an appropriate manner."	0
Potentiation of anticonvulsant effects does not occur.	0
Indication Recommended Dose MDD (2.1) Adolescents (2.1) Initial: 10 mg once daily Recommended: 10 mg once daily Maximum: 20 mg once daily Adults (2.1) Initial: 10 mg once daily Recommended: 10 mg once daily Maximum: 20 mg once daily GAD (2.2) Adults (2.2) Initial: 10 mg once daily Recommended: 10 mg once daily No additional benefits seen at 20 mg/day dose (2.1).	0
Commercially available standard plastic cannulae may be used to administer the infusion.	0
"To open the 250 mL premixed bag, first tear off its foil overpouch."	0
Aspirin : increased nitroglycerin levels ( 7.3 ) .	1
No information is available about the pharmacokinetics of citalopram in patients with severely reduced renal function (creatinine clearance < 20 mL/min).	0
Rare cases of drug rash with eosinophilia and systemic symptoms (DRESS) have been reported with the use of clomipramine.	0
"The antihypertensive effect of ACE inhibitors, including lisinopril, may be attenuated by NSAIDs."	0
"In addition, with some drugs, beta blockade may precipitate increased withdrawal effects."	0
The potential drug-drug interactions must be considered prior to and during therapy.	0
Severe anaphylactic/anaphylactoid reactions: Angioedema and anaphylaxis have been reported.	0
A gradual reduction in the dose rather than abrupt cessation is recommended whenever possible.	0
CNS Depressants: downward dose adjustment may be necessary due to additive effects (7)	0
"In patients already taking 2.5 mg twice daily, avoid coadministration of ELIQUIS with combined P-gp and strong CYP3A4 inhibitors."	0
Intervention Monitor frequently and adjust or use alternative therapy based on clinical response.	0
A clinical study has shown that PRISTIQ does not increase the impairment of mental and motor skills caused by ethanol.	0
"When the CYP3A4 inhibitor is withdrawn from the combination therapy, the iloperidone dose should be returned to the previous level."	0
"Since hypokalemia has been associated with ventricular arrhythmias, potassium insufficiency, secondary to diuretics, diarrhea, or other cause, should be corrected before ORAP therapy is initiated and normal potassium maintained during therapy."	0
"If the pharmacokinetics of CMI and DMI are nonlinear at doses above 150 mg, their elimination half-lives may be considerably lengthened at doses near the upper end of the recommended dosing range (i.e., 200 mg/day to 250 mg/day)."	0
"AUC was only slightly increased (6%) when drug was administered with food but the Cmax was 29% greater, while the time to reach peak plasma concentration decreased from 6.4 hours post-dosing to 4.9 hours."	1
"Examples selegiline, isocarboxazid, phenelzine, tranylcypromine Serotonergic Drugs Clinical Impact The concomitant use of VYVANSE and serotonergic drugs increases the risk of serotonin syndrome."	0
"Because these events have been reported voluntarily during clinical practice, estimates of frequency cannot be made and causal relationships between PI therapy and these events have not been established."	0
These data suggest that the conversion of losartan to its active metabolite is mediated primarily by P4502C9 and not P4503A4.	0
"In patients with impaired liver function, the metabolism of ramipril to ramiprilat appears to be slowed, possibly because of diminished activity of hepatic esterases, and plasma ramipril levels in these patients are increased about 3-fold."	0
"However, patients receiving warfarin should have their PT time or INR monitored when pitavastatin is added to their therapy."	0
There were no pharmacokinetic or pharmacodynamic interactions between eszopiclone and paroxetine.	0
"At failure, 38% (14/37) of virologic failure subjects' viruses had 2 or more NS5A substitutions at resistance-associated positions."	0
"Increased angina and/or myocardial infarction in patients with coronary artery disease: Rarely, patients, particularly those with severe obstructive coronary artery disease, have developed increased frequency, duration and/or severity of angina, or acute myocardial infarction on starting calcium channel blocker therapy or at the time of dosage increase."	0
CALAN has a local anesthetic action that is 1.6 times that of procaine on an equimolar basis.	0
"Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. must not be diluted with 4.2% Sodium Bicarbonate Infusion."	0
"See Contraindications (4.1), Warnings and Precautions (5.7), and Lotronex<U+2122><U+2020> (alosetron) package insert."	0
It is not known whether nisoldipine is excreted in human milk.	0
"If digitalis treatment is continued, monitor serum levels closely and observe patients for clinical evidence of toxicity [see Clinical Pharmacology (12.3)]."	0
Serotonin release by platelets plays an important role in hemostasis.	0
Adequate doses of atropine abolish various types of reflex vagal cardiac slowing or asystole.	0
"If necessary, give additional 25 to 50 mg injection in 1 hour."	0
CNS-depressant effects: Use can impair alertness and motor coordination.	0
"The clearance of R-warfarin is generally half that of S-warfarin, thus as the volumes of distribution are similar, the half-life of R-warfarin is longer than that of S-warfarin."	0
"Although extensive metabolizers have lower risperidone and higher 9-hydroxyrisperidone concentrations than poor metabolizers, the pharmacokinetics of risperidone and 9-hydroxyrisperidone combined, after single and multiple doses, are similar in extensive and poor metabolizers."	0
"It is recommended that chemical disinfection be accomplished by wiping the vial thoroughly with cotton or gauze that has been moistened with either 91% isopropyl alcohol or 70% ethyl alcohol, just prior to use."	0
Pathologic changes in the parathyroid glands with hypercalcemia and hypophosphatemia have been observed in a few patients on prolonged thiazide therapy.	0
For patients already using methylphenidate:Initiate Focalin XR therapy with half (1/2) the current total daily dose of methylphenidate.	0
Patients should continue to be monitored appropriately when fluvastatin therapy is initiated or when fluvastatin dose is changed.	0
Increased metoprolol plasma levels have been associated with decreased cardioselectivity.	0
"Severe liver dysfunction prolongs the elimination half-life of immediate release verapamil to about 14 to 16 hours; hence, approximately 30% of the dose given to patients with normal liver function should be administered to these patients."	0
"Phendimetrazine tartrate, a phenylalkylamine sympathomimetic amine, has pharmacological activity similar to the amphetamines , and other amphetamines are present in human milk."	0
Inhaled/nasal steroid: Fluticasone <U+2191> fluticasone concentration Concomitant use of fluticasone propionate and CRIXIVAN may increase plasma concentrations of fluticasone propionate.	1
"Triptan-na<U+00EF>ve patients who have multiple cardiovascular risk factors (e.g., increased age, diabetes, hypertension, smoking, obesity, strong family history of CAD) should have a cardiovascular evaluation prior to receiving MAXALT."	0
"If myelosuppression lasts <U+2265> 50 days or occurs on 2 consecutive cycles, assess a marrow aspirate for remission status."	0
"The interaction between fluoxetine and other highly protein-bound drugs has not been fully evaluated, but may be important."	0
"Alternative, nonsaturable pathways (non-2D6) also contribute to the metabolism of fluoxetine."	0
"For the primary endpoint and ESRD, the effects of losartan potassium tablets in patient subgroups defined by age, gender and race are shown in Table4 below."	0
Rare instances of cardiac arrhythmias and hypotension have been reported following the rapid administration of cimetidine hydrochloride injection by intravenous bolus.	0
The use of MAOIs intended to treat psychiatric disorders with NORPRAMIN or within 14 days of stopping treatment with NORPRAMIN is contraindicated because of an increased risk of serotonin syndrome.	0
ZYPREXA and Fluoxetine in Combination: Also refer to the Drug Interactions section of the package insert for Symbyax.	0
It must be appreciated that this group of patients had a serious disease with a high mortality rate.	0
Corticosteroid: Dexamethasone <U+2193> Saquinavir INVIRASE/ritonavir may be less effective due to decreased saquinavir plasma concentrations.	1
CRIXIVAN should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.	0
REYATAZ should be discontinued if severe rash develops.	0
"Overall, these studies demonstrated sertraline hydrochloride to be superior to placebo on the Hamilton Depression Rating Scale and the Clinical Global Impression Severity and Improvement scales."	0
These decreases in blood pressure are not accompanied by a significant change in heart rate or plasma catecholamine levels with chronic dosing.	0
Concomitant treatment with CYP2D6 inhibitors can increase the concentration of PROZAC.	1
"If oligohydramnios is observed, discontinue ACCURETIC, unless it is considered life-saving for the mother."	0
The efficacy of subsequent doses has not been demonstrated.	0
"However, jaundice has been reported as early as 1 week and as late as 8 years after the start of treatment with mercaptopurine."	0
"It may be necessary to adjust the dosage and monitor plasma drug concentration (or, in the case of coumarin, coagulation times), when initiating or discontinuing methylphenidate."	0
Zaleplon is primarily metabolized by aldehyde oxidase to form 5-oxo-zaleplon.	0
These drugs and potentially related adverse events are listed in Table 1.	0
Monitor for symptoms of hypotension and edema when amlodipine is co-administered with CYP3A inhibitors to determine the need for dose adjustment.	0
"Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function."	0
Excessive amounts of caffeine and chocolate may also cause hypertensive reactions.	0
"Sildenafil is an inhibitor of cGMP specific phosphodiesterase type-5 (PDE-5) in the smooth muscle of the pulmonary vasculature, where PDE-5 is responsible for degradation of cGMP."	0
Some cases presented with features resembling neuroleptic malignant syndrome.	0
"Meperidine should be given with caution and the initial dose should be reduced in certain patients such as the elderly or debilitated, and those with severe impairment of hepatic or renal function, hypothyroidism, Addison's disease, and prostatic hypertrophy or urethral stricture."	0
"Caution is advised in use of Savella in patients with a history of dysuria, notably in male patients with prostatic hypertrophy, prostatitis, and other lower urinary tract obstructive disorders."	0
"When VFEND is discontinued, tacrolimus concentrations must be frequently monitored and the dose increased as necessary."	1
The long-term maintenance effects of paroxetine in OCD were demonstrated in a long-term extension to Study 1.	0
Soft contact lenses may be permanently stained.	0
"If treatment with COREGis to be continued perioperatively, particular care should be taken when anesthetic agents that depress myocardial function, such as ether, cyclopropane, and trichloroethylene, are used."	0
This range represents data from both healthy subjects and renal dialysis patients under various conditions.	0
"XARELTO should not be used in patients with CrCl 15 to 80 mL/min who are receiving concomitant combined P-gp and moderate CYP3A4 inhibitors ( e.g. , erythromycin ) unless the potential benefit justifies the potential risk see Warnings and Precautions ( 5.4 ) and Clinical Pharmacology ( 12.3 ) ."	0
"Concomitant use of zolpidem with these drugs may increase drowsiness and psychomotor impairment, including impaired driving ability."	0
"Patients should be observed for signs of fluid or electrolyte disturbances, i.e., hyponatremia, hypochloremic alkalosis, and hypokalemia and hypomagnesemia."	0
(7.5) Ergotamine: increased bioavailability of ergotamine.	1
"When nefazodone (200 mg BID) was given to patients being treated with theophylline (600 to 1200 mg/day) for chronic obstructive pulmonary disease, there was no change in the steady-state pharmacokinetics of either nefazodone or theophylline."	0
For information regarding clinical recommendations see Drug Interactions (7.2).	0
It is recommended that a standard 20 mL (non-automated) syringe be used to ensure that the exact amount (19.0 mL) of Water for Injection is dispensed.	0
"If concomitant treatment with sumatriptan and an SSRI (e.g., fluoxetine, fluvoxamine, paroxetine, sertraline) is clinically warranted, appropriate observation of the patient is advised."	0
Iloperidone accumulation is predictable from single-dose pharmacokinetics.	0
"Therefore, the required volume of the 10 mg/mL VFEND concentrate should be further diluted as follows (appropriate diluents listed below): Calculate the volume of 10 mg/mL VFEND concentrate required based on the patient's weight."	0
"The effects of Lidocaine Hydrochloride Injection, USP solution on the mother and the fetus, when used in the management of cardiac arrhythmias during labor and delivery, are not known."	0
Any dose adjustment should be guided by clinical effect (tolerability and efficacy).	0
The concomitant use of INVIRASE/ritonavir and certain other drugs may result in known or potentially significant drug interactions.	0
"In the treatment of both tuberculosis and the meningococcal carrier state , the small number of resistant cells present within large populations of susceptible cells can rapidly become predominant."	0
(B) SPINAL/EPIDURAL HEMATOMA Epidural or spinal hematomas may occur in patients treated with ELIQUIS who are receiving neuraxial anesthesia or undergoing spinal puncture.	0
Average steady-state concentrations of either once-daily or once-weekly dosing are in relative proportion to the total dose administered.	0
COUMADIN is a racemic mixture of the R- and S-enantiomers of warfarin.	0
Elevated Blood Pressure: Control hypertension before initiating treatment.	0
Special populations: Special populations were not specifically studied.	0
"0.19(0.06, 0.33) Stavudine (d4T) 40 twice daily, 7 days 800 three times daily, 7 days 11 0.95(0.80, 1.11) 0.95(0.80, 1.12) 1.13(0.83, 1.53) Trimethoprim/Sulfamethoxazole 800 Trimethoprim/160 Sulfamethoxazole q12h, 7 days 400 four times daily, 7 days 12 1.12(0.87, 1.46) 0.98(0.81, 1.18) 0.83(0.72, 0.95) Zidovudine 200 three times daily, 7 days 1000 three times daily, 7 days 12 1.06(0.91, 1.25) 1.05(0.86, 1.28) 1.02(0.77, 1.35) Zidovudine/Lamivudine (3TC) 200/150 three times daily, 7 days 800 three times daily, 7 days 6, 9Parallel group design; n for indinavir + coadministered drug, n for indinavir alone."	0
"Due consideration of this possible state should be given to each patient who has leukopenia, thrombocytopenia or anemia."	0
"PDE5 inhibitors: Concomitant use contraindicated (4.1, 7.1) Antihypertensives: Possible additive hypotensive effects (7.2) Aspirin: increased nitroglycerin levels (7.3) Tissue-type plasminogen activator (t-PA): decreased thrombolytic effect (7.4) Heparin: anticoagulant effect of heparin may be reduced."	0
Geriatric and Gender: Losartan pharmacokinetics have been investigated in the elderly (65-75years) and in both genders.	0
"Anyone considering the use of Marplan or any other antidepressant in a child, adolescent or young adult must balance this risk with the clinical need."	0
Distribution Dabigatran is approximately 35% bound to human plasma proteins.	0
Pediatric Use: Dopamine infusions have been used in patients of every age from birth onwards.	0
"Calcium Channel Blockers: Because of significant inotropic and chronotropic effects in patients treated with beta-blockers and calcium channel blockers of the verapamil and diltiazem type, caution should be exercised in patients treated with these agents concomitantly."	0
MAXALT is contraindicated in patients taking MAO-A inhibitors and non-selective MAO inhibitors.	0
<U+2020> Results reflect CrCl of 15 mL/min based on regression analysis.	0
"With concomitant use of mTOR inhibitors (e.g., sirolimus, temsirolimus, and everolimus) and verapamil, consider appropriate dose reductions of both medications."	1
Other drugs that inhibit CYP1A2 metabolism include cimetidine and quinolone antimicrobials such as ciprofloxacin and enoxacin.	0
The use of SURMONTIL within 14 days of stopping an MAOI intended to treat psychiatric disorders is also contraindicated.	0
): Serotonin release by platelets plays an important role in hemostasis.	0
TENORMIN should be used with caution in diabetic patients if a beta-blocking agent is required.	0
"Since there is little clinical experience, the concurrent administration of paroxetine and digoxin should be undertaken with caution."	0
Warfarin <U+2194> S-Warfarin Frequent INR (international normalized ratio) monitoring upon initiation of APTIVUS/ritonavir therapy.	0
Other Increases in serum glucose may occur and latent diabetes mellitus may become manifest during chlorthalidone therapy.	0
"Thus, risperidone can be given with or without meals."	0
"Positive test results were also obtained in the Aspergillus nidulans nondisjunction assay, using an unspecified concentration of hydrochlorothiazide."	0
Nonlinearity in pharmacokinetics is observed with increasing doses.	0
"Because of the very low dose of HCTZ employed, hyperuricemia may be less likely with ZIAC."	0
"In hypertensive patients with normal renal function treated with PRINIVIL alone for up to 24 weeks, the mean increase in serum potassium was approximately 0.1 mEq/L; however, approximately 15% of patients had increases greater than 0.5 mEq/L and approximately 6% had a decrease greater than 0.5 mEq/L."	0
WARNING: EMBRYO-FETAL TOXICITY See full prescribing information for complete boxed warning.	0
Water distribution depends primarily on the concentration of electrolytes and sodium (Na+) plays a major role in maintaining physiologic equilibrium.	0
A modest amount of alkali should be provided in order to maintain urinary pH at a high normal range (6.5-7.0).	0
"The volume of diluent remaining in the bag or bottle should be such that when the 10 mg/mL VFEND concentrate is added, the final concentration is not less than 0.5 mg/mL nor greater than 5 mg/mL."	0
The influence of race on the pharmacokinetics of estazolam has not been studied.	0
Lexapro is not approved for use in pediatric patients less than 12 years of age.	0
Monitor complete blood cell counts on Days 1 and 8 of every cycle and more frequently if clinically indicated.	0
Increasing the indinavir dose to 1000 mg every 8 hours does not compensate for the increased indinavir metabolism due to efavirenz.	1
"Initiation of medications that inhibit or induce CYP3A may increase or decrease concentrations of INVIRASE/ritonavir, respectively."	1
The clinical impact of high selectivity for ETA is not known.	0
"Serotonergic Drugs (e.g., MAOIs, triptans, SSRIs, other SNRIs, linezolid, lithium, tramadol, or St. John<U+2019>s wort): Potential for serotonin syndrome."	0
"However, seizures have been reported infrequently in patients treated with Savella for disorders other than fibromyalgia."	0
"Patients with severe hepatic impairment (Child-Pugh class C) should be closely monitored, as the risk of adverse reactions is greater."	0
Initiate with lower doses and monitor patients for signs and symptoms of serotonin syndrome particularly during DESOXYN initiation and after a dosage increase.	0
"Following an intravenous dose of 14C-labeled losartan, about 45% of radioactivity is recovered in the urine and 50% in the feces."	0
The recommended dose range is 30 to 60mg once daily.	0
Pharmacokinetic behavior of paroxetine has not been evaluated in subjects who are deficient in CYP2D6 (poor metabolizers).	0
Take within 30 minutes of bedtime.	0
"When necessary, use aPTT or ECT, and not INR, to assess for anticoagulant activity in patients on PRADAXA."	0
General: A gastrointestinal hypersensitivity reaction characterized by severe nausea and vomiting has been reported.	0
Intestinal angioedema has been reported in patients treated with ACE inhibitors.	0
Gold: Nitritoid reactions have been reported (7.5).	0
The dose of ULORIC is limited to 40 mg once daily in patients with severe renal impairment.	0
"Coadministration of inhibitors of the uptake transporter ( rifampin , cyclosporine ) or efflux transporter ( ritonavir ) may increase the systemic exposure to valsartan ."	1
"Because of the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother."	0
Effects of 4-factor PCCs on the pharmacodynamics of apixaban were studied in healthy subjects.	0
"(7.1) Coadministration of antiplatelet agents, thrombolytics, heparin, aspirin, and chronic NSAID use increases the risk of bleeding."	0
This is especially true in patients who may subject themselves to an overdosage of drugs.	0
Patients who are switched from fluoxetine to nefazodone without an adequate washout period may experience similar transient adverse events.	0
"Treatment with CYMBALTA and any concomitant serotonergic agents, should be discontinued immediately if the above events occur and supportive symptomatic treatment should be initiated."	0
"Known hypersensitivity to any of the components of NEXTERONE Premixed Injection , including iodine ."	0
Do not start Effient in patients likely to undergo urgent coronary artery bypass graft surgery (CABG).	0
A controlled study found that concomitant fluconazole 200 mg once daily and cisapride 20 mg four times a day yielded a significant increase in cisapride plasma levels and prolongation of QTc interval.	0
Agranulocytosis did occur during ACCUPRIL treatment in one patient with a history of neutropenia during previous captopril therapy.	0
"Patients should be warned that the use of the above foods, beverages, or medications may cause a reaction characterized by headache and other serious symptoms due to a rise in blood pressure, with the exception of dextromethorphan which may cause reactions similar to those seen with meperidine."	0
Chronic administration of an antipsychotic also causes elevated prolactin levels in humans.	0
Patients with Renal Impairment: The pharmacokinetics of ledipasvir were studied with a single dose of 90 mg ledipasvir in HCV negative subjects with severe renal impairment (eGFR less than 30 mL/min by Cockcroft-Gault).	0
"The recommended dosage of DIFLUCAN for oropharyngeal candidiasis in children is 6 mg/kg on the first day, followed by 3 mg/kg once daily."	0
The primary treatment is to discontinue hydrochlorothiazide as rapidly as possible.	0
These changes may be reversed by decreasing the rate or discontinuing the infusion entirely.	0
The drug may cause exacerbation of psychosis in schizophrenic patients.	0
Some patients required either initiation or dose adjustments of insulin or oral hypoglycemic agents for treatment of these events.	0
"Other Drugs: Co-administration of telmisartan did not result in a clinically significant interaction with acetaminophen, amlodipine, glyburide, simvastatin, hydrochlorothiazide, warfarin, or ibuprofen."	0
"In other reactions the predominant manifestations have been hyperexcitability, convulsions, tachycardia, hyperpyrexia, and hypertension."	0
"Because of the gradual onset of action, acute hypotension is unlikely."	0
Bradycardia and heart block can occur and the left ventricular end diastolic pressure can rise when beta-blockers are administered with verapamil or diltiazem.	0
Obsessive Compulsive Disorder The effectiveness of paroxetine in the treatment of obsessive compulsive disorder (OCD) was demonstrated in two 12-week multicenter placebo-controlled studies of adult outpatients (Studies 1 and 2).	0
Heart Failure: Recommended starting dose is 12.5 mg or 25 mg doubled every two weeks to the highest dose tolerated or up to 200 mg. (2.3) Hypertension: Usual initial dosage is 25 to 100 mg once daily.	0
"Hepatic Impairment: In patients with chronic alcoholic liver disease, plasma concentrations of LIPITOR are markedly increased."	0
The pharmacokinetics and pharmacodynamics of prasugrel's active metabolite in patients with severe hepatic disease have not been studied.	0
"However, in clinical studies the consequences of concomitant irbesartan on the pharmacodynamics of warfarin were negligible."	0
"Although Lexapro did not potentiate the cognitive and motor effects of alcohol in a clinical trial, as with other psychotropic medications, the use of alcohol by patients taking Lexapro is not recommended."	0
"In studies in healthy subjects characterized as extensive metabolizers of dextromethorphan (antitussive drug and CYP2D6 probe substrate), terbinafine increases the dextromethorphan/dextrorphan metabolite ratio in urine by 16- to 97-fold on average."	0
"Patients who develop symptoms such as exertional chest pain, unexplained syncope, or other symptoms suggestive of cardiac disease during atomoxetine treatment should undergo a prompt cardiac evaluation."	0
"In extremely acidic conditions, duloxetine, unprotected by the enteric coating, may undergo hydrolysis to form naphthol."	0
"Signs and symptoms of hyponatremia include headache, difficulty concentrating, memory impairment, confusion, weakness, and unsteadiness, which may lead to falls."	0
"When Tenex is used with other centrally active depressants ( such as phenothiazines , barbiturates , or benzodiazepines ) , the potential for additive sedative effects should be considered ."	0
Its natriuretic activity is limited by the amount of sodium reaching its site of action.	0
"Penetration into the cerebrospinal fluid, eyes, and prostate is poor."	0
The metabolism of other proton pump inhibitors that are CYP2C19 substrates may also be inhibited by voriconazole and may result in increased plasma concentrations of other proton pump inhibitors.	1
Monoamine Oxidase Inhibitors (MAOIs)	0
PRIFTIN should be administered once-weekly in combination with isoniazid for 12 weeks as directly observed therapy.	0
"The recommended adult oral dosage for short-term treatment of active benign gastric ulcer is 800 mg at bedtime, or 300 mg 4 times a day with meals and at bedtime."	0
The majority of PPI-induced lupus erythematosus cases were CLE.	0
Co-administration of cyclosporine with LIVALO is contraindicated.	0
An increased risk of liver enzyme elevations was observed in patients receiving glyburide concomitantly with bosentan .	0
"Simvastatin exposure is approximately doubled with concomitant use of lomitapide; therefore, the dose of ZOCOR should be reduced by 50% if initiating lomitapide."	1
"Occlusive Vascular Disease: Patients with a history of occlusive vascular disease (e.g., arteriosclerosis, arterial embolism, Raynaud's disease, cold injury such as frostbite, diabetic endarteritis, and Buerger's disease) should be closely monitored for any changes in color or temperature of the skin of the extremities."	0
Poor metabolizers have higher than expected plasma concentrations of tricyclic antidepressants (TCAs) when given usual doses.	0
"Antiarrhythmics Amiodarone, bepridil, dofetilide, flecainide, lidocaine (systemic), propafenone, quinidine Potential for serious and/or life-threatening cardiac arrhythmia."	0
"The usual initial antihypertensive oral dose of NORVASC is 5 mg once daily, and the maximum dose is 10 mg once daily."	0
Patients should also be aware that these adverse events (gastrointestinal or paresthesias) may diminish as therapy is continued.	0
Patients who require premature discontinuation of a thienopyridine will be at increased risk for cardiac events.	0
"Families and caregivers of patients being treated with antidepressants for major depressive disorder or other indications, both psychiatric and nonpsychiatric, should be alerted about the need to monitor patients for the emergence of agitation, irritability, unusual changes in behavior, and the other symptoms described above, as well as the emergence of suicidality, and to report such symptoms immediately to health care providers."	0
It is not recommended as initial therapy but should be reserved for patients who have not responded satisfactorily to other antidepressants.	0
It is desirable to monitor TCA plasma levels whenever a TCA is going to be co-administered with another drug known to be an inhibitor of P450 2D6.	0
Bronchodilator:theophylline <U+2193> theophylline Increased dosage of theophylline may be required; therapeutic monitoring should be considered.	1
Increased Mortality in Elderly Patients with Dementia-Related Psychosis Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death.	0
Discontinuation symptoms have been systematically and prospectively evaluated in patients treated with PRISTIQ during clinical studies in Major Depressive Disorder.	0
"In a small study (N = 8) using various doses in older subjects (59 to 68 years), peak estazolam concentrations were found to be similar to those observed in younger subjects with a mean elimination half-life of 18.4 hours (range 13.5 to 34.6 hours)."	0
"Considering the extent of use of dihydroergotamine mesylate in patients with migraine, the incidence of these events is extremely low."	0
"Antineoplastics: dasatinib, nilotinib <U+2191> antineoplastics A decrease in the dosage or an adjustment of the dosing interval of dasatinib and nilotinib may be necessary for patients."	1
"In patients treated with potent inducers of CYP3A4 (i.e., phenytoin, carbamazepine, and rifampin), the clearance of ondansetron was significantly increased and ondansetron blood concentrations were decreased."	1
"Adverse reactions occurring 5 to 20 % include anorexia, nausea, vomiting, diarrhea, malaise, and rash."	0
Catecholamine-depleting drugs may have an additive effect when given with beta-blocking agents.	0
"Closely monitor blood pressure , renal function , and electrolytes in patients on VASOTEC and other agents that affect the RAS ."	0
Drug-Drug Interactions: The principal route of pitavastatin metabolism is glucuronidation via liver UGTs with subsequent formation of pitavastatin lactone.	0
A concentration-dependent increase in anti-FXa activity was observed in the dose range tested and was similar in healthy subjects and patients with AF.	0
Oral Contraceptives: Norethindrone and ethinyl estradiol may be increased (7.11).	1
"Cmax and t1/2 were increased 1.4-fold and 1.3-fold, respectively."	0
"If either occurs, decrease the dose of Cleviprex."	0
Some patients required either initiation or dose adjustments of insulin or oral hypoglycemic agents for treatment of these events.	0
Digoxin: Use of Savella concomitantly with digoxin may be associated with potentiation of adverse hemodynamic effects.	0
"It is critically important that if at any time this lower dose is increased, the patient needs to be rehospitalized for three days."	0
ATACAND may be administered with or without food.	0
Open-angle glaucoma is not a risk factor for angle closure glaucoma.	0
"Coadministration of other drugs known to prolong the QT interval and which are metabolized via the enzyme CYP3A4 such as cisapride, astemizole, erythromycin, pimozide, and quinidine are contraindicated in patients receiving fluconazole."	0
"Rarely, ACE inhibitors have been associated with a syndrome that starts with cholestatic jaundice and progresses to fulminant hepatic necrosis and (sometimes) death."	0
"Amlodipine Symptomatic hypotension is possible, particularly in patients with severe aortic stenosis."	0
All injections in VIAFLEX Plus plastic containers are intended for intravenous administration using sterile equipment.	0
"Hepatic Impairment In a study comparing 9 HIV-1 negative patients with mild (Child-Pugh Class A) hepatic impairment to 9 HIV-1 negative controls, the single and multiple dose plasma concentrations of tipranavir and ritonavir were increased in patients with hepatic impairment, but were within the range observed in clinical trials."	0
"Under steady-state conditions for duloxetine (20mg qhs) and temazepam (30mg qhs), the pharmacokinetics of duloxetine were not affected by co-administration."	0
"Therefore, in elderly patients the dose should not exceed 2 mg."	0
"In patients not controlled on monotherapy with irbesartan or hydrochlorothiazide, the recommended doses of AVALIDE, in order of increasing mean effect, are (irbesartan-hydrochlorothiazide) 150/12.5 mg, 300/12.5 mg, and 300/25 mg."	0
No dosage adjustment is necessary.	0
"Other Concentrations of verapamil may be increased by the concomitant administration of protease inhibitors such as ritonavir, and reduced by the concomitant administration of sulfinpyrazone, or St John<U+2019>s Wort."	1
"HMG-CoA Reductase Inhibitor:atorvastatin rosuvastatin <U+2191> atorvastatin <U+2191> rosuvastatin For contraindicated HMG-CoA reductase inhibitors,.Titrate atorvastatin and rosuvastatin dose carefully and use the lowest necessary dose.If NORVIR is used with another protease inhibitor, see the complete prescribing information for the concomitant protease inhibitor for details on co-administration with atorvastatin and rosuvastatin."	1
"In a study of ten patients administered a single 5 million unit dose of penicillin G intravenously over 3<U+2013>5 minutes, the mean serum concentrations were 400 mcg/mL, 273 mcg/mL and 3.0 mcg/mL at 5<U+2013>6 minutes, 10 minutes and 4 hours after completion of the injection, respectively."	0
"This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function."	0
Females of reproductive potential must comply with the pregnancy testing and contraception requirements.	0
"More than two 5 mg tablets of amiloride HCl daily usually are not needed, and there is little controlled experience with such doses."	0
"In order to prevent gout flares when ULORIC is initiated, concurrent prophylactic treatment with an NSAID or colchicine is recommended."	0
"There was considerable variation in risk of suicidality among drugs, but a tendency toward an increase in the younger patients for almost all drugs studied."	0
"Proteinuria, sometimes sufficiently severe to cause nephrotic syndrome, may develop from membranous glomerulopathy."	0
"Because NORVASC is extensively metabolized by the liver and the plasma elimination half-life (t 1/2) is 56 hours in patients with impaired hepatic function, titrate slowly when administering NORVASC to patients with severe hepatic impairment."	0
"Etoposide, vinorelbine, paclitaxel, and docetaxel No dosage adjustment needed."	0
"P-gp Inhibitors The dose of SAMSCA may have to be reduced when SAMSCA is co-administered with P-gp inhibitors, e.g., cyclosporine [see Dosage and Administration (2.3), Drug Interactions (7.1)]."	0
"However, at steady state, AUC and Cmax were similar for both sites of injection."	0
Sympathomimetic drugs : Sympathomimetic drugs having beta-adrenergic agonist activity will counteract effects of BREVIBLOC .	0
Sustained blood pressure increases could have adverse consequences.	0
Hypomagnesemia can result in hypokalemia which appears difficult to treat despite potassium repletion.	0
WARNING: ISCHEMIC HEART DISEASE See full prescribing information for complete boxed warning.	0
"Proton-pump inhibitors: omeprazole <U+2193> atazanavir Plasma concentrations of atazanavir were substantially decreased when REYATAZ 400 mg or REYATAZ 300 mg/ritonavir 100 mg once daily was administered with omeprazole 40 mg once daily in adults, which may result in loss of therapeutic effect and development of resistance."	1
Untreated acute angle-closure glaucoma can lead to permanent vision loss.	0
"During postmarketing experience, cases of increased thyroid stimulating hormone (TSH) levels have been reported in patients coadministered sevelamer hydrochloride and levothyroxine."	0
"The effect of alcohol on the release rate may lead to a change in the pharmacokinetics of diltiazem, such as a more rapid absorption and/or an increase in the systemic exposure of diltiazem."	1
Symptoms such as these may be associated with an increased risk for suicidal thinking and behavior and indicate a need for very close monitoring and possibly changes in the medication.	0
Anyone considering the use of nefazodone hydrochloride tablets in a child or adolescent must balance the potential risks with the clinical need.	0
Mean ETP levels continued to increase and exceeded pre-apixaban levels reaching a maximum (34%-51% increase over pre-apixaban levels) at 21 hours after initiating PCC and remained elevated (21%-27% increase) at the end of the study (69 hours after initiation of PCC).	0
"Paroxetine and Ketoconazole: Co-administration of paroxetine (20 mg once daily for 10 days), a CYP2D6 inhibitor, and ketoconazole (200 mg twice daily) with multiple doses of iloperidone (8 or 12 mg twice daily) to patients with schizophrenia ages 18-65 resulted in a 1.4 fold increase in steady-state concentrations of iloperidone and its metabolite P88 and a 1.4 fold decrease in the P95 in the presence of paroxetine."	1
Specific Populations Renal and Hepatic Impairment.	0
"Given the primary CNS effects of FANAPT, caution should be used when it is taken in combination with other centrally acting drugs and alcohol."	0
"The increase in Cmax is 54 and 30% and the AUC is increased by 65 and 32% for verapamil and norverapamil, respectively."	0
"Amiodarone is a substrate for CYP3A and CYP2C8, so inhibitors and inducers affect amiodarone exposure (7) Amiodarone inhibits p-glycoprotein and CYP1A2, CYP2C9, CYP2D6, and CYP3A, increasing exposure to other drugs (7) Drugs prolonging the QT interval: Co-administration of drugs prolonging the QT interval (such as class I and III antiarrhythmics, lithium, certain phenothiazines, tricyclic antidepressants, certain fluoroquinolone and macrolide antibiotics, azole antifungals, halogenated inhalation anesthetic agents) increases the risk of Torsade de Pointes."	0
Consult immunization guidelines for immunocompromised children.	0
DESOXYN should not be used concurrently with monoamine oxidase inhibitors.	0
"Because diethylpropion hydrochloride is a monoamine, hypertension may result when this agent is used with monoamine oxidase (MAO) inhibitors."	0
In vitro inhibition of HMG-CoA reductase by ortho- and parahydroxylated metabolites is equivalent to that of LIPITOR.	0
"If this dose is tolerated, using standing systolic pressure measured about 1hour after dosing as a guide, the dose should be maintained for 7 to 14days, and then increased to 12.5mg twice daily if needed, based on trough blood pressure, again using standing systolic pressure 1 hour after dosing as a guide for tolerance."	0
"During acute electrophysiologic studies, it increased heart rate and prolonged the corrected QT interval to a minor degree."	0
"Because ORAP prolongs the QT interval of the electrocardiogram, an additive effect on QT interval would be anticipated if administered with other drugs, such as phenothiazines, tricyclic antidepressants or antiarrhythmic agents, which prolong the QT interval."	0
"If a large amount of tyramine is absorbed systemically, it is taken up by adrenergic neurons and causes norepinephrine release from neuronal storage sites with resultant elevation of blood pressure."	0
Anticoagulants: warfarin <U+2191> warfarin Coadministration with REYATAZ has the potential to produce serious and/or life-threatening bleeding and has not been studied.	0
"Premature infants, or infants with impaired renal function, may be more likely to develop adverse effects."	0
"<U+2022> Serotonin Syndrome: Serotonin syndrome has been reported with SSRIs and SNRIs, including LUVOX CR Capsules, both when taken alone, but especially when co-administered with other serotonergic agents (including triptans, tricyclic antidepressants, fentanyl, lithium, tramadol, tryptophan, buspirone, amphetamines, and St. John<U+2019>s Wort)."	0
"In normal subjects, the beta1 selectivity of TENORMIN has been shown by its reduced ability to reverse the beta2-mediated vasodilating effect of isoproterenol as compared to equivalent beta-blocking doses of propranolol."	0
"PREZISTA 800 mg taken with ritonavir 100 mg once daily should only be considered in certain pregnant patients who are already on a stable PREZISTA 800 mg with ritonavir 100 mg once daily regimen prior to pregnancy, are virologically suppressed (HIV-1 RNA less than 50 copies per mL), and in whom a change to twice daily PREZISTA 600 mg with ritonavir 100 mg may compromise tolerability or compliance."	0
Treatment with fluvoxamine should be discontinued if seizures occur or if seizure frequency increases.	0
No case met the criteria of elevated ALT > 3x ULN and associated with an increase in bilirubin <U+2265> 2x ULN.	0
"Therefore, use of ELIQUIS is not recommended in these patients."	0
"In dogs, at a maternal dose of 80 mg/kg/day, fetal plasma drug levels were approximately 50% of maternal plasma drug levels both 1 and 2 hours after dosing."	0
Bronchospastic Disease: Avoid beta blockers.	0
Use tadalafil with caution at reduced doses of no more than 10 mg every 72 hours with increased monitoring of adverse events when administered concomitantly with INVIRASE/ritonavir.	1
Hypersensitivity to any component of this product.	0
"Prior to initiating therapy with TRISENOX, assess the QTc interval by electrocardiogram, correct pre-existing electrolyte abnormalities, and consider discontinuing drugs known to prolong QTc interval."	0
If bleeding cannot be controlled discontinue AGGRASTAT.	0
Nonselective <U+03B2>-blockers may potentiate insulin-induced hypoglycemia and delay recovery of serum glucose levels.	0
The potential for drug-drug interactions must be considered prior to and during therapy.	0
"Gender In a study of healthy subjects administered doses of up to 300 mg, women had an approximately 25% higher Cmax and an approximately 10% higher AUC than age-matched men."	0
REYATAZ has been shown to prolong the PR interval of the electrocardiogram in some patients.	0
Treatment-emergent adverse reactions of moderate or severe rash (occurring at a rate of <U+2265>2%) are presented for the individual clinical studies.	0
"The total warfarin (protein bound plus free drug) pharmacokinetics (AUCT,ss, Cmax,ss or tmax,ss) for both R- and S-warfarin were not altered by duloxetine."	0
Animal reproduction studies have not been conducted in phendimetrazine tartrate.	0
Consider discontinuation of REYATAZ in patients with progressive renal disease.	0
Atorvastatin AUC was significantly increased with concomitant administration of LIPITOR 10 mg and cyclosporine 5.2 mg/kg/day compared to that of LIPITOR alone.	1
"Following an oral dose of 14C<U+2011>labeled lovastatin in man, 10% of the dose was excreted in urine and 83% in feces."	0
"As an opioid, Meperidine Hydrochloride Injection exposes users to the risks of addiction, abuse, and misuse."	0
"Metabolism and Excretion Because candesartan is not significantly metabolized by the cytochrome P450 system and at therapeutic concentrations has no effects on P450 enzymes, interactions with drugs that inhibit or are metabolized by those enzymes would not be expected."	0
The dose of FANAPT should be reduced in patients co-administered a strong CYP2D6 or CYP3A4 inhibitor.	1
Patients should not take ROZEREM in conjunction with fluvoxamine (Luvox).	0
Patients to be treated with MYCOBUTIN should be made aware of these possibilities.	0
Extremely high concentrations of triazolam do not displace bilirubin bound to human serum albumin in vitro.	0
"In patients who may use alcohol excessively, it should be borne in mind that the potentiation may increase the danger inherent in any suicide attempt or overdosage."	0
Maintenance therapy is preferably administered as a single dose at bedtime.	0
Cimetidine tablets are contraindicated for patients known to have hypersensitivity to the product.	0
The highest doses in these studies produced systemic exposures in these species comparable to or slightly greater than human exposure.	0
"If diarrhea occurs, carefully monitor serum electrolytes and ECGs to reduce the risk and enable early detection of QT prolongation resulting from dehydration."	0
"As with any drug, caution should be exercised in patients with severe hepatic impairment."	0
Change in Cmax Cyclosporine - stable dose (b.i.d.	0
10 mg QD for 10 days 5- to 8-fold NDND = Analyte not determined.	0
Priapism <U+2013> Prompt medical attention is required in the event of suspected priapism.	0
TENORETIC may aggravate peripheral arterial circulatory disorders.	0
"Dual blockade of the renin-angiotensin system: Increased risk of renal impairment, hypotension, and hyperkalemia."	0
"In patients with impaired ventricular function, most acute studies have shown some increase in ejection fraction and reduction in left ventricular filling pressure."	0
"Consider increasing the BRINTELLIX dose when a strong CYP inducer (e.g., rifampicin, carbamazepine, phenytoin) is coadministered."	1
Do not use Meperidine Hydrochloride Injection in patients taking MAOIs or within 14 days of stopping such treatment.	0
"Therefore , patients receiving sublingual nitroglycerin should avoid ergotamine and related drugs or be monitored for symptoms of ergotism if this is not possible ."	0
It is desirable to monitor TCA plasma levels whenever a TCA is going to be co-administered with another drug known to be an inhibitor of P450 2D6.	0
"Following administration of apixaban dosed to steady state, endogenous thrombin potential (ETP) returned to pre-apixaban levels 4 hours after the initiation of a 30-minute PCC infusion, compared to 45 hours with placebo."	0
"Patients with major depressive disorder (MDD), both adult and pediatric, may experience worsening of their depression and/or the emergence of suicidal ideation and behavior (suicidality) or unusual changes in behavior, whether or not they are taking antidepressant medications, and this risk may persist until significant remission occurs."	0
"All patients starting therapy with ZOCOR, or whose dose of ZOCOR is being increased, should be advised of the risk of myopathy, including rhabdomyolysis, and told to report promptly any unexplained muscle pain, tenderness or weakness particularly if accompanied by malaise or fever or if muscle signs and symptoms persist after discontinuing ZOCOR."	0
"Therefore, if the initial dosage of ACCUPRIL is well tolerated, patients should then be titrated at weekly intervals until an effective dose, usually 20 to 40 mg daily given in two equally divided doses, is reached or undesirable hypotension, orthostatis, or azotemia prohibit reaching this dose."	0
Potential for serious and/or life-threatening events such as prolonged or increased sedation or respiratory depression.	0
"In vitro studies with human liver microsomes showed that terbinafine does not inhibit the metabolism of tolbutamide, ethinylestradiol, ethoxycoumarin, cyclosporine, cisapride and fluvastatin."	0
About 50 percent of a 20 mg dose of amiloride HCl is excreted in the urine and 40 percent in the stool within 72 hours.	0
"If persistent or worsening elevation of hepatic enzymes is detected, consideration should be given to discontinuing therapy."	0
"In man, diltiazem prevents spontaneous and ergonovine-provoked coronary artery spasm."	0
Such treatment should be initiated in a coronary care or similar unit immediately after the patient's hemodynamic condition has stabilized.	0
Avoid concomitant use of aliskiren with cyclosporine or itraconazole see Drug Interactions ( 7 ) .	0
"The mean increase in olanzapine AUC is 52% and 108%, respectively."	0
"Although the coadministration of nefazodone did decrease the subjects<U+2019> exposure to S-warfarin by 12%, the lack of effects on the prothrombin and bleeding times indicates this modest change is not clinically significant."	1
"Myocardial, peripheral vascular, and colonic ischemia have been reported with D.H.E."	0
A significant dose response relationship for improvement in maximal exercise tolerance has been observed with ACCUPRIL therapy.	0
"The risk differences (drug vs. placebo), however, were relatively stable within age strata and across indications."	0
NORVIR oral powder should only be used for dosing increments of 100 mg.	0
Nonsteroidal anti-inflammatory drugs (NSAIDs) may produce potassium retention by reducing renal synthesis of prostaglandin E and impairing the renin-angiotensin system.	0
The concomitant use of paroxetine with MAOIs (including linezolid and intravenous methylene blue) is contraindicated.	0
"In patients in whom there is cause for arrest or delay in tablet passage through the gastrointestinal tract, such as those suffering from delayed gastric emptying, esophageal compression, intestinal obstruction or stricture, or those taking anticholinergic medication."	0
"Therefore, when these drugs are administered concurrently, dosage adjustment of paroxetine after the 20-mg starting dose should be guided by clinical effect."	0
Do not administer BRILINTA with another oral P2Y12 platelet inhibitor .	0
"Dosage reduction of rifabutin by at least 75% of the usual dose of 300 mg/day is recommended (i.e., a maximum dose of 150 mg every other day or three times per week)."	1
Studies in rats indicate that quinapril and its metabolites do not cross the blood-brain barrier.	0
"In a double-blind, parallel dose-response study of doses from 60 mg to 480 mg once daily, CARDIZEM CD increased time to termination of exercise in a linear manner over the entire dose range studied."	0
"Administration of NitroMist is contraindicated in patients who are using a selective inhibitor of cyclic guanosine monophosphate ( cGMP ) - specific phosphodiesterase type 5 ( PDE5 ) , as PDE5 inhibitors such as sildenafil , vardenafil , and tadalafil have been shown to potentiate the hypotensive effects of organic nitrates see DRUG INTERACTIONS ( 7.1 ) ."	0
ZYTIGA is an inhibitor of the hepatic drug-metabolizing enzymes CYP2D6 and CYP2C8.	0
"Co-administration of SAMSCA with 400 mg ketoconazole daily or with other strong CYP 3A inhibitors ( e.g. , clarithromycin , itraconazole , telithromycin , saquinavir , nelfinavir , ritonavir and nefazodone ) at the highest labeled dose would be expected to cause an even greater increase in tolvaptan exposure ."	1
Other reported clinical experience has not identified differences in responses between the elderly and younger patients.	0
"At steady-state, multiple-dose accumulation of desvenlafaxine is linear and predictable from the single-dose pharmacokinetic profile."	0
This is typical of the interaction of meperidine and MAOIs.	0
"In some cases, a patient already receiving Anafranil therapy may require urgent treatment with linezolid or intravenous methylene blue."	0
All reports with methylene blue that provided information on the route of administration involved intravenous administration in the dose range of 1 mg/kg to 8 mg/kg.	0
At least 14 days must elapse between discontinuation of a monoamine oxidase inhibitor (MAOI) antidepressant and initiation of ZOLOFT.	0
"Under these circumstances, diethylpropion hydrochloride should be immediately discontinued, and the patient should be evaluated for the possible presence of pulmonary hypertension."	0
CAPRELSA increased plasma concentrations of digoxin.	1
"In several studies with oral clonidine hydrochloride, a dose-dependent increase in the incidence and severity of spontaneous retinal degeneration was seen in albino rats treated for six months or longer."	0
"Starting with a low dose, administration with food, and gradual up-titration should decrease the likelihood of syncope or excessive hypotension."	0
Mirtazapine has an absolute bioavailability of about 50%.	0
"At approximately 5 or more times the expected maximum daily dose for humans, some toxicity was seen in adult rats and rabbits and a decrease in rat pup growth and survival occurred."	0
"As with other calcium channel blockers, hemodynamic measurements of cardiac function at rest and during exercise (or pacing) in patients with normal ventricular function treated with amlodipine have generally demonstrated a small increase in cardiac index without significant influence on dP/dt or on left ventricular end diastolic pressure or volume."	0
Metoprolol is a beta1-selective (cardioselective) adrenergic receptor blocking agent.	0
"Gastric Malignancy: In adults, symptomatic response does not preclude presence of gastric malignancy."	0
"If NORPRAMIN is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics, careful consideration should be given to the pharmacology of the agents employed since the sedative effects of NORPRAMIN and benzodiazepines (e.g., chlordiazepoxide or diazepam) are additive."	0
"If an oral contraceptive is administered with REYATAZ plus ritonavir, it is recommended that the oral contraceptive contain at least 35 mcg of ethinyl estradiol."	0
Inclusion in the study required a baseline LDL<U+2011>C level between 189 and 500mg/dL and at least one parent with an LDL<U+2011>C level >189mg/dL.	0
Most (approximately 75%) patients in sevelamer hydrochloride clinical trials were receiving vitamin supplements.	0
"After the administration of either preparation, the t1/2 of rifampin averaged 2.9 hours."	0
"If CARDURA administration is discontinued for several days, therapy should be restarted using the initial dosing regimen."	0
"Coadministration of REYATAZ/ritonavir with diltiazem has not been studied. felodipine, nifedipine, nicardipine, and verapamil <U+2191> calcium channel blocker Caution is warranted."	0
"Furthermore, whenever sertraline hydrochloride is withdrawn from co-therapy, an increased dose of the co-administered drug may be required."	0
"Tizanidine Cmax was increased approximately 12-fold (range 5-fold to 32-fold), elimination half-life was increased by almost 3-fold, and AUC increased 33-fold (range 14-fold to 103-fold)."	1
"In addition, N-desmethyl metabolite AUC and Cmax values were significantly increased 200 % and 79 %, respectively, in subjects with severe renal impairment compared to subjects with normal renal function."	0
History of stroke or transient ischemic attack (TIA).	0
Herbal Products St. John's Wort (hypericum perforatum) May lead to loss of virologic response and possible resistance to NORVIR or to the class of protease inhibitors.	0
"Vardenafil: Indinavir (800 mg every 8 hours) coadministered with a single 10-mg dose of vardenafil resulted in a 16-fold increase in vardenafil AUC, a 7-fold increase in vardenafil Cmax, and a 2-fold increase in vardenafil half-life."	1
A 50% to 60% increase in anti-FXa activity was observed when apixaban was coadministered with enoxaparin or naproxen.	0
Hemodynamic studies have been carried out in man following acute single dose administration and during the course of long term maintenance therapy.	0
"A controlled pharmacokinetic study has shown no effect on plasma digoxin concentrations when coadministered with ACEON, but an effect of digoxin on the plasma concentration of perindopril/perindoprilat has not been excluded."	0
A causal relationship has not been established.	0
"Assess the risk of abuse prior to prescribing, and monitor for signs of abuse and dependence while on therapy."	0
Severe Liver Injury <U+2013> Should be discontinued and not restarted in patients with jaundice or laboratory evidence of liver injury.	0
This kinetic profile results in relatively consistent plasma drug levels with about a fourfold interpatient variation.	0
The dose of quetiapine should be reduced to one sixth of the original dose if coadministered with a strong CYP3A4 inhibitor.	1
The information available does not identify any particular opioids as being more likely to be associated with adrenal insufficiency.	0
"Following ingestion of a 30 mg temazepam capsule, measurable plasma concentrations were achieved 10 to 20 minutes after dosing with peak plasma levels ranging from 666 to 982 ng/mL (mean 865 ng/mL) occurring approximately 1.2 to 1.6 hours (mean 1.5 hours) after dosing."	0
Appropriate management of maternal hypertension during pregnancy is important to optimize outcomes for both mother and fetus.	0
"If a patient requires antipsychotic drug treatment after recovery from NMS, the potential reintroduction of drug therapy should be carefully considered."	0
"For unfractionated heparin being administered by continuous infusion , stop the infusion and start XARELTO at the same time ."	0
Its effect on electrolyte excretion reaches a peak between 6 and 10 hours and lasts about 24 hours.	0
"In the absence of an emergency, abrupt discontinuation not recommended (2.7, 5.2)."	0
